0.48231745.15358769.html.plaintext.txt	0	hsp90 chaperones wild type p53 tumor suppressor protein dawid walerych grzegorz kudla malgorzata gutkowska bartosz wawrzynow lin muller frank w king aleksandra helwak joanna boros alicja zylicz maciej zylicz
0.48231745.15358769.html.plaintext.txt	1	hsp90 chaperones wild type p53 tumor suppressor protein dawid walerych grzegorz kudla malgorzata gutkowska bartosz wawrzynow lin muller frank w king aleksandra helwak joanna boros alicja zylicz maciej zylicz
0.48231745.15358769.html.plaintext.txt	2	international institute molecular cell biology warsaw 02 109 warsaw poland nencki institute experimental biology polish academy sciences 02 093 warsaw poland department chemie technische universitat munchen 85 747 garching germany institute biochemistry biophysics 02 106 warsaw poland
0.48231745.15358769.html.plaintext.txt	3	received publication july 7 2004 revised form september 8 2004
0.48231745.15358769.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references immortalized human fibroblasts used investigate putative interactions hsp90 molecular chaperone wild type p53 tumor suppressor protein show geldanamycin radicicol specific inhibitors hsp90 diminish specific wild type p53 binding p21 promoter sequence consequently inhibitors decrease p21 mrna levels lead reduction cellular p21waf1 protein known induce cell cycle arrest control experiments show neither geldanamycin radicicol affect p53 mrna levels minor decrease p53 protein level following treatment human fibroblasts inhibitors suggests potential involvement hsp90 stabilization wild type p53 support vivo findings used reconstituted system highly purified recombinant proteins examine effects hsp90 wild type p53 binding p21 promoter sequence human recombinant hsp90 isoform well bovine brain hsp90 purified homogeneity molecular chaperones displayed atpase activity ability refold heat inactivated luciferase geldanamycin radicicol sensitive manner suggesting post translational modifications involved modulation hsp90 activity show incubation recombinant p53 37 degrees c decreases level wild type conformation strongly inhibits vitro binding p53 p21 promoter sequence interestingly hsp90 atp dependent manner positively modulate p53 dna binding incubation physiological temperature 37 degrees c recombinant human chaperones hsp70 hsp40 families able efficiently substitute hsp90 reaction consistent vivo results geldanamycin suppress hsp90 ability regulate vitro p53 dna binding promoter sequence summary results presented article state chaperone activity hsp90 important transcriptional activity genotypically wild type p53
0.48231745.15358769.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references immortalized human fibroblasts used investigate putative interactions hsp90 molecular chaperone wild type p53 tumor suppressor protein show geldanamycin radicicol specific inhibitors hsp90 diminish specific wild type p53 binding p21 promoter sequence consequently inhibitors decrease p21 mrna levels lead reduction cellular p21waf1 protein known induce cell cycle arrest control experiments show neither geldanamycin radicicol affect p53 mrna levels minor decrease p53 protein level following treatment human fibroblasts inhibitors suggests potential involvement hsp90 stabilization wild type p53 support vivo findings used reconstituted system highly purified recombinant proteins examine effects hsp90 wild type p53 binding p21 promoter sequence human recombinant hsp90 isoform well bovine brain hsp90 purified homogeneity molecular chaperones displayed atpase activity ability refold heat inactivated luciferase geldanamycin radicicol sensitive manner suggesting post translational modifications involved modulation hsp90 activity show incubation recombinant p53 37 degrees c decreases level wild type conformation strongly inhibits vitro binding p53 p21 promoter sequence interestingly hsp90 atp dependent manner positively modulate p53 dna binding incubation physiological temperature 37 degrees c recombinant human chaperones hsp70 hsp40 families able efficiently substitute hsp90 reaction consistent vivo results geldanamycin suppress hsp90 ability regulate vitro p53 dna binding promoter sequence summary results presented article state chaperone activity hsp90 important transcriptional activity genotypically wild type p53
0.48231745.15358769.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references p53 tumor suppressor protein transcription factor regulates cellular response stress abnormal cell proliferation dna damage 1 2 50 human cancers possess mutated p53 gene 3 inactivation p53 function leads cell transformation 4 5 oncogenic p53 mutations located dna binding domain inhibiting ability protein initiate transcription 3 however p53 may also rendered inactive cellular events sequestration wt p531 cytoplasm increased nuclear export 6 association p53 cytoplasmic proteins 7 8 recently shown p53 transported hek cells nucleus along microtubular tracks cytoplasmic dynein hsp90 molecular chaperone 9 similar mechanism described rapid ligand induced movement glucocorticoid receptor nucleus 10 11 processes inhibit p53 nuclear transport proteolysis also lead inactivation p53 protein 12 13
0.48231745.15358769.html.plaintext.txt	7	introduction top abstract introduction materials methods results discussion references p53 tumor suppressor protein transcription factor regulates cellular response stress abnormal cell proliferation dna damage 1 2 50 human cancers possess mutated p53 gene 3 inactivation p53 function leads cell transformation 4 5 oncogenic p53 mutations located dna binding domain inhibiting ability protein initiate transcription 3 however p53 may also rendered inactive cellular events sequestration wt p531 cytoplasm increased nuclear export 6 association p53 cytoplasmic proteins 7 8 recently shown p53 transported hek cells nucleus along microtubular tracks cytoplasmic dynein hsp90 molecular chaperone 9 similar mechanism described rapid ligand induced movement glucocorticoid receptor nucleus 10 11 processes inhibit p53 nuclear transport proteolysis also lead inactivation p53 protein 12 13
0.48231745.15358769.html.plaintext.txt	8	response various stresses ionizing radiation uv hypoxia p53 activated stabilized imported nucleus promotes transcription several genes whose products induce cell cycle arrest dna repair apoptosis 14 non stress situation level p53 cells mainly regulated post translational level mdm2 12 15 17
0.48231745.15358769.html.plaintext.txt	9	response various stresses ionizing radiation uv hypoxia p53 activated stabilized imported nucleus promotes transcription several genes whose products induce cell cycle arrest dna repair apoptosis 14 non stress situation level p53 cells mainly regulated post translational level mdm2 12 15 17
0.48231745.15358769.html.plaintext.txt	10	hsp90 abundant molecular chaperone important protecting cells stress high temperature additionally hsp90 regulates many signaling pathways hsp90 found complex several oncoproteins including v src c erb2 raf 1 akt bcr abl tumor suppressor p53 18 22 hsp90 inhibitor 17 allylaminogeldanamycin 17 aag currently phase ii clinical trials potential anti tumor drug hsp90 inhibitors usually induce ubiquitination degradation hsp90 client proteins 23 tumor cells hsp90 exists functionally distinct conformational form much efficiently recognized 17 aag form hsp90 possesses elevated atpase activity found multichaperone complex cochaperones p23 hop probably others 24
0.48231745.15358769.html.plaintext.txt	11	hsp90 abundant molecular chaperone important protecting cells stress high temperature additionally hsp90 regulates many signaling pathways hsp90 found complex several oncoproteins including v src c erb2 raf 1 akt bcr abl tumor suppressor p53 18 22 hsp90 inhibitor 17 allylaminogeldanamycin 17 aag currently phase ii clinical trials potential anti tumor drug hsp90 inhibitors usually induce ubiquitination degradation hsp90 client proteins 23 tumor cells hsp90 exists functionally distinct conformational form much efficiently recognized 17 aag form hsp90 possesses elevated atpase activity found multichaperone complex cochaperones p23 hop probably others 24
0.48231745.15358769.html.plaintext.txt	12	known years genotypically mutant p53 co immunoprecipitates members hsp70 hsp90 families 19 interactions lead formation p53 multichaperone complex responsible stabilization sequestration p53 cytoplasm 25 27 binding molecular chaperones mutant p53 inhibits ability mdm2 promote p53 ubiquitination degradation resulting stabilization p53 mdm2 28 29 also shown hsp90 directly associates mdm2 protein 30 hsp90 inhibitors partially disrupt interactions results degradation mutant p53 31 32 use highly purified proteins identified intermediate reactions lead assembly molecular chaperone complex p53 protein possessing wild type mutant sequence presence hsp90 complex wt p53 inhibits binding hsp40 hsc70 p53 however conformational mutant p53 possesses low affinity toward hsp90 form stable multichaperone complex hsp90 bound mutant p53 indirectly mut p53 hsp40 hsc70 hop hsp90 several independent methods surface plasmon resonance immunoprecipitation elisa cross linking used demonstrate hsp90 directly absence co chaperones associate genotypically wt p53 mutant p53 protein 33 accompanying article muller et al 34 supports findings moreover shown nmr hsp90 associates truncated version wt p53 suggested p53 core domain bound hsp90 predominantly unfolded lacking helical sheet secondary structure 35
0.48231745.15358769.html.plaintext.txt	13	known years genotypically mutant p53 co immunoprecipitates members hsp70 hsp90 families 19 interactions lead formation p53 multichaperone complex responsible stabilization sequestration p53 cytoplasm 25 27 binding molecular chaperones mutant p53 inhibits ability mdm2 promote p53 ubiquitination degradation resulting stabilization p53 mdm2 28 29 also shown hsp90 directly associates mdm2 protein 30 hsp90 inhibitors partially disrupt interactions results degradation mutant p53 31 32 use highly purified proteins identified intermediate reactions lead assembly molecular chaperone complex p53 protein possessing wild type mutant sequence presence hsp90 complex wt p53 inhibits binding hsp40 hsc70 p53 however conformational mutant p53 possesses low affinity toward hsp90 form stable multichaperone complex hsp90 bound mutant p53 indirectly mut p53 hsp40 hsc70 hop hsp90 several independent methods surface plasmon resonance immunoprecipitation elisa cross linking used demonstrate hsp90 directly absence co chaperones associate genotypically wt p53 mutant p53 protein 33 accompanying article muller et al 34 supports findings moreover shown nmr hsp90 associates truncated version wt p53 suggested p53 core domain bound hsp90 predominantly unfolded lacking helical sheet secondary structure 35
0.48231745.15358769.html.plaintext.txt	14	wild type p53 structurally unstable protein undergoes conformational changes elevated temperatures 36 37 proposed heat shock cytoplasmic p53 possessing wild type sequence could temporarily adopt mutant conformation subsequently initiating formation multichaperone complex could partially stabilize wt p53 19 results recently published article wang chen 38 support hypothesis found heat shock inhibited p53 ubiquitination initiated accumulation p53 post translational level two factors influence events heat stress 1 atm dependent phosphorylation p53 2 formation chaperone complex genotypically wt p53 adopts conformation characteristic mutant protein 38 evidence hsp90 binding mutant p53 conclusive whereas exact nature cellular interactions hsp90 genotypically wt p53 possessing either wild type mutant conformation still remains elucidated
0.48231745.15358769.html.plaintext.txt	15	wild type p53 structurally unstable protein undergoes conformational changes elevated temperatures 36 37 proposed heat shock cytoplasmic p53 possessing wild type sequence could temporarily adopt mutant conformation subsequently initiating formation multichaperone complex could partially stabilize wt p53 19 results recently published article wang chen 38 support hypothesis found heat shock inhibited p53 ubiquitination initiated accumulation p53 post translational level two factors influence events heat stress 1 atm dependent phosphorylation p53 2 formation chaperone complex genotypically wt p53 adopts conformation characteristic mutant protein 38 evidence hsp90 binding mutant p53 conclusive whereas exact nature cellular interactions hsp90 genotypically wt p53 possessing either wild type mutant conformation still remains elucidated
0.48231745.15358769.html.plaintext.txt	16	study demonstrate chaperone activity hsp90 required wt p53 dependent transcriptional activity specific hsp90 inhibitors geldanamycin radicicol inhibit p53 activity transcription factor dissociation p53 target dna promoter sequence sites results reconstituted vitro system clearly show hsp90 positively regulates p53 dna binding specific promoter sequence incubation physiological temperature 37 degrees c moreover hsp90 activity atp dependent inhibited geldanamycin
0.48231745.15358769.html.plaintext.txt	17	study demonstrate chaperone activity hsp90 required wt p53 dependent transcriptional activity specific hsp90 inhibitors geldanamycin radicicol inhibit p53 activity transcription factor dissociation p53 target dna promoter sequence sites results reconstituted vitro system clearly show hsp90 positively regulates p53 dna binding specific promoter sequence incubation physiological temperature 37 degrees c moreover hsp90 activity atp dependent inhibited geldanamycin
0.48231745.15358769.html.plaintext.txt	18	materials methods top abstract introduction materials methods results discussion references cell culture experiments k15 line human fibroblasts immortalized stable expression htert kind gift prof h kampinga cells cultured 37 degrees c humidified atmosphere containing 5 co2 hams f10 medium 15 fetal bovine serum inhibition topoisomerase activation p53 2 microm camptothecin sigma used inhibition hsp90 3 microm geldanamycin sigma 3 microm radicicol sigma used
0.48231745.15358769.html.plaintext.txt	19	western blot cells seeded 50 confluence costar 6 well plates indicated times cells lysed directly plate laemmli sample buffer proteins resolved sds page immunoblotting performed using following antibodies p53 1 santa cruz biotechnology 16000 phospho p53 ser 15 9284 cell signaling technology 11000 p21 sc 397 santa cruz biotechnology 1100 tubulin tub 21 sigma 12000 densitometry performed using quantity one software bio rad
0.48231745.15358769.html.plaintext.txt	20	western blot cells seeded 50 confluence costar 6 well plates indicated times cells lysed directly plate laemmli sample buffer proteins resolved sds page immunoblotting performed using following antibodies p53 1 santa cruz biotechnology 16000 phospho p53 ser 15 9284 cell signaling technology 11000 p21 sc 397 santa cruz biotechnology 1100 tubulin tub 21 sigma 12000 densitometry performed using quantity one software bio rad
0.48231745.15358769.html.plaintext.txt	21	real time rt pcr k15 cells seeded 60 mm plates total rna isolated using macherey nagel nucleospin kit rna examined agarose gel electrophoresis confirm equal amounts samples lack degradation first strand cdna synthesis done using fermentas revertaid kit oligodt primers real time pcr performed using lightcycler roche applied science follows p53 rt p53 u acctaccagggcagctacgg rt p53 l gctgcacagggcaggtcttg annealing temperature 55 degrees c 1 mm mgcl2 p21 rt p21 u ggacctgtcactgtcttgta rt p21 l ggcttcctcttggagaagat 53 degrees c 1 mm mgcl2 gapdh rt gapdh u gaaggtgaaggtcggagtca rt gapdh l gaagatggtgatgggatttc 51 degrees c 2 mm mgcl2 detection performed using sybr green
0.48231745.15358769.html.plaintext.txt	22	real time rt pcr k15 cells seeded 60 mm plates total rna isolated using macherey nagel nucleospin kit rna examined agarose gel electrophoresis confirm equal amounts samples lack degradation first strand cdna synthesis done using fermentas revertaid kit oligodt primers real time pcr performed using lightcycler roche applied science follows p53 rt p53 u acctaccagggcagctacgg rt p53 l gctgcacagggcaggtcttg annealing temperature 55 degrees c 1 mm mgcl2 p21 rt p21 u ggacctgtcactgtcttgta rt p21 l ggcttcctcttggagaagat 53 degrees c 1 mm mgcl2 gapdh rt gapdh u gaaggtgaaggtcggagtca rt gapdh l gaagatggtgatgggatttc 51 degrees c 2 mm mgcl2 detection performed using sybr green
0.48231745.15358769.html.plaintext.txt	23	chromatin immunoprecipitation chip chip assay done described ref 39 minor modifications briefly k15 cells cultured 100 mm plates experimental treatment cells cross linked 1 formaldehyde cross linking stopped addition glycine cells lysed radioimmune precipitation assay buffer dna disrupted pieces 500 600 bp sonication lysate cleared centrifugation protein sepharose beads added lysate together 1 microl anti p53 antibody 1 santa cruz biotechnology overnight incubation 4 degrees c beads washed cross linking reversed dna purified silica gel columns biotechnology real time pcr performed detect p21 promoter fragment using following primers p21 chip u gtggctctgattggctttctg p21 chip l ctgaaaacaggcagcccaag annealed 55 degrees c 1 mm mgcl2
0.48231745.15358769.html.plaintext.txt	24	protein purification human hsp90 fused mbp plasmid pmalc2x ahsp90 kind gift p csermely overexpressed escherichia coli bl 21 ril de3 strain 37 degrees c 3 h induction 01 mm isopropyl 1 thio d galactopyranoside cells harvested centrifugation 10000 x g 10 min frozen liquid nitrogen bacteria pellet lysed buffer 40 mm tris ph 75 01 mercaptoethanol 5 glycerol 05 mm phenylmethylsulfonyl fluoride containing 1 mgml lysozyme 1 h 4 degrees c constant stirring centrifugation proceeded 1 h 100000 x g
0.48231745.15358769.html.plaintext.txt	25	protein purification human hsp90 fused mbp plasmid pmalc2x ahsp90 kind gift p csermely overexpressed escherichia coli bl 21 ril de3 strain 37 degrees c 3 h induction 01 mm isopropyl 1 thio d galactopyranoside cells harvested centrifugation 10000 x g 10 min frozen liquid nitrogen bacteria pellet lysed buffer 40 mm tris ph 75 01 mercaptoethanol 5 glycerol 05 mm phenylmethylsulfonyl fluoride containing 1 mgml lysozyme 1 h 4 degrees c constant stirring centrifugation proceeded 1 h 100000 x g
0.48231745.15358769.html.plaintext.txt	26	supernatant loaded onto q sepharose column equilibrated buffer bound proteins eluted linear gradient 0 05 m kcl buffer fractions containing hsp90 salted 30 nh42so4 following centrifugation 70000 x g 20 min supernatant loaded onto butyl sepharose column equilibrated buffer containing 30 nh42so4 bound proteins eluted linear gradient 30 0 nh42so4 hsp90 mbp applied onto amylose resin neb eluted 10 mm maltose mbp tag cleaved factor xa protease neb according manufacturers suggestions hsp90 protein 95 purity concentrated resource q fplc column dialyzed buffer b 25 mm hepes ph 75 10 glycerol 150 mm kcl 1 mm dtt
0.48231745.15358769.html.plaintext.txt	27	bovine brain hsp90 purified described 40 human recombinant hsc70 hspa8 hdj1 overexpressed purified described 33 human recombinant hsp70 hspa1a purified exactly hsc70 overexpression bl21 ril e coli strain pet11b hsp70 construct kind gift prof r morimoto pmalc2x hdj2 pet30a hdj3 constructs encoding human hdj2 hdj3 kind gift prof k terada proteins purified e coli previously described 41 42 chaperones tested positive activity luciferase refolding assay see p53 human recombinant protein purified essentially described 43
0.48231745.15358769.html.plaintext.txt	28	bovine brain hsp90 purified described 40 human recombinant hsc70 hspa8 hdj1 overexpressed purified described 33 human recombinant hsp70 hspa1a purified exactly hsc70 overexpression bl21 ril e coli strain pet11b hsp70 construct kind gift prof r morimoto pmalc2x hdj2 pet30a hdj3 constructs encoding human hdj2 hdj3 kind gift prof k terada proteins purified e coli previously described 41 42 chaperones tested positive activity luciferase refolding assay see p53 human recombinant protein purified essentially described 43
0.48231745.15358769.html.plaintext.txt	29	atpase assay atpase activity measured previously described 44 10 microm hsp90 incubated 20 microl buffer 40 mm hepes ph 75 150 mm kcl 5 mm mgcl2 10 mm atp 05 microci 32patp100 microl reaction buffer geldanamycin concentration 500 microm added indicated reaction carried 37 degrees c time points 0 120 min 1 microl samples spotted pei cellulose plates plates resolved 1 m licl 1 m hcooh 11 dried spots corresponding non hydrolyzed atp free phosphate cut radioactivity measured liquid scintillation counter packard bioscience results corrected spontaneous atp hydrolysis
0.48231745.15358769.html.plaintext.txt	30	atpase assay atpase activity measured previously described 44 10 microm hsp90 incubated 20 microl buffer 40 mm hepes ph 75 150 mm kcl 5 mm mgcl2 10 mm atp 05 microci 32patp100 microl reaction buffer geldanamycin concentration 500 microm added indicated reaction carried 37 degrees c time points 0 120 min 1 microl samples spotted pei cellulose plates plates resolved 1 m licl 1 m hcooh 11 dried spots corresponding non hydrolyzed atp free phosphate cut radioactivity measured liquid scintillation counter packard bioscience results corrected spontaneous atp hydrolysis
0.48231745.15358769.html.plaintext.txt	31	luciferase refolding assay luciferase refolding assay modified version one described 45 10 microm hsp90 incubated 30 min room temperature buffer 25 mm tris ph 78 8 mm mgso4 1 bsa 10 glycerol 025 triton x 100 containing 2 mm atp geldanamycin concentration ranging 00 100 microm luciferase promega 1266 mgml diluted 400 times mixture incubated 5 min 50 degrees c cooling denatured luciferase mix diluted 6 fold renaturation buffer 10 mm tris ph 75 3 mm mgcl2 50 mm kcl 2 mm dtt 8 mm cp 002 u microl ck 2 mm atp 4 microm hsc 70 20 microm hdj 1 renaturation carried room temperature time points 0 120 min 5 microl aliquots taken activity renatured luciferase measured luminometer bmg labtechnologies addition bright glo substrate promega
0.48231745.15358769.html.plaintext.txt	32	luciferase refolding assay luciferase refolding assay modified version one described 45 10 microm hsp90 incubated 30 min room temperature buffer 25 mm tris ph 78 8 mm mgso4 1 bsa 10 glycerol 025 triton x 100 containing 2 mm atp geldanamycin concentration ranging 00 100 microm luciferase promega 1266 mgml diluted 400 times mixture incubated 5 min 50 degrees c cooling denatured luciferase mix diluted 6 fold renaturation buffer 10 mm tris ph 75 3 mm mgcl2 50 mm kcl 2 mm dtt 8 mm cp 002 u microl ck 2 mm atp 4 microm hsc 70 20 microm hdj 1 renaturation carried room temperature time points 0 120 min 5 microl aliquots taken activity renatured luciferase measured luminometer bmg labtechnologies addition bright glo substrate promega
0.48231745.15358769.html.plaintext.txt	33	p53 dna binding assay dna binding activity p53 quantified emsa gel shift assay 50 ng human recombinant p53 diluted final volume 5 microl emsa buffer 50 mm tris ph 75 5 glycerol 50 mm kcl 5 mm mgcl2 2 mm dtt samples supplemented optionally 5 microg hsp90 human recombinant bovine brain chaperones see fig 5c bsa 0 20 mm atp 5 microl samples incubated 4 37 degrees c 1 h thermocycler activation step followed included addition 15 microl mixture containing 1x emsa buffer 02 mdpm 32p labeled p21 sequence 1 microg nonspecific 44 bp dsdna sequence usage based ref 46 100 ng antibody pab421 ab 1 oncogene 20 microl samples specific p21 dna afterward incubated 5 10 min room temperature loaded onto 4 native polyacrylamide tris borate gel electrophoresed 15 ma 2 h 4 degrees c gels dried exposed overnight biomax ms 1 kodak film sigma
0.48231745.15358769.html.plaintext.txt	34	p53 dna binding assay dna binding activity p53 quantified emsa gel shift assay 50 ng human recombinant p53 diluted final volume 5 microl emsa buffer 50 mm tris ph 75 5 glycerol 50 mm kcl 5 mm mgcl2 2 mm dtt samples supplemented optionally 5 microg hsp90 human recombinant bovine brain chaperones see fig 5c bsa 0 20 mm atp 5 microl samples incubated 4 37 degrees c 1 h thermocycler activation step followed included addition 15 microl mixture containing 1x emsa buffer 02 mdpm 32p labeled p21 sequence 1 microg nonspecific 44 bp dsdna sequence usage based ref 46 100 ng antibody pab421 ab 1 oncogene 20 microl samples specific p21 dna afterward incubated 5 10 min room temperature loaded onto 4 native polyacrylamide tris borate gel electrophoresed 15 ma 2 h 4 degrees c gels dried exposed overnight biomax ms 1 kodak film sigma
0.48231745.15358769.html.plaintext.txt	35	view larger version 54k fig 5 bovine brain hsp90 effect vitro p53 hsp90 gtp replace atp reaction human chaperones substitute hsp90 lanes 5 6 bovine brain purified hsp90 used instead hsp90 25 microg hsp90s 0 5 mm atp used remaining reaction conditions similar fig 4 b lanes 1 3 contained 5 mm gtp substitute 5 mm atp lane 4 hsp90 dependent recovery p53 nevertheless apparent gtp protective activity p53 inactivated much presence atp nucleotide see c reactions carried 1 h indicated temperature 5 mm atp lanes bovine brain hsp90 lane 3 used 25 microg 56 microm human recombinant hsp70 hspa1a hsc70 hspa8 used 6 microm lanes 4 5 substitutes hsp90 combinations chaperones hsp70 hsp40 family hdj1 2 3 known efficiently refold denatured luciferase used lanes 6 11 molar ratio hspc70hsp40 21 63 microm lane 12 represents unspecific hdj1 binding p21 promoter dna absence p53
0.48231745.15358769.html.plaintext.txt	36	p53 activated ckii activation mix made containing per every 4 microl volume 50 ng p53 7 units ckii calbiochem 03 units creatine kinase 150 mm phosphocreatine atp regeneration system roche applied science 1 5 mm atp 1x emsa buffer ckii activation done 30 min 25 degrees c 4 microl ckii activation reaction supplemented separately hsp90bsa 1x emsa buffer 5 microl afterward 1 h incubation step either 4 37 degrees c performed followed addition 15 microl dna mixture without antibody electrophoresis performed described
0.48231745.15358769.html.plaintext.txt	37	p53 activated ckii activation mix made containing per every 4 microl volume 50 ng p53 7 units ckii calbiochem 03 units creatine kinase 150 mm phosphocreatine atp regeneration system roche applied science 1 5 mm atp 1x emsa buffer ckii activation done 30 min 25 degrees c 4 microl ckii activation reaction supplemented separately hsp90bsa 1x emsa buffer 5 microl afterward 1 h incubation step either 4 37 degrees c performed followed addition 15 microl dna mixture without antibody electrophoresis performed described
0.48231745.15358769.html.plaintext.txt	38	testing nonspecific p53 dna binding activity 02 mdpm nonspecific radiolabeled 44 bp dsdna used per sample instead labeled p21 sequence activation step remaining part experiment performed described specific dna additional unlabeled dna antibody ckii used case
0.48231745.15358769.html.plaintext.txt	39	testing nonspecific p53 dna binding activity 02 mdpm nonspecific radiolabeled 44 bp dsdna used per sample instead labeled p21 sequence activation step remaining part experiment performed described specific dna additional unlabeled dna antibody ckii used case
0.48231745.15358769.html.plaintext.txt	40	best results geldanamycin emsa assay obtained prior addition p53 hsp90 preincubated 83 500 microm ga presence 1x emsa buffer 30 min room temperature addition p53 atp 1x emsa buffer final ga concentrations 25 150 microm since stock solution ga contained 100 me2so ga titration experiments samples supplemented amount me2so added ga
0.48231745.15358769.html.plaintext.txt	41	best results geldanamycin emsa assay obtained prior addition p53 hsp90 preincubated 83 500 microm ga presence 1x emsa buffer 30 min room temperature addition p53 atp 1x emsa buffer final ga concentrations 25 150 microm since stock solution ga contained 100 me2so ga titration experiments samples supplemented amount me2so added ga
0.48231745.15358769.html.plaintext.txt	42	sequences used emsa p21 promoter derived sequences 5 tggccatcaggaacatgtcccaacatgttgagctctggca 3 5 tgccagagctcaacatgttgggacatgttcctgatggcca 3 nonspecific 44 bp dna 5 gcttcgagatgttccgagaggcgaatgaggccttggaactcaag 3 5 cttgagttccaaggcctcattcgcctctcggaacatctcgaagc 3
0.48231745.15358769.html.plaintext.txt	43	sequences annealed form double stranded dna thermocycler using following program 5 min 94 degrees c 5 min 50 degrees c 4 degrees c presence dsdna tested 16 polyacrylamide tris borate gel electrophoresis sequences used emsa assay labeled t4 polynucleotide kinase pnk fermentas described producers manual
0.48231745.15358769.html.plaintext.txt	44	elisa investigation p53 conformation carried using two site elisa first wells coated wt p53 conformation specific pab1620 monoclonal antibody 1 mouse origin oncogene science 50 ng per well carbonate buffer ph 92 4 degrees c 16 h wells blocked 1 h room temperature 100 microl blocking wash buffer 25 mm hepes koh ph 76 5 mm dtt 150 mm kcl 2 mgml bsa followed titration increasing amounts human recombinant p53 either kept 4 degrees c incubated 37 degrees c 1 h p53 dilutions done elisa reaction buffer 25 mm hepes koh ph 76 5 mm mgcl2 005 triton x 100 5 mm dtt 150 mm kcl 2 mgml bsa detection p53 protein carried using fl 393 antibody rabbit origin santa cruz biotechnology 1 h diluted blocking wash buffer room temperature followed addition anti rabbit igg horseradish peroxidase secondary antibodies santa cruz biotechnology analysis bound antibodies performed colorimetric detection tmb peroxidase eia substrate kit bio rad followed absorbance measurements microplate reader bio rad 450 nm
0.48231745.15358769.html.plaintext.txt	45	elisa investigation p53 conformation carried using two site elisa first wells coated wt p53 conformation specific pab1620 monoclonal antibody 1 mouse origin oncogene science 50 ng per well carbonate buffer ph 92 4 degrees c 16 h wells blocked 1 h room temperature 100 microl blocking wash buffer 25 mm hepes koh ph 76 5 mm dtt 150 mm kcl 2 mgml bsa followed titration increasing amounts human recombinant p53 either kept 4 degrees c incubated 37 degrees c 1 h p53 dilutions done elisa reaction buffer 25 mm hepes koh ph 76 5 mm mgcl2 005 triton x 100 5 mm dtt 150 mm kcl 2 mgml bsa detection p53 protein carried using fl 393 antibody rabbit origin santa cruz biotechnology 1 h diluted blocking wash buffer room temperature followed addition anti rabbit igg horseradish peroxidase secondary antibodies santa cruz biotechnology analysis bound antibodies performed colorimetric detection tmb peroxidase eia substrate kit bio rad followed absorbance measurements microplate reader bio rad 450 nm
0.48231745.15358769.html.plaintext.txt	46	results top abstract introduction materials methods results discussion references inhibition hsp90 human fibroblasts decreases wild type p53 transcriptional activity investigate possible interaction hsp90 molecular chaperone wt p53 vivo used k15 human fibroblasts k15 cells express genotypically wt p53 immunoprecipitated wt p53 specific pab1620 antibody mutant p53 specific pab240 antibody data shown suggests k15 cells p53 exists functional wild type conformation functionality p53 k15 cells demonstrated ability induce p21waf1 expression cell cycle arrest upon camptothecin treatment irradiation fig 1 data shown
0.48231745.15358769.html.plaintext.txt	47	results top abstract introduction materials methods results discussion references inhibition hsp90 human fibroblasts decreases wild type p53 transcriptional activity investigate possible interaction hsp90 molecular chaperone wt p53 vivo used k15 human fibroblasts k15 cells express genotypically wt p53 immunoprecipitated wt p53 specific pab1620 antibody mutant p53 specific pab240 antibody data shown suggests k15 cells p53 exists functional wild type conformation functionality p53 k15 cells demonstrated ability induce p21waf1 expression cell cycle arrest upon camptothecin treatment irradiation fig 1 data shown
0.48231745.15358769.html.plaintext.txt	48	view larger version 36k fig 1 hsp90 inhibitors decrease p53 activity transcription factor k15 cells cultured presence absence 2 microm camptothecin cpt 3 microm geldanamycin ga 3 microm radicicol r indicated time periods time course total p53 p53 p53 phosphorylated ser 15 ser15 p p53 p21waf1 protein p21 induction analyzed western blotting tubulin detected control total protein level b cellular p53 mrna levels 35 h addition camptothecin quantified real time rt pcr results normalized glyceraldehyde 3 phosphate dehydrogenase mrna c p53 binding p21 promoter sequence 4 h camptothecin treatment detected chip real time pcr d cellular p21waf1 mrna levels 35 h addition camptothecin quantified real time rt pcr results representative least three independent experiments
0.48231745.15358769.html.plaintext.txt	49	treatment k15 cells 2 microm camptothecin cpt drug induces dna damage inhibition topoisomerase results p53 regulation shown western blot analysis fig 1a camptothecin treatment performed presence specific hsp90 inhibitors geldanamycin radicicol 3 microm p53 induced somewhat lower levels time course induction slower fig 1a results shown importantly relative amount p53 phosphorylated serine 15 affected hsp90 inhibitors fig 1a suggests hsp90 might act p53 directly rather atr dna pk atm kinases known phosphorylate p53 position 47 48 exclude possibility lower p53 levels caused decrease transcription quantified p53 mrna real time rt pcr shown fig 1b treatment cells geldanamycin radicicol significantly change level p53 transcripts suggesting drugs regulate p53 protein level fluorescence microscopy cellular fractionation showed geldanamycin radicicol affect nuclear localization p53 results shown results indicate hsp90 might play role stabilization wt p53 protein
0.48231745.15358769.html.plaintext.txt	50	test whether hsp90 indeed influence transcriptional activity p53 analyzed binding p53 p21 promoter chip shown fig 1c camptothecin induced binding p53 p21 promoter almost completely disrupted geldanamycin chip experiment p21 promoter also successfully performed using anti hsp90 antibodies suggesting functional interaction wt p53 hsp902 shown real time rt pcr geldanamycin radicicol strongly inhibit expression p21 mrna following camptothecin treatment fig 1d decrease p21 level could also observed western blot fig 1a taken together described results suggest extent hsp90 stabilizes genotypically wt p53 protein level stronger effect visible transcriptional activity wt p53 phenomena evidently depend atp since drugs effectively compete atp binding hsp90
0.48231745.15358769.html.plaintext.txt	51	atpase chaperone activities hsp90 inhibited vitro answer question hsp90 affect transcriptional activity p53 used reconstituted vitro system highly purified recombinant proteins monitor p53 dna binding p21 promoter sequence tests used human recombinant hsp90 isoform control experiments also purified hsp90 bovine brain purified recombinant hsp90 well bovine hsp90 possess atpase activity inhibited geldanamycin fig 2a radicicol results shown test molecular chaperone activity purified hsp90 proteins used modified version previously described luciferase refolding assay 45 hsp90 bovine hsp90 present heat denaturation luciferase 5 min 50 degrees c efficient refolding luciferase observed reduced temperatures presence hsc70 hsp40 fig 2b refolding reaction dependent presence hsp90 denaturation process severely inhibited geldanamycin preincubated hsp90 bovine prior heat denaturation luciferase fig 2b
0.48231745.15358769.html.plaintext.txt	52	atpase chaperone activities hsp90 inhibited vitro answer question hsp90 affect transcriptional activity p53 used reconstituted vitro system highly purified recombinant proteins monitor p53 dna binding p21 promoter sequence tests used human recombinant hsp90 isoform control experiments also purified hsp90 bovine brain purified recombinant hsp90 well bovine hsp90 possess atpase activity inhibited geldanamycin fig 2a radicicol results shown test molecular chaperone activity purified hsp90 proteins used modified version previously described luciferase refolding assay 45 hsp90 bovine hsp90 present heat denaturation luciferase 5 min 50 degrees c efficient refolding luciferase observed reduced temperatures presence hsc70 hsp40 fig 2b refolding reaction dependent presence hsp90 denaturation process severely inhibited geldanamycin preincubated hsp90 bovine prior heat denaturation luciferase fig 2b
0.48231745.15358769.html.plaintext.txt	53	view larger version 16k fig 2 atpase luciferase refolding activities hsp90 hsp90 purified bovine brain bov inhibited geldanamycin hsp90 proteins concentration 10 microm incubated reaction buffer 10 mm atp 01 microci 32patp 37 degrees c 05 mm geldanamycin added indicated indicated time points 120 reaction mixture spotted pei cellulose plates resolving drying plates cut spots corresponding free phosphate non hydrolyzed atp counted radioactivity b hsp90 preparations incubated 2 mm atp 100 microm geldanamycin luciferase 1266 mgml 400 times diluted mixture incubated 5 min 50 degrees c cooling denatured luciferase 6 times diluted renaturation buffer containing hsc70 hdj 1 atp atp regeneration system using concentrations described materials methods refolding reaction carried 25 degrees c indicated time points 16 reaction tested luciferase activity using luciferase substrate controls shown contained hsp90s alone chaperones refolding activity similar hsp90 reactions
0.48231745.15358769.html.plaintext.txt	54	hsp90 proteins promote specific dna binding activity wild type p53 37 degrees c binding genotypically wild type recombinant p53 protein p21 promoter sequence monitored using emsa assay described 49 used antibody ab421 ckii activate wt p53 binding promoter dna 1 antibody perform p53 supershifts specificity controls shown p53 possesses two dna binding sites one sequence specific located central core domain p53 another non sequence specific located c terminal domain p53 protein eliminate effect second nonspecific p53 binding site p53 dna binding assays performed presence short dna competitor many previous vitro p53 dna binding studies long 100 bp dna competitors used polydi dc 50 pbluescript vector 49 salmon sperm dna 51 also initially performed dna binding experiments polydi dc pbluescript however shown anderson et al 46 long competitor dna molecules inhibited entry p53 dna complexes emsa gel caused decreased quality reproducibility results problem solved introduction short 44 bp competitor dna fragments dna binding reaction
0.48231745.15358769.html.plaintext.txt	55	hsp90 proteins promote specific dna binding activity wild type p53 37 degrees c binding genotypically wild type recombinant p53 protein p21 promoter sequence monitored using emsa assay described 49 used antibody ab421 ckii activate wt p53 binding promoter dna 1 antibody perform p53 supershifts specificity controls shown p53 possesses two dna binding sites one sequence specific located central core domain p53 another non sequence specific located c terminal domain p53 protein eliminate effect second nonspecific p53 binding site p53 dna binding assays performed presence short dna competitor many previous vitro p53 dna binding studies long 100 bp dna competitors used polydi dc 50 pbluescript vector 49 salmon sperm dna 51 also initially performed dna binding experiments polydi dc pbluescript however shown anderson et al 46 long competitor dna molecules inhibited entry p53 dna complexes emsa gel caused decreased quality reproducibility results problem solved introduction short 44 bp competitor dna fragments dna binding reaction
0.48231745.15358769.html.plaintext.txt	56	previously shown p53 protein exist constant state equilibrium wild type mutant conformation 52 53 possible elevated temperatures could shift equilibrium toward mutant conformation hence amount p53 possessing wild type conformation decreased indeed purified human recombinant wt p53 protein loses wild type conformation upon incubation 37 degrees c higher temperatures fig 3 results shown immunoprecipitation wt p53 pab 1620 specifically recognizing wt p53 conformation significantly reduced following incubation wt p53 37 degrees c fig 3a effect also observed using modified elisa test case less p53 detected conformation specific pab 1620 whereas comparable amount protein detected 1 temperatures fig 3b consistent experiments 1 h incubation 37 degrees c completely abolished dna binding activity genotypically wt p53 tested gel shift assay fig 4a lane 2 presence increasing amounts hsp90 incubation step 37 degrees c significantly enhances binding p53 p21 promoter sequence fig 4a regulation p53 dna binding hsp90 found atp dependent least 3 mm atp required distinct effect fig 4b used polydi dc nonspecific competitor atp dependence reaction less pronounced results shown
0.48231745.15358769.html.plaintext.txt	57	previously shown p53 protein exist constant state equilibrium wild type mutant conformation 52 53 possible elevated temperatures could shift equilibrium toward mutant conformation hence amount p53 possessing wild type conformation decreased indeed purified human recombinant wt p53 protein loses wild type conformation upon incubation 37 degrees c higher temperatures fig 3 results shown immunoprecipitation wt p53 pab 1620 specifically recognizing wt p53 conformation significantly reduced following incubation wt p53 37 degrees c fig 3a effect also observed using modified elisa test case less p53 detected conformation specific pab 1620 whereas comparable amount protein detected 1 temperatures fig 3b consistent experiments 1 h incubation 37 degrees c completely abolished dna binding activity genotypically wt p53 tested gel shift assay fig 4a lane 2 presence increasing amounts hsp90 incubation step 37 degrees c significantly enhances binding p53 p21 promoter sequence fig 4a regulation p53 dna binding hsp90 found atp dependent least 3 mm atp required distinct effect fig 4b used polydi dc nonspecific competitor atp dependence reaction less pronounced results shown
0.48231745.15358769.html.plaintext.txt	58	view larger version 19k fig 3 wild type human recombinant p53 loses wild type conformation upon incubation 37 degrees c p53 incubated indicated periods time 4 37 degrees c subsequently immunoprecipitated wild type specific antibody pab 1620 detection sds page blotting immunoprecipitates performed antibody 1 detecting total amount immunoprecipitated p53 lower amounts wild type conformation p53 immunoprecipitated p53 kept 37 degrees c longer time b elisa wells coated anti p53 antibodies pab 1620 50 ng wild type specific 1 50 ng pan specific increasing amounts p53 added wells upon incubation 37 degrees c 1 h amount mutant conformation p53 rises decrease pab 1620 antibody reactivity corresponds lower curve graph open circles comparison p53 kept 4 degrees c filled circles effect decreased antibody accessibility p53 caused aggregation since 1 antibody binding significantly change 37 degrees c incubation open filled squares presented values means four repeats od normalized appropriately maximum values antibodies
0.48231745.15358769.html.plaintext.txt	59	view larger version 31k fig 4 human recombinant hsp90 restores specific dna binding activity human recombinant p53 1 h inactivation 37 degrees c vitro p53 incubated 1 h 4 degrees clane 1 37 degrees c without presence increasing amount hsp90 h90 lanes 3 6 reactions contained 5 mm atp p53hsp90 mass ratio indicated lanes increasing amount hsp90 150 protein mass ratio 005 microg p53 used 022 microm monomer 25 microg hsp90 56 microm monomer b p53 incubated 1 h 4 37 degrees c without hsp90 indicated effect different amounts atp tested shown bars millimolar amounts atp used 5 microg bsa added instead 25 microg hsp90 lane 7 3 5 mm atp hsp90 dependent p53 rescue increases dramatically lanes 9 11 experiments performed described materials methods emsa bands following figures unless indicated otherwise correspond size p53 tetramer bound dna supershifted activating antibody ab421
0.48231745.15358769.html.plaintext.txt	60	results atpase luciferase refolding assays hsp90 bovine hsp90 indicate preparations possess atp dependent chaperone activity similarly hsp90 bovine hsp90 enhanced p53 dna binding promoter sequence fig 5a also determined whether gtp could substitute atp reaction order rule involvement second recently proposed nucleotide binding site hsp90 54 gtp unable substitute atp hsp90 dependent binding p53 promoter sequence fig 5b addition geldanamycin blocks n terminal nucleotide binding site hsp90 inhibits hsp90 dependent binding p53 p21 promoter dna fig 6 recombinant human chaperones hsp70 hsp40 families able efficiently substitute hsp90 reaction fig 5c neither alone results hdj proteins shown different hspc70 hdj combinations known refold denatured luciferase 41 42 suspected alter activity chaperone machines 55
0.48231745.15358769.html.plaintext.txt	61	results atpase luciferase refolding assays hsp90 bovine hsp90 indicate preparations possess atp dependent chaperone activity similarly hsp90 bovine hsp90 enhanced p53 dna binding promoter sequence fig 5a also determined whether gtp could substitute atp reaction order rule involvement second recently proposed nucleotide binding site hsp90 54 gtp unable substitute atp hsp90 dependent binding p53 promoter sequence fig 5b addition geldanamycin blocks n terminal nucleotide binding site hsp90 inhibits hsp90 dependent binding p53 p21 promoter dna fig 6 recombinant human chaperones hsp70 hsp40 families able efficiently substitute hsp90 reaction fig 5c neither alone results hdj proteins shown different hspc70 hdj combinations known refold denatured luciferase 41 42 suspected alter activity chaperone machines 55
0.48231745.15358769.html.plaintext.txt	62	view larger version 63k fig 6 vitro p53 rescuing activity hsp90 bovine brain hsp90 inhibited increasing amounts ga 125 microg human hsp90 preincubated 30 min indicated amount ga see materials methods used p53 rescue 37 degrees c inactivation presence 5 mm atp lanes 3 8 lanes reactions carried identically 5 mm atp excluding hsp90 lane 9 control confirming lack negative effect ga p53 binding dna absence hsp90 b reactions bovine brain hsp90 used instead hsp90 case isoform less ga required fully inhibit hsp90 explanation differences overall intensity bands b see materials methods
0.48231745.15358769.html.plaintext.txt	63	similar antibody activated p53 dna binding ckii activated p53 also positively regulated hsp90 fig 7 control experiment fig 7a lane 2 observed ckii treated p53 protein appeared resistant incubation 37 degrees c compared p53 activated pab421 antibody agreement earlier suggestions 43 surprisingly nonspecific binding p53 dsdna unstructured c terminal part protein responsible 56 also inhibited incubation 37 degrees c fig 7b however unlike sequence specific dna binding hsp90 presence 5 mm atp positively regulate nonspecific dna binding activity wt p53 fig 7b results suggest observed hsp90 mediated enhancement p53 dna binding 37 degrees c restricted p53 core domain responsible binding specific promoter derived dna molecules results fit domain specificity hsp90 p53 interaction described accompanying article muller et al 34
0.48231745.15358769.html.plaintext.txt	64	view larger version 26k fig 7 specific p53 dna binding activated ab421 ckii rescued hsp90 vitro specific binding p53 labeled p21 promoter dna activated antibody ab421 lanes 4 6 supershifted antibody ckii dependent phosphorylation lanes 1 3 supershifted could inactivated 1 h incubation 37 degrees c lanes 2 5 although difference binding strength 4 degrees c 37 degrees c smaller case ckii ab421 activation phosphorylation may protect heat inactivation see text reference hsp90 rescues p53 specific binding cases lanes 3 6 5 mm atp present reactions case ckii activation atp regeneration system used maintain atp concentration b 32p labeled nonspecific dna sequence nonspecific competitor used instead specific p21 promoter derived dna see materials methods p53 binding nonspecific dna also inactivated 37 degrees c 2 restored hsp90 3 reactions contained 5 mm atp protein amounts ratios b fig 5a
0.48231745.15358769.html.plaintext.txt	65	mode p53 hsp90 interaction suggests dynamic mechanism positive regulation wt p53 hsp90 ability hsp90 restore p53 binding promoter sequence 37 degrees c explained simple passive protection wild type conformation p53 elevated temperatures analogous described rna polymerase protection dnak 57 58 mentioned case presence atp diminishes great extent dnak dependent protection rna polymerase elevated temperatures however shown fig 8 concentration atp required hsp90 mediated binding p53 promoter sequence fig 4b also shifts equilibrium p53 hsp90 complex formation toward dissociation weaker effect amp pnp atp analog indicates least nucleotide hydrolysis probably exchange important reaction fig 8 consequently 5 mm amp pnp could substitute atp hsp90 dependent enhanced dna binding p53 emsa assay results shown hsp90 also cause p53 supershifts emsa assay hsp90 present reactions figs 4 5 6 7 may suggest transient nature protein protein interaction taken together results indicate dynamic repeated binding dissociation hsp90 p53 responsible positive regulation p53 dna binding activity physiological temperatures 37 degrees c
0.48231745.15358769.html.plaintext.txt	66	mode p53 hsp90 interaction suggests dynamic mechanism positive regulation wt p53 hsp90 ability hsp90 restore p53 binding promoter sequence 37 degrees c explained simple passive protection wild type conformation p53 elevated temperatures analogous described rna polymerase protection dnak 57 58 mentioned case presence atp diminishes great extent dnak dependent protection rna polymerase elevated temperatures however shown fig 8 concentration atp required hsp90 mediated binding p53 promoter sequence fig 4b also shifts equilibrium p53 hsp90 complex formation toward dissociation weaker effect amp pnp atp analog indicates least nucleotide hydrolysis probably exchange important reaction fig 8 consequently 5 mm amp pnp could substitute atp hsp90 dependent enhanced dna binding p53 emsa assay results shown hsp90 also cause p53 supershifts emsa assay hsp90 present reactions figs 4 5 6 7 may suggest transient nature protein protein interaction taken together results indicate dynamic repeated binding dissociation hsp90 p53 responsible positive regulation p53 dna binding activity physiological temperatures 37 degrees c
0.48231745.15358769.html.plaintext.txt	67	view larger version 18k fig 8 atp dissociates hsp90 p53 complex hsp90 500 ng coated onto elisa plate 50 ml buffer 25 mm hepes koh ph 75 100 mm kcl incubation proceeded 2 h room temperature washing blocking procedure 25 mm hepes koh ph 75 100 mm kcl 2 mgml bsa indicated amounts wt p53 reaction buffer 25 mm hepes koh ph 75 150 mm kcl 10 mm mgcl2 5 glycerol 005 triton x 100 1 mgml bsa added presence 5 mm atp analog amp pnp 1 h 25 degrees c detection p53 bound hsp90 followed described 33 values means four repeats
0.48231745.15358769.html.plaintext.txt	68	discussion top abstract introduction materials methods results discussion references significance cellular interactions p53 heat shock proteins normal tumor cells remains unclear demonstrated mutant p53 associates stabilized multichaperone complex 31 33 p53 protein encoded non mutated gene also found associated hsp90 presumably chaperones elevated temperatures probably due conformational transition p53 wild type form characteristic mutant protein 38 however possible co immunoprecipitate wild type conformation p53 molecular chaperones cell lysates 26 29 59 recently published study suggests hsp90 inhibitors influence degradation p53 temperature sensitive mutant permissive temperatures p53 presumably adopts wild type conformation 60 contrast articles groups show significant effect hsp90 inhibitors genotypically wt p53 level physiological temperature 26 38 59 although inhibitors may cause conformational change wt p53 30
0.48231745.15358769.html.plaintext.txt	69	discussion top abstract introduction materials methods results discussion references significance cellular interactions p53 heat shock proteins normal tumor cells remains unclear demonstrated mutant p53 associates stabilized multichaperone complex 31 33 p53 protein encoded non mutated gene also found associated hsp90 presumably chaperones elevated temperatures probably due conformational transition p53 wild type form characteristic mutant protein 38 however possible co immunoprecipitate wild type conformation p53 molecular chaperones cell lysates 26 29 59 recently published study suggests hsp90 inhibitors influence degradation p53 temperature sensitive mutant permissive temperatures p53 presumably adopts wild type conformation 60 contrast articles groups show significant effect hsp90 inhibitors genotypically wt p53 level physiological temperature 26 38 59 although inhibitors may cause conformational change wt p53 30
0.48231745.15358769.html.plaintext.txt	70	article show effect geldanamycin radicicol activity genotypically wt p53 human fibroblasts whereas presence geldanamycin radicicol minor effects cellular wt p53 level phosphorylation ser 15 hsp90 inhibitors dramatically influenced p53 activity transcription factor measured chromatin immunoprecipitation well quantitative analysis p21 mrna protein levels observed effect hsp90 inhibitors p53 transcriptional activity caused inhibition nuclear transport p53 results shown vivo data suggest hsp90 may play role regulation p53 promoted transcription examine possible effects hsp90 p53 dna binding activity vitro dna binding studies performed purified human hsp90 recombinant protein hsp90 purified bovine brain mixture bovine hsp90 isoforms hsp90 protein preparations displayed similar atpase luciferase refolding activities inhibited geldanamycin
0.48231745.15358769.html.plaintext.txt	71	article show effect geldanamycin radicicol activity genotypically wt p53 human fibroblasts whereas presence geldanamycin radicicol minor effects cellular wt p53 level phosphorylation ser 15 hsp90 inhibitors dramatically influenced p53 activity transcription factor measured chromatin immunoprecipitation well quantitative analysis p21 mrna protein levels observed effect hsp90 inhibitors p53 transcriptional activity caused inhibition nuclear transport p53 results shown vivo data suggest hsp90 may play role regulation p53 promoted transcription examine possible effects hsp90 p53 dna binding activity vitro dna binding studies performed purified human hsp90 recombinant protein hsp90 purified bovine brain mixture bovine hsp90 isoforms hsp90 protein preparations displayed similar atpase luciferase refolding activities inhibited geldanamycin
0.48231745.15358769.html.plaintext.txt	72	gel shift assay used monitor vitro p53 binding p21 promoter dna sequence wt p53 conformation recognized pab 1620 essential activity incubation p53 protein encoded non mutated sequence 37 degrees c decreases amount p53 protein found immunocomplex pab 1620 well p53 dna binding fact incubation wt p53 1 h 37 degrees c completely abolished p53 binding p21 promoter derived sequence interestingly presence increasing amounts hsp90 incubation p53 37 degrees c positively regulate p53 dna binding promoter sequence whereas human recombinant chaperone proteins hsp70 hsp40 families able substitute hsp90 activity activity atp dependent inhibited geldanamycin effects correlate vivo results geldanamycin inhibited p53 binding chromatin well transcription p21 promoter order examine possibility transient hsp90 interactions required positive regulation p53 dna binding promoter sequence 37 degrees c monitored direct binding hsp90 p53 presence absence atp similar hsp70 substrate complex formation 61 62 presence atp shifted bindingdissociation equilibrium toward dissociation results suggest influence hsp90 p53 dna binding explained passive protection wt p53 conformation caused static association hsp90 showed presence atp induces dissociation hsp90 p53 also promotes ability p53 bind dna promoter sequence 37 degrees c
0.48231745.15358769.html.plaintext.txt	73	gel shift assay used monitor vitro p53 binding p21 promoter dna sequence wt p53 conformation recognized pab 1620 essential activity incubation p53 protein encoded non mutated sequence 37 degrees c decreases amount p53 protein found immunocomplex pab 1620 well p53 dna binding fact incubation wt p53 1 h 37 degrees c completely abolished p53 binding p21 promoter derived sequence interestingly presence increasing amounts hsp90 incubation p53 37 degrees c positively regulate p53 dna binding promoter sequence whereas human recombinant chaperone proteins hsp70 hsp40 families able substitute hsp90 activity activity atp dependent inhibited geldanamycin effects correlate vivo results geldanamycin inhibited p53 binding chromatin well transcription p21 promoter order examine possibility transient hsp90 interactions required positive regulation p53 dna binding promoter sequence 37 degrees c monitored direct binding hsp90 p53 presence absence atp similar hsp70 substrate complex formation 61 62 presence atp shifted bindingdissociation equilibrium toward dissociation results suggest influence hsp90 p53 dna binding explained passive protection wt p53 conformation caused static association hsp90 showed presence atp induces dissociation hsp90 p53 also promotes ability p53 bind dna promoter sequence 37 degrees c
0.48231745.15358769.html.plaintext.txt	74	concentrations geldanamycin radicicol sufficient inhibit hsp90 dependent vivo transcriptional activity p53 lower concentration hsp90 inhibitors used vitro assays suggesting reconstituting minimum hsp90 chaperone systems vitro process testing hypothesis presence hsp90 co chaperones could influence inhibitors affinity hsp90 hsp90 dependent p53 binding promoter sequence however results already indicate influence hsp90 wt p53 activity taken consideration using hsp90 inhibitors therapeutic treatment cancer especially cancer cells possess wt p53
0.48231745.15358769.html.plaintext.txt	75	concentrations geldanamycin radicicol sufficient inhibit hsp90 dependent vivo transcriptional activity p53 lower concentration hsp90 inhibitors used vitro assays suggesting reconstituting minimum hsp90 chaperone systems vitro process testing hypothesis presence hsp90 co chaperones could influence inhibitors affinity hsp90 hsp90 dependent p53 binding promoter sequence however results already indicate influence hsp90 wt p53 activity taken consideration using hsp90 inhibitors therapeutic treatment cancer especially cancer cells possess wt p53
0.48231745.15358769.html.plaintext.txt	76	least two possibilities explaining mechanism hsp90 positive regulation p53 dna binding promoter sequence 37 degrees c first hsp90 inhibits p53 aggregation catalyzes disaggregation p53 protein elevated temperatures mechanism previously discovered chaperones belonging prokaryotic 57 58 eukaryotic 63 hsp70 families shown hsp90 presence p53 muller et al 34 second hsp90 association wt p53 could induce partial unfolding p53 following dissociation hsp90 p53 complex presence atp p53 could spontaneously refold back wild type conformation high affinity p21 promoter sequence similar mechanism molecular chaperone action proposed case hsp100 involved protein folding proteolysis 64 unfoldase activity hsp100 molecular chaperone eventually demonstrated subsequent study 65 recent data ted hupp laboratory 30 suggest hsp90 presence mdm2 could indeed partially unfold p53 propose partial unfolding p53 could catalyzed hsp90 subsequent spontaneous refolding p53 back wild type like conformation may prevent p53 aggregation thus increasing p53 dna binding promoter sequence see fig 9 importantly chaperone mediated actions would decrease probability formation kinetically trapped mutant like intermediates would allow shift conformational equilibrium toward active wt p53 conformation events would ultimately promote p53 transcriptional activity allow ubiquitination degradation p53 protein addition retention p53 wild type conformation transient hsp90 interaction would also inhibit formation multichaperone p53 complex prevents p53 degradation import nucleus fig 9
0.48231745.15358769.html.plaintext.txt	77	least two possibilities explaining mechanism hsp90 positive regulation p53 dna binding promoter sequence 37 degrees c first hsp90 inhibits p53 aggregation catalyzes disaggregation p53 protein elevated temperatures mechanism previously discovered chaperones belonging prokaryotic 57 58 eukaryotic 63 hsp70 families shown hsp90 presence p53 muller et al 34 second hsp90 association wt p53 could induce partial unfolding p53 following dissociation hsp90 p53 complex presence atp p53 could spontaneously refold back wild type conformation high affinity p21 promoter sequence similar mechanism molecular chaperone action proposed case hsp100 involved protein folding proteolysis 64 unfoldase activity hsp100 molecular chaperone eventually demonstrated subsequent study 65 recent data ted hupp laboratory 30 suggest hsp90 presence mdm2 could indeed partially unfold p53 propose partial unfolding p53 could catalyzed hsp90 subsequent spontaneous refolding p53 back wild type like conformation may prevent p53 aggregation thus increasing p53 dna binding promoter sequence see fig 9 importantly chaperone mediated actions would decrease probability formation kinetically trapped mutant like intermediates would allow shift conformational equilibrium toward active wt p53 conformation events would ultimately promote p53 transcriptional activity allow ubiquitination degradation p53 protein addition retention p53 wild type conformation transient hsp90 interaction would also inhibit formation multichaperone p53 complex prevents p53 degradation import nucleus fig 9
0.48231745.15358769.html.plaintext.txt	78	view larger version 23k fig 9 proposed model role molecular chaperones maintaining p53 cells wild type structure p53 represented circles whereas mutant conformation squares p53 sequence oncoproteins factors may shift equilibrium wild type mutant conformation aggregation among factors molecular chaperones immediate reactions involving hsp90 positive regulation wt p53 yet known hence question marks details included discussion
0.48231745.15358769.html.plaintext.txt	79	footnotes work supported state committee scientific research grant 3p04b02122 z foundation polish science m z v framework grant qlrt 2001 02833 grants deutsche forschungsgemeinschaft j b costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.48231745.15358769.html.plaintext.txt	80	authors contributed equally work recipients scholarship postgraduate school molecular medicine affiliated medical university warsaw
0.48231745.15358769.html.plaintext.txt	81	present address cancer research institute university california san francisco ca
0.48231745.15358769.html.plaintext.txt	82	correspondence addressed international institute molecular cell biology warsaw trojdena 4 st 02 109 warsaw poland tel 48 22 668 50 86 fax 48 22 668 50 57 e mail zyliczatiimcbgovpl u d
0.48231745.15358769.html.plaintext.txt	83	1 abbreviations used wt p53 wild type p53 hsp90 heat shock protein 90 amp pnp adenylyl imidodiphosphate chip chromatin immunoprecipitation elisa enzyme linked immunosorbent assay emsa electrophoretic mobility shift assay ga geldanamycin mut p53 p53 mutant conformation r radicicol dtt dithiothreitol bsa bovine serum albumin
0.48231745.15358769.html.plaintext.txt	84	acknowledgments thank johannes buchner helpful discussions sharing unpublished results concerning interactions hsp90 p53 thank peter csermely plasmid pmalc2x ahsp90 encoding human hsp90 ted hupp plasmid constructs p53 overexpression harm kampinga kind gift k15 cell line richard morimoto pet11b plasmid encoding human hsp70 kazutoyo terada constructs hdj2 hdj3 overexpression
0.48231745.15358769.html.plaintext.txt	85	acknowledgments thank johannes buchner helpful discussions sharing unpublished results concerning interactions hsp90 p53 thank peter csermely plasmid pmalc2x ahsp90 encoding human hsp90 ted hupp plasmid constructs p53 overexpression harm kampinga kind gift k15 cell line richard morimoto pet11b plasmid encoding human hsp70 kazutoyo terada constructs hdj2 hdj3 overexpression
0.48231745.15358769.html.plaintext.txt	86	references top abstract introduction materials methods results discussion references vogelstein b lane d levine j 2000 nature 408 307 310crossrefmedline order article via infotrieve sharpless n e depinho r 2002 cell 110 9 12medline order article via infotrieve hollstein m hergenhahn m yang q bartsch h wang z q hainaut p 1999 mutat res 431 199 209medline order article via infotrieve hollstein m sidransky d vogelstein b harris c c 1991 science 253 49 53medline order article via infotrieve levine j momand j finlay c 1991 nature 351 453 456crossrefmedline order article via infotrieve stommel j m marchenko n d jimenez g moll u m hope j wahl g m 1999 embo j 18 1660 1672abstractfree full text wadhwa r yaguchi hasan m k mitsui y reddel r r kaul c 2002 exp cell res 274 246 253crossrefmedline order article via infotrieve nikolaev y li m puskas n qin j gu w 2003 cell 112 29 40medline order article via infotrieve galigniana m d harrell j m ohagen h m ljungman m pratt w b 2004 j biol chem 279 22483 22489abstractfree full text galigniana m d scruggs j l herrington j welsh m j carter su c housley p r pratt w b 1998 mol endocrinol 12 1903 1913abstractfree full text kazlauskas sundstrom poellinger l pongratz 2001 mol cell biol 21 2594 2607abstractfree full text li m brooks c l wu baer f chen d baer r gu w 2003 science 302 1972 1975abstractfree full text insinga monestiroli ronzoni carbone r pearson m pruneri g viale g appella e pelicci p minucci 2004 embo j 23 1144 1154abstractfree full text balint e e vousden k h 2001 br j cancer 85 1813 1823medline order article via infotrieve haupt y maya r kazaz oren m 1997 nature 387 296 299crossrefmedline order article via infotrieve kubbutat m h jones n vousden k h 1997 nature 387 299 303crossrefmedline order article via infotrieve honda r tanaka h yasuda h 1997 febs lett 420 25 27crossrefmedline order article via infotrieve young j c moarefi hartl f u 2001 j cell biol 154 267 273abstractfree full text zylicz m king f w wawrzynow 2001 embo j 20 4634 4638free full text picard d 2002 cell mol life sci 59 1640 1648medline order article via infotrieve prodromou c pearl l h 2003 curr cancer drug targets 3 301 323medline order article via infotrieve wegele h muller l buchner j 2004 rev physiol biochem pharmacol 151 1 44medline order article via infotrieve workman p 2004 cancer lett 206 149 157crossrefmedline order article via infotrieve kamal thao l sensintaffar j zhang l boehm m f fritz l c burrows f j 2003 nature 425 407 410crossref sepehrnia b paz b dasgupta g momand j 1996 j biol chem 271 15084 15090abstractfree full text blagosklonny m v toretsky j bohen neckers l 1996 proc natl acad sci u 93 8379 8383abstractfree full text akakura yoshida m yoneda y horinouchi 2001 j biol chem 276 14649 14657abstractfree full text peng y chen l li c lu w agrawal chen j 2001 j biol chem 276 6874 6878abstractfree full text peng y chen l li c lu w chen j 2001 j biol chem 276 40583 40590abstractfree full text burch l shimizu h smith patterson c hupp r 2004 j mol biol 337 129 145crossrefmedline order article via infotrieve whitesell l sutphin p w g schulte blagosklonny m v neckers l 1997 oncogene 14 2809 2816crossrefmedline order article via infotrieve whitesell l sutphin p d pulcini e j martinez j d cook p h 1998 mol cell biol 18 1517 1524abstractfree full text king f w wawrzynow hohfeld j zylicz m 2001 embo j 20 6297 6305abstractfree full text muller l schaupp walerych d wegele h buchner j 2004 j biol chem 279 48846 48854abstractfree full text rudiger freund m veprintsev d b fersht r 2002 proc natl acad sci u 99 11085 11090abstractfree full text bullock n henckel j dedecker b johnson c m nikolova p v proctor m r lane d p fersht r 1997 proc natl acad sci u 94 14338 14342abstractfree full text bell klein c muller l hansen buchner j 2002 j mol biol 322 917 927crossrefmedline order article via infotrieve wang c chen j 2003 j biol chem 278 2066 2071abstractfree full text willis jung e j wakefield chen x 2004 oncogene 23 2330 2338crossrefmedline order article via infotrieve sullivan w stensgard b caucutt g bartha b mcmahon n alnemri e litwack g toft d 1997 j biol chem 272 8007 8012abstractfree full text terada k kanazawa m bukau b mori m 1997 j cell biol 139 1089 1095abstractfree full text terada k mori m 2000 j biol chem 275 24728 24734abstractfree full text nichols n m matthews k 2002 biochemistry 41 170 178crossrefmedline order article via infotrieve liberek k marszalek j ang d georgopoulos c zylicz m 1991 proc natl acad sci u 88 2874 2878abstractfree full text minami y minami m 1999 genes cells 4 721 729abstractfree full text anderson m e woelker b reed m wang p tegtmeyer p 1997 mol cell biol 17 6255 6264abstract shieh y ikeda m taya y prives c 1997 cell 91 325 334medline order article via infotrieve tibbetts r brumbaugh k m williams j m sarkaria j n cliby w shieh y taya y prives c abraham r 1999 genes dev 13 152 157abstractfree full text hupp r meek d w midgley c lane d p 1992 cell 71 875 886medline order article via infotrieve yakovleva pramanik kawasaki tan k gileva lindegren h langel u ekstrom j rigler r terenius l bakalkin g 2001 j biol chem 276 15650 15658abstractfree full text mclure k g lee p w 1998 embo j 17 3342 3350abstractfree full text milner j watson j v 1990 oncogene 5 1683 1690medline order article via infotrieve hainaut p rolley n davies m milner j 1995 oncogene 10 27 32medline order article via infotrieve soti c racz csermely p 2002 j biol chem 277 7066 7075abstractfree full text lu z cyr d m 1998 j biol chem 273 27824 27830abstractfree full text rustandi r r baldisseri d m weber d j 2000 nat struct biol 7 570 574crossrefmedline order article via infotrieve skowyra d georgopoulos c zylicz m 1990 cell 62 939 944medline order article via infotrieve ziemienowicz skowyra d zeilstra ryalls j fayet o georgopoulos c zylicz m 1993 j biol chem 268 25425 25431abstractfree full text blagosklonny m v toretsky j neckers l 1995 oncogene 11 933 939medline order article via infotrieve asher g lotem j kama r sachs l shaul y 2002 proc natl acad sci u 99 3099 3104abstractfree full text wawrzynow zylicz m 1995 j biol chem 270 19300 19306abstractfree full text wawrzynow banecki b wall d liberek k georgopoulos c zylicz m 1995 j biol chem 270 19307 19311abstractfree full text ziemienowicz zylicz m floth c hubscher u 1995 j biol chem 270 15479 15484abstractfree full text wawrzynow banecki b zylicz m 1996 mol microbiol 21 895 899medline order article via infotrieve weber ban e u reid b g miranker d horwich l 1999 nature 401 90 93crossrefmedline order article via infotrieve
0.48235416.15778501.html.plaintext.txt	0	jnk1 jnk2 oppositely regulate p53 signaling linked apoptosis triggered altered fibronectin matrix jnk links fak p53 elizabeth tafolla shaohui wang benita wong jeffrey leong yvonne l kapila
0.48235416.15778501.html.plaintext.txt	1	department stomatology school dentistry university california san francisco california 94143 0512 department periodontics prevention geriatrics school dentistry university michigan ann arbor michigan 48109 1078
0.48235416.15778501.html.plaintext.txt	2	received publication january 10 2005
0.48235416.15778501.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references extracellular matrix regulates many cellular processes including survival alterations matrix matrix survival signals trigger apoptosis previously showed altered fibronectin matrix triggers apoptosis primary cells via novel pathway regulated transcriptionally mediated decreases p53 c myc levels report apoptotic mechanism propagated decreased phosphorylation focal adhesion kinase fak linked increased phosphorylation c jun n terminal kinase jnk decreased levels p53 fak physically spatially linked jnk p53 relocalize nucleus cell membrane mediate interaction p53 participates feedback mechanism jnk regulate apoptotic process oppositely regulated jnk1 jnk2
0.48235416.15778501.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references extracellular matrix regulates many cellular processes including survival alterations matrix matrix survival signals trigger apoptosis previously showed altered fibronectin matrix triggers apoptosis primary cells via novel pathway regulated transcriptionally mediated decreases p53 c myc levels report apoptotic mechanism propagated decreased phosphorylation focal adhesion kinase fak linked increased phosphorylation c jun n terminal kinase jnk decreased levels p53 fak physically spatially linked jnk p53 relocalize nucleus cell membrane mediate interaction p53 participates feedback mechanism jnk regulate apoptotic process oppositely regulated jnk1 jnk2
0.48235416.15778501.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references alterations extracellular matrix inflammation development metastatic processes alter cellular biology governs processes conditions altered matrix result proteolytic cleavage alternative splicing matrix molecules inflammation proteolysis extracellular matrix molecules leads formation fragments fibronectin fn1 fragments elicit cellular responses different elicited intact molecule 1 5 example disease associated fragments fn trigger p53 mediated apoptosis primary cells intact molecule 6 8 similarly alternatively spliced variants fn elicit different cell responses specific domains fn regulate cell survival 4 5
0.48235416.15778501.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references alterations extracellular matrix inflammation development metastatic processes alter cellular biology governs processes conditions altered matrix result proteolytic cleavage alternative splicing matrix molecules inflammation proteolysis extracellular matrix molecules leads formation fragments fibronectin fn1 fragments elicit cellular responses different elicited intact molecule 1 5 example disease associated fragments fn trigger p53 mediated apoptosis primary cells intact molecule 6 8 similarly alternatively spliced variants fn elicit different cell responses specific domains fn regulate cell survival 4 5
0.48235416.15778501.html.plaintext.txt	7	previously reported altered fn matrix triggers apoptosis primary cells via novel pathway regulated transcriptionally mediated decreases p53 c myc levels primary cells 5 decipher apoptotic pathway explored possible connections integrinfak mediated signals regulation p53 hypothesized c jun n terminal kinase jnk might crossroads signaling pathway since fak associated focal adhesion proteins rac1pak1mkk4jnk linked p53 status apoptosis primary cells 9 10 addition jnk phosphorylate 11 form complex p53 stabilize 12 16 thereby influencing activity directly
0.48235416.15778501.html.plaintext.txt	8	previously reported altered fn matrix triggers apoptosis primary cells via novel pathway regulated transcriptionally mediated decreases p53 c myc levels primary cells 5 decipher apoptotic pathway explored possible connections integrinfak mediated signals regulation p53 hypothesized c jun n terminal kinase jnk might crossroads signaling pathway since fak associated focal adhesion proteins rac1pak1mkk4jnk linked p53 status apoptosis primary cells 9 10 addition jnk phosphorylate 11 form complex p53 stabilize 12 16 thereby influencing activity directly
0.48235416.15778501.html.plaintext.txt	9	fak integrin associated protein tyrosine kinase important integrin signaling activation triggered increased phosphorylation tyr397 sites implicated many cellular processes including cell survival n terminal domain fak directs interactions integrins growth factor receptors fak also central catalytic domain contains tyr397 major autophosphorylation site site interaction src homology 2 domain c terminal noncatalytic domain also known fak related non kinase frnk contains sites multiple protein protein interactions focal adhesion targeting fat region frnk fat act dominant negative fashion inhibit cell spreading migration growth factor mediated signals mitogen activated protein kinase 17
0.48235416.15778501.html.plaintext.txt	10	fak integrin associated protein tyrosine kinase important integrin signaling activation triggered increased phosphorylation tyr397 sites implicated many cellular processes including cell survival n terminal domain fak directs interactions integrins growth factor receptors fak also central catalytic domain contains tyr397 major autophosphorylation site site interaction src homology 2 domain c terminal noncatalytic domain also known fak related non kinase frnk contains sites multiple protein protein interactions focal adhesion targeting fat region frnk fat act dominant negative fashion inhibit cell spreading migration growth factor mediated signals mitogen activated protein kinase 17
0.48235416.15778501.html.plaintext.txt	11	jnk group mitogen activated protein kinases activated cytokines environmental stress participate various signaling pathways including apoptotic pathways jnk proteins encoded three genes jnk1 46 kda jnk2 54 kda jnk3 54 kda undergoes alternative splicing express various isoforms jnk activated phosphorylation specific threonine tyrosine residues mitogen activated protein kinase kinases 18 activated jnk1 modify p53 posttranslationally phosphorylation jnk2 jnk3 also phosphorylate p53 three associate p53 vivo 19
0.48235416.15778501.html.plaintext.txt	12	jnk group mitogen activated protein kinases activated cytokines environmental stress participate various signaling pathways including apoptotic pathways jnk proteins encoded three genes jnk1 46 kda jnk2 54 kda jnk3 54 kda undergoes alternative splicing express various isoforms jnk activated phosphorylation specific threonine tyrosine residues mitogen activated protein kinase kinases 18 activated jnk1 modify p53 posttranslationally phosphorylation jnk2 jnk3 also phosphorylate p53 three associate p53 vivo 19
0.48235416.15778501.html.plaintext.txt	13	study sought determine whether fak signaling pathways communicate p53 via jnk interactions altered matrix environment report apoptotic mechanism triggered altered fn matrix propagated decreases fak phosphorylation linked increased phosphorylation jnk decreased levels p53 oppositely regulated jnk1 jnk2
0.48235416.15778501.html.plaintext.txt	14	study sought determine whether fak signaling pathways communicate p53 via jnk interactions altered matrix environment report apoptotic mechanism triggered altered fn matrix propagated decreases fak phosphorylation linked increased phosphorylation jnk decreased levels p53 oppositely regulated jnk1 jnk2
0.48235416.15778501.html.plaintext.txt	15	experimental procedures top abstract introduction experimental procedures results discussion references fibroblast cell culture primary human fibroblasts obtained cultured tested apoptosis described 14 use human pdl periodontal ligament cells studies approved university california san francisco institutional review board committee human research p53 deficient wild type mouse fibroblasts provided dr caroline damsky university california san francisco 10 jnk2 deficient mouse synoviocytes wild type controls provided dr gary firestein university california san diego school medicine addition jnk2 deficient fibroblast cells wild type controls jnk1jnk2 deficient wild type control fibroblasts obtained respective knock mice controls provided dr roger davis howard hughes medical institute university massachusetts medical school worcester ma
0.48235416.15778501.html.plaintext.txt	16	experimental procedures top abstract introduction experimental procedures results discussion references fibroblast cell culture primary human fibroblasts obtained cultured tested apoptosis described 14 use human pdl periodontal ligament cells studies approved university california san francisco institutional review board committee human research p53 deficient wild type mouse fibroblasts provided dr caroline damsky university california san francisco 10 jnk2 deficient mouse synoviocytes wild type controls provided dr gary firestein university california san diego school medicine addition jnk2 deficient fibroblast cells wild type controls jnk1jnk2 deficient wild type control fibroblasts obtained respective knock mice controls provided dr roger davis howard hughes medical institute university massachusetts medical school worcester ma
0.48235416.15778501.html.plaintext.txt	17	plasmidsdna constructs fak fat frnk constructs provided dr caroline damsky dr dusko ilic university california san francisco constructs encoding jnk1 jnk2 dominant negative catalytically inactive jnk1 mutant thr183 tyr185 replaced ala183 phe185 provided dr roger davis human wild type p53 expression plasmid pc53 sn3 provided bert vogelstein john hopkins university school medicine baltimore md 20
0.48235416.15778501.html.plaintext.txt	18	oligonucleotides oligonucleotides used experiments shown table
0.48235416.15778501.html.plaintext.txt	19	view table table sequences antisense scrambled scr control oligonucleotides
0.48235416.15778501.html.plaintext.txt	20	recombinant fn proteins two recombinant fn fragments tested experiments fragments described elsewhere 3 included alternatively spliced v region v contained either unmutated h mutated nonfunctional h high affinity heparin binding domain
0.48235416.15778501.html.plaintext.txt	21	recombinant fn proteins two recombinant fn fragments tested experiments fragments described elsewhere 3 included alternatively spliced v region v contained either unmutated h mutated nonfunctional h high affinity heparin binding domain
0.48235416.15778501.html.plaintext.txt	22	view larger version 44k fig 1 altered fn matrix activates signaling pathway involves fak jnk p53 western blots cell lysates showing vh fn fragment decreased fak phosphorylation tyr397 increased jnk phosphorylation decreased total p53 levels primary human fibroblasts compared cells incubated control medium c control vh fn fragment 1 3 7 h actin served loading control b immunoprecipitation ip samples shown antibody pjnk western blotting primary antibodies p53 pfak tyr397 pulled p53 pfak respectively consistent complex formation pjnk p53 pjnk pfak c fluorescence images showing localization fak pjnk p53 primary human fibroblasts treated vh protein control medium ctl 6 h cells top row labeled first primary antibodies fak pjnk p53 secondary biotinylated antibodies finally fitc conjugated streptavidin cells bottom row stained dapi nuclear stain original magnification x400
0.48235416.15778501.html.plaintext.txt	23	western blot analysis western blot analysis cells incubated vh fragment vh fragment control serum free medium lysed 100 microlwell tne buffer 1 nonidet p 40 10 glycerol 150 mm sodium chloride tris ph 74 1 mm edta containing protease inhibitors 1 mm sodium orthovanadate 50 microm sodium molybdate 25 microgml aprotinin 25 microgml leupeptin 1 mm sodium fluoride 1 mm phenylmethylsulfonyl fluoride phosphatase inhibitor mixtures 1 2 sigma lysates adjusted protein concentration bca protein assay kit pierce resolved sds page transferred immobilon p membranes millipore billerica ma blots probed primary antibodies developed ecl plus detection system amersham biosciences primary antibodies rabbit anti human jnk1 c 17 mouse anti human jnk2 d 2 mouse anti human pjnk g 7 rabbit anti human fak c 20 goat anti human pfak tyr 925 mouse anti human p53 1 anti mouse p53 pab 240 goat anti human actin 19 santa cruz biotechnology santa cruz ca rabbit polyclonal anti fak py397 phosphospecific antibody rabbit polyclonal anti jnk1 2 sapk ptpy 1831850 phosphospecific antibody biosource camarillo ca images western blots captured nec ti 24a charge coupled device camera imported photoshop 503
0.48235416.15778501.html.plaintext.txt	24	western blot analysis western blot analysis cells incubated vh fragment vh fragment control serum free medium lysed 100 microlwell tne buffer 1 nonidet p 40 10 glycerol 150 mm sodium chloride tris ph 74 1 mm edta containing protease inhibitors 1 mm sodium orthovanadate 50 microm sodium molybdate 25 microgml aprotinin 25 microgml leupeptin 1 mm sodium fluoride 1 mm phenylmethylsulfonyl fluoride phosphatase inhibitor mixtures 1 2 sigma lysates adjusted protein concentration bca protein assay kit pierce resolved sds page transferred immobilon p membranes millipore billerica ma blots probed primary antibodies developed ecl plus detection system amersham biosciences primary antibodies rabbit anti human jnk1 c 17 mouse anti human jnk2 d 2 mouse anti human pjnk g 7 rabbit anti human fak c 20 goat anti human pfak tyr 925 mouse anti human p53 1 anti mouse p53 pab 240 goat anti human actin 19 santa cruz biotechnology santa cruz ca rabbit polyclonal anti fak py397 phosphospecific antibody rabbit polyclonal anti jnk1 2 sapk ptpy 1831850 phosphospecific antibody biosource camarillo ca images western blots captured nec ti 24a charge coupled device camera imported photoshop 503
0.48235416.15778501.html.plaintext.txt	25	view larger version 39k fig 2 fak overexpression suppresses jnk phosphorylation increases p53 levels whereas dominant negative constructs frnk fat fak antisense treatment increase jnk phosphorylation decrease p53 levels altered matrix conditions diagram top depicts three fak domains n terminal catalytic c terminal domains two major phosphorylation sites y397 y925 also illustrates c terminal domain known frnk domain contains fat region western blots illustrate levels fak pfak phosphorylated tyr397 tyr925 pjnk p53 primary human fibroblasts transfected fak frnk fat vector control treated vh fn fragment 1 3 7 h c untreated control actin served loading control b western blots cells transfected antisense fak oligonucleotide fak scrambled fak oligonucleotide control scr fak vector control ctl treated described
0.48235416.15778501.html.plaintext.txt	26	immunoprecipitation immunoprecipitation analysis cells incubated vh fragment vh fragment control serum free medium lysed tne buffer 100 microlwell containing protease inhibitors mentioned lysates adjusted protein concentration bca protein assay kit pierce precleared protein g amersham biosciences incubated pjnk santa cruz biotechnology antibody protein g overnight pelleted centrifugation resuspended lysis buffer boiled 5 min pelleted centrifugation supernatants resolved sds page transferred immobilon p membranes probed primary antibodies p53 santa cruz biotechnology pfak biosource developed ecl
0.48235416.15778501.html.plaintext.txt	27	immunoprecipitation immunoprecipitation analysis cells incubated vh fragment vh fragment control serum free medium lysed tne buffer 100 microlwell containing protease inhibitors mentioned lysates adjusted protein concentration bca protein assay kit pierce precleared protein g amersham biosciences incubated pjnk santa cruz biotechnology antibody protein g overnight pelleted centrifugation resuspended lysis buffer boiled 5 min pelleted centrifugation supernatants resolved sds page transferred immobilon p membranes probed primary antibodies p53 santa cruz biotechnology pfak biosource developed ecl
0.48235416.15778501.html.plaintext.txt	28	transient expression fak fat frnk jnk1 jnk2 dnjnk1 p53 primary cells 60 80 confluency 96 well tissue culture plates transiently transfected 01 microg dna 50 microl serum free medium control vector lipofectamine plus reagent invitrogen transfection efficiency cells measured green fluorescent protein vector pegfp clontech 60 transfected cells rinsed fresh serum free medium vh fn protein added test wells signaling assessed
0.48235416.15778501.html.plaintext.txt	29	transient expression fak fat frnk jnk1 jnk2 dnjnk1 p53 primary cells 60 80 confluency 96 well tissue culture plates transiently transfected 01 microg dna 50 microl serum free medium control vector lipofectamine plus reagent invitrogen transfection efficiency cells measured green fluorescent protein vector pegfp clontech 60 transfected cells rinsed fresh serum free medium vh fn protein added test wells signaling assessed
0.48235416.15778501.html.plaintext.txt	30	antisense experiments assess effect regulating expression fak jnk used antisense oligonucleotides listed table probes synthesized oligos etc wilsonville described 21 22 except oligonucleotides phosphorothioated positions minimize intracellular cleavage degradative enzymes enhance stability 23 purified high performance liquid chromatography level antisense oligonucleotide also synthesized sense oligonucleotide specific relevant control oligonucleotides dissolved double distilled water stored aliquots 20 degrees c
0.48235416.15778501.html.plaintext.txt	31	antisense experiments assess effect regulating expression fak jnk used antisense oligonucleotides listed table probes synthesized oligos etc wilsonville described 21 22 except oligonucleotides phosphorothioated positions minimize intracellular cleavage degradative enzymes enhance stability 23 purified high performance liquid chromatography level antisense oligonucleotide also synthesized sense oligonucleotide specific relevant control oligonucleotides dissolved double distilled water stored aliquots 20 degrees c
0.48235416.15778501.html.plaintext.txt	32	oligonucleotides final concentration 2 microm mixed 8 microl oligofectamine invitrogen incubated 20 min transfected cells 60 confluence cells typically cultured serum free medium different oligonucleotides 4 h 37 degrees c serum added cells incubated 48 h removal serum cells washed medium pretreated lactalbumin hydrolysate 1 mlwell invitrogen incubated fn proteins vh 1 3 7 h protein collected standardized concentration bca kit pierce resolved sds page transferred immobilon p membranes western blotting blots probed primary antibodies fak c 20 anti rabbit pfak rabbit anti fak py397 phosphospecific antibody jnk1 c 17 anti rabbit jnk2 d 2 anti mouse pjnk rabbit anti jnk1 2 sapk ptpy183185 phosphospecific antibody p53 pab 240 anti mouse actin 19 anti goat developed ecl reagents amersham biosciences
0.48235416.15778501.html.plaintext.txt	33	oligonucleotides final concentration 2 microm mixed 8 microl oligofectamine invitrogen incubated 20 min transfected cells 60 confluence cells typically cultured serum free medium different oligonucleotides 4 h 37 degrees c serum added cells incubated 48 h removal serum cells washed medium pretreated lactalbumin hydrolysate 1 mlwell invitrogen incubated fn proteins vh 1 3 7 h protein collected standardized concentration bca kit pierce resolved sds page transferred immobilon p membranes western blotting blots probed primary antibodies fak c 20 anti rabbit pfak rabbit anti fak py397 phosphospecific antibody jnk1 c 17 anti rabbit jnk2 d 2 anti mouse pjnk rabbit anti jnk1 2 sapk ptpy183185 phosphospecific antibody p53 pab 240 anti mouse actin 19 anti goat developed ecl reagents amersham biosciences
0.48235416.15778501.html.plaintext.txt	34	immunofluorescence fluorescence staining used localize fak jnk p53 cells incubated recombinant fn proteins control medium 6 h incubation cells fixed 3 paraformaldehyde solution phosphate buffered saline pbs ph 72 76 permeabilized acetone 20 degrees c nonspecific staining blocked biotin avidin blocking kit vector laboratories cells incubated primary antibody p53 1 anti mouse antibody pjnk g 7 anti mouse antibody fak g 20 anti rabbit antibody overnight washed pbs incubated secondary biotinylated antibodies washed pbs finally incubated fluorescein isothiocyanate fitc conjugated streptavidin antibodies santa cruz biotechnology washing cells dried mounted glass slides examined nikon e400 photomicroscope equipped fitc fluorescence filter imported photoshop 503
0.48235416.15778501.html.plaintext.txt	35	immunofluorescence fluorescence staining used localize fak jnk p53 cells incubated recombinant fn proteins control medium 6 h incubation cells fixed 3 paraformaldehyde solution phosphate buffered saline pbs ph 72 76 permeabilized acetone 20 degrees c nonspecific staining blocked biotin avidin blocking kit vector laboratories cells incubated primary antibody p53 1 anti mouse antibody pjnk g 7 anti mouse antibody fak g 20 anti rabbit antibody overnight washed pbs incubated secondary biotinylated antibodies washed pbs finally incubated fluorescein isothiocyanate fitc conjugated streptavidin antibodies santa cruz biotechnology washing cells dried mounted glass slides examined nikon e400 photomicroscope equipped fitc fluorescence filter imported photoshop 503
0.48235416.15778501.html.plaintext.txt	36	nuclear staining nuclear staining dna used assess quality nucleus cells incubated recombinant fn proteins control medium 16 well chamber slides 6 14 h incubation cells fixed ice cold 100 methanol 15 min stained fluorescent groove binding probe dna 46 diamidino 2 phenylindole dapi sigma 10 min rinsed three times calcium magnesium free pbs dried sealed coverslip mounting medium cells photographed x400 magnification nikon e400 photomicroscope equipped dapi filter
0.48235416.15778501.html.plaintext.txt	37	nuclear staining nuclear staining dna used assess quality nucleus cells incubated recombinant fn proteins control medium 16 well chamber slides 6 14 h incubation cells fixed ice cold 100 methanol 15 min stained fluorescent groove binding probe dna 46 diamidino 2 phenylindole dapi sigma 10 min rinsed three times calcium magnesium free pbs dried sealed coverslip mounting medium cells photographed x400 magnification nikon e400 photomicroscope equipped dapi filter
0.48235416.15778501.html.plaintext.txt	38	results top abstract introduction experimental procedures results discussion references altered fibronectin matrix activates signaling pathway involves fak jnk p53 examine possibility jnk might intersection fak p53 mediated signals apoptosis triggered altered fn matrix assessed protein expression levels primary human fibroblasts treated fn fragments containing alternatively spliced v region v either mutated h wild type h heparin binding domain fig 1a cells treated vh fragment previously shown induce apoptosis 18 19 phosphorylation jnk increased tandem decreases p53 fak phosphorylation fak phosphorylated tyr397 tyr925 total fak jnk protein levels altered
0.48235416.15778501.html.plaintext.txt	39	view larger version 44k fig 3 p53 levels suppressed overexpression jnk1 increased expression dominant negative jnk1 construct western blots showing levels jnk1 pjnk jnk2 fak pfak phosphorylated tyr397 p53 primary human fibroblasts transfected jnk1 vector control mock transfected treated vh fn fragment 1 3 7 h c untreated control actin served loading control b western blots primary human fibroblasts transfected transf dominant negative construct jnk jnk1 dn vector control mock transfected treated described
0.48235416.15778501.html.plaintext.txt	40	determine whether jnk physically linked signaling molecules performed immunoprecipitation immunofluorescence localization experiments primary human fibroblasts antibody phosphorylated jnk pjnk immunoprecipitated p53 pfak control conditions however upon treatment vh fn fragment associations decreased time fig 1b moreover fak localized cell membrane jnk p53 relocalized nucleus cell membrane fig 1c indicating fak jnk p53 spatially coincident nuclei cells treated vh appeared pyknotic condensed indicating apoptosis whereas nuclei control cells large oval apoptotic fig 1c findings suggest apoptotic mechanism triggered altered matrix jnk p53 form signaling complex interacts integrinmembranefak signaling molecules
0.48235416.15778501.html.plaintext.txt	41	determine whether jnk physically linked signaling molecules performed immunoprecipitation immunofluorescence localization experiments primary human fibroblasts antibody phosphorylated jnk pjnk immunoprecipitated p53 pfak control conditions however upon treatment vh fn fragment associations decreased time fig 1b moreover fak localized cell membrane jnk p53 relocalized nucleus cell membrane fig 1c indicating fak jnk p53 spatially coincident nuclei cells treated vh appeared pyknotic condensed indicating apoptosis whereas nuclei control cells large oval apoptotic fig 1c findings suggest apoptotic mechanism triggered altered matrix jnk p53 form signaling complex interacts integrinmembranefak signaling molecules
0.48235416.15778501.html.plaintext.txt	42	fak upstream regulator jnk phosphorylation p53 protein levels examine changes fak expression might affect jnk p53 signals transiently transfected cells fak cdna dominant negative deletion mutants fak fat frnk fak antisense oligonucleotide cells transfected fak treated proapoptotic fn fragment expressed lower levels pjnk higher levels p53 controls whereas cells transfected fat frnk fak antisense constructs expressed higher levels pjnk lower levels p53 controls fig 2 expected level phosphorylation fak tyr397 sustained fak transfected cells cells transfected frnk fat studies cells transfected empty vector scrambled oligonucleotides performed control nonspecific alterations protein phosphorylation levels studies showed jnk p53 act downstream fak phosphorylation tyr397 fak catalytic domain likely important pathway
0.48235416.15778501.html.plaintext.txt	43	fak upstream regulator jnk phosphorylation p53 protein levels examine changes fak expression might affect jnk p53 signals transiently transfected cells fak cdna dominant negative deletion mutants fak fat frnk fak antisense oligonucleotide cells transfected fak treated proapoptotic fn fragment expressed lower levels pjnk higher levels p53 controls whereas cells transfected fat frnk fak antisense constructs expressed higher levels pjnk lower levels p53 controls fig 2 expected level phosphorylation fak tyr397 sustained fak transfected cells cells transfected frnk fat studies cells transfected empty vector scrambled oligonucleotides performed control nonspecific alterations protein phosphorylation levels studies showed jnk p53 act downstream fak phosphorylation tyr397 fak catalytic domain likely important pathway
0.48235416.15778501.html.plaintext.txt	44	view larger version 49k fig 4 antisense jnk1 treatment increases p53 levels western blots showing levels jnk1 fak pfak phosphorylated tyr397 pjnk p53 primary human fibroblasts cells transfected antisense jnk1 jnk1 oligonucleotide scrambled jnk1 oligonucleotide scr jnk1 mock transfected treated vh fragment 1 3 7 h c untreated controls actin served loading control b western blots showing jnk1 pjnk p53 levels primary human fibroblasts transfected different antisense jnk1 oligonucleotide jnk1 scrambled jnk1 oligonucleotide scr jnk1 mock transfected treated vh fragment 1 3 7 h actin served loading control
0.48235416.15778501.html.plaintext.txt	45	jnk1 jnk2 opposite regulators p53 examine association jnk fak p53 signals apoptosis triggered altered matrix performed series experiments cells transfected jnk1 jnk2 cdna dominant negative catalytically inactive construct jnk1 antisense oligonucleotides jnk1 jnk2 jnk1 overexpressing cells treated proapoptotic fn fragment p53 decreased control cells fig 3a jnk phosphorylation increased levels fak fak phosphorylated tyr397 actin unchanged
0.48235416.15778501.html.plaintext.txt	46	jnk1 jnk2 opposite regulators p53 examine association jnk fak p53 signals apoptosis triggered altered matrix performed series experiments cells transfected jnk1 jnk2 cdna dominant negative catalytically inactive construct jnk1 antisense oligonucleotides jnk1 jnk2 jnk1 overexpressing cells treated proapoptotic fn fragment p53 decreased control cells fig 3a jnk phosphorylation increased levels fak fak phosphorylated tyr397 actin unchanged
0.48235416.15778501.html.plaintext.txt	47	view larger version 74k fig 5 overexpression jnk2 suppress p53 protein levels western blots showing levels jnk2 pjnk jnk1 fak pfak phosphorylated tyr397 p53 primary human fibroblasts transfected jnk2 vector control mock transfected treated vh fn fragment 1 3 7 h c untreated controls actin used loading control
0.48235416.15778501.html.plaintext.txt	48	view larger version 52k fig 6 antisense jnk2 treatment decreases p53 protein levels western blots showing levels jnk2 fak pfak phosphorylated tyr397 pjnk p53 primary human fibroblasts transfected antisense jnk2 oligonucleotide jnk2 scrambled jnk2 oligonucleotide scr jnk2 mock transfected treated vh fn fragment 1 3 7 h c untreated controls actin served loading control b western blots showing jnk2 pjnk p53 levels primary human fibroblasts transfected different antisense jnk2 oligonucleotide jnk2 scrambled jnk2 oligonucleotide scr jnk2 mock transfected treated vh fragment 1 3 7 h actin served loading control
0.48235416.15778501.html.plaintext.txt	49	view larger version 25k fig 7 p53 expression suppressed jnk2 deficient cells western blots showing levels fak pfak phosphorylated tyr397 pjnk jnk2 p53 jnk2 deficient control ctl cells treated vh fn fragment 1 3 7 h c untreated controls actin served loading control b western blot showing p53 levels jnk2 deficient cells two different sources wild type controls equal protein loaded sample analyzed c western blots showing levels fak pfak phosphorylated tyr397 jnk1 jnk2 pjnk mouse fibroblasts derived jnk1jnk2 double knock outs control cells treated vh fragment 1 3 7 h actin served loading control d western blot showing p53 levels mouse fibroblasts derived jnk1jnk2 double knock outs wild type controls equal protein loaded sample analyzed
0.48235416.15778501.html.plaintext.txt	50	view larger version 34k fig 8 p53 feed back pjnk decrease pjnk protein levels pathway overexpressing p53 leads greater decrease pjnk levels whereas knocking p53 gene leads greater increases pjnk protein levels pathway western blots showing levels p53 pjnk jnk1 jnk2 fak pfak phosphorylated tyr397 primary human fibroblasts transfected p53 vector control mock transfected treated vh fragment 1 3 7 h c untreated controls actin used loading control b western blots showing levels fak pfak phosphorylated tyr397 pjnk jnk2 jnk1 p53 p53 knock cells wild type controls treated vh fn fragment 1 3 7 h actin served loading control
0.48235416.15778501.html.plaintext.txt	51	cells transfected dominant negative jnk1 construct p53 levels increased jnk phosphorylation levels unchanged fig 3b latter finding surprising thr183 tyr185 phosphorylation sites jnk1 mutated preventing activation upstream signals blocking ability regulate p53 changes noted total fak jnk2 actin levels fak phosphorylation tyr397
0.48235416.15778501.html.plaintext.txt	52	view larger version 21k fig 9 model fibronectin fragment mediated apoptosis signaling model fibronectin fragments interact cell surface receptors prior studies kapila et al 4 indicate likely integrin proteoglycan receptors interaction initiates signal transduction pathway involves dephosphorylation fak likely involving tyrosine 397 fak dephosphorylation leads increase jnk1 phosphorylation likely suppression dashed arrow jnk2 jnk1 triggers decrease p53 protein levels negative regulator p53 feed back jnk1 negatively regulate jnk1 phosphorylation double ended arrow jnk2 positively regulates p53 jnk p53 relocalize red arrows nucleus cell membrane interact fak transmit apoptotic signal
0.48235416.15778501.html.plaintext.txt	53	jnk1 expression abrogated two different antisense oligonucleotides p53 levels increased greater extent control cells transfected scrambled oligonucleotide empty vector fig 4 levels total fak actin fak phosphorylated try397 unchanged
0.48235416.15778501.html.plaintext.txt	54	cells overexpressing jnk2 treatment proapoptotic fn fragment increased levels jnk2 pjnk decrease p53 fig 5 western blotting pjnk identified band 54 kda likely represents jnk2 transfection jnk2 cdna produced strong unique band size total fak protein phosphorylation levels unchanged jnk1 actin protein levels
0.48235416.15778501.html.plaintext.txt	55	surprisingly abrogating jnk2 expression antisense oligonucleotides resulted complete nearly complete early reduction p53 protein levels fig 6 nonspecific suppression pjnk bands corresponding jnk1 likely related processing western blot total fak actin protein levels unchanged fak phosphorylation levels p53 levels also completely suppressed jnk2 deficient cells jnk2 fig 7 b cells deficient jnk1 jnk2 express p53 fig 7 c d
0.48235416.15778501.html.plaintext.txt	56	p53 feeds back pjnk regulate pjnk protein levels finally examined cells overexpressing deficient p53 fig 8 overexpression p53 led greater decrease pjnk levels vector transfected controls suggesting negative feedback mechanism involving jnk p53 consistent finding p53 deficient cells treated proapoptotic fn fragment expressed higher levels pjnk similarly treated wild type controls total fak pfak total jnk1 2 actin levels unchanged
0.48235416.15778501.html.plaintext.txt	57	discussion top abstract introduction experimental procedures results discussion references previously described novel alternative pathway apoptosis driven transcriptionally mediated decreases p53 c myc levels primary cells response altered matrix study demonstrate signaling mechanism propagated decreases fak phosphorylation likely mediated tyr397 linked increases jnk phosphorylation decreases p53 protein levels furthermore jnk1 jnk2 opposite effects regulating p53 appeared participate feedback mechanism jnk facilitate apoptotic process fig 9
0.48235416.15778501.html.plaintext.txt	58	discussion top abstract introduction experimental procedures results discussion references previously described novel alternative pathway apoptosis driven transcriptionally mediated decreases p53 c myc levels primary cells response altered matrix study demonstrate signaling mechanism propagated decreases fak phosphorylation likely mediated tyr397 linked increases jnk phosphorylation decreases p53 protein levels furthermore jnk1 jnk2 opposite effects regulating p53 appeared participate feedback mechanism jnk facilitate apoptotic process fig 9
0.48235416.15778501.html.plaintext.txt	59	several studies shown jnk interacts 13 14 phosphorylate p53 11 fact p53 jnk form complex jnk regulator p53 stability 13 16 one study sustained activation jnk1 regulated p53 expression apoptosis 16 similar findings however found jnk1 jnk2 opposite regulators p53 surprisingly treatment antisense jnk2 suppressed p53 levels controls altered fn matrix conditions jnk1 antisense treatment however increased p53 levels p53 expression also suppressed jnk2 deficient cells data indicate jnk2 expression tightly linked p53 jnk1 jnk2 regulate p53 different mechanisms furthermore increases jnk1 expression pjnk1 decreased p53 protein levels decreases jnk1 expression pjnk1 increased p53 levels conversely increases jnk2 expression pjnk2 may increase p53 levels decreases jnk2 expression pjnk2 profoundly decreased p53 levels thus jnk1 negative regulator jnk2 positive regulator p53 expression
0.48235416.15778501.html.plaintext.txt	60	several studies shown jnk interacts 13 14 phosphorylate p53 11 fact p53 jnk form complex jnk regulator p53 stability 13 16 one study sustained activation jnk1 regulated p53 expression apoptosis 16 similar findings however found jnk1 jnk2 opposite regulators p53 surprisingly treatment antisense jnk2 suppressed p53 levels controls altered fn matrix conditions jnk1 antisense treatment however increased p53 levels p53 expression also suppressed jnk2 deficient cells data indicate jnk2 expression tightly linked p53 jnk1 jnk2 regulate p53 different mechanisms furthermore increases jnk1 expression pjnk1 decreased p53 protein levels decreases jnk1 expression pjnk1 increased p53 levels conversely increases jnk2 expression pjnk2 may increase p53 levels decreases jnk2 expression pjnk2 profoundly decreased p53 levels thus jnk1 negative regulator jnk2 positive regulator p53 expression
0.48235416.15778501.html.plaintext.txt	61	antibody used detect pjnk also detects jnk1 2 3 western blots pjnk showed two bands 54 46 kda several reasons however confident treatment altered fn matrix increased jnk1 phosphorylation jnk2 jnk3 first transfection jnk1 construct fig 3a dominant negative jnk1 construct fig 3b showed increase two bands visible pjnk western blots control conditions indicating bands jnk1 isoforms second treatment jnk1 antisense oligonucleotide decreased bands indicating jnk1 isoforms fig 4a third transfection jnk2 construct induced new higher molecular mass band 54 kda pjnk seen treatments likely represents phosphorylated form jnk2 fig 5 fourth western analysis jnk2 deficient cells showed two bands likely represent two isoforms jnk1 bands seen western blots cells deficient jnk1 jnk2
0.48235416.15778501.html.plaintext.txt	62	antibody used detect pjnk also detects jnk1 2 3 western blots pjnk showed two bands 54 46 kda several reasons however confident treatment altered fn matrix increased jnk1 phosphorylation jnk2 jnk3 first transfection jnk1 construct fig 3a dominant negative jnk1 construct fig 3b showed increase two bands visible pjnk western blots control conditions indicating bands jnk1 isoforms second treatment jnk1 antisense oligonucleotide decreased bands indicating jnk1 isoforms fig 4a third transfection jnk2 construct induced new higher molecular mass band 54 kda pjnk seen treatments likely represents phosphorylated form jnk2 fig 5 fourth western analysis jnk2 deficient cells showed two bands likely represent two isoforms jnk1 bands seen western blots cells deficient jnk1 jnk2
0.48235416.15778501.html.plaintext.txt	63	interestingly overexpression p53 limited phosphorylation jnk normally induced altered fn matrix suggesting p53 pjnk participate negative feedback mechanism similarly previous studies introduction p53 p53 null cells reduced jnk activity low basal level 24 possibly indicating feedback p53 jnk
0.48235416.15778501.html.plaintext.txt	64	interestingly overexpression p53 limited phosphorylation jnk normally induced altered fn matrix suggesting p53 pjnk participate negative feedback mechanism similarly previous studies introduction p53 p53 null cells reduced jnk activity low basal level 24 possibly indicating feedback p53 jnk
0.48235416.15778501.html.plaintext.txt	65	jnks family stress related kinases altered fn matrix represents stressful condition jnks seems play role sites inflammation extracellular matrix degraded proteolytic enzymes inflammatory milieu degraded matrix conveys messages different normally conveyed intact stable matrix degradation increases severity disease periodontal disease arthritis fn fragments abundant diseased sites 6 25 30 previously found proteolytic 40 kda fragment fn associated advanced disease also induced apoptosis periodontal ligament fibroblasts vitro regulating p53 c myc 6 7 40 kda fragment comparable recombinant fn fragment tested induced apoptosis fibroblasts via novel alternative pathway involves decreases fak phosphorylation regulation p53 c myc pathway appears triggered cooperative interactions integrins chondroitin sulfate proteoglycan 4 5 present findings add inflammation associated apoptotic pathway also involves interactions pfak jnk1 2 phosphorylated isoforms oppositely regulate p53 expression levels
0.48235416.15778501.html.plaintext.txt	66	jnks family stress related kinases altered fn matrix represents stressful condition jnks seems play role sites inflammation extracellular matrix degraded proteolytic enzymes inflammatory milieu degraded matrix conveys messages different normally conveyed intact stable matrix degradation increases severity disease periodontal disease arthritis fn fragments abundant diseased sites 6 25 30 previously found proteolytic 40 kda fragment fn associated advanced disease also induced apoptosis periodontal ligament fibroblasts vitro regulating p53 c myc 6 7 40 kda fragment comparable recombinant fn fragment tested induced apoptosis fibroblasts via novel alternative pathway involves decreases fak phosphorylation regulation p53 c myc pathway appears triggered cooperative interactions integrins chondroitin sulfate proteoglycan 4 5 present findings add inflammation associated apoptotic pathway also involves interactions pfak jnk1 2 phosphorylated isoforms oppositely regulate p53 expression levels
0.48235416.15778501.html.plaintext.txt	67	footnotes work supported national institutes health grants r01 de13725 y l k t32 de07306 b w t35 de07103 j l costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.48235416.15778501.html.plaintext.txt	68	authors contributed equally work
0.48235416.15778501.html.plaintext.txt	69	correspondence addressed dept periodonticspreventiongeriatrics university michigan school dentistry rm 5213 1011 n university ave ann arbor mi 48109 1078 tel 734 615 2295 fax 734 763 5503 e mail ykapilaatumichedu u d
0.48235416.15778501.html.plaintext.txt	70	correspondence addressed dept periodonticspreventiongeriatrics university michigan school dentistry rm 5213 1011 n university ave ann arbor mi 48109 1078 tel 734 615 2295 fax 734 763 5503 e mail ykapilaatumichedu u d
0.48235416.15778501.html.plaintext.txt	71	1 abbreviations used fn fibronectin jnk c jun n terminal kinase p eg pjnk phosphorylated sapk stress activated protein kinase fak focal adhesion kinase fat focal adhesion targeting frnk fak related non kinase vh recombinant fibronectin fragment containing alternatively spliced v region mutated heparin binding domain pbs phosphate buffered saline fitc fluorescein isothiocyanate dapi 46 diamidino 2 phenylindol
0.48235416.15778501.html.plaintext.txt	72	acknowledgments thank drs bert vogelstein caroline damsky dusko ilic roger davis gary firestein paul johnson gifts reagents stephen ordway editorial advice
0.48235416.15778501.html.plaintext.txt	73	acknowledgments thank drs bert vogelstein caroline damsky dusko ilic roger davis gary firestein paul johnson gifts reagents stephen ordway editorial advice
0.48235416.15778501.html.plaintext.txt	74	references top abstract introduction experimental procedures results discussion references kapila y l kapila johnson p w 1996 matrix biol 15 251 261crossrefmedline order article via infotrieve kapila y l lancero h johnson p w 1998 j periodontol 69 1008 1019medline order article via infotrieve kapila y l niu j johnson p w 1997 j biol chem 272 18932 18938abstractfree full text kapila y l wang johnson p w 1999 j biol chem 274 30906 30913abstractfree full text kapila y l wang dazin p tafolla e mass m j 2002 j biol chem 277 8482 8491abstractfree full text huynh q n wang tafolla e gansky kapila armitage g kapila y l 2002 j periodontol 73 1105 1114 tafolla e iwama wang kapila y 2003 j dent res 82b 2213 abstr tafolla e leong j wang kapila y l 2004 j dent res 83b 1621 abstr almeida e ilic d han q hauck c r jin f kawakatsu h schlaepfer d d damsky c h 2000 j cell biol 149 741 754abstractfree full text ilic d almeida e schlaepfer d d dazin p aizawa damsky c h 1998 j cell biol 143 547 560abstractfree full text adler v pincus m r minamoto fuchs y bluth m j brandt rauf p w friedman f k robinson r c chen j m wang x w harris c c ronai z 1997 proc natl acad sci u 94 1686 1691abstractfree full text buschmann adler v matsevich e fuchs y ronai z 2000 cancer res 60 896 900abstractfree full text fuchs y adler v buschmann yin z wu z jones n ronai z 1998 genes dev 12 2658 2663abstractfree full text fuchs y adler v pincus m r ronai 1998 proc natl acad sci u 95 10541 10546abstractfree full text metzler b hu y dietrich h xu q 2000 j pathol 156 1875 1886abstractfree full text wang j friedman e 2000 mol carcinog 29 179 18830co2 k 1416abstractfree full text ip y davis r j 1998 curr opin cell biol 10 205 219crossrefmedline order article via infotrieve hu m c qiu w r wang y p 1997 oncogene 15 2277 2287crossrefmedline order article via infotrieve baker j markowitz fearon e r willson j k vogelstein b 1990 science 249 912 915medline order article via infotrieve lallier bronner fraser m 1993 science 259 692 695medline order article via infotrieve townsend p villanova uhlmann e 2000 eur j cancer 36 397 409crossrefmedline order article via infotrieve akhtar kole r juliano r l 1991 life sci 49 1793 1801crossrefmedline order article via infotrieve shklyaev namba h sautin y mitsutake n nagayama y ishikawa n ito k zeki k yamashita 2001 anticancer res 21 2569 2575medline order article via infotrieve carsons lavietes b b diamond h kinney g 1985 arthritis rheum 28 601 612medline order article via infotrieve clemmensen andersen r b 1982 arthritis rheum 25 25 31medline order article via infotrieve griffiths m herbert k e perrett d scott d l 1989 clin chim acta 184 133 146crossrefmedline order article via infotrieve talonpoika j heino j larjava h hakkinen l paunio k 1989 scand j dent res 97 415 421medline order article via infotrieve talonpoika j paunio k soderling e 1993 scand j dent res 101 375 381medline order article via infotrieve xie d l meyers r homandberg g 1992 j rheum 19 1448 1452medline order article via infotrieve
0.4897949.15937335.html.plaintext.txt	0	induction p53 urokinase lung epithelial cells sreerama shetty margaret r gyetko andrew p mazar
0.4897949.15937335.html.plaintext.txt	1	department specialty care services university texas health center tyler texas 75708 pulmonary critical care medicine division department internal medicine ann arbor veterans affairs medical center university michigan medical center ann arbor michigan 48109 attenuon llc san diego california 92121
0.4897949.15937335.html.plaintext.txt	2	received publication november 22 2004 revised form april 29 2005
0.4897949.15937335.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references urokinase plasminogen activator upa serine protease catalyzes conversion plasminogen plasmin plasminogenplasmin system includes upa receptor inhibitor plasminogen activator inhibitor 1 interactions molecules regulate cellular proteolysis well adhesion cellular proliferation migration processes germane pathogenesis lung injury neoplasia previous studies found upa regulates cell surface fibrinolysis regulating expression well upa receptor plasminogen activator inhibitor 1 study found upa alters expression tumor suppressor protein p53 beas2b airway epithelial cells time concentration dependent manner effects require upa catalytic activity amino terminal fragment upa lacking catalytic activity potent two chain active upa single chain upa also enhanced p53 expression extent intact two chain active upa amino terminal fragment pretreatment cells anti 1 integrin antibody blocked upa induced p53 expression upa induced p53 expression occurs without increased p53 mrna expression however upa induced oncoprotein mdm2 concentration dependent manner upa induced p53 expression require activation tyrosine kinases inactivation protein tyrosine phosphatase shp 2 inhibits basal upa induced p53 expression plasmin alter upa mediated p53 expression induction p53 expression exposure lung epithelial cells upa newly recognized pathway urokinase may influence proliferation lung epithelial cells pathway could regulate pathophysiologic alterations p53 expression setting lung inflammation neoplasia
0.4897949.15937335.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references urokinase plasminogen activator upa serine protease catalyzes conversion plasminogen plasmin plasminogenplasmin system includes upa receptor inhibitor plasminogen activator inhibitor 1 interactions molecules regulate cellular proteolysis well adhesion cellular proliferation migration processes germane pathogenesis lung injury neoplasia previous studies found upa regulates cell surface fibrinolysis regulating expression well upa receptor plasminogen activator inhibitor 1 study found upa alters expression tumor suppressor protein p53 beas2b airway epithelial cells time concentration dependent manner effects require upa catalytic activity amino terminal fragment upa lacking catalytic activity potent two chain active upa single chain upa also enhanced p53 expression extent intact two chain active upa amino terminal fragment pretreatment cells anti 1 integrin antibody blocked upa induced p53 expression upa induced p53 expression occurs without increased p53 mrna expression however upa induced oncoprotein mdm2 concentration dependent manner upa induced p53 expression require activation tyrosine kinases inactivation protein tyrosine phosphatase shp 2 inhibits basal upa induced p53 expression plasmin alter upa mediated p53 expression induction p53 expression exposure lung epithelial cells upa newly recognized pathway urokinase may influence proliferation lung epithelial cells pathway could regulate pathophysiologic alterations p53 expression setting lung inflammation neoplasia
0.4897949.15937335.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references urokinase plasminogen activator upa1 serine protease catalyzes conversion plasminogen plasmin 1 3 proteolytic enzyme upa implicated pathogenesis lung inflammation growth lung tumors upa facilitates remodeling transitional stroma via breakdown basement membranes extracellular matrix proteins including fibrin 1 3 implicated stromal remodeling may occur either lung inflammation neoplasia
0.4897949.15937335.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references urokinase plasminogen activator upa1 serine protease catalyzes conversion plasminogen plasmin 1 3 proteolytic enzyme upa implicated pathogenesis lung inflammation growth lung tumors upa facilitates remodeling transitional stroma via breakdown basement membranes extracellular matrix proteins including fibrin 1 3 implicated stromal remodeling may occur either lung inflammation neoplasia
0.4897949.15937335.html.plaintext.txt	7	pathologic overexpression upa linked wide range inflammatory neoplastic lung diseases 4 5 example high levels upa well pai 1 upar lung tumor tissue correlate poor prognosis 6 7 addition increasingly compelling evidence involvement upa system cell proliferation migration tumor invasion metastasis 8 17 positioned plasminogen activation central propagation neoplasms 5 certain tumors neoplastic growth effectively attenuated pai 1 presumably interaction upa 18
0.4897949.15937335.html.plaintext.txt	8	pathologic overexpression upa linked wide range inflammatory neoplastic lung diseases 4 5 example high levels upa well pai 1 upar lung tumor tissue correlate poor prognosis 6 7 addition increasingly compelling evidence involvement upa system cell proliferation migration tumor invasion metastasis 8 17 positioned plasminogen activation central propagation neoplasms 5 certain tumors neoplastic growth effectively attenuated pai 1 presumably interaction upa 18
0.4897949.15937335.html.plaintext.txt	9	addition proteolytic properties recent data laboratory demonstrated upa enhanced expression upa upar pai 1 beas2b cells 19 21 elaboration molecules influences two major features associated lung neoplasia including excessive proliferation neoplastic cells capacity invade normal tissues clear pathogenesis lung neoplasia prominently involves expression tumor suppressor protein p53 22 24 well extracellular matrix degradation upa mediated plasminogen activation 6 7 24 among plethora potentially useful markers tumor virulence identified date upa p53 appear promising 24 25 prognostic value upa p53 accumulation reported primary breast cancer patients 8 16 supporting role tumor progression overall survival however direct relationship tumor suppression extracellular matrix degradation established date
0.4897949.15937335.html.plaintext.txt	10	addition proteolytic properties recent data laboratory demonstrated upa enhanced expression upa upar pai 1 beas2b cells 19 21 elaboration molecules influences two major features associated lung neoplasia including excessive proliferation neoplastic cells capacity invade normal tissues clear pathogenesis lung neoplasia prominently involves expression tumor suppressor protein p53 22 24 well extracellular matrix degradation upa mediated plasminogen activation 6 7 24 among plethora potentially useful markers tumor virulence identified date upa p53 appear promising 24 25 prognostic value upa p53 accumulation reported primary breast cancer patients 8 16 supporting role tumor progression overall survival however direct relationship tumor suppression extracellular matrix degradation established date
0.4897949.15937335.html.plaintext.txt	11	stimulation lung epithelium upa elicits proliferative responses via signaling mechanisms incompletely characterized present expression growth factor activity attributed upa stimulation suggests activation signaling processes 8 16 upa bound receptor activates intracellular signaling protein intermediates currently well understood overexpression either upa upar pai 1 tumor cells 19 25 28 well potent growth factor activity upa epithelial cells prompted us test possibility upa might regulate p53 expression lung epithelial cells possibility explored previously knowledge report new paradigm p53 expression lung epithelial cells regulated upa also characterize responsible mechanism pathway could influence alveolar p53 expression thereby modulate upa mediated responses lung epithelial cells lung injury neoplasia
0.4897949.15937335.html.plaintext.txt	12	stimulation lung epithelium upa elicits proliferative responses via signaling mechanisms incompletely characterized present expression growth factor activity attributed upa stimulation suggests activation signaling processes 8 16 upa bound receptor activates intracellular signaling protein intermediates currently well understood overexpression either upa upar pai 1 tumor cells 19 25 28 well potent growth factor activity upa epithelial cells prompted us test possibility upa might regulate p53 expression lung epithelial cells possibility explored previously knowledge report new paradigm p53 expression lung epithelial cells regulated upa also characterize responsible mechanism pathway could influence alveolar p53 expression thereby modulate upa mediated responses lung epithelial cells lung injury neoplasia
0.4897949.15937335.html.plaintext.txt	13	experimental procedures top abstract introduction experimental procedures results discussion references materials culture media penicillin streptomycin fetal calf serum purchased invitrogen tissue culture plastics discovery labware herbimycin genistein bovine serum albumin bsa ovalbumin tris base aprotinin dithiothreitol phenylmethylsulfonyl fluoride silver nitrate ammonium persulfate phorbol 12 myristate 13 acetate sigma acrylamide bisacrylamide nitrocellulose bio rad recombinant high molecular weight two chain hmw upa generous gift drs jack henkin abbott low molecular weight lmw amino terminal fragment atf anti upa anti upar antibodies obtained american diagnostics greenwich ct anti integrin antibodies calbiochem anti p53 anti mdm2 antibodies purchased santa cruz biotechnology santa cruz ca anti phosphoserine 15 serine 20 p53 antibodies cell signaling technology beverly ma a5 b428 compounds angstrom pharmaceuticals san diego ca xar x ray film purchased eastman kodak co
0.4897949.15937335.html.plaintext.txt	14	experimental procedures top abstract introduction experimental procedures results discussion references materials culture media penicillin streptomycin fetal calf serum purchased invitrogen tissue culture plastics discovery labware herbimycin genistein bovine serum albumin bsa ovalbumin tris base aprotinin dithiothreitol phenylmethylsulfonyl fluoride silver nitrate ammonium persulfate phorbol 12 myristate 13 acetate sigma acrylamide bisacrylamide nitrocellulose bio rad recombinant high molecular weight two chain hmw upa generous gift drs jack henkin abbott low molecular weight lmw amino terminal fragment atf anti upa anti upar antibodies obtained american diagnostics greenwich ct anti integrin antibodies calbiochem anti p53 anti mdm2 antibodies purchased santa cruz biotechnology santa cruz ca anti phosphoserine 15 serine 20 p53 antibodies cell signaling technology beverly ma a5 b428 compounds angstrom pharmaceuticals san diego ca xar x ray film purchased eastman kodak co
0.4897949.15937335.html.plaintext.txt	15	cell cultures human bronchial epithelial cells beas2b obtained atcc cells maintained lhc 9 rpmi 1640 medium containing 10 heat inactivated fetal calf serum 1 glutamine 1 antibiotics described previously 19 primary cultures human small airway epithelial sae cells obtained clonetics san diego cultured media described previously 19
0.4897949.15937335.html.plaintext.txt	16	cell cultures human bronchial epithelial cells beas2b obtained atcc cells maintained lhc 9 rpmi 1640 medium containing 10 heat inactivated fetal calf serum 1 glutamine 1 antibiotics described previously 19 primary cultures human small airway epithelial sae cells obtained clonetics san diego cultured media described previously 19
0.4897949.15937335.html.plaintext.txt	17	total protein extraction western blotting cells grown confluence serum starved overnight rpmi 1640 media cells treated without recombinant human two chain upa agents selected times serum free media supplemented 05 bsa following treatments cells suspended lysis buffer 10 mm tris hcl ph 74 containing 150 mm nacl 1 triton x 100 15 glycerol 1 mm na3vo4 1 mm naf 1 mm edta 1 mm phenylmethylsulfonyl fluoride 3 10 microg aprotinin per 100 ml cell lysates prepared using three cycles freezing thawing proteins beas2b cell lysates 50 microg separated sds page transferred nitrocellulose membrane membrane blocked 1 bsa wash buffer 1 h room temperature followed overnight hybridization anti p53 monoclonal antibody buffer 4 degrees c washed p53 immunoreactive proteins detected enhanced chemiluminescence membranes stripped mercaptoethanol subjected western blotting actin monoclonal antibody
0.4897949.15937335.html.plaintext.txt	18	total protein extraction western blotting cells grown confluence serum starved overnight rpmi 1640 media cells treated without recombinant human two chain upa agents selected times serum free media supplemented 05 bsa following treatments cells suspended lysis buffer 10 mm tris hcl ph 74 containing 150 mm nacl 1 triton x 100 15 glycerol 1 mm na3vo4 1 mm naf 1 mm edta 1 mm phenylmethylsulfonyl fluoride 3 10 microg aprotinin per 100 ml cell lysates prepared using three cycles freezing thawing proteins beas2b cell lysates 50 microg separated sds page transferred nitrocellulose membrane membrane blocked 1 bsa wash buffer 1 h room temperature followed overnight hybridization anti p53 monoclonal antibody buffer 4 degrees c washed p53 immunoreactive proteins detected enhanced chemiluminescence membranes stripped mercaptoethanol subjected western blotting actin monoclonal antibody
0.4897949.15937335.html.plaintext.txt	19	overexpression upa transfection beas2b cells upa cdna upa cdna 28 subcloned eukaryotic expression vector prccmv2 invitrogen containing cmv promoter hindiiinoti sites orientations sequences confirmed nucleotide sequencing beas2b cells transfected prepared plasmid constructs lipofection using lipofectamine invitrogen stable cell lines created treating beas2b cells neomycin 3 months cells carrying plasmid dna survived neomycin treatment scraped 6 well plates grown t75 flasks presence plasmid dna confirmed pcr using specific primers overexpression upa cdna transfected cells confirmed western blotting beas2b cell lysates well conditioned media using upa monoclonal antibody effect endogenous upa overexpression p53 induction measured western blot described 19
0.4897949.15937335.html.plaintext.txt	20	overexpression upa transfection beas2b cells upa cdna upa cdna 28 subcloned eukaryotic expression vector prccmv2 invitrogen containing cmv promoter hindiiinoti sites orientations sequences confirmed nucleotide sequencing beas2b cells transfected prepared plasmid constructs lipofection using lipofectamine invitrogen stable cell lines created treating beas2b cells neomycin 3 months cells carrying plasmid dna survived neomycin treatment scraped 6 well plates grown t75 flasks presence plasmid dna confirmed pcr using specific primers overexpression upa cdna transfected cells confirmed western blotting beas2b cell lysates well conditioned media using upa monoclonal antibody effect endogenous upa overexpression p53 induction measured western blot described 19
0.4897949.15937335.html.plaintext.txt	21	inhibition protein tyrosine phosphatase expression catalytically inactive mutants shp 1 shp 2 designated shp c shp 2 c prepared described previously 29 30 cdnas encoding shp 1 c shp 2 c inserted adenovirus transfer vector paccmvplpa 31 recombinant adenovirus generated co transfection 293 cells paccmvplpa construct pjm17 adenovirus genome dna ubiquitin activating enzyme ubiquitin protein isopeptide ligase deletions using fugene 6 cell transfection reagent roche applied science resulting recombinant viral clones purified soft agar plaque assay amplified 293 cells according standard procedure 31 positive clones selected based expression shp 1 c shp 2 c infected 293 cells subconfluent cells infected replication defective recombinant control vector cdna containing adenovirus multiplicity infection 10 20 plaque forming unitscell 36 h cells later treated phosphate buffered saline 50 ngml upa 24 h total cell lysates prepared analyzed p53 well phospho shp 2 total shp 2 expression western blot described confirm shp 2 regulates p53 expression separate experiment shp 2 cdna cloned eukaryotic expression vector pcdna31 beas2b cells transfected vector cdna vector dna containing shp 2 cdna using lipofectamine stable cell lines created treating beas2b cells neomycin 3 months described effect shp 2 overexpression p53 induction confirmed western blot
0.4897949.15937335.html.plaintext.txt	22	inhibition protein tyrosine phosphatase expression catalytically inactive mutants shp 1 shp 2 designated shp c shp 2 c prepared described previously 29 30 cdnas encoding shp 1 c shp 2 c inserted adenovirus transfer vector paccmvplpa 31 recombinant adenovirus generated co transfection 293 cells paccmvplpa construct pjm17 adenovirus genome dna ubiquitin activating enzyme ubiquitin protein isopeptide ligase deletions using fugene 6 cell transfection reagent roche applied science resulting recombinant viral clones purified soft agar plaque assay amplified 293 cells according standard procedure 31 positive clones selected based expression shp 1 c shp 2 c infected 293 cells subconfluent cells infected replication defective recombinant control vector cdna containing adenovirus multiplicity infection 10 20 plaque forming unitscell 36 h cells later treated phosphate buffered saline 50 ngml upa 24 h total cell lysates prepared analyzed p53 well phospho shp 2 total shp 2 expression western blot described confirm shp 2 regulates p53 expression separate experiment shp 2 cdna cloned eukaryotic expression vector pcdna31 beas2b cells transfected vector cdna vector dna containing shp 2 cdna using lipofectamine stable cell lines created treating beas2b cells neomycin 3 months described effect shp 2 overexpression p53 induction confirmed western blot
0.4897949.15937335.html.plaintext.txt	23	plasmid construction plasmid p53pgem obtained pcr amplification human lung cdna library cdna corresponding coding region 05 kb subcloned pgemr vector promega sequence clones confirmed nucleotide sequencing p53 insert released ncoi psti purified 1 agarose gels extracted phenolchloroform used cdna probe northern blotting
0.4897949.15937335.html.plaintext.txt	24	plasmid construction plasmid p53pgem obtained pcr amplification human lung cdna library cdna corresponding coding region 05 kb subcloned pgemr vector promega sequence clones confirmed nucleotide sequencing p53 insert released ncoi psti purified 1 agarose gels extracted phenolchloroform used cdna probe northern blotting
0.4897949.15937335.html.plaintext.txt	25	random priming p53 cdna cdna template p53 released ncoipsti purified 1 agarose gels labeled 32pdctp using rediprime labeling kit promega madison wi passage sephadex g 25 column removed unincorporated radioactivity specific activity product 6 7 x 108 cpm microg
0.4897949.15937335.html.plaintext.txt	26	random priming p53 cdna cdna template p53 released ncoipsti purified 1 agarose gels labeled 32pdctp using rediprime labeling kit promega madison wi passage sephadex g 25 column removed unincorporated radioactivity specific activity product 6 7 x 108 cpm microg
0.4897949.15937335.html.plaintext.txt	27	p53 mrna assessment northern blotting northern blotting used assess level p53 mrna confluent beas2b cells serum starved overnight rpmibsa media treated two chain human recombinant upa varying times 0 24 h media total rna isolated using trireagent rna 20 microg separated agaroseformaldehyde gels electrophoresis rna transferred hybond n according instructions manufacturer prehybridization hybridization done 65 degrees c nacl 1 m sds 1 100 microgml salmon sperm dna hybridization performed p53 cdna probes 1 ngml labeled 6 7 x 108 cpm microg dna overnight hybridization filters washed twice 15 min 65 degrees c 2x ssc 1 sds 1x ssc 1 sds 01 ssc 1 sds respectively membranes exposed x ray film 70 degrees c overnight intensity bands measured densitometry normalized actin
0.4897949.15937335.html.plaintext.txt	28	p53 mrna assessment northern blotting northern blotting used assess level p53 mrna confluent beas2b cells serum starved overnight rpmibsa media treated two chain human recombinant upa varying times 0 24 h media total rna isolated using trireagent rna 20 microg separated agaroseformaldehyde gels electrophoresis rna transferred hybond n according instructions manufacturer prehybridization hybridization done 65 degrees c nacl 1 m sds 1 100 microgml salmon sperm dna hybridization performed p53 cdna probes 1 ngml labeled 6 7 x 108 cpm microg dna overnight hybridization filters washed twice 15 min 65 degrees c 2x ssc 1 sds 1x ssc 1 sds 01 ssc 1 sds respectively membranes exposed x ray film 70 degrees c overnight intensity bands measured densitometry normalized actin
0.4897949.15937335.html.plaintext.txt	29	assessment apoptosis order determine whether upa induces apoptosis treated beas2b cells varying concentrations 0 1000 ngml upa cells assayed internucleosomal dna fragmentation laddering using isolation reagents r d systems minneapolis mn isolated dna size fractionated gel electrophoresis visualized ethidium bromide alternatively also determined programmed cell death measuring annexin v phosphatidylserine interaction using bd apoalert kit bd biosciences followed flow cytometry analysis described manufacturer
0.4897949.15937335.html.plaintext.txt	30	assessment apoptosis order determine whether upa induces apoptosis treated beas2b cells varying concentrations 0 1000 ngml upa cells assayed internucleosomal dna fragmentation laddering using isolation reagents r d systems minneapolis mn isolated dna size fractionated gel electrophoresis visualized ethidium bromide alternatively also determined programmed cell death measuring annexin v phosphatidylserine interaction using bd apoalert kit bd biosciences followed flow cytometry analysis described manufacturer
0.4897949.15937335.html.plaintext.txt	31	dna synthesis beas2b cells treated without tcupa 48 h pulse labeled 1 microciml 3hthymidine 8 h labeling cells washed cold 15 wv trichloroacetic acid followed four subsequent washes cold 10 trichloroacetic acid cells lysed cell associated radioactivity measured liquid scintillation counter
0.4897949.15937335.html.plaintext.txt	32	dna synthesis beas2b cells treated without tcupa 48 h pulse labeled 1 microciml 3hthymidine 8 h labeling cells washed cold 15 wv trichloroacetic acid followed four subsequent washes cold 10 trichloroacetic acid cells lysed cell associated radioactivity measured liquid scintillation counter
0.4897949.15937335.html.plaintext.txt	33	results top abstract introduction experimental procedures results discussion references time concentration dependent induction p53 upa found previously lung carcinoma derived cells differentially express upa vitro 25 upa induces expression beas2b cells 20 initially sought determine whether upa regulates p53 expression beas2b cells nonmalignant lung epithelial cell line therefore treated cells high molecular weight two chain form upa varying lengths 0 24 h time total proteins cell lysates used western blotting using anti p53 antibody surprise upa instead inhibiting p53 expression induced expression beas2b cells time dependent manner fig 1a induction detectable 30 min addition upa increases modestly 24 h identical upa treatment also induced p53 expression primary sae cells fig 1b
0.4897949.15937335.html.plaintext.txt	34	results top abstract introduction experimental procedures results discussion references time concentration dependent induction p53 upa found previously lung carcinoma derived cells differentially express upa vitro 25 upa induces expression beas2b cells 20 initially sought determine whether upa regulates p53 expression beas2b cells nonmalignant lung epithelial cell line therefore treated cells high molecular weight two chain form upa varying lengths 0 24 h time total proteins cell lysates used western blotting using anti p53 antibody surprise upa instead inhibiting p53 expression induced expression beas2b cells time dependent manner fig 1a induction detectable 30 min addition upa increases modestly 24 h identical upa treatment also induced p53 expression primary sae cells fig 1b
0.4897949.15937335.html.plaintext.txt	35	next treated beas2b cells varying amounts 0 1000 ngml 0 20 nm upa 24 h measured p53 expression western blotting data shown fig 1c indicate upa induced p53 expression beas2b cells concentration dependent manner effect apparent concentrations low 10 ngml 02 nm maximum p53 expression observed upa concentration 1 nm higher upa concentrations beyond 5 nm upa inhibited p53 expression beas2b cells
0.4897949.15937335.html.plaintext.txt	36	view larger version 36k fig 1 time concentration dependent p53 expression upa lung epithelial beas2b cells time dependent p53 expression upa confluent beas2b cells treated two chain upa 50 ngml 1 nm 0 24 h 37 degrees c basal medium containing 05 bsa total proteins separated 8 sds polyacrylamide gel transferred nitrocellulose membranes membrane immunoblotted anti p53 antibody data illustrated representative eight independent experiments lower panel shows actin proteins loading controls integrated densitometric data eight experiments shown line graph b western blot p53 protein primary sae cells treated phosphate buffered saline tcupa 24 h corresponding blots stripped developed actin monoclonal antibody assessment equal loading mean density individual bands presented bar graph c effect upa concentration p53 expression beas2b cells grown confluence treated varying amounts upa 0 1000 ngml 24 h 37 degrees c basal medium containing 05 bsa total proteins separated 8 sds polyacrylamide gel transferred nitrocellulose membrane membrane immunoblotted anti p53 antibody figure shown representative three separate experiments mean density individual bands presented line graph
0.4897949.15937335.html.plaintext.txt	37	rule contaminating lipopolysaccharides lps high molecular weight upa hmw upa preparation used responsible induction p53 measured lps content preparation limulus amebocyte lysate enzyme linked immunosorbent assay method found hmw upa preparation contains negligible amounts 1 pgml lps making unlikely lps could responsible induction p53 experiments
0.4897949.15937335.html.plaintext.txt	38	rule contaminating lipopolysaccharides lps high molecular weight upa hmw upa preparation used responsible induction p53 measured lps content preparation limulus amebocyte lysate enzyme linked immunosorbent assay method found hmw upa preparation contains negligible amounts 1 pgml lps making unlikely lps could responsible induction p53 experiments
0.4897949.15937335.html.plaintext.txt	39	induction p53 endogenous upa confirm independently lps content hmw upa preparation account induction p53 next prepared upa overproducing beas2b cells vector containing controls transfecting cells eukaryotic expression vector prccmv2 containing upa cdna prccmv2 cdna using lipofection analyzed p53 expression stable cell lines western blotting shown fig 2 beas2b cells transfected upa cdna expressed 35 fold p53 comparison vector transfected nontransfected control cells also found comparable increase p53 protein expression upa cdna transfected cells compared vector cdna nontransfected control cells metabolic labeling 35smethionine followed immunoprecipitation using anti p53 monoclonal antibody data shown
0.4897949.15937335.html.plaintext.txt	40	induction p53 endogenous upa confirm independently lps content hmw upa preparation account induction p53 next prepared upa overproducing beas2b cells vector containing controls transfecting cells eukaryotic expression vector prccmv2 containing upa cdna prccmv2 cdna using lipofection analyzed p53 expression stable cell lines western blotting shown fig 2 beas2b cells transfected upa cdna expressed 35 fold p53 comparison vector transfected nontransfected control cells also found comparable increase p53 protein expression upa cdna transfected cells compared vector cdna nontransfected control cells metabolic labeling 35smethionine followed immunoprecipitation using anti p53 monoclonal antibody data shown
0.4897949.15937335.html.plaintext.txt	41	view larger version 21k fig 2 overexpression endogenous upa induces p53 expression proteins cell lysates untreated beas2b cells 1st lane beas2b cells transfected expression vector prccmv alone 2nd lane beas2b cells transfected upa cdna eukaryotic expression vector prccmv 3rd lane assayed p53 expression proteins separated 8 sds polyacrylamide gels transferred nitrocellulose membrane membrane immunoblotted anti p53 antibody data illustrated representative three independent experiments lower panel shows actin proteins loading control mean density individual bands three independent experiments presented bar graph
0.4897949.15937335.html.plaintext.txt	42	induction p53 mrna expression upa lung epithelial cells determined upa mediates time dependent p53 protein expression beas2b cell next sought evaluate whether increased expression p53 attributable increased level p53 mrna measured steady state levels p53 mrna upa treated beas2b cells northern blotting using p53 cdna probe shown fig 3 upa failed induce p53 mrna beas2b cells data demonstrate upa increases p53 protein expression beas2b cells determined western blotting without altering expression p53 mrna
0.4897949.15937335.html.plaintext.txt	43	induction p53 mrna expression upa lung epithelial cells determined upa mediates time dependent p53 protein expression beas2b cell next sought evaluate whether increased expression p53 attributable increased level p53 mrna measured steady state levels p53 mrna upa treated beas2b cells northern blotting using p53 cdna probe shown fig 3 upa failed induce p53 mrna beas2b cells data demonstrate upa increases p53 protein expression beas2b cells determined western blotting without altering expression p53 mrna
0.4897949.15937335.html.plaintext.txt	44	effect upa phosphorylation p53 mdm2 expression upa induce p53 mrna expression p53 undergoes phosphorylation multiple sites vitro vivo 32 33 asked whether upa regulates p53 expression phosphorylation serine 15 20 p53 leads reduced interaction negative regulator oncoprotein mdm2 34 test hypothesis treated cells varying amounts upa 0 1000 ngml 24 h 37 degrees c analyzed cell lysates phosphorylation p53 ser 15 ser 20 western blotting using phosphospecific antibodies shown fig 4a upa 50 ngml 1 nm induced ser 15 phosphorylation however higher concentrations beyond 250 ngml 5 nm upa failed induce ser 15 phosphorylation upa induce ser 20 phosphorylation significant extent beas2b cells next treated bas2b cells upa 50 ngml 0 24 h analyzed phosphorylation p53 ser 15 found upa induced ser 15 phosphorylation early 10 min treatment elevated level maintained 24 h fig 4b
0.4897949.15937335.html.plaintext.txt	45	effect upa phosphorylation p53 mdm2 expression upa induce p53 mrna expression p53 undergoes phosphorylation multiple sites vitro vivo 32 33 asked whether upa regulates p53 expression phosphorylation serine 15 20 p53 leads reduced interaction negative regulator oncoprotein mdm2 34 test hypothesis treated cells varying amounts upa 0 1000 ngml 24 h 37 degrees c analyzed cell lysates phosphorylation p53 ser 15 ser 20 western blotting using phosphospecific antibodies shown fig 4a upa 50 ngml 1 nm induced ser 15 phosphorylation however higher concentrations beyond 250 ngml 5 nm upa failed induce ser 15 phosphorylation upa induce ser 20 phosphorylation significant extent beas2b cells next treated bas2b cells upa 50 ngml 0 24 h analyzed phosphorylation p53 ser 15 found upa induced ser 15 phosphorylation early 10 min treatment elevated level maintained 24 h fig 4b
0.4897949.15937335.html.plaintext.txt	46	next wanted test whether upa regulates p53 expression altering mdm2 expression oncoprotein prevents accumulation p53 targeting ubiquitination proteosomal degradation 35 36 initially treated beas2b cells two concentrations upa 50 1000 ngml 0 24 h analyzed expression mdm2 protein western blot using anti mdm2 antibody concentrations 50 ngml upa induced mdm2 expression around 3 h followed sharp decline basal level around 24 h fig 4c whereas higher upa concentrations mdm2 expression induced elevated level maintained 24 h fig 4d next treated beas2b cells varying amounts upa found upa induces mdm2 expression concentration dependent manner fig 4e
0.4897949.15937335.html.plaintext.txt	47	next wanted test whether upa regulates p53 expression altering mdm2 expression oncoprotein prevents accumulation p53 targeting ubiquitination proteosomal degradation 35 36 initially treated beas2b cells two concentrations upa 50 1000 ngml 0 24 h analyzed expression mdm2 protein western blot using anti mdm2 antibody concentrations 50 ngml upa induced mdm2 expression around 3 h followed sharp decline basal level around 24 h fig 4c whereas higher upa concentrations mdm2 expression induced elevated level maintained 24 h fig 4d next treated beas2b cells varying amounts upa found upa induces mdm2 expression concentration dependent manner fig 4e
0.4897949.15937335.html.plaintext.txt	48	view larger version 22k fig 3 time dependent induction p53 mrna upa beas2b cells treated described fig 1 0 24 h total rna 20 microglane isolated using trireagent separated agarose formaldehyde gel subjected northern blotting using 32p labeled p53 actin cdnas data shown representative four independent experiments data integrated densities individual bands presented line graph
0.4897949.15937335.html.plaintext.txt	49	effects phosphatase phosphotyrosine kinase inhibitors upa mediated p53 induction address strong inference upa mediated p53 expression involves cellular signaling pretreated beas2b cells herbimycin genistein separately combination upa shown fig 5a herbimycin genistein alone induce p53 expression either inhibitor reverse upa mediated p53 expression beas2b cells however pretreatment cells sodium orthovanadate tyrosine phosphatase inhibitor reversed upa mediated p53 expression order determine protein tyrosine phosphatase involved upa mediated p53 expression infected adenovirus overexpressing catalytically inactive mutants shp 1 shp 2 well vector cdna shown fig 5b basal upa induced p53 expression inhibited beas2b cells infected dominant negative shp 2 mutants order confirm involvement shp 2 p53 expression generated stable beas2b cells overexpressing shp 2 determined p53 expression western blot shown fig 5c shp 2 overexpression induced p53 expression indicating protein tyrosine phosphatase shp 2 regulates p53 expression
0.4897949.15937335.html.plaintext.txt	50	effect atf lmw upa p53 expression next sought determine molecular domains upa participate induction p53 therefore treated beas2b cells either atf lmw fragment upa determine whether induction p53 beas2b cells upa mediated occupancy receptor upar shown fig 6a hmw upa atf alone combination induced p53 expression similarly single chain inactive hmw upa also induced p53 expression lmw upa form upa bind upar failed induce p53 expression indicating process requires interaction upa upar
0.4897949.15937335.html.plaintext.txt	51	effect atf lmw upa p53 expression next sought determine molecular domains upa participate induction p53 therefore treated beas2b cells either atf lmw fragment upa determine whether induction p53 beas2b cells upa mediated occupancy receptor upar shown fig 6a hmw upa atf alone combination induced p53 expression similarly single chain inactive hmw upa also induced p53 expression lmw upa form upa bind upar failed induce p53 expression indicating process requires interaction upa upar
0.4897949.15937335.html.plaintext.txt	52	effect upa enzymatic activity upa induced expression p53 next used alternative independent techniques ascertain role upa enzymatic activity induction p53 upa treatment beas2b cells first tested ability anti upa monoclonal antibody inhibit p53 expression shown fig 6b antibody blocks upa enzymatic activity alone induce p53 expression failed alter upa mediated p53 expression similarly pretreatment upa b428 inhibitor upa plasminogen activator inhibitor pai 1 effect upa mediated induction p53 data confirm catalytic activity required upa mediated induction p53 beas2b cells
0.4897949.15937335.html.plaintext.txt	53	effect upa enzymatic activity upa induced expression p53 next used alternative independent techniques ascertain role upa enzymatic activity induction p53 upa treatment beas2b cells first tested ability anti upa monoclonal antibody inhibit p53 expression shown fig 6b antibody blocks upa enzymatic activity alone induce p53 expression failed alter upa mediated p53 expression similarly pretreatment upa b428 inhibitor upa plasminogen activator inhibitor pai 1 effect upa mediated induction p53 data confirm catalytic activity required upa mediated induction p53 beas2b cells
0.4897949.15937335.html.plaintext.txt	54	view larger version 29k fig 4 effect upa phosphorylation p53 mdm2 expression beas2b cells grown confluence treated varying amounts upa 0 1000 ngml 24 h 37 degrees c basal medium containing 05 bsa total proteins separated 8 sds polyacrylamide gel transferred nitrocellulose membrane membrane immunoblotted anti phospho ser 15 ser 20 p53 antibody membrane stripped developed anti p53 anti actin antibody b beas2b cells grown confluence treated 50 ngml upa 0 24 h cell lysates subjected western blotting phosphorylation ser 15 residue p53 described effect upa mdm2 expression beas2b cells treated 50 ngml c 1000 ngml d upa varying 0 24 h times described total proteins separated 8 sds polyacrylamide gel transferred nitrocellulose membrane membrane developed anti mdm2 antibody membrane stripped developed anti actin antibody equal loading e beas2b cells grown confluence treated varying amounts 0 1000 ngml upa 4 h lysate subjected western blotting using anti mdm2 antibody described c d figure shown representative three separate experiments
0.4897949.15937335.html.plaintext.txt	55	view larger version 37k fig 5 effect tyrosine kinase phosphatase inhibitors upa mediated p53 expression cells grown confluence treated without herbimycin herb2 microm genistein gen6 microgml sodium orthovanadate naor 10 microm 2 h followed upa 24 h 37 degrees c basal medium containing 05 bsa proteins isolated total proteins separated 8 sds polyacrylamide gel transferred nitrocellulose membrane membrane immunoblotted anti p53 antibody data illustrated representative findings three separate experiments mean density individual bands presented bar graph pbs phosphate buffered saline b effect phosphotyrosine phosphatases upa mediated p53 expression beas2b cells grown confluence infected adenovirus constructs expressing vector vp3 catalytically inactive shp 1 1cmutp3 shp 2 2cmutp3 cells treated without upa 50 ngml 24 h 37 degrees c basal medium containing 05 bsa total proteins separated 8 sds polyacrylamide gel transferred nitrocellulose membrane membrane immunoblotted anti p53 antibody c stable beas2b cells transfected vector vc cdna shp 2 cdna treated without upa 24 h cell lysates analyzed p53 expression western blotting
0.4897949.15937335.html.plaintext.txt	56	role upar upa mediated p53 expression confirm interaction upa upar required induce p53 beas2b cells pre treated cells selected agents block upar 2 h treated upa 24 h shown fig 6c upar antibody blocks upa upar interaction alone pretreatment upar antibody followed stimulation upa inhibited p53 expression confirm upa mediated p53 expression involves upar next treated beas2b cells a5 compound upar antagonist alone combination upa shown fig 6c a5 alone induce p53 however a5 combination upa inhibited upa mediated p53 expression third approach removed upar cell surface treating phosphatidylinositol phospholipase c pi plc tested see upa would stimulate p53 expression known upar gpi linked protein pi plc removes gpi linked proteins including upar cell surface 19 pi plc treatment inhibited upa mediated p53 expression data confirm involvement upar upa mediated p53 expression separate experiment found pi plc completely cleaved upar cell surface data shown experiments provide evidence upa mediated induction p53 mediated association upa upar cell surface
0.4897949.15937335.html.plaintext.txt	57	view larger version 38k fig 6 effect different fragments upa p53 expression beas2b cells grown confluence treated without tcupa 50 ngml atf 50 ngml single chain upa scupa 50 ngml lmw 50 ngml upa 24 h 37 degrees c basal medium containing 05 bsa beas2b cells treated atf 2 h followed tcupa 24 h atftcupa total proteins separated 8 sds polyacrylamide gel transferred nitrocellulose membrane membrane immunoblotted anti p53 antibody data representative findings three separate experiments mean density presented bar graph pbs phosphate buffered saline b effect upa inhibitors upa mediated p53 expression beas2b cells grown confluence treated without b 428 002 mm anti upa monoclonal antibody mab 2 microgml plasminogen activator inhibitor pai 1 4 microgml 2 h followed upa 24 h 37 degrees c basal medium containing 05 bsa total proteins separated 8 sds polyacrylamide gel transferred nitrocellulose membrane membrane immunoblotted anti p53 antibody data representative three independent experiments illustrated c role upar upa mediated p53 induction beas2b cells grown confluence treated without anti upar antibody 2 microgml a5 1 microgml compound pi plc 10 unitsml 2 h followed upa 24 h 37 degrees c basal medium containing 05 bsa proteins isolated total proteins separated 8 sds polyacrylamide gel transferred nitrocellulose membrane membrane immunoblotted anti p53 antibody data representative four independent experiments shown mean densities individual bands presented bar graphs
0.4897949.15937335.html.plaintext.txt	58	effect integrins p53 expression upa mediated p53 expression involves upa interaction upar upar transduce signals directly interior gpi anchor sought determine accessory molecule involved upa mediated p53 expression therefore treated beas2b cells anti v3 1 cd18cd11b anti upar antibodies igg 2 h followed stimulation upa 24 h cell lysates prepared p53 expression determined western blot shown fig 7 anti 1 anti upar antibody treated cells inhibited upa induced p53 expression
0.4897949.15937335.html.plaintext.txt	59	effect integrins p53 expression upa mediated p53 expression involves upa interaction upar upar transduce signals directly interior gpi anchor sought determine accessory molecule involved upa mediated p53 expression therefore treated beas2b cells anti v3 1 cd18cd11b anti upar antibodies igg 2 h followed stimulation upa 24 h cell lysates prepared p53 expression determined western blot shown fig 7 anti 1 anti upar antibody treated cells inhibited upa induced p53 expression
0.4897949.15937335.html.plaintext.txt	60	effect plasmin upa mediated p53 expression next sought determine whether plasmin product upa mediated plasminogen activation known involved remodeling extracellular matrix might influence upa induced p53 expression treatment plasmin alone combination upa failed alter p53 expression data shown
0.4897949.15937335.html.plaintext.txt	61	effect plasmin upa mediated p53 expression next sought determine whether plasmin product upa mediated plasminogen activation known involved remodeling extracellular matrix might influence upa induced p53 expression treatment plasmin alone combination upa failed alter p53 expression data shown
0.4897949.15937335.html.plaintext.txt	62	effect upa concentration beas2b cell apoptosis confirm upa mediated expression p53 induces apoptosis treated beas2b cells varying concentrations upa 0 3000 ngml quantified apoptosis flow cytometry flow cytometric analysis annexin v treated cells indicated upa 10 100 ngml concentration induced moderate level 35 apoptosis however number cells undergoing apoptosis gradually reduced increasing concentrations 100 1000 ngml upa fig 8a similar results also observed apoptosis determined dna fragmentation analysis using agarose gel electrophoresis ethidium bromide staining genomic dna data shown
0.4897949.15937335.html.plaintext.txt	63	effect upa concentration beas2b cell apoptosis confirm upa mediated expression p53 induces apoptosis treated beas2b cells varying concentrations upa 0 3000 ngml quantified apoptosis flow cytometry flow cytometric analysis annexin v treated cells indicated upa 10 100 ngml concentration induced moderate level 35 apoptosis however number cells undergoing apoptosis gradually reduced increasing concentrations 100 1000 ngml upa fig 8a similar results also observed apoptosis determined dna fragmentation analysis using agarose gel electrophoresis ethidium bromide staining genomic dna data shown
0.4897949.15937335.html.plaintext.txt	64	view larger version 26k fig 7 role upar integrin interaction p53 expression beas2b cells grown confluence treated without anti v3 monoclonal antibody v3 mab anti 1 monoclonal antibody 1 mab anti cd18cd11b monoclonal antibody cd18 mab anti icam monoclonal antibody icam mab anti upar monoclonal anti body upar mab antibodies igg 2 h followed stimulation upa 50 ngml 24 h 37 degrees c basal medium containing 05 bsa total proteins separated 8 sds polyacrylamide gel transferred nitrocellulose membrane membrane immunoblotted anti p53 antibody figure shown representative five separate experiments pbs phosphate buffered saline
0.4897949.15937335.html.plaintext.txt	65	view larger version 31k fig 8 effect upa beas2b cell survival proliferation beas2b cells grown confluence treated varying amounts upa 0 3000 ngml 48 h 37 degrees c basal medium containing 05 bsa cells later detached treated anti annexin v antibody propidium iodide apoptotic cells analyzed flow cytometry data shown representative five separate experiments bleomycin 40 microgml used positive control 1 b quiescent beas2b cells treated varying amounts upa described dna synthesis measured pulse labeling cells 1 microciml 3hthymidine last 8 h treatment cells washed extracted trichloroacetic acid incorporated radioactivity measured scintillation counter data shown representative three separate experiments
0.4897949.15937335.html.plaintext.txt	66	induction dna synthesis upa upa induced dna synthesis beas2b cells concentration dependent manner maximal induction 500 ngml fig 8b
0.4897949.15937335.html.plaintext.txt	67	discussion top abstract introduction experimental procedures results discussion references upa dependent proteolysis critical cellular migration tissue remodeling inflammation tumor growth metastasis 25 28 upa upar interaction promote cellular movement decrease cellular attachment surrounding ground substance processes may contribute remodeling lung acute respiratory distress syndrome interstitial lung diseases 37 38 interaction upa upar cancer cell surface also appears critical event pathogenesis neoplastic growth metastasis mediating tissue remodeling desmoplasia tumor cell invasion adhesion proliferation neoplastic cells 1 5 10 binding upa upar mediates cell proliferation several cell types including nonmalignant lung epithelial cells lung carcinoma derived cells malignant mesothelioma 12 39 tumor cell invasion often facilitated dramatic increase production plasminogen activators particularly upa 39 43 tumor suppressor p53 gene mutated suppressed majority human tumors 22 introduction wild type p53 gene p53 deficient tumor cells suppresses transformation tumorigenesis inhibits proliferation many malignant cell types 24 pathways regulate upa upar system p53 expression therefore germane pathogenesis lung injury neoplasia
0.4897949.15937335.html.plaintext.txt	68	discussion top abstract introduction experimental procedures results discussion references upa dependent proteolysis critical cellular migration tissue remodeling inflammation tumor growth metastasis 25 28 upa upar interaction promote cellular movement decrease cellular attachment surrounding ground substance processes may contribute remodeling lung acute respiratory distress syndrome interstitial lung diseases 37 38 interaction upa upar cancer cell surface also appears critical event pathogenesis neoplastic growth metastasis mediating tissue remodeling desmoplasia tumor cell invasion adhesion proliferation neoplastic cells 1 5 10 binding upa upar mediates cell proliferation several cell types including nonmalignant lung epithelial cells lung carcinoma derived cells malignant mesothelioma 12 39 tumor cell invasion often facilitated dramatic increase production plasminogen activators particularly upa 39 43 tumor suppressor p53 gene mutated suppressed majority human tumors 22 introduction wild type p53 gene p53 deficient tumor cells suppresses transformation tumorigenesis inhibits proliferation many malignant cell types 24 pathways regulate upa upar system p53 expression therefore germane pathogenesis lung injury neoplasia
0.4897949.15937335.html.plaintext.txt	69	shift toward proteolysis prevalent malignant tissues probably facilitates tumor invasion adjacent normal tissues context upa appears play cooperative role propagation spread neoplasms 5 change proto oncogene tumor suppressor gene expression 41 may facilitate epithelial cell transformation alter capacity lung epithelial cells effect proteolytic degradation extracellular matrix activity p53 tumor suppressor protein particular key role process therefore sought elucidate interactions upa p53 interact determine specifically p53 expressed regulated upa lung epithelial cells
0.4897949.15937335.html.plaintext.txt	70	shift toward proteolysis prevalent malignant tissues probably facilitates tumor invasion adjacent normal tissues context upa appears play cooperative role propagation spread neoplasms 5 change proto oncogene tumor suppressor gene expression 41 may facilitate epithelial cell transformation alter capacity lung epithelial cells effect proteolytic degradation extracellular matrix activity p53 tumor suppressor protein particular key role process therefore sought elucidate interactions upa p53 interact determine specifically p53 expressed regulated upa lung epithelial cells
0.4897949.15937335.html.plaintext.txt	71	study present evidence upa induces expression p53 cultured beas2b effect also observed primary sae cells pathway provides versatile regulatory system upa concentration ambient microenvironment pericellular proteolysis could regulate cellular transformation regulating expression p53 molecular mechanism may crucial determinant epithelial cell transformation invasiveness lung carcinomas excessive upa dependent pericellular proteolysis increases cellular proliferation invasiveness 5
0.4897949.15937335.html.plaintext.txt	72	study present evidence upa induces expression p53 cultured beas2b effect also observed primary sae cells pathway provides versatile regulatory system upa concentration ambient microenvironment pericellular proteolysis could regulate cellular transformation regulating expression p53 molecular mechanism may crucial determinant epithelial cell transformation invasiveness lung carcinomas excessive upa dependent pericellular proteolysis increases cellular proliferation invasiveness 5
0.4897949.15937335.html.plaintext.txt	73	upa mediated p53 expression induce p53 mrna induction indicating involvement post transcriptional mechanisms enhanced translation p53 mrna andor decreased proteolytic degradation protein 42 activation p53 following genotoxic damage achieved induction p53 levels modifications p53 protein phosphorylation acetylation 43 47 dna damage caused ionizing radiation chemotherapeutic drugs uv radiation alkylating agents environmental carcinogens induces p53 alteration p53 protein stability 48 54 however upa serine protease involved extracellular matrix degradation dna damage repair function attributed altered p53 protein expression translation rather transcription mutation p53 gene observed blast cells obtained patients acute myelogenous leukemia 55 present study observed upa induces phosphorylation ser 15 residue p53 concentration dependent manner consistent upa mediated induction p53 activation p53 lead either cell arrest dna repair apoptosis low concentrations upa beas2b cells undergo apoptosis consequence increased p53 accumulation accomplished two independent mechanisms first upa induces ser 15 phosphorylation concentration 50 ngml impairs p53 interaction mdm2 degradation second low concentration upa also fails maintain elevated levels mdm2 protein required p53 turnover however higher upa concentrations induction mdm2 protein well inhibition ser 15 phosphorylation leads increased degradation p53 results reduced apoptosis increased dna synthesis
0.4897949.15937335.html.plaintext.txt	74	upa mediated p53 expression induce p53 mrna induction indicating involvement post transcriptional mechanisms enhanced translation p53 mrna andor decreased proteolytic degradation protein 42 activation p53 following genotoxic damage achieved induction p53 levels modifications p53 protein phosphorylation acetylation 43 47 dna damage caused ionizing radiation chemotherapeutic drugs uv radiation alkylating agents environmental carcinogens induces p53 alteration p53 protein stability 48 54 however upa serine protease involved extracellular matrix degradation dna damage repair function attributed altered p53 protein expression translation rather transcription mutation p53 gene observed blast cells obtained patients acute myelogenous leukemia 55 present study observed upa induces phosphorylation ser 15 residue p53 concentration dependent manner consistent upa mediated induction p53 activation p53 lead either cell arrest dna repair apoptosis low concentrations upa beas2b cells undergo apoptosis consequence increased p53 accumulation accomplished two independent mechanisms first upa induces ser 15 phosphorylation concentration 50 ngml impairs p53 interaction mdm2 degradation second low concentration upa also fails maintain elevated levels mdm2 protein required p53 turnover however higher upa concentrations induction mdm2 protein well inhibition ser 15 phosphorylation leads increased degradation p53 results reduced apoptosis increased dna synthesis
0.4897949.15937335.html.plaintext.txt	75	previous studies others found upa influences upa upar pai 1 expression posttranscriptional pathways 19 21 similar influences upa upar pai 1 mrna stabilities also discovered lung cancer derived cell lines 25 56 reported previously p53 regulates fibrinolysis inhibiting upa expression suppression promoter enhancer activity upa gene activation pai 1 promoter 58 59 present study suggests upa may overcome transcriptional control p53 expression upa pai 1 inhibiting p53 expression higher concentration activation c myc stabilizes p53 protein quiescent mouse fibroblasts 57 indicating involvement p53 induced apoptosis cell cycle reentry prevent cell proliferation induced oncogene activation upa known induce cell proliferation wide variety cell types including fibroblasts 8 15 upa mediated p53 induction probably mediates apoptosis safeguard prevent unrestrained cell proliferation induced upa highly likely upa higher concentration probably induces cell proliferation disrupting safeguard mechanism mdm2 mediated ubiquitination
0.4897949.15937335.html.plaintext.txt	76	previous studies others found upa influences upa upar pai 1 expression posttranscriptional pathways 19 21 similar influences upa upar pai 1 mrna stabilities also discovered lung cancer derived cell lines 25 56 reported previously p53 regulates fibrinolysis inhibiting upa expression suppression promoter enhancer activity upa gene activation pai 1 promoter 58 59 present study suggests upa may overcome transcriptional control p53 expression upa pai 1 inhibiting p53 expression higher concentration activation c myc stabilizes p53 protein quiescent mouse fibroblasts 57 indicating involvement p53 induced apoptosis cell cycle reentry prevent cell proliferation induced oncogene activation upa known induce cell proliferation wide variety cell types including fibroblasts 8 15 upa mediated p53 induction probably mediates apoptosis safeguard prevent unrestrained cell proliferation induced upa highly likely upa higher concentration probably induces cell proliferation disrupting safeguard mechanism mdm2 mediated ubiquitination
0.4897949.15937335.html.plaintext.txt	77	identification newly defined mechanism upa regulates expression p53 suggests possibility novel pathways could likewise influence cellular transformation based upon previous observations induction upa upar pai 1 upa lung epithelial cells could likewise contribute altered p53 expression possibly influencing kinetics internalization trimeric complexes upa pai 1 upar precise regulatory levels upa induces p53 expression lung epithelial cells remain elucidated studies extend report
0.4897949.15937335.html.plaintext.txt	78	identification newly defined mechanism upa regulates expression p53 suggests possibility novel pathways could likewise influence cellular transformation based upon previous observations induction upa upar pai 1 upa lung epithelial cells could likewise contribute altered p53 expression possibly influencing kinetics internalization trimeric complexes upa pai 1 upar precise regulatory levels upa induces p53 expression lung epithelial cells remain elucidated studies extend report
0.4897949.15937335.html.plaintext.txt	79	found induction p53 upa beas2b cells requires receptor interaction lmw fragment could reproduce effect engagement 1 integrin specific antibody inhibited upa induced p53 expression indicating intricate connections expression p53 upa upar integrin mediated adhesion precedents mode upa mediated induction cellular responses upa mitogenic several different cell types mitogenic response likewise requires receptor interaction upa pleural mesothelioma well epidermal tumor cell lines 8 15 inhibitory effect tyrosine phosphatase inhibitor p53 expression indicates process involves cellular signaling mainly activation tyrosine phosphatases alternatively upa stimulation beas2b cells may also induce synthesis growth factors cytokines turn may induce p53 protein elucidation mechanisms responsible prolonged effect upa p53 protein level remains determined phosphorylation serines 15 20 following genotoxic stress 25 43 56 demonstrated impair interaction p53 mdm2 resulting enhanced p53 accumulation 45 contrast dna damage differential expression p53 predicated upa concentration act selective pressure tumor growth elimination cells wild type p53 clonal expansion cells diminished p53 expression induction p53 upa beas2b cells clearly mediated via generation plasmin exposure cells treatment plasmin affect p53 expression
0.4897949.15937335.html.plaintext.txt	80	found induction p53 upa beas2b cells requires receptor interaction lmw fragment could reproduce effect engagement 1 integrin specific antibody inhibited upa induced p53 expression indicating intricate connections expression p53 upa upar integrin mediated adhesion precedents mode upa mediated induction cellular responses upa mitogenic several different cell types mitogenic response likewise requires receptor interaction upa pleural mesothelioma well epidermal tumor cell lines 8 15 inhibitory effect tyrosine phosphatase inhibitor p53 expression indicates process involves cellular signaling mainly activation tyrosine phosphatases alternatively upa stimulation beas2b cells may also induce synthesis growth factors cytokines turn may induce p53 protein elucidation mechanisms responsible prolonged effect upa p53 protein level remains determined phosphorylation serines 15 20 following genotoxic stress 25 43 56 demonstrated impair interaction p53 mdm2 resulting enhanced p53 accumulation 45 contrast dna damage differential expression p53 predicated upa concentration act selective pressure tumor growth elimination cells wild type p53 clonal expansion cells diminished p53 expression induction p53 upa beas2b cells clearly mediated via generation plasmin exposure cells treatment plasmin affect p53 expression
0.4897949.15937335.html.plaintext.txt	81	summary report upa stimulates expression p53 lung epithelial cells culture operative vivo pathway could contribute relative local overexpression upa neoplastic transformation associated lung cancer knowledge newly identified pathway first description ability upa regulate expression p53 cell type
0.4897949.15937335.html.plaintext.txt	82	summary report upa stimulates expression p53 lung epithelial cells culture operative vivo pathway could contribute relative local overexpression upa neoplastic transformation associated lung cancer knowledge newly identified pathway first description ability upa regulate expression p53 cell type
0.4897949.15937335.html.plaintext.txt	83	footnotes work supported nhlbi grants r01 hl 62453 hl071147 national institutes health costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.4897949.15937335.html.plaintext.txt	84	footnotes work supported nhlbi grants r01 hl 62453 hl071147 national institutes health costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.4897949.15937335.html.plaintext.txt	85	correspondence addressed dept specialty care services university texas health center 11937 u highway 271 tyler tx 75708 3154 tel 903 877 7668 fax 903 877 7927 e mail sreeramashettyatuthctedu u d
0.4897949.15937335.html.plaintext.txt	86	correspondence addressed dept specialty care services university texas health center 11937 u highway 271 tyler tx 75708 3154 tel 903 877 7668 fax 903 877 7927 e mail sreeramashettyatuthctedu u d
0.4897949.15937335.html.plaintext.txt	87	1 abbreviations used upa urokinase type plasminogen activator upar urokinase type plasminogen activator receptor pai 1 plasminogen activator inhibitor 1 gpi glycosylphosphatidylinositol bsa bovine serum albumin hmw high molecular weight lmw low molecular weight atf amino terminal fragment beas2b human bronchial epithelial cell line cmv cytomegalovirus pi plc phosphatidylinositol phospholipase c sae small airway epithelial tcupa two chain active upa lps lipopolysaccharides
0.4897949.15937335.html.plaintext.txt	88	acknowledgments thank dr idell helpful discussions dr h tang sharing catalytically inactive shp 1 shp 2 adenovirus constructs also thank kathy johnson katy windham technical assistance
0.4897949.15937335.html.plaintext.txt	89	references top abstract introduction experimental procedures results discussion references dano k andreasen p grondahl hansen j kristensen p nielsen l skriver l 1985 adv cancer res 44 139 266medline order article via infotrieve liotta l stetler stevenson w g steeg p 1991 cancer investig 9 543 551medline order article via infotrieve mignatti p rifkin d b 1993 physiol rev 73 161 195free full text sprengers e d kluft c 1987 blood 69 381 387free full text mazar p henkin j goldfarb r h 1999 angiogenesis 3 15 32crossrefmedline order article via infotrieve soff g sanderowitz v gately verrusio e weiss brem kwaan h c 1995 j clin investig 96 2593 2600medline order article via infotrieve pedersen h brunner n francis d osterlind k ronne e hansen h h dano k grondahl hansen j 1994 cancer res 54 4671 4675abstract kirchheimer j c wojta j christ g binder b r 1989 eur j biochem 181 103 107abstract kirchheimer j c remold h g 1989 1989 blood 74 1396 1402abstractfree full text rabbani mazar p bernier m haq m bolivar henkin j golzman d 1992 j biol chem 267 14151 14156abstractfree full text depetro g copeta barlati 1994 exp cell res 213 286 294crossrefmedline order article via infotrieve shetty kumar johnson pueblitz idell 1995 j physiol 268 l972 l982medline order article via infotrieve shetty kumar johnson r idell 1995 antisense res dev 5 307 314medline order article via infotrieve bohuslav j horejsi v hansmann c stock j weidle u h majdic o bartke knapp w stockinger h 1995 j exp med 181 1381 1390abstractfree full text dulmer petri schleuning w d 1993 febs lett 322 37 40crossrefmedline order article via infotrieve konakova m hucho f schleuning w d 1998 eur j biochem 253 421 429abstract gyetko m r todd r f wilkinson c c sitrin r g 1994 j clin investig 93 1380 1387medline order article via infotrieve seiffert d wagner n n luskutoff d j 1990 j cell biol 111 1283 1291abstract shetty idell 2001 j biol chem 276 24549 24556abstractfree full text shetty penduthiri u halady p k azghani idell 2002 j physiol 283 l319 l328 shetty bdeir k cines d b idell 2003 j biol chem 278 18124 18131abstractfree full text greenbaltt p bennett w p hollstein m harris c c 1994 cancer res 54 4855 4878medline order article via infotrieve broet p spyratos f romain quillien v daver ricolleau g rallet taulas c asselain b 1999 br j cancer 80 536 545crossrefmedline order article via infotrieve lane d 2004 n engl j med 350 2711 2712free full text shetty idell 2000 j biol chem 275 13771 13779abstractfree full text boyd d florent g kim p brattain m 1988 1988 cancer res 48 3112 3116abstract vassalli j d sappino p belin d 1991 j clin investig 88 1067 1072medline order article via infotrieve axelrod j h reich r miskin r 1989 mol cell biol 9 2133 2141medline order article via infotrieve m zhao z 1997 j biol chem 272 23376 23381abstractfree full text zhao z tan wright j h diltz c d shen h krebs e g fischer e h 1995 j biol chem 270 11765 11769abstractfree full text becker c noel r j coats w gomez foix m alam gerard r d newgard c b 1994 methods cell biol 43 161 189medline order article via infotrieve meek d w 1994 semin cancer biol 5 203 210medline order article via infotrieve milczarek g j martinez j bowden g 1997 life sci 60 1 11crossrefmedline order article via infotrieve shieh y ikeda m taya y prives c 1997 cell 91 325 334crossrefmedline order article via infotrieve chehab n h malikzay stavridi e halazonetis d 1999 proc natl acad sci u 96 13777 13782abstractfree full text honda r tanaka h yasuda h 1997 febs lett 420 25 27crossrefmedline order article via infotrieve chapman h 2004 j clin investig 113 148 157abstractfree full text idell 1995 lung biology health disease phan h thrall r vol 80 pp 743 776 marcel dekker inc new york achbarou kaiser tremblay g ste marie l g brodt p goltzman d rabbani 1994 cancer res 54 2372 2377abstract ossowski l 1988 j cell biol 107 2437 2445abstract wang boyd d d 1995 int j oncol 7 143 146 haput y maya r kazaz oren m 1997 nature 387 296 299crossrefmedline order article via infotrieve canman c e lim d cimprich k taya tamai k sakaguchi m b appella m b kastan m b siliciano j d 1998 science 281 1677 1679abstractfree full text gu w roeder r g 1997 cell 90 595 606crossrefmedline order article via infotrieve ashcroft m kubbutat h g vousden k h 1999 mol cell biol 19 1751 1758abstractfree full text sheih y ikeda m taya y prives c 1999 embo j 18 1815 1823abstractfree full text sakaguchi k herrera j e siato miki bustin m vassilev anderson c w appella e 1998 genes dev 12 2831 2841abstractfree full text xu j morris g f 1999 mol cell biol 19 12 20abstractfree full text nakanishi y pei x takayama k bai f izumi m kimotsuki k inoue k minami wataya h hara n 2000 j respir cell mol biol 22 747 754abstractfree full text kastan m b onyekwere o sidransky d vogelstein b craig r w 1991 cancer res 51 6304 6311abstract kuebertiz j plunkett b walsh w v kastan m b 1992 proc natl acad sci u 89 7491 7495abstractfree full text kastan m b zhan q el deiry w carrier f jacks walsh w v plunkett b vogelstein b forance j 1992 cell 71 587 597crossrefmedline order article via infotrieve fritsche m haessler c brandner g 1993 oncogene 8 307 318medline order article via infotrieve maltzman w czyzyk l 1984 mol cell biol 4 1689 1694medline order article via infotrieve fu l minden m d benchimol 1996 embo j 15 4392 4401abstract shetty idell 2000 j physiol 278 l148 l156 hermeking h eick d 1994 science 265 2091 2093medline order article via infotrieve kunz c pebler otte j von der ahe d 1995 nucleic acids res 23 3710 3717abstract parra m jardi m koziczak m nagamine y munoz canoves p 2001 j biol chem 39 36303 36310crossref article abstract full text pdf versions article 2803028133 recent m413190200v1 purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager copyright permissions google scholar articles shetty articles mazar p articles citing article pubmed pubmed citation articles shetty articles mazar p
0.4897949.15937335.html.plaintext.txt	90	home help feedback subscriptions archive search table contents asbmb journals molecular cellular proteomics journal lipid research biochemistry molecular biology education copyright 2005 american society biochemistry molecular biology
0.4913497.11856728.html.plaintext.txt	0	accelerated publication loss p53 compensates v integrin function retinal neovascularization staffan stromblad arun fotedar howard brickner chandra theesfeld edith aguilar de diaz martin friedlander david cheresh
0.4913497.11856728.html.plaintext.txt	1	department microbiology pathology immunology karolinska institutet 141 86 huddinge sodertorns hogskola 141 04 huddinge sweden sidney kimmel cancer center san diego california 92121 departments cell biology immunology vascular biology scripps research institute la jolla california 92037
0.4913497.11856728.html.plaintext.txt	2	received publication january 23 2002 revised form february 19 2002
0.4913497.11856728.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references
0.4913497.11856728.html.plaintext.txt	4	v integrin antagonists block neovascularization various species whereas 20 v integrin null mice born many normal looking blood vessels given blockade v integrins angiogenesis induces p53 activity utilized p53 null mice elucidate whether loss p53 compensate v integrin function neovascularization retina murine retinal vascularization inhibited systemic administration v integrin antagonist contrast mice lacking p53 refractory treatment indicating neovascularization normal mice depends v integrin mediated suppression p53 blockade v integrins neovascularization resulted induction p21cip1 wild type surprisingly p53 null retinas indicating v integrin ligation regulates p21cip1 levels p53 independent manner conclusion demonstrate first time vivo intracellular mechanism compensation integrin function p53 v integrins act concert retinal neovascularization introduction top abstract introduction experimental procedures results discussion references
0.4913497.11856728.html.plaintext.txt	5	v integrin antagonists block neovascularization various species whereas 20 v integrin null mice born many normal looking blood vessels given blockade v integrins angiogenesis induces p53 activity utilized p53 null mice elucidate whether loss p53 compensate v integrin function neovascularization retina murine retinal vascularization inhibited systemic administration v integrin antagonist contrast mice lacking p53 refractory treatment indicating neovascularization normal mice depends v integrin mediated suppression p53 blockade v integrins neovascularization resulted induction p21cip1 wild type surprisingly p53 null retinas indicating v integrin ligation regulates p21cip1 levels p53 independent manner conclusion demonstrate first time vivo intracellular mechanism compensation integrin function p53 v integrins act concert retinal neovascularization introduction top abstract introduction experimental procedures results discussion references
0.4913497.11856728.html.plaintext.txt	6	previously found integrin v3 preferentially expressed newly forming blood vessels functionally involved controlling angiogenesis stimulated basic fibroblast growth factor tumor necrosis factor whereas another v integrin v5 functional vessel formation induced vascular endothelial growth factor transforming growth factor 1 2 importantly antagonists v integrins block neovascularization various animal models without exogenous angiogenic stimulation including chick chorioallantois mouse retina human skin trans plants scid mice causing apoptosis proliferating angiogenic vascular cells 3 8 suggests vessel formation v integrins promote signaling events ultimately promoting vascular cell survival thereby facilitating neovascularization however whereas 80 v integrin null mice die mid gestation 20 mice survive 1 day birth 9 similarly combinatorial gene knockout integrin 3 5 subunits mice results enhanced angiogenesis certain conditions 10 indicates either mice lacking integrins v3 v5 could compensate function v integrins blood vessel formation function vascular v integrins expressed blocked unligated inhibit neovascularization however present known whether possible compensatory redundant mechanisms mediate blood vessel formation absence functional v integrins experimental procedures top abstract introduction experimental procedures results discussion references
0.4913497.11856728.html.plaintext.txt	7	previously found integrin v3 preferentially expressed newly forming blood vessels functionally involved controlling angiogenesis stimulated basic fibroblast growth factor tumor necrosis factor whereas another v integrin v5 functional vessel formation induced vascular endothelial growth factor transforming growth factor 1 2 importantly antagonists v integrins block neovascularization various animal models without exogenous angiogenic stimulation including chick chorioallantois mouse retina human skin trans plants scid mice causing apoptosis proliferating angiogenic vascular cells 3 8 suggests vessel formation v integrins promote signaling events ultimately promoting vascular cell survival thereby facilitating neovascularization however whereas 80 v integrin null mice die mid gestation 20 mice survive 1 day birth 9 similarly combinatorial gene knockout integrin 3 5 subunits mice results enhanced angiogenesis certain conditions 10 indicates either mice lacking integrins v3 v5 could compensate function v integrins blood vessel formation function vascular v integrins expressed blocked unligated inhibit neovascularization however present known whether possible compensatory redundant mechanisms mediate blood vessel formation absence functional v integrins experimental procedures top abstract introduction experimental procedures results discussion references
0.4913497.11856728.html.plaintext.txt	8	p53 mice 11 used set p53 x p53 breeding pairs littermates matings used neovascularization assay genomic dna mouse tails genotyped p53 3 primer assay described previously 12 newborn mice injected subcutaneously twice daily starting within 8 h birth 40 microg cyclo rgdfv v antagonist peptide 66203 cyclo radfv control peptide 69601 lowercase denotes d amino acids dissolved phosphate buffered saline ph 74 cyclo rgdfv peptide binds specifically high affinity v3 v5 integrins blocks function vitro vivo whereas cyclo radfv peptide non functional 3 7 8 13 2 3 days eye globes taken fixed cold methanol 10 min followed 6 min 4 paraformaldehyde phosphate buffered saline ph 74 dissected stained collagen type iv photographed previously described 7 distance head optic nerve edge retinal vasculature 6 8 different representative points measured retina photographs mean vascular radius calculated mean vascular area two retinas animal calculated assuming circular shape vasculature without treatment difference vascular areas observed p53 heterozygous p53 null mice therefore standardize compare results different litters mean retinal vascular area p53 null mice litter considered represent fully developed vasculature p53 genotyping measurements retinal vasculature performed double blind fashion avoid bias measurements wild type retinas mean vascular area control treated retinas considered fully developed compared anti v treated retinas within litters western blot analysis retinas fixed cold methanol dissected retinas lysed modified radioimmune precipitation buffer analyzed western blot previously described 5 using 1 microgml anti p21cip1waf 1cip 1 polyclonal antibodies ab 5 oncogene cambridge ma anti v cytoplasmic tail polyclonal antibodies chemicon anti actin monoclonal antibody jla20 developmental studies hybridoma bank university iowa results top abstract introduction experimental procedures results discussion references
0.4913497.11856728.html.plaintext.txt	9	p53 mice 11 used set p53 x p53 breeding pairs littermates matings used neovascularization assay genomic dna mouse tails genotyped p53 3 primer assay described previously 12 newborn mice injected subcutaneously twice daily starting within 8 h birth 40 microg cyclo rgdfv v antagonist peptide 66203 cyclo radfv control peptide 69601 lowercase denotes d amino acids dissolved phosphate buffered saline ph 74 cyclo rgdfv peptide binds specifically high affinity v3 v5 integrins blocks function vitro vivo whereas cyclo radfv peptide non functional 3 7 8 13 2 3 days eye globes taken fixed cold methanol 10 min followed 6 min 4 paraformaldehyde phosphate buffered saline ph 74 dissected stained collagen type iv photographed previously described 7 distance head optic nerve edge retinal vasculature 6 8 different representative points measured retina photographs mean vascular radius calculated mean vascular area two retinas animal calculated assuming circular shape vasculature without treatment difference vascular areas observed p53 heterozygous p53 null mice therefore standardize compare results different litters mean retinal vascular area p53 null mice litter considered represent fully developed vasculature p53 genotyping measurements retinal vasculature performed double blind fashion avoid bias measurements wild type retinas mean vascular area control treated retinas considered fully developed compared anti v treated retinas within litters western blot analysis retinas fixed cold methanol dissected retinas lysed modified radioimmune precipitation buffer analyzed western blot previously described 5 using 1 microgml anti p21cip1waf 1cip 1 polyclonal antibodies ab 5 oncogene cambridge ma anti v cytoplasmic tail polyclonal antibodies chemicon anti actin monoclonal antibody jla20 developmental studies hybridoma bank university iowa results top abstract introduction experimental procedures results discussion references
0.4913497.11856728.html.plaintext.txt	10	interestingly inhibition angiogenesis blockade v integrins accompanied induction endothelial cell p53 activity 5 based hypothesized loss p53 might compensate v integrin function neovascularization examine possibility analyzed p53 null mice effect specific v integrin antagonist studied retinal neovascularization mouse retinal neovascularization occurs first days birth therefore newborn mice treated v integrin antagonist described 7 retinal vasculature wild type newborn mice treated 3 days v antagonist significantly less developed retinas control treated mice table accounting retinal vascular area already existing treatment started inhibition close 100 accordance previous observations 4 days treatment 7 targeted p53 null males mated p53 heterozygous females type mating necessary sufficient embryonic survival also allowed comparison p53 null mice heterozygous mice within litter double blind fashion including animals exactly age receiving identical treatment difference retinal vascularization could observed p53 null heterozygous mice first 3 days data shown addition difference degree neovascularization p53 null heterozygous mice could observed control treatment fig 1b table indicates p53 influence normal vascularization retina treated entire litters newborn mice mixed genotype see v integrin antagonist interestingly p53 heterozygous animals markedly less developed retinal vasculature compared p53 null mice treated v antagonist fig 1 table statistical analysis measurements performed vascular area retinas revealed vascular development anti v treated p53 heterozygous suppressed suppression found statistically significant p 57 x 107 compared p53 null animals litters receiving identical treatment table result closely resembled difference seen retinas antagonist versus control treated wild type mice table taken together findings indicate although p53 expression influence normal neovascularization loss p53 compensates function v integrins neovascularization
0.4913497.11856728.html.plaintext.txt	11	interestingly inhibition angiogenesis blockade v integrins accompanied induction endothelial cell p53 activity 5 based hypothesized loss p53 might compensate v integrin function neovascularization examine possibility analyzed p53 null mice effect specific v integrin antagonist studied retinal neovascularization mouse retinal neovascularization occurs first days birth therefore newborn mice treated v integrin antagonist described 7 retinal vasculature wild type newborn mice treated 3 days v antagonist significantly less developed retinas control treated mice table accounting retinal vascular area already existing treatment started inhibition close 100 accordance previous observations 4 days treatment 7 targeted p53 null males mated p53 heterozygous females type mating necessary sufficient embryonic survival also allowed comparison p53 null mice heterozygous mice within litter double blind fashion including animals exactly age receiving identical treatment difference retinal vascularization could observed p53 null heterozygous mice first 3 days data shown addition difference degree neovascularization p53 null heterozygous mice could observed control treatment fig 1b table indicates p53 influence normal vascularization retina treated entire litters newborn mice mixed genotype see v integrin antagonist interestingly p53 heterozygous animals markedly less developed retinal vasculature compared p53 null mice treated v antagonist fig 1 table statistical analysis measurements performed vascular area retinas revealed vascular development anti v treated p53 heterozygous suppressed suppression found statistically significant p 57 x 107 compared p53 null animals litters receiving identical treatment table result closely resembled difference seen retinas antagonist versus control treated wild type mice table taken together findings indicate although p53 expression influence normal neovascularization loss p53 compensates function v integrins neovascularization
0.4913497.11856728.html.plaintext.txt	12	view table table statistical evaluation effect retinal vascular development treatment v integrin antagonist statistical evaluation measured retinal vascular areas p53 p53 given p values represent statistical significance indicated groups compared identically treated homozygous p53 mice according unpaired two tail test using microsoft excel software wild type wt mice given p value represents statistical significance treated versus control treated retinas within litters analyzed unpaired test measurements genotyping performed double blind fashion
0.4913497.11856728.html.plaintext.txt	13	view table table statistical evaluation effect retinal vascular development treatment v integrin antagonist statistical evaluation measured retinal vascular areas p53 p53 given p values represent statistical significance indicated groups compared identically treated homozygous p53 mice according unpaired two tail test using microsoft excel software wild type wt mice given p value represents statistical significance treated versus control treated retinas within litters analyzed unpaired test measurements genotyping performed double blind fashion
0.4913497.11856728.html.plaintext.txt	14	view larger version 42k fig 1 retinal neovascularization genetically targeted p53 null mice refractory systemic treatment integrin v antagonist newborn mice injected subcutaneously twice daily integrin v antagonistic control cyclic peptides 2 3 days retinas dissected stained collagen type iv vessel basement membrane mounted flat photographed 10 x described experimental procedures representative retinas newborn mice mating p53 null male p53 heterozygous female entire litter treated 212 days v antagonist size bar 150 microm b measurements development retinal vasculature 4 5 litters per group standardized comparison described experimental procedures plotted undeveloped vasculature point represent mean retinal vascular area one mouse calculated mean two retinas animal
0.4913497.11856728.html.plaintext.txt	15	possible explanation lack response v integrin antagonist p53 null mice could deficient retinal integrin v expression test possibility retinal lysates analyzed v protein levels western blot analysis shown fig 2a v integrin levels p53 null retinas differ p53 heterozygous mice another possibility lack response v antagonist p53 null mice could cells lacking p53 insensitive treatment alterations v integrin function cell surface examine possibility examined v integrin function mouse embryonic fibroblasts lacking p53 including responsiveness v integrin antagonist compared mouse fibroblasts expressing p53 shown fig 2b responsiveness antagonist inhibiting v dependent attachment vitronectin virtually identical p53 null fibroblasts mouse fibroblast cell line nih 3t3 demonstrating lack p53 cause general insensitivity v integrin antagonists findings reveal loss p53 affect expression levels general function v integrins instead conclude intracellular events involving p53 mediate inhibition neovascularization v antagonists events may related activation endothelial cell p53 previously observed upon v integrin blockage angiogenesis 5
0.4913497.11856728.html.plaintext.txt	16	possible explanation lack response v integrin antagonist p53 null mice could deficient retinal integrin v expression test possibility retinal lysates analyzed v protein levels western blot analysis shown fig 2a v integrin levels p53 null retinas differ p53 heterozygous mice another possibility lack response v antagonist p53 null mice could cells lacking p53 insensitive treatment alterations v integrin function cell surface examine possibility examined v integrin function mouse embryonic fibroblasts lacking p53 including responsiveness v integrin antagonist compared mouse fibroblasts expressing p53 shown fig 2b responsiveness antagonist inhibiting v dependent attachment vitronectin virtually identical p53 null fibroblasts mouse fibroblast cell line nih 3t3 demonstrating lack p53 cause general insensitivity v integrin antagonists findings reveal loss p53 affect expression levels general function v integrins instead conclude intracellular events involving p53 mediate inhibition neovascularization v antagonists events may related activation endothelial cell p53 previously observed upon v integrin blockage angiogenesis 5
0.4913497.11856728.html.plaintext.txt	17	view larger version 11k fig 2 retinal v integrin expression levels sensitivity v antagonist regulation retina p21cip1 v antagonist independent p53 retinas isolated pooled three four p53 p53 mice respectively subjected western blot analysis integrin v protein expression levels using actin levels control b p53 filled squares nih3t3 p53 open circles mouse fibroblasts analyzed sensitivity integrin v antagonist used vivo experiments assayed cell adhesive capacity vitronectin described previously 23 allowing cells adhere 10 15 min values expressed percent cell adhesion absence inhibitor represent mean values three distinct experiments concentration v antagonist turn analyzed triplicate within experiment c retinas isolated pooled three four wild type p53 p53 mice treated without v antagonist respectively subjected western blot analysis p21cip1 protein levels presence absence full neovascularization respective retinas indicated
0.4913497.11856728.html.plaintext.txt	18	p53 known activator cell cycle suppressor p21cip1 fact addition regulating p53 ligation integrin v3 endothelial cells also suppresses p21cip1 protein levels angiogenesis 5 uv irradiated fibroblasts p53 exerts functional effect cell cycle arrest transcriptional activation cdk inhibitor p21cip1 14 shown fig 2c blockade v integrin neovascularization induces p21cip1 levels wild type p53 heterozygous retinas surprisingly whereas untreated p53 null mice display detectable p21cip1 numeric increase p21cip1 levels anti v treatment mice similar observed wild type mice resulting higher relative increase indicates regulation p21cip1 integrin v neovascularization independent p53 furthermore fact p21cip1 induced p53 null retinas upon blockade v integrins neovascularization still active suggests induction p21cip1 sufficient block neovascularization although exclude somewhat higher total levels p21cip1 heterozygous animals might contribute blockade discussion top abstract introduction experimental procedures results discussion references
0.4913497.11856728.html.plaintext.txt	19	p53 known activator cell cycle suppressor p21cip1 fact addition regulating p53 ligation integrin v3 endothelial cells also suppresses p21cip1 protein levels angiogenesis 5 uv irradiated fibroblasts p53 exerts functional effect cell cycle arrest transcriptional activation cdk inhibitor p21cip1 14 shown fig 2c blockade v integrin neovascularization induces p21cip1 levels wild type p53 heterozygous retinas surprisingly whereas untreated p53 null mice display detectable p21cip1 numeric increase p21cip1 levels anti v treatment mice similar observed wild type mice resulting higher relative increase indicates regulation p21cip1 integrin v neovascularization independent p53 furthermore fact p21cip1 induced p53 null retinas upon blockade v integrins neovascularization still active suggests induction p21cip1 sufficient block neovascularization although exclude somewhat higher total levels p21cip1 heterozygous animals might contribute blockade discussion top abstract introduction experimental procedures results discussion references
0.4913497.11856728.html.plaintext.txt	20	studies using targeted gene knockout mice cases revealed surprising results expected phenotypes found particularly surprising molecules found play role certain vivo events previous loss function studies including integrin v capacity least 20 v integrin null mice form blood vessels 9 capacity integrin 3 5 subunit combinatorial gene knockouts support enhanced pathological angiogenesis 10 cases combinatorial knockout two three related genes demonstrated compensatory mechanisms displaying phenotypes missing single gene knockout mice however unclear functions v integrins compensated end although represent possible mechanism v integrin compensation finding p53 null mice form blood vessels absence functional v integrins critical wild type mice reveals first vivo example intracellular mechanism able compensate loss integrin function
0.4913497.11856728.html.plaintext.txt	21	studies using targeted gene knockout mice cases revealed surprising results expected phenotypes found particularly surprising molecules found play role certain vivo events previous loss function studies including integrin v capacity least 20 v integrin null mice form blood vessels 9 capacity integrin 3 5 subunit combinatorial gene knockouts support enhanced pathological angiogenesis 10 cases combinatorial knockout two three related genes demonstrated compensatory mechanisms displaying phenotypes missing single gene knockout mice however unclear functions v integrins compensated end although represent possible mechanism v integrin compensation finding p53 null mice form blood vessels absence functional v integrins critical wild type mice reveals first vivo example intracellular mechanism able compensate loss integrin function
0.4913497.11856728.html.plaintext.txt	22	alternatively function v integrins neovascularization wild type animals may negatively regulate balance vessel formation unfavorable extracellular matrix environment order prevent angiogenesis inappropriate locations function v integrins would lead enhanced angiogenesis v3 lacking suggested reynolds et al 10 support model caspase 8 activated cell surface cell types unligated integrin v3 thereby causing apoptosis 15 mechanism might related p53 caspase 8 plays role certain p53 induced apoptosis 16 nevertheless alternative models function v integrins results suggest p53 may mediate v integrin regulation cell survival neovascularization
0.4913497.11856728.html.plaintext.txt	23	alternatively function v integrins neovascularization wild type animals may negatively regulate balance vessel formation unfavorable extracellular matrix environment order prevent angiogenesis inappropriate locations function v integrins would lead enhanced angiogenesis v3 lacking suggested reynolds et al 10 support model caspase 8 activated cell surface cell types unligated integrin v3 thereby causing apoptosis 15 mechanism might related p53 caspase 8 plays role certain p53 induced apoptosis 16 nevertheless alternative models function v integrins results suggest p53 may mediate v integrin regulation cell survival neovascularization
0.4913497.11856728.html.plaintext.txt	24	neovascularization critical component tumor growth tumor unable grow beyond minimal size without new blood vessels 17 fact previously observed v integrin antagonists could block growth human tumors animal models 3 4 addition uncontrolled ocular neovascularization major cause blindness various ocular diseases including diabetic retinopathy presumed ocular histoplasmosis syndrome age related macular degeneration integrins v3 v5 may involved regulation neovascularization diseases systemic treatment v integrin antagonists block retinal neovascularization 7 8 suggests v integrin antagonists constitute potential therapy ocular diseases cancer findings indicate molecular mechanism potential anti angiogenic treatment actively involves p53 similar recently indicated angiostatin tnp 470 18 20
0.4913497.11856728.html.plaintext.txt	25	neovascularization critical component tumor growth tumor unable grow beyond minimal size without new blood vessels 17 fact previously observed v integrin antagonists could block growth human tumors animal models 3 4 addition uncontrolled ocular neovascularization major cause blindness various ocular diseases including diabetic retinopathy presumed ocular histoplasmosis syndrome age related macular degeneration integrins v3 v5 may involved regulation neovascularization diseases systemic treatment v integrin antagonists block retinal neovascularization 7 8 suggests v integrin antagonists constitute potential therapy ocular diseases cancer findings indicate molecular mechanism potential anti angiogenic treatment actively involves p53 similar recently indicated angiostatin tnp 470 18 20
0.4913497.11856728.html.plaintext.txt	26	unable detect apoptosis retinal vasculature obscuring background large number apoptotic cells whole mounts developing retinas apparent differences groups data shown however previous studies models clearly demonstrate blocking v integrins neovascularization leads vascular cell apoptosis 3 5 suggests inhibition vessel formation v antagonists may caused induction apoptosis forming vascular cells fact vascular formation p53 null mice refractory v antagonist treatment suggests vessels undergo apoptosis fig 3 whereas p53 may mediate v integrin regulated apoptosis vascular cells induction p53 loss integrin ligation constitute generic mechanism regulation cell survival cells integrins example ligation integrin 31 vitro model mammary epithelial cells lead apoptosis absence functional p53 21 mechanism appears opposite findings vascular cell integrin v3 p53 neovascularization future studies interesting elucidate whether downstream integrin signaling pathways activation erks1 might involved regulation p53 erk12 signaling identified another critical v integrin mediated event angiogenesis 22 addition remains elucidated whether p53 mediated response v antagonist treatment vascular cells functionally related activation caspase 8 unligated v3 15
0.4913497.11856728.html.plaintext.txt	27	unable detect apoptosis retinal vasculature obscuring background large number apoptotic cells whole mounts developing retinas apparent differences groups data shown however previous studies models clearly demonstrate blocking v integrins neovascularization leads vascular cell apoptosis 3 5 suggests inhibition vessel formation v antagonists may caused induction apoptosis forming vascular cells fact vascular formation p53 null mice refractory v antagonist treatment suggests vessels undergo apoptosis fig 3 whereas p53 may mediate v integrin regulated apoptosis vascular cells induction p53 loss integrin ligation constitute generic mechanism regulation cell survival cells integrins example ligation integrin 31 vitro model mammary epithelial cells lead apoptosis absence functional p53 21 mechanism appears opposite findings vascular cell integrin v3 p53 neovascularization future studies interesting elucidate whether downstream integrin signaling pathways activation erks1 might involved regulation p53 erk12 signaling identified another critical v integrin mediated event angiogenesis 22 addition remains elucidated whether p53 mediated response v antagonist treatment vascular cells functionally related activation caspase 8 unligated v3 15
0.4913497.11856728.html.plaintext.txt	28	view larger version 40k fig 3 hypothetical model role p53 compensating v integrin function blood vessel formation neovascularization wild type animals left v3 andor v5 integrins activated 1 2 v integrins allowed ligate provisional matrix ligation necessary keep endothelial cell p53 inactive cells surviving vascularization facilitated 3 5 v integrins blocked wild type animals middle thereby prevented forming clusters endothelial cell p53 activity induced vascular cells undergo apoptosis leading block blood vessel formation 5 however p53 absent vascularization inhibition v integrins affect formation viable vessels right taken together suggests p53 v integrins linked pathway control blood vessel formation vegf vascular endothelial growth factor bfgf basic fibroblast growth factor ecm extracellular matrix
0.4913497.11856728.html.plaintext.txt	29	conclusion demonstrate loss p53 compensates function v integrins retinal neovascularization possibly interfering v integrin regulation vascular cell apoptosis indicates critical function v integrin ligation neovascularization suppressing p53 p53 constitutes important part control neovascularization acknowledgement
0.4913497.11856728.html.plaintext.txt	30	conclusion demonstrate loss p53 compensates function v integrins retinal neovascularization possibly interfering v integrin regulation vascular cell apoptosis indicates critical function v integrin ligation neovascularization suppressing p53 p53 constitutes important part control neovascularization acknowledgement
0.4913497.11856728.html.plaintext.txt	31	thank dr klas wiman providing p53 null mouse embryonic fibroblasts
0.4913497.11856728.html.plaintext.txt	32	work supported grants swedish cancer society swedish medical research council magnus bergvall foundation national institutes health grants ca74435 f ca 502289 ca 45726 d c nei national institutes health grant ey11254 m fthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.4913497.11856728.html.plaintext.txt	33	correspondence addressed karolinska institutet huddinge university hospital f46 se 141 86 huddinge sweden tel 46 8 585 81032 fax 46 8 585 81020 e mail staffanstromblad impikise
0.4913497.11856728.html.plaintext.txt	34	published jbc papers press february 20 2002 doi 101074jbcc200044200
0.4913497.11856728.html.plaintext.txt	35	abbreviation used erk extracellular signal regulated kinase
0.4913497.11856728.html.plaintext.txt	36	references top abstract introduction experimental procedures results discussion references 1 brooks p c clark r f cheresh d 1994 science 264 569 571medline order article via infotrieve 2 friedlander m brooks p c shaffer r w kincaid c m varner j cheresh d 1995 science 270 1500 1502abstract 3 brooks p c montgomery m p rosenfeld m reisfeld r hu klier g cheresh d 1994 cell 79 1157 1164medline order article via infotrieve 4 brooks p c stromblad klemke r visscher d sarkar f h cheresh d 1995 j clin invest 96 1815 1822medline order article via infotrieve 5 stromblad becker j c yebra y brooks p c cheresh d 1996 j clin invest 98 426 433abstractfree full text 6 stromblad cheresh d 1996 trends cell biol 6 462 468crossref 7 friedlander m theesfeld c l sugita m fruttiger m thomas m chang cheresh d 1996 proc natl acad sci u 93 9764 9769abstractfree full text 8 hammes h p brownlee m jonczyk sutter preissner k 1996 nat med 2 529 533medline order article via infotrieve 9 bader b l rayburn h crowley d hynes r o 1998 cell 95 507 519medline order article via infotrieve 10 reynolds l e wyder l lively j c taverna d robinson d huang x sheppard d hynes r o hodivala dilke k m 2002 nat med 8 27 34crossrefmedline order article via infotrieve 11 jacks remington l williams b o schmitt e m halachmi bronson r weinberg r 1994 curr biol 4 1 7medline order article via infotrieve 12 fotedar r brickner h saadatmandi n rousselle diederich l munshi jung b reed j c fotedar 1999 oncogene 18 3652 3658crossrefmedline order article via infotrieve 13 aumailley m gurrath m calvete j timpl r kessler h 1991 febs lett 291 50 54crossrefmedline order article via infotrieve 14 el diery w harper j w oconnor p m velculescu v e canman c e jackman j pietenpol j burrell m hill d e wang y 1994 cancer res 54 1169 1174abstract 15 stupack d g puente x boutsaboualoy storgard c m cheresh d 2001 j cell biol 155 459 470abstractfree full text 16 ding h f lin y l mcgill g juo p zhu h bleni j yuan j fisher d e 2000 j biol chem 275 38905 38911abstractfree full text 17 folkman j 1995 nat med 1 27 31medline order article via infotrieve 18 jimenez b volpert o v crawford e febbraio m silverstein r l bouck n 2000 nat med 6 41 48crossrefmedline order article via infotrieve 19 zhang y e c griffit e c sage j jacks liu j o 2000 proc natl acad sci u 97 6427 6432abstractfree full text 20 yeh j r j mohan r crews c m 2000 proc natl acad sci u 97 12782 12787abstractfree full text 21 seewaldt v l mrozek k sigle r dietze e c heine k hockenbery d m hobbs k b caldwell l e 2001 j cell biol 155 471 486abstractfree full text 22 elicieri b klemke r stromblad cheresh d 1998 j cell biol 140 1255 1263abstractfree full text 23 yebra m parry c n stromblad mackman n rosenberg mueller b m cheresh d 1996 j biol chem 271 29393 29399abstractfree full text
0.4913497.11856728.html.plaintext.txt	37	copyright 2002 american society biochemistry molecular biology inc
0.49328405.14576150.html.plaintext.txt	0	depletion endogenous nitric oxide enhances cisplatin induced apoptosis p53 dependent manner melanoma cell lines chi hui tang elizabeth grimm
0.49328405.14576150.html.plaintext.txt	1	university texas graduate school biomedical sciences department bioimmunotherapy university texas m d anderson cancer center houston texas 77030
0.49328405.14576150.html.plaintext.txt	2	received publication october 1 2003 revised form october 22 2003
0.49328405.14576150.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references expression inducible nitric oxide synthase melanoma tumor cells recently shown correlate strongly poor patient survival combination biochemotherapy p 0001 furthermore evidence suggests nitric oxide reaction product nitricoxide synthase exhibits antiapoptotic activity melanoma cells therefore hypothesized nitric oxide antagonizes chemotherapy induced apoptosis whether nitric oxide capable regulating cell growth apoptotic responses cisplatin treatment melanoma cell lines evaluated demonstrate herein depletion endogenously produced nitric oxide inhibit melanoma proliferation promote apoptosis moreover data indicate depletion nitric oxide leads changes cell cycle regulation enhances cisplatin induced apoptosis melanoma cells strikingly observed depletion nitric oxide inhibits cisplatin induced wild type p53 accumulation p21waf1cip1sdi1 expression melanoma cells cisplatin induced p53 binding p21waf1cip1sdi1 promoter examined found nitric oxide depletion significantly reduced presence p53 dna complexes cisplatin treatment furthermore dominant negative inhibition p53 activity enhanced cisplatin induced apoptosis together data strongly suggest endogenously produced nitric oxide required cisplatin induced p53 activation p21waf1cip1sdi1 expression regulate melanoma sensitivity cisplatin
0.49328405.14576150.html.plaintext.txt	4	introduction top abstract introduction experimental procedures results discussion references melanoma deadliest form skin cancer exhibits extremely aggressive growth characteristics prognosis patients disseminated disease invariably poor melanoma highly resistant chemotherapy radiation therapy therapies melanoma generally ineffective best rarely result sustained responses resistance cancer therapy attributable part mechanisms altered drug uptake transport intracellular detoxification altered dna repair dysregulation apoptotic pathway 1
0.49328405.14576150.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references melanoma deadliest form skin cancer exhibits extremely aggressive growth characteristics prognosis patients disseminated disease invariably poor melanoma highly resistant chemotherapy radiation therapy therapies melanoma generally ineffective best rarely result sustained responses resistance cancer therapy attributable part mechanisms altered drug uptake transport intracellular detoxification altered dna repair dysregulation apoptotic pathway 1
0.49328405.14576150.html.plaintext.txt	6	tumor suppressor p53 sensor diverse cellular stresses including dna damage oxidative stress hypoxia helps direct cell cycle arrest apoptosis least part transcriptional activation target genes like p21waf1cip1sdi1 p211 gadd45 14 3 3 bax 2 surprisingly p53 commonly mutated gene broad spectrum cancers inactivation frequently associated tumor progression resistance therapy poor prognosis however p53 gene rarely mutated melanoma 3 increased expression associated tumor progression 4 results several studies suggest p53 pathway dysregulated melanoma cells turn may lead inactivation alteration p53 function 5 instance many human melanoma cell lines containing wild type p53 showed abnormalities p53 pathway response irradiation 6 recent years studies suggested retention wild type p53 may actually confer resistance therapy number tumor systems 7 however role p53 function melanoma remains unclear
0.49328405.14576150.html.plaintext.txt	7	tumor suppressor p53 sensor diverse cellular stresses including dna damage oxidative stress hypoxia helps direct cell cycle arrest apoptosis least part transcriptional activation target genes like p21waf1cip1sdi1 p211 gadd45 14 3 3 bax 2 surprisingly p53 commonly mutated gene broad spectrum cancers inactivation frequently associated tumor progression resistance therapy poor prognosis however p53 gene rarely mutated melanoma 3 increased expression associated tumor progression 4 results several studies suggest p53 pathway dysregulated melanoma cells turn may lead inactivation alteration p53 function 5 instance many human melanoma cell lines containing wild type p53 showed abnormalities p53 pathway response irradiation 6 recent years studies suggested retention wild type p53 may actually confer resistance therapy number tumor systems 7 however role p53 function melanoma remains unclear
0.49328405.14576150.html.plaintext.txt	8	activated p53 bind p53 responsive elements promoter potent cell cycle regulator p21 induce expression 8 sufficiently expressed p21 induces g1 arrest direct binding cyclin dependent kinases 9 expression p21 implicated survival mechanism therapy 10 instance inhibition p21 antisense technology sensitized glioblastoma cells chemotherapeutic agents 11 radiation therapy 12 p21 also appears protect human colon carcinoma cells prostate cancer cells apoptosis 13 14 additionally evidence p21 may protect p53 mediated apoptosis human melanoma cells 15 precise involvement p21 resistance melanoma therapy remains largely undefined
0.49328405.14576150.html.plaintext.txt	9	activated p53 bind p53 responsive elements promoter potent cell cycle regulator p21 induce expression 8 sufficiently expressed p21 induces g1 arrest direct binding cyclin dependent kinases 9 expression p21 implicated survival mechanism therapy 10 instance inhibition p21 antisense technology sensitized glioblastoma cells chemotherapeutic agents 11 radiation therapy 12 p21 also appears protect human colon carcinoma cells prostate cancer cells apoptosis 13 14 additionally evidence p21 may protect p53 mediated apoptosis human melanoma cells 15 precise involvement p21 resistance melanoma therapy remains largely undefined
0.49328405.14576150.html.plaintext.txt	10	nitric oxide recently implicated regulation p53 specifically treating cells donors resulted conformational functional changes possible tyrosine nitration p53 protein 16 17 addition shown regulate ability p53 stimulate radiation induced cell cycle arrest mcf 7 breast cancer cell line 18 generated reaction product enzymatic conversion l arginine l citrulline three isotypes synthase nos endothelial enos neuronal nnos inducible inos noss expressed various tissue types enos nnos typically considered constitutively expressed whereas inos name implies inducible 19 involved neurotransmission vasodilation inflammation immunity 20 also believed play roles multiple stages various cancers 21 exhibits proapoptotic antiapoptotic characteristics depending concentration cell type 22 23 recently shown covalently modify proteins lead regulation activity including caspases 24 25 retinoblastoma protein 26 c src 27 p53 17
0.49328405.14576150.html.plaintext.txt	11	nitric oxide recently implicated regulation p53 specifically treating cells donors resulted conformational functional changes possible tyrosine nitration p53 protein 16 17 addition shown regulate ability p53 stimulate radiation induced cell cycle arrest mcf 7 breast cancer cell line 18 generated reaction product enzymatic conversion l arginine l citrulline three isotypes synthase nos endothelial enos neuronal nnos inducible inos noss expressed various tissue types enos nnos typically considered constitutively expressed whereas inos name implies inducible 19 involved neurotransmission vasodilation inflammation immunity 20 also believed play roles multiple stages various cancers 21 exhibits proapoptotic antiapoptotic characteristics depending concentration cell type 22 23 recently shown covalently modify proteins lead regulation activity including caspases 24 25 retinoblastoma protein 26 c src 27 p53 17
0.49328405.14576150.html.plaintext.txt	12	laboratory observed expression inos presence nitrotyrosine tumor cells melanoma patients correlated strongly poor patient outcome p 0001 002 respectively 28 suggesting important role melanoma resistance therapy presently samples 103 patients stage iii 36 patients stage iv melanoma analyzed similar results obtained2 others correlated nos activity inos expression melanoma progression 29 recently salvucci et al 30 provided evidence endogenous may serve survival factor human melanoma cells
0.49328405.14576150.html.plaintext.txt	13	using human melanoma cell lines cisplatin model system tested hypothesis regulates p53 signaling required melanoma resistance chemotherapy present evidence depletion endogenous melanoma cell lines leads increased sensitivity cisplatin consequence inhibition cisplatin induced p53 accumulation p21 expression findings support hypothesis required dna damage induced p53 activation acts protective factor apoptosis melanoma cells
0.49328405.14576150.html.plaintext.txt	14	using human melanoma cell lines cisplatin model system tested hypothesis regulates p53 signaling required melanoma resistance chemotherapy present evidence depletion endogenous melanoma cell lines leads increased sensitivity cisplatin consequence inhibition cisplatin induced p53 accumulation p21 expression findings support hypothesis required dna damage induced p53 activation acts protective factor apoptosis melanoma cells
0.49328405.14576150.html.plaintext.txt	15	experimental procedures top abstract introduction experimental procedures results discussion references reagents 2 4 carboxyphenyl 4455 tetramethylimidazoline 1 oxyl 3 oxide c ptio 31 3 morpholinosydnonimine sin 1 z 1 2 2 aminoethyl n 2 ammonioethylaminodiazen 1 ium 12 diolate deta aminoguanidine amg ng monomethyl l arginine monoacetate l nmma obtained alexis corp san diego ca n 3 aminomethylbenzylacetamidine dihydrochloride 1400w purchased g scientific san diego ca cisplatin purchased bristol myers squibb co 3hthymidine obtained perkinelmer life sciences 32patp purchased icn pharmaceuticals inc costa mesa ca antibodies p53 actin purchased oncogene research products san diego ca antibody p21 obtained upstate lake placid ny polyadp ribose polymerase parp antibody purchased bd pharmingen antibody cleaved caspase 3 acquired cell signaling beverly ma p53 v143a dominant negative pmev empty vectors obtained biomyx technology san diego ca lipofectamine 2000 lipo2k invitrogen fetal bovine serum purchased invitrogen dulbeccos modified eagles medium dmem dulbeccos phosphate buffered saline pbs 8 bromoguanosine 35 cyclic monophosphate 8 bromo cgmp 1h 124oxadiazolo43 aquinoxalin 1 one odq myoglobin reagents obtained sigma
0.49328405.14576150.html.plaintext.txt	16	cell culture a375 a375s2 sk mel 1 melanoma cell lines obtained american type culture collection a375sm mewo melanoma cell lines generous gifts j fidler d g menter respectively cell lines grown dmem supplemented hepes glutamine penicillin streptomycin 10 vv fetal bovine serum 37 degrees c 7 co2 cells generally seeded 6 well culture plates 20 30 confluence day start experimentation cell viability routinely checked trypan blue exclusion method
0.49328405.14576150.html.plaintext.txt	17	cell cycle synchronization indicated cells synchronized serum starvation 24 h followed addition serum 10 final concentration appropriate treatments 0 h serum starvation 24 h resulted 80 90 accumulation cells g0g1 phase
0.49328405.14576150.html.plaintext.txt	18	cell cycle synchronization indicated cells synchronized serum starvation 24 h followed addition serum 10 final concentration appropriate treatments 0 h serum starvation 24 h resulted 80 90 accumulation cells g0g1 phase
0.49328405.14576150.html.plaintext.txt	19	oxymyoglobin preparation oxymyoglobin prepared equine heart myoglobin previously described 32 briefly lyophilized myoglobin resuspended water reduced molar excess sodium dithionite sodium hydrosulfite sigma passed sephadex g 25 column pd 10 amersham biosciences oxymyoglobin recovered single bright red band column flow
0.49328405.14576150.html.plaintext.txt	20	oxymyoglobin preparation oxymyoglobin prepared equine heart myoglobin previously described 32 briefly lyophilized myoglobin resuspended water reduced molar excess sodium dithionite sodium hydrosulfite sigma passed sephadex g 25 column pd 10 amersham biosciences oxymyoglobin recovered single bright red band column flow
0.49328405.14576150.html.plaintext.txt	21	3hthymidine uptake assay 3hthymidine uptake assay performed essentially previously described 33 briefly cells treated indicated triplicate 96 well flat bottom culture plate 3hthymidine added cell cultures 16 h prior harvesting phd cell harvester cambridge technology inc cambridge ma glass filters containing harvested dna dried scintillation fluid added radioactive counts measured beckman coulter ls 6500 scintillation counter
0.49328405.14576150.html.plaintext.txt	22	3hthymidine uptake assay 3hthymidine uptake assay performed essentially previously described 33 briefly cells treated indicated triplicate 96 well flat bottom culture plate 3hthymidine added cell cultures 16 h prior harvesting phd cell harvester cambridge technology inc cambridge ma glass filters containing harvested dna dried scintillation fluid added radioactive counts measured beckman coulter ls 6500 scintillation counter
0.49328405.14576150.html.plaintext.txt	23	terminal deoxynucleotide transferase mediated dutp fitc nickend labeling tunel assay tunel assay fragel dna fragmentation detection assay oncogene research products performed according manufacturers protocol briefly cells harvested trypsinization washed pbs pelleted centrifugation 1000 x g 5 min cells fixed 4 formaldehyde pbs 10 min ambient temperature pelleted resuspended 80 ethanol storage 4 degrees c day staining cells rehydrated tris buffered saline 10 min ambient temperature permeabilized proteinase k treatment 5 min cells incubated 15 min manufacturer supplied equilibration buffer buffer removed cells incubated tdt labeling reaction mixture dark 15 h 37 degrees c mixture removed cells washed tris buffered saline incubated propidium iodide pirnase buffer phoenix flow systems san diego ca additional 30 min dark 37 degrees c cells analyzed flow cytometric analysis facscalibur flow cytometer bd biosciences sample population 10000 cells used analysis cellquest software
0.49328405.14576150.html.plaintext.txt	24	terminal deoxynucleotide transferase mediated dutp fitc nickend labeling tunel assay tunel assay fragel dna fragmentation detection assay oncogene research products performed according manufacturers protocol briefly cells harvested trypsinization washed pbs pelleted centrifugation 1000 x g 5 min cells fixed 4 formaldehyde pbs 10 min ambient temperature pelleted resuspended 80 ethanol storage 4 degrees c day staining cells rehydrated tris buffered saline 10 min ambient temperature permeabilized proteinase k treatment 5 min cells incubated 15 min manufacturer supplied equilibration buffer buffer removed cells incubated tdt labeling reaction mixture dark 15 h 37 degrees c mixture removed cells washed tris buffered saline incubated propidium iodide pirnase buffer phoenix flow systems san diego ca additional 30 min dark 37 degrees c cells analyzed flow cytometric analysis facscalibur flow cytometer bd biosciences sample population 10000 cells used analysis cellquest software
0.49328405.14576150.html.plaintext.txt	25	immunoassay p21 p53 cleaved caspase 3 parp actin cells washed pbs trypsinized washed icecold pbs lysis cells lysed buffer containing 25 mm tris hcl ph 75 140 mm nacl 10 mm naf 5 mm edta 1 nonidet p 40 1 mm phenylmethylsulfonyl fluoride 1 microgml leupeptin 2 microgml pepstatin 2 microgml aprotinin 30 min centrifuged 15000 x g 15 min 4 degrees c protein content resulting supernatants measured dc protein assay bio rad using bovine serum albumin standard twenty five 50 microg total protein fractionated sds page 12 gel proteins transferred polyvinylidene difluoride cellulose semi dry transfer apparatus bio rad membrane blocked pbs 5 milk 15 h incubated overnight 4 degrees c pbs 01 tween 20 pbs primary antibody monoclonal antibodies p21 p53 parp actin used 12000 12000 1500 15000 dilutions respectively rabbit polyclonal cleaved caspase 3 antibody used 11000 dilution three 5 min washes pbs membrane incubated 15 h ambient temperature pbs appropriate horseradish peroxidase conjugated secondary antibody 15000 p21 p53 11000 parp 12000 cleaved caspase 3 110000 actin washed three times total 15 20 min visualized ecl reagent exposed hyperfilm ecl amersham biosciences
0.49328405.14576150.html.plaintext.txt	26	immunoassay p21 p53 cleaved caspase 3 parp actin cells washed pbs trypsinized washed icecold pbs lysis cells lysed buffer containing 25 mm tris hcl ph 75 140 mm nacl 10 mm naf 5 mm edta 1 nonidet p 40 1 mm phenylmethylsulfonyl fluoride 1 microgml leupeptin 2 microgml pepstatin 2 microgml aprotinin 30 min centrifuged 15000 x g 15 min 4 degrees c protein content resulting supernatants measured dc protein assay bio rad using bovine serum albumin standard twenty five 50 microg total protein fractionated sds page 12 gel proteins transferred polyvinylidene difluoride cellulose semi dry transfer apparatus bio rad membrane blocked pbs 5 milk 15 h incubated overnight 4 degrees c pbs 01 tween 20 pbs primary antibody monoclonal antibodies p21 p53 parp actin used 12000 12000 1500 15000 dilutions respectively rabbit polyclonal cleaved caspase 3 antibody used 11000 dilution three 5 min washes pbs membrane incubated 15 h ambient temperature pbs appropriate horseradish peroxidase conjugated secondary antibody 15000 p21 p53 11000 parp 12000 cleaved caspase 3 110000 actin washed three times total 15 20 min visualized ecl reagent exposed hyperfilm ecl amersham biosciences
0.49328405.14576150.html.plaintext.txt	27	isolation nuclear extracts electrophoretic mobility shift nuclear extracts cell lines obtained essentially previously described 34 briefly cells harvested trypsinization washed pbs plasma membrane lysed without lysing nuclear membrane solution containing 20 mm hepes ph 79 10 mm nacl 3 mm mgcl2 01 nonidet p 40 10 glycerol 02 mm edta supplemented 1 mm dithiothreitol protease inhibitor mixture bd biosciences phosphatase inhibitor mixture ii sigma 15 min ice occasional tapping total lysis checked trypan blue exclusion nuclei pelleted centrifugation 1300 x g 4 degrees c 5 min washed wash buffer containing 20 mm hepes ph 79 02 mm edta 20 glycerol aforementioned supplements remove detergent nuclear proteins extracted using high salt buffer wash buffer 400 mm nacl 45 min ice occasional tapping dna debris removed centrifugation 15000 x g 4 degrees c 15 min
0.49328405.14576150.html.plaintext.txt	28	isolation nuclear extracts electrophoretic mobility shift nuclear extracts cell lines obtained essentially previously described 34 briefly cells harvested trypsinization washed pbs plasma membrane lysed without lysing nuclear membrane solution containing 20 mm hepes ph 79 10 mm nacl 3 mm mgcl2 01 nonidet p 40 10 glycerol 02 mm edta supplemented 1 mm dithiothreitol protease inhibitor mixture bd biosciences phosphatase inhibitor mixture ii sigma 15 min ice occasional tapping total lysis checked trypan blue exclusion nuclei pelleted centrifugation 1300 x g 4 degrees c 5 min washed wash buffer containing 20 mm hepes ph 79 02 mm edta 20 glycerol aforementioned supplements remove detergent nuclear proteins extracted using high salt buffer wash buffer 400 mm nacl 45 min ice occasional tapping dna debris removed centrifugation 15000 x g 4 degrees c 15 min
0.49328405.14576150.html.plaintext.txt	29	electrophoretic mobility shift assay double stranded oligonucleotide probe corresponding p53 binding site p21 promoter synthesized sigma genosys woodlands tx sequence 5 gaacatgtcccaacatgttg 3 8 complementary oligonucleotides annealed form probe labeled 32patp using t4 polynucleotide kinase resolved nap 5 sephadex g 25 column amersham biosciences remove unincorporated label dna binding reaction performed 6 microg nuclear extracts solution containing 20 mm tris hcl ph 75 2 mm nacl 5 mm dithiothreitol 10 glycerol 05 nonidet p 40 100 ng polydi dc 1 ng labeled probe 40 microl total volume 30 min ambient temperature 05 microg monoclonal anti p53 antibody pab421 added incubation continued another 30 min ambient temperature dna protein complexes resolved non denaturing 5 polyacrylamide gel detected autoradiography using bio max mr film eastman kodak co
0.49328405.14576150.html.plaintext.txt	30	electrophoretic mobility shift assay double stranded oligonucleotide probe corresponding p53 binding site p21 promoter synthesized sigma genosys woodlands tx sequence 5 gaacatgtcccaacatgttg 3 8 complementary oligonucleotides annealed form probe labeled 32patp using t4 polynucleotide kinase resolved nap 5 sephadex g 25 column amersham biosciences remove unincorporated label dna binding reaction performed 6 microg nuclear extracts solution containing 20 mm tris hcl ph 75 2 mm nacl 5 mm dithiothreitol 10 glycerol 05 nonidet p 40 100 ng polydi dc 1 ng labeled probe 40 microl total volume 30 min ambient temperature 05 microg monoclonal anti p53 antibody pab421 added incubation continued another 30 min ambient temperature dna protein complexes resolved non denaturing 5 polyacrylamide gel detected autoradiography using bio max mr film eastman kodak co
0.49328405.14576150.html.plaintext.txt	31	inhibition p53 activity transfection dominant negative expression vector transfection a375 melanoma cells performed according manufacturers protocol briefly cells plated one day prior transfection dmem supplemented 10 fetal bovine serum hepes glutamine without antibiotics give approximate cell density 95 confluence time transfection lipofectamine 2000 10 microlcm2 plasmids 04 microgcm2 added individually opti mem invitrogen 5 min combined incubated 20 min prior addition liposome dna complexes wells rinsed opti mem refilled fresh supplemented dmem without antibiotics transfection carried 24 h cells treated appropriate reagents another 24 h harvesting transfection confirmed western blotting hemagglutinin
0.49328405.14576150.html.plaintext.txt	32	inhibition p53 activity transfection dominant negative expression vector transfection a375 melanoma cells performed according manufacturers protocol briefly cells plated one day prior transfection dmem supplemented 10 fetal bovine serum hepes glutamine without antibiotics give approximate cell density 95 confluence time transfection lipofectamine 2000 10 microlcm2 plasmids 04 microgcm2 added individually opti mem invitrogen 5 min combined incubated 20 min prior addition liposome dna complexes wells rinsed opti mem refilled fresh supplemented dmem without antibiotics transfection carried 24 h cells treated appropriate reagents another 24 h harvesting transfection confirmed western blotting hemagglutinin
0.49328405.14576150.html.plaintext.txt	33	results top abstract introduction experimental procedures results discussion references effect melanoma cell proliferation implicated increased melanoma progression metastatic potential evaluated whether endogenously produced enhanced proliferation inos expressing a375 melanoma cells specific scavenger c ptio donor deta used modulate levels cells overnight 3hthymidine uptake measured depletion resulted dose dependent decrease proliferation fig 1a addition 50 microm deta lead increase 3hthymidine uptake fig 1b treatment cells 150 microm deta caused dose dependent decrease 3hthymidine uptake suggesting low levels enhances cell growth whereas higher concentrations lead inhibition growth similar results observed a375s2 melanoma cells data shown
0.49328405.14576150.html.plaintext.txt	34	results top abstract introduction experimental procedures results discussion references effect melanoma cell proliferation implicated increased melanoma progression metastatic potential evaluated whether endogenously produced enhanced proliferation inos expressing a375 melanoma cells specific scavenger c ptio donor deta used modulate levels cells overnight 3hthymidine uptake measured depletion resulted dose dependent decrease proliferation fig 1a addition 50 microm deta lead increase 3hthymidine uptake fig 1b treatment cells 150 microm deta caused dose dependent decrease 3hthymidine uptake suggesting low levels enhances cell growth whereas higher concentrations lead inhibition growth similar results observed a375s2 melanoma cells data shown
0.49328405.14576150.html.plaintext.txt	35	view larger version 19k fig 1 regulation melanoma cell growth 3hthymidine uptake a375 melanoma cells melanoma cells 25 30 confluence treated triplicate 24 h c ptio scavenger 3hthymidine added simultaneously modulators cells harvested described experimental procedures 3hthymidine incorporation measured scintillation counter b cells treated 24 h deta c cells treated c ptio sin 1 24 h d c ptio andor deta added melanoma cells incubated 37 degrees c 1 h cisplatin 3hthymidine added culture medium cells incubated 24 h 37 degrees c harvesting data expressed mean plus minus sd data shown representative least two separate experiments
0.49328405.14576150.html.plaintext.txt	36	addition inos presence nitrotyrosine also correlated poor outcome melanoma patients 28 assess whether increased protein tyrosine nitration enhances melanoma proliferation cells treated sin 1 donates superoxide 11 ratio 3hthymidine incorporation measured fig 1c superoxide form peroxynitrite responsible protein tyrosine nitration near diffusion controlled rate sin 1 treatment 300 microm little affect cell growth sin 1 also able reverse inhibition proliferation depletion
0.49328405.14576150.html.plaintext.txt	37	addition inos presence nitrotyrosine also correlated poor outcome melanoma patients 28 assess whether increased protein tyrosine nitration enhances melanoma proliferation cells treated sin 1 donates superoxide 11 ratio 3hthymidine incorporation measured fig 1c superoxide form peroxynitrite responsible protein tyrosine nitration near diffusion controlled rate sin 1 treatment 300 microm little affect cell growth sin 1 also able reverse inhibition proliferation depletion
0.49328405.14576150.html.plaintext.txt	38	assess whether depletion regulates growth inhibition cisplatin treatment incubated cells c ptio prior addition cisplatin fig 1d 3hthymidine uptake decreased dose dependent manner cisplatin treatment cells preincubated cisplatin c ptio proliferation decreased 2 fold induced cisplatin alone suggesting additive synergistic effect cisplatin treatment depletion concomitant addition donor c ptio restored cell growth baseline levels indicates antiproliferative effect specific scavenging properties c ptio
0.49328405.14576150.html.plaintext.txt	39	depletion endogenous enhances apoptosis cisplatin treated melanoma cells confirm antiproliferative effect depletion cell death tunel assay pi staining performed depletion alone result substantial increase percentage tunel positive cells number hypodiploid cells indicating observed decrease 3hthymidine uptake result cell death fig 2 b treatment a375 cells cisplatin resulted dose dependent increase tunel positivity indicating rise apoptotic cell death interestingly preincubation cells c ptio followed cisplatin treatment led significant increase apoptosis would expected depletion independent cisplatin induced dna damage quenched c ptio control effect apoptosis indicating observed effects specific similar rise apoptosis also seen a375s2 a375sm melanoma cells although cell lines showed increased apoptosis depletion alone data shown
0.49328405.14576150.html.plaintext.txt	40	depletion endogenous enhances apoptosis cisplatin treated melanoma cells confirm antiproliferative effect depletion cell death tunel assay pi staining performed depletion alone result substantial increase percentage tunel positive cells number hypodiploid cells indicating observed decrease 3hthymidine uptake result cell death fig 2 b treatment a375 cells cisplatin resulted dose dependent increase tunel positivity indicating rise apoptotic cell death interestingly preincubation cells c ptio followed cisplatin treatment led significant increase apoptosis would expected depletion independent cisplatin induced dna damage quenched c ptio control effect apoptosis indicating observed effects specific similar rise apoptosis also seen a375s2 a375sm melanoma cells although cell lines showed increased apoptosis depletion alone data shown
0.49328405.14576150.html.plaintext.txt	41	view larger version 29k fig 2 endogenous depletion enhances cisplatin induced apoptosis tunel assay flow cytometric analysis a375 melanoma cells pretreated 1 h c ptio prior 24 h incubation 0 8 microgml cisplatin 37 degrees c cells fixed tunel staining flow cytometric analysis performed described experimental procedures ten thousand cells counted treatment b graphic representation tunel staining shown quenched scavenger control differ corresponding control c immunoblot cleaved caspase 3 parp d cells incubated oxymyoglobin 1 h prior 24 h cisplatin treatment cells harvested analyzed
0.49328405.14576150.html.plaintext.txt	42	caspase activation subsequent parp cleavage additional markers apoptosis 35 caspase 3 cleavage leads activation parp cleavage determined western blot fig 2c data indicate cisplatin treatment alone trigger significant caspase 3 activation parp cleavage whereas depletion cisplatin treatment resulted strong caspase 3 activation parp cleavage cleavage parp closely correlated caspase 3 activation
0.49328405.14576150.html.plaintext.txt	43	caspase activation subsequent parp cleavage additional markers apoptosis 35 caspase 3 cleavage leads activation parp cleavage determined western blot fig 2c data indicate cisplatin treatment alone trigger significant caspase 3 activation parp cleavage whereas depletion cisplatin treatment resulted strong caspase 3 activation parp cleavage cleavage parp closely correlated caspase 3 activation
0.49328405.14576150.html.plaintext.txt	44	confirm depletion enhanced cisplatin induced apoptosis melanoma cells oxymyoglobin known scavenger 36 added cells prior cisplatin treatment 24 h fig 2d depletion oxymyoglobin concentrations similar used c ptio also found enhance cisplatin induced cell death furthermore addition doxycycline shown destabilize inos mrna j774 mouse macrophage cells 37 prior cisplatin treatment also enhanced cisplatin induced apoptosis data shown addition moderate levels donor prior cisplatin treatment alter level apoptosis
0.49328405.14576150.html.plaintext.txt	45	depletion causes alterations cell cycle distribution cell cycle response cisplatin cell cycle analysis pi staining showed treatment cisplatin alone led g1 arrest a375 melanoma cells possibly regulation p21 depletion alone led accumulation cells g2 phase consistent observed decrease proliferation cisplatin treatment depleted cells led loss g1 arrest accumulation cells g2 phases interestingly results tunel pi staining analyzed simultaneously tunel positive cisplatin treated cells mostly found near g1s boundary whereas tunel positivity depleted cells exposed cisplatin found cell cycle phases fig 3a similar findings observed a375s2 a375sm cells
0.49328405.14576150.html.plaintext.txt	46	depletion causes alterations cell cycle distribution cell cycle response cisplatin cell cycle analysis pi staining showed treatment cisplatin alone led g1 arrest a375 melanoma cells possibly regulation p21 depletion alone led accumulation cells g2 phase consistent observed decrease proliferation cisplatin treatment depleted cells led loss g1 arrest accumulation cells g2 phases interestingly results tunel pi staining analyzed simultaneously tunel positive cisplatin treated cells mostly found near g1s boundary whereas tunel positivity depleted cells exposed cisplatin found cell cycle phases fig 3a similar findings observed a375s2 a375sm cells
0.49328405.14576150.html.plaintext.txt	47	view larger version 42k fig 3 cell cycle regulation a375 melanoma cells treated c ptio andor deta cisplatin 24 h fixed stained analyzed flow cytometry tunelpi staining tunel positivity plotted along ordinate pi staining along abscissa approximate locations cells cell cycle phase indicated arrows data shown representative least three separate experiments b synchronized a375 cells treated specified amount time c ptio deta cisplatin indicated tunelpi analysis performed
0.49328405.14576150.html.plaintext.txt	48	dissect effects depletion cisplatin treatment cell cycle melanoma cells cell cycle distribution synchronized a375 cells treated c ptio cisplatin measured course 48 h fig 3b 0 h 80 90 cells g0g1 phase generally consistent synchronized cell systems depletion led increased accumulation cells g2 phase 24 h cell cycle distribution stabilized sustained g2 arrest time dependent increase apoptosis starting 24 h depletion seen treatment cisplatin alone caused accumulation melanoma cells g1s boundary 36 h point cell cycle distribution begins return normal cisplatin induced apoptosis observed 16 h cisplatin treatment depleted cells led slow decline cells g1 phase concomitant increase cells g2 phases 48 h apoptosis cells seen 8 h increased substantially 48 h quenched c ptio alter cell cycle distribution
0.49328405.14576150.html.plaintext.txt	49	depletion inhibits cisplatin induced p53 accumulation p21 expression p53 signaling pathway activated dna damaging agents involved induction apoptosis cell cycle arrest dna repair 38 depleted melanoma cells exhibited increased cisplatin induced apoptosis alterations cell cycle regulation suggesting possible role p53 p53 responsive cell cycle regulator p21 regulation melanoma cell response cisplatin baseline expression p53 p21 found low a375 a375s2 a735sm melanoma cells cisplatin treatment resulted stabilization nuclear accumulation wild type p53 fig 4a expression p53 downstream target p21 also regulated suggesting p53 activity increases result cisplatin treatment
0.49328405.14576150.html.plaintext.txt	50	depletion inhibits cisplatin induced p53 accumulation p21 expression p53 signaling pathway activated dna damaging agents involved induction apoptosis cell cycle arrest dna repair 38 depleted melanoma cells exhibited increased cisplatin induced apoptosis alterations cell cycle regulation suggesting possible role p53 p53 responsive cell cycle regulator p21 regulation melanoma cell response cisplatin baseline expression p53 p21 found low a375 a375s2 a735sm melanoma cells cisplatin treatment resulted stabilization nuclear accumulation wild type p53 fig 4a expression p53 downstream target p21 also regulated suggesting p53 activity increases result cisplatin treatment
0.49328405.14576150.html.plaintext.txt	51	view larger version 26k fig 4 depletion endogenous inhibits cisplatin induced p53 stabilization accumulation p21 expression melanoma cells a375 a375s2 melanoma cells incubated cisplatin 24 h 37 degrees c nuclear n cytosolic c extracts generated size fractionated sds page immunoblotting performed using 12000 anti p53 antibody immunoblotting 15000 tubulin antibody included verify purity nuclear extract b a375 melanoma cells pretreated c ptio scavenger 250 microm 1 h prior incubation cisplatin 24 h 37 degrees c cell lysates 25 microg size fractionated sds page immunoblotted p21 p53 actin c ptio quenched deta donor 250 microm included negative control c a375 melanoma cells treated oxymyoglobin context cisplatin 24 h immunoblots p21 p53 actin perform b
0.49328405.14576150.html.plaintext.txt	52	determine whether modulation regulates cisplatin induced p53 accumulation melanoma cell lines pretreated c ptio scavenger deta donor prior cisplatin treatment parallel experiments performed tunel pi analyses fig 2 fig 4b western blot analyses cell lysates showed depletion resulted substantial reduction cisplatin induced p53 accumulation melanoma cell lines tested depletion strongly inhibited cisplatin induced p21 expression close correlation decreased p53 accumulation suggests p21 expression p53 dependent melanoma cells depletion alone alter p53 protein levels localization whereas addition increased p53 accumulation slightly correspondingly p21 expression remained nearly undetectable either depletion addition alone quenched c ptio failed inhibit cisplatin induced expression p53 p21 confirming observed effect specific modulation similar results found a375s2 a375sm melanoma cell lines tested data shown
0.49328405.14576150.html.plaintext.txt	53	show regulation cisplatin induced p53 activation p21 expression specific cells treated overnight oxymyoglobin fig 4c oxymyoglobin able inhibit cisplatin induced p53 p21 expression consistent results obtained c ptio used scavenger moreover incubation pan nos inhibitor l nmma inos selective inhibitor amg inos specific inhibitor n 3 aminomethylbenzylacetamidine 1400w prior cisplatin treatment also reduced p53 p21 expression albeit lesser extent fig 5 c pretreatment melanoma cells doxycycline destabilizes inos mrna prior cisplatin treatment led inhibition cisplatin induced p53 accumulation p21 expression fig 5d thus data strongly suggest depletion inhibits p53 accumulation p21 expression response cisplatin enhances cisplatin induced apoptosis
0.49328405.14576150.html.plaintext.txt	54	view larger version 30k fig 5 nos inhibition reduces cisplatin induced p53 accumulation p21 expression immunoblot analysis p21 p53 a375 melanoma cells preincubated 24 h competitive pan nos inhibitor l nmma prior cisplatin treatment 24 h b cells treated inos selective inhibitor amg prior cisplatin treatment immunoblotting c inos specific inhibitor 1400w added cells 24 h prior cisplatin treatment immunoblotting d doxycycline destabilizes inos mrna added cells 24 h prior cisplatin treatment immunoblotting
0.49328405.14576150.html.plaintext.txt	55	regulation cisplatin induced p21 expression p21 activated p53 dependent independent pathways evaluated whether cisplatin induced p21 expression p53 dependent dna binding activity p53 cisplatin treatment examined electrophoretic mobility shift assay using radiolabeled double stranded oligonucleotides sequence corresponding p53 binding site p21 promoter probe cisplatin found induce strong dna binding p53 p53 binding site fig 6a suggesting increased p21 expression p53 dependent melanoma cells endogenous removed prior cisplatin treatment level p53 dna complex formed vastly reduced c ptio alone affect p53 dna binding quenched c ptio control inhibit cisplatin induced p53 dna binding addition nonspecific probe failed bind p53 compete binding specific probe data shown
0.49328405.14576150.html.plaintext.txt	56	regulation cisplatin induced p21 expression p21 activated p53 dependent independent pathways evaluated whether cisplatin induced p21 expression p53 dependent dna binding activity p53 cisplatin treatment examined electrophoretic mobility shift assay using radiolabeled double stranded oligonucleotides sequence corresponding p53 binding site p21 promoter probe cisplatin found induce strong dna binding p53 p53 binding site fig 6a suggesting increased p21 expression p53 dependent melanoma cells endogenous removed prior cisplatin treatment level p53 dna complex formed vastly reduced c ptio alone affect p53 dna binding quenched c ptio control inhibit cisplatin induced p53 dna binding addition nonspecific probe failed bind p53 compete binding specific probe data shown
0.49328405.14576150.html.plaintext.txt	57	view larger version 35k fig 6 inhibition cisplatin induced p21 expression depletion p53 dependent electrophoretic mobility shift assay immunoblotting nuclear extracts c ptio 250 microm cisplatin 4 microgml treated cells incubated 32p labeled double stranded 20 mer probe using p53 binding site p21 gene presence anti p53 antibody pab241 stabilize p53 dna complex resolved native 5 polyacrylamide gel visualized autoradiography deta donor 250 microm added quench c ptio scavenger specificity control c positive control mcf 7 breast cancer cell line wild type p53 exposed 5 gray irradiation cc cold competitor control 30 fold excess unlabeled probe added compete labeled probe b odq inhibitor sensitive guanylyl cyclase added a375 melanoma cells 24 h prior cisplatin treatment 24 h immunoblotting dimethyl sulfoxide dmso 02 vv added vehicle control c cells preincubated cgmp analog 8 bromo cgmp 24 h prior cisplatin treatment immunoblotting
0.49328405.14576150.html.plaintext.txt	58	determine whether p21 activated via cgmp dependent pathway odq inhibitor sensitive guanylyl cyclase added melanoma cells prior cisplatin treatment treatment odq inhibit cisplatin induced p21 expression paradoxically odq treatment appeared enhance p53 accumulation p21 expression similarly addition plasma membrane permeant cgmp analog 8 bromo cgmp reduced p21 expression slightly fig 6 b c suggesting possible regulatory role cgmp induction p21 via p53 pathway odq 8 bromo cgmp treatments affect cell cycle distribution level cisplatin induced apoptosis data shown taken together data strongly suggest p21 expression p53 dependent cgmp dependent
0.49328405.14576150.html.plaintext.txt	59	determine whether p21 activated via cgmp dependent pathway odq inhibitor sensitive guanylyl cyclase added melanoma cells prior cisplatin treatment treatment odq inhibit cisplatin induced p21 expression paradoxically odq treatment appeared enhance p53 accumulation p21 expression similarly addition plasma membrane permeant cgmp analog 8 bromo cgmp reduced p21 expression slightly fig 6 b c suggesting possible regulatory role cgmp induction p21 via p53 pathway odq 8 bromo cgmp treatments affect cell cycle distribution level cisplatin induced apoptosis data shown taken together data strongly suggest p21 expression p53 dependent cgmp dependent
0.49328405.14576150.html.plaintext.txt	60	inhibition p53 expression dominant negative p53 protein enhances cisplatin induced apoptosis a375 melanoma cells determine whether increased sensitivity cisplatin induced cell death depleted cells caused inhibition p53 activity melanoma cells transfected dominant negative form p53 p53dn block wild type p53 function expression p53dn enhanced cisplatin induced apoptosis 18 fold fig 7a basal levels apoptosis affected p53dn compared pmev empty vector p53dn protein tagged two hemagglutinin motifs seen p53dn transfected cells control cells fig 7b 54 kda hemagglutinin tagged band detectible p53dn transfectants pmev controls data shown wild type p53 activated p53dn pmev transfected cells cisplatin treatment however p21 expression p53dn transfected cells reduced relative control cells suggesting p53 function partially inhibited transfection p53 sirna also reduced p53 expression cisplatin treatment however level p53 reduction sufficient enhance cisplatin induced apoptosis data shown
0.49328405.14576150.html.plaintext.txt	61	inhibition p53 expression dominant negative p53 protein enhances cisplatin induced apoptosis a375 melanoma cells determine whether increased sensitivity cisplatin induced cell death depleted cells caused inhibition p53 activity melanoma cells transfected dominant negative form p53 p53dn block wild type p53 function expression p53dn enhanced cisplatin induced apoptosis 18 fold fig 7a basal levels apoptosis affected p53dn compared pmev empty vector p53dn protein tagged two hemagglutinin motifs seen p53dn transfected cells control cells fig 7b 54 kda hemagglutinin tagged band detectible p53dn transfectants pmev controls data shown wild type p53 activated p53dn pmev transfected cells cisplatin treatment however p21 expression p53dn transfected cells reduced relative control cells suggesting p53 function partially inhibited transfection p53 sirna also reduced p53 expression cisplatin treatment however level p53 reduction sufficient enhance cisplatin induced apoptosis data shown
0.49328405.14576150.html.plaintext.txt	62	view larger version 29k fig 7 inhibition p53 activity dominant negative p53 transfection enhances cisplatin induced apoptosis a375 melanoma cells transfected empty vector pmev p53 dominant negative vector dn 24 h prior 24 h incubation cisplatin dna fragmentation indicated tunel positivity dominant negative transfected melanoma cells cisplatin treatment b immunoblots p53 p21 actin dominant negative p53 tagged two copies hemagglutinin seen band slightly wild type p53 dominant negative transfected conditions
0.49328405.14576150.html.plaintext.txt	63	discussion top abstract introduction experimental procedures results discussion references shown involved diverse processes cellular signaling thought involved potentiation numerous tumors study demonstrated depletion endogenously generated melanoma cell lines containing wild type p53 decreases cell growth enhances cisplatin induced apoptosis inhibits p53 accumulation subsequent induction p21 cisplatin moreover showed increase cisplatin induced apoptosis melanoma cells caused regulation p53 expression exhibits protective role cisplatin treatment findings consistent clinical observation patients inos expressing melanomas significantly poorer survival inos negative counterparts addition findings inos regulated overall nos activity increased melanoma suggest role 29 39
0.49328405.14576150.html.plaintext.txt	64	discussion top abstract introduction experimental procedures results discussion references shown involved diverse processes cellular signaling thought involved potentiation numerous tumors study demonstrated depletion endogenously generated melanoma cell lines containing wild type p53 decreases cell growth enhances cisplatin induced apoptosis inhibits p53 accumulation subsequent induction p21 cisplatin moreover showed increase cisplatin induced apoptosis melanoma cells caused regulation p53 expression exhibits protective role cisplatin treatment findings consistent clinical observation patients inos expressing melanomas significantly poorer survival inos negative counterparts addition findings inos regulated overall nos activity increased melanoma suggest role 29 39
0.49328405.14576150.html.plaintext.txt	65	titration donor deta illustrates dichotomous role regulation proliferation addition 50 microm deta led increase proliferation whereas higher levels deta 150 microm markedly inhibited proliferation generally accepted high levels toxic whereas lower levels may growth promoting reviewed refs 40 41 although threshold low high levels still dependent cell type context within found
0.49328405.14576150.html.plaintext.txt	66	titration donor deta illustrates dichotomous role regulation proliferation addition 50 microm deta led increase proliferation whereas higher levels deta 150 microm markedly inhibited proliferation generally accepted high levels toxic whereas lower levels may growth promoting reviewed refs 40 41 although threshold low high levels still dependent cell type context within found
0.49328405.14576150.html.plaintext.txt	67	initial observations depletion cisplatin treatment resulted reduced proliferation melanoma cells led us evaluate whether effect attributable apoptosis number groups reported proapoptotic antiapoptotic properties depending cell type experimental system 22 23 42 45 observed depletion c ptio oxymyoglobin treatment capable enhancing cisplatin induced apoptosis melanoma cells however nos inhibitors including l nmma amg 1400w used block production melanoma cells minimally effective enhancing apoptosis cisplatin treatment salvucci et al 30 found serum completely suppresses apoptotic effect amg melanoma cells possible serum components interfere nos inhibitor activity complicate chemistry albumin act reservoir may control dependent processes vasculature 46 various thiol containing proteins low molecular weight thiols glutathione may also act store selectively release maintain cellular levels 47 use chemical scavenger would nullify stores quickly reacting newly released whereas inhibition production nos deplete possible cellular storage mechanisms another possibility c ptio possesses secondary reactivity 48 however lack effect quenched scavenger controls similar effects oxymyoglobin melanoma cells strongly suggest causal agent observations
0.49328405.14576150.html.plaintext.txt	68	initial observations depletion cisplatin treatment resulted reduced proliferation melanoma cells led us evaluate whether effect attributable apoptosis number groups reported proapoptotic antiapoptotic properties depending cell type experimental system 22 23 42 45 observed depletion c ptio oxymyoglobin treatment capable enhancing cisplatin induced apoptosis melanoma cells however nos inhibitors including l nmma amg 1400w used block production melanoma cells minimally effective enhancing apoptosis cisplatin treatment salvucci et al 30 found serum completely suppresses apoptotic effect amg melanoma cells possible serum components interfere nos inhibitor activity complicate chemistry albumin act reservoir may control dependent processes vasculature 46 various thiol containing proteins low molecular weight thiols glutathione may also act store selectively release maintain cellular levels 47 use chemical scavenger would nullify stores quickly reacting newly released whereas inhibition production nos deplete possible cellular storage mechanisms another possibility c ptio possesses secondary reactivity 48 however lack effect quenched scavenger controls similar effects oxymyoglobin melanoma cells strongly suggest causal agent observations
0.49328405.14576150.html.plaintext.txt	69	analysis cell cycle alterations showed depletion c ptio resulted significant g2 arrest a375 melanoma cells sustained g2 arrest subsequently accompanied increase apoptosis cell cycle alterations also shown result depletion pulmonary cells 49 precise involvement cell cycle regulation known however number cell cycle regulators appear targets prominent retinoblastoma protein 26 accumulation melanoma cells g1s boundary cisplatin treatment trend toward return normal cell cycle distribution 36 h suggest melanoma cells capable responding possibly repairing dna damage data suggest p53 response dna damage least partially intact evidenced stabilization nuclear accumulation p53 cisplatin treatment subsequent expression p21 depleted melanoma cells accumulate g1s boundary cisplatin treatment instead cells slowly progressed g2m phases may explained concomitant loss cisplatin induced p21 expression
0.49328405.14576150.html.plaintext.txt	70	analysis cell cycle alterations showed depletion c ptio resulted significant g2 arrest a375 melanoma cells sustained g2 arrest subsequently accompanied increase apoptosis cell cycle alterations also shown result depletion pulmonary cells 49 precise involvement cell cycle regulation known however number cell cycle regulators appear targets prominent retinoblastoma protein 26 accumulation melanoma cells g1s boundary cisplatin treatment trend toward return normal cell cycle distribution 36 h suggest melanoma cells capable responding possibly repairing dna damage data suggest p53 response dna damage least partially intact evidenced stabilization nuclear accumulation p53 cisplatin treatment subsequent expression p21 depleted melanoma cells accumulate g1s boundary cisplatin treatment instead cells slowly progressed g2m phases may explained concomitant loss cisplatin induced p21 expression
0.49328405.14576150.html.plaintext.txt	71	found depletion melanoma cells led reduced p53 accumulation activation cisplatin treatment melanoma cell lines tested depletion also reduced overexpression mutated p53 mewo melanoma cells suggests regulate wild type mutant p53 data shown sk mel 1 melanoma cells exhibit altered p53 p21 regulation depletion c ptio inhibited basal p21 overexpression cisplatin induced p53 accumulation dose dependent manner data shown data suggest may regulate p53 p21 regardless functional mutational status
0.49328405.14576150.html.plaintext.txt	72	found depletion melanoma cells led reduced p53 accumulation activation cisplatin treatment melanoma cell lines tested depletion also reduced overexpression mutated p53 mewo melanoma cells suggests regulate wild type mutant p53 data shown sk mel 1 melanoma cells exhibit altered p53 p21 regulation depletion c ptio inhibited basal p21 overexpression cisplatin induced p53 accumulation dose dependent manner data shown data suggest may regulate p53 p21 regardless functional mutational status
0.49328405.14576150.html.plaintext.txt	73	p53 inos shown participate negative regulatory loop 50 specifically able activate p53 turn inhibited inos expression observation led suggestion tumors expressing nos may selective pressure acquire p53 mutations 51 appears case melanoma inos upregulated p53 mutations rare precise mechanism modulates p53 signal transduction pathway remains clarified data suggest required proper stabilization activation p53 protein may exert protective role therapy
0.49328405.14576150.html.plaintext.txt	74	p53 inos shown participate negative regulatory loop 50 specifically able activate p53 turn inhibited inos expression observation led suggestion tumors expressing nos may selective pressure acquire p53 mutations 51 appears case melanoma inos upregulated p53 mutations rare precise mechanism modulates p53 signal transduction pathway remains clarified data suggest required proper stabilization activation p53 protein may exert protective role therapy
0.49328405.14576150.html.plaintext.txt	75	likely interact directly p53 regulate signaling components upstream p53 mcf 7 cells donor treatment resulted possible tyrosine nitration p53 improved dna binding low donor levels 025 05 mm inhibited dna binding higher donor concentrations 1 5 mm 16 alludes possibly complex interaction p53 superoxide known regulated melanoma 52 reacts quickly form peroxynitrite potent oxidizing agent capable nitrating tyrosines 53 recent study focused influence superoxide nitrosylation reactions may add insight exquisite edge balanced 32 may also regulate phosphorylation p53 response dna damage 55 56 addition cysteines present zinc finger dna binding motifs p53 may susceptible nitrosylation leading alterations p53 function
0.49328405.14576150.html.plaintext.txt	76	likely interact directly p53 regulate signaling components upstream p53 mcf 7 cells donor treatment resulted possible tyrosine nitration p53 improved dna binding low donor levels 025 05 mm inhibited dna binding higher donor concentrations 1 5 mm 16 alludes possibly complex interaction p53 superoxide known regulated melanoma 52 reacts quickly form peroxynitrite potent oxidizing agent capable nitrating tyrosines 53 recent study focused influence superoxide nitrosylation reactions may add insight exquisite edge balanced 32 may also regulate phosphorylation p53 response dna damage 55 56 addition cysteines present zinc finger dna binding motifs p53 may susceptible nitrosylation leading alterations p53 function
0.49328405.14576150.html.plaintext.txt	77	recently shown inhibit hdm2 p53 binding 57 hdm2 mdm2 mouse binds p53 inhibit transcriptional activity ubiquitinates p53 regulate stability plays pivotal role determining p53 localization nitrosylation cysteine 77 hydrophobic p53 binding pocket hdm2 thought interfere p53 binding hdm2 also found regulated melanoma cells containing wild type p53 58 findings suggest involved regulation p53 stability may help explain depletion endogenous inhibits cisplatin induced p53 accumulation melanoma cells whether endogenous inhibits hdm2 p53 interaction melanoma cells remains determined may regulate activity p53 upstream effectors ataxia telangectasia mutant kinase mutated rad3 related kinase dna pk example shown activate dna pkc protect dna damage 59 whether regulates activity dna damage activated kinases melanoma cells known
0.49328405.14576150.html.plaintext.txt	78	recently shown inhibit hdm2 p53 binding 57 hdm2 mdm2 mouse binds p53 inhibit transcriptional activity ubiquitinates p53 regulate stability plays pivotal role determining p53 localization nitrosylation cysteine 77 hydrophobic p53 binding pocket hdm2 thought interfere p53 binding hdm2 also found regulated melanoma cells containing wild type p53 58 findings suggest involved regulation p53 stability may help explain depletion endogenous inhibits cisplatin induced p53 accumulation melanoma cells whether endogenous inhibits hdm2 p53 interaction melanoma cells remains determined may regulate activity p53 upstream effectors ataxia telangectasia mutant kinase mutated rad3 related kinase dna pk example shown activate dna pkc protect dna damage 59 whether regulates activity dna damage activated kinases melanoma cells known
0.49328405.14576150.html.plaintext.txt	79	found depletion addition inhibiting p53 induction strongly inhibited cisplatin induced expression p21 downstream target p53 capable activating p21 via p53 cgmp pathways 60 61 observed inhibition p21 expression depletion consistently correlated reduced p53 accumulation depletion resulted near abrogation p53 binding p53 binding site p21 promoter inhibition p53 sirna dominant negative p53 expression also reduced p21 expression p53 p21 expression cell cycle distribution level apoptosis cisplatin treatment altered either odq 8 bromo cgmp furthermore melanoma cells frequently express sensitive isoform soluble guanylyl cyclase responds generate cgmp subsequently induce p21 expression 62 taken together data strongly suggests p21 activated p53 dependent manner melanoma cells wild type p53 cgmp signaling pathway involved whether p21 direct target modification derivatives known
0.49328405.14576150.html.plaintext.txt	80	found depletion addition inhibiting p53 induction strongly inhibited cisplatin induced expression p21 downstream target p53 capable activating p21 via p53 cgmp pathways 60 61 observed inhibition p21 expression depletion consistently correlated reduced p53 accumulation depletion resulted near abrogation p53 binding p53 binding site p21 promoter inhibition p53 sirna dominant negative p53 expression also reduced p21 expression p53 p21 expression cell cycle distribution level apoptosis cisplatin treatment altered either odq 8 bromo cgmp furthermore melanoma cells frequently express sensitive isoform soluble guanylyl cyclase responds generate cgmp subsequently induce p21 expression 62 taken together data strongly suggests p21 activated p53 dependent manner melanoma cells wild type p53 cgmp signaling pathway involved whether p21 direct target modification derivatives known
0.49328405.14576150.html.plaintext.txt	81	numerous studies highlighted ability p21 protect glioblastomas gliomas colon carcinomas prostate cancer 14 melanomas apoptosis inducing stimuli p21 also found overexpressed rarely mutated melanoma 54 63 data show p53 p21 upregulated melanoma response dna damage cisplatin suggests melanoma cells actively respond genotoxic insult inducing cell cycle arrest possibly carrying dna repair thus avoiding cell death transfection dominant negative form p53 a375 melanoma cells resulted substantial increase cisplatin sensitivity well reduction p21 expression cisplatin treatment confirming p53 activation following exposure cisplatin protects melanoma cells apoptosis inhibition p53 sirna partially reduced cisplatin induced p53 p21 expression sufficient enhance apoptosis cisplatin treatment transfection mutated p53 melanoma cells dominant effect case sirna transfection cells transfected sirna may still produce low levels wild type p53 thus could still capable responding dna damage indeed observed p53 sirna transfected cells still expressed p21 albeit lower concentration data shown
0.49328405.14576150.html.plaintext.txt	82	numerous studies highlighted ability p21 protect glioblastomas gliomas colon carcinomas prostate cancer 14 melanomas apoptosis inducing stimuli p21 also found overexpressed rarely mutated melanoma 54 63 data show p53 p21 upregulated melanoma response dna damage cisplatin suggests melanoma cells actively respond genotoxic insult inducing cell cycle arrest possibly carrying dna repair thus avoiding cell death transfection dominant negative form p53 a375 melanoma cells resulted substantial increase cisplatin sensitivity well reduction p21 expression cisplatin treatment confirming p53 activation following exposure cisplatin protects melanoma cells apoptosis inhibition p53 sirna partially reduced cisplatin induced p53 p21 expression sufficient enhance apoptosis cisplatin treatment transfection mutated p53 melanoma cells dominant effect case sirna transfection cells transfected sirna may still produce low levels wild type p53 thus could still capable responding dna damage indeed observed p53 sirna transfected cells still expressed p21 albeit lower concentration data shown
0.49328405.14576150.html.plaintext.txt	83	based data present model mechanism melanoma resistance cisplatin treatment fig 8 model key factor p53 dependent activation p21 expression cisplatin induced dna damage expression p21 results skewing cellular response toward cell cycle arrest dna repair cell survival away apoptosis inhibition p21 result loss g1 phase cell cycle arrest lead induction apoptosis therefore regulation expression via p53 signaling pathway may extreme importance melanoma resistance therapy case ability p53 induce p21 would determine whether tumor cells protected genotoxic insult insights offer several potential pathways target future therapies melanomas containing wild type p53
0.49328405.14576150.html.plaintext.txt	84	view larger version 23k fig 8 model pivotal role regulation dna damage induced p53 function cell cycle regulation apoptosis melanoma cells
0.49328405.14576150.html.plaintext.txt	85	footnotes work supported part national institutes health grant r01 ca90282 e g rosalie b hite research fellowship c h department bioimmunotherapy university texas m d anderson cancer center health science center houston university texas graduate school biomedical sciences houston costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.49328405.14576150.html.plaintext.txt	86	partial fulfillment requirements phd degree
0.49328405.14576150.html.plaintext.txt	87	correspondence addressed tel 713 792 3667 fax 713 792 2070 e mail egrimmatmdandersonorg u d
0.49328405.14576150.html.plaintext.txt	88	1 abbreviations used p21 p21waf1cip1sdi1 nitric oxide nos nitric oxide synthase enos endothelial nos inos inducible nos nnos neuronal nos c ptio 2 4 carboxyphenyl 4455 tetramethylimidazoline 1 oxyl 3 oxide sin 1 3 morpholinosydnonimine deta z 1 2 2 aminoethyl n 2 ammonioethylaminodiazen 1 ium 12 diolate odq 1h 124oxadiazole43 aquinoxalin 1 one tunelterminal deoxynucleotide transferase mediated dutp fluorescein isothiocyanate nick end labeling pi propidium iodide pbs phosphate buffered saline 01 tween 20 l nmma ng monomethyl l arginine amg aminoguanidine 1400w n 3 aminomethylbenzylacetamidine dihydrochloride parp polyadp ribose polymerase dmem dulbeccos modified eagles medium pbs phosphate buffered saline sirna small interfering rna
0.49328405.14576150.html.plaintext.txt	89	1 abbreviations used p21 p21waf1cip1sdi1 nitric oxide nos nitric oxide synthase enos endothelial nos inos inducible nos nnos neuronal nos c ptio 2 4 carboxyphenyl 4455 tetramethylimidazoline 1 oxyl 3 oxide sin 1 3 morpholinosydnonimine deta z 1 2 2 aminoethyl n 2 ammonioethylaminodiazen 1 ium 12 diolate odq 1h 124oxadiazole43 aquinoxalin 1 one tunelterminal deoxynucleotide transferase mediated dutp fluorescein isothiocyanate nick end labeling pi propidium iodide pbs phosphate buffered saline 01 tween 20 l nmma ng monomethyl l arginine amg aminoguanidine 1400w n 3 aminomethylbenzylacetamidine dihydrochloride parp polyadp ribose polymerase dmem dulbeccos modified eagles medium pbs phosphate buffered saline sirna small interfering rna
0.49328405.14576150.html.plaintext.txt	90	2 ekmekcioglu personal communication
0.49328405.14576150.html.plaintext.txt	91	acknowledgments sincerely thank john b mumm suhendan ekmekcioglu nancy j poindexter helpful discussions also thank michael g espey douglas d thomas harry ischiropoulos sharing knowledge chemistry
0.49328405.14576150.html.plaintext.txt	92	acknowledgments sincerely thank john b mumm suhendan ekmekcioglu nancy j poindexter helpful discussions also thank michael g espey douglas d thomas harry ischiropoulos sharing knowledge chemistry
0.49328405.14576150.html.plaintext.txt	93	references top abstract introduction experimental procedures results discussion references satyamoorthy k bogenrieder herlyn m 2001 trends mol med 7 191 194crossrefmedline order article via infotrieve bargonetti j manfredi j j 2002 curr opin oncol 14 86 91crossrefmedline order article via infotrieve chin l merlino g depinho r 1998 genes dev 12 3467 3481free full text basset seguin n moles j p mils v dereure o guilhou j j 1994 j investig dermatol 103 s102 s106crossrefmedline order article via infotrieve satyamoorthy k chehab n h waterman m j lien m c el deiry w herlyn m halazonetis d 2000 cell growth differ 11 467 474abstractfree full text bae smith m l sheikh m zhan q m scudiero d friend h oconnor p m fornace j jr 1996 cancer res 56 840 847abstract mcgill g fisher d e 1999 j clin investig 104 223 225free full text el deiry w tokino velculescu v e levy d b parsons r trent j m lin d mercer w e kinzler k w vogelstein b 1993 cell 75 817 825crossrefmedline order article via infotrieve harper j w adami g r wei n keyomarsi k elledge j 1993 cell 75 805 816crossrefmedline order article via infotrieve roninson b 2002 cancer lett 179 1 14crossrefmedline order article via infotrieve ruan b okcu m f pong r c andreeff m levin v hsieh j zhang w 1999 clin cancer res 5 197 202abstractfree full text kokunai urui tomita h tamaki n 2001 j neurooncol 51 111 119crossrefmedline order article via infotrieve mahyar roemer m roemer k 2001 oncogene 20 3387 3398crossrefmedline order article via infotrieve martinez l yang j vazquez e del carmen rodriguez vargas m olive m hsieh j logothetis c j navone n m 2002 carcinogenesis 23 1289 1296abstractfree full text gorospe m cirielli c wang x seth p capogrossi m c holbrook n j 1997 oncogene 14 929 935crossrefmedline order article via infotrieve calmels hainaut p ohshima h 1997 cancer res 57 3365 3369abstract chazotte aubert l hainaut p ohshima h 2000 biochem biophys res commun 267 609 613crossrefmedline order article via infotrieve chazotte aubert l pluquet o hainaut p ohshima h 2001 biochem biophys res commun 281 766 771crossrefmedline order article via infotrieve alderton w k cooper c e knowles r g 2001 biochem j 357 593 615crossrefmedline order article via infotrieve bogdan c 2001 nat immunol 2 907 916crossrefmedline order article via infotrieve wink d vodovotz y laval j laval f dewhirst m w mitchell j b 1998 carcinogenesis 19 711 721abstract brune b von knethen sandau k b 1999 cell death differ 6 969 975crossrefmedline order article via infotrieve liu l m stamler j 1999 cell death differ 6 937 942crossrefmedline order article via infotrieve rossig l fichtlscherer b breitschopf k haendeler j zeiher m mulsch dimmeler 1999 j biol chem 274 6823 6826abstractfree full text li j r billiar r talanian r v kim y m 1997 biochem biophys res commun 240 419 424crossrefmedline order article via infotrieve jaffrey r erdjument bromage h ferris c d tempst p snyder h 2001 nat cell biol 3 193 197crossrefmedline order article via infotrieve macmillan crow l greendorfer j vickers m thompson j 2000 arch biochem biophys 377 350 356crossrefmedline order article via infotrieve ekmekcioglu ellerhorst j smid c m prieto v g munsell m buzaid c grimm e 2000 clin cancer res 6 4768 4775abstractfree full text joshi m strandhoy j white w l 1996 melanoma res 6 121 126medline order article via infotrieve salvucci o carsana m bersani tragni g anichini 2001 cancer res 61 318 326abstractfree full text maeda h akaike yoshida m suga m 1994 j leukocyte biol 56 588 592abstractfree full text espey m g thomas d d miranda k m wink d 2002 proc natl acad sci u 99 11127 11132abstractfree full text robinson e k grau m evans d b smid c m chiao p j abbruzzese j l grimm e 1998 ann surg oncol 5 342 349abstract caruccio l banerjee r 1999 j immunol methods 230 1 10crossrefmedline order article via infotrieve patel gores g j kaufmann h 1996 faseb j 10 587 597abstractfree full text doyle m p hoekstra j w 1981 j inorg biochem 14 351 358crossrefmedline order article via infotrieve cillari e milano dagostino p di bella g la rosa m barbera c ferlazzo v cammarata g grimaudo tolomeo m feo 1998 adv dent res 12 126 130medline order article via infotrieve lakin n d jackson p 1999 oncogene 18 7644 7655crossrefmedline order article via infotrieve massi d franchi sardi magnelli l paglierani m borgognoni l maria r u santucci m 2001 j pathol 194 194 20030co2 320medline order article via infotrieve kim p k zamora r petrosko p billiar r 2001 int immunopharmacol 1 1421 1441crossrefmedline order article via infotrieve li j billiar r 1999 cell death differ 6 952 955crossrefmedline order article via infotrieve mortensen k skouv j hougaard d m larsson l 1999 j biol chem 274 37679 37684abstractfree full text suschek c v krischel v bruch gerharz d berendji d krutmann j kroncke k d kolb bachofen v 1999 j biol chem 274 6130 6137abstractfree full text kolb j p 2000 leukemia 14 1685 1694crossrefmedline order article via infotrieve rafikova o rafikov r nudler e 2002 proc natl acad sci u 99 5913 5918abstractfree full text giustarini d milzani colombo r dalle donne rossi r 2003 clin chim acta 330 85 98crossrefmedline order article via infotrieve pfeiffer leopold e hemmens b schmidt k werner e r mayer b 1997 free radic biol med 22 787 794crossrefmedline order article via infotrieve janssen y m soultanakis r steece k heerdt e singh r j joseph j kalyanaraman b 1998 j physiol 275 l1100 l1109medline order article via infotrieve forrester k ambs lupold e kapust r b spillare e weinberg w c felley bosco e wang x w geller d tzeng e billiar r harris c c 1996 proc natl acad sci u 93 2442 2447abstractfree full text ambs hussain p harris c c 1997 faseb j 11 443 448abstractfree full text meyskens f l jr mcnulty e buckmeier j tohidian n b spillane j kahlon r gonzalez r 2001 free radic biol med 31 799 808crossrefmedline order article via infotrieve pryor w squadrito g l 1995 j physiol 268 l699 l722medline order article via infotrieve vidal m j loganzo f jr de oliveira r hayward n k albino p 1995 melanoma res 5 243 250medline order article via infotrieve nakaya n lowe w taya y chenchik enikolopov g 2000 oncogene 19 6369 6375crossrefmedline order article via infotrieve fukunaga takenaka r fukunaga k tatemichi m ohshima h 2003 biochem biophys res commun 308 966 974crossrefmedline order article via infotrieve schonhoff c m daou m c jones n schiffer c ross h 2002 biochemistry 41 13570 13574crossrefmedline order article via infotrieve poremba c yandell d w metze d kamanabrou d bocker w dockhorn dworniczak b 1995 oncol res 7 331 339medline order article via infotrieve xu w liu l smith g c charles g 2000 nat cell biol 2 339 345crossrefmedline order article via infotrieve gartel l tyner l 1999 exp cell res 246 280 289crossrefmedline order article via infotrieve ishida sasaguri kosaka c nojima h ogata j 1997 j biol chem 272 10050 10057abstractfree full text ivanova k das p k van den wijngaard r m lenz w klockenbring malcharzyk v drummer c gerzer r 2001 j investig dermatol 116 409 416crossrefmedline order article via infotrieve trotter m j tang l tron v 1997 j cutaneous pathol 24 265 271medline order article via infotrieve
0.49731448.11567994.html.plaintext.txt	0	mpl ligand prevents lethal myelosuppression inhibiting p53 dependent apoptosis tamara pestina john l cleveland chunying yang gerard p zambetti carl w jackson
0.49731448.11567994.html.plaintext.txt	1	division experimental hematology department biochemistry st jude childrens research hospital memphis tn
0.49731448.11567994.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion references
0.49731448.11567994.html.plaintext.txt	3	single dose mpl ligand mpl l given immediately lethal dna damaging regimens prevents death mice however mechanism myeloprotection unknown induction p53 dependent apoptosis response dna damage signals suggests immediate administration mpl l may inhibit p53 dependent apoptosis hypothesis tested administering single injection pegylated murine megakaryocyte growth development factor peg rmmgdf truncated recombinant mpl l p53 wild type mice immediately carboplatin 80 mgkg 75 gy total body irradiation peg rmmgdf required prevent death wild type mice whereas p53 mice survived without exogenous cytokine degree platelet depression subsequent recovery comparable p53 mice wild type animals given peg rmmgdf hence either mpl l administration p53 deficiency protected multipotent hematopoietic progenitors committed megakaryocyte precursors myelosuppressive regimen induced expression p53 p53 target p21cipl wild type bone marrow indicating mpl l acts downstream p53 prevent apoptosis constitutive expression proapoptotic protein bax increased bax mice survived lethal regimen given peg rmmgdf however bax mice showed rapid hematopoietic recovery identically treated wild type mice therefore administration mpl l immediately myelosuppressive chemotherapy preparatory regimens autologous bone marrow transplantation prevent p53 dependent apoptosis decrease myelosuppression reduce need platelet transfusions blood 2001982084 2090 2001 american society hematology introduction top abstract introduction materials methods results discussion references
0.49731448.11567994.html.plaintext.txt	4	single dose mpl ligand mpl l given immediately lethal dna damaging regimens prevents death mice however mechanism myeloprotection unknown induction p53 dependent apoptosis response dna damage signals suggests immediate administration mpl l may inhibit p53 dependent apoptosis hypothesis tested administering single injection pegylated murine megakaryocyte growth development factor peg rmmgdf truncated recombinant mpl l p53 wild type mice immediately carboplatin 80 mgkg 75 gy total body irradiation peg rmmgdf required prevent death wild type mice whereas p53 mice survived without exogenous cytokine degree platelet depression subsequent recovery comparable p53 mice wild type animals given peg rmmgdf hence either mpl l administration p53 deficiency protected multipotent hematopoietic progenitors committed megakaryocyte precursors myelosuppressive regimen induced expression p53 p53 target p21cipl wild type bone marrow indicating mpl l acts downstream p53 prevent apoptosis constitutive expression proapoptotic protein bax increased bax mice survived lethal regimen given peg rmmgdf however bax mice showed rapid hematopoietic recovery identically treated wild type mice therefore administration mpl l immediately myelosuppressive chemotherapy preparatory regimens autologous bone marrow transplantation prevent p53 dependent apoptosis decrease myelosuppression reduce need platelet transfusions blood 2001982084 2090 2001 american society hematology introduction top abstract introduction materials methods results discussion references
0.49731448.11567994.html.plaintext.txt	5	recent studies indicate mpl ligand mpl l reduces hematopoietic toxicity much effectively administered immediately myelosuppressive insult given beforehand later times1 5 however mechanism multilineage myeloprotection defined
0.49731448.11567994.html.plaintext.txt	6	recent studies indicate mpl ligand mpl l reduces hematopoietic toxicity much effectively administered immediately myelosuppressive insult given beforehand later times1 5 however mechanism multilineage myeloprotection defined
0.49731448.11567994.html.plaintext.txt	7	involvement mpl l also known thrombopoietin tpo receptor mpl early hematopoiesis consistent following observations 1 mpl expressed aa4 sca subpopulation murine hematopoietic stem cells6 2 mpl l stimulates expansion immature precursors vitro vivo 3 mpl mpl l required optimal multilineage hematopoietic development well thrombocytopoietic differentiation latter point evident marked reductions granulocyte macrophage erythroid multipotential progenitor cells tpo c mpl mice78 suggesting mpl mpl l play significant roles megakaryocyte maturation maintenance multipotential hematopoietic progenitors910 signaling mpl l alone combination early acting cytokines also promotes survival primitive multipotent progenitor cells blocking apoptosis11 13
0.49731448.11567994.html.plaintext.txt	8	involvement mpl l also known thrombopoietin tpo receptor mpl early hematopoiesis consistent following observations 1 mpl expressed aa4 sca subpopulation murine hematopoietic stem cells6 2 mpl l stimulates expansion immature precursors vitro vivo 3 mpl mpl l required optimal multilineage hematopoietic development well thrombocytopoietic differentiation latter point evident marked reductions granulocyte macrophage erythroid multipotential progenitor cells tpo c mpl mice78 suggesting mpl mpl l play significant roles megakaryocyte maturation maintenance multipotential hematopoietic progenitors910 signaling mpl l alone combination early acting cytokines also promotes survival primitive multipotent progenitor cells blocking apoptosis11 13
0.49731448.11567994.html.plaintext.txt	9	recent studies indicate p53 mediates apoptosis hematopoietic progenitors exposed dna damaging drugs irradiation1415 vivo studies suggested p53 deficient mice survive lethal radiation dose due increased bone marrow resistance1617 furthermore p53 appears key regulator proliferation hematopoietic progenitors p53 status influences long short term repopulation following bone marrow transplantation however p53 appear affect lineage determination differentiation committed progenitorprecursor cells14
0.49731448.11567994.html.plaintext.txt	10	recent studies indicate p53 mediates apoptosis hematopoietic progenitors exposed dna damaging drugs irradiation1415 vivo studies suggested p53 deficient mice survive lethal radiation dose due increased bone marrow resistance1617 furthermore p53 appears key regulator proliferation hematopoietic progenitors p53 status influences long short term repopulation following bone marrow transplantation however p53 appear affect lineage determination differentiation committed progenitorprecursor cells14
0.49731448.11567994.html.plaintext.txt	11	report administration single dose polyethylene glycol conjugated recombinant murine megakaryocyte growth development factor peg rmmgdf truncated form mpl l sufficient prevent p53 dependent apoptosis murine model lethal myelosuppression findings suggest mpl l may clinically useful reducing neutropenia thrombocytopenia anemia caused myelosuppressive treatments radiation chemotherapy preparatory regimens hematopoietic stem cell transplantation
0.49731448.11567994.html.plaintext.txt	12	report administration single dose polyethylene glycol conjugated recombinant murine megakaryocyte growth development factor peg rmmgdf truncated form mpl l sufficient prevent p53 dependent apoptosis murine model lethal myelosuppression findings suggest mpl l may clinically useful reducing neutropenia thrombocytopenia anemia caused myelosuppressive treatments radiation chemotherapy preparatory regimens hematopoietic stem cell transplantation
0.49731448.11567994.html.plaintext.txt	13	materials methods top abstract introduction materials methods results discussion references reagents animals
0.49731448.11567994.html.plaintext.txt	14	peg rmmgdf recombinant form amino terminal half native murine mpl ligand tpo conjugation polyethylene glycol pegylation increases vivo potency protein approximately 10 20 fold largely delaying clearance thus prolonging plasma half life peg rmmgdf kindly provided amgen thousand oaks ca day administration stock solution diluted phosphate buffered saline pbs containing 1 isologous mouse serum
0.49731448.11567994.html.plaintext.txt	15	peg rmmgdf recombinant form amino terminal half native murine mpl ligand tpo conjugation polyethylene glycol pegylation increases vivo potency protein approximately 10 20 fold largely delaying clearance thus prolonging plasma half life peg rmmgdf kindly provided amgen thousand oaks ca day administration stock solution diluted phosphate buffered saline pbs containing 1 isologous mouse serum
0.49731448.11567994.html.plaintext.txt	16	p53 knockout mice c57bl6 purchased jackson laboratory bar harbor studied 25 months age prior development tumors atm wild type littermates b6129 kindly provided dr peter mckinnon st jude childrens research hospital34 breeding stocks bax mice b6129 obtained dr stanley korsmeyer dana farber cancer institute boston ma
0.49731448.11567994.html.plaintext.txt	17	p53 knockout mice c57bl6 purchased jackson laboratory bar harbor studied 25 months age prior development tumors atm wild type littermates b6129 kindly provided dr peter mckinnon st jude childrens research hospital34 breeding stocks bax mice b6129 obtained dr stanley korsmeyer dana farber cancer institute boston ma
0.49731448.11567994.html.plaintext.txt	18	mice given 80 mgkg carboplatin bristol laboratories princeton nj intravenously followed 75 gy total body irradiation tbi 137cs source j l shepherd san fernando ca mice undergone bone marrow transplantation received reduced tbi dose 70 gy
0.49731448.11567994.html.plaintext.txt	19	mice given 80 mgkg carboplatin bristol laboratories princeton nj intravenously followed 75 gy total body irradiation tbi 137cs source j l shepherd san fernando ca mice undergone bone marrow transplantation received reduced tbi dose 70 gy
0.49731448.11567994.html.plaintext.txt	20	bone marrow collected femurs tibias appropriate donor mice suspended dulbecco modified eagle medium dmem 10 fetal calf serum recipients exposed 1125 gy given donor cells intravenously within 2 hours irradiation recipient received marrow 1 2 bones mice used experiments 2 4 months transplantation blood cell indices returned normal range
0.49731448.11567994.html.plaintext.txt	21	single dose peg rmmgdf 50 65 microgkg injected lateral tail vein vasodilation induced warming examination lamp equivalent volume pbs 1 isologous mouse serum carrier injected intravenously control mice
0.49731448.11567994.html.plaintext.txt	22	single dose peg rmmgdf 50 65 microgkg injected lateral tail vein vasodilation induced warming examination lamp equivalent volume pbs 1 isologous mouse serum carrier injected intravenously control mice
0.49731448.11567994.html.plaintext.txt	23	blood collected ethylenediaminetetraacetic acid edta coated 20 microl microcapillary tubes cdc technologies oxford ct immediately diluted buffered diluent platelet counts white blood cell wbc counts hemoglobin concentration measured mascot automated hematology system cdc technologies
0.49731448.11567994.html.plaintext.txt	24	blood collected ethylenediaminetetraacetic acid edta coated 20 microl microcapillary tubes cdc technologies oxford ct immediately diluted buffered diluent platelet counts white blood cell wbc counts hemoglobin concentration measured mascot automated hematology system cdc technologies
0.49731448.11567994.html.plaintext.txt	25	mice injected intravenously 80 mgkg carboplatin irradiated 75 gy immediately afterward half animals injected intravenously 65 microgkg peg rmmgdf bone marrow cells aseptically harvested mouse femurs tibias flushing bone marrow cavity 2 ml mem minimum essential medium earle salts l glutamine life technologies grand island ny containing 2 fetal bovine serum fbs cell suspension prepared passing bone marrow 25 gauge needle concentration nucleated cells bone marrow cell suspension determined dilution 3 acetic acid lyse erythrocytes diluted cell suspensions recombinant mouse interleukin 3 rmil 3 mixed methylcellulose methocult m3230 stem cell technologies vancouver bc canada cell suspensions plated duplicate 35 mm culture dishes medium contained final concentration 09 methycellulose 30 fbs 1 bovine serum albumin 01 mm 2 mercaptoethanol 2 mm l glutamine cultured 37 degrees c 5 co2 day 1 assays 1 2 x 106 cells per dish cultured 20 uml rmil 3 day 2 assays due lower bone marrow cellularity time treatment fewer cells 04 x 106 per dish plated colonies scored day 13 colony sizes classified large 500 cellscolony medium 200 400 cellscolony small 15 150 cellscolony results expressed numbers colonies per 106 cells plated
0.49731448.11567994.html.plaintext.txt	26	bone marrow collected mouse femurs tibias flushing bone marrow cavity 1x dpbs dulbecco phosphate buffered saline life technologies bone marrow cells washed twice ehs buffer 1 mm na2edta 10 mm hepes ph 76 150 mm nacl collected centrifugation 900g 4 degrees c 10 minutes cell pellets suspended 60 volumes ehs buffer cells lysed boiling addition one third volume laemmli gel sample buffer 125 mm tris hcl ph 68 40 glycerol 8 sds 160 mm dithiothreitol 001 bromphenol blue proteins 50 150 microg per lane electrophoretically separated 75 15 linear polyacrylamide gradients 12 polyacrylamide gels containing sodium dodecyl sulfate sds transferred nitrocellulose membranes protran schleicher schuell dassel germany blotted antibodies specific p53 ab 7 calbiochem la jolla ca bax p21cip1 santa cruz biotechnology santa cruz ca actin boehringer mannheim indianapolis bound immune complexes detected enhanced chemiluminescence ecl reagent amersham arlington heights il supersignal pierce rockford il
0.49731448.11567994.html.plaintext.txt	27	bone marrow collected mouse femurs tibias flushing bone marrow cavity 1x dpbs dulbecco phosphate buffered saline life technologies bone marrow cells washed twice ehs buffer 1 mm na2edta 10 mm hepes ph 76 150 mm nacl collected centrifugation 900g 4 degrees c 10 minutes cell pellets suspended 60 volumes ehs buffer cells lysed boiling addition one third volume laemmli gel sample buffer 125 mm tris hcl ph 68 40 glycerol 8 sds 160 mm dithiothreitol 001 bromphenol blue proteins 50 150 microg per lane electrophoretically separated 75 15 linear polyacrylamide gradients 12 polyacrylamide gels containing sodium dodecyl sulfate sds transferred nitrocellulose membranes protran schleicher schuell dassel germany blotted antibodies specific p53 ab 7 calbiochem la jolla ca bax p21cip1 santa cruz biotechnology santa cruz ca actin boehringer mannheim indianapolis bound immune complexes detected enhanced chemiluminescence ecl reagent amersham arlington heights il supersignal pierce rockford il
0.49731448.11567994.html.plaintext.txt	28	results top abstract introduction materials methods results discussion references single dose mpl l loss p53 protects mice lethal myelosuppression
0.49731448.11567994.html.plaintext.txt	29	recent studies using mouse models established administration single high dose mpl l immediately lethal myelosuppressive regimen promotes hematopoietic recovery prevents death1 5 p53 tumor suppressor protein important mediator apoptosis response chemotherapeutic dna damaging agents irradiation414 therefore may contribute pathogenicity associated myelosuppression rationale hypothesis studies mpl l acting prevent cell death p53 dependent pathway mpl l administration p53 mice given myelosuppressive regimen provide hematopoietic protection carrier treated p53 null animals subjected dna damage alternatively cytokine blocks cell death via another pathway p53mice treated dna damaging agents mpl l display less myelosuppression faster hematopoietic recovery p53mice given myelosuppression carrier alone case mpl l protective effect additive loss p53 function
0.49731448.11567994.html.plaintext.txt	30	recent studies using mouse models established administration single high dose mpl l immediately lethal myelosuppressive regimen promotes hematopoietic recovery prevents death1 5 p53 tumor suppressor protein important mediator apoptosis response chemotherapeutic dna damaging agents irradiation414 therefore may contribute pathogenicity associated myelosuppression rationale hypothesis studies mpl l acting prevent cell death p53 dependent pathway mpl l administration p53 mice given myelosuppressive regimen provide hematopoietic protection carrier treated p53 null animals subjected dna damage alternatively cytokine blocks cell death via another pathway p53mice treated dna damaging agents mpl l display less myelosuppression faster hematopoietic recovery p53mice given myelosuppression carrier alone case mpl l protective effect additive loss p53 function
0.49731448.11567994.html.plaintext.txt	31	determine role p53 response whether protective effect mpl l due ability inhibit p53 dependent apoptosis exposed p53 deficient mice myelosuppressive regimen lethal wild type wt mice wt p53groups mice subdivided immediately following exposure lethal myelosuppressive treatment half group given single intravenous iv injection peg rmmgdf 50 microgkg half control group received 1 normal mouse serum 3 experiments wt mice treated peg rmmgdf survived however control wt mice died figure 1 contrast almost p53mice survived without peg rmmgdf therefore primary mechanism lethal myelosuppression p53 dependent
0.49731448.11567994.html.plaintext.txt	32	determine role p53 response whether protective effect mpl l due ability inhibit p53 dependent apoptosis exposed p53 deficient mice myelosuppressive regimen lethal wild type wt mice wt p53groups mice subdivided immediately following exposure lethal myelosuppressive treatment half group given single intravenous iv injection peg rmmgdf 50 microgkg half control group received 1 normal mouse serum 3 experiments wt mice treated peg rmmgdf survived however control wt mice died figure 1 contrast almost p53mice survived without peg rmmgdf therefore primary mechanism lethal myelosuppression p53 dependent
0.49731448.11567994.html.plaintext.txt	33	view larger version 22k figure 1 administration mpl ligand loss p53 protects mice lethal myelosuppression survival p53 mice knockout ko n 22 wild type mice wt c57bl6j n 15 given 50 microgkg peg rmmgdf immediately receiving 80 mgkg carboplatin intravenously 75 gy tbi control groups sizes given carrier 1 normal mouse serum pbs instead peg rmmgdf
0.49731448.11567994.html.plaintext.txt	34	view larger version 22k figure 1 administration mpl ligand loss p53 protects mice lethal myelosuppression survival p53 mice knockout ko n 22 wild type mice wt c57bl6j n 15 given 50 microgkg peg rmmgdf immediately receiving 80 mgkg carboplatin intravenously 75 gy tbi control groups sizes given carrier 1 normal mouse serum pbs instead peg rmmgdf
0.49731448.11567994.html.plaintext.txt	35	p53 promotes survival bone marrow derived progenitor cells exposed carboplatin irradiation
0.49731448.11567994.html.plaintext.txt	36	clarify mechanism p53 loss contributes survival measured extent myelosuppression rate subsequent hematopoietic recovery wt p53 deficient mice wt p53 mice treated peg rmmgdf well p53 animals injected carrier alone experienced nearly identical courses platelet suppression recovery following carboplatin irradiation ir whereas platelet counts carrier treated wt mice failed recover figure 2a results confirmed 2 repeat experiments contrast declines wbc hemoglobin values significantly less severe p53 mice without peg rmmgdf treatment compared wt animals given peg rmmgdf figure 2b c wild type mice treated peg rmmgdf appreciably lower wbc counts 2 p53 groups days 8 22 treatment p 02 001 3 experiments similarly decreases hemoglobin concentration significantly greater wt mice given peg rmmgdf groups p53 mice day 14 p 005 001 3 experiments hemoglobin levels wt mice treated peg rmmgdf recover level equal p53 mice day 22 figure 2b contrast peg rmmgdf administration enhance hematopoietic recovery p53 mice collectively findings suggest thrombopoiesis protected extent peg rmmgdf treated wt mice p53 mice conferring survival c mpl expressing multipotential hematopoietic precursors committed megakaryocyte progenitors contrast granulopoiesis erythropoiesis protected less efficiently peg rmmgdf wt mice p53 mice committed granulocyte erythroid precursors express c mpl
0.49731448.11567994.html.plaintext.txt	37	clarify mechanism p53 loss contributes survival measured extent myelosuppression rate subsequent hematopoietic recovery wt p53 deficient mice wt p53 mice treated peg rmmgdf well p53 animals injected carrier alone experienced nearly identical courses platelet suppression recovery following carboplatin irradiation ir whereas platelet counts carrier treated wt mice failed recover figure 2a results confirmed 2 repeat experiments contrast declines wbc hemoglobin values significantly less severe p53 mice without peg rmmgdf treatment compared wt animals given peg rmmgdf figure 2b c wild type mice treated peg rmmgdf appreciably lower wbc counts 2 p53 groups days 8 22 treatment p 02 001 3 experiments similarly decreases hemoglobin concentration significantly greater wt mice given peg rmmgdf groups p53 mice day 14 p 005 001 3 experiments hemoglobin levels wt mice treated peg rmmgdf recover level equal p53 mice day 22 figure 2b contrast peg rmmgdf administration enhance hematopoietic recovery p53 mice collectively findings suggest thrombopoiesis protected extent peg rmmgdf treated wt mice p53 mice conferring survival c mpl expressing multipotential hematopoietic precursors committed megakaryocyte progenitors contrast granulopoiesis erythropoiesis protected less efficiently peg rmmgdf wt mice p53 mice committed granulocyte erythroid precursors express c mpl
0.49731448.11567994.html.plaintext.txt	38	view larger version 15k figure 2 effect mpl ligand hematopoietic suppression recovery wild type p53 mice lethal myelosuppression effects peg rmmgdf administered immediately carboplatin ir platelet count hemoglobin concentration b wbc count c p53 mice 7 mice wild type c57bl6j mice 7 mice controls p53 mice wild type mice 7 mice per group treated carrier point represents plus minus sem trends reproducible 2 subsequent experiments
0.49731448.11567994.html.plaintext.txt	39	view larger version 15k figure 2 effect mpl ligand hematopoietic suppression recovery wild type p53 mice lethal myelosuppression effects peg rmmgdf administered immediately carboplatin ir platelet count hemoglobin concentration b wbc count c p53 mice 7 mice wild type c57bl6j mice 7 mice controls p53 mice wild type mice 7 mice per group treated carrier point represents plus minus sem trends reproducible 2 subsequent experiments
0.49731448.11567994.html.plaintext.txt	40	demonstrate p53 knockout mice survive lethal myelosuppression regimen increased hematopoietic cell survival examined wt mice transplanted p53 p53 bone marrow peripheral blood cell counts recipient mice recovered following transplantation exposed animals lethal dose carboplatin 80 mgkg ir 7 gy tbi mice receiving p53 bone marrow cell transplants n 7 survived whereas mice receiving p53 bone marrow transplants n 4 died within 19 days therefore p53 deficient mice survive lethal myelosuppressive regimen due intrinsic resistance hematopoietic progenitors dna damage
0.49731448.11567994.html.plaintext.txt	41	demonstrate p53 knockout mice survive lethal myelosuppression regimen increased hematopoietic cell survival examined wt mice transplanted p53 p53 bone marrow peripheral blood cell counts recipient mice recovered following transplantation exposed animals lethal dose carboplatin 80 mgkg ir 7 gy tbi mice receiving p53 bone marrow cell transplants n 7 survived whereas mice receiving p53 bone marrow transplants n 4 died within 19 days therefore p53 deficient mice survive lethal myelosuppressive regimen due intrinsic resistance hematopoietic progenitors dna damage
0.49731448.11567994.html.plaintext.txt	42	rescue bone marrow progenitors administration mpl l
0.49731448.11567994.html.plaintext.txt	43	determine whether beneficial effects peg rmmgdf targeted progenitor cells compared vitro colony forming ability bone marrow cells harvested days 1 2 myelosuppressive regimen marrow wt untreated mice bone marrow obtained mice plated methylcellulose containing il 3 colony number size scored 13 days colony formation marrow mice treated peg rmmgdf carrier collected day 1 day 2 treatment markedly decreased compared untreated marrow figure 3 however bone marrow cells collected 24 48 hours generated significantly greater colony numbers sizes derived mice treated peg rmmgdf compared carrier treated mice p 05 figure 3 middle bottom panels furthermore bone marrow mice given myelosuppression regimen peg rmmgdf yielded full spectrum colony sizes whereas bone marrow mice exposed myelosuppressive regimen without peg rmmgdf formed predominantly small colonies figure 3 middle bottom panels therefore mpl l promotes hematopoietic recovery protecting bone marrow progenitors dna damaging insults colony formation untreated p53 marrow cells significantly different untreated wt marrow figure 4 top panel figure 3 colony formation wt mice treated peg rmmgdf day 2 treatment significantly higher carrier treated p53 mice p 005 figure 4 middle panel contrast additional protective effect mpl l colony formation bone marrow cells p53 mice collected 48 hours myelosuppressive regimen number colonies derived mpl l carrier treated p53 mice different figure 4 bottom panel trend confirmed repeat experiment
0.49731448.11567994.html.plaintext.txt	44	determine whether beneficial effects peg rmmgdf targeted progenitor cells compared vitro colony forming ability bone marrow cells harvested days 1 2 myelosuppressive regimen marrow wt untreated mice bone marrow obtained mice plated methylcellulose containing il 3 colony number size scored 13 days colony formation marrow mice treated peg rmmgdf carrier collected day 1 day 2 treatment markedly decreased compared untreated marrow figure 3 however bone marrow cells collected 24 48 hours generated significantly greater colony numbers sizes derived mice treated peg rmmgdf compared carrier treated mice p 05 figure 3 middle bottom panels furthermore bone marrow mice given myelosuppression regimen peg rmmgdf yielded full spectrum colony sizes whereas bone marrow mice exposed myelosuppressive regimen without peg rmmgdf formed predominantly small colonies figure 3 middle bottom panels therefore mpl l promotes hematopoietic recovery protecting bone marrow progenitors dna damaging insults colony formation untreated p53 marrow cells significantly different untreated wt marrow figure 4 top panel figure 3 colony formation wt mice treated peg rmmgdf day 2 treatment significantly higher carrier treated p53 mice p 005 figure 4 middle panel contrast additional protective effect mpl l colony formation bone marrow cells p53 mice collected 48 hours myelosuppressive regimen number colonies derived mpl l carrier treated p53 mice different figure 4 bottom panel trend confirmed repeat experiment
0.49731448.11567994.html.plaintext.txt	45	view larger version 17k figure 3 mpl ligand promotes survival hematopoietic progenitor cells mice given 80 mgkg carboplatin intravenously 75 gy cs 137 tbi either peg rmmgdf carrier 1 2 mice per group bone marrow cells collected 1 middle panel 2 bottom panel days later plated methylcellulose containing medium il 3 2 dishes per bone marrow sample colonies scored day 13 colony sizes classified large 500 cellscolony medium 200 400 cellscolony small 15 150 cellscolony untreated top panel colonies formed bone marrow collected mice received carboplatintbi bars represent means plus minus sem
0.49731448.11567994.html.plaintext.txt	46	view larger version 17k figure 3 mpl ligand promotes survival hematopoietic progenitor cells mice given 80 mgkg carboplatin intravenously 75 gy cs 137 tbi either peg rmmgdf carrier 1 2 mice per group bone marrow cells collected 1 middle panel 2 bottom panel days later plated methylcellulose containing medium il 3 2 dishes per bone marrow sample colonies scored day 13 colony sizes classified large 500 cellscolony medium 200 400 cellscolony small 15 150 cellscolony untreated top panel colonies formed bone marrow collected mice received carboplatintbi bars represent means plus minus sem
0.49731448.11567994.html.plaintext.txt	47	view larger version 20k figure 4 effect mpl ligand survival hematopoietic progenitor cells marrow myelosuppressed p53 mice compared carrier treated p53 mice mice given 80 mgkg carboplatin intravenously 75 gy cs 137 tbi either peg rmmgdf carrier 1 2 mice per group bone marrow cells collected 2 days later plated methylcellulose containing medium il 3 2 dishes per bone marrow sample colonies scored day 13 colony sizes classified large 500 cellscolony medium 200 400 cellscolony small 15 150 cellscolony untreated top panel colonies formed bone marrow collected mice received carboplatintbi bars represent mean plus minus sem trend reproducible repeat experiment
0.49731448.11567994.html.plaintext.txt	48	view larger version 20k figure 4 effect mpl ligand survival hematopoietic progenitor cells marrow myelosuppressed p53 mice compared carrier treated p53 mice mice given 80 mgkg carboplatin intravenously 75 gy cs 137 tbi either peg rmmgdf carrier 1 2 mice per group bone marrow cells collected 2 days later plated methylcellulose containing medium il 3 2 dishes per bone marrow sample colonies scored day 13 colony sizes classified large 500 cellscolony medium 200 400 cellscolony small 15 150 cellscolony untreated top panel colonies formed bone marrow collected mice received carboplatintbi bars represent mean plus minus sem trend reproducible repeat experiment
0.49731448.11567994.html.plaintext.txt	49	effect mpl l administration p53 pathway bone marrow cells
0.49731448.11567994.html.plaintext.txt	50	p53 important regulator dna damage response mammalian cells dna damage followed rapid accumulation activation p53 induces expression number downstream target genes resulting cell cycle arrest apoptosis18 assess function p53 pathway response myelosuppression regimen analyzed expression p53 2 transcription targets p21cip1 bax bone marrow cells specific time intervals following carboplatin ir exposure immunoblotting figure 5 response regimen levels p53 protein increased rapidly sustained least 6 hours declining peg rmmgdf administration significantly alter magnitude kinetics p53 induction figure 5 repeated 5 separate experiments bax proapoptotic factor regulated p53 cell types19 23 constitutively expressed bone marrow cells exposed dna damaging regimen unaffected administration peg rmmgdf contrast expression p21cip1 cyclin kinase inhibitor24 markedly induced following carboplatin ir response paralleled induction p53 figure 5 peg rmmgdf consistent differential effect induction p21 dna damage indicating beneficial effect mpl l hematopoietic cells due direct disruption p53 response instead mpl l appears act downstream p53 prevent apoptosis see discussion
0.49731448.11567994.html.plaintext.txt	51	p53 important regulator dna damage response mammalian cells dna damage followed rapid accumulation activation p53 induces expression number downstream target genes resulting cell cycle arrest apoptosis18 assess function p53 pathway response myelosuppression regimen analyzed expression p53 2 transcription targets p21cip1 bax bone marrow cells specific time intervals following carboplatin ir exposure immunoblotting figure 5 response regimen levels p53 protein increased rapidly sustained least 6 hours declining peg rmmgdf administration significantly alter magnitude kinetics p53 induction figure 5 repeated 5 separate experiments bax proapoptotic factor regulated p53 cell types19 23 constitutively expressed bone marrow cells exposed dna damaging regimen unaffected administration peg rmmgdf contrast expression p21cip1 cyclin kinase inhibitor24 markedly induced following carboplatin ir response paralleled induction p53 figure 5 peg rmmgdf consistent differential effect induction p21 dna damage indicating beneficial effect mpl l hematopoietic cells due direct disruption p53 response instead mpl l appears act downstream p53 prevent apoptosis see discussion
0.49731448.11567994.html.plaintext.txt	52	view larger version 72k figure 5 treatment mpl ligand impair p53 response carboplatin radiation bone marrow cells c57bl6j mice 1 mouse per group harvested solubilized indicated intervals treatment 80 mgkg carboplatin administered intravenously 75 gy tbi followed immediately peg rmmgdf carrier samples assessed immunoblotting expression p53 bax p21cip1 immunoblotting actin immunoblot shown comparison protein loading per lane unt untreated bone marrow cells c57bl6j mice received carboplatintbi
0.49731448.11567994.html.plaintext.txt	53	view larger version 72k figure 5 treatment mpl ligand impair p53 response carboplatin radiation bone marrow cells c57bl6j mice 1 mouse per group harvested solubilized indicated intervals treatment 80 mgkg carboplatin administered intravenously 75 gy tbi followed immediately peg rmmgdf carrier samples assessed immunoblotting expression p53 bax p21cip1 immunoblotting actin immunoblot shown comparison protein loading per lane unt untreated bone marrow cells c57bl6j mice received carboplatintbi
0.49731448.11567994.html.plaintext.txt	54	bax influences hematopoietic recovery following lethal myelosuppression
0.49731448.11567994.html.plaintext.txt	55	previous studies reported bax expression induced radiosensitive tissues following irradiation25 contrast observed carboplatin ir without administration peg rmmgdf affect steady state level bax protein bone marrow cells results however rule possibility small changes bax expression andor posttranslational modifications could significantly regulate apoptotic response myelosuppressive regimen assess role bax p53 mediated apoptosis myelosuppression model measured survival hematopoietic recovery bax mice exposed carboplatin ir whether peg rmmgdf affects response similar wt littermate animals bax mice highly susceptible lethal effects dna damaging regimen assessment platelet counts wbc counts hemoglobin levels indicated bax mice died due hematopoietic failure figure 6a c confirmed 2 independent experiments interestingly bax mice treated peg rmmgdf exhibited rapid recovery hemoglobin levels day 14 p 005 days 18 22 p 001 platelet counts day 14 p 01 day 18 p 001 wbc counts day 10 p 025 day 18 p 001 compared wild type mice figure 6a c thus although clearly required bax appears play role p53 dependent apoptosis myelosuppression model
0.49731448.11567994.html.plaintext.txt	56	previous studies reported bax expression induced radiosensitive tissues following irradiation25 contrast observed carboplatin ir without administration peg rmmgdf affect steady state level bax protein bone marrow cells results however rule possibility small changes bax expression andor posttranslational modifications could significantly regulate apoptotic response myelosuppressive regimen assess role bax p53 mediated apoptosis myelosuppression model measured survival hematopoietic recovery bax mice exposed carboplatin ir whether peg rmmgdf affects response similar wt littermate animals bax mice highly susceptible lethal effects dna damaging regimen assessment platelet counts wbc counts hemoglobin levels indicated bax mice died due hematopoietic failure figure 6a c confirmed 2 independent experiments interestingly bax mice treated peg rmmgdf exhibited rapid recovery hemoglobin levels day 14 p 005 days 18 22 p 001 platelet counts day 14 p 01 day 18 p 001 wbc counts day 10 p 025 day 18 p 001 compared wild type mice figure 6a c thus although clearly required bax appears play role p53 dependent apoptosis myelosuppression model
0.49731448.11567994.html.plaintext.txt	57	view larger version 15k figure 6 deficiency bax enhances mpl ligand mediated hematopoietic recovery myelosuppressive regimen peg rmmgdf immediately administered bax mice bax ko n 17 wild type wt b6129 mice usually littermates n 17 lethal myelosuppression carrier treated bax mice n 12 wild type mice n 10 point represents mean plus minus sem
0.49731448.11567994.html.plaintext.txt	58	view larger version 15k figure 6 deficiency bax enhances mpl ligand mediated hematopoietic recovery myelosuppressive regimen peg rmmgdf immediately administered bax mice bax ko n 17 wild type wt b6129 mice usually littermates n 17 lethal myelosuppression carrier treated bax mice n 12 wild type mice n 10 point represents mean plus minus sem
0.49731448.11567994.html.plaintext.txt	59	loss atm compromises mpl l rescue lethal myelosuppression
0.49731448.11567994.html.plaintext.txt	60	atm member pi 3 serinethreonine kinase family phosphorylates activates p53 response certain dna damage signals2526 loss atm mice humans typically associated attenuated p53 responsiveness impaired cell cycle arrest paradoxically atm mice display remarkable susceptibility dna damaging insults2728 appears cell type specific largely attributable increased gastrointestinal sensitivity29 since p53 null bone marrow progenitors resistant dna damage tested whether loss atm would also influence response bone marrow derived progenitors carboplatin ir end assessed responses wt mice receiving atm p53 p53 wt bone marrow transplants dna damage animals transplanted atm marrow treated peg rmmgdf succumbed earlier myelosuppressive regimen similarly treated mice transplanted p53 wt bone marrow whereas mice receiving p53 transplants survived without peg rmmgdf treatment figure 7 atm p53 wt bone marrow transplanted mice treated carrier exposure myelosuppressive regimen died data shown inability atm bone marrow cells properly arrest response dna damage presumably overrode protective effects mpl l resulting dramatically earlier hematopoietic death atm mice
0.49731448.11567994.html.plaintext.txt	61	atm member pi 3 serinethreonine kinase family phosphorylates activates p53 response certain dna damage signals2526 loss atm mice humans typically associated attenuated p53 responsiveness impaired cell cycle arrest paradoxically atm mice display remarkable susceptibility dna damaging insults2728 appears cell type specific largely attributable increased gastrointestinal sensitivity29 since p53 null bone marrow progenitors resistant dna damage tested whether loss atm would also influence response bone marrow derived progenitors carboplatin ir end assessed responses wt mice receiving atm p53 p53 wt bone marrow transplants dna damage animals transplanted atm marrow treated peg rmmgdf succumbed earlier myelosuppressive regimen similarly treated mice transplanted p53 wt bone marrow whereas mice receiving p53 transplants survived without peg rmmgdf treatment figure 7 atm p53 wt bone marrow transplanted mice treated carrier exposure myelosuppressive regimen died data shown inability atm bone marrow cells properly arrest response dna damage presumably overrode protective effects mpl l resulting dramatically earlier hematopoietic death atm mice
0.49731448.11567994.html.plaintext.txt	62	view larger version 18k figure 7 loss atm augments lethal myelosuppression survival c57bl6 mice receiving bone marrow transplants atm atm ko n 8 p53 p53 ko n 7 p53 p53 hz n 6 wild type wt n 7 bone marrow mice receiving atm p53 wild type marrow transplants given peg rmmgdf intravenously exposure lethal myelosuppressive regimen
0.49731448.11567994.html.plaintext.txt	63	view larger version 18k figure 7 loss atm augments lethal myelosuppression survival c57bl6 mice receiving bone marrow transplants atm atm ko n 8 p53 p53 ko n 7 p53 p53 hz n 6 wild type wt n 7 bone marrow mice receiving atm p53 wild type marrow transplants given peg rmmgdf intravenously exposure lethal myelosuppressive regimen
0.49731448.11567994.html.plaintext.txt	64	discussion top abstract introduction materials methods results discussion references
0.49731448.11567994.html.plaintext.txt	65	mechanism mpl l protects animals lethal myelosuppressive regimen previously established myelosuppressive agents chemotherapy ir known activate p53 dependent apoptosis141530 mpl expressed multipotential hematopoietic progenitors7 931 ligand tpo prevents apoptosis progenitors vitro11 13 hypothesized mpl l protects mice preventing p53 dependent cell death hypotheses correct mpl l administration provide greater protection hematopoiesis p53 mice compared carrier treated p53 null animals following myeloablative regimen findings support hypothesis exposed myelosuppressive insult p53 deficient mice survived without mpl l treatment whereas wt mice died furthermore p53 mice subjected myelosuppression regimen treated peg rmmgdf degree myelosuppression hematopoietic recovery profile p53 mice given myelosuppressive regimen carrier alone findings indicate mpl l acting suppress p53 dependent apoptosis vivo
0.49731448.11567994.html.plaintext.txt	66	mechanism mpl l protects animals lethal myelosuppressive regimen previously established myelosuppressive agents chemotherapy ir known activate p53 dependent apoptosis141530 mpl expressed multipotential hematopoietic progenitors7 931 ligand tpo prevents apoptosis progenitors vitro11 13 hypothesized mpl l protects mice preventing p53 dependent cell death hypotheses correct mpl l administration provide greater protection hematopoiesis p53 mice compared carrier treated p53 null animals following myeloablative regimen findings support hypothesis exposed myelosuppressive insult p53 deficient mice survived without mpl l treatment whereas wt mice died furthermore p53 mice subjected myelosuppression regimen treated peg rmmgdf degree myelosuppression hematopoietic recovery profile p53 mice given myelosuppressive regimen carrier alone findings indicate mpl l acting suppress p53 dependent apoptosis vivo
0.49731448.11567994.html.plaintext.txt	67	increased resistance p53 deficient mice carboplatin ir regimen consistent results investigators noted p53 mice survive 10 gy ir dose lethal wt mice17 correlative evidence suggested radioresistance p53 deficient mice consequence reduced apoptosis bone marrow cells1618 results transplantation studies p53 deficient marrow provide direct proof loss p53 indeed protects mice lethal myelosuppression results also suggest p53 dependent apoptosis hematopoietic progenitors leads hematopoietic failure death nonetheless carboplatin ir treated p53 mice experienced substantial myelosuppression indicating hematopoietic cells also die p53 independent pathways
0.49731448.11567994.html.plaintext.txt	68	increased resistance p53 deficient mice carboplatin ir regimen consistent results investigators noted p53 mice survive 10 gy ir dose lethal wt mice17 correlative evidence suggested radioresistance p53 deficient mice consequence reduced apoptosis bone marrow cells1618 results transplantation studies p53 deficient marrow provide direct proof loss p53 indeed protects mice lethal myelosuppression results also suggest p53 dependent apoptosis hematopoietic progenitors leads hematopoietic failure death nonetheless carboplatin ir treated p53 mice experienced substantial myelosuppression indicating hematopoietic cells also die p53 independent pathways
0.49731448.11567994.html.plaintext.txt	69	observed interesting differences hematopoietic responses p53 deficient mice given peg rmmgdf carrier versus wt mice given peg rmmgdf myelosuppressive regimen hemoglobin concentration wbc counts reduced greater extent wt mice given peg rmmgdf p53 deficient mice given peg rmmgdf carrier alone contrast degree thrombocytopenia 3 groups virtually identical speculate difference reflects disparate patterns mpl expression various hematopoietic progenitors910 case p53 null multipotential hematopoietic progenitors committed precursors would protected p53 dependent apoptosis whereas normal phenotype hematopoietic cells express mpl would protected mpl l view correct concomitant administration mpl l combination erythropoietin granulocyte colony stimulating factor g csf immediately myelosuppressive insult might optimally reduce degree suppression 3 committed hematopoietic lineages
0.49731448.11567994.html.plaintext.txt	70	observed interesting differences hematopoietic responses p53 deficient mice given peg rmmgdf carrier versus wt mice given peg rmmgdf myelosuppressive regimen hemoglobin concentration wbc counts reduced greater extent wt mice given peg rmmgdf p53 deficient mice given peg rmmgdf carrier alone contrast degree thrombocytopenia 3 groups virtually identical speculate difference reflects disparate patterns mpl expression various hematopoietic progenitors910 case p53 null multipotential hematopoietic progenitors committed precursors would protected p53 dependent apoptosis whereas normal phenotype hematopoietic cells express mpl would protected mpl l view correct concomitant administration mpl l combination erythropoietin granulocyte colony stimulating factor g csf immediately myelosuppressive insult might optimally reduce degree suppression 3 committed hematopoietic lineages
0.49731448.11567994.html.plaintext.txt	71	number bone marrow derived colonies generated cultures il 3 substantially higher mice received peg rmmgdf myelosuppression regimen carrier controls finding suggests mpl l protects hematopoietic progenitors contrast assays bone marrow derived colonies generated myelosuppressed mpl l treated p53 mice compared carrier treated p53 mice demonstrated additional protective effect mpl l colony formation results support conclusion vivo experiments mpl l acting suppress p53 dependent apoptosis hematopoietic cells vivo
0.49731448.11567994.html.plaintext.txt	72	number bone marrow derived colonies generated cultures il 3 substantially higher mice received peg rmmgdf myelosuppression regimen carrier controls finding suggests mpl l protects hematopoietic progenitors contrast assays bone marrow derived colonies generated myelosuppressed mpl l treated p53 mice compared carrier treated p53 mice demonstrated additional protective effect mpl l colony formation results support conclusion vivo experiments mpl l acting suppress p53 dependent apoptosis hematopoietic cells vivo
0.49731448.11567994.html.plaintext.txt	73	analysis protein expression provides insight mpl l prevents p53 dependent apoptosis myelosuppressive regimen increase p53 protein levels bone marrow cells response carboplatin ir unaffected mpl l administration indicating peg rmmgdf protect hematopoietic cells directly suppressing p53 expression furthermore induction p21cip1 expression enhanced carboplatinradiation treated wt mice peg rmmgdf injection results indicate mpl l interfere p53 pathway level p53 induction rather cytokine appears protect bone marrow cells suppressing p53 function downstream step furthermore previously demonstrated cytokines il 3 erythropoietin protect p53 dependent apoptosis response dna damage inducing expression bcl 2 bcl xl potent suppressors cell death3233 findings support hypothesis cytokines block p53 mediated cell death antagonizing downstream target genes bax proapoptotic bcl 2 family members
0.49731448.11567994.html.plaintext.txt	74	analysis protein expression provides insight mpl l prevents p53 dependent apoptosis myelosuppressive regimen increase p53 protein levels bone marrow cells response carboplatin ir unaffected mpl l administration indicating peg rmmgdf protect hematopoietic cells directly suppressing p53 expression furthermore induction p21cip1 expression enhanced carboplatinradiation treated wt mice peg rmmgdf injection results indicate mpl l interfere p53 pathway level p53 induction rather cytokine appears protect bone marrow cells suppressing p53 function downstream step furthermore previously demonstrated cytokines il 3 erythropoietin protect p53 dependent apoptosis response dna damage inducing expression bcl 2 bcl xl potent suppressors cell death3233 findings support hypothesis cytokines block p53 mediated cell death antagonizing downstream target genes bax proapoptotic bcl 2 family members
0.49731448.11567994.html.plaintext.txt	75	bax directly transactivated p53 promotes apoptosis2134 also tested role gene using bax deficient mice myelosuppression model found bax constitutively expressed mouse bone marrow cells bax levels affected carboplatin plus ir administration peg rmmgdf consistent findings bax deficiency protect animals lethal dose carboplatin ir however peg rmmgdf given platelet counts wbc counts hemoglobin levels recovered rapidly bax mice wt mice indicating bax play proapoptotic role response multipotential hematopoietic cells myelosuppressive regimen findings convincingly demonstrate loss bax equivalent loss p53 protecting lethal myelosuppression downstream factors must mediate p53 dependent apoptosis conditions
0.49731448.11567994.html.plaintext.txt	76	bax directly transactivated p53 promotes apoptosis2134 also tested role gene using bax deficient mice myelosuppression model found bax constitutively expressed mouse bone marrow cells bax levels affected carboplatin plus ir administration peg rmmgdf consistent findings bax deficiency protect animals lethal dose carboplatin ir however peg rmmgdf given platelet counts wbc counts hemoglobin levels recovered rapidly bax mice wt mice indicating bax play proapoptotic role response multipotential hematopoietic cells myelosuppressive regimen findings convincingly demonstrate loss bax equivalent loss p53 protecting lethal myelosuppression downstream factors must mediate p53 dependent apoptosis conditions
0.49731448.11567994.html.plaintext.txt	77	increased radiosensitivity atm mice attributed high level apoptosis induced gastrointestinal tract mice29 however fact recipients atm bone marrow transplants died accelerated rate myelosuppressive regimen protected peg rmmgdf indicates marrow toxicity plays major role increased sensitivity mice dna damaging agents
0.49731448.11567994.html.plaintext.txt	78	summary observations indicate mpl l administered immediately lethal myelosuppressive regimen promotes survival hematopoietic progenitor cells vivo attenuating p53 dependent apoptosis myelosuppression toxicity limiting component chemotherapy andor radiation therapy major clinical problem autologous bone marrow transplantation regimens administration mpl l dna damaging treatments suppress p53 response thereby alleviating severity neutropenia thrombocytopenia anemia need platelet transfusions
0.49731448.11567994.html.plaintext.txt	79	summary observations indicate mpl l administered immediately lethal myelosuppressive regimen promotes survival hematopoietic progenitor cells vivo attenuating p53 dependent apoptosis myelosuppression toxicity limiting component chemotherapy andor radiation therapy major clinical problem autologous bone marrow transplantation regimens administration mpl l dna damaging treatments suppress p53 response thereby alleviating severity neutropenia thrombocytopenia anemia need platelet transfusions
0.49731448.11567994.html.plaintext.txt	80	authors thank shirley steward nancy hutson jinling wang dr christine eischen charles m strain joseph m emmons outstanding technical assistance staff st jude animal resources center support dr stanley korsmeyer providing bax mice dr peter mckinnon providing atm mice thank sharon naron editorial review report
0.49731448.11567994.html.plaintext.txt	81	submitted november 20 2000 accepted may 24 2001
0.49731448.11567994.html.plaintext.txt	82	supported part grants ca76379 dk44158 jlc ca63230 gpz ca21765 national institutes health assisi foundation memphis american lebanese syrian associated charities
0.49731448.11567994.html.plaintext.txt	83	publication costs article defrayed part page charge payment therefore solely indicate fact article hereby marked advertisement accordance 18 usc section 1734
0.49731448.11567994.html.plaintext.txt	84	publication costs article defrayed part page charge payment therefore solely indicate fact article hereby marked advertisement accordance 18 usc section 1734
0.49731448.11567994.html.plaintext.txt	85	reprints tamara pestina division experimental hematology st jude childrens research hospital 332 n lauderdale memphis tn 38105 2794 e mail tamarapestinaatstjudeorg u d
0.49731448.11567994.html.plaintext.txt	86	references top abstract introduction materials methods results discussion references 1 neelis kj visser tp dimjati w et al single dose thrombopoietin shortly myelosuppressive total body irradiation prevents pancytopenia mice promoting short term multilineage spleen repopulating cells transient expense bone marrow repopulating cells blood 1998921586 1597abstractfree full text 2 shibuya k akahori h takahashi k tahara e kato miyazaki h multilineage hematopoietic recovery single injection pegylated recombinant human megakaryocyte growth development factor myelosuppressed mice blood 19989137 45abstractfree full text 3 ulich tr del castillo j senaldi g harley c molineux g peg rhumgdf promotes multilineage hematopoietic recovery myelosuppressed mice exp hematol 1999271776 1781crossrefmedline order article via infotrieve 4 mouthon ma van der meeren gaugler mh et al thrombopoietin promotes hematopoietic recovery survival high dose whole body irradiation int j radiat oncol biol phys 199943867 875medline order article via infotrieve 5 pestina ti abushullaih b jackson cw single injection pegylated recombinant mouse megakaryocyte growth development factor peg rmmgdf prevents death lethally myelosuppressed mice inhibiting p53 dependent apoptosis exp hematol 199927abstract241 6 solar gp kerr wg zeigler fc et al role c mpl early hematopoiesis blood 1998924 10abstractfree full text 7 carver moore k broxmeyer luoh sm et al low levels erythroid myeloid progenitors tpo c mpl deficient mice blood 199688803 809abstractfree full text 8 alexander ws roberts aw nicola na li r metcalf d deficiencies progenitor cells multiple hematopoietic lineages defective megakaryocytopoiesis mice lacking thrombopoietin receptor c mpl blood 1996872162 2170abstractfree full text 9 de sauvage fj villeval jl shivdasani ra regulation megakaryocytopoiesis platelet production lessons animal models j lab clin med 1998131496 501medline order article via infotrieve 10 kimura roberts aw metcalf d alexander ws hematopoietic stem cell deficiencies mice lacking c mpl receptor thrombopoietin proc natl acad sci u 1998951195 2000abstractfree full text 11 borge oj ramsfjell v veiby op murphy mj look jacobsen sew thrombopoietin erythropoietin promotes viability inhibits apoptosis multipotent murine hematopoietic progenitor cells vitro blood 1996882859 2870abstractfree full text 12 van den oudenrijn de haas m calafat j van der schoot ce von dem borne ae combination megakaryocyte growth development factor interleukin 1 sufficient culture large numbers megakaryocytic progenitors megakaryocytes transfusion purposes br j haematol 1999106553 563medline order article via infotrieve 13 shimomura yonemura y miyazoe et al thrombopoietin stimulates murine lineage negative sca 1 c kit cd34 cells comparative study stem cell factor interleukin 3 int j hematol 20007133 39medline order article via infotrieve 14 wlodarski p wasik m ratajczak mz et al role p53 hematopoietic recovery cytotoxic treatment blood 1998912998 3006abstractfree full text 15 toefili l rutella putzulu r et al expression p53 bcl 2 bax cd34 cells recovering chemotherapy blood 199892letter4880 4881free full text 16 lotem j sachs l hematopoietic cells mice deficient wild type p53 resistant induction apoptosis agents blood 1993821092 1096abstract 17 westphal ch hoyes kp canman ce et al loss atm radiosensitizes multiple p53 null tissues cancer res 1998585637 5639abstract 18 levine aj p53 cellular gatekeeper growth division cell 199788323 331medline order article via infotrieve 19 zhan q fan bae et al induction bax genotoxic stress human cells correlates normal p53 status apoptosis oncogene 199493743 3751medline order article via infotrieve 20 kitada krajewski miyashita krajewska m reed jc gamma radiation induces upregulation bax protein apoptosis radiosensitive cells vivo oncogene 199612187 192medline order article via infotrieve 21 thornborrow ec manfredi jj one mechanism cell type specific regulation bax promoter tumor suppressor p53 dictated p53 response element j biol chem 199927433747 33756abstractfree full text 22 de feudis p vignati rossi c et al driving p53 response bax activation greatly enhances sensitivity taxol inducing massive apoptosis neoplasia 20002202 207medline order article via infotrieve 23 bouvard v zaitchouk vacher m et al tissue cell specific expression p53 target genes bax fas mdm2 waf1p21 following ionizing irradiation mice oncogene 200019649 660crossrefmedline order article via infotrieve 24 xiong y hannon gj zhang h et al p21 universal inhibitor cyclin kinases see comments nature 1993366701 704medline order article via infotrieve 25 canman ce lim ds cimprich ka et al activation atm kinase ionizing radiation phosphorylation p53 science 19982811677 1679abstractfree full text 26 banin moyal l shieh y et al enhanced phosphorylation p53 atm response dna damage science 19982811674 1677abstractfree full text 27 barlow c hirotsune paylor r et al atm deficient mice paradigm ataxia telangiectasia cell 199686159 171medline order article via infotrieve 28 morgan se kastan mb p53 atm cell cycle cell death cancer adv cancer res 1997711 25medline order article via infotrieve 29 westphal ch rowan schmaltz c elson fisher de leder p atm p53 cooperate apoptosis suppression tumorigenesis resistance acute radiation toxicity nat genet 199716397 401medline order article via infotrieve 30 ko lj prives c p53 puzzle paradigm genes dev 1996101054 1072crossrefmedline order article via infotrieve 31 zeigler fc de sauvage f widmer hr et al vitro megakaryocytopoietic thrombopoietic activity c mpl ligand tpo purified murine hematopoietic stem cells blood 1994844045 4052abstractfree full text 32 quelle f wang j l cleveland j ihle j zambetti g cytokine rescue p53 dependent apoptosis cell cycle arrest mediated distinct jak kinase signalling pathways genes dev 1998121099 1107abstractfree full text 33 packham g white e eischen c et al selective regulation bcl xl jak kinase dependent pathway bypassed murine hematopoietic malignancies genes dev 1998122475 2487abstractfree full text 34 miyashita reed jc tumor suppressor p53 direct transcriptional activator human bax gene cell 199580293 299medline order article via infotrieve
0.49731448.11567994.html.plaintext.txt	87	references top abstract introduction materials methods results discussion references 1 neelis kj visser tp dimjati w et al single dose thrombopoietin shortly myelosuppressive total body irradiation prevents pancytopenia mice promoting short term multilineage spleen repopulating cells transient expense bone marrow repopulating cells blood 1998921586 1597abstractfree full text 2 shibuya k akahori h takahashi k tahara e kato miyazaki h multilineage hematopoietic recovery single injection pegylated recombinant human megakaryocyte growth development factor myelosuppressed mice blood 19989137 45abstractfree full text 3 ulich tr del castillo j senaldi g harley c molineux g peg rhumgdf promotes multilineage hematopoietic recovery myelosuppressed mice exp hematol 1999271776 1781crossrefmedline order article via infotrieve 4 mouthon ma van der meeren gaugler mh et al thrombopoietin promotes hematopoietic recovery survival high dose whole body irradiation int j radiat oncol biol phys 199943867 875medline order article via infotrieve 5 pestina ti abushullaih b jackson cw single injection pegylated recombinant mouse megakaryocyte growth development factor peg rmmgdf prevents death lethally myelosuppressed mice inhibiting p53 dependent apoptosis exp hematol 199927abstract241 6 solar gp kerr wg zeigler fc et al role c mpl early hematopoiesis blood 1998924 10abstractfree full text 7 carver moore k broxmeyer luoh sm et al low levels erythroid myeloid progenitors tpo c mpl deficient mice blood 199688803 809abstractfree full text 8 alexander ws roberts aw nicola na li r metcalf d deficiencies progenitor cells multiple hematopoietic lineages defective megakaryocytopoiesis mice lacking thrombopoietin receptor c mpl blood 1996872162 2170abstractfree full text 9 de sauvage fj villeval jl shivdasani ra regulation megakaryocytopoiesis platelet production lessons animal models j lab clin med 1998131496 501medline order article via infotrieve 10 kimura roberts aw metcalf d alexander ws hematopoietic stem cell deficiencies mice lacking c mpl receptor thrombopoietin proc natl acad sci u 1998951195 2000abstractfree full text 11 borge oj ramsfjell v veiby op murphy mj look jacobsen sew thrombopoietin erythropoietin promotes viability inhibits apoptosis multipotent murine hematopoietic progenitor cells vitro blood 1996882859 2870abstractfree full text 12 van den oudenrijn de haas m calafat j van der schoot ce von dem borne ae combination megakaryocyte growth development factor interleukin 1 sufficient culture large numbers megakaryocytic progenitors megakaryocytes transfusion purposes br j haematol 1999106553 563medline order article via infotrieve 13 shimomura yonemura y miyazoe et al thrombopoietin stimulates murine lineage negative sca 1 c kit cd34 cells comparative study stem cell factor interleukin 3 int j hematol 20007133 39medline order article via infotrieve 14 wlodarski p wasik m ratajczak mz et al role p53 hematopoietic recovery cytotoxic treatment blood 1998912998 3006abstractfree full text 15 toefili l rutella putzulu r et al expression p53 bcl 2 bax cd34 cells recovering chemotherapy blood 199892letter4880 4881free full text 16 lotem j sachs l hematopoietic cells mice deficient wild type p53 resistant induction apoptosis agents blood 1993821092 1096abstract 17 westphal ch hoyes kp canman ce et al loss atm radiosensitizes multiple p53 null tissues cancer res 1998585637 5639abstract 18 levine aj p53 cellular gatekeeper growth division cell 199788323 331medline order article via infotrieve 19 zhan q fan bae et al induction bax genotoxic stress human cells correlates normal p53 status apoptosis oncogene 199493743 3751medline order article via infotrieve 20 kitada krajewski miyashita krajewska m reed jc gamma radiation induces upregulation bax protein apoptosis radiosensitive cells vivo oncogene 199612187 192medline order article via infotrieve 21 thornborrow ec manfredi jj one mechanism cell type specific regulation bax promoter tumor suppressor p53 dictated p53 response element j biol chem 199927433747 33756abstractfree full text 22 de feudis p vignati rossi c et al driving p53 response bax activation greatly enhances sensitivity taxol inducing massive apoptosis neoplasia 20002202 207medline order article via infotrieve 23 bouvard v zaitchouk vacher m et al tissue cell specific expression p53 target genes bax fas mdm2 waf1p21 following ionizing irradiation mice oncogene 200019649 660crossrefmedline order article via infotrieve 24 xiong y hannon gj zhang h et al p21 universal inhibitor cyclin kinases see comments nature 1993366701 704medline order article via infotrieve 25 canman ce lim ds cimprich ka et al activation atm kinase ionizing radiation phosphorylation p53 science 19982811677 1679abstractfree full text 26 banin moyal l shieh y et al enhanced phosphorylation p53 atm response dna damage science 19982811674 1677abstractfree full text 27 barlow c hirotsune paylor r et al atm deficient mice paradigm ataxia telangiectasia cell 199686159 171medline order article via infotrieve 28 morgan se kastan mb p53 atm cell cycle cell death cancer adv cancer res 1997711 25medline order article via infotrieve 29 westphal ch rowan schmaltz c elson fisher de leder p atm p53 cooperate apoptosis suppression tumorigenesis resistance acute radiation toxicity nat genet 199716397 401medline order article via infotrieve 30 ko lj prives c p53 puzzle paradigm genes dev 1996101054 1072crossrefmedline order article via infotrieve 31 zeigler fc de sauvage f widmer hr et al vitro megakaryocytopoietic thrombopoietic activity c mpl ligand tpo purified murine hematopoietic stem cells blood 1994844045 4052abstractfree full text 32 quelle f wang j l cleveland j ihle j zambetti g cytokine rescue p53 dependent apoptosis cell cycle arrest mediated distinct jak kinase signalling pathways genes dev 1998121099 1107abstractfree full text 33 packham g white e eischen c et al selective regulation bcl xl jak kinase dependent pathway bypassed murine hematopoietic malignancies genes dev 1998122475 2487abstractfree full text 34 miyashita reed jc tumor suppressor p53 direct transcriptional activator human bax gene cell 199580293 299medline order article via infotrieve
0.49731448.11567994.html.plaintext.txt	88	2001 american society hematology
0.4980571.15308639.html.plaintext.txt	0	cp 31398 restores dna binding activity mutant p53 vitro affect p53 homologs p63 p73 mark j demma serena wong eugene maxwell bimalendu dasmahapatra
0.4980571.15308639.html.plaintext.txt	1	cp 31398 restores dna binding activity mutant p53 vitro affect p53 homologs p63 p73 mark j demma serena wong eugene maxwell bimalendu dasmahapatra
0.4980571.15308639.html.plaintext.txt	2	schering plough research institute kenilworth new jersey 07033
0.4980571.15308639.html.plaintext.txt	3	received publication february 19 2004 revised form july 26 2004
0.4980571.15308639.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references p53 protein plays major role maintenance genome stability mammalian cells mutations p53 occur 50 cancers indicative highly aggressive cancers hard treat recently high degree interest therapeutic approaches restore growth suppression functions mutant p53 several compounds reported restore wild type function mutant p53 one compound cp 31398 shown effective vivo questions arisen whether actually affects p53 show mutant p53 isolated cells treated cp 31398 capable binding p53 response elements vitro also show compound restores dna binding activity mutant p53 cells determined chromatin immunoprecipitation assay addition using purified p53 core domain two different hotspot mutants r273h r249s show cp 31398 restore dna binding activity dose dependent manner using quantitative dna binding assay also show cp 31398 increases significantly amount mutant p53 binds cognate dna bmax affinity kd dna compound however affect affinity kd value wild type p53 dna increases bmax slightly similar assay prima1 effect p53 core dna binding activity also show cp 31398 effect dna binding activity p53 homologs p63 p73
0.4980571.15308639.html.plaintext.txt	5	abstract top abstract introduction experimental procedures results discussion references p53 protein plays major role maintenance genome stability mammalian cells mutations p53 occur 50 cancers indicative highly aggressive cancers hard treat recently high degree interest therapeutic approaches restore growth suppression functions mutant p53 several compounds reported restore wild type function mutant p53 one compound cp 31398 shown effective vivo questions arisen whether actually affects p53 show mutant p53 isolated cells treated cp 31398 capable binding p53 response elements vitro also show compound restores dna binding activity mutant p53 cells determined chromatin immunoprecipitation assay addition using purified p53 core domain two different hotspot mutants r273h r249s show cp 31398 restore dna binding activity dose dependent manner using quantitative dna binding assay also show cp 31398 increases significantly amount mutant p53 binds cognate dna bmax affinity kd dna compound however affect affinity kd value wild type p53 dna increases bmax slightly similar assay prima1 effect p53 core dna binding activity also show cp 31398 effect dna binding activity p53 homologs p63 p73
0.4980571.15308639.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references p53 tumor suppressor protein belongs superfamily transcription factors includes homologs p63 p73 p53 involved wide range cellular activities help ensure stability genome whereas p63 p73 involved ectodermal morphogenesis limb morphogenesis neurogenesis homeostatic control considered tumor suppressor genes 1 p53 involved dna damage repair cell cycle arrest apoptosis via transcriptional regulation genes involved activities direct interaction proteins 2 4 mutations inactivate p53 present 50 cancers indicative aggressive cancers difficult treat chemotherapy ionizing radiation 2 5
0.4980571.15308639.html.plaintext.txt	7	introduction top abstract introduction experimental procedures results discussion references p53 tumor suppressor protein belongs superfamily transcription factors includes homologs p63 p73 p53 involved wide range cellular activities help ensure stability genome whereas p63 p73 involved ectodermal morphogenesis limb morphogenesis neurogenesis homeostatic control considered tumor suppressor genes 1 p53 involved dna damage repair cell cycle arrest apoptosis via transcriptional regulation genes involved activities direct interaction proteins 2 4 mutations inactivate p53 present 50 cancers indicative aggressive cancers difficult treat chemotherapy ionizing radiation 2 5
0.4980571.15308639.html.plaintext.txt	8	majority inactivating mutations reside central core dna binding domain dbd1 p53 2 5 mutations divided two main classes dna contact mutants like r273h mutation alters residue involved contact dna structural mutants like r249s result structural changes p53 core domain 6 8 mutations affect function p53 distorting structure reducing thermal stability protein 6 8 alter ability p53 bind various p53 response elements variety genes hampering transcriptional regulation 9 addition mutations may alter p53 structure p53 longer induce apoptosis binding bclxl thereby inhibiting anti apoptotic function 10
0.4980571.15308639.html.plaintext.txt	9	majority inactivating mutations reside central core dna binding domain dbd1 p53 2 5 mutations divided two main classes dna contact mutants like r273h mutation alters residue involved contact dna structural mutants like r249s result structural changes p53 core domain 6 8 mutations affect function p53 distorting structure reducing thermal stability protein 6 8 alter ability p53 bind various p53 response elements variety genes hampering transcriptional regulation 9 addition mutations may alter p53 structure p53 longer induce apoptosis binding bclxl thereby inhibiting anti apoptotic function 10
0.4980571.15308639.html.plaintext.txt	10	one potential therapeutic approach cancer would restoration growth suppression activity mutant p53 several approaches tried ranging micro injection monoclonal antibody 421 c terminal peptide p53 small molecules 11 16 recently small molecules peptides cp 31398 prima1 cdb3 peptide shown effective restoring p53 function 17 25 prima1 cdb3 shown restore p53 dna binding activity vitro 18 21 whereas effects cp 31398 shown primarily cell based assays 17 22 25 cp 31398 prima1 shown reduce tumor size animal models 17 18 postulated two molecules perform similar tasks different mechanisms prima1 suggested work broadly restore p53 dna binding activity specific mechanism known 18 cp 31398 hand suggested stabilize p53 protectant thermal denaturation maintain monoclonal antibody 1620 epitope conformation newly synthesized p53 17 recently cp 31398 also shown stabilize wild type p53 cells inhibiting mdm2 mediated ubiquitination degradation 23 reports studies suggest cp 31398 interacts dna p53 vitro proposed act dna damaging agent 26 although shown effects cp 31398 p53 depend dna damage pathway 23 p53 independent cellular growth suppression effects higher concentrations lack demonstrated binding p53 protein raise confusion mechanism action 24 26 demonstrate cp 31398 promote mutant p53 bind p53 response elements vivo using chromatin immunoprecipitation chip assay addition using purified p53 core domain clearly demonstrate cp 31398 restore dna binding activity mutant p53 vitro also show cp 31398 effects dna binding activity p53 homologs p63 p73 contrast prima1 ineffective restoring dna binding activity isolated mutant p53 dna binding domain
0.4980571.15308639.html.plaintext.txt	11	one potential therapeutic approach cancer would restoration growth suppression activity mutant p53 several approaches tried ranging micro injection monoclonal antibody 421 c terminal peptide p53 small molecules 11 16 recently small molecules peptides cp 31398 prima1 cdb3 peptide shown effective restoring p53 function 17 25 prima1 cdb3 shown restore p53 dna binding activity vitro 18 21 whereas effects cp 31398 shown primarily cell based assays 17 22 25 cp 31398 prima1 shown reduce tumor size animal models 17 18 postulated two molecules perform similar tasks different mechanisms prima1 suggested work broadly restore p53 dna binding activity specific mechanism known 18 cp 31398 hand suggested stabilize p53 protectant thermal denaturation maintain monoclonal antibody 1620 epitope conformation newly synthesized p53 17 recently cp 31398 also shown stabilize wild type p53 cells inhibiting mdm2 mediated ubiquitination degradation 23 reports studies suggest cp 31398 interacts dna p53 vitro proposed act dna damaging agent 26 although shown effects cp 31398 p53 depend dna damage pathway 23 p53 independent cellular growth suppression effects higher concentrations lack demonstrated binding p53 protein raise confusion mechanism action 24 26 demonstrate cp 31398 promote mutant p53 bind p53 response elements vivo using chromatin immunoprecipitation chip assay addition using purified p53 core domain clearly demonstrate cp 31398 restore dna binding activity mutant p53 vitro also show cp 31398 effects dna binding activity p53 homologs p63 p73 contrast prima1 ineffective restoring dna binding activity isolated mutant p53 dna binding domain
0.4980571.15308639.html.plaintext.txt	12	experimental procedures top abstract introduction experimental procedures results discussion references cell culture widr cells contain r273h hotspot mutation grown dulbeccos modified eagles medium invitrogen supplemented 10 fetal bovine serum fbs penicillinstreptomycin h1299 cells grown rpmi medium invitrogen supplemented 10 fbs penicillin streptomycin skbr3 mtp53 cells grown mccoys medium invitrogen supplemented 10 fbs penicillinstreptomycin
0.4980571.15308639.html.plaintext.txt	13	experimental procedures top abstract introduction experimental procedures results discussion references cell culture widr cells contain r273h hotspot mutation grown dulbeccos modified eagles medium invitrogen supplemented 10 fetal bovine serum fbs penicillinstreptomycin h1299 cells grown rpmi medium invitrogen supplemented 10 fbs penicillin streptomycin skbr3 mtp53 cells grown mccoys medium invitrogen supplemented 10 fbs penicillinstreptomycin
0.4980571.15308639.html.plaintext.txt	14	cell transfection widr cells transfected either psuper psuper p53 gift dr j wischhusen 24 electroporation using bio rad genepulser
0.4980571.15308639.html.plaintext.txt	15	flow cytometry analysis h1299 p53 null skbr3 cells treated 24 h either 0 25 microgml cp 31398 24 h cells trypsinized fixed 70 methanol washed phosphate buffered saline fixed cells stained 50 microgml propidium iodide analyzed bd biosciences facs vantage instrument
0.4980571.15308639.html.plaintext.txt	16	cell lysis western blotting cell lysis widr cells carried using method foster et al 17 40 mg cell lysate run either 10 polyacrylamide gel p53 actin 4 20 polyacrylamide gradient gel p21 bax gels transferred nitrocellulose paper probed antibodies p53 do1 actin sigma bax santa cruz biotechnology p21 calbiochem
0.4980571.15308639.html.plaintext.txt	17	chromatin immunoprecipitation assay widr cells plated 107 cellsml treated 24 h either 1 me2so untreated 10 microgml cp 31398 1 me2so final chip assay performed described frank et al 27 immunoprecipitation performed presence absence p53 antibody do1 calbiochem pcr performed 10 microl dna 800 nm primers fluorescent probe 28 diluted final volume 30 microl accumulations fluorescence products monitored abi prism 7700 sequence detector primerprobe pairs used follows bax forward 5 tccccccgagaggtctttt 3 reverse 5 cggccccagttgaagttg 3 probe 6fam 5 tcagaaaacatgtcagctgccactcgg 3 p21 forward 5 tggagactctcagggtcgaaa 3 reverse 5 ggcgtttggagtggtagaaatc 3 probe 6fam 5 cggcggcagaccagcatgac 3 s9 forward 5 ggctccggaacaaacgtg 3 reverse 5 gcggccttgcggatct 3 probe 6fam 5 tctggagggtcaaatttaccctggcc 3
0.4980571.15308639.html.plaintext.txt	18	chromatin immunoprecipitation assay widr cells plated 107 cellsml treated 24 h either 1 me2so untreated 10 microgml cp 31398 1 me2so final chip assay performed described frank et al 27 immunoprecipitation performed presence absence p53 antibody do1 calbiochem pcr performed 10 microl dna 800 nm primers fluorescent probe 28 diluted final volume 30 microl accumulations fluorescence products monitored abi prism 7700 sequence detector primerprobe pairs used follows bax forward 5 tccccccgagaggtctttt 3 reverse 5 cggccccagttgaagttg 3 probe 6fam 5 tcagaaaacatgtcagctgccactcgg 3 p21 forward 5 tggagactctcagggtcgaaa 3 reverse 5 ggcgtttggagtggtagaaatc 3 probe 6fam 5 cggcggcagaccagcatgac 3 s9 forward 5 ggctccggaacaaacgtg 3 reverse 5 gcggccttgcggatct 3 probe 6fam 5 tctggagggtcaaatttaccctggcc 3
0.4980571.15308639.html.plaintext.txt	19	cloning expression purification dna binding domain p53 aa92 312 generated via pcr plasmid pctk53 isabella atencio canji inc using gene specific primers 5 atggatccatgtcatcttctgtcccttcc 3 5 taaagctttcaggtgttgttgggcagtgc 3 resulting product cloned bamhihindiii site plasmid pet42a novagen generate recombinant gst 5x fusion protein gst p53dbd wt mutant p53r249s generated method pctmr249s called pgst p53dbdr249s p53 mutant r273h generated mutagenesis pctk53 polymerase chain reaction subsequent mutant used generate mutated dna binding domain procedure wild type dna binding domain resulting pcr product also cloned bamhihindiii site pet42a generate recombinant gst 5x fusion protein gst p53dbdr273h dna binding domains p63 p73 generated polymerase chain reaction plasmids pcub 412 p63 pcub370 p73 gifts dr charles dicomo using gene specific primers 5 catgccatggcaagctccaccttcgatgctctc 3 5 cccaagctttcatgtcatctggataccatgtc 3 p63 5 catgccatggcaagctccaccttcgacaccatgtc 3 5 cccaagcttactcttcttcacaccggcacc 3 p73 resulting pcr products cloned similarly pet42a expressed gst 5x fusion protein gst p63dbd gst p73dbd
0.4980571.15308639.html.plaintext.txt	20	cloning expression purification dna binding domain p53 aa92 312 generated via pcr plasmid pctk53 isabella atencio canji inc using gene specific primers 5 atggatccatgtcatcttctgtcccttcc 3 5 taaagctttcaggtgttgttgggcagtgc 3 resulting product cloned bamhihindiii site plasmid pet42a novagen generate recombinant gst 5x fusion protein gst p53dbd wt mutant p53r249s generated method pctmr249s called pgst p53dbdr249s p53 mutant r273h generated mutagenesis pctk53 polymerase chain reaction subsequent mutant used generate mutated dna binding domain procedure wild type dna binding domain resulting pcr product also cloned bamhihindiii site pet42a generate recombinant gst 5x fusion protein gst p53dbdr273h dna binding domains p63 p73 generated polymerase chain reaction plasmids pcub 412 p63 pcub370 p73 gifts dr charles dicomo using gene specific primers 5 catgccatggcaagctccaccttcgatgctctc 3 5 cccaagctttcatgtcatctggataccatgtc 3 p63 5 catgccatggcaagctccaccttcgacaccatgtc 3 5 cccaagcttactcttcttcacaccggcacc 3 p73 resulting pcr products cloned similarly pet42a expressed gst 5x fusion protein gst p63dbd gst p73dbd
0.4980571.15308639.html.plaintext.txt	21	various plasmids transformed bl21de3 bacteria expression p53 containing plasmid transformed bacteria initially grown 30 degrees c reached a600 08 12 cooled 18 degrees c 1 h low temperature induced 04 mm isopropyl 1 thio d galactopyranoside sigma grown overnight 18 degrees c p63 p73 containing plasmid transformed bacteria initially grown 37 degrees c shifted 28 degrees c induced 04 mm isopropyl 1 thio d galactopyranoside cultures grown overnight 28 degrees c bacteria harvested centrifugation 10000 x g 10 min resuspended buffer containing 20 mm hepes ph 75 100 mm nacl 1 mm mercaptoethanol protease inhibitor tablets roche applied science resuspension triton x 100 sigma added 1 volume bacterial paste lysed sonication kontes lysate rotated 4 degrees c 30 min centrifuged 15000 x g 1 h lysate filtered whatman puradisc filter applied 20 ml q sepharose fast flow ap biotech column equilibrated 20 mm hepes ph 75 100 mm nacl 10 microm zncl2 flow first column wash collected applied hr1610 glutathione sepharose column ap biotech equilibrated buffer protein eluted single step 40 mm glutathione 50 mm hepes ph 83 100 mm nacl 10 microm zncl2 eluted peak applied mono hr55 column ap biotech equilibrated 20 mm hepes ph 79 100 mm nacl 10 microm zncl2 10 mm mercaptoethanol protein eluted salt gradient 01 1 m nacl buffer material pooled frozen 80 degrees c later use assays
0.4980571.15308639.html.plaintext.txt	22	various plasmids transformed bl21de3 bacteria expression p53 containing plasmid transformed bacteria initially grown 30 degrees c reached a600 08 12 cooled 18 degrees c 1 h low temperature induced 04 mm isopropyl 1 thio d galactopyranoside sigma grown overnight 18 degrees c p63 p73 containing plasmid transformed bacteria initially grown 37 degrees c shifted 28 degrees c induced 04 mm isopropyl 1 thio d galactopyranoside cultures grown overnight 28 degrees c bacteria harvested centrifugation 10000 x g 10 min resuspended buffer containing 20 mm hepes ph 75 100 mm nacl 1 mm mercaptoethanol protease inhibitor tablets roche applied science resuspension triton x 100 sigma added 1 volume bacterial paste lysed sonication kontes lysate rotated 4 degrees c 30 min centrifuged 15000 x g 1 h lysate filtered whatman puradisc filter applied 20 ml q sepharose fast flow ap biotech column equilibrated 20 mm hepes ph 75 100 mm nacl 10 microm zncl2 flow first column wash collected applied hr1610 glutathione sepharose column ap biotech equilibrated buffer protein eluted single step 40 mm glutathione 50 mm hepes ph 83 100 mm nacl 10 microm zncl2 eluted peak applied mono hr55 column ap biotech equilibrated 20 mm hepes ph 79 100 mm nacl 10 microm zncl2 10 mm mercaptoethanol protein eluted salt gradient 01 1 m nacl buffer material pooled frozen 80 degrees c later use assays
0.4980571.15308639.html.plaintext.txt	23	nuclear extract preparation nuclear extracts widr cells prepared according published method 28 cells grown 80 90 confluence 100 cm2 plates treated either 10 mgml cp 31398 final concentration 1 me2so 1 me2so 24 h cells washed 10 ml cold phosphate buffered saline scraped plate 10 ml phosphate buffered saline centrifuged 500 x g 4 degrees c 5 min volume packed pellet estimated added four volumes nonidet p 40 lysis buffer 50 mm tris hcl 10 mm nacl 5 mm mgcl2 05 nonidet p 40 protease inhibitor tablet pellet vortexed resuspended pellet left ice 5 min followed centrifugation 500 x g 5 min supernatant discarded pellet resuspended four volumes nonidet p 40 lysis buffer re centrifuged supernatant discarded packed nuclei volume estimated three volumes nuclear extraction buffer 20 mm hepes ph 79 05 m nacl 1 mm edta 20 glycerol 1mm dithiothreitol protease inhibitor added vortexing extract left 4 degrees c 30 min centrifuged 25 000 x g 30 min supernatant collected stored 80 degrees c use
0.4980571.15308639.html.plaintext.txt	24	nuclear extract preparation nuclear extracts widr cells prepared according published method 28 cells grown 80 90 confluence 100 cm2 plates treated either 10 mgml cp 31398 final concentration 1 me2so 1 me2so 24 h cells washed 10 ml cold phosphate buffered saline scraped plate 10 ml phosphate buffered saline centrifuged 500 x g 4 degrees c 5 min volume packed pellet estimated added four volumes nonidet p 40 lysis buffer 50 mm tris hcl 10 mm nacl 5 mm mgcl2 05 nonidet p 40 protease inhibitor tablet pellet vortexed resuspended pellet left ice 5 min followed centrifugation 500 x g 5 min supernatant discarded pellet resuspended four volumes nonidet p 40 lysis buffer re centrifuged supernatant discarded packed nuclei volume estimated three volumes nuclear extraction buffer 20 mm hepes ph 79 05 m nacl 1 mm edta 20 glycerol 1mm dithiothreitol protease inhibitor added vortexing extract left 4 degrees c 30 min centrifuged 25 000 x g 30 min supernatant collected stored 80 degrees c use
0.4980571.15308639.html.plaintext.txt	25	electrophoretic mobility shift assay emsa gel shift assay done nuclear extracts recombinant proteins protein added mixture containing 20 mm hepes ph 79 1 mm mgcl2 10 microm zncl2 5 glycerol 1 microgml bovine serum albumin 200 ng deoxyinosinedeoxycytodine 1 mm dithiothreitol 1 mm spermidine presence absence cp 31398 incubated 15 min room temperature 25 mer double stranded oligonucleotide containing p53 consensus dna binding sequence 5 agctggacatgcccgggcatgtcc 3 end labeled either 32p 33p added reaction mixture incubated additional 15 min mixture loaded onto 6 polyacrylamide gel tbe buffer 1x tbe 100 mm tris 90 mm boric acid 1 mm edta ph 84 run 150 v 05x tbe invitrogen gel dried exposed fuji fluorescent image analyzer image quantitated phosphorimaging software
0.4980571.15308639.html.plaintext.txt	26	electrophoretic mobility shift assay emsa gel shift assay done nuclear extracts recombinant proteins protein added mixture containing 20 mm hepes ph 79 1 mm mgcl2 10 microm zncl2 5 glycerol 1 microgml bovine serum albumin 200 ng deoxyinosinedeoxycytodine 1 mm dithiothreitol 1 mm spermidine presence absence cp 31398 incubated 15 min room temperature 25 mer double stranded oligonucleotide containing p53 consensus dna binding sequence 5 agctggacatgcccgggcatgtcc 3 end labeled either 32p 33p added reaction mixture incubated additional 15 min mixture loaded onto 6 polyacrylamide gel tbe buffer 1x tbe 100 mm tris 90 mm boric acid 1 mm edta ph 84 run 150 v 05x tbe invitrogen gel dried exposed fuji fluorescent image analyzer image quantitated phosphorimaging software
0.4980571.15308639.html.plaintext.txt	27	dna binding assay quantitate binding p53 either p53 consensus sequence bax promoter sequence 5 agcacaagcctgggcgtgggc 3 biotinylated double stranded oligonucleotides synthesized research genetics idt respectively first protein compound mixtures incubated reaction buffer 20 mm hepes ph 79 1 mm mgcl2 10 microm zncl2 1 microgml bovine serum albumin 200 ng deoxyinosinedeoxycytodine 1 mm dithiothreitol 01 nonidet p 40 10 min room temperature volume 45 microl 5 microl dna added mixture final volume 50 microl mixture incubated additional 10 min 167 fmol primary antibody anti penta monoclonal antibody qiagen 125 microg streptavidin magnetic beads dynal antibody buffer 20 mm hepes ph 79 1 mm mgcl2 10 microm zncl2 05 mm edta 01 nonidet p 40 added mixture shaken 1 h room temperature 1 h 333 fmol secondary goat anti mouse antibody jackson laboratories labeled ruthenium oxide igen added according manufacturers instructions mixture incubated shaking additional hour end incubation 75 microl antibody buffer added bring final volume 200 microl reaction mixture assayed either m8 analyzer m384 analyzer workstation igen using igen read stop buffer data analyzed using prism 30 software graph pad software
0.4980571.15308639.html.plaintext.txt	28	dna binding assay quantitate binding p53 either p53 consensus sequence bax promoter sequence 5 agcacaagcctgggcgtgggc 3 biotinylated double stranded oligonucleotides synthesized research genetics idt respectively first protein compound mixtures incubated reaction buffer 20 mm hepes ph 79 1 mm mgcl2 10 microm zncl2 1 microgml bovine serum albumin 200 ng deoxyinosinedeoxycytodine 1 mm dithiothreitol 01 nonidet p 40 10 min room temperature volume 45 microl 5 microl dna added mixture final volume 50 microl mixture incubated additional 10 min 167 fmol primary antibody anti penta monoclonal antibody qiagen 125 microg streptavidin magnetic beads dynal antibody buffer 20 mm hepes ph 79 1 mm mgcl2 10 microm zncl2 05 mm edta 01 nonidet p 40 added mixture shaken 1 h room temperature 1 h 333 fmol secondary goat anti mouse antibody jackson laboratories labeled ruthenium oxide igen added according manufacturers instructions mixture incubated shaking additional hour end incubation 75 microl antibody buffer added bring final volume 200 microl reaction mixture assayed either m8 analyzer m384 analyzer workstation igen using igen read stop buffer data analyzed using prism 30 software graph pad software
0.4980571.15308639.html.plaintext.txt	29	results top abstract introduction experimental procedures results discussion references cp 31398 restores p53 activity mutant p53 vivo evaluate effects cp 31398 restoring wild type p53 function mutant p53 tested see compound could restore p53 mediated apoptosis cells harboring mutant p53 treated h1299 cells p53 null cells skbr3 tumor cells p53 mutation r175h without 25 microgml cp 31398 assayed apoptosis via fluorescence activated cell sorting analysis fig 1a apoptosis seen skbr3 cells treated 25 microgml cp 31398 h1299 cells show apoptosis effect treated cp 31398 similar untreated h1299 cells previous reports 22 25 shown cp 31398 induce p53 mediated apoptosis mutant p53 tumor cells maximal effectiveness 10 microgml concentration used subsequent experiments
0.4980571.15308639.html.plaintext.txt	30	results top abstract introduction experimental procedures results discussion references cp 31398 restores p53 activity mutant p53 vivo evaluate effects cp 31398 restoring wild type p53 function mutant p53 tested see compound could restore p53 mediated apoptosis cells harboring mutant p53 treated h1299 cells p53 null cells skbr3 tumor cells p53 mutation r175h without 25 microgml cp 31398 assayed apoptosis via fluorescence activated cell sorting analysis fig 1a apoptosis seen skbr3 cells treated 25 microgml cp 31398 h1299 cells show apoptosis effect treated cp 31398 similar untreated h1299 cells previous reports 22 25 shown cp 31398 induce p53 mediated apoptosis mutant p53 tumor cells maximal effectiveness 10 microgml concentration used subsequent experiments
0.4980571.15308639.html.plaintext.txt	31	view larger version 27k fig 1 vivo effects cp 31398 fluorescence activated cell sorting analysis h1299 cells p53 null skbr 3 cells mutant p53 r175h treated 24 h either 0 25 microgml cp 31398 stained propidium iodide assayed flow cytometry pre g1 cells b dna binding activity nuclear extract widr cells treated 0 10 microgml cp 31398 1 microg nuclear extract incubated 33p labled p53 consensus oligonucleotide presence absence unlabeled p53 consensuses oligonucleotide subjected electrophoresis 6 tbe gel c western blotting widr cell lysates treated 0 10 microgml cp 31398 using anti p53 anti actin anti bax anti p21 antibodies cells untransfected transfected either psuper psuper p53 dna plasmids d quantitative pcr p21 bax s9 ribosomal promoter chip assay widr cells treated 0 10 microgml cp 31398 processed described experimental procedures assay performed using antibody recognizes p53 do1 closed bars antibody control open bars
0.4980571.15308639.html.plaintext.txt	32	effect cp 31398 seems dependent upon presence p53 treated widr cells colon tumor cell line harbors r273h hotspot mutation either 0 10 microgml cp 31398 24 h made nuclear extract used electrophoretic mobility shift assay emsa using consensus p53 dna binding site fig 1b see cp 31398 could restore sequence specific binding mutant p53 treatment cp 31398 causes shift labeled probe competed away unlabeled p53 consensus oligonucleotide cp 31398 treated nuclear extract whereas band occurs untreated extract indicating compound capable inducing mutant p53 bind p53 specific dna demonstrate effect cp 31398 specific p53 responsive genes treated widr cells 0 10 microgml cp 31398 24 h made cell lysate western blotted p53 bax p21 actin treatment cp 31398 alter level either p53 actin significantly increased level p21 bax fig 1c addition transiently transfected widr cells either psuper p53 encodes p53 sirna control empty vector psuper treated transfected cells either 0 10 microgml cp 31398 24 h made cell lysate western blotted p53 actin p21 bax cells transfected psuper behaved similarly untransfected widr cells fig 1c level p53 actin unaltered significant increase levels p21 bax presence cp 31398 psuper p53 transfected cells actin levels unaffected p53 levels significantly decreased without cp 31398 fig 1c addition induction p21 bax psuper p53 transfected cells indicating effects cp 31398 dependent presence p53
0.4980571.15308639.html.plaintext.txt	33	effect cp 31398 seems dependent upon presence p53 treated widr cells colon tumor cell line harbors r273h hotspot mutation either 0 10 microgml cp 31398 24 h made nuclear extract used electrophoretic mobility shift assay emsa using consensus p53 dna binding site fig 1b see cp 31398 could restore sequence specific binding mutant p53 treatment cp 31398 causes shift labeled probe competed away unlabeled p53 consensus oligonucleotide cp 31398 treated nuclear extract whereas band occurs untreated extract indicating compound capable inducing mutant p53 bind p53 specific dna demonstrate effect cp 31398 specific p53 responsive genes treated widr cells 0 10 microgml cp 31398 24 h made cell lysate western blotted p53 bax p21 actin treatment cp 31398 alter level either p53 actin significantly increased level p21 bax fig 1c addition transiently transfected widr cells either psuper p53 encodes p53 sirna control empty vector psuper treated transfected cells either 0 10 microgml cp 31398 24 h made cell lysate western blotted p53 actin p21 bax cells transfected psuper behaved similarly untransfected widr cells fig 1c level p53 actin unaltered significant increase levels p21 bax presence cp 31398 psuper p53 transfected cells actin levels unaffected p53 levels significantly decreased without cp 31398 fig 1c addition induction p21 bax psuper p53 transfected cells indicating effects cp 31398 dependent presence p53
0.4980571.15308639.html.plaintext.txt	34	prove induction bax p21 due promoter binding mutant p53 reactivated cp 31398 vivo performed chromatin immunoprecipitation chip assay widr cells treated either 0 10 microgml cp 31398 24 h fig 1d treatment cp 31398 specifically increased amount p21 bax promoter dna immunoprecipitated p53 specific antibody do1 whereas increase amount ribosomal protein s9 promoter dna whose promoter p53 response element indicates effect cp 31398 specific p53 promotes reactivation full length mutant p53 functional wild type p53 fully capable binding dna vivo
0.4980571.15308639.html.plaintext.txt	35	characterization cp 31398 effects p53 vitro given cp 31398 appears capable restoring dna binding activity full length mutant p53 vivo wanted see cp 31398 would equally effective system using purified protein free potential cellular contaminants previous reports 19 indicated cp 31398 protects dna binding domain p53 thermo denaturation vitro cloned expressed dna binding domain wild type mutant p53 gst fusion proteins fig 2a see recombinant material capable binding dna performed emsa using wild type p53 dna binding domain gst p53dbd wt fig 2b wild type protein bound labeled double stranded oligonucleotide containing p53 consensus binding sequence binding could competed away excess unlabeled p53 specific oligonucleotide excess unlabeled nonspecific oligonucleotide wild type protein doublet normally seen slower migrating band corresponds gst dimer protein also observed mutant protein faster migrating lower band monomeric gstp53 similar effects gst fusion proteins previously observed 29
0.4980571.15308639.html.plaintext.txt	36	characterization cp 31398 effects p53 vitro given cp 31398 appears capable restoring dna binding activity full length mutant p53 vivo wanted see cp 31398 would equally effective system using purified protein free potential cellular contaminants previous reports 19 indicated cp 31398 protects dna binding domain p53 thermo denaturation vitro cloned expressed dna binding domain wild type mutant p53 gst fusion proteins fig 2a see recombinant material capable binding dna performed emsa using wild type p53 dna binding domain gst p53dbd wt fig 2b wild type protein bound labeled double stranded oligonucleotide containing p53 consensus binding sequence binding could competed away excess unlabeled p53 specific oligonucleotide excess unlabeled nonspecific oligonucleotide wild type protein doublet normally seen slower migrating band corresponds gst dimer protein also observed mutant protein faster migrating lower band monomeric gstp53 similar effects gst fusion proteins previously observed 29
0.4980571.15308639.html.plaintext.txt	37	view larger version 46k fig 2 purification gst p53 wt bacteria lane 1 molecular weight markers lane 2 whole cell lysate lane 3 supernatant 15000 x g centrifugation lane 4 flow q sepharose fast flow column lane 5 gst sepharose column peak lane 6 mono column flow lane 7 first peak mono column lane 8 second peak mono column b emsa analysis wild type protein using competitive non competitive oligonucleotides compete specific binding labeled oligonucleotide c emsa analysis r273h recombinant p53 presence p53 c terminal peptide cp 31398 using either p53 consensus dna binding site oligonucleotide altered p53 consensus dna binding site oligonucleotide d concentration dependent effect cp 31398 emsa using mutant r273h gstp53 dna binding domain protein
0.4980571.15308639.html.plaintext.txt	38	see effect mutant p53 protein tested binding mutant r273h gst p53 dna binding domain protein consensus p53 dna binding site oligonucleotide altered p53 dna binding site fig 2c binding measured presence absence 500 nm c terminal peptide 500 nm cp 31398 peptide cp 31398 caused specific binding consensus oligonucleotide whereas binding seen altered oligonucleotide absence compound peptide next titrated various concentrations cp 31398 mutant protein fig 2d binding protein labeled oligonucleotide low absence compound compound increased 1 microm increase binding activity demonstrating cp 31398 dose dependently restore dna binding activity mutant p53 core domain vitro system apparent difference concentration used vivo concentration used vitro possibly due unstable nature cp 31398 26 stored solution room temperature extended period
0.4980571.15308639.html.plaintext.txt	39	quantitation cp 31398 effects p53 vitro quantitate effects cp 31398 p53 developed quantitative dna binding assay based upon igen electro chemiluminescence detection system captures biotinylated oligonucleotide streptavidin coated magnetic bead protein bound captured oligonucleotide detected using antibody specific protein followed secondary antibody labeled ruthenium advantage electro chemiluminescent system significantly sensitive enzyme linked immunosorbent assay capable generating robust signal helps detect weak interactions
0.4980571.15308639.html.plaintext.txt	40	quantitation cp 31398 effects p53 vitro quantitate effects cp 31398 p53 developed quantitative dna binding assay based upon igen electro chemiluminescence detection system captures biotinylated oligonucleotide streptavidin coated magnetic bead protein bound captured oligonucleotide detected using antibody specific protein followed secondary antibody labeled ruthenium advantage electro chemiluminescent system significantly sensitive enzyme linked immunosorbent assay capable generating robust signal helps detect weak interactions
0.4980571.15308639.html.plaintext.txt	41	assay validated using gst p53dbd wt biotinylated oligonucleotide containing p53 consensus binding sequence fig 3a amount dna varied 0 5 nm either 25 5 nm protein used show specificity assay excess unlabeled oligonucleotide used compete biotinylated oligonucleotide gst p53dbd wt showed saturable dna binding 25 5 nm could competed away unlabeled oligonucleotide cp 31398 discovered enzyme linked immunosorbent assay based conformation stabilization assay using recombinant wild type p53 dna binding domain 17 wanted see cp 31398 effect dna binding activity wild type p53 core protein assayed wild type p53 5 nm protein absence presence 500 nm cp 31398 fig 3b compound effect kd protein dna 128 plus minus 027 130 plus minus 029 respectively increases bmax 129004 plus minus 9302 191645 plus minus 14161 respectively suggesting compound increases number protein molecules bound dna
0.4980571.15308639.html.plaintext.txt	42	view larger version 17k fig 3 effect competitive dna wild type p53 dna binding domain protein dna binding assay dna binding assay conducted described either 25 5 nm protein increasing concentration dna presence absence 833 nm unlabeled oligonucleotide containing consensus p53 binding site b effect compound wt p53 dna binding assay performed 10 nm recombinant wild type p53 dna binding domain increasing concentration biotinylated oligonucleotide presence absence 500 nm cp 31398
0.4980571.15308639.html.plaintext.txt	43	next evaluated cp 31398 similar conditions two p53 mutants r273h dna contact point mutant r249s structural mutant fig 4 b mutants showed little binding absence compound presence 500 nm cp 31398 mutants showed dramatic increase dna binding bmax r273h 8890 plus minus 1242 alone versus 108047 plus minus 8309 cp 31398 r249s 8031 plus minus 739 alone versus 133187 plus minus 12614 cp 31398 increasing severalfold case r273h mutant binding affinity kd 47 plus minus 11 273 plus minus 040 increased less 2 fold whereas r249s mutant saw increase 6 fold kd 398 plus minus 061 alone versus 065 plus minus 019 cp 31398
0.4980571.15308639.html.plaintext.txt	44	view larger version 17k fig 4 effects cp 31398 mutant r273h r249s b dna binding assay performed 10 nm recombinant mutant p53 dna binding domain increasing concentrations biotinylated p53 consensus oligonucleotide presence absence 500 nm cp 31398
0.4980571.15308639.html.plaintext.txt	45	see effect specific p53 consensus dna binding sequence p53 dna binding site bax promoter substituted consensus site assay p53 binding site bax promoter referred bax site reported lower affinity p53 binds p53 much lesser extent consensus binding sequence 9 29 first confirmed effect cp 31398 wild type protein using bax site fig 5a consensus dna affinity wild type p53 kd bax site change presence 500 nm cp 31398 1062 plus minus 2727 alone versus 1045 plus minus 1871 cp 31398 bmax 224602 plus minus 19026 alone versus 353797 plus minus 26649 cp 31398 assayed r273h mutant protein bax site fig 5b found bmax changed severalfold 5072 plus minus 8705 alone versus 33115 plus minus 1838 cp 31398 affinity mutant protein bax site increased 5 fold kd 5764 plus minus 1395 alone versus 8120 plus minus 1158 cp 31398 contrary prima1 also reactivates mutant p53 18 effect kd bmax binding assay kd 5356 plus minus 1008 bmax 4121 plus minus 5397 indicating prima1 compound may act dna binding domain mutant p53 may function different mechanism
0.4980571.15308639.html.plaintext.txt	46	see effect specific p53 consensus dna binding sequence p53 dna binding site bax promoter substituted consensus site assay p53 binding site bax promoter referred bax site reported lower affinity p53 binds p53 much lesser extent consensus binding sequence 9 29 first confirmed effect cp 31398 wild type protein using bax site fig 5a consensus dna affinity wild type p53 kd bax site change presence 500 nm cp 31398 1062 plus minus 2727 alone versus 1045 plus minus 1871 cp 31398 bmax 224602 plus minus 19026 alone versus 353797 plus minus 26649 cp 31398 assayed r273h mutant protein bax site fig 5b found bmax changed severalfold 5072 plus minus 8705 alone versus 33115 plus minus 1838 cp 31398 affinity mutant protein bax site increased 5 fold kd 5764 plus minus 1395 alone versus 8120 plus minus 1158 cp 31398 contrary prima1 also reactivates mutant p53 18 effect kd bmax binding assay kd 5356 plus minus 1008 bmax 4121 plus minus 5397 indicating prima1 compound may act dna binding domain mutant p53 may function different mechanism
0.4980571.15308639.html.plaintext.txt	47	view larger version 21k fig 5 effects cp 31398 either wild type p53 mutant p53 r273h b using p53 binding oligonucleotide bax promoter bax site dna binding assay performed 10 nm recombinant protein increasing concentrations biotinylated oligonucleotide presence absence 500 nm cp 31398 wild type p53 dna binding domain presence absence either 500 nm cp 31398 prima compound mutant p53 dna binding domain protein r273h b
0.4980571.15308639.html.plaintext.txt	48	effects cp 31398 p63 p73 one potential issue cp 31398 tends cytotoxic doses 15 microgml p53 independent manner 17 23 25 part cytotoxicity could due effects p53 homologs p63 p73 see cp 31398 effect p63 p73 cloned expressed dna binding domains proteins gst fusions 29 fig 6a confirmed activity emsa fig 6b evaluated effects cp 31398 using bax site binding assay along wild type p53 comparison also tested peptide cdb3 similar concentrations cp 31398 see would effect p63 p73 similar reported effects p53 19 21 case p53 fig 7a cp 31398 cdb3 altered bmax table kd wild type p53 binding bax dna p63 p73 fig 7 b c increase bmax presence cp 31398 cdb3 reactions appeared similar reactions done absence cp 31398 table suggests cp 31398 cdb3 interact either p63 p73 dna binding domain thus excluding role activation p53 homologs cytotoxicity cp 31398
0.4980571.15308639.html.plaintext.txt	49	effects cp 31398 p63 p73 one potential issue cp 31398 tends cytotoxic doses 15 microgml p53 independent manner 17 23 25 part cytotoxicity could due effects p53 homologs p63 p73 see cp 31398 effect p63 p73 cloned expressed dna binding domains proteins gst fusions 29 fig 6a confirmed activity emsa fig 6b evaluated effects cp 31398 using bax site binding assay along wild type p53 comparison also tested peptide cdb3 similar concentrations cp 31398 see would effect p63 p73 similar reported effects p53 19 21 case p53 fig 7a cp 31398 cdb3 altered bmax table kd wild type p53 binding bax dna p63 p73 fig 7 b c increase bmax presence cp 31398 cdb3 reactions appeared similar reactions done absence cp 31398 table suggests cp 31398 cdb3 interact either p63 p73 dna binding domain thus excluding role activation p53 homologs cytotoxicity cp 31398
0.4980571.15308639.html.plaintext.txt	50	view larger version 41k fig 6 purification gst fused dna binding domains p53 homologs lane 1 whole cell lysate gst p73 dna binding domain lane 2 supernatant 15000 x g centrifugation lane 3 gst peak p73 dna binding domain lane 4 gst sepharose peak p63 dna binding protein lane 5 purified gst p53 dna binding domain wt standard b activity gst p73 gst p63 dna binding domain proteins emsa using competitive c non competitive nc oligonucleotides compete binding proteins labeled oligonucleotide
0.4980571.15308639.html.plaintext.txt	51	view larger version 19k fig 7 effects cp 31398 cdb 3 5 microm binding gst p53dbd gst p63dbd b gst p73dbd c compound peptide added 10 nm protein 10 min room temperature prior addition various concentration dna mixture incubated 10 min room temperature followed addition primary antibody magnetic beads incubated 1 h secondary antibody added mixture incubated room temperature assayed dna binding
0.4980571.15308639.html.plaintext.txt	52	view table table effect cp 31398 cdb3 p63 p73 bax dna
0.4980571.15308639.html.plaintext.txt	53	discussion top abstract introduction experimental procedures results discussion references restoration wild type function mutant p53 recently become viable interesting approach developing cancer therapeutics understood mutational defects p53 protein 2 4 recently several compounds peptides reported restore growth suppression functions mutant p53 vitro two compounds cp 31398 prima1 effective reducing tumor size animal models 17 18 cp 31398 discovered random screen small molecules ability protect wild type conformation monoclonal antibody 1620 epitope p53 core domain thermal denaturation 17 suggested p53 dynamic protein equilibrium exists conformations mutation shifts equilibrium toward inactive conformation promoting thermal denaturation physiological temperature 6 8 20 oncogenic mutations change conformation core domain thus abolishing binding cognate dna molecules 31 lack evidence direct interaction cp 31398 p53 core domain controversy potential mechanism action promising class molecules prompted us biochemically characterize effects dna binding activity wild type mutant p53 core domain
0.4980571.15308639.html.plaintext.txt	54	discussion top abstract introduction experimental procedures results discussion references restoration wild type function mutant p53 recently become viable interesting approach developing cancer therapeutics understood mutational defects p53 protein 2 4 recently several compounds peptides reported restore growth suppression functions mutant p53 vitro two compounds cp 31398 prima1 effective reducing tumor size animal models 17 18 cp 31398 discovered random screen small molecules ability protect wild type conformation monoclonal antibody 1620 epitope p53 core domain thermal denaturation 17 suggested p53 dynamic protein equilibrium exists conformations mutation shifts equilibrium toward inactive conformation promoting thermal denaturation physiological temperature 6 8 20 oncogenic mutations change conformation core domain thus abolishing binding cognate dna molecules 31 lack evidence direct interaction cp 31398 p53 core domain controversy potential mechanism action promising class molecules prompted us biochemically characterize effects dna binding activity wild type mutant p53 core domain
0.4980571.15308639.html.plaintext.txt	55	show cp 31398 promote p53 mediated apoptosis induce expression p53 specific genes p21 bax cells mutant p53 similar fashion reported 22 25 also show cp 31398 ability restore sequence specific dna binding activity mutant p53 compound treated nuclear extract vitro manner similar previous reports 25 addition using chip assay demonstrate cp 31398 promote binding mutant p53 response elements p53 regulated genes cells binding p53 p21 bax promoter failure p53 bind s9 ribosomal protein promoter indicate cp 31398 interacts specifically p53 dna previously suggested 26 cp 31398 functionally restore mutant p53 make capable acting like wild type p53 interact high p21 low bax affinity promoters 9 30 relatively high concentrations cp 31398 needed cellular experiments reported elsewhere 22 26 indicative possible unstable nature cp 31398 26
0.4980571.15308639.html.plaintext.txt	56	show cp 31398 promote p53 mediated apoptosis induce expression p53 specific genes p21 bax cells mutant p53 similar fashion reported 22 25 also show cp 31398 ability restore sequence specific dna binding activity mutant p53 compound treated nuclear extract vitro manner similar previous reports 25 addition using chip assay demonstrate cp 31398 promote binding mutant p53 response elements p53 regulated genes cells binding p53 p21 bax promoter failure p53 bind s9 ribosomal protein promoter indicate cp 31398 interacts specifically p53 dna previously suggested 26 cp 31398 functionally restore mutant p53 make capable acting like wild type p53 interact high p21 low bax affinity promoters 9 30 relatively high concentrations cp 31398 needed cellular experiments reported elsewhere 22 26 indicative possible unstable nature cp 31398 26
0.4980571.15308639.html.plaintext.txt	57	studies purified p53 dna binding domain wild type mutant p53 clearly show cp 31398 restores dna binding activity mutant p53 core domain increasing bmax kd values reaction interestingly compound stimulates dna binding activity wild type protein without effects affinity dna wild type protein bmax increased 15 fold kd remains presence compound whereas r273h r249s mutants bmax greatly increased kd 10 fold indicates cp 31398 acts non competitive agonist binding proteins alters rate reaction amount protein capable binding dna affecting affinity protein dna result suggests allosteric mechanism binding compound site away protein dna interface cause protein placed conformation capable binding dna 32 cdb3 cp 31398 affects mutant protein binding dna similar way bringing kd mutant p53 dna similar level wild type variations effect mainly due affinity individual mutants particular p53 dna binding site r273h maintains nearly wild type conformation ability transactivate consensus p53 dna binding site much reduced ability transactivate bind sites like bax much lower affinity p53 consensus sequence 7 9
0.4980571.15308639.html.plaintext.txt	58	studies purified p53 dna binding domain wild type mutant p53 clearly show cp 31398 restores dna binding activity mutant p53 core domain increasing bmax kd values reaction interestingly compound stimulates dna binding activity wild type protein without effects affinity dna wild type protein bmax increased 15 fold kd remains presence compound whereas r273h r249s mutants bmax greatly increased kd 10 fold indicates cp 31398 acts non competitive agonist binding proteins alters rate reaction amount protein capable binding dna affecting affinity protein dna result suggests allosteric mechanism binding compound site away protein dna interface cause protein placed conformation capable binding dna 32 cdb3 cp 31398 affects mutant protein binding dna similar way bringing kd mutant p53 dna similar level wild type variations effect mainly due affinity individual mutants particular p53 dna binding site r273h maintains nearly wild type conformation ability transactivate consensus p53 dna binding site much reduced ability transactivate bind sites like bax much lower affinity p53 consensus sequence 7 9
0.4980571.15308639.html.plaintext.txt	59	non competitive allosteric activation fits model suggested freidler et al 20 cp 31398 like cdb3 peptide functions chaperone enables p53 fold active conformation capable binding dna occurs dna binding source speculation freidlers model 20 compound displaced structural rearrangement p53 undergoes binds dna recent work freidler et al 33 shown cdb3 binds wild type mutant r249s r273h manner site away protein dna interface away site distorted r249s mutation thus cdb3 exerting effect via long range conformational change binding site different natural ligand dna allosteric mechanism
0.4980571.15308639.html.plaintext.txt	60	non competitive allosteric activation fits model suggested freidler et al 20 cp 31398 like cdb3 peptide functions chaperone enables p53 fold active conformation capable binding dna occurs dna binding source speculation freidlers model 20 compound displaced structural rearrangement p53 undergoes binds dna recent work freidler et al 33 shown cdb3 binds wild type mutant r249s r273h manner site away protein dna interface away site distorted r249s mutation thus cdb3 exerting effect via long range conformational change binding site different natural ligand dna allosteric mechanism
0.4980571.15308639.html.plaintext.txt	61	addition cp 31398 shown inhibit mdm2 mediated ubiquitination p53 possibly blocking mdm2 interaction core domain p53 23 25 binding mdm2 n terminus p53 causes conformational rearrangement p53 allows access core domain cp 31398 may prevent rearrangements addition maintenance wild type conformation may promote binding p53 core domain bclxl 10
0.4980571.15308639.html.plaintext.txt	62	addition cp 31398 shown inhibit mdm2 mediated ubiquitination p53 possibly blocking mdm2 interaction core domain p53 23 25 binding mdm2 n terminus p53 causes conformational rearrangement p53 allows access core domain cp 31398 may prevent rearrangements addition maintenance wild type conformation may promote binding p53 core domain bclxl 10
0.4980571.15308639.html.plaintext.txt	63	major difference cp 31398 cdb3 prima1 prima1 seems bind p53 core domain assay prima1 fails stimulate dna binding dna binding domain others reported prima1 works full length protein fails interact dna binding domain 18 21 recent report 34 showed prima1 could induce apoptosis absence new protein synthesis suggests compounds alter active conformation p53 turn wild type protein may also exert influence making p53 capable interacting bclxl bh3 domain containing proteins help mediate mitochondrial depolarization 10 34 35 given nature p53 likely binding somewhere dna binding domain could exert effects dna binding domain suggested binding occurs outside dna binding domain tetramerization domain 18 one possible effect could promote stabilize p53 tetramers conformation sufficient protein function dna binding mitochondrial depolarization
0.4980571.15308639.html.plaintext.txt	64	major difference cp 31398 cdb3 prima1 prima1 seems bind p53 core domain assay prima1 fails stimulate dna binding dna binding domain others reported prima1 works full length protein fails interact dna binding domain 18 21 recent report 34 showed prima1 could induce apoptosis absence new protein synthesis suggests compounds alter active conformation p53 turn wild type protein may also exert influence making p53 capable interacting bclxl bh3 domain containing proteins help mediate mitochondrial depolarization 10 34 35 given nature p53 likely binding somewhere dna binding domain could exert effects dna binding domain suggested binding occurs outside dna binding domain tetramerization domain 18 one possible effect could promote stabilize p53 tetramers conformation sufficient protein function dna binding mitochondrial depolarization
0.4980571.15308639.html.plaintext.txt	65	cp 31398 cdb3 appear specific p53 p63 p73 p63 p73 homologous dna binding domains p53 amino acid differences proteins 29 comparison models p53 dna binding domain p63 dna binding domain indicates p63 thermostable hydrophobic core making protein significantly stable p53 29 apparent fact p63 p73 protein expressed soluble form relatively high temperatures compared p53 29 interestingly second site suppressor mutations restore dna binding activity oncogenic mutants p53 36 38 recently crystal structure quadruple mutant p53 provides explanation loss hydrogen bonds v143a temperature sensitive mutant compensated second site mutation n268d suppressor mutation n268d increases overall stability oncogenic mutant also induces local change protein initially caused loss two methyl groups v143a 38 possible mechanism compounds like cp 31398 cdb3 interaction p53 core may provide energetically favorable compensatory hydrogen bonds increase overall stability many oncogenic mutants restore wild type function given hydrophobic cores p63 p73 stable may site compounds bind act give additional stability
0.4980571.15308639.html.plaintext.txt	66	cp 31398 cdb3 appear specific p53 p63 p73 p63 p73 homologous dna binding domains p53 amino acid differences proteins 29 comparison models p53 dna binding domain p63 dna binding domain indicates p63 thermostable hydrophobic core making protein significantly stable p53 29 apparent fact p63 p73 protein expressed soluble form relatively high temperatures compared p53 29 interestingly second site suppressor mutations restore dna binding activity oncogenic mutants p53 36 38 recently crystal structure quadruple mutant p53 provides explanation loss hydrogen bonds v143a temperature sensitive mutant compensated second site mutation n268d suppressor mutation n268d increases overall stability oncogenic mutant also induces local change protein initially caused loss two methyl groups v143a 38 possible mechanism compounds like cp 31398 cdb3 interaction p53 core may provide energetically favorable compensatory hydrogen bonds increase overall stability many oncogenic mutants restore wild type function given hydrophobic cores p63 p73 stable may site compounds bind act give additional stability
0.4980571.15308639.html.plaintext.txt	67	shown cp 31398 affect dna binding activity wild type mutant p53 vivo vitro also observed dna binding restored dna contact mutant r273h structural mutant r249s compound effect pronounced structural mutant r249s effects seem specific p53 cp 31398 cdb3 affect activity p63 p73 developing dna binding assay cp 31398 mutant p53 potentially look compounds perform similar activities cp 31398 cdb3 liabilities side effects molecules
0.4980571.15308639.html.plaintext.txt	68	shown cp 31398 affect dna binding activity wild type mutant p53 vivo vitro also observed dna binding restored dna contact mutant r273h structural mutant r249s compound effect pronounced structural mutant r249s effects seem specific p53 cp 31398 cdb3 affect activity p63 p73 developing dna binding assay cp 31398 mutant p53 potentially look compounds perform similar activities cp 31398 cdb3 liabilities side effects molecules
0.4980571.15308639.html.plaintext.txt	69	footnotes costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.4980571.15308639.html.plaintext.txt	70	footnotes costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.4980571.15308639.html.plaintext.txt	71	correspondence addressed schering plough research institute 2015 galloping hill rd keniworth nj 07033 tel 908 740 3033 fax 908 740 3918 e mail bimalendudasmahapatraatspcorpcom u d
0.4980571.15308639.html.plaintext.txt	72	1 abbreviations used dbd dna binding domain chip chromatin immunoprecipitation emsa electrophoretic mobility shift assay gst glutathione transferase 6fam 6 carboxy fluorescein
0.4980571.15308639.html.plaintext.txt	73	acknowledgments acknowledge dr alan mallams randall rossman synthesis cp 31398 thank dr rumin zhang james durkin synthesis p53 c terminal peptide cdb3 dr julie jia help developing dna binding assay drs w robert bishop jonathon pachter v girijavallabhan support helpful discussions thank drs charles dicomo isabella atencio jorg wischhusen yaolin wang gifts various plasmids used work addition thank asra mizra technical help chip assay
0.4980571.15308639.html.plaintext.txt	74	acknowledgments acknowledge dr alan mallams randall rossman synthesis cp 31398 thank dr rumin zhang james durkin synthesis p53 c terminal peptide cdb3 dr julie jia help developing dna binding assay drs w robert bishop jonathon pachter v girijavallabhan support helpful discussions thank drs charles dicomo isabella atencio jorg wischhusen yaolin wang gifts various plasmids used work addition thank asra mizra technical help chip assay
0.4980571.15308639.html.plaintext.txt	75	references top abstract introduction experimental procedures results discussion references bernard j douc rasy ahomadegbe j c 2003 human mutat 2 182 191crossref lane d p hupp r 2003 drug discov today 8 347 355crossrefmedline order article via infotrieve vousden k 2000 cell 103 691 694medline order article via infotrieve willis c chen x 2002 curr mol med 2 329 345medline order article via infotrieve bullock n fersht r 2001 nat rev cancer 1 68 76crossrefmedline order article via infotrieve wong k b dedecker b freund v proctor m r bycroft m fersht r 1999 proc nat acad sci u 96 8348 8442abstractfree full text bullock r henckel j dedecker b johnson c m nikolova p v proctor m r lane d p fersht r 1997 proc nat acad sci u 94 14338 14343abstractfree full text bullock n henckel j fersht r 2000 oncogene 19 1245 1256crossrefmedline order article via infotrieve nicholls c d mclure k g shields m lee p w k 2002 j biol chem 277 12937 12945abstractfree full text mihara m erster zaika petrenko o chittenden pancoska p moll u m 2003 mol cell 11 577 590medline order article via infotrieve abarzua p losardo j e gubler m l spathis r lu y felix neri 1996 oncogene 13 2477 2482medline order article via infotrieve abarzua p losardo j e gubler m l neri 1995 cancer res 55 3490 3494abstract halazonetis d davis l j kandil n 1993 embo j 12 1021 1028abstract wieczorek m waterman j l f waterman j f halazonetis d 1996 nat med 2 1143 1146medline order article via infotrieve selinova g ryabchenko l jansson e iotsova v wiman k g 1999 mol cell biol 19 3395 3402abstractfree full text peng y li c sebti chen j 2003 oncogene 22 4478 4487crossrefmedline order article via infotrieve foster b coffey h morin m j rastinejad f 1999 science 286 2507 2510abstractfree full text bykov v j n issaeva n shilov hultcrantz m pugacheva e chumakov p bergman j wiman k g selinova g 2002 nat med 8 282 288crossrefmedline order article via infotrieve friedler hansson l o veprintsev d b freund m v rippin m nikolova p v proctor m r rudiger fersht r 2002 proc nat acad sci u 99 937 942abstractfree full text freidler verprintsev d b hansson l fersht r 2003 j biol chem 278 24108 24112abstractfree full text issaeva n friedler bozko p wiman k g fersht r selivanova g 2003 proc nat acad sci u 100 13303 13307abstractfree full text luu y bush j cheung k j jr li g 2002 exp cell res 276 214 222crossrefmedline order article via infotrieve wang w takimoto r ratinejad f el diery w 2003 mol cell biol 23 2171 2181abstractfree full text wischhusen j naumann u ohgaki h rastinejad f weller m 2003 oncogene 22 8233 8245crossrefmedline order article via infotrieve takimoto r wang w dicker d rastinejad f lyssikatos j el diery w 2002 cancer biol ther 1 47 55medline order article via infotrieve rippin m bykov v j n freund m v selivanova g wiman k g fersht r 2002 oncogene 21 2119 2129crossrefmedline order article via infotrieve frank r schroeder m fernandez p taubert amati b 2001 genes dev 15 2069 2082abstractfree full text dignam j d lebowitz r m roeder r g 1983 nucleic acids res 11 1474 1489 klein c georges g kunkele k p huber r engh r hansen 2001 j biol chem 276 37390 37401abstractfree full text kaeser m d iggo r d 2002 proc nat acad sci u 99 95 100abstractfree full text cho y gorina jeffery p d paveletich n p 1994 science 265 346 355medline order article via infotrieve siegal h 1993 enzyme kinetics pp 125 143 john wiley sons new york friedler dedecker b freund m v blair c rudiger fersht r 2004 j mol biol 336 187 196crossrefmedline order article via infotrieve chipuk j maurer u green d r schuler m 2003 cancer cell 4 371 381medline order article via infotrieve dumont p leu j j della pitra iii c george d l murphy m 2003 nat genet 33 357 365crossrefmedline order article via infotrieve brachmann r k yu k eby y pavelitch n p boeke j d 1998 embo j 17 1847 1859free full text nikolova p v wong k b dedecker b henckel j fersht r 2000 embo j 19 370 378abstractfree full text joerger allen m d fersht r 2004 j biol chem 279 1291 1294abstractfree full text
0.4995434.15337767.html.plaintext.txt	0	n terminal interferon binding domain ibid homology domain p300 binds peptides homology p53 transactivation domain lee finlan ted r hupp
0.4995434.15337767.html.plaintext.txt	1	university edinburgh division oncology cruk cell signaling unit south crewe road edinburgh eh4 2xu scotland united kingdom
0.4995434.15337767.html.plaintext.txt	2	received publication may 28 2004 revised form august 25 2004
0.4995434.15337767.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references two high affinity ser 20 phospho lxxll p53 binding domains p300 map c terminal interferon binding domain ibid n terminal ibid homology domain ihd regions purified fractions recombinant ihd miniprotein active set vitro assays highlighting affinity n terminal lxxll domain p53 including dose dependent binding ser 20 phosphorylated p53 tetramers ii dna stimulated binding p53 tetramers iii inhibition mdm2 mediated p53 ubiquitination active component ihd miniprotein localized 75 amino acid fragment corresponding amino acids 401 475 human p300 minimal ihd miniprotein function vivo p53 binding polypeptide assays including complex formation vp16 lxxll peptide motifs two hybrid assay ii action dominant negative inhibitor p53 p21 luciferase templates iii attenuation endogenous p21 protein levels show irf 1 dependent stabilization reactivation p53pro protein lxxllpxxp neutralized minimal ihd miniprotein suggesting ihd bind p53 lxxll domain vivo phage peptide display ihd miniprotein gave rise lsqxtfsxlxxll consensus binding site displays significant homology lxxll transactivation domain p53 data validate ihd scaffold independent lxxll peptide binding domain within p300 protein complementing known peptide binding domains including ibid ch1 ch3
0.4995434.15337767.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references two high affinity ser 20 phospho lxxll p53 binding domains p300 map c terminal interferon binding domain ibid n terminal ibid homology domain ihd regions purified fractions recombinant ihd miniprotein active set vitro assays highlighting affinity n terminal lxxll domain p53 including dose dependent binding ser 20 phosphorylated p53 tetramers ii dna stimulated binding p53 tetramers iii inhibition mdm2 mediated p53 ubiquitination active component ihd miniprotein localized 75 amino acid fragment corresponding amino acids 401 475 human p300 minimal ihd miniprotein function vivo p53 binding polypeptide assays including complex formation vp16 lxxll peptide motifs two hybrid assay ii action dominant negative inhibitor p53 p21 luciferase templates iii attenuation endogenous p21 protein levels show irf 1 dependent stabilization reactivation p53pro protein lxxllpxxp neutralized minimal ihd miniprotein suggesting ihd bind p53 lxxll domain vivo phage peptide display ihd miniprotein gave rise lsqxtfsxlxxll consensus binding site displays significant homology lxxll transactivation domain p53 data validate ihd scaffold independent lxxll peptide binding domain within p300 protein complementing known peptide binding domains including ibid ch1 ch3
0.4995434.15337767.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references characterizing protein protein interactions assemble transcription complexes provide molecular basis combinatorial specificity promoter level give insight transcriptosomes affect tumorigenesis tumor suppressor p53 central regulatory component evolutionary conserved mechanism responds certain stresses impinge upon genomic integrity inducing regulated responses cell cycle arrest dna repair andor programmed cell death 1 stress activated tumor suppressor protein p53 well characterized transcription factor associates basal transcription machinery vast array genes p53 induces andor represses response cell injury provides excellent model system identify complex transient associations co activatorsrepressors core promoter transcriptional apparatus drive promoter activation 2 central stress activated transcription program p53 interaction transcriptional co activator p300 3
0.4995434.15337767.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references characterizing protein protein interactions assemble transcription complexes provide molecular basis combinatorial specificity promoter level give insight transcriptosomes affect tumorigenesis tumor suppressor p53 central regulatory component evolutionary conserved mechanism responds certain stresses impinge upon genomic integrity inducing regulated responses cell cycle arrest dna repair andor programmed cell death 1 stress activated tumor suppressor protein p53 well characterized transcription factor associates basal transcription machinery vast array genes p53 induces andor represses response cell injury provides excellent model system identify complex transient associations co activatorsrepressors core promoter transcriptional apparatus drive promoter activation 2 central stress activated transcription program p53 interaction transcriptional co activator p300 3
0.4995434.15337767.html.plaintext.txt	7	p300creb binding protein family proteins participate many physiological processes including proliferation differentiation apoptosis 4 p300 functions transcriptional co activator involved multiple signal dependent transcription events 5 viral onco proteins adenoviral e1a sv40 antigen possess high affinity specific binding sites p300 6 results loss cell growth control enhancement dna synthesis blocks cellular differentiation 7 data implicating altered p300 gene expression array human tumors 5 p300 contains three broad functional domains including acetyltransferase domain mediates substrate acetylation ii bromodomain implicated binding acetylated amino acids iii variety lxxll pxxp transactivation peptide binding domains coordinated function domains thought mediate role p300 bridge scaffold andor catalyst binding transcriptional components activation gene expression
0.4995434.15337767.html.plaintext.txt	8	p300creb binding protein family proteins participate many physiological processes including proliferation differentiation apoptosis 4 p300 functions transcriptional co activator involved multiple signal dependent transcription events 5 viral onco proteins adenoviral e1a sv40 antigen possess high affinity specific binding sites p300 6 results loss cell growth control enhancement dna synthesis blocks cellular differentiation 7 data implicating altered p300 gene expression array human tumors 5 p300 contains three broad functional domains including acetyltransferase domain mediates substrate acetylation ii bromodomain implicated binding acetylated amino acids iii variety lxxll pxxp transactivation peptide binding domains coordinated function domains thought mediate role p300 bridge scaffold andor catalyst binding transcriptional components activation gene expression
0.4995434.15337767.html.plaintext.txt	9	tetrameric nature p53 allosteric properties enzymatic activity p300 involved activation p53 multiple transactivation peptide binding domains p300 make p300p53 complex attractive model understand dynamic nature biological machine important goal dissection proteome molecular mechanism p53 tetramers interact p300 modulates acetylation beginning defined biochemically reconstitution purified forms p300p53 protein complex vitro followed validation vivo identified sequential stages p300p53 complex dynamics include docking dependent phosphorylation lxxll motif thr 18 ser 20 enzymes calcium calmodulin superfamily chk2 chk1 8 ii stabilization p300 binding p53 activation domain phosphorylation thr 18 ser 20 9 iii anchoring p300 contiguous phospho lxxll pxxp activation domains p53 10 iv sequence specific dna binding p53 induces conformational change tetramer forcing acetylation dna dependent pxxp dependent 10 v acetylation dna bound p53 turn stabilizes p300acetylated p53dna complex 11 multidomain scaffold arranges onto octavalent substrate p53 known known acetylation native p53 oligomer constrained absence consensus site dna ability 1 protein bind p300 stimulate p53 acetylation novel allosteric mechanism see also ref 22 highlights multifaceted dynamic nature p300p53 complex assembly continue dissecting p300 bind p53 mapped various ser 20 phospho lxxll pxxp peptide binding domains p300 found map regions distinct classic ch1 ch3 p53 activation binding domains 10 peptide binding regions p300 turn distinct binding irf 1 activation domain interfaces p300 see also ref 22 together mapping data approaches data identify least eight peptide binding minidomains p300 contact p53 including ch1 ch3 ibid1 ihd spc 1 spc 2 kix bromo
0.4995434.15337767.html.plaintext.txt	10	tetrameric nature p53 allosteric properties enzymatic activity p300 involved activation p53 multiple transactivation peptide binding domains p300 make p300p53 complex attractive model understand dynamic nature biological machine important goal dissection proteome molecular mechanism p53 tetramers interact p300 modulates acetylation beginning defined biochemically reconstitution purified forms p300p53 protein complex vitro followed validation vivo identified sequential stages p300p53 complex dynamics include docking dependent phosphorylation lxxll motif thr 18 ser 20 enzymes calcium calmodulin superfamily chk2 chk1 8 ii stabilization p300 binding p53 activation domain phosphorylation thr 18 ser 20 9 iii anchoring p300 contiguous phospho lxxll pxxp activation domains p53 10 iv sequence specific dna binding p53 induces conformational change tetramer forcing acetylation dna dependent pxxp dependent 10 v acetylation dna bound p53 turn stabilizes p300acetylated p53dna complex 11 multidomain scaffold arranges onto octavalent substrate p53 known known acetylation native p53 oligomer constrained absence consensus site dna ability 1 protein bind p300 stimulate p53 acetylation novel allosteric mechanism see also ref 22 highlights multifaceted dynamic nature p300p53 complex assembly continue dissecting p300 bind p53 mapped various ser 20 phospho lxxll pxxp peptide binding domains p300 found map regions distinct classic ch1 ch3 p53 activation binding domains 10 peptide binding regions p300 turn distinct binding irf 1 activation domain interfaces p300 see also ref 22 together mapping data approaches data identify least eight peptide binding minidomains p300 contact p53 including ch1 ch3 ibid1 ihd spc 1 spc 2 kix bromo
0.4995434.15337767.html.plaintext.txt	11	major ser 20 phospho lxxll p53 binding domains p300 mapped c terminal ibid 12 n terminal ihd scaffolds 11 miniproteins function dominant negative inhibitors p300 coactivated stimulation p53 depednent gene expression cells 11 however c terminal ibid domain examined structurally 12 ibid scaffold defined mapping regions p300 bind phosphorylated activation domain fragments irf 3 although miniprotein also bind non phosphorylated activation domain fragments proteins apparent lack sequence specificity ibid miniprotein binding activation domain peptides rationalized ability unstructured activation domain peptides acquire structure induced fit mechanism upon scaffold binding thus may capacity peptide form helix makes good ibid binding motif structure minimal lxxll peptide binding activity n terminal ihd miniprotein known known whether ihd scaffold intrinsic peptide consensus site selected polypeptides characterization ihd determination whether stringent peptide docking site consensus site advance dissection p300p53 complex assembly report define minimal ihd scaffold 75 aminoacid fragment homology minimal ibid region p300 demonstrate ihd contact lxxll region p53 variety assays including inhibition irf 1 reactivation p53pro demonstrate phage peptide display ihd miniprotein prefers consensus peptide motif significant homology lxxll motif p53 data indicate ihd bona fide lxxll p53 scaffold promotes formation transcriptionally active complex p53 co activator p300
0.4995434.15337767.html.plaintext.txt	12	major ser 20 phospho lxxll p53 binding domains p300 mapped c terminal ibid 12 n terminal ihd scaffolds 11 miniproteins function dominant negative inhibitors p300 coactivated stimulation p53 depednent gene expression cells 11 however c terminal ibid domain examined structurally 12 ibid scaffold defined mapping regions p300 bind phosphorylated activation domain fragments irf 3 although miniprotein also bind non phosphorylated activation domain fragments proteins apparent lack sequence specificity ibid miniprotein binding activation domain peptides rationalized ability unstructured activation domain peptides acquire structure induced fit mechanism upon scaffold binding thus may capacity peptide form helix makes good ibid binding motif structure minimal lxxll peptide binding activity n terminal ihd miniprotein known known whether ihd scaffold intrinsic peptide consensus site selected polypeptides characterization ihd determination whether stringent peptide docking site consensus site advance dissection p300p53 complex assembly report define minimal ihd scaffold 75 aminoacid fragment homology minimal ibid region p300 demonstrate ihd contact lxxll region p53 variety assays including inhibition irf 1 reactivation p53pro demonstrate phage peptide display ihd miniprotein prefers consensus peptide motif significant homology lxxll motif p53 data indicate ihd bona fide lxxll p53 scaffold promotes formation transcriptionally active complex p53 co activator p300
0.4995434.15337767.html.plaintext.txt	13	experimental procedures top abstract introduction experimental procedures results discussion references reagents enzymes recombinant human p53 purified insect cells bacterial expression systems using heparin sepharose described previously 13 ihd domain human p300 amino acids 401 575 subcloned invitrogen pdonr201 entry vector shuttled recombination tagged destination vector purification bacteria induction tagged ihd purified using nickel affinity resin protein concentration purity determined using bradford method coomassie blue stained sds gel quikchange site directed mutagenesis kit stratagene used create 3 stop codon insertions within pdonr ihd401 575 vector following primer designs table used create specific deletion mutants follows ihd401 553 ihd401 502 ihd401 475 ihd401 428 respectively subsequent gateway cloning carried transferring deletion mutants pbind pdest vectors used mammalian two hybrid assays p21 transcriptional assays endogenous protein assays carried 11
0.4995434.15337767.html.plaintext.txt	14	experimental procedures top abstract introduction experimental procedures results discussion references reagents enzymes recombinant human p53 purified insect cells bacterial expression systems using heparin sepharose described previously 13 ihd domain human p300 amino acids 401 575 subcloned invitrogen pdonr201 entry vector shuttled recombination tagged destination vector purification bacteria induction tagged ihd purified using nickel affinity resin protein concentration purity determined using bradford method coomassie blue stained sds gel quikchange site directed mutagenesis kit stratagene used create 3 stop codon insertions within pdonr ihd401 575 vector following primer designs table used create specific deletion mutants follows ihd401 553 ihd401 502 ihd401 475 ihd401 428 respectively subsequent gateway cloning carried transferring deletion mutants pbind pdest vectors used mammalian two hybrid assays p21 transcriptional assays endogenous protein assays carried 11
0.4995434.15337767.html.plaintext.txt	15	view table table mutagenesis primers fwd forward rev reverse
0.4995434.15337767.html.plaintext.txt	16	cell biological immunochemical assays cell lines used include hct116 p53 p53 null obtained dr bert vogelstein johns hopkins university h1299 saos 2 a375 indicated cells propagated either mccoys hct116 dulbeccos modified eagles medium supplemented 10 fetal calf serum mammalian two hybrid system evaluating p300 minidomain binding lxxll activation domain p53 described previously 11 p53pro lacking proline repeat transactivation domain described previously irf 1 expression plasmid gift dr kathryn ball university edinburgh vitro ubiquitination assays using purified mdm2 p53 described previously 14
0.4995434.15337767.html.plaintext.txt	17	cell biological immunochemical assays cell lines used include hct116 p53 p53 null obtained dr bert vogelstein johns hopkins university h1299 saos 2 a375 indicated cells propagated either mccoys hct116 dulbeccos modified eagles medium supplemented 10 fetal calf serum mammalian two hybrid system evaluating p300 minidomain binding lxxll activation domain p53 described previously 11 p53pro lacking proline repeat transactivation domain described previously irf 1 expression plasmid gift dr kathryn ball university edinburgh vitro ubiquitination assays using purified mdm2 p53 described previously 14
0.4995434.15337767.html.plaintext.txt	18	phage peptide display phage peptide display using purified ihd minidomain done described previously mdm2 14 p300 10 briefly phd 12 phage display library kit new england biolabs used contains random 12 mer peptides fused coat protein piii m13 phage displayed 12 mer peptides expressed n terminus piii followed short spacer gly gly gly ser coding region wild type piii protein complexity library defined 19 x 109 different peptide sequences titer 2 x 1012 plaque forming unitsml microlite 2 96 well flat bottom plate dynatech laboratories coated 1 microgml anti monoclonal antibody diluting 100 microl coating buffer 01 m nahco3 ph 86 incubated overnight 4 degrees c wells blocked blocking buffer 3 bovine serum albumin pbs 01 tween 20 1 h room temperature wells washed extensively pbs containing 01 tween 20 followed incubation ihd protein 100 ng 100 microl blocking buffer 1 h followed extensive washing pbs containing 01 tween 20 wells incubated 1 h 1 x 1011 phage particles pbs containing 01 tween 20 followed extensive washing pbs containing 01 tween 20 phage particles eluted incubation 02 m glycine hcl ph 22 1 mgml bovine serum albumin gentle rocking 10 min neutralized 15 microl 1 m tris hcl ph 91 eluted phage particles amplified infection er2378 cells 45 h phage polyethylene glycol precipitated according manufacturers instructions biopanning procedure repeated three times 1 x 1011 plaque forming units second third round amplified eluate used input phage addition tween 20 concentration binding wash buffers increased stepwise 01 05 successive round biopanning reduce nonspecific binding amplified phage peptide particles third round polyethylene glycol precipitated phage titrated individual plaques tested p53 specific binding activity dna amplified prepared according manufacturers new england biolabs protocol applied biosytems prism 377 automated dna sequencer used sequence dna 96giii primer sequence data 12 mer peptides obtained analyzed using e motif blast ncbi databases clustalw identify consensus peptide motifs homology known uncharacterized proteins see fig 8 summarized examples
0.4995434.15337767.html.plaintext.txt	19	view larger version 31k fig 8 phage peptide display identifies consensus sequence ihd miniprotein c purified bacterial expressed histidine tagged ihd captured onto elisa wells monoclonal anti his6 antibody following incubation naive phage peptide library elution phage acid propagation eluted phage three rounds amplification carried acquire phage bound high affinity p300 minidomain ihd peptide inserts phage sequenced determine insert peptide sequence thirty clones tested revealing consensus sequences 50 homology conserved box motif within p53 three representative classes peptides depicted d overview consensus match identified phage display directly compared evolutionary conserved transactivation domain p53 minimal core lsqxxfst consensus screened using e motif search engine data base domains homology results screen suggest number transcription associated factors viral oncogenes possess domains homology ihd consensus thus potential associate p300 via ihd region
0.4995434.15337767.html.plaintext.txt	20	elisa quantitation binding ihd p53 microlite 2 96 flat bottom plate dynatech laboratories coated purified p53 fractions indicated 01 m sodium borate ph 9 incubated 4 degrees c overnight wells blocked 3 bovine serum albumin phosphate buffered saline plus 01 tween 20 incubated 1 h room temperature following ihd protein increasing amounts fixed levels indicated diluted total volume 50 microl buffer containing 15 glycerol 25 mm hepes ph 75 002 triton x 100 05 mm dithiothreitol 01 mm benzamidine incubation 1 h room temperature 1500 dilution anti tagged antibody blocking buffer reactions detected rabbit anti mouse horseradish peroxidase monoclonal antibody dako developed detailed p53 consensus site dna included binding reactions consensus site pg dna added prior p53 addition wells
0.4995434.15337767.html.plaintext.txt	21	elisa quantitation binding ihd p53 microlite 2 96 flat bottom plate dynatech laboratories coated purified p53 fractions indicated 01 m sodium borate ph 9 incubated 4 degrees c overnight wells blocked 3 bovine serum albumin phosphate buffered saline plus 01 tween 20 incubated 1 h room temperature following ihd protein increasing amounts fixed levels indicated diluted total volume 50 microl buffer containing 15 glycerol 25 mm hepes ph 75 002 triton x 100 05 mm dithiothreitol 01 mm benzamidine incubation 1 h room temperature 1500 dilution anti tagged antibody blocking buffer reactions detected rabbit anti mouse horseradish peroxidase monoclonal antibody dako developed detailed p53 consensus site dna included binding reactions consensus site pg dna added prior p53 addition wells
0.4995434.15337767.html.plaintext.txt	22	results top abstract introduction experimental procedures results discussion references effects mdm2 p300 binding serine 20 phosphorylated p53 defined mdm2 binding affected serine 20 phosphorylation 15 whereas p300 full length p300 protein binding stabilized phosphate addition serine 20 residue 9 major serine 20 lxxll phospho binding domains p300 mapped two regions c terminal ibid interferon binding domain miniprotein n terminal 17 kda miniprotein homology ibid fig 1 b named ihd ibid homology domain
0.4995434.15337767.html.plaintext.txt	23	results top abstract introduction experimental procedures results discussion references effects mdm2 p300 binding serine 20 phosphorylated p53 defined mdm2 binding affected serine 20 phosphorylation 15 whereas p300 full length p300 protein binding stabilized phosphate addition serine 20 residue 9 major serine 20 lxxll phospho binding domains p300 mapped two regions c terminal ibid interferon binding domain miniprotein n terminal 17 kda miniprotein homology ibid fig 1 b named ihd ibid homology domain
0.4995434.15337767.html.plaintext.txt	24	view larger version 31k fig 1 domain structure p300 minidomains p300 interact lxxll motif p53 major functional domains respect p53 binding indicated ch1 ihd kix ch2 bromo acetyltransferase active site ch3 ibid minimal ibid domain expanded show helix turn helix turn helix secondary structural motifs 1 turn1 2 turn2 3 12 b comparison amino acid sequences ibid ihd regions p300 amino acid sequence ibid ihd domains aligned conserved amino acids shown purple minimal amino acid sequence c terminal ibid domain starting amino acid 2058 homologous amino acids n terminal ihd region starting amino acid 438 highlighted boxes labeled 1 2 3
0.4995434.15337767.html.plaintext.txt	25	fine map ihd evaluate specificity lxxll containing peptides his6 tagged 17 kda miniprotein amino acids 401 566 expressed purified bacterial expression systems specific activity ihd miniprotein measured using fractions p53 protein purified insect cell expression systems serine 20 phosphorylated pools p53 ie fraction 20 fig 2a chromatographically separated serine 20 unphosphorylated p53 ie fraction 16 fig 2a equivalent amounts total p53 protein 25 100 ng fraction 16 fraction 20 adsorbed onto elisa wells fixed amounts ihd added p53 dependent binding ihd miniprotein detected anti monoclonal antibody fig 2 b c serine 20 phosphorylated pool p53 fraction 20 bound stably ihd miniprotein 5 7 rlu fig 1c compared unphosphorylated p53 fraction 16 bound weaker ihd 07 1 rlu fig 1b titration ihd miniprotein elisa wells containing fixed amounts p53 solid phase also demonstrated stable complex binding serine 20 phosphorylated p53 fraction 20 versus fraction 16 10 versus 3 rlu respectively fig 2d control p53 protein fractions 16 20 normalization antibody 1 contacts p53 within mdm2 binding site fig 3a bound p53 fractions 16 20 similar extents 800 rlu fig 2e antibody 1 bound p53 relative affinity 50 fold higher ihd miniprotein compare rlu saturating protein levels 40 ng consistent known high affinity mab 1 epitope together data indicate purified forms ihd miniprotein show binding p53 turn stabilized phospho serine 20 residue
0.4995434.15337767.html.plaintext.txt	26	fine map ihd evaluate specificity lxxll containing peptides his6 tagged 17 kda miniprotein amino acids 401 566 expressed purified bacterial expression systems specific activity ihd miniprotein measured using fractions p53 protein purified insect cell expression systems serine 20 phosphorylated pools p53 ie fraction 20 fig 2a chromatographically separated serine 20 unphosphorylated p53 ie fraction 16 fig 2a equivalent amounts total p53 protein 25 100 ng fraction 16 fraction 20 adsorbed onto elisa wells fixed amounts ihd added p53 dependent binding ihd miniprotein detected anti monoclonal antibody fig 2 b c serine 20 phosphorylated pool p53 fraction 20 bound stably ihd miniprotein 5 7 rlu fig 1c compared unphosphorylated p53 fraction 16 bound weaker ihd 07 1 rlu fig 1b titration ihd miniprotein elisa wells containing fixed amounts p53 solid phase also demonstrated stable complex binding serine 20 phosphorylated p53 fraction 20 versus fraction 16 10 versus 3 rlu respectively fig 2d control p53 protein fractions 16 20 normalization antibody 1 contacts p53 within mdm2 binding site fig 3a bound p53 fractions 16 20 similar extents 800 rlu fig 2e antibody 1 bound p53 relative affinity 50 fold higher ihd miniprotein compare rlu saturating protein levels 40 ng consistent known high affinity mab 1 epitope together data indicate purified forms ihd miniprotein show binding p53 turn stabilized phospho serine 20 residue
0.4995434.15337767.html.plaintext.txt	27	view larger version 23k fig 2 ihd preferentially binds serine 20 phosphorylated p53 tetramers separation serine 20 phospho serine 20 non phospho isoforms p53 human p53 expressed sf9 cells fractionated using heparin sepharose 13 serine 20 phospho serine 20 non phospho isoforms defined immunoblotting anti serine 20 phospho monoclonal antibody reported previously 8 fraction containing p53 relatively large amount serine 20 phosphorylation fraction 20 whereas relatively low levels fraction 16 b c ihd binding reactions differing amounts p53 increasing amounts serine 20 phospho p53 0 100 ng fraction 20 c serine 20 non phospho p53 0 100 ng fraction 16 b 0 100 ng adsorbed onto elisa wells fixed amount tagged ihd miniprotein added detect ihd binding anti mab added followed peroxidase linked secondary antibody ihd binding p53 quantified relative light units rlu d e ihd titration d 1 titration e reactions fixed p53 fixed amounts serine 20 phospho p53 100 ng fraction 20 triangle serine 20 non phospho p53 non 0 100 ng fraction 16 square adsorbed onto elisa wells increasing amounts tagged ihd miniprotein d monoclonal antibody 1 e added detect ihd binding anti mab addition 1 mab binding peroxidase linked secondary antibody added binding p53 quantified usingchemiluminescence relative light units f g ihd binding p53 stimulated consensus site dna increasing amounts serine 20 phospho p53 0 100 ng fraction 20 g serine 20 non phospho p53 0 100 ng fraction 16 f adsorbed onto elisa wells fixed amount consensus site plasmid dna added followed fixed amount tagged ihd miniprotein detect ihd binding anti mab added followed peroxidase linked secondary antibody ihd binding p53 quantified relative light units
0.4995434.15337767.html.plaintext.txt	28	view larger version 21k fig 3 ihd miniprotein inhibits mdm2 mediated ubiquitination ub p53 contact sites mdm2 p300 activation domain p53 n terminal activation domain human p53 hp53 along homologous region fish p53 fp53 indicated upper arrows highlight key contacts mdm2 whereas lower arrows highlight contacts p300 ref 9 underlined amino acids conserved amino acids p300 consensus binding site b ihd inhibits wild type p53 ubiquitination mdm2 vitro ubiquitination reactions assembled without mdm2 lane 1 mdm2 lanes 2 12 control antibody lanes 4 8 increasing amounts ihd lanes 9 12 added ubiquitination reactions stopped 10 min reaction products blotted 1 detect p53 ubiquitination ladder c vivo p53 ubiquitination p53 wild type lane 2 mutant p53 encoded r175h allele lane 3 genes 05 microg dna transfected alone mdm2 h1299 cells 2 microg dna lanes 4 5 24 h cell lysates immunoblotted examine changes amount ubiquitination products immunoblotting antibodies p53 1 described previously shimizu et al 14 d ihd inhibits mutant p53r175h ubiquitination vivo co transfected mutant p53r175h mdm2 genes lanes 1 4 co transfected increasing amounts vp16 tagged ihd 01 025 05 1 microg dna lanes 2 4 24 h cell lysates immunoblotted look changes amount ubiquitination products immunoblotting antibodies p53 1 vp 16 antibody lower panel used show dose dependent increases vp16 tagged ihd miniprotein levels perturb mdm2 mediated ubiquitination p53
0.4995434.15337767.html.plaintext.txt	29	one notable feature p53 acetylation dna dependence acetylation reaction 11 data suggest dna binding changes conformation p53 permit stable docking p300 p53 fact sequence specific dna stabilize full length p300 binding p53 absence acetyl coa 11 tested whether purified ihd miniprotein bound stably p53 presence consensus site dna titration consensus site dna elisa reaction containing fixed amounts p53 solid phase stimulated ihd p53 protein complex formation fig 2 f g data suggest reason dna stabilizes p300p53 complex attributed least part enhanced affinity ihd miniprotein lxxll activation domain p53 ability dna change conformation p53 lxxll domain identifies allosteric effect p53 particular identifying interaction lxxll containing transactivation domain core dna binding domain
0.4995434.15337767.html.plaintext.txt	30	one notable feature p53 acetylation dna dependence acetylation reaction 11 data suggest dna binding changes conformation p53 permit stable docking p300 p53 fact sequence specific dna stabilize full length p300 binding p53 absence acetyl coa 11 tested whether purified ihd miniprotein bound stably p53 presence consensus site dna titration consensus site dna elisa reaction containing fixed amounts p53 solid phase stimulated ihd p53 protein complex formation fig 2 f g data suggest reason dna stabilizes p300p53 complex attributed least part enhanced affinity ihd miniprotein lxxll activation domain p53 ability dna change conformation p53 lxxll domain identifies allosteric effect p53 particular identifying interaction lxxll containing transactivation domain core dna binding domain
0.4995434.15337767.html.plaintext.txt	31	next evaluated whether ihd bind transactivation domain p53 defined ability interfere mdm2 mediated ubiquitination binds overlapping amino acids activation domain fig 3a mdm2 mediated ubiquitination p53 fig 3b lane 2 versus lane 1 unaffected control antibody binds denatured p53 fig 3b lanes 4 8 contrast titration ihd results inhibition mdm2 mediated ubiquitination p53 fig 3b lanes 9 12 vivo ubiquitination p53 catalyzed mdm2 fig 3c lanes 4 5 versus lanes 2 3 also attenuated ihd dose dependent manner fig 3d lanes 2 4 versus lane 1 together data identify three biochemical properties ihd miniprotein amino acids 401 566 suggestive ability interact lxxll transactivation domain p53 tetramers enhanced affinity serine 20 phosphorylated p53 tetramers ii dna stimulated ihd p53 tetramer complex stabilization iii sterical occlusion mdm2 p53 transactivation domain inhibition mdm2 catalyzed ubiquitination
0.4995434.15337767.html.plaintext.txt	32	lxxll binding activity associated ihd miniprotein fine mapped constructing progressive deletions ihd coding region fig 4g required determine region 17 kda ihd miniprotein primarily responsible lxxll binding activity especially comparison homology domain c terminus ibid ibid domain p300 localized 46 amino acid fragment homology extreme n terminus ihd fig 1b gal4 vp16 vivo two hybrid assay used evaluate specific activity ihd miniprotein fragments rather vitro specific activity since expression ihd deletion fragments escherichia coli proved relatively difficult data shown comparing vivo specific activity ihd miniprotein deletion derivatives lxxll containing peptides two peptide binding domains evaluated ibid binds phosphorylated activation domain fragments irf 3 well non phosphorylated fragments activation domains 12 ii spc 1 site proline contact 10 c terminal minidomain p300 containing half ch3 domain amino acid sequences without classic ch3 domain identified previously lxxll peptide binding activity despite lacking n terminal 56 amino acids standard ch3 domain 164 amino acids length control two hybrid assay myod fused vp16 displayed affinity peptide sequence inhibitor dna binding fused gal4 fig 4b whereas lxxll peptide p53 bound weakly myod fig 4b conditions used vivo two hybrid assay ihd miniprotein 401 566 active conditions toward lxxll peptide entire p53 activation domain fig 4c lower activity lxxll peptide short sequence lxxll activation domain p53 fig 4c
0.4995434.15337767.html.plaintext.txt	33	view larger version 27k fig 4 defining minimal ihd miniprotein vp16 gal4 two hybrid system used quantifying ihd activity showing vp16 fusion ihd binding gal4 fusion lxxll domain assay b f fixed amounts vp16 tagged p300 minidomain ibid myod ihd spc 1 ch3 pact vector gal4 tagged peptide pbind vector transfected hct116 p53 cells galactosidase control vector pcmv gal lysed 24 h later test ability affect transcription gal4 luciferase reporter construct pg5 luc gal4 peptide fusions include empty vector control pxxp amino acids 60 90 proline repeat activation domain p53 binds p300 spc 1 spc 2 minidomains lxxll amino acids 12 27 lxxll activation domain p53 box amino acids 15 26 activation domain p53 binding data depicted ratio chemoluminescence galactosidase activity rlu b myod vp16 preferentially binds gal4 id inhibitor dna binding peptide c lxxll gal4 preferentially binds vp16 ihd d lxxll gal4 preferentially binds vp16 spc 1 e relative affinities ibid ihd ch3 pan pan reactive peptide binding region p300 gal4 lxxll peptide f effects deletion ihd miniprotein lxxll binding activity g summary ihd deletion constructs
0.4995434.15337767.html.plaintext.txt	34	alterations growth conditions affect binding activity spc 1pan pan reactive peptide binding region p300 ibid peptides containing lxxll motifs ihd domain always display highest activity lxxll containing peptides fig 4e data shown suggesting competition endogenous lxxll binding proteins effect gal4 vp16 interaction extreme deletion ihd miniprotein amino acids 401 427 well motif homology ibid fig 1b inactivates lxxll binding activity associated miniprotein fig 4f interestingly region ihd maps first helix ibid domain required ibid activity 12 suggests minimal ihd domain directly overlaps similar primary structure ibid despite fact entire 165 amino acid fragment within ihd ibid share homology ihd miniprotein retained significant activity ihd 401 475 fig 4 thus localizing major lxxll peptide binding activity n terminal half rather c terminal region 17 kda ihd miniprotein
0.4995434.15337767.html.plaintext.txt	35	alterations growth conditions affect binding activity spc 1pan pan reactive peptide binding region p300 ibid peptides containing lxxll motifs ihd domain always display highest activity lxxll containing peptides fig 4e data shown suggesting competition endogenous lxxll binding proteins effect gal4 vp16 interaction extreme deletion ihd miniprotein amino acids 401 427 well motif homology ibid fig 1b inactivates lxxll binding activity associated miniprotein fig 4f interestingly region ihd maps first helix ibid domain required ibid activity 12 suggests minimal ihd domain directly overlaps similar primary structure ibid despite fact entire 165 amino acid fragment within ihd ibid share homology ihd miniprotein retained significant activity ihd 401 475 fig 4 thus localizing major lxxll peptide binding activity n terminal half rather c terminal region 17 kda ihd miniprotein
0.4995434.15337767.html.plaintext.txt	36	specific activity ihd miniprotein direct lxxll binding assay compared ability function dominant negative p300 inhibitor attenuating p53 dependent transcription p21 luciferase promoter system p300 stimulate maximal p53 dependent transcription fig 5a attenuated transfection increasing amounts ihd miniprotein encoding vector amino acids 401 566 fig 5b consistent ability bind p53 transactivation domain since ihd 401 566 bind proline repeat domain fig 4c ability ihd inhibit p53 activity presumably due binding proline repeat transactivation domain also contact p300 directly progressive deletions ihd 401 533 401 501 401 475 neutralize ihd activity p53 inhibitor fig 5 c e however deletions ihd region homology minimal ibid fragment ihd 401 427 lost activity p53 inhibitor fig 5 g versus h differences specific activity ihd miniprotein deletion variants p53 inhibitors example ihd derivative amino acids 401 501 effective dominant negative inhibitor p53 ihd derivatives amino acids 401 475 amino acids 401 553 especially intermediate levels gene transfected fig 5d versus c e data suggest polypeptide fragments encoded amino acids 476 501 affect specific activity ihd p53 binding domain andor factors vivo binding trans region competing away p53
0.4995434.15337767.html.plaintext.txt	37	specific activity ihd miniprotein direct lxxll binding assay compared ability function dominant negative p300 inhibitor attenuating p53 dependent transcription p21 luciferase promoter system p300 stimulate maximal p53 dependent transcription fig 5a attenuated transfection increasing amounts ihd miniprotein encoding vector amino acids 401 566 fig 5b consistent ability bind p53 transactivation domain since ihd 401 566 bind proline repeat domain fig 4c ability ihd inhibit p53 activity presumably due binding proline repeat transactivation domain also contact p300 directly progressive deletions ihd 401 533 401 501 401 475 neutralize ihd activity p53 inhibitor fig 5 c e however deletions ihd region homology minimal ibid fragment ihd 401 427 lost activity p53 inhibitor fig 5 g versus h differences specific activity ihd miniprotein deletion variants p53 inhibitors example ihd derivative amino acids 401 501 effective dominant negative inhibitor p53 ihd derivatives amino acids 401 475 amino acids 401 553 especially intermediate levels gene transfected fig 5d versus c e data suggest polypeptide fragments encoded amino acids 476 501 affect specific activity ihd p53 binding domain andor factors vivo binding trans region competing away p53
0.4995434.15337767.html.plaintext.txt	38	view larger version 32k fig 5 deletion ihd neutralize activity p53 inhibitor assayed p21 reporter p53 gene alone 1 microg without p300 3 microg together indicated ihd mutants 05 1 3 microg dna co transfected hct p53 cells along pcmv galactosidase 1 microg p53 responsive p21 luc reporter vector 1 microg relative transcription activity p53 depicted rlu includes following ihd mutants ihd ihd 401 566 b ihd 401 533 c ihd 401 501 d ihd 401 475 e ihd f ihd 401 427 g ihd 401 566 h
0.4995434.15337767.html.plaintext.txt	39	activity ihd deletion fragments dominant negative inhibitors p53 p21 lucifease assay compared ability attenuate endogenous p53 dependent induction p21 protein fig 6 transfection p300 p53 together gave rise increases p21 levels fig 6 lane 4 relative empty vector controls fig 6 lane 1 cotransfection ihd amino acids 401 566 attenuated p21 induction co transfected p300 p53 fig 6 lane 5 versus lane 4 whereas ihd deletion derivative ihd amino acids 401 427 inactive p53 inhibitor p53 activity measured p21 luciferase promoter fig 5g also unable attenuate p21 protein induction p300 p53 co transfection fig 6 lane 9 ihd derivatives attenuated p21 protein induction different extents fig 6 lanes 6 8 ihd fragment amino acids 401 501 least effective inhibitor fig 6 lane 7 latter data consistent lower specific activity ihd fragment amino acids 401 501 p53 inhibitor p21 luciferase promoter
0.4995434.15337767.html.plaintext.txt	40	view larger version 25k fig 6 deletion ihd neutralize activity p53 inhibitor assayed p21 protein induction indicated genes co transfected cells without vectors encoding indicated ihd miniproteins lane 1 vector lane 2 p300 lane 3 p53 lane 4 p53 p300 lane 5 p53 p300 ihd 401 566 lane 6 p53 p300 ihd 401 533 lane 7 p53 p300 ihd 401 501 lane 8 p53 p300 ihd 401 475 lane 9 p53 p300 ihd 401 427 24 h transfection lysates cells immunoblotted p21 protein levels corresponding ink staining blot bottom panel
0.4995434.15337767.html.plaintext.txt	41	second activation domain p53 proline rich contiguous lxxll activation domain 10 domains contact p300 different regions evaluated affinity ihd miniprotein toward p53 lxxll activation domain p53 variant lacks second transactivation domain within proline rich region p53pro transfection p53pro cells results little activity p21waf1 luciferase reporter fig 7a lane 2 little stimulation co transfected p300 fig 7a lane 6
0.4995434.15337767.html.plaintext.txt	42	second activation domain p53 proline rich contiguous lxxll activation domain 10 domains contact p300 different regions evaluated affinity ihd miniprotein toward p53 lxxll activation domain p53 variant lacks second transactivation domain within proline rich region p53pro transfection p53pro cells results little activity p21waf1 luciferase reporter fig 7a lane 2 little stimulation co transfected p300 fig 7a lane 6
0.4995434.15337767.html.plaintext.txt	43	view larger version 23k fig 7 ihd inhibits irf 1 stabilization p53pro irf 1 reactivate p53pro p21 promoter indicated genes co transfected cells along pcmv galactosidase 1 microg p53 responsive p21 luc reporter vector 1 microg 24 h lane 1 p300 lane 2 p53pro lane 3 p300 irf 1 lane 4 p53pro irf 1 lane 5 irf 1 lane 6 p300 p53pro lanes 7 10 p300 p53pro plus increasing amounts irf 1 relative transcription activity p53 depicted rlu b irf 1 stabilizes p53pro increasing amounts irf 1 lanes 1 4 5 8 transfected cells p53pro lanes 1 4 without p53pro lanes 5 8 lysates immunoblotted antibodies p53pro top irf 1 bottom c ihd inhibits irf 1 reactivation p53pro p21 promoter indicated genes co transfected cells along pcmv galactosidase 1 microg p53 responsive p21 luc reporter vector 1 microg 24 h lane 1 p53pro lane 2 irf 1 lane 3 p53pro irf 1 lanes 4 7 p53pro irf 1 increasing amounts ihd 401 566 lanes 8 11 p53pro irf 1 increasing amounts ihd 401 475 relative transcription activity p53 depicted rlu d ihd prevents irf 1 stabilization p53pro fixed amounts p53pro lanes 1 6 co transfected ihd 401 475 lanes 1 3 ihd 401 566 lanes 4 6 increasing amounts irf 1 lanes 2 3 5 6 lysates immunoblotted antibodies p53pro top irf 1 bottom indicated
0.4995434.15337767.html.plaintext.txt	44	shown independently genetic basis irf 1 cooperation p53 inducer p21 promoter 16 due ability irf 1 bind p300 allosterically stimulate dna dependent acetylation p532 although p53pro inactive due removal prolinerich activation domain inability acetylated p300 bound dna 10 transfected irf 1 effectively able reactivate p53pro ability induce p21 expression fig 7b lane 4 versus lanes 5 2 interestingly transfection increasing amounts irf 1 protein also able stabilize p53pro fig 7b lanes 2 4 versus lane 1 data indicate p53 activity uncoupled proline repeat activation domain presumably ability irf 1 enhance p300 contact lxxll activation domain p53 turn stabilizes activates p53pro hypothesis tested using ihd miniprotein irf 1 effects activating p53pro due stabilization p300lxxll motif would predict ihd would block irf 1 stimulatory effects maximal p53pro activity p21 luciferase reporter induced irf 1 transfection fig 7c lane 3 versus lanes 2 1 attenuated 17 kda ihd miniprotein fig 7c lanes 4 7 versus lane 3 well 8 kda ihd miniprotein fig 7c lanes 8 11 versus lane 3 attenuation ihd irf 1 dependent p53pro activity fig 7c also linked destabilization ihd p53pro protein levels presence irf 1 protein fig 7d using fixed amounts p53pro inhibitory levels ihd miniprotein fig 7d lanes 1 3 titration irf 1 protein actually destabilizes p53pro fig 7d lanes 2 3 versus lane 1 using fixed amounts p53pro small ihd derivative amino acids 401 475 fig 7d lanes 4 6 titration irf 1 protein similarly destabilizes p53pro fig 7d lanes 5 6 versus lane 3 data suggest lxxll activation domain indeed target irf 1 stabilization p53pro minimal ihd miniprotein contact lxxll domain p53 vivo
0.4995434.15337767.html.plaintext.txt	45	shown independently genetic basis irf 1 cooperation p53 inducer p21 promoter 16 due ability irf 1 bind p300 allosterically stimulate dna dependent acetylation p532 although p53pro inactive due removal prolinerich activation domain inability acetylated p300 bound dna 10 transfected irf 1 effectively able reactivate p53pro ability induce p21 expression fig 7b lane 4 versus lanes 5 2 interestingly transfection increasing amounts irf 1 protein also able stabilize p53pro fig 7b lanes 2 4 versus lane 1 data indicate p53 activity uncoupled proline repeat activation domain presumably ability irf 1 enhance p300 contact lxxll activation domain p53 turn stabilizes activates p53pro hypothesis tested using ihd miniprotein irf 1 effects activating p53pro due stabilization p300lxxll motif would predict ihd would block irf 1 stimulatory effects maximal p53pro activity p21 luciferase reporter induced irf 1 transfection fig 7c lane 3 versus lanes 2 1 attenuated 17 kda ihd miniprotein fig 7c lanes 4 7 versus lane 3 well 8 kda ihd miniprotein fig 7c lanes 8 11 versus lane 3 attenuation ihd irf 1 dependent p53pro activity fig 7c also linked destabilization ihd p53pro protein levels presence irf 1 protein fig 7d using fixed amounts p53pro inhibitory levels ihd miniprotein fig 7d lanes 1 3 titration irf 1 protein actually destabilizes p53pro fig 7d lanes 2 3 versus lane 1 using fixed amounts p53pro small ihd derivative amino acids 401 475 fig 7d lanes 4 6 titration irf 1 protein similarly destabilizes p53pro fig 7d lanes 5 6 versus lane 3 data suggest lxxll activation domain indeed target irf 1 stabilization p53pro minimal ihd miniprotein contact lxxll domain p53 vivo
0.4995434.15337767.html.plaintext.txt	46	structural studies ibid ch1 ch3 domains p300 demonstrated interaction minimal peptide binding domains activation domain peptides apparent sequence similarity generally held small peptides acquire helical structure bound peptide binding scaffold although characterization ihd indicates bind lxxll containing polypeptides yet clear whether ihd miniprotein displays sequence preference p53 sequence lxxll containing peptides alternate consensus sequences previously used phage peptide display vitro method identifying novel protein protein interfaces mdm2 p53 p300p53 complexes 10 14 technique advantage fixing bait protein solid phase native conformation incubating library containing random 12 mer peptides 17 kda tagged ihd miniprotein captured solid phase anti monoclonal antibody incubated phage libraries three rounds selection identical tagged bait capture methods identified proline repeat containing peptides preferentially enriched using full length p300 10 latter study relatively surprising lxxll containing peptides selected given number lxxll binding domains present p300 high affinity peptides enriched three rounds selection three general classes peptides identified first class peptides fig 8a striking similarity peptides isolated p53 activation domain identified critical consensus site contacts ihd three small motifs across activation domain plsq tfys sxlxxl data suggest ihd miniprotein display relative specificity p53 activation domain fragments although peptides match consensus identified using e motif search engine fig 8d second class peptides fig 8b showed less similarity class peptides display retention gln residue critical full length p300 contact serine 20 phosphorylated p53 activation domain core tsfwstde motif lxxl motif third class peptides displayed less resemblance p53 maintained gln residue relatively loose consensus stqxxfwystxxxxl general consensus site developed ihd plsqxfsx lxxll suggests either miniprotein high affinity p53 activation domain fragment consensus site peptide fragments capacity adopt helical conformation upon ihd scaffold binding giving rise apparent consensus site
0.4995434.15337767.html.plaintext.txt	47	structural studies ibid ch1 ch3 domains p300 demonstrated interaction minimal peptide binding domains activation domain peptides apparent sequence similarity generally held small peptides acquire helical structure bound peptide binding scaffold although characterization ihd indicates bind lxxll containing polypeptides yet clear whether ihd miniprotein displays sequence preference p53 sequence lxxll containing peptides alternate consensus sequences previously used phage peptide display vitro method identifying novel protein protein interfaces mdm2 p53 p300p53 complexes 10 14 technique advantage fixing bait protein solid phase native conformation incubating library containing random 12 mer peptides 17 kda tagged ihd miniprotein captured solid phase anti monoclonal antibody incubated phage libraries three rounds selection identical tagged bait capture methods identified proline repeat containing peptides preferentially enriched using full length p300 10 latter study relatively surprising lxxll containing peptides selected given number lxxll binding domains present p300 high affinity peptides enriched three rounds selection three general classes peptides identified first class peptides fig 8a striking similarity peptides isolated p53 activation domain identified critical consensus site contacts ihd three small motifs across activation domain plsq tfys sxlxxl data suggest ihd miniprotein display relative specificity p53 activation domain fragments although peptides match consensus identified using e motif search engine fig 8d second class peptides fig 8b showed less similarity class peptides display retention gln residue critical full length p300 contact serine 20 phosphorylated p53 activation domain core tsfwstde motif lxxl motif third class peptides displayed less resemblance p53 maintained gln residue relatively loose consensus stqxxfwystxxxxl general consensus site developed ihd plsqxfsx lxxll suggests either miniprotein high affinity p53 activation domain fragment consensus site peptide fragments capacity adopt helical conformation upon ihd scaffold binding giving rise apparent consensus site
0.4995434.15337767.html.plaintext.txt	48	discussion top abstract introduction experimental procedures results discussion references p53 shown regulated two distinct pathways direct biochemical actions tumor suppressor mdm2 forms component negative regulatory feedback pathway promotes ubiquitination p53 subsequent degradation p53 proteasome 17 p300 competes binding region mdm2 present within n terminal lxxll transactivation domain p53 co activator protein forms part positive regulatory component essential p53 required p53 stabilization dna damage induces transcriptional responses p300 catalyzed acetylation native p53 tetramers requires two associated events p300 docking two contiguous lxxll pxxppxp activation domains p53 sequence specific dna function allosteric activator removing conformational constraints p53 acetylation known p300 docks p53 tetramer whether involves one peptide binding domains p300 including ch1 ch3 ibid ihd spc 1 spc 2 whether rearrangement p300p53 complex occurs acetylation stabilize p300 bromo domain binding acetylated p53 residue rearrangement allosteric mechanism appears operate since small peptide derived irf 1p300 interface bind p300 stimulate trans enzymatic activity p300 22
0.4995434.15337767.html.plaintext.txt	49	discussion top abstract introduction experimental procedures results discussion references p53 shown regulated two distinct pathways direct biochemical actions tumor suppressor mdm2 forms component negative regulatory feedback pathway promotes ubiquitination p53 subsequent degradation p53 proteasome 17 p300 competes binding region mdm2 present within n terminal lxxll transactivation domain p53 co activator protein forms part positive regulatory component essential p53 required p53 stabilization dna damage induces transcriptional responses p300 catalyzed acetylation native p53 tetramers requires two associated events p300 docking two contiguous lxxll pxxppxp activation domains p53 sequence specific dna function allosteric activator removing conformational constraints p53 acetylation known p300 docks p53 tetramer whether involves one peptide binding domains p300 including ch1 ch3 ibid ihd spc 1 spc 2 whether rearrangement p300p53 complex occurs acetylation stabilize p300 bromo domain binding acetylated p53 residue rearrangement allosteric mechanism appears operate since small peptide derived irf 1p300 interface bind p300 stimulate trans enzymatic activity p300 22
0.4995434.15337767.html.plaintext.txt	50	means begin answering questions report fine mapped one p53 docking site p300 named ihd provided evidence minidomain p300 bona fide polypeptide binding domain possesses intrinsic ability bind peptides homology p53 lxxll activation domain one key feature ihd miniprotein mimics full length p300 stabilization phosphorylation serine 20 residue fig 2 although serine 20 phosphorylation function originally thought reduction mdm2 binding p53 biophysical studies demonstrated serine 20 phosphorylation impact mdm2 binding 15 rather phosphorylation stabilizes p300 binding p53 indirect consequence prevents mdm2 binding p53 23 genetic studies shown mutation serine 20 residue cell lines mice models attenuates p53 apoptotic activity 24 25 suggesting phosphorylation residue important p53 function mutation equivalent serine 20 residue murine p53 knockout known serine 20 kinase chk2 phenotype mice p53 protein still stabilized irradiation lower specific activity transcription factor apoptotic inducer 21 25 genetic data reinterpreted suggest role serine 20 phosphorylation stabilize p300 binding based following data p53 activity attenuated serine 20 phosphopeptide mimetics bind neutralize p300 9 ii full length p300 stabilized phosphorylation p53 activation domain serine 20 9 iii serine 20 phosphopeptides block dna dependent acetylation p53 p300 11 report show minimal ihd miniprotein bind preferentially full length p53 tetramers phosphorylated serine 20 ihd binding stimulated binding p53 consensus site dna fig 2 mimics full length p300 properties suggests ihd domain may important component p53 stabilization p300 dna damage via chk2 phosphorylation serine 20
0.4995434.15337767.html.plaintext.txt	51	means begin answering questions report fine mapped one p53 docking site p300 named ihd provided evidence minidomain p300 bona fide polypeptide binding domain possesses intrinsic ability bind peptides homology p53 lxxll activation domain one key feature ihd miniprotein mimics full length p300 stabilization phosphorylation serine 20 residue fig 2 although serine 20 phosphorylation function originally thought reduction mdm2 binding p53 biophysical studies demonstrated serine 20 phosphorylation impact mdm2 binding 15 rather phosphorylation stabilizes p300 binding p53 indirect consequence prevents mdm2 binding p53 23 genetic studies shown mutation serine 20 residue cell lines mice models attenuates p53 apoptotic activity 24 25 suggesting phosphorylation residue important p53 function mutation equivalent serine 20 residue murine p53 knockout known serine 20 kinase chk2 phenotype mice p53 protein still stabilized irradiation lower specific activity transcription factor apoptotic inducer 21 25 genetic data reinterpreted suggest role serine 20 phosphorylation stabilize p300 binding based following data p53 activity attenuated serine 20 phosphopeptide mimetics bind neutralize p300 9 ii full length p300 stabilized phosphorylation p53 activation domain serine 20 9 iii serine 20 phosphopeptides block dna dependent acetylation p53 p300 11 report show minimal ihd miniprotein bind preferentially full length p53 tetramers phosphorylated serine 20 ihd binding stimulated binding p53 consensus site dna fig 2 mimics full length p300 properties suggests ihd domain may important component p53 stabilization p300 dna damage via chk2 phosphorylation serine 20
0.4995434.15337767.html.plaintext.txt	52	based previous data suggested p300 minidomains ibid necessarily prefer specific polypeptide primary amino acid sequence work using phagepeptide display suggests ihd prefer specific peptide sequence find novel high affinity ligands ihd domain screened phage display peptide libraries ihd binding phage sequenced series clones encoding 12 mer peptides peptide sequences showed surprisingly good homology previously established p300 binding domain p53 14 25 amino acids confirming peptide plsqetfsdlwkllp region crucial interaction p300 p53 ihd responsible stabilizing p300p53 complexes transcriptionally competent underlined residues represent match phasepeptides p53 activation domain selection three submotif containing peptides lsq fs l l common experience technique therefore due overenrichment stickiness peptide class phage library example using full length p300 enriched proline repeat peptides pxxp using dapk3 enriched p21 like peptides rkkxt using ligand complexed mdm2 enriched variety peptides little homology p53 activation domain 10 14 18 using ligand free mdm2 control acquire peptides homology p53 activation domain consensus tfxxxwxxl fits known contacts mdm2 p53 activation domain structure 14
0.4995434.15337767.html.plaintext.txt	53	based previous data suggested p300 minidomains ibid necessarily prefer specific polypeptide primary amino acid sequence work using phagepeptide display suggests ihd prefer specific peptide sequence find novel high affinity ligands ihd domain screened phage display peptide libraries ihd binding phage sequenced series clones encoding 12 mer peptides peptide sequences showed surprisingly good homology previously established p300 binding domain p53 14 25 amino acids confirming peptide plsqetfsdlwkllp region crucial interaction p300 p53 ihd responsible stabilizing p300p53 complexes transcriptionally competent underlined residues represent match phasepeptides p53 activation domain selection three submotif containing peptides lsq fs l l common experience technique therefore due overenrichment stickiness peptide class phage library example using full length p300 enriched proline repeat peptides pxxp using dapk3 enriched p21 like peptides rkkxt using ligand complexed mdm2 enriched variety peptides little homology p53 activation domain 10 14 18 using ligand free mdm2 control acquire peptides homology p53 activation domain consensus tfxxxwxxl fits known contacts mdm2 p53 activation domain structure 14
0.4995434.15337767.html.plaintext.txt	54	another advantage phage peptide display peptide consensus sequences developed used identify novel binding partners used identify hsp90 novel mdm2 binding protein controls p53 unfolding identified novel cell cycle substrates interferon induced kinase dapk3 14 18 proline repeat peptides pulled using p300 bait 10 identified large panel lxxll containing transcription factors like p53 flanking lxxll motifs contiguous pxxp pxpxp motif transactivation domain examining ihd consensus peptides homology proteins databases several interesting transcription factors viral onco proteins possess ihd consensus sites could potentially interact also p300 docking site domain proteins include oncogenic ras related rab 721 cyclin g chk2 sv40 large antigen dna rna polymerases epstein barr nuclear antigen 6 ebna 6 fig 8 result large antigen could potentially bind p300 via ihd great interest since p53 responses abrogated presence antigen sv40 infection culminates degradation p53 loss proliferative control 19 thereby supporting notion antigen another mechanism disrupting critical activities tumor suppressor proteins fact antigen reported bind p300 20 may mediated part ihd domain
0.4995434.15337767.html.plaintext.txt	55	another advantage phage peptide display peptide consensus sequences developed used identify novel binding partners used identify hsp90 novel mdm2 binding protein controls p53 unfolding identified novel cell cycle substrates interferon induced kinase dapk3 14 18 proline repeat peptides pulled using p300 bait 10 identified large panel lxxll containing transcription factors like p53 flanking lxxll motifs contiguous pxxp pxpxp motif transactivation domain examining ihd consensus peptides homology proteins databases several interesting transcription factors viral onco proteins possess ihd consensus sites could potentially interact also p300 docking site domain proteins include oncogenic ras related rab 721 cyclin g chk2 sv40 large antigen dna rna polymerases epstein barr nuclear antigen 6 ebna 6 fig 8 result large antigen could potentially bind p300 via ihd great interest since p53 responses abrogated presence antigen sv40 infection culminates degradation p53 loss proliferative control 19 thereby supporting notion antigen another mechanism disrupting critical activities tumor suppressor proteins fact antigen reported bind p300 20 may mediated part ihd domain
0.4995434.15337767.html.plaintext.txt	56	summary characterized minimal ihd lxxll peptide binding region p300 determined display similar characteristics full length p300 including affinity lxxll containing peptides dna stimulated binding serine 20 phosphorylated p53 tetramers vivo interaction lxxll activation domain p53 future work involve determining dominance known lxxll binding domains p300 including ch1 ch3 ibid ihd domains effect dna dependent acetylation p53
0.4995434.15337767.html.plaintext.txt	57	summary characterized minimal ihd lxxll peptide binding region p300 determined display similar characteristics full length p300 including affinity lxxll containing peptides dna stimulated binding serine 20 phosphorylated p53 tetramers vivo interaction lxxll activation domain p53 future work involve determining dominance known lxxll binding domains p300 including ch1 ch3 ibid ihd domains effect dna dependent acetylation p53
0.4995434.15337767.html.plaintext.txt	58	footnotes costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.4995434.15337767.html.plaintext.txt	59	footnotes costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.4995434.15337767.html.plaintext.txt	60	correspondence addressed e mail tedhuppatedacuk u d
0.4995434.15337767.html.plaintext.txt	61	1 abbreviations used ibid interferon binding domain ihd ibid homology domain pbs phosphate buffered saline elisa enzyme linked immunosorbent assay mab monoclonal antibody creb camp response element binding protein rlu relative light units
0.4995434.15337767.html.plaintext.txt	62	references top abstract introduction experimental procedures results discussion references vousden k h lu x 2002 nat rev cancer 2 594 604crossrefmedline order article via infotrieve vogelstein b lane d levine j 2000 nature 408 307 310crossrefmedline order article via infotrieve grossman r 2001 eur j biochem 268 2773 2778abstractfree full text janknecht r 2002 histol histopathol 17 657 668medline order article via infotrieve chan h m la thangue n b 2001 j cell sci 114 2363 2373abstractfree full text arany rady p evers b m tyring k townsend c m jr 1994 surg oncol 3 153 159medline order article via infotrieve shikama n lutz w kretzschmar r sauter n roth j f marino wittwer j scheidweiler eckner r 2003 embo j 22 5175 5185abstractfree full text craig scott m burch l smith g ball k hupp 2003 embo rep 4 787 792abstractfree full text dornan d hupp r 2001 embo rep 2 139 144abstractfree full text dornan d shimizu h burch l smith j hupp r 2003 mol cell biol 23 8846 8861abstractfree full text dornan d shimizu h perkins n d hupp r 2003 j biol chem 278 13431 13441abstractfree full text lin c h hare b j wagner g harrison c maniatis fraenkel e 2001 mol cell 8 581 590medline order article via infotrieve hupp r lane d p 1994 curr biol 4 865 875medline order article via infotrieve burch l shimizu h smith patterson c hupp r 2004 j mol biol 337 129 145crossrefmedline order article via infotrieve schon o friedler bycroft m freund m fersht r 2002 j mol biol 323 491 501crossrefmedline order article via infotrieve tanaka n ishihara m lamphier m nozawa h matsuyama mak w aizawa tokino oren m taniguchi 1996 nature 382 816 818crossrefmedline order article via infotrieve lane d p hupp r 2003 drug discov today 8 347 355crossrefmedline order article via infotrieve burch l r scott m pohler e meek d hupp 2004 j mol biol 337 115 128crossrefmedline order article via infotrieve saenz robles m sullivan c pipas j m 2001 oncogene 20 7899 7907crossrefmedline order article via infotrieve eckner r ludlow j w lill n l oldread e arany z modjtahedi n decaprio j livingston d m morgan j 1996 mol cell biol 16 3454 3464abstract takai h naka k okada y watanabe m harada n saito anderson c w appella e nakanishi m suzuki h nagashima k sawa h ikeda k motoyama n 2002 embo j 21 5195 5205abstractfree full text dornan d eckart m shimizu h hupp ball kl 2004 mol cell biol press shimizu h hupp r 2003 trends biochem sci 28 346 349crossrefmedline order article via infotrieve unger juven gershon moallem e berger m vogt sionov r lozano g oren m haupt y 1999 embo j 18 1805 1814abstractfree full text macpherson d kim j kim rhee b k van oostrom c ditullio r venere m halazonetis d bronson r de vries fleming m jacks 2004 embo j press article abstract full text pdf versions article 2794749395 recent m405974200v1 purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager copyright permissions google scholar articles finlan l articles hupp r articles citing article pubmed pubmed citation articles finlan l articles hupp r
0.4995434.15337767.html.plaintext.txt	63	home help feedback subscriptions archive search table contents asbmb journals molecular cellular proteomics journal lipid research biochemistry molecular biology education copyright 2004 american society biochemistry molecular biology
0.50268346.12034830.html.plaintext.txt	0	interactions p53 hmsh2 hmsh6 hmg iy holliday junctions bulged bases deepa subramanian jack d griffith
0.50268346.12034830.html.plaintext.txt	1	lineberger comprehensive cancer center department microbiology immunology cb 7295 mason farm road university north carolina chapel hill chapel hill nc 27599 7295 usa
0.50268346.12034830.html.plaintext.txt	2	received february 6 2002 revised accepted april 9 2002
0.50268346.12034830.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references ability tumor suppressor protein p53 recognize certain types dna lesions may represent one mechanisms protein modulates cellular response dna damage p53 dna binding properties regulated several factors post translational modifications including phosphorylation acetylation regulation c terminal domain interactions cellular proteins substrates resembling holliday junctions extra base bulges used study effect three nuclear proteins hmg 1 hmg iy hmsh2 hmsh6 lesion binding properties p53 gel retardation assays revealed three proteins varying effects p53 binding substrates hmg 1 influence p53 binding holliday junctions 3 cytosine bulges hmg iy rapidly dissociated p53 complexes holliday junctions 3 cytosine bulges finally mismatch repair protein complex hmsh2 hmsh6 enhanced p53 binding substrates 3 4 fold together results demonstrate p53 dna binding activity highly influenced presence proteins dominant effect others negative effect
0.50268346.12034830.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references ability tumor suppressor protein p53 recognize certain types dna lesions may represent one mechanisms protein modulates cellular response dna damage p53 dna binding properties regulated several factors post translational modifications including phosphorylation acetylation regulation c terminal domain interactions cellular proteins substrates resembling holliday junctions extra base bulges used study effect three nuclear proteins hmg 1 hmg iy hmsh2 hmsh6 lesion binding properties p53 gel retardation assays revealed three proteins varying effects p53 binding substrates hmg 1 influence p53 binding holliday junctions 3 cytosine bulges hmg iy rapidly dissociated p53 complexes holliday junctions 3 cytosine bulges finally mismatch repair protein complex hmsh2 hmsh6 enhanced p53 binding substrates 3 4 fold together results demonstrate p53 dna binding activity highly influenced presence proteins dominant effect others negative effect
0.50268346.12034830.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references p53 key cell cycle checkpoint factor causes cells undergo either cell cycle arrest apoptosis following dna damage cells exposed uv x irradiation accumulation activation p53 reviewed 1 3 results downstream transactivation several genes whose products assist maintenance genomic integrity 45 however exact mechanism p53 activation following dna damage clear post translational modifications phosphorylation acetylation appear play important role process 67 additionally transcriptional response p53 requires tetramerization could influenced several factors 8 finally p53 activity could altered interactions proteins indeed p53 shown associate vitro vivo number proteins involved dna metabolic processes repair xpb xpd 9 wrn 10 replication dna polymerase 11 rpa 12 recombination hrad51 13
0.50268346.12034830.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references p53 key cell cycle checkpoint factor causes cells undergo either cell cycle arrest apoptosis following dna damage cells exposed uv x irradiation accumulation activation p53 reviewed 1 3 results downstream transactivation several genes whose products assist maintenance genomic integrity 45 however exact mechanism p53 activation following dna damage clear post translational modifications phosphorylation acetylation appear play important role process 67 additionally transcriptional response p53 requires tetramerization could influenced several factors 8 finally p53 activity could altered interactions proteins indeed p53 shown associate vitro vivo number proteins involved dna metabolic processes repair xpb xpd 9 wrn 10 replication dna polymerase 11 rpa 12 recombination hrad51 13
0.50268346.12034830.html.plaintext.txt	7	although p53 response dna damage largely mediated downstream proteins increasing evidence p53 directly interact dna lesions p53 bind single strand double strand breaks 14 three stranded dna structures 1516 extra base bulges 17 several basebase mismatches dna 18 additionally shown p53 binds extremely high affinity holliday junctions 16 lesions occur result typical recombination replication repair processes well dna damage caused environmental factors example holliday junctions natural intermediates homologous recombination however high levels sister chromatid exchange following irradiation suggests formation structures due dna damage 19 replication molecules containing thymidine dimers could result insertion additional nucleotides opposite existing lesion additionally two similar dna molecules non identical bases undergo recombination regions extra base bulges mismatches left behind replication errors also lead generation mismatches extra base bulges dna lesions need repaired cell cycle progression occur high affinity p53 several lesions strongly points important role damage recognition well downstream repair recombination pathways thus p53 response lesions dna caused normal metabolic processes dna damaging agents may 2 fold first transactive downstream genes enable cell cycle arrest apoptosis secondly recognize bind lesions signal repair pathways
0.50268346.12034830.html.plaintext.txt	8	although p53 response dna damage largely mediated downstream proteins increasing evidence p53 directly interact dna lesions p53 bind single strand double strand breaks 14 three stranded dna structures 1516 extra base bulges 17 several basebase mismatches dna 18 additionally shown p53 binds extremely high affinity holliday junctions 16 lesions occur result typical recombination replication repair processes well dna damage caused environmental factors example holliday junctions natural intermediates homologous recombination however high levels sister chromatid exchange following irradiation suggests formation structures due dna damage 19 replication molecules containing thymidine dimers could result insertion additional nucleotides opposite existing lesion additionally two similar dna molecules non identical bases undergo recombination regions extra base bulges mismatches left behind replication errors also lead generation mismatches extra base bulges dna lesions need repaired cell cycle progression occur high affinity p53 several lesions strongly points important role damage recognition well downstream repair recombination pathways thus p53 response lesions dna caused normal metabolic processes dna damaging agents may 2 fold first transactive downstream genes enable cell cycle arrest apoptosis secondly recognize bind lesions signal repair pathways
0.50268346.12034830.html.plaintext.txt	9	importance p53 dna binding sequence dependent transactivation sequence independent lesion recognition suggests activity tightly regulated number factors ensure proper p53 function correct times cell cycle p53 dna binding activity affected post translational modifications phosphorylation acetylation sumolation reviewed 20 binding monoclonal antibody pab421 2122 well interaction single strand dna 23 activates sequence specific dna binding identification several cellular viral proteins associate p53 suggests protein protein interactions play important role regulation dna binding activity supported demonstration ref 1 potent activator p53 dna binding activity 24 additionally jayaraman et al 25 shown high mobility group hmg protein hmg 1 stimulates sequence specific p53 dna binding
0.50268346.12034830.html.plaintext.txt	10	importance p53 dna binding sequence dependent transactivation sequence independent lesion recognition suggests activity tightly regulated number factors ensure proper p53 function correct times cell cycle p53 dna binding activity affected post translational modifications phosphorylation acetylation sumolation reviewed 20 binding monoclonal antibody pab421 2122 well interaction single strand dna 23 activates sequence specific dna binding identification several cellular viral proteins associate p53 suggests protein protein interactions play important role regulation dna binding activity supported demonstration ref 1 potent activator p53 dna binding activity 24 additionally jayaraman et al 25 shown high mobility group hmg protein hmg 1 stimulates sequence specific p53 dna binding
0.50268346.12034830.html.plaintext.txt	11	hmg proteins among largest group non histone chromatin proteins hmg proteins classified three groups hmg 12 hmg iy hmg 1417 families reviewed 26 exact cellular functions proteins fully understood architectural elements bind unusual structures dna low sequence specificity hmg 12 family abundant group proteins interact dna two conserved dna binding domains known hmg boxes 2728 preferentially bind dna structures contain sharp angles cruciforms four way junctions 29 well cisplatin dna adducts 3031 hmg iy proteins contain hook domains serve dna binding motifs recognize four way junctions 32 groups proteins induce bends linear dna templates well introduce supercoils topologically constrained molecules 33 growing evidence proteins may represent new class chaperone factors facilitate interactions proteins respective target sequence example hmg 1 induces structural change target sequence progesterone receptor thus facilitating protein binding 34 additionally hmg iy shown regulate long range enhancer dependent transcription altering dna topology 35 finally mentioned hmg 1 enhance sequence specific binding p53 25 thus group proteins seems enable loading proteins target sequences ability hmg group proteins recognize unusual dna structures influence various protein dna interactions well fact hmg 1 stimulates sequence specific binding p53 makes good candidates factors might affect lesion binding properties p53 thus critical ask whether hmg proteins influences p53 recognition dna damage study effects two hmg group proteins hmg 1 hmg iy p53 binding dna lesions examined two different substrates one containing three 3 cytosine bulges resembling holliday junctions used monitor effect hmg proteins p53 dna binding activity gel retardation assays
0.50268346.12034830.html.plaintext.txt	12	hmg proteins among largest group non histone chromatin proteins hmg proteins classified three groups hmg 12 hmg iy hmg 1417 families reviewed 26 exact cellular functions proteins fully understood architectural elements bind unusual structures dna low sequence specificity hmg 12 family abundant group proteins interact dna two conserved dna binding domains known hmg boxes 2728 preferentially bind dna structures contain sharp angles cruciforms four way junctions 29 well cisplatin dna adducts 3031 hmg iy proteins contain hook domains serve dna binding motifs recognize four way junctions 32 groups proteins induce bends linear dna templates well introduce supercoils topologically constrained molecules 33 growing evidence proteins may represent new class chaperone factors facilitate interactions proteins respective target sequence example hmg 1 induces structural change target sequence progesterone receptor thus facilitating protein binding 34 additionally hmg iy shown regulate long range enhancer dependent transcription altering dna topology 35 finally mentioned hmg 1 enhance sequence specific binding p53 25 thus group proteins seems enable loading proteins target sequences ability hmg group proteins recognize unusual dna structures influence various protein dna interactions well fact hmg 1 stimulates sequence specific binding p53 makes good candidates factors might affect lesion binding properties p53 thus critical ask whether hmg proteins influences p53 recognition dna damage study effects two hmg group proteins hmg 1 hmg iy p53 binding dna lesions examined two different substrates one containing three 3 cytosine bulges resembling holliday junctions used monitor effect hmg proteins p53 dna binding activity gel retardation assays
0.50268346.12034830.html.plaintext.txt	13	lesions mismatches extra base bulges recognized escherichia coli mismatch repair protein muts eukaryotic counterparts msh2 msh3 msh6 36 references therein p53 hmsh2 hmsh6 share number common features recognize extra base bulges holliday junctions vitro 16173738 proteins inhibit dna recombination encounter dna lesions vivo vitro 3940 additionally proteins play important role genome maintenance interacting repair replication factors relevance p53 lesion recognition events within cell demonstrated comparing effect hmg proteins dna binding activity hmsh2 hmsh6 results indicate hmg iy effectively compete p53 hmsh2 hmsh6 holliday junction binding however hmg iy effect p53 binding 3 cytosine bulges dissociating hmsh2 hmsh6 complexes substrate hand found hmsh2 hmsh6 stimulatory effect p53 binding holliday junctions 3 cytosine bulges thus p53 lesion binding activity modulated different ways negative regulation seen hmg iy positive hmsh2 hmsh6
0.50268346.12034830.html.plaintext.txt	14	lesions mismatches extra base bulges recognized escherichia coli mismatch repair protein muts eukaryotic counterparts msh2 msh3 msh6 36 references therein p53 hmsh2 hmsh6 share number common features recognize extra base bulges holliday junctions vitro 16173738 proteins inhibit dna recombination encounter dna lesions vivo vitro 3940 additionally proteins play important role genome maintenance interacting repair replication factors relevance p53 lesion recognition events within cell demonstrated comparing effect hmg proteins dna binding activity hmsh2 hmsh6 results indicate hmg iy effectively compete p53 hmsh2 hmsh6 holliday junction binding however hmg iy effect p53 binding 3 cytosine bulges dissociating hmsh2 hmsh6 complexes substrate hand found hmsh2 hmsh6 stimulatory effect p53 binding holliday junctions 3 cytosine bulges thus p53 lesion binding activity modulated different ways negative regulation seen hmg iy positive hmsh2 hmsh6
0.50268346.12034830.html.plaintext.txt	15	materials methods top abstract introduction materials methods results discussion references dna probes four way junction probes prepared annealing four oligonucleotides k1 k2 k3 k4 synthesized hplc purified gibco brl inc produce j12 junctions described previously 16 briefly oligonucleotide k1 end labeled 32patp using t4 polynucleotide kinase neb inc followed addition equal amounts three oligonucleotides unlabeled mixture heated 65 degrees c 10 min presence 04 m nacl allowed slowly cool room temperature 6 24 h duplex control probe prepared annealing oligonucleotide containing complementary sequence labeled k1 strand annealed products purified 10 non denaturing polyacrylamide gels probe containing 3 cytosine bulges prepared annealing 79 nt oligonucleotide 5 agt cgg aat tcg gct cga ccc agg ccc cgt ccc tct cgg agc act gca gaa ccg ctt tgg ccg ccg ccg gat ccc gag 3 70 nt oligonucleotide 5 act cgg gat ccg gcg gcg gcc aaa gcg gtt ctg cag tcg tcc gag aac ggg ttc gag ccg aat tcc cag 3 results duplex probe three sets 3 cytosine bulges top strand indicated bold described top strand first end labeled followed annealing bottom strand purification 10 polyacrylamide gel
0.50268346.12034830.html.plaintext.txt	16	materials methods top abstract introduction materials methods results discussion references dna probes four way junction probes prepared annealing four oligonucleotides k1 k2 k3 k4 synthesized hplc purified gibco brl inc produce j12 junctions described previously 16 briefly oligonucleotide k1 end labeled 32patp using t4 polynucleotide kinase neb inc followed addition equal amounts three oligonucleotides unlabeled mixture heated 65 degrees c 10 min presence 04 m nacl allowed slowly cool room temperature 6 24 h duplex control probe prepared annealing oligonucleotide containing complementary sequence labeled k1 strand annealed products purified 10 non denaturing polyacrylamide gels probe containing 3 cytosine bulges prepared annealing 79 nt oligonucleotide 5 agt cgg aat tcg gct cga ccc agg ccc cgt ccc tct cgg agc act gca gaa ccg ctt tgg ccg ccg ccg gat ccc gag 3 70 nt oligonucleotide 5 act cgg gat ccg gcg gcg gcc aaa gcg gtt ctg cag tcg tcc gag aac ggg ttc gag ccg aat tcc cag 3 results duplex probe three sets 3 cytosine bulges top strand indicated bold described top strand first end labeled followed annealing bottom strand purification 10 polyacrylamide gel
0.50268346.12034830.html.plaintext.txt	17	proteins human p53 overexpressed insect sf9 cells using baculovirus vector provided dr arnold levine purified described previously 41 hmsh2 hmsh6 heterodimer purified described previously baculovirus infected cells using vector provided dr richard fishel 42
0.50268346.12034830.html.plaintext.txt	18	proteins human p53 overexpressed insect sf9 cells using baculovirus vector provided dr arnold levine purified described previously 41 hmsh2 hmsh6 heterodimer purified described previously baculovirus infected cells using vector provided dr richard fishel 42
0.50268346.12034830.html.plaintext.txt	19	hmg1 purified calf thymus tissue described previously 43 approximately 07 mg hmg 1 molecular weight 28 kda recovered 65 g calf thymus tissue protein found protease nuclease free protein purified 95 homogeneity determined sds page analysis reactive anti hmg 1 antibody anti hmg 2 antibody western blots data shown
0.50268346.12034830.html.plaintext.txt	20	hmg iy overexpressed ecoli purified described previously 44 using vector provided dr michael bustin approximately 08 mg hmg iy molecular weight 22 kda obtained 15 l bacterial cells protein 95 homogeneity determined sds page found free nuclease protease activity
0.50268346.12034830.html.plaintext.txt	21	hmg iy overexpressed ecoli purified described previously 44 using vector provided dr michael bustin approximately 08 mg hmg iy molecular weight 22 kda obtained 15 l bacterial cells protein 95 homogeneity determined sds page found free nuclease protease activity
0.50268346.12034830.html.plaintext.txt	22	gel retardation assays reactions 20 microl containing probes 75 nm proteins see figure legends concentrations incubated room temperature 20 min buffer containing 10 mm hepes koh ph 78 25 mm kcl 05 mm dtt 001 mm edta 10 glycerol 50 ng salmon sperm dna non specific competitor reactions adjusted 10 glycerol loaded 5 non denaturing polyacrylamide gels 05x tbe 45 mm tris borate 1 mm edta gels run 200 v 25 h 4 degrees c dried analyzed autoradiography quantified using storm 840 phosphoimager molecular dynamics
0.50268346.12034830.html.plaintext.txt	23	gel retardation assays reactions 20 microl containing probes 75 nm proteins see figure legends concentrations incubated room temperature 20 min buffer containing 10 mm hepes koh ph 78 25 mm kcl 05 mm dtt 001 mm edta 10 glycerol 50 ng salmon sperm dna non specific competitor reactions adjusted 10 glycerol loaded 5 non denaturing polyacrylamide gels 05x tbe 45 mm tris borate 1 mm edta gels run 200 v 25 h 4 degrees c dried analyzed autoradiography quantified using storm 840 phosphoimager molecular dynamics
0.50268346.12034830.html.plaintext.txt	24	results top abstract introduction materials methods results discussion references hmg 1 stimulate p53 binding holliday junctions templates resemble holliday junctions prepared annealing four oligonucleotides based j12 molecule properties described previously 45 creates four way junction crossover point centrally located capable branch migrating 12 bp core junctions used extensively model junctions binding studies p53 ymsh2 ymsh2 ymsh6 163846 gel retardation assays performed determine whether hmg 1 influences p53 binding holliday junctions p53 hmg 1 incubated probes room temperature 20 min followed separation proteindna complexes free dna non denaturing polyacrylamide gel electrophoresis molar ratios 110 115 dna p53 tetramers used increasing amounts hmg 1 added achieve p53 hmg 1 molar ratio ranged 101 12 duplex dna containing one strands j12 junction complementary sequence lower strand used negative control observed previously p53 high affinity four way junctions fig 1 lanes 2 8 bind duplex control lane 16 indicating specificity protein four way structures increasing amounts hmg 1 added p53 containing reactions visible change levels p53holliday junction complexes lanes 3 7 9 13 even 10 fold excess hmg 1 p53 elicit increase p53 binding holliday junctions data shown activity hmg 1 confirmed examining ability enhance p53 sequence specific binding concurrence data jayaraman et al 25 p53 binding consensus sequence stimulated addition purified hmg 1 concentrations used holliday junction templates data shown results indicate hmg 1 purified active enhance p53 binding holliday junctions hmg 1 involved promoting p53 binding consensus sequence another member family proteins may responsible regulating binding holliday junctions lesions dna
0.50268346.12034830.html.plaintext.txt	25	results top abstract introduction materials methods results discussion references hmg 1 stimulate p53 binding holliday junctions templates resemble holliday junctions prepared annealing four oligonucleotides based j12 molecule properties described previously 45 creates four way junction crossover point centrally located capable branch migrating 12 bp core junctions used extensively model junctions binding studies p53 ymsh2 ymsh2 ymsh6 163846 gel retardation assays performed determine whether hmg 1 influences p53 binding holliday junctions p53 hmg 1 incubated probes room temperature 20 min followed separation proteindna complexes free dna non denaturing polyacrylamide gel electrophoresis molar ratios 110 115 dna p53 tetramers used increasing amounts hmg 1 added achieve p53 hmg 1 molar ratio ranged 101 12 duplex dna containing one strands j12 junction complementary sequence lower strand used negative control observed previously p53 high affinity four way junctions fig 1 lanes 2 8 bind duplex control lane 16 indicating specificity protein four way structures increasing amounts hmg 1 added p53 containing reactions visible change levels p53holliday junction complexes lanes 3 7 9 13 even 10 fold excess hmg 1 p53 elicit increase p53 binding holliday junctions data shown activity hmg 1 confirmed examining ability enhance p53 sequence specific binding concurrence data jayaraman et al 25 p53 binding consensus sequence stimulated addition purified hmg 1 concentrations used holliday junction templates data shown results indicate hmg 1 purified active enhance p53 binding holliday junctions hmg 1 involved promoting p53 binding consensus sequence another member family proteins may responsible regulating binding holliday junctions lesions dna
0.50268346.12034830.html.plaintext.txt	26	view larger version 74k figure 1 hmg 1 significantly affect p53 binding holliday junctions holliday junction probes 75 nm incubated p53 hmg iy proteins room temperature 20 min reaction products separated non denaturing polyacrylamide gel electrophoresis followed autoradiography lanes 1 15 probe lanes 2 7 16 75 nm p53 lanes 8 13 115 nm p53 lanes 3 9 10 nm hmg1 lanes 4 10 20 nm hmg1 lanes 5 11 40 nm hmg1 lanes 6 12 80 nm hmg1 lanes 7 13 170 nm hmg1 lanes 14 17 17 nm hmg1 arrows brackets indicate positions probe p53dna complexes hmg1dna complexes
0.50268346.12034830.html.plaintext.txt	27	view larger version 74k figure 1 hmg 1 significantly affect p53 binding holliday junctions holliday junction probes 75 nm incubated p53 hmg iy proteins room temperature 20 min reaction products separated non denaturing polyacrylamide gel electrophoresis followed autoradiography lanes 1 15 probe lanes 2 7 16 75 nm p53 lanes 8 13 115 nm p53 lanes 3 9 10 nm hmg1 lanes 4 10 20 nm hmg1 lanes 5 11 40 nm hmg1 lanes 6 12 80 nm hmg1 lanes 7 13 170 nm hmg1 lanes 14 17 17 nm hmg1 arrows brackets indicate positions probe p53dna complexes hmg1dna complexes
0.50268346.12034830.html.plaintext.txt	28	hmg iy causes dissociation p53 holliday junction substrates hmg iy class proteins shown different spectrum activities hmg 1 much higher affinity four way junctions 47 thus proteins seemed likely influence binding p53 holliday junction molecules gel retardation assays performed using conditions hmg 1 reactions p53 added 110 ratio dna tetramers molar ratio p53 hmg iy ranged 101 12 shown figure 2a absence hmg iy p53 bound high affinity holliday junction probes lane 2 hmg iy also bound holliday junction probes lane 8 well duplex probe lane 14 albeit lower level four way junctions hmg iyholliday junction complexes higher mobility p53 complexes thus allowing clear distinction two protein dna species p53 hmg iy incubated together holliday junction probe decrease specific p53dna complexes increasing amounts hmg iy added lanes 3 7 addition 20 nm hmg iy caused almost complete elimination p53holliday junction complexes seen figure 2a multiple hmg iydna complexes detected higher amounts protein added lanes 7 8 likely concentration template saturated hmg iy making unavailable p53 however 10 nm hmg iy added represents equimolar ratio protein dna unbound probe seen gel indicating substrate available binding yet p53dna complexes reduced 20 results suggest active dissociation p53holliday junction interactions hmg iy
0.50268346.12034830.html.plaintext.txt	29	hmg iy causes dissociation p53 holliday junction substrates hmg iy class proteins shown different spectrum activities hmg 1 much higher affinity four way junctions 47 thus proteins seemed likely influence binding p53 holliday junction molecules gel retardation assays performed using conditions hmg 1 reactions p53 added 110 ratio dna tetramers molar ratio p53 hmg iy ranged 101 12 shown figure 2a absence hmg iy p53 bound high affinity holliday junction probes lane 2 hmg iy also bound holliday junction probes lane 8 well duplex probe lane 14 albeit lower level four way junctions hmg iyholliday junction complexes higher mobility p53 complexes thus allowing clear distinction two protein dna species p53 hmg iy incubated together holliday junction probe decrease specific p53dna complexes increasing amounts hmg iy added lanes 3 7 addition 20 nm hmg iy caused almost complete elimination p53holliday junction complexes seen figure 2a multiple hmg iydna complexes detected higher amounts protein added lanes 7 8 likely concentration template saturated hmg iy making unavailable p53 however 10 nm hmg iy added represents equimolar ratio protein dna unbound probe seen gel indicating substrate available binding yet p53dna complexes reduced 20 results suggest active dissociation p53holliday junction interactions hmg iy
0.50268346.12034830.html.plaintext.txt	30	view larger version 68k figure 2 hmg iy effects p53 complexes holliday junction 3 cytosine bulge probes dissociation p53holliday junction complexes hmg iy holliday junction duplex probes 75 nm incubated either p53 hmg iy proteins room temperature 20 min reaction products separated non denaturing polyacrylamide gel electrophoresis followed autoradiography concentrations proteins used indicated lane arrows brackets indicate positions probe p53dna complexes hmg iydna complexes b pre formed p53holliday junction complexes also dissociated hmg iy holliday junction probes 75 nm pre incubated p53 115 nm 20 min followed addition hmg iy 20 nm increasing amounts time reaction products analyzed non denaturing polyacrylamide gel electrophoresis c rate dissociation p53holliday junction complexes similar three concentrations p53 tested holliday junction probes incubated 34 nm circles 75 nm squares 115 nm p53 triangles presence increasing amounts hmg iy followed gel retardation assays p53dna complexes quantified normalized complex formation absence hmg iy plotted function hmg iy concentration
0.50268346.12034830.html.plaintext.txt	31	view larger version 68k figure 2 hmg iy effects p53 complexes holliday junction 3 cytosine bulge probes dissociation p53holliday junction complexes hmg iy holliday junction duplex probes 75 nm incubated either p53 hmg iy proteins room temperature 20 min reaction products separated non denaturing polyacrylamide gel electrophoresis followed autoradiography concentrations proteins used indicated lane arrows brackets indicate positions probe p53dna complexes hmg iydna complexes b pre formed p53holliday junction complexes also dissociated hmg iy holliday junction probes 75 nm pre incubated p53 115 nm 20 min followed addition hmg iy 20 nm increasing amounts time reaction products analyzed non denaturing polyacrylamide gel electrophoresis c rate dissociation p53holliday junction complexes similar three concentrations p53 tested holliday junction probes incubated 34 nm circles 75 nm squares 115 nm p53 triangles presence increasing amounts hmg iy followed gel retardation assays p53dna complexes quantified normalized complex formation absence hmg iy plotted function hmg iy concentration
0.50268346.12034830.html.plaintext.txt	32	examine mechanism hmg iy eliminates p53 interactions holliday junctions p53dna complexes pre formed incubating protein probe 20 min room temperature followed addition hmg iy various amounts time hmg iy competes p53 binding sites p53 bound holliday junctions unavailable hmg iy would continue exist time however hmg iy dissociates p53 dna complexes would disappear time course seen figure 2b pre formed p53holliday junction interactions eliminated within 2 min hmg iy addition results indicate hmg iy able dissociate p53 actively holliday junctions
0.50268346.12034830.html.plaintext.txt	33	examine mechanism hmg iy eliminates p53 interactions holliday junctions p53dna complexes pre formed incubating protein probe 20 min room temperature followed addition hmg iy various amounts time hmg iy competes p53 binding sites p53 bound holliday junctions unavailable hmg iy would continue exist time however hmg iy dissociates p53 dna complexes would disappear time course seen figure 2b pre formed p53holliday junction interactions eliminated within 2 min hmg iy addition results indicate hmg iy able dissociate p53 actively holliday junctions
0.50268346.12034830.html.plaintext.txt	34	measure rate dissociation p53dna complexes increasing amounts hmg iy added three different concentrations p53 gel retardation assays p53dna complexes quantified binding absence hmg iy considered 100 fold reduction p53dna complexes determined plotted function hmg iy concentration fig 2c approximately 40 nm hmg iy sufficient cause 50 reduction p53dna complexes three concentrations protein tested would correspond 02 molecules hmg iy per p53 tetramer highest concentration p53 tested
0.50268346.12034830.html.plaintext.txt	35	measure rate dissociation p53dna complexes increasing amounts hmg iy added three different concentrations p53 gel retardation assays p53dna complexes quantified binding absence hmg iy considered 100 fold reduction p53dna complexes determined plotted function hmg iy concentration fig 2c approximately 40 nm hmg iy sufficient cause 50 reduction p53dna complexes three concentrations protein tested would correspond 02 molecules hmg iy per p53 tetramer highest concentration p53 tested
0.50268346.12034830.html.plaintext.txt	36	hmg iy affect interaction p53 3 cytosine bulges previously showed p53 binds substrates containing single multiple 3 cytosine bulges presence three 3 cytosine bulges could result severe kink duplex dna shown hmg proteins tend bind distortions dna 48 determine whether hmg iy effect p53 binding recombination products dna molecules designed contain three 3 cytosine bulges separated 3 bp one strands see materials methods gel retardation assays performed using ratios p53 hmg iy used holliday junction probe fig 3a complexes p53 3 cytosine bulge detected absence hmg iy lane 2 however upon addition hmg iy complexes remained either unchanged showed slight increase complexes quantified normalized value detected absence hmg iy plotted function hmg iy concentration fig 3b results show hmg iy significantly influence p53 interactions 3 cytosine bulge probe complex formation remained fairly constant across range hmg iy tested fact slight increase detected concentrations tested hmg iy bind 3 cytosine bulge probe lane 3 however since probe smaller holliday junction template complexes effectively separate free probe therefore likely hmg iy interacts 3 cytosine bulges manner affect p53 binding substrates
0.50268346.12034830.html.plaintext.txt	37	hmg iy affect interaction p53 3 cytosine bulges previously showed p53 binds substrates containing single multiple 3 cytosine bulges presence three 3 cytosine bulges could result severe kink duplex dna shown hmg proteins tend bind distortions dna 48 determine whether hmg iy effect p53 binding recombination products dna molecules designed contain three 3 cytosine bulges separated 3 bp one strands see materials methods gel retardation assays performed using ratios p53 hmg iy used holliday junction probe fig 3a complexes p53 3 cytosine bulge detected absence hmg iy lane 2 however upon addition hmg iy complexes remained either unchanged showed slight increase complexes quantified normalized value detected absence hmg iy plotted function hmg iy concentration fig 3b results show hmg iy significantly influence p53 interactions 3 cytosine bulge probe complex formation remained fairly constant across range hmg iy tested fact slight increase detected concentrations tested hmg iy bind 3 cytosine bulge probe lane 3 however since probe smaller holliday junction template complexes effectively separate free probe therefore likely hmg iy interacts 3 cytosine bulges manner affect p53 binding substrates
0.50268346.12034830.html.plaintext.txt	38	view larger version 33k figure 3 effect hmg iy p53 binding 3 cytosine bulge containing templates hmg iy significant effect p53 binding dna containing 3 cytosine bulges 3 cytosine bulge probe 75 nm incubated 75 nm p53 increasing amounts hmg iy products analyzed gel retardation assays protein concentrations indicated lanes b p53 complexes 3 cytosine bulge probe remain constant concentrations hmg iy tested probes containing 3 cytosine bulges 75 nm incubated 75 nm circles 115 nm p53 squares presence increasing amounts hmg iy followed gel retardation assays p53dna complexes quantified plotted function hmg iy concentration
0.50268346.12034830.html.plaintext.txt	39	view larger version 33k figure 3 effect hmg iy p53 binding 3 cytosine bulge containing templates hmg iy significant effect p53 binding dna containing 3 cytosine bulges 3 cytosine bulge probe 75 nm incubated 75 nm p53 increasing amounts hmg iy products analyzed gel retardation assays protein concentrations indicated lanes b p53 complexes 3 cytosine bulge probe remain constant concentrations hmg iy tested probes containing 3 cytosine bulges 75 nm incubated 75 nm circles 115 nm p53 squares presence increasing amounts hmg iy followed gel retardation assays p53dna complexes quantified plotted function hmg iy concentration
0.50268346.12034830.html.plaintext.txt	40	hmg iy dissociates hmsh2 msh6 complexes formed holliday junctions 3 cytosine bulges holliday junctions 3 cytosine bulges also recognized mismatch repair protein complex hmsh2 hmsh6 participates proteins repair lesions via mismatch recombination repair pathways determine whether hmg iy affects hmsh2 hmsh6 binding activity gel retardation assays performed using holliday junction probes two proteins seen figure 4a hmsh2 hmsh6 110 molar ratio dna heterodimers showed strong binding holliday junction probes lane 2 low level binding also seen duplex control lane 9 expected hmsh2 hmsh6 shown exhibit non specific dna binding 42 addition increasing amounts hmg iy resulted decrease hmsh2 hmsh6dna complexes fig 4a dissociation curve complexes resembled seen p53 compare figs 2c 4b complexes reduced 50 addition 20 nm hmg iy concentrations hmsh2 hmsh6 tested found hmg iy also caused dissociation hmsh2 hmsh6 binding 3 cytosine bulge preferred target lesion repair protein fig 4b hmsh2 hmsh6dna complexes probes quantified normalized complex formation absence hmg iy plotted function hmg iy concentration fig 4b found rate dissociation 3 cytosine bulge complexes slightly slower holliday junction probe thus hmg iy effect p53 hmsh2 hmsh6 binding similar holliday junction template quite different 3 cytosine bulge substrate
0.50268346.12034830.html.plaintext.txt	41	hmg iy dissociates hmsh2 msh6 complexes formed holliday junctions 3 cytosine bulges holliday junctions 3 cytosine bulges also recognized mismatch repair protein complex hmsh2 hmsh6 participates proteins repair lesions via mismatch recombination repair pathways determine whether hmg iy affects hmsh2 hmsh6 binding activity gel retardation assays performed using holliday junction probes two proteins seen figure 4a hmsh2 hmsh6 110 molar ratio dna heterodimers showed strong binding holliday junction probes lane 2 low level binding also seen duplex control lane 9 expected hmsh2 hmsh6 shown exhibit non specific dna binding 42 addition increasing amounts hmg iy resulted decrease hmsh2 hmsh6dna complexes fig 4a dissociation curve complexes resembled seen p53 compare figs 2c 4b complexes reduced 50 addition 20 nm hmg iy concentrations hmsh2 hmsh6 tested found hmg iy also caused dissociation hmsh2 hmsh6 binding 3 cytosine bulge preferred target lesion repair protein fig 4b hmsh2 hmsh6dna complexes probes quantified normalized complex formation absence hmg iy plotted function hmg iy concentration fig 4b found rate dissociation 3 cytosine bulge complexes slightly slower holliday junction probe thus hmg iy effect p53 hmsh2 hmsh6 binding similar holliday junction template quite different 3 cytosine bulge substrate
0.50268346.12034830.html.plaintext.txt	42	view larger version 59k figure 4 hmg iy effects hmsh2 hmsh6 complexes holliday junction 3 cytosine bulge templates hmg iy dissociates hmsh2 hmsh6 complexes holliday junctions 3 cytosine bulges holliday junction duplex 3 cytosine bulge probes 75 nm incubated hmsh2 hmsh6 hmg iy proteins room temperature 20 min reaction products separated non denaturing polyacrylamide gel electrophoresis followed autoradiography protein concentrations indicated lane arrows brackets indicate positions probe hmsh2 hmsh6dna complexes hmg iydna complexes b hmg iy causes dissociation hmsh2 hmsh6 complexes holliday junction probes rate 3 cytosine bulge probes probes containing 3 cytosine bulges holliday junctions 75 nm incubated 75 nm hmsh2 hmsh6 presence increasing amounts hmg iy followed gel retardation assays proteindna complexes quantified plotted function hmg iy concentration
0.50268346.12034830.html.plaintext.txt	43	view larger version 59k figure 4 hmg iy effects hmsh2 hmsh6 complexes holliday junction 3 cytosine bulge templates hmg iy dissociates hmsh2 hmsh6 complexes holliday junctions 3 cytosine bulges holliday junction duplex 3 cytosine bulge probes 75 nm incubated hmsh2 hmsh6 hmg iy proteins room temperature 20 min reaction products separated non denaturing polyacrylamide gel electrophoresis followed autoradiography protein concentrations indicated lane arrows brackets indicate positions probe hmsh2 hmsh6dna complexes hmg iydna complexes b hmg iy causes dissociation hmsh2 hmsh6 complexes holliday junction probes rate 3 cytosine bulge probes probes containing 3 cytosine bulges holliday junctions 75 nm incubated 75 nm hmsh2 hmsh6 presence increasing amounts hmg iy followed gel retardation assays proteindna complexes quantified plotted function hmg iy concentration
0.50268346.12034830.html.plaintext.txt	44	hmsh2 hmsh6 enhances p53 complex formation holliday junctions 3 cytosine bulges studies found hmg iy protein binds four way junction structures competes p53 hmsh2 hmsh6 substrate results imply hmg iy higher affinity holliday junctions two proteins places dna conformation unfavorable p53 hmsh2 hmsh6 binding also possible latter proteins labile readily associate dissociate dna explore nature p53 hmsh2 hmsh6 complexes four way junctions 3 cytosine bulges interaction proteins two probes tested gel retardation assays two proteins show different mobilities respective complexes could easily distinguished fig 5a compare lane 3 lane 6 proteins present hmsh2 hmsh6 promoted p53 binding holliday junction compare lane 3 8 lane 4 9 lane 5 10 results indicate hmsh2 hmsh6 enhances p53 binding holliday junctions appears assist loading p53 template hand presence p53 decrease hmsh2 hmsh6dna complexes compare lane 6 lane 10 free probe detected reactions containing proteins indicating loss hmsh2 hmsh6 complexes due dissociation p53 lack substrate dna p53dna complexes absence presence increasing amounts hmsh2 hmsh6 quantified results revealed 4 5 fold increase p53 binding holliday junction probe hmsh2 hmsh6 added fig 5b interaction two proteins 3 cytosine bulge substrate also tested fig 5c similar holliday junction substrate increase p53dna complexes addition hmsh2 hmsh6 concomitant decrease hmsh2 hmsh6dna complexes thus contrast hmg iy p53 binding activity holliday junctions 3 cytosine bulges enhanced hmsh2 hmsh6
0.50268346.12034830.html.plaintext.txt	45	hmsh2 hmsh6 enhances p53 complex formation holliday junctions 3 cytosine bulges studies found hmg iy protein binds four way junction structures competes p53 hmsh2 hmsh6 substrate results imply hmg iy higher affinity holliday junctions two proteins places dna conformation unfavorable p53 hmsh2 hmsh6 binding also possible latter proteins labile readily associate dissociate dna explore nature p53 hmsh2 hmsh6 complexes four way junctions 3 cytosine bulges interaction proteins two probes tested gel retardation assays two proteins show different mobilities respective complexes could easily distinguished fig 5a compare lane 3 lane 6 proteins present hmsh2 hmsh6 promoted p53 binding holliday junction compare lane 3 8 lane 4 9 lane 5 10 results indicate hmsh2 hmsh6 enhances p53 binding holliday junctions appears assist loading p53 template hand presence p53 decrease hmsh2 hmsh6dna complexes compare lane 6 lane 10 free probe detected reactions containing proteins indicating loss hmsh2 hmsh6 complexes due dissociation p53 lack substrate dna p53dna complexes absence presence increasing amounts hmsh2 hmsh6 quantified results revealed 4 5 fold increase p53 binding holliday junction probe hmsh2 hmsh6 added fig 5b interaction two proteins 3 cytosine bulge substrate also tested fig 5c similar holliday junction substrate increase p53dna complexes addition hmsh2 hmsh6 concomitant decrease hmsh2 hmsh6dna complexes thus contrast hmg iy p53 binding activity holliday junctions 3 cytosine bulges enhanced hmsh2 hmsh6
0.50268346.12034830.html.plaintext.txt	46	view larger version 48k figure 5 hmsh2 hmsh6 effect p53 binding holliday junction 3 cytosine bulge templates hmsh2 hmsh6 induces p53 complex formation holliday junction substrates holliday junction probes 75 nm incubated either p53 hmsh2 hmsh6 proteins concentrations indicated lane complexes separated free probe gel retardation assays b quantification p53 complexes holliday junctions presence hmsh2 hmsh6 holliday junction probes 75 nm incubated 75 nm p53 0 17 34 51 65 nm hmsh2 hmsh6 complexes separated gel retardation assays n 4 p53dna complexes quantified fold increase complex formation plotted function hmsh2 hmsh6 concentration c hmsh2 hmsh6 induces p53 complex formation 3 cytosine bulges holliday junction probes 75 nm incubated either p53 hmsh2 hmsh6 proteins concentrations indicated lane complexes separated free probe gel retardation assays
0.50268346.12034830.html.plaintext.txt	47	view larger version 48k figure 5 hmsh2 hmsh6 effect p53 binding holliday junction 3 cytosine bulge templates hmsh2 hmsh6 induces p53 complex formation holliday junction substrates holliday junction probes 75 nm incubated either p53 hmsh2 hmsh6 proteins concentrations indicated lane complexes separated free probe gel retardation assays b quantification p53 complexes holliday junctions presence hmsh2 hmsh6 holliday junction probes 75 nm incubated 75 nm p53 0 17 34 51 65 nm hmsh2 hmsh6 complexes separated gel retardation assays n 4 p53dna complexes quantified fold increase complex formation plotted function hmsh2 hmsh6 concentration c hmsh2 hmsh6 induces p53 complex formation 3 cytosine bulges holliday junction probes 75 nm incubated either p53 hmsh2 hmsh6 proteins concentrations indicated lane complexes separated free probe gel retardation assays
0.50268346.12034830.html.plaintext.txt	48	discussion top abstract introduction materials methods results discussion references lesion binding p53 represents important biological feature protein date p53 shown bind range damage intermediates including 3 cytosine bulges holliday junctions well single double strand breaks role damage recognition downstream pathways clear one possibility activation p53 sequence specific binding enable transactivation various gene products play key role cell cycle arrest apoptosis additionally p53 interactions might facilitate direct recruitment repair recombination proteins resolution lesions finally binding damage sites may ensure p53 close proximity protein kinases activate p53 phosphorylating specific serine residues recent studies argued allosteric regulation p53 sequence specific binding vivo 49 thus damage binding may play important role recruitment repair factors events leading post translational modifications p53
0.50268346.12034830.html.plaintext.txt	49	discussion top abstract introduction materials methods results discussion references lesion binding p53 represents important biological feature protein date p53 shown bind range damage intermediates including 3 cytosine bulges holliday junctions well single double strand breaks role damage recognition downstream pathways clear one possibility activation p53 sequence specific binding enable transactivation various gene products play key role cell cycle arrest apoptosis additionally p53 interactions might facilitate direct recruitment repair recombination proteins resolution lesions finally binding damage sites may ensure p53 close proximity protein kinases activate p53 phosphorylating specific serine residues recent studies argued allosteric regulation p53 sequence specific binding vivo 49 thus damage binding may play important role recruitment repair factors events leading post translational modifications p53
0.50268346.12034830.html.plaintext.txt	50	multiple roles p53 dna recognition binding necessitate tight regulation protein host factors ensure proper interactions various recognition sites study effect three different proteins p53 binding holliday junctions extra base bulges examined two members hmg group proteins hmg 1 hmg iy mismatch repair protein hmsh2 hmsh6 tested binding properties p53 substrates modulated different ways proteins found hmg 1 effect p53 binding either substrate hand hmg iy reduced p53 hmsh2 hmsh6 binding holliday junction templates interestingly hmg iy also dissociated hmsh2 hmsh6 3 cytosine bulges affect p53 binding template finally hmsh2 hmsh6 enhanced p53 complex formation templates
0.50268346.12034830.html.plaintext.txt	51	multiple roles p53 dna recognition binding necessitate tight regulation protein host factors ensure proper interactions various recognition sites study effect three different proteins p53 binding holliday junctions extra base bulges examined two members hmg group proteins hmg 1 hmg iy mismatch repair protein hmsh2 hmsh6 tested binding properties p53 substrates modulated different ways proteins found hmg 1 effect p53 binding either substrate hand hmg iy reduced p53 hmsh2 hmsh6 binding holliday junction templates interestingly hmg iy also dissociated hmsh2 hmsh6 3 cytosine bulges affect p53 binding template finally hmsh2 hmsh6 enhanced p53 complex formation templates
0.50268346.12034830.html.plaintext.txt	52	dissociation p53 hmsh2 hmsh6 holliday junction structures hmg iy may result alteration dna conformation holliday junctions adopt two different conformations stacked x structure square open form presence divalent cations four way junctions adopt stacked x conformation 60 degrees 120 degrees angles arms whereas absence divalent cations junctions square open form 90 degrees angles arms hmg iy shown preferentially bind open form four way junction maintain junctions configuration 50 previous studies laboratory suggested p53 may prefer bind dna stacked x conformation opposed open form 16 determined electron microscopy large percent protein bound holliday junctions adopted conformation resembling stacked x structure hmg iy binding could causing conformation change holliday junction making unfavorable substrate p53 studies also show hmg iy dissociate p53holliday junction complexes pre formed possible p53 actively associates dissociates junction crossover dissociated hmg iy could rapidly bind junction altering conformation thus preventing p53 re association hand dissociation p53 hmsh2 hmsh6 complexes holliday junctions may due direct influence hmg iy proteins
0.50268346.12034830.html.plaintext.txt	53	dissociation p53 hmsh2 hmsh6 holliday junction structures hmg iy may result alteration dna conformation holliday junctions adopt two different conformations stacked x structure square open form presence divalent cations four way junctions adopt stacked x conformation 60 degrees 120 degrees angles arms whereas absence divalent cations junctions square open form 90 degrees angles arms hmg iy shown preferentially bind open form four way junction maintain junctions configuration 50 previous studies laboratory suggested p53 may prefer bind dna stacked x conformation opposed open form 16 determined electron microscopy large percent protein bound holliday junctions adopted conformation resembling stacked x structure hmg iy binding could causing conformation change holliday junction making unfavorable substrate p53 studies also show hmg iy dissociate p53holliday junction complexes pre formed possible p53 actively associates dissociates junction crossover dissociated hmg iy could rapidly bind junction altering conformation thus preventing p53 re association hand dissociation p53 hmsh2 hmsh6 complexes holliday junctions may due direct influence hmg iy proteins
0.50268346.12034830.html.plaintext.txt	54	hmg 1 shown interact p53 using far western assays jayaraman et al 25 however unable detect similar interactions p53 hmg iy using assay data shown additionally immunoprecipitation assays using purified proteins reveal direct interactions p53 hmg iy even presence dna substrates data shown thus dissociation p53 hmsh2 hmsh6 holliday junction templates hmg iy appears result differing binding affinities proteins
0.50268346.12034830.html.plaintext.txt	55	ability hmg iy displace proteins four way junction substrates demonstrated previously four way junction substrates used mimic linker dna near entrance exit points nucleosomes histone h1 shown bind high affinity structures however hmg iy added active dissociation h1 templates 47 suggested since hmg iy plays important role genetic recombination retroviral integration dissociates h1 structures allow recombination events proceed may occur direct recruitment proteins junction resolution hmg iy may act marker signify location four way junction displacement p53 hmsh2 hmsh6 holliday junctions hmg iy may occur similar reasons event dna damage environmental factors increase formation four way junctions due illegitimate sister chromatid exchange cell p53 hmsh2 hmsh6 hmg iy bind four way structures recognize initial recognition lesions would primarily carried hmsh2 hmsh6 p53 interactions sites damage may provide backup mechanism signaling repair hmg proteins abundant cells hence hmg iy dissociation p53 hmsh2 hmsh6 certain lesions structures would expected dominate however following dna damaging events levels stability p53 hmsh2 hmsh6 may alter causing changes hmg iy effect genetic studies altering hmg protein levels may complicated interpret regard example p53 mediated genomic stability hmsh2 hmsh6 catalyzed repair due multiple pathways involved considerations underscore need studies involving multiple proteins approach learn lesions signaled cell
0.50268346.12034830.html.plaintext.txt	56	ability hmg iy displace proteins four way junction substrates demonstrated previously four way junction substrates used mimic linker dna near entrance exit points nucleosomes histone h1 shown bind high affinity structures however hmg iy added active dissociation h1 templates 47 suggested since hmg iy plays important role genetic recombination retroviral integration dissociates h1 structures allow recombination events proceed may occur direct recruitment proteins junction resolution hmg iy may act marker signify location four way junction displacement p53 hmsh2 hmsh6 holliday junctions hmg iy may occur similar reasons event dna damage environmental factors increase formation four way junctions due illegitimate sister chromatid exchange cell p53 hmsh2 hmsh6 hmg iy bind four way structures recognize initial recognition lesions would primarily carried hmsh2 hmsh6 p53 interactions sites damage may provide backup mechanism signaling repair hmg proteins abundant cells hence hmg iy dissociation p53 hmsh2 hmsh6 certain lesions structures would expected dominate however following dna damaging events levels stability p53 hmsh2 hmsh6 may alter causing changes hmg iy effect genetic studies altering hmg protein levels may complicated interpret regard example p53 mediated genomic stability hmsh2 hmsh6 catalyzed repair due multiple pathways involved considerations underscore need studies involving multiple proteins approach learn lesions signaled cell
0.50268346.12034830.html.plaintext.txt	57	p53dna lesion complexes form high affinity possible protein quite labile dna thus hmg iy readily able dissociate interactions ability p53 form stable complexes dna may require protein post translationally modified several studies shown p53 binding properties modulated post translational modifications phosphorylation acetylation purified p53 used studies obtained baculovirus infected insect cells determined phosphorylated least one site phosphorylation andor acetylation may result conformation changes p53 enable stable binding indeed mentioned p53 binding lesions may function bring protein close proximity various kinases studies currently underway laboratory test effect phosphorylating various serine residues specific kinases lesion binding properties p53 noted presence hmsh2 hmsh6 p53 complexes lesions enhanced suggesting protein interactions vicinity lesion dictate dna binding rather lability p53
0.50268346.12034830.html.plaintext.txt	58	p53dna lesion complexes form high affinity possible protein quite labile dna thus hmg iy readily able dissociate interactions ability p53 form stable complexes dna may require protein post translationally modified several studies shown p53 binding properties modulated post translational modifications phosphorylation acetylation purified p53 used studies obtained baculovirus infected insect cells determined phosphorylated least one site phosphorylation andor acetylation may result conformation changes p53 enable stable binding indeed mentioned p53 binding lesions may function bring protein close proximity various kinases studies currently underway laboratory test effect phosphorylating various serine residues specific kinases lesion binding properties p53 noted presence hmsh2 hmsh6 p53 complexes lesions enhanced suggesting protein interactions vicinity lesion dictate dna binding rather lability p53
0.50268346.12034830.html.plaintext.txt	59	effect hmsh2 hmsh6 p53holliday junction complexes observed direct contrast hmg iy repair protein stimulatory effect p53 binding increase p53 complexes also results concomitant decrease hmsh2 hmsh6 complexes substrate reduction seen even molar excesses hmsh2 hmsh6 added reactions data shown additionally hmsh2 hmsh6 pre incubated substrates followed addition p53 enhancement p53dna complexes observed data shown similar effects seen 3 cytosine bulge template preferred substrate hmsh2 hmsh6 hence appears hmsh2 hmsh6 also able load p53 3 cytosine bulge substrate possible p53 hmsh2 hmsh6 interact lesion sites however case would expect novel band containing ternary complex proteins appear gel retardation assays complexes detected presence proteins either probe used furthermore immunoprecipitation assays reveal interaction two proteins solution data shown thus hmsh2 hmsh6 appears either recruiting p53 lesion sites stabilizing p53dna interactions manner may occur ensure lesion signaled necessary downstream proteins cell cycle arrest apoptosis pathways executed
0.50268346.12034830.html.plaintext.txt	60	effect hmsh2 hmsh6 p53holliday junction complexes observed direct contrast hmg iy repair protein stimulatory effect p53 binding increase p53 complexes also results concomitant decrease hmsh2 hmsh6 complexes substrate reduction seen even molar excesses hmsh2 hmsh6 added reactions data shown additionally hmsh2 hmsh6 pre incubated substrates followed addition p53 enhancement p53dna complexes observed data shown similar effects seen 3 cytosine bulge template preferred substrate hmsh2 hmsh6 hence appears hmsh2 hmsh6 also able load p53 3 cytosine bulge substrate possible p53 hmsh2 hmsh6 interact lesion sites however case would expect novel band containing ternary complex proteins appear gel retardation assays complexes detected presence proteins either probe used furthermore immunoprecipitation assays reveal interaction two proteins solution data shown thus hmsh2 hmsh6 appears either recruiting p53 lesion sites stabilizing p53dna interactions manner may occur ensure lesion signaled necessary downstream proteins cell cycle arrest apoptosis pathways executed
0.50268346.12034830.html.plaintext.txt	61	nucleus dna exists several different configurations range proteins bind various forms paper examined dynamics three proteins bind holliday junctions shown interact different ways p53 binding recombination intermediates affected opposite ways hmg iy hmsh2 hmsh6 hmg iy dissociates hmsh2 hmsh6 promotes binding holliday junctions 3 cytosine bulges presumably cellular environment proteins contribute dictate specific interactions proteins dna
0.50268346.12034830.html.plaintext.txt	62	nucleus dna exists several different configurations range proteins bind various forms paper examined dynamics three proteins bind holliday junctions shown interact different ways p53 binding recombination intermediates affected opposite ways hmg iy hmsh2 hmsh6 hmg iy dissociates hmsh2 hmsh6 promotes binding holliday junctions 3 cytosine bulges presumably cellular environment proteins contribute dictate specific interactions proteins dna
0.50268346.12034830.html.plaintext.txt	63	acknowledgements work supported part national institutes health grants gm31819 ca70343 thank members griffith laboratory helpful discussion dr arnold levine dr richard fishel dr michael bustin providing vectors protein purification
0.50268346.12034830.html.plaintext.txt	64	acknowledgements work supported part national institutes health grants gm31819 ca70343 thank members griffith laboratory helpful discussion dr arnold levine dr richard fishel dr michael bustin providing vectors protein purification
0.50268346.12034830.html.plaintext.txt	65	footnotes correspondence addressed tel 1 919 966 2151 fax 1 919 966 3015 email jdgatmeduncedu
0.50268346.12034830.html.plaintext.txt	66	footnotes correspondence addressed tel 1 919 966 2151 fax 1 919 966 3015 email jdgatmeduncedu
0.50268346.12034830.html.plaintext.txt	67	references top abstract introduction materials methods results discussion references kolj privesc 1996 p53 puzzle paradigm genes dev 10 1054 1072isimedline
0.51028955.12507923.html.plaintext.txt	0	mutant p53 dependent growth suppression distinguishes prima 1 known anticancer drugs statistical analysis information national cancer institute database
0.51028955.12507923.html.plaintext.txt	1	karolinska institutet department oncology pathology cancer center karolinska cck r804 karolinska hospital se 171 76 stockholm sweden
0.51028955.12507923.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion references recently identified prima 1 low molecular weight compound restores tumor suppressor function mutant p53 proteins anti tumor activity vivo 1 report statistical analysis effect prima 1 panel human tumor cell lines using information available database developmental therapeutics program national cancer institute nci extracted growth inhibition profiles prima 1 44 known anticancer agents p53 status cell lines population doubling time level p53 protein expression nci database data analyzed linear regression wilcoxon matched pairs test cluster analysis subset human cell lines derived colon ovarian renal non small cell lung cancer melanoma level mutant p53 expression correlated cell population doubling time r 053 p 0018 gi50 values prima 1 correlated levels mutant p53 r 075 p 00002 prima 1 showed statistically significant preference p 004 growth inhibition tumor cell lines expressing mutant p53 compared lines expressing wild type p53 contrast none several known anticancer drugs showed preference prima 1 inhibited growth cell lines derived various human tumor types mutant p53 dependent manner distinguishes prima 1 known anticancer drugs supports idea prima 1 serve lead development novel therapeutic compounds
0.51028955.12507923.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references recently identified prima 1 low molecular weight compound restores tumor suppressor function mutant p53 proteins anti tumor activity vivo 1 report statistical analysis effect prima 1 panel human tumor cell lines using information available database developmental therapeutics program national cancer institute nci extracted growth inhibition profiles prima 1 44 known anticancer agents p53 status cell lines population doubling time level p53 protein expression nci database data analyzed linear regression wilcoxon matched pairs test cluster analysis subset human cell lines derived colon ovarian renal non small cell lung cancer melanoma level mutant p53 expression correlated cell population doubling time r 053 p 0018 gi50 values prima 1 correlated levels mutant p53 r 075 p 00002 prima 1 showed statistically significant preference p 004 growth inhibition tumor cell lines expressing mutant p53 compared lines expressing wild type p53 contrast none several known anticancer drugs showed preference prima 1 inhibited growth cell lines derived various human tumor types mutant p53 dependent manner distinguishes prima 1 known anticancer drugs supports idea prima 1 serve lead development novel therapeutic compounds
0.51028955.12507923.html.plaintext.txt	4	introduction top abstract introduction materials methods results discussion references tumor suppressor p53 crucial mediator cell cycle arrest apoptosis response various forms cellular stress including dna damage oncogene activation hypoxia 2 5 least 50 human tumors harbor mutations p53 6 anticancer drugs current clinical use except paclitaxel target primarily tumor cells carry wild type p53 78 accordingly tumors carrying mutant p53 frequently show increased resistance chemotherapy compared carrying wild type p53 9 11 thus great need develop novel drugs treatment tumors carrying mutant p53
0.51028955.12507923.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references tumor suppressor p53 crucial mediator cell cycle arrest apoptosis response various forms cellular stress including dna damage oncogene activation hypoxia 2 5 least 50 human tumors harbor mutations p53 6 anticancer drugs current clinical use except paclitaxel target primarily tumor cells carry wild type p53 78 accordingly tumors carrying mutant p53 frequently show increased resistance chemotherapy compared carrying wild type p53 9 11 thus great need develop novel drugs treatment tumors carrying mutant p53
0.51028955.12507923.html.plaintext.txt	6	repository low molecular weight compounds national cancer institute consists main library 140 000 compounds diversity set 2000 compounds selected represent structural types main library growth suppression activity 70 000 compounds main library well many known anticancer drugs assessed panel 60 tumor cell lines 712 14 results analysis well information regarding status various cancer related genes including p53 available database nci silico analysis may allow identification lead compounds evaluation activity comparison known anticancer drugs also opens possibilities rapid investigation potential mechanisms action identified compounds possible mechanisms cellular resistance
0.51028955.12507923.html.plaintext.txt	7	repository low molecular weight compounds national cancer institute consists main library 140 000 compounds diversity set 2000 compounds selected represent structural types main library growth suppression activity 70 000 compounds main library well many known anticancer drugs assessed panel 60 tumor cell lines 712 14 results analysis well information regarding status various cancer related genes including p53 available database nci silico analysis may allow identification lead compounds evaluation activity comparison known anticancer drugs also opens possibilities rapid investigation potential mechanisms action identified compounds possible mechanisms cellular resistance
0.51028955.12507923.html.plaintext.txt	8	previously screened nci diversity set using saos 2 273 osteosarcoma cells expressing 273 mutant p53 control tetracycline dependent promoter identified one compound prima 1 22 bishydroxymethyl 1 azabicyclo222octan 3 one kill tumor cells mutant p53 dependent manner 1 showed prima 1 restore wild type conformation specific dna binding mutant p53 trigger apoptosis mutant p53 dependent anti tumor activity vivo 1
0.51028955.12507923.html.plaintext.txt	9	previously screened nci diversity set using saos 2 273 osteosarcoma cells expressing 273 mutant p53 control tetracycline dependent promoter identified one compound prima 1 22 bishydroxymethyl 1 azabicyclo222octan 3 one kill tumor cells mutant p53 dependent manner 1 showed prima 1 restore wild type conformation specific dna binding mutant p53 trigger apoptosis mutant p53 dependent anti tumor activity vivo 1
0.51028955.12507923.html.plaintext.txt	10	used information available nci database evaluate effect prima 1 tumor cell lines different origin compare mode action five known anticancer drugs currently used clinic 5 fluorouracil cisplatin methotrexate adriamycin paclitaxel statistical analysis revealed prima 1 consistently effective inhibiting growth mutant p53 carrying cell lines compared wild type p53 carrying lines derived various human tumors moreover sensitivity prima 1 related mutant p53 expression levels
0.51028955.12507923.html.plaintext.txt	11	used information available nci database evaluate effect prima 1 tumor cell lines different origin compare mode action five known anticancer drugs currently used clinic 5 fluorouracil cisplatin methotrexate adriamycin paclitaxel statistical analysis revealed prima 1 consistently effective inhibiting growth mutant p53 carrying cell lines compared wild type p53 carrying lines derived various human tumors moreover sensitivity prima 1 related mutant p53 expression levels
0.51028955.12507923.html.plaintext.txt	12	materials methods top abstract introduction materials methods results discussion references data 60 human tumor cell lines extracted database development therapeutic program nci see web site httpdtpncinihgov selected 34 lines using following criteria availability sequence information p53 status data p53 protein levels growth suppression profiles compounds selected analysis data least two cell lines carrying wild type p53 two lines carrying mutant p53 cancer type extracted growth inhibition profiles 44 drugs representing major mechanisms activity alkylating agents topoisomerase inhibitors topoisomerase ii inhibitors antimitotic agents dna antimetabolites dnarna antimetabolites prima 1 designation nsc 281668 nci database
0.51028955.12507923.html.plaintext.txt	13	statistical analysis carried using statistica 99 edition statistical package gi50 profiles compared using compare algorithm nci database 15 gi50 defined concentration tested compound causes 50 growth inhibition serves index cytotoxicity obtained gi50 values analyzed wilcoxon matched pairs test cluster analysis performed according ward method evaluates distance clusters analysis variance minimizing sum squares two hypothetical clusters formed step ward amalgamation method generates coherent clusters compared average linkage methods available statistica 99 edition statistical package linkage distance clusters chosen pearson correlation coefficient
0.51028955.12507923.html.plaintext.txt	14	statistical analysis carried using statistica 99 edition statistical package gi50 profiles compared using compare algorithm nci database 15 gi50 defined concentration tested compound causes 50 growth inhibition serves index cytotoxicity obtained gi50 values analyzed wilcoxon matched pairs test cluster analysis performed according ward method evaluates distance clusters analysis variance minimizing sum squares two hypothetical clusters formed step ward amalgamation method generates coherent clusters compared average linkage methods available statistica 99 edition statistical package linkage distance clusters chosen pearson correlation coefficient
0.51028955.12507923.html.plaintext.txt	15	results top abstract introduction materials methods results discussion references prima 1 sensitivity correlates mutant p53 expression levels available data levels different molecular targets 60 cell lines nci database provided us tool find associations target expression levels sensitivity resistance particular drug therefore used mutant p53 levels seed compare program search diversity set nci library variance parameter set 005 analysis gi50 patterns mutant p53 carrying cell lines database revealed several compounds diversity set showed correlation mutant p53 expression levels sensitivity prima 1 emerged ranking position 28 correlation prima 1 sensitivity mutant p53 levels relatively weak pearson correlation coefficient 033 search among subset mutant p53 carrying cell lines selected described materials methods table resulted ranking position 9 prima 1 three compounds showed highest correlation coefficients nsc117281 r 0818 nsc321206 r 0815 nsc150117 r 0781 compound showed statistically significant preference growth inhibition mutant p53 carrying cell lines p 004 according wilcoxon matched pairs test nsc117281 compound also showed moderate correlation proliferation rate sensitivity treatment r 04 p 0096 neither nsc321206 nsc150117 showed statistically significant growth inhibition mutant p53 carrying lines p 035 compounds none compounds compounds showed correlation mutant p53 levels sensitivity scored previous experimental screening approach employed cells expressing mutant p53 p53 null cells 1
0.51028955.12507923.html.plaintext.txt	16	results top abstract introduction materials methods results discussion references prima 1 sensitivity correlates mutant p53 expression levels available data levels different molecular targets 60 cell lines nci database provided us tool find associations target expression levels sensitivity resistance particular drug therefore used mutant p53 levels seed compare program search diversity set nci library variance parameter set 005 analysis gi50 patterns mutant p53 carrying cell lines database revealed several compounds diversity set showed correlation mutant p53 expression levels sensitivity prima 1 emerged ranking position 28 correlation prima 1 sensitivity mutant p53 levels relatively weak pearson correlation coefficient 033 search among subset mutant p53 carrying cell lines selected described materials methods table resulted ranking position 9 prima 1 three compounds showed highest correlation coefficients nsc117281 r 0818 nsc321206 r 0815 nsc150117 r 0781 compound showed statistically significant preference growth inhibition mutant p53 carrying cell lines p 004 according wilcoxon matched pairs test nsc117281 compound also showed moderate correlation proliferation rate sensitivity treatment r 04 p 0096 neither nsc321206 nsc150117 showed statistically significant growth inhibition mutant p53 carrying lines p 035 compounds none compounds compounds showed correlation mutant p53 levels sensitivity scored previous experimental screening approach employed cells expressing mutant p53 p53 null cells 1
0.51028955.12507923.html.plaintext.txt	17	view table table growth inhibition profiles correlation mutant p53 expression levels gi50 value prima 1 statistically significant r 075 p 00002 figure 1 contrast significant correlation prima 1 sensitivity wild type p53 expression levels r 018 p 051 also observed association levels mutant p53 expression cell population doubling time r 053 p 0018 figure 1 wild type p53 expression levels correlate population doubling time r 016 p 057 since cell proliferation rate correlated mutant p53 levels tested whether association sensitivity prima 1 cell population doubling time regression analysis revealed r 026 p 029 mutant p53 carrying lines r 007 p 079 wild type p53 carrying lines figure 1 therefore concluded cell population doubling time important factor sensitivity prima 1
0.51028955.12507923.html.plaintext.txt	18	view larger version 30k fig 1 regression analysis relationship gi50 values prima 1 p53 expression levels p53 expression levels cell population doubling time gi50 values prima 1 cell population doubling time upper panel shows analysis mutant p53 carrying cell lines lower panel analysis wild type p53 carrying cell lines p53 expression levels shown relative units ru
0.51028955.12507923.html.plaintext.txt	19	next examined contribution mutant p53 expression levels cell growth rate sensitivity 44 known anticancer agents prima 1 words unique observed association mutant p53 levels sensitivity prima 1 results regression analysis presented table ii although drugs showed correlation mutant p53 expression levels sensitivity correlations general weaker prima 1 drug ftorafur highest correlation coefficient levels mutant p53 expression prima 1 r 064 p 0003 strong association cell population doubling time r 051 p 003 also observed population doubling time could important factor determining sensitivity cells treatment drugs interfere dnarna synthesis table ii drugs showed correlation gi50 value population doubling time included 5 fluorouracil methotrexate dichlorallyl lawsone aminopterin derivative paclitaxel dolastatin 10 busulfan mitomycin c correlations gi50 values p53 levels positive wild type p53 expressing cell lines negative mutant p53 expressing lines thus cells overexpressing wild type p53 appear resistant treatment variety drugs compared cells expressing low levels wild type p53 statistically significant correlations observed cyclocytidine ara c 2 deoxy 5 fluorouridine topoisomerase inhibitors mitomycin c gi50 values correlated population doubling time cell lines carrying wild type p53 hence rapidly proliferating cells wild type p53 status sensitive treatment drugs thiopurine macbecin ii pala dichlorallyl lawsone deoxydoxorubicin nn dibenzyl daunomycin
0.51028955.12507923.html.plaintext.txt	20	next examined contribution mutant p53 expression levels cell growth rate sensitivity 44 known anticancer agents prima 1 words unique observed association mutant p53 levels sensitivity prima 1 results regression analysis presented table ii although drugs showed correlation mutant p53 expression levels sensitivity correlations general weaker prima 1 drug ftorafur highest correlation coefficient levels mutant p53 expression prima 1 r 064 p 0003 strong association cell population doubling time r 051 p 003 also observed population doubling time could important factor determining sensitivity cells treatment drugs interfere dnarna synthesis table ii drugs showed correlation gi50 value population doubling time included 5 fluorouracil methotrexate dichlorallyl lawsone aminopterin derivative paclitaxel dolastatin 10 busulfan mitomycin c correlations gi50 values p53 levels positive wild type p53 expressing cell lines negative mutant p53 expressing lines thus cells overexpressing wild type p53 appear resistant treatment variety drugs compared cells expressing low levels wild type p53 statistically significant correlations observed cyclocytidine ara c 2 deoxy 5 fluorouridine topoisomerase inhibitors mitomycin c gi50 values correlated population doubling time cell lines carrying wild type p53 hence rapidly proliferating cells wild type p53 status sensitive treatment drugs thiopurine macbecin ii pala dichlorallyl lawsone deoxydoxorubicin nn dibenzyl daunomycin
0.51028955.12507923.html.plaintext.txt	21	figure 2 shows efficiency drugs mutant wild type p53 carrying lines tumor type assessed average gi50 values prima 1 statistically significant preference mutant p53 carrying lines p 004 according wilcoxon matched pairs test statistical analysis reveal preferences growth inhibition pattern adriamycin p 047 methotrexate p 035 paclitaxel p 09 cisplatin significantly stronger effect cells carrying wild type p53 p 008 similarly 5 fluorouracil efficient lines carrying wild type p53 difference statistically significant p 014
0.51028955.12507923.html.plaintext.txt	22	figure 2 shows efficiency drugs mutant wild type p53 carrying lines tumor type assessed average gi50 values prima 1 statistically significant preference mutant p53 carrying lines p 004 according wilcoxon matched pairs test statistical analysis reveal preferences growth inhibition pattern adriamycin p 047 methotrexate p 035 paclitaxel p 09 cisplatin significantly stronger effect cells carrying wild type p53 p 008 similarly 5 fluorouracil efficient lines carrying wild type p53 difference statistically significant p 014
0.51028955.12507923.html.plaintext.txt	23	view larger version 26k fig 2 specificity six tested agents mutant p53 expressing cell lines average gi50 values cells harboring mutant wild type p53 compared table ii mean plus minus se plus minus sd
0.51028955.12507923.html.plaintext.txt	24	shown figure 3 prima 1 stronger growth inhibitory effect tumor lines harboring mutant p53 compared wild type p53 carrying lines cancer types studied paclitaxel even selective mutant p53 expressing cells prima 1 lines derived ovarian renal cancer methotrexate preferentially inhibited growth mutant p53 carrying ovarian cancer lines adriamycin show preferences towards wild type mutant p53 carrying lines tumor types cisplatin showed selectivity wild type p53 carrying colon cancer lines particularly melanoma lines finally 5 fluorouracil efficient wild type p53 carrying cell lines derived colon cancer non small cell lung cancer
0.51028955.12507923.html.plaintext.txt	25	shown figure 3 prima 1 stronger growth inhibitory effect tumor lines harboring mutant p53 compared wild type p53 carrying lines cancer types studied paclitaxel even selective mutant p53 expressing cells prima 1 lines derived ovarian renal cancer methotrexate preferentially inhibited growth mutant p53 carrying ovarian cancer lines adriamycin show preferences towards wild type mutant p53 carrying lines tumor types cisplatin showed selectivity wild type p53 carrying colon cancer lines particularly melanoma lines finally 5 fluorouracil efficient wild type p53 carrying cell lines derived colon cancer non small cell lung cancer
0.51028955.12507923.html.plaintext.txt	26	view larger version 18k fig 3 growth inhibition profiles six tested agents cell lines derived colon non small cell lung cancer nsclc ovarian renal cancer melanoma data calculated factors selectivity towards wild type wtp53 mutant p53 carrying lines mtp53 factor specificity f agent towards p53 status determined follows gi50wt gi50mt f gi50wtgi50mt gi50wt gi50mt f gi50mtgi50wt f 1 agent specifically targeting cells mutant p53 f 1 agent specifically targeting cells wtp53
0.51028955.12507923.html.plaintext.txt	27	possible mechanisms resistance prima 1 running compare program reverse manner cell lines carrying mutant p53 obtained correlation levels specific molecular targets resistance treatment found resistance prima 1 associated expression igf1 insulin like growth factor 1 receptor r 035 levels fer proto oncogene tyrosine kinase r 044 drugs tested resistance associated activity mdr multidrug resistance gene expression different growth factors non small cell lung cancer cell lines resistance prima 1 associated high levels drug efflux pumps lrp lung resistance protein r 09 mrp multidrug resistance protein r 079
0.51028955.12507923.html.plaintext.txt	28	possible mechanisms resistance prima 1 running compare program reverse manner cell lines carrying mutant p53 obtained correlation levels specific molecular targets resistance treatment found resistance prima 1 associated expression igf1 insulin like growth factor 1 receptor r 035 levels fer proto oncogene tyrosine kinase r 044 drugs tested resistance associated activity mdr multidrug resistance gene expression different growth factors non small cell lung cancer cell lines resistance prima 1 associated high levels drug efflux pumps lrp lung resistance protein r 09 mrp multidrug resistance protein r 079
0.51028955.12507923.html.plaintext.txt	29	prima 1 clusters separately known anticancer drugs next asked whether prima 1 could grouped known anticancer drugs using cluster analysis generated dendrogram based activity pattern 43 drugs selected 34 cell lines selected compounds either clinical use clinical trials figure 4 shows clustering selected compounds mutant p53 expressing cell lines growth inhibition data normalized cell population doubling time prima 1 clustered together purine analogs thioguanine thiopurine major groups compounds easily recognizable case analysis 118 compounds cell lines nci database 13 however clustering according mechanism action obtained drugs eg camptothecin formed tight cluster others formed groups two three different clusters per type agent
0.51028955.12507923.html.plaintext.txt	30	prima 1 clusters separately known anticancer drugs next asked whether prima 1 could grouped known anticancer drugs using cluster analysis generated dendrogram based activity pattern 43 drugs selected 34 cell lines selected compounds either clinical use clinical trials figure 4 shows clustering selected compounds mutant p53 expressing cell lines growth inhibition data normalized cell population doubling time prima 1 clustered together purine analogs thioguanine thiopurine major groups compounds easily recognizable case analysis 118 compounds cell lines nci database 13 however clustering according mechanism action obtained drugs eg camptothecin formed tight cluster others formed groups two three different clusters per type agent
0.51028955.12507923.html.plaintext.txt	31	view larger version 27k fig 4 dendrogram showing hierarchical clustering 43 different anticancer agents prima 1 cluster tree 44 compounds based data cell lines mutant p53 gi50 values normalized cell population doubling time distance metric used 1 pearson correlation coefficient expressed percentage maximum distance clusters clustering performed according ward method
0.51028955.12507923.html.plaintext.txt	32	discussion top abstract introduction materials methods results discussion references tumors carrying mutant p53 often resistant conventional cancer therapy 9 11 therefore important develop novel therapeutic strategies target mutant p53 tumors recently identified novel mutant p53 reactivating molecule prima 1 1 study analyzed sensitivity prima 1 human tumor cell lines using available information database nci asked extent prima 1 would preferentially suppress growth mutant p53 carrying lines compared growth inhibition pattern prima 1 known anticancer drugs
0.51028955.12507923.html.plaintext.txt	33	discussion top abstract introduction materials methods results discussion references tumors carrying mutant p53 often resistant conventional cancer therapy 9 11 therefore important develop novel therapeutic strategies target mutant p53 tumors recently identified novel mutant p53 reactivating molecule prima 1 1 study analyzed sensitivity prima 1 human tumor cell lines using available information database nci asked extent prima 1 would preferentially suppress growth mutant p53 carrying lines compared growth inhibition pattern prima 1 known anticancer drugs
0.51028955.12507923.html.plaintext.txt	34	silico search among 2000 compounds nci diversity set compounds inhibit cell growth mutant p53 dependent manner yielded eight compounds showed higher correlation mutant p53 expression prima 1 however compounds score cellular screening assay 1 several possible reasons discrepancy first cellular screening assay designed identify compounds active presence mutant p53 inactive p53 null cells therefore compounds whose activity correlates mutant p53 levels may necessarily score assay may also explain prima 1 show best correlation sensitivity treatment mutant p53 expression levels among compounds diversity set
0.51028955.12507923.html.plaintext.txt	35	silico search among 2000 compounds nci diversity set compounds inhibit cell growth mutant p53 dependent manner yielded eight compounds showed higher correlation mutant p53 expression prima 1 however compounds score cellular screening assay 1 several possible reasons discrepancy first cellular screening assay designed identify compounds active presence mutant p53 inactive p53 null cells therefore compounds whose activity correlates mutant p53 levels may necessarily score assay may also explain prima 1 show best correlation sensitivity treatment mutant p53 expression levels among compounds diversity set
0.51028955.12507923.html.plaintext.txt	36	second used one concentration compounds cellular screening ie 25 microm obvious compounds gi50 values significantly higher lower 25 microm would score selective mutant p53 expressing cells screening apparently case nsc321206 nsc150117 scored ranking positions 2 3 respectively silico search toxic mutant p53 independent manner cellular screening vbykov unpublished data average gi50 values 400 fold nsc321206 15 fold nsc150117 lower prima
0.51028955.12507923.html.plaintext.txt	37	third relevant consider possibility mutant p53 levels correlate cell proliferation rate indicated information nci database consistent previous studies showing p53 mutants growth stimulatory activity 1617 might least part due ability induce illegitimate expression growth promoting genes like c myc nf b pcna others 18 21 conceivable mutant p53 proteins stimulate cell proliferation therefore correlation mutant p53 levels growth suppression nsc117281 compounds showed similar correlation could simply reflect preferential effect rapidly dividing cells contrast sensitivity prima 1 correlate cell proliferation rate may indicate prima 1 targets broader range p53 mutants capable stimulating cell growth
0.51028955.12507923.html.plaintext.txt	38	third relevant consider possibility mutant p53 levels correlate cell proliferation rate indicated information nci database consistent previous studies showing p53 mutants growth stimulatory activity 1617 might least part due ability induce illegitimate expression growth promoting genes like c myc nf b pcna others 18 21 conceivable mutant p53 proteins stimulate cell proliferation therefore correlation mutant p53 levels growth suppression nsc117281 compounds showed similar correlation could simply reflect preferential effect rapidly dividing cells contrast sensitivity prima 1 correlate cell proliferation rate may indicate prima 1 targets broader range p53 mutants capable stimulating cell growth
0.51028955.12507923.html.plaintext.txt	39	observed positive correlation sensitivity treatment prima 1 levels mutant p53 expression consistent previous study demonstrating prima 1 reactivates mutant p53 preferentially kills mutant p53 expressing tumor cells bykov et al 2002 contrast regression analysis 44 selected anticancer agents showed negative correlation levels mutant p53 drug sensitivity cases compounds showed positive correlation although weaker prima 1 several compounds growth inhibition tumor cells correlated positively cell population doubling time indicating cell proliferation rate important factor p53 status sensitivity drugs
0.51028955.12507923.html.plaintext.txt	40	observed positive correlation sensitivity treatment prima 1 levels mutant p53 expression consistent previous study demonstrating prima 1 reactivates mutant p53 preferentially kills mutant p53 expressing tumor cells bykov et al 2002 contrast regression analysis 44 selected anticancer agents showed negative correlation levels mutant p53 drug sensitivity cases compounds showed positive correlation although weaker prima 1 several compounds growth inhibition tumor cells correlated positively cell population doubling time indicating cell proliferation rate important factor p53 status sensitivity drugs
0.51028955.12507923.html.plaintext.txt	41	observe significant negative correlations gi50 values wild type p53 levels indicating overexpression wild type p53 renders cells resistant many drugs plausible explanation tumor cells accumulate number apoptosis evading genetic changes order survive high levels wild type p53 resulting increased drug resistance
0.51028955.12507923.html.plaintext.txt	42	observe significant negative correlations gi50 values wild type p53 levels indicating overexpression wild type p53 renders cells resistant many drugs plausible explanation tumor cells accumulate number apoptosis evading genetic changes order survive high levels wild type p53 resulting increased drug resistance
0.51028955.12507923.html.plaintext.txt	43	compare sensitivity prima 1 known anticancer drugs selected cisplatin 5 fluorouracil adriamycin paclitaxel methotrexate widely used cancer therapy agents cisplatin 22 5 fluorouracil 8 shown preferentially affect cells carrying wild type p53 paclitaxel specificity towards cells expressing mutant p53 7 unusual property paclitaxel made important component frontline adjuvant treatment number chemotherapeutic regimens used clinic today 23 analysis revealed prima 1 overall selectivity mutant p53 carrying tumor cell lines respect prima 1 superior paclitaxel also selectivity cancer types studied however paclitaxel showed significant selectivity mutant p53 carrying ovarian renal carcinoma lines prima 1 agent showed mutant p53 selective effect lung colon carcinoma lines importance view fact p53 mutations occur almost 60 lung carcinomas around 50 colon carcinomas 6 similar selectivity mutant p53 expressing lines observed melanoma although around 10 melanomas carry p53 mutation 6 finally analysis showed 5 fluorouracil cisplatin preferentially inhibited growth lines carrying wild type p53 agreement previous studies 12
0.51028955.12507923.html.plaintext.txt	44	compare sensitivity prima 1 known anticancer drugs selected cisplatin 5 fluorouracil adriamycin paclitaxel methotrexate widely used cancer therapy agents cisplatin 22 5 fluorouracil 8 shown preferentially affect cells carrying wild type p53 paclitaxel specificity towards cells expressing mutant p53 7 unusual property paclitaxel made important component frontline adjuvant treatment number chemotherapeutic regimens used clinic today 23 analysis revealed prima 1 overall selectivity mutant p53 carrying tumor cell lines respect prima 1 superior paclitaxel also selectivity cancer types studied however paclitaxel showed significant selectivity mutant p53 carrying ovarian renal carcinoma lines prima 1 agent showed mutant p53 selective effect lung colon carcinoma lines importance view fact p53 mutations occur almost 60 lung carcinomas around 50 colon carcinomas 6 similar selectivity mutant p53 expressing lines observed melanoma although around 10 melanomas carry p53 mutation 6 finally analysis showed 5 fluorouracil cisplatin preferentially inhibited growth lines carrying wild type p53 agreement previous studies 12
0.51028955.12507923.html.plaintext.txt	45	database analysis provided several clues possible mechanisms resistance prima 1 one obvious mechanism loss mutant p53 expression addition seems likely increased expression igf1 receptor receptors mediate survival signalling could raise apoptotic threshold thus contribute resistance common mechanisms resistance chemotherapy expression mdr gene drug efflux pumps 24 could presumably also make cells less sensitive prima 1
0.51028955.12507923.html.plaintext.txt	46	database analysis provided several clues possible mechanisms resistance prima 1 one obvious mechanism loss mutant p53 expression addition seems likely increased expression igf1 receptor receptors mediate survival signalling could raise apoptotic threshold thus contribute resistance common mechanisms resistance chemotherapy expression mdr gene drug efflux pumps 24 could presumably also make cells less sensitive prima 1
0.51028955.12507923.html.plaintext.txt	47	cluster analysis demonstrated prima 1 belong tight clusters chemotherapeutic drugs formed dendrogram prima 1 clustered purine analogs belonging group dna antimetabolites clustering group quite loose indicating different mechanisms action drugs within group prima 1 structural resemblance nucleotide analogs would favor mechanism activity similar thioguanine thiopurine argues prima 1 acts mechanisms different major groups anticancer agents
0.51028955.12507923.html.plaintext.txt	48	cluster analysis demonstrated prima 1 belong tight clusters chemotherapeutic drugs formed dendrogram prima 1 clustered purine analogs belonging group dna antimetabolites clustering group quite loose indicating different mechanisms action drugs within group prima 1 structural resemblance nucleotide analogs would favor mechanism activity similar thioguanine thiopurine argues prima 1 acts mechanisms different major groups anticancer agents
0.51028955.12507923.html.plaintext.txt	49	based analyses information nci database conclude prima 1 preferential growth inhibitory activity human tumor cell lines carrying mutant p53 distinguishes prima 1 commonly used anticancer drugs results support notion prima 1 structural analogs prima 1 may serve lead compounds development novel anticancer drugs efficient treatment tumors carrying mutant p53
0.51028955.12507923.html.plaintext.txt	50	based analyses information nci database conclude prima 1 preferential growth inhibitory activity human tumor cell lines carrying mutant p53 distinguishes prima 1 commonly used anticancer drugs results support notion prima 1 structural analogs prima 1 may serve lead compounds development novel anticancer drugs efficient treatment tumors carrying mutant p53
0.51028955.12507923.html.plaintext.txt	51	notes 1 correspondence addressed email klaswimanatmtckise
0.51028955.12507923.html.plaintext.txt	52	acknowledgments work supported project grants swedish cancer society cancerfonden cancer society stockholm european union 5th framework program swedish medical research council karolinska institute vjnb supported postdoctoral fellowship swedish cancer society
0.51028955.12507923.html.plaintext.txt	53	references top abstract introduction materials methods results discussion references bykovvjn issaevan shilova hultcrantzm pugachevae chumakovp bergmanj wimankg selivanovag 1985 restoration tumor suppressor function mutant p53 low molecular weight compound nat med 8 282 288 kolj privesc 1996 p53 puzzle paradigm genes dev 10 1054 1072isimedline sherrcj 1998 tumor surveillance via arf p53 pathway genes dev 12 2984 2991free full text giacciaaj kastanmb 1998 complexity p53 modulation emerging patterns divergent signals genes dev 12 2973 2983free full text askerc wimankg selivanovag 1999 p53 induced apoptosis safeguard cancer biochem biophys res commun 265 1 6isimedline greenblattms bennettwp hollsteinm harriscc 1994 mutations p53 tumour suppressor gene clues cancer etiology molecular pathogenesis cancer res 54 4855 4878isimedline weinsteinjn myerstg oconnorpm et al 1997 information intensive approach molecular pharmacology cancer science 275 343 349abstractfree full text bunzf hwangpm torrancec et al 1999 disruption p53 human cancer cells alters responses therapeutic agents j clin invest 104 263 269abstractfree full text levineaj 1997 p53 cellular gatekeeper growth division cell 88 323 331isimedline wellerm 1998 predicting response cancer chemotherapy role p53 cell tissue res 292 435 445isimedline yeagertr reznikoffca 1998 methotrexate resistance human uroepithelial cells p53 alterations j urol 159 581 585isimedline oconnorpm jackmanj baei et al 1997 characterization p53 tumor suppressor pathway cell lines national cancer institute anticancer drug screen correlations growth inhibitory potency 123 anticancer agents cancer res 57 4285 4300abstract scherfu rossdt walthamm et al 2000 gene expression database molecular pharmacology cancer nat genet 24 236 244isimedline shilm fany leejk walthamm andrewsdt scherfu paullkd weinsteinjn 2000 mining visualizing large anticancer drug discovery databases j chem inf comput sci 40 367 379isimedline paullkd shoemakerrh hodesl monksa scudieroda rubinsteinl plowmanj boydmr 1989 display analysis patterns differential activity drugs human tumor cell lines development mean graph compare algorithm j natl cancer inst 81 1088 1092abstract hsuch leesc yangyc lianst shinsj linsr 2001 p53 codon 249 mutant derived human functional adrenal tumors modify cell shape normal adrenocortical transfected cells cancer lett 170 63 71isimedline karlssonl leserg delleu horvathg 1997 tumour growth cell kinetics variants human endometrial adenocarcinoma expressing either wild type mutant p53 acta oncol 36 729 733isimedline fraziermw hex wangj guz clevelandjl zambettigp 1998 activation c myc gene expression tumor derived p53 mutants requires discrete c terminal domain mol cell biol 18 3735 3743abstractfree full text debd scianm rothke liw keigerj chakrabortias debsp debs 2002 hetero oligomerization compromise gain function tumor derived p53 mutants oncogene 21 176 189isimedline logingwt reismand 1999 elevated expression ribosomal protein genes l37 rpp 1 s2 presence mutant p53 cancer epidemiol biomarkers prev 8 1011 1016abstractfree full text mathupalasp heesec pedersenpl 1997 glucose catabolism cancer cells type ii hexokinase promote contains functionally active response elements tumor suppressor p53 j biol chem 272 22776 22780abstractfree full text anthoneyda mcilwrathaj gallagherwm edlinarm brownr 1996 microsatellite instability apoptosis loss p53 function drug resistant tumour cells cancer res 56 1374 1381abstract bakeraf dorrrt 2001 drug interactions taxanes clinical implications cancer treat rev 27 221 233isimedline making hickmanja 2000 apoptosis cancer chemotherapy cell tissue res 301 143 152isimedline received may 28 2002 accepted august 21 2002
0.5127752.15888490.html.plaintext.txt	0	complicating complexity p53 karen yee karen h vousden
0.5127752.15888490.html.plaintext.txt	1	beatson institute cancer research garscube estate switchback road bearsden glasgow g61 1bd uk
0.5127752.15888490.html.plaintext.txt	2	correspondence addressed tel 44 0141 330 2424 fax 44 0141 943 0372 email kvousdenatbeatsonglaacuk
0.5127752.15888490.html.plaintext.txt	3	correspondence addressed tel 44 0141 330 2424 fax 44 0141 943 0372 email kvousdenatbeatsonglaacuk
0.5127752.15888490.html.plaintext.txt	4	abstract top abstract references recent studies suggested straightforward role p53 transcription factor functions inducing apoptotic target genes eliminate developing tumor cells part much complicated story firm body evidence supporting transcriptionally independent activity p53 functional structural homologue bh3 proteins although information adds another nuance mechanism p53 induce apoptosis studies indicate apoptotic function p53 represents part tumor suppressive activity although complicating understanding p53 new insights may also provide exciting new targets design therapeutics reactivate p53 cancers
0.5127752.15888490.html.plaintext.txt	5	abstract top abstract references recent studies suggested straightforward role p53 transcription factor functions inducing apoptotic target genes eliminate developing tumor cells part much complicated story firm body evidence supporting transcriptionally independent activity p53 functional structural homologue bh3 proteins although information adds another nuance mechanism p53 induce apoptosis studies indicate apoptotic function p53 represents part tumor suppressive activity although complicating understanding p53 new insights may also provide exciting new targets design therapeutics reactivate p53 cancers
0.5127752.15888490.html.plaintext.txt	6	p53 tumor suppressor gene encodes one intensively studied proteins interest p53 engendered essential role p53 normal growth development contribution p53 tumor suppression loss alterations function p53 found human cancers including major epithelial malignancies may soon responsible deaths western world 12 understanding treating cancers become matter urgency p53 pathway attractive candidate development targeted cancer therapies therapies successfully developed compared kinases popular successful cancer drug targets date p53 remains elusive quarry many functions ascribed p53 relate activities diverse transcriptional activation mitochondrial membrane permeabilization exonuclease activity dna repair regulation angiogenesis 3 6 ability p53 signal variety growth inhibitory responses including induction cell cycle arrest senescence differentiation apoptosis 78 establish central role p53 master regulator tumor suppression 9 however despite efforts many researchers many years relative contributions activities tumor suppression remain hotly disputed past years even unassailable truths p53 called question leaving us uncomfortable feeling learn less know two examples reasonably well established facts p53 recently become complicated importance p53 transcription factor role apoptosis tumor suppression discuss briefly review
0.5127752.15888490.html.plaintext.txt	7	p53 tumor suppressor gene encodes one intensively studied proteins interest p53 engendered essential role p53 normal growth development contribution p53 tumor suppression loss alterations function p53 found human cancers including major epithelial malignancies may soon responsible deaths western world 12 understanding treating cancers become matter urgency p53 pathway attractive candidate development targeted cancer therapies therapies successfully developed compared kinases popular successful cancer drug targets date p53 remains elusive quarry many functions ascribed p53 relate activities diverse transcriptional activation mitochondrial membrane permeabilization exonuclease activity dna repair regulation angiogenesis 3 6 ability p53 signal variety growth inhibitory responses including induction cell cycle arrest senescence differentiation apoptosis 78 establish central role p53 master regulator tumor suppression 9 however despite efforts many researchers many years relative contributions activities tumor suppression remain hotly disputed past years even unassailable truths p53 called question leaving us uncomfortable feeling learn less know two examples reasonably well established facts p53 recently become complicated importance p53 transcription factor role apoptosis tumor suppression discuss briefly review
0.5127752.15888490.html.plaintext.txt	8	activities p53 none firmly accepted function p53 transcription factor 10 12 assembling tetramer p53 shows sequence specific dna binding activity central domain figure 1 activates expression genes contain p53 binding sites promoters virtue interactions n terminal domain p53 transcriptional machinery almost tumor derived p53 mutants contain point mutation within dna binding domain prevents cases alters recognition p53 binding sites general p53 mutants expressed tumors lose ability activate expression target genes responsive wild type p53 although may acquire unique transcriptional activities shared wild type protein suggests transcriptional function p53 likely important tumor suppression identification target genes activated p53 supported concept hundreds p53 inducible target genes identified far compelling evidence several play role mediating various downstream responses p53 p21waf1cip1 cyclin dependent kinase inhibitor amongst first p53 targets identified deletion p21waf1cip1 number cell systems strongly abrogates ability p53 induce g1 cell cycle arrest 1314 recently products transcriptional targets p53 shown play role mediating various p53 responses including large group genes encoding proteins apoptotic activity 3 analysis number genes indicated knocking one individually failed protect cells completely p53 induced death suggesting response reflects combined effect number targets however recently bh3 domain protein puma emerged promising candidate key p53 inducible apoptotic target 1516 puma shown critical p53 mediated cell death number cells tissues knock knock puma resulting severely impeded apoptosis 1718 models enhancing tumor development 19 however given nothing threshold nature apoptotic response seems unwise conclude puma end p53 induced apoptosis indeed clear cells types inactivation p53 target genes like noxa equally profound effect apoptotic response 1820 taken together seems likely coordinated activity many p53 inducible apoptotic target genes play key role governing life death decision response stresses activate p53
0.5127752.15888490.html.plaintext.txt	9	activities p53 none firmly accepted function p53 transcription factor 10 12 assembling tetramer p53 shows sequence specific dna binding activity central domain figure 1 activates expression genes contain p53 binding sites promoters virtue interactions n terminal domain p53 transcriptional machinery almost tumor derived p53 mutants contain point mutation within dna binding domain prevents cases alters recognition p53 binding sites general p53 mutants expressed tumors lose ability activate expression target genes responsive wild type p53 although may acquire unique transcriptional activities shared wild type protein suggests transcriptional function p53 likely important tumor suppression identification target genes activated p53 supported concept hundreds p53 inducible target genes identified far compelling evidence several play role mediating various downstream responses p53 p21waf1cip1 cyclin dependent kinase inhibitor amongst first p53 targets identified deletion p21waf1cip1 number cell systems strongly abrogates ability p53 induce g1 cell cycle arrest 1314 recently products transcriptional targets p53 shown play role mediating various p53 responses including large group genes encoding proteins apoptotic activity 3 analysis number genes indicated knocking one individually failed protect cells completely p53 induced death suggesting response reflects combined effect number targets however recently bh3 domain protein puma emerged promising candidate key p53 inducible apoptotic target 1516 puma shown critical p53 mediated cell death number cells tissues knock knock puma resulting severely impeded apoptosis 1718 models enhancing tumor development 19 however given nothing threshold nature apoptotic response seems unwise conclude puma end p53 induced apoptosis indeed clear cells types inactivation p53 target genes like noxa equally profound effect apoptotic response 1820 taken together seems likely coordinated activity many p53 inducible apoptotic target genes play key role governing life death decision response stresses activate p53
0.5127752.15888490.html.plaintext.txt	10	view larger version 19k fig 1 diagram showing domain structure p53 protein p53 protein transcription factor contains several well defined domains n terminus transactivation domain proline rich region required apoptotic function within n terminus interaction sites p53 components transcriptional machinery well ubiquitin ligase mdm2 central domain harbors sequence specific dna binding region tumor associated mutations occur central region also contains binding sites interaction members bcl2 protein family c terminal region contains oligomerization domain well nuclear localisation export signals several sites within n terminal region shown phosphorylated c terminal region contains numerous sites modification influence stability localization activity p53
0.5127752.15888490.html.plaintext.txt	11	despite strong evidence supporting role p53 transcription factor consistent debate whether p53 may also transcriptionally independent activities certainly p53 also shows transcriptional repressor functions strongly correlated apoptosis 21 23 however number early studies suggested p53 may apoptotic function completely separate regulation gene expression 24 27 explanation activity provided recently observation following stress proportion p53 appears function outside nucleus cytoplasm mitochondria p53 found association several members bcl2 family proteins 28 bcl2 related proteins key components intrinsic apoptotic pathway fall three main groups function perturb mitochondrial membrane potential directly bax bak bh3 proteins directly indirectly drive activation bax bak anti apoptotic proteins sequester pro apoptotic family members hold inactive bcl2 bclxl mcl1 bh3 proteins divided two groups bind bax bak directly activate activators bim bid bind anti apoptotic family members release activators enablers like bad bik 2930 figure 2 unexpectedly would seem p53 function manner analogous bh3 proteins evidence support two broad mutually exclusive models first p53 functions like enabler bh3 domain protein interacting anti apoptotic proteins presumably releasing pro apoptotic bh3 domain proteins drive apoptosis figure 2a b 31 second model based recent observation p53 function manner analogous activator bh3 proteins directly activating apoptotic function bax bak figure 2c d 3233 either case remarkable parallels function p53 bh3 proteins reflected obvious amino acid sequence similarity although possible parts p53 adopt similar structure bh3 domain interestingly however mutations dna binding domain p53 frequently found tumors also prevent interaction p53 bclxl 31 indicating loss apoptotic activity mutants may derive concomitant failure induce transcription loss mitochondrial activity
0.5127752.15888490.html.plaintext.txt	12	despite strong evidence supporting role p53 transcription factor consistent debate whether p53 may also transcriptionally independent activities certainly p53 also shows transcriptional repressor functions strongly correlated apoptosis 21 23 however number early studies suggested p53 may apoptotic function completely separate regulation gene expression 24 27 explanation activity provided recently observation following stress proportion p53 appears function outside nucleus cytoplasm mitochondria p53 found association several members bcl2 family proteins 28 bcl2 related proteins key components intrinsic apoptotic pathway fall three main groups function perturb mitochondrial membrane potential directly bax bak bh3 proteins directly indirectly drive activation bax bak anti apoptotic proteins sequester pro apoptotic family members hold inactive bcl2 bclxl mcl1 bh3 proteins divided two groups bind bax bak directly activate activators bim bid bind anti apoptotic family members release activators enablers like bad bik 2930 figure 2 unexpectedly would seem p53 function manner analogous bh3 proteins evidence support two broad mutually exclusive models first p53 functions like enabler bh3 domain protein interacting anti apoptotic proteins presumably releasing pro apoptotic bh3 domain proteins drive apoptosis figure 2a b 31 second model based recent observation p53 function manner analogous activator bh3 proteins directly activating apoptotic function bax bak figure 2c d 3233 either case remarkable parallels function p53 bh3 proteins reflected obvious amino acid sequence similarity although possible parts p53 adopt similar structure bh3 domain interestingly however mutations dna binding domain p53 frequently found tumors also prevent interaction p53 bclxl 31 indicating loss apoptotic activity mutants may derive concomitant failure induce transcription loss mitochondrial activity
0.5127752.15888490.html.plaintext.txt	13	view larger version 24k fig 2 models p53 function bh3 protein left two possible roles p53 enabler type bh3 protein models p53 able disrupt interaction anti apoptotic proteins bclxl bcl2 mcl1 pro apoptotic proteins could directly relieve inhibition bax bak free activator type bh3 proteins bid bim activate bax bak b right models p53 functions activator type bh3 protein activation bax bak might involve binding releasing interaction anti apoptotic proteins c alternatively p53 may held inactive interaction anti apoptotic proteins case possible enabler bh3 proteins like puma might able displace p53 anti apoptotic proteins thus allowing activate baxbak d note although evidence support models interactions indicated figure confirmed
0.5127752.15888490.html.plaintext.txt	14	although experimental systems mitochondrial activity p53 alone sufficient cell death seems likely physiological conditions function cooperate ability p53 activate transcription genes like puma drive full apoptotic response although possible puma mitochondrial p53 activate independent apoptotic signals combine push cell apoptotic threshold interesting consider closer relationship two p53 activities one possibility accumulation mitochondrial p53 immediate response stress sensitizing cells apoptotic signals like expression puma recent studies shown mice subjected dna damage treatment rapid p53 mitochondrial translocation precedes p53 target gene activation triggers early wave apoptosis followed later second wave transcription dependent 34 study mitochondrial p53 found preferentially radiosensitive organs cultured cells respond p53 undergoing apoptosis rather cell cycle arrest results suggest ability accumulate mitochondrial p53 may distinguishing feature radiosensitive radioresistant organs determinant whether cell die response p53 however another model recently proposed intertwines activity p53 mitochondria function puma even closely 35 mentioned earlier p53 interact pro survival bh3 proteins like bclxl possible interaction serves inhibit activator function p53 puma high affinity pro survival proteins appears function like enabler bh3 protein 3637 therefore expressed sufficiently high levels puma may able dissociate p53 pro survival proteins thereby drive activation apoptosis figure 2d clearly route puma functions since puma induces apoptosis p53 null cells 15 however likely principal role puma release enabler proteins would encompass bid bim p53 anti apoptotic proteins drive activation bax bak model nicely ties together transcriptionally independent activity p53 transcriptionally dependent activation proteins like puma suggests final apoptotic response may require events
0.5127752.15888490.html.plaintext.txt	15	although experimental systems mitochondrial activity p53 alone sufficient cell death seems likely physiological conditions function cooperate ability p53 activate transcription genes like puma drive full apoptotic response although possible puma mitochondrial p53 activate independent apoptotic signals combine push cell apoptotic threshold interesting consider closer relationship two p53 activities one possibility accumulation mitochondrial p53 immediate response stress sensitizing cells apoptotic signals like expression puma recent studies shown mice subjected dna damage treatment rapid p53 mitochondrial translocation precedes p53 target gene activation triggers early wave apoptosis followed later second wave transcription dependent 34 study mitochondrial p53 found preferentially radiosensitive organs cultured cells respond p53 undergoing apoptosis rather cell cycle arrest results suggest ability accumulate mitochondrial p53 may distinguishing feature radiosensitive radioresistant organs determinant whether cell die response p53 however another model recently proposed intertwines activity p53 mitochondria function puma even closely 35 mentioned earlier p53 interact pro survival bh3 proteins like bclxl possible interaction serves inhibit activator function p53 puma high affinity pro survival proteins appears function like enabler bh3 protein 3637 therefore expressed sufficiently high levels puma may able dissociate p53 pro survival proteins thereby drive activation apoptosis figure 2d clearly route puma functions since puma induces apoptosis p53 null cells 15 however likely principal role puma release enabler proteins would encompass bid bim p53 anti apoptotic proteins drive activation bax bak model nicely ties together transcriptionally independent activity p53 transcriptionally dependent activation proteins like puma suggests final apoptotic response may require events
0.5127752.15888490.html.plaintext.txt	16	ability p53 function mitochondria also led reassessment consequences nuclearcytoplasmic shuttling p53 might regulated rather intriguingly brings us back considering one main negative regulators p53 function mdm2 role mdm2 controlling p53 function clear numerous studies cells mice stress induced inhibition mdm2 function key activation p53 38 mdm2 binds n terminal region p53 also contains transcriptional activation domain figure 1 interaction mdm2 p53 block binding components transcriptional machinery inhibit ability p53 activate transcription mdm2 also directly repress transcription part ability function ubiquitin ligase e3 ubiquitinate histones 39 e3 activity mdm2 also critically important ubiquitination p53 activity leads degradation maintenance low levels p53 unstressed cells importance negative regulation p53 mdm2 demonstrated many systems generally accepted inhibition mdm2 result activation p53 therefore somewhat heretical suggest mdm2 may also enabling p53 functions observation mdm2 required p53 export nucleus 4041 suggests mdm2 activity might contribute mitochondrial cytoplasmic activities p53 mechanism mdm2 drives nuclear export p53 completely clear although associated ubiquitination p53 4243 many involve unmasking nuclear export sequences present c terminal region p53 figure 1 ubiquitination p53 mdm2 therefore appears two roles targeting p53 proteasome degradation nuclear export differentiation two responses depends extent ubiquitination whereas mono ubiquitination p53 sufficient nuclear export polyubiquitination necessary degradation 43 interestingly support model p53 found mitochondria shown ubiquitin modified 44
0.5127752.15888490.html.plaintext.txt	17	ability p53 function mitochondria also led reassessment consequences nuclearcytoplasmic shuttling p53 might regulated rather intriguingly brings us back considering one main negative regulators p53 function mdm2 role mdm2 controlling p53 function clear numerous studies cells mice stress induced inhibition mdm2 function key activation p53 38 mdm2 binds n terminal region p53 also contains transcriptional activation domain figure 1 interaction mdm2 p53 block binding components transcriptional machinery inhibit ability p53 activate transcription mdm2 also directly repress transcription part ability function ubiquitin ligase e3 ubiquitinate histones 39 e3 activity mdm2 also critically important ubiquitination p53 activity leads degradation maintenance low levels p53 unstressed cells importance negative regulation p53 mdm2 demonstrated many systems generally accepted inhibition mdm2 result activation p53 therefore somewhat heretical suggest mdm2 may also enabling p53 functions observation mdm2 required p53 export nucleus 4041 suggests mdm2 activity might contribute mitochondrial cytoplasmic activities p53 mechanism mdm2 drives nuclear export p53 completely clear although associated ubiquitination p53 4243 many involve unmasking nuclear export sequences present c terminal region p53 figure 1 ubiquitination p53 mdm2 therefore appears two roles targeting p53 proteasome degradation nuclear export differentiation two responses depends extent ubiquitination whereas mono ubiquitination p53 sufficient nuclear export polyubiquitination necessary degradation 43 interestingly support model p53 found mitochondria shown ubiquitin modified 44
0.5127752.15888490.html.plaintext.txt	18	idea mdm2 may actually contribute apoptotic activity p53 provides rationale observed differences apoptotic activity two common polymorphic forms p53 carrying either arginine proline amino acid residue 72 arg72 variant shows enhanced ability interact mdm2 crm1 efficiently exported nucleus localized mitochondria pro72 form 44 consistent importance localization p53 arg72 variant shows significantly higher apoptotic activity interestingly apoptotic defect p53 proteins mutated n terminus ascribed loss transcriptional function 45 47 may also reflect failure bind mdm2 relocalize mitochondria
0.5127752.15888490.html.plaintext.txt	19	idea mdm2 may actually contribute apoptotic activity p53 provides rationale observed differences apoptotic activity two common polymorphic forms p53 carrying either arginine proline amino acid residue 72 arg72 variant shows enhanced ability interact mdm2 crm1 efficiently exported nucleus localized mitochondria pro72 form 44 consistent importance localization p53 arg72 variant shows significantly higher apoptotic activity interestingly apoptotic defect p53 proteins mutated n terminus ascribed loss transcriptional function 45 47 may also reflect failure bind mdm2 relocalize mitochondria
0.5127752.15888490.html.plaintext.txt	20	taken together seems p53 induced apoptosis represents culmination many activities including activation expression number target genes repression gene expression ability activate bax bak transcriptionally independent manner dissecting relative importance functions overall apoptotic activity p53 complex identification mutant could separate functions would certainly extremely helpful
0.5127752.15888490.html.plaintext.txt	21	taken together seems p53 induced apoptosis represents culmination many activities including activation expression number target genes repression gene expression ability activate bax bak transcriptionally independent manner dissecting relative importance functions overall apoptotic activity p53 complex identification mutant could separate functions would certainly extremely helpful
0.5127752.15888490.html.plaintext.txt	22	clarity vision p53 functions becoming even clouded growing appreciation importance p53 induced responses apoptosis preventing tumor development certainly ability induce cell death strongly linked function p53 tumor suppressor 4849 compelling studies showing transformed cells sensitive p53 mediated apoptosis conditions myc e1a driven tumorigenesis mice blocking apoptosis overexpression bcl2 50 loss apaf1 51 could substitute loss p53 strongly suggest ability induce cell death might key success p53 tumor suppressor vivo model systems examining myc induced lymphomas also provide elegant support tumor suppressive role puma studies loss puma effective accelerating tumor development loss p53 19 however accumulating evidence simply preventing apoptotic response p53 losing p53 function completely example puma knock mice resemble p53 null animals respect tumor development despite showing profound defects apoptotic response many tissues 1718 observations therefore suggest activities p53 induction cell cycle arrest senescence contribution maintenance genomic stability also play important role tumor suppression apoptosis pinning contribution cell cycle arrest response p53 tumor suppression complicated although deletion p21waf1cip1 one key mediators proliferative block induced p53 enhance susceptibility cancer development models 52 loss p21waf1cip1 equivalent loss p53 indeed systems loss p21waf1cip1 may even impede tumorigenesis possibly reflection tissue system dependent pro apoptotic anti apoptotic activities p21waf1cip1 53 however notwithstanding complexity contribution p21waf1cip1 seems clear proliferative block induced p53 shape cell cycle arrest senescence may important preventing cancer development induction cell death evidence come reexamination specific tumor derived p53 mutants dissociate p53s apoptotic cell cycle responses initial tissue culture studies indicated mutants remain competent induction cell cycle arrest fail induce apoptosis 54 interestingly p53 mutants function enhance transformation cells culture 55 adding weight suggestion apoptosis key tumor suppressor function p53 recently however knock mouse expressing one mutant p53 created interestingly despite showing complete loss p53 mediated apoptosis reduced p53 induced cell cycle arrest mice retained ability resist tumor development 56 although clearly susceptible cancer wild type littermates suggesting apoptosis indeed play role incidence tumor development far less seen p53 null mice strongly indicating ability induce proliferative block matched maintenance genomic stability important weapon tumor suppressive armoury p53 model systems encourage us think p53 activities trying restore therapy concentrate apoptosis cell cycle progression even senescence 57 even ability p53 induce proliferative block inhibit tumor development also true reinstating p53 dependent cell cycle arrest help cure cancer importantly attempts modulate proliferative block tumor cells effects apoptotic response example identification p21waf1cip1 survival factor might ideally inhibited part tumor therapy 58 suggests reactivating p53 response may unanticipated undesirable consequences tumor cell survival
0.5127752.15888490.html.plaintext.txt	23	clarity vision p53 functions becoming even clouded growing appreciation importance p53 induced responses apoptosis preventing tumor development certainly ability induce cell death strongly linked function p53 tumor suppressor 4849 compelling studies showing transformed cells sensitive p53 mediated apoptosis conditions myc e1a driven tumorigenesis mice blocking apoptosis overexpression bcl2 50 loss apaf1 51 could substitute loss p53 strongly suggest ability induce cell death might key success p53 tumor suppressor vivo model systems examining myc induced lymphomas also provide elegant support tumor suppressive role puma studies loss puma effective accelerating tumor development loss p53 19 however accumulating evidence simply preventing apoptotic response p53 losing p53 function completely example puma knock mice resemble p53 null animals respect tumor development despite showing profound defects apoptotic response many tissues 1718 observations therefore suggest activities p53 induction cell cycle arrest senescence contribution maintenance genomic stability also play important role tumor suppression apoptosis pinning contribution cell cycle arrest response p53 tumor suppression complicated although deletion p21waf1cip1 one key mediators proliferative block induced p53 enhance susceptibility cancer development models 52 loss p21waf1cip1 equivalent loss p53 indeed systems loss p21waf1cip1 may even impede tumorigenesis possibly reflection tissue system dependent pro apoptotic anti apoptotic activities p21waf1cip1 53 however notwithstanding complexity contribution p21waf1cip1 seems clear proliferative block induced p53 shape cell cycle arrest senescence may important preventing cancer development induction cell death evidence come reexamination specific tumor derived p53 mutants dissociate p53s apoptotic cell cycle responses initial tissue culture studies indicated mutants remain competent induction cell cycle arrest fail induce apoptosis 54 interestingly p53 mutants function enhance transformation cells culture 55 adding weight suggestion apoptosis key tumor suppressor function p53 recently however knock mouse expressing one mutant p53 created interestingly despite showing complete loss p53 mediated apoptosis reduced p53 induced cell cycle arrest mice retained ability resist tumor development 56 although clearly susceptible cancer wild type littermates suggesting apoptosis indeed play role incidence tumor development far less seen p53 null mice strongly indicating ability induce proliferative block matched maintenance genomic stability important weapon tumor suppressive armoury p53 model systems encourage us think p53 activities trying restore therapy concentrate apoptosis cell cycle progression even senescence 57 even ability p53 induce proliferative block inhibit tumor development also true reinstating p53 dependent cell cycle arrest help cure cancer importantly attempts modulate proliferative block tumor cells effects apoptotic response example identification p21waf1cip1 survival factor might ideally inhibited part tumor therapy 58 suggests reactivating p53 response may unanticipated undesirable consequences tumor cell survival
0.5127752.15888490.html.plaintext.txt	24	clearly many questions remain answered despite obvious gaps understanding exactly p53 works role p53 tumor suppression indisputable encouraged development numerous approaches harnessing power p53 tumor therapy including gene therapy directly express wild type p53 59 well development small molecules restore function mutant p53 60 reactivate wild type p53 61 latter approach depends observation many tumors retain wild type p53 gene show defects pathways allow activation p53 response stress cases resulting inability turn mdm2 tumors targeting mdm2 would expected stabilize activate p53 one extremely promising approach identify small molecule inhibitors mdm2 p53 interaction 62 although inhibition protein protein interactions usually favourite target drug development case success nutlin compounds may reflect extremely tightly defined interaction small domain p53 deep pocket mdm2 63 approaches include use antisense oligonucleotides inihibit mdm2 expression 64 identification small molecules inhibit e3 activity mdm2 65 interestingly although inhibition mdm2 activity also hinder mitochondrial function p53 preventing nuclear export results indicate p53 activity restored sufficient efficiency induce apoptotic response
0.5127752.15888490.html.plaintext.txt	25	clearly many questions remain answered despite obvious gaps understanding exactly p53 works role p53 tumor suppression indisputable encouraged development numerous approaches harnessing power p53 tumor therapy including gene therapy directly express wild type p53 59 well development small molecules restore function mutant p53 60 reactivate wild type p53 61 latter approach depends observation many tumors retain wild type p53 gene show defects pathways allow activation p53 response stress cases resulting inability turn mdm2 tumors targeting mdm2 would expected stabilize activate p53 one extremely promising approach identify small molecule inhibitors mdm2 p53 interaction 62 although inhibition protein protein interactions usually favourite target drug development case success nutlin compounds may reflect extremely tightly defined interaction small domain p53 deep pocket mdm2 63 approaches include use antisense oligonucleotides inihibit mdm2 expression 64 identification small molecules inhibit e3 activity mdm2 65 interestingly although inhibition mdm2 activity also hinder mitochondrial function p53 preventing nuclear export results indicate p53 activity restored sufficient efficiency induce apoptotic response
0.5127752.15888490.html.plaintext.txt	26	although promising approaches means exhausted potential p53 therapeutic target discover p53 list possible drug targets might allow reactivation least facet p53 tumor suppression also increases look forward continuing boom understanding basic biology p53 advancing hand hand increased ability exploit knowledge cancer therapy
0.5127752.15888490.html.plaintext.txt	27	although promising approaches means exhausted potential p53 therapeutic target discover p53 list possible drug targets might allow reactivation least facet p53 tumor suppression also increases look forward continuing boom understanding basic biology p53 advancing hand hand increased ability exploit knowledge cancer therapy
0.5127752.15888490.html.plaintext.txt	28	acknowledgments grateful kevin ryan helpful comments would also like thank cancer research uk west scotland womens bowling association providing generous support ksy
0.5127752.15888490.html.plaintext.txt	29	acknowledgments grateful kevin ryan helpful comments would also like thank cancer research uk west scotland womens bowling association providing generous support ksy
0.5127752.15888490.html.plaintext.txt	30	conflict interest statement none declared
0.5127752.15888490.html.plaintext.txt	31	references top abstract references hollsteinm ricek greenblattms soussit fuchsr sorliet hovige smith sorensenb montesanor harriscc 1994 database p53 gene somatic mutations human tumors cell lines nucleic acids res 22 3551 3555abstract olivierm hussainsp de fromentelc hainautp harriscc 2004 tp53 mutation spectra load tool generating hypotheses etiology cancer iarc sci pul 157 247 270 vousdenkh lux 2002 live let die cells response p53 nat rev cancer 2 594 604crossrefisimedline meekdw 2004 p53 response dna damage dna repair 3 1049 1056crossrefisimedline manfredijj 2003 p53 apoptosis nucleus anymore mol cell 11 552 554crossrefisimedline senguptas harriscc 2005 p53 traffic cop crossroads dna repair recombination nat rev mol cell biol 6 44 55crossrefisimedline vogelsteinb laned levineaj 2000 surfing p53 network nature 408 307 310crossrefisimedline hofsethlj hussainsp harriscc 2004 p53 25 years discovery trends pharmacol sci 25 177 181crossrefisimedline lowesw ceperoe evang 2004 intrinsic tumour suppression nature 432 307 315crossrefisimedline polyakk xiay zweierjl kinzlerkw vogelsteinb 1997 model p53 induced apoptosis nature 389 300 305crossrefisimedline yuj zhangl hwangpm ragoc kinzlerk vogelsteinb 1999 identification classification p53 regulated genes proc natl acad sci usa 96 14517 14522abstractfree full text zhaor gishk murphym yiny nottermand hoffmanwh tome mackdh levineaj 2000 analysis p53 regulated gene expression patterns using oligonucleotide arrays genes dev 14 981 993abstractfree full text brugarolasj chandrasekaranc gordonji beachd jackst hannongj 1995 radiation induced cell cycle arrest compromised p21 deficiency nature 377 552 556crossrefisimedline dengc zhangp harperjw elledgesj lederp 1995 mice lacking p21cip1waf1 undergo normal development defective g1 checkpoint control cell 82 675 684crossrefisimedline nakanok vousdenkh 2001 puma novel pro apopototic gene induced p53 mol cell 7 683 694crossrefisimedline yuj zhangl hwangpm kinzlerkw vogelsteinb 2001 puma induces rapid apoptosis colorectal cancer cells mol cell 7 673 682crossrefisimedline jeffersjr parganase leey et al 2003 puma essential mediator p53 dependent independent apoptotic pathways cancer cell 4 321 3238crossrefisimedline villungera michalakem coultasl mullauerf bockg ausserlechnermj adamsjm strassera 2003 p53 drug induced apoptotic responses mediated bh3 proteins puma noxa science 302 1036 1038abstractfree full text hemannmt zilfoujt zhaoz burgessdj hannongl lowesw 2004 suppression tumorigenesis p53 target puma proc natl acad sci usa 101 9333 9338abstractfree full text shibuet takedak odae tanakah murasawah takaokaa morishitay akiras taniguchit tanakan 2003 integral role noxa p53 mediated apoptotic response genes dev 17 2233 2238abstractfree full text ryankm vousdenkh 1998 characterization structural p53 mutants show selective defects apoptosis cell cycle arrest mol cell biol 18 3692 3698abstractfree full text murphym ahnj walkerkk hoffmanwh evansrm levineaj georgedl 1999 transcriptional repression wild type p53 utilizes histone deacetylases mediated interaction msin3a genes dev 13 2490 2501abstractfree full text khops wangz zhuangl liy chewjl nghh liuet yuq 2004 p53 regulated transcriptional program associated genotoxic stress induced apoptosis j biol chem 279 21183 21192abstractfree full text caellesc helmberga karinm 1994 p53 dependent apoptosis absence transcriptional activation p53 target genes nature 370 220 223crossrefisimedline wagneraj kokontisjm hayn 1994 myc mediated apoptosis requires wild type p53 manner independent cell cycle arrest ability p53 induce p21waf1cip1 genes dev 8 2817 2830abstract haupty rowans shauliane vousdenkh orenm 1995 induction apoptosis hela cells trans activation deficient p53 genes dev 9 2170 2183abstract chenx kolj jayaramanl privesc 1996 p53 levels functional domains dna damage determine extent apoptotic response tumor cells genes dev 10 2438 2451abstract corys adamsjm 2002 bcl2 family regulators cellular life death switch nat rev cancer 2 647 656crossrefisimedline chittendent 2002 bh3 domains intracellular death ligands critical initiating apoptosis cancer cell 2 165 166crossrefisimedline letaik bassikmc walenskyld sorcinellimd weilers korsmeyersj 2002 distinctive bh3 domains either sensitize activate mitochondrial apoptosis serving prototype cancer therapeutics cancer cell 2 183 192crossrefisimedline miharam ersters zaikaa petrenkoo chittendent pancoskap mollum 2003 p53 direct apoptogenic role mitochondria mol cell 11 577 590crossrefisimedline chipukje kuwanat bouchier hayesl droinnm newmeyerdd schulerm greendr 2004 direct activation bax p53 mediates mitochondrial membrane permeabilization apoptosis science 303 1010 1014abstractfree full text leuji dumontp hafeym murphymp georgedl 2004 mitochondrial p53 activates bak causes disruption bak mcl1 complex nature cell biol 6 443 450crossrefisimedline ersters miharam kimrh petrenkoo mollum 2004 vivo mitochrondrial p53 translocation triggers rapid first wave cell death response dna damage precede p53 target gene activation mol cell biol 24 6728 6741abstractfree full text schulerm greendr 2005 transcription apoptosis p53 catch 22 trends genet 21 182 187crossrefisimedline chenl willissn weia smithbj fletcherji hindsmg colmanpm daycl adamsjm huangdc 2005 differential targeting prosurvival bcl 2 proteins bh3 ligands allows complementary apoptotic function mol cell 17 393 403crossrefisimedline kuwanat bouchier hayesl chipukje bonzonc sullivanba greendr newmeyerdd 2005 bh3 domains bh3 proteins differentially regulate bax mediated mitochondrial membrane permeabilization directly indirectly mol cell 17 525 535crossrefisimedline bondgl huw levineaj 2005 mdm2 central node p53 pathway 12 years counting curr cancer drug targets 5 3 8crossrefisimedline minskyn orenm 2004 ring domain mdm2 mediates histone ubiquitylation transcriptional repression mol cell 16 631 639crossrefisimedline boydsd tsaiky jackst 2000 intact hdm2 ring finger domain required nuclear exclusion p53 nat cell biol 2 563 568crossrefisimedline geyerrk yuzk makicg 2000 mdm2 ring finger domain required promote p53 nuclear export nat cell biol 2 569 573crossrefisimedline lohrummae woodsdb ludwigrl balinte vousdenkh 2001 c terminal ubiquitination p53 contributes nuclear export mol cell biol 21 8521 8532abstractfree full text lim brookscl wu baerf chend baerr guw 2003 mono versus polyubiquitination differential control p53 fate mdm2 science 302 1972 1975abstractfree full text dumontp leuji della pietraac georgedl murphymp 2003 codon 72 polymorphic variants p53 markedly different apoptotic potential nat genet 33 357 365crossrefisimedline chaoc saitos kangj andersoncw appellae xuy 2000 p53 transcriptional activity essential p53 dependent apoptosis following dna damage embo j 19 4967 4975abstractfree full text jimenezgs nisterm stommeljm beechem barcarseea zhangx q ogormans wahlg 2000 transactivation deficient mouse model provides insights trp53 regulation function nat genet 26 37 41crossrefisimedline nisterm tangm zhangxq yinc beechem hux enbladg van dyket wahlgm 2005 p53 must competent transcriptional regulation suppress tumor formation oncogene press wangxw 1999 role p53 apoptosis carcinogenesis anticancer res 19 4759 4771isimedline fridmansj lowesw 2003 control apoptosis p53 oncogene 22 9030 9040crossrefisimedline schmittca fridmansj yangm baranove hoffmanrm lowesw 2002 dissecting p53 tumor suppressor functions vivo cancer cell 1 289 298crossrefisimedline soengasms alarconrm yoshidah giacciaaj hakemr maktw lowesw 1999 apaf 1 caspase 9 p53 dependent apoptosis tumor inhibition science 284 156 9abstractfree full text martin caballeroj floresjm garcia palenciap serranom 2001 tumor susceptibility p21 waf1cip1 deficicent mice cancer res 61 6234 6238abstractfree full text lius bishopwr lium 2003 differential effects cell cycle regulatory protien p21 waf1cip1 apoptosis sensitivity cancer chemotherapy drug resist updat 6 183 195crossrefisimedline rowans ludwigrl haupty batess lux orenm vousdenkh 1996 specific loss apoptotic cell cycle arrest function human tumour derived p53 mutant embo j 15 827 838abstract crookt marstonnj saraea vousdenkh 1994 transcriptional activation p53 correlates suppression growth transformation cell 79 817 827crossrefisimedline liug parantjm langg chaup chavez reyesa el naggarak multania changs lozanog 2004 chromosomal stability absence apoptosis critical suppression tumorigenesis trp53 mutant mice nat genet 36 63 68crossrefisimedline campisij 2005 senescent cells tumor suppression organismal aging good citizens bad neighbors cell 120 513 522crossrefisimedline weissrh 2003 p21waf1cip1 therapeutic target breast cancers cancer cell 4 425 429crossrefisimedline edelmanj edelmanj nemunaitisj 2003 adenoviral p53 gene therapy squamous cell cancer head neck region curr opin mol ther 5 611 617isimedline wangw rastinejadf el deiryws 2003 restoring p53 dependent tumor suppression cancer biol ther 2 s55 63isimedline bykovvj wimankg 2003 novel cancer therapy reactivation p53 apoptosis pathway ann med 35 458 465crossrefisimedline kleinc vassilevlt 2004 targeting p53 mdm2 interaction treat cancer br j cancer 91 1415 1419isimedline vassilevlt vubt gravesb carvajald podlaskif filipovicz kingn kammlottu lukacsc kleinc fotouhin liuea 2004 vivo activation p53 pathway small molecular antagonists mdm2 science 303 844 848abstractfree full text zhangr wangh agrawals 2005 novel antisense anti mdm2 mixed backbone oligonuceotides proof principal vitro vivo activities mechanisms curr cancer drug targets 5 43 49crossrefisimedline yangy ludwigrl jensensjp pierres medagliamv davydovi safiranyj oberoip kentenj phillipsac weissmanam vousdenkh 2005 small molecule inhibitors hdm2 ubiquitin ligase activity stabilize activate p53 cells cancer cell press received april 30 2005 accepted may 3 2005
0.5136099.11673474.html.plaintext.txt	0	rockefeller university press 0021 9525200110471 500 journal cell biology volume 155 number 3 october 29 2001 471 486 article
0.5136099.11673474.html.plaintext.txt	1	rockefeller university press 0021 9525200110471 500 journal cell biology volume 155 number 3 october 29 2001 471 486 article
0.5136099.11673474.html.plaintext.txt	2	suppression p53 function normal human mammary epithelial cells increases sensitivity extracellular matrix induced apoptosis victoria l seewaldt1 krzysztof mrozek2 randy sigle3 eric c dietze1 kevin heine4 david m hockenbery4 katherine b hobbs1 l elizabeth caldwell5
0.5136099.11673474.html.plaintext.txt	3	suppression p53 function normal human mammary epithelial cells increases sensitivity extracellular matrix induced apoptosis victoria l seewaldt1 krzysztof mrozek2 randy sigle3 eric c dietze1 kevin heine4 david m hockenbery4 katherine b hobbs1 l elizabeth caldwell5
0.5136099.11673474.html.plaintext.txt	4	1 division medical oncology duke university durham nc 27710 2 division hematology oncology comprehensive cancer center ohio state university columbus oh 43210 3 division basic science fred hutchinson cancer research center seattle wa 98109 4 division clinical research molecular medicine fred hutchinson cancer research center seattle wa 98109 5 program electron microscopy fred hutchinson cancer research center seattle wa 98109
0.5136099.11673474.html.plaintext.txt	5	address correspondence victoria l seewaldt box 2628 duke university medical center durham nc 27710 tel 919 668 2455 fax 919 668 2458 e mail seewa001atmcdukeedu
0.5136099.11673474.html.plaintext.txt	6	address correspondence victoria l seewaldt box 2628 duke university medical center durham nc 27710 tel 919 668 2455 fax 919 668 2458 e mail seewa001atmcdukeedu
0.5136099.11673474.html.plaintext.txt	7	abstract top abstract introduction results discussion materials methods references little known fate normal human mammary epithelial cells hmecs lose p53 function context extracellular matrix ecm derived growth polarity signals retrovirally mediated expression human papillomavirus type 16 hpv 16 e6 antisense oligodeoxynucleotides odns used suppress p53 function hmecs model early breast cancer p53 hmec vector controls grew exponentially reconstituted ecm recm day 6 underwent growth arrest day 7 ultrastructural examination day 7 vector controls revealed acinus like structures characteristic normal mammary epithelium contrast early passage p53 hmec cells proliferated recm day 6 underwent apoptosis day 7 p53 hmec e6 passaged non recm culture rapidly 8 10 passages lost sensitivity recm induced growth arrest polarity also developed resistance recm induced apoptosis resistance associated altered expression 3 integrin treatment early passage p53 hmec e6 cells either 3 ss1 integrin function blocking antibodies inhibited recm mediated growth arrest induction apoptosis results indicate suppression p53 expression hmecs hpv 16 e6 odns may sensitize cells recm induced apoptosis suggest role 3ss1 heterodimer mediating apoptosis hmecs grown contact recm
0.5136099.11673474.html.plaintext.txt	8	abstract top abstract introduction results discussion materials methods references little known fate normal human mammary epithelial cells hmecs lose p53 function context extracellular matrix ecm derived growth polarity signals retrovirally mediated expression human papillomavirus type 16 hpv 16 e6 antisense oligodeoxynucleotides odns used suppress p53 function hmecs model early breast cancer p53 hmec vector controls grew exponentially reconstituted ecm recm day 6 underwent growth arrest day 7 ultrastructural examination day 7 vector controls revealed acinus like structures characteristic normal mammary epithelium contrast early passage p53 hmec cells proliferated recm day 6 underwent apoptosis day 7 p53 hmec e6 passaged non recm culture rapidly 8 10 passages lost sensitivity recm induced growth arrest polarity also developed resistance recm induced apoptosis resistance associated altered expression 3 integrin treatment early passage p53 hmec e6 cells either 3 ss1 integrin function blocking antibodies inhibited recm mediated growth arrest induction apoptosis results indicate suppression p53 expression hmecs hpv 16 e6 odns may sensitize cells recm induced apoptosis suggest role 3ss1 heterodimer mediating apoptosis hmecs grown contact recm
0.5136099.11673474.html.plaintext.txt	9	key words extracellular matrix mammary epithelial cells apoptosis p53 3ss1 integrin
0.5136099.11673474.html.plaintext.txt	10	introduction top abstract introduction results discussion materials methods references interactions extracellular matrix ecmand mammary epithelial cells critical regulation cellular proliferation polarity apoptosis petersen et al 1992 strange et al 1992 normal interactions may disrupted breast carcinogenesis petersen et al 1992 zutter et al 1995 observed although normal mammary epithelial cells undergo growth arrest culture presence reconstituted ecm recm breast cancer cells established breast cancer cell lines fail exhibit similar growth arrest petersen et al 1992 thus hypothesized interaction ecm may serve distinguish growth patterns normal malignant mammary epithelial cells
0.5136099.11673474.html.plaintext.txt	11	mechanism ecm mediated signal transduction events might result changes gene expression subject current investigation shown recm regulates biomechanical biochemical signaling events conversely alterations cell morphology alter response cells recm folkman moscona 1978 roskelley et al 1994 hypothesized malignant cells altered response recm ecm signaling pathways may utilize tumor suppressor checkpoints critical cellular organization polarity petersen et al 1992 howlett et al 1994 weaver et al 1997
0.5136099.11673474.html.plaintext.txt	12	mechanism ecm mediated signal transduction events might result changes gene expression subject current investigation shown recm regulates biomechanical biochemical signaling events conversely alterations cell morphology alter response cells recm folkman moscona 1978 roskelley et al 1994 hypothesized malignant cells altered response recm ecm signaling pathways may utilize tumor suppressor checkpoints critical cellular organization polarity petersen et al 1992 howlett et al 1994 weaver et al 1997
0.5136099.11673474.html.plaintext.txt	13	integrins heterodimeric cell surface receptors link ecm structural functional components within cell hynes 1992 increasing evidence integrins important regulators normal mammary morphology since mammary carcinoma cells frequently demonstrate atypical patterns integrin expression including loss downregulation improper localization koukoulis et al 1991 glukhova et al 1995 lichtner et al 1998 normal mammary gland 3ss1 integrin expressed basal surface luminal epithelial cells koukoulis et al 1991 glukhova et al 1995 contrast invasive breast carcinomas demonstrate weak staining redistribution 3ss1 integrin recently 3ss1 integrin attracted considerable interest since function appears versatile example integrin 3ss1 functions cell adhesion receptor laminin 5 epiligrin major ecm protein present basement membrane xia et al 1996 3ss1 integrin recruited focal adhesion contacts cultured cells thereby plays important role linking ecm components actin cytoskeleton carter et al 1990b grenz et al 1993 dipersio et al 1995 integrin 3ss1 critical mediator intracellular adhesion kawano et al 2001 studies keratinocytes suggest 3ss1 plays critical role cell spreading migration promotes gap junctional communication carter et al 1990b xia et al 1996 dipersio et al 1997 recently 3ss1 integrin shown involved initiation apoptosis sato et al 1999 taken together studies illustrate multifaceted role 3ss1 integrin mediating interactions ecm epithelial cells perhaps initiating apoptosis
0.5136099.11673474.html.plaintext.txt	14	integrins heterodimeric cell surface receptors link ecm structural functional components within cell hynes 1992 increasing evidence integrins important regulators normal mammary morphology since mammary carcinoma cells frequently demonstrate atypical patterns integrin expression including loss downregulation improper localization koukoulis et al 1991 glukhova et al 1995 lichtner et al 1998 normal mammary gland 3ss1 integrin expressed basal surface luminal epithelial cells koukoulis et al 1991 glukhova et al 1995 contrast invasive breast carcinomas demonstrate weak staining redistribution 3ss1 integrin recently 3ss1 integrin attracted considerable interest since function appears versatile example integrin 3ss1 functions cell adhesion receptor laminin 5 epiligrin major ecm protein present basement membrane xia et al 1996 3ss1 integrin recruited focal adhesion contacts cultured cells thereby plays important role linking ecm components actin cytoskeleton carter et al 1990b grenz et al 1993 dipersio et al 1995 integrin 3ss1 critical mediator intracellular adhesion kawano et al 2001 studies keratinocytes suggest 3ss1 plays critical role cell spreading migration promotes gap junctional communication carter et al 1990b xia et al 1996 dipersio et al 1997 recently 3ss1 integrin shown involved initiation apoptosis sato et al 1999 taken together studies illustrate multifaceted role 3ss1 integrin mediating interactions ecm epithelial cells perhaps initiating apoptosis
0.5136099.11673474.html.plaintext.txt	15	tissue homeostasis maintained dynamic equilibrium cellular proliferation cell death evan littlewood 1998 apoptosis considered predominant mechanism cell death plays central role controlling cell number eliminating cells sustaining dna damage ashkenazi dixit 1998 role tumor suppressor p53 ecm induced growth arrest polarity apoptosis unknown tp53 cell cycle checkpoint gene critical cell cycle regulation functionally inactivated human cancer high frequency hansen oren 1997 mutations tp53 gene detected commonly breast cancers associated increased risk malignancy ashkenazi dixit 1998 levesque et al 1998 aberrant expression p53 mammary epithelial cells may biomarker predicting risk subsequent breast carcinogenesis accumulation p53 protein mammary epithelial cells detected frequently women high risk development breast cancer fabian et al 1996 associated increased risk progression breast cancer women benign breast disease rohan et al 1998
0.5136099.11673474.html.plaintext.txt	16	tissue homeostasis maintained dynamic equilibrium cellular proliferation cell death evan littlewood 1998 apoptosis considered predominant mechanism cell death plays central role controlling cell number eliminating cells sustaining dna damage ashkenazi dixit 1998 role tumor suppressor p53 ecm induced growth arrest polarity apoptosis unknown tp53 cell cycle checkpoint gene critical cell cycle regulation functionally inactivated human cancer high frequency hansen oren 1997 mutations tp53 gene detected commonly breast cancers associated increased risk malignancy ashkenazi dixit 1998 levesque et al 1998 aberrant expression p53 mammary epithelial cells may biomarker predicting risk subsequent breast carcinogenesis accumulation p53 protein mammary epithelial cells detected frequently women high risk development breast cancer fabian et al 1996 associated increased risk progression breast cancer women benign breast disease rohan et al 1998
0.5136099.11673474.html.plaintext.txt	17	retrovirally mediated introduction human papillomavirus type 16 hpv 16 e6 protein cells provides model isolated loss p53 function e6 protein cancer associated hpv 16 binds p53 targets degradation ubiquitin pathway demers et al 1996 employed approach antisense oligondeoxyucleotides odns acutely suppress p53 function normal human mammary epithelial cells hmecs order model p53 loss context ecm signaling
0.5136099.11673474.html.plaintext.txt	18	retrovirally mediated introduction human papillomavirus type 16 hpv 16 e6 protein cells provides model isolated loss p53 function e6 protein cancer associated hpv 16 binds p53 targets degradation ubiquitin pathway demers et al 1996 employed approach antisense oligondeoxyucleotides odns acutely suppress p53 function normal human mammary epithelial cells hmecs order model p53 loss context ecm signaling
0.5136099.11673474.html.plaintext.txt	19	results showed control hmecs expressing p53 underwent recm mediated growth arrest formed polarized epithelium contrast hmecs hpv 16 e6 odn suppressed p53 expression underwent recm induced growth arrest followed apoptosis p53 hmec e6 cells passaged non recm culture rapidly acquired resistance recm mediated growth arrest polarity apoptosis 8 10 passages culture treatment early passage p53 hmec e6 cells either 3 ss1 integrin function altering antibodies abs blocked recm mediated growth arrest induction apoptosis observations model system suggest recm may play important role induction apoptosis early passage p53 hmecs via 3ss1 signaling pathway
0.5136099.11673474.html.plaintext.txt	20	results showed control hmecs expressing p53 underwent recm mediated growth arrest formed polarized epithelium contrast hmecs hpv 16 e6 odn suppressed p53 expression underwent recm induced growth arrest followed apoptosis p53 hmec e6 cells passaged non recm culture rapidly acquired resistance recm mediated growth arrest polarity apoptosis 8 10 passages culture treatment early passage p53 hmec e6 cells either 3 ss1 integrin function altering antibodies abs blocked recm mediated growth arrest induction apoptosis observations model system suggest recm may play important role induction apoptosis early passage p53 hmecs via 3ss1 signaling pathway
0.5136099.11673474.html.plaintext.txt	21	results top abstract introduction results discussion materials methods references p53 protein suppression hmecs retrovirally mediated expression hpv 16 e6 protein used suppress normal intracellular p53 protein levels hmecs plxsn16e6 retroviral vector containing coding sequence hpv 16 e6 viral protein described previously demers et al 1994 actively dividing passage 9 ag11132 cells infected retroviral vector lxsn16e6 control vector lxsn infected cells selected described materials methods experiments described subsequently performed mass cultures hmec p parental cells p53 hmec lxsn controls p53 hmec e6 cells passaged serially culture plastic tissue culture plates previously observed seewaldt et al 1999ab p53 hmec lxsn controls hmec p parental cells exhibited progressive increase doubling time continued serial passaging entered phase b growth plateau passage 23 romanov et al 2001 contrast p53 hmec e6 cells exhibited extended lifespan culture entered growth plateau passage 40
0.5136099.11673474.html.plaintext.txt	22	results top abstract introduction results discussion materials methods references p53 protein suppression hmecs retrovirally mediated expression hpv 16 e6 protein used suppress normal intracellular p53 protein levels hmecs plxsn16e6 retroviral vector containing coding sequence hpv 16 e6 viral protein described previously demers et al 1994 actively dividing passage 9 ag11132 cells infected retroviral vector lxsn16e6 control vector lxsn infected cells selected described materials methods experiments described subsequently performed mass cultures hmec p parental cells p53 hmec lxsn controls p53 hmec e6 cells passaged serially culture plastic tissue culture plates previously observed seewaldt et al 1999ab p53 hmec lxsn controls hmec p parental cells exhibited progressive increase doubling time continued serial passaging entered phase b growth plateau passage 23 romanov et al 2001 contrast p53 hmec e6 cells exhibited extended lifespan culture entered growth plateau passage 40
0.5136099.11673474.html.plaintext.txt	23	northern blot analysis performed p53 hmec p parental cells p53 hmec e6 cells p53 hmec lxsn controls passage 11 18 test hpv 16 e6 mrna expression expression ltr initiated e6 mrna transcript observed p53 hmec e6 cells passage 11 18 parental vector controls fig 1
0.5136099.11673474.html.plaintext.txt	24	northern blot analysis performed p53 hmec p parental cells p53 hmec e6 cells p53 hmec lxsn controls passage 11 18 test hpv 16 e6 mrna expression expression ltr initiated e6 mrna transcript observed p53 hmec e6 cells passage 11 18 parental vector controls fig 1
0.5136099.11673474.html.plaintext.txt	25	view larger version 40k figure 1 expression p53 hpv 16 e6 mrna p53 proteins hmecs expression endogenous p53 exogenous hpv 16 e6 mrna hmecs passage 10 18 p53 hmec p parental cells parental p53 hmec lxsn controls lxsn p53 hmec e6 cells e6 analyzed p53 hpv 16 e6 mrna expression 10 microg rna loaded per lane 36b4 served loading control b expression p53 protein suppressed p53 hmec e6 cells passage 10 18 p53 hmec p parental cells parental p53 hmec lxsn controls lxsn p53 hmec e6 cells e6 analyzed p53 protein expression described materials methods equal amounts protein lysate loaded per lane protein gel stained coomassie blue unknown 45 kd protein band used loading control
0.5136099.11673474.html.plaintext.txt	26	view larger version 40k figure 1 expression p53 hpv 16 e6 mrna p53 proteins hmecs expression endogenous p53 exogenous hpv 16 e6 mrna hmecs passage 10 18 p53 hmec p parental cells parental p53 hmec lxsn controls lxsn p53 hmec e6 cells e6 analyzed p53 hpv 16 e6 mrna expression 10 microg rna loaded per lane 36b4 served loading control b expression p53 protein suppressed p53 hmec e6 cells passage 10 18 p53 hmec p parental cells parental p53 hmec lxsn controls lxsn p53 hmec e6 cells e6 analyzed p53 protein expression described materials methods equal amounts protein lysate loaded per lane protein gel stained coomassie blue unknown 45 kd protein band used loading control
0.5136099.11673474.html.plaintext.txt	27	western blots performed p53 hmec p parental cells p53 hmec e6 cells p53 hmec lxsn controls passage 11 18 determine relative levels p53 protein expression expression p53 protein observed p53 hmec p parental cells p53 hmec lxsn vector controls detectable western analysis p53 hmec e6 cells either passage 11 18 fig 1 b
0.5136099.11673474.html.plaintext.txt	28	western blots performed p53 hmec p parental cells p53 hmec e6 cells p53 hmec lxsn controls passage 11 18 determine relative levels p53 protein expression expression p53 protein observed p53 hmec p parental cells p53 hmec lxsn vector controls detectable western analysis p53 hmec e6 cells either passage 11 18 fig 1 b
0.5136099.11673474.html.plaintext.txt	29	cytogenetic analysis early late passage p53 p53 hmecs cytogenetic analysis p53 hmec p parental cells p53 hmec lxsn controls early passage p53 hmec e6 cells performed using spectral karyotyping sky dapi staining test whether parental vector control cells exhibited normal karyotype b verify early passage p53 hmec e6 cells exhibit specific karyotypic abnormalities
0.5136099.11673474.html.plaintext.txt	30	38 early passage p53 hmec p parental cells passage 8 karyotyped 35 92 metaphase cells normal diploid karyotype three cells 8 exhibited random chromosome loss
0.5136099.11673474.html.plaintext.txt	31	38 early passage p53 hmec p parental cells passage 8 karyotyped 35 92 metaphase cells normal diploid karyotype three cells 8 exhibited random chromosome loss
0.5136099.11673474.html.plaintext.txt	32	similarly 22 early passage p53 hmec lxsn control cells passage 10 karyotyped 20 91 p53 hmec lxsn metaphase cells normal diploid karyotype two cells 9 exhibited random chromosome loss
0.5136099.11673474.html.plaintext.txt	33	similarly 22 early passage p53 hmec lxsn control cells passage 10 karyotyped 20 91 p53 hmec lxsn metaphase cells normal diploid karyotype two cells 9 exhibited random chromosome loss
0.5136099.11673474.html.plaintext.txt	34	22 late passage p53 hmec lxsn control cells passage 17 karyotyped 18 82 p53 hmec lxsn metaphase cells normal diploid karyotype three cells 13 exhibited random chromosome loss one cell 5 tetraploid 92 chromosomes results consistent karyotypes reported late phase pregrowth plateau hmecs romanov et al 2001
0.5136099.11673474.html.plaintext.txt	35	22 late passage p53 hmec lxsn control cells passage 17 karyotyped 18 82 p53 hmec lxsn metaphase cells normal diploid karyotype three cells 13 exhibited random chromosome loss one cell 5 tetraploid 92 chromosomes results consistent karyotypes reported late phase pregrowth plateau hmecs romanov et al 2001
0.5136099.11673474.html.plaintext.txt	36	total 21 early passage p53 hmec e6 metaphase cells passage 10 karyotyped two cells analyzed sky 19 cells analyzed using inverted contrast enhanced dapi staining majority cells 12 cells 57 normal diploid chromosome content three cells random chromosome loss 14 remaining cells aneuploid three cells 14 multiple losses whole chromosomes occurred resulting chromosomes number 30 32 36 respectively three cells 14 either tetraploid 92 chromosomes hypotetraploid 90 80 chromosomes two cells near diploid studied using dapi staining displayed structural chromosome changes inv20p11q131 one cell delxp21 dic1419q32q134 marker chromosome another
0.5136099.11673474.html.plaintext.txt	37	total 21 early passage p53 hmec e6 metaphase cells passage 10 karyotyped two cells analyzed sky 19 cells analyzed using inverted contrast enhanced dapi staining majority cells 12 cells 57 normal diploid chromosome content three cells random chromosome loss 14 remaining cells aneuploid three cells 14 multiple losses whole chromosomes occurred resulting chromosomes number 30 32 36 respectively three cells 14 either tetraploid 92 chromosomes hypotetraploid 90 80 chromosomes two cells near diploid studied using dapi staining displayed structural chromosome changes inv20p11q131 one cell delxp21 dic1419q32q134 marker chromosome another
0.5136099.11673474.html.plaintext.txt	38	contrast early passage cells late passage p53 hmec e6 passage 18 markedly abnormal numerical structural chromosome aberrations total 35 metaphase cells analyzed 27 using sky 8 using inverted contrast enhanced dapi staining table results published previously seewaldt et al 2001 cell normal diploid karyotype predominant types structural changes deletions whole arm translocations dicentric chromosomes breakpoints pericentromeric andor telomeric regions although majority 35 cells contained complex chromosomal rearrangements resistant cell analyzed unique suggests chromosome aberrations observed late passage p53 hmec e6 cell population resulted generalized event causing karyotypic instability inconsistent outgrowth mutant clone
0.5136099.11673474.html.plaintext.txt	39	contrast early passage cells late passage p53 hmec e6 passage 18 markedly abnormal numerical structural chromosome aberrations total 35 metaphase cells analyzed 27 using sky 8 using inverted contrast enhanced dapi staining table results published previously seewaldt et al 2001 cell normal diploid karyotype predominant types structural changes deletions whole arm translocations dicentric chromosomes breakpoints pericentromeric andor telomeric regions although majority 35 cells contained complex chromosomal rearrangements resistant cell analyzed unique suggests chromosome aberrations observed late passage p53 hmec e6 cell population resulted generalized event causing karyotypic instability inconsistent outgrowth mutant clone
0.5136099.11673474.html.plaintext.txt	40	view table table karyotype late passage p53 hmec e6 cells
0.5136099.11673474.html.plaintext.txt	41	morphologic appearance early late passage hmecs hpv 16 e6 suppressed p53 expression early passage p53 hmec lxsn controls passage 10 p53 hmec e6 cells passage 10 similar appearance fig 2 b late passage p53 hmec lxsn cells passage 21 exhibited morphologic changes characteristic senescence including increased cell size increased cytoplasmic vesicles fig 2 c contrast late passage p53 hmec e6 cells passage 18 morphologically similar identical passage 10 cells fig 2 d
0.5136099.11673474.html.plaintext.txt	42	view larger version 156k figure 2 morphologic appearance early late passage hmecs expressing hpv 16 e6 electron micrographs early passage passage 10 p53 hmec lxsn controls p53 hmec e6 cells b grown tissue culture 4 d similar appearance c late passage passage 21 p53 hmec lxsn vector control cells approaching vitro senescence significantly larger early passage cells contained increased numbers vesicles d passage 18 p53 hmec e6 cells similar appearance identical passage 10 cells
0.5136099.11673474.html.plaintext.txt	43	view larger version 156k figure 2 morphologic appearance early late passage hmecs expressing hpv 16 e6 electron micrographs early passage passage 10 p53 hmec lxsn controls p53 hmec e6 cells b grown tissue culture 4 d similar appearance c late passage passage 21 p53 hmec lxsn vector control cells approaching vitro senescence significantly larger early passage cells contained increased numbers vesicles d passage 18 p53 hmec e6 cells similar appearance identical passage 10 cells
0.5136099.11673474.html.plaintext.txt	44	recm induced growth arrest hmecs altered acute expression hpv 16 e6 early passage p53 hmec lxsn controls passage 10 p53 hmec e6 cells passage 10 grown prepared recm single cell suspension p53 hmec lxsn p53 hmec e6 cells grew exponentially recm day 6 growth arrested day 6 7 fig 3 formed uniform population spherical colonies mean diameter p53 hmec lxsn p53 hmec colonies day 7 305 plus minus 74 33 plus minus 55 microm respectively fig 3 decrease mean sphere diameter p53 hmec e6 cells relative controls day 9 statistically significant data suggest acute suppression p53 function hmecs hpv 16 e6 alters neither proliferation cells contact recm recm induced growth inhibition measured colony diameter vitro system
0.5136099.11673474.html.plaintext.txt	45	recm induced growth arrest hmecs altered acute expression hpv 16 e6 early passage p53 hmec lxsn controls passage 10 p53 hmec e6 cells passage 10 grown prepared recm single cell suspension p53 hmec lxsn p53 hmec e6 cells grew exponentially recm day 6 growth arrested day 6 7 fig 3 formed uniform population spherical colonies mean diameter p53 hmec lxsn p53 hmec colonies day 7 305 plus minus 74 33 plus minus 55 microm respectively fig 3 decrease mean sphere diameter p53 hmec e6 cells relative controls day 9 statistically significant data suggest acute suppression p53 function hmecs hpv 16 e6 alters neither proliferation cells contact recm recm induced growth inhibition measured colony diameter vitro system
0.5136099.11673474.html.plaintext.txt	46	view larger version 19k figure 3 recm induced growth arrest early passage p53 hmec e6 cells p53 hmec lxsn controls mean diameter spheres formed p53 hmec lxsn controls passage 10 p53 hmec e6 cells passage 10 plotted function days culture cells plated recm day 0 diameter growing spherical cell colonies measured eye piece equipped micrometer spindle p53 hmec lxsn controls p53 hmec e6 cells 20 largest colonies measured time point data representative three separate experiments
0.5136099.11673474.html.plaintext.txt	47	view larger version 19k figure 3 recm induced growth arrest early passage p53 hmec e6 cells p53 hmec lxsn controls mean diameter spheres formed p53 hmec lxsn controls passage 10 p53 hmec e6 cells passage 10 plotted function days culture cells plated recm day 0 diameter growing spherical cell colonies measured eye piece equipped micrometer spindle p53 hmec lxsn controls p53 hmec e6 cells 20 largest colonies measured time point data representative three separate experiments
0.5136099.11673474.html.plaintext.txt	48	acute expression hpv 16 e6 induces apoptosis recm growth arrested hmecs absence p53 expression em performed early passage recm growth arrested p53 hmec lxsn controls p53 hmec e6 cells test whether suppression p53 expression hpv 16 e6 altered response hmecs recm p53 hmec lxsn control cells passage 10 proliferated contact recm day 6 underwent recm induced growth arrest day 6 7
0.5136099.11673474.html.plaintext.txt	49	acute expression hpv 16 e6 induces apoptosis recm growth arrested hmecs absence p53 expression em performed early passage recm growth arrested p53 hmec lxsn controls p53 hmec e6 cells test whether suppression p53 expression hpv 16 e6 altered response hmecs recm p53 hmec lxsn control cells passage 10 proliferated contact recm day 6 underwent recm induced growth arrest day 6 7
0.5136099.11673474.html.plaintext.txt	50	observed previously seewaldt et al 1997b day 7 p53 hmec lxsn cells grown recm exhibited acinus like structure consistent normal nonlactating mammary glandular epithelium fig 4 evidence apoptosis day 14 p53 hmec lxsn cells likewise exhibit evidence apoptosis fig 4 b
0.5136099.11673474.html.plaintext.txt	51	observed previously seewaldt et al 1997b day 7 p53 hmec lxsn cells grown recm exhibited acinus like structure consistent normal nonlactating mammary glandular epithelium fig 4 evidence apoptosis day 14 p53 hmec lxsn cells likewise exhibit evidence apoptosis fig 4 b
0.5136099.11673474.html.plaintext.txt	52	view larger version 223k figure 4 early passage p53 hmec e6 cells undergo apoptosis cultured contact recm starting 7 d b electron micrographs p53 hmec lxsn vector control cells passage 10 grown recm 7 14 b d p53 hmec lxsn controls formed acini like structures demonstrated central lumen l consistent nonlactating mammary glandular epithelium 1 nuclei aligned predominantly basal surface 2 secretory vesicles v present luminal surface basal surface 3 mitochondria m located basolateral surface c d p53 hmec e6 cells grown recm 6 c 7 d d 6 d c p53 hmec e6 cells organized around central lumen cell separation nuclei primarily oriented basal surface vesicles v present typically luminal surface 7 d d p53 hmec e6 cells demonstrated evidence apoptosis including 1 nuclear condensation 2 cell shrinkage sh separation 3 margination chromatin mr 4 presence apoptotic bodies ap containing cytoplasmic elements
0.5136099.11673474.html.plaintext.txt	53	view larger version 223k figure 4 early passage p53 hmec e6 cells undergo apoptosis cultured contact recm starting 7 d b electron micrographs p53 hmec lxsn vector control cells passage 10 grown recm 7 14 b d p53 hmec lxsn controls formed acini like structures demonstrated central lumen l consistent nonlactating mammary glandular epithelium 1 nuclei aligned predominantly basal surface 2 secretory vesicles v present luminal surface basal surface 3 mitochondria m located basolateral surface c d p53 hmec e6 cells grown recm 6 c 7 d d 6 d c p53 hmec e6 cells organized around central lumen cell separation nuclei primarily oriented basal surface vesicles v present typically luminal surface 7 d d p53 hmec e6 cells demonstrated evidence apoptosis including 1 nuclear condensation 2 cell shrinkage sh separation 3 margination chromatin mr 4 presence apoptotic bodies ap containing cytoplasmic elements
0.5136099.11673474.html.plaintext.txt	54	contrast early passage p53 hmec e6 cells passage 10 proliferated recm day 6 underwent apoptosis day 7 morphologic evidence apoptosis day 6 recm cultures fig 4 c day 7 100 early passage p53 hmec e6 cell clusters surveyed presence absence apoptosis 98 clusters 98 exhibited morphologic evidence apoptosis following criteria nuclear condensation b cell shrinkage separation c margination chromatin d presence apoptotic bodies e mitochondrial condensation fig 4 d
0.5136099.11673474.html.plaintext.txt	55	contrast early passage p53 hmec e6 cells passage 10 proliferated recm day 6 underwent apoptosis day 7 morphologic evidence apoptosis day 6 recm cultures fig 4 c day 7 100 early passage p53 hmec e6 cell clusters surveyed presence absence apoptosis 98 clusters 98 exhibited morphologic evidence apoptosis following criteria nuclear condensation b cell shrinkage separation c margination chromatin d presence apoptotic bodies e mitochondrial condensation fig 4 d
0.5136099.11673474.html.plaintext.txt	56	second hmec strain ag11134 tested ensure observations hmec strain specific similar observations made hmec strain ag11132 ag1134 lxsn controls underwent growth arrest formed acinus like structure contact recm day 7 unpublished data b early passage ag11134 e6 cells exhibited morphologic evidence apoptosis day 7 unpublished data
0.5136099.11673474.html.plaintext.txt	57	second hmec strain ag11134 tested ensure observations hmec strain specific similar observations made hmec strain ag11132 ag1134 lxsn controls underwent growth arrest formed acinus like structure contact recm day 7 unpublished data b early passage ag11134 e6 cells exhibited morphologic evidence apoptosis day 7 unpublished data
0.5136099.11673474.html.plaintext.txt	58	terminal deoxynucleotidyl transferase tdt method also used detect presence absence apoptotic strand breaks day 7 recm culture 3 hydroxyl termini apoptotic induced strand breaks labeled biotin dutp exogenous tdt detected situ hrp conjugated streptavidin day 7 recm growth arrested early passage p53 hmec lxsn controls passage 10 demonstrate evidence apoptosis unpublished data contrast early passage day 7 p53 hmec e6 transduced cells passage 10 grown contact recm exhibited apoptotic strand breaks unpublished data
0.5136099.11673474.html.plaintext.txt	59	terminal deoxynucleotidyl transferase tdt method also used detect presence absence apoptotic strand breaks day 7 recm culture 3 hydroxyl termini apoptotic induced strand breaks labeled biotin dutp exogenous tdt detected situ hrp conjugated streptavidin day 7 recm growth arrested early passage p53 hmec lxsn controls passage 10 demonstrate evidence apoptosis unpublished data contrast early passage day 7 p53 hmec e6 transduced cells passage 10 grown contact recm exhibited apoptotic strand breaks unpublished data
0.5136099.11673474.html.plaintext.txt	60	observations indicate whereas early passage p53 hmec lxsn controls undergo recm induced growth arrest early passage p53 hmec e6 cells undergo recm mediated growth arrest day 6 followed induction apoptosis day 7 results vitro model recm induced apoptosis hmecs suggest association hpv 16 e6 induced suppression p53 function induction recm mediated apoptosis
0.5136099.11673474.html.plaintext.txt	61	observations indicate whereas early passage p53 hmec lxsn controls undergo recm induced growth arrest early passage p53 hmec e6 cells undergo recm mediated growth arrest day 6 followed induction apoptosis day 7 results vitro model recm induced apoptosis hmecs suggest association hpv 16 e6 induced suppression p53 function induction recm mediated apoptosis
0.5136099.11673474.html.plaintext.txt	62	acute suppression p53 approach hmecs promotes sensitivity recm mediated apoptosis since hpv 16 e6 may effects suppression p53 approach used test whether acute suppression p53 function promotes sensitivity recm mediated apoptosis p53 protein expression suppressed using p53 odn hmecs western blot analysis demonstrated almost complete suppression p53 protein expression hmecs treated p53 odn p53 hmec suppression p53 protein expression hmecs treated scrambled sequence p53 odn p53 hmec scrambled scras fig 5
0.5136099.11673474.html.plaintext.txt	63	acute suppression p53 approach hmecs promotes sensitivity recm mediated apoptosis since hpv 16 e6 may effects suppression p53 approach used test whether acute suppression p53 function promotes sensitivity recm mediated apoptosis p53 protein expression suppressed using p53 odn hmecs western blot analysis demonstrated almost complete suppression p53 protein expression hmecs treated p53 odn p53 hmec suppression p53 protein expression hmecs treated scrambled sequence p53 odn p53 hmec scrambled scras fig 5
0.5136099.11673474.html.plaintext.txt	64	view larger version 53k figure 5 expression p53 protein suppressed p53 hmec cells passage 10 p53 hmec p parental cells parental p53 hmec scras controls scras p53 hmec cells grown without recm analyzed p53 protein expression described materials methods equal amounts protein lysate loaded per lane hybridization abs actin serves loading control
0.5136099.11673474.html.plaintext.txt	65	view larger version 53k figure 5 expression p53 protein suppressed p53 hmec cells passage 10 p53 hmec p parental cells parental p53 hmec scras controls scras p53 hmec cells grown without recm analyzed p53 protein expression described materials methods equal amounts protein lysate loaded per lane hybridization abs actin serves loading control
0.5136099.11673474.html.plaintext.txt	66	consistent results obtained early passage p53 hmec e6 cells acute suppression p53 function approach alter ability p53 hmec p53 hmec scras controls proliferate recm undergo recm mediated growth arrest fig 6 mean diameter p53 hmec scras p53 hmec colonies day 7 32 plus minus 40 31 plus minus 50 microm respectively fig 6 data suggest acute suppression p53 function hmecs approach neither alters proliferation cells contact recm alter recm induced growth inhibition measured colony diameter
0.5136099.11673474.html.plaintext.txt	67	view larger version 18k figure 6 recm induced growth arrest early passage p53 hmec cells p53 hmec scras controls mean diameter spheres formed p53 hmec scras controls passage 10 p53 hmec cells passage 10 plotted function days culture cells plated recm day 0 diameter growing spherical cell colonies measured eye piece equipped micrometer spindle 20 largest colonies measured time point data representative three separate experiments
0.5136099.11673474.html.plaintext.txt	68	view larger version 18k figure 6 recm induced growth arrest early passage p53 hmec cells p53 hmec scras controls mean diameter spheres formed p53 hmec scras controls passage 10 p53 hmec cells passage 10 plotted function days culture cells plated recm day 0 diameter growing spherical cell colonies measured eye piece equipped micrometer spindle 20 largest colonies measured time point data representative three separate experiments
0.5136099.11673474.html.plaintext.txt	69	tested whether inhibition p53 protein expression approach promoted recm mediated apoptosis day 7 100 early passage p53 hmec cell clusters surveyed presence absence apoptosis similar early passage p53 hmec e6 cells p53 hmec cells underwent apoptosis day 7 fig 7 b 90 clusters 90 exhibited morphologic evidence apoptosis following criteria nuclear condensation b cell shrinkage separation c margination chromatin d presence apoptotic bodies e mitochondrial condensation fig 7 b contrast early passage p53 hmec scras cells exhibit morphologic evidence apoptosis day 7 14 fig 7 unpublished data observations support hypothesis acute suppression p53 function promotes recm mediated apoptosis
0.5136099.11673474.html.plaintext.txt	70	tested whether inhibition p53 protein expression approach promoted recm mediated apoptosis day 7 100 early passage p53 hmec cell clusters surveyed presence absence apoptosis similar early passage p53 hmec e6 cells p53 hmec cells underwent apoptosis day 7 fig 7 b 90 clusters 90 exhibited morphologic evidence apoptosis following criteria nuclear condensation b cell shrinkage separation c margination chromatin d presence apoptotic bodies e mitochondrial condensation fig 7 b contrast early passage p53 hmec scras cells exhibit morphologic evidence apoptosis day 7 14 fig 7 unpublished data observations support hypothesis acute suppression p53 function promotes recm mediated apoptosis
0.5136099.11673474.html.plaintext.txt	71	view larger version 106k figure 7 early passage p53 hmec cells undergo apoptosis cultured contact recm starting 7 d electron micrographs p53 hmec scras control cells passage 10 grown recm 14 d p53 hmec lxsn controls formed acini like structures b p53 hmec cells grown recm 7 d demonstrated evidence apoptosis including 1 nuclear condensation 2 cell shrinkage separation 3 margination chromatin mr 4 presence apoptotic bodies ap containing cytoplasmic elements
0.5136099.11673474.html.plaintext.txt	72	view larger version 106k figure 7 early passage p53 hmec cells undergo apoptosis cultured contact recm starting 7 d electron micrographs p53 hmec scras control cells passage 10 grown recm 14 d p53 hmec lxsn controls formed acini like structures b p53 hmec cells grown recm 7 d demonstrated evidence apoptosis including 1 nuclear condensation 2 cell shrinkage separation 3 margination chromatin mr 4 presence apoptotic bodies ap containing cytoplasmic elements
0.5136099.11673474.html.plaintext.txt	73	late passage p53 hmec e6 cells acquire resistance recm induced growth arrest starting passage 16 18 p53 hmec e6 cells acquired resistance recm induced growth arrest evidenced continued increase sphere diameter day 5 9 fig 8 mean sphere diameter 37 plus minus 3 microm day 7 48 plus minus 5 microm day 9 contrast passage 17 p53 hmec lxsn cells exhibited sensitivity recm induced growth arrest fig 8
0.5136099.11673474.html.plaintext.txt	74	view larger version 18k figure 8 late passage p53 hmec e6 cells resistant recm induced growth arrest mean diameter spheres formed late passage p53 hmec lxsn controls passage 17 p53 hmec e6 cells passage 18 plotted function days culture described materials methods data representative three separate experiments
0.5136099.11673474.html.plaintext.txt	75	view larger version 18k figure 8 late passage p53 hmec e6 cells resistant recm induced growth arrest mean diameter spheres formed late passage p53 hmec lxsn controls passage 17 p53 hmec e6 cells passage 18 plotted function days culture described materials methods data representative three separate experiments
0.5136099.11673474.html.plaintext.txt	76	late passage hmecs hpv 16 e6 suppressed p53 function exhibit dysregulated growth resistant recm induced apoptosis late passage p53 hmec lxsn controls passage 17 p53 hmec e6 cells passage 18 cultured recm contrast early passage p53 hmec e6 cells late passage cells demonstrated disorganized growth evidence apoptosis day 7 14 fig 9 b similar early passage p53 hmec lxsn vector controls electron micrographs late passage controls demonstrated normal acinus like structure without evidence apoptosis day 7 unpublished data 14 fig 9 c passage 18 p53 hmec e6 cells grown recm formed disorganized multilayered irregularly shaped colonies fig 9 b morphologic evidence apoptosis passage 18 p53 hmec e6 cells grown recm second hmec strain ag11134 tested confirm results strain specific late passage ag11134 e6 cells grown recm similar late passage p53 hmec e6 cells ag11134 e6 cells formed disorganized aggregates cells demonstrate evidence apoptosis unpublished data results suggest p53 hmec e6 cells passaged vitro acquire resistance recm induced apoptosis
0.5136099.11673474.html.plaintext.txt	77	late passage hmecs hpv 16 e6 suppressed p53 function exhibit dysregulated growth resistant recm induced apoptosis late passage p53 hmec lxsn controls passage 17 p53 hmec e6 cells passage 18 cultured recm contrast early passage p53 hmec e6 cells late passage cells demonstrated disorganized growth evidence apoptosis day 7 14 fig 9 b similar early passage p53 hmec lxsn vector controls electron micrographs late passage controls demonstrated normal acinus like structure without evidence apoptosis day 7 unpublished data 14 fig 9 c passage 18 p53 hmec e6 cells grown recm formed disorganized multilayered irregularly shaped colonies fig 9 b morphologic evidence apoptosis passage 18 p53 hmec e6 cells grown recm second hmec strain ag11134 tested confirm results strain specific late passage ag11134 e6 cells grown recm similar late passage p53 hmec e6 cells ag11134 e6 cells formed disorganized aggregates cells demonstrate evidence apoptosis unpublished data results suggest p53 hmec e6 cells passaged vitro acquire resistance recm induced apoptosis
0.5136099.11673474.html.plaintext.txt	78	view larger version 270k figure 9 late passage p53 hmec e6 cells resistant recm mediated apoptosis electron micrographs late passage p53 hmec e6 cells grown recm 7 14 b d p53 hmec lxsn controls grown recm 14 d c passage 18 p53 hmec e6 cells b grew disorganized multilayered irregularly shaped colonies without morphologic evidence normal cellular polarity apoptosis morphologic evidence lack polarity included following 1 cells organized spherical single layer structures 2 lumen present 3 secretory vacuoles distributed randomly throughout cytoplasm addition cells exhibited prominent nucleolus nu disorganized tonofilaments consistent less differentiated phenotype contrast late passage p53 hmec lxsn vector control cells passage 17 grown recm 14 d c formed acini like structures
0.5136099.11673474.html.plaintext.txt	79	view larger version 270k figure 9 late passage p53 hmec e6 cells resistant recm mediated apoptosis electron micrographs late passage p53 hmec e6 cells grown recm 7 14 b d p53 hmec lxsn controls grown recm 14 d c passage 18 p53 hmec e6 cells b grew disorganized multilayered irregularly shaped colonies without morphologic evidence normal cellular polarity apoptosis morphologic evidence lack polarity included following 1 cells organized spherical single layer structures 2 lumen present 3 secretory vacuoles distributed randomly throughout cytoplasm addition cells exhibited prominent nucleolus nu disorganized tonofilaments consistent less differentiated phenotype contrast late passage p53 hmec lxsn vector control cells passage 17 grown recm 14 d c formed acini like structures
0.5136099.11673474.html.plaintext.txt	80	late passage p53 hmec e6 cells grown contact recm lack polarized expression e cadherin early late passage p53 hmec lxsn early passage p53 hmec e6 cells grown contact recm demonstrated basolateral expression e cadherin including lateral staining cell cell junctions consistent polarized epithelium fig 10 c 20 cell clusters surveyed per data point results similar observed normal breast sections consistent results obtained investigators mammary epithelial cells grown contact recm weaver et al 1997 spancake et al 1999 contrast late passage p53 hmec e6 cells exhibited punctate dispersed intracellular staining consistent loss epithelial polarity fig 10 d results similar observed tumorigenic mammary epithelial cells lack epithelial polarity grown recm weaver et al 1997
0.5136099.11673474.html.plaintext.txt	81	view larger version 15k figure 10 localization e cadherin p53 hmec lxsn p53 hmec e6 cells using immunofluorescence microscopy frozen section early passage p53 hmec lxsn controls passage 11 early passage p53 hmec e6 cells passage 11 b late passage p53 hmec lxsn controls passage 16 c late passage p53 hmec e6 cells passage 21 d grown recm 6 d cryosectioned stained mab e cadherin described materials methods e cadherin localized basolateral surface points cell cell contact early late passage p53 hmec lxsn cells early passage p53 hmec e6 cells c arrows contrast late passage p53 hmec e6 cells showed punctate dispersed membrane intracellular staining d arrowheads
0.5136099.11673474.html.plaintext.txt	82	view larger version 15k figure 10 localization e cadherin p53 hmec lxsn p53 hmec e6 cells using immunofluorescence microscopy frozen section early passage p53 hmec lxsn controls passage 11 early passage p53 hmec e6 cells passage 11 b late passage p53 hmec lxsn controls passage 16 c late passage p53 hmec e6 cells passage 21 d grown recm 6 d cryosectioned stained mab e cadherin described materials methods e cadherin localized basolateral surface points cell cell contact early late passage p53 hmec lxsn cells early passage p53 hmec e6 cells c arrows contrast late passage p53 hmec e6 cells showed punctate dispersed membrane intracellular staining d arrowheads
0.5136099.11673474.html.plaintext.txt	83	laminin critical induction apoptosis early passage p53 hmec e6 cells identify component recm promotes apoptosis early passage p53 hmec e6 cells p53 hmec lxsn controls cultured growth factor depleted matrigeltm collagen iiv gels collagen iiv supplemented laminin early passage p53 hmec e6 cells underwent apoptosis cultured 7 d growth factor depleted matrigeltm fig 11 suggesting depletion growth factors present matrigeltm critical induction apoptosis early passage p53 hmec lxsn controls undergo apoptosis cultured growth factor depleted matrigeltm fig 11 b early passage p53 hmec e6 cells cultured presence collagen iiv evidence apoptosis 7 14 d fig 11 c unpublished data likewise early passage p53 hmec lxsn controls exhibit evidence apoptosis grown presence collagen iiv fig 11 d interestingly neither early passage p53 hmec lxsn controls p53 hmec e6 cells formed acinar structures grown collage iiv fig 11 c d human placental laminin added collagen iiv gel early passage p53 hmec e6 cells p53 hmec lxsn vector controls developed branching tubular structures terminated spherical aggregates fig 11 e g early passage p53 hmec e6 cells present branched aggregate structures exhibited evidence apoptosis 7 10 d fig 11 g day 14 cells visualized em unpublished data likewise early passage p53 hmec e6 cells cultured laminin coated substratum presence 11 dilution standard medium laminin formed similar three dimensional branching aggregates also underwent apoptosis days 7 10 determined em unpublished data contrast early passage p53 hmec lxsn controls grown collagen iiv supplemented laminin exhibit evidence apoptosis 14 d fig 11 h observations suggest critical role laminin induction apoptosis p53 hmec e6 cells
0.5136099.11673474.html.plaintext.txt	84	laminin critical induction apoptosis early passage p53 hmec e6 cells identify component recm promotes apoptosis early passage p53 hmec e6 cells p53 hmec lxsn controls cultured growth factor depleted matrigeltm collagen iiv gels collagen iiv supplemented laminin early passage p53 hmec e6 cells underwent apoptosis cultured 7 d growth factor depleted matrigeltm fig 11 suggesting depletion growth factors present matrigeltm critical induction apoptosis early passage p53 hmec lxsn controls undergo apoptosis cultured growth factor depleted matrigeltm fig 11 b early passage p53 hmec e6 cells cultured presence collagen iiv evidence apoptosis 7 14 d fig 11 c unpublished data likewise early passage p53 hmec lxsn controls exhibit evidence apoptosis grown presence collagen iiv fig 11 d interestingly neither early passage p53 hmec lxsn controls p53 hmec e6 cells formed acinar structures grown collage iiv fig 11 c d human placental laminin added collagen iiv gel early passage p53 hmec e6 cells p53 hmec lxsn vector controls developed branching tubular structures terminated spherical aggregates fig 11 e g early passage p53 hmec e6 cells present branched aggregate structures exhibited evidence apoptosis 7 10 d fig 11 g day 14 cells visualized em unpublished data likewise early passage p53 hmec e6 cells cultured laminin coated substratum presence 11 dilution standard medium laminin formed similar three dimensional branching aggregates also underwent apoptosis days 7 10 determined em unpublished data contrast early passage p53 hmec lxsn controls grown collagen iiv supplemented laminin exhibit evidence apoptosis 14 d fig 11 h observations suggest critical role laminin induction apoptosis p53 hmec e6 cells
0.5136099.11673474.html.plaintext.txt	85	view larger version 295k figure 11 early passage p53 hmec e6 cells undergo apoptosis cultured contact growth factor depleted recm laminin evidenced em 7 d passage 11 p53 hmec e6 cells grown contract growth factor depleted recm demonstrated evidence apoptosis including following 1 nuclear condensation 2 cell shrinkage sh separation 3 margination chromatin mr 4 presence apoptotic bodies ap containing cytoplasmic elements contrast passage 11 p53 hmec lxsn controls b grown contact growth factor depleted recm demonstrate evidence apoptosis 14 d passage 11 p53 hmec e6 cells c passage 11 p53 hmec lxsn controls d grown collagen iiv 7 d demonstrate evidence apoptosis morphologic criteria light micrographs passage 11 p53 hmec e6 cells grown collagen iiv supplemented laminin e exhibited branching structures terminated spherical cell clusters electron micrographs passage 11 p53 hmec e6 cells grown collagen iiv supplemented laminin g demonstrated morphologic evidence apoptosis including cell shrinkage sh nuclear condensation nu 7 d light micrographs passage 11 p53 hmec lxsn vector controls grown collagen supplemented laminin demonstrated branching structures similar exhibited early passage p53 hmec e6 cells f demonstrate evidence apoptosis em h
0.5136099.11673474.html.plaintext.txt	86	view larger version 295k figure 11 early passage p53 hmec e6 cells undergo apoptosis cultured contact growth factor depleted recm laminin evidenced em 7 d passage 11 p53 hmec e6 cells grown contract growth factor depleted recm demonstrated evidence apoptosis including following 1 nuclear condensation 2 cell shrinkage sh separation 3 margination chromatin mr 4 presence apoptotic bodies ap containing cytoplasmic elements contrast passage 11 p53 hmec lxsn controls b grown contact growth factor depleted recm demonstrate evidence apoptosis 14 d passage 11 p53 hmec e6 cells c passage 11 p53 hmec lxsn controls d grown collagen iiv 7 d demonstrate evidence apoptosis morphologic criteria light micrographs passage 11 p53 hmec e6 cells grown collagen iiv supplemented laminin e exhibited branching structures terminated spherical cell clusters electron micrographs passage 11 p53 hmec e6 cells grown collagen iiv supplemented laminin g demonstrated morphologic evidence apoptosis including cell shrinkage sh nuclear condensation nu 7 d light micrographs passage 11 p53 hmec lxsn vector controls grown collagen supplemented laminin demonstrated branching structures similar exhibited early passage p53 hmec e6 cells f demonstrate evidence apoptosis em h
0.5136099.11673474.html.plaintext.txt	87	3 integrin expression altered recm resistant late passage p53 hmec e6 cells early late passage p53 hmec lxsn controls p53 hmec e6 cells tested 2 3 6 ss1 ss4 integrin expression immunohistochemistry early late passage p53 hmec lxsn controls early passage p53 hmec e6 cells stained positively 2 3 ss1 integrins weakly 6 ss4 integrins fig 12 unpublished data late passage p53 hmec e6 cells grown non recm culture exhibited qualitative decrease expression 3 integrin fig 12 d
0.5136099.11673474.html.plaintext.txt	88	3 integrin expression altered recm resistant late passage p53 hmec e6 cells early late passage p53 hmec lxsn controls p53 hmec e6 cells tested 2 3 6 ss1 ss4 integrin expression immunohistochemistry early late passage p53 hmec lxsn controls early passage p53 hmec e6 cells stained positively 2 3 ss1 integrins weakly 6 ss4 integrins fig 12 unpublished data late passage p53 hmec e6 cells grown non recm culture exhibited qualitative decrease expression 3 integrin fig 12 d
0.5136099.11673474.html.plaintext.txt	89	view larger version 317k figure 12 late passage p53 hmec e6 cells exhibit decreased expression integrin 3 early passage p53 hmec lxsn controls passage 10 e early passage p53 hmec e6 cells passage 10 b f late passage p53 hmec lxsn controls passage 18 c g late passage p53 hmec e6 cells passage 21 d h grown glass coverslips 48 h stained indirect immunofluorescence mab p1f2 integrin 3 d p4c10 ss1 integrin e h
0.5136099.11673474.html.plaintext.txt	90	view larger version 317k figure 12 late passage p53 hmec e6 cells exhibit decreased expression integrin 3 early passage p53 hmec lxsn controls passage 10 e early passage p53 hmec e6 cells passage 10 b f late passage p53 hmec lxsn controls passage 18 c g late passage p53 hmec e6 cells passage 21 d h grown glass coverslips 48 h stained indirect immunofluorescence mab p1f2 integrin 3 d p4c10 ss1 integrin e h
0.5136099.11673474.html.plaintext.txt	91	early late passage p53 hmec lxsn controls p53 hmec e6 cells grown recm tested 3 ss1 integrin expression immunohistochemistry clones p1f2 p4c10 respectively early late passage p53 hmec lxsn controls early passage p53 hmec e6 cells exhibited polarized basal expression 3 ss1 integrins fig 13 contrast late passage p53 hmec e6 cells grown recm demonstrated disorganized plasma membrane cytosolic expression 3 integrins fig 13 d redistribution 3 integrins seen previously investigators association loss mammary epithelial cell polarity recm culture consistent findings weaver et al 1997 late passage p53 hmec e6 cells grown recm exhibited polarized basal ss1 integrin expression increase amount cytosolic expression relative early passage cells fig 13 h
0.5136099.11673474.html.plaintext.txt	92	early late passage p53 hmec lxsn controls p53 hmec e6 cells grown recm tested 3 ss1 integrin expression immunohistochemistry clones p1f2 p4c10 respectively early late passage p53 hmec lxsn controls early passage p53 hmec e6 cells exhibited polarized basal expression 3 ss1 integrins fig 13 contrast late passage p53 hmec e6 cells grown recm demonstrated disorganized plasma membrane cytosolic expression 3 integrins fig 13 d redistribution 3 integrins seen previously investigators association loss mammary epithelial cell polarity recm culture consistent findings weaver et al 1997 late passage p53 hmec e6 cells grown recm exhibited polarized basal ss1 integrin expression increase amount cytosolic expression relative early passage cells fig 13 h
0.5136099.11673474.html.plaintext.txt	93	view larger version 25k figure 13 localization 3 ss1 integrin expression p53 hmec lxsn p53 hmec e6 cells using immunofluorescence microscopy frozen section early passage p53 hmec lxsn controls passage 11 e early passage p53 hmec e6 cells passage 11 b f late passage p53 hmec lxsn controls passage 16 c g late passage p53 hmec e6 cells passage 21 d h grown recm 6 d cryosectioned stained monoclonal abs 3 d ss1 e h integrins described materials methods integrins 3 ss1 localized cell recm junction early late passage p53 hmec lxsn cells early passage p53 hmec e6 cells c e g contrast late passage p53 hmec e6 cells demonstrated disorganized membrane cytosolic staining d
0.5136099.11673474.html.plaintext.txt	94	view larger version 25k figure 13 localization 3 ss1 integrin expression p53 hmec lxsn p53 hmec e6 cells using immunofluorescence microscopy frozen section early passage p53 hmec lxsn controls passage 11 e early passage p53 hmec e6 cells passage 11 b f late passage p53 hmec lxsn controls passage 16 c g late passage p53 hmec e6 cells passage 21 d h grown recm 6 d cryosectioned stained monoclonal abs 3 d ss1 e h integrins described materials methods integrins 3 ss1 localized cell recm junction early late passage p53 hmec lxsn cells early passage p53 hmec e6 cells c e g contrast late passage p53 hmec e6 cells demonstrated disorganized membrane cytosolic staining d
0.5136099.11673474.html.plaintext.txt	95	3 ss1 integrin function altering abs inhibit ecm induced growth arrest early passage p53 p53 hmec e6 cells early passage p53 hmec e6 cells passage 10 treated either 3 ss1 integrin function altering abs control mouse nonimmune igg grown prepared recm single cell suspension expected p53 hmec lxsn controls p53 hmec e6 cells treated nonimmune mouse igg ss1 integrin stimulating ab clone b3b11 grew exponentially recm day 6 growth arrested day 6 7 fig 14 unpublished data forming uniform population spherical colonies contrast p53 hmec lxsn controls p53 hmec e6 cells treated 3 ss1 integrin blocking abs clones p1b5 jb1a respectively undergo growth arrest day 6 7 continued proliferate fig 14 b c mean diameter control p53 hmec e6 colonies treated nonspecific mouse igg day 7 9 30 plus minus 3 27 plus minus 4 microm respectively fig 14 mean diameter p53 hmec e6 cells treated 3 ss1 integrin blocking abs day 9 51 plus minus 5 52 plus minus 4 microm respectively fig 14 c p53 hmec lxsn controls treated 3 ss1 integrin blocking abs demonstrated similar results fig 14 b data show interruption 3ss1 integrin signaling blocking ab inhibits recm mediated growth arrest p53 hmec lxsn controls early passage p53 hmec e6
0.5136099.11673474.html.plaintext.txt	96	3 ss1 integrin function altering abs inhibit ecm induced growth arrest early passage p53 p53 hmec e6 cells early passage p53 hmec e6 cells passage 10 treated either 3 ss1 integrin function altering abs control mouse nonimmune igg grown prepared recm single cell suspension expected p53 hmec lxsn controls p53 hmec e6 cells treated nonimmune mouse igg ss1 integrin stimulating ab clone b3b11 grew exponentially recm day 6 growth arrested day 6 7 fig 14 unpublished data forming uniform population spherical colonies contrast p53 hmec lxsn controls p53 hmec e6 cells treated 3 ss1 integrin blocking abs clones p1b5 jb1a respectively undergo growth arrest day 6 7 continued proliferate fig 14 b c mean diameter control p53 hmec e6 colonies treated nonspecific mouse igg day 7 9 30 plus minus 3 27 plus minus 4 microm respectively fig 14 mean diameter p53 hmec e6 cells treated 3 ss1 integrin blocking abs day 9 51 plus minus 5 52 plus minus 4 microm respectively fig 14 c p53 hmec lxsn controls treated 3 ss1 integrin blocking abs demonstrated similar results fig 14 b data show interruption 3ss1 integrin signaling blocking ab inhibits recm mediated growth arrest p53 hmec lxsn controls early passage p53 hmec e6
0.5136099.11673474.html.plaintext.txt	97	view larger version 37k figure 14 treatment 3 ss1 integrin function altering abs blocks recm mediated growth arrest p53 p53 hmecs mean diameter spheres formed p53 hmec lxsn controls passage 10 b p53 hmec e6 cells passage 10 c treated 3 ss1 integrin function altering abs b c nonimmune mouse igg plotted function days culture cells plated recm day 0 diameter growing spherical cell colonies measured eye piece equipped micrometer spindle 20 largest colonies measured time point early passage passage 10 p53 hmec lxsn controls p53 hmec e6 transduced cells treated nonimmune mouse igg control antiserum proliferated grown contact recm day 7 underwent growth arrest contrast early passage passage 10 p53 hmec lxsn p53 hmec e6 cells treated 3 ss1 integrin function altering abs resistant recm induced growth arrest continued proliferate day 7 data representative three separate experiments
0.5136099.11673474.html.plaintext.txt	98	view larger version 37k figure 14 treatment 3 ss1 integrin function altering abs blocks recm mediated growth arrest p53 p53 hmecs mean diameter spheres formed p53 hmec lxsn controls passage 10 b p53 hmec e6 cells passage 10 c treated 3 ss1 integrin function altering abs b c nonimmune mouse igg plotted function days culture cells plated recm day 0 diameter growing spherical cell colonies measured eye piece equipped micrometer spindle 20 largest colonies measured time point early passage passage 10 p53 hmec lxsn controls p53 hmec e6 transduced cells treated nonimmune mouse igg control antiserum proliferated grown contact recm day 7 underwent growth arrest contrast early passage passage 10 p53 hmec lxsn p53 hmec e6 cells treated 3 ss1 integrin function altering abs resistant recm induced growth arrest continued proliferate day 7 data representative three separate experiments
0.5136099.11673474.html.plaintext.txt	99	3 ss1 integrin function altering abs inhibit recm mediated apoptosis early passage p53 hmec e6 cells early passage p53 hmec e6 cells early passage p53 hmec lxsn controls treated either 3 ss1 integrin function altering abs control mouse nonimmune igg grown recm electron micrographs early passage p53 hmec e6 cells early passage p53 hmec lxsn controls treated either 3 ss1 integrin blocking abs clones p1b5 jb1a respectively demonstrated disorganized cell aggregates without evidence apoptosis day 7 14 fig 15 unpublished data early passage p53 hmec e6 cells treated ss1 integrin blocking abs also exhibited increased cell cell separation fig 15 b control p53 hmec e6 cells treated nonspecific mouse igg ss1 integrin stimulatory ab clone b3b11 underwent apoptosis day 7 unpublished data control p53 hmec lxsn controls treated nonspecific mouse igg exhibit apoptosis day 7 unpublished data results suggest 3ss1 integrin mediated signal transduction may critical induction apoptosis early passage p53 hmec e6 cells grown contact recm
0.5136099.11673474.html.plaintext.txt	100	3 ss1 integrin function altering abs inhibit recm mediated apoptosis early passage p53 hmec e6 cells early passage p53 hmec e6 cells early passage p53 hmec lxsn controls treated either 3 ss1 integrin function altering abs control mouse nonimmune igg grown recm electron micrographs early passage p53 hmec e6 cells early passage p53 hmec lxsn controls treated either 3 ss1 integrin blocking abs clones p1b5 jb1a respectively demonstrated disorganized cell aggregates without evidence apoptosis day 7 14 fig 15 unpublished data early passage p53 hmec e6 cells treated ss1 integrin blocking abs also exhibited increased cell cell separation fig 15 b control p53 hmec e6 cells treated nonspecific mouse igg ss1 integrin stimulatory ab clone b3b11 underwent apoptosis day 7 unpublished data control p53 hmec lxsn controls treated nonspecific mouse igg exhibit apoptosis day 7 unpublished data results suggest 3ss1 integrin mediated signal transduction may critical induction apoptosis early passage p53 hmec e6 cells grown contact recm
0.5136099.11673474.html.plaintext.txt	101	view larger version 227k figure 15 inhibition 3 ss1 integrin signaling blocks induction recm mediated apoptosis electron micrographs passage 10 p53 hmec e6 cells b passage 10 p53 hmec lxsn controls c d treated 10 microgml 3 c 20 microgml ss1 b d integrin blocking abs grown recm 7 d cells grew multilayered colonies growth arrest day 6 7 morphologic evidence apoptosis evidence lack polarity included following 1 cells organized spherical single layer structures 2 lumen present 3 vacuoles nuclei randomly distributed throughout cytoplasm cells treated ss1 integrin blocking abs exhibited cell cell separation evidence apoptosis
0.5136099.11673474.html.plaintext.txt	102	view larger version 227k figure 15 inhibition 3 ss1 integrin signaling blocks induction recm mediated apoptosis electron micrographs passage 10 p53 hmec e6 cells b passage 10 p53 hmec lxsn controls c d treated 10 microgml 3 c 20 microgml ss1 b d integrin blocking abs grown recm 7 d cells grew multilayered colonies growth arrest day 6 7 morphologic evidence apoptosis evidence lack polarity included following 1 cells organized spherical single layer structures 2 lumen present 3 vacuoles nuclei randomly distributed throughout cytoplasm cells treated ss1 integrin blocking abs exhibited cell cell separation evidence apoptosis
0.5136099.11673474.html.plaintext.txt	103	discussion top abstract introduction results discussion materials methods references p53 critical regulator cell cycle control high frequency p53 functionally inactivated human malignancy attests key role preventing clonal expansion mutated cells hansen oren 1997 goetz et al 2001 although extensive experimental evidence demonstrating importance p53 tumor suppressor promoting differentiation little known fate normal human cells acutely lose p53 function context recm regulatory signals
0.5136099.11673474.html.plaintext.txt	104	abnormal p53 expression benign breast tissue associated subsequent development breast cancer may represent early event breast carcinogenesis fabian et al 1996 levesque et al 1998 rohan et al 1998 interactions mammary epithelial cells ecm play critical role maintaining normal tissue homeostasis likely disrupted breast carcinogenesis report describe vitro system investigating interactions hmecs suppressed p53 protein expression recm potential model early mammary carcinogenesis
0.5136099.11673474.html.plaintext.txt	105	retrovirally mediated expression hpv 16 e6 odns used acutely inhibit p53 protein expression hmecs figs 1 5 combination approaches allowed us utilize viral nonviral methods suppress p53 observed early passage p53 hmec control cells underwent recm mediated growth arrest day 6 7 formed acinus like structure figs 3 4 10 contrast early passage p53 hmec e6 cells early passage p53 hmec cells proliferated day 6 figs 3 4 6 underwent apoptosis day 7 evidenced em situ tdt staining figs 4 7 unpublished data observations suggest acute suppression p53 function hmecs hpv 16 e6 odns may promote sensitivity recm induced apoptosis
0.5136099.11673474.html.plaintext.txt	106	ecm shown provide essential signals mammary epithelial cell survival absence cells undergo apoptosis streuli et al 1991 strange et al 1992 pullan et al 1996 critical relationship ecm signaling p53 expression highlighted recent report ecm survival signals transduced focal adhesion kinase suppress p53 mediated apoptosis ilic et al 1998 however significant evidence growth arrest differentiation survival signals may also promote apoptosis genetically damaged cells seewaldt et al 1995 hong sporn 1997 mancini et al 1997 seewaldt et al 1997b
0.5136099.11673474.html.plaintext.txt	107	observation acute suppression p53 hmecs promotes sensitivity apoptosis consistent several reports human mouse primary fibroblasts acute suppression p53 results apoptosis sensitivity hawkins et al 1996 wahl et al 1996 lanni et al 1997 mechanism acute loss p53 function might promote apoptosis unknown however observe immediately suppression p53 hpv 16 e6 hmecs exhibited high percentage tetraploid cells 14 increased sensitivity apoptosis tumor suppressor p53 critical component spindle checkpoint ensures maintenance diploidy increase tetraploidy observed cultured fibroblasts p53 deficient mouse embryo fibroblasts cross et al 1995 speculate possible loss spindle checkpoint might promote induction apoptosis early passage p53 hmec cells exposed either survival growth arrest signals alternatively p53 also plays important role differentiation therefore lack p53 might result cellular disregulation promotes cell death observe early passage p53 hmecs sensitive induction apoptosis agents promote growth arrest p53 hmecs equimolar concentrations example observed although tamoxifen promotes g1s phase arrest early passage p53 hmec controls tamoxifen promoted apoptosis early passage p53 hmecs dietze et al 2001 seewaldt et al 2001 taken together observations provide evidence acute suppression p53 might promote induction apoptosis cells exposed growth arrest survival signals
0.5136099.11673474.html.plaintext.txt	108	although early passage p53 hmec e6 cells underwent apoptosis cultured recm late passage cells resistant recm induced growth arrest exhibit epithelial polarity failed undergo apoptosis fig 9 loss epithelial polarity based morphologic appearance em lack polarized expression e cadherin figs 9 10 development apoptosis resistance correlated appearance complex karyotypic abnormalities unlike early passage cells late passage p53 hmec e6 cells continued proliferate recm formed multilayered aggregates cells subsequently undergo apoptosis figs 8 9 based upon observations vitro system propose resistance recm mediated growth arrest polarity may promote resistance apoptosis
0.5136099.11673474.html.plaintext.txt	109	investigated component recm may proapoptotic early passage p53 hmec e6 cells grown collagen form acinar structures undergo apoptosis fig 11 based observations speculate presence collagen iiv 11 ratio model system sufficient induce apoptosis promote acinar structure laminin added collagen iiv gels early passage p53 hmec e6 cells formed organized branched tubular structures terminated spherical cell clusters underwent apoptosis fig 11 early passage p53 hmec e6 cells cultured laminin suspension absence plastic substratum adhesion formed similar three dimensional structures likewise underwent apoptosis suggests contact laminin critical induction apoptosis early passage p53 hmec e6 cells
0.5136099.11673474.html.plaintext.txt	110	investigated component recm may proapoptotic early passage p53 hmec e6 cells grown collagen form acinar structures undergo apoptosis fig 11 based observations speculate presence collagen iiv 11 ratio model system sufficient induce apoptosis promote acinar structure laminin added collagen iiv gels early passage p53 hmec e6 cells formed organized branched tubular structures terminated spherical cell clusters underwent apoptosis fig 11 early passage p53 hmec e6 cells cultured laminin suspension absence plastic substratum adhesion formed similar three dimensional structures likewise underwent apoptosis suggests contact laminin critical induction apoptosis early passage p53 hmec e6 cells
0.5136099.11673474.html.plaintext.txt	111	integrin 3ss1 critical mediator intracellular adhesion important receptor laminin 5 xia et al 1996 kawano et al 2001 recently 3ss1 integrin shown play potential role initiation apoptosis cells sato et al 1999 resistance recm mediated apoptosis late passage p53 hmec e6 cells associated altered expression 3 integrin figs 12 13 redistribution 3 integrin seen previously investigators association loss mammary epithelial cell polarity recm culture consistent findings weaver et al 1997 treatment early passage p53 hmec e6 cells 3 ss1 integrin function altering abs blocked recm mediated growth arrest inhibited induction apoptosis figs 14 15 taken together observations suggest important role 3ss1 signaling recm mediated growth regulation apoptosis
0.5136099.11673474.html.plaintext.txt	112	previous investigators tested ability 3 ss1 integrin blocking abs mediate growth breast cell lines recm collagen fibrin gels howlett et al 1995 alford et al 1998 hmt 3522 nontumorigeneic breast cell line demonstrated decreased proliferation recm culture treated either inhibitory anti 3 integrin ab p1b5 anti ss1 integrin ab aiib2 howlett et al 1995 contrast observed dysregulated proliferation treated hmecs either inhibitory anti 3 integrin ab p1b5 anti ss1 integrin ab jb1a induction stimulatory inhibitory functions abs directed defined integrin subunits observed previously anti ss1 anti 3 integrin abs lenter et al 1993 driessens et al 1995 lichtner et al 1998 felt highly cell type specific hypothesize utilization nonimmortalized cells low levels 6ss4 integrin expression may account differences results obtained howlett et al 1995
0.5136099.11673474.html.plaintext.txt	113	conclusion shown whereas p53 hmec lxsn cells undergo growth arrest form polarized epithelium grown contact recm p53 hmec e6 p53 hmec cells acutely lost p53 function undergo apoptosis resistance recm mediated growth arrest polarity results resistance recm mediated apoptosis associated altered expression 3 integrin treatment apoptosis sensitive early passage p53 hmec e6 cells either 3 ss1 integrin function altering abs results loss recm mediated growth arrest resistance recm mediated apoptosis suggest sensitivity resistance recm mediated apoptosis p53 hmecs dependent ability form polarized epithelium may require 3ss1 integrin signaling
0.5136099.11673474.html.plaintext.txt	114	conclusion shown whereas p53 hmec lxsn cells undergo growth arrest form polarized epithelium grown contact recm p53 hmec e6 p53 hmec cells acutely lost p53 function undergo apoptosis resistance recm mediated growth arrest polarity results resistance recm mediated apoptosis associated altered expression 3 integrin treatment apoptosis sensitive early passage p53 hmec e6 cells either 3 ss1 integrin function altering abs results loss recm mediated growth arrest resistance recm mediated apoptosis suggest sensitivity resistance recm mediated apoptosis p53 hmecs dependent ability form polarized epithelium may require 3ss1 integrin signaling
0.5136099.11673474.html.plaintext.txt	115	materials methods top abstract introduction results discussion materials methods references cell culture media hmec strains ag11132 ag11134 m stampfer lawrence berkeley national laboratory berkeley ca purchased national institute aging cell culture repository stampfer 1985 hmec strains ag11132 ag11134 established normal tissue obtained reduction mammoplasty limited life span culture fail divide 20 25 passages ag11132 ag11134 cells exhibit low level estrogen receptor staining characteristic normal mammary cells ag11132 ag11134 passage 8 time receipt hmecs grown standard medium mammary epithelial cell basal medium clonetics supplemented 4 mgml bovine pituitary extract cc4009 clonetics 5 mgml insulin upstate biotechnology 10 ngml egf upstate biotechnology 05 mgml hydrocortisone sigma aldrich 10 5 m isoproterenol sigma aldrich 10 mm hepes buffer sigma aldrich g418 gibco brl containing standard medium prepared addition 300 mgml g418 standard medium cells cultured 37 degrees c humidified incubator 5 co295 air mycoplasma testing performed reported previously seewaldt et al 1997a
0.5136099.11673474.html.plaintext.txt	116	materials methods top abstract introduction results discussion materials methods references cell culture media hmec strains ag11132 ag11134 m stampfer lawrence berkeley national laboratory berkeley ca purchased national institute aging cell culture repository stampfer 1985 hmec strains ag11132 ag11134 established normal tissue obtained reduction mammoplasty limited life span culture fail divide 20 25 passages ag11132 ag11134 cells exhibit low level estrogen receptor staining characteristic normal mammary cells ag11132 ag11134 passage 8 time receipt hmecs grown standard medium mammary epithelial cell basal medium clonetics supplemented 4 mgml bovine pituitary extract cc4009 clonetics 5 mgml insulin upstate biotechnology 10 ngml egf upstate biotechnology 05 mgml hydrocortisone sigma aldrich 10 5 m isoproterenol sigma aldrich 10 mm hepes buffer sigma aldrich g418 gibco brl containing standard medium prepared addition 300 mgml g418 standard medium cells cultured 37 degrees c humidified incubator 5 co295 air mycoplasma testing performed reported previously seewaldt et al 1997a
0.5136099.11673474.html.plaintext.txt	117	retroviral transduction lxsn16e6 retroviral vector containing hpv 16 e6 coding sequence provided d galloway fred hutchinson cancer research center seattle wa described previously halbert et al 1991 demers et al 1994 hmecs passage 9 plated four 75 tissue culture flasks corning standard medium grown 50 confluency transducing virions either pa317 lxsn16e6 control pa317 lxsn without insert retroviral producer line added multiplicity infection 11 presence 4 microgml polybrene sigma aldrich log phase cells grown 75 flasks two remaining 75 flasks infected virus 48 h two flasks containing transduced cells one flask untransduced cells passaged 13 passage 10 selected standard medium containing 300 microgml g418 cells grown g418 containing standard medium 1 wk 100 control untransduced cells dead transduction efficiency high selection cells passaged 13 completion selection passage 11 cells maintained absence selection immediately proceeding apoptosis experiments fourth flask unselected untransduced parental control cells passaged parallel selected transduced experimental vector control cells parental ag11132 cells designated hmec p transduced cells expressing hpv 16e6 construct designated p53 hmec e6 vector control clones designated p53 hmec lxsn cells maintained standard medium transfection absence g418 selection ensure chromosomal abnormalities apoptosis resistance observed due continued exposure g418 experiments performed mass cultures
0.5136099.11673474.html.plaintext.txt	118	retroviral transduction lxsn16e6 retroviral vector containing hpv 16 e6 coding sequence provided d galloway fred hutchinson cancer research center seattle wa described previously halbert et al 1991 demers et al 1994 hmecs passage 9 plated four 75 tissue culture flasks corning standard medium grown 50 confluency transducing virions either pa317 lxsn16e6 control pa317 lxsn without insert retroviral producer line added multiplicity infection 11 presence 4 microgml polybrene sigma aldrich log phase cells grown 75 flasks two remaining 75 flasks infected virus 48 h two flasks containing transduced cells one flask untransduced cells passaged 13 passage 10 selected standard medium containing 300 microgml g418 cells grown g418 containing standard medium 1 wk 100 control untransduced cells dead transduction efficiency high selection cells passaged 13 completion selection passage 11 cells maintained absence selection immediately proceeding apoptosis experiments fourth flask unselected untransduced parental control cells passaged parallel selected transduced experimental vector control cells parental ag11132 cells designated hmec p transduced cells expressing hpv 16e6 construct designated p53 hmec e6 vector control clones designated p53 hmec lxsn cells maintained standard medium transfection absence g418 selection ensure chromosomal abnormalities apoptosis resistance observed due continued exposure g418 experiments performed mass cultures
0.5136099.11673474.html.plaintext.txt	119	p53 oligonucleotides p53 oligonucleotide 18 mer targeting region initiation codon six base pairs immediately first first four coding codons 5 cggctcctccatggcagt 3 odn used previously several investigators suppress p53 function bi et al 1994 capoulade et al 2001 p53 control odn 5 cggctcctcatggcagt 3 chosen scrambled sequence odn ensure identical nucleotide content minimize differences potentially attributable nucleic acid content capoulade et al 2001 odns first last three nucleotides phosphorothiolate modified increase stability vitro
0.5136099.11673474.html.plaintext.txt	120	p53 oligonucleotides p53 oligonucleotide 18 mer targeting region initiation codon six base pairs immediately first first four coding codons 5 cggctcctccatggcagt 3 odn used previously several investigators suppress p53 function bi et al 1994 capoulade et al 2001 p53 control odn 5 cggctcctcatggcagt 3 chosen scrambled sequence odn ensure identical nucleotide content minimize differences potentially attributable nucleic acid content capoulade et al 2001 odns first last three nucleotides phosphorothiolate modified increase stability vitro
0.5136099.11673474.html.plaintext.txt	121	early passage p53 hmec p parental cells plated 75 plates standard medium allowing 24 h attachment cell cultures treated 72 h either 01 microm active scras p53 odns culture medium replaced new standard medium containing fresh odns every 24 h western blot analysis performed confirm suppression p53 expression described resulting film images digitized quantitated using eastman kodak co 1d image analysis software
0.5136099.11673474.html.plaintext.txt	122	early passage p53 hmec p parental cells plated 75 plates standard medium allowing 24 h attachment cell cultures treated 72 h either 01 microm active scras p53 odns culture medium replaced new standard medium containing fresh odns every 24 h western blot analysis performed confirm suppression p53 expression described resulting film images digitized quantitated using eastman kodak co 1d image analysis software
0.5136099.11673474.html.plaintext.txt	123	recm culture follows cells trypsinized 104 cells resuspended 100 microl recm containing 01 microm either active p53 scras odn ice recm cultures prepared described recm cultures overlayed standard medium containing 01 microm either active scrambled p53 odns overlay medium changed every 24 h ensure fresh supply odns diameter growing colonies determined cell colonies prepared em described measure p53 protein expression cells grown recm culture colonies released matrix 60 min incubation 37 degrees c dispase 5000 uml caseinolytic activity collaborative research released cells washed using ice cold pbs 5 mm edta twice pbs alone resulting pellet tested p53 protein expression western blot analysis described
0.5136099.11673474.html.plaintext.txt	124	recm culture follows cells trypsinized 104 cells resuspended 100 microl recm containing 01 microm either active p53 scras odn ice recm cultures prepared described recm cultures overlayed standard medium containing 01 microm either active scrambled p53 odns overlay medium changed every 24 h ensure fresh supply odns diameter growing colonies determined cell colonies prepared em described measure p53 protein expression cells grown recm culture colonies released matrix 60 min incubation 37 degrees c dispase 5000 uml caseinolytic activity collaborative research released cells washed using ice cold pbs 5 mm edta twice pbs alone resulting pellet tested p53 protein expression western blot analysis described
0.5136099.11673474.html.plaintext.txt	125	western blotting preparation cellular lysates immunoblotting performed previously described seewaldt et al 1995 1997b p53 expression detected using 1100 dilution mouse anti human p53 ab 2 oncogene research products detected ecl western blotting detection reagents amersham pharmacia biotech described manufacturer
0.5136099.11673474.html.plaintext.txt	126	northern blot analysis rna extracted guanidium isothiocyanate subjected northern blotting formaldehyde denaturing gels described previously seewaldt et al 1995 10 mg rna loaded per lane molecular probes used northern blot analysis follows human p53 probe 19 kb bamh1 fragment seewaldt et al 1997b 36b4 probe 700 bp psti fragment used loading transfer control probe seewaldt et al 1995
0.5136099.11673474.html.plaintext.txt	127	hmec culture reconstituted ecm mammary epithelial cells grown recm methods developed bissell others folkman moscona 1978 howlett et al 1994 roskelley et al 1994 seewaldt et al 1997b 100 microl recm matrigeltm collaborative research growth factor depleted recm growth factor reduced matrigeltm collaborative research added per well 48 well plate allowed gel 37 degrees c 20 min p53 hmec e6 transduced cells p53 hmec lxsn vector controls trypsinized counted pelleted sterile microcentrifuge tube approximately 104 cells resuspended 100 microl recm ice gently overlaid initial undercoating ecm allowed gel 37 degrees c 20 min standard medium added wells inspected ensure equal distribution cells well cells grown 5 14 d culture medium changed daily
0.5136099.11673474.html.plaintext.txt	128	integrin blocking experiments 104 p53 hmec lxsn vector control cells passage 11 p53 hmec e6 cells passage 10 pelleted resuspended 100 microl standard medium containing either abs 3 ss1 integrins chemicon international control nonimmune mouse igg 15 min room temperature rt final concentration 3 integrin blocking ab cdw496 clone p1b5 10 microgml ss1 integrin blocking ab cd29 clone jb1a 20 microgml ss1 integrin stimulatory ab cd29 clone b3b11 10 microgml 100 microl recm added cell suspension gently mixed overlaid described 1 ml standard medium containing respective concentration blocking ab added well changed every day cells grown 5 9 d recm culture
0.5136099.11673474.html.plaintext.txt	129	integrin blocking experiments 104 p53 hmec lxsn vector control cells passage 11 p53 hmec e6 cells passage 10 pelleted resuspended 100 microl standard medium containing either abs 3 ss1 integrins chemicon international control nonimmune mouse igg 15 min room temperature rt final concentration 3 integrin blocking ab cdw496 clone p1b5 10 microgml ss1 integrin blocking ab cd29 clone jb1a 20 microgml ss1 integrin stimulatory ab cd29 clone b3b11 10 microgml 100 microl recm added cell suspension gently mixed overlaid described 1 ml standard medium containing respective concentration blocking ab added well changed every day cells grown 5 9 d recm culture
0.5136099.11673474.html.plaintext.txt	130	collagenlaminin morphogenesis assays collagen collagenlaminin gels prepared modification methods developed alford et al 1998 collagen type sigma aldrich human placental collagen type iv sigma aldrich solubilized 0018 n acetic acid final concentration 3 mgml three parts collagen type mixed one part collagen type iv collagen iiv solution neutralized mixing 8 vol collagen solution 1 vol sterile pbs 1 vol sterile 01 m naoh final ph 74 100 microl neutralized collagen iiv solution added per well 48 well plate allowed gel 37 degrees c 20 min approximately 104 early passage p53 hmec e6 cells p53 hmec lxsn controls resuspended 100 microl neutralized collagen iiv solution ice gently overlaid initial undercoating collagen allowed gel 37 degrees c 20 min standard medium added wells inspected ensure equal distribution single cells suspended well cells grown 5 9 d culture prepared em described previously seewaldt et al 1997b collagenlaminin gels nine parts collagen iiv added one part human placental laminin sigma aldrich gels prepared laminin cultures prepared follows 48 well plates coated 100 microl neutralized collagen iiv solution baked 65 degrees c 24 h repeated three times 100 microl human placental laminin added per well baked 50 degrees c laminin solution hardened repeated three times approximately 104 early passage p53 hmec e6 cells suspended 11 mixture standard medium human placental laminin cells grown 7 d prepared em previously described seewaldt et al 1997b
0.5136099.11673474.html.plaintext.txt	131	transmission em p53 hmec e6 cells p53 hmec lxsn vector control cells grown contact recm described em preformed described previously seewaldt et al 1997b
0.5136099.11673474.html.plaintext.txt	132	cell growth determination recm culture cell growth determined following criteria size growing spherical cell colonies measured eye piece equipped micrometer spindle p53 hmec lxsn vector controls p53 hmec e6 transduced cells 20 largest colonies measured
0.5136099.11673474.html.plaintext.txt	133	cell growth determination recm culture cell growth determined following criteria size growing spherical cell colonies measured eye piece equipped micrometer spindle p53 hmec lxsn vector controls p53 hmec e6 transduced cells 20 largest colonies measured
0.5136099.11673474.html.plaintext.txt	134	detection apoptosis situ tunel p53 hmec e6 cells p53 hmec lxsn vector control cells grown contact recm described 5 9 d cells fixed pbs 10 formalin embedded paraffin sections deparaffinized quenched methanol containing 21 hydrogen peroxide antigen retrieval achieved placing slides 10 mm citric acid 95 degrees c 10 min nuclear proteins stripped 20 microgml proteinase k slides washed deionized water positive controls immersed dn buffer 30 mm tris ph 72 140 mm sodium cacodylate 4 mm magnesium chloride 01 mm dtt 5 min rt incubated dnasei roche dn buffer 10 min rt negative controls treated 5 fbs samples immersed tdt buffer 30 mm tris ph 72 140 mm sodium cacodylate 10 mm cobalt chloride 5 min rt sections covered tdtbio 14 datp solution 800 microl tdt buffer containing 120 u terminal transferase 50 nm bio 14 datp gibco brl incubated 1 h rt reaction terminated pbs sections blocked 2 bsa 10 min rt treated abc solution elite sections allowed complex ice 30 min incubated 30 min 37 degrees c washed pbs sections stained dab 2 nickel chloride 01 hydrogen peroxide 3 min rt counterstained
0.5136099.11673474.html.plaintext.txt	135	detection apoptosis situ tunel p53 hmec e6 cells p53 hmec lxsn vector control cells grown contact recm described 5 9 d cells fixed pbs 10 formalin embedded paraffin sections deparaffinized quenched methanol containing 21 hydrogen peroxide antigen retrieval achieved placing slides 10 mm citric acid 95 degrees c 10 min nuclear proteins stripped 20 microgml proteinase k slides washed deionized water positive controls immersed dn buffer 30 mm tris ph 72 140 mm sodium cacodylate 4 mm magnesium chloride 01 mm dtt 5 min rt incubated dnasei roche dn buffer 10 min rt negative controls treated 5 fbs samples immersed tdt buffer 30 mm tris ph 72 140 mm sodium cacodylate 10 mm cobalt chloride 5 min rt sections covered tdtbio 14 datp solution 800 microl tdt buffer containing 120 u terminal transferase 50 nm bio 14 datp gibco brl incubated 1 h rt reaction terminated pbs sections blocked 2 bsa 10 min rt treated abc solution elite sections allowed complex ice 30 min incubated 30 min 37 degrees c washed pbs sections stained dab 2 nickel chloride 01 hydrogen peroxide 3 min rt counterstained
0.5136099.11673474.html.plaintext.txt	136	e cadherin immunostaining early late passage p53 hmec e6 cells p53 hmec lxsn vector control cells grown recm described 6 d embedded oct miles cells snap frozen 5 microm sections obtained sections fixed 30 min rt 37 formaldehyde pbs blocked 05 heat denatured bsa hd bsa pbs 1 h rt cells incubated 30 min mouse anti human e cadherin ab bd signal transduction laboratories diluted pbs 05 hd bsa 30 min rt washed six times pbs rt immunofluorescence cells incubated fitc conjugated goat anti mouse ab 1200 ab dilution santa cruz biotechnology inc pbs 05 hd bsa 30 min rt washed sections mounted 30 glycerol pbs visualized immunofluorescence using zeiss lsm 410 fluorescence microscope
0.5136099.11673474.html.plaintext.txt	137	e cadherin immunostaining early late passage p53 hmec e6 cells p53 hmec lxsn vector control cells grown recm described 6 d embedded oct miles cells snap frozen 5 microm sections obtained sections fixed 30 min rt 37 formaldehyde pbs blocked 05 heat denatured bsa hd bsa pbs 1 h rt cells incubated 30 min mouse anti human e cadherin ab bd signal transduction laboratories diluted pbs 05 hd bsa 30 min rt washed six times pbs rt immunofluorescence cells incubated fitc conjugated goat anti mouse ab 1200 ab dilution santa cruz biotechnology inc pbs 05 hd bsa 30 min rt washed sections mounted 30 glycerol pbs visualized immunofluorescence using zeiss lsm 410 fluorescence microscope
0.5136099.11673474.html.plaintext.txt	138	immunodetection integrin expression early late passage p53 hmec e6 cells p53 hmec lxsn vector control cells grown glass coverslips 48 h standard medium cells fixed 20 min rt 2 formaldehyde 01 m sodium cacodylate 01 m sucrose ph 72 permeabilized 01 triton x 100 10 min rt blocked 05 hd bsa pbs 1 h rt cells incubated primary ab diluted pbs 05 hd bsa 1 h rt washed six times pbs rt abs integrin subunits 2 p1h5 3 p1f2 p1b5 ss1 p4c10 gift william carter fred hutchinson cancer research center described previously wayner carter 1987 wayner et al 1988 carter et al 1990ab abs integrin 6 goh3 ss4 3e1 obtained chemicon international immunofluorescence cells incubated either fitc conjugated goat anti mouse ab 11500 dilution goat anti rat ab 14000 dilution dako pbs 05 hd bsa 1 h rt washed sections mounted solution containing 25 mgml 14 diazobicyclo 222octane glycerol visualized immunofluorescence using zeiss lsm 410 fluorescence microscope
0.5136099.11673474.html.plaintext.txt	139	immunodetection integrin expression early late passage p53 hmec e6 cells p53 hmec lxsn vector control cells grown glass coverslips 48 h standard medium cells fixed 20 min rt 2 formaldehyde 01 m sodium cacodylate 01 m sucrose ph 72 permeabilized 01 triton x 100 10 min rt blocked 05 hd bsa pbs 1 h rt cells incubated primary ab diluted pbs 05 hd bsa 1 h rt washed six times pbs rt abs integrin subunits 2 p1h5 3 p1f2 p1b5 ss1 p4c10 gift william carter fred hutchinson cancer research center described previously wayner carter 1987 wayner et al 1988 carter et al 1990ab abs integrin 6 goh3 ss4 3e1 obtained chemicon international immunofluorescence cells incubated either fitc conjugated goat anti mouse ab 11500 dilution goat anti rat ab 14000 dilution dako pbs 05 hd bsa 1 h rt washed sections mounted solution containing 25 mgml 14 diazobicyclo 222octane glycerol visualized immunofluorescence using zeiss lsm 410 fluorescence microscope
0.5136099.11673474.html.plaintext.txt	140	recm culture early late passage p53 hmec e6 cells p53 hmec lxsn vector control cells grown contact recm 6 d standard medium cells embedded oct snap frozen sectioned described sections fixed 20 min rt 2 formaldehyde 01 m sodium cacodylate 01 m sucrose ph 72 blocked 05 hd bsa pbs 1 h rt sections stained abs integrin subunits 3 p1f2 ss1 p4c10 visualized described
0.5136099.11673474.html.plaintext.txt	141	recm culture early late passage p53 hmec e6 cells p53 hmec lxsn vector control cells grown contact recm 6 d standard medium cells embedded oct snap frozen sectioned described sections fixed 20 min rt 2 formaldehyde 01 m sodium cacodylate 01 m sucrose ph 72 blocked 05 hd bsa pbs 1 h rt sections stained abs integrin subunits 3 p1f2 ss1 p4c10 visualized described
0.5136099.11673474.html.plaintext.txt	142	cytogenetic analysis early passage transduced parental hmecs cultures p53 hmec p parental cells passage 10 p53 hmec lxsn vector controls passage 10 p53 hmec e6 cells passage 10 p53 hmec e6 cells passage 18 checked sufficient numbers dividing cells exposed colcemid gibco brl final concentration 001 002 microgml 2 3 h subsequently cells released flasks trypsinization exposed hypotonic solution fixed described previously mrozek et al 1993 chromosome preparations made appropriate aging slides subjected sky method enables simultaneous display human chromosomes different colors schrock et al 1996 additional slides also stained dapi vector laboratories alone sky slides hybridized sky probe mixture containing combinatorially labeled painting probes autosomes sex chromosomes applied spectral imaging 42 45 h 37 degrees c hybridization detection procedures performed according manufacturers protocol applied spectral imaging chromosomes counterstained dapi antifade solution multicolor hybridizations visualized spectracube sd 200 system applied spectral imaging mounted zeiss axioplan 2 epifluorescence microscope using custom designed optical filter sky 1 chroma technology dapi images metaphase cells acquired using dapi specific optical filter spectral analysis classification performed using skyview 12r visualization analysis software applied spectral imaging assignment breakpoints structural abnormalities made comparison images sky classified chromosomes images chromosomes stained dapi inverted electronically contrast enhanced skyview 12r software karyotypic abnormalities classified according recommendations international system human cytogenetic nomenclature mitelman 1995
0.5136099.11673474.html.plaintext.txt	143	footnotes abbreviations used paper antisense ecm extracellular matrix hmec human mammary epithelial cells hpv 16 human papillomavirus type 16 recm reconstituted ecm rt room temperature sky spectral karyotyping odn oligodeoxynucleotide scras scrambled tdt terminal deoxynucleotidyl transferase
0.5136099.11673474.html.plaintext.txt	144	acknowledgments authors indebted judy goombridge franque remington preparation em specimens gratefully acknowledge william carter gift integrin specific abs authors wish thank mr mrs jack marcia slane generous gift zeiss lsm 410 fluorescence microscope duke university comprehensive cancer center
0.5136099.11673474.html.plaintext.txt	145	acknowledgments authors indebted judy goombridge franque remington preparation em specimens gratefully acknowledge william carter gift integrin specific abs authors wish thank mr mrs jack marcia slane generous gift zeiss lsm 410 fluorescence microscope duke university comprehensive cancer center
0.5136099.11673474.html.plaintext.txt	146	work supported national institutes healthnational cancer institute grants r01ca88799 vl seewaldt 2p30ca14236 26 vl seewaldt 5p30ca16058 k mrozek national institutes healthnational institute diabetes digestive kidney diseases grant 2p30dk 35816 11 vl seewaldt american cancer society award cce 99898 vl seewaldt charlotte geyer award vl seewaldt v foundation award vl seewaldt susan g komen breast cancer award vl seewaldt
0.5136099.11673474.html.plaintext.txt	147	submitted 1 november 2000revised 15 august 2001accepted 14 september 2001
0.5136099.11673474.html.plaintext.txt	148	references top abstract introduction results discussion materials methods references
0.5138107.11925449.html.plaintext.txt	0	conformationally flexible s9 s10 linker region core domain p53 contains novel mdm2 binding site whose mutation increases ubiquitination p53 vivo harumi shimizu lindsay r burch amanda j smith david dornan maura wallace kathryn l ball ted r hupp
0.5138107.11925449.html.plaintext.txt	1	departments molecular cellular pathology surgery molecular oncology cancer research uk laboratories university dundee dundee dd1 9sy scotland
0.5138107.11925449.html.plaintext.txt	2	received publication march 8 2002
0.5138107.11925449.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references
0.5138107.11925449.html.plaintext.txt	4	although n terminal box domain tumor suppressor protein p53 contains primary docking site mdm2 previous studies demonstrated rna stabilizes mdm2 p53 complex using p53 mutant lacking box motif vitro assays measuring specific activity mdm2 ligand free rna bound state identified novel mdm2 interaction site core domain p53 defined using phage peptide display rna mdm2 isoform exhibited notable switch peptide binding specificity enhanced affinity novel peptide sequences either p53 small nuclear ribonucleoprotein u snrnp u substantially reduced affinity primary p53 binding site box domain consensus binding site rna mdm2 complex within p53 sgxllgesxf links s9 s10 sheets flanking box iv box v motifs core domain site reversible conformational flexibility p53 mutation conserved amino acids linker ser261 leu264 bridges s9 s10 sheets stimulated p53 activity reporter templates increased mdm2 dependent ubiquitination p53 furthermore mutation conserved phe270 within s10 sheet resulted mutant p53 binds stably rna mdm2 complexes vitro strikingly hyper ubiquitinated vivo introducing ala19 mutation p53f270a protein abolished rna mdm2 complex binding hyper ubiquitination vivo thus indicating p53f270a protein hyper ubiquitination depends upon mdm2 binding primary site box domain together data identify novel mdm2 binding interface within s9 s10 sheet region p53 plays regulatory role modulating rate mdm2 dependent ubiquitination p53 cells introduction top abstract introduction experimental procedures results discussion references
0.5138107.11925449.html.plaintext.txt	5	although n terminal box domain tumor suppressor protein p53 contains primary docking site mdm2 previous studies demonstrated rna stabilizes mdm2 p53 complex using p53 mutant lacking box motif vitro assays measuring specific activity mdm2 ligand free rna bound state identified novel mdm2 interaction site core domain p53 defined using phage peptide display rna mdm2 isoform exhibited notable switch peptide binding specificity enhanced affinity novel peptide sequences either p53 small nuclear ribonucleoprotein u snrnp u substantially reduced affinity primary p53 binding site box domain consensus binding site rna mdm2 complex within p53 sgxllgesxf links s9 s10 sheets flanking box iv box v motifs core domain site reversible conformational flexibility p53 mutation conserved amino acids linker ser261 leu264 bridges s9 s10 sheets stimulated p53 activity reporter templates increased mdm2 dependent ubiquitination p53 furthermore mutation conserved phe270 within s10 sheet resulted mutant p53 binds stably rna mdm2 complexes vitro strikingly hyper ubiquitinated vivo introducing ala19 mutation p53f270a protein abolished rna mdm2 complex binding hyper ubiquitination vivo thus indicating p53f270a protein hyper ubiquitination depends upon mdm2 binding primary site box domain together data identify novel mdm2 binding interface within s9 s10 sheet region p53 plays regulatory role modulating rate mdm2 dependent ubiquitination p53 cells introduction top abstract introduction experimental procedures results discussion references
0.5138107.11925449.html.plaintext.txt	6	p53 function tumor suppressor linked role coordinator damage induced cell cycle checkpoint pathway whose action prevents propagation permanently damaged clones induction apoptosis growth arrest 1 biochemical activity p53 linked tumor suppression function sequence specific dna binding protein transcription factor controls expression large panel gene products implicated normal growth control dna repair cell cycle arrest apoptosis angiogenesis 2 stress regulated transactivation function p53 driven sequence specific dna binding domain coordinated specific protein protein interactions turn modulated covalent non covalent modifications central core domain p53 amino acids 90 295 contains sequence specific dna binding domain 3 inactivating mutations p53 200 different amino acid positions within core dna binding domain detected human cancers 4 mutation often results unfolding accumulation p53 protein nucleus cancer cell 5 oligomerization domain amino acids 320 356 flanks conserved core sequence specific dna binding domain required assemble p53 tetrameric structure 6 7
0.5138107.11925449.html.plaintext.txt	7	p53 function tumor suppressor linked role coordinator damage induced cell cycle checkpoint pathway whose action prevents propagation permanently damaged clones induction apoptosis growth arrest 1 biochemical activity p53 linked tumor suppression function sequence specific dna binding protein transcription factor controls expression large panel gene products implicated normal growth control dna repair cell cycle arrest apoptosis angiogenesis 2 stress regulated transactivation function p53 driven sequence specific dna binding domain coordinated specific protein protein interactions turn modulated covalent non covalent modifications central core domain p53 amino acids 90 295 contains sequence specific dna binding domain 3 inactivating mutations p53 200 different amino acid positions within core dna binding domain detected human cancers 4 mutation often results unfolding accumulation p53 protein nucleus cancer cell 5 oligomerization domain amino acids 320 356 flanks conserved core sequence specific dna binding domain required assemble p53 tetrameric structure 6 7
0.5138107.11925449.html.plaintext.txt	8	regulatory domains n c termini p53 modulate protein protein interactions dna protein interactions affect rate p53 dependent transcription 8 c terminus p53 contains negative regulatory domain whose phosphorylation ser315 cyclin dependent kinases 9 acetylation multiple lysine residues p300 10 stimulates transcription activity p53 vivo n terminal regulatory domain p53 contains highly conserved box domain directs binding p53 proteins including positive effector p300 inhibitor mdm2 balance regulates tumor suppressor activity p53 phosphorylation ser15 thr18 ser20 either reduce mdm2 binding 11 12 stabilize p53 p300 transcription complex 13 resulting net activation p53 function thus concerted activation sequence specific dna binding function p53 post translational modification c terminal domain kinase dependent stabilization p53 p300 complex provide working model explain basic mechanism p53 dependent gene expression activated
0.5138107.11925449.html.plaintext.txt	9	regulatory domains n c termini p53 modulate protein protein interactions dna protein interactions affect rate p53 dependent transcription 8 c terminus p53 contains negative regulatory domain whose phosphorylation ser315 cyclin dependent kinases 9 acetylation multiple lysine residues p300 10 stimulates transcription activity p53 vivo n terminal regulatory domain p53 contains highly conserved box domain directs binding p53 proteins including positive effector p300 inhibitor mdm2 balance regulates tumor suppressor activity p53 phosphorylation ser15 thr18 ser20 either reduce mdm2 binding 11 12 stabilize p53 p300 transcription complex 13 resulting net activation p53 function thus concerted activation sequence specific dna binding function p53 post translational modification c terminal domain kinase dependent stabilization p53 p300 complex provide working model explain basic mechanism p53 dependent gene expression activated
0.5138107.11925449.html.plaintext.txt	10	contrast p53 activation reactions inhibition p53 activity less understood involves mdm2 dependent pathway functions cycling cells degrade p53 keep transcriptional activity relatively low mdm2 protein contains least four independent functional domains including 1 n terminal domain recognizes box domain p53 14 2 central domain binds tumor suppressor protein p14arf 3 putative zinc binding domain 15 4 ring finger rna binding domain 16 original localization primary mdm2 docking site p53 protein n terminal box domain defined using small peptide mimetics 17 crystallographic analysis 18 mutational studies 15 19 36 studies revealed highly conserved hydrophobic series amino acids within n terminal region p53 amino acids 14 27 interact hydrophobic binding pocket n terminal domain mdm2 protein microinjection monoclonal antibodies p53 binding interface mdm2 protein activate p53 dependent expression providing direct evidence mdm2 normally negative regulator p53 function vivo 20 21 scaffold proteins fused box domain p53 activate p53 function virtue binding mdm2 protein 13 22 providing additional evidence importance small box domain independent binding motif recognized mdm2 protein vivo
0.5138107.11925449.html.plaintext.txt	11	contrast p53 activation reactions inhibition p53 activity less understood involves mdm2 dependent pathway functions cycling cells degrade p53 keep transcriptional activity relatively low mdm2 protein contains least four independent functional domains including 1 n terminal domain recognizes box domain p53 14 2 central domain binds tumor suppressor protein p14arf 3 putative zinc binding domain 15 4 ring finger rna binding domain 16 original localization primary mdm2 docking site p53 protein n terminal box domain defined using small peptide mimetics 17 crystallographic analysis 18 mutational studies 15 19 36 studies revealed highly conserved hydrophobic series amino acids within n terminal region p53 amino acids 14 27 interact hydrophobic binding pocket n terminal domain mdm2 protein microinjection monoclonal antibodies p53 binding interface mdm2 protein activate p53 dependent expression providing direct evidence mdm2 normally negative regulator p53 function vivo 20 21 scaffold proteins fused box domain p53 activate p53 function virtue binding mdm2 protein 13 22 providing additional evidence importance small box domain independent binding motif recognized mdm2 protein vivo
0.5138107.11925449.html.plaintext.txt	12	although mdm2 binding p53 tetramer results polyubiquitination c terminal domain p53 subsequent degradation box motif sufficient targeting heterologous fusion protein degradation mdm2 protein 23 latter data identify minimal polypeptide fragment modified mdm2 dependent degradation machinery vivo mdm2 protein interacts native p53 tetramer undefined example although box motif promote degradation heterologous fusion protein cells 13 23 monomeric p53 protein paradoxically degraded mdm2 59 indicating determinants p53 tetramer regulate mdm2 binding cells recent study shown mdm2 protein complexed rna vitro bind p53 lacking box domain suggesting rna induce conformational change mdm2 directs binding novel site p53 25 purpose study use biochemical approach begin reconstitute mdm2 p53 tetramer complex vitro determine whether co factors modulate vitro stability mdm2 p53 complex provide direct evidence secondary docking site mdm2 within core domain p53 resides within conformationally flexible s9 s10 sheet region flanked conserved domains box iv box v mutant forms p53 contain single point mutations conserved amino acids within s9 s10 sheet region increased levels mdm2 dependent ubiquitination cells conformationally flexible motif interestingly constrained wild type p53 protein dna complex 3 s9 s10 sheet region unfolded denatured mutant p53 protein within human cancers 5 35 denaturation unfolding p53 protein defined first molecular defect p53 pathway human cancer cells refolding p53 protein small molecules subject recent screening programs aimed reactivating mutant p53 protein function 60 62 together data identifying conformationally flexible linker within s9 s10 sheet region p53 protein novel mdm2 binding interface suggest interplay may exist p53 protein unfolding factors modulate rate mdm2 dependent ubiquitination p53 vivo experimental procedures top abstract introduction experimental procedures results discussion references
0.5138107.11925449.html.plaintext.txt	13	although mdm2 binding p53 tetramer results polyubiquitination c terminal domain p53 subsequent degradation box motif sufficient targeting heterologous fusion protein degradation mdm2 protein 23 latter data identify minimal polypeptide fragment modified mdm2 dependent degradation machinery vivo mdm2 protein interacts native p53 tetramer undefined example although box motif promote degradation heterologous fusion protein cells 13 23 monomeric p53 protein paradoxically degraded mdm2 59 indicating determinants p53 tetramer regulate mdm2 binding cells recent study shown mdm2 protein complexed rna vitro bind p53 lacking box domain suggesting rna induce conformational change mdm2 directs binding novel site p53 25 purpose study use biochemical approach begin reconstitute mdm2 p53 tetramer complex vitro determine whether co factors modulate vitro stability mdm2 p53 complex provide direct evidence secondary docking site mdm2 within core domain p53 resides within conformationally flexible s9 s10 sheet region flanked conserved domains box iv box v mutant forms p53 contain single point mutations conserved amino acids within s9 s10 sheet region increased levels mdm2 dependent ubiquitination cells conformationally flexible motif interestingly constrained wild type p53 protein dna complex 3 s9 s10 sheet region unfolded denatured mutant p53 protein within human cancers 5 35 denaturation unfolding p53 protein defined first molecular defect p53 pathway human cancer cells refolding p53 protein small molecules subject recent screening programs aimed reactivating mutant p53 protein function 60 62 together data identifying conformationally flexible linker within s9 s10 sheet region p53 protein novel mdm2 binding interface suggest interplay may exist p53 protein unfolding factors modulate rate mdm2 dependent ubiquitination p53 vivo experimental procedures top abstract introduction experimental procedures results discussion references
0.5138107.11925449.html.plaintext.txt	14	purification full length human mdm2 protein reagents sigma chemical co unless indicated otherwise bacterially expressed p53 purified described previously 24 full length human mdm2 expressed escherichia coli bl21 cells 25 27 mdm2 induced addition 1 mm final concentration isopropyl 1 thio d galactopyranoside harvested cells washed ice cold 50 mm tris hcl ph 80 final pellet resuspended 066 gml 10 sucrose 50 mm tris hcl ph 80 followed addition lysozyme 150 microgml final concentration nacl 015 m final concentration cell suspension incubated ice bath 45 min warmed 37 degrees c 1 min returned 0 degrees c cells lysed ice sonication addition pefabloc 2 mm roche molecular biochemicals dtt1 5 mm bdh laboratory supplies benzamidine 1 mm lysate centrifuged supernatant fractionated 5 ml hitrap sp column amersham biosciences inc equilibrated buffer 15 glycerol 25 mm hepes ph 80 002 triton x 100 5 mm dtt 1 mm benzamidine supernatant diluted buffer prior application onto column bound protein eluted linear gradient buffer 005 10 m kcl aliquots 1 microl fractions column assayed purity mdm2 sds gel presence mdm2 western blotting determine oligomerization state p53 purified mdm2 protein applied onto size exclusion chromatography superose 12 hr 1030 amersham biosciences inc buffer b 10 mm kcl 25 mm hepes ph 74 quikchange site directed mutagenesis kit stratagene used create p53 mutants primers designed change phe19 ser261 leu264 phe270 alanine
0.5138107.11925449.html.plaintext.txt	15	immunochemical assays peptide p53 tetramer binding activity mdm2 examined elisa described previously 25 26 essentially 96 well plates dynex microlite 2 first coated p53 mdm2 streptavidin indicated biotinylated peptide 16 h described previously 13 26 non reactive sites blocked 3 bovine serum albumin pbs tween 20 002 vv reduce nonspecific binding followed titrating increasing amounts p53 mdm2 peptides rna polyg 3 bovine serum albumin pbs tween 20 002 vv 1 h followed extensive wash incubation indicated igg reactions carried 4 degrees c detected appropriate secondary antibody linked horseradish peroxidase dako signal detection enhanced chemiluminescence developed using fluoroscan ascent fl human p14arf domain peptide contained sequence mvrrflvtlrirracgpprv 27 box domain p53 contains amino acids 14 27 described previously 13 12 epitope peptide used contained sequence sgnllgrnsfevrvcacpgrdr phage peptide display antibody captured bacterially expressed mdm2 protein bacterially expressed mdm2 protein reconstituted rna polyrg carried using three rounds phage peptide selection described previously purified phospho specific monoclonal antibodies toward phospho epitopes p53 9 28
0.5138107.11925449.html.plaintext.txt	16	immunochemical assays peptide p53 tetramer binding activity mdm2 examined elisa described previously 25 26 essentially 96 well plates dynex microlite 2 first coated p53 mdm2 streptavidin indicated biotinylated peptide 16 h described previously 13 26 non reactive sites blocked 3 bovine serum albumin pbs tween 20 002 vv reduce nonspecific binding followed titrating increasing amounts p53 mdm2 peptides rna polyg 3 bovine serum albumin pbs tween 20 002 vv 1 h followed extensive wash incubation indicated igg reactions carried 4 degrees c detected appropriate secondary antibody linked horseradish peroxidase dako signal detection enhanced chemiluminescence developed using fluoroscan ascent fl human p14arf domain peptide contained sequence mvrrflvtlrirracgpprv 27 box domain p53 contains amino acids 14 27 described previously 13 12 epitope peptide used contained sequence sgnllgrnsfevrvcacpgrdr phage peptide display antibody captured bacterially expressed mdm2 protein bacterially expressed mdm2 protein reconstituted rna polyrg carried using three rounds phage peptide selection described previously purified phospho specific monoclonal antibodies toward phospho epitopes p53 9 28
0.5138107.11925449.html.plaintext.txt	17	p53 mdm2 co immunoprecipitation immunoprecipitation performed using 5 microl wild type mutant p53 proteins translated tnt quick coupled transcriptiontranslation systems promega 10 microl mdm2 purified method indicated sp fraction rabbit reticulocyte lysates containing translated p53 protein incubated 1 h room temperature 500 microl immunoprecipitation buffer 1 triton x 100 50 mm tris ph 75 150 mm nacl 1 mm edta 1 mm dtt protease inhibitors protein g sepharose 4 fast flow amersham biosciences inc p53 monoclonal antibody pab421 absence presence mdm2 protein sp fraction absence presence 1 microg rnase sigma protein g washed four times immunoprecipitation buffer bound proteins eluted 20 microl sds sample buffer eluted samples 10 microl loaded onto sds acrylamide gel blotted mdm2 using monoclonal antibody 2a10
0.5138107.11925449.html.plaintext.txt	18	p53 mdm2 co immunoprecipitation immunoprecipitation performed using 5 microl wild type mutant p53 proteins translated tnt quick coupled transcriptiontranslation systems promega 10 microl mdm2 purified method indicated sp fraction rabbit reticulocyte lysates containing translated p53 protein incubated 1 h room temperature 500 microl immunoprecipitation buffer 1 triton x 100 50 mm tris ph 75 150 mm nacl 1 mm edta 1 mm dtt protease inhibitors protein g sepharose 4 fast flow amersham biosciences inc p53 monoclonal antibody pab421 absence presence mdm2 protein sp fraction absence presence 1 microg rnase sigma protein g washed four times immunoprecipitation buffer bound proteins eluted 20 microl sds sample buffer eluted samples 10 microl loaded onto sds acrylamide gel blotted mdm2 using monoclonal antibody 2a10
0.5138107.11925449.html.plaintext.txt	19	transfection assays h1299 p53 cells saos 2 p53 cells incubated rpmi 1640 dulbeccos modified eagles medium respectively supplemented 10 fetal calf serum cells cultured 37 degrees c 5 co2 humidified atmosphere 1 x 106 h1299 cells a375 cells 45 x 106 saos 2 cells seeded 6 cm tissue culture plates transfected using lipofectamine 2000 reagent invitrogen according manufactures protocol p53 dependent transcription carried described previously 13 briefly saos 2 h1299 a375 cells harvested 24 h post transfection lysed reporter lysis buffer corresponding luciferase galactosidase assays carried according manufacturers protocol promega exact quantity dna transfected indicated experiment necessary carrier dna transfected keep amount dna consistent transfection detection protein western blot analysis 24 h post transfection cells harvested lysed nonidet p 40 lysis buffer 150 mm nacl 50 mm tris hcl ph 80 5 mm edta 1 nonidet p 40 2 mm dithiothreitol dtt containing protease inhibitor mixture protein concentration determined bradford assay equal amount total protein loaded onto sds gels p53 ubiquitination assays using p53 transfected h1299 cells carried described previously 29 detection ubiquitinated p53 24 h post transfection h1299 cells treated proteasome inhibitor n acetyl leu leu norleucinal final concentration 50 microm 4 h prior lysis using lysis buffer hs 100 mm tris hcl ph 80 100 mm dtt containing protease inhibitor mixture half life p53 protein indicated mutants examined h1299 cells transfected 1 microg p53 dna wild type mutant p53 absence presence 1 3 microg mdm2 expression dna cells treated 133 mm protein synthesis inhibitor cycloheximide spelco 24 h post transfection harvested indicated time points results top abstract introduction experimental procedures results discussion references
0.5138107.11925449.html.plaintext.txt	20	transfection assays h1299 p53 cells saos 2 p53 cells incubated rpmi 1640 dulbeccos modified eagles medium respectively supplemented 10 fetal calf serum cells cultured 37 degrees c 5 co2 humidified atmosphere 1 x 106 h1299 cells a375 cells 45 x 106 saos 2 cells seeded 6 cm tissue culture plates transfected using lipofectamine 2000 reagent invitrogen according manufactures protocol p53 dependent transcription carried described previously 13 briefly saos 2 h1299 a375 cells harvested 24 h post transfection lysed reporter lysis buffer corresponding luciferase galactosidase assays carried according manufacturers protocol promega exact quantity dna transfected indicated experiment necessary carrier dna transfected keep amount dna consistent transfection detection protein western blot analysis 24 h post transfection cells harvested lysed nonidet p 40 lysis buffer 150 mm nacl 50 mm tris hcl ph 80 5 mm edta 1 nonidet p 40 2 mm dithiothreitol dtt containing protease inhibitor mixture protein concentration determined bradford assay equal amount total protein loaded onto sds gels p53 ubiquitination assays using p53 transfected h1299 cells carried described previously 29 detection ubiquitinated p53 24 h post transfection h1299 cells treated proteasome inhibitor n acetyl leu leu norleucinal final concentration 50 microm 4 h prior lysis using lysis buffer hs 100 mm tris hcl ph 80 100 mm dtt containing protease inhibitor mixture half life p53 protein indicated mutants examined h1299 cells transfected 1 microg p53 dna wild type mutant p53 absence presence 1 3 microg mdm2 expression dna cells treated 133 mm protein synthesis inhibitor cycloheximide spelco 24 h post transfection harvested indicated time points results top abstract introduction experimental procedures results discussion references
0.5138107.11925449.html.plaintext.txt	21	purification full length mdm2 protein human mdm2 protein contains n terminal domain binds n terminal box domain p53 c terminal sub domains interact zinc rna tumor suppressor protein p14arf 30 although mdm2 protein known bind n terminal box domain p53 recent study shown rna binding mdm2 promote mdm2 protein interaction box deletion mutant p53 protein using surface plasmon resonance 25 latter data suggest rna induces conformational change mdm2 protein via ring finger domain promotes interaction p53 outside canonical box motif current study set initially determine fact whether ligand binding c terminal domain mdm2 could change conformation whether change directs mdm2 interact previously unidentified motif within core domain p53 begin address possibility full length human mdm2 protein first purified native state bacterial expression systems following lysis using gentle perturbations maintain recombinant protein conformational integrity purification mdm2 protein developed using standard chromatographic methods best purification obtained using cation exchange chromatography mdm2 protein eluted triplet three protein bands conductivity equivalent 04 05 m kcl fig 1a lanes 1 4 immunoblotting peak fractions using distinct monoclonal antibodies confirms triplet protein bands interest mdm2 protein fig 1b lanes 1 4 known whether three protein bands stem alternative translational reading termination mdm2 transcript e coli proteolysis mdm2 protein addition mdm2 protein predicted molecular mass 55 kda yet migrates denaturing gel molecular mass greater 90 kda altered protein folding pathways utilized translation may produce isoforms migrate anomalously denaturing sds gel
0.5138107.11925449.html.plaintext.txt	22	purification full length mdm2 protein human mdm2 protein contains n terminal domain binds n terminal box domain p53 c terminal sub domains interact zinc rna tumor suppressor protein p14arf 30 although mdm2 protein known bind n terminal box domain p53 recent study shown rna binding mdm2 promote mdm2 protein interaction box deletion mutant p53 protein using surface plasmon resonance 25 latter data suggest rna induces conformational change mdm2 protein via ring finger domain promotes interaction p53 outside canonical box motif current study set initially determine fact whether ligand binding c terminal domain mdm2 could change conformation whether change directs mdm2 interact previously unidentified motif within core domain p53 begin address possibility full length human mdm2 protein first purified native state bacterial expression systems following lysis using gentle perturbations maintain recombinant protein conformational integrity purification mdm2 protein developed using standard chromatographic methods best purification obtained using cation exchange chromatography mdm2 protein eluted triplet three protein bands conductivity equivalent 04 05 m kcl fig 1a lanes 1 4 immunoblotting peak fractions using distinct monoclonal antibodies confirms triplet protein bands interest mdm2 protein fig 1b lanes 1 4 known whether three protein bands stem alternative translational reading termination mdm2 transcript e coli proteolysis mdm2 protein addition mdm2 protein predicted molecular mass 55 kda yet migrates denaturing gel molecular mass greater 90 kda altered protein folding pathways utilized translation may produce isoforms migrate anomalously denaturing sds gel
0.5138107.11925449.html.plaintext.txt	23	view larger version 31k fig 1 purification human mdm2 protein sp sepharose full length untagged human mdm2 protein purified bacterial expression system using gentle lysis technique 24 coomassie blue stained gel mdm2 protein b immunochemical blot mdm2 protein lanes 1 4 represent peak fractions containing mdm2 protein numbered 21 24 eluted sp sepharose column using linear gradient buffer 005 1 m kcl described experimental procedures arrows point three major bands elute position mdm2 protein coomassie blue stained gel immunoblot c d quantitation p53 binding activity mdm2 protein c box domain peptides derived p53 1 microg d p53 tetramers 3 ng fixed elisa wells described previously 13 26 mdm2 protein 05 24 ng protein titrated wells stabilizing buffer monoclonal antibody 2a10 open squares 4b2 black squares titrated elisa wells amount mdm2 protein bound p53 quantitated using peroxidase coupled anti mouse igg enhanced chemiluminescence data depicted luminescence relative light units rlu function mdm2 protein
0.5138107.11925449.html.plaintext.txt	24	mdm2 protein eluted monomer gel filtration data shown indicating native mdm2 protein purified bacteria large oligomeric inclusion body intermediate specific activity native fraction full length mdm2 protein tested box peptide binding assay p53 tetrameric binding assay determine whether mdm2 active purified conditions mdm2 titrated streptavidin elisa wells pre coated biotinylated box domain peptide dose dependent increase mdm2 binding observed using two different monoclonal antibodies detection system fig 1c mdm2 protein also active binding native p53 tetramers fig 1d indicating fraction monomeric mdm2 fully competent peptide protein binding assays however differences specific activity mdm2 protein toward p53 tetramers box peptide depend monoclonal antibody used detection system fig 1 d versus c latter data suggest either mab 4b2 de stabilizes p53 tetramer mdm2 protein complex mab 2a10 stabilizes p53 tetramer mdm2 protein complex
0.5138107.11925449.html.plaintext.txt	25	mdm2 protein eluted monomer gel filtration data shown indicating native mdm2 protein purified bacteria large oligomeric inclusion body intermediate specific activity native fraction full length mdm2 protein tested box peptide binding assay p53 tetrameric binding assay determine whether mdm2 active purified conditions mdm2 titrated streptavidin elisa wells pre coated biotinylated box domain peptide dose dependent increase mdm2 binding observed using two different monoclonal antibodies detection system fig 1c mdm2 protein also active binding native p53 tetramers fig 1d indicating fraction monomeric mdm2 fully competent peptide protein binding assays however differences specific activity mdm2 protein toward p53 tetramers box peptide depend monoclonal antibody used detection system fig 1 d versus c latter data suggest either mab 4b2 de stabilizes p53 tetramer mdm2 protein complex mab 2a10 stabilizes p53 tetramer mdm2 protein complex
0.5138107.11925449.html.plaintext.txt	26	rna stabilize mdm2 tetrameric p53 protein complex functional domains mdm2 protein include n terminal p53 binding site amino acids 19 102 ii n terminal p14arf binding site amino acids 212 244 iii nuclear localization signal amino acids 181 185 iv nuclear export sequence amino acids 197 205 v c terminal zinc finger vi c terminal ring finger domain vii nucleolar localization signal sequence amino acids 466 473 quantitative elisa used determine whether ligands bind c terminal domain mdm2 change stability tetrameric p53 mdm2 protein complex ligands included rna polyrg binds extreme c terminal ring finger domain zinc binds n terminal zinc binding site p14arf binds central domain mdm2
0.5138107.11925449.html.plaintext.txt	27	rna stabilize mdm2 tetrameric p53 protein complex functional domains mdm2 protein include n terminal p53 binding site amino acids 19 102 ii n terminal p14arf binding site amino acids 212 244 iii nuclear localization signal amino acids 181 185 iv nuclear export sequence amino acids 197 205 v c terminal zinc finger vi c terminal ring finger domain vii nucleolar localization signal sequence amino acids 466 473 quantitative elisa used determine whether ligands bind c terminal domain mdm2 change stability tetrameric p53 mdm2 protein complex ligands included rna polyrg binds extreme c terminal ring finger domain zinc binds n terminal zinc binding site p14arf binds central domain mdm2
0.5138107.11925449.html.plaintext.txt	28	first sequence events involved analyzing affects rna specific activity mdm2 protein included adsorption mdm2 protein onto solid phase followed incubation mdm2 protein rna ending incubation ligand free form mdm2 mdm2 rna complex native p53 rna used homopolyribonucleotide polyrg binds high affinity mdm2 protein 16 conditions dose dependent increase amount p53 bound mdm2 occurs addition 100 pg 100 ng rna fig 2a sequence events changed first capturing mdm2 protein 4b2 monoclonal antibody similar trend observed addition rna mdm2 enhanced stability p53 mdm2 protein complex fig 2b however increase amount p53 bound mdm2 increases addition 100 ng 10 microg rna resulting 1000 fold reduction sensitivity mdm2 rna mab 4b2 also less intrinsically efficient capturing p53 mdm2 protein complex mab 2a10 fig 1 4b2 capture method quantitating mdm2 p53 complex used
0.5138107.11925449.html.plaintext.txt	29	first sequence events involved analyzing affects rna specific activity mdm2 protein included adsorption mdm2 protein onto solid phase followed incubation mdm2 protein rna ending incubation ligand free form mdm2 mdm2 rna complex native p53 rna used homopolyribonucleotide polyrg binds high affinity mdm2 protein 16 conditions dose dependent increase amount p53 bound mdm2 occurs addition 100 pg 100 ng rna fig 2a sequence events changed first capturing mdm2 protein 4b2 monoclonal antibody similar trend observed addition rna mdm2 enhanced stability p53 mdm2 protein complex fig 2b however increase amount p53 bound mdm2 increases addition 100 ng 10 microg rna resulting 1000 fold reduction sensitivity mdm2 rna mab 4b2 also less intrinsically efficient capturing p53 mdm2 protein complex mab 2a10 fig 1 4b2 capture method quantitating mdm2 p53 complex used
0.5138107.11925449.html.plaintext.txt	30	view larger version 13k fig 2 rna mdm2 isoform forms stable complex p53 protein rna stabilizes mdm2 p53 complex mdm2 protein 7 ng adsorbed elisa wells increasing amounts rna 0001 10000 ng titrated reactions described previously 25 washing away unbound rna p53 protein 3 ng added reactions amount p53 bound mdm2 quantitated using peroxidase coupled anti p53 polyclonal igg cm1 enhanced chemiluminescence data depicted luminescence relative light units rlu function rna nanograms b rna stabilizes antibody captured mdm2 p53 complex mdm2 protein 7 ng captured onto elisa wells pre coated monoclonal antibody 4b2 40 ngwell increasing amounts rna 0001 10000 ng titrated reactions washing away unbound rna p53 protein 3 ng added reactions amount p53 bound mdm2 quantitated using anti p53 polyclonal igg cm1 enhanced chemiluminescence data depicted luminescence rlu function rna nanograms c rna binding p53 destabilizes mdm2 p53 complex p53 protein 3 ng adsorbed elisa wells increasing amounts rna 0001 10000 ng titrated reactions washing away unbound rna mdm2 protein 7 ng added reactions amount mdm2 bound p53 quantitated using anti mdm2 monoclonal igg 4b2 enhanced chemiluminescence data depicted luminescence rlu function rna nanograms
0.5138107.11925449.html.plaintext.txt	31	conformation p53 known change upon binding nucleic acid 31 32 control performed determine whether effects rna due changes mdm2 conformation rather p53 sequence events included adsorption p53 tetramers onto solid phase followed incubation p53 protein rna ending incubation p53 rna complex native mdm2 protein conditions decrease amount mdm2 bound p53 occurs addition 100 pg 10 ng rna fig 2c data contrast affects rna stabilizing mdm2 p53 complex fig 2 b consistent observation p53 dna complexes exhibit reduced binding mdm2 25
0.5138107.11925449.html.plaintext.txt	32	conformation p53 known change upon binding nucleic acid 31 32 control performed determine whether effects rna due changes mdm2 conformation rather p53 sequence events included adsorption p53 tetramers onto solid phase followed incubation p53 protein rna ending incubation p53 rna complex native mdm2 protein conditions decrease amount mdm2 bound p53 occurs addition 100 pg 10 ng rna fig 2c data contrast affects rna stabilizing mdm2 p53 complex fig 2 b consistent observation p53 dna complexes exhibit reduced binding mdm2 25
0.5138107.11925449.html.plaintext.txt	33	rna destabilize formation mdm2 p53 box domain complex experiments next carried determine whether stabilization mdm2 p53 complex rna involves changes interaction mdm2 protein box domain p53 andor interaction mdm2 novel site core domain p53 example rna may stabilize mdm2 p53 complex increasing affinity mdm2 protein n terminal box domain p53 specific activity mdm2 protein thus subsequently tested box peptide binding assay use small p53 derived peptide also minimizes affects regions p53 bind either rna zinc p14arf
0.5138107.11925449.html.plaintext.txt	34	rna destabilize formation mdm2 p53 box domain complex experiments next carried determine whether stabilization mdm2 p53 complex rna involves changes interaction mdm2 protein box domain p53 andor interaction mdm2 novel site core domain p53 example rna may stabilize mdm2 p53 complex increasing affinity mdm2 protein n terminal box domain p53 specific activity mdm2 protein thus subsequently tested box peptide binding assay use small p53 derived peptide also minimizes affects regions p53 bind either rna zinc p14arf
0.5138107.11925449.html.plaintext.txt	35	strikingly preincubation mdm2 protein rna reduced substantially formation mdm2 box peptide complex fig 3a addition magnesiumatp affect stability mdm2 box domain complex whereas addition either zinc p14arf also reduced stability mdm2 box domain complex fig 3a extent data indicate three distinct c terminal binding ligands mdm2 reduce stability mdm2 box peptide complex suggest ability rna mdm2 complexes bind p53 protein coincides conformational change ligand bound form mdm2 protein see data also consistent observation mdm2 rna complexes bind stably p53 tetramers lacking n terminal box domain 25 stability mdm2 p14arf complex similarly reduced enhanced preincubation mdm2 either atp rna zinc fig 3b
0.5138107.11925449.html.plaintext.txt	36	view larger version 47k fig 3 ligand binding mdm2 destabilizes mdm2 box domain complex mdm2 p53 box domain stability box domain peptides derived p53 fixed elisa wells described previously 13 26 briefly 1 microg biotinylated box domain peptides immobilized streptavidin coated 96 well plates mdm2 7 ng incubated ligands 1 microg polyrg 1 mm atps calbiochem 1 mm zinc sulfate 08 microg p14arf 1 h mixtures added box domain coated wells excess mdm2 washed away using pbs tween 20 002 vv monoclonal antibody smp14 subsequently added reactions amount mdm2 protein bound box domain quantitated using peroxidase coupled anti mouse igg enhanced chemiluminescence data depicted luminescence rlu percentage control function mdm2 isoform b mdm2 p14arf domain stability p14arf domain peptides derived n terminal domain p14arf fixed elisa wells briefly 1 microg biotinylated p14arf domain peptides immobilized streptavidin coated 96 well plates mdm2 7 ng incubated ligands 1 microg polyrg 1 mm atps calbiochem 1 mm zinc sulfate 1 h mixtures added p14arf domain coated wells excess mdm2 washed away using pbs tween 20 002 vv monoclonal antibody smp14 subsequently added reactions amount mdm2 protein bound p14arf domain quantitated using peroxidase coupled anti mouse igg enhanced chemiluminescence data depicted luminescence rlu percentage control function mdm2 isoform
0.5138107.11925449.html.plaintext.txt	37	together data indicate binding mdm2 protein ligands affect specific activity p53 binding protein fact rna simultaneously stabilize p53 mdm2 protein complex reduce stability mdm2 box domain complex internally consistent however reduced stability mdm2 box domain complex presence zinc fig 3 compensated increase stability mdm2 tetrameric p53 complex presence zinc data shown latter data suggest rna zinc induce distinct conformational changes mdm2 protein partial proteolysis used determine whether fact evidence could found difference conformation rna mdm2 protein complex zinc mdm2 protein complex first analysis designed examine proteolytic cleavage products mdm2 protein absence presence rna using trypsin fig 4a titration trypsin reactions containing mdm2 protein presence rna fig 4a lanes 6 8 gave rise different pattern proteolytic products reactions without rna fig 4a lanes 2 4 notable resistance 27 kda fragment proteolysis presence rna fig 4a lanes 7 8 versus lanes 3 4 accumulation 23 kda fragment resistant proteolysis presence rna fig 4a lane 8 versus lane 4 using protease glu c similar resistance proteolysis 53 kda fragment observed mdm2 protein incubated rna fig 4b lanes 4 5 versus lanes 2 3 finally although rna zinc reduce binding mdm2 protein box domain resistance proteolysis 52 45 kda fragment uniquely observed mdm2 protein incubated zinc fig 4b lanes 6 7 versus lanes 1 5 together data suggest ability rna stabilize mdm2 tetrameric p53 complex inhibit mdm2 box peptide complex fig 3a may due conformational change mdm2 protein distinct induced zinc
0.5138107.11925449.html.plaintext.txt	38	together data indicate binding mdm2 protein ligands affect specific activity p53 binding protein fact rna simultaneously stabilize p53 mdm2 protein complex reduce stability mdm2 box domain complex internally consistent however reduced stability mdm2 box domain complex presence zinc fig 3 compensated increase stability mdm2 tetrameric p53 complex presence zinc data shown latter data suggest rna zinc induce distinct conformational changes mdm2 protein partial proteolysis used determine whether fact evidence could found difference conformation rna mdm2 protein complex zinc mdm2 protein complex first analysis designed examine proteolytic cleavage products mdm2 protein absence presence rna using trypsin fig 4a titration trypsin reactions containing mdm2 protein presence rna fig 4a lanes 6 8 gave rise different pattern proteolytic products reactions without rna fig 4a lanes 2 4 notable resistance 27 kda fragment proteolysis presence rna fig 4a lanes 7 8 versus lanes 3 4 accumulation 23 kda fragment resistant proteolysis presence rna fig 4a lane 8 versus lane 4 using protease glu c similar resistance proteolysis 53 kda fragment observed mdm2 protein incubated rna fig 4b lanes 4 5 versus lanes 2 3 finally although rna zinc reduce binding mdm2 protein box domain resistance proteolysis 52 45 kda fragment uniquely observed mdm2 protein incubated zinc fig 4b lanes 6 7 versus lanes 1 5 together data suggest ability rna stabilize mdm2 tetrameric p53 complex inhibit mdm2 box peptide complex fig 3a may due conformational change mdm2 protein distinct induced zinc
0.5138107.11925449.html.plaintext.txt	39	view larger version 38k fig 4 rna zinc induce distinct conformational changes mdm2 protein mdm2 protein 100 ng subjected partial proteolysis 1 h 30 degrees c buffer b using increasing amounts trypsin 1 10 100 ng respectively absence rna lanes 2 4 versus lane 1 presence 1 microg rna lanes 6 8 versus lane 5 reaction products separated sds polyacrylamide gel protein immunoblotted probing using monoclonal antibody specific mdm2 protein 4b2 position mdm2 marked arrows indicate proteolytic fragments differentially accumulate presence rna b mdm2 protein 100 ng subjected partial proteolysis 1 h 30 degrees c using increasing amounts endoproteinase glu c 1 10 ng respectively absence co factor lanes 2 3 presence rna 1 microg lanes 4 5 presence zinc sulfate 1 mm lanes 6 7 reaction products separated sds polyacrylamide gel protein immunoblotted probing using monoclonal antibody specific mdm2 protein 2a10 position mdm2 marked cross hatches indicate proteolytic fragments differentially accumulate presence rna asterisk marks proteolytic fragments differentially accumulate presence zinc
0.5138107.11925449.html.plaintext.txt	40	localization secondary binding site p53 mdm2 protein difficulty predicting putative secondary docking site rna mdm2 isoform core domain p53 resulted two distinct approaches first involved using phage peptide display identify novel peptide domains bind rna mdm2 isoform determining using search engine whether domains homology site common core domain p53 second approach determine using search engine whether tumor suppressor protein prb contains atypical undefined interaction site mdm2 33 motif common core domain p53
0.5138107.11925449.html.plaintext.txt	41	localization secondary binding site p53 mdm2 protein difficulty predicting putative secondary docking site rna mdm2 isoform core domain p53 resulted two distinct approaches first involved using phage peptide display identify novel peptide domains bind rna mdm2 isoform determining using search engine whether domains homology site common core domain p53 second approach determine using search engine whether tumor suppressor protein prb contains atypical undefined interaction site mdm2 33 motif common core domain p53
0.5138107.11925449.html.plaintext.txt	42	first instance ligand free form mdm2 mdm2 rna isoform adsorbed solid phase capture using mdm2 specific monoclonal antibody subjected three rounds phage peptide display using 12 mer peptide library described previously two phospho specific monoclonal antibodies toward p53 9 28 phage peptide display versatile technique give rise high affinity peptide ligands contain homology bona fide binding proteins example phage peptide display analysis using ligand free form full length mdm2 protein yielded series peptides high homology box domain p53 fig 5a high affinity binding phage purified sequenced giving rise two distinct classes peptides first class obtained using ligand free full length mdm2 protein fig 5a homology box domain p53 residues critical mdm2 binding phe19 x x x trp23 x x leu26 18 results identical phage peptide display performed n terminal fragment mdm2 protein fused gst 34 except analysis also included thr18 residue important component mdm2 binding giving rise consensus sequence thr18 phe19 x x x trp23 x x leu26 fig 5a latter data consistent pronounced instability mdm2 p53 box domain complex containing phosphate residue thr18 26 distinct class peptides obtained using mdm2 rna isoform fig 5a protein sequence high homology snrnp u obtained peptides obtained homology box domain p53 data consistent observation rna changes conformation mdm2 fig 4 mdm2 rna complexes bind p53 lacking box domain 25 snrnp u p53 scanned similar sites homology motif significant degree homology found conserved box iv box v domains p53 fig 5b sgxllgesxf thus identifying putative rna mdm2 isoform interaction site core domain p53
0.5138107.11925449.html.plaintext.txt	43	first instance ligand free form mdm2 mdm2 rna isoform adsorbed solid phase capture using mdm2 specific monoclonal antibody subjected three rounds phage peptide display using 12 mer peptide library described previously two phospho specific monoclonal antibodies toward p53 9 28 phage peptide display versatile technique give rise high affinity peptide ligands contain homology bona fide binding proteins example phage peptide display analysis using ligand free form full length mdm2 protein yielded series peptides high homology box domain p53 fig 5a high affinity binding phage purified sequenced giving rise two distinct classes peptides first class obtained using ligand free full length mdm2 protein fig 5a homology box domain p53 residues critical mdm2 binding phe19 x x x trp23 x x leu26 18 results identical phage peptide display performed n terminal fragment mdm2 protein fused gst 34 except analysis also included thr18 residue important component mdm2 binding giving rise consensus sequence thr18 phe19 x x x trp23 x x leu26 fig 5a latter data consistent pronounced instability mdm2 p53 box domain complex containing phosphate residue thr18 26 distinct class peptides obtained using mdm2 rna isoform fig 5a protein sequence high homology snrnp u obtained peptides obtained homology box domain p53 data consistent observation rna changes conformation mdm2 fig 4 mdm2 rna complexes bind p53 lacking box domain 25 snrnp u p53 scanned similar sites homology motif significant degree homology found conserved box iv box v domains p53 fig 5b sgxllgesxf thus identifying putative rna mdm2 isoform interaction site core domain p53
0.5138107.11925449.html.plaintext.txt	44	view larger version 32k fig 5 phage peptide display identifies novel rna responsive mdm2 binding motif phage peptide consensus sequences bind ligand free mdm2 rna bound mdm2 mdm2 protein mdm2 rna complexes coated onto elisa wells indicated fig 2 subjected phage peptide display using 12 mer peptide library described previously 9 28 briefly native mdm2 protein sp sepharose fraction fig 1 rna mdm2 isoform captured onto elisa wells anti mdm2 monoclonal antibody described fig 2 legend following incubation naive phage peptide library elution phage acid propagation eluted phage three rounds amplification carried acquire phage bind high affinity indicated isoform mdm2 peptide inserts phage tested specificity sequenced determine insert peptide sequence ligand free form mdm2 protein gave rise general consensus derived box domain p53 indicated whereas rna mdm2 isoform gave rise consensus sequence matched closely snrnp u indicated b putative consensus site rna responsive mdm2 binding site c terminal domain tumor suppressor protein prb binds mdm2 protein undefined site 33 region prb entire coding region snrnp u screened using e motif search engine domains homology p53 protein motif central domain p53 conserved box iv box v domain amino acids 261 270 found significant homology prb snrnp u wee1 give rise general consensus site sgxllgesxf
0.5138107.11925449.html.plaintext.txt	45	independent approach c terminal domain prb scanned putative homology motifs within central coding region p53 region prb non canonical undefined mdm2 docking site 33 striking degree primary amino acid homology observed p53 snrnp u prb p53 motif residing conserved box iv box v domains fig 5b subsequent scan polypeptides protein data base consensus motif identified series signaling proteins including wee1 mcm5 data shown producing consensus site sgxllgesxf fig 5b within p53 sgxllgesxf motif links s9 s10 strands crystal structure p53 dna complex 3 intriguingly defined 12 monoclonal antibody epitope 35 classic reversible unfoldingfolding p53 tetramer defined changes exposure cryptic epitopes monoclonal antibodies 11 pab240 12 reside amino acid ranges 210 215 224 231 255 270 respectively 5 35 defined crystal structure p53 dna complex 3 cryptic epitopes buried actually reside constrained surface p53 protein interesting p53 rna complexes p53 dna complexes reduced binding full length mdm2 protein fig 2c 25 p53 protein complexed dna reduced binding conformationally responsive monoclonal antibodies including 12 pab240 fig 6a occlusion presumably due fact dna binding p53 constrains exposed 12 loop conformation incompatible binding monoclonal antibody 12 mdm2
0.5138107.11925449.html.plaintext.txt	46	independent approach c terminal domain prb scanned putative homology motifs within central coding region p53 region prb non canonical undefined mdm2 docking site 33 striking degree primary amino acid homology observed p53 snrnp u prb p53 motif residing conserved box iv box v domains fig 5b subsequent scan polypeptides protein data base consensus motif identified series signaling proteins including wee1 mcm5 data shown producing consensus site sgxllgesxf fig 5b within p53 sgxllgesxf motif links s9 s10 strands crystal structure p53 dna complex 3 intriguingly defined 12 monoclonal antibody epitope 35 classic reversible unfoldingfolding p53 tetramer defined changes exposure cryptic epitopes monoclonal antibodies 11 pab240 12 reside amino acid ranges 210 215 224 231 255 270 respectively 5 35 defined crystal structure p53 dna complex 3 cryptic epitopes buried actually reside constrained surface p53 protein interesting p53 rna complexes p53 dna complexes reduced binding full length mdm2 protein fig 2c 25 p53 protein complexed dna reduced binding conformationally responsive monoclonal antibodies including 12 pab240 fig 6a occlusion presumably due fact dna binding p53 constrains exposed 12 loop conformation incompatible binding monoclonal antibody 12 mdm2
0.5138107.11925449.html.plaintext.txt	47	view larger version 24k fig 6 identification rna mdm2 binding site central domain p53 p53 dna complexes destabilize epitopes conformationally sensitive monoclonal antibodies control monoclonal antibodies 1 pab421 conformationally sensitive monoclonal antibodies bind distinct epitopes core domain 12 pab240 absorbed onto elisa wells indicated p53 forms added elisa wells p53 white p53 dna complexes black p53r175h protein dark gray p53r175h dna complexes light gray amount p53 captured indicated antibodies quantitated using peroxidase coupled anti p53 polyclonal igg cm1 tetramethylbenzidine kirkegaard perry laboratories data depicted absorbance function monoclonal antibody used capture p53 b ligand binding mdm2 changes binding affinity distinct domains p53 box domain peptides right three panels s9 s10 linker peptide contained within 12 epitope peptide left three panels derived p53 titrated fixed elisa wells described experimental procedures increasing amounts peptide preincubated mdm2 bound indicated ligand addition rna zinc added elisa wells stabilizing buffer monoclonal antibody 2a10 subsequently added reactions amount mdm2 protein bound box domain s9 s10 linker peptide domain quantitated using peroxidase coupled anti mouse igg enhanced chemiluminescence data depicted luminescence rlu function mdm2 isoform c consensus rna mdm2 binding site located conformationally constrained loop amino acids 261 264 indicated joins s10 sheet region indicated black loop sheet region also contains epitope monoclonal antibody 12 represents conformationally flexible region central domain p53 3 35
0.5138107.11925449.html.plaintext.txt	48	final prediction studies would ligand free mdm2 protein would bind better box domain display little affinity 12 epitope peptide s9 s10 linker peptide containing sequence sgnllgrnsf contrast rna mdm2 complex would predicted switch specificity box domain bind higher affinity s9 s10 linker peptide containing sgnllgrnsf polypeptide sequence change specificity observed experimentally mdm2 rna complex displaying significant affinity 12 epitope peptide fig 6b specific activity rna mdm2 complex s9 s10 linker peptide 34 fold lower ligand free form mdm2 protein box domain peptide fig 6b although zinc reduced stability mdm2 box domain complex fig 3 changed conformation mdm2 protein fig 4 ion affect stimulating mdm2 s9 s10 linker peptide complex fig 6b consistent fact zinc rna induce conformational change mdm2 protein fig 4
0.5138107.11925449.html.plaintext.txt	49	final prediction studies would ligand free mdm2 protein would bind better box domain display little affinity 12 epitope peptide s9 s10 linker peptide containing sequence sgnllgrnsf contrast rna mdm2 complex would predicted switch specificity box domain bind higher affinity s9 s10 linker peptide containing sgnllgrnsf polypeptide sequence change specificity observed experimentally mdm2 rna complex displaying significant affinity 12 epitope peptide fig 6b specific activity rna mdm2 complex s9 s10 linker peptide 34 fold lower ligand free form mdm2 protein box domain peptide fig 6b although zinc reduced stability mdm2 box domain complex fig 3 changed conformation mdm2 protein fig 4 ion affect stimulating mdm2 s9 s10 linker peptide complex fig 6b consistent fact zinc rna induce conformational change mdm2 protein fig 4
0.5138107.11925449.html.plaintext.txt	50	s9 s10 linker mutants p53s261a p53l264a exhibit increased steady state levels mdm2 dependent ubiquitination subtle mutation full length p53 within consensus site sgnllgrnsf performed determine whether single amino acid change full length p53 altered mdm2 dependent ubiquitination sgnllgrnsf motif divided two regions 1 sgxl motif contained loop bridges s9 s10 sheets fig 6c 2 gesxf motif contained within s10 sheet fig 6c marked deletion multiple mutation linker region s10 sheet performed may unfold entire subdomain reduce mdm2 binding global defects core domain structure particular three missense mutants constructed two amino acids fit consensus p53 snrnp u prb s9 s10 linker loop ser261 leu264 remaining one invariant amino acid sgnllgrnsf consensus motif extends s10 sheet phe270 mutating amino acids surface loop may inactivate p53 fact mutation phe270 impair p53 activity see two surface loop mutants alanine substitutions ser261 leu264 first constructed presumably little affect internal structure activity p53 alanine substitutions generally thought subtle charged aromatic residues however even single alanine substitutions reactive motif either reduce stimulate protein protein interaction 58
0.5138107.11925449.html.plaintext.txt	51	s9 s10 linker mutants p53s261a p53l264a exhibit increased steady state levels mdm2 dependent ubiquitination subtle mutation full length p53 within consensus site sgnllgrnsf performed determine whether single amino acid change full length p53 altered mdm2 dependent ubiquitination sgnllgrnsf motif divided two regions 1 sgxl motif contained loop bridges s9 s10 sheets fig 6c 2 gesxf motif contained within s10 sheet fig 6c marked deletion multiple mutation linker region s10 sheet performed may unfold entire subdomain reduce mdm2 binding global defects core domain structure particular three missense mutants constructed two amino acids fit consensus p53 snrnp u prb s9 s10 linker loop ser261 leu264 remaining one invariant amino acid sgnllgrnsf consensus motif extends s10 sheet phe270 mutating amino acids surface loop may inactivate p53 fact mutation phe270 impair p53 activity see two surface loop mutants alanine substitutions ser261 leu264 first constructed presumably little affect internal structure activity p53 alanine substitutions generally thought subtle charged aromatic residues however even single alanine substitutions reactive motif either reduce stimulate protein protein interaction 58
0.5138107.11925449.html.plaintext.txt	52	activities p53s261a p53l264a mutant proteins first tested transfection p53 null cell line commonly used study properties p53 saos 2 s9 s10 linker mutant proteins displayed similar activity compared wild type p53 co transfection p21 luciferase reporter constructs saos 2 cells fig 7a mutants displayed significantly higher activity bax luciferase reporter fig 7b increased activity mutant p53 proteins attributed changes half life wild type p53 mutant p53 proteins similar reduction half life transfection mdm2 data shown see fig 13 rather significant increase mdm2 mediated ubiquitination mutant forms p53 fig 8 lanes 5 6 versus lanes 1 4 marginal increase ubiquitination p53l264a absence transfected mdm2 protein fig 9 lanes 4 8 12 versus lanes 2 6 10 p53 ubiquitination uncoupled degradation thus precedent situations increases p53 protein ubiquitination correlates increases activity notable physiological situations endogenous p53 protein examined uv irradiated cells promotes reduction ubiquitination p53 upon activation whereas x irradiation promotes p53 ubiquitination increases coincident activation transcription factor 46
0.5138107.11925449.html.plaintext.txt	53	activities p53s261a p53l264a mutant proteins first tested transfection p53 null cell line commonly used study properties p53 saos 2 s9 s10 linker mutant proteins displayed similar activity compared wild type p53 co transfection p21 luciferase reporter constructs saos 2 cells fig 7a mutants displayed significantly higher activity bax luciferase reporter fig 7b increased activity mutant p53 proteins attributed changes half life wild type p53 mutant p53 proteins similar reduction half life transfection mdm2 data shown see fig 13 rather significant increase mdm2 mediated ubiquitination mutant forms p53 fig 8 lanes 5 6 versus lanes 1 4 marginal increase ubiquitination p53l264a absence transfected mdm2 protein fig 9 lanes 4 8 12 versus lanes 2 6 10 p53 ubiquitination uncoupled degradation thus precedent situations increases p53 protein ubiquitination correlates increases activity notable physiological situations endogenous p53 protein examined uv irradiated cells promotes reduction ubiquitination p53 upon activation whereas x irradiation promotes p53 ubiquitination increases coincident activation transcription factor 46
0.5138107.11925449.html.plaintext.txt	54	view larger version 38k fig 7 s9 s10 linker mutants encoded p53s261a p53l264a alleles active sequence specific transcription factors expression vectors encoding wild type p53 p53s261a p53l264a 1 2 5 microg dna indicated co transfected saos 2 cells p21 luciferase galactosidase reporter dnas b bax luciferase galactosidase reporter dnas activity p53 expressed ratio chemiluminescence reporter vector internal galactosidase control vector
0.5138107.11925449.html.plaintext.txt	55	view larger version 33k fig 8 s9 s10 linker mutants encoded p53s261a p53l264a alleles exhibit increases mdm2 dependent ubiquitination expression vectors encoding wild type p53 p53s261a p53l264a alleles indicated 1 microg dna either without mdm2 left lanes 1 3 mdm2 encoding vector left lanes 4 6 transfected h1299 cells cell lysates immunoblotted examine changes amount ubiquitination products immunoblotting antibodies p53 1 described previously 29 ladder protein bands full length p53 position pronounced two linker mutants
0.5138107.11925449.html.plaintext.txt	56	view larger version 93k fig 9 s10 sheet mutant encoded p53f270a allele hyper ubiquitinated absence transfected mdm2 expression vectors encoding wild type p53 p53s261a p53l264a p53f270a alleles 05 1 2 microg dna indicated transfected h1299 cells expressed proteins examined changes steady state levels p53 amount ubiquitination products immunoblotting antibodies p53 top panel ladder protein bands full length p53 position striking p53f270a allele lesser extent p53l264a allele amount endogenous mdm2 protein induced middle panel endogenous p21 protein produced bottom panel indicated p53 transfections shown using indicated antibodies mdm2 p21 respectively
0.5138107.11925449.html.plaintext.txt	57	s10 sheet mutant p53f270a exhibits mdm2 dependent hyper ubiquitination vivo differential modification p53s261a p53l264a mutant proteins suggested alanine substitution s9 s10 linker loop increases mdm2 binding affinity internal motif vivo remaining mutant p53f270a c terminal end consensus sequence sgxllgesxf also examined changes ubiquitination wild type mutant forms p53 transfected cell line ubiquitination intermediates easily identified addition proteasome inhibitors h1299 cells wild type p53 p53s261a p53l264a mutant genes transfected h1299 cells 05 1 2 microg dna induced accumulation endogenous mdm2 p21 proteins fig 9 middle panel bottom panel indicating p53s261a p53l264a proteins biochemically active endogenous well transfected promoter templates fig 7 additionally although ubiquitination wild type p53 p53s261a p53l264a proteins pronounced co transfection mdm2 gene fig 8 p53l264a protein exhibited slightly increases levels ubiquitination absence transfected mdm2 fig 9 lanes 4 8 12 versus lanes 2 6 10 strikingly p53f270a mutant protein hyper ubiquitinated transfection h1299 cells using 05 1 2 microg dna fig 9 top panel lanes 5 9 13 due hyper induction endogenous mdm2 protein p53f270a mutant protein relatively inactive transcription factor p21 promoter fig 10 endogenous mdm2 p21 promoters fig 9 middle panel bottom panel lanes 5 9 13 versus lanes 2 6 10
0.5138107.11925449.html.plaintext.txt	58	s10 sheet mutant p53f270a exhibits mdm2 dependent hyper ubiquitination vivo differential modification p53s261a p53l264a mutant proteins suggested alanine substitution s9 s10 linker loop increases mdm2 binding affinity internal motif vivo remaining mutant p53f270a c terminal end consensus sequence sgxllgesxf also examined changes ubiquitination wild type mutant forms p53 transfected cell line ubiquitination intermediates easily identified addition proteasome inhibitors h1299 cells wild type p53 p53s261a p53l264a mutant genes transfected h1299 cells 05 1 2 microg dna induced accumulation endogenous mdm2 p21 proteins fig 9 middle panel bottom panel indicating p53s261a p53l264a proteins biochemically active endogenous well transfected promoter templates fig 7 additionally although ubiquitination wild type p53 p53s261a p53l264a proteins pronounced co transfection mdm2 gene fig 8 p53l264a protein exhibited slightly increases levels ubiquitination absence transfected mdm2 fig 9 lanes 4 8 12 versus lanes 2 6 10 strikingly p53f270a mutant protein hyper ubiquitinated transfection h1299 cells using 05 1 2 microg dna fig 9 top panel lanes 5 9 13 due hyper induction endogenous mdm2 protein p53f270a mutant protein relatively inactive transcription factor p21 promoter fig 10 endogenous mdm2 p21 promoters fig 9 middle panel bottom panel lanes 5 9 13 versus lanes 2 6 10
0.5138107.11925449.html.plaintext.txt	59	view larger version 34k fig 10 s10 sheet mutant encoded p53f270a allele inactive p53 dependent transactivation assay expression vectors encoding wild type p53 p53s261a p53l264a p53f270a p53r175h 1 2 5 microg dna indicated co transfected a375 cells p21 luciferase galactosidase reporter dnas activity p53 expressed ratio chemiluminescence reporter vector internal galactosidase control vector
0.5138107.11925449.html.plaintext.txt	60	summary characterization three mutant proteins vivo alanine substitutions central mdm2 interaction site revealed differing degrees enhancement ubiquitination although alanine substitution common change made protein bring reduction stability protein protein interaction instances stabilization protein docking site alanine mutation occurs 58 63 data suggest protein protein interactions evolved maintain lower affinity allowing reversibility binding binding affinity improved artificially improvement reported mdm2 p53 box complex mutation led improvement mdm2 peptide binding affinity many orders magnitude 22 34
0.5138107.11925449.html.plaintext.txt	61	summary characterization three mutant proteins vivo alanine substitutions central mdm2 interaction site revealed differing degrees enhancement ubiquitination although alanine substitution common change made protein bring reduction stability protein protein interaction instances stabilization protein docking site alanine mutation occurs 58 63 data suggest protein protein interactions evolved maintain lower affinity allowing reversibility binding binding affinity improved artificially improvement reported mdm2 p53 box complex mutation led improvement mdm2 peptide binding affinity many orders magnitude 22 34
0.5138107.11925449.html.plaintext.txt	62	subsequently investigated whether hyper ubiquitination p53f270a mutant protein mdm2 depenent vivo examining levels ubiquitination using p53f19af270a double mutant fig 11 hyper ubiquitination p53f270a protein fig 11a lane 1 prevented additional ala19 substitution fig 11a lane 2 furthermore p53f19af270a protein ubiquitinated co transfection mdm2 fig 11a lanes 4 6 conditions p53f270a mutant protein showed increases ubiquitination pattern fig 11a lanes 3 5 mdm2 protein levels similar transfection p53f270a mutant protein p53f19af270a double mutant protein fig 11b indicating changes mdm2 protein levels explain increases p53f270a mutant protein ubiquitination interesting therefore wild type p53 requires transfected mdm2 catalyze ubiquitination whereas p53f270a protein rely small levels endogenous mdm2 ubiquitination
0.5138107.11925449.html.plaintext.txt	63	view larger version 58k fig 11 hyper ubiquitination mutant encoded inactive p53f270a allele mdm2 dependent expression vectors encoding either p53f270a allele lanes 1 3 5 p53f19af270a double mutant allele lanes 2 4 6 without mdm2 lanes 1 2 increasing mdm2 expression vector lanes 3 6 transfected h1299 cells expressed proteins examined changes ubiquitination products immunoblotting antibodies p53 ladder protein bands full length p53 position striking p53f270a allele b amount endogenous mdm2 protein induced lanes 1 2 transfected mdm2 levels lanes 3 6 indicated p53 transfections shown using antibody mdm2
0.5138107.11925449.html.plaintext.txt	64	next examined whether hyper ubiquitination p53f270a mutant protein due increases mdm2 binding affinity mutant whether half life hyper ubiquitinated p53f270a protein mdm2 dependent first various p53 mutants synthesized reticulocyte lysates fig 12 determine whether mdm2 protein sp fraction fig 1 binds higher affinity due alanine substituted mutant p53 p53f270a mutant protein formed stable complex mdm2 protein mutants tested fig 12a lane 5 versus lanes 2 4 relatively difficult form native protein protein complex vitro wild type p53 protein synthesized crude reticulocyte lysates bacterially expressed mdm2 fig 12a lane 2 significant mdm2 p53f270a mutant protein complex detected mdm2 binds high affinity 28 rrna 55 present reticulocyte lysates lysate treated p53 protein synthesis rnase destabilized mdm2 p53f270a mutant protein complex fig 12b lane 5 versus fig 12a lane 5 mdm2 p53f270a mutant protein complex appeared mdm2 dependent double mutant protein p53f19af270a bound mdm2 fig 12a lane 6 versus lane 5 thus enhanced ubiquitination p53f270a mutant protein cells may explained stable interaction mdm2 rna complex
0.5138107.11925449.html.plaintext.txt	65	next examined whether hyper ubiquitination p53f270a mutant protein due increases mdm2 binding affinity mutant whether half life hyper ubiquitinated p53f270a protein mdm2 dependent first various p53 mutants synthesized reticulocyte lysates fig 12 determine whether mdm2 protein sp fraction fig 1 binds higher affinity due alanine substituted mutant p53 p53f270a mutant protein formed stable complex mdm2 protein mutants tested fig 12a lane 5 versus lanes 2 4 relatively difficult form native protein protein complex vitro wild type p53 protein synthesized crude reticulocyte lysates bacterially expressed mdm2 fig 12a lane 2 significant mdm2 p53f270a mutant protein complex detected mdm2 binds high affinity 28 rrna 55 present reticulocyte lysates lysate treated p53 protein synthesis rnase destabilized mdm2 p53f270a mutant protein complex fig 12b lane 5 versus fig 12a lane 5 mdm2 p53f270a mutant protein complex appeared mdm2 dependent double mutant protein p53f19af270a bound mdm2 fig 12a lane 6 versus lane 5 thus enhanced ubiquitination p53f270a mutant protein cells may explained stable interaction mdm2 rna complex
0.5138107.11925449.html.plaintext.txt	66	view larger version 55k fig 12 mutant encoded p53f270a allele binds mdm2 better wild type p53 protein rna dependent manner indicated p53 alleles lane 1 vector lane 2 wt p53 lane 3 p53s261a lane 4 p53l264a lane 5 p53f270a lane 6 p53f19af270a lane 7 p53r175h added reticulocyte transcription translation reactions left untreated b treated rnase crude lysates incubated bacterially expressed mdm2 protein see fig 1 1 h p53 protein immunoprecipitated pab421 immunoprecipitates immunoblotted probed presence mdm2 protein arrow marks position mdm2 protein bound preferentially p53f270a lane 5
0.5138107.11925449.html.plaintext.txt	67	half lives 1 p53f270a mutant protein 2 p53f19af270a double mutant protein 3 wild type p53 protein 4 endogenous mdm2 protein 5 transfected mdm2 protein examined determine whether degradation rate hyper ubiquitinated p53f270a mutant protein mdm2 dependent whether differed wild type p53 fig 13 following transfection wild type p53 fig 13a lanes 1 7 wild type p53 mdm2 fig 13a lanes 8 14 p53f270a fig 13b lanes 1 7 p53f270a mdm2 fig 13b lanes 8 14 p53f19af270a fig 13c lanes 1 7 p53f19af270a mdm2 fig 13c lanes 8 14 cycloheximide added times indicated 30 min 8 h fig 13 lane 2 7 9 14 membranes blotted either anti p53 monoclonal antibody 1 anti mdm2 monoclonal antibody 2a10 steady state levels p53 protein fig 13 c mdm2 protein fig 13 d f examined
0.5138107.11925449.html.plaintext.txt	68	view larger version 54k fig 13 half life hyper ubiquitinated mutant encoded p53f270a allele controlled differently either endogenous transfected mdm2 expression vectors encoding d lanes 1 7 wild type p53 b e lanes 1 7 p53f270a allele c f lanes 1 7 p53f19af270a double mutant allele transfected h1299 cells 24 h post transfection cycloheximide added indicated times prior cell harvesting lane 1 cycloheximide lane 2 30 min lane 3 1 h lane 4 2 h lane 5 4 h lane 6 6 h lane 7 8 h expressed proteins examined changes steady state levels p53 mdm2 amount ubiquitination products immunoblotting antibodies p53 c lanes 1 7 mdm2 d f lanes 1 7 examine effects transfected mdm2 protein ubiquitinated p53 protein half life expression vectors encoding wild type p53 mdm2 d lanes 8 14 p53f270a allele mdm2 b e lanes 8 14 p53f19af270a double mutant allele mdm2 c f lanes 8 14 transfected h1299 cells 24 h post transfection cycloheximide added indicated times prior cell harvesting lane 8 cycloheximide lane 9 30 min lane 10 1 h lane 11 2 h lane 12 4 h lane 13 6 h lane 14 8 h expressed proteins examined changes steady state levels p53 mdm2 amount ubiquitination products immunoblotting antibodies p53 c lanes 8 14 mdm2 d f lanes 8 14 panels b c asterisk identifies ubiquitinated p53 short half life mdm2 transfected cells upon addition cycloheximide arrows point full length un ubiquitinated stable p53 protein
0.5138107.11925449.html.plaintext.txt	69	three major points discussed first transfection wild type p53 fig 13a induces endogenous mdm2 protein accumulation fig 13d lane 1 addition cycloheximide results rapid degradation endogenous mdm2 fig 13d lanes 2 4 versus lane 1 endogenous mdm2 protein appears incapable promoting ubiquitination transfected wild type p53 protein transfected mdm2 results ubiquitination wild type p53 fig 13a lane 8 versus lane 1 addition cycloheximide results degradation ubiquitinated p53 fig 13a lanes 9 14 mirrors degradation transfected mdm2 fig 13d lanes 9 14 non ubiquitinated p53 protein apparently degraded conditions fig 13a lanes 9 14 consistent fact ubiquitination required target po53 degradation thus mdm2 dependent ubiquitination p53 transfected mdm2 gene rate limiting dependent upon half life mdm2
0.5138107.11925449.html.plaintext.txt	70	three major points discussed first transfection wild type p53 fig 13a induces endogenous mdm2 protein accumulation fig 13d lane 1 addition cycloheximide results rapid degradation endogenous mdm2 fig 13d lanes 2 4 versus lane 1 endogenous mdm2 protein appears incapable promoting ubiquitination transfected wild type p53 protein transfected mdm2 results ubiquitination wild type p53 fig 13a lane 8 versus lane 1 addition cycloheximide results degradation ubiquitinated p53 fig 13a lanes 9 14 mirrors degradation transfected mdm2 fig 13d lanes 9 14 non ubiquitinated p53 protein apparently degraded conditions fig 13a lanes 9 14 consistent fact ubiquitination required target po53 degradation thus mdm2 dependent ubiquitination p53 transfected mdm2 gene rate limiting dependent upon half life mdm2
0.5138107.11925449.html.plaintext.txt	71	second transfection p53f270a mutant protein resulting hyper ubiquitination fig 13b lane 1 marginally induces endogenous mdm2 protein accumulation fig 13e lane 1 consistent lower specific activity reporter assays fig 10 however addition cycloheximide result rapid degradation hyper ubiquitinated p53f270a mutant protein fig 13b lanes 2 7 conditions endogenous mdm2 degraded fig 13e lanes 2 4 contrast co transfection mdm2 p53f270a mutant switched ubiquitination pattern p53f270a mutant protein fig 13b lane 8 versus lane 1 addition cycloheximide resulted degradation ubiquitinated p53f270a mutant protein fig 13b lanes 9 14 mirrored degradation transfected mdm2 protein fig 13e lanes 8 14 additionally high molecular species p53f270a actually increase presence cycloheximide fig 13b lanes 2 7 versus lane 1 absent transfection mdm2 fig 13b lanes 9 14 data indicate ubiquitination p53f270a mutant protein carried distinct mechanism presence transfected endogenous mdm2 consistent use tagged ubiquitin transfection assay yield hyper ubiquitination p53f270a mutant protein data shown suggesting endogenous pools ubiquitin specifically recruited onto p53f270a mutant protein
0.5138107.11925449.html.plaintext.txt	72	second transfection p53f270a mutant protein resulting hyper ubiquitination fig 13b lane 1 marginally induces endogenous mdm2 protein accumulation fig 13e lane 1 consistent lower specific activity reporter assays fig 10 however addition cycloheximide result rapid degradation hyper ubiquitinated p53f270a mutant protein fig 13b lanes 2 7 conditions endogenous mdm2 degraded fig 13e lanes 2 4 contrast co transfection mdm2 p53f270a mutant switched ubiquitination pattern p53f270a mutant protein fig 13b lane 8 versus lane 1 addition cycloheximide resulted degradation ubiquitinated p53f270a mutant protein fig 13b lanes 9 14 mirrored degradation transfected mdm2 protein fig 13e lanes 8 14 additionally high molecular species p53f270a actually increase presence cycloheximide fig 13b lanes 2 7 versus lane 1 absent transfection mdm2 fig 13b lanes 9 14 data indicate ubiquitination p53f270a mutant protein carried distinct mechanism presence transfected endogenous mdm2 consistent use tagged ubiquitin transfection assay yield hyper ubiquitination p53f270a mutant protein data shown suggesting endogenous pools ubiquitin specifically recruited onto p53f270a mutant protein
0.5138107.11925449.html.plaintext.txt	73	lastly despite fact ubiquitinated p53f270a mutant protein relatively long half life fig 13b lanes 2 7 conditions mdm2 transfected reaction appears mdm2 dependent addition ala19 mutation p53f270a mutant protein prevents hyper ubiquitination fig 13c lanes 1 7 fig 11 furthermore addition cycloheximide alter immunoreactive p53f19af270a double mutant protein bands remain fig 13c lanes 2 7 versus lane 1 mdm2 promote ubiquitination p53f19af270a double mutant protein fig 13c lanes 8 14 conditions transfected mdm2 half life transfections fig 13f lanes 8 14 versus fig 13 d e lanes 8 14 together data indicate hyper ubiquitination p53f270a mutant protein mdm2 dependent half life ubiquitinated p53f270a mutant protein different depending upon whether endogenous exogenous mdm2 present data point novel assay dissect physiologically relevant regulatory steps affect rate rate p53 ubiquitination mdm2 discussion top abstract introduction experimental procedures results discussion references
0.5138107.11925449.html.plaintext.txt	74	lastly despite fact ubiquitinated p53f270a mutant protein relatively long half life fig 13b lanes 2 7 conditions mdm2 transfected reaction appears mdm2 dependent addition ala19 mutation p53f270a mutant protein prevents hyper ubiquitination fig 13c lanes 1 7 fig 11 furthermore addition cycloheximide alter immunoreactive p53f19af270a double mutant protein bands remain fig 13c lanes 2 7 versus lane 1 mdm2 promote ubiquitination p53f19af270a double mutant protein fig 13c lanes 8 14 conditions transfected mdm2 half life transfections fig 13f lanes 8 14 versus fig 13 d e lanes 8 14 together data indicate hyper ubiquitination p53f270a mutant protein mdm2 dependent half life ubiquitinated p53f270a mutant protein different depending upon whether endogenous exogenous mdm2 present data point novel assay dissect physiologically relevant regulatory steps affect rate rate p53 ubiquitination mdm2 discussion top abstract introduction experimental procedures results discussion references
0.5138107.11925449.html.plaintext.txt	75	p53 protein conformationally dynamic allosterically regulated homo tetramer multiple binding sites regulatory protein co factors p53 protein forms basis model oligomeric protein give insights basic mechanisms protein self assembly protein kinase function transcription polyubiquitination mechanisms p53 protein contains independent sub domains direct sequence specific dna binding nonspecific dna binding mdm2 p300 binding protein kinase binding homo tetramerization domain linked full length protein intradomain allosteric regulation p53 dependent activity observed example polyproline domain n terminus p53 negatively regulates mdm2 protein binding 29 whereas c n terminal domains p53 regulate allosterically sequence specific dna binding 8 37 40
0.5138107.11925449.html.plaintext.txt	76	p53 protein conformationally dynamic allosterically regulated homo tetramer multiple binding sites regulatory protein co factors p53 protein forms basis model oligomeric protein give insights basic mechanisms protein self assembly protein kinase function transcription polyubiquitination mechanisms p53 protein contains independent sub domains direct sequence specific dna binding nonspecific dna binding mdm2 p300 binding protein kinase binding homo tetramerization domain linked full length protein intradomain allosteric regulation p53 dependent activity observed example polyproline domain n terminus p53 negatively regulates mdm2 protein binding 29 whereas c n terminal domains p53 regulate allosterically sequence specific dna binding 8 37 40
0.5138107.11925449.html.plaintext.txt	77	mdm2 protein negatively regulates tumor suppressor activity p53 variety overlapping mechanisms binding mdm2 n terminal transactivation domain p53 block p53 dependent transcription steric mechanisms 41 42 mdm2 protein also normally promotes polyubiquitination p53 43 44 mechanism mdm2 modulate steady state levels p53 protein example conditions ubiquitination associated rapid degradation p53 45 however polyubiquitination endogenous p53 also increases certain types dna damage normal human fibroblasts indicating ubiquitin modification always trigger immediate turnover p53 46 nevertheless control p53s degradation involve cytoplasmic transport p53 protein mdm2 p53 degraded proteasome pathway contrast inhibitory affects mdm2 p53 protein levels mdm2 protein stimulate tafii250 dependent expression cyclin promoter indicating mdm2 protein binding distinct affects different pathways 47 48 mdm2 modulate e2f dependent activity 64
0.5138107.11925449.html.plaintext.txt	78	mdm2 protein negatively regulates tumor suppressor activity p53 variety overlapping mechanisms binding mdm2 n terminal transactivation domain p53 block p53 dependent transcription steric mechanisms 41 42 mdm2 protein also normally promotes polyubiquitination p53 43 44 mechanism mdm2 modulate steady state levels p53 protein example conditions ubiquitination associated rapid degradation p53 45 however polyubiquitination endogenous p53 also increases certain types dna damage normal human fibroblasts indicating ubiquitin modification always trigger immediate turnover p53 46 nevertheless control p53s degradation involve cytoplasmic transport p53 protein mdm2 p53 degraded proteasome pathway contrast inhibitory affects mdm2 p53 protein levels mdm2 protein stimulate tafii250 dependent expression cyclin promoter indicating mdm2 protein binding distinct affects different pathways 47 48 mdm2 modulate e2f dependent activity 64
0.5138107.11925449.html.plaintext.txt	79	regulation mdm2 p53 polypeptide function facilitated historically first dissecting proteins individual functional domains mdm2 protein contains several independent subdomains either bind n terminal box domain p53 n terminus tumor suppressor p14arf zinc rna current study addresses intradomain allosteric regulation full length mdm2 protein evidence ligand binding mdm2 protein switches affinity andor specificity box domain p53 conformationally responsive loop flanked box iv box v domains three pieces biochemical data suggested previously mdm2 protein interface tetrameric forms p53 involves determinants outside primary n terminal box domain p53 first observation mdm2 bind mutant forms p53 altered core domain conformation 25 49 second observation full length mdm2 protein bind p53 dna complexes vitro whereas truncated n terminal domain mdm2 bind stably p53 dna complexes 18 25 final observation mdm2 rna complexes bind p53 protein lacking n terminal box domain 25 determinants within p53 tetramer modulate mdm2 protein binding box domain stabilize mdm2 protein binding sites outside box domain undefined prior studies described report
0.5138107.11925449.html.plaintext.txt	80	regulation mdm2 p53 polypeptide function facilitated historically first dissecting proteins individual functional domains mdm2 protein contains several independent subdomains either bind n terminal box domain p53 n terminus tumor suppressor p14arf zinc rna current study addresses intradomain allosteric regulation full length mdm2 protein evidence ligand binding mdm2 protein switches affinity andor specificity box domain p53 conformationally responsive loop flanked box iv box v domains three pieces biochemical data suggested previously mdm2 protein interface tetrameric forms p53 involves determinants outside primary n terminal box domain p53 first observation mdm2 bind mutant forms p53 altered core domain conformation 25 49 second observation full length mdm2 protein bind p53 dna complexes vitro whereas truncated n terminal domain mdm2 bind stably p53 dna complexes 18 25 final observation mdm2 rna complexes bind p53 protein lacking n terminal box domain 25 determinants within p53 tetramer modulate mdm2 protein binding box domain stabilize mdm2 protein binding sites outside box domain undefined prior studies described report
0.5138107.11925449.html.plaintext.txt	81	first protein shown bind p53 sv40 antigen 50 51 although details structure complex lacking interaction results inactivation p53 function binding occurs within central domain p53 tetramer point mutations unfold p53 tetramer destabilize p53 antigen complex suggesting non linear binding interaction exists two proteins 52 additionally classically purified antigen bind p53 tetramers unless antigen reconstituted metal ions like zinc 53 purification antigen results loss activating metal ion re binding zinc induces pronounced conformational change antigen restores binding interface p53 53 cellular protein shares similar features viral antigen p53 binding protein bp2 latter protein identified yeast two hybrid screen attempted define cellular proteins interact wild type mutant forms p53 54 like antigen bp2 interacts p53 central domain certain classes mutations disrupt p53 tetramer prevent stable binding bp2 52 thus antigen bp2 proteins form precedent polypeptides interact relatively complex dynamic fashion within central domain folded p53 tetramer mdm2 protein interaction p53 appears similarly sensitive conformational effects
0.5138107.11925449.html.plaintext.txt	82	first protein shown bind p53 sv40 antigen 50 51 although details structure complex lacking interaction results inactivation p53 function binding occurs within central domain p53 tetramer point mutations unfold p53 tetramer destabilize p53 antigen complex suggesting non linear binding interaction exists two proteins 52 additionally classically purified antigen bind p53 tetramers unless antigen reconstituted metal ions like zinc 53 purification antigen results loss activating metal ion re binding zinc induces pronounced conformational change antigen restores binding interface p53 53 cellular protein shares similar features viral antigen p53 binding protein bp2 latter protein identified yeast two hybrid screen attempted define cellular proteins interact wild type mutant forms p53 54 like antigen bp2 interacts p53 central domain certain classes mutations disrupt p53 tetramer prevent stable binding bp2 52 thus antigen bp2 proteins form precedent polypeptides interact relatively complex dynamic fashion within central domain folded p53 tetramer mdm2 protein interaction p53 appears similarly sensitive conformational effects
0.5138107.11925449.html.plaintext.txt	83	mdm2 protein composed least four independent functional domains isolation bind rna zinc arf14 box domain p53 set report develop quantitative biochemical assay used begin dissect interdomain allosteric communication domains mdm2 three highlights follows 1 mdm2 protein changes conformation bound rna 2 conformational change reduces mdm2 affinity primary peptide binding site n terminal domain p53 3 conformational change switches specificity distinct peptide motif core domain p53 prb rnp u knowledge first evidence protein ligand free ligand bound state switching specificity target protein underscores dynamic nature mdm2 protein conformation control yet clear ligand binding mdm2 possible permutations ie mdm2 p14arf mdm2 rna mdm2 zinc mdm2 rnazinc etc modulated cells due difficulty quantitating mdm2 ligand complexes living cells yet clear rna binding mdm2 regulate p53 protein transactivation polyubiquitination nuclear export degradation however data demonstrate dynamic nature hetero oligomeric protein protein interaction multiple ligand binding sites direct docking site specificity identify important mdm2 ligand study insights p53 pathway example although homopolyribonucleotide polyrg used rna ligand binds mdm2 steady state levels accessibility classes cellular rna bind mdm2 like l5 ribosomal protein associated 5 ribosomal rna 16 28 ribosomal rna 55 presumably regulate pools mdm2 cell prefer bind box 1 domain p53 s9 s10 linker region p53 addition rna binding ring finger domain required p53 transport mdm2 28 rna complex may example important mediator p53 regulation vivo 55 degradation 28 rrna occurs apoptosis vivo 56 degradation destabilizes mdm2 rna complex may reduce ability mdm2 bind inhibit activity p53 protein thus freeing p53 induce cell death initial data suggest significant pool mdm2 rna complexes may exist vivo based observation s9 s10 linker mutant p53 proteins expressed higher steady state levels wild type p53 protein data shown exhibit increases mdm2 dependent ubiquitination cells figs 9 13 quantitative cell based assays may reveal subtle changes levels wild type p53 s9 s10 linker p53 protein mutants providing indirect measure mdm2 rna isoform ligand free forms mdm2 cells rna bound form mdm2 reveals new peptide binding motif present proteins like snrnp u protein complex involved assembly andor export ribosomal rna particles 57 data suggest first amount rna complexed mdm2 may modulate stability cellular proteins second therapeutic agents may developed discriminate ligand free rna bound forms mdm2 acknowledgement
0.5138107.11925449.html.plaintext.txt	84	mdm2 protein composed least four independent functional domains isolation bind rna zinc arf14 box domain p53 set report develop quantitative biochemical assay used begin dissect interdomain allosteric communication domains mdm2 three highlights follows 1 mdm2 protein changes conformation bound rna 2 conformational change reduces mdm2 affinity primary peptide binding site n terminal domain p53 3 conformational change switches specificity distinct peptide motif core domain p53 prb rnp u knowledge first evidence protein ligand free ligand bound state switching specificity target protein underscores dynamic nature mdm2 protein conformation control yet clear ligand binding mdm2 possible permutations ie mdm2 p14arf mdm2 rna mdm2 zinc mdm2 rnazinc etc modulated cells due difficulty quantitating mdm2 ligand complexes living cells yet clear rna binding mdm2 regulate p53 protein transactivation polyubiquitination nuclear export degradation however data demonstrate dynamic nature hetero oligomeric protein protein interaction multiple ligand binding sites direct docking site specificity identify important mdm2 ligand study insights p53 pathway example although homopolyribonucleotide polyrg used rna ligand binds mdm2 steady state levels accessibility classes cellular rna bind mdm2 like l5 ribosomal protein associated 5 ribosomal rna 16 28 ribosomal rna 55 presumably regulate pools mdm2 cell prefer bind box 1 domain p53 s9 s10 linker region p53 addition rna binding ring finger domain required p53 transport mdm2 28 rna complex may example important mediator p53 regulation vivo 55 degradation 28 rrna occurs apoptosis vivo 56 degradation destabilizes mdm2 rna complex may reduce ability mdm2 bind inhibit activity p53 protein thus freeing p53 induce cell death initial data suggest significant pool mdm2 rna complexes may exist vivo based observation s9 s10 linker mutant p53 proteins expressed higher steady state levels wild type p53 protein data shown exhibit increases mdm2 dependent ubiquitination cells figs 9 13 quantitative cell based assays may reveal subtle changes levels wild type p53 s9 s10 linker p53 protein mutants providing indirect measure mdm2 rna isoform ligand free forms mdm2 cells rna bound form mdm2 reveals new peptide binding motif present proteins like snrnp u protein complex involved assembly andor export ribosomal rna particles 57 data suggest first amount rna complexed mdm2 may modulate stability cellular proteins second therapeutic agents may developed discriminate ligand free rna bound forms mdm2 acknowledgement
0.5138107.11925449.html.plaintext.txt	85	thank dr dimitrius xirodimas helpful discussions
0.5138107.11925449.html.plaintext.txt	86	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5138107.11925449.html.plaintext.txt	87	costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5138107.11925449.html.plaintext.txt	88	cancer research uk senior research fellow
0.5138107.11925449.html.plaintext.txt	89	supported career establishment grant uk medical research council program grant cancer research uk correspondence addressed tel 44 1382 496 430 fax 44 1382 633 952 e mail trhuppdundeeacuk
0.5138107.11925449.html.plaintext.txt	90	supported career establishment grant uk medical research council program grant cancer research uk correspondence addressed tel 44 1382 496 430 fax 44 1382 633 952 e mail trhuppdundeeacuk
0.5138107.11925449.html.plaintext.txt	91	published jbc papers press march 29 2002 doi 101074jbcm202296200
0.5138107.11925449.html.plaintext.txt	92	abbreviations used dtt dithiothreitol elisa enzyme linked immunosorbent assay pbs phosphate buffered saline mab monoclonal antibody rlu relative light units atps adenosine 5 o thiotriphosphate snrnp u small nuclear ribonucleoprotein u
0.5138107.11925449.html.plaintext.txt	93	references top abstract introduction experimental procedures results discussion references 1 oren m 1999 j biol chem 274 36031 36034free full text 2 vogelstein b lane d levine j 2000 nature 408 307 310crossrefmedline order article via infotrieve 3 cho y gorina jeffrey p d pavletich n p 1994 science 265 346 355medline order article via infotrieve 4 hollstein m hergenhahn m yang q bartsch h wang z q hainaut p 1999 mutat res 431 199 209medline order article via infotrieve 5 gannon j v greaves r iggo r lane d p 1990 embo j 9 1595 1602abstract 6 mateu m g fersht r 1998 embo j 17 2748 2758abstractfree full text 7 mateu m g sanche zdel pino m m fersht r 1999 nat struct biol 6 191 198crossrefmedline order article via infotrieve 8 hupp r lane d p ball k l 2000 biochem j 352 1 17crossrefmedline order article via infotrieve 9 blaydes j p luciani m g pospisilova ball h m vojtesek b hupp r 2001 j biol chem 276 4699 4708abstractfree full text 10 sakaguchi k herrera j e saito miki bustin m vassilev anderson c w appella e 1998 genes dev 12 2831 2841abstractfree full text 11 shieh y ahn j tamai k taya y prives c 2000 genes dev 14 289 300abstractfree full text 12 sakaguchi k saito higashimoto y roy anderson c w appella e 2000 j biol chem 275 9278 9283abstractfree full text 13 dornan d hupp r 2001 embo rep 2 139 144abstractfree full text 14 lin j chen j elenbaas b levine j 1994 genes dev 8 1235 1246abstract 15 marechal v elenbaas b taneyhill l piette j mechali m nicolas j c levine j moreau j 1997 oncogene 14 1427 1433crossrefmedline order article via infotrieve 16 elenbaas b dobbelstein m roth j shenk levine j 1996 mol med 2 439 451medline order article via infotrieve 17 picksley m vojtesek b sparks lane d p 1994 oncogene 9 2523 2529medline order article via infotrieve 18 kussie p h gorina marechal v elenbaas b moreau j levine j pavletich n p 1996 science 274 948 953abstractfree full text 19 freedman d epstein c b roth j c levine j 1997 mol med 3 248 259medline order article via infotrieve 20 blaydes j p gire v rowson j m wynford thomas d 1997 oncogene 14 1859 1868crossrefmedline order article via infotrieve 21 blaydes j p wynford thomas d 1998 oncogene 16 3317 3322crossrefmedline order article via infotrieve 22 bottger bottger v sparks liu w l howard f lane d p 1997 curr biol 7 860 869medline order article via infotrieve 23 haupt y maya r kazaz oren m 1997 nature 387 296 299crossrefmedline order article via infotrieve 24 hupp r lane d p 1994 curr biol 4 865 875medline order article via infotrieve 25 burch l r midgley c currie r lane d p hupp r 2000 febs lett 472 93 98crossrefmedline order article via infotrieve 26 craig l burch l vojtesek b mikutowska j thompson hupp r 1999 biochem j 342 133 141crossrefmedline order article via infotrieve 27 midgley c desterro j m saville m k howard sparks hay r lane d p 2000 oncogene 19 2312 2323crossrefmedline order article via infotrieve 28 blaydes j p craig l wallace m ball m l traynor n gibbs n hupp r 2000 oncogene 19 3829 3839crossrefmedline order article via infotrieve 29 berger m vogt sionov r levine j haupt y 2001 j biol chem 276 3785 3790abstractfree full text 30 woods d b vousden k h 2001 exp cell res 264 56 66crossrefmedline order article via infotrieve 31 halazonetis d davis l j kandil n 1993 embo j 12 1021 1028abstract 32 hansen hupp r lane d p 1996 j biol chem 271 3917 3924abstractfree full text 33 xiao z x chen j levine j modjtahedi n xing j sellers w r livingston d m 1995 nature 375 694 698crossrefmedline order article via infotrieve 34 bottger v bottger howard f picksley m chene p garcia echeverria c hochkeppel h k lane d p 1996 oncogene 13 2141 2147medline order article via infotrieve 35 vojtesek b dolezalova h lauerova l svitakova m havlis p kovarik j midgley c lane d p 1995 oncogene 10 389 393medline order article via infotrieve 36 wu x bayle j h olson d levine j 1993 genes dev 7 1126 1132abstract 37 friedlander p legros y soussi prives c 1996 j biol chem 271 25468 25478abstractfree full text 38 hansen midgley c lane d p freeman b c morimoto r hupp r 1996 j biol chem 271 30922 30928abstractfree full text 39 hansen lane d p midgley c 1997 j mol biol 275 575 588crossref 40 jayaraman l prives c 1999 cell mol life sci 55 76 87crossrefmedline order article via infotrieve 41 thut c j chen j l klemm r tjian r 1995 science 267 100 104medline order article via infotrieve 42 thut c j goodrich j tjian r 1997 genes dev 11 1974 1986abstractfree full text 43 honda r yasuda h 1999 embo j 18 22 27abstractfree full text 44 honda r tanaka h yasuda h 1997 febs lett 420 25 27crossrefmedline order article via infotrieve 45 fuchs y adler v buschmann wu x ronai z 1998 oncogene 17 2543 2547crossrefmedline order article via infotrieve 46 maki c g howley p m 1997 mol cell biol 17 355 363abstract 47 wasylyk c wasylyk b 2000 mol cell biol 20 5554 5570abstractfree full text 48 leveillard wasylyk b 1997 j biol chem 272 30651 30661abstractfree full text 49 maki c g 1999 j biol chem 274 16531 16535abstractfree full text 50 linzer d levine j 1979 cell 17 43 52medline order article via infotrieve 51 lane d p crawford l v 1979 nature 278 261 263medline order article via infotrieve 52 thukral k blain g c chang k k fields 1994 mol cell biol 14 8315 8321abstract 53 kernohan n m hupp r lane d p 1996 j biol chem 271 4954 4960abstractfree full text 54 iwabuchi k bartel p l li b marraccino r fields 1994 proc natl acad sci u 91 6098 6102abstract 55 roth j dobbelstein m freedman d shenk levine j 1998 embo j 17 554 564abstractfree full text 56 nadano d sato 2000 j biol chem 275 13967 13973abstractfree full text 57 scheer u weisenberger d 1994 curr opin cell biol 6 354 359medline order article via infotrieve 58 luciani m g hutchins j r zheleva d hupp r 2000 j mol biol 300 503 518crossrefmedline order article via infotrieve 59 marston n j jenkins j r vousden k h 1995 oncogene 10 1709 1715medline order article via infotrieve 60 xirodimas d p lane d p 1999 j biol chem 274 28042 28049abstractfree full text 61 nikolova p v henckel j lane d p fersht r 1998 proc natl acad sci u 95 14675 14680abstractfree full text 62 foster b coffey h morin m j rastinejad f 1999 science 286 2507 2510abstractfree full text 63 ball k l lain fahraeus r smythe c lane d p 1997 curr biol 7 71 80medline order article via infotrieve 64 loughran o la thangue n b 2000 mol cell biol 20 2186 2197abstractfree full text
0.5138107.11925449.html.plaintext.txt	94	copyright 2002 american society biochemistry molecular biology inc
0.51632494.14707141.html.plaintext.txt	0	hgtse 1 expression stimulates cytoplasmic localization p53 martin monte roberta benetti licio collavin luigi marchionni giannino del sal claudio schneider
0.51632494.14707141.html.plaintext.txt	1	laboratorio nazionale del consorzio interuniversitario per le biotecnologie lncib area science park padriciano 99 34012 trieste italy dipartimento di biochimica biofisica e chimica delle macromolecole universita di trieste via giorgeri 1 34100 trieste italy dipartimento di scienze e tecnologie biomediche universita di udine piazzale kolbe 33100 udine italy
0.51632494.14707141.html.plaintext.txt	2	received publication october 9 2003 revised form december 22 2003
0.51632494.14707141.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references hgtse 1 human g2 phase expressed 1 cell cycle regulated protein mainly localized cytoplasm apparently associated microtubules hgtse 1 able regulate levels activity p53 tumor suppressor protein binds c terminal region p53 represses ability induce apoptosis dna damage report dna damage hgtse 1 becomes stabilized p53 independent way accumulated nucleus characterization hgtse 1 localization revealed increased nuclear staining unstressed cells treatment nuclear export inhibitor leptomycin b nuclear export signal nes located c terminal region mutated finally provide evidence hgtse 1 ectopic expression addition p53 protein levels regulation able enhance cytoplasmic localization p53 interestingly nes mutated hgtse 1 accumulates nucleus binds p53 looses ability enhance cytoplasmic redistribution p53 regulate p53 protein levels similarly wild type hgtse 1 functions p53 analyzed cells lacking mdm2 failed regulating p53 localization protein levels thus indicating hgtse 1 requires intact nes functional mdm2 regulation p53 results provide new insights mechanism hgtse 1 function whereby characterized nucleo cytoplasmic shuttling ability required regulate p53
0.51632494.14707141.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references hgtse 1 human g2 phase expressed 1 cell cycle regulated protein mainly localized cytoplasm apparently associated microtubules hgtse 1 able regulate levels activity p53 tumor suppressor protein binds c terminal region p53 represses ability induce apoptosis dna damage report dna damage hgtse 1 becomes stabilized p53 independent way accumulated nucleus characterization hgtse 1 localization revealed increased nuclear staining unstressed cells treatment nuclear export inhibitor leptomycin b nuclear export signal nes located c terminal region mutated finally provide evidence hgtse 1 ectopic expression addition p53 protein levels regulation able enhance cytoplasmic localization p53 interestingly nes mutated hgtse 1 accumulates nucleus binds p53 looses ability enhance cytoplasmic redistribution p53 regulate p53 protein levels similarly wild type hgtse 1 functions p53 analyzed cells lacking mdm2 failed regulating p53 localization protein levels thus indicating hgtse 1 requires intact nes functional mdm2 regulation p53 results provide new insights mechanism hgtse 1 function whereby characterized nucleo cytoplasmic shuttling ability required regulate p53
0.51632494.14707141.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references p53 mediated response pathway among frequent targets inactivation human cancers tumor suppressor p53 protein nuclear transcription factor transactivates variety genes involved growth arrest apoptosis 1 failure p53 function attributed following inactivation p53 mutations altering dna binding capability 2 b deregulation proteins control p53 levels activity ie cellular viral oncogenes 3 5 c nuclear exclusion interferes role transcription factor 6
0.51632494.14707141.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references p53 mediated response pathway among frequent targets inactivation human cancers tumor suppressor p53 protein nuclear transcription factor transactivates variety genes involved growth arrest apoptosis 1 failure p53 function attributed following inactivation p53 mutations altering dna binding capability 2 b deregulation proteins control p53 levels activity ie cellular viral oncogenes 3 5 c nuclear exclusion interferes role transcription factor 6
0.51632494.14707141.html.plaintext.txt	7	regulation wt p53 protein based strict physiological turnover including ubiquitination degradation cytoplasm nuclear cytoplasmic shuttling p53 depends nuclear export signals nes1 nuclear localization sequences nlss located n c termini protein 7 main regulator p53 mdm2 interacts n terminal p53 thus blocking p53 transcriptional activation promoting degradation ubiquitin proteasome pathway 8 nucleo cytoplasmic shuttling p53 seems essential degradation mdm2 9 10 moreover demonstrated mdm2 expression key factor efficiently promotes nuclear export p53 11 12 important stimuli leading p53 activation stabilization dna damage causes phosphorylation n terminal nes 13 p14arf expression interferes mdm2 activity 14 efficiently inhibit p53 nuclear exclusion contrary proteins like e1b55k 15 mot 2 16 parc 17 psf tfe3 18 able regulate destabilize p53 cytoplasmic sequestration thus emphasizing importance p53 relocalization effective means control function
0.51632494.14707141.html.plaintext.txt	8	regulation wt p53 protein based strict physiological turnover including ubiquitination degradation cytoplasm nuclear cytoplasmic shuttling p53 depends nuclear export signals nes1 nuclear localization sequences nlss located n c termini protein 7 main regulator p53 mdm2 interacts n terminal p53 thus blocking p53 transcriptional activation promoting degradation ubiquitin proteasome pathway 8 nucleo cytoplasmic shuttling p53 seems essential degradation mdm2 9 10 moreover demonstrated mdm2 expression key factor efficiently promotes nuclear export p53 11 12 important stimuli leading p53 activation stabilization dna damage causes phosphorylation n terminal nes 13 p14arf expression interferes mdm2 activity 14 efficiently inhibit p53 nuclear exclusion contrary proteins like e1b55k 15 mot 2 16 parc 17 psf tfe3 18 able regulate destabilize p53 cytoplasmic sequestration thus emphasizing importance p53 relocalization effective means control function
0.51632494.14707141.html.plaintext.txt	9	c terminal domain p53 characterized key domain involved control p53 localization 19 20 three nlss one nes located within amino acids 316 384 p53 proposed p53 localization mainly regulated nes maskingnes exposition switch 21 mdm2 driven ubiquitination certain mutations p53 c terminal region enhance p53 relocalization cytoplasm 22 23
0.51632494.14707141.html.plaintext.txt	10	c terminal domain p53 characterized key domain involved control p53 localization 19 20 three nlss one nes located within amino acids 316 384 p53 proposed p53 localization mainly regulated nes maskingnes exposition switch 21 mdm2 driven ubiquitination certain mutations p53 c terminal region enhance p53 relocalization cytoplasm 22 23
0.51632494.14707141.html.plaintext.txt	11	mouse gtse 1 g2 phase expressed previously named b99 cell cycle regulated protein mainly localizes microtubules induced wt p53 upon dna damage 24 25 recently shown human homologue hgtse 1 26 able control dna damage induced apoptosis regulating p53 function 27 hgtse 1 binds c terminal domain p53 355 393 induces regulation p53 levels activity although hgtse 1 binding p53 seems required repressing p53 activity unclear hgtse 1 regulates p53 stability
0.51632494.14707141.html.plaintext.txt	12	mouse gtse 1 g2 phase expressed previously named b99 cell cycle regulated protein mainly localizes microtubules induced wt p53 upon dna damage 24 25 recently shown human homologue hgtse 1 26 able control dna damage induced apoptosis regulating p53 function 27 hgtse 1 binds c terminal domain p53 355 393 induces regulation p53 levels activity although hgtse 1 binding p53 seems required repressing p53 activity unclear hgtse 1 regulates p53 stability
0.51632494.14707141.html.plaintext.txt	13	report hgtse 1 protein accumulates dna damage p53 independent mechanism concomitant relocalization cytoplasm nucleus studying hgtse 1 subcellular localization found nucleo cytoplasmic shuttling protein containing active nes c terminal region also demonstrate addition decreasing p53 levels hgtse 1 expression promotes p53 localization cytoplasm finally show shuttling activity hgtse 1 well mdm2 required regulation p53 localization levels
0.51632494.14707141.html.plaintext.txt	14	report hgtse 1 protein accumulates dna damage p53 independent mechanism concomitant relocalization cytoplasm nucleus studying hgtse 1 subcellular localization found nucleo cytoplasmic shuttling protein containing active nes c terminal region also demonstrate addition decreasing p53 levels hgtse 1 expression promotes p53 localization cytoplasm finally show shuttling activity hgtse 1 well mdm2 required regulation p53 localization levels
0.51632494.14707141.html.plaintext.txt	15	experimental procedures top abstract introduction experimental procedures results discussion references cell lines treatments cell lines cultured 37 degrees c dulbeccos modified eagles medium supplemented 10 fetal calf serum 2 mm l glutamine penicillin 100 unitsml streptomycin 100 microgml d4h cells saos 2 cells expressing v143a ts p53 mutant form 28 at6 cells u2os cells expressing v143a ts p53 mutant form sk23 cells skov3 cells expressing murine val 135 ts p53 mutant 29 mcf7 cells u2os cells contain wild type p53 t47d cells express mutated p53 mef p53 obtained p53 knockout mice
0.51632494.14707141.html.plaintext.txt	16	experimental procedures top abstract introduction experimental procedures results discussion references cell lines treatments cell lines cultured 37 degrees c dulbeccos modified eagles medium supplemented 10 fetal calf serum 2 mm l glutamine penicillin 100 unitsml streptomycin 100 microgml d4h cells saos 2 cells expressing v143a ts p53 mutant form 28 at6 cells u2os cells expressing v143a ts p53 mutant form sk23 cells skov3 cells expressing murine val 135 ts p53 mutant 29 mcf7 cells u2os cells contain wild type p53 t47d cells express mutated p53 mef p53 obtained p53 knockout mice
0.51632494.14707141.html.plaintext.txt	17	cells treated methyl methanesulfonate fluka incubated 4 h drug followed extensive washing medium replacement end treatment etoposide et sigma treatment consisted addition et indicated time uv irradiation treatments performed previously described 30 31
0.51632494.14707141.html.plaintext.txt	18	cells treated methyl methanesulfonate fluka incubated 4 h drug followed extensive washing medium replacement end treatment etoposide et sigma treatment consisted addition et indicated time uv irradiation treatments performed previously described 30 31
0.51632494.14707141.html.plaintext.txt	19	leptomycin b 5 ngml sigma added cell culture 18 h transfection additional 12 h mg132 50 microm sigma added cell culture 8 h 16 h transfection
0.51632494.14707141.html.plaintext.txt	20	leptomycin b 5 ngml sigma added cell culture 18 h transfection additional 12 h mg132 50 microm sigma added cell culture 8 h 16 h transfection
0.51632494.14707141.html.plaintext.txt	21	transfection vectors cells mid log growth phase transfected using fugene 6 roche diagnostics reagent indicated manufacturer hgtse 1 gtse 1 nes mutants cloned pcdna3 invitrogen expression vector hgtse 1 gtse 1 nes double point mutants generated pcr hgtse 1 nes mutant isoleucine 628 leucine 630 changed alanine whereas gtse 1 nes mutant leucines 648 650 changed alanine p53 localization pegfp p53 expressing wt p53 used 2223 p53 expression vector encodes l22qw23s p53 mutant
0.51632494.14707141.html.plaintext.txt	22	transfection vectors cells mid log growth phase transfected using fugene 6 roche diagnostics reagent indicated manufacturer hgtse 1 gtse 1 nes mutants cloned pcdna3 invitrogen expression vector hgtse 1 gtse 1 nes double point mutants generated pcr hgtse 1 nes mutant isoleucine 628 leucine 630 changed alanine whereas gtse 1 nes mutant leucines 648 650 changed alanine p53 localization pegfp p53 expressing wt p53 used 2223 p53 expression vector encodes l22qw23s p53 mutant
0.51632494.14707141.html.plaintext.txt	23	immunofluorescence cell fractionation immunofluorescence assay cells fixed 3 paraformaldehyde treated triton x 100 staining performed using specific antibodies incubated 5 bovine serum albumin phosphate buffered saline 37 degrees c followed fluorescein isothiocyanate tetramethylrhodamine isothiocyanate conjugated secondary antibodies sigma indicated hgtse 1 gtse 1 staining used affinity purified polyclonal antibodies 24 26 cell fractionation performed using subcellular proteome extraction kit calbiochem described manufacturer
0.51632494.14707141.html.plaintext.txt	24	immunofluorescence cell fractionation immunofluorescence assay cells fixed 3 paraformaldehyde treated triton x 100 staining performed using specific antibodies incubated 5 bovine serum albumin phosphate buffered saline 37 degrees c followed fluorescein isothiocyanate tetramethylrhodamine isothiocyanate conjugated secondary antibodies sigma indicated hgtse 1 gtse 1 staining used affinity purified polyclonal antibodies 24 26 cell fractionation performed using subcellular proteome extraction kit calbiochem described manufacturer
0.51632494.14707141.html.plaintext.txt	25	immunoprecipitation western blotting cells harvested ice cold nonidet p 40 buffer containing 50 mm tris hcl ph 8 150 mm nacl 1 nonidet p 40 01 mm sodium orthovanadate 2 mm dithiothreitol 01 mm phenylmethylsulfonyl fluoride 5 mm edta 10 microgml chymostatin leupeptin antipain pepstatin 10 min 4 degrees c lysates clarified centrifugation precleared 20 microl protein speharose cl 4b amersham biosciences antibody prebound 20 microl protein sepharose cl 4b added incubated 4 degrees c 4 h resin washed bound proteins eluted sds page sample buffer
0.51632494.14707141.html.plaintext.txt	26	immunoprecipitation western blotting cells harvested ice cold nonidet p 40 buffer containing 50 mm tris hcl ph 8 150 mm nacl 1 nonidet p 40 01 mm sodium orthovanadate 2 mm dithiothreitol 01 mm phenylmethylsulfonyl fluoride 5 mm edta 10 microgml chymostatin leupeptin antipain pepstatin 10 min 4 degrees c lysates clarified centrifugation precleared 20 microl protein speharose cl 4b amersham biosciences antibody prebound 20 microl protein sepharose cl 4b added incubated 4 degrees c 4 h resin washed bound proteins eluted sds page sample buffer
0.51632494.14707141.html.plaintext.txt	27	western blot analysis performed according standard procedures using following primary antibodies affinity purified lf1 anti hgtse 1 polyclonal antibody 1 anti p53 monoclonal antibody santa cruz biotechnology anti actin polyclonal antibody sigma anti p21waf 1 polyclonal antibody santa cruz biotechnology affinity purified anti gfp polyclonal antibody affinity purified anti p53 polyclonal antibody anti ha 12ca5 monoclonal antibody roche molecular biochemicals bound primary antibodies visualized enhanced chemiluminescence ecl amersham biosciences addition horseradish peroxidase conjugated secondary antibodies
0.51632494.14707141.html.plaintext.txt	28	western blot analysis performed according standard procedures using following primary antibodies affinity purified lf1 anti hgtse 1 polyclonal antibody 1 anti p53 monoclonal antibody santa cruz biotechnology anti actin polyclonal antibody sigma anti p21waf 1 polyclonal antibody santa cruz biotechnology affinity purified anti gfp polyclonal antibody affinity purified anti p53 polyclonal antibody anti ha 12ca5 monoclonal antibody roche molecular biochemicals bound primary antibodies visualized enhanced chemiluminescence ecl amersham biosciences addition horseradish peroxidase conjugated secondary antibodies
0.51632494.14707141.html.plaintext.txt	29	results top abstract introduction experimental procedures results discussion references dna damage stabilizes relocalizes hgtse 1 nucleus previously demonstrated wt p53 induces murine gtse 1 transcription active p53 binding site located promoter region nevertheless similarly p53 target genes mouse gtse 1 also induced dna damage cells lacking functional p53 24
0.51632494.14707141.html.plaintext.txt	30	results top abstract introduction experimental procedures results discussion references dna damage stabilizes relocalizes hgtse 1 nucleus previously demonstrated wt p53 induces murine gtse 1 transcription active p53 binding site located promoter region nevertheless similarly p53 target genes mouse gtse 1 also induced dna damage cells lacking functional p53 24
0.51632494.14707141.html.plaintext.txt	31	characterize p53 dependent regulation hgtse 1 protein used human cell lines expressing temperature sensitive p53 allele ts p53 mutant conformation 37 degrees c wt conformation 32 degrees c shown fig 1a differences hgtse 1 protein levels observed wt mutant p53 conformations indicating expression hgtse 1 protein induced wt p53 observation supported fact p53 failed increase hgtse 1 mrna levels northern blot analysis cellular system data shown
0.51632494.14707141.html.plaintext.txt	32	view larger version 37k fig 1 regulation hgtse 1 protein levels p53 activation dna damage western blot analysis hgtse 1 protein wt p53 induction different ts p53 cells activity p53 followed monitoring expression p21waf 1 middle panel b western blot analysis hgtse 1 mcf 7 cells wt p53 t47d cells mutant p53 saos 2 cells null p53 24 h irradiation 400 rads c time course analysis hgtse 1 p53 p21waf 1 protein levels et treatment u2os cells
0.51632494.14707141.html.plaintext.txt	33	analyzed hgtse 1 protein levels response dna damaging agents radiation et cells containing different forms endogenous p53 mcf 7 wt p53 t47d cells mutant p53 saos 2 cells p53 null shown fig 1b hgtse 1 expression increased irradiation 400 rads tested cell lines similar results obtained using 100 microm et data shown suggesting hgtse 1 protein levels increase genotoxic stress independently p53 status time course experiment et treatment performed study behavior endogenous hgtse 1 protein upon dna damage u2os cells shown fig 1c western blot analysis revealed hgtse 1 protein increased 15 18 h treatment et furthermore analysis p53 response context showed hgtse 1 becomes accumulated slower kinetic compared p53 p53 induced protein p21waf 1 32 detected 3 6 9 h et treatment respectively indicating hgtse 1 increases late phase dna damage
0.51632494.14707141.html.plaintext.txt	34	analyzing hgtse 1 intracellular localization observed similar murine protein hgtse 1 cytoplasmic protein localized microtubules 26 overexpression hgtse 1 however revealed small subpopulation cells addition cytoplasmic staining displayed nuclear staining data shown observation prompted us analyze whether change hgtse 1 localization could associated dna damage response purpose endogenous ectopically expressed hgtse 1 localization analyzed u2os cells 24 h et treatment shown fig 2a et treatment evidenced significant fraction cells nuclear localized hgtse 1 scoring hgtse 1 localization cells treated et well localization cells treated dna damaging agents methyl methanesulfonate 100 microm uv irradiation 20 jm2 see experimental procedures indicated dna damage efficiently relocalized hgtse 1 nucleus fig 2b finally kinetics hgtse 1 relocalization monitored u2os cells ectopically expressing hgtse 1 different time points et treatment shown fig 2c et treatment strongly enhanced hgtse 1 relocalization nucleus 13 18 h damage coincident previous information related accumulation endogenous protein fig 1c altogether observations indicate hgtse 1 becomes stabilized relocalized nucleus response dna damage signals
0.51632494.14707141.html.plaintext.txt	35	analyzing hgtse 1 intracellular localization observed similar murine protein hgtse 1 cytoplasmic protein localized microtubules 26 overexpression hgtse 1 however revealed small subpopulation cells addition cytoplasmic staining displayed nuclear staining data shown observation prompted us analyze whether change hgtse 1 localization could associated dna damage response purpose endogenous ectopically expressed hgtse 1 localization analyzed u2os cells 24 h et treatment shown fig 2a et treatment evidenced significant fraction cells nuclear localized hgtse 1 scoring hgtse 1 localization cells treated et well localization cells treated dna damaging agents methyl methanesulfonate 100 microm uv irradiation 20 jm2 see experimental procedures indicated dna damage efficiently relocalized hgtse 1 nucleus fig 2b finally kinetics hgtse 1 relocalization monitored u2os cells ectopically expressing hgtse 1 different time points et treatment shown fig 2c et treatment strongly enhanced hgtse 1 relocalization nucleus 13 18 h damage coincident previous information related accumulation endogenous protein fig 1c altogether observations indicate hgtse 1 becomes stabilized relocalized nucleus response dna damage signals
0.51632494.14707141.html.plaintext.txt	36	view larger version 33k fig 2 changes hgtse 1 subcellular localization dna damage immunofluorescence images showing localization endogenous 1 2 overexpressed hgtse 1 3 4 et treated untreated u2os cells indicated cells fixed processed immunofluorescence analysis visualize hgtse 1 localization using specific polyclonal antibody fluorescein isothiocyanate conjugated secondary antibody arrows indicate cells expressing hgtse 1 b diagram showing percentage u2os cells nuclear hgtse 1 localization indicated stimuli c hgtse 1 nuclear localization time course analysis et treatment u2os cells transfected hgtse 1 expression vector
0.51632494.14707141.html.plaintext.txt	37	hgtse 1 nuclear cytoplasmic shuttling protein observation hgtse 1 able move cytoplasm nucleus prompted us study mechanism hgtse 1 change intracellular localization purpose analyzed intracellular distribution hgtse 1 mouse homologue gtse 1 unstressed u2os cells treatment nuclear export inhibitor leptomycin b lmb 18 h cell transfection human mouse gtse 1 lmb added additional 12 h shown fig 3a inhibition nuclear export lmb correlated hgtse 1 gtse 1 accumulation nucleus indicating shuttling proteins could driven ness
0.51632494.14707141.html.plaintext.txt	38	hgtse 1 nuclear cytoplasmic shuttling protein observation hgtse 1 able move cytoplasm nucleus prompted us study mechanism hgtse 1 change intracellular localization purpose analyzed intracellular distribution hgtse 1 mouse homologue gtse 1 unstressed u2os cells treatment nuclear export inhibitor leptomycin b lmb 18 h cell transfection human mouse gtse 1 lmb added additional 12 h shown fig 3a inhibition nuclear export lmb correlated hgtse 1 gtse 1 accumulation nucleus indicating shuttling proteins could driven ness
0.51632494.14707141.html.plaintext.txt	39	view larger version 52k fig 3 hgtse 1 nucleo cytoplasmic shuttling protein localization hgtse 1 wt gtse 1 u2os cells treated lmb b comparison nuclear export sequences red hgtse 1 gtse 1 nucleo cytoplasmic shuttling proteins amino acids changed hgtse 1 gtse 1 nes underlined c localization hgtse 1 gtse 1 nes mutants u2os cells 24 h transfection
0.51632494.14707141.html.plaintext.txt	40	previous studies using set mouse gtse 1 deletion mutants suggested c terminal region protein involved controlling localization2 analysis mouse gtse 1 amino acid sequence revealed conserved leucine rich sequence fig 3b conforming criteria established ness similar observed hiv 1 rev protein 33 generated human mouse gtse 1 constructs double point mutation within putative nes hgtse 1 nes gtse 1 nes respectively changing isoleucine 628 leucine 630 alanine hgtse 1 leucines 648 650 alanine gtse 1 indicated fig 3b hgtse 1 nes gtse 1 nes constructs transfected u2os cells 24 h later localizations assessed immunofluorescence shown fig 3c nes mutants displayed enhanced nuclear localization thus identifying presence active nes within gtse 1 proteins result accordance enhanced nuclear localization hgtse 1 gtse 1 observed lmb treatment drug inhibits nuclear export pathways require crm1 receptor leucine rich ness 34 36 accumulation gtse 1 proteins nucleus could imply another control level nuclear entry addition described regulation nuclear export however point mutation two putative nlss starting amino acids 235 542 failed completely abolish nuclear localization hgtse 1 data shown indicating signals factors could involved activity
0.51632494.14707141.html.plaintext.txt	41	previous studies using set mouse gtse 1 deletion mutants suggested c terminal region protein involved controlling localization2 analysis mouse gtse 1 amino acid sequence revealed conserved leucine rich sequence fig 3b conforming criteria established ness similar observed hiv 1 rev protein 33 generated human mouse gtse 1 constructs double point mutation within putative nes hgtse 1 nes gtse 1 nes respectively changing isoleucine 628 leucine 630 alanine hgtse 1 leucines 648 650 alanine gtse 1 indicated fig 3b hgtse 1 nes gtse 1 nes constructs transfected u2os cells 24 h later localizations assessed immunofluorescence shown fig 3c nes mutants displayed enhanced nuclear localization thus identifying presence active nes within gtse 1 proteins result accordance enhanced nuclear localization hgtse 1 gtse 1 observed lmb treatment drug inhibits nuclear export pathways require crm1 receptor leucine rich ness 34 36 accumulation gtse 1 proteins nucleus could imply another control level nuclear entry addition described regulation nuclear export however point mutation two putative nlss starting amino acids 235 542 failed completely abolish nuclear localization hgtse 1 data shown indicating signals factors could involved activity
0.51632494.14707141.html.plaintext.txt	42	hgtse 1 overexpression enhances cytoplasmic localization p53 previously reported hgtse 1 able bind c terminal region p53 regulate levels activity 27 c terminal region p53 shown critical regulating stability 37 well subcellular localization 21 23 studied effect hgtse 1 expression respect p53 localization
0.51632494.14707141.html.plaintext.txt	43	hgtse 1 overexpression enhances cytoplasmic localization p53 previously reported hgtse 1 able bind c terminal region p53 regulate levels activity 27 c terminal region p53 shown critical regulating stability 37 well subcellular localization 21 23 studied effect hgtse 1 expression respect p53 localization
0.51632494.14707141.html.plaintext.txt	44	analyze effect hgtse 1 expression subcellular localization p53 cotransfected hgtse 1 gfp p53 expression vectors human osteosarcoma cells lacking p53 mg 63 chose gfp tagged p53 construct represents sensible broadly used method detect p53 localization 10 12 19 poorly sensitive hgtse 1 induced degradation see fig 5c 24 h post transfection cells fixed gfp p53 localization analyzed gfp fluorescence shown fig 4a hgtse 1 overexpression markedly increased cytoplasmic localization gfp p53 control effect performed experiments p53 knockout mouse embryo fibroblasts mef p53 gfp p53 importantly mouse gtse 1 induced similar effects p53 cellular distribution fig 4b strengthening relevance proteins p53 function quantify ability induce cytoplasmic localization p53 three independent experiments performed considering least 200 cells coexpressing gfp p53 hgtse 1 gtse 1 per assay shown fig 4 c d hgtse 1 gtse 1 expression significantly correlate cells displaying increased cytoplasmic p53 thus suggesting gtse 1 proteins able promote cytoplasmic localization p53 result confirmed nucleo cytoplasmic cell fractionation followed western blot see fig 5c hgtse 1 wt hgtse 1 gfp p53 transfected mouse cells p53 relocalized cytoplasm efficiently observed human cells indicating observed effect cell species specific data shown
0.51632494.14707141.html.plaintext.txt	45	analyze effect hgtse 1 expression subcellular localization p53 cotransfected hgtse 1 gfp p53 expression vectors human osteosarcoma cells lacking p53 mg 63 chose gfp tagged p53 construct represents sensible broadly used method detect p53 localization 10 12 19 poorly sensitive hgtse 1 induced degradation see fig 5c 24 h post transfection cells fixed gfp p53 localization analyzed gfp fluorescence shown fig 4a hgtse 1 overexpression markedly increased cytoplasmic localization gfp p53 control effect performed experiments p53 knockout mouse embryo fibroblasts mef p53 gfp p53 importantly mouse gtse 1 induced similar effects p53 cellular distribution fig 4b strengthening relevance proteins p53 function quantify ability induce cytoplasmic localization p53 three independent experiments performed considering least 200 cells coexpressing gfp p53 hgtse 1 gtse 1 per assay shown fig 4 c d hgtse 1 gtse 1 expression significantly correlate cells displaying increased cytoplasmic p53 thus suggesting gtse 1 proteins able promote cytoplasmic localization p53 result confirmed nucleo cytoplasmic cell fractionation followed western blot see fig 5c hgtse 1 wt hgtse 1 gfp p53 transfected mouse cells p53 relocalized cytoplasm efficiently observed human cells indicating observed effect cell species specific data shown
0.51632494.14707141.html.plaintext.txt	46	view larger version 39k fig 5 requirement hgtse 1 nes relocalize regulate p53 images showing p53 hgtse 1 nes localization mef p53 cells transfected gfp p53 nes defective hgtse 1 stained using hgtse 1 antibody upper panel whereas p53 identified gfp green fluorescence lower panel b diagram indicating localization gfp p53 cells transfected hgtse 1 wt nes mutant histogram shows percent cells displaying nuclear n nuclear cytoplasmic nc gfp p53 bars represent sd c cell fractionation assay mef p53 transfected gfp p53 together empty vector hgtse 1 wt wt hgtse 1 nes nes c represents cytoplasmic cytoskeleton protein fractions n nuclear fraction actin histone h3 used cytoplasmic nuclear fraction markers respectively d coimmunoprecipitation wt nes hemagglutinin ha tagged hgtse 1 gfp p53 hek293 cells cotransfected gfp p53 together ha hgtse 1 wt ha hgtse 1 nes empty vector indicated immunoprecipitated using hemagglutinin monoclonal antibody gfp p53 detected using gfp polyclonal antibody ha hgtse 1 using ha monoclonal antibody e determination p53 protein levels mg 63 cells cotransfected wt p53 together empty vector hgtse 1 wt wt nes hgtse 1 nes treated proteasome inhibitor mg132 gfp used transfection control hgtse 1 signal empty vector lanes corresponds endogenous protein
0.51632494.14707141.html.plaintext.txt	47	view larger version 30k fig 4 hgtse 1 expression enhances cytoplasmic localization p53 images mg 63 cells expressing gfp p53 gfp p53 hgtse 1 indicating enhanced cytoplasmic localization gfp staining coexpressed hgtse 1 b similar experiments performed using murine gtse 1 p53 deficient cells mef p53 c scoring gfp p53 localization mg 63 cells expressing hgtse 1 diagram represents percent cells displaying nuclear n nuclear cytoplasmic nc localization gfp p53 bars represent sd d score gfp p53 localization mef p53 expressing murine gtse 1 indicated c
0.51632494.14707141.html.plaintext.txt	48	hgtse 1 nuclear export required regulating p53 localization stability characterize whether nucleo cytoplasmic shuttling activity hgtse 1 affected subcellular localization p53 analyzed effect hgtse 1 nes defective derivative p53 localization address point transfected hgtse 1 nes mutant together gfp p53 mef p53 similarly performed fig 4 indicated representative images shown fig 5a hgtse 1 nes displayed impaired ability enhancing cytoplasmic relocalization p53 fig 5b shows comparative analysis using wt nes mutant hgtse 1 indicating intact hgtse 1 nes necessary promoting nuclear export p53 analyzed mechanism performing cell fractionation assay aim transfected mef p53 empty vector hgtse 1 nes mutant together gfp p53 shown fig 5b 24 h cells harvested fractionated cytoplasmic cytoskeleton proteins named c nuclear proteins named n obtained empty vector hgtse 1 wt hgtse 1 nes transfectants analyzed western blot detect gfp p53 1 monoclonal antibody used detect gfp p53 whereas specific anti hgtse 1 polyclonal antibody poorly recognizes endogenous mouse gtse 1 used detect hgtse 1 actin histone h3 used markers c n fractions respectively indicated fig 5c gfp p53 preferentially detected n fraction cotransfected empty vector however gfp p53 strongly detected c fraction cotransfected hgtse 1 wt protein weakly hgtse 1 nes used thus confirming data obtained microscopy analysis addition increased accumulation hgtse 1 nes nucleus compared wt protein biochemically demonstrated cell fractionation supporting data presented fig 3c altogether data indicate shuttling activity hgtse 1 required promoting nuclear export p53
0.51632494.14707141.html.plaintext.txt	49	hgtse 1 nuclear export required regulating p53 localization stability characterize whether nucleo cytoplasmic shuttling activity hgtse 1 affected subcellular localization p53 analyzed effect hgtse 1 nes defective derivative p53 localization address point transfected hgtse 1 nes mutant together gfp p53 mef p53 similarly performed fig 4 indicated representative images shown fig 5a hgtse 1 nes displayed impaired ability enhancing cytoplasmic relocalization p53 fig 5b shows comparative analysis using wt nes mutant hgtse 1 indicating intact hgtse 1 nes necessary promoting nuclear export p53 analyzed mechanism performing cell fractionation assay aim transfected mef p53 empty vector hgtse 1 nes mutant together gfp p53 shown fig 5b 24 h cells harvested fractionated cytoplasmic cytoskeleton proteins named c nuclear proteins named n obtained empty vector hgtse 1 wt hgtse 1 nes transfectants analyzed western blot detect gfp p53 1 monoclonal antibody used detect gfp p53 whereas specific anti hgtse 1 polyclonal antibody poorly recognizes endogenous mouse gtse 1 used detect hgtse 1 actin histone h3 used markers c n fractions respectively indicated fig 5c gfp p53 preferentially detected n fraction cotransfected empty vector however gfp p53 strongly detected c fraction cotransfected hgtse 1 wt protein weakly hgtse 1 nes used thus confirming data obtained microscopy analysis addition increased accumulation hgtse 1 nes nucleus compared wt protein biochemically demonstrated cell fractionation supporting data presented fig 3c altogether data indicate shuttling activity hgtse 1 required promoting nuclear export p53
0.51632494.14707141.html.plaintext.txt	50	inability hgtse 1 nes relocalizing p53 cytoplasm could attributed defective shuttling activity interact p53 similarly wt protein demonstrated coimmunoprecipitation experiments ha tagged hgtse 1 wt nes constructs cotransfected gfp p53 hek293 cells immunoprecipitated using anti ha antibody shown fig 5d hgtse 1 nes bound p53 efficiently wt protein results obtained transfecting mouse gtse 1 wt nes proteins gfp p53 u2os cells data shown thus supporting notion hgtse 1 shuttling activity required induce p53 nuclear exclusion
0.51632494.14707141.html.plaintext.txt	51	inability hgtse 1 nes relocalizing p53 cytoplasm could attributed defective shuttling activity interact p53 similarly wt protein demonstrated coimmunoprecipitation experiments ha tagged hgtse 1 wt nes constructs cotransfected gfp p53 hek293 cells immunoprecipitated using anti ha antibody shown fig 5d hgtse 1 nes bound p53 efficiently wt protein results obtained transfecting mouse gtse 1 wt nes proteins gfp p53 u2os cells data shown thus supporting notion hgtse 1 shuttling activity required induce p53 nuclear exclusion
0.51632494.14707141.html.plaintext.txt	52	previous results indicated overexpression hgtse 1 regulates p53 protein levels 27 p53 degradation described occur mainly cytoplasm 38 investigated whether regulation p53 protein stability via hgtse 1 expression linked enhanced cytoplasmic localization p53 analyzing effect wt nes defective hgtse 1 proteins p53 levels purpose p53 null mg 63 cells transfected vectors expressing wt nes hgtse 1 p53 together empty gfp vector used transfection control perform experiment transfected low levels untagged wt p53 appreciate alterations stability observed stable gfp p53 fusion protein represent sensitive assay hgtse 1 dependent regulation see fig 5c 24 h later cell lysates prepared p53 protein levels assessed western blotting observed fig 5e left panel hgtse 1 wt reduced p53 levels nes mutant effect regulating p53 suggesting relocalization p53 cytoplasm could mechanism hgtse 1 controls p53 levels finally investigated whether regulation p53 levels hgtse 1 required proteasome activity experiments performed adding proteasome inhibitor mg132 cells transfected parallel shown left panel fig 5e cells treated mg132 last 8 h lysis shown fig 5e right panel inhibition proteasome abolished p53 regulation wt hgtse 1 indicating proteasome activity required control p53 stability hgtse 1
0.51632494.14707141.html.plaintext.txt	53	previous results indicated overexpression hgtse 1 regulates p53 protein levels 27 p53 degradation described occur mainly cytoplasm 38 investigated whether regulation p53 protein stability via hgtse 1 expression linked enhanced cytoplasmic localization p53 analyzing effect wt nes defective hgtse 1 proteins p53 levels purpose p53 null mg 63 cells transfected vectors expressing wt nes hgtse 1 p53 together empty gfp vector used transfection control perform experiment transfected low levels untagged wt p53 appreciate alterations stability observed stable gfp p53 fusion protein represent sensitive assay hgtse 1 dependent regulation see fig 5c 24 h later cell lysates prepared p53 protein levels assessed western blotting observed fig 5e left panel hgtse 1 wt reduced p53 levels nes mutant effect regulating p53 suggesting relocalization p53 cytoplasm could mechanism hgtse 1 controls p53 levels finally investigated whether regulation p53 levels hgtse 1 required proteasome activity experiments performed adding proteasome inhibitor mg132 cells transfected parallel shown left panel fig 5e cells treated mg132 last 8 h lysis shown fig 5e right panel inhibition proteasome abolished p53 regulation wt hgtse 1 indicating proteasome activity required control p53 stability hgtse 1
0.51632494.14707141.html.plaintext.txt	54	functional mdm2 required hgtse 1 dependent p53 nuclear export obtained results suggest hgtse 1 able regulate p53 protein levels mechanism involving p53 cytoplasmic relocalization mdm2 major regulator p53 4 5 strongly promotes p53 nuclear exclusion 11 12 reason next analyzed requirement mdm2 hgtse 1 dependent regulation p53 subcellular localization
0.51632494.14707141.html.plaintext.txt	55	functional mdm2 required hgtse 1 dependent p53 nuclear export obtained results suggest hgtse 1 able regulate p53 protein levels mechanism involving p53 cytoplasmic relocalization mdm2 major regulator p53 4 5 strongly promotes p53 nuclear exclusion 11 12 reason next analyzed requirement mdm2 hgtse 1 dependent regulation p53 subcellular localization
0.51632494.14707141.html.plaintext.txt	56	first approach analyze effect hgtse 1 subcellular localization gfp p53 mdm2 deficient cells mef p53 mdm2 cells transfected gfp p53 together empty vector hgtse 1 wt expression vector 24 h post transfection cells fixed gfp p53 localization analyzed gfp fluorescence indicated representative images shown fig 6a hgtse 1 expression failed promote p53 cytoplasmic localization mdm2 deficient cells moreover effect hgtse 1 p53 nuclear export partially rescued mdm2 expression thus indicating effect hgtse 1 p53 nuclear export requires functional mdm2 fig 6b
0.51632494.14707141.html.plaintext.txt	57	first approach analyze effect hgtse 1 subcellular localization gfp p53 mdm2 deficient cells mef p53 mdm2 cells transfected gfp p53 together empty vector hgtse 1 wt expression vector 24 h post transfection cells fixed gfp p53 localization analyzed gfp fluorescence indicated representative images shown fig 6a hgtse 1 expression failed promote p53 cytoplasmic localization mdm2 deficient cells moreover effect hgtse 1 p53 nuclear export partially rescued mdm2 expression thus indicating effect hgtse 1 p53 nuclear export requires functional mdm2 fig 6b
0.51632494.14707141.html.plaintext.txt	58	view larger version 32k fig 6 functional mdm2 required hgtse 1 dependent regulation p53 localization stability gfp p53 localization mef p53 mdm2 overexpressing hgtse 1 image shows hgtse 1 upper panel gfp p53 lower panel staining field b mef p53 mdm2 transfected hgtse 1 mdm2 combination indicated together gfp p53 expressing vector p53 localization determined fluorescence microscopy described c wt p53 2223 p53 transfected together gfp gfp hgtse 1 indicated mef p53 p53 stained using specific polyclonal antibody p53 localization determined cells expressing gfp gfp hgtse 1 fluorescence microscopy d determination p53 protein levels mef p53 mdm2 cotransfected wt p53 together empty vector hgtse 1 wt wt 1 monoclonal antibody used detect p53 gfp used transfection control
0.51632494.14707141.html.plaintext.txt	59	second approach analyzed effect hgtse 1 cellular localization l22qw23s p53 mutant 2223 p53 unable bind mdm2 39 relocalize cytoplasm upon mdm2 overexpression 11 12 mef p53 cells transfected wt p53 2223 p53 combination gfp hgtse 1 gfp vectors analyzed staining specific anti p53 polyclonal antibody shown fig 6c whereas gfp hgtse 1 expression enhanced wt p53 nuclear export failed relocalizing 2223 p53 cytoplasm mef p53 supporting previous results indicating hgtse 1 enhances p53 cytoplasmic localization mdm2 dependent mechanism
0.51632494.14707141.html.plaintext.txt	60	second approach analyzed effect hgtse 1 cellular localization l22qw23s p53 mutant 2223 p53 unable bind mdm2 39 relocalize cytoplasm upon mdm2 overexpression 11 12 mef p53 cells transfected wt p53 2223 p53 combination gfp hgtse 1 gfp vectors analyzed staining specific anti p53 polyclonal antibody shown fig 6c whereas gfp hgtse 1 expression enhanced wt p53 nuclear export failed relocalizing 2223 p53 cytoplasm mef p53 supporting previous results indicating hgtse 1 enhances p53 cytoplasmic localization mdm2 dependent mechanism
0.51632494.14707141.html.plaintext.txt	61	finally using mef p53 mdm2 hgtse 1 fails relocalizing p53 cytoplasm investigated whether hgtse 1 could affect p53 stability purpose cells transfected vectors expressing wt nes hgtse 1 p53 together empty gfp vector used transfection control performed fig 5e western blot analysis indicated hgtse 1 markedly affect p53 stability suggesting hgtse 1 could regulate p53 levels enhancing cytoplasmic relocalization mdm2 dependent mechanism
0.51632494.14707141.html.plaintext.txt	62	finally using mef p53 mdm2 hgtse 1 fails relocalizing p53 cytoplasm investigated whether hgtse 1 could affect p53 stability purpose cells transfected vectors expressing wt nes hgtse 1 p53 together empty gfp vector used transfection control performed fig 5e western blot analysis indicated hgtse 1 markedly affect p53 stability suggesting hgtse 1 could regulate p53 levels enhancing cytoplasmic relocalization mdm2 dependent mechanism
0.51632494.14707141.html.plaintext.txt	63	discussion top abstract introduction experimental procedures results discussion references present new insights function hgtse 1 recently characterized negative regulator p53 27 provide evidence hgtse 1 nucleo cytoplasmic shuttling protein becomes stabilized accumulates nucleus dna damage independently p53 status show hgtse 1 nuclear export depends c terminal nes mutated increases nuclear localization interestingly hgtse 1 overexpression enhances cytoplasmic localization p53 requiring intact nes functional mdm2 efficiently exert function
0.51632494.14707141.html.plaintext.txt	64	discussion top abstract introduction experimental procedures results discussion references present new insights function hgtse 1 recently characterized negative regulator p53 27 provide evidence hgtse 1 nucleo cytoplasmic shuttling protein becomes stabilized accumulates nucleus dna damage independently p53 status show hgtse 1 nuclear export depends c terminal nes mutated increases nuclear localization interestingly hgtse 1 overexpression enhances cytoplasmic localization p53 requiring intact nes functional mdm2 efficiently exert function
0.51632494.14707141.html.plaintext.txt	65	unstressed cells number positive negative regulators maintain steady state level p53 stress conditions p53 activated variety post translational modifications altogether lead rapid stabilization accumulation nucleus 7 modifications usually necessary association p53 factors involved stabilization activation pin 1 40 andor dissociation factors negatively regulate p53 like mdm2 jnk 41 42 contrary post damage recovery negative regulators play critical role regulating p53 levels activity restore steady state function hypothesized recovery phase requests regulators like hgtse 1 addition established ones
0.51632494.14707141.html.plaintext.txt	66	unstressed cells number positive negative regulators maintain steady state level p53 stress conditions p53 activated variety post translational modifications altogether lead rapid stabilization accumulation nucleus 7 modifications usually necessary association p53 factors involved stabilization activation pin 1 40 andor dissociation factors negatively regulate p53 like mdm2 jnk 41 42 contrary post damage recovery negative regulators play critical role regulating p53 levels activity restore steady state function hypothesized recovery phase requests regulators like hgtse 1 addition established ones
0.51632494.14707141.html.plaintext.txt	67	report show hgtse 1 protein levels increase response several dna damaging agents recently demonstrated hgtse 1 expression attenuates dna damage induced apoptosis controlling p53 function 27 increased levels hgtse 1 protein dna damage may involved negative feedback regulation p53 signaling pathway consistent model sirna mediated regulation hgtse 1 sensitizes cells p53 dependent apoptosis upon dna damage 27 thus hgtse 1 may play important role dna damage response preventing prolonged p53 activation analysis behavior hgtse 1 allowed us show dna damage hgtse 1 clearly relocalized cytoplasm nucleus time course experiments performed dissect kinetics hgtse 1 enhanced expression nuclear accumulation dna damage indicate occur slower rate compared p53 stabilization activation p21waf 1 induction observation could imply early time points dna damage hgtse 1 interfere p53 response rather could play critical role controlling later phase p53 response likely post damage recovery phase
0.51632494.14707141.html.plaintext.txt	68	report show hgtse 1 protein levels increase response several dna damaging agents recently demonstrated hgtse 1 expression attenuates dna damage induced apoptosis controlling p53 function 27 increased levels hgtse 1 protein dna damage may involved negative feedback regulation p53 signaling pathway consistent model sirna mediated regulation hgtse 1 sensitizes cells p53 dependent apoptosis upon dna damage 27 thus hgtse 1 may play important role dna damage response preventing prolonged p53 activation analysis behavior hgtse 1 allowed us show dna damage hgtse 1 clearly relocalized cytoplasm nucleus time course experiments performed dissect kinetics hgtse 1 enhanced expression nuclear accumulation dna damage indicate occur slower rate compared p53 stabilization activation p21waf 1 induction observation could imply early time points dna damage hgtse 1 interfere p53 response rather could play critical role controlling later phase p53 response likely post damage recovery phase
0.51632494.14707141.html.plaintext.txt	69	show hgtse 1 actively shuttles cytoplasm nucleus evidenced nuclear export inhibitor lmb caused clear nuclear accumulation hgtse 1 furthermore mutation c terminal nes hgtse 1 nes enhanced hgtse 1 nuclear localization
0.51632494.14707141.html.plaintext.txt	70	show hgtse 1 actively shuttles cytoplasm nucleus evidenced nuclear export inhibitor lmb caused clear nuclear accumulation hgtse 1 furthermore mutation c terminal nes hgtse 1 nes enhanced hgtse 1 nuclear localization
0.51632494.14707141.html.plaintext.txt	71	shuttling activity hgtse 1 therefore emerged potentially critical mechanism controlling p53 localization stability line hypothesis coexpression hgtse 1 p53 used gfp tagged protein resulted increased cytoplasmic distribution p53 compared localization p53 alone hgtse 1 known interact p53 region mapped amino acids 355 393 27 two nls located 7 mdm2 dependent ubiquitination lysine residues found within nlss results enhanced cytoplasmic localization p53 23 suggesting modification region could lead p53 nuclear export context physical interaction hgtse 1 p53 could affect region enhancing p53 cytoplasmic localization importantly hgtse 1 shuttling activity required promote p53 localization cytoplasm results clearly demonstrate nes defective hgtse 1 failed enhancing p53 distribution cytoplasm although ability associate p53 comparable wt hgtse 1 therefore conceivable cytoplasmic redistribution p53 enhanced hgtse 1 merely alterations modifications c terminal domain p53 caused interaction rather data also indicate requirement hgtse 1 shuttling activity interestingly mdm2 known efficiently promote p53 nuclear exclusion 11 12 also required hgtse 1 effect p53 localization observed hgtse 1 wt shows impaired ability relocalizing p53 mdm2 deficient cells
0.51632494.14707141.html.plaintext.txt	72	shuttling activity hgtse 1 therefore emerged potentially critical mechanism controlling p53 localization stability line hypothesis coexpression hgtse 1 p53 used gfp tagged protein resulted increased cytoplasmic distribution p53 compared localization p53 alone hgtse 1 known interact p53 region mapped amino acids 355 393 27 two nls located 7 mdm2 dependent ubiquitination lysine residues found within nlss results enhanced cytoplasmic localization p53 23 suggesting modification region could lead p53 nuclear export context physical interaction hgtse 1 p53 could affect region enhancing p53 cytoplasmic localization importantly hgtse 1 shuttling activity required promote p53 localization cytoplasm results clearly demonstrate nes defective hgtse 1 failed enhancing p53 distribution cytoplasm although ability associate p53 comparable wt hgtse 1 therefore conceivable cytoplasmic redistribution p53 enhanced hgtse 1 merely alterations modifications c terminal domain p53 caused interaction rather data also indicate requirement hgtse 1 shuttling activity interestingly mdm2 known efficiently promote p53 nuclear exclusion 11 12 also required hgtse 1 effect p53 localization observed hgtse 1 wt shows impaired ability relocalizing p53 mdm2 deficient cells
0.51632494.14707141.html.plaintext.txt	73	similarly observed p53 relocalization intact nes functional mdm2 seem required hgtse 1 regulation p53 protein levels indicating relationship ability hgtse 1 relocalize p53 cytoplasm regulate stability moreover inhibition proteasome activity prevents p53 protein regulation hgtse 1 expression indicating cytoplasmic localization p53 could accompanied proteasome dependent degradation mdm2 ring finger domain ability ubiquitinate p53 shown critical promoting p53 nuclear export 11 12 degradation cytoplasm 10 38 possibility hgtse 1 could promote p53 nuclear export enhancing mdm2 dependent ubiquitination p53 seem consistent data detectable increase p53 ubiquitination observed vivo ubiquitination assay data shown thus favor hypothesis hgtse 1 accelerates p53 nuclear export process mdm2 dependent ubiquitination
0.51632494.14707141.html.plaintext.txt	74	similarly observed p53 relocalization intact nes functional mdm2 seem required hgtse 1 regulation p53 protein levels indicating relationship ability hgtse 1 relocalize p53 cytoplasm regulate stability moreover inhibition proteasome activity prevents p53 protein regulation hgtse 1 expression indicating cytoplasmic localization p53 could accompanied proteasome dependent degradation mdm2 ring finger domain ability ubiquitinate p53 shown critical promoting p53 nuclear export 11 12 degradation cytoplasm 10 38 possibility hgtse 1 could promote p53 nuclear export enhancing mdm2 dependent ubiquitination p53 seem consistent data detectable increase p53 ubiquitination observed vivo ubiquitination assay data shown thus favor hypothesis hgtse 1 accelerates p53 nuclear export process mdm2 dependent ubiquitination
0.51632494.14707141.html.plaintext.txt	75	nuclear accumulated hgtse 1 looses ability regulate localization levels p53 demonstrated using nes defective hgtse 1 therefore could hypothesize nuclear accumulation hgtse 1 response dna damage could phosphorylation dependent mechanism inactivating nes function subsequently post damage recovery phase reactivation hgtse 1 nes activity dephosphorylation could required efficient regulatory function hgtse 1 p53
0.51632494.14707141.html.plaintext.txt	76	nuclear accumulated hgtse 1 looses ability regulate localization levels p53 demonstrated using nes defective hgtse 1 therefore could hypothesize nuclear accumulation hgtse 1 response dna damage could phosphorylation dependent mechanism inactivating nes function subsequently post damage recovery phase reactivation hgtse 1 nes activity dephosphorylation could required efficient regulatory function hgtse 1 p53
0.51632494.14707141.html.plaintext.txt	77	conceivable similar function hgtse 1 takes place unstressed cells cell cycle shown control basal p53 levels preferentially g2 phases 27 moreover p53 localization reported change cell cycle increased cytoplasmic distribution g2 43 44 coincident hgtse 1 highest expression together data could suggest physiological function hgtse 1 regulating p53 stability nuclear exclusion p53 unstressed cells possibly specific phases cell cycle require additional stringent negative regulators
0.51632494.14707141.html.plaintext.txt	78	conceivable similar function hgtse 1 takes place unstressed cells cell cycle shown control basal p53 levels preferentially g2 phases 27 moreover p53 localization reported change cell cycle increased cytoplasmic distribution g2 43 44 coincident hgtse 1 highest expression together data could suggest physiological function hgtse 1 regulating p53 stability nuclear exclusion p53 unstressed cells possibly specific phases cell cycle require additional stringent negative regulators
0.51632494.14707141.html.plaintext.txt	79	results indicate dna damage hgtse 1 stabilized independently p53 status suggesting response damage hgtse 1 could play specific functions parallel involving p53 regulation fact ability hgtse 1 regulate cell cycle progression p53 independent 27 proteins jnk 42 pin 1 40 p38 kinase 45 play role p53 signaling although regulation depend p53 thus suggesting p53 function tightly controlled independent signaling pathways
0.51632494.14707141.html.plaintext.txt	80	results indicate dna damage hgtse 1 stabilized independently p53 status suggesting response damage hgtse 1 could play specific functions parallel involving p53 regulation fact ability hgtse 1 regulate cell cycle progression p53 independent 27 proteins jnk 42 pin 1 40 p38 kinase 45 play role p53 signaling although regulation depend p53 thus suggesting p53 function tightly controlled independent signaling pathways
0.51632494.14707141.html.plaintext.txt	81	present possible mechanism hgtse 1 regulate p53 dna damage highlighting relevance nucleo cytoplasmic shuttling activity functional requirement mdm2 hgtse 1 like mouse homologue gtse 1 cell cycle regulated protein maintains g2 specific expression even induced dna damaging agents 25 therefore propose role hgtse 1 part negative feedback loop involved control dna damage specific phases cell cycle require effective means regulate p53 activity levels
0.51632494.14707141.html.plaintext.txt	82	present possible mechanism hgtse 1 regulate p53 dna damage highlighting relevance nucleo cytoplasmic shuttling activity functional requirement mdm2 hgtse 1 like mouse homologue gtse 1 cell cycle regulated protein maintains g2 specific expression even induced dna damaging agents 25 therefore propose role hgtse 1 part negative feedback loop involved control dna damage specific phases cell cycle require effective means regulate p53 activity levels
0.51632494.14707141.html.plaintext.txt	83	footnotes work supported associazione italiana per la ricerca sul cancro grant airc 0661 00 ministero dellistruzione delluniversita e della ricerca grant miur mm05187239004 consiglio nazionale delle ricerche cnr genomica funzionale sp4 c costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.51632494.14707141.html.plaintext.txt	84	correspondence addressed tel 39 040 398985 fax 39 040 398990 e mail schneideatsciareatriesteit u d
0.51632494.14707141.html.plaintext.txt	85	1 abbreviations used nes nuclear export signal nls nuclear localization signal et etoposide ts p53 temperature sensitive p53 wt wild type lmb leptomycin b gfp green fluorescent protein
0.51632494.14707141.html.plaintext.txt	86	acknowledgments thanks dr c brancolini collaboration confocal microscopy dr d delia cooperation irradiation experiments stefania marzinotto technical support cell culture
0.51632494.14707141.html.plaintext.txt	87	references top abstract introduction experimental procedures results discussion references ko l j prives c 1996 genes dev 10 1054 1072crossrefmedline order article via infotrieve kern e pietenpol j thiagalingam seymour kinzler k w vogelstein b 1992 science 256 827 830medline order article via infotrieve lin h j eviner v prendergast g c white e 1995 mol cell biol 15 4536 4544abstract haupt y maya r kazaz oren m 1997 nature 387 296 299crossrefmedline order article via infotrieve kubbutat m h jones n vousden k h 1997 nature 387 299 303crossrefmedline order article via infotrieve moll u m ostermeyer g haladay r winkfield b frazier m zambetti g 1996 mol cell biol 16 1126 1137abstract liang h clarke m f 2001 eur j biochem 268 2779 2783abstractfree full text ryan k m phillips c vousden k h 2001 curr opin cell biol 13 332 337crossrefmedline order article via infotrieve roth j dobbelstein m freedman d shenk levine j 1998 embo j 17 554 564abstractfree full text okeefe k li h zhang y 2003 mol cell biol 23 6396 6405abstractfree full text geyer r k yu z k maki c g 2000 nat cell biol 2 569 573crossrefmedline order article via infotrieve boyd d tsai k y jacks 2000 nat cell biol 2 563 668crossrefmedline order article via infotrieve zhang y xiong y 2001 science 292 1910 1915abstractfree full text zhang y xiong y 1999 mol cell 3 579 591medline order article via infotrieve maheswaran englert c lee b ezzel r m settleman j haber d 1998 oncogene 16 2041 2050crossrefmedline order article via infotrieve wadhwa r yaguchi hasan m k mitsui y reddel r r kaul c 2002 exp cell res 274 246 253crossrefmedline order article via infotrieve nikolaev y li m puskas n qin j gu w 2003 cell 112 29 40medline order article via infotrieve mathur m das samuels h h 2003 oncogene 22 5031 5044crossrefmedline order article via infotrieve liang h hong d clarke m f 1998 j biol chem 273 19817 19821abstractfree full text ostermeyer g runko e winkfield b ahn b moll u m 1996 proc natl acad sci u 93 15190 15194abstractfree full text stommel j m marchenko n d jimenez g moll u m hope j wahl g m 1999 embo j 18 1660 1672abstractfree full text gu j nie l wiederschain d yuan z m 2001 mol cell biol 21 8533 8546abstractfree full text lohrum m woods d b ludwig r l balint e vousden k h 2001 mol cell biol 21 8521 8532abstractfree full text utrera r collavin l lazarevic d delia d schneider c 1998 embo j 17 5015 5025abstractfree full text collavin l monte m verardo r pfleger c schneider c 2000 febs lett 481 57 62crossrefmedline order article via infotrieve monte m collavin l lazarevic d utrera r dragani schneider c 2000 gene amst 254 229 236crossrefmedline order article via infotrieve monte m benetti r buscami g sandy p del sal g schneider c 2003 j biol chem 278 30356 30364abstractfree full text buckbinder l talbott r seizinger b r kley n 1994 proc natl acad sci u 91 10640 10644abstractfree full text vikhanskaya f erba e dincalci m broggini m 1994 nucleic acids res 22 1012 1017abstract benetti r del sal g monte m paroni g brancolini c schneider c 2001 embo j 20 2702 2714abstractfree full text delia d goi k mizutani yamada aiello fontanella e lamorte g iwata ishioka c krajewski reed j c pierotti m 1997 oncogene 14 2137 2147crossrefmedline order article via infotrieve el deiry w tokino velculescu v e levy d b parsons r trent j m lin d mercer w e kinzler k w vogelstein b 1993 cell 75 817 825medline order article via infotrieve fischer u huber j boelens w c mattaj w luhrmann r 1995 cell 82 475 483medline order article via infotrieve fornerod m ohno m yoshida m mattaj w 1997 cell 90 1051 1060medline order article via infotrieve fukuda m asano nakamura adachi m yoshida m yanagida m nishida e 1997 nature 390 308 311crossrefmedline order article via infotrieve ossareh nazari b bachelerie f dargemont c 1997 science 278 141 144abstractfree full text chernov m v bean l j lerner n stark g r 2001 j biol chem 276 31819 31824abstractfree full text freedman d levine j 1998 mol cell biol 18 7288 7293abstractfree full text lin j chen j elenbaas b levine j 1994 genes dev 8 1235 1246abstract zacchi p gostissa m uccida salvano c avorio f volinia ronai z blandino g schneider c del sal g 2002 nature 419 853 857crossrefmedline order article via infotrieve shieh y ikeda m taya y prives c 1997 cell 91 325 334medline order article via infotrieve fuchs y adler v buschmann yin z wu x jones n ronai z 1998 genes dev 12 2658 2663abstractfree full text david pfeuty chakrani f ory k nouvian dooghe y 1996 cell growth differ 7 1211 1225abstract shaulsky g ben zeev rotter v 1990 oncogene 5 1707 1711medline order article via infotrieve bulavin d v saito hollander m c sakaguchi k anderson c w appella e fornace j jr 1999 embo j 18 6845 6854abstractfree full text article abstract full text pdf versions article 2791211744 recent m311123200v1 purchase article view shopping cart alert article cited alert correction posted citation map services email article friend similar articles journal similar articles pubmed alert new issues journal download citation manager copyright permissions google scholar articles monte m articles schneider c articles citing article pubmed pubmed citation articles monte m articles schneider c
0.51632494.14707141.html.plaintext.txt	88	home help feedback subscriptions archive search table contents asbmb journals molecular cellular proteomics journal lipid research biochemistry molecular biology education copyright 2004 american society biochemistry molecular biology
0.5221876.11805092.html.plaintext.txt	0	biogenesis p53 involves cotranslational dimerization monomers posttranslational dimerization dimers implications dominant negative effect chris d nicholls kevin g mclure michael shields patrick w k lee
0.5221876.11805092.html.plaintext.txt	1	cancer biology research group department microbiology infectious diseases university calgary health sciences centre calgary alberta canada t2n 4n1
0.5221876.11805092.html.plaintext.txt	2	received publication september 12 2001 revised form january 16 2002
0.5221876.11805092.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references
0.5221876.11805092.html.plaintext.txt	4	precisely mutant p53 exerts dominant negative effect wild type p53 enigma understand wild type mutant p53 form hetero oligomers studied p53 biogenesis vitro show p53 dimers formed cotranslationally polysome whereas tetramers formed posttranslationally dimerization dimers solution coexpression wild type mutant p53 therefore results 50 p53 generated heterotetramers comprised single species wild type dimermutant dimer using hot spot mutants p53 variety natural target sites show wild typemutant heterotetramers manifest impaired dna binding activity impairment due mutant dimeric subunit inhibiting association complex dna rather due lack significant contribution positive cooperativity mutant partner heterotetramers bias binding particularly pronounced sequences genes responsible apoptosis rather cell growth arrest results explain molecular basis p53 dominant negative effect suggest functional role regulation p53 tetramerization introduction top abstract introduction experimental procedures results discussion references
0.5221876.11805092.html.plaintext.txt	5	precisely mutant p53 exerts dominant negative effect wild type p53 enigma understand wild type mutant p53 form hetero oligomers studied p53 biogenesis vitro show p53 dimers formed cotranslationally polysome whereas tetramers formed posttranslationally dimerization dimers solution coexpression wild type mutant p53 therefore results 50 p53 generated heterotetramers comprised single species wild type dimermutant dimer using hot spot mutants p53 variety natural target sites show wild typemutant heterotetramers manifest impaired dna binding activity impairment due mutant dimeric subunit inhibiting association complex dna rather due lack significant contribution positive cooperativity mutant partner heterotetramers bias binding particularly pronounced sequences genes responsible apoptosis rather cell growth arrest results explain molecular basis p53 dominant negative effect suggest functional role regulation p53 tetramerization introduction top abstract introduction experimental procedures results discussion references
0.5221876.11805092.html.plaintext.txt	6	importance p53 tumor suppressor well documented half human cancers mutated gene encoding p53 many viruses induce transformation host cell p53 inactivation ref 1 reviewed refs 2 3 furthermore inheriting germline p53 mutation characteristic li fraumeni syndrome confers strong predisposition cancer 50 afflicted acquire cancer age 30 4 5 role p53 tumorigenesis also demonstrated animal tumor model p53 mice found prone cancer development primarily lymphomas compared wild type p53 heterozygous p53 littermates 6 7 loss p53 function therefore clearly linked tumor formation
0.5221876.11805092.html.plaintext.txt	7	importance p53 tumor suppressor well documented half human cancers mutated gene encoding p53 many viruses induce transformation host cell p53 inactivation ref 1 reviewed refs 2 3 furthermore inheriting germline p53 mutation characteristic li fraumeni syndrome confers strong predisposition cancer 50 afflicted acquire cancer age 30 4 5 role p53 tumorigenesis also demonstrated animal tumor model p53 mice found prone cancer development primarily lymphomas compared wild type p53 heterozygous p53 littermates 6 7 loss p53 function therefore clearly linked tumor formation
0.5221876.11805092.html.plaintext.txt	8	guardian genome p53 activated number genotoxic stress signals ionizing radiation ultraviolet light ribonucleotide depletion hypoxia oxidative stress heat shock exposure nitric oxide reviewed ref 8 critical tumor suppressing function activated p53 ability bind sequence specific dna sites induce transcription genes involved cell cycle arrest dna repair apoptosis illustrated fact p53 mutations occur dna binding domain affect sequence specific dna binding ability 1 mutations called hot spot mutations divided two categories class mutations affect residues make direct contact dna whereas class ii mutations occur residues crucial maintaining conformation dna binding domain 9
0.5221876.11805092.html.plaintext.txt	9	consensus p53 binding site consists two copies 10 bp half site 5 pupupucatatgpypypy 3 separated 13 bp 10 minor variations consensus sequence found p53 target genes half site consists two inverted repeat 5 bp quarter sites p53 binds consensus dna sequence pair clamps two monomers within dimer binding two consecutive quarter sites within half site 11 two dimers within tetramer therefore bind two half sites juxtaposition resulting overall enhanced stability p53 dna complex lack cooperative binding single dimer half site interaction accounts drastically reduced stability dimer half site complex relative tetramer full site complex also reflected observation contrast full sites half sites confer transcriptional responsiveness p531
0.5221876.11805092.html.plaintext.txt	10	consensus p53 binding site consists two copies 10 bp half site 5 pupupucatatgpypypy 3 separated 13 bp 10 minor variations consensus sequence found p53 target genes half site consists two inverted repeat 5 bp quarter sites p53 binds consensus dna sequence pair clamps two monomers within dimer binding two consecutive quarter sites within half site 11 two dimers within tetramer therefore bind two half sites juxtaposition resulting overall enhanced stability p53 dna complex lack cooperative binding single dimer half site interaction accounts drastically reduced stability dimer half site complex relative tetramer full site complex also reflected observation contrast full sites half sites confer transcriptional responsiveness p531
0.5221876.11805092.html.plaintext.txt	11	although little doubt tumors often arise deletion mutation p53 alleles two hit model 12 increasing evidence point mutation deletion single allele could result increased susceptibility cancer 13 17 cases mutant wild type p53 expressed suggested mutant protein exerts dominant negative effect wild type protein essentially rendering latter inactive reviewed refs 18 19 end result drastic decrease level functional p53 turn promotes genomic instability cancer development mere reduction functional p53 levels may sufficient promote tumorigenesis also recently shown animal tumor model heterozygous p53 mice containing single wild type p53 allele develop tumors much earlier mice two functional p53 alleles 17
0.5221876.11805092.html.plaintext.txt	12	although little doubt tumors often arise deletion mutation p53 alleles two hit model 12 increasing evidence point mutation deletion single allele could result increased susceptibility cancer 13 17 cases mutant wild type p53 expressed suggested mutant protein exerts dominant negative effect wild type protein essentially rendering latter inactive reviewed refs 18 19 end result drastic decrease level functional p53 turn promotes genomic instability cancer development mere reduction functional p53 levels may sufficient promote tumorigenesis also recently shown animal tumor model heterozygous p53 mice containing single wild type p53 allele develop tumors much earlier mice two functional p53 alleles 17
0.5221876.11805092.html.plaintext.txt	13	fact many human tumors contain mutant wild type allele led speculations mutant p53 affect wild type p53 function proposed generally believed tumors mutant p53 protein complexes wild type counterpart drives latter mutant conformation nonfunctional ie incapable binding dna model portrays mutant p53 dominant wild type p53 leading called dominant negative effect support model come largely experiments mutant wild type p53 found coprecipitatable coexpressed 20 recent data suggest c terminal oligomerization domain p53 absolutely required manifestation dominant negative effect p53 mutants without functional tetramerization domain dominant negative oncogenic 21 22 although seems clear p53 mutants need interact wild type p53 impart dominant negative effect 23 concrete evidence effect result induced conformational change wild type protein indeed reported mutant p53 proteins wild type conformation class mutants also able impart dominant negative effect 24 corroboration observation demonstration c terminal oligomerization domain alone sufficient disrupt normal wild type p53 function 25 26 view somewhat fragmentary times apparently contradictory information obtained thus far pertaining mechanistic aspects p53 dominant negative effect reviewed refs 18 19 unifying concept accommodate observations made date badly needed information would provide better understanding role p53 mutants tumor development would lead design precise effective therapeutic measures restoring wild type p53 function
0.5221876.11805092.html.plaintext.txt	14	fact many human tumors contain mutant wild type allele led speculations mutant p53 affect wild type p53 function proposed generally believed tumors mutant p53 protein complexes wild type counterpart drives latter mutant conformation nonfunctional ie incapable binding dna model portrays mutant p53 dominant wild type p53 leading called dominant negative effect support model come largely experiments mutant wild type p53 found coprecipitatable coexpressed 20 recent data suggest c terminal oligomerization domain p53 absolutely required manifestation dominant negative effect p53 mutants without functional tetramerization domain dominant negative oncogenic 21 22 although seems clear p53 mutants need interact wild type p53 impart dominant negative effect 23 concrete evidence effect result induced conformational change wild type protein indeed reported mutant p53 proteins wild type conformation class mutants also able impart dominant negative effect 24 corroboration observation demonstration c terminal oligomerization domain alone sufficient disrupt normal wild type p53 function 25 26 view somewhat fragmentary times apparently contradictory information obtained thus far pertaining mechanistic aspects p53 dominant negative effect reviewed refs 18 19 unifying concept accommodate observations made date badly needed information would provide better understanding role p53 mutants tumor development would lead design precise effective therapeutic measures restoring wild type p53 function
0.5221876.11805092.html.plaintext.txt	15	approached problem first studying biogenesis p53 vitro demonstrate dimerization p53 occurs polysome ie cotranslationally whereas tetramerization dimer dimer interaction occurs solution ie posttranslationally thus coexpression wild type mutant p53 results single heterotetrameric species p53 wild type dimermutant dimer representing 50 total p53 use hot spot mutants p53 none capable strong binding dna variety natural p53 target sites show heterotetramers bind poorly sites compared wild type p53 tetramer impaired binding likely due mutant imposed conformational change wild type p53 rather due lack complementary binding mutant dimeric subunit positive dimer dimer cooperativity propose incompetent partner model reconciles number puzzling observations date basis p53 dominant negative effect dominant negative effect pronounced sequences linked apoptotic response responsible cell growth arrest supporting notion lack apoptotic cell death likely plays important role loss cell growth control cancer development experimental procedures top abstract introduction experimental procedures results discussion references
0.5221876.11805092.html.plaintext.txt	16	approached problem first studying biogenesis p53 vitro demonstrate dimerization p53 occurs polysome ie cotranslationally whereas tetramerization dimer dimer interaction occurs solution ie posttranslationally thus coexpression wild type mutant p53 results single heterotetrameric species p53 wild type dimermutant dimer representing 50 total p53 use hot spot mutants p53 none capable strong binding dna variety natural p53 target sites show heterotetramers bind poorly sites compared wild type p53 tetramer impaired binding likely due mutant imposed conformational change wild type p53 rather due lack complementary binding mutant dimeric subunit positive dimer dimer cooperativity propose incompetent partner model reconciles number puzzling observations date basis p53 dominant negative effect dominant negative effect pronounced sequences linked apoptotic response responsible cell growth arrest supporting notion lack apoptotic cell death likely plays important role loss cell growth control cancer development experimental procedures top abstract introduction experimental procedures results discussion references
0.5221876.11805092.html.plaintext.txt	17	cloning full length constructs used pgemhp53wtb wild type tetrameric human p53 hp53 pgem a344 dimeric human p53 a344 gifts halazonetis 27 hp53n a344n created pcr following primers 5 atatgaattcaaccagcagcctcccgcgaccatggttctgtcccccttgcc 3 3 gggatatcactcagcataat 5 p53 mutants used also kind gift halazonetis
0.5221876.11805092.html.plaintext.txt	18	vitro transcription translation rna made linearizing purified plasmid dna hindiii transcribing sp6 polymerase using megascript kit ambion translation small aliquots rna added rabbit reticulocyte lysate promega typical reaction consisted 175 microl rabbit reticulocyte lysate 45 microl diethyl pyrocarbonate treated h2o 1 microl amino acids minus methionine 1 microl 35s methionine 05 mbq microl 1 microl rna typically 25 ng microl situations unlabeled p53 used complete amino acid mixture added translation reaction 35s methionine translations carried 37 degrees c 12 min
0.5221876.11805092.html.plaintext.txt	19	vitro transcription translation rna made linearizing purified plasmid dna hindiii transcribing sp6 polymerase using megascript kit ambion translation small aliquots rna added rabbit reticulocyte lysate promega typical reaction consisted 175 microl rabbit reticulocyte lysate 45 microl diethyl pyrocarbonate treated h2o 1 microl amino acids minus methionine 1 microl 35s methionine 05 mbq microl 1 microl rna typically 25 ng microl situations unlabeled p53 used complete amino acid mixture added translation reaction 35s methionine translations carried 37 degrees c 12 min
0.5221876.11805092.html.plaintext.txt	20	immunoprecipitations aliquots translation mixture diluted 15 ice cold phosphate buffered saline incubated ice 1 microl p53 monoclonal antibody 1 santa cruz equivalent amount normal mouse igg santa cruz 50 microl inactivated staphylococcus igsorb enzyme center added mixture incubated additional 30 min ice pellets washed four times wash buffer 400 mm nacl 50 mm tris ph 75 1 nonidet p 40 05 sodium deoxycholate 01 sds resuspended protein sample buffer 50 mm tris ph 68 1 sds 2 mercaptoethanol 10 glycerol 001 bromphenol blue samples boiled 5 min prior electrophoresis 10 polyacrylamide gels containing sds gels fixed 10 acetic acid 15 methanol embedded diphenyloxazole sigma dried exposed x omat ar film kodak 70 degrees c quantification performed unaltered images sigmagel software spss science see fig 4b
0.5221876.11805092.html.plaintext.txt	21	immunoprecipitations aliquots translation mixture diluted 15 ice cold phosphate buffered saline incubated ice 1 microl p53 monoclonal antibody 1 santa cruz equivalent amount normal mouse igg santa cruz 50 microl inactivated staphylococcus igsorb enzyme center added mixture incubated additional 30 min ice pellets washed four times wash buffer 400 mm nacl 50 mm tris ph 75 1 nonidet p 40 05 sodium deoxycholate 01 sds resuspended protein sample buffer 50 mm tris ph 68 1 sds 2 mercaptoethanol 10 glycerol 001 bromphenol blue samples boiled 5 min prior electrophoresis 10 polyacrylamide gels containing sds gels fixed 10 acetic acid 15 methanol embedded diphenyloxazole sigma dried exposed x omat ar film kodak 70 degrees c quantification performed unaltered images sigmagel software spss science see fig 4b
0.5221876.11805092.html.plaintext.txt	22	dna binding analysis typical dna binding reaction contained 25 microl translation mixture 12 microl glycerol 1 microl salmon testes dna 01 microg microl 04 microl bovine serum albumin 50 microg microl sigma 025 microl dithiothreitol 01 m sigma 025 microl pab421 oncogene science 29 microl tris buffered saline 1 microl 32p labeled dna 1 ng microl situations 1 added supershift p53 dna complex additional 025 microl 1 santa cruz included mixture reactions incubated 22 degrees c 45 min cooled 4 degrees c electrophoresed high ionic strength nondenaturing polyacrylamide gel 11 gels dried exposed x omat blue xb 1 film kodak 70 degrees c quantification done using storm 860 phosphorimager molecular dynamics imagequant software see fig 7 sigmagel software spss science unaltered images see fig 4c sequences con h1 reported previously 11 others given table except hindiii overhangs added end label dna 32pdctp using klenow polymerase invitrogen
0.5221876.11805092.html.plaintext.txt	23	dna binding analysis typical dna binding reaction contained 25 microl translation mixture 12 microl glycerol 1 microl salmon testes dna 01 microg microl 04 microl bovine serum albumin 50 microg microl sigma 025 microl dithiothreitol 01 m sigma 025 microl pab421 oncogene science 29 microl tris buffered saline 1 microl 32p labeled dna 1 ng microl situations 1 added supershift p53 dna complex additional 025 microl 1 santa cruz included mixture reactions incubated 22 degrees c 45 min cooled 4 degrees c electrophoresed high ionic strength nondenaturing polyacrylamide gel 11 gels dried exposed x omat blue xb 1 film kodak 70 degrees c quantification done using storm 860 phosphorimager molecular dynamics imagequant software see fig 7 sigmagel software spss science unaltered images see fig 4c sequences con h1 reported previously 11 others given table except hindiii overhangs added end label dna 32pdctp using klenow polymerase invitrogen
0.5221876.11805092.html.plaintext.txt	24	view table table various natural p53 target sites consensus p53 binding site shown along con artificial p53 target sequence matching consensus site 20 bases 11 nine naturally occurring human p53 target sequences also shown nucleotides matching consensus sequence shown capital letters whereas matching mismatches spaces half sites shown lowercase letters underlined nucleotides 14 3 3 bax sequences likely p53 binding sites 56 61 results top abstract introduction experimental procedures results discussion references
0.5221876.11805092.html.plaintext.txt	25	view table table various natural p53 target sites consensus p53 binding site shown along con artificial p53 target sequence matching consensus site 20 bases 11 nine naturally occurring human p53 target sequences also shown nucleotides matching consensus sequence shown capital letters whereas matching mismatches spaces half sites shown lowercase letters underlined nucleotides 14 3 3 bax sequences likely p53 binding sites 56 61 results top abstract introduction experimental procedures results discussion references
0.5221876.11805092.html.plaintext.txt	26	p53 dimerization occurs cotranslationally gain complete understanding p53 monomers reach tetrameric state carried vitro experiments study biogenesis pathway p53 important first determine whether p53 dimerization occurs cotranslationally posttranslationally end used transcripts dimeric mutant named a344 vitro translation rabbit reticulocyte lysate mutant contains point mutation residue 344 leucine alanine disrupts dimer dimer interface results formation dimeric rather tetrameric p53 27 reasoned p53 dimerization posttranslational event efficiency dimer formation would strictly dependent concentration translated a344 protein hence concentration transcripts reaction conversely efficiency cotranslational dimer formation ie polysome would affected transcript concentration accordingly various amounts a344 transcripts translated vitro rabbit reticulocyte lysate dimer formation reactions assessed direct half site dna binding analysis using electrophoretic mobility shift assay emsa2 monomeric p53 bind dna 22 results relatively unambiguous fig 1 shows regardless transcript concentration reactions three serial 2 fold dilutions dimertotal a344 ratios remained relatively constant results consistent notion p53 dimerization occurs cotranslationally rather posttranslationally
0.5221876.11805092.html.plaintext.txt	27	p53 dimerization occurs cotranslationally gain complete understanding p53 monomers reach tetrameric state carried vitro experiments study biogenesis pathway p53 important first determine whether p53 dimerization occurs cotranslationally posttranslationally end used transcripts dimeric mutant named a344 vitro translation rabbit reticulocyte lysate mutant contains point mutation residue 344 leucine alanine disrupts dimer dimer interface results formation dimeric rather tetrameric p53 27 reasoned p53 dimerization posttranslational event efficiency dimer formation would strictly dependent concentration translated a344 protein hence concentration transcripts reaction conversely efficiency cotranslational dimer formation ie polysome would affected transcript concentration accordingly various amounts a344 transcripts translated vitro rabbit reticulocyte lysate dimer formation reactions assessed direct half site dna binding analysis using electrophoretic mobility shift assay emsa2 monomeric p53 bind dna 22 results relatively unambiguous fig 1 shows regardless transcript concentration reactions three serial 2 fold dilutions dimertotal a344 ratios remained relatively constant results consistent notion p53 dimerization occurs cotranslationally rather posttranslationally
0.5221876.11805092.html.plaintext.txt	28	view larger version 29k fig 1 effect transcript concentration p53 dimer formation low a344 transcript concentrations serially diluted 2 fold 625 078 ng microl translated rabbit reticulocyte lysates presence 35smethionine identical fixed volumes 35s labeled translation mixture analyzed sds page total a344 protein expressed upper panel emsa dimeric a344 binding 32p labeled half site h1 lower panel b similar except amounts translation mixture analyzed adjusted compensate dilution factor samples contained approximately amount translated protein emsa analysis 35s signal blocked interfere film exposure 32p
0.5221876.11805092.html.plaintext.txt	29	confirm p53 dimerization cotranslational event made use another dimeric construct a344n fig 2a a344n derived a344 small deletion n terminus residues 2 30 making migrate faster a344 upon sds page like a344 a344n bound consensus dna half site dimeric p53 fig 2b furthermore deletion a344n unable interact anti p53 antibody 1 readily recognized a344 fig 2c lanes 1 6 1 capable recognizing monomer within dimer see used coprecipitation studies see whether cotranslation two constructs could lead formation a344a344n heterodimers detectable antibody results show translation conditions using normal concentrations rna two constructs formed dimers readily assessed emsa 1 precipitated a344 a344n fig 2c lanes 7 8 data strongly suggest p53 dimers form cotranslationally rule possibility a344a344n heterodimers unstable undetectable cotranslated two transcripts high rna concentrations conditions space constraint allowed nascent polypeptide chains neighboring transcripts interact 28 resulting small amount a344n complexing a344 precipitable 1 fig 2c lanes 9 10 shows lack detection a344a344n heterodimers translation conditions using normal concentrations rna due instability a344a344n heterodimers also demonstrates antibody 1 capable interacting monomer within p53 dimer
0.5221876.11805092.html.plaintext.txt	30	view larger version 28k fig 2 p53 dimers form cotranslationally diagram showing two constructs used figure immunoreactivity p53 monoclonal antibody 1 b hp53 wild type human p53 a344 a344n translated rabbit reticulocyte lysates subjected emsa analysis determine oligomeric status binding 32p labeled half site h1 c a344 a344n translated separately together presence 35smethionine samples immunoprecipitated control ctrl antibody p53 monoclonal antibody 1 cotranslations performed high concentrations rna used 100 ng transcript instead normal 25 ng different exposure times used approximately equalize band intensity translations carried normal high rna concentrations exp represents sample translation reaction removed prior immunoprecipitation monitor protein expression asterisks represent truncated p53 proteins produced vitro translations alternate start site codon 40
0.5221876.11805092.html.plaintext.txt	31	p53 tetramerization occurs posttranslationally proceeded determine whether p53 tetramerization occurs cotranslationally posttranslationally approach similar except tetrameric rather dimeric p53 constructs ie without a344 mutation used first translated various amounts wild type human p53 hp53 vitro assessed formation dimeric tetrameric p53 direct half site dna binding using emsa fig 3 shows low transcript hence low protein concentrations p53 made mostly dimeric form higher transcript concentrations ratio tetramerdimer increased dramatically consistent notion whereas p53 dimers formed cotranslationally tetramers formed posttranslationally
0.5221876.11805092.html.plaintext.txt	32	p53 tetramerization occurs posttranslationally proceeded determine whether p53 tetramerization occurs cotranslationally posttranslationally approach similar except tetrameric rather dimeric p53 constructs ie without a344 mutation used first translated various amounts wild type human p53 hp53 vitro assessed formation dimeric tetrameric p53 direct half site dna binding using emsa fig 3 shows low transcript hence low protein concentrations p53 made mostly dimeric form higher transcript concentrations ratio tetramerdimer increased dramatically consistent notion whereas p53 dimers formed cotranslationally tetramers formed posttranslationally
0.5221876.11805092.html.plaintext.txt	33	view larger version 39k fig 3 effect transcript concentration p53 tetramer formation low hp53 transcript concentrations serially diluted 2 fold 625 078 ng microl translated rabbit reticulocyte lysates parallel without presence 35smethionine identical fixed volumes 35s labeled translation mixture analyzed sds page total hp53 protein expressed upper panel emsa dimeric tetrameric hp53 binding 32p labeled half site h1 lower panel
0.5221876.11805092.html.plaintext.txt	34	demonstrate point cotranslation experiments carried using wild type hp53 construct truncated construct hp53n fig 4a two constructs translated separately 1 precipitated wild type p53 hp53 truncated construct hp53n fig 4b lanes 1 6 two transcripts mixed approximately equimolar ratios translated heterotetramers formed readily detectable 1 fig 4b lanes 7 8 furthermore ratio hp53 hp53n following immunoprecipitation 1 21 normalizing expression levels precisely would expected dimers species randomly oligomerizing solution form tetramers see results therefore suggest tetramerization dimerization dimers posttranslational process
0.5221876.11805092.html.plaintext.txt	35	view larger version 20k fig 4 p53 tetramers form posttranslationally diagram showing constructs used figure immunoreactivity p53 monoclonal antibody 1 b hp53 hp53n translated separately together rabbit reticulocyte lysate presence 35smethionine samples immunoprecipitated control ctrl antibody p53 monoclonal antibody 1 exp represents sample translation reaction removed prior immunoprecipitation monitor protein expression asterisks represent truncated p53 proteins produced vitro translations alternate start site codon 40 ratio hp53 hp53n lane 8 relative expression levels lane 7 1910 c hp53 hp53n translated separately together subjected emsa analysis determine oligomeric status binding 32p labeled consensus site con 1 added supershift p53 dna complex indicated lanes control ctrl lanes included translation reactions rna added relative intensities hp534 hp532hp53n2 hp53n4 lane 8 07 21 10 respectively
0.5221876.11805092.html.plaintext.txt	36	p53 assembly involves cotranslational dimerization followed posttranslational tetramerization cotranslation equal molar amounts hp53 hp53n generate three tetrameric species hp534 hp532hp53n2 hp53n4 ideally molar ratio 121 species clearly discernible using antibody 1 supershift experiments emsa results experiment shown fig 4c translated separately hp53 hp53n supershifted 1 fig 4c compare lanes 4 6 cotranslation hp53 hp53n transcripts yielded total three species two could supershifted 1 fig 4c compare lanes 7 8 results consistent cotranslational dimerizationposttranslational tetramerization model mentioned molar ratio three species ideally 121 assuming proteins two constructs synthesized equimolar amounts however consistently found hp534 somewhat represented fig 4c lane 8 top band likely due 1 partially blocking binding hp534 consensus sequence thereby reducing level hp534 bound dna fig 4c compare lanes 3 4 similar observation previously reported antibody pab246 recognizes wild type murine p53 11 binding hp532hp53n2 tetramer dna apparently unaffected 1 possibly one two dimers interacted antibody overall results two sets experiments involving dimeric tetrameric constructs respectively consistent idea p53 biogenesis two step process cotranslational dimerization followed posttranslational tetramerization agreement previous results folding peptides tetramerization domain p53 29
0.5221876.11805092.html.plaintext.txt	37	p53 assembly involves cotranslational dimerization followed posttranslational tetramerization cotranslation equal molar amounts hp53 hp53n generate three tetrameric species hp534 hp532hp53n2 hp53n4 ideally molar ratio 121 species clearly discernible using antibody 1 supershift experiments emsa results experiment shown fig 4c translated separately hp53 hp53n supershifted 1 fig 4c compare lanes 4 6 cotranslation hp53 hp53n transcripts yielded total three species two could supershifted 1 fig 4c compare lanes 7 8 results consistent cotranslational dimerizationposttranslational tetramerization model mentioned molar ratio three species ideally 121 assuming proteins two constructs synthesized equimolar amounts however consistently found hp534 somewhat represented fig 4c lane 8 top band likely due 1 partially blocking binding hp534 consensus sequence thereby reducing level hp534 bound dna fig 4c compare lanes 3 4 similar observation previously reported antibody pab246 recognizes wild type murine p53 11 binding hp532hp53n2 tetramer dna apparently unaffected 1 possibly one two dimers interacted antibody overall results two sets experiments involving dimeric tetrameric constructs respectively consistent idea p53 biogenesis two step process cotranslational dimerization followed posttranslational tetramerization agreement previous results folding peptides tetramerization domain p53 29
0.5221876.11805092.html.plaintext.txt	38	dimers within tetramers monomers within dimers exchangeable demonstration dimers formed cotranslationally suggests posttranslational exchange monomeric subunits dimers probably efficient occurs hand dimer dimer interaction tetramerization posttranslational event good possibility dimeric subunit exchange p53 tetramers occur certain degree efficiency 30 important consideration would imply equilibrium could exist dimers tetramers external factors parameters could influence equilibrium hence p53 function
0.5221876.11805092.html.plaintext.txt	39	dimers within tetramers monomers within dimers exchangeable demonstration dimers formed cotranslationally suggests posttranslational exchange monomeric subunits dimers probably efficient occurs hand dimer dimer interaction tetramerization posttranslational event good possibility dimeric subunit exchange p53 tetramers occur certain degree efficiency 30 important consideration would imply equilibrium could exist dimers tetramers external factors parameters could influence equilibrium hence p53 function
0.5221876.11805092.html.plaintext.txt	40	test hypothesis first necessary confirm relative lack monomeric exchange dimers 35s labeled a344 a344n translated separately cycloheximide added halt translation incubation continued additional hour allow time reaction reach equilibrium two reactions mixed incubated 2 h immunoprecipitation 1 carried look heterodimer formation would indicative subunit exchange results showed a344n could coprecipitated a344 fig 5a suggesting exchange monomers dimers occur therefore cotranslational formation p53 dimers appears one way process also agreement observation p53 monomers exist solution
0.5221876.11805092.html.plaintext.txt	41	test hypothesis first necessary confirm relative lack monomeric exchange dimers 35s labeled a344 a344n translated separately cycloheximide added halt translation incubation continued additional hour allow time reaction reach equilibrium two reactions mixed incubated 2 h immunoprecipitation 1 carried look heterodimer formation would indicative subunit exchange results showed a344n could coprecipitated a344 fig 5a suggesting exchange monomers dimers occur therefore cotranslational formation p53 dimers appears one way process also agreement observation p53 monomers exist solution
0.5221876.11805092.html.plaintext.txt	42	view larger version 28k fig 5 dimers within tetramer monomers within dimer exchangeable a344 a344n translated separately rabbit reticulocyte lysate presence 35smethionine reactions incubated ice 60 min following addition cycloheximide inhibit translation achieve equilibrium equal amounts translation reaction mixed incubated ice time indicated immunoprecipitation p53 monoclonal antibody 1 exp represents sample translation reaction removed prior immunoprecipitation monitor protein expression asterisks represent truncated p53 proteins produced vitro translations alternate start site codon 40 b similar except hp53 hp53n used place a344 a344n
0.5221876.11805092.html.plaintext.txt	43	determine whether dimerdimer exchange take place tetramers similar experiment performed hp53 hp53n fig 5b 2 h incubation period clear increase heterotetramer formation shows dimers within tetramer p53 exchange one another equilibrium equilibrium strongly favors tetramers dimers vast majority p53 present following translation maturation tetrameric 11 demonstration dimer exchange tetramers congruent concept p53 tetramerization posttranslational process involving dimerization dimers
0.5221876.11805092.html.plaintext.txt	44	wild typemutant p53 heterotetramers mutant p53 dimeric subunit completely abrogate binding tetramer consensus sequence suggested previously wild type p53mutant p53 complexes mutant p53 subunits induce mutant conformation wild type 53 subunits 20 resulting called dominant negative effect present demonstration p53 tetramers formed posttranslational dimerization dimers suggests cells eg li fraumeni cells containing wild type mutant p53 allele single species heterotetramers would generated wt p532mu p532 recently established two dimers within p53 tetramer conformationally independent 31 would interest assess binding heterotetramers consensus sequence con end cotranslated hp53n five common p53 mutants human cancers 1 addition wild type hp53 control five mutants used three contact class mutants named h273 w248 q248 whose mutations lie amino acids directly associate dna whereas two conformational class ii mutants named s249 h175 whose mutations destablilize structure core domain p53 9
0.5221876.11805092.html.plaintext.txt	45	wild typemutant p53 heterotetramers mutant p53 dimeric subunit completely abrogate binding tetramer consensus sequence suggested previously wild type p53mutant p53 complexes mutant p53 subunits induce mutant conformation wild type 53 subunits 20 resulting called dominant negative effect present demonstration p53 tetramers formed posttranslational dimerization dimers suggests cells eg li fraumeni cells containing wild type mutant p53 allele single species heterotetramers would generated wt p532mu p532 recently established two dimers within p53 tetramer conformationally independent 31 would interest assess binding heterotetramers consensus sequence con end cotranslated hp53n five common p53 mutants human cancers 1 addition wild type hp53 control five mutants used three contact class mutants named h273 w248 q248 whose mutations lie amino acids directly associate dna whereas two conformational class ii mutants named s249 h175 whose mutations destablilize structure core domain p53 9
0.5221876.11805092.html.plaintext.txt	46	immunoprecipitation cotranslation reactions 1 antibody reveals like wild type p53 five mutants efficiently complexed hp53n fig 6a expected five mutant homotetramers manifest extremely low affinity p53 consensus sequence fig 6b lanes 1 5 9 13 17 contrast five heterotetramers manifested significant consensus sequence binding activity ranging 40 100 control hp532hp53n2 tetramer figs 6b 7 moreover five dna bound heterotetramers stably bound half lives ranging 47 175 min data shown significantly longer wild type dimer bound half site half life 1 11 31 therefore class class ii mutants inability mutant dimeric subunit bind con negatively affect capacity wild type dimer subunit bind dna thus seems unlikely mutantwild type p53 heterotetramer mutant dimer imposes mutant conformation upon wild type dimer consistent observations others heterotetramer binding dna 32 33 previous demonstration within p53 tetramer two dimeric subunits conformationally independent 31
0.5221876.11805092.html.plaintext.txt	47	view larger version 62k fig 6 mutant p53 dimers oligomerize hp53n dimers hp53n dimer retains ability bind dna hp53n various class h273 w248 q248 class ii s249 h175 p53 mutants cotranslated rabbit reticulocyte lysate presence 35smethionine subjected immunoprecipitation control ctrl antibody p53 monoclonal antibody 1 exp represents sample translation reaction removed prior immunoprecipitation monitor protein expression asterisk represents truncated p53 protein produced vitro translations caused alternate start site codon 40 ratios h273 w248 q248 s249 h175 hp53n relative expression levels 1810 2010 1810 2010 2010 respectively b p53 mutants translated separately together hp53n rabbit reticulocyte lysate translation reactions subject emsa analysis binding 32p labeled consensus site con supershifted p53 monoclonal antibody 1 indicated separate different tetrameric species
0.5221876.11805092.html.plaintext.txt	48	mutantwild type p53 heterotetramers biased sequences govern apoptosis rather cell growth arrest relatively strong binding five heterotetramers con sequence led us wonder whether case con exception rather rule address issue chose wide range natural human p53 target sites table taken genes involved cell cycle arrest p21 14 3 3 apoptosis cyclin g fas pidd igf bp3 bax dna repair gadd45 p53 stability hdm2 whose transcription found occur p53 dependent manner con sequence included reference control shown fig 7 left panels cotranslation hp53 hp53n wild type control generated three tetrameric species hp534 hp532hp53n2 hp53n4 bound 10 sequences approximate ratio 121 slight variation migration rates target sequences due size charge differences sequences however cotranslation five mutants hp53n revealed different scenario first none mutant homotetramers capable efficient binding target sites ie equivalent uppermost band shown control hp534 either weak present mutanthp53n cotranslations unexpected mutants known class class ii mutants second importantly five mutant p53hp53n heterotetramers bind 10 target sites relatively poorly compared wild type p53hp53n heterotetramer although binding con least affected fig 7 right panels reduced binding capacity heterotetramer less pronounced mutant h273 clearly manifest four mutants h175 s249 q248 w248 note different scales used reason reduced binding natural p53 target sequences likely due lack significant input form complementary cooperative binding mutant dimeric partner third interesting observation pertains extent reduced binding heterotetramers different sequences particular mutant heterotetramers show drastically reduced binding promoter sequences govern apoptosis namely pidd igf bp3 bax compared promoters p21 regulate cell cycle progression
0.5221876.11805092.html.plaintext.txt	49	mutantwild type p53 heterotetramers biased sequences govern apoptosis rather cell growth arrest relatively strong binding five heterotetramers con sequence led us wonder whether case con exception rather rule address issue chose wide range natural human p53 target sites table taken genes involved cell cycle arrest p21 14 3 3 apoptosis cyclin g fas pidd igf bp3 bax dna repair gadd45 p53 stability hdm2 whose transcription found occur p53 dependent manner con sequence included reference control shown fig 7 left panels cotranslation hp53 hp53n wild type control generated three tetrameric species hp534 hp532hp53n2 hp53n4 bound 10 sequences approximate ratio 121 slight variation migration rates target sequences due size charge differences sequences however cotranslation five mutants hp53n revealed different scenario first none mutant homotetramers capable efficient binding target sites ie equivalent uppermost band shown control hp534 either weak present mutanthp53n cotranslations unexpected mutants known class class ii mutants second importantly five mutant p53hp53n heterotetramers bind 10 target sites relatively poorly compared wild type p53hp53n heterotetramer although binding con least affected fig 7 right panels reduced binding capacity heterotetramer less pronounced mutant h273 clearly manifest four mutants h175 s249 q248 w248 note different scales used reason reduced binding natural p53 target sequences likely due lack significant input form complementary cooperative binding mutant dimeric partner third interesting observation pertains extent reduced binding heterotetramers different sequences particular mutant heterotetramers show drastically reduced binding promoter sequences govern apoptosis namely pidd igf bp3 bax compared promoters p21 regulate cell cycle progression
0.5221876.11805092.html.plaintext.txt	50	view larger version 41k fig 7 heterotetramer dna binding varies depending mutation one dimer target site hp53n translated hp53 various class h273 q248 w248 class ii s249 h175 p53 mutants rabbit reticulocyte lysate samples translation reaction subjected emsa analysis binding various 32p labeled target sites indicated left panels table radioactivity counts 32p labeled target site equalized prior use film exposure dried gels used phosphorimager analysis quantify heterotetramer band intensity right panels hp53hp53n bands served controls intensity set 100 quantified mutant hp53n heterotetramer bands expressed percentage hp53 hp53n band intensity experiments performed three times average band intensity standard deviation shown discussion top abstract introduction experimental procedures results discussion references
0.5221876.11805092.html.plaintext.txt	51	generally accepted p53 tetramer dimer dimers however precisely comes enigma assumed p53 comes polysome monomers dimerize solution form dimers dimer dimer interaction turn leads formation tetramers 34 35 present study shows scenario incorrect demonstrate p53 dimerization occurs cotranslationally ie polysome whereas tetramerization occurs posttranslationally ie solution fig 8a normal cells p53 alleles wild type whether dimerization occurs cotranslationally posttranslationally probably major theoretical ramifications however case cell harbors wild type mutant p53 allele based posttranslational dimerizationposttranslational tetramerization mechanism currently accepted model wild type p53 tetramers cells would comprise total p53 hand alternative mechanism cotranslational dimerizationposttranslational tetramerization would result 14 total p53 cells wild type tetramers 4 fold difference may well sufficient alter fate cells upon exposure genotoxic stress important consideration view recent observation mere reduction p53 levels sufficient promote tumorigenesis 17 results compatible cotranslational dimerizationposttranslational tetramerization model
0.5221876.11805092.html.plaintext.txt	52	generally accepted p53 tetramer dimer dimers however precisely comes enigma assumed p53 comes polysome monomers dimerize solution form dimers dimer dimer interaction turn leads formation tetramers 34 35 present study shows scenario incorrect demonstrate p53 dimerization occurs cotranslationally ie polysome whereas tetramerization occurs posttranslationally ie solution fig 8a normal cells p53 alleles wild type whether dimerization occurs cotranslationally posttranslationally probably major theoretical ramifications however case cell harbors wild type mutant p53 allele based posttranslational dimerizationposttranslational tetramerization mechanism currently accepted model wild type p53 tetramers cells would comprise total p53 hand alternative mechanism cotranslational dimerizationposttranslational tetramerization would result 14 total p53 cells wild type tetramers 4 fold difference may well sufficient alter fate cells upon exposure genotoxic stress important consideration view recent observation mere reduction p53 levels sufficient promote tumorigenesis 17 results compatible cotranslational dimerizationposttranslational tetramerization model
0.5221876.11805092.html.plaintext.txt	53	view larger version 29k fig 8 model p53 biogenesis heterotetramer dna binding dominant negative effect p53 biogenesis assembly two p53 nascent polypeptide chains occurs cotranslationally two chains interacting final stages protein synthesis ie close 3 end mrna p53 leaves polysome dimer eventually interacts another dimer form tetramer posttranslational tetramerization b p53 dna binding dominant negative effect panel wild type p53 homotetramer binds target site dimeric subunits interacting two half sites target sequence stability binding enhanced positive cooperative interaction two dimers panel ii mutant p53 homotetramers unable bind dna bind dna poorly mutations either residues make direct contact dna class mutants residues crucial maintaining conformation dna binding domain class ii mutants panel iii p53 dominant negative effect incompetent partner model wild type p53mutant p53 heterotetramers unlikely mutant dimer imposes conformational change wild type dimer still bind half site inability mutant dimer properly bind half site contribute significantly positive cooperativity results unstable heterotetramer dna complex extent reduced positive cooperativity varies target sequences
0.5221876.11805092.html.plaintext.txt	54	concluding p53 dimerization occurs cotranslationally suggesting neighboring nascent p53 chains polysome interact prior released cytosol fig 8a dimerization scheme would highly efficient would spare individual p53 subunits need search partners soluble pool precisely monomeric p53 nascent chains interact unclear present based current knowledge p53 dimerization domain located c terminus protein residues 323 356 30 36 38 would seem logical deduce interaction neighboring chains occurs late stages translation process close 3 end p53 transcript prior release p53 chains polysome however one rule possibility interaction neighboring nascent chains first occurs upstream sites gives way stable interaction c terminal oligomerization domain soon becomes feasible considering highly hydrophobic nature oligomerization domain 30 36 38 cotranslational dimerization would offer efficient means hydrophobic residues neighboring chains could quickly interact protein misfolding would greatly minimized
0.5221876.11805092.html.plaintext.txt	55	light model presented biogenesis possible tetramerization process could represent form functional regulation assuming p53 imported nucleus dimer attractive hypothesis would dimeric p53 represents latent inactive form p53 requiring signal induce tetramerization activation following activation degradation could achieved forming dimers reveal nuclear export sequence hidden tetramerization domain 34 39 40 one way accomplishing could posttranslational modification p53 date numerous posttranslational modifications described reviewed ref 8 vitro phosphorylation ser 315 ser 392 shown affect p53 tetramerization 41 42 others suggested potential roles sumoylation ubiquitination p53 activation degradation altering oligomeric state 39 40 43 44 experimentation needed properly address issue
0.5221876.11805092.html.plaintext.txt	56	light model presented biogenesis possible tetramerization process could represent form functional regulation assuming p53 imported nucleus dimer attractive hypothesis would dimeric p53 represents latent inactive form p53 requiring signal induce tetramerization activation following activation degradation could achieved forming dimers reveal nuclear export sequence hidden tetramerization domain 34 39 40 one way accomplishing could posttranslational modification p53 date numerous posttranslational modifications described reviewed ref 8 vitro phosphorylation ser 315 ser 392 shown affect p53 tetramerization 41 42 others suggested potential roles sumoylation ubiquitination p53 activation degradation altering oligomeric state 39 40 43 44 experimentation needed properly address issue
0.5221876.11805092.html.plaintext.txt	57	perhaps important conclusion studies pertains called p53 dominant negative effect whereby mutant p53 protein somehow negatively affects function wild type counterpart reviewed refs18 19 results suggest cells possessing wild type mutant p53 allele one type heterotetramer produced namely wild type dimermutant dimer mutant dimeric subunit within heterotetramer exert negative effect totally abrogating dna binding complex based results present study previous observation two dimers within tetramer conformationally independent 31 favor idea mutant dimer cause conformational change wild type dimer rather lack significant contribution positive cooperativity mutant partner leads overall weakened dna binding heterotetramer fig 8b heterotetramers bind dna stronger wild type dimers alone likely cooperativity still exists different target sites require varying degrees dimer dimer cooperativity within p53 tetramer dna binding model incompetent partner model also explains small polypeptides corresponding p53 oligomerization domain alone could interfere wild type p53 function 25 26 block wild type p53 tetramerization dimerization mutants without functional tetramerization domain oncogenic 22 interfere wild type p53 tetramer formation
0.5221876.11805092.html.plaintext.txt	58	although present study clearly demonstrates essentially wild typemutant heterotetramers manifest reduced dna binding affinity compared wild type protein extent reduction varies greatly depends mutant target sequence five mutants examined h273 appears exert least dominant negative effect wild type protein example presence heterotetramer little affect binding latter con p21 sequence whereas heterotetramers bind sequences greatly reduced efficiency could explain unlike p53 mutants ectopically expressed mutant h273 still capable con dependent transactivation 45 47 sequences however h273 exerts clear dominant negative effect wild type protein effect pronounced manifested mutants interesting h273 second common p53 mutation human cancer least dominant negative accounts results indicate mutants w248 q248 dominant negative mutants five could turn explain li fraumeni patients mutations arg 248 rarely display loss heterozygosity 48 apparently arg 248 mutation one allele sufficient incapacitate wild type p53 normal allele
0.5221876.11805092.html.plaintext.txt	59	although present study clearly demonstrates essentially wild typemutant heterotetramers manifest reduced dna binding affinity compared wild type protein extent reduction varies greatly depends mutant target sequence five mutants examined h273 appears exert least dominant negative effect wild type protein example presence heterotetramer little affect binding latter con p21 sequence whereas heterotetramers bind sequences greatly reduced efficiency could explain unlike p53 mutants ectopically expressed mutant h273 still capable con dependent transactivation 45 47 sequences however h273 exerts clear dominant negative effect wild type protein effect pronounced manifested mutants interesting h273 second common p53 mutation human cancer least dominant negative accounts results indicate mutants w248 q248 dominant negative mutants five could turn explain li fraumeni patients mutations arg 248 rarely display loss heterozygosity 48 apparently arg 248 mutation one allele sufficient incapacitate wild type p53 normal allele
0.5221876.11805092.html.plaintext.txt	60	another striking observation pertains target sequences five mutants used p21 sequence regulates cell growth arrest far least sensitive dominant negative effects mutants sharp contrast sequences regulate apoptosis bax pidd igf bp3 manifest low affinity heterotetramers additionally found half lives p21 heterotetramer complexes markedly longer 10 30 fold bax pidd igf bp3 heterotetramers data shown bias also demonstrable using wild type p53 data shown differential binding affinity explains recent transactivation studies showing p53 mutants dominant negative induction apoptosis growth arrest human cancer cell lines 49 also shows mutants dominant negative vivo assayed p53 dependent growth arrest 50 51
0.5221876.11805092.html.plaintext.txt	61	another striking observation pertains target sequences five mutants used p21 sequence regulates cell growth arrest far least sensitive dominant negative effects mutants sharp contrast sequences regulate apoptosis bax pidd igf bp3 manifest low affinity heterotetramers additionally found half lives p21 heterotetramer complexes markedly longer 10 30 fold bax pidd igf bp3 heterotetramers data shown bias also demonstrable using wild type p53 data shown differential binding affinity explains recent transactivation studies showing p53 mutants dominant negative induction apoptosis growth arrest human cancer cell lines 49 also shows mutants dominant negative vivo assayed p53 dependent growth arrest 50 51
0.5221876.11805092.html.plaintext.txt	62	summary studying p53 biogenesis vitro demonstrate first time p53 dimerization occurs cotranslationally whereas dimer dimer interaction tetramerization occurs posttranslationally thus cells possessing wild type mutant p53 allele one type heterotetramers present wild type dimer mutant dimer heterotetramers manifest reduced binding affinity p53 target sequences tested mutant dimer necessarily imposes mutant conformation wild type dimer low affinity dna therefore significantly contribute overall stability p53 dna complex reduced affinity particularly marked sequences govern apoptosis rather cell growth arrest suggesting defects apoptotic cell death probably play important role cancer development li fraumeni patients acknowledgements
0.5221876.11805092.html.plaintext.txt	63	summary studying p53 biogenesis vitro demonstrate first time p53 dimerization occurs cotranslationally whereas dimer dimer interaction tetramerization occurs posttranslationally thus cells possessing wild type mutant p53 allele one type heterotetramers present wild type dimer mutant dimer heterotetramers manifest reduced binding affinity p53 target sequences tested mutant dimer necessarily imposes mutant conformation wild type dimer low affinity dna therefore significantly contribute overall stability p53 dna complex reduced affinity particularly marked sequences govern apoptosis rather cell growth arrest suggesting defects apoptotic cell death probably play important role cancer development li fraumeni patients acknowledgements
0.5221876.11805092.html.plaintext.txt	64	thank thanos halazonetis pgemhp53wtb pgema344 p53 mutant plasmids ray turner help pcr
0.5221876.11805092.html.plaintext.txt	65	work supported national cancer institute canada funds canadian cancer society p w k lthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5221876.11805092.html.plaintext.txt	66	recipient studentships national sciences engineering research council alberta heritage foundation medical research
0.5221876.11805092.html.plaintext.txt	67	present address dept hematology oncology st jude childrens research hospital memphis tn 38105
0.5221876.11805092.html.plaintext.txt	68	correspondence addressed tel 403 220 7548 fax 403 270 8520 e mail pleeucalgaryca
0.5221876.11805092.html.plaintext.txt	69	published jbc papers press january 22 2002 doi 101074jbcm108815200
0.5221876.11805092.html.plaintext.txt	70	abbreviation used emsa electrophoretic mobility shift assay
0.5221876.11805092.html.plaintext.txt	71	references top abstract introduction experimental procedures results discussion references 1 hollstein m shomer b greenblatt m soussi hovig e montesano r harris c c 1996 nucleic acids res 24 141 146abstractfree full text 2 levine j 1990 virology 177 419 426crossrefmedline order article via infotrieve 3 liu y kulesz martin m 2001 carcinogenesis 22 851 860abstractfree full text 4 malkin d li f p strong l c fraumeni j f jr nelson c e kim d h kassel j gryka m bischoff f z tainsky m friend h 1990 science 250 1233 1238medline order article via infotrieve 5 malkin d 1993 cancer genet cytogenet 66 83 92crossrefmedline order article via infotrieve 6 donehower l harvey m slagle b l mcarthur m j montgomery c jr butel j bradley 1992 nature 356 215 221crossrefmedline order article via infotrieve 7 harvey m mcarthur m j montgomery c jr butel j bradley donehower l 1993 nat genet 5 225 229medline order article via infotrieve 8 ljungmann m 2000 neoplasia 2 208 225medline order article via infotrieve 9 cho y gorina jeffrey p d pavletich n p 1994 science 265 346 355medline order article via infotrieve 10 el deiry w kern e pietenpol j kinzler k w vogelstein b 1992 nat genet 1 45 49medline order article via infotrieve 11 mclure k g lee p w 1998 embo j 17 3342 3350abstractfree full text 12 knudsen g jr 1971 proc natl acad sci u 68 820 823abstract 13 nigro j m baker j preisinger c jessup j m hostetter r cleary k bigner h davidson n baylin devilee p glover collins f weston modali r harris c c vogelstein b 1989 nature 342 705 708crossrefmedline order article via infotrieve 14 mulligan l m matlashewski g j scrabble h j cavenee w k 1990 proc natl acad sci u 87 5863 5867abstract 15 davidoff m kerns b j iglehart j d marks j r 1991 cancer res 51 2605 2610abstract 16 mazars r spinardi l bencheikh m simony lafontaine j jeanteur p theillet c 1992 cancer res 52 3918 3923abstract 17 venkatachalam shi y p jones n vogel h bradley pinkel d donehower l 1998 embo j 17 4657 4667abstractfree full text 18 roemer k 1999 biol chem 380 879 887 19 blagosklonny m v 2000 faseb j 14 1901 1907abstractfree full text 20 milner j metcalf e 1991 cell 65 765 774medline order article via infotrieve 21 chene p mittl p grutter m 1997 j mol biol 273 873 881crossrefmedline order article via infotrieve 22 chene p bechter e 1999 j mol biol 286 1269 1274crossrefmedline order article via infotrieve 23 waterman m j waterman j l halazonetis d 1996 cancer res 56 158 163abstract 24 chene p 1998 j mol biol 281 205 209crossrefmedline order article via infotrieve 25 shaulian e zauberman ginsberg d oren m 1992 mol cell biol 12 5581 5592abstract 26 deb d chakraborti lanyi troyer d deb 1999 int j oncol 15 413 422medline order article via infotrieve 27 waterman j l shenk j l halazonetis d 1995 embo j 14 512 519abstract 28 gilmore r coffey m c leone g mclure k g lee p w k 1996 embo j 15 2651 2658abstract 29 mateu m g sanchez del pino m m fersht r 1999 nat struct biol 6 191 198crossrefmedline order article via infotrieve 30 lee w harvey yin y yau p litchfield d arrowsmith c h 1994 nat struct biol 1 877 890medline order article via infotrieve 31 mclure k g lee p w 1999 embo j 18 763 770abstractfree full text 32 bargonetti j reynisdottir freidman p n prives c 1992 genes dev 6 1886 1898abstract 33 rolley n butcher milner j 1995 oncogene 11 763 770medline order article via infotrieve 34 stommell j m marchenko n d jimenez g moll u m hope j wahl g m 1999 embo j 18 1660 1672abstractfree full text 35 hara arai k koiki k 2000 exp cell res 258 152 161crossrefmedline order article via infotrieve 36 clore g m omichinski j g sakaguchi k zambrano n sakamoto h appella e gronenborn m 1994 science 265 386 391medline order article via infotrieve 37 clore g m ernst j clubb r omichinski j g kennedy w m sakaguchi k appella e gronenborn m 1995 nat struct biol 2 321 333medline order article via infotrieve 38 jeffrey p d gorina pavletich n p 1995 science 267 1498 1502medline order article via infotrieve 39 boyd d tsai k y jacks 2000 nat cell biol 2 563 568crossrefmedline order article via infotrieve 40 geyer r k yu z k maki c g 2000 nat cell biol 2 569 573crossrefmedline order article via infotrieve 41 sakaguchi k sakamoto h lewis m anderson c w erickson j w appella e xie d 1997 biochemistry 36 10117 10124crossrefmedline order article via infotrieve 42 sakaguchi k sakamoto h xie d erickson j w lewis m appella e 1997 j protein chem 16 553 556crossrefmedline order article via infotrieve 43 gostissa m hengstermann fogal v sandy p schwartz e scheffner m del sal g 1999 embo j 18 6462 6471abstractfree full text 44 rodriguez m desterro j m lain midgley c lane d p hay r 1999 embo j 18 6455 6461abstractfree full text 45 chumakov m miller c w chen d l koeffler h p 1993 oncogene 8 3005 3011medline order article via infotrieve 46 hachiya m chumakov miller c w akashi m said j koeffler h p 1994 anticancer res 14 1853 1859medline order article via infotrieve 47 park d j nakamura h chumakov m said j w miller c w chen d l koeffler h p 1994 oncogene 9 1899 1906medline order article via infotrieve 48 varley j m thorncroft m mcgown g appleby j kelsey m tricker k j evans d g birch j m 1997 oncogene 14 865 871crossrefmedline order article via infotrieve 49 aurelio o n kong x gupta stanbridge e j 2000 mol cell biol 20 770 778abstractfree full text 50 frebourg sadelain m ng y kassel j friend h 1994 cancer res 54 878 881abstract 51 williams k j heighway j birch j m norton j d scott d 1996 br j cancer 74 698 703medline order article via infotrieve 52 el deiry w tokino velculescu v e levy d b parsons r trent j m lin d mercer w e kinzler k w vogelstein b 1993 cell 75 817 825medline order article via infotrieve 53 kastan m b zhan q el diery w carrier f jacks walsh w v plunkett b vogelstein b fornace j jr 1992 cell 71 587 597medline order article via infotrieve 54 okamoto k beach d 1994 embo j 13 4816 4822abstract 55 muller m wilder bannasch d israeli d lehlbach k li weber m friedman l galle p r stremmel w oren m krammer p h 1998 j exp med 188 2033 2045abstractfree full text 56 hermeking h lengauer c polyak k c zhang l thiagalingam kinzler k w vogelstein b 1997 mol cell 1 3 11medline order article via infotrieve 57 lin y ma w benchimol 2000 nat genet 26 122 127crossrefmedline order article via infotrieve 58 buckbinder l talbott r velasco miguel takenaka faha b seizinger b r kley n 1995 nature 377 646 649crossrefmedline order article via infotrieve 59 zauberman flusberg d haupt y barak y oren m 1995 nucleic acids res 23 2584 2592abstract 60 miyashita reed j c 1995 cell 80 293 299medline order article via infotrieve 61 thornborrow e c manfredi j j 1999 j biol chem 274 33747 33756abstractfree full text
0.5221876.11805092.html.plaintext.txt	72	copyright 2002 american society biochemistry molecular biology inc
0.5222594.9531612.html.plaintext.txt	0	role p53 hematopoietic recovery cytotoxic treatment
0.5222594.9531612.html.plaintext.txt	1	pawel wlodarski mariusz wasik mariusz z ratajczak cinzia sevignani grazyna hoser jerzy kawiak alan m gewirtz bruno calabretta thomas skorski
0.5222594.9531612.html.plaintext.txt	2	pawel wlodarski mariusz wasik mariusz z ratajczak cinzia sevignani grazyna hoser jerzy kawiak alan m gewirtz bruno calabretta thomas skorski
0.5222594.9531612.html.plaintext.txt	3	department microbiology immunology kimmel cancer institute thomas jefferson university philadelphia pa department pathology laboratory medicine university pennsylvania philadelphia pa medical center postgraduate education warsaw poland
0.5222594.9531612.html.plaintext.txt	4	abstract abstract introduction methods results discussion references
0.5222594.9531612.html.plaintext.txt	5	prompt reconstitution hematopoiesis cytoreductive therapy essential patient recovery may positive impact long term prognosis examined role p53 tumor suppressor gene hematopoietic recovery vivo treatment cytotoxic drug 5 fluorouracil 5 fu used p53 knock p53 wild type p53 mice injected 5 fu experimental model analysis repopulation ability clonogenic activity hematopoietic stem cells hscs lineage committed descendants showed greater number hscs responsible reconstitution lethally irradiated recipients p53 bone marrow cells bmcs recovering 5 fu treatment corresponding p53 bmcs post 5 fu recovering bmcs percentage hsc enriched lin sca 1 c kit cells threefold higher p53 p53 cells although percentage primitive hscs lin sca 1 c kit cd34low depend p53 percentage multipotential hscs committed progenitors lin sca 1 c kit cd34high almost fourfold higher post 5 fu recovering p53 bmcs p53 counterparts pool hscs 5 fu treated p53 bmcs exhausted slowly p53 population shown vivo using pre spleen colony forming unit cfu assay vitro using long term culture initiating cells ltc ics methylcellulose replating assays clonogenic activity various lineage specific descendants significantly higher post 5 fu regenerating p53 bmcs p53 bmcs probably increased sensitivity growth factors despite changes dramatic difference sensitivity p53 p53 bmcs 5 fu induced apoptosis lineage commitment differentiation hematopoietic progenitors appeared independent p53 status studies suggest suppression p53 function facilitates hematopoietic reconstitution cytoreductive therapy 1 delaying exhaustion primitive hsc pool 2 stimulating production multipotential hscs 3 increasing sensitivity hematopoietic cells growth factors 4 decreasing sensitivity apoptosis
0.5222594.9531612.html.plaintext.txt	6	prompt reconstitution hematopoiesis cytoreductive therapy essential patient recovery may positive impact long term prognosis examined role p53 tumor suppressor gene hematopoietic recovery vivo treatment cytotoxic drug 5 fluorouracil 5 fu used p53 knock p53 wild type p53 mice injected 5 fu experimental model analysis repopulation ability clonogenic activity hematopoietic stem cells hscs lineage committed descendants showed greater number hscs responsible reconstitution lethally irradiated recipients p53 bone marrow cells bmcs recovering 5 fu treatment corresponding p53 bmcs post 5 fu recovering bmcs percentage hsc enriched lin sca 1 c kit cells threefold higher p53 p53 cells although percentage primitive hscs lin sca 1 c kit cd34low depend p53 percentage multipotential hscs committed progenitors lin sca 1 c kit cd34high almost fourfold higher post 5 fu recovering p53 bmcs p53 counterparts pool hscs 5 fu treated p53 bmcs exhausted slowly p53 population shown vivo using pre spleen colony forming unit cfu assay vitro using long term culture initiating cells ltc ics methylcellulose replating assays clonogenic activity various lineage specific descendants significantly higher post 5 fu regenerating p53 bmcs p53 bmcs probably increased sensitivity growth factors despite changes dramatic difference sensitivity p53 p53 bmcs 5 fu induced apoptosis lineage commitment differentiation hematopoietic progenitors appeared independent p53 status studies suggest suppression p53 function facilitates hematopoietic reconstitution cytoreductive therapy 1 delaying exhaustion primitive hsc pool 2 stimulating production multipotential hscs 3 increasing sensitivity hematopoietic cells growth factors 4 decreasing sensitivity apoptosis
0.5222594.9531612.html.plaintext.txt	7	introduction abstract introduction methods results discussion references
0.5222594.9531612.html.plaintext.txt	8	hematopoiesis regulated numerous growth factors act concert regulate proliferation including self renewal differentiation apoptosis thus generating relatively constant pool functionally mature blood cells however normal hematopoiesis perturbed variety factors infection reduced oxygen concentration irradiation drugs cytostatics routinely used antineoplastic drugs toxic bone marrow cells light importance prompt bone marrow repopulation patient outcome analyses mechanisms regulating process hold promise leading novel therapies facilitate hematopoietic repopulation cytostatic treatment bone marrow transplantation
0.5222594.9531612.html.plaintext.txt	9	hematopoiesis regulated numerous growth factors act concert regulate proliferation including self renewal differentiation apoptosis thus generating relatively constant pool functionally mature blood cells however normal hematopoiesis perturbed variety factors infection reduced oxygen concentration irradiation drugs cytostatics routinely used antineoplastic drugs toxic bone marrow cells light importance prompt bone marrow repopulation patient outcome analyses mechanisms regulating process hold promise leading novel therapies facilitate hematopoietic repopulation cytostatic treatment bone marrow transplantation
0.5222594.9531612.html.plaintext.txt	10	p53 tumor suppressor gene may one key genes involved regulating hematopoietic repopulation although hematopoiesis p53 knock p53 mice appears proceed normally1 numerous vitro studies indicate p53 involved proliferation differentiation apoptosis hematopoietic cells2 7 moreover p53 deletions mutations found high frequency acute leukemias chronic myelogenous leukemia blast crisis8 p53 phosphoprotein acts transcriptional activator genes containing p53 binding sites9 also potent inhibitor transcription many genes containing tata boxes lacking p53 binding sites10 p53 plays critical role cell proliferation modulating expression genes waf 1 required progression cell cycle11 furthermore p53 involved induction apoptosis dna damage12 possibly transactivating bax proapoptotic member bcl 2 family13
0.5222594.9531612.html.plaintext.txt	11	p53 tumor suppressor gene may one key genes involved regulating hematopoietic repopulation although hematopoiesis p53 knock p53 mice appears proceed normally1 numerous vitro studies indicate p53 involved proliferation differentiation apoptosis hematopoietic cells2 7 moreover p53 deletions mutations found high frequency acute leukemias chronic myelogenous leukemia blast crisis8 p53 phosphoprotein acts transcriptional activator genes containing p53 binding sites9 also potent inhibitor transcription many genes containing tata boxes lacking p53 binding sites10 p53 plays critical role cell proliferation modulating expression genes waf 1 required progression cell cycle11 furthermore p53 involved induction apoptosis dna damage12 possibly transactivating bax proapoptotic member bcl 2 family13
0.5222594.9531612.html.plaintext.txt	12	present study examined role p53 vivo recovery hematopoiesis treatment cytostatic agents bone marrow cells obtained p53 knock p53 p53 wild type p53 mice treated 5 fluorouracil 5 fu tested vivo repopulation ability clonogenic activity hematopoietic stem cells hscs lineage committed progenitors
0.5222594.9531612.html.plaintext.txt	13	present study examined role p53 vivo recovery hematopoiesis treatment cytostatic agents bone marrow cells obtained p53 knock p53 p53 wild type p53 mice treated 5 fluorouracil 5 fu tested vivo repopulation ability clonogenic activity hematopoietic stem cells hscs lineage committed progenitors
0.5222594.9531612.html.plaintext.txt	14	materials methods abstract introduction methods results discussion references mice p53 knock inbred mice c57 bl6tacfbr kop53n4 p53 wild type mice purchased taconic farms germantown ny mice 6 10 weeks old experiments
0.5222594.9531612.html.plaintext.txt	15	materials methods abstract introduction methods results discussion references mice p53 knock inbred mice c57 bl6tacfbr kop53n4 p53 wild type mice purchased taconic farms germantown ny mice 6 10 weeks old experiments
0.5222594.9531612.html.plaintext.txt	16	isolation bone marrow cells bmcs mice injected intraperitoneally ip 150 mgkg 5 fu solopak laboratories inc elk grove village il physiological saline day 0 sacrificed cervical dislocation 2 4 6 days later bmcs obtained one femur two tibias two brachial bones suspended iscoves modified dulbecco medium imdm supplemented 10 heat inactivated fetal bovine serum fbs l glutamine penicillinstreptomycin complete imdm red blood cells removed lysis hypotonic solution 085 nh4cl 17 mmoll tris hcl ph 74 5 minutes ice number cells obtained femur multiplied two contralateral femur used microscopy fixation bone marrow stromal cells removed 2 hour incubation complete imdm concentration 106 cellsml petri dish nonadherent cells collected gentle agitation used experiments
0.5222594.9531612.html.plaintext.txt	17	isolation bone marrow cells bmcs mice injected intraperitoneally ip 150 mgkg 5 fu solopak laboratories inc elk grove village il physiological saline day 0 sacrificed cervical dislocation 2 4 6 days later bmcs obtained one femur two tibias two brachial bones suspended iscoves modified dulbecco medium imdm supplemented 10 heat inactivated fetal bovine serum fbs l glutamine penicillinstreptomycin complete imdm red blood cells removed lysis hypotonic solution 085 nh4cl 17 mmoll tris hcl ph 74 5 minutes ice number cells obtained femur multiplied two contralateral femur used microscopy fixation bone marrow stromal cells removed 2 hour incubation complete imdm concentration 106 cellsml petri dish nonadherent cells collected gentle agitation used experiments
0.5222594.9531612.html.plaintext.txt	18	bone marrow transplantation p53 mice underwent total body irradiation tbi lethal dose 875 cgy 137cs source 48 hours later injected intravenously iv bone marrow cells specified assay
0.5222594.9531612.html.plaintext.txt	19	competitive long term reconstitution assay tbi treated p53 mice injected mixture 5 x 104 p53 5 x 104 p53 bmcs 16 weeks mice sacrificed genomic dna isolated bmcs ratio p53 p53 cells repopulating host bone marrow evaluated quantitative polymerase chain reaction pcr two sets primers 1 2 1 3 used simultaneously detect p53 wild type p53 knock alleles respectively14 primer 1 5 gggacagccaagtctgttatgtgc located upstream deleted region p53 gene therefore common mutated wild type alleles primer 2 3 ctgtcttccagatactcgggatac located fragment deleted knock p53 allele specific wild type allele primer 3 3 tttacggagccctggcgctcgatgt located polii promoter region neo cassette present knock allele pcr performed using 2 microg genomic dna products separated electrophoresis transferred zetabind membrane cuno inc meriden ct hybridized internal probe 5 ttcctcttcagcctgtagactgtg 3 specific intron 1 p53 gene thus recognizing pcr products wild type knock alleles ratio pcr products compared calibration blot prepared using mixture p53 p53 cells predetermined proportions
0.5222594.9531612.html.plaintext.txt	20	competitive long term reconstitution assay tbi treated p53 mice injected mixture 5 x 104 p53 5 x 104 p53 bmcs 16 weeks mice sacrificed genomic dna isolated bmcs ratio p53 p53 cells repopulating host bone marrow evaluated quantitative polymerase chain reaction pcr two sets primers 1 2 1 3 used simultaneously detect p53 wild type p53 knock alleles respectively14 primer 1 5 gggacagccaagtctgttatgtgc located upstream deleted region p53 gene therefore common mutated wild type alleles primer 2 3 ctgtcttccagatactcgggatac located fragment deleted knock p53 allele specific wild type allele primer 3 3 tttacggagccctggcgctcgatgt located polii promoter region neo cassette present knock allele pcr performed using 2 microg genomic dna products separated electrophoresis transferred zetabind membrane cuno inc meriden ct hybridized internal probe 5 ttcctcttcagcctgtagactgtg 3 specific intron 1 p53 gene thus recognizing pcr products wild type knock alleles ratio pcr products compared calibration blot prepared using mixture p53 p53 cells predetermined proportions
0.5222594.9531612.html.plaintext.txt	21	flow cytometry following antibodies used fluorescein isothiocyanate fitc sca 1 fitc c kit fitc gr 1 fitc mac 1 fitc cd3 phycoerythrin pe ter 119 pe b220 cd34 pharmingen san diego ca pe cd4 pe cd8 boehringer mannheim indianapolis biotin f480 serotec ltd oxford uk cells 105 per 100 microl phosphate buffered saline pbs 2 fbs 01 nan3 incubated fc block pharmingen 10 minutes room temperature followed 45 minute incubation indicated antibodies 4 degrees c appropriate incubated secondary antibody coupled fitc streptavidin linked pe flow cytometry performed epics profile analyzer coulter corp hialeah fl
0.5222594.9531612.html.plaintext.txt	22	cell sorting lineage positive lin cells removed magnet mpc 1 dynal inc oslo norway staining mixture biotinylated antibodies gr 1 mac 1 b220 cd4 cd8 ter 119 incubation dynabeads dynal inc great neck ny according manufacturers protocol cells suspension incubated streptavidin red 670 sv r670 gibco brl grand island ny sorted coulter cell sorter remove remaining lin cells lin cells subsequently incubated cocktail pe sca 1 fitc c kit biotin cd34 antibodies washed extensively incubated sv r670 washed sorted using 3 color fluorescence activated cell sorting epics elite coulter corp lin sca 1 c kit cd34high lin sca 1 c kit cd34low populations selected according osawa et al15 used experiments
0.5222594.9531612.html.plaintext.txt	23	colony formation assay methylcellulose cells 5 x 104 resuspended methylcellulose semisolid medium hcc 4320 stemcell technologies inc vancouver canada plated 35 mm wells presence following recombinant murine growth factors 10 uml interleukin 3 il 3 genetics institute inc cambridge ma 50 uml il 2 genetics institute inc 30 uml il 7 genetics institute inc 10 ngml kit ligand kl r d system inc minneapolis mn 10 uml erythropoietin epo amgen inc thousand oaks ca 7 10 days colonies clusters counted inverted microscope described16
0.5222594.9531612.html.plaintext.txt	24	colony formation assay methylcellulose cells 5 x 104 resuspended methylcellulose semisolid medium hcc 4320 stemcell technologies inc vancouver canada plated 35 mm wells presence following recombinant murine growth factors 10 uml interleukin 3 il 3 genetics institute inc cambridge ma 50 uml il 2 genetics institute inc 30 uml il 7 genetics institute inc 10 ngml kit ligand kl r d system inc minneapolis mn 10 uml erythropoietin epo amgen inc thousand oaks ca 7 10 days colonies clusters counted inverted microscope described16
0.5222594.9531612.html.plaintext.txt	25	determine long term clonogenic efficiency cells plated methylcellulose presence kl il 3 epo colonies counted cells harvested 10 days later washed medium counted replated 104 cellsplate presence indicated growth factors
0.5222594.9531612.html.plaintext.txt	26	megakaryocytic colony forming unit cfu meg assay 4a5 hybridoma cells producing antimouse megakaryocyte antibodies17 obtained dr paul friese university oklahoma health sciences center oklahoma city ok ascites harvested pristane pretreated scid mice injected ip 4a5 cells igg fraction purified protein affinity column oncogene science uniondale ny used staining megakaryocytic colonies grown plasma cloth presence recombinant il 6 il 3 epo described18 cfu meg colonies detected staining plasma cloths antimouse megakaryocyte antibody igg followed fitc conjugated antirat igg colonies counted fluorescence microscope
0.5222594.9531612.html.plaintext.txt	27	megakaryocytic colony forming unit cfu meg assay 4a5 hybridoma cells producing antimouse megakaryocyte antibodies17 obtained dr paul friese university oklahoma health sciences center oklahoma city ok ascites harvested pristane pretreated scid mice injected ip 4a5 cells igg fraction purified protein affinity column oncogene science uniondale ny used staining megakaryocytic colonies grown plasma cloth presence recombinant il 6 il 3 epo described18 cfu meg colonies detected staining plasma cloths antimouse megakaryocyte antibody igg followed fitc conjugated antirat igg colonies counted fluorescence microscope
0.5222594.9531612.html.plaintext.txt	28	fibroblast like colony forming unit cfu f assay bmcs 104 mouse plated 35 mm petri dish complete imdm 2 hour incubation floating cells removed adherent cells cultured dulbeccos modified eagles medium 10 fbs 5 7 days colonies fibroblasts fixed methanol washed pbs stained giemsa counted light microscope
0.5222594.9531612.html.plaintext.txt	29	fibroblast like colony forming unit cfu f assay bmcs 104 mouse plated 35 mm petri dish complete imdm 2 hour incubation floating cells removed adherent cells cultured dulbeccos modified eagles medium 10 fbs 5 7 days colonies fibroblasts fixed methanol washed pbs stained giemsa counted light microscope
0.5222594.9531612.html.plaintext.txt	30	assay ltc ics bmcs isolated six p53 six p53 mice evaluated ltc ic content two sets independent experiments described19 briefly 5 x 104 bmcs recovered 5 fu treated mice plated irradiated 1500 cgy syngeneic murine stromal monolayers 24 well plates corning cambridge ma containing 1 ml imdm gibco brl supplemented 125 calf serum hyclone logan ut 125 horse serum hyclone cells isolated every mouse cultured 16 independent wells half population floating cells collected every 2 weeks fresh medium added remaining cells collected cells derived animal pooled washed analyzed colony formation methylcellulose containing 10 ngml recombinant murine kl described16
0.5222594.9531612.html.plaintext.txt	31	cfu pre cfu assay bmcs 105 injected iv tbi treated p53 mice 12 days spleens removed fixed teleyesnizky solution 70 ethanol 5 acetic acid 2 formaldehyde cfu counted time 105 bmcs isolated injected secondary tbi treated recipients 12 days recipient mice sacrificed spleens fixed teleyesnizky solution pre cfu counted
0.5222594.9531612.html.plaintext.txt	32	western blotting bmcs 106 lysed ripa buffer pbs supplemented 1 np40 05 sodium deoxycholate 01 sodium dodecyl sulfate proteinase inhibitors 1 mmoll phenylmethyl sulfonyl fluoride 10 microgml aprotinin 10 microgml leupeptin 1 mmoll sodium orthovanadate 05 mmoll edta lysates analyzed sodium dodecyl sulfate polyacrylamide gel electrophoresis followed western blotting antibodies pcna waf 1 bak bcl 2 p53 actin oncogene science cambridge ma bcl xls p16 bax biotechnology inc santa cruz ca secondary antibodies amersham life science inc arlington heights il bands detected ecl kit amersham
0.5222594.9531612.html.plaintext.txt	33	apoptosis assay femurs fixed 4 paraformaldehyde decalcified embedded paraffin sections immobilized slides rehydrated apoptotic cells detected using tacs 2 tdt situ apoptosis detection kit trevigen inc gaithersburg md according manufacturers protocol
0.5222594.9531612.html.plaintext.txt	34	histological cytological analysis bone marrow tissue sections fixed phosphate buffered formalin embedded paraffin slides stained hematoxylineosin cytospin preparations stained wright giemsa
0.5222594.9531612.html.plaintext.txt	35	histological cytological analysis bone marrow tissue sections fixed phosphate buffered formalin embedded paraffin slides stained hematoxylineosin cytospin preparations stained wright giemsa
0.5222594.9531612.html.plaintext.txt	36	results abstract introduction methods results discussion references role p53 5 fu induced toxicity bmcs number bmcs p53 mice decreased dramatically injection 5 fu whereas drug markedly less potent p53 mice fig 1 day 6 5 fu administration p53 mice contained fivefold eightfold bmcs wild type counterparts phenomenon probably reflects diminished apoptosis p53 cells injection 5 fu p53 mice resulted massive apoptosis bmcs days 2 4 whereas bmcs p53 mice became apoptotic sporadically fig 2
0.5222594.9531612.html.plaintext.txt	37	results abstract introduction methods results discussion references role p53 5 fu induced toxicity bmcs number bmcs p53 mice decreased dramatically injection 5 fu whereas drug markedly less potent p53 mice fig 1 day 6 5 fu administration p53 mice contained fivefold eightfold bmcs wild type counterparts phenomenon probably reflects diminished apoptosis p53 cells injection 5 fu p53 mice resulted massive apoptosis bmcs days 2 4 whereas bmcs p53 mice became apoptotic sporadically fig 2
0.5222594.9531612.html.plaintext.txt	38	view larger version 50k fig 1 number bmcs p53 black bars p53 shadowed bars mice injection 5 fu results represent mean standard deviation five micegroups
0.5222594.9531612.html.plaintext.txt	39	view larger version 50k fig 1 number bmcs p53 black bars p53 shadowed bars mice injection 5 fu results represent mean standard deviation five micegroups
0.5222594.9531612.html.plaintext.txt	40	view larger version 109k fig 2 induction apoptosis p53 5 fu treatment apoptotic cells detected tacs apoptosis assay femoral bone marrows p53 left panel p53 right panel mice days 0 2 4 6 5 fu injection results representative three independent experiments
0.5222594.9531612.html.plaintext.txt	41	view larger version 109k fig 2 induction apoptosis p53 5 fu treatment apoptotic cells detected tacs apoptosis assay femoral bone marrows p53 left panel p53 right panel mice days 0 2 4 6 5 fu injection results representative three independent experiments
0.5222594.9531612.html.plaintext.txt	42	analysis growth factor requirements colony forming units indicated post 5 fu repopulating p53 bmcs compared p53 counterparts formed colonies threshold 01 uml suboptimal 1 uml saturating 10 uml concentrations recombinant murine il 3 fig 3 thus absence p53 regenerating cells underlies increased sensitivity stimulation growth factors consistent previous studies showing importance p53 status response hematopoietic cells growth factor stimulation4
0.5222594.9531612.html.plaintext.txt	43	analysis growth factor requirements colony forming units indicated post 5 fu repopulating p53 bmcs compared p53 counterparts formed colonies threshold 01 uml suboptimal 1 uml saturating 10 uml concentrations recombinant murine il 3 fig 3 thus absence p53 regenerating cells underlies increased sensitivity stimulation growth factors consistent previous studies showing importance p53 status response hematopoietic cells growth factor stimulation4
0.5222594.9531612.html.plaintext.txt	44	view larger version 37k fig 3 increased sensitivity p53 bmcs stimulation il 3 p53 black bars p53 shadowed bars cells collected day 6 5 fu administration incubated methylcellulose presence indicated concentrations il 3 colonies clusters scored 10 days later results mean standard deviation three experiments
0.5222594.9531612.html.plaintext.txt	45	view larger version 37k fig 3 increased sensitivity p53 bmcs stimulation il 3 p53 black bars p53 shadowed bars cells collected day 6 5 fu administration incubated methylcellulose presence indicated concentrations il 3 colonies clusters scored 10 days later results mean standard deviation three experiments
0.5222594.9531612.html.plaintext.txt	46	view larger version 26k fig 4 western blot analysis cell cycle related apoptosis related proteins p53 p53 bmcs repopulating 5 fu treatment
0.5222594.9531612.html.plaintext.txt	47	view larger version 26k fig 4 western blot analysis cell cycle related apoptosis related proteins p53 p53 bmcs repopulating 5 fu treatment
0.5222594.9531612.html.plaintext.txt	48	differences p53 p53 bmcs proliferation potential sensitivity apoptosis confirmed western blotting analysis proteins involved cell cycle activity pcna waf 1 p16ink4a apoptosis bcl 2 bax bcl xl bak days 0 2 4 6 5 fu injection fig 4 p53 expression detectable day 0 increased significantly days 2 4 6 p53 samples accord previous findings20 expected p53 detectable p53 samples high levels pcna detected sample p53 bmcs 5 fu treatment whereas p53 bmcs pcna expression decreased day 2 undetectable day 4 detectable day 6 injection drug p16ink4a levels decreased slightly p53 bmcs days 2 4 6 contrast p16ink4a expression low days 0 2 4 markedly increased day 6 p53 bmcs waf 1 levels increased p53 p53 bmcs 5 fu treatment increase detectable earlier pronounced p53 population together data confirmed p53 bmcs regenerating 5 fu higher proliferative potential p53 counterparts analysis apoptosis related proteins showed markedly enhanced bcl 2 levels p53 bmcs days 2 4 low level expression time points p53 samples expression bcl xl similar p53 p53 populations bax bak proteins highly expressed days 2 4 p53 bmcs undetectable samples including p53 cells thus expression proapoptotic effectors bax bak relative antiapoptotic bcl 2 bcl xl effectors high p53 cells days 2 4 5 fu treatment whereas reverse observed p53 cells
0.5222594.9531612.html.plaintext.txt	49	differences p53 p53 bmcs proliferation potential sensitivity apoptosis confirmed western blotting analysis proteins involved cell cycle activity pcna waf 1 p16ink4a apoptosis bcl 2 bax bcl xl bak days 0 2 4 6 5 fu injection fig 4 p53 expression detectable day 0 increased significantly days 2 4 6 p53 samples accord previous findings20 expected p53 detectable p53 samples high levels pcna detected sample p53 bmcs 5 fu treatment whereas p53 bmcs pcna expression decreased day 2 undetectable day 4 detectable day 6 injection drug p16ink4a levels decreased slightly p53 bmcs days 2 4 6 contrast p16ink4a expression low days 0 2 4 markedly increased day 6 p53 bmcs waf 1 levels increased p53 p53 bmcs 5 fu treatment increase detectable earlier pronounced p53 population together data confirmed p53 bmcs regenerating 5 fu higher proliferative potential p53 counterparts analysis apoptosis related proteins showed markedly enhanced bcl 2 levels p53 bmcs days 2 4 low level expression time points p53 samples expression bcl xl similar p53 p53 populations bax bak proteins highly expressed days 2 4 p53 bmcs undetectable samples including p53 cells thus expression proapoptotic effectors bax bak relative antiapoptotic bcl 2 bcl xl effectors high p53 cells days 2 4 5 fu treatment whereas reverse observed p53 cells
0.5222594.9531612.html.plaintext.txt	50	role p53 repopulation hscs 5 fu treatment vivo compare ability p53 p53 bmcs obtained 5 fu treated mice rescue animals exposed lethal dose tbi decreasing numbers p53 p53 bmcs injected recipient mice long term survival scored 16 weeks postinjection lower numbers p53 bmcs p53 bmcs required rescue tbi treated recipient mice table 1 suggesting post 5 fu repopulating p53 bmcs contain hscs capable reconstituting hematopoiesis vivo bmcs p53 p53 mice treated 5 fu showed difference ability repopulate tbi treated recipients data shown pcr analysis assess presence p53 knock wild type alleles mononuclear fraction bmcs obtained mice transplanted p53 bmcs showed knock allele shown thus long term hematopoiesis transplanted hosts caused p53 marrow cells normal marrow cells may escaped lethal irradiation analysis blood smears bone marrow sections showed normal hematopoiesis mice transplanted either p53 p53 bmcs data shown quantitative pcr followed southern blotting assess proportion p53 p53 bmcs tbi treated recipient mice injected iv 11 mixture indicated ratio 101 1001 bone marrow obtained 16 weeks transplantation fig 5 mice free leukemia time bmc collection confirmed histological analysis bone marrow organs blood spleen thymus results suggest absence p53 gene expression positive impact repopulation ability bmcs treatment 5 fu
0.5222594.9531612.html.plaintext.txt	51	role p53 repopulation hscs 5 fu treatment vivo compare ability p53 p53 bmcs obtained 5 fu treated mice rescue animals exposed lethal dose tbi decreasing numbers p53 p53 bmcs injected recipient mice long term survival scored 16 weeks postinjection lower numbers p53 bmcs p53 bmcs required rescue tbi treated recipient mice table 1 suggesting post 5 fu repopulating p53 bmcs contain hscs capable reconstituting hematopoiesis vivo bmcs p53 p53 mice treated 5 fu showed difference ability repopulate tbi treated recipients data shown pcr analysis assess presence p53 knock wild type alleles mononuclear fraction bmcs obtained mice transplanted p53 bmcs showed knock allele shown thus long term hematopoiesis transplanted hosts caused p53 marrow cells normal marrow cells may escaped lethal irradiation analysis blood smears bone marrow sections showed normal hematopoiesis mice transplanted either p53 p53 bmcs data shown quantitative pcr followed southern blotting assess proportion p53 p53 bmcs tbi treated recipient mice injected iv 11 mixture indicated ratio 101 1001 bone marrow obtained 16 weeks transplantation fig 5 mice free leukemia time bmc collection confirmed histological analysis bone marrow organs blood spleen thymus results suggest absence p53 gene expression positive impact repopulation ability bmcs treatment 5 fu
0.5222594.9531612.html.plaintext.txt	52	view table table 1 long term repopulation ability post 5 fu recovering p53 p53 bmcs
0.5222594.9531612.html.plaintext.txt	53	view larger version 34k fig 5 competitive long term reconstitution assay detection p53 knock wild type allele bmcs tbi treated mice injected 16 weeks earlier 11 mixture p53 p53 bmcs pcr followed southern blotting left panel 1 2 3 4 individual mice known mixtures p53 p53 cells percentages indicated top bottom blot analyzed generate calibration blot right panel
0.5222594.9531612.html.plaintext.txt	54	view larger version 34k fig 5 competitive long term reconstitution assay detection p53 knock wild type allele bmcs tbi treated mice injected 16 weeks earlier 11 mixture p53 p53 bmcs pcr followed southern blotting left panel 1 2 3 4 individual mice known mixtures p53 p53 cells percentages indicated top bottom blot analyzed generate calibration blot right panel
0.5222594.9531612.html.plaintext.txt	55	role p53 regulation hscs 5 fu treatment determine whether vigorous repopulation ability p53 bmcs reflected increased number hscs immunostaining followed flow cytometry used quantitate hscs p53 bmcs repopulated 5 fu treatment contained threefold hscs phenotype lin sca 1 c kit 21 p53 counterparts table 2 staining anti cd34 antibody discriminated two hsc subpopulations lin sca 1 c kit cd34low cd34low primitive hscs lin sca 1 c kit cd34high cd34high multipotential hscs15 difference percentage cd34low cells p53 p53 bmcs regenerating 5 fu however percentage cd34high cells threefold fourfold higher p53 population difference content cd34high cd34low populations observed bmcs obtained p53 p53 mice treated 5 fu data shown
0.5222594.9531612.html.plaintext.txt	56	role p53 regulation hscs 5 fu treatment determine whether vigorous repopulation ability p53 bmcs reflected increased number hscs immunostaining followed flow cytometry used quantitate hscs p53 bmcs repopulated 5 fu treatment contained threefold hscs phenotype lin sca 1 c kit 21 p53 counterparts table 2 staining anti cd34 antibody discriminated two hsc subpopulations lin sca 1 c kit cd34low cd34low primitive hscs lin sca 1 c kit cd34high cd34high multipotential hscs15 difference percentage cd34low cells p53 p53 bmcs regenerating 5 fu however percentage cd34high cells threefold fourfold higher p53 population difference content cd34high cd34low populations observed bmcs obtained p53 p53 mice treated 5 fu data shown
0.5222594.9531612.html.plaintext.txt	57	view table table 2 frequency hscs post 5 fu regenerating p53 p53 bmcs
0.5222594.9531612.html.plaintext.txt	58	examine role p53 exhaustion hsc pool 104 cd34low cd34high cells p53 p53 genotype plated methylcellulose presence kl il 3 epo colonies counted every 10 days cells collected replated colony forming ability cd34low cd34high populations isolated bmcs 5 fu treated p53 mice persisted replatings compared p53 bmcs fig 6a p53 influence lineage commitment differentiation status cells indicated morphological analysis wright giemsa stained cytospin preparations cells used replating data shown types colonies showed predominantly cells myeloid origin whereas early 10 day cultures showed mainly myeloid precursors later 20 30 day cultures showed preponderance mature myeloid cells including neutrophils macrophages regardless origin phenotype cells used establish cultures consistent methylcellulose replating experiments ltc ic assay showed 5 fu treated p53 bmcs retained ability generate hematopoietic colonies longer time p53 counterparts fig 6b
0.5222594.9531612.html.plaintext.txt	59	examine role p53 exhaustion hsc pool 104 cd34low cd34high cells p53 p53 genotype plated methylcellulose presence kl il 3 epo colonies counted every 10 days cells collected replated colony forming ability cd34low cd34high populations isolated bmcs 5 fu treated p53 mice persisted replatings compared p53 bmcs fig 6a p53 influence lineage commitment differentiation status cells indicated morphological analysis wright giemsa stained cytospin preparations cells used replating data shown types colonies showed predominantly cells myeloid origin whereas early 10 day cultures showed mainly myeloid precursors later 20 30 day cultures showed preponderance mature myeloid cells including neutrophils macrophages regardless origin phenotype cells used establish cultures consistent methylcellulose replating experiments ltc ic assay showed 5 fu treated p53 bmcs retained ability generate hematopoietic colonies longer time p53 counterparts fig 6b
0.5222594.9531612.html.plaintext.txt	60	view larger version 29k fig 6 role p53 hsc exhaustion number colonies arising 104 lin sca 1 c kit cd34low upper panel lin sca 1 c kit cd34high lower panel cells passaged every 10 days methylcellulose semisolid medium containing kl il 3 epo results mean standard deviation three experiments b bmcs cocultured irradiated stromal layers clonogenic activity measured every 2 weeks presence kl results mean standard deviation two independent experiments 3 mice per experiment c cfu pre cfu counted day 12 bmc transplantation mean standard deviation six mice microscopic colonies present black shadowed bars represent results p53 p53 cells respectively
0.5222594.9531612.html.plaintext.txt	61	effect p53 5 fu induced exhaustion primitive hscs also examined spleen colony formation assays thus 105 bmcs obtained p53 p53 mice 6 days 5 fu treatment injected tbi recipients 12 days later cfu scored total 105 bmcs harvested mice used examine cfu formation retransplanted secondary tbi treated recipients pre cfu counted 12 days later p53 moderate effect number cfu formed post 5 fu bmcs fig 6c morphological analysis colonies showed major differences numerous large pre cfu formed post 5 fu recovering p53 bmcs secondary recipients fig 6c whereas p53 marrow cells form classical pre cfu although numerous microscopic nodules hematopoiesis noted low power microscopy p53 pre cfu showed large cellular nodules obliterating normal splenic architecture high power colonies composed erythroid myeloid cells latter showing partial inhibition maturation evident contrast evaluation p53 microscopic nodules showed overall preserved architecture spleen small numerous cellular aggregates high power view x 600 showed mixed hematopoietic cell populations preponderance erythroid precursors smaller number myeloid cells difference cfu pre cfu forming ability found p53 p53 bmcs obtained mice treated 5 fu data shown
0.5222594.9531612.html.plaintext.txt	62	effect p53 5 fu induced exhaustion primitive hscs also examined spleen colony formation assays thus 105 bmcs obtained p53 p53 mice 6 days 5 fu treatment injected tbi recipients 12 days later cfu scored total 105 bmcs harvested mice used examine cfu formation retransplanted secondary tbi treated recipients pre cfu counted 12 days later p53 moderate effect number cfu formed post 5 fu bmcs fig 6c morphological analysis colonies showed major differences numerous large pre cfu formed post 5 fu recovering p53 bmcs secondary recipients fig 6c whereas p53 marrow cells form classical pre cfu although numerous microscopic nodules hematopoiesis noted low power microscopy p53 pre cfu showed large cellular nodules obliterating normal splenic architecture high power colonies composed erythroid myeloid cells latter showing partial inhibition maturation evident contrast evaluation p53 microscopic nodules showed overall preserved architecture spleen small numerous cellular aggregates high power view x 600 showed mixed hematopoietic cell populations preponderance erythroid precursors smaller number myeloid cells difference cfu pre cfu forming ability found p53 p53 bmcs obtained mice treated 5 fu data shown
0.5222594.9531612.html.plaintext.txt	63	together results indicate absence p53 responsible increased number hscs decreased rate exhaustion hsc pool treatment 5 fu
0.5222594.9531612.html.plaintext.txt	64	role p53 recovery lineage specific progenitors 5 fu treatment vivo morphological analysis p53 p53 bmcs recovering 5 fu treatment showed presence major lineage specific precursors myelopoiesis erythropoiesis megakaryopoiesis lymphopoiesis data shown consistent findings immunophenotyping analysis cell populations showed statistically significant differences percentage following single stained cell populations b220 ig cells b lymphocytes precursors cd3 cells cells ter 119 cells erythroid precursors mac 1 myeloblasts monocytes f480 monocytes macrophages gr 1 granulocytes data shown data suggest p53 status affect differentiation post 5 fu regenerating marrow cells
0.5222594.9531612.html.plaintext.txt	65	role p53 recovery lineage specific progenitors 5 fu treatment vivo morphological analysis p53 p53 bmcs recovering 5 fu treatment showed presence major lineage specific precursors myelopoiesis erythropoiesis megakaryopoiesis lymphopoiesis data shown consistent findings immunophenotyping analysis cell populations showed statistically significant differences percentage following single stained cell populations b220 ig cells b lymphocytes precursors cd3 cells cells ter 119 cells erythroid precursors mac 1 myeloblasts monocytes f480 monocytes macrophages gr 1 granulocytes data shown data suggest p53 status affect differentiation post 5 fu regenerating marrow cells
0.5222594.9531612.html.plaintext.txt	66	analyze effect p53 proliferative potential various lineage specific precursors bmcs regenerating 5 fu treatment vitro clonogenic assays performed presence several growth factors colony forming ability myeloid cfu gm il 3 erythroid bfu e kl epo megakaryocytic cfu meg il 6 epo b lymphocytic b cfu il 7 lymphocytic cfu il 2 precursors well stromal cells cfu f higher post 5 fu regenerating p53 p53 bmcs fig 7
0.5222594.9531612.html.plaintext.txt	67	analyze effect p53 proliferative potential various lineage specific precursors bmcs regenerating 5 fu treatment vitro clonogenic assays performed presence several growth factors colony forming ability myeloid cfu gm il 3 erythroid bfu e kl epo megakaryocytic cfu meg il 6 epo b lymphocytic b cfu il 7 lymphocytic cfu il 2 precursors well stromal cells cfu f higher post 5 fu regenerating p53 p53 bmcs fig 7
0.5222594.9531612.html.plaintext.txt	68	view larger version 34k fig 7 clonogenic activity various hematopoietic progenitors stromal cells bone marrows p53 black bars p53 shadowed bars mice analyzed days 0 2 4 6 5 fu treatment results mean standard deviation three independent experiments y axis number colonies x axis days 5 fu treatment
0.5222594.9531612.html.plaintext.txt	69	view larger version 34k fig 7 clonogenic activity various hematopoietic progenitors stromal cells bone marrows p53 black bars p53 shadowed bars mice analyzed days 0 2 4 6 5 fu treatment results mean standard deviation three independent experiments y axis number colonies x axis days 5 fu treatment
0.5222594.9531612.html.plaintext.txt	70	discussion abstract introduction methods results discussion references
0.5222594.9531612.html.plaintext.txt	71	regeneration mature blood cells cytotoxic treatment results proliferative activity small number hscs high limited capacity self renewal2223 despite much recent progress identifying cytokines regulate proliferation hscs lineage specific descendants cytoreductive therapy genetic mechanism responsible intrinsic control self renewal differentiation cells remains largely undefined increasing evidence points importance p53 tumor suppressor gene regulating hematopoiesis2 7 using marrow cells p53 knockout wild type mice found p53 profound effect proliferation exhaustion hscs well proliferation lineage specific precursors bone marrow regenerating 5 fu treatment however p53 measurable effects lineage determination differentiation cells nevertheless 5 fu induced dysregulation cell growth appear lead leukemia translated altered output mature blood cells altered commitment specific blood cell lineage least period observation 5 months data also suggest regulatory mechanisms involving p16ink4a waf 1 may compensate loss function p53 changes occur stem cell population recovery 5 fu treatment seem likely reflect relevant physiological processes important bone marrow transplantation chemotherapy procedures
0.5222594.9531612.html.plaintext.txt	72	regeneration mature blood cells cytotoxic treatment results proliferative activity small number hscs high limited capacity self renewal2223 despite much recent progress identifying cytokines regulate proliferation hscs lineage specific descendants cytoreductive therapy genetic mechanism responsible intrinsic control self renewal differentiation cells remains largely undefined increasing evidence points importance p53 tumor suppressor gene regulating hematopoiesis2 7 using marrow cells p53 knockout wild type mice found p53 profound effect proliferation exhaustion hscs well proliferation lineage specific precursors bone marrow regenerating 5 fu treatment however p53 measurable effects lineage determination differentiation cells nevertheless 5 fu induced dysregulation cell growth appear lead leukemia translated altered output mature blood cells altered commitment specific blood cell lineage least period observation 5 months data also suggest regulatory mechanisms involving p16ink4a waf 1 may compensate loss function p53 changes occur stem cell population recovery 5 fu treatment seem likely reflect relevant physiological processes important bone marrow transplantation chemotherapy procedures
0.5222594.9531612.html.plaintext.txt	73	randall weissman24 reported 5 fu treatment number hscs lin sca 1 c kit thy11low p53 mice begins increase day 2 approximately 50 cells sg2m phase day 6 thus bmcs studies collected day 6 5 fu injection finding fewer p53 bmcs regenerating 5 fu treatment required rescue long term hematopoiesis tbi treated recipient mice suggests cells contain hscs p53 counterparts indeed percentage lin sca 1 c kit cells highly enriched hscs21 almost threefold higher p53 p53 bmcs recovering 5 fu treatment differences observed untreated mice however pool hscs subdivided long term reconstituting primitive hscs p hscs extensive self renewal capacity transiently repopulating hscs hscs self renew mice 3 6 weeks25 populations essential different times rescue hematopoiesis tbi treated animals recently immunophenotype populations determined15 lin sca 1 c kit cd34low p hscs lin sca 1 c kit cd34high hscs found percentage p hscs p53 p53 bmc populations similar 5 fu administration also untreated mice data shown however 5 fu responsible almost fourfold increase percentage hscs p53 bmcs compared p53 bmcs thus seems likely long term repopulating capacity 5 fu treated p53 bmcs results increased content hscs essential hematopoietic recovery critical initial weeks transplantation p hsc descendants become major source long term hematopoiesis moreover p53 mice contained five eight times bmcs p53 mice 6 days 5 fu treatment number p hscs hscs five eight times 20 32 times higher respectively p53 mice bone marrows long term reconstituted animals transplanted 11 mixture p53 p53 bmcs regenerating 5 fu contained 90 99 p53 cells thus even percentage p hscs similar 5 fu treated p53 p53 mice long term repopulating activity former cells much higher possibly increased production hscs apparently p53 plays important role bmc regeneration 5 fu treatment controlling total number p hscs organism also production early descendants hscs represent functional subpopulation responsible actual repopulation
0.5222594.9531612.html.plaintext.txt	74	randall weissman24 reported 5 fu treatment number hscs lin sca 1 c kit thy11low p53 mice begins increase day 2 approximately 50 cells sg2m phase day 6 thus bmcs studies collected day 6 5 fu injection finding fewer p53 bmcs regenerating 5 fu treatment required rescue long term hematopoiesis tbi treated recipient mice suggests cells contain hscs p53 counterparts indeed percentage lin sca 1 c kit cells highly enriched hscs21 almost threefold higher p53 p53 bmcs recovering 5 fu treatment differences observed untreated mice however pool hscs subdivided long term reconstituting primitive hscs p hscs extensive self renewal capacity transiently repopulating hscs hscs self renew mice 3 6 weeks25 populations essential different times rescue hematopoiesis tbi treated animals recently immunophenotype populations determined15 lin sca 1 c kit cd34low p hscs lin sca 1 c kit cd34high hscs found percentage p hscs p53 p53 bmc populations similar 5 fu administration also untreated mice data shown however 5 fu responsible almost fourfold increase percentage hscs p53 bmcs compared p53 bmcs thus seems likely long term repopulating capacity 5 fu treated p53 bmcs results increased content hscs essential hematopoietic recovery critical initial weeks transplantation p hsc descendants become major source long term hematopoiesis moreover p53 mice contained five eight times bmcs p53 mice 6 days 5 fu treatment number p hscs hscs five eight times 20 32 times higher respectively p53 mice bone marrows long term reconstituted animals transplanted 11 mixture p53 p53 bmcs regenerating 5 fu contained 90 99 p53 cells thus even percentage p hscs similar 5 fu treated p53 p53 mice long term repopulating activity former cells much higher possibly increased production hscs apparently p53 plays important role bmc regeneration 5 fu treatment controlling total number p hscs organism also production early descendants hscs represent functional subpopulation responsible actual repopulation
0.5222594.9531612.html.plaintext.txt	75	increased production hscs may reduce pool p hscs investigated role p53 exhaustion hsc pool 5 fu treatment unfortunately could use vivo bmc serial retransplantation assay mice transplanted p53 bmcs developed lymphomas 5 6 months consistent previous observations126 therefore used vivo pre cfu assay vitro ltc ic methylcellulose replating assays although p53 p53 bmcs 5 fu treatment developed similar numbers cfu p53 bmcs regenerated cells forming pre cfu thus p53 expression facilitates exhaustion cells forming pre cfu believed belong p hsc pool27 ltc ic assay methylcellulose replating assay confirmed longer duration colony forming ability p53 p53 hscs regenerating 5 fu summary vivo vitro assays showed absence p53 bmcs regenerating 5 fu treatment increases pool hscs also delays exhaustion increase total number p hscs p53 mice 5 fu treatment may reflect reduced sensitivity apoptosis increased proliferative capacity p53 bmcs quiescent state p hsc28 may explain absence difference percentage cells 5 fu treatment contrast hscs may represent cycling cells p53 cells proliferative advantage total number well percentage cells bmcs regenerating 5 fu treatment increased p53 mice compared p53 mice accord hypothesis p53 bmcs recovering 5 fu treatment displayed much higher multilineage clonogenic activity presence growth factors effect appeared rest proliferative advantage p53 cells rather different number precursor cells immunophenotypic analysis showed significant differences content lineage specific precursors p53 p53 bmcs also possible absence p53 production hscs p hscs increased different unknown mechanism
0.5222594.9531612.html.plaintext.txt	76	increased production hscs may reduce pool p hscs investigated role p53 exhaustion hsc pool 5 fu treatment unfortunately could use vivo bmc serial retransplantation assay mice transplanted p53 bmcs developed lymphomas 5 6 months consistent previous observations126 therefore used vivo pre cfu assay vitro ltc ic methylcellulose replating assays although p53 p53 bmcs 5 fu treatment developed similar numbers cfu p53 bmcs regenerated cells forming pre cfu thus p53 expression facilitates exhaustion cells forming pre cfu believed belong p hsc pool27 ltc ic assay methylcellulose replating assay confirmed longer duration colony forming ability p53 p53 hscs regenerating 5 fu summary vivo vitro assays showed absence p53 bmcs regenerating 5 fu treatment increases pool hscs also delays exhaustion increase total number p hscs p53 mice 5 fu treatment may reflect reduced sensitivity apoptosis increased proliferative capacity p53 bmcs quiescent state p hsc28 may explain absence difference percentage cells 5 fu treatment contrast hscs may represent cycling cells p53 cells proliferative advantage total number well percentage cells bmcs regenerating 5 fu treatment increased p53 mice compared p53 mice accord hypothesis p53 bmcs recovering 5 fu treatment displayed much higher multilineage clonogenic activity presence growth factors effect appeared rest proliferative advantage p53 cells rather different number precursor cells immunophenotypic analysis showed significant differences content lineage specific precursors p53 p53 bmcs also possible absence p53 production hscs p hscs increased different unknown mechanism
0.5222594.9531612.html.plaintext.txt	77	results suggest p53 key regulator proliferation hematopoietic progenitor cells responsible long short term repopulation whereas affect lineage determination differentiation committed progenitorprecursor cells findings raise possibility manipulation p53 expression might delay decline hscs occurs chemotherapy andor bone marrow transplantation
0.5222594.9531612.html.plaintext.txt	78	results suggest p53 key regulator proliferation hematopoietic progenitor cells responsible long short term repopulation whereas affect lineage determination differentiation committed progenitorprecursor cells findings raise possibility manipulation p53 expression might delay decline hscs occurs chemotherapy andor bone marrow transplantation
0.5222594.9531612.html.plaintext.txt	79	submitted july 7 1997 accepted november 29 1997 supported part nih grants amg bc r29 ca70815 grant elisa u pardee grant ts address reprint requests thomas skorski md phd department microbiology immunology kimmel cancer institute thomas jefferson university 372 jah 1020 locust st philadelphia pa 19107 publication costs article defrayed part page charge payment article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5222594.9531612.html.plaintext.txt	80	submitted july 7 1997 accepted november 29 1997 supported part nih grants amg bc r29 ca70815 grant elisa u pardee grant ts address reprint requests thomas skorski md phd department microbiology immunology kimmel cancer institute thomas jefferson university 372 jah 1020 locust st philadelphia pa 19107 publication costs article defrayed part page charge payment article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5222594.9531612.html.plaintext.txt	81	thank david dicker technical assistance cell sorting
0.5222594.9531612.html.plaintext.txt	82	references abstract introduction methods results discussion references 1 donehower la harvey m slagle bl mcarthur mj montgomery jr ca butel js bradley mice deficient p53 developmentally normal susceptible spontaneous tumours nature 356215 1992medline order article via infotrieve 2 kastan mb radin ai kuerbitz sj onyekwere o wolkow ca civin ci stone kd woo ravindranath y craig rw levels p53 protein increase maturation human hematopoietic cells cancer res 514279 1991abstract 3 schalusky g goldfinger n peled rotter v involvement wild type p53 pre b cell differentiation vitro proc natl acad sci usa 888982 1991abstract 4 shounan y dolnikov mackenzie kl miller m chan yy symonds g retroviral transduction hematopoietic progenitor cells mutant p53 promotes survival proliferation modifies differentiation potential inhibits apoptosis leukemia 101619 1996medline order article via infotrieve 5 lotem j sachs l hematopoietic cells mice deficient wild type p53 resistant induction apoptosis agents blood 821092 1993abstract 6 banerjee d lenz hj schnieders b manno dj ju jf spears cp hochhauser d danenberg k danenberg p bertino jr transfection wild type mutant p53 induces early monocytic differentiation hl60 cells increases sensitivity stress cell growth differ 61405 1995abstract 7 jiang d lenardo mj zuniga pflucker c p53 prevents maturation cd4cd8 stage thymocyte differentiation absence cell receptor rearrangement j exp med 1831923 1996abstract 8 prokocimer m rotter v structure function p53 normal cells aberrations cancer cells projection hematologic cell lineages blood 842391 1994free full text 9 el deiry ws tokino velculescu ve levy db parsons r trent jm lin d mercer kinzler kw vogelstein b waf1 potential mediator p53 tumor suppression cell 75817 1993medline order article via infotrieve 10 seto e usheva zambetti gp momand j horikoshi n weinmann r levine aj shenk wild type p53 binds tata binding protein represses transcription proc natl acad sci usa 8912028 1992abstract 11 el deiry ws harper jw oconnor pm velculescu ve canman ce jackman j pietenpol ja burrell m hill de wang y wiman kg mercer kastan mb kohn kw elledge sj kinzler kw vogelstein b waf1cip1 induced p53 mediated g1 arrest apoptosis cancer res 541169 1994abstract 12 lowe sw schmitt em smith sw osborne ba jacks p53 required radiation induced apoptosis mouse thymocytes nature 362847 1993medline order article via infotrieve 13 miyashita reed jc tumor suppressor p53 direct transcriptional activator human bax gene cell 80293 1995medline order article via infotrieve 14 weinberg wc azzoli cg kadiwar n yuspa sh p53 gene dosage modifies growth malignant progression keratinocytes expressing v rasha oncogene cancer res 545584 1994abstract 15 osawa m hanada k hamada h nakauchi h long term lymphohematopoietic reconstitution single cd34 lownegative hematopoietic stem cell science 273242 1996abstract 16 skorski szczylik c ratajczak mz malaguarnera l gewirtz calabretta b growth factor dependent inhibition normal hematopoiesis n ras antisense oligodeoxynucleotides j exp med 175743 1992abstract 17 burstein friese p downs mei r characteristics novel rat anti mouse platelet monoclonal antibody application studies megakaryocytes exp hematol 201170 1992medline order article via infotrieve 18 skorski kanakaraj p nieborowska skorska m ratajczak mz wen sc zon g gewirtz perussia b calabretta b phosphatidylinositol 3 kinase activity regulated bcrabl required growth philadelphia chromosome positive cells blood 86726 1995abstractfree full text 19 ratajczak mz gerwitz civin ci stk 1 human homologue flk2flt 3 selectively expressed cd34 human bone marrow cells involved proliferation early progenitorstem cells proc natl acad sci usa 91459 1994abstract 20 kastan mb onyekwere o sidransky d vogelstein b craig rw participation p53 protein cellular response dna damage cancer res 516304 1991abstract 21 moore ka ema h lemischka r vitro maintenance highly purified transplantable hematopoietic stem cells blood 894337 1997abstractfree full text 22 harrison de astle cm loss stem cell repopulating ability upon transplantation effects donor age cell number transplantation procedure j exp med 1561767 1982abstract 23 mauch p hellman loss hematopoietic stem cell self renewal bone marrow transplantation blood 74872 1989abstract 24 randall weissman il phenotypic functional changes induced clonal level hematopoietic stem cells 5 fluorouracil treatment blood 893596 1997abstractfree full text 25 morrison sj weissman il long term repopulating subset hematopoietic stem cells deterministic isolatable phenotype immunity 1661 1994medline order article via infotrieve 26 jacks remington l williams bo schmitt em halachmi bronson rt weinberg ra tumor spectrum analysis p53 mutant mice current biology 41 1994 medline order article via infotrieve 27 jd ploemacher re transient permanent engraftment potential murine hematopoietic stem cell subsets differential effects host conditioning gamma radiation cytotoxic drugs exp hematol 21913 1993medline order article via infotrieve 28 lerner c harrison de 5 fluorouracil spares hemopoietic stem cells responsible long term repopulation exp hematol 18114 1990medline order article via infotrieve 1998 american society hematology 0006 49719891 00313000
0.5222594.9531612.html.plaintext.txt	83	references abstract introduction methods results discussion references 1 donehower la harvey m slagle bl mcarthur mj montgomery jr ca butel js bradley mice deficient p53 developmentally normal susceptible spontaneous tumours nature 356215 1992medline order article via infotrieve 2 kastan mb radin ai kuerbitz sj onyekwere o wolkow ca civin ci stone kd woo ravindranath y craig rw levels p53 protein increase maturation human hematopoietic cells cancer res 514279 1991abstract 3 schalusky g goldfinger n peled rotter v involvement wild type p53 pre b cell differentiation vitro proc natl acad sci usa 888982 1991abstract 4 shounan y dolnikov mackenzie kl miller m chan yy symonds g retroviral transduction hematopoietic progenitor cells mutant p53 promotes survival proliferation modifies differentiation potential inhibits apoptosis leukemia 101619 1996medline order article via infotrieve 5 lotem j sachs l hematopoietic cells mice deficient wild type p53 resistant induction apoptosis agents blood 821092 1993abstract 6 banerjee d lenz hj schnieders b manno dj ju jf spears cp hochhauser d danenberg k danenberg p bertino jr transfection wild type mutant p53 induces early monocytic differentiation hl60 cells increases sensitivity stress cell growth differ 61405 1995abstract 7 jiang d lenardo mj zuniga pflucker c p53 prevents maturation cd4cd8 stage thymocyte differentiation absence cell receptor rearrangement j exp med 1831923 1996abstract 8 prokocimer m rotter v structure function p53 normal cells aberrations cancer cells projection hematologic cell lineages blood 842391 1994free full text 9 el deiry ws tokino velculescu ve levy db parsons r trent jm lin d mercer kinzler kw vogelstein b waf1 potential mediator p53 tumor suppression cell 75817 1993medline order article via infotrieve 10 seto e usheva zambetti gp momand j horikoshi n weinmann r levine aj shenk wild type p53 binds tata binding protein represses transcription proc natl acad sci usa 8912028 1992abstract 11 el deiry ws harper jw oconnor pm velculescu ve canman ce jackman j pietenpol ja burrell m hill de wang y wiman kg mercer kastan mb kohn kw elledge sj kinzler kw vogelstein b waf1cip1 induced p53 mediated g1 arrest apoptosis cancer res 541169 1994abstract 12 lowe sw schmitt em smith sw osborne ba jacks p53 required radiation induced apoptosis mouse thymocytes nature 362847 1993medline order article via infotrieve 13 miyashita reed jc tumor suppressor p53 direct transcriptional activator human bax gene cell 80293 1995medline order article via infotrieve 14 weinberg wc azzoli cg kadiwar n yuspa sh p53 gene dosage modifies growth malignant progression keratinocytes expressing v rasha oncogene cancer res 545584 1994abstract 15 osawa m hanada k hamada h nakauchi h long term lymphohematopoietic reconstitution single cd34 lownegative hematopoietic stem cell science 273242 1996abstract 16 skorski szczylik c ratajczak mz malaguarnera l gewirtz calabretta b growth factor dependent inhibition normal hematopoiesis n ras antisense oligodeoxynucleotides j exp med 175743 1992abstract 17 burstein friese p downs mei r characteristics novel rat anti mouse platelet monoclonal antibody application studies megakaryocytes exp hematol 201170 1992medline order article via infotrieve 18 skorski kanakaraj p nieborowska skorska m ratajczak mz wen sc zon g gewirtz perussia b calabretta b phosphatidylinositol 3 kinase activity regulated bcrabl required growth philadelphia chromosome positive cells blood 86726 1995abstractfree full text 19 ratajczak mz gerwitz civin ci stk 1 human homologue flk2flt 3 selectively expressed cd34 human bone marrow cells involved proliferation early progenitorstem cells proc natl acad sci usa 91459 1994abstract 20 kastan mb onyekwere o sidransky d vogelstein b craig rw participation p53 protein cellular response dna damage cancer res 516304 1991abstract 21 moore ka ema h lemischka r vitro maintenance highly purified transplantable hematopoietic stem cells blood 894337 1997abstractfree full text 22 harrison de astle cm loss stem cell repopulating ability upon transplantation effects donor age cell number transplantation procedure j exp med 1561767 1982abstract 23 mauch p hellman loss hematopoietic stem cell self renewal bone marrow transplantation blood 74872 1989abstract 24 randall weissman il phenotypic functional changes induced clonal level hematopoietic stem cells 5 fluorouracil treatment blood 893596 1997abstractfree full text 25 morrison sj weissman il long term repopulating subset hematopoietic stem cells deterministic isolatable phenotype immunity 1661 1994medline order article via infotrieve 26 jacks remington l williams bo schmitt em halachmi bronson rt weinberg ra tumor spectrum analysis p53 mutant mice current biology 41 1994 medline order article via infotrieve 27 jd ploemacher re transient permanent engraftment potential murine hematopoietic stem cell subsets differential effects host conditioning gamma radiation cytotoxic drugs exp hematol 21913 1993medline order article via infotrieve 28 lerner c harrison de 5 fluorouracil spares hemopoietic stem cells responsible long term repopulation exp hematol 18114 1990medline order article via infotrieve 1998 american society hematology 0006 49719891 00313000
0.52467555.12855557.html.plaintext.txt	0	fanconi anemia type c p53 cooperate apoptosis tumorigenesis brian freie xiaxin li samantha l m ciccone kathy nawa scott cooper catherine vogelweid laurel schantz laura haneline attilio orazi hal e broxmeyer suk hee lee d wade clapp
0.52467555.12855557.html.plaintext.txt	1	herman b wells center pediatric research departments microbiology immunology pediatrics medicine laboratory animal research center pathology biochemistry walther oncology center indiana university school medicine indianapolis
0.52467555.12855557.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion references fanconi anemia fa recessive genomic instability syndrome characterized developmental defects progressive bone marrow failure cancer fa genetically heterogeneous however proteins encoded different fa loci interact functionally brca1 brca2 atm gene products although patients fa highly predisposed development myeloid leukemia solid tumors alterations biochemical pathways responsible progression tumorigenesis patients remain unknown fa cells hypersensitive range genotoxic cellular stresses activate signaling pathways mediating apoptosis show ionizing radiation ir induces modestly elevated levels p53 cells fa type c fancc mutant mice inactivation trp53 rescues tumor necrosis factor induced apoptosis myeloid cells fancc mice whereas fancc mice failed form hematopoietic solid malignancies mice mutant fancc trp53 developed tumors rapidly mice mutant trp53 alone shortened latency associated appearance tumor types found patients fa mice mutant trp53 collectively data demonstrate p53 fancc interact functionally regulate apoptosis tumorigenesis fancc deficient cells blood 20031024146 4152
0.52467555.12855557.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references fanconi anemia fa recessive genomic instability syndrome characterized developmental defects progressive bone marrow failure cancer fa genetically heterogeneous however proteins encoded different fa loci interact functionally brca1 brca2 atm gene products although patients fa highly predisposed development myeloid leukemia solid tumors alterations biochemical pathways responsible progression tumorigenesis patients remain unknown fa cells hypersensitive range genotoxic cellular stresses activate signaling pathways mediating apoptosis show ionizing radiation ir induces modestly elevated levels p53 cells fa type c fancc mutant mice inactivation trp53 rescues tumor necrosis factor induced apoptosis myeloid cells fancc mice whereas fancc mice failed form hematopoietic solid malignancies mice mutant fancc trp53 developed tumors rapidly mice mutant trp53 alone shortened latency associated appearance tumor types found patients fa mice mutant trp53 collectively data demonstrate p53 fancc interact functionally regulate apoptosis tumorigenesis fancc deficient cells blood 20031024146 4152
0.52467555.12855557.html.plaintext.txt	4	introduction top abstract introduction materials methods results discussion references fanconi anemia fa autosomal recessive disorder characterized progressive bone marrow failure developmental defects cancer individuals fa 500 1000 fold increased risk developing myeloid leukemia range solid tumors preferentially affect head neck skin gastrointestinal genitourinary systems1 4 recent studies identified existence 7 fa gene products denoted fanca fancg appear function least part complex signaling proteins modulate genomic stability review see joenje patel5 addition one gene product fancc appears role modulating apoptosis addition role fanca fancg complex6 8 ways different fa proteins interact biochemical pathways maintain genomic stability prevent tumor formation area active investigation
0.52467555.12855557.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references fanconi anemia fa autosomal recessive disorder characterized progressive bone marrow failure developmental defects cancer individuals fa 500 1000 fold increased risk developing myeloid leukemia range solid tumors preferentially affect head neck skin gastrointestinal genitourinary systems1 4 recent studies identified existence 7 fa gene products denoted fanca fancg appear function least part complex signaling proteins modulate genomic stability review see joenje patel5 addition one gene product fancc appears role modulating apoptosis addition role fanca fancg complex6 8 ways different fa proteins interact biochemical pathways maintain genomic stability prevent tumor formation area active investigation
0.52467555.12855557.html.plaintext.txt	6	although mechanisms underlying tumor formation patients fa incompletely understood epidemiologic experimental observations raise number possibilities first development malignant cells primary cells frequently requires alterations apoptosis cell cycle control myeloid malignancies predominantly occur context progressive apoptotic depletion hematopoietic progenitors patients fa9 fancc mice10 hypothesized leukemogenesis results accumulation mutations precipitates emergence apoptotic resistant precursors second p53 pivotal sensor genotoxic nongenotoxic stress activates signaling pathways result cell cycle arrest apoptosis apoptosis fancc deficient lymphoblasts previously shown due activation protein kinase r pkr11 p53 downstream effector pkr12 14 inactivation polymorphisms p53 proteins p53 pathway may important target cellular transformation fa associated myeloid malignancies third patients fa predisposed solid tumors including epithelial squamous cell carcinomas high rate p53 alteration sporadic malignancies1516 risk solid tumors patients fa goes markedly 20 years age increases cumulative risk 90 40 years age2 finally recent studies positioned fa proteins biochemical pathway includes brca1 brca21718 fact truncating hypomorphic mutations brca2 observed fa d1 complementation group18 studies using brca1 brca2 conditional knockout mice support role p53 tumor progression19 21
0.52467555.12855557.html.plaintext.txt	7	although mechanisms underlying tumor formation patients fa incompletely understood epidemiologic experimental observations raise number possibilities first development malignant cells primary cells frequently requires alterations apoptosis cell cycle control myeloid malignancies predominantly occur context progressive apoptotic depletion hematopoietic progenitors patients fa9 fancc mice10 hypothesized leukemogenesis results accumulation mutations precipitates emergence apoptotic resistant precursors second p53 pivotal sensor genotoxic nongenotoxic stress activates signaling pathways result cell cycle arrest apoptosis apoptosis fancc deficient lymphoblasts previously shown due activation protein kinase r pkr11 p53 downstream effector pkr12 14 inactivation polymorphisms p53 proteins p53 pathway may important target cellular transformation fa associated myeloid malignancies third patients fa predisposed solid tumors including epithelial squamous cell carcinomas high rate p53 alteration sporadic malignancies1516 risk solid tumors patients fa goes markedly 20 years age increases cumulative risk 90 40 years age2 finally recent studies positioned fa proteins biochemical pathway includes brca1 brca21718 fact truncating hypomorphic mutations brca2 observed fa d1 complementation group18 studies using brca1 brca2 conditional knockout mice support role p53 tumor progression19 21
0.52467555.12855557.html.plaintext.txt	8	although epidemiologic biochemical data suggest role p53 mediating apoptosis cancer fa previous study found dominant negative p53 affect apoptosis fancc deficient immortalized lymphoblasts exposed genotoxic stress22 however use immortalized cell lines may altered p53 function23 inherent limitation studies therefore model endogenous stresses incurred organism vivo performed genetic intercross fancc trp53 mutant mice characterize genes interact mediating apoptosis tumorigenesis
0.52467555.12855557.html.plaintext.txt	9	although epidemiologic biochemical data suggest role p53 mediating apoptosis cancer fa previous study found dominant negative p53 affect apoptosis fancc deficient immortalized lymphoblasts exposed genotoxic stress22 however use immortalized cell lines may altered p53 function23 inherent limitation studies therefore model endogenous stresses incurred organism vivo performed genetic intercross fancc trp53 mutant mice characterize genes interact mediating apoptosis tumorigenesis
0.52467555.12855557.html.plaintext.txt	10	materials methods top abstract introduction materials methods results discussion references cell culture
0.52467555.12855557.html.plaintext.txt	11	primary murine embryo fibroblasts mefs obtained day 12 14 mouse embryos derived breeding fancc mice embryos obtained small amount tissue used polymerase chain reaction pcr analysis fibroblasts derived mincing embryos culturing tissue culture dishes growth media consisting dulbecco modified eaglef12 media containing 10 fetal calf serum fcs supplemented 2 mm l glutamine 100 uml penicillin 100 uml streptomycin gibco brl grand island ny 3 days culture plates trypsinized cells expanded experimental use frozen mefs maintained basis 3t3 protocol experiments using mefs performed cells passage 4 6 treating cells ionizing radiation ir used gammacell 40 exactor nordion ottawa canada containing 137cs source
0.52467555.12855557.html.plaintext.txt	12	primary murine embryo fibroblasts mefs obtained day 12 14 mouse embryos derived breeding fancc mice embryos obtained small amount tissue used polymerase chain reaction pcr analysis fibroblasts derived mincing embryos culturing tissue culture dishes growth media consisting dulbecco modified eaglef12 media containing 10 fetal calf serum fcs supplemented 2 mm l glutamine 100 uml penicillin 100 uml streptomycin gibco brl grand island ny 3 days culture plates trypsinized cells expanded experimental use frozen mefs maintained basis 3t3 protocol experiments using mefs performed cells passage 4 6 treating cells ionizing radiation ir used gammacell 40 exactor nordion ottawa canada containing 137cs source
0.52467555.12855557.html.plaintext.txt	13	mice containing disruption fancc gene generously provided dr manuel buchwald university toronto hospital sick children24 mice back crossed 10 generations c57bl6j strain mice genotyped using pcr detect wild type mutant fancc alleles described8 mice harboring disruption trp53 gene previously described25 obtained c57bl6j strain jackson laboratories bar harbor trp53 genotype determined using pcr method primer sequences provided jackson laboratories fancc trp53 compound heterozygous mice generated mating fancc mice trp53 mice f2 generation produced crossing compound heterozygotes derived f1 mice mice monitored long term tumors morbidity due low frequency fancc trp53 mice obtained mice genotype generated crossing fancc trp53 mice
0.52467555.12855557.html.plaintext.txt	14	mice containing disruption fancc gene generously provided dr manuel buchwald university toronto hospital sick children24 mice back crossed 10 generations c57bl6j strain mice genotyped using pcr detect wild type mutant fancc alleles described8 mice harboring disruption trp53 gene previously described25 obtained c57bl6j strain jackson laboratories bar harbor trp53 genotype determined using pcr method primer sequences provided jackson laboratories fancc trp53 compound heterozygous mice generated mating fancc mice trp53 mice f2 generation produced crossing compound heterozygotes derived f1 mice mice monitored long term tumors morbidity due low frequency fancc trp53 mice obtained mice genotype generated crossing fancc trp53 mice
0.52467555.12855557.html.plaintext.txt	15	histology immunohistochemistry
0.52467555.12855557.html.plaintext.txt	16	mice moribund killed autopsies performed veterinary pathologist tissues tumors fixed 10 formalin paraffin sections obtained immunohistochemistry used specifically identify lineage malignant cells tumors using mac 2 m338 cedarlane laboratories hornby canada antibody widely accepted marker tissue macrophagesmonocytes myeloid malignancy26 immunohistochemistry performed recommended antibody supplier donkey antirat secondary antibody jackson immunoresearch labs west grove pa detected using streptavidin horseradish peroxidase hrp lsab2 system dako carpinteria ca
0.52467555.12855557.html.plaintext.txt	17	mice moribund killed autopsies performed veterinary pathologist tissues tumors fixed 10 formalin paraffin sections obtained immunohistochemistry used specifically identify lineage malignant cells tumors using mac 2 m338 cedarlane laboratories hornby canada antibody widely accepted marker tissue macrophagesmonocytes myeloid malignancy26 immunohistochemistry performed recommended antibody supplier donkey antirat secondary antibody jackson immunoresearch labs west grove pa detected using streptavidin horseradish peroxidase hrp lsab2 system dako carpinteria ca
0.52467555.12855557.html.plaintext.txt	18	whole cell protein extracts obtained cells lysis buffer 100 mm tris cl trishydroxymethylaminomethane ph 74 01 np 40 150 mm nacl 1 mm dithiothreitol dtt quantitated using bradford assay equivalent amounts protein electrophoresed 10 sodium dodecyl sulfate polyacrylamide gel electrophoresis sds page gels transferred polyvinylidene difluoride pvdf immobilon p membranes millipore billerica ma proteins detected western blotting enhanced chemiluminescence ecl system amersham pharmacia piscataway nj polyclonal antibodies p21waf cip1 c 19 actin c 19 obtained santa cruz biotechnology santa cruz ca antibody p53 ab1 obtained oncogene research products boston ma antibodies used specified manufacturer
0.52467555.12855557.html.plaintext.txt	19	binding p53 consensus sequence assessed irradiated whole cell extracts previously described2728 using modified procedure precipitate oligonucleotide bound p53 protein p53 consensus sequence tacagaacatgtctaagcatgctggggact conjugated agarose beads well beads containing control p53 consensus sequence obtained santa cruz biotechnology briefly lymphocytes obtained spleens mice cultured density 1 x 106 cellsml 22 microgml concanavalin 48 hours cells treated ir whole cell extracts obtained lysis buffer containing 05 np 40 150 mm nacl 20 mm hepes n 2 hydroxyethylpiperazine n 2 ethanesulfonic acid ph 79 1 mm dtt 10 microgml pepstatin 10 microgml aprotonin 1 mm phenylmethylsulfonyl fluoride pmsf equivalent amounts protein 100 500 microg incubated presence agarose beadoligonucleotide conjugate incubation carried binding buffer 10 glycerol 25 mm mgcl2 50 mm nacl 20 mm hepes ph 79 05 mm dtt followed extensive washing beads binding buffer electrophoresis active p53 protein bound beads carried 10 sds page gels detected western blot anti p53 antibody
0.52467555.12855557.html.plaintext.txt	20	binding p53 consensus sequence assessed irradiated whole cell extracts previously described2728 using modified procedure precipitate oligonucleotide bound p53 protein p53 consensus sequence tacagaacatgtctaagcatgctggggact conjugated agarose beads well beads containing control p53 consensus sequence obtained santa cruz biotechnology briefly lymphocytes obtained spleens mice cultured density 1 x 106 cellsml 22 microgml concanavalin 48 hours cells treated ir whole cell extracts obtained lysis buffer containing 05 np 40 150 mm nacl 20 mm hepes n 2 hydroxyethylpiperazine n 2 ethanesulfonic acid ph 79 1 mm dtt 10 microgml pepstatin 10 microgml aprotonin 1 mm phenylmethylsulfonyl fluoride pmsf equivalent amounts protein 100 500 microg incubated presence agarose beadoligonucleotide conjugate incubation carried binding buffer 10 glycerol 25 mm mgcl2 50 mm nacl 20 mm hepes ph 79 05 mm dtt followed extensive washing beads binding buffer electrophoresis active p53 protein bound beads carried 10 sds page gels detected western blot anti p53 antibody
0.52467555.12855557.html.plaintext.txt	21	hematopoietic progenitor assays
0.52467555.12855557.html.plaintext.txt	22	hematopoietic progenitors assays performed plating triplicate 5 x 104 bone marrow low density cells per milliliter cultures established 1 iscove modified dulbecco medium imdm methylcellulose culture medium 30 fcs 50 ngml recombinant murine steel factor immunex seattle wa 1 uml recombinant human erythropoietin amgen thousand oaks ca 5 volvol pokeweed mitogen spleen conditioned media pwmscm 01 mmol hemin sigma st louis mo cells incubated 37 degrees c 5 co2 lowered 5 o2 bone marrow cells cultured methylcellulose progenitor assays increasing concentrations mitomycin c sigma recombinant murine tumor necrosis factor tnf r d systems minneapolis mn generate dose response curves fancc fancc hematopoietic progenitor cells granulocyte macrophage colony forming unit cfu gm colonies scored day 7 culture investigator blinded genotypes cultures
0.52467555.12855557.html.plaintext.txt	23	hematopoietic progenitors assays performed plating triplicate 5 x 104 bone marrow low density cells per milliliter cultures established 1 iscove modified dulbecco medium imdm methylcellulose culture medium 30 fcs 50 ngml recombinant murine steel factor immunex seattle wa 1 uml recombinant human erythropoietin amgen thousand oaks ca 5 volvol pokeweed mitogen spleen conditioned media pwmscm 01 mmol hemin sigma st louis mo cells incubated 37 degrees c 5 co2 lowered 5 o2 bone marrow cells cultured methylcellulose progenitor assays increasing concentrations mitomycin c sigma recombinant murine tumor necrosis factor tnf r d systems minneapolis mn generate dose response curves fancc fancc hematopoietic progenitor cells granulocyte macrophage colony forming unit cfu gm colonies scored day 7 culture investigator blinded genotypes cultures
0.52467555.12855557.html.plaintext.txt	24	measurement cell hypersensitivity apoptosis assay
0.52467555.12855557.html.plaintext.txt	25	mefs treated 50 ngml tnf cultured 72 hours viable cells counted trypan blue exclusion assess viable cell numbers assess apoptosis cells fixed paraformaldehyde 48 hours tnf treatment analyzed terminal deoxynucleotidyl transferase mediated deoxuridine triphosphate nick end labeling tunel assay using apo direct system annexin v bd biosciences mountain view ca recommended manufacturer
0.52467555.12855557.html.plaintext.txt	26	mefs treated 50 ngml tnf cultured 72 hours viable cells counted trypan blue exclusion assess viable cell numbers assess apoptosis cells fixed paraformaldehyde 48 hours tnf treatment analyzed terminal deoxynucleotidyl transferase mediated deoxuridine triphosphate nick end labeling tunel assay using apo direct system annexin v bd biosciences mountain view ca recommended manufacturer
0.52467555.12855557.html.plaintext.txt	27	results top abstract introduction materials methods results discussion references expression function p53 protein primary murine fancc deficient cells
0.52467555.12855557.html.plaintext.txt	28	determine whether p53 appropriately activated fancc deficient cells first used primary cells inbred fancc mice investigate p53 function following dna damage levels p53 measured western blotting primary passage 4 mefs exposed ir figure 1 course p53 induction wild type cells consistent previous reports detailing cyclic behavior p53 induction following ir29 amount p53 protein observed following ir damage modestly increased fancc cells analogous previous studies using mitomycin c2230 addition basal p53 level fancc mefs modestly elevated mean 32 plus minus 05 x 103 normalized density units fancc versus 12 plus minus 01 x 103 density units fancc n 3 experiments used consensus p53 binding assay verify p53 protein derived fancc lymphocytes appropriately bound dna data shown collectively data indicate p53 protein induced primary fancc mutant cells functional
0.52467555.12855557.html.plaintext.txt	29	determine whether p53 appropriately activated fancc deficient cells first used primary cells inbred fancc mice investigate p53 function following dna damage levels p53 measured western blotting primary passage 4 mefs exposed ir figure 1 course p53 induction wild type cells consistent previous reports detailing cyclic behavior p53 induction following ir29 amount p53 protein observed following ir damage modestly increased fancc cells analogous previous studies using mitomycin c2230 addition basal p53 level fancc mefs modestly elevated mean 32 plus minus 05 x 103 normalized density units fancc versus 12 plus minus 01 x 103 density units fancc n 3 experiments used consensus p53 binding assay verify p53 protein derived fancc lymphocytes appropriately bound dna data shown collectively data indicate p53 protein induced primary fancc mutant cells functional
0.52467555.12855557.html.plaintext.txt	30	view larger version 19k figure 1 evaluation p53 protein fancc cells radiation induced p53 protein fancc deficient cells mefs treated 10 gy ir cultured indicated time periods protein extracts 50 microg analyzed western blotting using antibody specific p53 representative 3 independent experiments shown total protein levels normalized using actin control shown bottom panel
0.52467555.12855557.html.plaintext.txt	31	view larger version 19k figure 1 evaluation p53 protein fancc cells radiation induced p53 protein fancc deficient cells mefs treated 10 gy ir cultured indicated time periods protein extracts 50 microg analyzed western blotting using antibody specific p53 representative 3 independent experiments shown total protein levels normalized using actin control shown bottom panel
0.52467555.12855557.html.plaintext.txt	32	hypersensitivity fancc deficient cells apoptosis significantly p53 dependent
0.52467555.12855557.html.plaintext.txt	33	role p53 executing apoptosis well characterized response stress including inhibitory cytokines tnf dna damaging agents1231 33 fancc deficient cells hypersensitive cellular stresses induce apoptosis including tnf interferon ifn 78113435 investigated functional p53 required increased apoptosis observed fancc cells test hypothesis intercrossed fancc trp53 mutant mice generate f2 animals deficient loci fancc trp53 assessed sensitivity bone marrow derived hematopoietic progenitor cells tnf myeloid progenitor cells initially used cells hypersensitive low concentrations tnf loss hypersensitivity observed myeloid malignancies fa experimental murine model10 patients fa9 cultures scored investigator blinded experimental genotypes consistent previous studies8 fancc deficient cells hypersensitive tnf figure 2a strikingly hypersensitivity completely abrogated cells lacking fancc trp53 figure 2a indicating hypersensitivity fancc mutant cells tnf dependent p53 also tested whether hypersensitivity fancc myeloid progenitors mitomycin c p53 dependent contrast progenitors deficient fancc number fancc trp53 progenitors rescued wild type levels low concentrations mitomycin c indicating hypersensitivity significantly p53 dependent figure 2b rescue mitomycin c hypersensitivity maintained higher mitomycin c doses indicating p53 independent pathway apoptosis also contributed hypersensitivity fancc cells mitomycin c
0.52467555.12855557.html.plaintext.txt	34	role p53 executing apoptosis well characterized response stress including inhibitory cytokines tnf dna damaging agents1231 33 fancc deficient cells hypersensitive cellular stresses induce apoptosis including tnf interferon ifn 78113435 investigated functional p53 required increased apoptosis observed fancc cells test hypothesis intercrossed fancc trp53 mutant mice generate f2 animals deficient loci fancc trp53 assessed sensitivity bone marrow derived hematopoietic progenitor cells tnf myeloid progenitor cells initially used cells hypersensitive low concentrations tnf loss hypersensitivity observed myeloid malignancies fa experimental murine model10 patients fa9 cultures scored investigator blinded experimental genotypes consistent previous studies8 fancc deficient cells hypersensitive tnf figure 2a strikingly hypersensitivity completely abrogated cells lacking fancc trp53 figure 2a indicating hypersensitivity fancc mutant cells tnf dependent p53 also tested whether hypersensitivity fancc myeloid progenitors mitomycin c p53 dependent contrast progenitors deficient fancc number fancc trp53 progenitors rescued wild type levels low concentrations mitomycin c indicating hypersensitivity significantly p53 dependent figure 2b rescue mitomycin c hypersensitivity maintained higher mitomycin c doses indicating p53 independent pathway apoptosis also contributed hypersensitivity fancc cells mitomycin c
0.52467555.12855557.html.plaintext.txt	35	view larger version 18k figure 2 apoptotic hypersensitivity fancc cells tnf p53 dependent effect p53 deficiency tnf induced hypersensitivity fancc progenitors hematopoietic progenitor colonies bone marrow low density mononuclear cells cultured presence increasing amounts tnf colonies scored data plotted percent control cfu gm colonies scored absence tnf percent control shown y axis tnf dose shown x axis mean data point plus minus sd shown genotype indicated corresponding symbol shown key statistics assessed using student test fancc trp53 genotypes statistically different groups p 001 representative experiment conducted triplicate cultures shown b effect p53 deficiency mitomycin c induced hypersensitivity fancc progenitors hematopoietic colonies scored presence absence increasing doses mitomycin c data shown percent control untreated colony formation genotype indicated corresponding symbol shown legend mean data point plus minus sd shown fancc trp53 genotypes statistically different fancc trp53 progenitors 25 50 nm mitomycin c concentrations student test p 01 c hypersensitivity primary fancc mefs tnf dependent p53 mefs cultured presence absence tnf 50 ngml counted 72 hours culture representative experiment n 5 similar results shown change cell number due tnf treatment expressed percent control untreated cells genotype percent control shown y axis genotype shown beneath bar error bars indicate sd statistical analysis performed using student test differences fancctrp53 fancc trp53 groups statistically significant
0.52467555.12855557.html.plaintext.txt	36	view larger version 18k figure 2 apoptotic hypersensitivity fancc cells tnf p53 dependent effect p53 deficiency tnf induced hypersensitivity fancc progenitors hematopoietic progenitor colonies bone marrow low density mononuclear cells cultured presence increasing amounts tnf colonies scored data plotted percent control cfu gm colonies scored absence tnf percent control shown y axis tnf dose shown x axis mean data point plus minus sd shown genotype indicated corresponding symbol shown key statistics assessed using student test fancc trp53 genotypes statistically different groups p 001 representative experiment conducted triplicate cultures shown b effect p53 deficiency mitomycin c induced hypersensitivity fancc progenitors hematopoietic colonies scored presence absence increasing doses mitomycin c data shown percent control untreated colony formation genotype indicated corresponding symbol shown legend mean data point plus minus sd shown fancc trp53 genotypes statistically different fancc trp53 progenitors 25 50 nm mitomycin c concentrations student test p 01 c hypersensitivity primary fancc mefs tnf dependent p53 mefs cultured presence absence tnf 50 ngml counted 72 hours culture representative experiment n 5 similar results shown change cell number due tnf treatment expressed percent control untreated cells genotype percent control shown y axis genotype shown beneath bar error bars indicate sd statistical analysis performed using student test differences fancctrp53 fancc trp53 groups statistically significant
0.52467555.12855557.html.plaintext.txt	37	also measured tnf hypersensitivity verify observations nonhematopoietic cells mefs f2 genotypes cultured presence absence tnf figure 2c like fancc deficient hematopoietic progenitors growth fancc mefs abnormally sensitive tnf genetic disruption trp53 abrogated hypersensitivity phenotype fancc trp53 cells addition consistent previous studies hematopoietic cells increased sensitivity fancc mefs tnf associated increased apoptosis hypersensitivity lost cells deficient loci data shown taken together data show hypersensitivity fancc deficient cells cytokine mediated apoptosis mitomycin c extent rescued inactivation trp53
0.52467555.12855557.html.plaintext.txt	38	also measured tnf hypersensitivity verify observations nonhematopoietic cells mefs f2 genotypes cultured presence absence tnf figure 2c like fancc deficient hematopoietic progenitors growth fancc mefs abnormally sensitive tnf genetic disruption trp53 abrogated hypersensitivity phenotype fancc trp53 cells addition consistent previous studies hematopoietic cells increased sensitivity fancc mefs tnf associated increased apoptosis hypersensitivity lost cells deficient loci data shown taken together data show hypersensitivity fancc deficient cells cytokine mediated apoptosis mitomycin c extent rescued inactivation trp53
0.52467555.12855557.html.plaintext.txt	39	fancc trp53 cooperate tumorigenesis
0.52467555.12855557.html.plaintext.txt	40	increased p53 levels fancc cells ability p53 modulate apoptosis fancc cells suggested fancc trp53 might cooperate vivo test hypothesis compound fancc trp53 heterozygotes mated produce offspring f2 mutant trp53 fancc alleles expected mendelian frequency obtained genotypes 399 mice generated intercross exception mice nullizygous fancc trp53 actual number viable animals genotype 1 70 compared expected frequency 1 16 p 001 comparing number viable embryos predicted frequency indicating lethal developmental defect approximately 75 embryos
0.52467555.12855557.html.plaintext.txt	41	increased p53 levels fancc cells ability p53 modulate apoptosis fancc cells suggested fancc trp53 might cooperate vivo test hypothesis compound fancc trp53 heterozygotes mated produce offspring f2 mutant trp53 fancc alleles expected mendelian frequency obtained genotypes 399 mice generated intercross exception mice nullizygous fancc trp53 actual number viable animals genotype 1 70 compared expected frequency 1 16 p 001 comparing number viable embryos predicted frequency indicating lethal developmental defect approximately 75 embryos
0.52467555.12855557.html.plaintext.txt	42	although fancc mice spontaneously develop tumors trp53 trp53 mice high incidence lymphoma sarcoma mice fancc trp53 genetic intercross monitored weekly tumor formation figure 3 total 107 mice 6 genotypes shown figure monitored 15 years consistent previous studies fancc mice develop tumors tumor formation survival trp53 trp53 c57bl6 mice comparable previous studies using mouse line25 trp53 trp53 mice median survival 534 185 days respectively importantly absence fancc gene significantly reduced latency tumor formation fancc trp53 fancc trp53 mice median survival 336 105 days respectively figure 3
0.52467555.12855557.html.plaintext.txt	43	although fancc mice spontaneously develop tumors trp53 trp53 mice high incidence lymphoma sarcoma mice fancc trp53 genetic intercross monitored weekly tumor formation figure 3 total 107 mice 6 genotypes shown figure monitored 15 years consistent previous studies fancc mice develop tumors tumor formation survival trp53 trp53 c57bl6 mice comparable previous studies using mouse line25 trp53 trp53 mice median survival 534 185 days respectively importantly absence fancc gene significantly reduced latency tumor formation fancc trp53 fancc trp53 mice median survival 336 105 days respectively figure 3
0.52467555.12855557.html.plaintext.txt	44	view larger version 22k figure 3 fancc p53 cooperate progression tumorigenesis mice mice deficient fancc trp53 monitored long term 15 years tumors 107 total mice mice killed observance tumors significant morbidity kaplan meier plot percent survival y axis function time x axis shown genotypes indicated next plot statistical significance differences survival groups assessed log rank analysis p 0001 comparing fancctrp53 franc trp53 p 005 comparing fancctrp53 fancc trp53
0.52467555.12855557.html.plaintext.txt	45	view larger version 22k figure 3 fancc p53 cooperate progression tumorigenesis mice mice deficient fancc trp53 monitored long term 15 years tumors 107 total mice mice killed observance tumors significant morbidity kaplan meier plot percent survival y axis function time x axis shown genotypes indicated next plot statistical significance differences survival groups assessed log rank analysis p 0001 comparing fancctrp53 franc trp53 p 005 comparing fancctrp53 fancc trp53
0.52467555.12855557.html.plaintext.txt	46	detailed histopathology performed determine types neoplasms intercrossed mice table 1 figure 4 spectrum tumors observed trp53 trp53 mice similar previous studies25 include osteosarcoma lymphoma soft tissue sarcomas although overlap spectrum tumors observed mice mutant trp53 fancc compared mice deficient trp53 several differences observed consistent prior studies myeloid malignancies observed either trp53 trp53 mice wild type fancc2536 one fancc trp53 mouse myeloid malignancy histiocytic sarcoma extensive myeloid invasion liver spleen vertebrae figure 4a f also undifferentiated spindle cell tumor neck figure 4g h ovarian tumor figure 4i observed fancc trp53 mice fancctrp53 mice majority tumors derived fancc trp53 mice 4 5 analyzed exhibited loss heterozygosity normal p53 allele data shown addition although sample size tumors low fancc trp53 group due utero demise majority animals fancc trp53 mice developed medulloblastoma adenocarcinoma figure 4j l observed patients fa37 unmanipulated trp53 mice2536
0.52467555.12855557.html.plaintext.txt	47	detailed histopathology performed determine types neoplasms intercrossed mice table 1 figure 4 spectrum tumors observed trp53 trp53 mice similar previous studies25 include osteosarcoma lymphoma soft tissue sarcomas although overlap spectrum tumors observed mice mutant trp53 fancc compared mice deficient trp53 several differences observed consistent prior studies myeloid malignancies observed either trp53 trp53 mice wild type fancc2536 one fancc trp53 mouse myeloid malignancy histiocytic sarcoma extensive myeloid invasion liver spleen vertebrae figure 4a f also undifferentiated spindle cell tumor neck figure 4g h ovarian tumor figure 4i observed fancc trp53 mice fancctrp53 mice majority tumors derived fancc trp53 mice 4 5 analyzed exhibited loss heterozygosity normal p53 allele data shown addition although sample size tumors low fancc trp53 group due utero demise majority animals fancc trp53 mice developed medulloblastoma adenocarcinoma figure 4j l observed patients fa37 unmanipulated trp53 mice2536
0.52467555.12855557.html.plaintext.txt	48	view table table 1 location type tumors observed mice fancctrp53 intercross
0.52467555.12855557.html.plaintext.txt	49	view larger version 131k figure 4 histopathology tumors fancc trp53 intercrossed mice f myeloid malignancy histiocytic sarcoma fancc trp53 mouse b malignant histiocytes observed red pulp spleen indicated panel arrow c immunohistochemical characterization demonstrates malignant cells within spleen mac 2 d e malignant histiocytes also observed liver indicated arrow f malignant cells shown mac 2 immunohistochemical staining g h dermal spindle cell tumor neck fancc trp53 mouse shows high mitotic index undifferentiated cells cigar shaped nuclei ovarian tumor fancc trp53 mouse showing nests round tumor cells rounded pale nuclei j k medulloblastoma cerebellum fancc trp53 animal characteristic neoplastic cells carrot shaped nuclei hyperchromatic coarse chromatin almost nonvisible cytoplasm frequent mitotic figures indicated arrows arranged sheets pseudo rosette formations visible l adenocarcinoma prostate fancc trp53 mouse shows malignant cells arranged irregularly shaped glandular structures invading surrounding smooth muscle original magnifications x 100 g x 200 adhj x 400 b ce fik l x 600 h inset
0.52467555.12855557.html.plaintext.txt	50	view larger version 131k figure 4 histopathology tumors fancc trp53 intercrossed mice f myeloid malignancy histiocytic sarcoma fancc trp53 mouse b malignant histiocytes observed red pulp spleen indicated panel arrow c immunohistochemical characterization demonstrates malignant cells within spleen mac 2 d e malignant histiocytes also observed liver indicated arrow f malignant cells shown mac 2 immunohistochemical staining g h dermal spindle cell tumor neck fancc trp53 mouse shows high mitotic index undifferentiated cells cigar shaped nuclei ovarian tumor fancc trp53 mouse showing nests round tumor cells rounded pale nuclei j k medulloblastoma cerebellum fancc trp53 animal characteristic neoplastic cells carrot shaped nuclei hyperchromatic coarse chromatin almost nonvisible cytoplasm frequent mitotic figures indicated arrows arranged sheets pseudo rosette formations visible l adenocarcinoma prostate fancc trp53 mouse shows malignant cells arranged irregularly shaped glandular structures invading surrounding smooth muscle original magnifications x 100 g x 200 adhj x 400 b ce fik l x 600 h inset
0.52467555.12855557.html.plaintext.txt	51	discussion top abstract introduction materials methods results discussion references p53 critical sensor cell stress modulator apoptosis broad range stimuli recent data demonstrated apoptotic function p53 critical protection tumorigenesis3839 genetic evidence indicates increased stress induced apoptosis observed fancc deficient cells least part p53 dependent apoptosis hematopoietic progenitors abrogated absence p53 doses cytotoxic cytokine tnf induce dna damage disruption trp53 fancc cells reduced apoptosis fancc cells low high doses mitomycin c indicating apoptosis induced cross linking agents fancc mutant cells partially p53 dependent dna cross linking agents including mitomycin c induce breaks lesions signal activation p5340 induce apoptosis largely p53 dependent mechanisms41 however studies significant p53 independent mechanism apoptosis mediating hypersensitivity fancc deficient cells mitomycin c also observed previously fancc deficient cells22 potential candidate consider future studies may mediate apoptosis fancc deficient cells p53 related protein p73 p73 able activate transcription p53 dependent promoters42 addition others shown p73 functions absence p53 mediating apoptosis induced cross linking proapoptotic agents4344 therefore functional p73 may able induce apoptosis absence p53 fancc trp53 cells dose mitomycin c increased
0.52467555.12855557.html.plaintext.txt	52	discussion top abstract introduction materials methods results discussion references p53 critical sensor cell stress modulator apoptosis broad range stimuli recent data demonstrated apoptotic function p53 critical protection tumorigenesis3839 genetic evidence indicates increased stress induced apoptosis observed fancc deficient cells least part p53 dependent apoptosis hematopoietic progenitors abrogated absence p53 doses cytotoxic cytokine tnf induce dna damage disruption trp53 fancc cells reduced apoptosis fancc cells low high doses mitomycin c indicating apoptosis induced cross linking agents fancc mutant cells partially p53 dependent dna cross linking agents including mitomycin c induce breaks lesions signal activation p5340 induce apoptosis largely p53 dependent mechanisms41 however studies significant p53 independent mechanism apoptosis mediating hypersensitivity fancc deficient cells mitomycin c also observed previously fancc deficient cells22 potential candidate consider future studies may mediate apoptosis fancc deficient cells p53 related protein p73 p73 able activate transcription p53 dependent promoters42 addition others shown p73 functions absence p53 mediating apoptosis induced cross linking proapoptotic agents4344 therefore functional p73 may able induce apoptosis absence p53 fancc trp53 cells dose mitomycin c increased
0.52467555.12855557.html.plaintext.txt	53	fa proteins implicated range caretaker functions including dna repair cell cycle control apoptosis redox modulation collectively function maintain genomic integrity review see joenje patel5 least 3 potential mechanisms explain cooperation trp53 fancc first abnormalities fa functions lead basal genotoxic induced chromosome instability model p53 activated following stress limit cell growth initiate apoptosis oncogenic cells mechanism tumor avoidance thus speculate modestly increased p53 protein levels observed fancc deficient cells current report figure 1 following genotoxic nongenotoxic stress could result intrinsic genomic instability present cells detected signaling network activates p53 important priority future studies examine role p53 suppressing genetic mutations fancc deficient mice using marker genetic instability hypoxanthine guanine phosphoribosyltransferase
0.52467555.12855557.html.plaintext.txt	54	fa proteins implicated range caretaker functions including dna repair cell cycle control apoptosis redox modulation collectively function maintain genomic integrity review see joenje patel5 least 3 potential mechanisms explain cooperation trp53 fancc first abnormalities fa functions lead basal genotoxic induced chromosome instability model p53 activated following stress limit cell growth initiate apoptosis oncogenic cells mechanism tumor avoidance thus speculate modestly increased p53 protein levels observed fancc deficient cells current report figure 1 following genotoxic nongenotoxic stress could result intrinsic genomic instability present cells detected signaling network activates p53 important priority future studies examine role p53 suppressing genetic mutations fancc deficient mice using marker genetic instability hypoxanthine guanine phosphoribosyltransferase
0.52467555.12855557.html.plaintext.txt	55	second possibility suggested studies linking function fa protein members brca1 dependent mono ubiquitination fancd2 identification brca2 mutations fa d1 complementation group brca1 reported physically interact p534546 mammary cells brca1 knockout mice undergo increased apoptosis alleviated absence trp53 acquire mammary cell malignancies loss p53 function19 interestingly like fancc mice basal p53 protein increased brca1 conditional mutant mice compared wild type mice21 contrast whereas fancc cells slightly increased p53 activity following dna damage brca1 cells reduced levels induced p53 protein compared wild type controls therefore although fa proteins functionally interact brca117 based current previously published21 murine models specific cooperation p53 fancc brca1 respectively distinct studies also demonstrated cooperation brca2 p53 one study activity function p53 brca2 deficient cells elevated analogous studies47 loss p53 conditional brca2 deficient mice associated decreased latency tumorigenesis20 precise biochemical relationship p53 brca2 may due interaction proteins homologous recombination machinery physical association brca2 p53 demonstrated complex also contains rad5148 studies therefore raise interesting possibility fancc also may functionally interact p53 dna repair cell cycle pathway
0.52467555.12855557.html.plaintext.txt	56	second possibility suggested studies linking function fa protein members brca1 dependent mono ubiquitination fancd2 identification brca2 mutations fa d1 complementation group brca1 reported physically interact p534546 mammary cells brca1 knockout mice undergo increased apoptosis alleviated absence trp53 acquire mammary cell malignancies loss p53 function19 interestingly like fancc mice basal p53 protein increased brca1 conditional mutant mice compared wild type mice21 contrast whereas fancc cells slightly increased p53 activity following dna damage brca1 cells reduced levels induced p53 protein compared wild type controls therefore although fa proteins functionally interact brca117 based current previously published21 murine models specific cooperation p53 fancc brca1 respectively distinct studies also demonstrated cooperation brca2 p53 one study activity function p53 brca2 deficient cells elevated analogous studies47 loss p53 conditional brca2 deficient mice associated decreased latency tumorigenesis20 precise biochemical relationship p53 brca2 may due interaction proteins homologous recombination machinery physical association brca2 p53 demonstrated complex also contains rad5148 studies therefore raise interesting possibility fancc also may functionally interact p53 dna repair cell cycle pathway
0.52467555.12855557.html.plaintext.txt	57	lastly fancc may affect p53 network negatively regulating pkr fancc recently shown directly interact hsp70 protein interaction inhibits function pkr executing apoptosis3549 given p53 activated pkr1314 studies suggest possibility fancc could function complex closely associated regulating p53 function via pkr
0.52467555.12855557.html.plaintext.txt	58	lastly fancc may affect p53 network negatively regulating pkr fancc recently shown directly interact hsp70 protein interaction inhibits function pkr executing apoptosis3549 given p53 activated pkr1314 studies suggest possibility fancc could function complex closely associated regulating p53 function via pkr
0.52467555.12855557.html.plaintext.txt	59	although fancc mice intact trp53 develop tumors genetic loss fancc trp53 results markedly shortened latency tumorigenesis trp53 gene dose dependent fashion spectrum tumors observed intercrossed mice overlaps observed patients fa data consistent hypothesis loss p53 effectors important role malignant progression human fa tumors particularly considering patients fa highly predisposed head neck cancers epithelial malignancies3 others shown inactivation p53 occurs majority types malignancies usually either mutation15 inactivation due papilloma virus infection50 54 data report support rationale thorough evaluation p53 pathway malignancies patients fa
0.52467555.12855557.html.plaintext.txt	60	although fancc mice intact trp53 develop tumors genetic loss fancc trp53 results markedly shortened latency tumorigenesis trp53 gene dose dependent fashion spectrum tumors observed intercrossed mice overlaps observed patients fa data consistent hypothesis loss p53 effectors important role malignant progression human fa tumors particularly considering patients fa highly predisposed head neck cancers epithelial malignancies3 others shown inactivation p53 occurs majority types malignancies usually either mutation15 inactivation due papilloma virus infection50 54 data report support rationale thorough evaluation p53 pathway malignancies patients fa
0.52467555.12855557.html.plaintext.txt	61	summary present study mice identified p53 important cofactor fancc suppressing tumorigenesis findings establish p53 important modulator apoptosis fancc deficient mice vitro consistent observations mice mutant loci acquire tumors accelerated rate vivo finally mice provide model address fundamental aspects fa test molecular therapeutic strategies
0.52467555.12855557.html.plaintext.txt	62	summary present study mice identified p53 important cofactor fancc suppressing tumorigenesis findings establish p53 important modulator apoptosis fancc deficient mice vitro consistent observations mice mutant loci acquire tumors accelerated rate vivo finally mice provide model address fundamental aspects fa test molecular therapeutic strategies
0.52467555.12855557.html.plaintext.txt	63	acknowledgements thank lee ann baldridge excellent technical assistance immunohistochemistry also thank dr kevin shannon department pediatrics university california san francisco reading manuscript
0.52467555.12855557.html.plaintext.txt	64	acknowledgements thank lee ann baldridge excellent technical assistance immunohistochemistry also thank dr kevin shannon department pediatrics university california san francisco reading manuscript
0.52467555.12855557.html.plaintext.txt	65	footnotes submitted march 31 2003 accepted june 23 2003
0.52467555.12855557.html.plaintext.txt	66	prepublished online blood first edition paper july 10 2003 doi 101182blood 2003 03 0971
0.52467555.12855557.html.plaintext.txt	67	supported national institutes health grants ro1 hl 63219 dwc niddk p30 dk49218 dwc 1ro1 hl56416 heb ro1 hl67384 heb it32 dk07519 slmc nih 1k08hl dk04071 01 lsh riley childrens foundation
0.52467555.12855557.html.plaintext.txt	68	publication costs article defrayed part page charge payment therefore solely indicate fact article hereby marked advertisement accordance 18 usc section 1734
0.52467555.12855557.html.plaintext.txt	69	publication costs article defrayed part page charge payment therefore solely indicate fact article hereby marked advertisement accordance 18 usc section 1734
0.52467555.12855557.html.plaintext.txt	70	reprints d wade clapp cancer research institute 1044 w walnut st r4408 indianapolis 46202 e mail dclappatiupuiedu u d
0.52467555.12855557.html.plaintext.txt	71	references top abstract introduction materials methods results discussion references auerbach ad allen rg leukemia preleukemia fanconi anemia patients review literature report international fanconi anemia registry cancer genet cytogenet 199151 1 12crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	72	references top abstract introduction materials methods results discussion references auerbach ad allen rg leukemia preleukemia fanconi anemia patients review literature report international fanconi anemia registry cancer genet cytogenet 199151 1 12crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	73	rosenberg ps greene mh alter bp cancer incidence persons fanconis anemia blood 2002
0.52467555.12855557.html.plaintext.txt	74	rosenberg ps greene mh alter bp cancer incidence persons fanconis anemia blood 2002
0.52467555.12855557.html.plaintext.txt	75	kutler di auerbach ad satagopan j et al high incidence head neck squamous cell carcinoma patients fanconi anemia arch otolaryngol head neck surg 2003129 106 112abstractfree full text
0.52467555.12855557.html.plaintext.txt	76	kutler di auerbach ad satagopan j et al high incidence head neck squamous cell carcinoma patients fanconi anemia arch otolaryngol head neck surg 2003129 106 112abstractfree full text
0.52467555.12855557.html.plaintext.txt	77	kutler di singh b satagopan j et al 20 year perspective international fanconi anemia registry ifar blood 2003101 1249 1256abstractfree full text
0.52467555.12855557.html.plaintext.txt	78	kutler di singh b satagopan j et al 20 year perspective international fanconi anemia registry ifar blood 2003101 1249 1256abstractfree full text
0.52467555.12855557.html.plaintext.txt	79	joenje h patel kj emerging genetic molecular basis fanconi anaemia nat rev genet 20012 446 457crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	80	cumming rc liu jm youssoufian h buchwald m suppression apoptosis hematopoietic factor dependent progenitor cell lines expression fac gene blood 199688 4558 4567abstractfree full text
0.52467555.12855557.html.plaintext.txt	81	cumming rc liu jm youssoufian h buchwald m suppression apoptosis hematopoietic factor dependent progenitor cell lines expression fac gene blood 199688 4558 4567abstractfree full text
0.52467555.12855557.html.plaintext.txt	82	rathbun rk faulkner gr ostroski mh et al inactivation fanconi anemia group c gene augments interferon gamma induced apoptotic responses hematopoietic cells blood 199790 974 985abstractfree full text
0.52467555.12855557.html.plaintext.txt	83	rathbun rk faulkner gr ostroski mh et al inactivation fanconi anemia group c gene augments interferon gamma induced apoptotic responses hematopoietic cells blood 199790 974 985abstractfree full text
0.52467555.12855557.html.plaintext.txt	84	haneline ls broxmeyer cooper et al multiple inhibitory cytokines induce deregulated progenitor growth apoptosis hematopoietic cells fac mice blood 199891 4092 4098abstractfree full text
0.52467555.12855557.html.plaintext.txt	85	haneline ls broxmeyer cooper et al multiple inhibitory cytokines induce deregulated progenitor growth apoptosis hematopoietic cells fac mice blood 199891 4092 4098abstractfree full text
0.52467555.12855557.html.plaintext.txt	86	lensch mw rathbun rk olson sb jones gr bagby gc jr selective pressure essential force molecular evolution myeloid leukemic clones view window fanconi anemia leukemia 199913 1784 1789crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	87	lensch mw rathbun rk olson sb jones gr bagby gc jr selective pressure essential force molecular evolution myeloid leukemic clones view window fanconi anemia leukemia 199913 1784 1789crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	88	haneline ls li x ciccone sl et al retroviral mediated expression recombinant fancc enhances repopulating ability fancc hematopoietic stem cells decreases risk clonal evolution blood 2003101 1299 1307abstractfree full text
0.52467555.12855557.html.plaintext.txt	89	haneline ls li x ciccone sl et al retroviral mediated expression recombinant fancc enhances repopulating ability fancc hematopoietic stem cells decreases risk clonal evolution blood 2003101 1299 1307abstractfree full text
0.52467555.12855557.html.plaintext.txt	90	pang q keeble w diaz j et al role double stranded rna dependent protein kinase mediating hypersensitivity fanconi anemia complementation group c cells interferon gamma tumor necrosis factor alpha double stranded rna blood 200197 1644 1652abstractfree full text
0.52467555.12855557.html.plaintext.txt	91	pang q keeble w diaz j et al role double stranded rna dependent protein kinase mediating hypersensitivity fanconi anemia complementation group c cells interferon gamma tumor necrosis factor alpha double stranded rna blood 200197 1644 1652abstractfree full text
0.52467555.12855557.html.plaintext.txt	92	yeung mc lau tumor suppressor p53 component tumor necrosis factor induced protein kinase pkr mediated apoptotic pathway human promonocytic u937 cells j biol chem 1998273 25198 25202abstractfree full text
0.52467555.12855557.html.plaintext.txt	93	cuddihy ar li tam nw et al double stranded rna activated protein kinase pkr enhances transcriptional activation tumor suppressor p53 mol cell biol 199919 2475 2484abstractfree full text
0.52467555.12855557.html.plaintext.txt	94	cuddihy ar li tam nw et al double stranded rna activated protein kinase pkr enhances transcriptional activation tumor suppressor p53 mol cell biol 199919 2475 2484abstractfree full text
0.52467555.12855557.html.plaintext.txt	95	cuddihy ar wong ah tam nw li koromilas ae double stranded rna activated protein kinase pkr physically associates tumor suppressor p53 protein phosphorylates human p53 serine 392 vitro oncogene 199918 2690 2702crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	96	cuddihy ar wong ah tam nw li koromilas ae double stranded rna activated protein kinase pkr physically associates tumor suppressor p53 protein phosphorylates human p53 serine 392 vitro oncogene 199918 2690 2702crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	97	somers kd merrick ma lopez incognito ls schechter gl casey g frequent p53 mutations head neck cancer cancer res 199252 5997 6000abstract
0.52467555.12855557.html.plaintext.txt	98	somers kd merrick ma lopez incognito ls schechter gl casey g frequent p53 mutations head neck cancer cancer res 199252 5997 6000abstract
0.52467555.12855557.html.plaintext.txt	99	prime ss thakker ns pring m guest pg paterson ic review inherited cancer syndromes relevance oral squamous cell carcinoma oral oncol 200137 1 16crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	100	prime ss thakker ns pring m guest pg paterson ic review inherited cancer syndromes relevance oral squamous cell carcinoma oral oncol 200137 1 16crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	101	garcia higuera taniguchi ganesan et al interaction fanconi anemia proteins brca1 common pathway mol cell 20017 249 262medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	102	garcia higuera taniguchi ganesan et al interaction fanconi anemia proteins brca1 common pathway mol cell 20017 249 262medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	103	howlett ng taniguchi olson et al biallelic inactivation brca2 fanconi anemia science 2002297 606 609abstractfree full text
0.52467555.12855557.html.plaintext.txt	104	howlett ng taniguchi olson et al biallelic inactivation brca2 fanconi anemia science 2002297 606 609abstractfree full text
0.52467555.12855557.html.plaintext.txt	105	xu x wagner ku larson d et al conditional mutation brca1 mammary epithelial cells results blunted ductal morphogenesis tumour formation nat genet 199922 37 43crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	106	xu x wagner ku larson d et al conditional mutation brca1 mammary epithelial cells results blunted ductal morphogenesis tumour formation nat genet 199922 37 43crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	107	jonkers j meuwissen r van der gulden h peterse h van der valk m berns synergistic tumor suppressor activity brca2 p53 conditional mouse model breast cancer nat genet 200129 418 425crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	108	jonkers j meuwissen r van der gulden h peterse h van der valk m berns synergistic tumor suppressor activity brca2 p53 conditional mouse model breast cancer nat genet 200129 418 425crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	109	xu x qiao w linke sp et al genetic interactions tumor suppressors brca1 p53 apoptosis cell cycle tumorigenesis nat genet 200128 266 271crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	110	kruyt fa dijkmans lm van den berg tk joenje h fanconi anemia genes act suppress cross linker inducible p53 independent apoptosis pathway lymphoblastoid cell lines blood 199687 938 948abstractfree full text
0.52467555.12855557.html.plaintext.txt	111	kruyt fa dijkmans lm van den berg tk joenje h fanconi anemia genes act suppress cross linker inducible p53 independent apoptosis pathway lymphoblastoid cell lines blood 199687 938 948abstractfree full text
0.52467555.12855557.html.plaintext.txt	112	mauser saito appella e anderson cw seaman wt kenney epstein barr virus immediate early protein bzlf1 regulates p53 function multiple mechanisms j virol 200276 12503 12512abstractfree full text
0.52467555.12855557.html.plaintext.txt	113	mauser saito appella e anderson cw seaman wt kenney epstein barr virus immediate early protein bzlf1 regulates p53 function multiple mechanisms j virol 200276 12503 12512abstractfree full text
0.52467555.12855557.html.plaintext.txt	114	chen m tomkins dj auerbach w et al inactivation fac mice produces inducible chromosomal instability reduced fertility reminiscent fanconi anaemia nat genet 199612 448 451medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	115	chen m tomkins dj auerbach w et al inactivation fac mice produces inducible chromosomal instability reduced fertility reminiscent fanconi anaemia nat genet 199612 448 451medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	116	jacks remington l williams bo et al tumor spectrum analysis p53 mutant mice curr biol 19944 1 7medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	117	jacks remington l williams bo et al tumor spectrum analysis p53 mutant mice curr biol 19944 1 7medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	118	eischen cm rehg je korsmeyer sj cleveland jl loss bax alters tumor spectrum tumor numbers arf deficient mice cancer res 200262 2184 2191abstractfree full text
0.52467555.12855557.html.plaintext.txt	119	eischen cm rehg je korsmeyer sj cleveland jl loss bax alters tumor spectrum tumor numbers arf deficient mice cancer res 200262 2184 2191abstractfree full text
0.52467555.12855557.html.plaintext.txt	120	wu y huang h miner z kulesz martin m activities response dna damage latent active sequence specific dna binding forms mouse p53 proc natl acad sci u 199794 8982 8987abstractfree full text
0.52467555.12855557.html.plaintext.txt	121	wu y huang h miner z kulesz martin m activities response dna damage latent active sequence specific dna binding forms mouse p53 proc natl acad sci u 199794 8982 8987abstractfree full text
0.52467555.12855557.html.plaintext.txt	122	luo jl yang q tong wm hergenhahn m wang zq hollstein m knock mice chimeric humanmurine p53 gene develop normally show wild type p53 responses dna damaging agents new biomedical research tool oncogene 200120 320 328crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	123	luo jl yang q tong wm hergenhahn m wang zq hollstein m knock mice chimeric humanmurine p53 gene develop normally show wild type p53 responses dna damaging agents new biomedical research tool oncogene 200120 320 328crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	124	lev bar r maya r segel la alon u levine aj oren m generation oscillations p53 mdm2 feedback loop theoretical experimental study proc natl acad sci u 200097 11250 11255abstractfree full text
0.52467555.12855557.html.plaintext.txt	125	lev bar r maya r segel la alon u levine aj oren m generation oscillations p53 mdm2 feedback loop theoretical experimental study proc natl acad sci u 200097 11250 11255abstractfree full text
0.52467555.12855557.html.plaintext.txt	126	kupfer gm dandrea ad effect fanconi anemia polypeptide fac upon p53 induction g2 checkpoint regulation blood 199688 1019 1025abstractfree full text
0.52467555.12855557.html.plaintext.txt	127	klefstrom j arighi e littlewood et al induction tnf sensitive cellular phenotype c myc involves p53 impaired nf kappab activation embo j 199716 7382 7392abstractfree full text
0.52467555.12855557.html.plaintext.txt	128	klefstrom j arighi e littlewood et al induction tnf sensitive cellular phenotype c myc involves p53 impaired nf kappab activation embo j 199716 7382 7392abstractfree full text
0.52467555.12855557.html.plaintext.txt	129	ameyar m shatrov v bouquet c et al adenovirus mediated transfer wild type p53 gene sensitizes tnf resistant mcf7 derivatives cytotoxic effect cytokine relationship c myc rb oncogene 199918 5464 5472crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	130	ameyar m shatrov v bouquet c et al adenovirus mediated transfer wild type p53 gene sensitizes tnf resistant mcf7 derivatives cytotoxic effect cytokine relationship c myc rb oncogene 199918 5464 5472crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	131	kastan mb onyekwere o sidransky d vogelstein b craig rw participation p53 protein cellular response dna damage cancer res 199151 6304 6311abstract
0.52467555.12855557.html.plaintext.txt	132	kastan mb onyekwere o sidransky d vogelstein b craig rw participation p53 protein cellular response dna damage cancer res 199151 6304 6311abstract
0.52467555.12855557.html.plaintext.txt	133	rathbun rk christianson ta faulkner gr et al interferon gamma induced apoptotic responses fanconi anemia group c hematopoietic progenitor cells involve caspase 8 dependent activation caspase 3 family members blood 200096 4204 4211abstractfree full text
0.52467555.12855557.html.plaintext.txt	134	rathbun rk christianson ta faulkner gr et al interferon gamma induced apoptotic responses fanconi anemia group c hematopoietic progenitor cells involve caspase 8 dependent activation caspase 3 family members blood 200096 4204 4211abstractfree full text
0.52467555.12855557.html.plaintext.txt	135	pang q christianson ta keeble w koretsky bagby gc anti apoptotic function hsp70 pkr mediated death signaling pathway requires fanconi anemia protein fancc j biol chem 2002277 49638 49643abstractfree full text
0.52467555.12855557.html.plaintext.txt	136	pang q christianson ta keeble w koretsky bagby gc anti apoptotic function hsp70 pkr mediated death signaling pathway requires fanconi anemia protein fancc j biol chem 2002277 49638 49643abstractfree full text
0.52467555.12855557.html.plaintext.txt	137	donehower la harvey m slagle bl et al mice deficient p53 developmentally normal susceptible spontaneous tumours nature 1992356 215 221crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	138	donehower la harvey m slagle bl et al mice deficient p53 developmentally normal susceptible spontaneous tumours nature 1992356 215 221crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	139	alter bp cancer fanconi anemia 1927 2001 cancer 200397 425 440crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	140	schmitt ca fridman js yang m baranov e hoffman rm lowe sw dissecting p53 tumor suppressor functions vivo cancer cell 20021 289 298crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	141	schmitt ca fridman js yang m baranov e hoffman rm lowe sw dissecting p53 tumor suppressor functions vivo cancer cell 20021 289 298crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	142	hemann mt fridman js zilfou jt et al epi allelic series p53 hypomorphs created stable rnai produces distinct tumor phenotypes vivo nat genet 200333 396 400crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	143	hemann mt fridman js zilfou jt et al epi allelic series p53 hypomorphs created stable rnai produces distinct tumor phenotypes vivo nat genet 200333 396 400crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	144	tishler rb calderwood sk coleman cn price bd increases sequence specific dna binding p53 following treatment chemotherapeutic dna damaging agents cancer res 199353 2212 2216abstract
0.52467555.12855557.html.plaintext.txt	145	tishler rb calderwood sk coleman cn price bd increases sequence specific dna binding p53 following treatment chemotherapeutic dna damaging agents cancer res 199353 2212 2216abstract
0.52467555.12855557.html.plaintext.txt	146	xu c meikrantz w schlegel r sager r human papilloma virus 16e6 gene sensitizes human mammary epithelial cells apoptosis induced dna damage proc natl acad sci u 199592 7829 7833abstract
0.52467555.12855557.html.plaintext.txt	147	xu c meikrantz w schlegel r sager r human papilloma virus 16e6 gene sensitizes human mammary epithelial cells apoptosis induced dna damage proc natl acad sci u 199592 7829 7833abstract
0.52467555.12855557.html.plaintext.txt	148	jost ca marin mc kaelin wg jr p73 simian correction human p53 related protein induce apoptosis nature 1997389 191 194crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	149	jost ca marin mc kaelin wg jr p73 simian correction human p53 related protein induce apoptosis nature 1997389 191 194crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	150	irwin m marin mc phillips ac et al role p53 homologue p73 e2f 1 induced apoptosis nature 2000407 645 648crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	151	irwin m marin mc phillips ac et al role p53 homologue p73 e2f 1 induced apoptosis nature 2000407 645 648crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	152	gong jg costanzo yang hq et al tyrosine kinase c abl regulates p73 apoptotic response cisplatin induced dna damage nature 1999399 806 809crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	153	gong jg costanzo yang hq et al tyrosine kinase c abl regulates p73 apoptotic response cisplatin induced dna damage nature 1999399 806 809crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	154	zhang h somasundaram k peng y et al brca1 physically associates p53 stimulates transcriptional activity oncogene 199816 1713 1721crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	155	zhang h somasundaram k peng y et al brca1 physically associates p53 stimulates transcriptional activity oncogene 199816 1713 1721crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	156	chai yl cui j shao n shyam e reddy p rao vn second brct domain brca1 proteins interacts p53 stimulates transcription p21waf1cip1 promoter oncogene 199918 263 268crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	157	chai yl cui j shao n shyam e reddy p rao vn second brct domain brca1 proteins interacts p53 stimulates transcription p21waf1cip1 promoter oncogene 199918 263 268crossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	158	connor f bertwistle d mee pj et al tumorigenesis dna repair defect mice truncating brca2 mutation nat genet 199717 423 430medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	159	connor f bertwistle d mee pj et al tumorigenesis dna repair defect mice truncating brca2 mutation nat genet 199717 423 430medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	160	marmorstein ly ouchi aaronson sa brca2 gene product functionally interacts p53 rad51 proc natl acad sci u 199895 13869 13874abstractfree full text
0.52467555.12855557.html.plaintext.txt	161	marmorstein ly ouchi aaronson sa brca2 gene product functionally interacts p53 rad51 proc natl acad sci u 199895 13869 13874abstractfree full text
0.52467555.12855557.html.plaintext.txt	162	pang q keeble w christianson ta faulkner gr bagby gc fancc interacts hsp70 protect hematopoietic cells ifn gammatnf alpha mediated cytotoxicity embo j 200120 4478 4489abstractfree full text
0.52467555.12855557.html.plaintext.txt	163	pang q keeble w christianson ta faulkner gr bagby gc fancc interacts hsp70 protect hematopoietic cells ifn gammatnf alpha mediated cytotoxicity embo j 200120 4478 4489abstractfree full text
0.52467555.12855557.html.plaintext.txt	164	werness ba levine aj howley pm association human papillomavirus types 16 18 e6 proteins p53 science 1990248 76 79medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	165	werness ba levine aj howley pm association human papillomavirus types 16 18 e6 proteins p53 science 1990248 76 79medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	166	crook wrede d tidy j scholefield j crawford l vousden kh status c myc p53 retinoblastoma genes human papillomavirus positive negative squamous cell carcinomas anus oncogene 19916 1251 1257medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	167	crook wrede d tidy j scholefield j crawford l vousden kh status c myc p53 retinoblastoma genes human papillomavirus positive negative squamous cell carcinomas anus oncogene 19916 1251 1257medline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	168	balz v scheckenbach k gotte k bockmuhl u petersen bier h p53 inactivation frequency squamous cell carcinomas head neck underestimated analysis p53 exons 2 11 human papillomavirus 1618 e6 transcripts 123 unselected tumor specimens cancer res 200363 1188 1191abstractfree full text
0.52467555.12855557.html.plaintext.txt	169	balz v scheckenbach k gotte k bockmuhl u petersen bier h p53 inactivation frequency squamous cell carcinomas head neck underestimated analysis p53 exons 2 11 human papillomavirus 1618 e6 transcripts 123 unselected tumor specimens cancer res 200363 1188 1191abstractfree full text
0.52467555.12855557.html.plaintext.txt	170	scheffner m munger k byrne jc howley pm state p53 retinoblastoma genes human cervical carcinoma cell lines proc natl acad sci u 199188 5523 5527abstract
0.52467555.12855557.html.plaintext.txt	171	scheffner m munger k byrne jc howley pm state p53 retinoblastoma genes human cervical carcinoma cell lines proc natl acad sci u 199188 5523 5527abstract
0.52467555.12855557.html.plaintext.txt	172	mao ej schwartz sm daling jr oda d tickman l beckmann human papilloma viruses p53 mutations normal pre malignant malignant oral epithelia int j cancer 199669 152 15833co2 elinktypedoicrossrefmedline order article via infotrieve
0.52467555.12855557.html.plaintext.txt	173	mao ej schwartz sm daling jr oda d tickman l beckmann human papilloma viruses p53 mutations normal pre malignant malignant oral epithelia int j cancer 199669 152 15833co2 elinktypedoicrossrefmedline order article via infotrieve
0.5264005.15917304.html.plaintext.txt	0	human p53 knock hupki mice differ liver tumor response counterparts murine p53
0.5264005.15917304.html.plaintext.txt	1	maike jaworski stephan hailfinger albrecht buchmann manfred hergenhahn 1 monica hollstein 1 carina ittrich 2 michael schwarz
0.5264005.15917304.html.plaintext.txt	2	department toxicology institute pharmacology toxicology university tubingen wilhelmstrasse 56 72074 tubingen germany 1 department genetic alterations carcinogenesis 2 central unit biostatistics german cancer research center po box 101949 69009 heidelberg germany
0.5264005.15917304.html.plaintext.txt	3	correspondence addressed tel 49 7071 29 77398 fax 49 7071 29 2273 email michaelschwarzatuni tuebingende
0.5264005.15917304.html.plaintext.txt	4	correspondence addressed tel 49 7071 29 77398 fax 49 7071 29 2273 email michaelschwarzatuni tuebingende
0.5264005.15917304.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references mouse models important tools toxicologic research differences species pathways contributing tumor development however raise question far mouse models valid human risk assessment one striking difference relates frequency spontaneous liver cancer high certain mouse strains rather low humans similarly mutation frequencies cancer genes characteristically different ie p53 mutations frequent human rare murine liver tumors whereas ras genes often mutated mouse liver tumors hardly ever human liver cancers since p53 shown control oncogenic ras human cells hypothesized function tumor suppressor could differ mouse hepatocytes test hypothesis used hupki human p53 knock mice carry partly humanized p53 sequence p53ki study report results first hepatocarcinogenesis experiment strain mice mice genotypes p53kiki p53wtki p53wtwt treated n nitrosodiethylamine 2 weeks age killed 35 weeks later frequency liver tumors glucose 6 phosphatase altered liver lesions almost identical three p53 genotypes 40 50 liver tumors showed activating mutations codon 61 ha ras gene independent genotype moreover p53 positive lesions observed without nuclear localization protein suggesting absence p53 mutations data suggest hupki allele behaves like murine ortholog mouse hepatocarcinogenesis
0.5264005.15917304.html.plaintext.txt	6	abstract top abstract introduction materials methods results discussion references mouse models important tools toxicologic research differences species pathways contributing tumor development however raise question far mouse models valid human risk assessment one striking difference relates frequency spontaneous liver cancer high certain mouse strains rather low humans similarly mutation frequencies cancer genes characteristically different ie p53 mutations frequent human rare murine liver tumors whereas ras genes often mutated mouse liver tumors hardly ever human liver cancers since p53 shown control oncogenic ras human cells hypothesized function tumor suppressor could differ mouse hepatocytes test hypothesis used hupki human p53 knock mice carry partly humanized p53 sequence p53ki study report results first hepatocarcinogenesis experiment strain mice mice genotypes p53kiki p53wtki p53wtwt treated n nitrosodiethylamine 2 weeks age killed 35 weeks later frequency liver tumors glucose 6 phosphatase altered liver lesions almost identical three p53 genotypes 40 50 liver tumors showed activating mutations codon 61 ha ras gene independent genotype moreover p53 positive lesions observed without nuclear localization protein suggesting absence p53 mutations data suggest hupki allele behaves like murine ortholog mouse hepatocarcinogenesis
0.5264005.15917304.html.plaintext.txt	7	abbreviations den n nitrosodiethylamine g6pase glucose 6 phosphatase gs glutamine synthetase hcc hepatocellular carcinoma hupki human p53 knock ppd polyproline domain
0.5264005.15917304.html.plaintext.txt	8	introduction top abstract introduction materials methods results discussion references primary hepatocellular carcinomas hccs one ten frequent human cancers worldwide 1 risk factors like hepatitis b c virus aflatoxins given southern africa southern china make hcc frequent cause cancer death countries populations industrialized countries however show comparatively low incidence hcc indicating development spontaneous hcc rather rare event humans contrast certain strains laboratory mice eg c3h show high incidence spontaneous liver tumors reach 100 end animals lives 2 opposing findings paralleled differences molecular level one striking differences lies mutation frequencies genes two pathways namely p53 mitogen activated protein map kinase signaling pathway
0.5264005.15917304.html.plaintext.txt	9	introduction top abstract introduction materials methods results discussion references primary hepatocellular carcinomas hccs one ten frequent human cancers worldwide 1 risk factors like hepatitis b c virus aflatoxins given southern africa southern china make hcc frequent cause cancer death countries populations industrialized countries however show comparatively low incidence hcc indicating development spontaneous hcc rather rare event humans contrast certain strains laboratory mice eg c3h show high incidence spontaneous liver tumors reach 100 end animals lives 2 opposing findings paralleled differences molecular level one striking differences lies mutation frequencies genes two pathways namely p53 mitogen activated protein map kinase signaling pathway
0.5264005.15917304.html.plaintext.txt	10	transcription factor p53 well known tumor suppressor protein induces cell growth arrest apoptosis senescence response various types stress unstressed cells p53 maintained low levels action ubiquitin e3 ligase mdm2 earmarks p53 degradation proteasome 3 mdm2 also bind transactivation domain p53 thus reducing transcriptional activity 4 dna damage oncogenic stress eg caused mutated ctnnb1 ss catenin c myc ras lead stabilization p53 protein 5 7 transcriptional activation battery caretaker genes 8
0.5264005.15917304.html.plaintext.txt	11	transcription factor p53 well known tumor suppressor protein induces cell growth arrest apoptosis senescence response various types stress unstressed cells p53 maintained low levels action ubiquitin e3 ligase mdm2 earmarks p53 degradation proteasome 3 mdm2 also bind transactivation domain p53 thus reducing transcriptional activity 4 dna damage oncogenic stress eg caused mutated ctnnb1 ss catenin c myc ras lead stabilization p53 protein 5 7 transcriptional activation battery caretaker genes 8
0.5264005.15917304.html.plaintext.txt	12	ras mediated signal transduction pathways involved regulation cell growth apoptosis differentiation constitute fundamental processes deregulated tumors carrying mutated ras genes 9 11 common mutations ras affect gtpase activity small monomeric g protein resulting constitutively active molecule may amongst others permanently stimulate cell cycle progression via activation map kinase effector pathways 9 tumorigenic transformation cells ras oncogenes prevented p53 controlled mechanisms inappropriate stimulation cell cycle progression leads e2f mediated upregulation tumor suppressor protein p1419arf bind mdm2 inactivate ability initiate p53 degradation 712 14 thus human cells p53 controls oncogenic ras activation ras tumor cells often accompanied ablation p53 dependent responses
0.5264005.15917304.html.plaintext.txt	13	ras mediated signal transduction pathways involved regulation cell growth apoptosis differentiation constitute fundamental processes deregulated tumors carrying mutated ras genes 9 11 common mutations ras affect gtpase activity small monomeric g protein resulting constitutively active molecule may amongst others permanently stimulate cell cycle progression via activation map kinase effector pathways 9 tumorigenic transformation cells ras oncogenes prevented p53 controlled mechanisms inappropriate stimulation cell cycle progression leads e2f mediated upregulation tumor suppressor protein p1419arf bind mdm2 inactivate ability initiate p53 degradation 712 14 thus human cells p53 controls oncogenic ras activation ras tumor cells often accompanied ablation p53 dependent responses
0.5264005.15917304.html.plaintext.txt	14	inactivation p53 mutation frequently observed human hccs 15 17 whereas ras downstream effector b raf rarely mutated human hccs 218 liver tumors mice however hardly ever mutated p53 219 rather harbor activating mutations ha ras 2021 b raf 22 evidence could indicate murine p53 may control activated ras oncoprotein mouse liver opposed human ortholog suggesting p53 protein may differ function mice men although p53 shows high homology two species overall amino acid sequence 74 dna binding domain 91 homology less n terminal c terminal regions polyproline domains ppds mouse p53 lacks example residues constitute important phosphorylation sites human ortholog eg serine 37 46 amino acids relevant modulation p53 stress response cells proline 72 role apoptotic responses 2324
0.5264005.15917304.html.plaintext.txt	15	inactivation p53 mutation frequently observed human hccs 15 17 whereas ras downstream effector b raf rarely mutated human hccs 218 liver tumors mice however hardly ever mutated p53 219 rather harbor activating mutations ha ras 2021 b raf 22 evidence could indicate murine p53 may control activated ras oncoprotein mouse liver opposed human ortholog suggesting p53 protein may differ function mice men although p53 shows high homology two species overall amino acid sequence 74 dna binding domain 91 homology less n terminal c terminal regions polyproline domains ppds mouse p53 lacks example residues constitute important phosphorylation sites human ortholog eg serine 37 46 amino acids relevant modulation p53 stress response cells proline 72 role apoptotic responses 2324
0.5264005.15917304.html.plaintext.txt	16	aim present work investigate whether structural differences human mouse p53 proteins critical determinants hepatocarcinogenesis potent tool address question transgenic hupki human p53 knock mouse parts murine p53 gene replaced respective human sequences exons 4 9 containing serine 46 proline 72 threonines 76 86 25 jackson laboratory repository designation knock allele trp53tmholl abbreviated p53ki following opposed wild type allele p53 humanized hupki p53 seems carry normal functions mouse p53 investigated point 25 27 analyzed frequency liver tumors induced single injection n nitrosodiethylamine den c3h mice carrying p53ki allele homozygously heterozygously comparison c3h mice wild type murine p53 p53 c3h mice chosen high susceptibility liver tumor formation 28 addition ploidy status hepatocytes normal liver ha ras mutation frequencies liver tumors mice different genotypes analyzed
0.5264005.15917304.html.plaintext.txt	17	aim present work investigate whether structural differences human mouse p53 proteins critical determinants hepatocarcinogenesis potent tool address question transgenic hupki human p53 knock mouse parts murine p53 gene replaced respective human sequences exons 4 9 containing serine 46 proline 72 threonines 76 86 25 jackson laboratory repository designation knock allele trp53tmholl abbreviated p53ki following opposed wild type allele p53 humanized hupki p53 seems carry normal functions mouse p53 investigated point 25 27 analyzed frequency liver tumors induced single injection n nitrosodiethylamine den c3h mice carrying p53ki allele homozygously heterozygously comparison c3h mice wild type murine p53 p53 c3h mice chosen high susceptibility liver tumor formation 28 addition ploidy status hepatocytes normal liver ha ras mutation frequencies liver tumors mice different genotypes analyzed
0.5264005.15917304.html.plaintext.txt	18	materials methods top abstract introduction materials methods results discussion references breeding c3h p53kiki p53ki p53 mice c57bl p53ki mice introduced laboratory university tubingen via embryo transfer mice backcrossed c3h background six generations prior study c3h p53ki f6 mated male offspring used experiment p53 genotyping performed duplex pcr using following primer pairs gcex7f 5 gcctcatcttgggcctgtgttatctcc 3 gcex7r 5 ggccagtgtgcagggtggcaagtggctc 3 specific human p53 p42a 5 actccatggcccctgtcatc 3 p42b 5 aggtcacacgaaagacaact 3 specific mouse p53 2529
0.5264005.15917304.html.plaintext.txt	19	materials methods top abstract introduction materials methods results discussion references breeding c3h p53kiki p53ki p53 mice c57bl p53ki mice introduced laboratory university tubingen via embryo transfer mice backcrossed c3h background six generations prior study c3h p53ki f6 mated male offspring used experiment p53 genotyping performed duplex pcr using following primer pairs gcex7f 5 gcctcatcttgggcctgtgttatctcc 3 gcex7r 5 ggccagtgtgcagggtggcaagtggctc 3 specific human p53 p42a 5 actccatggcccctgtcatc 3 p42b 5 aggtcacacgaaagacaact 3 specific mouse p53 2529
0.5264005.15917304.html.plaintext.txt	20	induction liver tumors animal study carried according german guidelines animal care treatment single dose n nitrosodiethylamine 10 microgg body wt injected ip 15 male c3h mice genotype p53kiki p53ki p53 2 weeks age weaning mice housed individually macrolon cages kept standard diet without treatment mice killed 35 weeks carcinogen treatment livers removed weighed normal appearing liver tissue excised isolation nuclei larger tumors isolated immediately frozen liquid nitrogen stored 70 degrees c remaining liver lobes frozen dry ice fixed carnoys solution preparation tissue sections
0.5264005.15917304.html.plaintext.txt	21	induction liver tumors animal study carried according german guidelines animal care treatment single dose n nitrosodiethylamine 10 microgg body wt injected ip 15 male c3h mice genotype p53kiki p53ki p53 2 weeks age weaning mice housed individually macrolon cages kept standard diet without treatment mice killed 35 weeks carcinogen treatment livers removed weighed normal appearing liver tissue excised isolation nuclei larger tumors isolated immediately frozen liquid nitrogen stored 70 degrees c remaining liver lobes frozen dry ice fixed carnoys solution preparation tissue sections
0.5264005.15917304.html.plaintext.txt	22	enzyme immunohistochemistry sections 10 microm thick prepared frozen liver tissue cryostat microtome glucose 6 phosphatase g6pase staining performed according ref 30 transections g6pase altered liver lesions quantified using computer assisted digitizer system previously described 31
0.5264005.15917304.html.plaintext.txt	23	p53 stained immunohistochemically sections 5 microm thick paraffin embedded liver blocks previously described 32 brief sections deparaffinized rehydrated incubated polyclonal panspecific rabbit anti p53 antibody ncl p53 cm1 novocastra laboratories newcastle uk 11500 dilution following incubation secondary goat anti rabbit igg antibody coupled biotin biospa milano italy 1200 dilution sections incubated streptavidin alkaline phosphatase conjugates biospa milano italy 30 min washing sections phosphate buffered saline bound antibody visualized using alkaline phosphatase substrate fastredtm kem en tech copenhagen denmark glutamine synthetase gs staining sections incubated monoclonal anti gs antibody bd biosciences heidelberg germany 1500 dilution blocking endogenous peroxidase activity incubation hrp coupled anti mouse lgg secondary antibody sigma aldrich taufkirchen germany 120 dilution sections stained aminoethylcarbazoleh2o2 solution nuclei counterstained hematoxylin
0.5264005.15917304.html.plaintext.txt	24	p53 stained immunohistochemically sections 5 microm thick paraffin embedded liver blocks previously described 32 brief sections deparaffinized rehydrated incubated polyclonal panspecific rabbit anti p53 antibody ncl p53 cm1 novocastra laboratories newcastle uk 11500 dilution following incubation secondary goat anti rabbit igg antibody coupled biotin biospa milano italy 1200 dilution sections incubated streptavidin alkaline phosphatase conjugates biospa milano italy 30 min washing sections phosphate buffered saline bound antibody visualized using alkaline phosphatase substrate fastredtm kem en tech copenhagen denmark glutamine synthetase gs staining sections incubated monoclonal anti gs antibody bd biosciences heidelberg germany 1500 dilution blocking endogenous peroxidase activity incubation hrp coupled anti mouse lgg secondary antibody sigma aldrich taufkirchen germany 120 dilution sections stained aminoethylcarbazoleh2o2 solution nuclei counterstained hematoxylin
0.5264005.15917304.html.plaintext.txt	25	isolation nuclei mouse liver facs analysis isolation liver nuclei standard protocol used 33 100 280 mg normal tissue 17 mouse livers removed transferred immediately cold 025 m tkm solution 025 m sucrose 50 mm tris hcl ph 75 25 mm kcl 5 mm mgcl2 subsequent operations performed temperature near 0 degrees c tissue weighed homogenized potter motor driven teflon pestle elvehjem tissue grinder clearance 0025 cm two volumes ice cold 025 m sucrose tkm homogenate filtered four layers gauze liquid fraction mixed two volumes 23 m sucrose tkm preparation underlaid one volume 23 m sucrose tkm centrifuged 30 min 126 000 gav 4 degrees c beckman coulter fullerton usa optimatm tl ultracentrifuge tla 1004 rotor 55 000 rpm supernatant discarded nuclear pellet taken 1 ml tkm buffer nuclei concentration determined
0.5264005.15917304.html.plaintext.txt	26	isolation nuclei mouse liver facs analysis isolation liver nuclei standard protocol used 33 100 280 mg normal tissue 17 mouse livers removed transferred immediately cold 025 m tkm solution 025 m sucrose 50 mm tris hcl ph 75 25 mm kcl 5 mm mgcl2 subsequent operations performed temperature near 0 degrees c tissue weighed homogenized potter motor driven teflon pestle elvehjem tissue grinder clearance 0025 cm two volumes ice cold 025 m sucrose tkm homogenate filtered four layers gauze liquid fraction mixed two volumes 23 m sucrose tkm preparation underlaid one volume 23 m sucrose tkm centrifuged 30 min 126 000 gav 4 degrees c beckman coulter fullerton usa optimatm tl ultracentrifuge tla 1004 rotor 55 000 rpm supernatant discarded nuclear pellet taken 1 ml tkm buffer nuclei concentration determined
0.5264005.15917304.html.plaintext.txt	27	sample aliquot 100 000 nuclei centrifuged nuclei resuspended 15 microl pi solution 01 wv sodium citrate 01 wv triton x 100 50 microgml propidium iodide 5 min incubation dna content nuclei measured facs analysis facscalibur becton dickinson franklin lakes usa sample 10 000 events counted triplicate measurements made animal averaged data analyzed cellquest 31f software
0.5264005.15917304.html.plaintext.txt	28	statistical analyses statistical analyses carried using software package r version 201 34 comparisons relative liver weight area fraction g6pase altered lesions liver ploidy status three groups p53kiki p53 p53ki performed kruskal wallis rank sum tests frequencies ha ras mutations three groups p53kiki p53 p53ki compared fishers exact test count data
0.5264005.15917304.html.plaintext.txt	29	results top abstract introduction materials methods results discussion references study determined tumor response livers mice single injection ip liver carcinogen n nitrosodiethylamine mice differing p53 genotype used 15 per group mice carrying mouse p53 wild type allele p53 mice heterozygous humanized p53 ki hupki allele p53ki mice homozygous p53 ki allele p53kiki animals killed 35 weeks treatment except one animal p53 group killed 19 weeks study developed overt signs malady end study animals enlarged sponge like livers harboring numerous tumors visible surface livers mice three groups showed increased liver weights liverbody weight ratios caused high liver tumor burden without significant differences groups table historical controls untreated wild type c3h mice showed liverbody weight ratio 4 5 value almost doubled den treated mice present study
0.5264005.15917304.html.plaintext.txt	30	view table table neoplastic response hupki p53kiki compared p53 wild type p53 p53 heterozygous p53ki mice
0.5264005.15917304.html.plaintext.txt	31	neoplastic response liver determined enzyme histochemical staining frozen sections g6pase circumstances decreased activity hepatocellular preneoplastic foci adenomas carcinomas frequently employed marker identification lesions 35 study majority liver lesions g6pase negative phenotype addition lesions observed showed increases rather decreases g6pase activity often inhomogeneous staining patterns fraction g6pase altered tissue liver quantitatively evaluated found range 60 70 without significant difference groups table therefore p53 effect development liver tumors mice effect differ endogenous mouse protein humanized p53 ortholog
0.5264005.15917304.html.plaintext.txt	32	neoplastic response liver determined enzyme histochemical staining frozen sections g6pase circumstances decreased activity hepatocellular preneoplastic foci adenomas carcinomas frequently employed marker identification lesions 35 study majority liver lesions g6pase negative phenotype addition lesions observed showed increases rather decreases g6pase activity often inhomogeneous staining patterns fraction g6pase altered tissue liver quantitatively evaluated found range 60 70 without significant difference groups table therefore p53 effect development liver tumors mice effect differ endogenous mouse protein humanized p53 ortholog
0.5264005.15917304.html.plaintext.txt	33	view table table ii distribution nuclear ploidy hepatocytes hupki p53kiki compared p53 wild type p53 p53 heterozygous p53ki mice
0.5264005.15917304.html.plaintext.txt	34	role p53 maintaining genomic integrity well established mammalian cells show p53 dependent growth arrest reach tetraploidy 36 failure p53 pathway lead aneuploidy 3738 p53 may thus play role control cellular ploidy differences may exist activity murine human protein therefore analyzed ploidy distribution nuclei isolated non tumorous liver tissue den treated p53 p53ki p53kiki mice nuclei isolated dna content measured facs analysis staining propidium iodide diploid nuclei formed majority 45 closely followed tetraploid 33 octaploid nuclei 7 without significant differences mice three groups table ii
0.5264005.15917304.html.plaintext.txt	35	role p53 maintaining genomic integrity well established mammalian cells show p53 dependent growth arrest reach tetraploidy 36 failure p53 pathway lead aneuploidy 3738 p53 may thus play role control cellular ploidy differences may exist activity murine human protein therefore analyzed ploidy distribution nuclei isolated non tumorous liver tissue den treated p53 p53ki p53kiki mice nuclei isolated dna content measured facs analysis staining propidium iodide diploid nuclei formed majority 45 closely followed tetraploid 33 octaploid nuclei 7 without significant differences mice three groups table ii
0.5264005.15917304.html.plaintext.txt	36	since hepatocytes often binuclear polynuclear liver sections stained hematoxylin scored microscopically binuclear cells 6 hepatocytes found binuclear without correction stereology without apparent differences genotypes
0.5264005.15917304.html.plaintext.txt	37	since hepatocytes often binuclear polynuclear liver sections stained hematoxylin scored microscopically binuclear cells 6 hepatocytes found binuclear without correction stereology without apparent differences genotypes
0.5264005.15917304.html.plaintext.txt	38	previously screened liver tumors mice present study presence mutation b raf 22 course study ha ras mutations analyzed parallel since emphasis study b raf since significant differences mutation frequencies p53 genotypes detectable discriminate previous publication genotypes table iii present ha ras codon 61 mutation patterns liver tumors grouped genotype animals point mutations ha ras codon 61 detected 40 50 tumors without significant differences frequencies patterns mice three genotypes
0.5264005.15917304.html.plaintext.txt	39	previously screened liver tumors mice present study presence mutation b raf 22 course study ha ras mutations analyzed parallel since emphasis study b raf since significant differences mutation frequencies p53 genotypes detectable discriminate previous publication genotypes table iii present ha ras codon 61 mutation patterns liver tumors grouped genotype animals point mutations ha ras codon 61 detected 40 50 tumors without significant differences frequencies patterns mice three genotypes
0.5264005.15917304.html.plaintext.txt	40	view table table iii frequencies patterns ha ras mutations liver tumours hupki p53kiki compared p53 wild type p53 p53 heterozygous p53ki mice
0.5264005.15917304.html.plaintext.txt	41	mutation p53 often associated nuclear accumulation protein thus immunohistochemical p53 staining common fast method indirectly score presence p53 mutations tumor tissues study analyzed 42 liver sections stained p53 14 genotype p53 p53ki p53kiki p53 accumulation tumor transections altogether 347 tumor transections could identified 4 showed positive p53 staining nuclear staining often indicative p53 mutation observed lesions figure 1 two p53 mice two p53kiki mice p53 positive lesions stained also positive glutamine synthetase indicative activation ss catenin mutation gene 3940 figure 1
0.5264005.15917304.html.plaintext.txt	42	mutation p53 often associated nuclear accumulation protein thus immunohistochemical p53 staining common fast method indirectly score presence p53 mutations tumor tissues study analyzed 42 liver sections stained p53 14 genotype p53 p53ki p53kiki p53 accumulation tumor transections altogether 347 tumor transections could identified 4 showed positive p53 staining nuclear staining often indicative p53 mutation observed lesions figure 1 two p53 mice two p53kiki mice p53 positive lesions stained also positive glutamine synthetase indicative activation ss catenin mutation gene 3940 figure 1
0.5264005.15917304.html.plaintext.txt	43	view larger version 99k fig 1 p53 glutamine synthetase gs colocalize p53 positive mouse liver lesions proteins stained frozen sections immunohistochemistry note cytoplasmic localization p53 horizontal bars equal 01 mm
0.5264005.15917304.html.plaintext.txt	44	discussion top abstract introduction materials methods results discussion references results present study demonstrate carcinogen treated hupki mice harbor human p53 sequence exons 4 9 replacing corresponding murine exons 4 9 show differences neoplastic response liver compared mice harboring respective murine allele several studies pinpointed fact p53 plays central role tumorigenesis humans experimental systems example gene dosage p53 affects malignant development murine skin p53 null mice highly susceptible radiation induced tumorigenesis 4142 also well known heterozygous p53 null mice show overall increase tumor burden compared wild type mice 43 interestingly however hepatocarcinogenesis enhanced treatment heterozygous p53 null mice chemical carcinogen 43 48 results may interpreted sense murine p53 plays important role control malignant development organs mice liver quite contrast human liver frequent inactivation p53 hccs points toward important control function suppressor protein malignant transformation however recent data mouse models li fraumeni syndrome show point mutant p53 mice develop carcinomas number tissue sites including liver reopening debate effects p53 mutation murine hepatooncogenesis 49
0.5264005.15917304.html.plaintext.txt	45	discussion top abstract introduction materials methods results discussion references results present study demonstrate carcinogen treated hupki mice harbor human p53 sequence exons 4 9 replacing corresponding murine exons 4 9 show differences neoplastic response liver compared mice harboring respective murine allele several studies pinpointed fact p53 plays central role tumorigenesis humans experimental systems example gene dosage p53 affects malignant development murine skin p53 null mice highly susceptible radiation induced tumorigenesis 4142 also well known heterozygous p53 null mice show overall increase tumor burden compared wild type mice 43 interestingly however hepatocarcinogenesis enhanced treatment heterozygous p53 null mice chemical carcinogen 43 48 results may interpreted sense murine p53 plays important role control malignant development organs mice liver quite contrast human liver frequent inactivation p53 hccs points toward important control function suppressor protein malignant transformation however recent data mouse models li fraumeni syndrome show point mutant p53 mice develop carcinomas number tissue sites including liver reopening debate effects p53 mutation murine hepatooncogenesis 49
0.5264005.15917304.html.plaintext.txt	46	humanized p53 protein contains several important phosphorylation sites possibly regulated differentially mice men p53 proteins share high homology species although post transcriptional modifications mouse protein well understood human counterpart evidence number species specific sequence differences especially replaced ppd possibly lead differential post translational regulation p53s function
0.5264005.15917304.html.plaintext.txt	47	humanized p53 protein contains several important phosphorylation sites possibly regulated differentially mice men p53 proteins share high homology species although post transcriptional modifications mouse protein well understood human counterpart evidence number species specific sequence differences especially replaced ppd possibly lead differential post translational regulation p53s function
0.5264005.15917304.html.plaintext.txt	48	residue 72 important site apoptosis response chemotherapy human cells 5051 humans polymorphic encoding arginine proline whereby arginine variant common form northern european populations correlates enhanced response apoptotic stimuli comparing sequence mice straightforward since lies one divergent parts protein discussed 52 corresponding position mouse p53 codon 69 alanine hupki protein part sequence human arginine site data indicate induce difference respect control ras mutated cells p53 since prevalence ha ras mutated tumors similar mice three p53 genotypes
0.5264005.15917304.html.plaintext.txt	49	residue 72 important site apoptosis response chemotherapy human cells 5051 humans polymorphic encoding arginine proline whereby arginine variant common form northern european populations correlates enhanced response apoptotic stimuli comparing sequence mice straightforward since lies one divergent parts protein discussed 52 corresponding position mouse p53 codon 69 alanine hupki protein part sequence human arginine site data indicate induce difference respect control ras mutated cells p53 since prevalence ha ras mutated tumors similar mice three p53 genotypes
0.5264005.15917304.html.plaintext.txt	50	serine 46 human cells hupki cells mh unpublished data phosphorylated yet unidentified kinase massive dna damage 24 substitution serine 46 blocks expression p53aip1 p53 regulated apoptosis inducing protein 1 important mediator p53 dependent apoptosis 53 murine protein lacks phosphorylation site serine 46 might also provide link p53 cell cycle control since based sequence homologies could target cyclin dependent map kinases human cells 24 constitutive activation map kinase signaling ras mutated cells carrying humanized ki alleles could therefore lead feedback inhibition fewer ras mutated tumors effect detectable study
0.5264005.15917304.html.plaintext.txt	51	murine threonines 76 86 ppd expected sites phosphorylation map kinases 5455 increased phosphorylation detected stimulation cells tpa 12 o tetradecanoyl phorbol 13 acetate 5456 equivalent site human sequence data show lack phosphorylation site affects neither tumor response liver ha ras mutation prevalence tumors
0.5264005.15917304.html.plaintext.txt	52	murine threonines 76 86 ppd expected sites phosphorylation map kinases 5455 increased phosphorylation detected stimulation cells tpa 12 o tetradecanoyl phorbol 13 acetate 5456 equivalent site human sequence data show lack phosphorylation site affects neither tumor response liver ha ras mutation prevalence tumors
0.5264005.15917304.html.plaintext.txt	53	liver lesions present study stained infrequently positive p53 1 accumulation p53 hallmark mutation gene nuclear p53 accumulation however observed positively stained lesions mutation within dna binding domain p53 often results loss proteins ability act transcription factor result mdm2 one target genes longer transcribed eliminates feedback loop negatively controls intracellular concentration p53 57 therefore conclude mutation p53 infrequent mouse liver tumors irrespective whether mice harbored murine humanized p53 alleles also found rare p53 positive lesions detected simultaneously positive glutamine synthetase absent normal hepatocytes except small ring cells directly located around central veins 58 glutamine synthetase overexpressed hepatoma cells activated version ss catenin may serve marker indicating mutation gene 3940 ss catenin p53 may fact interact activation ss catenin signaling provoked licl treatment cells mutation gene leads stabilization p53 cell cycle arrest induction senescence endothelial cells 59 mouse fibroblasts 60 therefore suggest accumulation p53 protein glutamine synthetase positive liver lesions study may caused presence activated form ss catenin cells lesions
0.5264005.15917304.html.plaintext.txt	54	liver lesions present study stained infrequently positive p53 1 accumulation p53 hallmark mutation gene nuclear p53 accumulation however observed positively stained lesions mutation within dna binding domain p53 often results loss proteins ability act transcription factor result mdm2 one target genes longer transcribed eliminates feedback loop negatively controls intracellular concentration p53 57 therefore conclude mutation p53 infrequent mouse liver tumors irrespective whether mice harbored murine humanized p53 alleles also found rare p53 positive lesions detected simultaneously positive glutamine synthetase absent normal hepatocytes except small ring cells directly located around central veins 58 glutamine synthetase overexpressed hepatoma cells activated version ss catenin may serve marker indicating mutation gene 3940 ss catenin p53 may fact interact activation ss catenin signaling provoked licl treatment cells mutation gene leads stabilization p53 cell cycle arrest induction senescence endothelial cells 59 mouse fibroblasts 60 therefore suggest accumulation p53 protein glutamine synthetase positive liver lesions study may caused presence activated form ss catenin cells lesions
0.5264005.15917304.html.plaintext.txt	55	results present study demonstrate hupki mice behave like p53 wild type mice respect hepatocarcinogenesis induced den treatment protocol difference tumor response ha ras mutation prevalence tumors similar indication p53 mutations liver tumors hupki mice analogy demonstrated mice unmodified p53 locus 19 findings support hypothesis p53 harboring human polyproline dna binding domains growth control function lacking normal murine p53 mouse hepatocytes exclude possibility segments murine p53 replaced hupki model could influence outcome study figure 2 another possibility hupki allele may novel properties nevertheless behaves like mouse protein genetic environment mouse either human specific proteins interact p53 missing mouse specific proteins block control function mediated human allele reason mutation prevalences ras p53 liver tumors mice men different remains unveiled
0.5264005.15917304.html.plaintext.txt	56	results present study demonstrate hupki mice behave like p53 wild type mice respect hepatocarcinogenesis induced den treatment protocol difference tumor response ha ras mutation prevalence tumors similar indication p53 mutations liver tumors hupki mice analogy demonstrated mice unmodified p53 locus 19 findings support hypothesis p53 harboring human polyproline dna binding domains growth control function lacking normal murine p53 mouse hepatocytes exclude possibility segments murine p53 replaced hupki model could influence outcome study figure 2 another possibility hupki allele may novel properties nevertheless behaves like mouse protein genetic environment mouse either human specific proteins interact p53 missing mouse specific proteins block control function mediated human allele reason mutation prevalences ras p53 liver tumors mice men different remains unveiled
0.5264005.15917304.html.plaintext.txt	57	view larger version 17k fig 2 comparison mouse wildtype hupki human p53 protein sequences gray boxes indicate sequences mouse white boxes human origin tad transactivation domain ppd polyproline domain dbd specific dna binding domain ommf oligomerizationmultifunctional domain important residues mentioned text indicated
0.5264005.15917304.html.plaintext.txt	58	notes authors contributed equally work
0.5264005.15917304.html.plaintext.txt	59	acknowledgments paper written memory late colleague manfred hergenhahn passed away preparation manuscript excellent technical assistance elke zabinsky johanna mahr greatly acknowledged also thank dr gerburg stein dr sebastian wesselborg help facs analysis
0.5264005.15917304.html.plaintext.txt	60	acknowledgments paper written memory late colleague manfred hergenhahn passed away preparation manuscript excellent technical assistance elke zabinsky johanna mahr greatly acknowledged also thank dr gerburg stein dr sebastian wesselborg help facs analysis
0.5264005.15917304.html.plaintext.txt	61	conflict interest statement none declared
0.5264005.15917304.html.plaintext.txt	62	references top abstract introduction materials methods results discussion references parkindm brayfi devesass 2001 cancer burden year 2000 global picture eur j cancer 37 suppl 8 4 66crossref schwarzm buchmanna stinchcombes luebeckg moolgavkars bockkw 1995 role receptors human rodent hepatocarcinogenesis mutat res 333 69 79crossrefisimedline haupty mayar kazaza orenm 1997 mdm2 promotes rapid degradation p53 nature 387 296 299crossrefisimedline wux baylejh olsond levineaj 1993 p53 mdm 2 autoregulatory feedback loop genes dev 7 1126 1132abstract hermekingh eickd 1994 mediation c myc induced apoptosis p53 science 265 2091 2093isimedline damalasa ben zeeva simchai shtutmanm lealjf zhurinskyj geigerb orenm 1999 excess beta catenin promotes accumulation transcriptionally active p53 embo j 18 3054 3063abstractfree full text serranom linaw mccurrachme beachd lowesw 1997 oncogenic ras provokes premature cell senescence associated accumulation p53 p16ink4a cell 88 593 602crossrefisimedline vogelsteinb kinzlerkw 1993 multistep nature cancer trends genet 9 138 141crossrefisimedline huntert 1997 oncoprotein networks cell 88 333 346crossrefisimedline malumbresm barbacidm 2003 ras oncogenes first 30 years nat rev cancer 3 459 465crossrefisimedline downwardj 2003 targeting ras signalling pathways cancer therapy nat rev cancer 3 11 22crossrefisimedline linaw barradasm stonejc van aelstl serranom lowesw 1998 premature senescence involving p53 p16 activated response constitutive mekmapk mitogenic signaling genes dev 12 3008 3019abstractfree full text pomerantzj schreiber agusn liegeoisnj et al 1998 ink4a tumor suppressor gene product p19arf interacts mdm2 neutralizes mdm2s inhibition p53 cell 92 713 723crossrefisimedline palmeroi pantojac serranom 1998 p19arf links tumour suppressor p53 ras nature 395 125 126crossrefisimedline hollsteinm sidranskyd vogelsteinb harriscc 1991 p53 mutations human cancers science 253 49 53isimedline hollsteinm ricek greenblattms soussit fuchsr sorliet hovige smith sorensenb montesanor harriscc 1994 database p53 gene somatic mutations human tumors cell lines nucleic acids res 22 3551 3555abstract vogelsteinb laned levineaj 2000 surfing p53 network nature 408 307 310crossrefisimedline tannapfela sommererf benickem katalinica uhlmannd witzigmannh haussj wittekindc 2003 mutations braf gene cholangiocarcinoma hepatocellular carcinoma gut 52 706 712abstractfree full text kresss konigj schweizerj loehrkeh bauer hofmannr schwarzm 1992 p53 mutations absent carcinogen induced mouse liver tumors occur cell lines established tumors mol carcinog 6 148 158isimedline buchmanna bauer hofmannr mahrj drinkwaternr luza schwarzm 1991 mutational activation c ha ras gene liver tumors different rodent strains correlation susceptibility hepatocarcinogenesis proc natl acad sci usa 88 911 915abstractfree full text maronpotrr foxt malarkeyde goldsworthytl 1995 mutations ras proto oncogene clues etiology molecular pathogenesis mouse liver tumors toxicology 101 125 156crossrefisimedline jaworskim buchmanna bauerp riesso schwarzm 2005 b raf ha ras mutations chemically induced mouse liver tumors oncogene 24 1290 1295crossrefisimedline dohoneykm guillermc whitefordc elbic lambertpf hagergl bradyjn 2004 phosphorylation p53 serine 37 important transcriptional activity regulation response dna damage oncogene 23 49 57crossrefisimedline odak arakawah tanakat et al 2000 p53alp1 potential mediator p53 dependent apoptosis regulation ser 46 phosphorylated p53 cell 102 849 862crossrefisimedline luojl yangq tongwm hergenhahnm wangzq hollsteinm 2001 knock mice chimeric humanmurine p53 gene develop normally show wild type p53 responses dna damaging agents new biomedical research tool oncogene 20 320 328crossrefisimedline luojl tongwm yoonjh hergenhahnm koomagir yangq galendod pfeifergp wangzq hollsteinm 2001 uv induced dna damage mutations hupki human p53 knock mice recapitulate p53 hotspot alterations sun exposed human skin cancer res 61 8158 8163abstractfree full text liuz hergenhahnm schmeiserhh wogangn honga hollsteinm 2004 human tumor p53 mutations selected mouse embryonic fibroblasts harboring humanized p53 gene proc natl acad sci usa 101 2963 2968abstractfree full text drinkwaternr bennettlm 1991 genetic control carcinogenesis experimental animals prog exp tumor res 33 1 20isimedline ushijimat makinoh okonogih hosoyay sugimurat nagaom 1995 mutation loss heterozygosity recombination p53 gene mouse forestomach tumors induced 2 amino 34 dimethylimidazo45 fquinoline mol carcinog 12 23 30isimedline wachsteinm meisele 1957 histochemistry hepatic phosphatases physiologic ph special reference demonstration bile canaliculi j clin pathol 27 13 23isimedline schwarzm buchmanna schultem pearsond kunzw 1989 heterogeneity enzyme altered foci rat liver toxicol lett 49 297 317crossrefisimedline ungerc buchmanna bunemanncl kresss schwarzm 1998 wild type function p53 tumor suppressor protein required apoptosis mouse hepatoma cells cell death differ 5 87 95crossrefisimedline blobelg pottervr 1966 nuclei rat liver isolation method combines purity high yield science 154 1662 1665isimedline r development core team 2003 r language environment statistical computing vienna austria pitothc 1990 altered hepatic foci role murine hepatocarcinogenesis ann rev pharmacol toxicol 30 465 500crossrefisimedline andreassenpr lohezod lacroixfb margolisrl 2001 tetraploid state induces p53 dependent arrest nontransformed mammalian cells g1 mol biol cell 12 1315 1328abstractfree full text harveym sandsat weissrs hegime wisemanrw pantazisp giovanellabc tainskyma bradleya donehowerla 1993 vitro growth characteristics embryo fibroblasts isolated p53 deficient mice oncogene 8 2457 2467isimedline gualbertoa aldapek kozakiewiczk tlstytd 1998 oncogenic form p53 confers dominant gain function phenotype disrupts spindle checkpoint control proc natl acad sci usa 95 5166 5171abstractfree full text loeppens schneiderd gaunitzf gebhardtr kurekr buchmanna schwarzm 2002 overexpression glutamine synthetase associated beta catenin mutations mouse liver tumors promotion hepatocarcinogenesis phenobarbital cancer res 62 5685 5688abstractfree full text cadoreta ovejeroc terrisb souile levyl lamerswh kitajewskij kahna perretc 2002 new targets beta catenin signaling liver involved glutamine metabolism oncogene 21 8293 8301crossrefisimedline kempcj donehowerla bradleya balmaina 1993 reduction p53 gene dosage increase initiation promotion enhances malignant progression chemically induced skin tumors cell 74 813 822crossrefisimedline kempcj wheldont balmaina 1994 p53 deficient mice extremely susceptible radiation induced tumorigenesis nat genet 8 66 69crossrefisimedline harveym mcarthurmj montgomerycajr buteljs bradleya donehowerla 1993 spontaneous carcinogen induced tumorigenesis p53 deficient mice nat genet 5 225 229crossrefisimedline kempcj 1995 hepatocarcinogenesis p53 deficient mice mol carcinog 12 132 136isimedline dasssb buccitj heflichrh cascianoda 1999 evaluation transgenic p53 mouse detecting genotoxic liver carcinogens short term bioassay cancer lett 143 81 85crossrefisimedline sukatat ozakik uwagawas sekit wanibuchih yamamotos okunoy fukushimas 2000 organ specific carcinogen induced increases cell proliferation p53 deficient mice cancer res 60 74 79abstractfree full text frenchje lacksgd trempusc dunnickjk foleyj mahlerj ticerr tennantrw 2001 loss heterozygosity frequency trp53 locus p53 deficient mouse tumors carcinogen tissue dependent carcinogenesis 22 99 106abstractfree full text ueharat kashiday watanabet yasuharak onoderah hirosem mitsumorik 2002 susceptibility liver proliferative lesions heterozygous p53 deficient cba mice various carcinogens j vet med sci 64 551 556crossrefisimedline olivekp tuvesonda ruhezc yinb willisna bronsonrt crowleyd jackst 2004 mutant p53 gain function two mouse models li fraumeni syndrome cell 119 847 860crossrefisimedline marinmc jostca brooksla et al 2000 common polymorphism acts intragenic modifier mutant p53 behaviour nat genet 25 47 54crossrefisimedline bergamaschid gascom hillerl et al 2003 p53 polymorphism influences response cancer chemotherapy via modulation p73 dependent apoptosis cancer cell 3 387 402crossrefisimedline hergenhahnm luojl hollsteinm 2004 p53 designer genes modern mouse cell cycle 3 738 741isimedline matsudak yoshidak tayay nakamurak nakamuray arakawah 2002 p53aip1 regulates mitochondrial apoptotic pathway cancer res 62 2883 2889abstractfree full text milnedm campbelldg caudwellfb meekdw 1994 phosphorylation tumor suppressor protein p53 mitogen activated protein kinases j biol chem 269 9253 9260abstractfree full text jardinelj milnedm dumazn meekdw 1999 phosphorylation murine p53 human p53 map kinase vitro cultured cells highlights species dependent variation post translational modification oncogene 18 7602 7607crossrefisimedline milnedm mckendrickl jardinelj deacone lordjm meekdw 1996 murine p53 phosphorylated within pab421 epitope protein kinase c vitro vivo even stimulation phorbol ester o tetradecanoylphorbol 13 acetate oncogene 13 205 211isimedline midgleyca lanedp 1997 p53 protein stability tumour cells determined mutation dependent mdm2 binding oncogene 15 1179 1189crossrefisimedline gebhardtr mecked 1983 heterogeneous distribution glutamine synthetase among rat liver parenchymal cells situ primary culture embo j 2 567 570isimedline maocd hoangp dicorletope 2001 lithium inhibits cell cycle progression induces stabilization p53 bovine aortic endothelial cells j biol chem 276 26180 26188abstractfree full text damalasa kahans shtutmanm ben zeeva orenm 2001 deregulated beta catenin induces p53 arf dependent growth arrest cooperates ras transformation embo j 20 4912 4922abstractfree full text received april 8 2005 revised may 20 2005 accepted may 23 2005
0.5264005.15917304.html.plaintext.txt	63	article abstract full text pdf versions article 26101829 recent bgi142v2 bgi142v1 alert article cited alert correction posted services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal add personal archive download citation manager search citing articles isi web science 1 request permissions google scholar articles jaworski m articles schwarz m pubmed pubmed citation articles jaworski m articles schwarz m online issn 1460 2180 print issn 0143 3334 copyright 2006 oxford university press oxford journals oxford university press site map terms conditions privacy policy frequently asked questions oxford university press sites oxford university press american national biography booksellers information service childrens fiction poetry childrens reference corporate special sales dictionaries dictionary national biography digital reference english language teaching higher education textbooks humanities international education unit law medicine music online products oxford english dictionary reference rights permissions science school books social sciences short introductions worlds classics
0.5353734.14699137.html.plaintext.txt	0	inhibition human p53 basal transcription regulation protein kinase c tarek abbas david white li hui kiyotsugu yoshida david foster jill bargonetti
0.5353734.14699137.html.plaintext.txt	1	inhibition human p53 basal transcription regulation protein kinase c tarek abbas david white li hui kiyotsugu yoshida david foster jill bargonetti
0.5353734.14699137.html.plaintext.txt	2	institute biomolecular structure function department biological sciences hunter college graduate school city university new york new york new york 10021 department molecular genetics medical research institute tokyo medical dental university tokyo 113 8510 japan
0.5353734.14699137.html.plaintext.txt	3	received publication july 1 2003 revised form december 1 2003
0.5353734.14699137.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references response dna damage signal transduction pathways activated result increase p53 protein levels leading either growth arrest apoptosis protein kinase c pkc implicated tumor suppressor regulated tumor promoting phorbol esters mouse skin cell culture models report tumor promoting phorbol ester 12 o tetradecanoylphorbol 13 acetate prevents dna damage induced regulation p53 regulating pkc regulation p53 response stress commonly occurs preventing ubiquitination degradation p53 protein surprisingly suppression p53 expression inhibition pkc caused inhibition p53 synthesis increased degradation p53 protein inhibiting pkc blocked basal transcription human p53 gene initiation transcription human p53 promoter therefore tumor suppressing effects pkc mediated least part activating p53 transcription
0.5353734.14699137.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references response dna damage signal transduction pathways activated result increase p53 protein levels leading either growth arrest apoptosis protein kinase c pkc implicated tumor suppressor regulated tumor promoting phorbol esters mouse skin cell culture models report tumor promoting phorbol ester 12 o tetradecanoylphorbol 13 acetate prevents dna damage induced regulation p53 regulating pkc regulation p53 response stress commonly occurs preventing ubiquitination degradation p53 protein surprisingly suppression p53 expression inhibition pkc caused inhibition p53 synthesis increased degradation p53 protein inhibiting pkc blocked basal transcription human p53 gene initiation transcription human p53 promoter therefore tumor suppressing effects pkc mediated least part activating p53 transcription
0.5353734.14699137.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references tumor suppressor protein p53 plays central role mediating stress dna damage induced growth arrest apoptosis 1 p53 protein regulates normal responses dna damage forms genotoxic stress key element maintaining genomic stability 2 fact p53 tumor suppressor gene frequently inactivated gene human malignancy 3 level p53 protein largely undetectable normal cells rapidly increases response variety stress signals mechanism p53 protein stabilized completely understood post translational modification plays pivotal role 4 mutations p53 gene frequently associated formation human cancer however p53 pathway also derailed numerous oncogenic proteins 5 mice engineered p53 gene knocked develop tumors increased rate 6 critical position p53 plays tumor suppression suggests many agents may inhibit p53 pathway part road toward tumor promotion however mechanisms action many chemical agents promote tumor development elucidated central role p53 mind logical presume agents promote tumor formation might block p53 pathway
0.5353734.14699137.html.plaintext.txt	7	introduction top abstract introduction materials methods results discussion references tumor suppressor protein p53 plays central role mediating stress dna damage induced growth arrest apoptosis 1 p53 protein regulates normal responses dna damage forms genotoxic stress key element maintaining genomic stability 2 fact p53 tumor suppressor gene frequently inactivated gene human malignancy 3 level p53 protein largely undetectable normal cells rapidly increases response variety stress signals mechanism p53 protein stabilized completely understood post translational modification plays pivotal role 4 mutations p53 gene frequently associated formation human cancer however p53 pathway also derailed numerous oncogenic proteins 5 mice engineered p53 gene knocked develop tumors increased rate 6 critical position p53 plays tumor suppression suggests many agents may inhibit p53 pathway part road toward tumor promotion however mechanisms action many chemical agents promote tumor development elucidated central role p53 mind logical presume agents promote tumor formation might block p53 pathway
0.5353734.14699137.html.plaintext.txt	8	tumor promoting phorbol ester 12 o tetradecanoylphorbol 13 acetate tpa1 promotes tumor formation variety mice tissue culture models associated regulation protein kinase c pkc 7 tpa known activate regulate diacylglyceroldependent pkc isoforms 7 8 demonstrated tumor promoting activities tpa mediated least part regulating pkc 9 12 moreover transgenic mice overexpressing pkc epidermis resistant tumor promotion tpa 13 increasing evidence suggests pkc player dna damage response pathways pkc activated dna damage response tyrosine phosphorylation cleavage pkc 40 kda constitutively active catalytic fragment 14 15 furthermore downregulation pkc expression inhibitors sirna associated attenuation dna damage induced response 14 16
0.5353734.14699137.html.plaintext.txt	9	tumor promoting phorbol ester 12 o tetradecanoylphorbol 13 acetate tpa1 promotes tumor formation variety mice tissue culture models associated regulation protein kinase c pkc 7 tpa known activate regulate diacylglyceroldependent pkc isoforms 7 8 demonstrated tumor promoting activities tpa mediated least part regulating pkc 9 12 moreover transgenic mice overexpressing pkc epidermis resistant tumor promotion tpa 13 increasing evidence suggests pkc player dna damage response pathways pkc activated dna damage response tyrosine phosphorylation cleavage pkc 40 kda constitutively active catalytic fragment 14 15 furthermore downregulation pkc expression inhibitors sirna associated attenuation dna damage induced response 14 16
0.5353734.14699137.html.plaintext.txt	10	many chemotherapeutic drugs work inducing cell death via p53 pathway 17 previous studies suggested tpa inhibit dna damage mediated induction p53 18 19 moreover studies protein kinase inhibitors suggested pkc regulates p53 pathway 20 21 report examined effect pkc p53 protein gene expression report pkc required basal transcription p53 gene results discussed context tumor promotion phorbol esters
0.5353734.14699137.html.plaintext.txt	11	many chemotherapeutic drugs work inducing cell death via p53 pathway 17 previous studies suggested tpa inhibit dna damage mediated induction p53 18 19 moreover studies protein kinase inhibitors suggested pkc regulates p53 pathway 20 21 report examined effect pkc p53 protein gene expression report pkc required basal transcription p53 gene results discussed context tumor promotion phorbol esters
0.5353734.14699137.html.plaintext.txt	12	materials methods top abstract introduction materials methods results discussion references reagents camptothecin propidium iodide calpain inhibitor n acetyl leu leu norleu al llnl purchased sigma etoposide rottlerin tpa purchased calbiochem zeocin purchased invitrogen rpmi 1640 fetal bovine serum purchased invitrogen d m vyas bristol myers squibb co supplied mc dmc synthesized mc previously described 22 trizol reagent purchased life technologies inc bryostatin 1 purchased lc laboratories actinomycin d purchased calbiochem used concentration 10 microgml
0.5353734.14699137.html.plaintext.txt	13	materials methods top abstract introduction materials methods results discussion references reagents camptothecin propidium iodide calpain inhibitor n acetyl leu leu norleu al llnl purchased sigma etoposide rottlerin tpa purchased calbiochem zeocin purchased invitrogen rpmi 1640 fetal bovine serum purchased invitrogen d m vyas bristol myers squibb co supplied mc dmc synthesized mc previously described 22 trizol reagent purchased life technologies inc bryostatin 1 purchased lc laboratories actinomycin d purchased calbiochem used concentration 10 microgml
0.5353734.14699137.html.plaintext.txt	14	cell culture ml 1 wild type p53 cells generous gift michael kastan k562 p53 expression mcf 7 wild type p53 cells obtained american type culture collection h460 h1299 cells provided arnold j levine used another model compare cells without p53 23 cell lines exception mcf 7 grown rpmi 1640 10 fetal bovine serum 5 co2 seeded density 25 x 105ml exponentially growing cells used experiments mcf 7 cells grown dulbeccos modified eagles medium 10 calf serum
0.5353734.14699137.html.plaintext.txt	15	cell culture ml 1 wild type p53 cells generous gift michael kastan k562 p53 expression mcf 7 wild type p53 cells obtained american type culture collection h460 h1299 cells provided arnold j levine used another model compare cells without p53 23 cell lines exception mcf 7 grown rpmi 1640 10 fetal bovine serum 5 co2 seeded density 25 x 105ml exponentially growing cells used experiments mcf 7 cells grown dulbeccos modified eagles medium 10 calf serum
0.5353734.14699137.html.plaintext.txt	16	flow cytometry flow cytometry carried becton dickinson facscan cells spun 2300 rpm 7 min washed twice phosphate buffered saline 136 mm nacl 26 mm kcl 14 mm kh2po4 42 mm na2hpo4 resuspended 20 ml phosphate buffered saline containing 2 bovine serum albumin 01 nan3 ethanol 9 ml added dropwise vortexing propidium iodide staining rnase treatment carried 37 degrees c 30 min 24 h prior flow cytometry
0.5353734.14699137.html.plaintext.txt	17	flow cytometry flow cytometry carried becton dickinson facscan cells spun 2300 rpm 7 min washed twice phosphate buffered saline 136 mm nacl 26 mm kcl 14 mm kh2po4 42 mm na2hpo4 resuspended 20 ml phosphate buffered saline containing 2 bovine serum albumin 01 nan3 ethanol 9 ml added dropwise vortexing propidium iodide staining rnase treatment carried 37 degrees c 30 min 24 h prior flow cytometry
0.5353734.14699137.html.plaintext.txt	18	protein extract preparation protein extracts prepared using variation dignam protocol 24 cells spun resuspended 5 packed cell pellet volumes buffer 10 mm hepes ph 79 15 mm mgcl2 10 mm kcl 05 mm phenylmethylsulfonyl fluoride 05 mm dithiothreitol put ice 10 min prior centrifugation 10 min 2000 rpm 4 degrees c pellet resuspended 2 packed cell pellet volumes buffer volume prior initial wash cells run 25 gauge needle twice nuclei spun 2000 rpm 10 min 4 degrees c followed additional 20 min spin 15000 rpm 4 degrees c supernatant saved cytoplasmic extract pellet resuspended 109 cells per 3 ml buffer b 20 mm hepes ph 79 25 glycerol 042 mm nacl 15 mm mgcl2 02 mm edta 05 mm phenylmethylsulfonyl fluoride 05 mm dithiothreitol running 25 gauge needle twice suspension rocked gently 30 min 4 degrees c extract centrifuged 30 min 15000 rpm 4 degrees c supernatant aliquots stored 80 degrees c
0.5353734.14699137.html.plaintext.txt	19	protein extract preparation protein extracts prepared using variation dignam protocol 24 cells spun resuspended 5 packed cell pellet volumes buffer 10 mm hepes ph 79 15 mm mgcl2 10 mm kcl 05 mm phenylmethylsulfonyl fluoride 05 mm dithiothreitol put ice 10 min prior centrifugation 10 min 2000 rpm 4 degrees c pellet resuspended 2 packed cell pellet volumes buffer volume prior initial wash cells run 25 gauge needle twice nuclei spun 2000 rpm 10 min 4 degrees c followed additional 20 min spin 15000 rpm 4 degrees c supernatant saved cytoplasmic extract pellet resuspended 109 cells per 3 ml buffer b 20 mm hepes ph 79 25 glycerol 042 mm nacl 15 mm mgcl2 02 mm edta 05 mm phenylmethylsulfonyl fluoride 05 mm dithiothreitol running 25 gauge needle twice suspension rocked gently 30 min 4 degrees c extract centrifuged 30 min 15000 rpm 4 degrees c supernatant aliquots stored 80 degrees c
0.5353734.14699137.html.plaintext.txt	20	western blot analysis protein samples electrophoresed 10 sds polyacrylamide gel electrophoresis electrotransferred nitrocellulose blots probed either mixture monoclonal antibodies specific p53 1801 240 421 supernatant monoclonal anti polyadp ribose polymerase parp antibody pharmingen monoclonal anti pkc antibody sc 937 santa cruz biotechnology anti p21 antibody cell signaling anti actin sigma signals visualized incubation goat anti mouse goat anti rabbit secondary antibody using ecl system amersham biosciences
0.5353734.14699137.html.plaintext.txt	21	western blot analysis protein samples electrophoresed 10 sds polyacrylamide gel electrophoresis electrotransferred nitrocellulose blots probed either mixture monoclonal antibodies specific p53 1801 240 421 supernatant monoclonal anti polyadp ribose polymerase parp antibody pharmingen monoclonal anti pkc antibody sc 937 santa cruz biotechnology anti p21 antibody cell signaling anti actin sigma signals visualized incubation goat anti mouse goat anti rabbit secondary antibody using ecl system amersham biosciences
0.5353734.14699137.html.plaintext.txt	22	rna extraction northern blot analysis total rna extracted using trizol reagent invitrogen according manufacturer total rna 10 50 microg resolved denaturing formaldehyde gel electrotransferred overnight nylon membrane membrane incubated 10 ml prehybridization buffer amersham biosciences 15 h radiolabeled probes added directly prehybridization buffer 24 h membranes washed twice 2x ssc buffer 65 degrees c shaking 5 min followed another wash 1x ssc buffer 65 degrees c shaking 15 min twice 01x ssc buffer 65 degrees c shaking 5 min signal visualized autoradiography
0.5353734.14699137.html.plaintext.txt	23	rna extraction northern blot analysis total rna extracted using trizol reagent invitrogen according manufacturer total rna 10 50 microg resolved denaturing formaldehyde gel electrotransferred overnight nylon membrane membrane incubated 10 ml prehybridization buffer amersham biosciences 15 h radiolabeled probes added directly prehybridization buffer 24 h membranes washed twice 2x ssc buffer 65 degrees c shaking 5 min followed another wash 1x ssc buffer 65 degrees c shaking 15 min twice 01x ssc buffer 65 degrees c shaking 5 min signal visualized autoradiography
0.5353734.14699137.html.plaintext.txt	24	quantitative rt pcr sample 3 microg total rna obtained trizol sigma used cdna synthesis using high capacity cdna archive kit applied biosystems 3 microl rt products used pcr amplification taqman primer probes human glyceraldehyde 3 phosphate dehydrogenase p53 obtained applied biosystems assays demand manufacturers conditions followed taqman pcr applied biosystems 5700 sequence detection system perkinelmer life sciences one cycle 50 degrees c ung incubation 2 min 94 degrees c priming 10 min followed 40 cycles 94 degrees c denaturation 15 60 degrees c annealing 1 min fluorescence measured annealing step plotted automatically sample
0.5353734.14699137.html.plaintext.txt	25	quantitative rt pcr sample 3 microg total rna obtained trizol sigma used cdna synthesis using high capacity cdna archive kit applied biosystems 3 microl rt products used pcr amplification taqman primer probes human glyceraldehyde 3 phosphate dehydrogenase p53 obtained applied biosystems assays demand manufacturers conditions followed taqman pcr applied biosystems 5700 sequence detection system perkinelmer life sciences one cycle 50 degrees c ung incubation 2 min 94 degrees c priming 10 min followed 40 cycles 94 degrees c denaturation 15 60 degrees c annealing 1 min fluorescence measured annealing step plotted automatically sample
0.5353734.14699137.html.plaintext.txt	26	transient transfection luciferase activity assay wild type p53 expressing sn3 plasmid obtained bert vogelstein 25 gfp pkc k r expressing plasmid kinase negative mutant lysine residue position 378 putative atp binding site substituted arginine site directed mutagenesis cloned pegfp c1 clontech renilla luciferase expressing plasmid prl tk purchased promega human p1 p53 promoter generous gift david reisman 26 human p2 mdm2 promoter cloned pgl2 basic promega generous gift gareth bond arnold levine h460 h1299 cells used model p53 present absent cell lines grown described subconfluent cultures transiently transfected various plasmid constructs using lipofectamine 2000 transfection reagent invitrogen according manufacturer transfection various sirna constructs 50 confluent cultures transfected using lipofectamine 2000 reagent according manufacturers indications invitrogen sirna duplexes obtained qiagen 14 sirna targeting gfp mrna qiagen used negative control transiently transfected cells harvested analyzed using dual luciferase reporter assay system promega according manufacturers indications luciferase activity assayed using luminoskan reader
0.5353734.14699137.html.plaintext.txt	27	transient transfection luciferase activity assay wild type p53 expressing sn3 plasmid obtained bert vogelstein 25 gfp pkc k r expressing plasmid kinase negative mutant lysine residue position 378 putative atp binding site substituted arginine site directed mutagenesis cloned pegfp c1 clontech renilla luciferase expressing plasmid prl tk purchased promega human p1 p53 promoter generous gift david reisman 26 human p2 mdm2 promoter cloned pgl2 basic promega generous gift gareth bond arnold levine h460 h1299 cells used model p53 present absent cell lines grown described subconfluent cultures transiently transfected various plasmid constructs using lipofectamine 2000 transfection reagent invitrogen according manufacturer transfection various sirna constructs 50 confluent cultures transfected using lipofectamine 2000 reagent according manufacturers indications invitrogen sirna duplexes obtained qiagen 14 sirna targeting gfp mrna qiagen used negative control transiently transfected cells harvested analyzed using dual luciferase reporter assay system promega according manufacturers indications luciferase activity assayed using luminoskan reader
0.5353734.14699137.html.plaintext.txt	28	results top abstract introduction materials methods results discussion references tpa inhibits apoptosis cells wild type p53 cells lacking p53 demonstrated previously tpa virtue regulation pkc provides survival signal prevents apoptosis 12 investigate whether survival signals generated tpa involved p53 examined effect tpa upon dna damage induced apoptosis human cancer cell lines 27 28 without wild type p53 29 dna damaging agents cpt mc dmc induced apoptosis human myeloid leukemia cell line ml 1 wild type p53 demonstrated cleavage caspase 3 substrate parp widely used indicator apoptosis fig 1a lanes 3 5 7 30 however ml 1 cells pretreated tpa 24 h parp cleavage induced dna damaging agents almost completely inhibited cpt mc fig 1a lanes 4 6 similar data obtained using flow cytometry cpt induced appearance sub g1 dna also prevented tpa treatment data shown tpa also able inhibit cpt mc induced apoptosis number cell lines expressing wild type p53 including lncap h460 mcf 7 data shown fig 3d whereas cpt mc require p53 order mediate significant apoptosis dmc addition activating p53 pathway also able induce apoptosis absence p53 31 similar experiment performed k562 cells lack p53 dna damaging agent dmc induced significant parp cleavage however tpa treatment effect upon parp cleavage cells fig 1b lanes 7 8 modest parp cleavage also induced cpt mc k562 cells cleavage similarly unaffected tpa treatment fig 1b lanes 3 6 demonstration lack tpa inhibition p53 independent apoptosis shown fig 1c neither dmc induced apoptosis h460 cells containing wild type p53 h1299 cells without wild type p53 rescued tpa pretreatment mechanism action dmc current investigation interestingly observed tpa able partially rescue dmc induced apoptosis ml 1 cells fig 1a time know tpa able inhibit dmc induced apoptosis ml 1 cells detract finding cell lines p53 apoptosis inhibited tpa
0.5353734.14699137.html.plaintext.txt	29	results top abstract introduction materials methods results discussion references tpa inhibits apoptosis cells wild type p53 cells lacking p53 demonstrated previously tpa virtue regulation pkc provides survival signal prevents apoptosis 12 investigate whether survival signals generated tpa involved p53 examined effect tpa upon dna damage induced apoptosis human cancer cell lines 27 28 without wild type p53 29 dna damaging agents cpt mc dmc induced apoptosis human myeloid leukemia cell line ml 1 wild type p53 demonstrated cleavage caspase 3 substrate parp widely used indicator apoptosis fig 1a lanes 3 5 7 30 however ml 1 cells pretreated tpa 24 h parp cleavage induced dna damaging agents almost completely inhibited cpt mc fig 1a lanes 4 6 similar data obtained using flow cytometry cpt induced appearance sub g1 dna also prevented tpa treatment data shown tpa also able inhibit cpt mc induced apoptosis number cell lines expressing wild type p53 including lncap h460 mcf 7 data shown fig 3d whereas cpt mc require p53 order mediate significant apoptosis dmc addition activating p53 pathway also able induce apoptosis absence p53 31 similar experiment performed k562 cells lack p53 dna damaging agent dmc induced significant parp cleavage however tpa treatment effect upon parp cleavage cells fig 1b lanes 7 8 modest parp cleavage also induced cpt mc k562 cells cleavage similarly unaffected tpa treatment fig 1b lanes 3 6 demonstration lack tpa inhibition p53 independent apoptosis shown fig 1c neither dmc induced apoptosis h460 cells containing wild type p53 h1299 cells without wild type p53 rescued tpa pretreatment mechanism action dmc current investigation interestingly observed tpa able partially rescue dmc induced apoptosis ml 1 cells fig 1a time know tpa able inhibit dmc induced apoptosis ml 1 cells detract finding cell lines p53 apoptosis inhibited tpa
0.5353734.14699137.html.plaintext.txt	30	view larger version 28k fig 1 tpa protects p53 mediated apoptosis induced dna damage effect tpa upon dna damage induced parp cleavage ml 1 cells wild type p53 determined western blot analysis cell extracts prepared ml 1 cells either left untreated lane 1 treated 24 h 05 microm cpt lanes 3 4 5 microm mc lanes 5 6 5 microm dmc lanes 7 8 indicated cells pretreated tpa 10 nm 21 h prior addition dna damaging agent 25 microg nuclear proteins resolved electrophoresis 10 sds page transferred nitrocellulose membrane probed anti human parp antibody blots stripped reprobed anti actin antibody b effect tpa upon dna damage induced parp cleavage k562 cells lacking p53 determined exactly c dmc mediated apoptosis examined h460 cells wild type p53 h1299 cells lacking p53 exponentially growing cells either left untreated treated dmc 5 microm 24 h indicated cells pretreated tpa 10 nm 21 h prior addition dmc proteins analyzed d kinetics tpa effect upon dna damage induced parp cleavage ml 1 cells determined cells either left untreated lane 1 pretreated tpa 10 nm times indicated prior 3 h cpt treatment dmso me2so
0.5353734.14699137.html.plaintext.txt	31	view larger version 43k fig 3 pharmacological inhibition regulation pkc specifically inhibits dna damage induced p53 protein stabilization protects p53 dependent apoptosis effect tpa bryostatin 1 upon dna damage induced parp cleavage p53 levels mcf 7 cells determined western blot analysis fig 2 whole cell extracts prepared cells either left untreated lane 1 treated 1 microm cpt 16 h lane 2 pretreated tpa 400 nm 24 h prior cpt treatment lane 3 pretreated 400 nm tpa bryostatin 1 1 microm 24 h lane 4 prior treatment cpt b extracts mcf 7 cells shown also analyzed western blot pkc c ability rottlerin inhibit ml 1 cell apoptosis examined florescence activated cell sorting exponentially growing ml 1 cells either treated 6 microm rottlerin 05 microm pct presence absence 6 microm rottlerin 4 h d ability rottlerin inhibit dna damage induced stabilization p53 ml 1 cells examined western blot analysis nuclear extracts level p21 expression also monitored indicated exponentially growing cells either left untreated lanes 1 2 treated 05 microm cpt lanes 3 4 8 microm etoposide lanes 5 6 50 microgml zeocin lanes 7 8 5 microm mc lanes 9 10 4 h presence absence 6 microm rottlerin e corresponding cytoplasmic extracts also examined dmso me2so
0.5353734.14699137.html.plaintext.txt	32	data implicated p53 involved tpamediated rescue apoptosis interested kinetics rescue tpa examined kinetics tpa induced prevention cpt induced parp cleavage ml 1 cells shown fig 1d prevention cptinduced parp cleavage begin detected 6 9 h kinetics important tpa treatment known initially activate pkc time depletion cellular pkc levels occurs via ubiquitin proteosome pathway 9 10 therefore went examine relationship tpa mediated inhibition apoptosis depletion pkc ability dna damaging drugs induce p53 protein accumulation
0.5353734.14699137.html.plaintext.txt	33	data implicated p53 involved tpamediated rescue apoptosis interested kinetics rescue tpa examined kinetics tpa induced prevention cpt induced parp cleavage ml 1 cells shown fig 1d prevention cptinduced parp cleavage begin detected 6 9 h kinetics important tpa treatment known initially activate pkc time depletion cellular pkc levels occurs via ubiquitin proteosome pathway 9 10 therefore went examine relationship tpa mediated inhibition apoptosis depletion pkc ability dna damaging drugs induce p53 protein accumulation
0.5353734.14699137.html.plaintext.txt	34	dna damage induced stabilization p53 inhibited depletion inhibition pkc investigation influence tpa p53 pathway dna damage induced p53 compared presence absence tpa ml 1 cells pretreated tpa increasing times influence induction p53 observed western blot analysis treatment ml 1 cells 05 microm cpt rapidly induces nuclear accumulation p53 protein fig 2a compare lanes 1 2 pretreatment ml 1 cells 10 nm tpa 6 h longer inhibited cpt induced p53 accumulation time dependent manner fig 2a lanes 3 9 ability tpa inhibit p53 nuclear accumulation due change p53 shuttling since tpa pretreatment detectable accumulation cytoplasmic p53 data shown shown fig 2b pkc largely depleted 6 h tpa treatment ml 1 cells kinetics pkc depletion slightly preceded disappearance p53 induction observed fig 2a compare lanes 4 9 b consistent inhibition p53 induction due depletion pkc also shown fig 2b cpt induced appearance 40 kda catalytically active fragment pkc 40 kda fragment associated apoptosis catalytic fragment equally depleted tpa pretreatment fig 2b lanes 3 5 15
0.5353734.14699137.html.plaintext.txt	35	dna damage induced stabilization p53 inhibited depletion inhibition pkc investigation influence tpa p53 pathway dna damage induced p53 compared presence absence tpa ml 1 cells pretreated tpa increasing times influence induction p53 observed western blot analysis treatment ml 1 cells 05 microm cpt rapidly induces nuclear accumulation p53 protein fig 2a compare lanes 1 2 pretreatment ml 1 cells 10 nm tpa 6 h longer inhibited cpt induced p53 accumulation time dependent manner fig 2a lanes 3 9 ability tpa inhibit p53 nuclear accumulation due change p53 shuttling since tpa pretreatment detectable accumulation cytoplasmic p53 data shown shown fig 2b pkc largely depleted 6 h tpa treatment ml 1 cells kinetics pkc depletion slightly preceded disappearance p53 induction observed fig 2a compare lanes 4 9 b consistent inhibition p53 induction due depletion pkc also shown fig 2b cpt induced appearance 40 kda catalytically active fragment pkc 40 kda fragment associated apoptosis catalytic fragment equally depleted tpa pretreatment fig 2b lanes 3 5 15
0.5353734.14699137.html.plaintext.txt	36	view larger version 39k fig 2 tpa inhibits p53 protein stabilization response variety dna damaging agents depletes cells pkc effect tpa dna damage induced increases p53 protein determined western blot analysis p53 protein nuclear extracts ml 1 cells either left untreated treated 10 nm tpa times indicated followed treatment 05 microm cpt 3 h 25 microg nuclear protein resolved electrophoresis 10 sds page transferred nitrocellulose membrane probed mixture p53 specific monoclonal antibodies 240 421 1801 b effect tpa pkc levels determined western blot analysis preparation extract shown cytoplasmic extracts ml 1 cells resolved electrophoresis probed anti human pkc antibody anti actin loading control c effect tpa upon dna damage induced p53 protein levels performed using 5 microm mc lanes 3 4 5 microm dmc lanes 5 6 50 microgml zeocin lanes 7 8 dna damaging agents added 4 h indicated cells pretreated 10 nm tpa 21 h prior addition dna damaging agent d influence tpa level pkc analyzed b e ability tpa regulate p53 stabilization level pkc respectively also analyzed extracts h460 cell line e f cells either left untreated treated cpt 05 microm etoposide 8 microm mc 5 microm 4 h indicated cells pretreated tpa 10 nm 21 h prior addition dna damaging agent blots probed p53 pkc actin b
0.5353734.14699137.html.plaintext.txt	37	pretreatment ml 1 cells tpa also inhibited dna damage mediated induction p53 mc dmc zeocin fig 2c suggesting effect tpa p53 nuclear accumulation able block different dna damage sensor pathways evoked different drugs depletion pkc correlated block p53 accumulation fig 2d cell type specific phenomenon since correlation inhibition p53 accumulation pkc depletion observed h460 cells treated mc dmc zeocin fig 2 e f
0.5353734.14699137.html.plaintext.txt	38	pretreatment ml 1 cells tpa also inhibited dna damage mediated induction p53 mc dmc zeocin fig 2c suggesting effect tpa p53 nuclear accumulation able block different dna damage sensor pathways evoked different drugs depletion pkc correlated block p53 accumulation fig 2d cell type specific phenomenon since correlation inhibition p53 accumulation pkc depletion observed h460 cells treated mc dmc zeocin fig 2 e f
0.5353734.14699137.html.plaintext.txt	39	investigate whether effect tpa p53 p53 dependent apoptosis fact dependent ability tpa regulate pkc took advantage observation bryostatin 1 specifically prevent downregulation pkc tpa certain cell lines specific conditions 9 32 examined effect tpa upon dna damage induced apoptosis mcf 7 human breast cancer cell line also wild type p53 28 shown fig 3a cpt strongly induced parp cleavage completely inhibited tpa pretreatment 24 h importantly effect tpa overcome bryostatin 1 fig 3a bryostatin 1 shown prevent tumor promoting effects tpa number cell lines 9 32 seen fig 3b addition bryostatin 1 mcf 7 cells able reverse tpa mediated depletion pkc additionally tpa mediated inhibition p53 accumulation rescued presence bryostatin 1 thus antiapoptotic effect tpa mcf 7 cells probably due regulation pkc
0.5353734.14699137.html.plaintext.txt	40	investigate whether effect tpa p53 p53 dependent apoptosis fact dependent ability tpa regulate pkc took advantage observation bryostatin 1 specifically prevent downregulation pkc tpa certain cell lines specific conditions 9 32 examined effect tpa upon dna damage induced apoptosis mcf 7 human breast cancer cell line also wild type p53 28 shown fig 3a cpt strongly induced parp cleavage completely inhibited tpa pretreatment 24 h importantly effect tpa overcome bryostatin 1 fig 3a bryostatin 1 shown prevent tumor promoting effects tpa number cell lines 9 32 seen fig 3b addition bryostatin 1 mcf 7 cells able reverse tpa mediated depletion pkc additionally tpa mediated inhibition p53 accumulation rescued presence bryostatin 1 thus antiapoptotic effect tpa mcf 7 cells probably due regulation pkc
0.5353734.14699137.html.plaintext.txt	41	rottlerin compound widely used inhibit pkc 14 16 33 examined effect rottlerin upon dna damage mediated induction p53 ml 1 cells inhibition pkc activity resulted inhibition cptmediated apoptosis indicated lack sub g1 dna content observed florescence activated cell sorting analysis cells treated cpt together rottlerin fig 3c consistent hypothesis pkc required p53 accumulation specific pkc inhibitor rottlerin blocked accumulation p53 response several dnadamaging agents fig 3d inhibition p53 accumulation rottlerin evident cytoplasmic well nuclear extract fig 3 d e demonstrating inhibition p53 accumulation result change p53 transport treatment ml 1 cells conventional pkc isotype specific inhibitor go6976 11 effect p53 induction dna damaging agents data shown indicating regulation conventional pkc isoforms play role effects observed data suggest ability suppress p53 accumulation mediated inhibition pkc
0.5353734.14699137.html.plaintext.txt	42	rottlerin compound widely used inhibit pkc 14 16 33 examined effect rottlerin upon dna damage mediated induction p53 ml 1 cells inhibition pkc activity resulted inhibition cptmediated apoptosis indicated lack sub g1 dna content observed florescence activated cell sorting analysis cells treated cpt together rottlerin fig 3c consistent hypothesis pkc required p53 accumulation specific pkc inhibitor rottlerin blocked accumulation p53 response several dnadamaging agents fig 3d inhibition p53 accumulation rottlerin evident cytoplasmic well nuclear extract fig 3 d e demonstrating inhibition p53 accumulation result change p53 transport treatment ml 1 cells conventional pkc isotype specific inhibitor go6976 11 effect p53 induction dna damaging agents data shown indicating regulation conventional pkc isoforms play role effects observed data suggest ability suppress p53 accumulation mediated inhibition pkc
0.5353734.14699137.html.plaintext.txt	43	stabilization p53 proteosome inhibitors blocked tpa treatment pharmacological inhibition pkc increase level p53 dna damage demonstrated occur post transcriptional level although regulation p53 level transcription observed 34 36 ubiquitin proteosome pathway involved degradation p53 dna damage p53 protein post translationally modified longer targeted degradation 37 levels p53 therefore increased chemically using inhibitors proteosome pathway 4 38 39 reasoned tpa pretreatment cells inhibiting stabilization p53 increased degradation protein chemical inhibition proteosome pathway would able increase p53 levels even cells pretreated tpa however surprisingly observed tpa pretreatment ml 1 cells completely inhibited ability proteosome inhibitor llnl stabilize p53 fig 4a similarly rottlerin also able prevent p53 accumulation induced proteosome inhibition fig 4b implicating requirement pkc synthesis p53 therefore inhibitory effect tpa pkc inhibition p53 protein accumulation apparently due enhanced p53 degradation proteosome mediated proteolysis pathway
0.5353734.14699137.html.plaintext.txt	44	stabilization p53 proteosome inhibitors blocked tpa treatment pharmacological inhibition pkc increase level p53 dna damage demonstrated occur post transcriptional level although regulation p53 level transcription observed 34 36 ubiquitin proteosome pathway involved degradation p53 dna damage p53 protein post translationally modified longer targeted degradation 37 levels p53 therefore increased chemically using inhibitors proteosome pathway 4 38 39 reasoned tpa pretreatment cells inhibiting stabilization p53 increased degradation protein chemical inhibition proteosome pathway would able increase p53 levels even cells pretreated tpa however surprisingly observed tpa pretreatment ml 1 cells completely inhibited ability proteosome inhibitor llnl stabilize p53 fig 4a similarly rottlerin also able prevent p53 accumulation induced proteosome inhibition fig 4b implicating requirement pkc synthesis p53 therefore inhibitory effect tpa pkc inhibition p53 protein accumulation apparently due enhanced p53 degradation proteosome mediated proteolysis pathway
0.5353734.14699137.html.plaintext.txt	45	view larger version 36k fig 4 p53 stabilization proteosome inhibition blocked tpa inhibition pkc effect tpa upon elevated p53 expression induced proteosome inhibitor llnl determined western blot analysis fig 2 nuclear protein prepared ml 1 cells left untreated lane 1 treated 20 microm llnl lanes 3 4 4 h indicated cells preincubated 10 nm tpa 21 h prior addition llnl b effect rottlerin upon elevated p53 expression induced proteosome inhibitor llnl determined nuclear extracts prepared ml 1 cells left untreated lane 1 treated 20 microm llnl lanes 3 4 presence lanes 2 4 absence lanes 1 3 6 microm rottlerin dmso me2so
0.5353734.14699137.html.plaintext.txt	46	basal transcription p53 blocked tpa treatment inhibition pkc light proteosome inhibition data became clear ability tpa suppress p53 accumulation due destabilization protein usually case regulation p53 37 therefore investigated whether tpa regulating p53 transcription ml 1 cells treated tpa increasing times rna extracted northern blot analysis using p53 probe carried clear reduction basal level p53 transcript evident increasing time tpa pretreatment beginning 8 h fig 5a inhibition p53 basal transcription 8 h tpa treatment quantified using taqman quantitative rt pcr fig 5b importantly inhibitory effect tpa p53 maintained cells treated various dna damaging agents data shown slightly greater 50 inhibition p53 mrna levels observed 8 h tpa treatment regulation pkc expression sirna associated attenuation dna damage induced response 14 16 used sipkc additional means confirm requirement pkc basal transcription p53 fig 5c sirna pkc able inhibit level pkc protein 38 determined densitometry scanning western blot analysis basal p53 message monitored quantitative taqman rt pcr inhibited 35 significantly addition tpa pkc inhibitor also blocked p53 transcription fig 5d whereas proteosome inhibitor llnl affect level p53 mrna reduction p53 mrna evident presence llnl pkc inhibitor fig 5d inhibition p53 mrna rottlerin also associated inhibition transcription p53 downstream target genes p21 hdm2 activated presence llnl treatment fig 5d compare lanes 2 4 conventional pkc inhibitor go6976 effect level either p53 p21 induced dna damaging agents data shown indicating inhibition conventional pkc isoforms play role effects tpa observed reduction kinetics message stability presence tpa observed taqman quantitative pcr samples actinomycin d treated cells fig 5e
0.5353734.14699137.html.plaintext.txt	47	basal transcription p53 blocked tpa treatment inhibition pkc light proteosome inhibition data became clear ability tpa suppress p53 accumulation due destabilization protein usually case regulation p53 37 therefore investigated whether tpa regulating p53 transcription ml 1 cells treated tpa increasing times rna extracted northern blot analysis using p53 probe carried clear reduction basal level p53 transcript evident increasing time tpa pretreatment beginning 8 h fig 5a inhibition p53 basal transcription 8 h tpa treatment quantified using taqman quantitative rt pcr fig 5b importantly inhibitory effect tpa p53 maintained cells treated various dna damaging agents data shown slightly greater 50 inhibition p53 mrna levels observed 8 h tpa treatment regulation pkc expression sirna associated attenuation dna damage induced response 14 16 used sipkc additional means confirm requirement pkc basal transcription p53 fig 5c sirna pkc able inhibit level pkc protein 38 determined densitometry scanning western blot analysis basal p53 message monitored quantitative taqman rt pcr inhibited 35 significantly addition tpa pkc inhibitor also blocked p53 transcription fig 5d whereas proteosome inhibitor llnl affect level p53 mrna reduction p53 mrna evident presence llnl pkc inhibitor fig 5d inhibition p53 mrna rottlerin also associated inhibition transcription p53 downstream target genes p21 hdm2 activated presence llnl treatment fig 5d compare lanes 2 4 conventional pkc inhibitor go6976 effect level either p53 p21 induced dna damaging agents data shown indicating inhibition conventional pkc isoforms play role effects tpa observed reduction kinetics message stability presence tpa observed taqman quantitative pcr samples actinomycin d treated cells fig 5e
0.5353734.14699137.html.plaintext.txt	48	view larger version 33k fig 5 basal transcription p53 rna blocked tpa treatment inhibition pkc effect tpa upon level p53 rna ml 1 cells examined northern blot analysis total rna isolated exponentially growing ml 1 cells either left untreated lane 1 treated 10 nm tpa various times indicated 10 microg total rna resolved denaturing formaldehyde gel transferred electrophoretically nylon membrane probed p53 18 rrna used loading control b basal human p53 mrna level also examined quantitative rt pcr analysis using applied biosystems taqman assays demand p53 primer set ml 1 cells either left untreated control treated 10 nm tpa 8 h c inhibition pkc sirna effect p53 gene transcription examined quantitative rt pcr analysis p53 mrna histogram b well western blot analysis pkc protein level inset h460 cell line transfected sirna pkc h460 cells transfected described materials methods either sirna gfp mrna pkc mrna indicated data representative four independent experiments d effect llnl rottlerin p53 p21 hdm2 glyceraldehyde 3 phosphate dehydrogenase rna levels northern blot analysis ml 1 total rna exponentially growing ml 1 cells either left untreated lane 1 treated 20 microm llnl 4 h presence lane 4 absence lane 2 6 microm rottlerin added time shown 50 microg total rna resolved denaturing formaldehyde gel transferred electrophoretically nylon membrane probed p53 p21 hdm2 glyceraldehyde 3 phosphate dehydrogenase gapdh e determine whether tpa interfered stability p53 mrna ml 1 cells cells treated actinomycin d ml 1 cells either left untreated control treated tpa 10 nm 5 h time 0 h control tpa treated cells treated actinomycin d 10 microgml aliquots harvested 2 4 6 8 h treatment actinomycin d data representative four independent experiments total rna extracted analyzed b
0.5353734.14699137.html.plaintext.txt	49	next examined effect pkc inhibition upon gene expression p53 promoter studies regulation p53 promoter activation plentiful however demonstrated numerous transcription factors influence human p53 transcription including ap 1 hoxa5 yy1 nf b myc 40 using human p53 promoter luciferase construct containing region previously shown regulated mentioned transcription factors 34 examined influence inhibiting pkc activity p53 promoter activity transient transfection experiments carried h1299 cells endogenous p53 observed dominant negative pkc construct able inhibit transcription p53 promoter fig 6a whereas construct inhibit transcription p53 dependent mdm2 p2 promoter either presence absence exogenous p53 protein fig 6b similar results observed k562 cells data shown expressed pkc tagged gfp allowing us monitor transfection efficiency experiments greater 90 data normalized renilla expression data indicate pkc activity plays important role initiation p53 transcription
0.5353734.14699137.html.plaintext.txt	50	next examined effect pkc inhibition upon gene expression p53 promoter studies regulation p53 promoter activation plentiful however demonstrated numerous transcription factors influence human p53 transcription including ap 1 hoxa5 yy1 nf b myc 40 using human p53 promoter luciferase construct containing region previously shown regulated mentioned transcription factors 34 examined influence inhibiting pkc activity p53 promoter activity transient transfection experiments carried h1299 cells endogenous p53 observed dominant negative pkc construct able inhibit transcription p53 promoter fig 6a whereas construct inhibit transcription p53 dependent mdm2 p2 promoter either presence absence exogenous p53 protein fig 6b similar results observed k562 cells data shown expressed pkc tagged gfp allowing us monitor transfection efficiency experiments greater 90 data normalized renilla expression data indicate pkc activity plays important role initiation p53 transcription
0.5353734.14699137.html.plaintext.txt	51	view larger version 9k fig 6 regulation pkc specifically inhibits transcription p53 promoter p53 promoter activation investigated transient transfection h1299 cells lack p53 p53 hp1 luc plasmid provided david reisman h1299 cells transiently transfected described materials methods p53 hp1 luc luciferase reporter driven human p1 p53 promoter indicated cells cotransfected increasing concentration dominant negative mutant gfp pkc pkc k r kinase negative mutant lysine residue position 378 putative atp binding site substituted arginine site directed mutagenesis extracts prepared according manufacturer assay system firefly luciferase expression monitored data p53 hp1 luc represent luciferase activity normalized co transfected renilla reporter expression b specificity pkc k r p53 promoter tested examining effect mdm2 p2 promoter h1299 cells either transfected human mdm2 p2 p53 specific promoter driving luciferase mdm2 luc cotransfected wild type p53 expressing sn3 plasmid presence increasing concentrations gfp pkc k r plasmid protein extracts analyzed presented luciferase activity relative mdm2 luc transfected cells normalized renilla
0.5353734.14699137.html.plaintext.txt	52	discussion top abstract introduction materials methods results discussion references agents environment often associated promotion tumor formation however none shown directly inhibit transcription p53 gene document dna damage induced increase p53 accumulation mediated cpt mc etoposide zeocin dramatically inhibited pretreatment cells tumor promoter tpa additionally pkc inhibitor rottlerin also able block dna damage mediated induction p53 drugs significantly show pretreatment cells tpa treatment rottlerin results inhibition basal p53 transcription therefore accumulation p53 could achieved means including proteosome inhibition tpa rottlerin treatment p53 transcription blocked
0.5353734.14699137.html.plaintext.txt	53	discussion top abstract introduction materials methods results discussion references agents environment often associated promotion tumor formation however none shown directly inhibit transcription p53 gene document dna damage induced increase p53 accumulation mediated cpt mc etoposide zeocin dramatically inhibited pretreatment cells tumor promoter tpa additionally pkc inhibitor rottlerin also able block dna damage mediated induction p53 drugs significantly show pretreatment cells tpa treatment rottlerin results inhibition basal p53 transcription therefore accumulation p53 could achieved means including proteosome inhibition tpa rottlerin treatment p53 transcription blocked
0.5353734.14699137.html.plaintext.txt	54	agreement previously proposed models results support idea pkc involved tumor suppressor pathway involves p53 19 recently role pkc accumulation p53 induction apoptosis bovine endothelial cells shown 41 additionally shown previously tumor promoting phorbol ester 4 phorbol 12 myristate 13 acetate transiently modulated p53 mrna levels 42 using sirna inactivate pkc demonstrated direct requirement pkc controlling basal human p53 transcription addition demonstrating tpa treatment decrease p53 message stability used dominant negative pkc co transfection studies extend analysis pkc inhibition extension examines p53 promoter regulation results show initiation transcription p53 promoter blocked inhibition pkc whereas studies rule additional effect tpa pkc regulation upon p53 protein stability reveal novel mechanism suppressing p53 expression probably contributes tumor promotion phorbol esters fact preliminary data show tpa increase level mdm2 protein mdm2 mrna remains constant2 suggests additional mechanism also present efficiently eliminate existing p53
0.5353734.14699137.html.plaintext.txt	55	agreement previously proposed models results support idea pkc involved tumor suppressor pathway involves p53 19 recently role pkc accumulation p53 induction apoptosis bovine endothelial cells shown 41 additionally shown previously tumor promoting phorbol ester 4 phorbol 12 myristate 13 acetate transiently modulated p53 mrna levels 42 using sirna inactivate pkc demonstrated direct requirement pkc controlling basal human p53 transcription addition demonstrating tpa treatment decrease p53 message stability used dominant negative pkc co transfection studies extend analysis pkc inhibition extension examines p53 promoter regulation results show initiation transcription p53 promoter blocked inhibition pkc whereas studies rule additional effect tpa pkc regulation upon p53 protein stability reveal novel mechanism suppressing p53 expression probably contributes tumor promotion phorbol esters fact preliminary data show tpa increase level mdm2 protein mdm2 mrna remains constant2 suggests additional mechanism also present efficiently eliminate existing p53
0.5353734.14699137.html.plaintext.txt	56	results raise several important questions regarding tumor promoters might regulate initiation p53 transcription suggest model dna damage presence tumor promoters could result malignant transformation fig 7 versus b repression p53 promoter suggested mechanism tumor promotion 34 43 damaged genes tumor cells usually thought mechanistic drivers toward oncogenesis however regulation endogenous genes specifically tumor suppressors may also key regulatory mechanism resulting tumor promotion data provide transcriptional repression mechanism tumor promotion tpa predict agents interfere activity pkc may inhibit p53 responses begun compare dna binding activity transcription factors known bind p53 promoter extracts cells inactivation pkc presently found dna binding activity transcription factor inhibited confirmed previous finding nf b activated tpa treatment cell lines tested3 continued promoter studies progress search either repressor activator involved p53 transcription may regulated pkc one possibility ets 2 protein binding site protein p53 promoter pkc regulates level ets 2 protein 44
0.5353734.14699137.html.plaintext.txt	57	view larger version 19k fig 7 inhibition pkc promotes malignant transformation inhibition basal p53 transcription dna damage activates pathway stabilize p53 thus initiate growth arrest apoptosis b dna damage presence inhibition pkc unable activate p53 stabilization p53 mrna reduced resulting p53 protein therefore genomic instability malignant transformation result
0.5353734.14699137.html.plaintext.txt	58	since activating p53 apoptotic pathway checkpoint used cells avoid mutations damaged dna target many chemotherapeutic regimes possible agents pkc activating properties may provide synergistic cytotoxic activity conversely agents pkc inactivating potential may drastically reduce chemotherapeutic drug efficacy regard interest bryostatin 1 clinical trials several cancers 45 modulates activity pkc isoforms may antineoplastic properties bryostatin 1 due effects upon pkc findings demonstrate focusing transcriptional regulation p53 presents novel targeted approach war cancer highlights possibility agents environment may adversely affect p53 pathway inhibiting transcription tumor suppressor genes
0.5353734.14699137.html.plaintext.txt	59	since activating p53 apoptotic pathway checkpoint used cells avoid mutations damaged dna target many chemotherapeutic regimes possible agents pkc activating properties may provide synergistic cytotoxic activity conversely agents pkc inactivating potential may drastically reduce chemotherapeutic drug efficacy regard interest bryostatin 1 clinical trials several cancers 45 modulates activity pkc isoforms may antineoplastic properties bryostatin 1 due effects upon pkc findings demonstrate focusing transcriptional regulation p53 presents novel targeted approach war cancer highlights possibility agents environment may adversely affect p53 pathway inhibiting transcription tumor suppressor genes
0.5353734.14699137.html.plaintext.txt	60	footnotes work supported part national science foundation grant mcb 9722262 j b nci national institutes health nih grant ca46677 d f work also supported national center research resources nih research centers minority institutions award rr 03037 supports infrastructure instrumentation biological sciences department hunter college costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5353734.14699137.html.plaintext.txt	61	supported nih score grant gm60754
0.5353734.14699137.html.plaintext.txt	62	correspondence addressed institute biomolecular structure function department biological sciences hunter college graduate school city university new york 695 park ave new york ny 10021 e mail bargonettiatgenectrhuntercunyedu u d
0.5353734.14699137.html.plaintext.txt	63	1 abbreviations used tpa 12 o tetradecanoylphorbol 13 acetate cpt camptothecin dmc 10 decarbomyl mitomycin c mc mitomycin c parp polyadp ribose polymerase pkc protein kinase c sirna small interfering rna llnl n acetyl leu leu norleu al rt reverse transcriptase gfp green fluorescent protein
0.5353734.14699137.html.plaintext.txt	64	acknowledgments thank david reisman p53 promoter luciferase plasmid p53 hp1 luc donald kufe reagents maria tomasz dmc grateful desmond jackson advice concerning pkc experiments extend thanks benjamin ortiz carol prives david reisman critical comments manuscript
0.5353734.14699137.html.plaintext.txt	65	acknowledgments thank david reisman p53 promoter luciferase plasmid p53 hp1 luc donald kufe reagents maria tomasz dmc grateful desmond jackson advice concerning pkc experiments extend thanks benjamin ortiz carol prives david reisman critical comments manuscript
0.5353734.14699137.html.plaintext.txt	66	references top abstract introduction materials methods results discussion references bargonetti j manfredi j j 2002 curr opin oncol 14 86 91crossrefmedline order article via infotrieve vogelstein b lane d levine j 2000 nature 408 307 310crossrefmedline order article via infotrieve nigro j m baker j presinger c jessup j m hostetter r cleary k bigner h davidson n baylin devilee p glover collins f weston modali r harris c c vogelstein b 1989 nature 342 705 708crossrefmedline order article via infotrieve shieh y ikeda m taya y prives c 1997 cell 91 325 334medline order article via infotrieve oren m damalas gottlieb michael d taplick j leal j f maya r moas m seger r taya y ben zeev 2002 biochem pharmacol 64 865 871crossrefmedline order article via infotrieve donehower l harvey m slagle b l mcarthur m j montgomery c jr butel j bradley 1992 nature 356 215 221crossrefmedline order article via infotrieve hansen l monteiro riviere n smart r c 1990 cancer res 50 5740 5745abstract fournier murray w 1987 nature 330 767 769crossrefmedline order article via infotrieve lu z hornia jiang y w zang q ohno foster d 1997 mol cell biol 17 3418 3428abstract lu z liu d hornia devonish w pagano m foster d 1998 mol cell biol 18 839 845abstractfree full text hornia lu z sukezane zhong m joseph frankel p foster d 1999 mol cell biol 19 7672 7680abstractfree full text zhong m lu z foster d 2002 oncogene 21 1071 1078crossrefmedline order article via infotrieve reddig p j dreckschmidt n e ahrens h simsiman r tseng c p zou j oberley d verma k 1999 cancer res 59 5710 5718abstractfree full text yoshida k miki y kufe d 2002 j biol chem 277 48372 48378abstractfree full text ren j datta r shioya h li y oki e biedermann v bharti kufe d 2002 j biol chem 277 33758 33765abstractfree full text basu woolard m d johnson c l 2001 cell death differ 8 899 908crossrefmedline order article via infotrieve lowe w ruley h e jacks housman d e 1993 cell 74 957 967medline order article via infotrieve magnelli l cinelli m chiarugi v 1995 biochem biophys res commun 215 641 645crossrefmedline order article via infotrieve magnelli l cinelli m chiarugi v 1998 biochem biophys res commun 249 222 225crossrefmedline order article via infotrieve ghosh j c suzuki k kodama watanabe m 1999 j radiat res tokyo 40 23 37crossrefmedline order article via infotrieve heit wieser r j herget faust d borchert stuhltrager m oesch f dietrich c 2001 oncogene 20 5143 5154crossrefmedline order article via infotrieve kim y rockwell 1995 oncol res 7 39 47 su f overholtzer m besser d levine j 2002 genes dev 16 46 57abstractfree full text dignam j d martin p l shastry b roeder r g 1983 methods enzymol 101 582 598medline order article via infotrieve kern e pietenpol j thiagalingam seymour kinzler k w vogelstein b 1992 science 256 827 830medline order article via infotrieve durland busbice reisman d 2002 leukemia 16 2165 2167crossrefmedline order article via infotrieve kastan m b radin kuerbitz j onyekwere o wolkow c civin c stone k d woo ravindranath craig r w 1991 cancer res 51 4279 4286abstract ramet m castren k jarvinen k pekkala k turpeenniemi hujanen soini y paakko p vahakangas k 1995 carcinogenesis 16 2117 2124abstract law j c ritke m k yalowich j c leder g h ferrell r e 1993 leuk res 17 1045 1050medline order article via infotrieve lazebnik y kaufmann h desnoyers poirier g g earnshaw w c 1994 nature 371 346 347crossrefmedline order article via infotrieve abbas olivier m lopez j houser xiao g kumar g tomasz m bargonetti j 2002 j biol chem 277 40513 40519abstractfree full text szallasi z denning m f smith c b dlugosz yuspa h pettit g r blumberg p m 1994 mol pharmacol 46 840 850abstract gschwendt m muller h j kielbassa k zang r kittstein w rincke g marks f 1994 biochem biophys res commun 199 93 98crossrefmedline order article via infotrieve raman v martensen reisman d evron e odenwald w f jaffee e marks j sukumar 2000 nature 405 974 978crossrefmedline order article via infotrieve kirch h c flaswinkel rumpf h brockmann d esche h 1999 oncogene 18 2728 2738crossrefmedline order article via infotrieve maltzman w czyzyk l 1984 mol cell biol 4 1689 1694medline order article via infotrieve ashcroft m taya y vousden k h 2000 mol cell biol 20 3224 3233abstractfree full text siliciano j d canman c e taya y sakaguchi k appela e kastan m b 1997 genes dev 11 3471 3481abstractfree full text chernov m v bean l j lerner n stark g r 2001 j biol chem 276 31819 31824abstractfree full text reisman d loging w 1998 semin cancer biol 8 317 324medline order article via infotrieve niwa k inanami o yamamori ohta hamasu karino kuwabara m 2002 free radic res 36 1147 1153crossrefmedline order article via infotrieve skouv j jensen p o forchhammer j larsen j k lund l r 1994 cell growth differ 5 329 340abstract stuart e haffner r oren m gruss p 1995 embo j 14 5638 5645abstract fujiwara fisher r j bhat n k diaz de la espina m papas 1988 mol cell biol 8 4700 4706medline order article via infotrieve clamp jayson g c 2002 anticancer drugs 13 673 683crossrefmedline order article via infotrieve
0.542364.11859067.html.plaintext.txt	0	accelerated publication p53 binds telomeric single strand overhangs loop junctions vitro rachel m stansel deepa subramanian jack d griffith
0.542364.11859067.html.plaintext.txt	1	accelerated publication p53 binds telomeric single strand overhangs loop junctions vitro rachel m stansel deepa subramanian jack d griffith
0.542364.11859067.html.plaintext.txt	2	lineberger comprehensive cancer center university north carolina chapel hill north carolina 27599 7295
0.542364.11859067.html.plaintext.txt	3	received publication december 27 2001 revised form february 15 2002
0.542364.11859067.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references
0.542364.11859067.html.plaintext.txt	5	interaction p53 human model telomere vitro examined electron microscopy p53 demonstrated sequence independent affinity telomeric dna vitro localizing 3 single strand overhang loop junction presence absence associated trf2 binding observed background along duplex telomeric repeats however efficiency trf2 catalyzed loop formation model dna increased 2 fold presence p53 although variety single strand holliday junction binding proteins facilitate loop formation results suggest p53 active role telomere maintenance structure association loop junction introduction top abstract introduction experimental procedures results discussion references
0.542364.11859067.html.plaintext.txt	6	interaction p53 human model telomere vitro examined electron microscopy p53 demonstrated sequence independent affinity telomeric dna vitro localizing 3 single strand overhang loop junction presence absence associated trf2 binding observed background along duplex telomeric repeats however efficiency trf2 catalyzed loop formation model dna increased 2 fold presence p53 although variety single strand holliday junction binding proteins facilitate loop formation results suggest p53 active role telomere maintenance structure association loop junction introduction top abstract introduction experimental procedures results discussion references
0.542364.11859067.html.plaintext.txt	7	recent studies implicated several proteins required dna damage recognition repair telomere maintenance mammalian protein ku binds double strand ds1 ends central ds break repair shown bind telomeric dna directly 1 2 associate two duplex telomere repeat binding factors trf1 trf2 3 4 saccharomyces cerevisiae yeast homolog yku required proper telomere function 5 recent studies tong et al 6 revealed tumor suppressor protein p53 involved maintenance telomeric tract length mice observed although level telomere associated fluorescence p53 mouse embryo fibroblasts equivalent wild type cells increased heterogeneity telomere lengths telomeres longer seen wild type cells whereas others short lost entirely shortened telomeres resulted high frequency telomere telomere fusions
0.542364.11859067.html.plaintext.txt	8	recent studies implicated several proteins required dna damage recognition repair telomere maintenance mammalian protein ku binds double strand ds1 ends central ds break repair shown bind telomeric dna directly 1 2 associate two duplex telomere repeat binding factors trf1 trf2 3 4 saccharomyces cerevisiae yeast homolog yku required proper telomere function 5 recent studies tong et al 6 revealed tumor suppressor protein p53 involved maintenance telomeric tract length mice observed although level telomere associated fluorescence p53 mouse embryo fibroblasts equivalent wild type cells increased heterogeneity telomere lengths telomeres longer seen wild type cells whereas others short lost entirely shortened telomeres resulted high frequency telomere telomere fusions
0.542364.11859067.html.plaintext.txt	9	telomere specific protein trf2 plays central role concealing telomere ends ds break recognition repair factors 7 8 expression dominant negative allele trf2 cultured human cells triggers changes typical induced ds breaks loss 3 single strand ss overhang induction end end chromosome fusions 8 induction apoptosis p53atm dependent dna damage checkpoint pathway 7 induction p53 dependent dna replication suggesting inhibition trf2 function telomeres signals p53 directly
0.542364.11859067.html.plaintext.txt	10	telomere specific protein trf2 plays central role concealing telomere ends ds break recognition repair factors 7 8 expression dominant negative allele trf2 cultured human cells triggers changes typical induced ds breaks loss 3 single strand ss overhang induction end end chromosome fusions 8 induction apoptosis p53atm dependent dna damage checkpoint pathway 7 induction p53 dependent dna replication suggesting inhibition trf2 function telomeres signals p53 directly
0.542364.11859067.html.plaintext.txt	11	recent studies telomere architecture provide possible structural solution telomere ends hidden dna break repairrecognition factors studies showed mammalian telomeres arranged large duplex loops vivo loops 9 formation loops vitro requires trf2 telomeric junction consists 3 ss overhang least one ttaggg repeat adjacent ds portion telomere 10 termini micronuclear chromosomes oxytricha nova 11 telomeres trypanosoma brucei minichromosomes 12 telomeres pisum sativum2 shown form looped structures vivo whereas cerevisiae telomeres appear form fold back structures 13 15 plausible telomeric looping common mechanism protecting termini linear chromosomes
0.542364.11859067.html.plaintext.txt	12	recent studies telomere architecture provide possible structural solution telomere ends hidden dna break repairrecognition factors studies showed mammalian telomeres arranged large duplex loops vivo loops 9 formation loops vitro requires trf2 telomeric junction consists 3 ss overhang least one ttaggg repeat adjacent ds portion telomere 10 termini micronuclear chromosomes oxytricha nova 11 telomeres trypanosoma brucei minichromosomes 12 telomeres pisum sativum2 shown form looped structures vivo whereas cerevisiae telomeres appear form fold back structures 13 15 plausible telomeric looping common mechanism protecting termini linear chromosomes
0.542364.11859067.html.plaintext.txt	13	proposed loop structure formed strand invasion g rich ss overhang preceding duplex ttaggg tract 9 10 invasion would generate d loop would effectively hide natural end dna protect machinery scans dna broken ends addition recent data support possibility portion c rich strand ssds telomeric junction may also invade duplex resulting formation holliday junction like structure base loop fig 1a 10 p53 tightly binds holliday junctions vitro enhances resolution junction cleaving enzymes 16 p53 strong affinity ss dna 17 would presumably bind ss telomeric overhang telomere affinity p53 structures points importance investigating p53 binding telomeric overhang loop junction well examining influence p53 loop assembly trf2 vitro
0.542364.11859067.html.plaintext.txt	14	proposed loop structure formed strand invasion g rich ss overhang preceding duplex ttaggg tract 9 10 invasion would generate d loop would effectively hide natural end dna protect machinery scans dna broken ends addition recent data support possibility portion c rich strand ssds telomeric junction may also invade duplex resulting formation holliday junction like structure base loop fig 1a 10 p53 tightly binds holliday junctions vitro enhances resolution junction cleaving enzymes 16 p53 strong affinity ss dna 17 would presumably bind ss telomeric overhang telomere affinity p53 structures points importance investigating p53 binding telomeric overhang loop junction well examining influence p53 loop assembly trf2 vitro
0.542364.11859067.html.plaintext.txt	15	using electron microscopy em found p53 present loop junction presence absence associated trf2 addition localization p53 3 ss overhang observed trf2 mediated loop formation increased 2 fold model telomere dna addition p53 studies suggest p53 may involved maintenance telomere structure experimental procedures top abstract introduction experimental procedures results discussion references
0.542364.11859067.html.plaintext.txt	16	using electron microscopy em found p53 present loop junction presence absence associated trf2 addition localization p53 3 ss overhang observed trf2 mediated loop formation increased 2 fold model telomere dna addition p53 studies suggest p53 may involved maintenance telomere structure experimental procedures top abstract introduction experimental procedures results discussion references
0.542364.11859067.html.plaintext.txt	17	dna substrates proteins model telomere contains 3 kb plasmid sequences followed 576 bp duplex telomeric dna terminates 54 nt telomeric overhang 5 ttaggg9 3 10 overhang removed treatment mung bean nuclease create telomeric tract terminates blunt end 10 linear dna substrates containing 576 bp tract located internally generated cleavage prst5 plasmid afliii new england biolabs inc beverly ma placing 334 bp 5 end 2597 bp 3 end
0.542364.11859067.html.plaintext.txt	18	dna substrates proteins model telomere contains 3 kb plasmid sequences followed 576 bp duplex telomeric dna terminates 54 nt telomeric overhang 5 ttaggg9 3 10 overhang removed treatment mung bean nuclease create telomeric tract terminates blunt end 10 linear dna substrates containing 576 bp tract located internally generated cleavage prst5 plasmid afliii new england biolabs inc beverly ma placing 334 bp 5 end 2597 bp 3 end
0.542364.11859067.html.plaintext.txt	19	human p53 protein overexpressed sf9 cells using vector provided dr arnold levine purified described previously 18 tagged trf2 protein overexpressed sf9 cells using vector provided dr titia de lange purified described previously 19 escherichia coli ssb purified described previously 20 t4 gene 32 protein gift dr nancy nossal human rpa gift dr louise chow human msh 26 protein overexpressed sf9 cells using vector provided dr richard fishel purified described previously 21 hmgiy bacterial plasmid provided dr beverly emerson protein purified described previously 22
0.542364.11859067.html.plaintext.txt	20	human p53 protein overexpressed sf9 cells using vector provided dr arnold levine purified described previously 18 tagged trf2 protein overexpressed sf9 cells using vector provided dr titia de lange purified described previously 19 escherichia coli ssb purified described previously 20 t4 gene 32 protein gift dr nancy nossal human rpa gift dr louise chow human msh 26 protein overexpressed sf9 cells using vector provided dr richard fishel purified described previously 21 hmgiy bacterial plasmid provided dr beverly emerson protein purified described previously 22
0.542364.11859067.html.plaintext.txt	21	binding p53 telomeric dna examine binding p53 telomeric dna 25 ng dna incubated purified p53 ratio 2 8 tetramers p53 per dna molecule buffer containing 20 mm hepes ph 75 50 mm kcl 20 min room temperature complexes fixed adding glutaraldehyde final concentration 06 5 min room temperature followed chromatography 2 ml column bio gel 5m bio rad equilibrated 10 mm tris ph 75 1 mm edta samples mixed buffer containing spermidine adsorbed glow charged thin carbon foils dehydrated series waterethanol washes rotary shadow cast tungsten described previously 9
0.542364.11859067.html.plaintext.txt	22	binding p53 telomeric dna examine binding p53 telomeric dna 25 ng dna incubated purified p53 ratio 2 8 tetramers p53 per dna molecule buffer containing 20 mm hepes ph 75 50 mm kcl 20 min room temperature complexes fixed adding glutaraldehyde final concentration 06 5 min room temperature followed chromatography 2 ml column bio gel 5m bio rad equilibrated 10 mm tris ph 75 1 mm edta samples mixed buffer containing spermidine adsorbed glow charged thin carbon foils dehydrated series waterethanol washes rotary shadow cast tungsten described previously 9
0.542364.11859067.html.plaintext.txt	23	generation loops electron microscopy loops formed model dna trf2 previously described 10 protein free loops generated cross linking dna 4 aminomethyltrioxsalen amt sigma uv light followed treatment 05 sds 05 mgml proteinase k 15 min 37 degrees c dna purified chromatography 2 ml column bio gel 5m equilibrated 10 mm tris ph 75 1 mm edta absence residual trf2 verified em
0.542364.11859067.html.plaintext.txt	24	generation loops electron microscopy loops formed model dna trf2 previously described 10 protein free loops generated cross linking dna 4 aminomethyltrioxsalen amt sigma uv light followed treatment 05 sds 05 mgml proteinase k 15 min 37 degrees c dna purified chromatography 2 ml column bio gel 5m equilibrated 10 mm tris ph 75 1 mm edta absence residual trf2 verified em
0.542364.11859067.html.plaintext.txt	25	samples examined philips em400 cm12 instrument micrographs scanned negatives using nikon 4500af multiformat film scanner contrast optimized panels arranged using adobe photoshop location p53 binding dna molecules measured using phillips cm 12 digital micrograph software gatan inc pleasanton ca
0.542364.11859067.html.plaintext.txt	26	samples examined philips em400 cm12 instrument micrographs scanned negatives using nikon 4500af multiformat film scanner contrast optimized panels arranged using adobe photoshop location p53 binding dna molecules measured using phillips cm 12 digital micrograph software gatan inc pleasanton ca
0.542364.11859067.html.plaintext.txt	27	effect p53 single strand holliday junction binding proteins loop formation dna 100 ng incubated trf2 3 dimers per ttaggg repeat either p53 2 8 tetramers per dna e coli ssb 6 tetramers per dna t4 gene 32 protein 2 heterotrimers per dna human rpa 2 monomers per dna human msh26 2 4 heterodimers per dna hmgiy 5 10 monomers per dna 20 min room temperature buffer containing 20 mm hepes ph 75 50 mm kcl complexes cross linked amtuv deproteinized purified previously described 9 10
0.542364.11859067.html.plaintext.txt	28	effect p53 single strand holliday junction binding proteins loop formation dna 100 ng incubated trf2 3 dimers per ttaggg repeat either p53 2 8 tetramers per dna e coli ssb 6 tetramers per dna t4 gene 32 protein 2 heterotrimers per dna human rpa 2 monomers per dna human msh26 2 4 heterodimers per dna hmgiy 5 10 monomers per dna 20 min room temperature buffer containing 20 mm hepes ph 75 50 mm kcl complexes cross linked amtuv deproteinized purified previously described 9 10
0.542364.11859067.html.plaintext.txt	29	immunological electron microscopy examine binding p53 loops presence trf2 proteins incubated model telomere dna 20 mm hepes ph 75 50 mm kcl 20 min room temperature complexes incubated polyclonal rabbit igg raised p53 05 microl cell signaling technology beverly ma 30 min room temperature gold conjugated protein 10 nm particles 05 microl amersham biosciences added additional 30 min room temperature followed fixation preparation em described results top abstract introduction experimental procedures results discussion references
0.542364.11859067.html.plaintext.txt	30	immunological electron microscopy examine binding p53 loops presence trf2 proteins incubated model telomere dna 20 mm hepes ph 75 50 mm kcl 20 min room temperature complexes incubated polyclonal rabbit igg raised p53 05 microl cell signaling technology beverly ma 30 min room temperature gold conjugated protein 10 nm particles 05 microl amersham biosciences added additional 30 min room temperature followed fixation preparation em described results top abstract introduction experimental procedures results discussion references
0.542364.11859067.html.plaintext.txt	31	p53 binds loop junction high affinity recent data support model loop junction strands insert form holliday junction like structure fig 1a 10 interest examine ability p53 bind loop structures loops generated incubation model telomere trf2 stabilization amtuv photocross linking protein removal see experimental procedures 9 p53 incubated purified dna resulting complexes examined em purified dna contained looped 10 plus minus 3 n 100sample three experiments unlooped 90 plus minus 3 n 100sample three experiments molecules overall 59 plus minus 21 n 100sample three experiments input dna bound p53 p53 binding occurred one end dna internally along duplex repeats loop junction p53 bound non looped species showed strong preference dna ends fig 2 b see loops observed 88 plus minus 11 n 100sample three experiments showed p53 bound exclusively loop junction junction loop linear tail fig 2 c d mass p53 complex loop junction appeared consistent presence one two tetramers small portion molecules containing larger complexes similarly trf2 incubated deproteinized cross linked dna binding observed exclusively loop junction 100 plus minus 1 n 100sample three experiments trf1 however rarely bound junction binding instead along telomeric tract data shown results demonstrate p53 high affinity loop junction
0.542364.11859067.html.plaintext.txt	32	view larger version 12k fig 1 loop models diagram loop form g rich strand overhang portion c rich strand invaded duplex repeat region form holliday junction like structure b model telomere dna used study 10 consists 3 kb plasmid segment followed 576 bp duplex ttaggg repeats terminates 54 nt 3 overhang
0.542364.11859067.html.plaintext.txt	33	view larger version 208k fig 2 visualization binding p53 model telomere dna loops dna assembled loops trf2 stabilized cross linking deproteinized incubated p53 samples prepared em fixation air drying rotary shadow casting tungsten see experimental procedures p53 associated dna end higher frequency along duplex dna tract b p53 localized high specificity loop junction c d reverse contrast used bar equivalent 1 kb
0.542364.11859067.html.plaintext.txt	34	p53 bind telomeric dna sequence dependent manner based observation p53 binds loop junction interest determine whether association p53 loop sequence specific shown p53 capable associating dna sequence dependent reviewed refs 23 25 sequence independent manner 26 27 electrophoretic mobility shift assays em used examine affinity p53 duplex ttaggg repeat tracts well model telomere containing duplex tract adjacent ss 3 overhang containing ttaggg repeats electrophoretic mobility shift assays performed p53 200 bp dna fragment consisting tandem ttaggg repeats even input ratio 30 tetramers per dna molecule p53 showed low binding easily competed nonspecific dna data shown
0.542364.11859067.html.plaintext.txt	35	p53 bind telomeric dna sequence dependent manner based observation p53 binds loop junction interest determine whether association p53 loop sequence specific shown p53 capable associating dna sequence dependent reviewed refs 23 25 sequence independent manner 26 27 electrophoretic mobility shift assays em used examine affinity p53 duplex ttaggg repeat tracts well model telomere containing duplex tract adjacent ss 3 overhang containing ttaggg repeats electrophoretic mobility shift assays performed p53 200 bp dna fragment consisting tandem ttaggg repeats even input ratio 30 tetramers per dna molecule p53 showed low binding easily competed nonspecific dna data shown
0.542364.11859067.html.plaintext.txt	36	association p53 telomeric repeats examined em p53 incubated 96 repeat ttaggg tract located center 3 kb dna molecule ratio 20 p53 tetramers per dna molecule 60 input template bound p53 molecule containing one p53 particle location p53 molecules along dna measured micrographs results revealed bound dna 12 p53 located within telomeric tract remaining 88 contained p53 randomly distributed along length dna n 200 observations conclude p53 bind ttaggg repeat tract sequence dependent manner
0.542364.11859067.html.plaintext.txt	37	association p53 telomeric repeats examined em p53 incubated 96 repeat ttaggg tract located center 3 kb dna molecule ratio 20 p53 tetramers per dna molecule 60 input template bound p53 molecule containing one p53 particle location p53 molecules along dna measured micrographs results revealed bound dna 12 p53 located within telomeric tract remaining 88 contained p53 randomly distributed along length dna n 200 observations conclude p53 bind ttaggg repeat tract sequence dependent manner
0.542364.11859067.html.plaintext.txt	38	binding p53 natural telomeric overhang examined em using model telomere containing terminal 576 bp duplex tract adjacent 54 nt 3 ss ttaggg overhang fig 1b see experimental procedures 10 p53 shown bind ss dna high affinity non telomeric end dna terminated blunt end conditions optimized dna showed one p53 particle bound 20 tetramers per dna see experimental procedures bound molecules 68 plus minus 9 n 100sample three experiments contained p53 localized end dna whereas remainder 32 plus minus 9 bound molecules n 100sample three experiments showed p53 scattered random along length dna fig 2 c d removal 3 overhang decreased fraction end bound p53 6 demonstrating end localization p53 likely association ss overhang based data conclude p53 binds ss telomeric overhang strong affinity
0.542364.11859067.html.plaintext.txt	39	binding p53 natural telomeric overhang examined em using model telomere containing terminal 576 bp duplex tract adjacent 54 nt 3 ss ttaggg overhang fig 1b see experimental procedures 10 p53 shown bind ss dna high affinity non telomeric end dna terminated blunt end conditions optimized dna showed one p53 particle bound 20 tetramers per dna see experimental procedures bound molecules 68 plus minus 9 n 100sample three experiments contained p53 localized end dna whereas remainder 32 plus minus 9 bound molecules n 100sample three experiments showed p53 scattered random along length dna fig 2 c d removal 3 overhang decreased fraction end bound p53 6 demonstrating end localization p53 likely association ss overhang based data conclude p53 binds ss telomeric overhang strong affinity
0.542364.11859067.html.plaintext.txt	40	trf2 mediated loop formation enhanced p53 interest examine effect p53 ability trf2 form loops vitro possible p53 binding ss dna overhang would inhibit loop formation preventing trf2 localizing ssds junction critical step loop assembly 10 alternately binding ss overhang might enhance loop formation facilitating strand invasion event studies others suggested p53 strand transfer activity 28 might either assist trf2 mediated loop formation catalyze loop formation absence trf2 finally p53 may stabilize loops formed binding loop junction either holliday junction like structure displaced ss portion d loop investigate possibilities p53 trf2 incubated together model telomere dna number loops assembled monitored em
0.542364.11859067.html.plaintext.txt	41	trf2 mediated loop formation enhanced p53 interest examine effect p53 ability trf2 form loops vitro possible p53 binding ss dna overhang would inhibit loop formation preventing trf2 localizing ssds junction critical step loop assembly 10 alternately binding ss overhang might enhance loop formation facilitating strand invasion event studies others suggested p53 strand transfer activity 28 might either assist trf2 mediated loop formation catalyze loop formation absence trf2 finally p53 may stabilize loops formed binding loop junction either holliday junction like structure displaced ss portion d loop investigate possibilities p53 trf2 incubated together model telomere dna number loops assembled monitored em
0.542364.11859067.html.plaintext.txt	42	first possible interaction p53 trf2 absence dna examined knowledge evidence association reported p53 trf2 coexpressed sf9 cells immunoprecipitated using standard techniques association detected similarly purified trf2 incubated purified p53 proteins failed coimmunoprecipitate data shown
0.542364.11859067.html.plaintext.txt	43	first possible interaction p53 trf2 absence dna examined knowledge evidence association reported p53 trf2 coexpressed sf9 cells immunoprecipitated using standard techniques association detected similarly purified trf2 incubated purified p53 proteins failed coimmunoprecipitate data shown
0.542364.11859067.html.plaintext.txt	44	trf2 p53 incubated together model telomere dna smaller loops could obscured presence large protein mass junction thus alternative approach scoring looped molecules utilized following assembly complexes dna molecules photocross linked deproteinized prepared em examination using classic surface spreading method cytochrome c see experimental procedures looped structures rarely seen dna absence trf2 3 plus minus 1 n 100sample three experiments treated p53 alone 4 plus minus 1 n 100sample three experiments incubations contained trf2 p53 13 plus minus 3 n 100sample three experiments input dna assembled loops number slightly reduced number loops usually observed 10 likely use buffer optimized binding proteins p53 trf2 added reaction four p53 tetramers per dna three trf2 dimers per ttaggg repeat number loops rose significantly 24 plus minus 3 n 100sample three experiments p 0005 reduction level p53 two p53 tetramers per dna eliminated increase loop assembly 14 plus minus 1 n 100sample two experiments rise efficiency detected either increased levels p53 six eight p53 tetramers per dna 23 plus minus 1 n 100sample two experiments time incubation data shown
0.542364.11859067.html.plaintext.txt	45	trf2 p53 incubated together model telomere dna smaller loops could obscured presence large protein mass junction thus alternative approach scoring looped molecules utilized following assembly complexes dna molecules photocross linked deproteinized prepared em examination using classic surface spreading method cytochrome c see experimental procedures looped structures rarely seen dna absence trf2 3 plus minus 1 n 100sample three experiments treated p53 alone 4 plus minus 1 n 100sample three experiments incubations contained trf2 p53 13 plus minus 3 n 100sample three experiments input dna assembled loops number slightly reduced number loops usually observed 10 likely use buffer optimized binding proteins p53 trf2 added reaction four p53 tetramers per dna three trf2 dimers per ttaggg repeat number loops rose significantly 24 plus minus 3 n 100sample three experiments p 0005 reduction level p53 two p53 tetramers per dna eliminated increase loop assembly 14 plus minus 1 n 100sample two experiments rise efficiency detected either increased levels p53 six eight p53 tetramers per dna 23 plus minus 1 n 100sample two experiments time incubation data shown
0.542364.11859067.html.plaintext.txt	46	one possible explanation increase number loops observed presence trf2 p53 loops may stabilized p53 vitro loops may form dissociate throughout incubation association p53 displaced ss holliday junction like portion loop junction might stabilize looped form thus increasing fraction loops present one time case ss holliday junction binding protein would expected produce effect three ss binding proteins e coli ssb t4 gene 32 protein human rpa separately incubated model dna trf2 loops stabilized amtuv cross linking deproteinized prepared em increase number loops observed addition ssb 14 plus minus 1 n 100sample three experiments t4 gene 32 protein 14 plus minus 4 n 100sample three experiments human rpa 14 plus minus 2 n 100sample three experiments reaction similarly two holliday junction binding proteins human msh26 hmgiy separately incubated model dna trf2 dna prepared em neither msh26 hmgiy showed ability enhance trf2 mediated loop assembly vitro 13 plus minus 2 15 plus minus 1 respectively n 100sample three experiments results suggest specific role p53 loop formationstabilization
0.542364.11859067.html.plaintext.txt	47	one possible explanation increase number loops observed presence trf2 p53 loops may stabilized p53 vitro loops may form dissociate throughout incubation association p53 displaced ss holliday junction like portion loop junction might stabilize looped form thus increasing fraction loops present one time case ss holliday junction binding protein would expected produce effect three ss binding proteins e coli ssb t4 gene 32 protein human rpa separately incubated model dna trf2 loops stabilized amtuv cross linking deproteinized prepared em increase number loops observed addition ssb 14 plus minus 1 n 100sample three experiments t4 gene 32 protein 14 plus minus 4 n 100sample three experiments human rpa 14 plus minus 2 n 100sample three experiments reaction similarly two holliday junction binding proteins human msh26 hmgiy separately incubated model dna trf2 dna prepared em neither msh26 hmgiy showed ability enhance trf2 mediated loop assembly vitro 13 plus minus 2 15 plus minus 1 respectively n 100sample three experiments results suggest specific role p53 loop formationstabilization
0.542364.11859067.html.plaintext.txt	48	p53 may increase numbers loops facilitating loop formation trf2 bound overhang p53 might assist strand invasion process alternately p53 might stabilize assembled loops binding directly loop junction contrasted displaced ss binding overhang responsible increase loops preincubation p53 might expected increase numbers loops formed compared preincubation trf2 instead p53 stabilizes loop junction preincubation p53 would expected enhance loop formation test possibilities p53 trf2 first incubated individually model telomere dna 5 min followed addition second protein 15 min trf2 assembled 13 plus minus 1 n 100sample two experiments dna loops absence p53 dna preincubated p53 followed addition trf2 number loops rose 20 plus minus 7 n 100sample two experiments similarly 19 plus minus 2 n 100sample two experiments dna molecules looped preincubated trf2 followed addition p53 thus order addition p53 trf2 model telomere dna affect ability p53 enhance loop frequency together data suggest p53 dependent increase loop observed em due simply binding p53 ss overhang instead may involve direct role p53 loop formation stabilization
0.542364.11859067.html.plaintext.txt	49	p53 may increase numbers loops facilitating loop formation trf2 bound overhang p53 might assist strand invasion process alternately p53 might stabilize assembled loops binding directly loop junction contrasted displaced ss binding overhang responsible increase loops preincubation p53 might expected increase numbers loops formed compared preincubation trf2 instead p53 stabilizes loop junction preincubation p53 would expected enhance loop formation test possibilities p53 trf2 first incubated individually model telomere dna 5 min followed addition second protein 15 min trf2 assembled 13 plus minus 1 n 100sample two experiments dna loops absence p53 dna preincubated p53 followed addition trf2 number loops rose 20 plus minus 7 n 100sample two experiments similarly 19 plus minus 2 n 100sample two experiments dna molecules looped preincubated trf2 followed addition p53 thus order addition p53 trf2 model telomere dna affect ability p53 enhance loop frequency together data suggest p53 dependent increase loop observed em due simply binding p53 ss overhang instead may involve direct role p53 loop formation stabilization
0.542364.11859067.html.plaintext.txt	50	trf2 exclude p53 binding loop junction larger mass protein present base loop p53 trf2 present reaction suggests proteins capable binding junction simultaneously possibility examined using immunoelectron microscopy trf2 p53 incubated model telomere dna p53 detected addition anti p53 polyclonal rabbit igg followed incubation 10 nm gold particles conjugated protein cross reactivity antibody trf2 seen em western blot hence labeled molecules must contain p53 data shown p53 unable assemble loops absence trf2 previously shown trf2 binds loop junctions looped molecules must also contain trf2 10 loop junctions labeled gold particles therefore presumed contain p53 trf2
0.542364.11859067.html.plaintext.txt	51	trf2 exclude p53 binding loop junction larger mass protein present base loop p53 trf2 present reaction suggests proteins capable binding junction simultaneously possibility examined using immunoelectron microscopy trf2 p53 incubated model telomere dna p53 detected addition anti p53 polyclonal rabbit igg followed incubation 10 nm gold particles conjugated protein cross reactivity antibody trf2 seen em western blot hence labeled molecules must contain p53 data shown p53 unable assemble loops absence trf2 previously shown trf2 binds loop junctions looped molecules must also contain trf2 10 loop junctions labeled gold particles therefore presumed contain p53 trf2
0.542364.11859067.html.plaintext.txt	52	approach 100 individual molecules placed five classes protein free dna 38 dna single protein complex bound end 23 dna single protein complex bound along dna end 7 dna protein bound base loop 14 dna aggregates held together large protein mass 17 class divided molecules gold labeled 20 molecules remained unlabeled 80 studies gold particles observed end bound molecules loops aggregates loops detected 86 labeled gold particles loop junction demonstrating association trf2 p53 fig 3a addition 43 end bound molecules tagged gold labels fig 3b labeled end bound complexes may contain proteins p53 results provide direct evidence presence p53 trf2 bound loop junctions location p53 binding within junction either displaced strand holliday junction like structure could resolved using methods
0.542364.11859067.html.plaintext.txt	53	approach 100 individual molecules placed five classes protein free dna 38 dna single protein complex bound end 23 dna single protein complex bound along dna end 7 dna protein bound base loop 14 dna aggregates held together large protein mass 17 class divided molecules gold labeled 20 molecules remained unlabeled 80 studies gold particles observed end bound molecules loops aggregates loops detected 86 labeled gold particles loop junction demonstrating association trf2 p53 fig 3a addition 43 end bound molecules tagged gold labels fig 3b labeled end bound complexes may contain proteins p53 results provide direct evidence presence p53 trf2 bound loop junctions location p53 binding within junction either displaced strand holliday junction like structure could resolved using methods
0.542364.11859067.html.plaintext.txt	54	view larger version 96k fig 3 p53 localizes loop junction presence trf2 complexes p53 trf2 formed model telomere dna detected addition anti p53 polyclonal rabbit igg followed incubation 10 nm gold particles conjugated protein samples prepared em described fig 2 gold labeling observed loop junction dna ends b reverse contrast used bar equivalent 1 kb discussion top abstract introduction experimental procedures results discussion references
0.542364.11859067.html.plaintext.txt	55	study used purified trf2 p53 model telomere dna examine binding p53 telomeric structures including duplex repeats ss overhang loop junction evidence preferential binding p53 duplex telomeric dna observed p53 bind strongly ss overhang expected based previous studies showing p53 high affinity ss dna 17 p53 also associates loop junction high affinity found cooperate trf2 formation loops model telomere template produced 2 fold increase frequency loops monitored em p53 detected loop junction presence trf2 binding suggesting proteins present complex loop junction
0.542364.11859067.html.plaintext.txt	56	study used purified trf2 p53 model telomere dna examine binding p53 telomeric structures including duplex repeats ss overhang loop junction evidence preferential binding p53 duplex telomeric dna observed p53 bind strongly ss overhang expected based previous studies showing p53 high affinity ss dna 17 p53 also associates loop junction high affinity found cooperate trf2 formation loops model telomere template produced 2 fold increase frequency loops monitored em p53 detected loop junction presence trf2 binding suggesting proteins present complex loop junction
0.542364.11859067.html.plaintext.txt	57	remains possible enhancement trf2 mediated loop formation p53 results interactions overhang junction interactions p53 junction may add stability prevent loop loss vitro loops could lost migration junction along duplex repeat tract dissociation trf2 association ss overhang may facilitate localization trf2 ssds overhang would result increase loop assembly
0.542364.11859067.html.plaintext.txt	58	remains possible enhancement trf2 mediated loop formation p53 results interactions overhang junction interactions p53 junction may add stability prevent loop loss vitro loops could lost migration junction along duplex repeat tract dissociation trf2 association ss overhang may facilitate localization trf2 ssds overhang would result increase loop assembly
0.542364.11859067.html.plaintext.txt	59	several biologically significant roles p53 localization loop junction envisioned normally p53 translocates cytoplasm nucleus g1s transition shuttled back cytoplasm shortly thereafter presence p53 loop junction prior dna replication may promote resolution junction facilitate telomere replication also possible p53 sequestered loop junction allow immediate recognition loss end protection p53 cell cycle arrest apoptosis triggered additionally protein factors may recruited chromosome end interactions p53 factors may essential telomere structure function acknowledgements
0.542364.11859067.html.plaintext.txt	60	several biologically significant roles p53 localization loop junction envisioned normally p53 translocates cytoplasm nucleus g1s transition shuttled back cytoplasm shortly thereafter presence p53 loop junction prior dna replication may promote resolution junction facilitate telomere replication also possible p53 sequestered loop junction allow immediate recognition loss end protection p53 cell cycle arrest apoptosis triggered additionally protein factors may recruited chromosome end interactions p53 factors may essential telomere structure function acknowledgements
0.542364.11859067.html.plaintext.txt	61	thank members griffith laboratory helpful discussion drs arnold levine titia de lange richard fishel beverly emerson providing vectors protein purification drs nancy nossal louise chow providing purified proteins
0.542364.11859067.html.plaintext.txt	62	thank members griffith laboratory helpful discussion drs arnold levine titia de lange richard fishel beverly emerson providing vectors protein purification drs nancy nossal louise chow providing purified proteins
0.542364.11859067.html.plaintext.txt	63	work supported part ellison medical foundation national institutes health grants ca70343 gm31819the costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.542364.11859067.html.plaintext.txt	64	work supported part ellison medical foundation national institutes health grants ca70343 gm31819the costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.542364.11859067.html.plaintext.txt	65	current address dept genetics duke university medical center durham nc 27710
0.542364.11859067.html.plaintext.txt	66	correspondence addressed tel 919 966 8563 fax 919 966 3015 e mail jdgmeduncedu
0.542364.11859067.html.plaintext.txt	67	published jbc papers press february 21 2002 doi 101074jbcc100764200
0.542364.11859067.html.plaintext.txt	68	abbreviations used ds double strand ss single strand em electron microscopy nt nucleotide amt 4 aminomethyltrioxsalen rpa replication protein
0.542364.11859067.html.plaintext.txt	69	references top abstract introduction experimental procedures results discussion references 1 hsu h l gilley d blackburn e h chen d j 1999 proc natl acad sci u 96 12454 12458abstractfree full text 2 bianchi de lange 1999 j biol chem 274 21223 21227abstractfree full text 3 hsu h l gilley d galande hande m p allen b kim h li g c campisi j kohwi shigematsu chen d j 2000 genes dev 14 2807 2812abstractfree full text 4 song k jung d jung y lee g lee 2000 febs lett 481 81 85crossrefmedline order article via infotrieve 5 gravel larrivee m labrecque p wellinger r j 1998 science 280 741 744abstractfree full text 6 tong w m hande m p lansdorp p m wang z q 2001 mol cell biol 21 4046 4054abstractfree full text 7 karlseder j broccoli d dai y hardy de lange 1999 science 283 1321 1325abstractfree full text 8 van steensel b smogorzewska de lange 1998 cell 92 401 413medline order article via infotrieve 9 griffith j d comeau l rosenfield stansel r m bianchi moss h de lange 1999 cell 97 503 514medline order article via infotrieve 10 stansel r m de lange griffith j d 2001 embo j 20 5532 5540abstractfree full text 11 murti k g prescott d m 1999 proc natl acad sci u 96 14436 14439abstractfree full text 12 munoz jordan j l cross g de lange griffith j d 2001 embo j 20 579 588abstractfree full text 13 grunstein m 1997 curr opin cell biol 9 383 387crossrefmedline order article via infotrieve 14 de bruin d kantrow m liberatore r zakian v 2000 mol cell biol 20 7991 8000abstractfree full text 15 de bruin d zaman z liberatore r ptashne m 2001 nature 409 109 113crossrefmedline order article via infotrieve 16 lee cavallo l griffith j 1997 j biol chem 272 7532 7539abstractfree full text 17 jayaraman j prives c 1995 cell 81 1021 1029medline order article via infotrieve 18 wu l bayle j h elenbaas b pavletich n p levine j 1995 mol cell biol 15 497 504abstract 19 bianchi 1999 doctoral dissertation rockefeller university 20 chase j w whittier r f auerbach j sancar rupp w d 1980 nucleic acids res 8 3215 3227abstract 21 nissen m angan reeves r 1991 j biol chem 266 19945 19952abstractfree full text 22 gradia acharya fishel r 1997 cell 91 995 1005medline order article via infotrieve 23 ko l j prives c 1996 genes dev 10 1054 1072crossrefmedline order article via infotrieve 24 levine j 1997 cell 88 323 331medline order article via infotrieve 25 oren m rotter v 1999 cell mol life sci 55 9 11crossrefmedline order article via infotrieve 26 steinmeyer k deppert w 1988 oncogene 3 501 507medline order article via infotrieve 27 kern e kinzler k w bruskin jarosz d friedman p prives c vogelstein b 1991 science 252 1708 1711medline order article via infotrieve 28 bakalkin g yakovleva selivanova g magnusson k p szekely l kiseleva e klein g terenius l wiman k g 1994 proc natl acad sci u 91 413 417abstract
0.542364.11859067.html.plaintext.txt	70	copyright 2002 american society biochemistry molecular biology inc
0.544895.16118209.html.plaintext.txt	0	protein kinase c delta induces apoptosis vascular smooth muscle cells induction tumor suppressor p53 p38 dependent p38 independent mechanisms evan j ryer kenji sakakibara chunjie wang devanand sarkar paul b fisher1 peter l faries k craig kent bo liu2
0.544895.16118209.html.plaintext.txt	1	protein kinase c delta induces apoptosis vascular smooth muscle cells induction tumor suppressor p53 p38 dependent p38 independent mechanisms evan j ryer kenji sakakibara chunjie wang devanand sarkar paul b fisher1 peter l faries k craig kent bo liu2
0.544895.16118209.html.plaintext.txt	2	department surgery division vascular surgery new york presbyterian hospital weill medical college cornell university new york new york 10021 departments pathology neurosurgery urology herbert irving comprehensive cancer center columbia university college physicians surgeons new york new york 10032
0.544895.16118209.html.plaintext.txt	3	received publication july 1 2005 revised form august 11 2005
0.544895.16118209.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references apoptotic death vascular smooth muscle cells smcs prominent feature blood vessel remodeling present study examined novel pkc isoform protein kinase c delta pkc role vascular smc apoptosis a10 smcs overexpression pkc sufficient induce apoptosis whereas inhibition pkc diminished h2o2 induced apoptosis moreover evidence provided tumor suppressor p53 essential mediator pkc induced apoptosis smcs activation pkc led accumulation well phosphorylation p53 smcs induction correlated apoptosis furthermore blocking p53 induction small interference rna targeted gene deletion prevented pkc induced apoptosis whereas restoring p53 expression rescued ability pkc induce apoptosis p53 null smcs also establish pkc regulates p53 transcriptional post translational levels specifically transcriptional regulation required p38 mapk whereas post translational modification least serine 46 involve mapk additionally pkc p38 mapk p53 co associate cells conditions favoring apoptosis together data suggest smc apoptosis proceeds pathway involves pkc intermediary p38 mapk downstream target tumor suppressor p53
0.544895.16118209.html.plaintext.txt	5	abstract top abstract introduction experimental procedures results discussion references apoptotic death vascular smooth muscle cells smcs prominent feature blood vessel remodeling present study examined novel pkc isoform protein kinase c delta pkc role vascular smc apoptosis a10 smcs overexpression pkc sufficient induce apoptosis whereas inhibition pkc diminished h2o2 induced apoptosis moreover evidence provided tumor suppressor p53 essential mediator pkc induced apoptosis smcs activation pkc led accumulation well phosphorylation p53 smcs induction correlated apoptosis furthermore blocking p53 induction small interference rna targeted gene deletion prevented pkc induced apoptosis whereas restoring p53 expression rescued ability pkc induce apoptosis p53 null smcs also establish pkc regulates p53 transcriptional post translational levels specifically transcriptional regulation required p38 mapk whereas post translational modification least serine 46 involve mapk additionally pkc p38 mapk p53 co associate cells conditions favoring apoptosis together data suggest smc apoptosis proceeds pathway involves pkc intermediary p38 mapk downstream target tumor suppressor p53
0.544895.16118209.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references apoptosis vascular smooth muscle cells smcs3 well established component remodeling occurs normal development circulatory system 1 2 well course neointimal formation intervention atherosclerosis 3 5 increased total cellularity prominent feature occluding neointima balance proliferation apoptosis vessel healing appears central pathologic process 6 7 indeed accumulating evidence suggests abnormal smc apoptosis leads neointimal hyperplasia 8 11 however despite importance smc apoptosis precise molecular mechanism underlying regulation apoptotic pathways smcs remains largely undetermined
0.544895.16118209.html.plaintext.txt	7	introduction top abstract introduction experimental procedures results discussion references apoptosis vascular smooth muscle cells smcs3 well established component remodeling occurs normal development circulatory system 1 2 well course neointimal formation intervention atherosclerosis 3 5 increased total cellularity prominent feature occluding neointima balance proliferation apoptosis vessel healing appears central pathologic process 6 7 indeed accumulating evidence suggests abnormal smc apoptosis leads neointimal hyperplasia 8 11 however despite importance smc apoptosis precise molecular mechanism underlying regulation apoptotic pathways smcs remains largely undetermined
0.544895.16118209.html.plaintext.txt	8	apoptosis multistage genetically controlled process selective cell deletion protein kinases regulate early stages apoptosis phosphorylating key proteins 12 13 whereas caspases family cysteine proteases main effectors whose activation results characteristic morphological changes associated programmed cell death membrane blebbing chromatin condensation dna fragmentation 14 15
0.544895.16118209.html.plaintext.txt	9	apoptosis multistage genetically controlled process selective cell deletion protein kinases regulate early stages apoptosis phosphorylating key proteins 12 13 whereas caspases family cysteine proteases main effectors whose activation results characteristic morphological changes associated programmed cell death membrane blebbing chromatin condensation dna fragmentation 14 15
0.544895.16118209.html.plaintext.txt	10	members protein kinase c pkc family activated diverse stimuli participate multiple cellular processes growth differentiation apoptosis 16 novel pkc isoform protein kinase c delta pkc shown associated response dna damage apoptotic stimuli specific cell types 17 20 critical role pkc vascular smc apoptosis pathogenesis neointimal lesion recently demonstrated using pkc knock mice pkc null mice developed exacerbated vein graft intimal lesions contain fewer apoptotic vascular cells compared wild type mice 21 furthermore aortic smcs isolated pkc null mice resistant apoptotic stimuli including h2o2 however mechanism pkc mediates smc apoptosis remains defined
0.544895.16118209.html.plaintext.txt	11	members protein kinase c pkc family activated diverse stimuli participate multiple cellular processes growth differentiation apoptosis 16 novel pkc isoform protein kinase c delta pkc shown associated response dna damage apoptotic stimuli specific cell types 17 20 critical role pkc vascular smc apoptosis pathogenesis neointimal lesion recently demonstrated using pkc knock mice pkc null mice developed exacerbated vein graft intimal lesions contain fewer apoptotic vascular cells compared wild type mice 21 furthermore aortic smcs isolated pkc null mice resistant apoptotic stimuli including h2o2 however mechanism pkc mediates smc apoptosis remains defined
0.544895.16118209.html.plaintext.txt	12	tumor suppressor p53 master regulator cell cycle arrest apoptosis particular important role p53 pathogenesis vascular diseases suggested decreased p53 levels human restenotic 22 atherosclerotic lesions 23 importance p53 also confirmed various animal models adenovirus mediated gene transfer p53 rat carotid arteries inhibited neointimal formation following balloon injury 24 whereas target deletion p53 led larger intimal lesions mouse vein graft model 25
0.544895.16118209.html.plaintext.txt	13	tumor suppressor p53 master regulator cell cycle arrest apoptosis particular important role p53 pathogenesis vascular diseases suggested decreased p53 levels human restenotic 22 atherosclerotic lesions 23 importance p53 also confirmed various animal models adenovirus mediated gene transfer p53 rat carotid arteries inhibited neointimal formation following balloon injury 24 whereas target deletion p53 led larger intimal lesions mouse vein graft model 25
0.544895.16118209.html.plaintext.txt	14	mitogen activated protein kinase mapk p38 shown activated cellular stress uv light radiation growth factor withdrawal pro inflammatory cytokines 26 29 upon activation p38 phosphorylates various transcription factors particular note demonstrated phosphorylate tumor suppressor p53 30 p38 mapk also implicated pro apoptotic anti apoptotic signaling pathways 12 31 however activity likely cell type specific studies focusing predominantly inflammatory cells 32
0.544895.16118209.html.plaintext.txt	15	mitogen activated protein kinase mapk p38 shown activated cellular stress uv light radiation growth factor withdrawal pro inflammatory cytokines 26 29 upon activation p38 phosphorylates various transcription factors particular note demonstrated phosphorylate tumor suppressor p53 30 p38 mapk also implicated pro apoptotic anti apoptotic signaling pathways 12 31 however activity likely cell type specific studies focusing predominantly inflammatory cells 32
0.544895.16118209.html.plaintext.txt	16	report scrutinized precise molecular mechanism pkc induced vascular smc apoptosis provide evidence pkc activation leads accumulationmodification p53 essential induction apoptosis moreover role p38 intermediate pkc induced p53 accumulation apoptosis also demonstrated total studies provide explicit link pkc p38 activation p53 modulation process smc apoptosis findings implications development improved approaches prevention management restenosis
0.544895.16118209.html.plaintext.txt	17	report scrutinized precise molecular mechanism pkc induced vascular smc apoptosis provide evidence pkc activation leads accumulationmodification p53 essential induction apoptosis moreover role p38 intermediate pkc induced p53 accumulation apoptosis also demonstrated total studies provide explicit link pkc p38 activation p53 modulation process smc apoptosis findings implications development improved approaches prevention management restenosis
0.544895.16118209.html.plaintext.txt	18	experimental procedures top abstract introduction experimental procedures results discussion references general materials phorbol 12 myristate 13 acetate pma purchased biomol plymouth meeting pennsylvania dimethyl sulfoxide me2so rottlerin sb20358 h2o2 along chemicals specified purchased sigma dulbeccos modified eagles medium cell culture reagents invitrogen
0.544895.16118209.html.plaintext.txt	19	experimental procedures top abstract introduction experimental procedures results discussion references general materials phorbol 12 myristate 13 acetate pma purchased biomol plymouth meeting pennsylvania dimethyl sulfoxide me2so rottlerin sb20358 h2o2 along chemicals specified purchased sigma dulbeccos modified eagles medium cell culture reagents invitrogen
0.544895.16118209.html.plaintext.txt	20	antibodies rabbit polyclonal antibody pkc mouse monoclonal antibody actin obtained santa cruz biotechnology santa cruz california polyclonal rabbit antibodies cleaved casapase 3 phospho p38 obtained cell signaling technology inc beverly massachusetts biotinylated p53 antibody antibody phosphorylated p53 obtained r d systems minneapolis minnesota
0.544895.16118209.html.plaintext.txt	21	antibodies rabbit polyclonal antibody pkc mouse monoclonal antibody actin obtained santa cruz biotechnology santa cruz california polyclonal rabbit antibodies cleaved casapase 3 phospho p38 obtained cell signaling technology inc beverly massachusetts biotinylated p53 antibody antibody phosphorylated p53 obtained r d systems minneapolis minnesota
0.544895.16118209.html.plaintext.txt	22	smc culture rat aortic a10 smcs obtained american tissue culture collection grown recommended mouse aortic smcs isolated thoracic aorta p53 male mice 33 jackson laboratories bar harbor maine based protocol described clowes et al 34 maintained dulbeccos modified eagles medium containing 10 fetal bovine serum 37 degrees c 5 co2
0.544895.16118209.html.plaintext.txt	23	smc culture rat aortic a10 smcs obtained american tissue culture collection grown recommended mouse aortic smcs isolated thoracic aorta p53 male mice 33 jackson laboratories bar harbor maine based protocol described clowes et al 34 maintained dulbeccos modified eagles medium containing 10 fetal bovine serum 37 degrees c 5 co2
0.544895.16118209.html.plaintext.txt	24	construction adenoviral vectors infection recombinant adenoviral vector constructed express pkc briefly dna fragment containing desired sequence generated pcr using human cdna template following dna sequencing pcr product cloned e1 e3 deficient adenoviral vector peasy adenoviruses propagated hek 293 cells purified cscl density gradient centrifugation recombinant adenovirus encoding wild type p53 protein generous gift enrico ascher 24 35
0.544895.16118209.html.plaintext.txt	25	construction adenoviral vectors infection recombinant adenoviral vector constructed express pkc briefly dna fragment containing desired sequence generated pcr using human cdna template following dna sequencing pcr product cloned e1 e3 deficient adenoviral vector peasy adenoviruses propagated hek 293 cells purified cscl density gradient centrifugation recombinant adenovirus encoding wild type p53 protein generous gift enrico ascher 24 35
0.544895.16118209.html.plaintext.txt	26	apoptosis assay dna fragmentation determined using cell death detection elisa system roche applied science assay based quantitative sandwich enzyme immunoassay principle using mouse monoclonal antibodies directed dna histones activation caspase 3 quantified western blotting using antibody specific cleaved caspase 3
0.544895.16118209.html.plaintext.txt	27	apoptosis assay dna fragmentation determined using cell death detection elisa system roche applied science assay based quantitative sandwich enzyme immunoassay principle using mouse monoclonal antibodies directed dna histones activation caspase 3 quantified western blotting using antibody specific cleaved caspase 3
0.544895.16118209.html.plaintext.txt	28	immunoblotting protein extracts resolved electrophoresis described previously 36 equal amounts protein extracts separated sds page transferred polyvinylidene difluoride membrane blotted antibodies labeled proteins visualized ecl system amersham biosciences
0.544895.16118209.html.plaintext.txt	29	immunoblotting protein extracts resolved electrophoresis described previously 36 equal amounts protein extracts separated sds page transferred polyvinylidene difluoride membrane blotted antibodies labeled proteins visualized ecl system amersham biosciences
0.544895.16118209.html.plaintext.txt	30	transient transfection luciferase activity assay p1 p53 promoter luciferase reporter generous gift david reisman 37 transient transfections luciferase assays performed described previously 38 briefly plasmid dna introduced a10 smcs using superfect qiagen valencia ca transfection cells recovered media containing 10 fetal bovine serum 48 h followed pma 1 microm 12 h experiments 50 ng renilla luciferase construct prl cmv co transfected internal control
0.544895.16118209.html.plaintext.txt	31	transient transfection luciferase activity assay p1 p53 promoter luciferase reporter generous gift david reisman 37 transient transfections luciferase assays performed described previously 38 briefly plasmid dna introduced a10 smcs using superfect qiagen valencia ca transfection cells recovered media containing 10 fetal bovine serum 48 h followed pma 1 microm 12 h experiments 50 ng renilla luciferase construct prl cmv co transfected internal control
0.544895.16118209.html.plaintext.txt	32	antisense oligo antisense oligonucleotide specific rat pkc scrambled control obtained biognostik gottingen germany 200 microm oligo introduced media cultured a10 smcs seeded 18 h earlier equal density efficacy oligo uptake smcs 90 determined using fluorescein isothiocyanate labeled oligo provided manufacturer
0.544895.16118209.html.plaintext.txt	33	antisense oligo antisense oligonucleotide specific rat pkc scrambled control obtained biognostik gottingen germany 200 microm oligo introduced media cultured a10 smcs seeded 18 h earlier equal density efficacy oligo uptake smcs 90 determined using fluorescein isothiocyanate labeled oligo provided manufacturer
0.544895.16118209.html.plaintext.txt	34	quantitative reverse transcription pcr per laboratorys protocol 36 total rna isolated using rna aqueous ambion austin texas reverse transcribed using reverse transcriptase kit probes applied biosystems foster city calif quantification mrna performed using abi prism7700 applied biosystems
0.544895.16118209.html.plaintext.txt	35	quantitative reverse transcription pcr per laboratorys protocol 36 total rna isolated using rna aqueous ambion austin texas reverse transcribed using reverse transcriptase kit probes applied biosystems foster city calif quantification mrna performed using abi prism7700 applied biosystems
0.544895.16118209.html.plaintext.txt	36	immunoprecipitation immunoprecipitation carried described previously laboratory 39 briefly smcs lysed nonidet p 40 buffer total protein concentration determined modification method lowry protein amount sample equalized following primary antibody incubation centrifugation pellets washed three times nonidet p 40 buffer one time 50 mm tris final pellet re suspended 30 microl sample buffer heated 95 degrees c 3 min samples subjected sds page
0.544895.16118209.html.plaintext.txt	37	immunoprecipitation immunoprecipitation carried described previously laboratory 39 briefly smcs lysed nonidet p 40 buffer total protein concentration determined modification method lowry protein amount sample equalized following primary antibody incubation centrifugation pellets washed three times nonidet p 40 buffer one time 50 mm tris final pellet re suspended 30 microl sample buffer heated 95 degrees c 3 min samples subjected sds page
0.544895.16118209.html.plaintext.txt	38	statistical analysis values expressed fold increase means plus minus se unpaired students test used evaluate statistical differences values p 005 considered significant experiments repeated least three times
0.544895.16118209.html.plaintext.txt	39	results top abstract introduction experimental procedures results discussion references pkc necessary smooth muscle cell apoptosis began studies testing whether inhibition pkc affects ability smcs undergo apoptosis a10 smcs treated apoptotic stimulus h2o2 concentration 200 microm 6 h presence absence pkc specific inhibitor rottlerin similar reported previously mouse vascular smcs a10 cells rat aortic smc line responded h2o2 large increase dna fragmentation pre treatment a10 cells rottlerin 1 microm 1 h diminished induction dna fragmentation induced h2o2 fig 1a alternatively inhibited pkc expression treating cells antisense oligonucleotide compared control oligo pkc antisense oligo produced significant reduction level endogenous pkc fig 1b importantly pkc antisense oligo treated cells became resistant h2o2 treatment fig 1b taken together data confirmed pkc necessary component apoptotic pathway vascular smcs
0.544895.16118209.html.plaintext.txt	40	results top abstract introduction experimental procedures results discussion references pkc necessary smooth muscle cell apoptosis began studies testing whether inhibition pkc affects ability smcs undergo apoptosis a10 smcs treated apoptotic stimulus h2o2 concentration 200 microm 6 h presence absence pkc specific inhibitor rottlerin similar reported previously mouse vascular smcs a10 cells rat aortic smc line responded h2o2 large increase dna fragmentation pre treatment a10 cells rottlerin 1 microm 1 h diminished induction dna fragmentation induced h2o2 fig 1a alternatively inhibited pkc expression treating cells antisense oligonucleotide compared control oligo pkc antisense oligo produced significant reduction level endogenous pkc fig 1b importantly pkc antisense oligo treated cells became resistant h2o2 treatment fig 1b taken together data confirmed pkc necessary component apoptotic pathway vascular smcs
0.544895.16118209.html.plaintext.txt	41	overexpression pkc induces apoptosis accumulation tumor suppressor p53 next evaluated whether overexpression pkc would sufficient induce vascular smc apoptosis end employed adenovirus encoding full length wild type pkc adpkc led marked increase cellular levels pkc fig 2b additionally adpkc induced small significant elevation level fragmented dna cleaved caspase 3 fig 2 b facilitate activation ectopically expressed pkc treated a10 smcs 1 5 microm pma 12 h concentrations pma alone induce apoptosis indicated lack fragmented dna well absence activated caspase 3 however pkc activator pma combination overexpression pkc resulted increase dna fragmentation 3 fold fig 2a cleaved caspase 3 300 fig 2b data establish overexpression pkc sufficient induce smc apoptosis p53 implicated smc apoptosis investigated whether overexpression pkc dramatic increase smc apoptosis associated induction p53 shown fig 2b overexpression pkc a10 smcs significantly increased p53 levels parallel induction apoptosis ability adpkc induce p53 expression enhanced pma fig 2b next tested whether pkc induced p53 accumulation leads enhanced p53 dependent gene transcription using luciferase reporter gene containing p53 specific enhancer element 40 41 co transfection pkc expression vector significantly increased p53 reporter activity importantly addition pkc activator pma facilitated effect pkc p53 reporter consistent ability pkc induce p53 expression smc apoptosis fig 2c
0.544895.16118209.html.plaintext.txt	42	overexpression pkc induces apoptosis accumulation tumor suppressor p53 next evaluated whether overexpression pkc would sufficient induce vascular smc apoptosis end employed adenovirus encoding full length wild type pkc adpkc led marked increase cellular levels pkc fig 2b additionally adpkc induced small significant elevation level fragmented dna cleaved caspase 3 fig 2 b facilitate activation ectopically expressed pkc treated a10 smcs 1 5 microm pma 12 h concentrations pma alone induce apoptosis indicated lack fragmented dna well absence activated caspase 3 however pkc activator pma combination overexpression pkc resulted increase dna fragmentation 3 fold fig 2a cleaved caspase 3 300 fig 2b data establish overexpression pkc sufficient induce smc apoptosis p53 implicated smc apoptosis investigated whether overexpression pkc dramatic increase smc apoptosis associated induction p53 shown fig 2b overexpression pkc a10 smcs significantly increased p53 levels parallel induction apoptosis ability adpkc induce p53 expression enhanced pma fig 2b next tested whether pkc induced p53 accumulation leads enhanced p53 dependent gene transcription using luciferase reporter gene containing p53 specific enhancer element 40 41 co transfection pkc expression vector significantly increased p53 reporter activity importantly addition pkc activator pma facilitated effect pkc p53 reporter consistent ability pkc induce p53 expression smc apoptosis fig 2c
0.544895.16118209.html.plaintext.txt	43	view larger version 23k figure 1 pkc necessary smc apoptosis a10 cells treated h2o2 200 microm 6 h indicated cells pretreated rottlerin 1 microm control solvent me2so 1 h prior addition h2o2 apoptosis quantified using elisa measured dna fragmentation described experimental procedures b a10 smcs evaluated following incubation pkc specific antisense oligonucleotide scrambled control oligonucleotide 10 nm 48 h prior h2o2 treatment 200 microm 6 h dna fragmentation quantified via elisa p 005 compared non treated control n 3
0.544895.16118209.html.plaintext.txt	44	view larger version 23k figure 1 pkc necessary smc apoptosis a10 cells treated h2o2 200 microm 6 h indicated cells pretreated rottlerin 1 microm control solvent me2so 1 h prior addition h2o2 apoptosis quantified using elisa measured dna fragmentation described experimental procedures b a10 smcs evaluated following incubation pkc specific antisense oligonucleotide scrambled control oligonucleotide 10 nm 48 h prior h2o2 treatment 200 microm 6 h dna fragmentation quantified via elisa p 005 compared non treated control n 3
0.544895.16118209.html.plaintext.txt	45	p53 necessary pkc induced apoptosis confirm significance p53 pkc induced apoptosis designed specific p53 small interference rna sirna block p53 translation 72 h following administration p53 sirna 50 nm levels p53 a10 smcs decreased 44 plus minus 22 fig 3a next examined whether p53 sirna affects apoptosis 48 h following infection adpkc adnull a10 cells incubated p53 sirna 50 nm 72 h prior pma treatment 1 microm 12 h cell apoptosis assessed using elisa dna fragmentation western blot analysis cleaved caspase 3 inhibition p53 specific sirna led significant decrease pkc induced cleaved caspase 3 fig 3a dna fragmentation fig 3b suggesting p53 necessary pkc induced smc apoptosis confirm findings using sirna isolated smcs thoracic aorta p53 null mice tested ability undergo apoptosis following overexpression pkc activation pma interestingly adpkc failed induce apoptosis p53 null smcs fig 3c next attempted rescue apoptosis restoring p53 expression using adenovirus encoding wild type p53 35 overexpression p53 alone induce apoptosis consistent reports hct116 colon carcinoma cells 42 however expression p53 restored completely ability pkc induce apoptosis fig 3c results provide confirmation requirement p53 pkc induced apoptosis vascular smcs
0.544895.16118209.html.plaintext.txt	46	p53 necessary pkc induced apoptosis confirm significance p53 pkc induced apoptosis designed specific p53 small interference rna sirna block p53 translation 72 h following administration p53 sirna 50 nm levels p53 a10 smcs decreased 44 plus minus 22 fig 3a next examined whether p53 sirna affects apoptosis 48 h following infection adpkc adnull a10 cells incubated p53 sirna 50 nm 72 h prior pma treatment 1 microm 12 h cell apoptosis assessed using elisa dna fragmentation western blot analysis cleaved caspase 3 inhibition p53 specific sirna led significant decrease pkc induced cleaved caspase 3 fig 3a dna fragmentation fig 3b suggesting p53 necessary pkc induced smc apoptosis confirm findings using sirna isolated smcs thoracic aorta p53 null mice tested ability undergo apoptosis following overexpression pkc activation pma interestingly adpkc failed induce apoptosis p53 null smcs fig 3c next attempted rescue apoptosis restoring p53 expression using adenovirus encoding wild type p53 35 overexpression p53 alone induce apoptosis consistent reports hct116 colon carcinoma cells 42 however expression p53 restored completely ability pkc induce apoptosis fig 3c results provide confirmation requirement p53 pkc induced apoptosis vascular smcs
0.544895.16118209.html.plaintext.txt	47	view larger version 35k figure 2 overexpression pkc induces expression tumor suppressor p53 smc apoptosis a10 smcs infected adenovirus containing wild type pkc adpkc empty viral vector adnull following infection cells treated indicated concentrations pma equal amounts solvent me2so 12 h apoptosis determined elisa measured dna fragmentation b a10 cells treated exactly described panel cell lysate analyzed anti pkc p53 cleaved caspase 3 antibody c a10 cells transiently transfected luciferase reporter gene control p53 specific enhancer elements either pkc expression control plasmid following infection cells treated pma 1 microm 12 h reporter activity expressed ratio firefly luciferase renilla luciferase p 005 p 001 compared non pma treated control n 3
0.544895.16118209.html.plaintext.txt	48	view larger version 35k figure 2 overexpression pkc induces expression tumor suppressor p53 smc apoptosis a10 smcs infected adenovirus containing wild type pkc adpkc empty viral vector adnull following infection cells treated indicated concentrations pma equal amounts solvent me2so 12 h apoptosis determined elisa measured dna fragmentation b a10 cells treated exactly described panel cell lysate analyzed anti pkc p53 cleaved caspase 3 antibody c a10 cells transiently transfected luciferase reporter gene control p53 specific enhancer elements either pkc expression control plasmid following infection cells treated pma 1 microm 12 h reporter activity expressed ratio firefly luciferase renilla luciferase p 005 p 001 compared non pma treated control n 3
0.544895.16118209.html.plaintext.txt	49	pkc increases p53 transcription next explored mechanism pkc regulates p53 began examining effect pkc overexpression level p53 mrna a10 smcs infected adnull adpkc treated pkc activator pma 1 microm 6h total rna isolated control pkcpma treated cells p53 quantified using taqman real time reverse transcription pcr analysis shown fig 4a overexpressed pkc elicited significant increase level p53 mrna determine whether increase p53 mrna secondary increased promoter activity employed luciferase construct containing proximal portion human p53 promoter 37 cotransfected a10 cells pkc expression control vector luciferase reporter experiment demonstrated increase p53 promoter activity response pkc overexpression fig 4b indicating pkc regulates p53 transcription regulating promoter activity vascular smcs
0.544895.16118209.html.plaintext.txt	50	pkc increases p53 transcription next explored mechanism pkc regulates p53 began examining effect pkc overexpression level p53 mrna a10 smcs infected adnull adpkc treated pkc activator pma 1 microm 6h total rna isolated control pkcpma treated cells p53 quantified using taqman real time reverse transcription pcr analysis shown fig 4a overexpressed pkc elicited significant increase level p53 mrna determine whether increase p53 mrna secondary increased promoter activity employed luciferase construct containing proximal portion human p53 promoter 37 cotransfected a10 cells pkc expression control vector luciferase reporter experiment demonstrated increase p53 promoter activity response pkc overexpression fig 4b indicating pkc regulates p53 transcription regulating promoter activity vascular smcs
0.544895.16118209.html.plaintext.txt	51	view larger version 21k figure 3 p53 necessary pkc induced smc apoptosis b a10 smcs infected adpkc cells incubated p53 sirna scrambled control sirna 50 nm 72 h pma 1 microm 12 h p53 inhibition confirmed western blot analysis cell lysate apoptosis assessed measuring levels cleaved caspase 3 via immunoblot elisa measured dna fragmentation b c smcs harvested thoracic aorta p53 male mice 24 h following seeding equal densities 10 fetal bovine serum media mouse aortic smcs infected equal quantities adnull adpkc adenovirus ad p53 30000 total viral particles per cell following pma treatment 1 microm 12 h apoptosis evaluated though elisa measured dna fragmentation p 005 compared non treated control n 3
0.544895.16118209.html.plaintext.txt	52	view larger version 21k figure 3 p53 necessary pkc induced smc apoptosis b a10 smcs infected adpkc cells incubated p53 sirna scrambled control sirna 50 nm 72 h pma 1 microm 12 h p53 inhibition confirmed western blot analysis cell lysate apoptosis assessed measuring levels cleaved caspase 3 via immunoblot elisa measured dna fragmentation b c smcs harvested thoracic aorta p53 male mice 24 h following seeding equal densities 10 fetal bovine serum media mouse aortic smcs infected equal quantities adnull adpkc adenovirus ad p53 30000 total viral particles per cell following pma treatment 1 microm 12 h apoptosis evaluated though elisa measured dna fragmentation p 005 compared non treated control n 3
0.544895.16118209.html.plaintext.txt	53	overexpression pkc results phosphorylation p53 phosphorylation important element p53 regulation next investigated possibility pkc may affect p53 phosphorylation assess pkc induced p53 phosphorylation utilized specific antibody p53 phosphorylated serine residue 46 shown others provide p53 greater affinity promoters apoptosis related genes 43 pkc substantially increased level phospho p53 serine 46 barely detectable cells infected empty viral vector fig 5a confirm role pkc induced p53 phosphorylation apoptosis evaluated phosphorylation status p53 a10 cells treated h2o2 stimulus apoptosis p53 phosphorylation 44 indeed western blot analysis a10 cell lysates demonstrated significant increase p53 phosphorylation serine 46 following treatment h2o2 200 microm 4 h importantly pre incubation pkc chemical inhibitor rottlerin 1 microm 1 h dramatically diminished ability h2o2 induce p53 phosphorylation fig 5b data demonstrate pkc responsible directly indirectly p53 phosphorylation lastly searched mechanism enables interaction pkc p53 examining potential physical association two proteins lysates a10 smcs infected adpkc immunoprecipitated p53 followed western blotting pkc negative control cell lysate immunoprecipitated normal rabbit igg found prominent p53 band pkc immunoprecipitate converse experiment pkc detected p53 immunocomplex fig 5c findings suggest pkc physically associated p53 conditions favoring apoptosis
0.544895.16118209.html.plaintext.txt	54	overexpression pkc results phosphorylation p53 phosphorylation important element p53 regulation next investigated possibility pkc may affect p53 phosphorylation assess pkc induced p53 phosphorylation utilized specific antibody p53 phosphorylated serine residue 46 shown others provide p53 greater affinity promoters apoptosis related genes 43 pkc substantially increased level phospho p53 serine 46 barely detectable cells infected empty viral vector fig 5a confirm role pkc induced p53 phosphorylation apoptosis evaluated phosphorylation status p53 a10 cells treated h2o2 stimulus apoptosis p53 phosphorylation 44 indeed western blot analysis a10 cell lysates demonstrated significant increase p53 phosphorylation serine 46 following treatment h2o2 200 microm 4 h importantly pre incubation pkc chemical inhibitor rottlerin 1 microm 1 h dramatically diminished ability h2o2 induce p53 phosphorylation fig 5b data demonstrate pkc responsible directly indirectly p53 phosphorylation lastly searched mechanism enables interaction pkc p53 examining potential physical association two proteins lysates a10 smcs infected adpkc immunoprecipitated p53 followed western blotting pkc negative control cell lysate immunoprecipitated normal rabbit igg found prominent p53 band pkc immunoprecipitate converse experiment pkc detected p53 immunocomplex fig 5c findings suggest pkc physically associated p53 conditions favoring apoptosis
0.544895.16118209.html.plaintext.txt	55	view larger version 13k figure 4 pkc increases p53 transcription a10 smcs infected pkc adenovirus adpkc empty viral vector adnull stimulated 6 h 1 microm pma level p53 mrna determined real time reverse transcription pcr b a10 cells transfected p53 luciferase reporter either pkc control vector following transfection cells stimulated 12 h 1 microm pma reporter activity expressed ratio firefly luciferase renilla luciferase p 005 compared non treated control n 3
0.544895.16118209.html.plaintext.txt	56	view larger version 13k figure 4 pkc increases p53 transcription a10 smcs infected pkc adenovirus adpkc empty viral vector adnull stimulated 6 h 1 microm pma level p53 mrna determined real time reverse transcription pcr b a10 cells transfected p53 luciferase reporter either pkc control vector following transfection cells stimulated 12 h 1 microm pma reporter activity expressed ratio firefly luciferase renilla luciferase p 005 compared non treated control n 3
0.544895.16118209.html.plaintext.txt	57	p38 mapk necessary pkc induced regulation p53 next explored molecular mechanisms underlying p53 induction evaluating stress activated kinase p38 response pkc overexpression overexpression pkc a10 smcs activated p38 demonstrated marked increase p38 phosphorylation fig 6a investigate possible role p38 pkc induced p53 expression inhibited p38 using p38 chemical inhibitor sb20358 20 microm 1 h pkc overexpressing cells found p38 inhibition resulted large decrease ability pkc regulate p53 protein levels fig 6b next tested effect sb20358 p53 promoter activity shown p53 promoter activity increased response pkc overexpression however inhibition p38 sb20358 diminished ability pkc regulate p53 transcription fig 6c data suggest p38 intermediate responsible induction p53 transcription pkc overexpressing smcs
0.544895.16118209.html.plaintext.txt	58	p38 mapk necessary pkc induced regulation p53 next explored molecular mechanisms underlying p53 induction evaluating stress activated kinase p38 response pkc overexpression overexpression pkc a10 smcs activated p38 demonstrated marked increase p38 phosphorylation fig 6a investigate possible role p38 pkc induced p53 expression inhibited p38 using p38 chemical inhibitor sb20358 20 microm 1 h pkc overexpressing cells found p38 inhibition resulted large decrease ability pkc regulate p53 protein levels fig 6b next tested effect sb20358 p53 promoter activity shown p53 promoter activity increased response pkc overexpression however inhibition p38 sb20358 diminished ability pkc regulate p53 transcription fig 6c data suggest p38 intermediate responsible induction p53 transcription pkc overexpressing smcs
0.544895.16118209.html.plaintext.txt	59	view larger version 30k figure 5 overexpression pkc results p53 phosphorylation a10 smcs infected adpkc adnull stimulated 12 h 1 microm pma cell lysates examined via western blotting total phosphorylated p53 b a10 cells treated h2o2 200 microm 4 h pre incubated pkc chemical inhibitor rottlerin 1 microm 1 h control solvent me2so indicated western blot analysis performed antibody specific phospho p53 serine 46 c a10 smcs infected adpkc stimulated pma 1 microm 12 h cell lysates immunoprecipitated anti p53 anti pkc antibody negative control cell lysates also immunoprecipitated normal igg immunoprecipitate analyzed pkc p53 via western blot wb analysis
0.544895.16118209.html.plaintext.txt	60	view larger version 30k figure 5 overexpression pkc results p53 phosphorylation a10 smcs infected adpkc adnull stimulated 12 h 1 microm pma cell lysates examined via western blotting total phosphorylated p53 b a10 cells treated h2o2 200 microm 4 h pre incubated pkc chemical inhibitor rottlerin 1 microm 1 h control solvent me2so indicated western blot analysis performed antibody specific phospho p53 serine 46 c a10 smcs infected adpkc stimulated pma 1 microm 12 h cell lysates immunoprecipitated anti p53 anti pkc antibody negative control cell lysates also immunoprecipitated normal igg immunoprecipitate analyzed pkc p53 via western blot wb analysis
0.544895.16118209.html.plaintext.txt	61	p38 mapk necessary pkc induced p53 phosphorylation investigations non vascular cell types demonstrated p38 mapk potential p53 serine 46 kinase p53 mediated apoptosis dependent event explored whether findings apply smcs chemical inhibition p38 failed block pkc induced p53 phosphorylation decrease total p53 protein levels demonstrated fig 7a despite lack influence p38 mapk serine 46 phosphorylation found proteins co associated pkc co immunoprecipitation assays fig 7b
0.544895.16118209.html.plaintext.txt	62	p38 mapk necessary pkc induced p53 phosphorylation investigations non vascular cell types demonstrated p38 mapk potential p53 serine 46 kinase p53 mediated apoptosis dependent event explored whether findings apply smcs chemical inhibition p38 failed block pkc induced p53 phosphorylation decrease total p53 protein levels demonstrated fig 7a despite lack influence p38 mapk serine 46 phosphorylation found proteins co associated pkc co immunoprecipitation assays fig 7b
0.544895.16118209.html.plaintext.txt	63	p38 mapk necessary pkc induced smc apoptosis establishing potential direct interaction pkc p38 necessity p38 pkc induced regulation p53 investigated role p38 mapk smc apoptosis using p38 inhibitor sb20358 interestingly treatment inhibitor 20 microm 1 h prior pma activation1 microm 12 h decreased apoptosis 50 quantified cleaved caspase 3 fig 8a dna fragmentation fig 8b thus p38 mapk contributes part pkc induced smc apoptosis
0.544895.16118209.html.plaintext.txt	64	p38 mapk necessary pkc induced smc apoptosis establishing potential direct interaction pkc p38 necessity p38 pkc induced regulation p53 investigated role p38 mapk smc apoptosis using p38 inhibitor sb20358 interestingly treatment inhibitor 20 microm 1 h prior pma activation1 microm 12 h decreased apoptosis 50 quantified cleaved caspase 3 fig 8a dna fragmentation fig 8b thus p38 mapk contributes part pkc induced smc apoptosis
0.544895.16118209.html.plaintext.txt	65	view larger version 27k figure 6 p38 mapk necessary pkc induced regulation p53 expression a10 smcs infected adpkc adnull stimulated pma 1 microm 12 h cell lysate examined via western blotting total phosphorylated p38 mapk b a10 cells infected adpkc underwent pretreatment control solvent me2so p38 mapk inhibitor sb20358 20 microm 1 h prior stimulation pma 1 microm 12 h total p53 protein levels assessed via western blot c a10 cells co transfected pkc expression control vector luciferase construct containing p53 promoter sb20358 20 microm 1 h used inhibit p38 activity prior addition pma 1 microm 12 h p53 reporter activity expressed ratio firefly luciferase renilla luciferase p 005 compared non treated control
0.544895.16118209.html.plaintext.txt	66	view larger version 27k figure 6 p38 mapk necessary pkc induced regulation p53 expression a10 smcs infected adpkc adnull stimulated pma 1 microm 12 h cell lysate examined via western blotting total phosphorylated p38 mapk b a10 cells infected adpkc underwent pretreatment control solvent me2so p38 mapk inhibitor sb20358 20 microm 1 h prior stimulation pma 1 microm 12 h total p53 protein levels assessed via western blot c a10 cells co transfected pkc expression control vector luciferase construct containing p53 promoter sb20358 20 microm 1 h used inhibit p38 activity prior addition pma 1 microm 12 h p53 reporter activity expressed ratio firefly luciferase renilla luciferase p 005 compared non treated control
0.544895.16118209.html.plaintext.txt	67	discussion top abstract introduction experimental procedures results discussion references pkc member novel pkc subfamily pro apoptotic anti apoptotic depending cell types stimuli agreement previous report 21 results support notion pkc proapoptotic vascular smcs molecular activation pkc alone sufficient result caspase 3 activation dna fragmentation speculate activation pkc early event leading onset programmed cell death smcs
0.544895.16118209.html.plaintext.txt	68	discussion top abstract introduction experimental procedures results discussion references pkc member novel pkc subfamily pro apoptotic anti apoptotic depending cell types stimuli agreement previous report 21 results support notion pkc proapoptotic vascular smcs molecular activation pkc alone sufficient result caspase 3 activation dna fragmentation speculate activation pkc early event leading onset programmed cell death smcs
0.544895.16118209.html.plaintext.txt	69	molecular mechanisms linking pkc induction apoptosis explored extent non smooth muscle cells several studies suggest presence positive regulatory loop pkc caspase 3 however exactly pkc might stimulate caspase 3 remains unclear 45 46 another important target pkc mitochondria demonstrated hela cells 47 keratinocytes 48 overexpression activation pkc leads reduction mitochondrial membrane potential release cytochrome c subsequently leads activation caspases apoptosis additionally several nuclear proteins including dna dependent protein kinase 49 p73 50 lamin b 51 identified pkc targetssubstrates activated pkc associates phosphorylates proteins interactions least part contribute apoptosis current study present evidence tumor suppressor p53 necessary mediator pkc induced apoptosis vascular smcs shown activation pkc led accumulation well phosphorylation p53 smcs induction correlated smc apoptosis moreover blocking p53 induction sirna prevented apoptosis finally targeted gene deletion p53 prevented pkc induced apoptosis whereas restoring p53 expression adenovirus mediated p53 gene transfer rescued ability pkc induce apoptosis knowledge first demonstration direct involvement p53 regulation smc apoptosis pkc
0.544895.16118209.html.plaintext.txt	70	molecular mechanisms linking pkc induction apoptosis explored extent non smooth muscle cells several studies suggest presence positive regulatory loop pkc caspase 3 however exactly pkc might stimulate caspase 3 remains unclear 45 46 another important target pkc mitochondria demonstrated hela cells 47 keratinocytes 48 overexpression activation pkc leads reduction mitochondrial membrane potential release cytochrome c subsequently leads activation caspases apoptosis additionally several nuclear proteins including dna dependent protein kinase 49 p73 50 lamin b 51 identified pkc targetssubstrates activated pkc associates phosphorylates proteins interactions least part contribute apoptosis current study present evidence tumor suppressor p53 necessary mediator pkc induced apoptosis vascular smcs shown activation pkc led accumulation well phosphorylation p53 smcs induction correlated smc apoptosis moreover blocking p53 induction sirna prevented apoptosis finally targeted gene deletion p53 prevented pkc induced apoptosis whereas restoring p53 expression adenovirus mediated p53 gene transfer rescued ability pkc induce apoptosis knowledge first demonstration direct involvement p53 regulation smc apoptosis pkc
0.544895.16118209.html.plaintext.txt	71	view larger version 19k figure 7 p38 co associates pkc p53 necessary pkc induced p53 phosphorylation a10 smcs infected adpkc adnull preincubated p38 mapk inhibitor sb20358 20 microm 1 h prior stimulation pma 1 microm 12 h cell lysates examined via western blotting using phospho p53 antibody specific serine residue 46 b a10 smcs infected adpkc stimulated pma 1 microm 12 h cell lysates immunoprecipitated anti p38 antibody negative control cell lysates also immunoprecipitated normal igg immunoprecipitate analyzed pkc p53 via western blot wb analysis
0.544895.16118209.html.plaintext.txt	72	view larger version 19k figure 7 p38 co associates pkc p53 necessary pkc induced p53 phosphorylation a10 smcs infected adpkc adnull preincubated p38 mapk inhibitor sb20358 20 microm 1 h prior stimulation pma 1 microm 12 h cell lysates examined via western blotting using phospho p53 antibody specific serine residue 46 b a10 smcs infected adpkc stimulated pma 1 microm 12 h cell lysates immunoprecipitated anti p38 antibody negative control cell lysates also immunoprecipitated normal igg immunoprecipitate analyzed pkc p53 via western blot wb analysis
0.544895.16118209.html.plaintext.txt	73	view larger version 33k figure 8 p38 mapk necessary pkc induced smc apoptosis a10 smcs infected adpkc preincubated p38 mapk inhibitor sb20358 20 microm 1 h prior stimulation pma 1 microm 12 h apoptosis assessed measuring levels cleaved caspase 3 via immunoblot elisa measured dna fragmentation b p 005 compared non treated control
0.544895.16118209.html.plaintext.txt	74	view larger version 33k figure 8 p38 mapk necessary pkc induced smc apoptosis a10 smcs infected adpkc preincubated p38 mapk inhibitor sb20358 20 microm 1 h prior stimulation pma 1 microm 12 h apoptosis assessed measuring levels cleaved caspase 3 via immunoblot elisa measured dna fragmentation b p 005 compared non treated control
0.544895.16118209.html.plaintext.txt	75	experimental evidence provided pkc regulates p53 transcriptional post translational levels apparently mediated separate signaling mechanisms specifically transcriptional regulation requires p38 mapk whereas post translational modification least ser 46 require mapk importance post translational regulation p53 pkc demonstrated observation ectopic expression p53 alone insufficient induce apoptosis co expressed pkc p53 able restore apoptosis p53 null cells presumably pkc dependent phosphorylation surprising p38 mapk specific inhibitor sb20358 significantly inhibited pkc induced accumulation p53 affect p53 phosphorylation ser 46 direct interaction p53 p38 mapk 52 suggested previously indeed showed three proteins p53 p38 pkc co associated immunoprecipitation complex isolated smc lysates attempts evaluate serine residues within p53 molecule currently possible due lack specific phospho antibodies therefore remains determined whether pkc p38 stimulate p53 phosphorylation additional residues respect ser 46 data suggest p38 independent
0.544895.16118209.html.plaintext.txt	76	experimental evidence provided pkc regulates p53 transcriptional post translational levels apparently mediated separate signaling mechanisms specifically transcriptional regulation requires p38 mapk whereas post translational modification least ser 46 require mapk importance post translational regulation p53 pkc demonstrated observation ectopic expression p53 alone insufficient induce apoptosis co expressed pkc p53 able restore apoptosis p53 null cells presumably pkc dependent phosphorylation surprising p38 mapk specific inhibitor sb20358 significantly inhibited pkc induced accumulation p53 affect p53 phosphorylation ser 46 direct interaction p53 p38 mapk 52 suggested previously indeed showed three proteins p53 p38 pkc co associated immunoprecipitation complex isolated smc lysates attempts evaluate serine residues within p53 molecule currently possible due lack specific phospho antibodies therefore remains determined whether pkc p38 stimulate p53 phosphorylation additional residues respect ser 46 data suggest p38 independent
0.544895.16118209.html.plaintext.txt	77	potential role pkc regulation p53 accumulation suggested previously using selective pkc inhibitor rottlerin niwa et al 44 demonstrated inhibition pkc decreases h2o2 induced p53 accumulation bovine endothelial cells nih3t3 cells lee et al 53 observed increase p53 level overexpressing pkc whereas abbas et al 54 demonstrated suppression p53 basal expression inhibiting pkc ml 1 cells acute myeloid leukemia cells demonstrated vascular smcs overexpression pkc increased accumulation p53 protein mrna contrast johnson et al 55 found pkc inhibitor rottlerin increases p53 levels cisplatin treated hela cells whereas pkc activator phorbol 1213 dibutyrate attenuates p53 levels cell line therefore likely pkc paralleling dual functions apoptosis plays multiple roles regulating p53 expression dependent upon cell type stimuli employed
0.544895.16118209.html.plaintext.txt	78	potential role pkc regulation p53 accumulation suggested previously using selective pkc inhibitor rottlerin niwa et al 44 demonstrated inhibition pkc decreases h2o2 induced p53 accumulation bovine endothelial cells nih3t3 cells lee et al 53 observed increase p53 level overexpressing pkc whereas abbas et al 54 demonstrated suppression p53 basal expression inhibiting pkc ml 1 cells acute myeloid leukemia cells demonstrated vascular smcs overexpression pkc increased accumulation p53 protein mrna contrast johnson et al 55 found pkc inhibitor rottlerin increases p53 levels cisplatin treated hela cells whereas pkc activator phorbol 1213 dibutyrate attenuates p53 levels cell line therefore likely pkc paralleling dual functions apoptosis plays multiple roles regulating p53 expression dependent upon cell type stimuli employed
0.544895.16118209.html.plaintext.txt	79	findings pma alone induce apoptosis control adnull infected smcs seemingly surprising cells express endogenous pkc pma activates pkc lack cell death associated pma treatment may related effect pma pkc isotypes shown previously smcs express least eight isotypes pkc among six activated pma 56 pma sensitive pkc isoforms pkc pro apoptotic whereas others pkc demonstrated anti apoptotic non smcs 57 59 data show overexpressing pkc shifts pma response favor apoptosis however outcome simultaneously activating multiple pkc isotypes may occur control smcs treated pma appears result net effect cell death
0.544895.16118209.html.plaintext.txt	80	findings pma alone induce apoptosis control adnull infected smcs seemingly surprising cells express endogenous pkc pma activates pkc lack cell death associated pma treatment may related effect pma pkc isotypes shown previously smcs express least eight isotypes pkc among six activated pma 56 pma sensitive pkc isoforms pkc pro apoptotic whereas others pkc demonstrated anti apoptotic non smcs 57 59 data show overexpressing pkc shifts pma response favor apoptosis however outcome simultaneously activating multiple pkc isotypes may occur control smcs treated pma appears result net effect cell death
0.544895.16118209.html.plaintext.txt	81	present study highlights another interesting finding pkc stimulates p53 gene expression p38 mapk showed inhibition p38 completely eliminated pkc stimulated accumulation p53 protein mrna moreover analyses using p53 promoter reporter demonstrated pkc regulated p53 promoter activity also p38 dependent manner several transcription factors identified bind regulate murine p53 promoter including nfb 60 interestingly kim et al 61 showed articular chondrocytes induced activation p38 regulates p53 expression nfb moreover nfb pathway shown activated pkc several cell types 62 64 future studies mandatory directly test role nfbinpkc induced p38 dependent transcriptional regulation p53
0.544895.16118209.html.plaintext.txt	82	present study highlights another interesting finding pkc stimulates p53 gene expression p38 mapk showed inhibition p38 completely eliminated pkc stimulated accumulation p53 protein mrna moreover analyses using p53 promoter reporter demonstrated pkc regulated p53 promoter activity also p38 dependent manner several transcription factors identified bind regulate murine p53 promoter including nfb 60 interestingly kim et al 61 showed articular chondrocytes induced activation p38 regulates p53 expression nfb moreover nfb pathway shown activated pkc several cell types 62 64 future studies mandatory directly test role nfbinpkc induced p38 dependent transcriptional regulation p53
0.544895.16118209.html.plaintext.txt	83	summary results demonstrate pkc plays pivotal role signal transduction pathway leading vascular smc apoptosis p38 dependent accumulation independent phosphorylation p53 pkc contributes least part smc apoptosis given critical role apoptosis intimal hyperplasia possible enhancement pkc activity different stages vascular intervention may provide new strategy prevention treatment restenosis
0.544895.16118209.html.plaintext.txt	84	summary results demonstrate pkc plays pivotal role signal transduction pathway leading vascular smc apoptosis p38 dependent accumulation independent phosphorylation p53 pkc contributes least part smc apoptosis given critical role apoptosis intimal hyperplasia possible enhancement pkc activity different stages vascular intervention may provide new strategy prevention treatment restenosis
0.544895.16118209.html.plaintext.txt	85	footnotes work supported part nhlbi national institutes health grant hl 68673 k c k b l american heart association heritage foundation grant aid 0455859t b l national institutes health training grant t32 ca68971 07 e j r additional support studies provided part samuel waxman cancer research foundation chernow endowment costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.544895.16118209.html.plaintext.txt	86	1 michael stella chernow urological cancer research scientist samuel waxman cancer research foundation investigator
0.544895.16118209.html.plaintext.txt	87	2 correspondence addressed dept surgery new york presbyterian hospital 525 e 68th st payson 707 new york ny 10021 tel 212 746 5192 fax 212 746 5812 e mail bol2001atmedcornelledu u d
0.544895.16118209.html.plaintext.txt	88	2 correspondence addressed dept surgery new york presbyterian hospital 525 e 68th st payson 707 new york ny 10021 tel 212 746 5192 fax 212 746 5812 e mail bol2001atmedcornelledu u d
0.544895.16118209.html.plaintext.txt	89	3 abbreviations used smc smooth muscle cell adnull empty adenovirus vector adpkc adenovirus encoding full length wild type pkc elisa enzyme linked immunosorbent assay mapk mitogen activated protein kinase pkc protein kinase c pma phorbol 12 myristate 13 acetate sirna small interference rna
0.544895.16118209.html.plaintext.txt	90	acknowledgments thank dr e ascher maimonedes medical center brooklyn ny recombinant adenovirus p53 vector dr d resiman university wisconsin madison wi p53 luciferase construct also thank dr n heckatte gene therapy core facility weill cornell medical college assistance adenovirus preparation sophia chu technical assistance
0.544895.16118209.html.plaintext.txt	91	references top abstract introduction experimental procedures results discussion references kerr j f r harmon b v 1991 apoptosis molecular basis cell death tomei l d cope f o eds vol 3 pp 5 29 cold spring harbor laboratory press cold spring harbor laboratory ny wyllie 1992 cancer metastasis rev 11 95 103crossrefmedline order article via infotrieve bauriedel g schluckebier hutter r welsch u kandolf r luderitz b prescott m f 1998 arterioscler thromb vasc biol 18 1132 1139abstractfree full text han d haudenschild c hong m tinkle b leon m liau g 1995 j pathol 147 267 277abstract bochaton piallat m gabbiani f redard m desmouliere gabbiani g 1995 j pathol 146 1059 1064abstract ross r 1993 nature 362 801 809crossrefmedline order article via infotrieve xu q 2000 trends cardiovasc med 10 35 41crossrefmedline order article via infotrieve geng y libby p 1995 j pathol 147 251 266abstract isner j m kearney m bortman passeri j 1995 circulation 91 2703 2711abstractfree full text newby c george j 1996 curr opin cardiol 11 574 582medline order article via infotrieve kockx m m 1998 arterioscler thromb vasc biol 18 1519 1522abstractfree full text franklin r mccubrey j 2000 leukemia 14 2019 2034crossrefmedline order article via infotrieve cross g scheel toellner d henriquez n v deacon e salmon m lord j m 2000 exp cell res 256 34 41crossrefmedline order article via infotrieve kroemer g 1997 nat med 3 614 620crossrefmedline order article via infotrieve strasser connor l dixit v m 2000 annu rev biochem 69 217 245crossrefmedline order article via infotrieve hug h sarre 1993 biochem j 15 329 343 fukumoto nishizawa y hosoi m koyama h yamakawa k ohno morii h 1997 j biol chem 272 13816 13822abstractfree full text li w jiang y x zhang j soon l flechner l kapoor v pierce j h wang l h 1998 mol cell biol 18 5888 5898abstractfree full text li p f maasch c haller h dietz r von harsdorf r 1999 circulation 100 967 973abstractfree full text majumder p k pandey p sun x cheng k datta r saxena kharbanda kufe d 2000 j biol chem 275 21793 21796abstractfree full text leitges m mayr m braun u mayr u li c pfister g ghaffari tabrizi n baier g hu y xu q 2001 j clin investig 108 1505 1512abstractfree full text yonemitsu y kaneda y tanaka nakashima y komori k sugimachi k sueishi k 1998 circ res 82 147 156abstractfree full text george j angelini g d capogrossi m c baker h 2001 gene ther 8 668 676crossrefmedline order article via infotrieve scheinman m ascher e levi g hingorani shirazian d seth p 1999 j vasc surg 29 360 369medline order article via infotrieve mayr u mayr m li c wernig f dietrich h hu y xu q 2002 circ res 90 197 204abstractfree full text sarkar d su z z lebedeva v sauane m gopalkrishnan r v valerie k dent p fisher p b 2002 proc natl acad sci u 99 10054 10059abstractfree full text wada penninger j m 2004 oncogene 23 2838 2849crossrefmedline order article via infotrieve wada furuichi k sakai n hisada y kobayashi k mukaida n tomosugi n matsushima k yokoyama h 2001 j kidney dis 38 1169 1177medline order article via infotrieve sauane m gopalkrishnan r v lebedeva mei m x sarkar d su z z kang d c dent p pestka fisher p b 2003 j cell physiol 196 334 345crossrefmedline order article via infotrieve harris l levine j 2005 oncogene 24 2899 2908crossrefmedline order article via infotrieve xia z dickens m raingeaud j davis r j greenberg m e 1995 science 270 1326 1331abstract kumar boehm j lee j c 2003 nat rev drug discov 2 717 726crossrefmedline order article via infotrieve miyamoto nakayama k imaki h hirose jiang y abe m tsukiyama nagahama h ohno hatakeyama nakayama k 2002 nature 416 865 869crossrefmedline order article via infotrieve clowes m m lynch c m miller d miller d g osborne w r clowes w 1994 j clin investig 93 644 651medline order article via infotrieve scheinman m ascher e kallakuri hingorani gade p sherman m seth p jacob 1999 surgery 126 863 868crossrefmedline order article via infotrieve sakakibara k kubota k worku b ryer e j miller j p koff kent k c liu b 2005 j biol chem 280 25470 25477abstractfree full text durland busbice reisman d 2002 leukemia 16 2165 2167crossrefmedline order article via infotrieve kubota k okazaki j louie o kent k c liu b 2003 j surg res 109 43 50crossrefmedline order article via infotrieve hollenbeck itoh h louie o faries p l liu b kent k c 2004 biochem biophys res commun 325 328 337crossrefmedline order article via infotrieve el deiry w kern e pietenpol j kinzler k w vogelstein b 1992 nat genet 1 45 49crossrefmedline order article via infotrieve tokino thiagalingam el deiry w waldman kinzler k w vogelstein b 1994 hum mol genet 3 1537 1542abstract kokontis j m wagner j oleary m liao hay n 2001 oncogene 20 659 668crossrefmedline order article via infotrieve oda k arakawa h tanaka matsuda k tanikawa c mori nishimori h tamai k tokino nakamura y taya y 2000 cell 102 849 862crossrefmedline order article via infotrieve niwa k inanami o kuwabara m 2002 free radic res 36 1147 1153crossrefmedline order article via infotrieve thornberry n lazebnik y 1998 science 281 1312 1316abstractfree full text ghayur hugunin m talanian r v ratnofsky quinlan c emoto y pandey p datta r huang y kharbanda allen h kamen r wong w kufe d 1996 j exp med 184 2399 2404abstractfree full text basu woolard m d johnson c l 2001 cell death differ 8 899 908crossrefmedline order article via infotrieve li l lorenzo p bogi k blumberg p m yuspa h 1999 mol cell biol 19 8547 8558abstractfree full text bharti kraeft k gounder m pandey p jin yuan z m lees miller p weichselbaum r weaver d chen l b kufe d kharbanda 1998 mol cell biol 18 6719 6728abstractfree full text ren j datta r shioya h li y oki e biedermann v bharti kufe d 2002 j biol chem 277 33758 33765abstractfree full text cross griffiths g deacon e sallis r gough m watters d lord j m 2000 oncogene 19 2331 2337crossrefmedline order article via infotrieve q b chen n dong z 2000 j biol chem 275 20444 20449abstractfree full text lee y j soh j w dean n m cho c k kim h lee j lee y 2002 cell growth differ 13 237 246abstractfree full text abbas white d hui l yoshida k foster d bargonetti j 2004 j biol chem 279 9970 9977abstractfree full text johnson c l lu d huang j basu 2002 mol cancer ther 1 861 867abstractfree full text itoh h yamamura ware j zhuang mii liu b kent k c 2001 j physiol 281 h359 h370 leirdal m sioud m 1999 br j cancer 80 1558 1564crossrefmedline order article via infotrieve jorgensen k skrede m cruciani v mikalsen o slipicevic florenes v 2005 biochem biophys res commun 329 266 274crossrefmedline order article via infotrieve whelan r d h parker p j 1998 oncogene 16 1939 1944crossrefmedline order article via infotrieve reisman d balint e loging w rotter v almon e 1996 genomics 38 364 370crossrefmedline order article via infotrieve kim j hwang g shin d y kang chun j 2002 j biol chem 277 33501 33508abstractfree full text satoh gukovskaya nieto j m cheng j h gukovsky reeve j r jr shimosegawa pandol j 2004 j physiol 287 g582 g591 wang q wang x evers b m 2003 j biol chem 278 51091 51099abstractfree full text zhao c kukreja r c 2003 j physiol 285 h434 h441
0.54812837.11375889.html.plaintext.txt	0	p53 protein hub cellular dna damage response pathways sequence specific non sequence specific dna binding
0.54812837.11375889.html.plaintext.txt	1	yuangang liu molly kulesz martin1
0.54812837.11375889.html.plaintext.txt	2	department dermatology oregon cancer center oregon health sciences university portland 97201 usa
0.54812837.11375889.html.plaintext.txt	3	abstract top abstract introduction p53 guardian regulation p53 sequence p53 non sequence specific references environment contains physical chemical pathological agents challenge integrity dna addition dna repair higher multicellular organisms evolved multiple pathways response damage including programmed cell death apoptosis p53 protein appears sense multiple types dna damage coordinate multiple options cellular response p53 protein activities depend upon dna binding specific p53 protein post translational modifications required efficient sequence specific binding transcriptional activities non sequence specific dna binding may involve wide spectrum p53 proteins predominate dna damage severe p53 protein highly induced p53 protein strictly required dna damage sensing repair rather p53 protein may govern apoptosis checkpoint competition dna repair proteins non sequence specific binding exposed single stranded regions dna duplex model provides framework testing mechanisms p53 mediated apoptosis dependent upon p53 protein modification state level p53 protein accumulation level dna damage capacity damaged cell repair
0.54812837.11375889.html.plaintext.txt	4	abbreviations ber base excision repair cak cyclin activated kinase dsdna double stranded dna ner nucleotide excision repair rpa replication protein ssdna single stranded dna sds dna single strandeddouble stranded dna transition
0.54812837.11375889.html.plaintext.txt	5	introduction top abstract introduction p53 guardian regulation p53 sequence p53 non sequence specific references p53 protein central cellular response higher multicellular organisms variety potentially damaging extracellular stimuli including uv light irradiation chemical carcinogens chemotherapeutic agents dna repair machinery evolved maintain genomic integrity stability various kinds dna damage nucleotide excision repair ner eliminates pyrimidine dimers caused uv light base excision repair ber targets base modifications caused dna hydrolysis alkylation mismatch repair corrects errors dna replication dna strand breaks remedied dna recombination using unbroken alleles templates cell cycle checkpoint surveillance mechanism coordinates dna repair delaying progress cell cycle following dna damage 1 delay allows time cells repair dna replication segregation defective chromosomes thus preventing propagation heritable genetic errors prokaryotes dna damage blocks cell division activating sos feedback control system 2 prevents cell division increases capacity repair damaged dna yeast increased genetic instability following irradiation seen mutants rad9 defect g2 checkpoint 3 addition cell cycle checkpoints apoptosis evolved multicellular organisms mechanism ensure integrity organism eliminating cells irreparable dna damage article review sequence specific non sequence specific dna binding p53 protein comment p53 protein guardian genome might orchestrate cellular response dna damage concert dna repair machinery order select among multiple effector pathways toward dna repair survival apoptosis
0.54812837.11375889.html.plaintext.txt	6	p53 guardian genome top abstract introduction p53 guardian regulation p53 sequence p53 non sequence specific references critical role p53 gene maintaining integrity genome evident p53 commonly altered gene human cancer mutation frequency exceeding 50 4 mutations missense mutations within evolutionarily conserved dna binding domain 5 mutation p53 gene results loss p53 function also gain oncogenic functions 6 adoption dominant negative conformation able inactivate protein product normal allele heterotetramerization 7 germline mutations p53 found li fraumeni syndrome inherited disorder high risk developing variety cancers early age 8 impact p53 alterations tumorigenesis considerably statistics p53 gene mutation indicate wild type p53 may functionally inactivated mechanisms p53 protein inactivated viral oncogenes defects p53 activation pathway dna tumor viruses evolved mechanisms order gain advantage replicate genome e6 protein human papillomavirus hpv cervical carcinoma degrades p53 ubiquitin mediated proteolysis 9 hepatitis b viruses hbv involved pathogenesis 90 human hepatocarcinoma encode hbxag binds n terminal domain p53 inactivates transactivation activity 10 sv40 viral antigen abolishes dna binding activity p53 associating dna binding domain p53 11 adenoviral e1b protein inhibits transactivation activity p53 protein 12 although sv40 adenovirus transform primarily rodent cells exemplify mechanisms cellular proteins yet recognized might inactivate p53 human cancer
0.54812837.11375889.html.plaintext.txt	7	research last decade reveals p53 protein dispensable normal development pivotal cellular response dna damage p53 activity tightly controlled negligible levels normal cells p53 protein rapidly induced dna damage stimuli ionizing irradiation 13 uv light 14 ribonucleotide depletion 15 induction p53 achieved post translational mechanism reduces p53 turnover induced p53 functions transcription factor downstream genes function pathways cell cycle regulation apoptosis dna repair transactivation inhibitor cyclin dependent kinase cdk p21 one better understood mechanisms p53 response dna damage 16 addition cdk inhibition p21 binds proliferating cell nuclear antigen pcna binding preferentially inhibits processivity dna polymerase dna replication dna repair may contribute coordinating growth arrest dna repair phase 17
0.54812837.11375889.html.plaintext.txt	8	research last decade reveals p53 protein dispensable normal development pivotal cellular response dna damage p53 activity tightly controlled negligible levels normal cells p53 protein rapidly induced dna damage stimuli ionizing irradiation 13 uv light 14 ribonucleotide depletion 15 induction p53 achieved post translational mechanism reduces p53 turnover induced p53 functions transcription factor downstream genes function pathways cell cycle regulation apoptosis dna repair transactivation inhibitor cyclin dependent kinase cdk p21 one better understood mechanisms p53 response dna damage 16 addition cdk inhibition p21 binds proliferating cell nuclear antigen pcna binding preferentially inhibits processivity dna polymerase dna replication dna repair may contribute coordinating growth arrest dna repair phase 17
0.54812837.11375889.html.plaintext.txt	9	far 20 p53 downstream genes identified 18 involved diverse cellular activities p21 g1 growth arrest 14 3 3 g2m checkpoint bax p53 induced genes pigs apoptosis gadd45 xpe dna repair common feature downstream genes contain one p53 consensus binding sites regulatory regions p53 consensus binding site contains two copies 10 bp half site 5 pupupucattagpypypy 3 19 p53 protein binds complete consensus site tetramer crystallographic analysis p53 protein binding consensus dna revealed four evolutionarily conserved regions within dna binding domain directly contact major minor grooves p53 consensus dna 20 residues frequently mutated human cancers make critical contributions dna binding directly contacting dna fostering conformation support dna binding 90 p53 mutations located within sequence specific dna binding domain 5 indicates importance p53 dna binding response dna damage therefore important understand p53 binding dna regulated
0.54812837.11375889.html.plaintext.txt	10	far 20 p53 downstream genes identified 18 involved diverse cellular activities p21 g1 growth arrest 14 3 3 g2m checkpoint bax p53 induced genes pigs apoptosis gadd45 xpe dna repair common feature downstream genes contain one p53 consensus binding sites regulatory regions p53 consensus binding site contains two copies 10 bp half site 5 pupupucattagpypypy 3 19 p53 protein binds complete consensus site tetramer crystallographic analysis p53 protein binding consensus dna revealed four evolutionarily conserved regions within dna binding domain directly contact major minor grooves p53 consensus dna 20 residues frequently mutated human cancers make critical contributions dna binding directly contacting dna fostering conformation support dna binding 90 p53 mutations located within sequence specific dna binding domain 5 indicates importance p53 dna binding response dna damage therefore important understand p53 binding dna regulated
0.54812837.11375889.html.plaintext.txt	11	regulation p53 sequence specific binding dna top abstract introduction p53 guardian regulation p53 sequence p53 non sequence specific references covalent modification p53 protein induction post transcriptional modification response dna damage mechanism permits rapid activation avoids relying transcription potentially damaged dna template n c terminal domains p53 protein subjected extensive covalent modifications phosphorylation acetylation sumolation shown human p53 table modifications contribute p53 regulation affecting dna binding degradation localization oligomerization association cellular factors since many excellent reviews p53 modifications 21 focus mainly modifications regulate p53 dna binding phosphorylation s378 pkc enhances p53 binding dna similarly c terminal p53 activating antibody pab421 22 phosphorylation s392 correlated increased dna binding probably facilitating p53 tetramerization phosphorylations c terminal amino acids generally enhance p53 sequence specific binding dna conflicting results phosphorylation s315 cdk enhances p53 binding specific dna confers binding site preference 23 however dephosphorylation site reportedly facilitate tetramerization nuclear localization critical p53 function 24 remains tested whether phosphorylation s376 correlated dna binding regulation enhanced p53 binding specific dna associated phosphorylation s376 cyclin activated kinase cak one report 25 14 3 3 binding p53 dependent upon dephosphorylation s376 another report 26 studies suggest p53 modification complex process involving multiple enzymes acting sequence although direct effect p53 dna binding increased phosphorylation n terminal amino acids 27 phosphorylation s15 s37 recruits p300cbp protein acetylates lysines 373 382 c terminus resulting activation p53 binding specific dna 28 phosphorylation s15 s37 chk1 chk2 heavily dependent upon tetramerization p53 29 tetramerization p53 protein facilitated phosphorylation p53 s392 dephosphorylation s315 24 regulation p53 multiple levels provides means p53 protein select among downstream events response diverse genotoxic stress signals testing cascade events cells responding dna damage major ongoing challenge even greater challenge determine p53 modifications might confer specificity transactivation 20 p53 downstream genes dna sequence variation p53 binding sites genes complexity possible p53 modifications provide mechanism specificity relaying signals different genotoxic oncogenic pathways different downstream genes
0.54812837.11375889.html.plaintext.txt	12	view table table p53 protein post translational modifications effects p53 associated factors although dna binding domain p53 binds well specific dna 30 binding highly subject regulation regions p53 protein hypothesized p53 dna binding subject allosteric regulation c terminal domains lock p53 tetramers latent state dna binding 31 inhibition overcome c terminal modifications phosphorylation proteolytic truncation alternative splicing association cellular factors 32 potential p53 regulation p53 associated factors long implicated vitro dna binding activation pab421 recognizes c terminal amino acids 372 381 number cellular viral proteins identified p53 associated factors biological relevance associations remains verified several cellular factors shown bind c terminal region p53 activate dna binding activity 14 3 3 p53 downstream gene mediates g2 arrest sequestering phosphorylated cdc25c 33 upon dephosphorylation s376 14 3 3 binds p53 enhances dna binding activity thus forming positive feedback loop p53 26 c abl non receptor tyrosine kinase activated dna damage mediates phosphorylation jnk p38 mapk 3435 jnk p38 mapk kinases phosphorylate p53 dna damage dependent manner recently nie et al reported c abl capable binding p53 stabilizing dna binding 36 activation p53 dna binding c abl independent kinase activity direct activation p53 dna binding may synergize c abl kinase cascade mediated p53 activation amplify response dna damage although n terminal domain p53 frequently targeted transcriptional repression cellular viral oncogenes 123738 evidence n terminal association may participate regulation p53 dna binding ways replication protein rpa single stranded dna ssdna binding protein binds n terminus p53 vitro study miller et al showed association rpa blocks p53 binding specific dna 39 association rpa p53 disrupted ssdna dna repair dependent phosphorylation rpa 40 c terminal associations generally linked enhanced dna binding outcomes n terminal interactions less consistent zauberman et al found mdm2 protein association abolishes p53 binding specific dna cell lysates determined means mckay assay 41 however complex p53 dna mdm2 detected purified recombinant proteins emsa 42 nevertheless authenticity biological relevance associations need evaluated context general transcription machinery p53 associated several general transcription factors including tfiid tfiih p300cbp 43 45 transcription factors form multiprotein complexes span n c terminal domains p53 protein example p62 polypeptide component tfiih binds p53 n terminus whereas xpd xpb tfiih bind c terminus found p53 dna binding stabilized association tfiid p300cbp association p53 general transcription factors may closely reflect nature p53 regulation chromatin context
0.54812837.11375889.html.plaintext.txt	13	chromatin architecture unfolding chromatin structure required transcription histone acetyltransferase activity associated number transcriptional activators p300cbp creb binding protein pcaf p300cbp associated factor tafii250 tata binding protein associated factor 46 addition acetylating p53 protein lysine 373 382 28 binding n terminally phosphorylated p53 could position p300cbp open nucleosomes recruitment transcription factors promoters p53 downstream genes p53 binding sites p53 downstream genes vary position relative promoter two p53 binding sites waf 1 gene located 2 3 kb upstream transcription start site 16 two p53 binding sites separated 17 bp located 15 kb downstream start site within first intron mdm2 gene 47 p53 binding sites cyclin g gene separated half kilobase interval first exon 48 dna loop formation described mechanism transactivation mediated stacking tetramers central domain p53 protein 49 recently observed active dna binding p53 protein absence pab421 endogenous mdm2 p53 binding sequence two p53 binding sites separated 17 bp sequence two mdm2 p53 binding sites replaced waf 1 sites 121 unpublished data moreover p53 binding double sites could fully competed either single site p53 binding dna like dna binding proteins represents dynamic onoff state 50 chance dissociating two p53 dna complexes simultaneously much lower single binding therefore formation multi p53 dna complex may provide stable scaffold transcription machinery well enhance complexity p53 regulation
0.54812837.11375889.html.plaintext.txt	14	chromatin architecture unfolding chromatin structure required transcription histone acetyltransferase activity associated number transcriptional activators p300cbp creb binding protein pcaf p300cbp associated factor tafii250 tata binding protein associated factor 46 addition acetylating p53 protein lysine 373 382 28 binding n terminally phosphorylated p53 could position p300cbp open nucleosomes recruitment transcription factors promoters p53 downstream genes p53 binding sites p53 downstream genes vary position relative promoter two p53 binding sites waf 1 gene located 2 3 kb upstream transcription start site 16 two p53 binding sites separated 17 bp located 15 kb downstream start site within first intron mdm2 gene 47 p53 binding sites cyclin g gene separated half kilobase interval first exon 48 dna loop formation described mechanism transactivation mediated stacking tetramers central domain p53 protein 49 recently observed active dna binding p53 protein absence pab421 endogenous mdm2 p53 binding sequence two p53 binding sites separated 17 bp sequence two mdm2 p53 binding sites replaced waf 1 sites 121 unpublished data moreover p53 binding double sites could fully competed either single site p53 binding dna like dna binding proteins represents dynamic onoff state 50 chance dissociating two p53 dna complexes simultaneously much lower single binding therefore formation multi p53 dna complex may provide stable scaffold transcription machinery well enhance complexity p53 regulation
0.54812837.11375889.html.plaintext.txt	15	p53 binding dna affected dna structure also chromatin nuclear proteins high mobility group protein 1 hmg 1 non histone chromosomal protein shown activate p53 dna binding 51 perhaps mediated dna bending stabilizes p53 dna complex formation unlike p53 activators hmg 1 present p53 dna complex hmg 1 may allow p53 overcome energy barrier bend dna intermediate step p53 binding dna dna bending common mechanism transactivation helps formation stable dna protein complexes also assembly transcription complexes chromatin context however understanding p53 regulation chromatin level largely limited speculations vitro studies depend upon new development technology vivo evidence recently rubbi milner provided evidence p53 preferentially localized sites active rna synthesis 52 p53 protein also associates centrosome first shown brown et al 53 deppert found mutant p53 protein anchors matrix associated regions mar elements 54 far one demonstrated wild type p53 associations nuclear matrix chromatin situ powerful analytical microscopy image analysis p53 localization associations cells defined contribute better understanding p53 regulation activity
0.54812837.11375889.html.plaintext.txt	16	p53 binding dna affected dna structure also chromatin nuclear proteins high mobility group protein 1 hmg 1 non histone chromosomal protein shown activate p53 dna binding 51 perhaps mediated dna bending stabilizes p53 dna complex formation unlike p53 activators hmg 1 present p53 dna complex hmg 1 may allow p53 overcome energy barrier bend dna intermediate step p53 binding dna dna bending common mechanism transactivation helps formation stable dna protein complexes also assembly transcription complexes chromatin context however understanding p53 regulation chromatin level largely limited speculations vitro studies depend upon new development technology vivo evidence recently rubbi milner provided evidence p53 preferentially localized sites active rna synthesis 52 p53 protein also associates centrosome first shown brown et al 53 deppert found mutant p53 protein anchors matrix associated regions mar elements 54 far one demonstrated wild type p53 associations nuclear matrix chromatin situ powerful analytical microscopy image analysis p53 localization associations cells defined contribute better understanding p53 regulation activity
0.54812837.11375889.html.plaintext.txt	17	redox modification hainaut milner shown specific dna binding p53 highly dependent upon reduction state p53 protein 55 p53 protein unique zinc finger composed c176 h179 c238 c242 zinc finger forms dna binding interface bridging two loop helix structures dna binding domain additional seven cysteine residues involved direct dna binding conformation dna binding domain mutations cysteine residues result loss p53 dna binding activity 56 presence cysteine residues critical positions p53 protein renders susceptible regulation cellular redox status p53 specific binding dna requires thiol reducing agent like dithiothreitol dtt oxidation p53 thiol oxidants like diamide abolishes p53 binding specific dna similar effect achieved metal chelation since zinc binding correlated thiol reduction considering oxidative stress caused dna damage genotoxic stimuli essential cell maintain reductive state p53 function cellular redox state maintained highly efficient manner antioxidant molecules enzymes like glutathione thioredoxin superoxide dismutase addition scavenging oxidants participate transcription regulation response oxidative stress example thioredoxin thiol reducing molecule capable stimulating dna binding activity various transcription factors like nfb 57 ap 1 58 recently thioredoxin shown enhance p53 dna binding transactivation 59 p53 transcriptional activity suppressed yeast strains thioredoxin reductase mutation deletion 6061 interestingly p53 binding specific dna activated ref 1 dual functional protein serves ap endonuclease ber modulates dna binding various transcription factors response oxidative stress 62 since dna damage associated production oxygen free radical species regulation p53 ref 1 may provide mechanism coordinate dna repair redox states addition modulated redox proteins p53 participates redox metabolism transactivation reducing molecules like glutathione peroxidase repression oxidating molecules like nitric oxide synthase 6364 accumulating evidence suggests p53 pathway integrates signals dna strand breaks also oxidative stress pathways
0.54812837.11375889.html.plaintext.txt	18	redox modification hainaut milner shown specific dna binding p53 highly dependent upon reduction state p53 protein 55 p53 protein unique zinc finger composed c176 h179 c238 c242 zinc finger forms dna binding interface bridging two loop helix structures dna binding domain additional seven cysteine residues involved direct dna binding conformation dna binding domain mutations cysteine residues result loss p53 dna binding activity 56 presence cysteine residues critical positions p53 protein renders susceptible regulation cellular redox status p53 specific binding dna requires thiol reducing agent like dithiothreitol dtt oxidation p53 thiol oxidants like diamide abolishes p53 binding specific dna similar effect achieved metal chelation since zinc binding correlated thiol reduction considering oxidative stress caused dna damage genotoxic stimuli essential cell maintain reductive state p53 function cellular redox state maintained highly efficient manner antioxidant molecules enzymes like glutathione thioredoxin superoxide dismutase addition scavenging oxidants participate transcription regulation response oxidative stress example thioredoxin thiol reducing molecule capable stimulating dna binding activity various transcription factors like nfb 57 ap 1 58 recently thioredoxin shown enhance p53 dna binding transactivation 59 p53 transcriptional activity suppressed yeast strains thioredoxin reductase mutation deletion 6061 interestingly p53 binding specific dna activated ref 1 dual functional protein serves ap endonuclease ber modulates dna binding various transcription factors response oxidative stress 62 since dna damage associated production oxygen free radical species regulation p53 ref 1 may provide mechanism coordinate dna repair redox states addition modulated redox proteins p53 participates redox metabolism transactivation reducing molecules like glutathione peroxidase repression oxidating molecules like nitric oxide synthase 6364 accumulating evidence suggests p53 pathway integrates signals dna strand breaks also oxidative stress pathways
0.54812837.11375889.html.plaintext.txt	19	single stranded dna addition activation mechanisms ssdna stimulates p53 binding specific dna jayaraman prives found p53 binding gadd45 p53 binding site enhanced ssdna detected dnase protection assay 65 even interesting short oligonucleotides 40 bases length capable activating p53 sequence specific dna binding activation completely reversed increasing length oligomer 66 bases p53 protein found bind ssdna facilitate annealing strand transfer 66 deletion analysis revealed c terminal domain p53 protein binds end dna strand whereas central domain contributes binding internal segment ssdna 67 inhibitory effect long oligonucleotides may attributed ability bind central domain therefore competing specific dna binding 68 binding site ssdna mapped residues 361 382 p53 protein including region p53 activated pab421 binding s378 phosphorylation data imply removal negative control imposed c terminal domain mechanism ssdna binding activates p53
0.54812837.11375889.html.plaintext.txt	20	single stranded dna addition activation mechanisms ssdna stimulates p53 binding specific dna jayaraman prives found p53 binding gadd45 p53 binding site enhanced ssdna detected dnase protection assay 65 even interesting short oligonucleotides 40 bases length capable activating p53 sequence specific dna binding activation completely reversed increasing length oligomer 66 bases p53 protein found bind ssdna facilitate annealing strand transfer 66 deletion analysis revealed c terminal domain p53 protein binds end dna strand whereas central domain contributes binding internal segment ssdna 67 inhibitory effect long oligonucleotides may attributed ability bind central domain therefore competing specific dna binding 68 binding site ssdna mapped residues 361 382 p53 protein including region p53 activated pab421 binding s378 phosphorylation data imply removal negative control imposed c terminal domain mechanism ssdna binding activates p53
0.54812837.11375889.html.plaintext.txt	21	ssdna segments products intermediates dna repair dna replication production ssdna 5 3 exonuclease end dna strand break initial step repair double stranded dna dsdna breaks homologous recombination 69 ssdna gaps also formed excision damaged dna ner ber ssdna vulnerable nuclease attack active dna recombination therefore well protected ssdna binding proteins dna repair replication accumulation ssdna evident cells subjected dna damage considerable evidence suggests ssdna mediates sos response bacteria cell cycle checkpoints yeast 70 activation p53 ssdna seems attractive model p53 coordinate cellular response dna damage however almost impossible p53 activated damage site transactivate distant downstream genes short ssdna generated excision repair rapidly degraded cell plausible model ssdna binding effects p53 protein may activation p53 protein enhanced non sequence dependent binding adjacent dsdna
0.54812837.11375889.html.plaintext.txt	22	ssdna segments products intermediates dna repair dna replication production ssdna 5 3 exonuclease end dna strand break initial step repair double stranded dna dsdna breaks homologous recombination 69 ssdna gaps also formed excision damaged dna ner ber ssdna vulnerable nuclease attack active dna recombination therefore well protected ssdna binding proteins dna repair replication accumulation ssdna evident cells subjected dna damage considerable evidence suggests ssdna mediates sos response bacteria cell cycle checkpoints yeast 70 activation p53 ssdna seems attractive model p53 coordinate cellular response dna damage however almost impossible p53 activated damage site transactivate distant downstream genes short ssdna generated excision repair rapidly degraded cell plausible model ssdna binding effects p53 protein may activation p53 protein enhanced non sequence dependent binding adjacent dsdna
0.54812837.11375889.html.plaintext.txt	23	p53 non sequence specific binding dna biological relevance top abstract introduction p53 guardian regulation p53 sequence p53 non sequence specific references addition binding specifically dna p53 consensus sites p53 binds non specifically dna besides ssdna noted p53 capable binding dna duplex free ends nicked dna generated dnase dna damaged irradiation 71 dna duplex insertion deletion lesion idl mismatches 72 dna holliday junctions 73 triple stranded dna 74 dna single stranded gaps cprives 10th p53 workshop dna structures represent intermediates dna damage dna repair binding non specific dna primarily mapped c terminal domain p53 protein non sequence specific dna binding c terminal polypeptide competed specific dna 30 c terminal domain p53 protein responsible binding ssdna mentioned binding ssdna activates p53 bind sequence specifically non sequence specifically dna 2 nt overhang dna segment sufficient activate binding p53 protein 67 although c terminal domain p53 protein sufficient non sequence specific dna binding binding affinity always lower full length p53 protein implying participation central domain crystallographic analysis p53 central domain reveals flexible structure ideal binding dsdna indeed central domain capable binding non sequence specifically dna p53 protein last 30 amino acids truncated bind non sequence specifically dsdna 68 remains determined ssdna binding p53 binding non specific dsdna largely dependent upon wild type conformation 75 p53 protein binding dna duplex idl mismatches reported wild type specific 76 binding competed dna p53 consensus site unpublished data thus p53 binding non sequence specifically dna likely synergistic c terminal binding ssdna central domain binding dsdna survey dna templates targeted p53 non sequence specific binding reveals general structure composed ssdna dna duplex context summarized figure 1 refer region ssdna adjacent dsdna single strandeddouble stranded dna transition sds dna common structure may explain ability p53 protein bind dna damage induced many different agents
0.54812837.11375889.html.plaintext.txt	24	view larger version 23k fig 1 structures dna targeted non sequence specific binding p53 protein ssdna regions indicated bold structures shown exception ssdna common feature ssdna adjacent dsdna referred sds dna idl indicates insertion deletion lesion
0.54812837.11375889.html.plaintext.txt	25	sds dna transitions generated dna repair dna replication dna structures recognized dna repair proteins checkpoint proteins mediate cellular response dna damage unwinding damaged dna duplex form bubble ss dsdna junctures essential ner y shaped dna dna bubbles recognized incised uv light response induced dna repair protein uvrbc absence uvra 77 analysis dna dependent protein kinase dna pk electron crystallography suggests dna pk binds sds dna separate binding sites one dsdna one ssdna 78 binding sds dna activates kinase activities evidence supporting concept sds dna signal activate p53 protein induction p53 found dependent upon presence unwound dna intermediates ner 79 microinjection dsdna 4 nt 5 overhangs dna duplexes blunt ends induces p53 dependent growth arrest fibroblasts 80 clear p53 activation sds dna mediated checkpoint proteins phosphatidyl inositol 3 kinase activity like atm atr dna pk biological relevance p53 binding sds dna still matter speculation albrechtsen et al recently reviewed activation status p53 protein particular attention role p53 protein dna repair 81 following sections discuss possible biological functions p53 protein non sequence specific binding dna
0.54812837.11375889.html.plaintext.txt	26	sds dna transitions generated dna repair dna replication dna structures recognized dna repair proteins checkpoint proteins mediate cellular response dna damage unwinding damaged dna duplex form bubble ss dsdna junctures essential ner y shaped dna dna bubbles recognized incised uv light response induced dna repair protein uvrbc absence uvra 77 analysis dna dependent protein kinase dna pk electron crystallography suggests dna pk binds sds dna separate binding sites one dsdna one ssdna 78 binding sds dna activates kinase activities evidence supporting concept sds dna signal activate p53 protein induction p53 found dependent upon presence unwound dna intermediates ner 79 microinjection dsdna 4 nt 5 overhangs dna duplexes blunt ends induces p53 dependent growth arrest fibroblasts 80 clear p53 activation sds dna mediated checkpoint proteins phosphatidyl inositol 3 kinase activity like atm atr dna pk biological relevance p53 binding sds dna still matter speculation albrechtsen et al recently reviewed activation status p53 protein particular attention role p53 protein dna repair 81 following sections discuss possible biological functions p53 protein non sequence specific binding dna
0.54812837.11375889.html.plaintext.txt	27	p53 damage sensor prevalent hypothesis biological relevance p53 binding altered dna structures p53 damage sensor accordingly p53 recognizes damaged dna recruits dna repair machinery damaged site identification dna repair proteins xpb xpd p53 associated factors well phosphorylation p53 protein cak addition activate p53 sequence specific binding strongly favor idea although p53 binding damaged mismatched dna resembles mismatch repair sensor msh2 evidence show p53 protein participates mismatch repair dna repair machinery complex factor sense damaged dna binding damaged dna sensor avid highly specific target appropriate dna repair machinery particular type dna damage example xpc hhr23b damage sensor ner binds specifically pyrimidine dimers kd value 5x10 9 specifically recruits xpa tfiih damage site 82 p53 protein offers obvious specificity particular repair machinery binds different types dna structures proteins involved different types repair like xpb xpd ner rad51 dna recombination since dna repair proteins already components sense dna damage cell require p53 protein strictly damage sensor
0.54812837.11375889.html.plaintext.txt	28	p53 damage sensor prevalent hypothesis biological relevance p53 binding altered dna structures p53 damage sensor accordingly p53 recognizes damaged dna recruits dna repair machinery damaged site identification dna repair proteins xpb xpd p53 associated factors well phosphorylation p53 protein cak addition activate p53 sequence specific binding strongly favor idea although p53 binding damaged mismatched dna resembles mismatch repair sensor msh2 evidence show p53 protein participates mismatch repair dna repair machinery complex factor sense damaged dna binding damaged dna sensor avid highly specific target appropriate dna repair machinery particular type dna damage example xpc hhr23b damage sensor ner binds specifically pyrimidine dimers kd value 5x10 9 specifically recruits xpa tfiih damage site 82 p53 protein offers obvious specificity particular repair machinery binds different types dna structures proteins involved different types repair like xpb xpd ner rad51 dna recombination since dna repair proteins already components sense dna damage cell require p53 protein strictly damage sensor
0.54812837.11375889.html.plaintext.txt	29	p53 dna repair effector p53 protein primarily damage sensor directly involved repair several biochemical properties associated p53 non sequence specific binding dna suggested direct involvement dna repair p53 protein able mediate ssdna reannealing dna strand transfer 667183 activities resemble dna strand invasion single strand annealing homologous recombination homologous recombination well conserved cellular mechanism repair damaged dna mediate chromatin exchange crossover normal cellular processes like antibody generation meiosis recombination also common cause chromosomal abnormality cancer development results vivo studies show inter intra chromosomal recombination significantly inhibited wild type p53 8485 indicates p53 may function regulator dna recombination recognizing dna ends reannealing ssdna block abnormal recombination however possible dna recombination enhanced high levels p53 protein binding c terminus domain mutant p53 remains intact cases stabilization mutant makes highly available genetically destabilizing activity suggested increased non homologous recombination may contribute gain function phenotype associated p53 mutants implicated p53 c terminal activation topoisomerase catalytic activity 86 vitro vivo studies shown p53 protein capable rejoining dna double strand breaks indicating role non homologous end joining nhej 808788 although nhej required preventing chromosomal translocation 8990 lack specificity dna end rejoining p53 protein may contribute gain function phenotype mutant p53 equally active rejoining dna ends 8788
0.54812837.11375889.html.plaintext.txt	30	p53 dna repair effector p53 protein primarily damage sensor directly involved repair several biochemical properties associated p53 non sequence specific binding dna suggested direct involvement dna repair p53 protein able mediate ssdna reannealing dna strand transfer 667183 activities resemble dna strand invasion single strand annealing homologous recombination homologous recombination well conserved cellular mechanism repair damaged dna mediate chromatin exchange crossover normal cellular processes like antibody generation meiosis recombination also common cause chromosomal abnormality cancer development results vivo studies show inter intra chromosomal recombination significantly inhibited wild type p53 8485 indicates p53 may function regulator dna recombination recognizing dna ends reannealing ssdna block abnormal recombination however possible dna recombination enhanced high levels p53 protein binding c terminus domain mutant p53 remains intact cases stabilization mutant makes highly available genetically destabilizing activity suggested increased non homologous recombination may contribute gain function phenotype associated p53 mutants implicated p53 c terminal activation topoisomerase catalytic activity 86 vitro vivo studies shown p53 protein capable rejoining dna double strand breaks indicating role non homologous end joining nhej 808788 although nhej required preventing chromosomal translocation 8990 lack specificity dna end rejoining p53 protein may contribute gain function phenotype mutant p53 equally active rejoining dna ends 8788
0.54812837.11375889.html.plaintext.txt	31	although p53 binds ssdna mismatched dna direct evidence support involvement p53 either ner mismatch repair cell free systems obvious dna repair defects p53 knock mice observations suggest p53 guardian genome primarily involved dna repair however offer et al recently provided evidence p53 participates ber 91 incorporation radiolabeled dntp depurinated plasmids nuclear extracts indicative ber activity enhanced cells expressing wild type p53 reduced cells expressing mutant p53 proteins experimental evidence show p53 participates ber mummenbrauer et al found wild type p53 protein possesses intrinsic 3 5 exonuclease activity presence magnesium ions 92 activity localized central domain p53 protein based deletion analysis structural similarity catalytic domain exonuclease iii escherichia coli 3 5 exonuclease activity common mechanism ensure sequence fidelity dna replication dna repair activity provides molecular basis p53 involvement ber also dna repair machinery complexes proofreading necessary exonuclease activity p53 seems mutually exclusive specific dna binding activity c terminal domain negatively controls specific dna binding exonuclease activity p53 exonuclease activity p53 inhibited activation events specific dna binding phosphorylation pab421 association inhibition 3 5 exonuclease activity pab421 phosphorylation events activate p53 suggest association latent p53 proteins 81 however binding non specific dna also affected activation events noted latent activated p53 proteins capable binding indicating general function p53 proteins binding non sequence specifically dna
0.54812837.11375889.html.plaintext.txt	32	although p53 binds ssdna mismatched dna direct evidence support involvement p53 either ner mismatch repair cell free systems obvious dna repair defects p53 knock mice observations suggest p53 guardian genome primarily involved dna repair however offer et al recently provided evidence p53 participates ber 91 incorporation radiolabeled dntp depurinated plasmids nuclear extracts indicative ber activity enhanced cells expressing wild type p53 reduced cells expressing mutant p53 proteins experimental evidence show p53 participates ber mummenbrauer et al found wild type p53 protein possesses intrinsic 3 5 exonuclease activity presence magnesium ions 92 activity localized central domain p53 protein based deletion analysis structural similarity catalytic domain exonuclease iii escherichia coli 3 5 exonuclease activity common mechanism ensure sequence fidelity dna replication dna repair activity provides molecular basis p53 involvement ber also dna repair machinery complexes proofreading necessary exonuclease activity p53 seems mutually exclusive specific dna binding activity c terminal domain negatively controls specific dna binding exonuclease activity p53 exonuclease activity p53 inhibited activation events specific dna binding phosphorylation pab421 association inhibition 3 5 exonuclease activity pab421 phosphorylation events activate p53 suggest association latent p53 proteins 81 however binding non specific dna also affected activation events noted latent activated p53 proteins capable binding indicating general function p53 proteins binding non sequence specifically dna
0.54812837.11375889.html.plaintext.txt	33	p53 protein mediate apoptosis checkpoint p53 mediated dna repair critical maintaining genomic integrity p53 related dna repair function well conserved bacteria humans however p53 newly discovered members p53 gene family present multicellular organisms p73 p63 family members bind p53 consensus 9394 date reports capacity non sequence specific binding example mismatched dna p53 homolog drosophila primitive relative p53 identified far drosophila p53 mediates dna damage induced apoptosis growth arrest suggesting primitive function p53 mediate apoptosis genome maintenance 95 97 eliminating cells damaged dna apoptosis vital multicellular organisms prevent genetic transformation 98 generally accepted p53 mediated apoptosis p53 induced cell cycle checkpoints two major mechanisms p53 protein activity tumor suppressor p53 mediated cell cycle checkpoint activated checkpoint proteins well conserved yeast atm atr chk2 however mechanism p53 mediated apoptosis largely unknown despite identification apoptosis related genes downstream transcriptional targets p53 far clear p53 mediates growth arrest certain cells apoptosis others responding dna damage given cell type determines response different dna damaging agents even different doses agent clearly certain signals sensed p53 protein trigger apoptosis pathway given role p53 guardian genome unrepaired dna legitimate signal p53 protein direct cell towards apoptosis pathway evidence dna damage repaired activation p53 lead apoptosis 90 binding sds dna defined suggests biochemical basis whereby p53 protein might monitor apoptosis checkpoint response variety types dna damage rather sensing damage primarily recruit repair proteins p53 protein may sense equilibrium amounts damaged dna available dna repair proteins equilibrium would dependent upon p53 protein modification state level p53 protein accumulation level dna damage capacity damaged cell repair since sds dna also targeted dna repair proteins like rpa rad51 tempting propose p53 proteins dna repair proteins competing sds dna dynamically reflected equation sds dna p53dna repair proteins apoptosis according scheme represented figure 2 dna damage leads accumulation activated p53 proteins increased affinity dna distinct p53 modifications may target different genes certain cells higher capacity repair less capacity rapid renewal might arrest repair survive levels repair proteins generally far exceed p53 protein sites damaged dna would occupied predominantly dna repair proteins damage mild however even limited levels p53 protein may bind damaged dna threshold dna repair protein availability alternatively high levels p53 induced dna damage oncogenic events could compete dna repair proteins limited amount dna lesions triggering apoptosis abundant evidence apoptosis highly correlated level p53 protein extent dna damage 99 furthermore increased apoptosis linked p53 dna repair inhibited inactivation polyadp ribose polymerase parp ubiquitous dna binding protein involved repair possibly apoptosis 100 possible test proposed apoptotic checkpoint equation microinjection fluorescein labeled sds dna cells huang et al reported microinjection plasmid long gap dna 5 overhang fibroblasts induced p53 dependent growth arrest 80 cells apoptotic potential could used test hypothesis sds dna dosage extent association p53 sds dna directly correlated p53 dependent apoptosis comparison fibroblasts refractory apoptosis epithelial cells competent apoptosis might provide clues cell type specific transcriptional events lead survival apoptosis apoptosis checkpoint controlled p53 binding non sequence specifically dna hypothetical provides framework explaining p53 mediated apoptosis dependent upon cell type extent dna damage apoptosis likely induced cells less robust dna repair proteins
0.54812837.11375889.html.plaintext.txt	34	p53 protein mediate apoptosis checkpoint p53 mediated dna repair critical maintaining genomic integrity p53 related dna repair function well conserved bacteria humans however p53 newly discovered members p53 gene family present multicellular organisms p73 p63 family members bind p53 consensus 9394 date reports capacity non sequence specific binding example mismatched dna p53 homolog drosophila primitive relative p53 identified far drosophila p53 mediates dna damage induced apoptosis growth arrest suggesting primitive function p53 mediate apoptosis genome maintenance 95 97 eliminating cells damaged dna apoptosis vital multicellular organisms prevent genetic transformation 98 generally accepted p53 mediated apoptosis p53 induced cell cycle checkpoints two major mechanisms p53 protein activity tumor suppressor p53 mediated cell cycle checkpoint activated checkpoint proteins well conserved yeast atm atr chk2 however mechanism p53 mediated apoptosis largely unknown despite identification apoptosis related genes downstream transcriptional targets p53 far clear p53 mediates growth arrest certain cells apoptosis others responding dna damage given cell type determines response different dna damaging agents even different doses agent clearly certain signals sensed p53 protein trigger apoptosis pathway given role p53 guardian genome unrepaired dna legitimate signal p53 protein direct cell towards apoptosis pathway evidence dna damage repaired activation p53 lead apoptosis 90 binding sds dna defined suggests biochemical basis whereby p53 protein might monitor apoptosis checkpoint response variety types dna damage rather sensing damage primarily recruit repair proteins p53 protein may sense equilibrium amounts damaged dna available dna repair proteins equilibrium would dependent upon p53 protein modification state level p53 protein accumulation level dna damage capacity damaged cell repair since sds dna also targeted dna repair proteins like rpa rad51 tempting propose p53 proteins dna repair proteins competing sds dna dynamically reflected equation sds dna p53dna repair proteins apoptosis according scheme represented figure 2 dna damage leads accumulation activated p53 proteins increased affinity dna distinct p53 modifications may target different genes certain cells higher capacity repair less capacity rapid renewal might arrest repair survive levels repair proteins generally far exceed p53 protein sites damaged dna would occupied predominantly dna repair proteins damage mild however even limited levels p53 protein may bind damaged dna threshold dna repair protein availability alternatively high levels p53 induced dna damage oncogenic events could compete dna repair proteins limited amount dna lesions triggering apoptosis abundant evidence apoptosis highly correlated level p53 protein extent dna damage 99 furthermore increased apoptosis linked p53 dna repair inhibited inactivation polyadp ribose polymerase parp ubiquitous dna binding protein involved repair possibly apoptosis 100 possible test proposed apoptotic checkpoint equation microinjection fluorescein labeled sds dna cells huang et al reported microinjection plasmid long gap dna 5 overhang fibroblasts induced p53 dependent growth arrest 80 cells apoptotic potential could used test hypothesis sds dna dosage extent association p53 sds dna directly correlated p53 dependent apoptosis comparison fibroblasts refractory apoptosis epithelial cells competent apoptosis might provide clues cell type specific transcriptional events lead survival apoptosis apoptosis checkpoint controlled p53 binding non sequence specifically dna hypothetical provides framework explaining p53 mediated apoptosis dependent upon cell type extent dna damage apoptosis likely induced cells less robust dna repair proteins
0.54812837.11375889.html.plaintext.txt	35	view larger version 41k fig 2 model p53 protein mediates apoptosis checkpoint response dna damage p53 protein activated dna damaging stimuli multiple post translational modifications cell type andor dna damage specific responses dependent upon transcriptional non transcriptional effects dna binding p53 proteins apoptosis checkpoint determined thresholds p53 proteins damaged dna sds dna relative constant level ubiquitous dna repair proteins see text
0.54812837.11375889.html.plaintext.txt	36	transcriptional non transcriptional p53 dependent arms p53 response dna damage could theoretically exercised independently cooperatively mainly transcriptional events might occur cases p53 induced low levels sds dna non transcriptional events might predominate severely damaged cells transcriptional activities p53 protein compromised conformational changes due oxidative stress 101 cell type specific responses may require cooperation events accumulation proteins encoded p53 downstream target genes tip balance toward survival either due reversible prolonged cell cycle arrest apoptosis apoptosis regulated transcriptional level p53 p53 dependent apoptosis achieved transcription independent manner examples p53 mediated apoptosis presence inhibitors transcription translation 102103 apoptosis mediated p53 mutants lacking transcriptional activities 104 although n terminal proline rich domain c terminus p53 protein required p53 dependent apoptosis 99105 central domain must participate p53 mediated apoptosis tumor cells p53 mutations resistant apoptosis general furthermore certain p53 mutants ala143 his273 substantial transactivation activities defective apoptosis 106107 using p53 dna binding assay applicable cells tissues found p53 mutant his273 human colon carcinoma cell sw480 lost ability bind non specific dna retaining ability bind specific dna unpublished data associates defect p53 binding non sequence specifically dna defect p53 mediated transcription independent apoptosis worthy exploration p53 mutants
0.54812837.11375889.html.plaintext.txt	37	transcriptional non transcriptional p53 dependent arms p53 response dna damage could theoretically exercised independently cooperatively mainly transcriptional events might occur cases p53 induced low levels sds dna non transcriptional events might predominate severely damaged cells transcriptional activities p53 protein compromised conformational changes due oxidative stress 101 cell type specific responses may require cooperation events accumulation proteins encoded p53 downstream target genes tip balance toward survival either due reversible prolonged cell cycle arrest apoptosis apoptosis regulated transcriptional level p53 p53 dependent apoptosis achieved transcription independent manner examples p53 mediated apoptosis presence inhibitors transcription translation 102103 apoptosis mediated p53 mutants lacking transcriptional activities 104 although n terminal proline rich domain c terminus p53 protein required p53 dependent apoptosis 99105 central domain must participate p53 mediated apoptosis tumor cells p53 mutations resistant apoptosis general furthermore certain p53 mutants ala143 his273 substantial transactivation activities defective apoptosis 106107 using p53 dna binding assay applicable cells tissues found p53 mutant his273 human colon carcinoma cell sw480 lost ability bind non specific dna retaining ability bind specific dna unpublished data associates defect p53 binding non sequence specifically dna defect p53 mediated transcription independent apoptosis worthy exploration p53 mutants
0.54812837.11375889.html.plaintext.txt	38	due lack sequence dependence apoptosis mediated sds dna binding protein protein interactions instead transactivation several lines evidence coming laboratory harris others indicate dna repair machinery involved p53 mediated apoptosis p53 mediated apoptosis abrogated cells either xpb xpd mutations restored introduction wild type xp genes 108 attenuation p53 mediated apoptosis also observed cells defect wnr dna helicase mutated werner syndrome 109 first glance observations seem contrary hypothesis since repair defects might expected result higher frequency sds dna increased p53 binding apoptosis however increased p53 binding sds dna may occur apoptosis consequence may blocked repair protein defect repair protein defects may provide clues signal p53 binding sds dna transduced linked apoptosis pathway xpb xpd mutants associated attenuated apoptosis whereas csb mutants result enhanced apoptosis p53 protein found associated xpb xpd csb inhibition helicase activities proteins association p53 suggests enhancement dna repair mechanism p53 maintains genomic integrity least association repair proteins since dna repair necessary cells committed apoptosis associations may primarily involved apoptosis association p53 dna repair proteins suggests transcription independent apoptosis another possibility p53 binding non sequence specifically sites dna damage mediates p53 modifications dna repair machinery modifications may confer specificity p53 dna binding transactivate pro apoptotic genes evidence supporting hypothesis comes p53 modification cak component tfiih 25110 would transcriptional means convey apoptotic signal p53 protein dissociates complex upon modification availability functionally distinct p53 mutants model systems simpler organism drosophila provide tools dissect mechanism p53 mediated apoptosis
0.54812837.11375889.html.plaintext.txt	39	due lack sequence dependence apoptosis mediated sds dna binding protein protein interactions instead transactivation several lines evidence coming laboratory harris others indicate dna repair machinery involved p53 mediated apoptosis p53 mediated apoptosis abrogated cells either xpb xpd mutations restored introduction wild type xp genes 108 attenuation p53 mediated apoptosis also observed cells defect wnr dna helicase mutated werner syndrome 109 first glance observations seem contrary hypothesis since repair defects might expected result higher frequency sds dna increased p53 binding apoptosis however increased p53 binding sds dna may occur apoptosis consequence may blocked repair protein defect repair protein defects may provide clues signal p53 binding sds dna transduced linked apoptosis pathway xpb xpd mutants associated attenuated apoptosis whereas csb mutants result enhanced apoptosis p53 protein found associated xpb xpd csb inhibition helicase activities proteins association p53 suggests enhancement dna repair mechanism p53 maintains genomic integrity least association repair proteins since dna repair necessary cells committed apoptosis associations may primarily involved apoptosis association p53 dna repair proteins suggests transcription independent apoptosis another possibility p53 binding non sequence specifically sites dna damage mediates p53 modifications dna repair machinery modifications may confer specificity p53 dna binding transactivate pro apoptotic genes evidence supporting hypothesis comes p53 modification cak component tfiih 25110 would transcriptional means convey apoptotic signal p53 protein dissociates complex upon modification availability functionally distinct p53 mutants model systems simpler organism drosophila provide tools dissect mechanism p53 mediated apoptosis
0.54812837.11375889.html.plaintext.txt	40	clearly p53 multifunctional protein multiple potential modifications biochemical properties major challenge field correlate biochemical properties biological behaviors cells significantly vivo remaining questions include transcriptional non transcriptional arms p53 response dna damage coordinated specific cell types nature interactions p53 proteins dna repair proteins constitutive induced proteins required p53 dependent apoptosis p53 proteins postulated apoptosis checkpoint trigger next steps apoptosis cascade answer questions dna binding studies must extended test tube cells requiring increasing sensitivity molecular profiling p53 downstream genes means dna chip technology affinity assays cellular p53 protein binding range specific non specific dna templates identification discrete p53 proteins modified phosphorylation acetylation means specific antibodies make powerful combination defining p53 pathway response different genotoxic stresses cells tissues application approaches permit defining p53 response dna damage sequence specific non sequence specific binding dna may reveal p53 selectively turns expression certain sets genes sequence specific dna binding face overwhelming dna damage uses variety dna repair machinery components trigger apoptosis non sequence specific dna binding finally approaches may uncover specific post translationally modified p53 proteins integrate response different upstream signals fully understand p53 proteins orchestrate cellular response dna damage may essential view location extent p53 binding specific dna damaged dna association p53 protein proteins chromatin context cells responding dna damage
0.54812837.11375889.html.plaintext.txt	41	clearly p53 multifunctional protein multiple potential modifications biochemical properties major challenge field correlate biochemical properties biological behaviors cells significantly vivo remaining questions include transcriptional non transcriptional arms p53 response dna damage coordinated specific cell types nature interactions p53 proteins dna repair proteins constitutive induced proteins required p53 dependent apoptosis p53 proteins postulated apoptosis checkpoint trigger next steps apoptosis cascade answer questions dna binding studies must extended test tube cells requiring increasing sensitivity molecular profiling p53 downstream genes means dna chip technology affinity assays cellular p53 protein binding range specific non specific dna templates identification discrete p53 proteins modified phosphorylation acetylation means specific antibodies make powerful combination defining p53 pathway response different genotoxic stresses cells tissues application approaches permit defining p53 response dna damage sequence specific non sequence specific binding dna may reveal p53 selectively turns expression certain sets genes sequence specific dna binding face overwhelming dna damage uses variety dna repair machinery components trigger apoptosis non sequence specific dna binding finally approaches may uncover specific post translationally modified p53 proteins integrate response different upstream signals fully understand p53 proteins orchestrate cellular response dna damage may essential view location extent p53 binding specific dna damaged dna association p53 protein proteins chromatin context cells responding dna damage
0.54812837.11375889.html.plaintext.txt	42	notes 1 correspondence addressed email kuleszmaatohsuedu
0.54812837.11375889.html.plaintext.txt	43	acknowledgments thank jennifer carlson michelle bryant assistance preparation manuscript work laboratory supported nih ca31101 oregon health sciences foundation oregon cancer center grant p30ca69533
0.54812837.11375889.html.plaintext.txt	44	acknowledgments thank jennifer carlson michelle bryant assistance preparation manuscript work laboratory supported nih ca31101 oregon health sciences foundation oregon cancer center grant p30ca69533
0.54812837.11375889.html.plaintext.txt	45	references top abstract introduction p53 guardian regulation p53 sequence p53 non sequence specific references hartwelllh weinertta 1989 checkpoints controls ensure order cell cycle events science 246 629 634isimedline walkergc 1985 inducible dna repair systems annu rev biochem 54 425 457isimedline weinertta hartwelllh 1988 rad9 gene controls cell cycle response dna damage saccharomyces cerevisiae science 241 317 322isimedline harriscc hollsteinm 1993 clinical implications p53 tumor suppressor gene n engl j med 329 1318 1327free full text hollsteinm ricek greenblattms soussit fuchsr sorliet hovige smith sorensenb montesanor harriscc 1994 database p53 gene somatic mutations human tumors cell lines nucleic acids res 22 3551 3555abstract dittmerd patis zambettig chus tereskyak moorem finlayc levineaj 1993 gain function mutations p53 nature genet 4 42 46isi milnerj medcalfea 1991 cotranslation activated mutant p53 wild type drives wild type p53 protein mutant conformation cell 65 765 774isimedline malkind lifp stronglc fraumenijfjr nelsonce kimdh kasselj grykama bischofffz tainskyma 1990 germ line p53 mutations familial syndrome breast cancer sarcomas neoplasms science 250 1233 1238isimedline howleypm 1991 role human papillomaviruses human cancer cancer res 51 5019s 5022sabstract uedah ullrichsj gangemijd kappelca ngol feitelsonma jayg 1995 functional inactivation structural mutation p53 causes liver cancer nature genet 9 41 47isimedline tanth wallisj levineaj 1986 identification p53 protein domain involved formation simian virus 40 large antigen p53 protein complex j virol 59 574 583isimedline yewpr berkaj 1992 inhibition p53 transactivation required transformation adenovirus early 1b protein nature 357 82 85isimedline kastanmb onyekwereo sidranskyd vogelsteinb craigrw 1991 participation p53 protein cellular response dna damage cancer res 51 6304 6311abstract maltzmanw czyzykl 1984 uv irradiation stimulates levels p53 cellular tumor antigen nontransformed mouse cells mol cell biol 4 1689 1694isimedline linkesp clarkinkc di leonardoa tsoua wahlgm 1996 reversible p53 dependent g0g1 cell cycle arrest induced ribonucleotide depletion absence detectable dna damage genes dev 10 934 947abstract el deiryws tokinot velculescuve levydb parsonsr trentjm lind mercerwe kinzlerkw vogelsteinb 1993 waf1 potential mediator p53 tumor suppression cell 75 817 825isimedline lir wagas hannongj beachd stillmanb 1994 differential effects p21 cdk inhibitor pcna dependent dna replication repair nature 371 534 537isimedline el deiryws 1998 regulation p53 downstream genes semin cancer biol 8 345 357isimedline el deiryws kernse pietenpolja kinzlerkw vogelsteinb 1992 definition consensus binding site p53 nature genet 1 45 49isimedline choy gorinas jeffreypd pavletichnp 1994 crystal structure p53 tumor suppressor dna complex understanding tumorigenic mutations science 265 346 355isimedline meekdw 1999 mechanisms switching p53 role covalent modification oncogene 18 7666 7675isimedline takenakai morinf seizingerbr kleyn 1995 regulation sequence specific dna binding function p53 protein kinase c protein phosphatases j biol chem 270 5405 5411abstractfree full text wangy privesc 1995 increased altered dna binding human p53 g2m g1 cyclin dependent kinases nature 376 88 91isimedline sakaguchik sakamotoh lewisms andersoncw ericksonjw appellae xied 1997 phosphorylation serine 392 stabilizes tetramer formation tumor suppressor protein p53 biochemistry 36 10117 10124isimedline luh fisherrp baileyp levineaj 1997 cdk7 cych p36 complex transcription factor iih phosphorylates p53 enhancing sequence specific dna binding activity vitro mol cell biol 17 5923 5934abstract watermanmj stavridies watermanjl halazonetistd 1998 atm dependent activation p53 involves dephosphorylation association 14 3 3 proteins nature genet 19 175 178isimedline shiehsy ikedam tayay privesc 1997 dna damage induced phosphorylation p53 alleviates inhibition mdm2 cell 91 325 334isimedline sakaguchik herreraje saitos mikit bustinm vassileva andersoncw appellae 1998 dna damage activates p53 phosphorylation acetylation cascade genes dev 12 2831 2841abstractfree full text shiehsy tayay privesc 1999 dna damage inducible phosphorylation p53 n terminal sites including novel site ser20 requires tetramerization embo j 18 1815 1823abstractfree full text pavletichnp chamberska paboco 1993 dna binding domain p53 contains four conserved regions major mutation hot spots genes dev 7 2556 2564abstract hupptr lanedp 1994 allosteric activation latent p53 tetramers curr biol 4 865 875isimedline kolj privesc 1996 p53 puzzle paradigm genes dev 10 1054 1072isimedline pengcy gravespr thomars wuz shawas piwnica wormsh 1997 mitotic g2 checkpoint control regulation 14 3 3 protein binding phosphorylation cdc25c serine 216 science 277 1501 1505abstractfree full text kharbandas renr pandeyp shafmantd fellersm weichselbaumrr kufedw 1995 activation c abl tyrosine kinase stress response dna damaging agents nature 376 785 788isimedline pandeyp raingeaudj kanekim weichselbaumr davisrj kufed kharbandas 1996 activation p38 mitogen activated protein kinase c abl dependent independent mechanisms j biol chem 271 23775 23779abstractfree full text niey lihh bulacm liux 2000 stimulation p53 dna binding c abl requires p53 c terminus tetramerization mol cell biol 20 741 748abstractfree full text wangxw forresterk yehh feitelsonma gujr harriscc 1994 hepatitis b virus x protein inhibits p53 sequence specific dna binding transcriptional activity association transcription factor ercc3 proc natl acad sci usa 91 2230 2234abstract momandj zambettigp olsondc georged levineaj 1992 mdm 2 oncogene product forms complex p53 protein inhibits p53 mediated transactivation cell 69 1237 1245isimedline millersd mosesk jayaramanl privesc 1997 complex formation p53 replication protein inhibits sequence specific dna binding p53 regulated single stranded dna mol cell biol 17 2194 2201abstract abramovana russellj botchanm lir 1997 interaction replication protein p53 disrupted uv damage dna repair dependent manner proc natl acad sci usa 94 7186 7191abstractfree full text zaubermana baraky ragimovn levyn orenm 1993 sequence specific dna binding p53 identification target sites lack binding p53 mdm2 complexes embo j 12 2799 2808abstract bottgera bottgerv garcia echeverriac chenep hochkeppelhk sampsonw angk howardsf picksleysm lanedp 1997 molecular characterization hdm2 p53 interaction j mol biol 269 744 756isimedline chenx farmerg zhuh prywesr privesc 1993 cooperative dna binding p53 tfiid tbp possible mechanism transcriptional activation genes dev 7 1837 1849abstract wangxw yehh schaefferl royr moncollinv eglyjm wangz freidbergec evansmk taffebg 1995 p53 modulation tfiih associated nucleotide excision repair activity nature genet 10 188 195isimedline lillnl grossmansr ginsbergd decaprioj livingstondm 1997 binding modulation p53 p300cbp coactivators nature 387 823 827isimedline wadepa prussd wolffeap 1997 histone acetylation chromatin action trends biochem sci 22 128 132isimedline wux baylejh olsond levineaj 1993 p53 mdm 2 autoregulatory feedback loop genes dev 7 1126 1132abstract zaubermana lupoa orenm 1995 identification p53 target genes immune selection genomic dna cyclin g gene contains two distinct p53 binding sites oncogene 10 2361 2366isimedline stengerje tegtmeyerp mayrga reedm wangy wang p houghpv mastrangeloia 1994 p53 oligomerization dna looping linked transcriptional activation embo j 13 6011 6020abstract bargonettij reynisdottiri friedmanpn privesc 1992 site specific binding wild type p53 cellular dna inhibited sv40 antigen mutant p53 genes dev 6 1886 1898abstract jayaramanl moorthync murthykg manleyjl bustinm privesc 1998 high mobility group protein 1 hmg 1 unique activator p53 genes dev 12 462 472abstractfree full text rubbicp milnerj 2000 non activated p53 co localizes sites transcription within nucleoplasm nucleolus oncogene 19 85 96isimedline browncr doxseysj whitee welchwj 1994 viral adenovirus e1b cellular hsp 70 p53 components interact centrosomes j cell physiol 160 47 60isimedline deppertw 2000 nuclear matrix target viral cellular oncogenes crit rev eukaryot gene expr 10 45 61isimedline hainautp milnerj 1993 redox modulation p53 conformation sequence specific dna binding vitro cancer res 53 4469 4473abstract suny oberleylw 1996 redox regulation transcriptional activators free radic biol med 21 335 348isimedline matthewsjr wakasugin virelizierjl yodoij hayrt 1992 thioredoxin regulates dna binding activity nfb reduction disulphide bond involving cysteine 62 nucleic acids res 20 3821 3830abstract xanthoudakiss currant 1992 identification characterization ref 1 nuclear protein facilitates ap 1 dna binding activity embo j 11 653 665abstract uenom masutanih arairj yamauchia hirotak sakait inamotot yamaokay yodoij nikaidot 1999 thioredoxin dependent redox regulation p53 mediated p21 activation j biol chem 274 35809 35815abstractfree full text cassod beachd 1996 mutation thioredoxin reductase homolog suppresses p53 induced growth inhibition fission yeast schizosaccharomyces pombe mol gen genet 252 518 529isimedline pearsongd merrillgf 1998 deletion saccharomyces cerevisiae trr1 gene encoding thioredoxin reductase inhibits p53 dependent reporter gene expression j biol chem 273 5431 5434abstractfree full text jayaramanl murthykg zhuc currant xanthoudakiss privesc 1997 identification redoxrepair protein ref 1 potent activator p53 genes dev 11 558 570abstract tanm lis swaroopm guank oberleylw suny 1999 transcriptional activation human glutathione peroxidase promoter p53 j biol chem 274 12061 12066abstractfree full text forresterk ambss lupoldse et al 1996 nitric oxide induced p53 accumulation regulation inducible nitric oxide synthase expression wild type p53 proc natl acad sci usa 93 2442 2447abstractfree full text jayaramanj privesc 1995 activation p53 sequence specific dna binding short single strands dna requires p53 c terminus cell 81 1021 1029isimedline bakalking yakovlevat selivanovag magnussonkp szekelyl kiselevae kleing tereniusl wimankg 1994 p53 binds single stranded dna ends catalyzes dna renaturation strand transfer proc natl acad sci usa 91 413 417abstract bakalking selivanovag yakovlevat kiselevae kashubae magnussonkp szekelyl kleing tereniusl wimankg 1995 p53 binds single stranded dna ends c terminal domain internal dna segments via middle domain nucleic acids res 23 362 369abstract selivanovag iotsovav kiselevae stromm bakalking grafstromrc wimankg 1996 single stranded dna end binding site p53 coincides c terminal regulatory region nucleic acids res 24 3560 3567abstractfree full text tsubouchih ogawah 1998 novel mre11 mutation impairs processing double strand breaks dna mitosis meiosis mol cell biol 18 260 268abstractfree full text elledgesj 1996 cell cycle checkpoints preventing identity crisis science 274 1664 1672abstractfree full text reedm woelkerb wangp wangy andersonme tegtmeyerp 1995 c terminal domain p53 recognizes dna damaged ionizing radiation proc natl acad sci usa 92 9455 9459abstract lees elenbaasb levinea griffithj 1995 p53 14 kda c terminal domain recognize primary dna damage form insertiondeletion mismatches cell 81 1013 1020isimedline lees cavallol griffithj 1997 human p53 binds holliday junctions strongly facilitates cleavage j biol chem 272 7532 7539abstractfree full text dudenhofferc rohalyg willk deppertw wiesmullerl 1998 specific mismatch recognition heteroduplex intermediates p53 suggests role fidelity control homologous recombination mol cell biol 18 5332 5342abstractfree full text kernse kinzlerkw bakersj nigrojm rotterv levineaj friedmanp privesc vogelsteinb 1991 mutant p53 proteins bind dna abnormally vitro oncogene 6 131 136isimedline szakst pietenpolja 1999 high affinity insertiondeletion lesion binding p53 evidence role p53 central domain j biol chem 274 3904 3909abstractfree full text zouy van houtenb 1999 strand opening uvra2b complex allows dynamic recognition dna damage embo j 18 4889 4901abstractfree full text leutherkk hammarsteno kornbergrd chug 1999 structure dna dependent protein kinase implications regulation dna embo j 18 1114 1123abstractfree full text nelsonwg kastanmb 1994 dna strand breaks dna template alterations trigger p53 dependent dna damage response pathways mol cell biol 14 1815 1823abstract huanglc clarkinkc wahlgm 1996 sensitivity selectivity dna damage sensor responsible activating p53 dependent g1 arrest proc natl acad sci usa 93 4827 4832abstractfree full text albrechtsenn dornreiteri grossef kime wiesmullerl deppertw 1999 maintenance genomic integrity p53 complementary roles activated non activated p53 oncogene 18 7706 7717isimedline wakasugim sancara 1999 order assembly human dna repair excision nuclease j biol chem 274 18759 18768abstractfree full text wul baylejh elenbaasb pavletichnp levineaj 1995 alternatively spliced forms carboxy terminal domain p53 protein regulate ability promote annealing complementary single strands nucleic acids mol cell biol 15 497 504abstract wiesmullerl cammengaj deppertww 1996 vivo assay p53 function homologous recombination simian virus 40 chromosomes j virol 70 737 744abstract mekeelkl tangw kachnicla luocm defrankjs powellsn 1997 inactivation p53 results high rates homologous recombination oncogene 14 1847 1857isimedline albora kakus kulesz martinm 1998 wild type mutant forms p53 activate human topoisomerase possible mechanism gain function mutants cancer res 58 2091 2094abstract tangw willersh powellsn 1999 p53 directly enhances rejoining dna double strand breaks cohesive ends gamma irradiated mouse fibroblasts cancer res 59 2562 2565abstractfree full text billca yuy miselisnr littlejb nickoloffja 1997 role p53 dna end rejoining human cell extracts mutat res 385 21 29isimedline fergusondo sekiguchijm changs frankkm gaoy depinhora altfw 2000 nonhomologous end joining pathway dna repair required genomic stability suppression translocations proc natl acad sci usa 97 6630 6633abstractfree full text gaoy fergusondo xiew manisjp sekiguchij frankkm chaudhurij hornerj depinhora altfw 2000 interplay p53 dna repair protein xrcc4 tumorigenesis genomic stability development nature 404 897 900isimedline offerh wolkowiczr matasd blumensteins livnehz rotterv 1999 direct involvement p53 base excision repair pathway dna repair machinery febs lett 450 197 204isimedline mummenbrauert janusf mullerb wiesmullerl deppertw grossef 1996 p53 protein exhibits 3 5 exonuclease activity cell 85 1089 1099isimedline kaghadm bonneth yanga et al 1997 monoallelically expressed gene related p53 1p36 region frequently deleted neuroblastoma human cancers cell 90 809 819isimedline yanga kaghadm wangy gillette flemingmd dotschv andrewsnc caputd mckeonf 1998 p63 p53 homolog 3q27 29 encodes multiple products transactivating death inducing dominant negative activities mol cell 2 305 316isimedline brodskymh nordstromw tsangg kwane rubingm abramsjm 2000 drosophila p53 binds damage response element reaper locus cell 101 103 113isimedline ollmannm younglm di comocj et al 2000 drosophila p53 structural functional homolog tumor suppressor p53 cell 101 91 101isimedline jins martineks joows wortmanjr mirkovicn salia yandellmd pavletichnp youngmw levineaj 2000 identification characterization p53 homologue drosophila melanogaster proc natl acad sci usa 97 7301 7306abstractfree full text evang littlewoodt 1998 matter life cell death science 281 1317 1322abstractfree full text chenx kolj jayaramanl privesc 1996 p53 levels functional domains dna damage determine extent apoptotic response tumor cells genes dev 10 2438 2451abstract beneker geisenc dna excision repair dna damage induced apoptosis linked polyadp ribosylation different requirements p53 mol cell biol 20 6695 6703 parksd bolingerr mannk 1997 redox state regulates binding p53 sequence specific dna non specific mismatched dna nucleic acids res 25 1289 1295abstractfree full text caellesc helmberga karinm 1994 p53 dependent apoptosis absence transcriptional activation p53 target genes nature 370 220 223isimedline wagneraj kokontisjm hayn 1994 myc mediated apoptosis requires wild type p53 manner independent cell cycle arrest ability p53 induce p21waf1cip1 genes dev 8 2817 2830abstract haupty rowans shauliane vousdenkh orenm 1995 induction apoptosis hela cells trans activation deficient p53 genes dev 9 2170 2183abstract venotc maratratm dureuilc conseillere braccol debusschel 1998 requirement p53 proline rich functional domain mediation apoptosis correlated specific pig3 gene transactivation transcriptional repression embo j 17 4668 4679abstractfree full text parkdj nakamurah chumakovam saidjw millercw chendl koefflerhp 1994 transactivational dna binding abilities endogenous p53 p53 mutant cell lines oncogene 9 1899 1906isimedline friedlanderp haupty privesc orenm 1996 mutant p53 discriminates p53 responsive genes induce apoptosis mol cell biol 16 4961 4971abstract wangxw vermeulenw coursenjd et al 1996 xpb xpd dna helicases components p53 mediated apoptosis pathway genes dev 10 1219 1232abstract spillareea roblesai wangxw shenjc yuce schellenberg gd harriscc 1999 p53 mediated apoptosis attenuated werner syndrome cells genes dev 13 1355 1360abstractfree full text kolj shiehsy chenx jayaramanl tamaik tayay privesc panzq 1997 p53 phosphorylated cdk7 cyclin h p36mat1 dependent manner mol cell biol 17 7220 7229abstract tibbettsrs brumbaughkm williamsjm sarkariajn clibywa shiehsy tayay privesc abrahamrt 1999 role atr dna damage induced phosphorylation p53 genes dev 13 152 157abstractfree full text lambertpf kashanchif radonovichmf shiekhattarr bradyjn 1998 phosphorylation p53 serine 15 increases interaction cbp j biol chem 273 33048 33053abstractfree full text sakaguchik saitos higashimotoy roys andersoncw appellae 2000 damage mediated phosphorylation human p53 threonine 18 cascade mediated casein 1 like kinase effect mdm2 binding j biol chem 275 9278 9283abstractfree full text chehabnh malikzaya appelm halazonetistd 2000 chk2hcds1 functions dna damage checkpoint g1 stabilizing p53 genes dev 14 278 288abstractfree full text bulavindv saitos hollandermc sakaguchik andersoncw appellae fornaceajjr 1999 phosphorylation human p53 p38 kinase coordinates n terminal phosphorylation apoptosis response uv radiation embo j 18 6845 6854abstractfree full text lil ljungmanm dixonje 2000 human cdc14 phosphatases interact dephosphorylate tumor suppressor protein p53 j biol chem 275 2410 2414abstractfree full text liul scolnickdm trievelrc zhanghb marmorsteinr halazonetistd bergersl 1999 p53 sites acetylated vitro pcaf p300 acetylated vivo response dna damage mol cell biol 19 1202 1209abstractfree full text rodriguezms desterrojm lains midgleyca lanedp hayrt 1999 sumo 1 modification activates transcriptional response p53 embo j 18 6455 6461abstractfree full text gostissam hengstermanna fogalv sandyp schwarzse scheffnerm del salg 1999 activation p53 conjugation ubiquitin like protein sumo 1 embo j 18 6462 6471abstractfree full text kapoorm lozanog 1998 functional activation p53 via phosphorylation following dna damage uv gamma radiation proc natl acad sci usa 95 2834 2837abstractfree full text kakus albora kulesz martinm 2001 dissociation dna binding vitro transcriptional activities dependent upon carboxy terminus p53 proteins biochem biophys res comm 280 204 211isimedline received september 22 2000 revised december 8 2000 accepted december 20 2000
0.5554981.15705792.html.plaintext.txt	0	stress induced activation p53 tumor suppressor leukemia cells normal lymphocytes requires mitochondrial activity reactive oxygen species leonid karawajew peter rhein grit czerwony wolf dieter ludwig
0.5554981.15705792.html.plaintext.txt	1	department hematology oncology tumor immunology robert rossle clinic helios klinikum berlin buch charite medical school berlin germany
0.5554981.15705792.html.plaintext.txt	2	abstract top abstract introduction materials methods results discussion references p53 system highly stress sensitive integrates diverse intracellular signals complex poorly defined manner report high dependence stress induced p53 activation mitochondrial activity regulation mitochondrial transmembrane potential mtmp inhibitors electron transport rotenone thenoyltrifluoroacetone ttfa adenosine triphosphate atp synthesis oligomycin prevented stress induced p53 protein accumulation abrogated p53 dependent apoptosis wild type p53 leukemia cell line molt 3 primary leukemia cells normal lymphocytes using genome wide gene expression analysis stress induced regulation p53 transcriptional targets specific inhibition oligomycin demonstrated oligomycin impair p53 independent apoptosis caused slight reduction intracellular atp levels reactive oxygen species ros localized mitochondria decreased presence oligomycin stress induced p53 activation showed strong ros sensitivity leukemic normal cells observations identify mitochondrial activity described mtmp ros levels critical intracellular determinant p53 stress sensitivity suggest potential implications linkage mechanisms chemoresistance acute leukemia cells blood 20051054767 4775
0.5554981.15705792.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references p53 system highly stress sensitive integrates diverse intracellular signals complex poorly defined manner report high dependence stress induced p53 activation mitochondrial activity regulation mitochondrial transmembrane potential mtmp inhibitors electron transport rotenone thenoyltrifluoroacetone ttfa adenosine triphosphate atp synthesis oligomycin prevented stress induced p53 protein accumulation abrogated p53 dependent apoptosis wild type p53 leukemia cell line molt 3 primary leukemia cells normal lymphocytes using genome wide gene expression analysis stress induced regulation p53 transcriptional targets specific inhibition oligomycin demonstrated oligomycin impair p53 independent apoptosis caused slight reduction intracellular atp levels reactive oxygen species ros localized mitochondria decreased presence oligomycin stress induced p53 activation showed strong ros sensitivity leukemic normal cells observations identify mitochondrial activity described mtmp ros levels critical intracellular determinant p53 stress sensitivity suggest potential implications linkage mechanisms chemoresistance acute leukemia cells blood 20051054767 4775
0.5554981.15705792.html.plaintext.txt	4	introduction top abstract introduction materials methods results discussion references sublethal damage impairment cellular functions result cellular responses include activation repair mechanisms cell cycle checkpoints induction endogenous apoptotic programs cellular stress response often implicates activation proapoptotic p53 dependent machinery determines threshold level cellular stress able trigger apoptosis12 p53 regulated mainly posttranscriptional level protein level absence stress consistently low due high rate p53 protein degradation via proteasome pathway stress induced signaling results modification p53 protein either phosphorylation acetylation resistance p53 proteasome degradation34 basic regulatory mechanism p53 system interaction p53 negative regulator mdm2 protein acts p53 specific e3 ligase turn transcriptionally regulated p535 importance p53mdm2 interactions underscored variety mechanisms used cell disrupt interactions response stress including posttranslational modifications subcellular redistribution inhibition mdm2 activity transcription5 recently nicotinamide adenine dinucleotide phosphate nadh quinone oxidoreductase 1 nqo1 demonstrated regulate p53 stability6 nqo1 suggested interact physically p53 stabilize p53 mdm2 independent mechanisms78
0.5554981.15705792.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references sublethal damage impairment cellular functions result cellular responses include activation repair mechanisms cell cycle checkpoints induction endogenous apoptotic programs cellular stress response often implicates activation proapoptotic p53 dependent machinery determines threshold level cellular stress able trigger apoptosis12 p53 regulated mainly posttranscriptional level protein level absence stress consistently low due high rate p53 protein degradation via proteasome pathway stress induced signaling results modification p53 protein either phosphorylation acetylation resistance p53 proteasome degradation34 basic regulatory mechanism p53 system interaction p53 negative regulator mdm2 protein acts p53 specific e3 ligase turn transcriptionally regulated p535 importance p53mdm2 interactions underscored variety mechanisms used cell disrupt interactions response stress including posttranslational modifications subcellular redistribution inhibition mdm2 activity transcription5 recently nicotinamide adenine dinucleotide phosphate nadh quinone oxidoreductase 1 nqo1 demonstrated regulate p53 stability6 nqo1 suggested interact physically p53 stabilize p53 mdm2 independent mechanisms78
0.5554981.15705792.html.plaintext.txt	6	intracellular p53 accumulation hallmark p53 activation pathway results p53 protein complexation nuclear localization p53 tetramers induction transcriptional activity resulting complex pattern p53 target genes depends stress conditions cell type context indicated gene profiling using oligonucleotide microarrays9 broad spectrum p53 transcriptional targets indicates interference p53 stress signaling multiple cellular functions10 list targets includes genes encoding proteins critically involved cell cycle regulation p21 gadd45a apoptosis bax puma cd95 trail intracellular redox state pig3 pig129 12
0.5554981.15705792.html.plaintext.txt	7	intracellular p53 accumulation hallmark p53 activation pathway results p53 protein complexation nuclear localization p53 tetramers induction transcriptional activity resulting complex pattern p53 target genes depends stress conditions cell type context indicated gene profiling using oligonucleotide microarrays9 broad spectrum p53 transcriptional targets indicates interference p53 stress signaling multiple cellular functions10 list targets includes genes encoding proteins critically involved cell cycle regulation p21 gadd45a apoptosis bax puma cd95 trail intracellular redox state pig3 pig129 12
0.5554981.15705792.html.plaintext.txt	8	mitochondrion plays dual role cell regulator apoptosis cellular powerhouse multiple mitochondrial components involved regulatory processes energy metabolism stress induced apoptosis signaling1314 molecular mechanism mitochondrial energy transformation involves electron transport chain consists electron transfer complexes iv embedded inner mitochondrial membrane electron transport chain serves convert high energy potential electrons nadh fadh2 molecules energy proton gradient across inner membrane defined mitochondrial transmembrane potential mtmp deltapsim m mtmp level proportional number protons pumped outer side inner mitochondrial membrane electron transport reflects mitochondrial activity cell free energy proton gradient finally drives synthesis atp adenosine diphosphate adp phosphate occurring site atp synthase complex v f0f1 atpase14 mitochondrial activity critically contributes intracellular redox state major source reactive oxygen species ros generated result occasional escape electrons electron transport chain1516
0.5554981.15705792.html.plaintext.txt	9	mitochondrion plays dual role cell regulator apoptosis cellular powerhouse multiple mitochondrial components involved regulatory processes energy metabolism stress induced apoptosis signaling1314 molecular mechanism mitochondrial energy transformation involves electron transport chain consists electron transfer complexes iv embedded inner mitochondrial membrane electron transport chain serves convert high energy potential electrons nadh fadh2 molecules energy proton gradient across inner membrane defined mitochondrial transmembrane potential mtmp deltapsim m mtmp level proportional number protons pumped outer side inner mitochondrial membrane electron transport reflects mitochondrial activity cell free energy proton gradient finally drives synthesis atp adenosine diphosphate adp phosphate occurring site atp synthase complex v f0f1 atpase14 mitochondrial activity critically contributes intracellular redox state major source reactive oxygen species ros generated result occasional escape electrons electron transport chain1516
0.5554981.15705792.html.plaintext.txt	10	p53 dependent proapoptotic signaling key events leading activation caspases apoptotic cell death permeabilization outer mitochondrial membrane subsequent release apoptogenic factors especially mitochondrial cytochrome c1718 mitochondrial permeabilization preceded complex decision phase involves integration pro antiapoptotic signals converges bcl 2 family proteins1819 several genes encoding proapoptotic bcl 2 related proteins including bax puma direct transcriptional targets p532021 recently proposed direct cooperation bax mitochondrial atp synthase process mitochondrial cytochrome c release22 mitochondria involved critically later stages apoptosis mitochondrial dysfunction defines irreversible stage apoptosis characterized mtmp loss redox shift increase intracellular ros levels23
0.5554981.15705792.html.plaintext.txt	11	p53 dependent proapoptotic signaling key events leading activation caspases apoptotic cell death permeabilization outer mitochondrial membrane subsequent release apoptogenic factors especially mitochondrial cytochrome c1718 mitochondrial permeabilization preceded complex decision phase involves integration pro antiapoptotic signals converges bcl 2 family proteins1819 several genes encoding proapoptotic bcl 2 related proteins including bax puma direct transcriptional targets p532021 recently proposed direct cooperation bax mitochondrial atp synthase process mitochondrial cytochrome c release22 mitochondria involved critically later stages apoptosis mitochondrial dysfunction defines irreversible stage apoptosis characterized mtmp loss redox shift increase intracellular ros levels23
0.5554981.15705792.html.plaintext.txt	12	mitochondrial involvement proapoptotic p53 signaling largely investigated downstream p53 activation cellular systems overexpressing either wild type wt temperature sensitive mutant p531722 address contribution mitochondrial components early stress signaling upstream p53 activation end investigated cellular systems endogenously expressed wt p53 including normal lymphocytes wt p53 leukemia molt 3 cell line24 26 also focused primary cells patients acute leukemia diagnosis p53 mutations infrequent27 29 results demonstrate strong dependence stress induced p53 activation mitochondrial activity suggests mitochondrial status implicated mechanisms chemoresistance acute leukemia cells
0.5554981.15705792.html.plaintext.txt	13	mitochondrial involvement proapoptotic p53 signaling largely investigated downstream p53 activation cellular systems overexpressing either wild type wt temperature sensitive mutant p531722 address contribution mitochondrial components early stress signaling upstream p53 activation end investigated cellular systems endogenously expressed wt p53 including normal lymphocytes wt p53 leukemia molt 3 cell line24 26 also focused primary cells patients acute leukemia diagnosis p53 mutations infrequent27 29 results demonstrate strong dependence stress induced p53 activation mitochondrial activity suggests mitochondrial status implicated mechanisms chemoresistance acute leukemia cells
0.5554981.15705792.html.plaintext.txt	14	materials methods top abstract introduction materials methods results discussion references cells
0.5554981.15705792.html.plaintext.txt	15	primary leukemia normal cells purified either bone marrow bm peripheral blood pb samples pediatric acute lymphoblastic leukemia patients pb healthy donors ficoll hypaque density gradient centrifugation viability cells always 90 determined trypan blue propidium iodide pi sigma aldrich taufkirchen germany exclusion samples contained 85 leukemic cells based morphologic immunophenotypic criteria patients enrolled multicenter bfm study gave informed consent
0.5554981.15705792.html.plaintext.txt	16	primary leukemia normal cells purified either bone marrow bm peripheral blood pb samples pediatric acute lymphoblastic leukemia patients pb healthy donors ficoll hypaque density gradient centrifugation viability cells always 90 determined trypan blue propidium iodide pi sigma aldrich taufkirchen germany exclusion samples contained 85 leukemic cells based morphologic immunophenotypic criteria patients enrolled multicenter bfm study gave informed consent
0.5554981.15705792.html.plaintext.txt	17	human leukemia cell line molt 3 obtained dsm cell culture bank braunschweig germany p53 gene status molt 3 cells analyzed previously single strand conformation polymorphism polymerase chain reaction sscp pcr analysis24
0.5554981.15705792.html.plaintext.txt	18	human leukemia cell line molt 3 obtained dsm cell culture bank braunschweig germany p53 gene status molt 3 cells analyzed previously single strand conformation polymorphism polymerase chain reaction sscp pcr analysis24
0.5554981.15705792.html.plaintext.txt	19	cells maintained rpmi 1640 standard medium containing 2 mgml glucose supplemented 10 heat inactivated fetal calf serum gibco invitrogen karlsruhe germany 37 degrees c humidified atmosphere 5 co2 air atp depletion assays cells washed resuspended glucose free rpmi 1640 medium gibco invitrogen
0.5554981.15705792.html.plaintext.txt	20	cells maintained rpmi 1640 standard medium containing 2 mgml glucose supplemented 10 heat inactivated fetal calf serum gibco invitrogen karlsruhe germany 37 degrees c humidified atmosphere 5 co2 air atp depletion assays cells washed resuspended glucose free rpmi 1640 medium gibco invitrogen
0.5554981.15705792.html.plaintext.txt	21	stimulate normal cells pb lymphocytes healthy donors incubated presence 25 microgml phytohemagglutinin pha roche mannheim germany 60 uml recombinant human interleukin 2 il 2 strathmann biotec hamburg germany 24 48 72 hours control experiments showed pb cell samples incubated 24 hours longer contained 90 cells
0.5554981.15705792.html.plaintext.txt	22	stimulate normal cells pb lymphocytes healthy donors incubated presence 25 microgml phytohemagglutinin pha roche mannheim germany 60 uml recombinant human interleukin 2 il 2 strathmann biotec hamburg germany 24 48 72 hours control experiments showed pb cell samples incubated 24 hours longer contained 90 cells
0.5554981.15705792.html.plaintext.txt	23	assess drug effects 02 x 106 molt 3 cellswell 05 x 106 primary cellswell cultured presence absence drugs 24 well 96 well microtiter plates nunc wiesbaden germany respectively short time assays 6 hours cells preincubated 2 hours overnight
0.5554981.15705792.html.plaintext.txt	24	mitochondrial inhibitors purchased sigma included electron transport chain inhibitors rotenone complex inhibitor thenoyltrifluoroacetone ttfa complex ii inhibitor antimycin complex iii inhibitor uncoupler oxidative phosphorylation carbonyl cyanide p trifluoromethoxyphenyl hydrazone fccp inhibitor atp synthase oligomycin
0.5554981.15705792.html.plaintext.txt	25	cellular stressapoptosis generated using doxorubicin pharmacia erlangen germany etoposide sigma lactacystin sigma staurosporine merck schwalbach germany h2o2 sigma
0.5554981.15705792.html.plaintext.txt	26	death receptor mediated apoptosis induced agonistic cd95 antibody 01 microgml clone ch 11 beckman coulter marseille france
0.5554981.15705792.html.plaintext.txt	27	death receptor mediated apoptosis induced agonistic cd95 antibody 01 microgml clone ch 11 beckman coulter marseille france
0.5554981.15705792.html.plaintext.txt	28	antioxidant n acetyl l cysteine nac nonmetabolizable glucose analog 2 deoxy d glucose 2 dg purchased sigma
0.5554981.15705792.html.plaintext.txt	29	flow cytometric measurements performed using facscan flow cytometer becton dickinson san jose ca flow cytometric data analyzed using either cellquest pro software becton dickinson cytomics rxp software beckman coulter miami fl cellquest rxp software use scaling fluorescence log scale 4 decades different ranges 101 104 10 1 103 avoid confusion channel numbers dot plots histograms depicted figures
0.5554981.15705792.html.plaintext.txt	30	flow cytometric measurements performed using facscan flow cytometer becton dickinson san jose ca flow cytometric data analyzed using either cellquest pro software becton dickinson cytomics rxp software beckman coulter miami fl cellquest rxp software use scaling fluorescence log scale 4 decades different ranges 101 104 10 1 103 avoid confusion channel numbers dot plots histograms depicted figures
0.5554981.15705792.html.plaintext.txt	31	assessment mitochondrial transmembrane potential
0.5554981.15705792.html.plaintext.txt	32	measure mitochondrial potential mtmp cells incubated j aggregate forming cationic dye jc 1 molecular probes karlsruhe germany concentration 10 microgml 10 minutes 37 degrees c jc 1 fluorescence detected facscan flow cytometer
0.5554981.15705792.html.plaintext.txt	33	measure mitochondrial potential mtmp cells incubated j aggregate forming cationic dye jc 1 molecular probes karlsruhe germany concentration 10 microgml 10 minutes 37 degrees c jc 1 fluorescence detected facscan flow cytometer
0.5554981.15705792.html.plaintext.txt	34	detect activated caspase 3 cells fixed permeabilized using fixation permeabilization kit fix perm caltag hamburg germany stained phycoerythrin pe conjugated purified rabbit antiserum specific activated caspase 3 557091 bd pharmingen hamburg germany described previously30
0.5554981.15705792.html.plaintext.txt	35	detect apoptotic cells plasma membrane changes cells stained fluoroscein isothiocyanate fitc conjugated annexin v pi using annexin v kit caltag previously described31 thereafter samples analyzed flow cytometry facscan presence viable annexin v pi early apoptotic annexin v pi late apoptoticnecrotic annexin v pi cells
0.5554981.15705792.html.plaintext.txt	36	detect apoptotic cells plasma membrane changes cells stained fluoroscein isothiocyanate fitc conjugated annexin v pi using annexin v kit caltag previously described31 thereafter samples analyzed flow cytometry facscan presence viable annexin v pi early apoptotic annexin v pi late apoptoticnecrotic annexin v pi cells
0.5554981.15705792.html.plaintext.txt	37	quantification p53 flow cytometry
0.5554981.15705792.html.plaintext.txt	38	assess p53 accumulation cell preparation fixation permeabilization using 1 paraformaldehyde 100 methanol cell staining using anti p53 monoclonal mouse antibodies clone 1 merck performed according bonsing et al32 antigen expression defined difference p53 specific isotype control fluorescences quantified flow cytometry molecules equivalent soluble fluorochrome mesf units using calibration beads dako fluorospheres dako glostrup denmark fluorescence standards obtain fluorescence intensities mesf units calibration beads known numbers fluorochrome molecules ie mesf values per bead measured fluorescence activated cell sorting facs calibration curve constructed thereafter experimental samples measured identical facs settings mesf values calculated using calibration curve
0.5554981.15705792.html.plaintext.txt	39	assess p53 accumulation cell preparation fixation permeabilization using 1 paraformaldehyde 100 methanol cell staining using anti p53 monoclonal mouse antibodies clone 1 merck performed according bonsing et al32 antigen expression defined difference p53 specific isotype control fluorescences quantified flow cytometry molecules equivalent soluble fluorochrome mesf units using calibration beads dako fluorospheres dako glostrup denmark fluorescence standards obtain fluorescence intensities mesf units calibration beads known numbers fluorochrome molecules ie mesf values per bead measured fluorescence activated cell sorting facs calibration curve constructed thereafter experimental samples measured identical facs settings mesf values calculated using calibration curve
0.5554981.15705792.html.plaintext.txt	40	hydroethidine dihydrofluorescein diacetate dcfda nonyl acridine orange nao purchased molecular probes
0.5554981.15705792.html.plaintext.txt	41	detect ros cells incubated dcfda 30 minutes 37 degrees c final concentrations 10 microm 5 microm respectively nao staining performed incubating cells 15 minutes 37 degrees c final concentration 025 microm
0.5554981.15705792.html.plaintext.txt	42	detect ros cells incubated dcfda 30 minutes 37 degrees c final concentrations 10 microm 5 microm respectively nao staining performed incubating cells 15 minutes 37 degrees c final concentration 025 microm
0.5554981.15705792.html.plaintext.txt	43	assessment intracellular atp
0.5554981.15705792.html.plaintext.txt	44	intracellular atp detected using luminescence atp detection assay system atplite perkinelmer rodgau jugesheim germany cells treated according manufacturers instructions luminescence measured using microlumat lb96p luminometer eg g berthold bad wildbad germany
0.5554981.15705792.html.plaintext.txt	45	intracellular atp detected using luminescence atp detection assay system atplite perkinelmer rodgau jugesheim germany cells treated according manufacturers instructions luminescence measured using microlumat lb96p luminometer eg g berthold bad wildbad germany
0.5554981.15705792.html.plaintext.txt	46	gene expression analysis dna microarrays
0.5554981.15705792.html.plaintext.txt	47	molt 3 cells lysed recombinant lymphotoxin rlt buffer qiagen hilden germany total rna extracted using qiagen rneasy mini kit including qiashredder homogenizer dnase column digest biotin labeled crna bioarray high yield rna transcription kit enzo diagnostics farmingdale ny hybridized affymetrix hg focus array affymetrix santa clara ca genechips stained biotinylated antistreptavidin antibody streptavidin pe conjugate signal amplification microarrays scanned genechip system confocal scanner hewlett packard santa clara ca normalized gene expression values generated global scaling methods target value 200 using microarray suite version 50 software affymetrix normalized data exported spss version 120 statistical software chicago il ranking filtering genes
0.5554981.15705792.html.plaintext.txt	48	molt 3 cells lysed recombinant lymphotoxin rlt buffer qiagen hilden germany total rna extracted using qiagen rneasy mini kit including qiashredder homogenizer dnase column digest biotin labeled crna bioarray high yield rna transcription kit enzo diagnostics farmingdale ny hybridized affymetrix hg focus array affymetrix santa clara ca genechips stained biotinylated antistreptavidin antibody streptavidin pe conjugate signal amplification microarrays scanned genechip system confocal scanner hewlett packard santa clara ca normalized gene expression values generated global scaling methods target value 200 using microarray suite version 50 software affymetrix normalized data exported spss version 120 statistical software chicago il ranking filtering genes
0.5554981.15705792.html.plaintext.txt	49	experiments performed triplicate mean values given mean plus minus standard deviation sd differences p evaluated using 2 tailed nonparametric mann whitney test continuous variables test fisher exact test categorical variables associations continuous variables evaluated using bivariate nonparametric spearman correlation statistics differences considered significant p values less 05 statistical analysis performed using spss software
0.5554981.15705792.html.plaintext.txt	50	experiments performed triplicate mean values given mean plus minus standard deviation sd differences p evaluated using 2 tailed nonparametric mann whitney test continuous variables test fisher exact test categorical variables associations continuous variables evaluated using bivariate nonparametric spearman correlation statistics differences considered significant p values less 05 statistical analysis performed using spss software
0.5554981.15705792.html.plaintext.txt	51	results top abstract introduction materials methods results discussion references inhibitors oxidative phosphorylation regulate mtmp prevent early accumulation p53 abrogate etoposide induced apoptosis
0.5554981.15705792.html.plaintext.txt	52	effect mitochondrial inhibitors mitochondrial activity investigated analysis mtmp changes molt 3 cells mtmp assessed staining cells potentiometric dye jc 1 aggregated form jc 1 fluorescence shifts green red thus provides relative measure mtmp quantified arbitrary units intensity red fluorescence red green fluorescence ratio33 experimental setting modes mtmp quantification red green ratio figure 1a red fluorescence shown provided similar results modulation mtmp levels mitochondrial inhibitors molt 3 cells rotenone complex ttfa complex ii oligomycin complex v atp synthase effectively regulated mtmp figure 1a antimycin complex iii inhibitor electron transport uncoupler fccp however either caused mtmp loss cell death lower concentrations affect mtmp figure 1a shown
0.5554981.15705792.html.plaintext.txt	53	effect mitochondrial inhibitors mitochondrial activity investigated analysis mtmp changes molt 3 cells mtmp assessed staining cells potentiometric dye jc 1 aggregated form jc 1 fluorescence shifts green red thus provides relative measure mtmp quantified arbitrary units intensity red fluorescence red green fluorescence ratio33 experimental setting modes mtmp quantification red green ratio figure 1a red fluorescence shown provided similar results modulation mtmp levels mitochondrial inhibitors molt 3 cells rotenone complex ttfa complex ii oligomycin complex v atp synthase effectively regulated mtmp figure 1a antimycin complex iii inhibitor electron transport uncoupler fccp however either caused mtmp loss cell death lower concentrations affect mtmp figure 1a shown
0.5554981.15705792.html.plaintext.txt	54	etoposide treatment molt 3 cells responded accumulation p53 figure 1b became detectable 1 hour p 05 test figure 1c oligomycin 10 microgml effectively inhibited accumulation p53 figure 1c rotenone 004 mm ttfa 02 mm also prevented drug induced increase p53 protein levels figure 1d used without etoposide oligomycin rotenone caused slight reduction basal levels p53 protein p 05 test significant figure 1d
0.5554981.15705792.html.plaintext.txt	55	apoptotic cascade molt 3 cells investigated mitochondrial caspase 3 plasma membrane levels figure 2a upon etoposide treatment apoptotic changes become detectable 4 hours incubation p 01 test figure 2b oligomycin highly effective inhibitor apoptosis almost totally abrogated apoptotic cascade without induction necrosis figure 2a b rotenone 004 mm ttfa 02 mm also able prevent etoposide induced apoptosis revealed cytotoxicity 6 hours incubation reduction cell viability 18 20 respectively contrast oligomycin 10 microgml impair viability molt 3 cells least 8 hours incubation data shown
0.5554981.15705792.html.plaintext.txt	56	apoptotic cascade molt 3 cells investigated mitochondrial caspase 3 plasma membrane levels figure 2a upon etoposide treatment apoptotic changes become detectable 4 hours incubation p 01 test figure 2b oligomycin highly effective inhibitor apoptosis almost totally abrogated apoptotic cascade without induction necrosis figure 2a b rotenone 004 mm ttfa 02 mm also able prevent etoposide induced apoptosis revealed cytotoxicity 6 hours incubation reduction cell viability 18 20 respectively contrast oligomycin 10 microgml impair viability molt 3 cells least 8 hours incubation data shown
0.5554981.15705792.html.plaintext.txt	57	moderate reduction intracellular atp levels impair p53 dependent drug response
0.5554981.15705792.html.plaintext.txt	58	oligomycin inhibits atp production oxidative phosphorylation investigated changes intracellular atp levels presence oligomycin contribution observed interference p53 signaling luminometric quantification atp molt 3 cells revealed reduction intracellular atp levels 15 presence oligomycin 10 microgml compared molt 3 cells cultured standard medium p 01 test figure 3a
0.5554981.15705792.html.plaintext.txt	59	oligomycin inhibits atp production oxidative phosphorylation investigated changes intracellular atp levels presence oligomycin contribution observed interference p53 signaling luminometric quantification atp molt 3 cells revealed reduction intracellular atp levels 15 presence oligomycin 10 microgml compared molt 3 cells cultured standard medium p 01 test figure 3a
0.5554981.15705792.html.plaintext.txt	60	view larger version 27k figure 1 inhibitors oxidative phosphorylation regulate mtmp prevent etoposide induced accumulation p53 molt 3 cells incubated oligomycin 10 microgml rotenone 004 mm ttfa 02 mm fccp 1 5 microm left right dot plots respectively 3 hours assessed mtmp levels jc 1 red green fluorescence ratios indicated x y axes show 4 decade log scale b flow cytometric detection p53 protein levels molt 3 cells cultured 3 hours presence etoposide 1 microm andor oligomycin 10 microgml x axis shows fluorescence intensity 4 decade log scale dotted vertical line indicates peak position isotype control c kinetics p53 accumulation molt 3 cells incubated etoposide without oligomycin 10 microgml d inhibition etoposide induced p53 accumulation molt 3 cells mitochondrial inhibitors 10 microgml 004 mm 02 mm oligomycin rotenone ttfa respectively molt 3 cells incubated without etoposide 1 microm 3 hours
0.5554981.15705792.html.plaintext.txt	61	view larger version 27k figure 1 inhibitors oxidative phosphorylation regulate mtmp prevent etoposide induced accumulation p53 molt 3 cells incubated oligomycin 10 microgml rotenone 004 mm ttfa 02 mm fccp 1 5 microm left right dot plots respectively 3 hours assessed mtmp levels jc 1 red green fluorescence ratios indicated x y axes show 4 decade log scale b flow cytometric detection p53 protein levels molt 3 cells cultured 3 hours presence etoposide 1 microm andor oligomycin 10 microgml x axis shows fluorescence intensity 4 decade log scale dotted vertical line indicates peak position isotype control c kinetics p53 accumulation molt 3 cells incubated etoposide without oligomycin 10 microgml d inhibition etoposide induced p53 accumulation molt 3 cells mitochondrial inhibitors 10 microgml 004 mm 02 mm oligomycin rotenone ttfa respectively molt 3 cells incubated without etoposide 1 microm 3 hours
0.5554981.15705792.html.plaintext.txt	62	order investigate contribution atp reduction cellular drug response modulated intracellular atp levels addition glucose antimetabolite 2 dg moderate reduction atp levels achieved addition 03 mm 2 dg standard culture medium 77 control level figure 3a incubation molt 3 cells glucose serum free medium decreased atp levels 50 addition 1 mm 2 dg glucose serum free medium caused severe depletion atp figure 3a
0.5554981.15705792.html.plaintext.txt	63	order investigate contribution atp reduction cellular drug response modulated intracellular atp levels addition glucose antimetabolite 2 dg moderate reduction atp levels achieved addition 03 mm 2 dg standard culture medium 77 control level figure 3a incubation molt 3 cells glucose serum free medium decreased atp levels 50 addition 1 mm 2 dg glucose serum free medium caused severe depletion atp figure 3a
0.5554981.15705792.html.plaintext.txt	64	view larger version 23k figure 2 oligomycin abrogates drug induced apoptosis molt 3 cells cascade apoptotic events indicated arrows characterized mtmp loss jc 1 staining activation caspase 3 immunofluorescence annexin v staining annexin vpi test jc 1 caspase 3 annexin v pi fluorescence 4 decade log scaling molt 3 cells incubated etoposide 1 microm oligomycin 10 microgml 6 hours b kinetics apoptotic events molt 3 cells incubated etoposide 1 microm without oligomycin 10 microgml indicates mtmp loss indicates act caspase 3 indicates annexin v
0.5554981.15705792.html.plaintext.txt	65	view larger version 23k figure 2 oligomycin abrogates drug induced apoptosis molt 3 cells cascade apoptotic events indicated arrows characterized mtmp loss jc 1 staining activation caspase 3 immunofluorescence annexin v staining annexin vpi test jc 1 caspase 3 annexin v pi fluorescence 4 decade log scaling molt 3 cells incubated etoposide 1 microm oligomycin 10 microgml 6 hours b kinetics apoptotic events molt 3 cells incubated etoposide 1 microm without oligomycin 10 microgml indicates mtmp loss indicates act caspase 3 indicates annexin v
0.5554981.15705792.html.plaintext.txt	66	atp depletion molt 3 cells resulted cell death necrosis evidenced appearance annexin v pi cell fraction figure 3b contrast moderate reduction atp level presence 03 mm 2 dg affect cell viability figure 3b
0.5554981.15705792.html.plaintext.txt	67	atp depletion molt 3 cells resulted cell death necrosis evidenced appearance annexin v pi cell fraction figure 3b contrast moderate reduction atp level presence 03 mm 2 dg affect cell viability figure 3b
0.5554981.15705792.html.plaintext.txt	68	basal levels p53 presence 01 03 mm 2 dg decreased 5 statistically significant 22 p 01 test respectively however 2 dg 01 mm 03 mm figure 3c able prevent etoposide induced p53 accumulation moreover 2 dg significantly affect drug induced apoptosis figure 3c note mtmp levels change presence 01 03 mm 2 dg data shown
0.5554981.15705792.html.plaintext.txt	69	view larger version 31k figure 3 moderate intracellular atp reduction impair molt 3 cell viability drug response b molt 3 cells incubated 3 hours standard medium oligomycin 10 microgml 2 dg 01 mm 03 mm glucose serum free medium glu absence presence 1 mm 2 dg cells assessed intracellular atp levels using luminometric assay apoptosis necrosis b annexin vpi staining percentages necrotic cells upper right quadrant indicated c molt 3 cells incubated etoposide 1 microm standard medium absence presence 01 mm 03 mm 2 dg cells assessed p53 protein levels 3 hours incubation apoptosis annexinpi staining 6 hours incubation
0.5554981.15705792.html.plaintext.txt	70	view larger version 31k figure 3 moderate intracellular atp reduction impair molt 3 cell viability drug response b molt 3 cells incubated 3 hours standard medium oligomycin 10 microgml 2 dg 01 mm 03 mm glucose serum free medium glu absence presence 1 mm 2 dg cells assessed intracellular atp levels using luminometric assay apoptosis necrosis b annexin vpi staining percentages necrotic cells upper right quadrant indicated c molt 3 cells incubated etoposide 1 microm standard medium absence presence 01 mm 03 mm 2 dg cells assessed p53 protein levels 3 hours incubation apoptosis annexinpi staining 6 hours incubation
0.5554981.15705792.html.plaintext.txt	71	oligomycin affect p53 independent apoptosis signaling
0.5554981.15705792.html.plaintext.txt	72	effect oligomycin drug induced apoptosis investigated context different stress factors able induce apoptosis p53 accumulation molt 3 cells observed response dna damage doxorubicin exogeneous oxidative stress h2o2 proteasome inhibition lactacystin figure 4 cases oligomycin prevented p53 accumulation drug induced apoptosis figure 4 contrast inhibition protein kinase c staurosporine34 triggering cd95 death receptor pathway agonistic cd95 antibodies engage p53 system oligomycin affect resulting apoptotic cell death figure 4 observations suggest specific link mitochondrial activity proapoptotic p53 signaling
0.5554981.15705792.html.plaintext.txt	73	effect oligomycin drug induced apoptosis investigated context different stress factors able induce apoptosis p53 accumulation molt 3 cells observed response dna damage doxorubicin exogeneous oxidative stress h2o2 proteasome inhibition lactacystin figure 4 cases oligomycin prevented p53 accumulation drug induced apoptosis figure 4 contrast inhibition protein kinase c staurosporine34 triggering cd95 death receptor pathway agonistic cd95 antibodies engage p53 system oligomycin affect resulting apoptotic cell death figure 4 observations suggest specific link mitochondrial activity proapoptotic p53 signaling
0.5554981.15705792.html.plaintext.txt	74	view larger version 20k figure 4 oligomycin affect p53 independent apoptosis signaling molt 3 cells incubated presence absence oligomycin 10 microgml different apoptosis inducing agents 1 microm doxorubicin 30 microm h2o2 2 microm lactacystin 05 microm staurosporine 01 microgml cd95 assessed intracellular p53 protein levels apoptosis annexinpi staining 3 hours 6 hours incubation respectively
0.5554981.15705792.html.plaintext.txt	75	view larger version 20k figure 4 oligomycin affect p53 independent apoptosis signaling molt 3 cells incubated presence absence oligomycin 10 microgml different apoptosis inducing agents 1 microm doxorubicin 30 microm h2o2 2 microm lactacystin 05 microm staurosporine 01 microgml cd95 assessed intracellular p53 protein levels apoptosis annexinpi staining 3 hours 6 hours incubation respectively
0.5554981.15705792.html.plaintext.txt	76	gene expression profiling drug oligomycin treated molt 3 cells
0.5554981.15705792.html.plaintext.txt	77	gene expression mrna level drug stressed cells modulation oligomycin investigated dna microarray technique using focus affymetrix dna chip harbors 8800 cdna probe sets encoding known proteins quality crna preparation hybridization samples met minimum requirements 3 5 ratio 3 background noise 100 percentage positive calls 45 comparative analysis molt 3 cells either untreated medium treated etoposide doxorubicin presence absence oligomycin identified limited number gene transcripts whose levels changed threefold greater least one treated versus untreated sample 44 genes regulated 29 genes regulated data shown list genes changed expression least threefold least 2 treated samples summarized table 1 many genes described p53 transcriptional targets involved processes cell cycle regulation p2135 cellular redox state fdxr36 dna repair gadds ddb23738 proapoptotic p53 targets bax bik39 regulation bik particularly strong cases oligomycin counteracted regulation p53 targets table 1 cases effect absolute consistent fact oligomycin concentrations used 10 microgml fully prevent p53 accumulation figure 1 moreover p53 target genes also reported activated cell damage directly response dna damage eg gadd45a ddb2 genes3738 two early stress response genes sgk egr1 reported transcriptionally repressed wt p534041 regulation presence oligomycin indicates oligomycin also inhibited p53 activity transcriptional repressor table 1 noted p53 mrna levels change significantly presence doxorubicin etoposide andor oligomycin table 1 thus excluding possibility oligomycin could directly prevent p53 accumulation transcriptional level
0.5554981.15705792.html.plaintext.txt	78	gene expression mrna level drug stressed cells modulation oligomycin investigated dna microarray technique using focus affymetrix dna chip harbors 8800 cdna probe sets encoding known proteins quality crna preparation hybridization samples met minimum requirements 3 5 ratio 3 background noise 100 percentage positive calls 45 comparative analysis molt 3 cells either untreated medium treated etoposide doxorubicin presence absence oligomycin identified limited number gene transcripts whose levels changed threefold greater least one treated versus untreated sample 44 genes regulated 29 genes regulated data shown list genes changed expression least threefold least 2 treated samples summarized table 1 many genes described p53 transcriptional targets involved processes cell cycle regulation p2135 cellular redox state fdxr36 dna repair gadds ddb23738 proapoptotic p53 targets bax bik39 regulation bik particularly strong cases oligomycin counteracted regulation p53 targets table 1 cases effect absolute consistent fact oligomycin concentrations used 10 microgml fully prevent p53 accumulation figure 1 moreover p53 target genes also reported activated cell damage directly response dna damage eg gadd45a ddb2 genes3738 two early stress response genes sgk egr1 reported transcriptionally repressed wt p534041 regulation presence oligomycin indicates oligomycin also inhibited p53 activity transcriptional repressor table 1 noted p53 mrna levels change significantly presence doxorubicin etoposide andor oligomycin table 1 thus excluding possibility oligomycin could directly prevent p53 accumulation transcriptional level
0.5554981.15705792.html.plaintext.txt	79	view table table 1 stress oligomycin induced changes gene expression molt 3 cells
0.5554981.15705792.html.plaintext.txt	80	addition p53 specific targets observed regulation several genes ikba traf4 cd69 reported nfb specific transcriptional targets4243 interestingly regulation genes counteracted even enhanced oligomycin table1 thus indicating oligomycin might differentially affect p53 nfkb stress induced signaling
0.5554981.15705792.html.plaintext.txt	81	addition p53 specific targets observed regulation several genes ikba traf4 cd69 reported nfb specific transcriptional targets4243 interestingly regulation genes counteracted even enhanced oligomycin table1 thus indicating oligomycin might differentially affect p53 nfkb stress induced signaling
0.5554981.15705792.html.plaintext.txt	82	expression several genes consistently regulated presence oligomycin table 1 expected genes encoding proteins involved energy homeostasis adaptive regulation metabolic pathways vldlr44 trb344 cebp beta cebpb45 strongly regulated furthermore strong regulation highly stress sensitive atf3 transcription factor46 presence drugs oligomycin indicated presence oligomycin reduce overall extent intracellular stress oligomycin obviously suppress overall mrna synthesis genes found consistently regulated oligomycin 23 genes regulated 15 fold table 1 data shown among genes encoding oxidoreductase relevant protein ndufc1 heat shock protein hsp70b chaperone multiple applications including regulation nqo1 oxidoreductase47
0.5554981.15705792.html.plaintext.txt	83	expression several genes consistently regulated presence oligomycin table 1 expected genes encoding proteins involved energy homeostasis adaptive regulation metabolic pathways vldlr44 trb344 cebp beta cebpb45 strongly regulated furthermore strong regulation highly stress sensitive atf3 transcription factor46 presence drugs oligomycin indicated presence oligomycin reduce overall extent intracellular stress oligomycin obviously suppress overall mrna synthesis genes found consistently regulated oligomycin 23 genes regulated 15 fold table 1 data shown among genes encoding oxidoreductase relevant protein ndufc1 heat shock protein hsp70b chaperone multiple applications including regulation nqo1 oxidoreductase47
0.5554981.15705792.html.plaintext.txt	84	p53 system coupled mitochondrial activity activated cells primary leukemia cells
0.5554981.15705792.html.plaintext.txt	85	linkage mitochondrial activity p53 system investigated primary cells studied resting activated cells peripheral blood found increased mtmp levels activated cells figure 5a also found oligomycin treatment regulated mtmp activated resting cells disclosed similar levels mtmp presence oligomycin figure 5a presence etoposide resting cells showed small increase p53 figure 5b upon activation 24 hours figure 5b 72 hours data shown cells acquired drug sensitivity p53 level line previous report48 etoposide induced p53 accumulation activated cells effectively counteracted oligomycin figure 5b
0.5554981.15705792.html.plaintext.txt	86	linkage mitochondrial activity p53 system investigated primary cells studied resting activated cells peripheral blood found increased mtmp levels activated cells figure 5a also found oligomycin treatment regulated mtmp activated resting cells disclosed similar levels mtmp presence oligomycin figure 5a presence etoposide resting cells showed small increase p53 figure 5b upon activation 24 hours figure 5b 72 hours data shown cells acquired drug sensitivity p53 level line previous report48 etoposide induced p53 accumulation activated cells effectively counteracted oligomycin figure 5b
0.5554981.15705792.html.plaintext.txt	87	view larger version 28k figure 5 mitochondrial dependence drug induced p53 accumulation activated cells primary leukemia normal pb cells cells incubated oligomycin 10 microgml andor etoposide 30 microm 6 hours assessed mtmp p53 levels mtmp jc 1 fluorescence 4 decade log scaling increased activated cells regulated oligomycin 10 microgml b oligomycin prevents etoposide induced p53 accumulation activated cells indicates medium indicates etoposide indicates etoposide plus oligomycin c heterogeneous sensitivity etoposide oligomycin series samples individual leukemic sample presented point positioned according value drug specific p53 accumulation presence y axis absence x axis oligomycin d constitutive mtmp levels correlate p53 drug sensitivity series samples spearman analysis rs 068 p 05
0.5554981.15705792.html.plaintext.txt	88	view larger version 28k figure 5 mitochondrial dependence drug induced p53 accumulation activated cells primary leukemia normal pb cells cells incubated oligomycin 10 microgml andor etoposide 30 microm 6 hours assessed mtmp p53 levels mtmp jc 1 fluorescence 4 decade log scaling increased activated cells regulated oligomycin 10 microgml b oligomycin prevents etoposide induced p53 accumulation activated cells indicates medium indicates etoposide indicates etoposide plus oligomycin c heterogeneous sensitivity etoposide oligomycin series samples individual leukemic sample presented point positioned according value drug specific p53 accumulation presence y axis absence x axis oligomycin d constitutive mtmp levels correlate p53 drug sensitivity series samples spearman analysis rs 068 p 05
0.5554981.15705792.html.plaintext.txt	89	primary leukemia cells patients low intrinsic levels p53 protein observed data shown p53 mutations usually result increased intrinsic p53 levels observation pointed absence p53 mutations cells line general infrequency p53 mutations childhood initial diagnosis27 29 respect drug induced p53 accumulation blasts showed heterogeneous pattern stress sensitivity oligomycin differentially prevented drug induced p53 accumulation cells figure 5c also found considerable heterogeneity constitutive mtmp levels leukemic samples figure 5d interestingly drug induced p53 accumulation constitutive mtmp levels significantly correlated series samples rs 068 p 05 figure 5d
0.5554981.15705792.html.plaintext.txt	90	primary leukemia cells patients low intrinsic levels p53 protein observed data shown p53 mutations usually result increased intrinsic p53 levels observation pointed absence p53 mutations cells line general infrequency p53 mutations childhood initial diagnosis27 29 respect drug induced p53 accumulation blasts showed heterogeneous pattern stress sensitivity oligomycin differentially prevented drug induced p53 accumulation cells figure 5c also found considerable heterogeneity constitutive mtmp levels leukemic samples figure 5d interestingly drug induced p53 accumulation constitutive mtmp levels significantly correlated series samples rs 068 p 05 figure 5d
0.5554981.15705792.html.plaintext.txt	91	p53 accumulation ros sensitive oligomycin reduces mitochondrial ros levels
0.5554981.15705792.html.plaintext.txt	92	electron transport chain mitochondria known site ros generation resulting occasional escape transported electrons1516 therefore asked whether regulation mitochondrial activity mtmp levels oligomycin might affect ros levels molt 3 cells oligomycin small effect total cellular level ros assessed ros sensitive dyes dcfda decreased 5 10 data shown order detect mitochondrially localized ros mitochondria specific dye nao used nao binds specifically mitochondrial cardiolipin binding affinity fluorescence properties depend oxidation state cardiolipin49 51 nao binds high affinity nonoxidized cardiolipin 21 ratio fluorescence shifts toward longer wavelength 525 nm green 640 nm red result nao dimerization site mitochondrial membrane4950 case oxidized cardiolipin nao reported bind cardiolipin decreased affinity reflected lower levels red fluorescence49 therefore oxidative stress localized mitochondria assessed red fluorescence measurement nao51 using approach observed 26 increase nao red fluorescence molt 3 cells presence oligomycin compared cells cultured medium p 001 test figure 6a therefore oligomycin predominantly decreased levels ros localized mitochondria
0.5554981.15705792.html.plaintext.txt	93	electron transport chain mitochondria known site ros generation resulting occasional escape transported electrons1516 therefore asked whether regulation mitochondrial activity mtmp levels oligomycin might affect ros levels molt 3 cells oligomycin small effect total cellular level ros assessed ros sensitive dyes dcfda decreased 5 10 data shown order detect mitochondrially localized ros mitochondria specific dye nao used nao binds specifically mitochondrial cardiolipin binding affinity fluorescence properties depend oxidation state cardiolipin49 51 nao binds high affinity nonoxidized cardiolipin 21 ratio fluorescence shifts toward longer wavelength 525 nm green 640 nm red result nao dimerization site mitochondrial membrane4950 case oxidized cardiolipin nao reported bind cardiolipin decreased affinity reflected lower levels red fluorescence49 therefore oxidative stress localized mitochondria assessed red fluorescence measurement nao51 using approach observed 26 increase nao red fluorescence molt 3 cells presence oligomycin compared cells cultured medium p 001 test figure 6a therefore oligomycin predominantly decreased levels ros localized mitochondria
0.5554981.15705792.html.plaintext.txt	94	view larger version 27k figure 6 involvement ros drug induced p53 accumulation leukemic cells activated lymphocytes increased nao red fluorescence indicates decreased mitochondrial ros levels presence oligomycin molt 3 cells incubated oligomycin 10 microgml andor etoposide 1 microm 3 hours assessed nao fluorescence open bars indicate oligomycin gray bars indicate oligomycin b nac prevents etoposide induced p53 accumulation apoptosis molt 3 cells incubated nac 10 mm andor etoposide 1 microm assessed p53 protein levels 3 hours incubation apoptosis jc 1 annexinpi staining 6 hours incubation jc 1 caspase 3 annexin v pi fluorescence 4 decade log scaling nac affect mtmp levels indicated jc 1 red green fluorescence ratios viable cell fractions indicated arrows c nac 10 mm prevents etoposide induced p53 accumulation activated cells cells incubated nac 10 mm andor etoposide 30 microm 6 hours assessed p53 levels hatched bars indicate medium black bars etoposide gray bars etoposide plus nac d nac 10 mm differentially prevents etoposide induced p53 accumulation series samples cells incubated nac 10 mm andor etoposide 30 microm 6 hours assessed p53 levels individual leukemic sample presented point positioned according value drug specific p53 accumulation presence y axis absence x axis nac
0.5554981.15705792.html.plaintext.txt	95	view larger version 27k figure 6 involvement ros drug induced p53 accumulation leukemic cells activated lymphocytes increased nao red fluorescence indicates decreased mitochondrial ros levels presence oligomycin molt 3 cells incubated oligomycin 10 microgml andor etoposide 1 microm 3 hours assessed nao fluorescence open bars indicate oligomycin gray bars indicate oligomycin b nac prevents etoposide induced p53 accumulation apoptosis molt 3 cells incubated nac 10 mm andor etoposide 1 microm assessed p53 protein levels 3 hours incubation apoptosis jc 1 annexinpi staining 6 hours incubation jc 1 caspase 3 annexin v pi fluorescence 4 decade log scaling nac affect mtmp levels indicated jc 1 red green fluorescence ratios viable cell fractions indicated arrows c nac 10 mm prevents etoposide induced p53 accumulation activated cells cells incubated nac 10 mm andor etoposide 30 microm 6 hours assessed p53 levels hatched bars indicate medium black bars etoposide gray bars etoposide plus nac d nac 10 mm differentially prevents etoposide induced p53 accumulation series samples cells incubated nac 10 mm andor etoposide 30 microm 6 hours assessed p53 levels individual leukemic sample presented point positioned according value drug specific p53 accumulation presence y axis absence x axis nac
0.5554981.15705792.html.plaintext.txt	96	involvement ros drug induced p53 accumulation investigated using glutathione progenitor nac general antioxidant known reduce intracellular ros levels52 titration experiments data shown nac concentration 10 mm found prevent almost totally early accumulation p53 consequent apoptotic events molt 3 cells treated etoposide figure 6b nac also abrogated p53 accumulation molt 3 cells treated lactacystin h2o2 doxorubicin data shown mtmp levels remained almost constant presence nac etoposide treated untreated cells figure 6b effect nac implicate changes mtmp levels
0.5554981.15705792.html.plaintext.txt	97	involvement ros drug induced p53 accumulation investigated using glutathione progenitor nac general antioxidant known reduce intracellular ros levels52 titration experiments data shown nac concentration 10 mm found prevent almost totally early accumulation p53 consequent apoptotic events molt 3 cells treated etoposide figure 6b nac also abrogated p53 accumulation molt 3 cells treated lactacystin h2o2 doxorubicin data shown mtmp levels remained almost constant presence nac etoposide treated untreated cells figure 6b effect nac implicate changes mtmp levels
0.5554981.15705792.html.plaintext.txt	98	addition molt 3 system also observed nac inhibition etoposide induced p53 accumulation activated cells figure 6c moreover also clear inhibitory effect nac p53 accumulation primary cells figure 6d
0.5554981.15705792.html.plaintext.txt	99	addition molt 3 system also observed nac inhibition etoposide induced p53 accumulation activated cells figure 6c moreover also clear inhibitory effect nac p53 accumulation primary cells figure 6d
0.5554981.15705792.html.plaintext.txt	100	discussion top abstract introduction materials methods results discussion references present study addressed contribution mitochondrial components involved oxidative phosphorylation proapoptotic stress signaling cell systems endogenously expressing wt p53 identified link mitochondrial activity stress responsiveness p53 system leukemia cells normal lymphocytes result linkage regulation constitutively low mtmp levels conferred chemoresistance cells p53 level
0.5554981.15705792.html.plaintext.txt	101	discussion top abstract introduction materials methods results discussion references present study addressed contribution mitochondrial components involved oxidative phosphorylation proapoptotic stress signaling cell systems endogenously expressing wt p53 identified link mitochondrial activity stress responsiveness p53 system leukemia cells normal lymphocytes result linkage regulation constitutively low mtmp levels conferred chemoresistance cells p53 level
0.5554981.15705792.html.plaintext.txt	102	various mitochondrial inhibitors able regulate mtmp oligomycin revealed highest efficacy prevent stress induced p53 accumulation p53 dependent apoptosis oligomycin recently reported inhibit apoptosis cellular systems transiently activated p5322 atp synthase shown cooperate p53 target bax thus indicating contribution mitochondrial components oxidative phosphorylation proapoptotic signaling downstream p53 activation investigations cellular systems endogenous wt p53 suggest contribution mitochondrial oxidative phosphorylation proapoptotic signaling upstream p53 activation moreover observation apoptotic signaling via p53 independent pathways either mitochondrial staurosporine extrinsic cd95 death receptor affected mitochondrial inhibitors indicates selective linkage mitochondrial activity p53 supported genome wide gene expression analysis molt 3 cells demonstrated largely selective inhibition oligomycin p53 specific targets stress inducible including nfb dependent transcriptional targets
0.5554981.15705792.html.plaintext.txt	103	various mitochondrial inhibitors able regulate mtmp oligomycin revealed highest efficacy prevent stress induced p53 accumulation p53 dependent apoptosis oligomycin recently reported inhibit apoptosis cellular systems transiently activated p5322 atp synthase shown cooperate p53 target bax thus indicating contribution mitochondrial components oxidative phosphorylation proapoptotic signaling downstream p53 activation investigations cellular systems endogenous wt p53 suggest contribution mitochondrial oxidative phosphorylation proapoptotic signaling upstream p53 activation moreover observation apoptotic signaling via p53 independent pathways either mitochondrial staurosporine extrinsic cd95 death receptor affected mitochondrial inhibitors indicates selective linkage mitochondrial activity p53 supported genome wide gene expression analysis molt 3 cells demonstrated largely selective inhibition oligomycin p53 specific targets stress inducible including nfb dependent transcriptional targets
0.5554981.15705792.html.plaintext.txt	104	concentrations able effectively abrogate drug induced p53 signaling apoptosis oligomycin caused low moderate reduction intracellular atp levels line oligomycin impair atp dependent cascade p53 independent apoptotic events5354 cause switch necrotic cell death54 particular importance moderate atp decrease inhibition glycolysis inhibit stress induced p53 accumulation apoptosis data suggest reduction intracellular atp levels unlikely mechanism suppression drug induced p53 activation
0.5554981.15705792.html.plaintext.txt	105	concentrations able effectively abrogate drug induced p53 signaling apoptosis oligomycin caused low moderate reduction intracellular atp levels line oligomycin impair atp dependent cascade p53 independent apoptotic events5354 cause switch necrotic cell death54 particular importance moderate atp decrease inhibition glycolysis inhibit stress induced p53 accumulation apoptosis data suggest reduction intracellular atp levels unlikely mechanism suppression drug induced p53 activation
0.5554981.15705792.html.plaintext.txt	106	ros implicated second messengers multiple signaling pathways5556 mitochondrion main site ros generation results escape transported electrons electron transport chain1516 reduction mitochondrial ros overexpression mitochondrial redox regulating thioredoxin reported confer cellular resistance etoposide57 general antioxidant nac reported prevent p53 accumulation induced drugs generating ros prevent cell death downstream p53 activation58 62 redox dependence stress induced signaling cell systems demonstrated investigations ros levels effects nac data demonstrated ros involved stress induced signaling upstream p53 activation striking similarity observed cellular systems studied effects oligomycin nac etoposide induced p53 accumulation furthermore oligomycin found regulate mitochondrial ros nac affect mtmp levels data suggest mitochondrial ros may implicated second messengers mitochondrial electron transport activity stress induced p53 activation
0.5554981.15705792.html.plaintext.txt	107	ros implicated second messengers multiple signaling pathways5556 mitochondrion main site ros generation results escape transported electrons electron transport chain1516 reduction mitochondrial ros overexpression mitochondrial redox regulating thioredoxin reported confer cellular resistance etoposide57 general antioxidant nac reported prevent p53 accumulation induced drugs generating ros prevent cell death downstream p53 activation58 62 redox dependence stress induced signaling cell systems demonstrated investigations ros levels effects nac data demonstrated ros involved stress induced signaling upstream p53 activation striking similarity observed cellular systems studied effects oligomycin nac etoposide induced p53 accumulation furthermore oligomycin found regulate mitochondrial ros nac affect mtmp levels data suggest mitochondrial ros may implicated second messengers mitochondrial electron transport activity stress induced p53 activation
0.5554981.15705792.html.plaintext.txt	108	redox regulating oxidoreductases recently emerged novel class interaction partners p53 protein indicating importance intracellular redox regulating factors stress induced p53 activation chang et al63 identified wox1 oxidoreductase proapoptotic protein became phosphorylated response stress apoptotic stimuli formed complex activated p53 p53 complex wild type mutant wox1 translocated mitochondria nuclei mediate apoptosis series studies asher et al66465 demonstrated nqo1 oxidoreductase regulates p53 mdm2 independent manner addition anwar et al7 demonstrated p53 stabilization requires physical interaction p53 nqo1 also shown heat shock protein hsp70b interacts immature form nqo1 responsible stability functionality oxidoreductase47 observed regulation hsp70b encoding gene gene encoding component mitochondrial complex nadh dehydrogenase activity ndufc1 changes indicate interference oligomycin cellular redox regulation transcriptional level particular interest small number genes consistently regulated oligomycin table 1 remains elucidated whether oxidoreductase specific p53 regulation may operative ros mediated linkage mitochondrial activity p53 system
0.5554981.15705792.html.plaintext.txt	109	redox regulating oxidoreductases recently emerged novel class interaction partners p53 protein indicating importance intracellular redox regulating factors stress induced p53 activation chang et al63 identified wox1 oxidoreductase proapoptotic protein became phosphorylated response stress apoptotic stimuli formed complex activated p53 p53 complex wild type mutant wox1 translocated mitochondria nuclei mediate apoptosis series studies asher et al66465 demonstrated nqo1 oxidoreductase regulates p53 mdm2 independent manner addition anwar et al7 demonstrated p53 stabilization requires physical interaction p53 nqo1 also shown heat shock protein hsp70b interacts immature form nqo1 responsible stability functionality oxidoreductase47 observed regulation hsp70b encoding gene gene encoding component mitochondrial complex nadh dehydrogenase activity ndufc1 changes indicate interference oligomycin cellular redox regulation transcriptional level particular interest small number genes consistently regulated oligomycin table 1 remains elucidated whether oxidoreductase specific p53 regulation may operative ros mediated linkage mitochondrial activity p53 system
0.5554981.15705792.html.plaintext.txt	110	quantification intracellular mtmp levels provides useful intrinsic determinant describing mitochondrial activity heerdt et al6667 reported dependence intrinsic mtmp levels extent growth arrest apoptosis cancer cells harper et al68 found decreased mtmp levels characteristic drug resistant leukemia cell lines compared mtmp levels drug sensitive counterparts particular interest chemoresistant cells found switch energy metabolism oxidative phosphorylation anaerobic energy sources thus preserving energy supply reducing mitochondrial activity68 data suggest cellular metabolic strategy would decrease abolish cellular stress sensitivity p53 level thus providing clinically relevant mechanism chemoresistance wt p53 cells would interest investigate whether differential mtmp levels observed primary cells might due metabolic differences cells
0.5554981.15705792.html.plaintext.txt	111	quantification intracellular mtmp levels provides useful intrinsic determinant describing mitochondrial activity heerdt et al6667 reported dependence intrinsic mtmp levels extent growth arrest apoptosis cancer cells harper et al68 found decreased mtmp levels characteristic drug resistant leukemia cell lines compared mtmp levels drug sensitive counterparts particular interest chemoresistant cells found switch energy metabolism oxidative phosphorylation anaerobic energy sources thus preserving energy supply reducing mitochondrial activity68 data suggest cellular metabolic strategy would decrease abolish cellular stress sensitivity p53 level thus providing clinically relevant mechanism chemoresistance wt p53 cells would interest investigate whether differential mtmp levels observed primary cells might due metabolic differences cells
0.5554981.15705792.html.plaintext.txt	112	recent studies indicated impact wt p53 mitochondrial function mouse embryos homozygous p53 null mutation showed mitochondrial deficiency stage development embryo switches anaerobic aerobic metabolism69 wt p53 cells constitutive stress dependent colocalization p53 mitochondria reported7071 mitochondrial targeting dominant negative p53 mutant protein resulted decreased mtmp levels72 data provide experimental evidence activation p53 system requires mitochondrial activity point mitochondrial ros secondary messengers respiratory chain proapoptotic p53 machinery linkage potential clinical implications mechanisms chemoresistance normal malignant cells
0.5554981.15705792.html.plaintext.txt	113	recent studies indicated impact wt p53 mitochondrial function mouse embryos homozygous p53 null mutation showed mitochondrial deficiency stage development embryo switches anaerobic aerobic metabolism69 wt p53 cells constitutive stress dependent colocalization p53 mitochondria reported7071 mitochondrial targeting dominant negative p53 mutant protein resulted decreased mtmp levels72 data provide experimental evidence activation p53 system requires mitochondrial activity point mitochondrial ros secondary messengers respiratory chain proapoptotic p53 machinery linkage potential clinical implications mechanisms chemoresistance normal malignant cells
0.5554981.15705792.html.plaintext.txt	114	acknowledgements thank r hoffmann excellent technical assistance dr c beltinger ulm giving advice using nao staining mitochondrial ros indicator prof dr d b davies london critical reading manuscript
0.5554981.15705792.html.plaintext.txt	115	acknowledgements thank r hoffmann excellent technical assistance dr c beltinger ulm giving advice using nao staining mitochondrial ros indicator prof dr d b davies london critical reading manuscript
0.5554981.15705792.html.plaintext.txt	116	footnotes submitted september 3 2004 accepted february 3 2005
0.5554981.15705792.html.plaintext.txt	117	prepublished online blood first edition paper february 10 2005 doi 101182blood 2004 09 3428
0.5554981.15705792.html.plaintext.txt	118	supported part grant federal ministery education research bmbf national genome research network ngfn pr
0.5554981.15705792.html.plaintext.txt	119	publication costs article defrayed part page charge payment therefore solely indicate fact article hereby marked advertisement accordance 18 usc section 1734
0.5554981.15705792.html.plaintext.txt	120	publication costs article defrayed part page charge payment therefore solely indicate fact article hereby marked advertisement accordance 18 usc section 1734
0.5554981.15705792.html.plaintext.txt	121	reprints leonid karawajew robert rossle clinic charite lindenberger weg 80 13125 berlin germany e mail karawajewatrrkcharite buchde u d
0.5554981.15705792.html.plaintext.txt	122	references top abstract introduction materials methods results discussion references slee ea oconnor dj lu x die die p53 decide oncogene 200423 2809 2818crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	123	references top abstract introduction materials methods results discussion references slee ea oconnor dj lu x die die p53 decide oncogene 200423 2809 2818crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	124	pluquet o hainaut p genotoxic non genotoxic pathways p53 induction cancer lett 2001174 1 15crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	125	brooks cl gu w ubiquitination phosphorylation acetylation molecular basis p53 regulation curr opin cell biol 200315 164 171crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	126	giaccia aj kastan mb complexity p53 modulation emerging patterns divergent signals genes dev 199812 2973 2983free full text
0.5554981.15705792.html.plaintext.txt	127	momand j wu hh dasgupta g mdm2 master regulator p53 tumor suppressor protein gene 2000242 15 29crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	128	asher g lotem j sachs l shaul y p53 dependent apoptosis nadphquinone oxidoreductase 1 methods enzymol 2004382 278 293medline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	129	asher g lotem j sachs l shaul y p53 dependent apoptosis nadphquinone oxidoreductase 1 methods enzymol 2004382 278 293medline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	130	anwar dehn d siegel d et al interaction human nadphquinone oxidoreductase 1 nqo1 tumor suppressor protein p53 cells cell free systems j biol chem 2003278 10368 10373abstractfree full text
0.5554981.15705792.html.plaintext.txt	131	anwar dehn d siegel d et al interaction human nadphquinone oxidoreductase 1 nqo1 tumor suppressor protein p53 cells cell free systems j biol chem 2003278 10368 10373abstractfree full text
0.5554981.15705792.html.plaintext.txt	132	asher g lotem j sachs l kahana c shaul y mdm 2 ubiquitin independent p53 proteasomal degradation regulated nqo1 proc natl acad sci u 200299 13125 13130abstractfree full text
0.5554981.15705792.html.plaintext.txt	133	asher g lotem j sachs l kahana c shaul y mdm 2 ubiquitin independent p53 proteasomal degradation regulated nqo1 proc natl acad sci u 200299 13125 13130abstractfree full text
0.5554981.15705792.html.plaintext.txt	134	zhao r gish k murphy m et al analysis p53 regulated gene expression patterns using oligonucleotide arrays genes dev 200014 981 993abstractfree full text
0.5554981.15705792.html.plaintext.txt	135	zhao r gish k murphy m et al analysis p53 regulated gene expression patterns using oligonucleotide arrays genes dev 200014 981 993abstractfree full text
0.5554981.15705792.html.plaintext.txt	136	kannan k amariglio n rechavi g et al dna microarrays identification primary secondary target genes regulated p53 oncogene 200120 2225 2234crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	137	kannan k amariglio n rechavi g et al dna microarrays identification primary secondary target genes regulated p53 oncogene 200120 2225 2234crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	138	yu j zhang l hwang pm rago c kinzler kw vogelstein b identification classification p53 regulated genes proc natl acad sci u 199996 14517 14522abstractfree full text
0.5554981.15705792.html.plaintext.txt	139	yu j zhang l hwang pm rago c kinzler kw vogelstein b identification classification p53 regulated genes proc natl acad sci u 199996 14517 14522abstractfree full text
0.5554981.15705792.html.plaintext.txt	140	polyak k xia y zweier jl kinzler kw vogelstein b model p53 induced apoptosis nature 1997389 300 305crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	141	polyak k xia y zweier jl kinzler kw vogelstein b model p53 induced apoptosis nature 1997389 300 305crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	142	ravagnan l roumier kroemer g mitochondria killer organelles weapons j cell physiol 2002192 131 137crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	143	ravagnan l roumier kroemer g mitochondria killer organelles weapons j cell physiol 2002192 131 137crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	144	saraste m oxidative phosphorylation fin de siecle science 1999283 1488 1493abstractfree full text
0.5554981.15705792.html.plaintext.txt	145	brookes ps levonen al shiva sarti p darley usmar vm mitochondria regulators signal transduction reactive oxygen nitrogen species free radic biol med 200233 755 764crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	146	brookes ps levonen al shiva sarti p darley usmar vm mitochondria regulators signal transduction reactive oxygen nitrogen species free radic biol med 200233 755 764crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	147	inoue m sato ef nishikawa m et al mitochondrial generation reactive oxygen species role aerobic life curr med chem 200310 2495 2505crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	148	inoue m sato ef nishikawa m et al mitochondrial generation reactive oxygen species role aerobic life curr med chem 200310 2495 2505crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	149	schuler m bossy wetzel e goldstein jc fitzgerald p green dr p53 induces apoptosis caspase activation mitochondrial cytochrome c release j biol chem 2000275 7337 7342abstractfree full text
0.5554981.15705792.html.plaintext.txt	150	schuler m bossy wetzel e goldstein jc fitzgerald p green dr p53 induces apoptosis caspase activation mitochondrial cytochrome c release j biol chem 2000275 7337 7342abstractfree full text
0.5554981.15705792.html.plaintext.txt	151	kroemer g reed jc mitochondrial control cell death nat med 20006 513 519crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	152	chao dt korsmeyer sj bcl 2 family regulators cell death annu rev immunol 199816 395 419crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	153	miyashita reed jc tumor suppressor p53 direct transcriptional activator human bax gene cell 199580 293 299crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	154	oda e ohki r murasawa h et al noxa bh3 member bcl 2 family candidate mediator p53 induced apoptosis science 2000288 1053 1058abstractfree full text
0.5554981.15705792.html.plaintext.txt	155	oda e ohki r murasawa h et al noxa bh3 member bcl 2 family candidate mediator p53 induced apoptosis science 2000288 1053 1058abstractfree full text
0.5554981.15705792.html.plaintext.txt	156	matsuyama xu q velours j reed jc mitochondrial f0f1 atpase proton pump required function proapoptotic protein bax yeast mammalian cells mol cell 19981 327 336crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	157	matsuyama xu q velours j reed jc mitochondrial f0f1 atpase proton pump required function proapoptotic protein bax yeast mammalian cells mol cell 19981 327 336crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	158	zamzami n marchetti p castedo m et al sequential reduction mitochondrial transmembrane potential generation reactive oxygen species early programmed cell death j exp med 1995182 367 377abstractfree full text
0.5554981.15705792.html.plaintext.txt	159	zamzami n marchetti p castedo m et al sequential reduction mitochondrial transmembrane potential generation reactive oxygen species early programmed cell death j exp med 1995182 367 377abstractfree full text
0.5554981.15705792.html.plaintext.txt	160	cai z lin m wuchter c et al apoptotic response homoharringtonine human wt p53 leukemic cells independent reactive oxygen species generation implicates bax translocation mitochondrial cytochrome c release caspase activation leukemia 200115 567 574crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	161	karawajew l glibin en maleev vy et al role crown like side chains biological activity substituted phenoxazone drugs anticancer drug des 200015 331 338medline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	162	karawajew l glibin en maleev vy et al role crown like side chains biological activity substituted phenoxazone drugs anticancer drug des 200015 331 338medline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	163	wuchter c ruppert v schrappe m dorken b ludwig wd karawajew l vitro susceptibility dexamethasone doxorubicin induced apoptotic cell death context maturation stage responsiveness interleukin 7 early cytoreduction vivo childhood cell acute lymphoblastic leukemia blood 200299 4109 4115abstractfree full text
0.5554981.15705792.html.plaintext.txt	164	wuchter c ruppert v schrappe m dorken b ludwig wd karawajew l vitro susceptibility dexamethasone doxorubicin induced apoptotic cell death context maturation stage responsiveness interleukin 7 early cytoreduction vivo childhood cell acute lymphoblastic leukemia blood 200299 4109 4115abstractfree full text
0.5554981.15705792.html.plaintext.txt	165	fenaux p jonveaux p quiquandon et al mutations p53 gene b cell lymphoblastic acute leukemia report 60 cases leukemia 19926 42 46medline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	166	fenaux p jonveaux p quiquandon et al mutations p53 gene b cell lymphoblastic acute leukemia report 60 cases leukemia 19926 42 46medline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	167	wada m bartram cr nakamura h et al analysis p53 mutations large series lymphoid hematologic malignancies childhood blood 199382 3163 3169abstract
0.5554981.15705792.html.plaintext.txt	168	wada m bartram cr nakamura h et al analysis p53 mutations large series lymphoid hematologic malignancies childhood blood 199382 3163 3169abstract
0.5554981.15705792.html.plaintext.txt	169	jonveaux p berger r infrequent mutations p53 gene primary human cell acute lymphoblastic leukemia leukemia 19915 839 840medline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	170	stahnke k mohr liu j meyer lh karawajew l debatin km identification deficient mitochondrial signaling apoptosis resistant leukemia cells flow cytometric analysis intracellular cytochrome c caspase 3 apoptosis apoptosis 20049 457 465crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	171	stahnke k mohr liu j meyer lh karawajew l debatin km identification deficient mitochondrial signaling apoptosis resistant leukemia cells flow cytometric analysis intracellular cytochrome c caspase 3 apoptosis apoptosis 20049 457 465crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	172	karawajew l ruppert v wuchter c et al inhibition vitro spontaneous apoptosis il 7 correlates bcl 2 regulation corticalmature immunophenotype better early cytoreduction childhood cell acute lymphoblastic leukemia blood 200096 297 306abstractfree full text
0.5554981.15705792.html.plaintext.txt	173	karawajew l ruppert v wuchter c et al inhibition vitro spontaneous apoptosis il 7 correlates bcl 2 regulation corticalmature immunophenotype better early cytoreduction childhood cell acute lymphoblastic leukemia blood 200096 297 306abstractfree full text
0.5554981.15705792.html.plaintext.txt	174	bonsing ba corver gorsira mc et al specificity seven monoclonal antibodies p53 evaluated western blotting immunohistochemistry confocal laser scanning microscopy flow cytometry cytometry 199728 11 2430co2 klinktypedoi crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	175	bonsing ba corver gorsira mc et al specificity seven monoclonal antibodies p53 evaluated western blotting immunohistochemistry confocal laser scanning microscopy flow cytometry cytometry 199728 11 2430co2 klinktypedoi crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	176	salvioli ardizzoni franceschi c cossarizza jc 1 dioc63 rhodamine 123 reliable fluorescent probe assess delta psi changes intact cells implications studies mitochondrial functionality apoptosis febs lett 1997411 77 82crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	177	salvioli ardizzoni franceschi c cossarizza jc 1 dioc63 rhodamine 123 reliable fluorescent probe assess delta psi changes intact cells implications studies mitochondrial functionality apoptosis febs lett 1997411 77 82crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	178	stepczynska lauber k engels ih et al staurosporine conventional anticancer drugs induce overlapping yet distinct pathways apoptosis caspase activation oncogene 200120 1193 1202crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	179	stepczynska lauber k engels ih et al staurosporine conventional anticancer drugs induce overlapping yet distinct pathways apoptosis caspase activation oncogene 200120 1193 1202crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	180	kho ps wang z zhuang l et al p53 regulated transcriptional program associated genotoxic stress induced apoptosis j biol chem 2004279 21183 21192abstractfree full text
0.5554981.15705792.html.plaintext.txt	181	kho ps wang z zhuang l et al p53 regulated transcriptional program associated genotoxic stress induced apoptosis j biol chem 2004279 21183 21192abstractfree full text
0.5554981.15705792.html.plaintext.txt	182	liu g chen x ferredoxin reductase gene regulated p53 family sensitizes cells oxidative stress induced apoptosis oncogene 200221 7195 7204crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	183	amundson sa patterson kt fornace aj jr nucleotide excision repair master switch p53 regulated coordinate induction global genomic repair genes cancer biol ther 20021 145 149medline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	184	amundson sa patterson kt fornace aj jr nucleotide excision repair master switch p53 regulated coordinate induction global genomic repair genes cancer biol ther 20021 145 149medline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	185	khanna kk jackson sp dna double strand breaks signaling repair cancer connection nat genet 200127 247 254crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	186	mathai jp germain m marcellus rc shore gc induction endoplasmic reticulum location biknbk response apoptotic signaling e1a p53 oncogene 200221 2534 2544crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	187	mathai jp germain m marcellus rc shore gc induction endoplasmic reticulum location biknbk response apoptotic signaling e1a p53 oncogene 200221 2534 2544crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	188	maiyar ac phu pt huang aj firestone gl repression glucocorticoid receptor transactivation dna binding glucocorticoid response element within serumglucocorticoid inducible protein kinase sgk gene promoter p53 tumor suppressor protein mol endocrinol 199711 312 329abstractfree full text
0.5554981.15705792.html.plaintext.txt	189	maiyar ac phu pt huang aj firestone gl repression glucocorticoid receptor transactivation dna binding glucocorticoid response element within serumglucocorticoid inducible protein kinase sgk gene promoter p53 tumor suppressor protein mol endocrinol 199711 312 329abstractfree full text
0.5554981.15705792.html.plaintext.txt	190	krones herzig adamson e mercola d early growth response 1 protein upstream gate keeper p53 tumor suppressor controls replicative senescence proc natl acad sci u 2003100 3233 3238abstractfree full text
0.5554981.15705792.html.plaintext.txt	191	krones herzig adamson e mercola d early growth response 1 protein upstream gate keeper p53 tumor suppressor controls replicative senescence proc natl acad sci u 2003100 3233 3238abstractfree full text
0.5554981.15705792.html.plaintext.txt	192	kucharczak j simmons mj fan y gelinas c nf kappab answer role relnf kappab regulation apoptosis oncogene 200322 8961 8982crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	193	kucharczak j simmons mj fan y gelinas c nf kappab answer role relnf kappab regulation apoptosis oncogene 200322 8961 8982crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	194	glauner h siegmund d motejadded h et al intracellular localization transcriptional regulation tumor necrosis factor tnf receptor associated factor 4 traf4 eur j biochem 2002269 4819 4829abstractfree full text
0.5554981.15705792.html.plaintext.txt	195	glauner h siegmund d motejadded h et al intracellular localization transcriptional regulation tumor necrosis factor tnf receptor associated factor 4 traf4 eur j biochem 2002269 4819 4829abstractfree full text
0.5554981.15705792.html.plaintext.txt	196	tacken pj hofker mh havekes lm van dijk kw living name role vldl receptor lipid metabolism curr opin lipidol 200112 275 279crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	197	tacken pj hofker mh havekes lm van dijk kw living name role vldl receptor lipid metabolism curr opin lipidol 200112 275 279crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	198	arizmendi c liu croniger c poli v friedman je transcription factor ccaatenhancer binding protein beta regulates gluconeogenesis phosphoenolpyruvate carboxykinase gtp gene transcription diabetes j biol chem 1999274 13033 13040abstractfree full text
0.5554981.15705792.html.plaintext.txt	199	arizmendi c liu croniger c poli v friedman je transcription factor ccaatenhancer binding protein beta regulates gluconeogenesis phosphoenolpyruvate carboxykinase gtp gene transcription diabetes j biol chem 1999274 13033 13040abstractfree full text
0.5554981.15705792.html.plaintext.txt	200	hai wolfgang cd marsee dk allen ae sivaprasad u atf3 stress responses gene expr 19997 321 335medline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	201	anwar siegel d kepa jk ross d interaction molecular chaperone hsp70 human nadphquinone oxidoreductase 1 j biol chem 2002277 14060 14067abstractfree full text
0.5554981.15705792.html.plaintext.txt	202	anwar siegel d kepa jk ross d interaction molecular chaperone hsp70 human nadphquinone oxidoreductase 1 j biol chem 2002277 14060 14067abstractfree full text
0.5554981.15705792.html.plaintext.txt	203	stahnke k fulda friesen c strauss g debatin km activation apoptosis pathways peripheral blood lymphocytes vivo chemotherapy blood 200198 3066 3073abstractfree full text
0.5554981.15705792.html.plaintext.txt	204	stahnke k fulda friesen c strauss g debatin km activation apoptosis pathways peripheral blood lymphocytes vivo chemotherapy blood 200198 3066 3073abstractfree full text
0.5554981.15705792.html.plaintext.txt	205	garcia fernandez m troiano l moretti l et al changes intramitochondrial cardiolipin distribution apoptosis resistant hcw 2 cells derived human promyelocytic leukemia hl 60 febs lett 2000478 290 294crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	206	garcia fernandez m troiano l moretti l et al changes intramitochondrial cardiolipin distribution apoptosis resistant hcw 2 cells derived human promyelocytic leukemia hl 60 febs lett 2000478 290 294crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	207	garcia fernandez m troiano l moretti l et al early changes intramitochondrial cardiolipin distribution apoptosis cell growth differ 200213 449 455abstractfree full text
0.5554981.15705792.html.plaintext.txt	208	garcia fernandez m troiano l moretti l et al early changes intramitochondrial cardiolipin distribution apoptosis cell growth differ 200213 449 455abstractfree full text
0.5554981.15705792.html.plaintext.txt	209	nomura k imai h koumura kobayashi nakagawa y mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits release cytochrome c mitochondria suppressing peroxidation cardiolipin hypoglycaemia induced apoptosis biochem j 2000351 183 193crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	210	nomura k imai h koumura kobayashi nakagawa y mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits release cytochrome c mitochondria suppressing peroxidation cardiolipin hypoglycaemia induced apoptosis biochem j 2000351 183 193crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	211	sen ck redox signaling emerging therapeutic potential thiol antioxidants biochem pharmacol 199855 1747 1758crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	212	leist m single b castoldi af kuhnle nicotera p intracellular adenosine triphosphate atp concentration switch decision apoptosis necrosis j exp med 1997185 1481 1486abstractfree full text
0.5554981.15705792.html.plaintext.txt	213	leist m single b castoldi af kuhnle nicotera p intracellular adenosine triphosphate atp concentration switch decision apoptosis necrosis j exp med 1997185 1481 1486abstractfree full text
0.5554981.15705792.html.plaintext.txt	214	eguchi y shimizu tsujimoto y intracellular atp levels determine cell death fate apoptosis necrosis cancer res 199757 1835 1840abstract
0.5554981.15705792.html.plaintext.txt	215	eguchi y shimizu tsujimoto y intracellular atp levels determine cell death fate apoptosis necrosis cancer res 199757 1835 1840abstract
0.5554981.15705792.html.plaintext.txt	216	mayer m noble m n acetyl l cysteine pluri potent protector cell death enhancer trophic factor mediated cell survival vitro proc natl acad sci u 199491 7496 7500abstractfree full text
0.5554981.15705792.html.plaintext.txt	217	punj v chakrabarty redox proteins mammalian cell death evolutionarily conserved function mitochondria prokaryotes cell microbiol 20035 225 231crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	218	damdimopoulos ae miranda vizuete pelto huikko m gustafsson ja spyrou g human mitochondrial thioredoxin involvement mitochondrial membrane potential cell death j biol chem 2002277 33249 33257abstractfree full text
0.5554981.15705792.html.plaintext.txt	219	damdimopoulos ae miranda vizuete pelto huikko m gustafsson ja spyrou g human mitochondrial thioredoxin involvement mitochondrial membrane potential cell death j biol chem 2002277 33249 33257abstractfree full text
0.5554981.15705792.html.plaintext.txt	220	johnson tm yu zx ferrans vj lowenstein ra finkel reactive oxygen species stream mediators p53 dependent apoptosis proc natl acad sci u 199693 11848 11852abstractfree full text
0.5554981.15705792.html.plaintext.txt	221	johnson tm yu zx ferrans vj lowenstein ra finkel reactive oxygen species stream mediators p53 dependent apoptosis proc natl acad sci u 199693 11848 11852abstractfree full text
0.5554981.15705792.html.plaintext.txt	222	mates jm sanchez jimenez fm role reactive oxygen species apoptosis implications cancer therapy int j biochem cell biol 200032 157 170crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	223	han dc lee shin kd et al 2 benzoyloxy cinnamaldehyde induces apoptosis human carcinoma via reactive oxygen species j biol chem 2004279 6911 6920abstractfree full text
0.5554981.15705792.html.plaintext.txt	224	verhaegh gw richard mj hainaut p regulation p53 metal ions antioxidants dithiocarbamate regulates p53 dna binding activity increasing intracellular level copper mol cell biol 199717 5699 5706abstract
0.5554981.15705792.html.plaintext.txt	225	verhaegh gw richard mj hainaut p regulation p53 metal ions antioxidants dithiocarbamate regulates p53 dna binding activity increasing intracellular level copper mol cell biol 199717 5699 5706abstract
0.5554981.15705792.html.plaintext.txt	226	ye j wang leonard ss et al role reactive oxygen species p53 chromiumvi induced apoptosis j biol chem 1999274 34974 34980abstractfree full text
0.5554981.15705792.html.plaintext.txt	227	ye j wang leonard ss et al role reactive oxygen species p53 chromiumvi induced apoptosis j biol chem 1999274 34974 34980abstractfree full text
0.5554981.15705792.html.plaintext.txt	228	chang ns doherty j ensign et al molecular mechanisms underlying wox1 activation apoptotic stress responses biochem pharmacol 200366 1347 1354crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	229	chang ns doherty j ensign et al molecular mechanisms underlying wox1 activation apoptotic stress responses biochem pharmacol 200366 1347 1354crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	230	asher g lotem j kama r sachs l shaul y nqo1 stabilizes p53 distinct pathway proc natl acad sci u 200299 3099 3104abstractfree full text
0.5554981.15705792.html.plaintext.txt	231	asher g lotem j kama r sachs l shaul y nqo1 stabilizes p53 distinct pathway proc natl acad sci u 200299 3099 3104abstractfree full text
0.5554981.15705792.html.plaintext.txt	232	asher g lotem j cohen b sachs l shaul y regulation p53 stability p53 dependent apoptosis nadh quinone oxidoreductase 1 proc natl acad sci u 200198 1188 1193abstractfree full text
0.5554981.15705792.html.plaintext.txt	233	asher g lotem j cohen b sachs l shaul y regulation p53 stability p53 dependent apoptosis nadh quinone oxidoreductase 1 proc natl acad sci u 200198 1188 1193abstractfree full text
0.5554981.15705792.html.plaintext.txt	234	heerdt bg houston ma augenlicht lh short chain fatty acid initiated cell cycle arrest apoptosis colonic epithelial cells linked mitochondrial function cell growth differ 19978 523 532abstract
0.5554981.15705792.html.plaintext.txt	235	heerdt bg houston ma augenlicht lh short chain fatty acid initiated cell cycle arrest apoptosis colonic epithelial cells linked mitochondrial function cell growth differ 19978 523 532abstract
0.5554981.15705792.html.plaintext.txt	236	heerdt bg houston ma wilson aj augenlicht lh intrinsic mitochondrial membrane potential deltapsim associated steady state mitochondrial activity extent colonic epithelial cells undergo butyrate mediated growth arrest apoptosis cancer res 200363 6311 6319abstractfree full text
0.5554981.15705792.html.plaintext.txt	237	heerdt bg houston ma wilson aj augenlicht lh intrinsic mitochondrial membrane potential deltapsim associated steady state mitochondrial activity extent colonic epithelial cells undergo butyrate mediated growth arrest apoptosis cancer res 200363 6311 6319abstractfree full text
0.5554981.15705792.html.plaintext.txt	238	harper antoniou villalobos menuey e et al characterization novel metabolic strategy used drug resistant tumor cells faseb j 200216 1550 1557abstractfree full text
0.5554981.15705792.html.plaintext.txt	239	harper antoniou villalobos menuey e et al characterization novel metabolic strategy used drug resistant tumor cells faseb j 200216 1550 1557abstractfree full text
0.5554981.15705792.html.plaintext.txt	240	long dj 2nd gaikwad multani et al disruption nadphquinone oxidoreductase 1 nqo1 gene mice causes myelogenous hyperplasia cancer res 200262 3030 3036abstractfree full text
0.5554981.15705792.html.plaintext.txt	241	long dj 2nd gaikwad multani et al disruption nadphquinone oxidoreductase 1 nqo1 gene mice causes myelogenous hyperplasia cancer res 200262 3030 3036abstractfree full text
0.5554981.15705792.html.plaintext.txt	242	marchenko nd zaika moll um death signal induced localization p53 protein mitochondria potential role apoptotic signaling j biol chem 2000275 16202 16212abstractfree full text
0.5554981.15705792.html.plaintext.txt	243	mahyar roemer m fritzsche c wagner laue m roemer k mitochondrial p53 levels parallel total p53 levels independent stress response human colorectal carcinoma glioblastoma cells oncogene 2004
0.5554981.15705792.html.plaintext.txt	244	mahyar roemer m fritzsche c wagner laue m roemer k mitochondrial p53 levels parallel total p53 levels independent stress response human colorectal carcinoma glioblastoma cells oncogene 2004
0.5554981.15705792.html.plaintext.txt	245	donahue rj razmara m hoek jb knudsen tb direct influence p53 tumor suppressor mitochondrial biogenesis function faseb j 200115 635 644abstractfree full text
0.5554981.15705792.html.plaintext.txt	246	donahue rj razmara m hoek jb knudsen tb direct influence p53 tumor suppressor mitochondrial biogenesis function faseb j 200115 635 644abstractfree full text
0.5554981.15705792.html.plaintext.txt	247	huang yh wu jy zhang y wu mx synergistic opposing regulation stress responsive gene iex 1 p53 c myc multiple nf kappabrel complexes oncogene 200221 6819 6828crossrefmedline order article via infotrieve
0.5554981.15705792.html.plaintext.txt	248	huang yh wu jy zhang y wu mx synergistic opposing regulation stress responsive gene iex 1 p53 c myc multiple nf kappabrel complexes oncogene 200221 6819 6828crossrefmedline order article via infotrieve
0.5579345.9417035.html.plaintext.txt	0	minireview p53 network munna l agarwal william r taylor michail v chernov olga b chernova george r stark
0.5579345.9417035.html.plaintext.txt	1	department molecular biology lerner research institute cleveland clinic foundation cleveland ohio 44195
0.5579345.9417035.html.plaintext.txt	2	introduction top introduction references
0.5579345.9417035.html.plaintext.txt	3	loss control genomic stability central development cancer p53 regulating normal responses dna damage forms genotoxic stress key element maintaining genomic stability thus surprise functional p53 lost half human cancers half one possibility p53 independent regulatory mechanisms lost another inactivation p53 dependent pathways occur several different points p53 merely common target example p53 inhibitor mdm2 overexpressed tumors independently p53 mutation review pathways signal p53 response different forms stress pathways signal triggered activated p53 clear p53 central component complex network signaling pathways components pathways pose alternative targets inactivation additional recent reviews see refs 1 2
0.5579345.9417035.html.plaintext.txt	4	loss control genomic stability central development cancer p53 regulating normal responses dna damage forms genotoxic stress key element maintaining genomic stability thus surprise functional p53 lost half human cancers half one possibility p53 independent regulatory mechanisms lost another inactivation p53 dependent pathways occur several different points p53 merely common target example p53 inhibitor mdm2 overexpressed tumors independently p53 mutation review pathways signal p53 response different forms stress pathways signal triggered activated p53 clear p53 central component complex network signaling pathways components pathways pose alternative targets inactivation additional recent reviews see refs 1 2
0.5579345.9417035.html.plaintext.txt	5	amount p53 protein increases response variety signals damaged dna arrest dna rna synthesis nucleotide depletion stimuli also activate p53 mostly latent absence stress increase amount protein often achieved increase half life 30 min untreated cells 150 min example uv treated cells 3 however increase rate translational initiation p53 mrna also affect steady state level protein example see ref 4 ubiquitin pathway probably plays important role degrading p53 5 evidence ubiquitin independent mechanism degradation also presented 6
0.5579345.9417035.html.plaintext.txt	6	amount p53 protein increases response variety signals damaged dna arrest dna rna synthesis nucleotide depletion stimuli also activate p53 mostly latent absence stress increase amount protein often achieved increase half life 30 min untreated cells 150 min example uv treated cells 3 however increase rate translational initiation p53 mrna also affect steady state level protein example see ref 4 ubiquitin pathway probably plays important role degrading p53 5 evidence ubiquitin independent mechanism degradation also presented 6
0.5579345.9417035.html.plaintext.txt	7	recent evidence also shown mdm2 protein binds p53 accelerates degradation possibly ubiquitin pathway 7 8 fact mdm2 gene transcriptional target p53 suggests molecular basis commonly observed increased metabolic half life mutant p53 proteins defective transactivation thus stability mutant proteins appears due inability regulate expression mdm2 protein involved degradation rather intrinsic property conferring resistance degradation per se
0.5579345.9417035.html.plaintext.txt	8	recent evidence also shown mdm2 protein binds p53 accelerates degradation possibly ubiquitin pathway 7 8 fact mdm2 gene transcriptional target p53 suggests molecular basis commonly observed increased metabolic half life mutant p53 proteins defective transactivation thus stability mutant proteins appears due inability regulate expression mdm2 protein involved degradation rather intrinsic property conferring resistance degradation per se
0.5579345.9417035.html.plaintext.txt	9	increase transactivation due p53 increase level protein found cells treated low doses uv radiation microinjection antibody c terminal domain also stimulated p53 dependent transcription even absence dna damage 9 chernov stark 10 found sodium salicylate inhibits protein kinases inhibits activation p53 significant effect accumulation protein several processes might involved activating p53 1 including phosphorylation glycosylation binding regulatory proteins alternative splicing acetylation 11
0.5579345.9417035.html.plaintext.txt	10	increase transactivation due p53 increase level protein found cells treated low doses uv radiation microinjection antibody c terminal domain also stimulated p53 dependent transcription even absence dna damage 9 chernov stark 10 found sodium salicylate inhibits protein kinases inhibits activation p53 significant effect accumulation protein several processes might involved activating p53 1 including phosphorylation glycosylation binding regulatory proteins alternative splicing acetylation 11
0.5579345.9417035.html.plaintext.txt	11	p53 sense signals several known proteins suspects dna dependent protein kinase dnapk1 plausible candidate binds activated broken ends dna 12 phosphorylate residues 15 37 p53 dna dependent manner vitro 13 phosphorylation serine 15 affects transactivation growth arrest functions p53 cells 14 however cells lacking dnapk show defect p53 mediated inhibition cell cycle revealing dnapk role regulating p53 components must able compensate loss 15
0.5579345.9417035.html.plaintext.txt	12	p53 sense signals several known proteins suspects dna dependent protein kinase dnapk1 plausible candidate binds activated broken ends dna 12 phosphorylate residues 15 37 p53 dna dependent manner vitro 13 phosphorylation serine 15 affects transactivation growth arrest functions p53 cells 14 however cells lacking dnapk show defect p53 mediated inhibition cell cycle revealing dnapk role regulating p53 components must able compensate loss 15
0.5579345.9417035.html.plaintext.txt	13	many protein kinases shown phosphorylate p53 vitro candidates upstream regulators 1 however little vivo evidence exists role phosphorylation regulating p53 recent work showing p53 acetylated vitro intriguing suggests possibility additional mechanism regulation 11 however still necessary show acetylation occurs response stress
0.5579345.9417035.html.plaintext.txt	14	many protein kinases shown phosphorylate p53 vitro candidates upstream regulators 1 however little vivo evidence exists role phosphorylation regulating p53 recent work showing p53 acetylated vitro intriguing suggests possibility additional mechanism regulation 11 however still necessary show acetylation occurs response stress
0.5579345.9417035.html.plaintext.txt	15	polyadp ribose polymerase parp long known role recognizing dna damage dna repair parp null chinese hamster cells defective activating p53 resistant apoptosis induced dna damage 16 however embryo fibroblasts parp null mice normal dna repair dna damage induced apoptosis 17 although significant decrease induction p53 protein dna damage nucleotide depletion change p53 activity cellular responses stress 18 therefore although parp involved increasing amount p53 protein mouse fibroblasts signaling pathways must important activating p53 response dna damage consistent experiments showing least two levels 53 regulation 9 10 loss atm product ataxia telangiectasia gene slows induction p53 protein response dna strand breaks caused radiation response pyrimidine dimers caused uv radiation 19 20 similarly p53 induced normally human atm null cells treatment n phosphonacetyl l aspartate pala blocks de novo ump biosynthesis adriamycin damages dna2 p53 atm may components complexes function recombination 21 similarly gene product involved nijmegen breakage syndrome nbs also placed upstream p53 pathway responds ionizing radiation responses dna damaging agents 22 defects p53 induction atm null nbs null parp null cells partial selective certain kinds dna damage gene products involved signals double triple knock outs profound perhaps even complete defect p53 induction response dna damage similar partial defects p53 signaling observed fanconi anemia syndrome fas blooms syndrome bls fibroblasts suggesting many pathways regulate p53 20 23
0.5579345.9417035.html.plaintext.txt	16	polyadp ribose polymerase parp long known role recognizing dna damage dna repair parp null chinese hamster cells defective activating p53 resistant apoptosis induced dna damage 16 however embryo fibroblasts parp null mice normal dna repair dna damage induced apoptosis 17 although significant decrease induction p53 protein dna damage nucleotide depletion change p53 activity cellular responses stress 18 therefore although parp involved increasing amount p53 protein mouse fibroblasts signaling pathways must important activating p53 response dna damage consistent experiments showing least two levels 53 regulation 9 10 loss atm product ataxia telangiectasia gene slows induction p53 protein response dna strand breaks caused radiation response pyrimidine dimers caused uv radiation 19 20 similarly p53 induced normally human atm null cells treatment n phosphonacetyl l aspartate pala blocks de novo ump biosynthesis adriamycin damages dna2 p53 atm may components complexes function recombination 21 similarly gene product involved nijmegen breakage syndrome nbs also placed upstream p53 pathway responds ionizing radiation responses dna damaging agents 22 defects p53 induction atm null nbs null parp null cells partial selective certain kinds dna damage gene products involved signals double triple knock outs profound perhaps even complete defect p53 induction response dna damage similar partial defects p53 signaling observed fanconi anemia syndrome fas blooms syndrome bls fibroblasts suggesting many pathways regulate p53 20 23
0.5579345.9417035.html.plaintext.txt	17	recently role oncogenic ras mitogen activated protein map kinase pathway p53 modulation function revealed human rodent cells high expression ras activation mosmapk pathway induces wild type p53 levels causes permanent growth arrest similar cellular senescence 24 25 cells lacking p53 tolerate high levels mapk display loss p53 dependent cell cycle arrest enhanced genomic instability 24 cell line defective map kinase pathway p53 expression increased expression map kinase erk2 restores normal levels p53 clearly placing erk2 pathway regulates steady state level p533 mapk shown phosphorylate residue 73 83 murine p53 vitro phosphorylation may important stabilizing protein 26 kinases dnapk ii cyclin cdc2 cyclin b cdc2 known phosphorylate p53 protein vitro may play role stabilizing 14 27 mechanisms p53 induction response different types stress still largely unknown
0.5579345.9417035.html.plaintext.txt	18	recently role oncogenic ras mitogen activated protein map kinase pathway p53 modulation function revealed human rodent cells high expression ras activation mosmapk pathway induces wild type p53 levels causes permanent growth arrest similar cellular senescence 24 25 cells lacking p53 tolerate high levels mapk display loss p53 dependent cell cycle arrest enhanced genomic instability 24 cell line defective map kinase pathway p53 expression increased expression map kinase erk2 restores normal levels p53 clearly placing erk2 pathway regulates steady state level p533 mapk shown phosphorylate residue 73 83 murine p53 vitro phosphorylation may important stabilizing protein 26 kinases dnapk ii cyclin cdc2 cyclin b cdc2 known phosphorylate p53 protein vitro may play role stabilizing 14 27 mechanisms p53 induction response different types stress still largely unknown
0.5579345.9417035.html.plaintext.txt	19	p53 involved several different aspects cell cycle arrest apoptosis control genome integrity dna repair 1 2 regulate many different processes p53 tetramer bind specific sequences thus transactivate group genes reviewed ref 1 example p21waf1 gadd45 mdm2 cyclin g bax igf bp3 several groups found active p53 sensed differently different promoters resulting differential dna binding transactivation example see ref 28 p53 also inhibit expression genes example see topoisomerase iia 29 furthermore p53 dependent phenotypes involve transcriptional regulation example see ref 30
0.5579345.9417035.html.plaintext.txt	20	p53 involved several different aspects cell cycle arrest apoptosis control genome integrity dna repair 1 2 regulate many different processes p53 tetramer bind specific sequences thus transactivate group genes reviewed ref 1 example p21waf1 gadd45 mdm2 cyclin g bax igf bp3 several groups found active p53 sensed differently different promoters resulting differential dna binding transactivation example see ref 28 p53 also inhibit expression genes example see topoisomerase iia 29 furthermore p53 dependent phenotypes involve transcriptional regulation example see ref 30
0.5579345.9417035.html.plaintext.txt	21	g1 transition antibodies recognizing c terminus p53 prevent serum stimulated fibroblasts entering phase 31 result originally interpreted evidence positive function p53 required posed paradox overexpression wild type p53 found cause growth arrest 32 paradox resolved found antibodies activate rather inhibit p53 9 understood clearly p53 mediates g1 arrest response dna damage caused uv radiation chemotherapeutic drugs nucleotide deprivation 33 35 cell type variability p53 dependent g1 arrest illustrated studies radiation normal diploid fibroblasts causes long term p53 dependent arrest associated prolonged induction p21waf1 36 irreversibility arrest depends inability cells repair even small number double strand dna breaks activating signal persists 37 contrast irradiation ht1080 cells derived fibrosarcoma wild type p53 causes transient g1 arrest 38 whereas colorectal tumor line rko breast tumor line mcf7 also wild type p53 fail arrest g1 following irradiation 39 differences may indicate tumor formation may involve inactivation components upstream downstream p53 causing cellular response dna damage fail example irradiation activates p53 turn transcription p21waf1 binds inhibits cyclin dependent kinases causing hypophosphorylation rb thus preventing release e2f blocking g1 transition fig 1 alteration downstream components may effect similar inactivating p53 preventing pathway functioning
0.5579345.9417035.html.plaintext.txt	22	g1 transition antibodies recognizing c terminus p53 prevent serum stimulated fibroblasts entering phase 31 result originally interpreted evidence positive function p53 required posed paradox overexpression wild type p53 found cause growth arrest 32 paradox resolved found antibodies activate rather inhibit p53 9 understood clearly p53 mediates g1 arrest response dna damage caused uv radiation chemotherapeutic drugs nucleotide deprivation 33 35 cell type variability p53 dependent g1 arrest illustrated studies radiation normal diploid fibroblasts causes long term p53 dependent arrest associated prolonged induction p21waf1 36 irreversibility arrest depends inability cells repair even small number double strand dna breaks activating signal persists 37 contrast irradiation ht1080 cells derived fibrosarcoma wild type p53 causes transient g1 arrest 38 whereas colorectal tumor line rko breast tumor line mcf7 also wild type p53 fail arrest g1 following irradiation 39 differences may indicate tumor formation may involve inactivation components upstream downstream p53 causing cellular response dna damage fail example irradiation activates p53 turn transcription p21waf1 binds inhibits cyclin dependent kinases causing hypophosphorylation rb thus preventing release e2f blocking g1 transition fig 1 alteration downstream components may effect similar inactivating p53 preventing pathway functioning
0.5579345.9417035.html.plaintext.txt	23	view larger version 31k fig 1 components p53 signaling pathways p53 accumulates modified activated response signals generated variety genotoxic stresses several proteins including atm parp fas bls nbs see text full names involved activation pathways lead modification largely unknown ras map kinase pathway involved establishing basal levels p53 may also affect function cellular functions affected p53 compromised deregulated expression myc bcl2 e1b e2f control p53 activity includes autoregulatory loop involving mdm2 intact set p53 dependent pathways helps maintain genomic integrity eliminating damaged cells either arresting permanently apoptosis p53 also helps regulate entry mitosis spindle formation centrosome integrity cell cycle checkpoints likely involved preventing dna damage occurring
0.5579345.9417035.html.plaintext.txt	24	spindle checkpoint p53 involved checkpoint blocks re replication dna mitotic spindle damaged dna content embryo fibroblasts measured treatment nocodazole inhibitors microtubule assembly found normal fibroblasts arrest 4 n content dna whereas p53 null fibroblasts attain dna contents 8 16 n 40 spindle destruction might block progression mitosis re replication might controlled blocking entry phase murine cell line wild type p53 nocodazole causes transient mitotic arrest followed entry g1 without chromosome segregation 41 p53 induced mitosis complete conclusion p53 induced response spindle damage blocks entry phase also reached analyzing dna synthesis fibroblasts exposed nocodazole colcemid 42 interestingly fibroblasts p21waf1 null mice re replicate dna treated spindle poisons consistent observation g1 arrest response number agents partially abrogated cells 43 therefore p53 must also utilize p21 independent mechanisms arrest cells g1 thus inhibit re replication response spindle poisons
0.5579345.9417035.html.plaintext.txt	25	spindle checkpoint p53 involved checkpoint blocks re replication dna mitotic spindle damaged dna content embryo fibroblasts measured treatment nocodazole inhibitors microtubule assembly found normal fibroblasts arrest 4 n content dna whereas p53 null fibroblasts attain dna contents 8 16 n 40 spindle destruction might block progression mitosis re replication might controlled blocking entry phase murine cell line wild type p53 nocodazole causes transient mitotic arrest followed entry g1 without chromosome segregation 41 p53 induced mitosis complete conclusion p53 induced response spindle damage blocks entry phase also reached analyzing dna synthesis fibroblasts exposed nocodazole colcemid 42 interestingly fibroblasts p21waf1 null mice re replicate dna treated spindle poisons consistent observation g1 arrest response number agents partially abrogated cells 43 therefore p53 must also utilize p21 independent mechanisms arrest cells g1 thus inhibit re replication response spindle poisons
0.5579345.9417035.html.plaintext.txt	26	centrosome homeostasis embryo fibroblasts p53 null mice acquire two centrosomes leading mitosis two spindle poles frequent mitotic failure 44 p53 associated centrosomes thus may affect centrosome duplication directly 45 alternatively improper duplication centrosomes may signal p53 activation could turn cause arrest g2 g1 intriguing map kinase cdc2 capable phosphorylating p53 also bound centrosomes 1 26 46 47 like p53 map kinase important centrosome homeostasis 46
0.5579345.9417035.html.plaintext.txt	27	centrosome homeostasis embryo fibroblasts p53 null mice acquire two centrosomes leading mitosis two spindle poles frequent mitotic failure 44 p53 associated centrosomes thus may affect centrosome duplication directly 45 alternatively improper duplication centrosomes may signal p53 activation could turn cause arrest g2 g1 intriguing map kinase cdc2 capable phosphorylating p53 also bound centrosomes 1 26 46 47 like p53 map kinase important centrosome homeostasis 46
0.5579345.9417035.html.plaintext.txt	28	g2 m transition human mouse fibroblasts overexpression wild type p53 inhibit entry mitosis 48 49 recent results show property p53 important novel cell cycle checkpoint controls entry mitosis dna synthesis blocked4 hydroxyurea treated cells synthesis dntps blocked rapidly p53 plays vital role inhibiting premature entry mitosis wild type mouse embryo fibroblasts attempt mitosis hydroxyurea contrast p53 null mouse embryo fibroblasts continue attempt mitosis entering metaphase condensed chromatin high levels phosphorylated histone h1 however cytokinesis occur mitosis aborted presumably spindles segregate incompletely replicated dna presumably responses present prevent segregation damaged incompletely synthesized dna
0.5579345.9417035.html.plaintext.txt	29	g2 m transition human mouse fibroblasts overexpression wild type p53 inhibit entry mitosis 48 49 recent results show property p53 important novel cell cycle checkpoint controls entry mitosis dna synthesis blocked4 hydroxyurea treated cells synthesis dntps blocked rapidly p53 plays vital role inhibiting premature entry mitosis wild type mouse embryo fibroblasts attempt mitosis hydroxyurea contrast p53 null mouse embryo fibroblasts continue attempt mitosis entering metaphase condensed chromatin high levels phosphorylated histone h1 however cytokinesis occur mitosis aborted presumably spindles segregate incompletely replicated dna presumably responses present prevent segregation damaged incompletely synthesized dna
0.5579345.9417035.html.plaintext.txt	30	p53 plays role triggering apoptosis certain cell types eg cells hematopoietic origin stimuli dna damage withdrawal growth factors expression myc e1a also cause p53 dependent apoptosis 50 54 p53 must able function transcription factor block g1 transition p53 mediated apoptosis necessarily require transcriptional activation inhibition transcription actinomycin d translation cycloheximide always affect p53 dependent apoptosis 30 54 furthermore inhibitors protein phosphatases induce p53 dependent apoptosis absence transactivation 55 however pro apoptotic proteins bax igf bp3 transcriptional targets p53 suggesting transactivation p53 important inducing apoptosis circumstances addition anti apoptotic proteins bcl2 adenovirus 19 kda e1b protein prevent p53 mediated apoptosis 53 56
0.5579345.9417035.html.plaintext.txt	31	p53 induces apoptosis cell types cell cycle arrest others response stimulus although mechanisms divergent responses known deletion p21waf1 cause cells would otherwise undergo p53 dependent cell cycle arrest undergo apoptosis instead underscoring major role genetic background determining cellular responses 57 several variables extent dna damage levels p53 also affect choice cell cycle arrest apoptosis 58 also cross talk p53 rb pathways may important determining biological responses dna damage example inactivation rb results loss g1 arrest induction apoptosis dna damage 59 might explained release e2f fig 1 overexpressed induce apoptosis 60 furthermore overexpression rb blocks p53 mediated apoptosis 61 thus modulation rb e2f p53 signaling response dna damage may play central role determining balance cell cycle arrest apoptosis
0.5579345.9417035.html.plaintext.txt	32	p53 induces apoptosis cell types cell cycle arrest others response stimulus although mechanisms divergent responses known deletion p21waf1 cause cells would otherwise undergo p53 dependent cell cycle arrest undergo apoptosis instead underscoring major role genetic background determining cellular responses 57 several variables extent dna damage levels p53 also affect choice cell cycle arrest apoptosis 58 also cross talk p53 rb pathways may important determining biological responses dna damage example inactivation rb results loss g1 arrest induction apoptosis dna damage 59 might explained release e2f fig 1 overexpressed induce apoptosis 60 furthermore overexpression rb blocks p53 mediated apoptosis 61 thus modulation rb e2f p53 signaling response dna damage may play central role determining balance cell cycle arrest apoptosis
0.5579345.9417035.html.plaintext.txt	33	p53 dependent cell cycle control maintains genetic integrity populations cells gene amplification widely used model study genetic integrity transformed immortalized cells drugs pala methotrexate inhibit synthesis nucleotide precursors select amplification target genes whose products overcome inhibition carbamyl p synthetaseaspartate transcarbamylasedihydro orotase cad case pala dihydrofolate reductase methotrexate 62 however normal cells 63 rare cell lines ref52 64 give rise resistant colonies drugs function p53 lost frequently process tumorigenesis 65 spontaneous immortalization primary cells 66 indicating p53 main factor determining permissivity gene amplification indeed embryo fibroblasts p53 null mice permissive gene amplification 67 primary human cells li fraumeni patients became permissive soon lost single copy wild type p53 67 68 transformation ref52 cells either sv40 large antigen activated ras plus e1a abolishes p53 dependent cell cycle control allows cells become permissive gene amplification 64 signal generated part mechanism gene amplification could activate p53 dependent pathways prevent propagation drug resistant cells current model amplification involves essential early step multiple bridge breakage fusion cycles broken dna formed throughout entire lineage daughter cells 69 70 importance dna damage regulating early stages gene amplification demonstrated ref52 cells transfected temperature sensitive mutant sv40 large antigen 71 cells selected pala low temperature active large antigen inactivates p53 rendering cells permissive gene amplification restoration p53 inactivating large antigen higher temperature early process forming pala resistant colonies stably arrests cells containing newly amplified dna
0.5579345.9417035.html.plaintext.txt	34	p53 dependent cell cycle control maintains genetic integrity populations cells gene amplification widely used model study genetic integrity transformed immortalized cells drugs pala methotrexate inhibit synthesis nucleotide precursors select amplification target genes whose products overcome inhibition carbamyl p synthetaseaspartate transcarbamylasedihydro orotase cad case pala dihydrofolate reductase methotrexate 62 however normal cells 63 rare cell lines ref52 64 give rise resistant colonies drugs function p53 lost frequently process tumorigenesis 65 spontaneous immortalization primary cells 66 indicating p53 main factor determining permissivity gene amplification indeed embryo fibroblasts p53 null mice permissive gene amplification 67 primary human cells li fraumeni patients became permissive soon lost single copy wild type p53 67 68 transformation ref52 cells either sv40 large antigen activated ras plus e1a abolishes p53 dependent cell cycle control allows cells become permissive gene amplification 64 signal generated part mechanism gene amplification could activate p53 dependent pathways prevent propagation drug resistant cells current model amplification involves essential early step multiple bridge breakage fusion cycles broken dna formed throughout entire lineage daughter cells 69 70 importance dna damage regulating early stages gene amplification demonstrated ref52 cells transfected temperature sensitive mutant sv40 large antigen 71 cells selected pala low temperature active large antigen inactivates p53 rendering cells permissive gene amplification restoration p53 inactivating large antigen higher temperature early process forming pala resistant colonies stably arrests cells containing newly amplified dna
0.5579345.9417035.html.plaintext.txt	35	human cell lines achieve resistance pala mechanisms gene amplification situ far common mechanism rodent cells pala resistant colonies several different human cell lines either contain amplified cad dna increase copy number cad isochromosomes 2p 72 however cases p53 dependent pathways still involved depletion pyrimidine nucleotides caused pala generates signal p53 induction dna damage occurs 35 arresting cells preventing pala resistant colonies forming recent work shown overexpressing endogenous exogenous n myc allows ref52 cells overcome p53 dependent cell cycle arrest caused dna damage making cells permissive gene amplification 73 observation emphasizes fact p53 dependent pathways inhibited several different points fig 1
0.5579345.9417035.html.plaintext.txt	36	human cell lines achieve resistance pala mechanisms gene amplification situ far common mechanism rodent cells pala resistant colonies several different human cell lines either contain amplified cad dna increase copy number cad isochromosomes 2p 72 however cases p53 dependent pathways still involved depletion pyrimidine nucleotides caused pala generates signal p53 induction dna damage occurs 35 arresting cells preventing pala resistant colonies forming recent work shown overexpressing endogenous exogenous n myc allows ref52 cells overcome p53 dependent cell cycle arrest caused dna damage making cells permissive gene amplification 73 observation emphasizes fact p53 dependent pathways inhibited several different points fig 1
0.5579345.9417035.html.plaintext.txt	37	p53 signaling pathways connect tumor suppressors oncogenes known influence cell cycle machinery fig 1 alterations components either upstream downstream p53 may analogous inactivation p53 preventing part entire pathway functioning leading deregulation cell cycle controls genomic instability development cancer addition recently discovered protein p73 high degree structural functional homology p53 may another important target inactivation development cancer 74 remains determined p73 affects signals impinging emanating p53 central component independent signaling network
0.5579345.9417035.html.plaintext.txt	38	minireview reprinted 1997 minireview compendium available december 1997 work supported national institutes health grant gm49345
0.5579345.9417035.html.plaintext.txt	39	minireview reprinted 1997 minireview compendium available december 1997 work supported national institutes health grant gm49345
0.5579345.9417035.html.plaintext.txt	40	correspondence addressed dept molecular biology lerner research inst cleveland clinic foundation 9500 euclid ave cleveland oh 44195 tel 216 444 3900 fax 216 444 3279 e mail starkg2cesmtpccforg
0.5579345.9417035.html.plaintext.txt	41	correspondence addressed dept molecular biology lerner research inst cleveland clinic foundation 9500 euclid ave cleveland oh 44195 tel 216 444 3900 fax 216 444 3279 e mail starkg2cesmtpccforg
0.5579345.9417035.html.plaintext.txt	42	1 abbreviations used dnapk dna dependent protein kinase parp polyadp ribose polymerase pala n phosphonacetyl l aspartate nbs nijmegen breakage syndrome map mitogen activated protein mapk map kinase cad carbamyl p synthetaseaspartate transcarbamylasedihydro orotase
0.5579345.9417035.html.plaintext.txt	43	references top introduction references ko l j prives c 1996 genes dev 10 1054 1072crossrefmedline order article via infotrieve levine j 1997 cell 88 323 331medline order article via infotrieve maltzman w czyzyk l 1984 mol cell biol 4 1689 1694medline order article via infotrieve mosner j mummenbrauer bauer c sczakiel g grosse f deppert w 1995 embo j 14 4442 4449abstract maki c g howley p m 1997 mol cell biol 17 355 363abstract kubbutat m h g vousden k h 1997 mol cell biol 17 460 468abstract haupt y maya r kazaz oren m 1997 nature 387 296 299crossrefmedline order article via infotrieve kubbutat m h jones n vousden k h 1997 nature 387 299 303crossrefmedline order article via infotrieve hupp r sparks lane d p 1995 cell 83 237 245medline order article via infotrieve chernov m v stark g r 1997 oncogene 14 2503 2510crossrefmedline order article via infotrieve gu w roeder r g 1997 cell 90 595 606medline order article via infotrieve gottlieb m jackson p 1993 cell 72 131 142medline order article via infotrieve lees miller p sakaguchi k ullrich j appella e anderson c w 1992 mol cell biol 12 5041 5049abstract fiscella m ullrich j zambrano n shields m lin d lees miller p anderson c w mercer w e appella e 1993 oncogene 8 1519 1528medline order article via infotrieve huang l c clarkin k c wahl g m 1996 cancer res 56 2940 2944abstract whitacre c m hashimoto h tsai m l chatterjee berger j berger n 1995 cancer res 55 3697 3701abstract wang z q auer b stingl l berghammer h haidacher d schweiger m wagner e f 1995 genes dev 9 509 520abstract agarwal m l agarwal taylor w r wang z q wagner e f stark g r 1997 oncogene 15 1035 1041crossrefmedline order article via infotrieve kastan m b zhan q el deiry w carrier f jacks walsh w v plunkett b vogelstein b fornace j jr 1992 cell 71 587 597medline order article via infotrieve lu x lane d p 1993 cell 75 765 778medline order article via infotrieve hawley r friend h 1996 genes dev 10 2383 2388crossrefmedline order article via infotrieve jongmans w vuillaume m chrzanowska k smeets d sperling k hall j 1997 mol cell biol 17 5016 5022abstract rosselli f ridet soussi duchaud e alapetite c moustacchi e 1995 oncogene 10 9 17medline order article via infotrieve fukasawa k vande woude g f 1997 mol cell biol 17 506 518abstract serrano m lin w mccurrach m e beach d lowe w 1997 cell 88 593 602crossrefmedline order article via infotrieve milne d m campbell d g caudwell f b meek d w 1994 j biol chem 269 9253 9260abstractfree full text wang y prives c 1995 nature 376 88 91crossrefmedline order article via infotrieve lohrum m scheidtmann k h 1996 oncogene 13 2527 2539medline order article via infotrieve wang q zambetti g p suttle d p 1997 mol cell biol 17 389 397abstract caelles c helmberg karin m 1994 nature 370 220 223crossrefmedline order article via infotrieve mercer w e nelson d deleo b old l j baserga r 1982 proc natl acad sci u 79 6309 6312abstract michalovitz d halevy o oren m 1990 cell 62 671 680medline order article via infotrieve kastan m b onyekwere o sidransky d vogelstein b craig r w 1991 cancer res 51 6304 6311abstract van laar steegenga w jochemsen g terleth c van der eb j 1994 oncogene 9 981 983medline order article via infotrieve linke p clarkin k c di leonardo tsou wahl g m 1996 genes dev 10 934 947abstract di leonardo linke p clarkin k wahl g m 1994 genes dev 8 2540 2551abstract huang l c clarkin k c wahl g m 1996 proc natl acad sci u 93 4827 4832abstractfree full text pellegata n antoniono r j redpath j l stanbridge e j 1996 proc natl acad sci u 93 15209 15214abstractfree full text nagasawa h li c y maki c g imrich c little j b 1995 cancer res 55 1842 1846abstract cross m sanchez c morgan c schimke m k ramel idzerda r l raskind w h reid b 1995 science 267 1353 1356medline order article via infotrieve minn j boise l h thompson c b 1996 genes dev 10 2621 2631abstract di leonardo khan h linke p greco v seidita g wahl g m 1997 cancer res 57 1013 1019abstract deng c zhang p harper j w elledge j leder p 1995 cell 82 675 684medline order article via infotrieve fukasawa k choi kuriyama r rulong vande woude g f 1996 science 271 1744 1747abstract brown c r doxsey j white e welch w j 1994 j cell physiol 160 47 60medline order article via infotrieve wang w m zhai y ferrell j e jr 1997 j cell biol 137 433 443abstractfree full text pockwinse m krockmalnic g doxsey j nickerson j lian j b van wijnen j stein j l stein g penman 1997 proc natl acad sci u 94 3022 3027abstractfree full text stewart n hicks g g paraskevas f mowat m 1995 oncogene 10 109 115medline order article via infotrieve agarwal m l agarwal taylor w r stark g r 1995 proc natl acad sci u 92 8493 8497abstract yonish rouach e resnitzky d lotem j sachs l kimchi oren m 1991 nature 352 345 347crossrefmedline order article via infotrieve clarke r purdie c harrison d j morris r g bird c c hooper m l wyllie h 1993 nature 362 849 852crossrefmedline order article via infotrieve lowe w ruley h e 1993 genes dev 7 535 545abstract debbas m white e 1993 genes dev 7 546 554abstract wagner j kokontis j m hay n 1994 genes dev 8 2817 2830abstract yan y shay j w wright w e mumby m c 1997 j biol chem 272 15220 15236abstractfree full text chiou k rao l white e 1994 mol cell biol 14 2556 2563abstract polyak k waldman c kinzler k w vogelstein b 1996 genes dev 10 1945 1952abstract chen x ko l j jayaraman l prives c 1996 genes dev 10 2438 2451abstract morgenbesser d williams b o jacks depinho r 1994 nature 371 72 74crossrefmedline order article via infotrieve qin x q livingston d m kaelin w g jr adams p d 1994 proc natl acad sci u 91 10918 10922abstractfree full text haupt y rowan shaulian e vousden k h oren m 1995 genes dev 9 2170 2183abstract chernova o b chernov m v agarwal m l taylor w r stark g r 1995 trends biochem sci 20 431 434crossrefmedline order article via infotrieve wright j smith h watt f m hancock m c hudson d l stark g r 1990 proc natl acad sci u 87 1791 1795abstract perry m e commane m stark g r 1992 proc natl acad sci u 89 8112 8116abstract vogelstein b 1990 nature 348 681 682crossrefmedline order article via infotrieve harvey d m levine j 1991 genes dev 5 2375 2385abstract livingstone l r white sprouse j livanos e jacks tlsty d 1992 cell 70 923 935medline order article via infotrieve yin y tainsky m bischoff f z strong l c wahl g m 1992 cell 70 937 948medline order article via infotrieve stark g r 1993 adv cancer res 61 87 113medline order article via infotrieve coquelle pipiras e toledo f buttin g debatisse m 1997 cell 89 215 225medline order article via infotrieve ishizaka y chernov m v burns c m stark g r 1995 proc natl acad sci u 92 3224 3228abstract smith k chernova o b groves r p stark m b martinez j l davidson j n trent j m patterson e agarwal duncan p agarwal m l stark g r 1997 proc natl acad sci u 94 1816 1821abstractfree full text chernova o b chernov m v ishizaka y agarwal m l stark g r 1998 mol cell biol 18 press kaghad m bonnet h yang creancier l biscan j c valent minty 1997 cell 90 809 819medline order article via infotrieve
0.5579345.9417035.html.plaintext.txt	44	copyright 1998 american society biochemistry molecular biology inc
0.562309.14752107.html.plaintext.txt	0	dna dependent protein kinase checkpoint kinase 2 synergistically activate latent population p53 upon dna damage melissa jack richard woo noboru motoyama hitoyuki takai patrick w k lee
0.562309.14752107.html.plaintext.txt	1	cancer biology research group department microbiology infectious diseases university calgary health sciences centre calgary alberta t2n 4n1 canada department geriatric research national institute longevity sciences obu aichi 474 8522 japan
0.562309.14752107.html.plaintext.txt	2	received publication september 8 2003 revised form january 20 2004
0.562309.14752107.html.plaintext.txt	3	abstract top abstract introduction experimental procedures results discussion references role checkpoint kinase 2 chk2 upstream activator p53 following dna damage controversial recently shown chk2 dna dependent protein kinase dna pk involved dna damage induced apoptosis g1 arrest mouse embryo fibroblasts demonstrate chk2 required activate p53 vitro measured ability bind consensus dna target sequence following dna damage fact previously unidentified factor working synergistically dna pk activate p53 gene mutated ataxia telangiectasia involved p53 activation using wortmannin serine 15 mutants p53 dna pk null cells chk2 null cells demonstrate dna pk chk2 act independently sequentially p53 furthermore p53 target two kinases represents latent preexisting population p53 taken together results studies consistent model dna damage causes immediate sequential modification latent p53 dna pk chk2 appropriate conditions lead apoptosis
0.562309.14752107.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references role checkpoint kinase 2 chk2 upstream activator p53 following dna damage controversial recently shown chk2 dna dependent protein kinase dna pk involved dna damage induced apoptosis g1 arrest mouse embryo fibroblasts demonstrate chk2 required activate p53 vitro measured ability bind consensus dna target sequence following dna damage fact previously unidentified factor working synergistically dna pk activate p53 gene mutated ataxia telangiectasia involved p53 activation using wortmannin serine 15 mutants p53 dna pk null cells chk2 null cells demonstrate dna pk chk2 act independently sequentially p53 furthermore p53 target two kinases represents latent preexisting population p53 taken together results studies consistent model dna damage causes immediate sequential modification latent p53 dna pk chk2 appropriate conditions lead apoptosis
0.562309.14752107.html.plaintext.txt	5	introduction top abstract introduction experimental procedures results discussion references response dna damage induced ionizing radiation ir1 eukaryotic cells activate cell cycle checkpoints apoptosis p53 tumor suppressor mediates cell responses 1 4 however understanding mechanism activation remains elusive upstream candidates include gene mutated ataxia telangiectasia atm 5 6 dna dependent protein kinase dna pk catalytic subunit 7 9 recently evolutionarily conserved checkpoint kinases chk1 chk2 10 15
0.562309.14752107.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references response dna damage induced ionizing radiation ir1 eukaryotic cells activate cell cycle checkpoints apoptosis p53 tumor suppressor mediates cell responses 1 4 however understanding mechanism activation remains elusive upstream candidates include gene mutated ataxia telangiectasia atm 5 6 dna dependent protein kinase dna pk catalytic subunit 7 9 recently evolutionarily conserved checkpoint kinases chk1 chk2 10 15
0.562309.14752107.html.plaintext.txt	7	chk2 demonstrated form stable complexes p53 16 proposed activate p53 via kinase activity toward ser 20 p53 10 11 furthermore chk2 identified subset li fraumeni patients normal p53 alleles making potential tumor suppressor protein 17 19 endogenous chk2 functions capacity focus many recent studies chk2 murine embryonic stem cells examined reported unable maintain ir induced g2 arrest murine chk2 thymocytes mouse embryo fibroblasts mefs shown attenuated apoptotic response 12 role chk2 g1 cell cycle checkpoint murine model controversial groups reporting requirement whereas others reporting unnecessary p53 mediated g1s arrest 12 15
0.562309.14752107.html.plaintext.txt	8	chk2 demonstrated form stable complexes p53 16 proposed activate p53 via kinase activity toward ser 20 p53 10 11 furthermore chk2 identified subset li fraumeni patients normal p53 alleles making potential tumor suppressor protein 17 19 endogenous chk2 functions capacity focus many recent studies chk2 murine embryonic stem cells examined reported unable maintain ir induced g2 arrest murine chk2 thymocytes mouse embryo fibroblasts mefs shown attenuated apoptotic response 12 role chk2 g1 cell cycle checkpoint murine model controversial groups reporting requirement whereas others reporting unnecessary p53 mediated g1s arrest 12 15
0.562309.14752107.html.plaintext.txt	9	role chk2 human p53 responses recently questioned ahn et al 20 purified chk2 dna damaged human cells demonstrate p53 phosphorylation enhanced ir furthermore following introduction chk2 short interfering rna three different human tumor cell lines p53 still found stabilized active ir concurrently jallepalli et al 21 disrupted chk2 gene human cancer cells found p53 ser 20 phosphorylation stabilization transcriptional activation well cell cycle mediated arrest apoptotic responses remained intact two reports call question role chk2 human cells question whether chk2 lies upstream p53 dependent apoptotic response seems clear lie upstream murine system recently however craig et al 22 demonstrated chk2 regulated allosteric effects p53 kinase dependent phosphorylation p53 requires conformational docking sites p53 lending evidence role human p53 target chk2 phosphorylation
0.562309.14752107.html.plaintext.txt	10	disruption p53 tumor suppressor often found many human cancers understanding mechanism p53 activation essential progress treatment cancer recently reported dna pk chk2 required p53 mediated apoptosis mefs function pathway uses latent p53 mediate response 8 13 study used various approaches establish link two kinases p53 activation following dna damage show chk2 dna pk act synergistically parallel activate p53 including human p53 measured ability bind consensus dna target sequence p53 target two kinases latent preexisting population p53 gene mutated atm involved p53 activation results consistent model immediate actions dna pk chk2 latent p53 following dna damage first events dictate subsequent cellular apoptotic response
0.562309.14752107.html.plaintext.txt	11	disruption p53 tumor suppressor often found many human cancers understanding mechanism p53 activation essential progress treatment cancer recently reported dna pk chk2 required p53 mediated apoptosis mefs function pathway uses latent p53 mediate response 8 13 study used various approaches establish link two kinases p53 activation following dna damage show chk2 dna pk act synergistically parallel activate p53 including human p53 measured ability bind consensus dna target sequence p53 target two kinases latent preexisting population p53 gene mutated atm involved p53 activation results consistent model immediate actions dna pk chk2 latent p53 following dna damage first events dictate subsequent cellular apoptotic response
0.562309.14752107.html.plaintext.txt	12	experimental procedures top abstract introduction experimental procedures results discussion references cell culture preparation nuclear extracts two glioma cell lines m059k m059j grown dulbeccos modified eagles mediumf 12 supplemented 10 fetal bovine serum invitrogen lymphoblasts obtained atcc cultured dulbeccos modified eagles mediumf 12 20 fetal bovine serum invitrogen dna pk chk2 mouse embryo fibroblasts isolated 125 day old embryos cultured dulbeccos modified eagles medium supplemented 10 fetal bovine serum cells grown 80 confluency irradiated 137cs irradiator rate 25 grays min 1 2 min nuclear extracts prepared described previously 13
0.562309.14752107.html.plaintext.txt	13	experimental procedures top abstract introduction experimental procedures results discussion references cell culture preparation nuclear extracts two glioma cell lines m059k m059j grown dulbeccos modified eagles mediumf 12 supplemented 10 fetal bovine serum invitrogen lymphoblasts obtained atcc cultured dulbeccos modified eagles mediumf 12 20 fetal bovine serum invitrogen dna pk chk2 mouse embryo fibroblasts isolated 125 day old embryos cultured dulbeccos modified eagles medium supplemented 10 fetal bovine serum cells grown 80 confluency irradiated 137cs irradiator rate 25 grays min 1 2 min nuclear extracts prepared described previously 13
0.562309.14752107.html.plaintext.txt	14	cell free vitro translation cell free vitro translation cytoplasmic extracts m059k m059j cells prepared reported previously 7 wild type mutants human p53 mrna synthesized vitro transcription using t7 polymerase megascript kit ambion human chk2 mrna synthesized using t7 polymerase kit vector containing wild type human chk2 sequence kindly provided dr halazonetis wistar institute human chk1 clone kind gift dr y sanchez university cincinnati vitro translation reactions carried final volume 50 microl containing following components 30 microl cytoplasmic extract 1 mm atp 05 mm gtp1mgml 1 creatine phosphokinase icn 10 mm creatine phosphate 40 mm hemin icn 80 mm kcl 5 mm magnesium acetate 1 mm dithiothreitol 5 microm amino acid promega placental rnase inhibitor rna guard amersham biosciences either water mock translations p53 mrna p53 translations translation reactions incubated 37 degrees c 30 min followed addition equal volume nuclear extract mock treated irradiated m059k m059j cells see immunodepleted endogenous p53 using anti p53 monoclonal antibody pab421 preadsorbed onto inactivated staphylococcus igsorb enzyme center reaction mixtures subjected electrophoretic mobility shift assay emsa described
0.562309.14752107.html.plaintext.txt	15	cell free vitro translation cell free vitro translation cytoplasmic extracts m059k m059j cells prepared reported previously 7 wild type mutants human p53 mrna synthesized vitro transcription using t7 polymerase megascript kit ambion human chk2 mrna synthesized using t7 polymerase kit vector containing wild type human chk2 sequence kindly provided dr halazonetis wistar institute human chk1 clone kind gift dr y sanchez university cincinnati vitro translation reactions carried final volume 50 microl containing following components 30 microl cytoplasmic extract 1 mm atp 05 mm gtp1mgml 1 creatine phosphokinase icn 10 mm creatine phosphate 40 mm hemin icn 80 mm kcl 5 mm magnesium acetate 1 mm dithiothreitol 5 microm amino acid promega placental rnase inhibitor rna guard amersham biosciences either water mock translations p53 mrna p53 translations translation reactions incubated 37 degrees c 30 min followed addition equal volume nuclear extract mock treated irradiated m059k m059j cells see immunodepleted endogenous p53 using anti p53 monoclonal antibody pab421 preadsorbed onto inactivated staphylococcus igsorb enzyme center reaction mixtures subjected electrophoretic mobility shift assay emsa described
0.562309.14752107.html.plaintext.txt	16	dna binding analysis emsa dna binding analyzed emsa using 32p labeled p53 consensus sequence 5 agcttagacatgcctagacatgccaagct 3 described previously 7
0.562309.14752107.html.plaintext.txt	17	western blotting sds page protein samples boiled 5 10 min protein sample buffer 50 mm tris hcl ph 68 1 sds 10 glycerol 2 mercapto ethanol 001 bromphenol blue electrophoresis carried room temperature applied current 35 ma 3 h proteins transferred nitrocellulose membranes 2 h 80 v 4 degrees c blot rinsed tris buffered saline plus 02 tween 20 placed blocking buffer 5 nonfat milk powder tris buffered saline plus 02 tween 20 overnight blot next incubated primary antibody fl393 santa cruz biotechnology p53 ser 15 phosphospecific antibody chk2 thr 68 phosphospecific antibody cell signaling technology dilution 1 1000 blocking buffer 1 h following incubation primary antibody blot thoroughly washed blocking buffer anti rabbit jackson laboratories igg horseradish peroxidase secondary antibody used 15000 dilution blocking buffer incubated room temperature 30 45 min followed washing blocking buffer blot subjected chemiluminescence ecl amersham biosciences exposed kodak x omat ar film protein loading control monoclonal antibody actin tubulin sigma used 110000 dilution processing carried described
0.562309.14752107.html.plaintext.txt	18	western blotting sds page protein samples boiled 5 10 min protein sample buffer 50 mm tris hcl ph 68 1 sds 10 glycerol 2 mercapto ethanol 001 bromphenol blue electrophoresis carried room temperature applied current 35 ma 3 h proteins transferred nitrocellulose membranes 2 h 80 v 4 degrees c blot rinsed tris buffered saline plus 02 tween 20 placed blocking buffer 5 nonfat milk powder tris buffered saline plus 02 tween 20 overnight blot next incubated primary antibody fl393 santa cruz biotechnology p53 ser 15 phosphospecific antibody chk2 thr 68 phosphospecific antibody cell signaling technology dilution 1 1000 blocking buffer 1 h following incubation primary antibody blot thoroughly washed blocking buffer anti rabbit jackson laboratories igg horseradish peroxidase secondary antibody used 15000 dilution blocking buffer incubated room temperature 30 45 min followed washing blocking buffer blot subjected chemiluminescence ecl amersham biosciences exposed kodak x omat ar film protein loading control monoclonal antibody actin tubulin sigma used 110000 dilution processing carried described
0.562309.14752107.html.plaintext.txt	19	results top abstract introduction experimental procedures results discussion references dna pk chk2 required activate p53 dna binding vitro previously demonstrated dna pk necessary sufficient activate p53 dna binding vitro unknown factor present dna damaged cells also required p53 activation 7 recently reported dna pk chk2 involved p53 dependent apoptosis latent rather inducible population p53 implicated process 8 13 determine whether unknown factor collaborated dna pk activating p53 vitro chk2 employed cell free translation system used previously show dna pk acts upstream p53 promoting p53 sequence specific binding 7 accordingly wild type human p53 translated cytoplasmic extract prepared human glioma cell line m059j lacks dna pk activity defective expression dna pk catalytic subunit 23 nuclear extract either dna pk positive m059k null m059j glioma cell lines untreated irradiated added test whether translated p53 could activated p53 binding previously reported 7 irradiated glioma line dna pk m059k activated p53 binding glioma line lacking dna pk m059j supplemented purified dna pk fig 1 lanes 1 4 importantly whereas dna pk chk2 vitro translated alone unable activate p53 lanes 5 6 together activated p53 binding extent irradiated nuclear extract lane 7 specificity chk2 kinase role confirmed chk1 kinase cooperate dna pk activate p53 data shown ability dna pk activate p53 absence dna damage case explained fact dna pk activated presence dna ends supplied consensus dna sequence also shown recently overexpression chk2 result autophosphorylation trans phosphorylation events activate chk2 absence ir 24 therefore experiment identifies previously hypothesized unknown nuclear factor acting dna pk activate p53 dna binding vitro 13 checkpoint kinase chk2 addition components involved human origin experiment supports possible role chk2 upstream human p53
0.562309.14752107.html.plaintext.txt	20	results top abstract introduction experimental procedures results discussion references dna pk chk2 required activate p53 dna binding vitro previously demonstrated dna pk necessary sufficient activate p53 dna binding vitro unknown factor present dna damaged cells also required p53 activation 7 recently reported dna pk chk2 involved p53 dependent apoptosis latent rather inducible population p53 implicated process 8 13 determine whether unknown factor collaborated dna pk activating p53 vitro chk2 employed cell free translation system used previously show dna pk acts upstream p53 promoting p53 sequence specific binding 7 accordingly wild type human p53 translated cytoplasmic extract prepared human glioma cell line m059j lacks dna pk activity defective expression dna pk catalytic subunit 23 nuclear extract either dna pk positive m059k null m059j glioma cell lines untreated irradiated added test whether translated p53 could activated p53 binding previously reported 7 irradiated glioma line dna pk m059k activated p53 binding glioma line lacking dna pk m059j supplemented purified dna pk fig 1 lanes 1 4 importantly whereas dna pk chk2 vitro translated alone unable activate p53 lanes 5 6 together activated p53 binding extent irradiated nuclear extract lane 7 specificity chk2 kinase role confirmed chk1 kinase cooperate dna pk activate p53 data shown ability dna pk activate p53 absence dna damage case explained fact dna pk activated presence dna ends supplied consensus dna sequence also shown recently overexpression chk2 result autophosphorylation trans phosphorylation events activate chk2 absence ir 24 therefore experiment identifies previously hypothesized unknown nuclear factor acting dna pk activate p53 dna binding vitro 13 checkpoint kinase chk2 addition components involved human origin experiment supports possible role chk2 upstream human p53
0.562309.14752107.html.plaintext.txt	21	view larger version 67k fig 1 co requirement dna pk chk2 activation p53 dna binding vitro wild type p53 translated cytoplasmic extracts m059j cells following added reaction lane 1 control nothing added lane 2 nuclear extract irradiated m059j j cells lane 3 lane 2 exception purified dna pk holoenzyme also added lane 4 nuclear extract irradiated m059k k cells lane 5 purified dna pk holoenzyme lane 6 chk2 vitro translated lane 7 purified dna pk holoenzyme chk2 combination samples reactions tested p53 sequence specific dna binding activity emsa
0.562309.14752107.html.plaintext.txt	22	atm required activation p53 sequence specific binding vitro previously reported whereas dna pk chk2 required activating latent p53 mediated apoptosis mefs atm dispensable activity 8 13 seek determine whether vitro system required atm activate p53 dna binding establish whether system reflects observed apoptotic situation mefs
0.562309.14752107.html.plaintext.txt	23	atm required activation p53 sequence specific binding vitro previously reported whereas dna pk chk2 required activating latent p53 mediated apoptosis mefs atm dispensable activity 8 13 seek determine whether vitro system required atm activate p53 dna binding establish whether system reflects observed apoptotic situation mefs
0.562309.14752107.html.plaintext.txt	24	end nuclear cell extracts prepared ataxia telangiectasia lymphoblastoid cell line examined ability activate p53 dna binding cell free translation system p53 cells highly unstable therefore endogenous p53 protein detectable emsa fig 2 lanes 6 7 western blot data shown however nuclear extracts ir treated cells similar ir treated m059k cells able activate vitro translated p53 fig 2 lanes 2 5 finding suggests atm although necessary stabilization p53 required activation p53 dna binding independent experiment cells treated leptomycin b determine whether accumulation p53 stabilization alone enough activate p53 dna binding found data shown finding consistent previous results demonstrating chk2 functions independently atm activate p53 apoptotic response 13
0.562309.14752107.html.plaintext.txt	25	end nuclear cell extracts prepared ataxia telangiectasia lymphoblastoid cell line examined ability activate p53 dna binding cell free translation system p53 cells highly unstable therefore endogenous p53 protein detectable emsa fig 2 lanes 6 7 western blot data shown however nuclear extracts ir treated cells similar ir treated m059k cells able activate vitro translated p53 fig 2 lanes 2 5 finding suggests atm although necessary stabilization p53 required activation p53 dna binding independent experiment cells treated leptomycin b determine whether accumulation p53 stabilization alone enough activate p53 dna binding found data shown finding consistent previous results demonstrating chk2 functions independently atm activate p53 apoptotic response 13
0.562309.14752107.html.plaintext.txt	26	view larger version 50k fig 2 atm dispensable vitro activation p53 dna binding wild type 53 synthesized cell free translation system nuclear extracts non dna damaged irradiated ir m059k cells lymphoblasts added reaction mixtures assayed p53 sequence specific binding emsa
0.562309.14752107.html.plaintext.txt	27	dna pk chk2 act independently sequentially activate p53 proceeded determine whether dna pk chk2 act independently one another whether required others action number experimental approaches taken examine sequence events activation p53 dna pk chk2
0.562309.14752107.html.plaintext.txt	28	dna pk chk2 act independently sequentially activate p53 proceeded determine whether dna pk chk2 act independently one another whether required others action number experimental approaches taken examine sequence events activation p53 dna pk chk2
0.562309.14752107.html.plaintext.txt	29	using vitro system fungal metabolite wortmannin employed inhibit dna pk addition various components pathway seen fig 3a dna pk activity required activate p53 inhibition dna pk prior incubation p53 prevented p53 dna binding compare lanes 3 4 contrast dna pk p53 allowed interact dna pk inhibited wortmannin prior chk2 addition p53 binding still observed fig 3a lane 5 finding suggests dna pk acts directly p53 upstream chk2
0.562309.14752107.html.plaintext.txt	30	view larger version 38k fig 3 dna pk chk2 act independently sequentially activate p53 effect wortmannin p53 activation dna pk chk2 wild type p53 translated vitro following added reaction lane 1 control nothing added lane 2 chk2 vitro translated lane 3 chk2 purified dna pk holoenzyme combination lane 4 dna pk inactivated wortmannin 10 min followed chk2 lane 5 dna pk 10 min wortmannin 10 min chk2 p53 dna binding assayed emsa b chk2 required dna pk dispensable ser 15 p53 mutant dna binding s15a s15d p53 mutants translated assayed requirement chk2 dna pk induce dna binding consensus sequence assayed emsa c comparing serine 15 modification s15a serine phosphorylation sites s315a s392a s37a s20a s20d terms requirement dna pk chk2 activation s15a requires chk2 whereas wild type well serine mutants p53 require dna pk chk2 activation d comparing dna damage induced phosphorylation serine 15 p53 chk2 chk2 mefs cells exposed irradiation harvested various times thereafter following sds page transfer nitrocellulose membrane membrane probed anti phosphoserine 15 antibody total p53 protein e comparing dna damage induced phosphorylation threonine 68 chk2 m059k m059j cells cells exposed irradiation harvested various times thereafter following sds page transfer nitrocellulose membrane membrane probed anti phosphothreonine 68 antibody total chk2 protein
0.562309.14752107.html.plaintext.txt	31	previously demonstrated ser 15 latent p53 target dna pk immediately following dna damage residue plays role ir induced apoptosis mefs 8 determine whether ser 15 also involved vitro activation p53 dna pk two ser 15 mutants p53 s15a s15d tested vitro activation assays s15d mimics phospho ser 15 expected active even absence dna pk whereas s15a would innately inactive unexpectedly found mutants chk2 absolutely required dna pk dispensable activation dna binding fig 3b finding suggests conformational changes p53 brought ser 15 phosphorylation rather difference charge responsible dna pk induced activation p53 observation s15a s15d mutants chk2 alone able activate dna binding absence dna pk also strongly argues independence chk2 dna pk implies upon dna damage p53 probably first acted dna pk modified chk2
0.562309.14752107.html.plaintext.txt	32	previously demonstrated ser 15 latent p53 target dna pk immediately following dna damage residue plays role ir induced apoptosis mefs 8 determine whether ser 15 also involved vitro activation p53 dna pk two ser 15 mutants p53 s15a s15d tested vitro activation assays s15d mimics phospho ser 15 expected active even absence dna pk whereas s15a would innately inactive unexpectedly found mutants chk2 absolutely required dna pk dispensable activation dna binding fig 3b finding suggests conformational changes p53 brought ser 15 phosphorylation rather difference charge responsible dna pk induced activation p53 observation s15a s15d mutants chk2 alone able activate dna binding absence dna pk also strongly argues independence chk2 dna pk implies upon dna damage p53 probably first acted dna pk modified chk2
0.562309.14752107.html.plaintext.txt	33	also altered serine phosphorylation sites p53 see whether mutations would affect p53 activation dna pk chk2 way included two n terminal phosphorylation sites ser 20 known target site chk2 ser 37 another known dna pk target site two c terminal phosphorylation sites ser 315 ser 392 none mutations found alleviate dependence dna pk chk2 p53 activation fig 3c also interesting mutation p53 ser 20 known chk2 target site either alanine simulating unphosphorylated state aspartic acid simulating constitutive phosphorylation effect requirement chk2 turn suggests ser 20 target chk2 p53 activation vitro
0.562309.14752107.html.plaintext.txt	34	also altered serine phosphorylation sites p53 see whether mutations would affect p53 activation dna pk chk2 way included two n terminal phosphorylation sites ser 20 known target site chk2 ser 37 another known dna pk target site two c terminal phosphorylation sites ser 315 ser 392 none mutations found alleviate dependence dna pk chk2 p53 activation fig 3c also interesting mutation p53 ser 20 known chk2 target site either alanine simulating unphosphorylated state aspartic acid simulating constitutive phosphorylation effect requirement chk2 turn suggests ser 20 target chk2 p53 activation vitro
0.562309.14752107.html.plaintext.txt	35	dna pk chk2 probably act p53 independently suggested following observations first chk2 chk2 mefs displayed similar levels dna pk dependent ser 15 phosphorylation upon ir fig 3d second chk2 phosphorylation thr 68 often used measure chk2 activation 25 28 found immediate comparable levels human cells without dna pk m059k m059j respectively upon irradiation fig 3e observations combined wortmannin s15a s15d studies described fig 3 b respectively led us conclude dna pk chk2 work sequentially independently one another activating p53 upon dna damage
0.562309.14752107.html.plaintext.txt	36	dna pk chk2 probably act p53 independently suggested following observations first chk2 chk2 mefs displayed similar levels dna pk dependent ser 15 phosphorylation upon ir fig 3d second chk2 phosphorylation thr 68 often used measure chk2 activation 25 28 found immediate comparable levels human cells without dna pk m059k m059j respectively upon irradiation fig 3e observations combined wortmannin s15a s15d studies described fig 3 b respectively led us conclude dna pk chk2 work sequentially independently one another activating p53 upon dna damage
0.562309.14752107.html.plaintext.txt	37	latent inducible p53 requires chk2 dna pk vitro dna binding recently reported latent population p53 sufficient mediate chk2 dna pk directed p53 apoptotic response 7 13 determine whether latent population p53 whose dna binding activity regulated dna pk chk2 wild type chk2 null dna pk null mefs exposed ir presence absence cycloheximide treatment cells cycloheximide blocks translation new p53 protein allows us assess dna binding activity preexisting latent p53 fig 4 clearly shows latent p53 population wild type mefs activated bind dna upon ir contrast induced latent population p53 activated dna pk cells finding consistent previous contention dna pk targets latent p53 whereas atm targets induced p53 8 13 likewise examination wild type versus chk2 cells yielded results suggesting chk2 absolutely required latent p53 binding consensus sequence fig 4
0.562309.14752107.html.plaintext.txt	38	latent inducible p53 requires chk2 dna pk vitro dna binding recently reported latent population p53 sufficient mediate chk2 dna pk directed p53 apoptotic response 7 13 determine whether latent population p53 whose dna binding activity regulated dna pk chk2 wild type chk2 null dna pk null mefs exposed ir presence absence cycloheximide treatment cells cycloheximide blocks translation new p53 protein allows us assess dna binding activity preexisting latent p53 fig 4 clearly shows latent p53 population wild type mefs activated bind dna upon ir contrast induced latent population p53 activated dna pk cells finding consistent previous contention dna pk targets latent p53 whereas atm targets induced p53 8 13 likewise examination wild type versus chk2 cells yielded results suggesting chk2 absolutely required latent p53 binding consensus sequence fig 4
0.562309.14752107.html.plaintext.txt	39	view larger version 47k fig 4 dna pk chk2 required activation latent p53 dna binding following dna damage wild type dna pk chk2 mefs mock treated ctrl irradiated ir cycloheximide treated chx chx treated followed ir chr ir nuclear extracts prepared assayed p53 dna binding emsa
0.562309.14752107.html.plaintext.txt	40	discussion top abstract introduction experimental procedures results discussion references following dna damage ionizing radiation cell signaling events cause cell cycle arrest apoptosis p53 tumor suppressor central responses shown target number kinases including atm atr dna pk chk1 chk2 recently strongly suggested following ir chk2 kinase upstream mediator p53 cell cycle apoptotic responses recent evidence questioning role chk2 human cancer cell lines important decipher role chk2 plays activating p53 responses
0.562309.14752107.html.plaintext.txt	41	discussion top abstract introduction experimental procedures results discussion references following dna damage ionizing radiation cell signaling events cause cell cycle arrest apoptosis p53 tumor suppressor central responses shown target number kinases including atm atr dna pk chk1 chk2 recently strongly suggested following ir chk2 kinase upstream mediator p53 cell cycle apoptotic responses recent evidence questioning role chk2 human cancer cell lines important decipher role chk2 plays activating p53 responses
0.562309.14752107.html.plaintext.txt	42	examine role chk2 upstream p53 utilized vitro cell free translation system whereby p53 activation could assessed ability bind consensus sequence system previously used demonstrate dna pk acts upstream p53 response dna damage unknown factor also activated dna damage also involved process show unknown factor chk2 two kinases work synergistically activate p53 dna binding demonstrable vitro whether p53 binding actual indication p53 transcriptional activity simply readout conformation change p53 protein induced chk2 dna pk unclear present clear however chk2 dna pk together capable activating p53 including human p53 vitro
0.562309.14752107.html.plaintext.txt	43	examine role chk2 upstream p53 utilized vitro cell free translation system whereby p53 activation could assessed ability bind consensus sequence system previously used demonstrate dna pk acts upstream p53 response dna damage unknown factor also activated dna damage also involved process show unknown factor chk2 two kinases work synergistically activate p53 dna binding demonstrable vitro whether p53 binding actual indication p53 transcriptional activity simply readout conformation change p53 protein induced chk2 dna pk unclear present clear however chk2 dna pk together capable activating p53 including human p53 vitro
0.562309.14752107.html.plaintext.txt	44	observation human atm cell extract also capable promoting p53 dna binding also consistent previous demonstration chk2 activates p53 mediated apoptosis independently atm protein results indicate although atm necessary stabilize p53 protein ability chk2 dna pk activate p53 require atm also underscores need consider stabilization activation p53 two separate events
0.562309.14752107.html.plaintext.txt	45	observation human atm cell extract also capable promoting p53 dna binding also consistent previous demonstration chk2 activates p53 mediated apoptosis independently atm protein results indicate although atm necessary stabilize p53 protein ability chk2 dna pk activate p53 require atm also underscores need consider stabilization activation p53 two separate events
0.562309.14752107.html.plaintext.txt	46	independent nature dna pk chk2 activating p53 vitro sequential order involvement determined using number approaches used wortmannin show dna pk must act upon p53 since inhibition kinase activity completely abolished p53 binding however dna pk first allowed interact p53 subsequent addition wortmannin interfere activating effect chk2 added later indicates dna pk required upstream chk2 promote p53 activation demonstration ser 15 phosphorylated dna pk equally well chk2 chk2 cells attests complete independence action two kinases
0.562309.14752107.html.plaintext.txt	47	independent nature dna pk chk2 activating p53 vitro sequential order involvement determined using number approaches used wortmannin show dna pk must act upon p53 since inhibition kinase activity completely abolished p53 binding however dna pk first allowed interact p53 subsequent addition wortmannin interfere activating effect chk2 added later indicates dna pk required upstream chk2 promote p53 activation demonstration ser 15 phosphorylated dna pk equally well chk2 chk2 cells attests complete independence action two kinases
0.562309.14752107.html.plaintext.txt	48	evidence parallel sequential mechanism p53 activation dna pk chk2 comes observation two p53 ser 15 mutants s15a s15d require dna pk activated chk2 alone although result expected s15d mutant mimics phospho ser 15 came initially surprise case s15a mutant logical explanation mutants able bypass dna pk requirement modification serine 15 means phosphorylation mutation leads altered conformation p53 recognizable chk2 indeed previous work shieh et al 29 shows phosphorylation serine 15 site dna pk alters tertiary structure p53 recently craig et al 22 demonstrated two peptides derived dna binding domain p53 could bind chk2 allosterically stimulate phosphorylation full length p53 based present findings contend reason full length p53 activate chk2 probably chk2 docking sites native p53 cryptic exposed phosphorylation ser 15 dna pk thus initial modification p53 dna pk prerequisite subsequent modification chk2 two events probably occurring quickly tandem resulting full p53 activation
0.562309.14752107.html.plaintext.txt	49	evidence parallel sequential mechanism p53 activation dna pk chk2 comes observation two p53 ser 15 mutants s15a s15d require dna pk activated chk2 alone although result expected s15d mutant mimics phospho ser 15 came initially surprise case s15a mutant logical explanation mutants able bypass dna pk requirement modification serine 15 means phosphorylation mutation leads altered conformation p53 recognizable chk2 indeed previous work shieh et al 29 shows phosphorylation serine 15 site dna pk alters tertiary structure p53 recently craig et al 22 demonstrated two peptides derived dna binding domain p53 could bind chk2 allosterically stimulate phosphorylation full length p53 based present findings contend reason full length p53 activate chk2 probably chk2 docking sites native p53 cryptic exposed phosphorylation ser 15 dna pk thus initial modification p53 dna pk prerequisite subsequent modification chk2 two events probably occurring quickly tandem resulting full p53 activation
0.562309.14752107.html.plaintext.txt	50	finally study suggests latent population p53 activated dna pk chk2 upon dna damage finding consistent previous observation latent p53 becomes phosphorylated serine 15 immediately upon ir treatment latent p53 rather inducible p53 sufficient induce apoptosis dna pk dependent chk2 dependent manner therefore therefore appears fate cell cell growth arrest apoptosis determined early possibly immediately following dna damage depending nature extent dna damage p53 appears later scene inducible p53 may modified kinases atm atr may function distinct latent population p53
0.562309.14752107.html.plaintext.txt	51	finally study suggests latent population p53 activated dna pk chk2 upon dna damage finding consistent previous observation latent p53 becomes phosphorylated serine 15 immediately upon ir treatment latent p53 rather inducible p53 sufficient induce apoptosis dna pk dependent chk2 dependent manner therefore therefore appears fate cell cell growth arrest apoptosis determined early possibly immediately following dna damage depending nature extent dna damage p53 appears later scene inducible p53 may modified kinases atm atr may function distinct latent population p53
0.562309.14752107.html.plaintext.txt	52	summary results investigation consistent model wherein upon dna damage dna pk chk2 act synergistically sequentially dna pk followed chk2 latent population p53 fig 5 modified p53 manifests dna binding activity vitro may reflect actual event vivo altered conformational state unrelated dna binding activity either case extent modifications latent population p53 probably dictates subsequent course action depending cell context lead apoptosis
0.562309.14752107.html.plaintext.txt	53	view larger version 20k fig 5 model activation pathway latent p53 apoptosis immediately following dna damage dna pk activated strand breaks phosphorylates latent preexisting population p53 ser 15 induces conformational change p53 protein recognized chk2 kinase phosphorylates activates latent p53 severity nature dna damage incurred dictates extent latent p53 activation many cell types probably represents first obligatory event leads apoptosis circumstances cell growth arrest dna repair preferred outcome separate pathway data shown involving inducible p53 mediated atm atr kinases comes play
0.562309.14752107.html.plaintext.txt	54	footnotes work supported national cancer institute canada funds canadian cancer society p w k l costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.562309.14752107.html.plaintext.txt	55	recipient studentship alberta cancer board
0.562309.14752107.html.plaintext.txt	56	correspondence addressed dept microbiology immunology 7 p sir charles tupper medical bldg dalhousie university 5850 college st halifax nova scotia b3h 1x5 canada tel 902 494 8048 fax 902 494 5125 e mail patrickleeatdalca u d
0.562309.14752107.html.plaintext.txt	57	correspondence addressed dept microbiology immunology 7 p sir charles tupper medical bldg dalhousie university 5850 college st halifax nova scotia b3h 1x5 canada tel 902 494 8048 fax 902 494 5125 e mail patrickleeatdalca u d
0.562309.14752107.html.plaintext.txt	58	1 abbreviations used ir ionizing radiation atm ataxia telangiectasia mutated dna pk dna dependent protein kinase chk checkpoint kinase mef mouse embryo fibroblast emsa electrophoretic mobility shift assay
0.562309.14752107.html.plaintext.txt	59	acknowledgments thank dr halazonetis wistar institute chk2 clone dr y sanchez university cincinnati chk1 clone dr susan lees miller university calgary purified dna pk
0.562309.14752107.html.plaintext.txt	60	references top abstract introduction experimental procedures results discussion references kastan m b onyekwere o sidransky d vogelstein b craig r w 1991 cancer res 51 6304 6311abstract kastan m b zhan q el deiry w carrier f jacks walsh w v plunkett b vogelstein b fornace j 1992 cell 71 587 597medline order article via infotrieve kuerbitz j plunkett b walsh w v kastan m b 1992 proc natl acad sci u 89 7491 7495abstract symonds h krall l remington l saenz robles m lowe jacks van dyke 1994 cell 78 703 711medline order article via infotrieve canman c e lim d cimprich k taya y tamai k sakaguchi k appella e kastan m b siliciano j d 1998 science 281 1677 1679abstractfree full text barlow c brown k d deng c x tagle d wynshaw boris 1997 nat genet 17 453 456medline order article via infotrieve woo r mclure k g lees miller p rancourt d e lee p w 1998 nature 394 700 704crossrefmedline order article via infotrieve woo r jack m xu y burma chen d j lee p w 2002 embo j 21 3000 3008abstractfree full text wang guo m ouyang h li x cordon cardo c kurimasa chen d j fuks z ling c c li g c 2000 proc natl acad sci u 97 1584 1588abstractfree full text chehab n h malikzay appel m halazonetis d 2002 genes dev 14 278 288 shieh y ahn j tamai k taya y prives c 2000 genes dev 14 289 300abstractfree full text hirao kong y matsuoka wakeham ruland j yoshida h liu d elledge j mak w 2000 science 287 1824 1827abstractfree full text jack m woo r hirao cheung mak w lee p w 2002 proc natl acad sci u 99 9825 9829abstractfree full text takai h naka k okada y watanabe m harada n saito anderson c w apella e nakanishi m suzuki h nagashima k sawa h ikeda k motoyama n 2002 embo j 21 5195 5205abstractfree full text hirao cheung duncan g girard p m elia j bistrow r g suda lowe w jeggo p elledge j mak w 2002 mol cell biol 22 6521 6523abstractfree full text falck j lukas c protopopova m lukas j selivanova g bartek j 2001 oncogene 20 5503 5510crossrefmedline order article via infotrieve bell d w varley j m szydlo e kang d h wahrer d c shannon k e lubratovich m nerselis j isselbacher k j fraumani j f birch j m li f p garber j e haber d 1999 science 286 2528 2531abstractfree full text lee b kim h bell d w wahrer d c schiripo jorczak m m sgroi d c garber j e li f p nichols k e varley j m godwin k shannon k m harlow e haber d 2001 cancer res 61 8062 8067abstractfree full text vahteristo p tamminen karvinen p eerola h ecklund c aalotnen l blomqvist c aittomak k nevanlinna h 2001 cancer res 61 5718 5722abstractfree full text ahn j urist m prives c 2003 j biol chem 278 20480 20489abstractfree full text jallepalli p v lengauer c vogelstein b bunz f 2003 j biol chem 278 20475 20479abstractfree full text craig scott m burch l smith g ball k hupp 2003 embo j 4 787 792crossref lees miller p godbout r chan d w weinfeld m day r iii barron g m allalunis turner j 1995 science 267 1183 1185medline order article via infotrieve schwarz j k lovly c m piwnica worms h 2003 mol cancer res 1 598 609abstractfree full text melchionna r chen x b blasina mcgowan c h 2000 nat cell biol 2 762 765crossrefmedline order article via infotrieve ahn j y schwarz j k piwnica worms h canman c e 2000 cancer res 60 5934 5936abstractfree full text ahn j y li x davis h l canman c e 2002 j biol chem 277 19389 19395abstractfree full text ward m wu x chen j 2001 j biol chem 276 47755 47758abstractfree full text shieh y ikeda m taya y prives c 1997 cell 91 325 334medline order article via infotrieve
0.5641164.15231688.html.plaintext.txt	0	remodelling chromatin global scale novel protective function p53 simon j allison1 jo milner
0.5641164.15231688.html.plaintext.txt	1	ycr p53 research group department biology university york york yo10 5dd uk
0.5641164.15231688.html.plaintext.txt	2	1 correspondence addressed email sja13atyorkacuk
0.5641164.15231688.html.plaintext.txt	3	abstract top abstract introduction p53 transcriptional regulation global chromatin remodelling p53 histone regulation s10 h3 perspectivefuture directions references tumour suppressor p53 essential role maintaining genomic integrity mammalian cell achieved part function transcription factor enabling induce either growth arrest apoptosis response cellular stress changes gene expression commonly require localized chromatin remodelling p53 known interact vivo variety transcriptional co activators co repressors intrinsic histone modifying activities examine links p53 chromatin structures associated transcriptional regulation gene expression ii dna repair part process nucleotide excision repair iii histone modifications impact upon chromosomal condensation ploidy
0.5641164.15231688.html.plaintext.txt	4	abbreviations cpd cyclobutane pyrimidine dimers ggr global genomic repair ner nucleotide excision repair
0.5641164.15231688.html.plaintext.txt	5	introduction top abstract introduction p53 transcriptional regulation global chromatin remodelling p53 histone regulation s10 h3 perspectivefuture directions references packaging dna chromatin major obstacle transcription well dna repair recombination replication 1 chromatin remodelling necessary allow processes proceed may defined discernible alteration chromatin structure results change accessibility region dna encompasses changes induced atp dependent remodelling complexes alter nucleosomal positioning post translational modification nucleosomal histones may alter interactions histones dna 23 post translational histone modification may also play role chromatin remodelling indirectly specific recruitment non histone proteins atp dependent remodelling complexes chromatin 45 n termini core histones subject plethora site specific modifications including acetylation methylation phosphorylation 5 significance modifications vary different histones example modification histone h3 critical roles heterochromatin euchromatin formation 6 global chromatin condensation mitosis 7 11 chromatin remodelling transcription repair 51213
0.5641164.15231688.html.plaintext.txt	6	tumour suppressor p53 crucial roles transcription dna repair recombination 14 discuss links p53 chromatin structures associated transcriptional regulation gene expression ii dna repair part process nucleotide excision repair ner iii histone modifications impact upon chromosomal condensation ploidy
0.5641164.15231688.html.plaintext.txt	7	tumour suppressor p53 crucial roles transcription dna repair recombination 14 discuss links p53 chromatin structures associated transcriptional regulation gene expression ii dna repair part process nucleotide excision repair ner iii histone modifications impact upon chromosomal condensation ploidy
0.5641164.15231688.html.plaintext.txt	8	p53 transcriptional regulation role local chromatin remodelling top abstract introduction p53 transcriptional regulation global chromatin remodelling p53 histone regulation s10 h3 perspectivefuture directions references although euchromatin transcriptionally competent access transcriptional machinery dna severely restricted transcription genes located within euchromatin still requires local chromatin remodelling order proceed susceptibility different genes chromatin repression vary considerably however depending upon factors exact positioning nucleosomes gene promoter ability transcription factors compete histones binding dna 115 consequently contribution chromatin remodelling regulation gene expression also differ drastically genes
0.5641164.15231688.html.plaintext.txt	9	number transcriptional co activators co repressor complexes bind p53 vivo possess histone modifying activities 16 20 suggesting targeted chromatin remodelling may important p53 function transcription factor moreover several cases ability protein act transcriptional co activator co repressor shown dependent upon enzymatic activity 2122 however histone acetyltransferases histone deacetylases also target non histone proteins acetylationdeacetylation interestingly targets include p53 16 192324 p53 regulated multiple post translational modifications including acetylation number sites c terminus 192324 co activator hat p300 directly acetylates p53 several lysine residues acetylation reported affect aspects p53 function including dna binding 192324 stability 2526 subcellular localization 2728 since p53 substrate hats hdacs 16 1923 26 quite likely changes p53 dependent transcription upon recruitment activities may necessarily due changes histone acetylation number studies addressed issue directly p53 target genes histone modification rather modification p53 important p53 dependent changes gene expression 2029 31
0.5641164.15231688.html.plaintext.txt	10	number transcriptional co activators co repressor complexes bind p53 vivo possess histone modifying activities 16 20 suggesting targeted chromatin remodelling may important p53 function transcription factor moreover several cases ability protein act transcriptional co activator co repressor shown dependent upon enzymatic activity 2122 however histone acetyltransferases histone deacetylases also target non histone proteins acetylationdeacetylation interestingly targets include p53 16 192324 p53 regulated multiple post translational modifications including acetylation number sites c terminus 192324 co activator hat p300 directly acetylates p53 several lysine residues acetylation reported affect aspects p53 function including dna binding 192324 stability 2526 subcellular localization 2728 since p53 substrate hats hdacs 16 1923 26 quite likely changes p53 dependent transcription upon recruitment activities may necessarily due changes histone acetylation number studies addressed issue directly p53 target genes histone modification rather modification p53 important p53 dependent changes gene expression 2029 31
0.5641164.15231688.html.plaintext.txt	11	p53 activate repress transcription variety cellular genes 3233 p53 induced growth arrest seems mediated transactivation p21 gene several independent studies sought understand mechanisms p53 regulates p21 transcription using reconstituted vitro transcription system chromatin assembled p21 promoter epsinosa emerson found ability p53 p300 activate p21 transcription dependent upon cooperation overcome repressive effects chromatin packing rather acetylation p53 p300 29 chromatin immunoprecipitation experiments suggest p53 recruits p300 p21 promoter thereby enabling targeted acetylation chromatin assembled core histones h2a h2b h3 h4 29
0.5641164.15231688.html.plaintext.txt	12	p53 activate repress transcription variety cellular genes 3233 p53 induced growth arrest seems mediated transactivation p21 gene several independent studies sought understand mechanisms p53 regulates p21 transcription using reconstituted vitro transcription system chromatin assembled p21 promoter epsinosa emerson found ability p53 p300 activate p21 transcription dependent upon cooperation overcome repressive effects chromatin packing rather acetylation p53 p300 29 chromatin immunoprecipitation experiments suggest p53 recruits p300 p21 promoter thereby enabling targeted acetylation chromatin assembled core histones h2a h2b h3 h4 29
0.5641164.15231688.html.plaintext.txt	13	barlev colleagues investigated acetylation p53 increases transcription p21 vivo 30 following gamma irradiation used chromatin immunoprecipitation analyse effects p53 acetylation status association p53 non acetylatable p53 mutants endogenous p21 promoter 30 consistent results epsinosa emerson acetylation p53 discernible effect p53 binding endogenous p21 promoter exploring possibilities found acetylation p53 promotes association co activators cbp trrap p21 promoter 30 cbp intrinsic hat activity 34 trrap component multiple co activator complexes hat activity including pcaf tftc staga tip60 complexes 3536 recruitment cbp trrap acetylated p53 correlated elevated levels acetylated h3 h4 endogenous p21 promoter 30 another study variety p53 mutants expressed stable cell lines analysed ability activate endogenous p21 transcription 37 chip analysis revealed abilities mutants bind p21 promoter equivalent wild type p53 differences ability activate transcription correlated directly extent histone acetylation levels p300cbp p21 promoter 37 support importance chromatin remodelling p53 mediated regulation p21 transcription lagger et al discovered recently p53 histone deacetylase hdac1 antagonistic regulators p21 gene expression vivo p53 displace hdac1 p21 promoter 38 transcriptional targets p53 include mdm2 transcriptional activation dependent recruitment trrap correlating increased histone acetylation suggesting chromatin remodelling also important p53 dependent regulation mdm2 transcription 31
0.5641164.15231688.html.plaintext.txt	14	barlev colleagues investigated acetylation p53 increases transcription p21 vivo 30 following gamma irradiation used chromatin immunoprecipitation analyse effects p53 acetylation status association p53 non acetylatable p53 mutants endogenous p21 promoter 30 consistent results epsinosa emerson acetylation p53 discernible effect p53 binding endogenous p21 promoter exploring possibilities found acetylation p53 promotes association co activators cbp trrap p21 promoter 30 cbp intrinsic hat activity 34 trrap component multiple co activator complexes hat activity including pcaf tftc staga tip60 complexes 3536 recruitment cbp trrap acetylated p53 correlated elevated levels acetylated h3 h4 endogenous p21 promoter 30 another study variety p53 mutants expressed stable cell lines analysed ability activate endogenous p21 transcription 37 chip analysis revealed abilities mutants bind p21 promoter equivalent wild type p53 differences ability activate transcription correlated directly extent histone acetylation levels p300cbp p21 promoter 37 support importance chromatin remodelling p53 mediated regulation p21 transcription lagger et al discovered recently p53 histone deacetylase hdac1 antagonistic regulators p21 gene expression vivo p53 displace hdac1 p21 promoter 38 transcriptional targets p53 include mdm2 transcriptional activation dependent recruitment trrap correlating increased histone acetylation suggesting chromatin remodelling also important p53 dependent regulation mdm2 transcription 31
0.5641164.15231688.html.plaintext.txt	15	p53 also interacts histone deacetylase complexes vivo work murphy et al indicates interactions may important transcriptional repression p53 20 p53 recruits transcriptional co repressor msin3a binds hdac1 endogenous map4 promoter found correlate histone deacetylation reduced transcription 20 histone deacetylase inhibitor trichostatin abrogated ability p53 repress transcription p53 target genes map4 stathmin 20
0.5641164.15231688.html.plaintext.txt	16	p53 also interacts histone deacetylase complexes vivo work murphy et al indicates interactions may important transcriptional repression p53 20 p53 recruits transcriptional co repressor msin3a binds hdac1 endogenous map4 promoter found correlate histone deacetylation reduced transcription 20 histone deacetylase inhibitor trichostatin abrogated ability p53 repress transcription p53 target genes map4 stathmin 20
0.5641164.15231688.html.plaintext.txt	17	several subunits atp dependent remodelling complex swisnf also shown bind p53 p53 recruit hsnf hbrg1 endogenous p21 promoter vivo 39 moreover whilst expression hsnf5 brg1 stimulated p53 dependent transcription reporter construct dominant negative forms hsnf5 brg1 repressed transcription p53 induced growth arrest apoptosis 39
0.5641164.15231688.html.plaintext.txt	18	several subunits atp dependent remodelling complex swisnf also shown bind p53 p53 recruit hsnf hbrg1 endogenous p21 promoter vivo 39 moreover whilst expression hsnf5 brg1 stimulated p53 dependent transcription reporter construct dominant negative forms hsnf5 brg1 repressed transcription p53 induced growth arrest apoptosis 39
0.5641164.15231688.html.plaintext.txt	19	apparent studies regulation local chromatin structure p53 mediated varying actions histone deacetylases hats atp dependent remodelling complexes important p53 function transcription factor summarized figure 1 shows schematic transcriptional repression transcriptional activation p53 local changes chromatin structure evidence mechanisms p53 activates represses transcription may differ different genes chromatin remodelling may important changes gene expression genes others 3140 majority studies focused p21 gene work required look relative contribution chromatin remodelling p53 mediated changes transcription different p53 target genes
0.5641164.15231688.html.plaintext.txt	20	apparent studies regulation local chromatin structure p53 mediated varying actions histone deacetylases hats atp dependent remodelling complexes important p53 function transcription factor summarized figure 1 shows schematic transcriptional repression transcriptional activation p53 local changes chromatin structure evidence mechanisms p53 activates represses transcription may differ different genes chromatin remodelling may important changes gene expression genes others 3140 majority studies focused p21 gene work required look relative contribution chromatin remodelling p53 mediated changes transcription different p53 target genes
0.5641164.15231688.html.plaintext.txt	21	view larger version 30k fig 1 schematic showing examples p53 dependent transcriptional regulation local chromatin remodelling transcriptional repression p53 recruitment histone deacetylase activity targeted core histone deacetylation map 4 promoter 20 b p53 transcriptional activation p21 promoter mediated displacement hdac1 38 recruitment histone acetyltransferases p300 29 cbp trrap 30 targeted histone acetylation 2930 nucleosomal remodelling atp dependent remodelling components hsnf5 hbrg1 39
0.5641164.15231688.html.plaintext.txt	22	global chromatin remodelling repair discrete p53 function top abstract introduction p53 transcriptional regulation global chromatin remodelling p53 histone regulation s10 h3 perspectivefuture directions references mammalian genome prone bombardment multiplicity genotoxic insults well naturally occurring errors need repaired amongst common forms dna damage bulky dna lesions cyclobutane pyrimidine dimers cpds 6 4 photoproducts caused uv irradiation environmental carcinogens 41 types lesions eliminated ner comprises two subpathways transcription coupled repair tcr removes lesions actively transcribed regions genome global genomic repair ggr erases damage non transcribed regions 41 efficient detection lesions requires chromatin relaxation 42 45 tcr opening chromatin passage rna polymerase along template seems sufficient 45 ggr global chromatin relaxation required allow detection lesions throughout genome 43 45
0.5641164.15231688.html.plaintext.txt	23	although well documented efficient ner requires p53 46 exact role difficult define significantly ner reconstituted vitro naked dna requirement p53 47 p53 necessary efficient ner natural context chromatin notably ggr 4849 moreover effect p53 efficiency ggr much greater cpds 6 4 photoproducts 4849 cpds often located within nucleosomes thus much dependent chromatin relaxation repair 6 4 photoproducts found linker dna 50 together data clearly suggestive p53 may function ner facilitating access chromatin ggr using microscopy rubbi milner asked p53 induce global chromatin relaxation ggr demonstrated p53 required global chromatin relaxation induced uv irradiation figure 2 43 interestingly uv dose 4 jm2 used study half minimum dose necessary activate p53 transcription factor 51 53 suggests p53 dependent global chromatin relaxation due transcription independent effects p53 furthermore xeroderma pigmentosum cells deficient p48 xpc xpa showed normal uv induced global chromatin relaxation ggr 43 thus demonstrating p53 requirement global chromatin relaxation mediated p48 xpc transcriptional targets p53 conditions p53 activated transcription factor likely p53 also additional roles ner perhaps chromatin accessibility transcriptional induction repair factors p48 xpc 54 57 recent work ford colleagues shown p48 rapidly co localize cpd containing foci following localized uv irradiation p48 facilitates localization xpc foci leading suggestion p48 may remodel chromatin thereby enabling recognition cpds xpc 5657 important distinguish chromatin relaxation chromatin remodelling note p48 dispensable p53 dependent chromatin relaxation 43 see may facilitate chromatin remodelling 5657
0.5641164.15231688.html.plaintext.txt	24	although well documented efficient ner requires p53 46 exact role difficult define significantly ner reconstituted vitro naked dna requirement p53 47 p53 necessary efficient ner natural context chromatin notably ggr 4849 moreover effect p53 efficiency ggr much greater cpds 6 4 photoproducts 4849 cpds often located within nucleosomes thus much dependent chromatin relaxation repair 6 4 photoproducts found linker dna 50 together data clearly suggestive p53 may function ner facilitating access chromatin ggr using microscopy rubbi milner asked p53 induce global chromatin relaxation ggr demonstrated p53 required global chromatin relaxation induced uv irradiation figure 2 43 interestingly uv dose 4 jm2 used study half minimum dose necessary activate p53 transcription factor 51 53 suggests p53 dependent global chromatin relaxation due transcription independent effects p53 furthermore xeroderma pigmentosum cells deficient p48 xpc xpa showed normal uv induced global chromatin relaxation ggr 43 thus demonstrating p53 requirement global chromatin relaxation mediated p48 xpc transcriptional targets p53 conditions p53 activated transcription factor likely p53 also additional roles ner perhaps chromatin accessibility transcriptional induction repair factors p48 xpc 54 57 recent work ford colleagues shown p48 rapidly co localize cpd containing foci following localized uv irradiation p48 facilitates localization xpc foci leading suggestion p48 may remodel chromatin thereby enabling recognition cpds xpc 5657 important distinguish chromatin relaxation chromatin remodelling note p48 dispensable p53 dependent chromatin relaxation 43 see may facilitate chromatin remodelling 5657
0.5641164.15231688.html.plaintext.txt	25	view larger version 41k fig 2 schematic p53 induced global chromatin relaxation response uv irradiation allows access repair machinery dna lesions ggr recruitment p300 p53 dependent acetylation lysine 9 histone h3 may involved ability p53 induce global chromatin relaxation likely additional histone acetylation factors also required see text ref 43
0.5641164.15231688.html.plaintext.txt	26	histone deacetylase inhibitor trichostatin overcomes requirement p53 suggesting p53 may induce global chromatin relaxation changes histone acetylation 43 following uv irradiation histone acetylation increases 58 moreover comparison p53 p53 cells selective depletion functional p53 antibody microinjection rubbi milner showed uv induced acetylation lysine 9 histone h3 p53 dependent 43 histone acetyltransferase p300 co localizes p53 sites ner inhibition p300 antibody microinjection inhibits ner suggesting p53 dependent recruitment p300 hat activity may mechanistically involved ability p53 induce global chromatin relaxation 43
0.5641164.15231688.html.plaintext.txt	27	histone deacetylase inhibitor trichostatin overcomes requirement p53 suggesting p53 may induce global chromatin relaxation changes histone acetylation 43 following uv irradiation histone acetylation increases 58 moreover comparison p53 p53 cells selective depletion functional p53 antibody microinjection rubbi milner showed uv induced acetylation lysine 9 histone h3 p53 dependent 43 histone acetyltransferase p300 co localizes p53 sites ner inhibition p300 antibody microinjection inhibits ner suggesting p53 dependent recruitment p300 hat activity may mechanistically involved ability p53 induce global chromatin relaxation 43
0.5641164.15231688.html.plaintext.txt	28	also worth considering happens dna repair clearly need restore chromatin original state condensation help protect genome incurring damage transient nature relaxed chromatin state indicated temporal profile histone acetylation post uv irradiation 435859 interesting see whether p53 active role chromatin condensation repair complete
0.5641164.15231688.html.plaintext.txt	29	also worth considering happens dna repair clearly need restore chromatin original state condensation help protect genome incurring damage transient nature relaxed chromatin state indicated temporal profile histone acetylation post uv irradiation 435859 interesting see whether p53 active role chromatin condensation repair complete
0.5641164.15231688.html.plaintext.txt	30	p53 histone modification complex affair top abstract introduction p53 transcriptional regulation global chromatin remodelling p53 histone regulation s10 h3 perspectivefuture directions references local p53 dependent changes histone acetylation observed promoters number p53 target genes 2029 31373860 62 demonstration p53 induce global alterations chromatin structure raised possibility p53 might influence histone modification global scale focusing upon modification histone h3 central role local global chromatin remodelling 5 912 compared pattern modification specific residues h3 isogenic clones human p53 p53 cells since general increase histone acetylation following uv treatment 58 particularly interested see whether lysine residues histone h3 addition k9 similarly acetylated response uv irradiation contrast k9 levels acetylated k18 histone h3 change response uv irradiation 59 however p53 facilitate rise acetylated k14 levels 59 results demonstrate p53 directly indirectly site specific effects histone h3 acetylation response uv irradiation interesting see changes mediated contribute p53 induced global chromatin relaxation ggr recent advances sirna technology possible confirm effects p53 upon histone h3 modification already observed isogenic clones human p53 p53 cells rna interference also allow examination p53 effects range cell types wild type mutant p53 background isogenic clones yet available
0.5641164.15231688.html.plaintext.txt	31	uv dosage 10 jm2 used study also sufficient activate p53 transcription factor site specific effects histone h3 acetylation may also mechanistically involved p53 regulated transcription indeed acetylation k9 k14 regulated p53 associated chromatin relaxation transcription 12 changes histone acetylation observed previously p53 target genes evidence differential core histone acetylation different genes 61 results identify differential effects p53 upon individual residues within histone h3 key determinant chromatin organization p53 also influences histone h3 modification normal growth conditions p53 activated transcription factor observations summarized figure 3 see ref 59 details clearly important implications suggests additional roles p53 chromatin remodelling beyond uv induced global relaxation repair localized remodelling transcription
0.5641164.15231688.html.plaintext.txt	32	uv dosage 10 jm2 used study also sufficient activate p53 transcription factor site specific effects histone h3 acetylation may also mechanistically involved p53 regulated transcription indeed acetylation k9 k14 regulated p53 associated chromatin relaxation transcription 12 changes histone acetylation observed previously p53 target genes evidence differential core histone acetylation different genes 61 results identify differential effects p53 upon individual residues within histone h3 key determinant chromatin organization p53 also influences histone h3 modification normal growth conditions p53 activated transcription factor observations summarized figure 3 see ref 59 details clearly important implications suggests additional roles p53 chromatin remodelling beyond uv induced global relaxation repair localized remodelling transcription
0.5641164.15231688.html.plaintext.txt	33	view larger version 26k fig 3 schematic illustrating complexity site specificity p53 dependent histone h3 modification uv 20 min post uv irradiation 10 jm2 tsa tsa treated 20 h see text ref 59 figure adapted ref 59
0.5641164.15231688.html.plaintext.txt	34	evident observations effects p53 histone modification extremely complex perhaps reflecting central role p53 multiple cellular activities require chromatin remodelling remarkable specificity effects p53 histone modification evidence differential effects p53 modification different residues core histone figure 3 ref 59 indicate complex problem prove difficult resolve especially case modification different residues different functional consequences 12 28 different histone residues known post translationally modified 63 modifications influenced p53 deciphering consequences modifications occur enormous task progress areas greatly facilitate understanding reciprocal relationship chromatin remodelling p53 functions
0.5641164.15231688.html.plaintext.txt	35	evident observations effects p53 histone modification extremely complex perhaps reflecting central role p53 multiple cellular activities require chromatin remodelling remarkable specificity effects p53 histone modification evidence differential effects p53 modification different residues core histone figure 3 ref 59 indicate complex problem prove difficult resolve especially case modification different residues different functional consequences 12 28 different histone residues known post translationally modified 63 modifications influenced p53 deciphering consequences modifications occur enormous task progress areas greatly facilitate understanding reciprocal relationship chromatin remodelling p53 functions
0.5641164.15231688.html.plaintext.txt	36	regulation s10 h3 phosphorylation p53 protection aneuploidy top abstract introduction p53 transcriptional regulation global chromatin remodelling p53 histone regulation s10 h3 perspectivefuture directions references addition site specific effects histone h3 acetylation p53 also affects levels phosphorylated s10 histone h3 figure 3 ref 59 phosphorylation s10 histone h3 least two distinct roles cell level local chromatin remodelling s10 phosphorylation important transcriptional activation specific genes including immediate early genes c fos c jun 64 66 larger scale chromatin remodelling global s10 h3 phosphorylation occurs g2m phase cell cycle required proper chromosome condensation segregation mitosis 7 10
0.5641164.15231688.html.plaintext.txt	37	mitotic kinase aim1aurora b appears principal kinase involved phosphorylation s10 h3 initiation chromosomal condensation late g2 1067 significantly aim1aurora b expressed many human cancer cell lines abnormalities s10 phosphorylation shown cause chromosomal abnormalities segregation defects resulting aneuploidy 71068 loss p53 also causes abnormalities s10 h3 phosphorylation 59 constitutive growth conditions consistently found total levels s10p h3 least several fold higher absence p53 59 moreover whereas total levels s10p h3 remained relatively constant response various treatments p53 cells absence p53 levels s10p h3 found vary enormously tight inverse relationship total levels acetylated k9 h3 59 seems absence p53 s10p levels dictated large extent levels acetylated k9 dependency upon levels another modification potentially dangerous cell may allow appropriate regulation s10 phosphorylation critical proper chromosomal condensation mitosis maintenance normal ploidy abnormal s10p h3 levels also observed p53 cells following release nocodazole induced g2m arrest correlated impaired cell cycle recovery 59 possibly due defective chromosomal management
0.5641164.15231688.html.plaintext.txt	38	mitotic kinase aim1aurora b appears principal kinase involved phosphorylation s10 h3 initiation chromosomal condensation late g2 1067 significantly aim1aurora b expressed many human cancer cell lines abnormalities s10 phosphorylation shown cause chromosomal abnormalities segregation defects resulting aneuploidy 71068 loss p53 also causes abnormalities s10 h3 phosphorylation 59 constitutive growth conditions consistently found total levels s10p h3 least several fold higher absence p53 59 moreover whereas total levels s10p h3 remained relatively constant response various treatments p53 cells absence p53 levels s10p h3 found vary enormously tight inverse relationship total levels acetylated k9 h3 59 seems absence p53 s10p levels dictated large extent levels acetylated k9 dependency upon levels another modification potentially dangerous cell may allow appropriate regulation s10 phosphorylation critical proper chromosomal condensation mitosis maintenance normal ploidy abnormal s10p h3 levels also observed p53 cells following release nocodazole induced g2m arrest correlated impaired cell cycle recovery 59 possibly due defective chromosomal management
0.5641164.15231688.html.plaintext.txt	39	abnormalities s10 phosphorylation absence p53 may contribute development aneuploidy critical step carcinogenesis 69 regulating s10 h3 phosphorylation p53 may support fidelity mitosis cell ploidy
0.5641164.15231688.html.plaintext.txt	40	abnormalities s10 phosphorylation absence p53 may contribute development aneuploidy critical step carcinogenesis 69 regulating s10 h3 phosphorylation p53 may support fidelity mitosis cell ploidy
0.5641164.15231688.html.plaintext.txt	41	perspectivefuture directions top abstract introduction p53 transcriptional regulation global chromatin remodelling p53 histone regulation s10 h3 perspectivefuture directions references recent advances suggest chromatin remodelling plays crucial role p53 function extends beyond role transcription factor figure 4 field awaits studies decipher exactly p53 exerts effects chromatin example p53 induce global chromatin relaxation ggr may mediated part recruitment p300 p53 chromatin acetylation lysine 9 histone h3 really sufficient hats chromatin modifying complexes involved shown p53 differentially affects multiple modifications core histone work needed elucidate functional consequences distinct pattern histone modifications determine p53 achieves specificity
0.5641164.15231688.html.plaintext.txt	42	view larger version 14k fig 4 schematic summarizing central role chromatin remodelling p53 function guardian genome addition local chromatin remodelling transcription p53 also influence chromatin global scale important ggr 43 may also support fidelity mitosis ploidy global alterations chromatin structure ref 59 see text details
0.5641164.15231688.html.plaintext.txt	43	research chromatin modification exploded recent years original correlation increased histone acetylation relaxed chromatin structure still applies 70 also clear something oversimplification histone code exists proteins able distinguish different modifications modification specific binding domains chromo bromodomains 7172 combinatorial approach even modification different residues 412 case methylated k9 k4 histone h3 exemplifies modification different residues histone presumed equivalent 6 clearly need define detail pattern modification specific genes example pattern histone modification differ gene repressed p53 gene activated p53 effect p53 pattern histone modification genes transactivated tumour suppressor effects vary depending upon stress correlate pattern gene expression ie choice growth arrest death chromatin immunoprecipitation coupled engineered mutation histones selected sites 4 prove invaluable addressing questions example thanos co workers used reconstituted vitro transcription system nucleosomal templates assembled wild type mutant modified histones define specific role particular histone modifications activation ifn ss gene 4 relationship chromatin remodelling p53 worthwhile topic investigation may hold important insights multiplicity p53 functions mammalian cells
0.5641164.15231688.html.plaintext.txt	44	research chromatin modification exploded recent years original correlation increased histone acetylation relaxed chromatin structure still applies 70 also clear something oversimplification histone code exists proteins able distinguish different modifications modification specific binding domains chromo bromodomains 7172 combinatorial approach even modification different residues 412 case methylated k9 k4 histone h3 exemplifies modification different residues histone presumed equivalent 6 clearly need define detail pattern modification specific genes example pattern histone modification differ gene repressed p53 gene activated p53 effect p53 pattern histone modification genes transactivated tumour suppressor effects vary depending upon stress correlate pattern gene expression ie choice growth arrest death chromatin immunoprecipitation coupled engineered mutation histones selected sites 4 prove invaluable addressing questions example thanos co workers used reconstituted vitro transcription system nucleosomal templates assembled wild type mutant modified histones define specific role particular histone modifications activation ifn ss gene 4 relationship chromatin remodelling p53 worthwhile topic investigation may hold important insights multiplicity p53 functions mammalian cells
0.5641164.15231688.html.plaintext.txt	45	acknowledgments indebted bert vogelstein making available isogenic clones hct116 p53 p53 cells work funded yorkshire cancer research project grant jm
0.5641164.15231688.html.plaintext.txt	46	acknowledgments indebted bert vogelstein making available isogenic clones hct116 p53 p53 cells work funded yorkshire cancer research project grant jm
0.5641164.15231688.html.plaintext.txt	47	references top abstract introduction p53 transcriptional regulation global chromatin remodelling p53 histone regulation s10 h3 perspectivefuture directions references wolffea 1998 chromatin structure function academic press san diego lussera kadonagajt 2003 chromatin remodeling atp dependent molecular machines bioessays 25 1192 1200crossrefisimedline kingstonre narlikargj 1999 atp dependent remodeling acetylation regulators chromatin fluidity genes dev 13 2339 2352free full text agaliotit cheng thanosd 2002 deciphering transcriptional histone acetylation code human gene cell 111 381 392isimedline iizukam smithmm 2003 functional consequences histone modifications curr opin genet dev 13 154 160crossrefisimedline lachnerm jenuweint 2002 many faces histone lysine methylation curr opin cell biol 14 286 298crossrefisimedline weiy yul bowenj gorovskyma alliscd 1999 phosphorylation histone h3 required proper chromosome condensation segregation cell 97 99 109isimedline hooserav goodrichdw alliscd brinkleybr mancinima 1998 histone h3 phosphorylation required initiation maintenance mammalian chromosome condensation j cell sci 111 3497 3506abstractfree full text hendzelmj weiy mancinima hooserav ranallit brinkleybr bazett jonesdp alliscd 1997 mitosis specific phosphorylation histone h3 initiates primarily within pericentromeric heterochromatin g2 spreads ordered fashion coincident chromosome condensation chromosoma 106 348 360crossrefisimedline gietr gloverdm 2001 drosophila aurora b kinase required histone h3 phosphorylation condensin recruitment chromosome condensation organise central spindle cytokinesis j cell biol 152 669 682abstractfree full text hsuj y sunzw lix et al 2000 mitotic phosphorylation histone h3 governed ip1aurora kinase glc7ppi phosphatase budding yeast nematodes cell 102 279 291isimedline jenuweint alliscd 2001 translating histone code science 293 1074 1079abstractfree full text qins parthunmr 2002 histone h3 histone acetyltransferase hat1p contribute dna double strand break repair mol cell biol 22 8353 8365abstractfree full text vogelsteinb laned levineaj 2000 surfing p53 network nature 408 307 310crossrefisimedline hayesjj wolffeap 1992 interaction transcription factors nucleosomal dna bioessays 14 597 603isimedline vazirih dessainsk ng eatone imaisi fryera panditatk guarentel weinbergra 2001 hsir2sirt1 functions nad dependent p53 deacetylase cell 107 149 159isimedline luoj nikolaevay imais chend suf shiloha guarentel guw 2001 negative control p53 sir2 promotes cell survival stress cell 107 137 148isimedline langleye pearsonm farettam bauerum fryera minuccis peliccipg kouzaridest 2002 human sir2 deacetylates p53 antagonises pmlp53 induced cellular senescence embo j 21 2383 2396abstractfree full text liul scolnickdm trievelrc zhanghb marmorsteinr halazonetistd bergersl 1999 p53 sites acetylated vitro pcaf p300 acetylated vivo response dna damage mol cell biol 19 1202 1209abstractfree full text murphym ahnj walkerkk hoffmanwh evansrm levineaj georgedl 1999 transcriptional repression wild type p53 utilizes histone deacetylases mediated interaction msin3a genes dev 13 2490 2501abstractfree full text kuomh zhouj jambeckp churchillmea alliscd 1998 histone acetyltransferase activity yeast gcn5 required activation target genes vivo genes dev 12 627 639abstractfree full text marsolierm c tanakas livingstone zatchejm grunsteinm thomaf sentenaca 1995 reciprocal interferences nucleosomal organization transcriptional activity yeast snr6 gene genes dev 9 410 422abstract guw roederrg 1997 activation p53 sequence specific dna binding acetylation p53 c terminal domain cell 90 595 606isimedline sakaguchik herreraje saitos mikit bustinm vassileva andersoncw appellae 1998 dna damage activates p53 phosphorylation acetylation cascade genes dev 12 2831 2841abstractfree full text itoa kawaguchiy laich kovacsjj higashimotoy appellae yaotp 2002 mdm2 hdac1 mediated deacetylation p53 required degradation embo j 21 6236 6245abstractfree full text itoa laich zhaox saitos hamiltonmh appellae yaotp 2001 p300cbp mediated p53 acetylation commonly induced p53 activating agents inhibited mdm2 embo j 20 1331 1340abstractfree full text nakamuras rothja mukhopadhyayt 2000 multiple lysine mutations c terminal domain p53 interfere mdm2 dependent protein degradation ubiquitination mol cell biol 20 9391 9398abstractfree full text pearsonm carboner sebastianic et al 2000 pml regulates p53 acetylation premature senescence induced oncogenic ras nature 406 207 210crossrefisimedline espinosajm emersonb 2001 transcriptional regulation p53 intrinsic dnachromatin binding site directed cofactor recruitment mol cell 8 57 69isimedline barlevna liul chehabnh mansfieldk harriskg halazonetistd bergersl 2001 acetylation p53 activates transcription recruitment coactivatorshistone acetyltransferases mol cell 8 1243 1254isimedline ardpg chattterjeec kunjibettus adsidelr gralinskile mcmahonsb 2002 transcriptional regulation mdm2 oncogene p53 requires trrap acetyltransferase complexes mol cell biol 22 5650 5661abstractfree full text kolj privesc 1996 p53 puzzle paradigm genes dev 10 1054 1072crossrefisimedline levineaj 1997 p53 cellular gatekeeper growth division cell 88 323 331isimedline bannisteraj kouzaridest 1996 cbp co activator histone acetyltransferase nature 384 641 643crossrefisimedline vassileva yamauchij kotanit privesc avantaggiatiml qinj nakataniy 1998 400 kda subunit pcaf histone acetylase complex belongs atm superfamily mol cell 2 869 875isimedline ikurat ogryzkovv grigorievm groismanr wangj horikoshim scullyr qinj nakataniy 2000 involvement tip60 histone acetylase complex dna repair apoptosis cell 102 463 473isimedline liug xiat chenx 2003 activation domains proline rich domain c terminal basic domain p53 necessary acetylation histones proximal p21 promoter interaction p300creb binding protein j biol chem 278 17557 17565abstractfree full text laggerg doetzlhofera schuettengruberb et al 2003 tumor suppressor p53 histone deacetylase 1 antagonistic regulators cyclin dependent kinase inhibitor p21waf1cip1 gene mol cell biol 23 2669 2679abstractfree full text leed kimjw seot hwangsg choie j choej 2002 swisnf complex interacts tumor suppressor p53 necessary activation p53 mediated transcription j biol chem 277 22330 22337abstractfree full text crightond woiwodea zhangc mandavian mortonjp warnocklj milnerj whiterj johnsondl 2003 p53 represses rna polymerase iii transcription targeting tbp inhibiting promoter occupancy tfiiib embo j 22 2810 2820abstractfree full text freidbergec walkergc siedew 1995 dna repair mutagenesis asm press washington dc smerdonmj thomaf 1998 modulations chromatin structure dna damage formation repair nickoloffja hoekstramf eds dna damage repair volume ii dna repair higher eukaryotes humana press totowa nj pp 199 222 rubbicp milnerj 2003 p53 chromatin accessibility factor nucleotide excision repair dna damage embo j 22 975 986abstractfree full text greencm almouznig 2002 repair meets chromatin embo rep 3 28 33abstractfree full text freidbergec 2001 nucleotide excision repair protects cancer nature rev cancer 1 22 33crossrefmedline hanawaltpc 2001 controlling efficiency excision repair mutat res 485 3 13isimedline leveillardt anderal bissonnetten schaefferl braccol eglyjm wasylykb 1996 functional interactions p53 tfiih complex affected tumour associated mutations embo j 15 1615 1624abstract fordjm hanawaltpc 1995 li fraumeni syndrome fibroblasts homozygous p53 mutations deficient global dna repair exhibit normal transcription coupled repair enhanced uv resistance proc natl acad sci usa 92 8876 8880abstract fordjm hanawaltpc 1997 expression wild type p53 required efficient global genomic nucleotide excision repair uv irradiated human fibroblasts j biol chem 272 28073 28080abstractfree full text thomaf 1999 light dark chromatin repair repair uv induced dna lesions photolyase nucleotide excision repair embo j 18 6585 6598abstractfree full text yamaizumim suganot 1994 uv induced nuclear accumulation p53 evoked dna damage actively transcribed genes independent cell cycle oncogene 9 2775 2784isimedline ljungmanm zhangf 1996 blockage rna polymerase possible trigger uv light induced apoptosis oncogene 13 823 831isimedline rubbicp milnerj 2003 disruption nucleolus mediates stabilization p53 response dna damage stresses embo j 22 6068 6077abstractfree full text hwangbj fordjm hanawaltpc chug 1999 expression p48 xeroderma pigmentosum gene p53 dependent involved global genomic repair proc natl acad sci usa 96 424 428abstractfree full text adimoolams fordjm 2002 p53 dna damage inducible expression xeroderma pigmentosum group c gene proc natl acad sci usa 99 12985 12990abstractfree full text fitchme crossiv fordjm 2003 p53 responsive nucleotide excision repair gene products p48 xpc p53 localise sites uv irradiation induced dna damage vivo carcinogenesis 24 843 850abstractfree full text fitchme nakajimas yasuia fordjm 2003 vivo recruitment xpc uv induced cyclobutane pyrimidine dimers ddb2 gene product j biol chem 278 46906 46910abstractfree full text ramanathanb smerdonmj 1986 changes nuclear protein acetylation uv damaged human cells carcinogenesis 7 1087 1094abstract allisonsj milnerj 2003 loss p53 site specific effects histone h3 modification including serine 10 phosphorylation important maintenance ploidy cancer res 63 6674 6679abstractfree full text juanl j shiaw j chenm h yangw m setoe liny wuc w 2000 histone deacetylases specifically regulate p53 dependent gene activation j biol chem 275 20436 20443abstractfree full text kaesermd iggord 2004 promoter specific p53 dependent histone acetylation following dna damage oncogene 23 4007 4013crossrefisimedline shanb xuj zhuoy morrisca morrisgf 2003 induction p53 dependent activation human proliferating cell nuclear antigen gene chromatin ionizing radiation j biol chem 278 44009 44017abstractfree full text kouzaridest 2003 chromatin modifying enzymes transcription cancer biochem soc transact 31 741 743crossrefisimedline cheungp tannerkg cheungwl sassone corsip denujm alliscd 2000 synergistic coupling histone h3 phosphorylation acetylation response epidermal growth factor stimulation mol cell 5 905 915isimedline chadeedn hendzelmj tylipskicp alliscd bazett jonesdp wrightjm daviejr 1999 increased ser 10 phosphorylation histone h3 mitogen stimulated oncogene transformed mouse fibroblasts j biol chem 274 24914 24920abstractfree full text claytonal roses barrattmj mahadevanlc 2000 phosphoacetylation histone h3 c fos c jun associated nucleosomes upon gene activation embo j 19 3714 3726abstractfree full text crosioc fimiagm louryr kimuram okanoy zhouh sens alliscd sassone corsip 2002 mitotic phosphorylation histone h3 spatio temporal regulation mammalian aurora kinases mol cell biol 22 874 885abstractfree full text otat sutos katayamah hanz b suzukif maedam taninom teraday tatsukam 2002 increased mitotic phosphorylation histone h3 attributable aim 1aurora b overexpression contributes chromosome number instability cancer res 62 5168 5177abstractfree full text stockrp bialyh 2003 sigmoidal curve cancer nature biotech 21 13 14crossrefisimedline grunsteinm 1997 histone acetylation chromatin structure transcription nature 389 349 352crossrefisimedline dhalluinc carlsonje zengl hec aggarwalak zhoumm 1999 structure ligand histone acetyltransferase bromodomain nature 399 491 496crossrefisimedline jacobssa khorasanizadehs 2002 structure hp1 chromodomain bound lysine 9 methylated histone h3 tail science 295 2080 2083abstractfree full text received april 15 2004 revised june 2 2004 accepted june 6 2004
0.5670807.15178678.html.plaintext.txt	0	inhibiting s100b restores p53 levels primary malignant melanoma cancer cells jing lin qingyuan yang zhe yan joseph markowitz paul wilder france carrier david j weber
0.5670807.15178678.html.plaintext.txt	1	inhibiting s100b restores p53 levels primary malignant melanoma cancer cells jing lin qingyuan yang zhe yan joseph markowitz paul wilder france carrier david j weber
0.5670807.15178678.html.plaintext.txt	2	department biochemistry molecular biology university maryland school medicine baltimore maryland 21201
0.5670807.15178678.html.plaintext.txt	3	received publication may 14 2004 revised form june 2 2004
0.5670807.15178678.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references s100 calcium binding proteins s100b elevated primary malignant melanoma used markers numerous cancers wild type p53 protein levels relatively low cancer cells ie compared cells without s100b elevated rna antisense s100b introduced result implicates s100b regulation p53 consistent large decreases p53 protein levels observed previously transient co transfections p53 s100b lin j blake m tang c zimmer d rustandi r r weber d j carrier f 2001 j biol chem 276 35037 35041 regulation p53 primary malignant melanoma cells likely result direct interaction s100b observed co immunoprecipitation experiments furthermore p53 binds regions s100b promoter one matches 20 nucleotide p53 binding consensus dna sequence perfectly therefore p53 levels increase contributes demise regulating transcription s100b part negative feedback loop analogous found another protein regulates p53 namely hdm2 human double mutant 2
0.5670807.15178678.html.plaintext.txt	5	abstract top abstract introduction experimental procedures results discussion references s100 calcium binding proteins s100b elevated primary malignant melanoma used markers numerous cancers wild type p53 protein levels relatively low cancer cells ie compared cells without s100b elevated rna antisense s100b introduced result implicates s100b regulation p53 consistent large decreases p53 protein levels observed previously transient co transfections p53 s100b lin j blake m tang c zimmer d rustandi r r weber d j carrier f 2001 j biol chem 276 35037 35041 regulation p53 primary malignant melanoma cells likely result direct interaction s100b observed co immunoprecipitation experiments furthermore p53 binds regions s100b promoter one matches 20 nucleotide p53 binding consensus dna sequence perfectly therefore p53 levels increase contributes demise regulating transcription s100b part negative feedback loop analogous found another protein regulates p53 namely hdm2 human double mutant 2
0.5670807.15178678.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references tumor suppressor p53 transcription activator signals cell cycle arrest apoptosis plays pivotal role maintenance regulation normal cellular functions 1 2 inactivation affects cell cycle checkpoints apoptosis gene amplification centrosome duplication ploidy 2 9 p53 inactivated mutation found 50 human cancers cell cycle proceeds unregulated cell growth proliferates likewise apoptosis pathways induced proliferating cells transform cancerous ones 3 10 hand p53 levels high phenotypes associated aging particularly associated problems skin bone observed 11 reasons important p53 protein levels highly regulated achieved post translational modifications interactions proteins inside cell 5 12 15 interactions p53 members s100 family calcium binding proteins ie s100b particularly intriguing link p53 biology calcium mediated signal transduction pathways
0.5670807.15178678.html.plaintext.txt	7	introduction top abstract introduction experimental procedures results discussion references tumor suppressor p53 transcription activator signals cell cycle arrest apoptosis plays pivotal role maintenance regulation normal cellular functions 1 2 inactivation affects cell cycle checkpoints apoptosis gene amplification centrosome duplication ploidy 2 9 p53 inactivated mutation found 50 human cancers cell cycle proceeds unregulated cell growth proliferates likewise apoptosis pathways induced proliferating cells transform cancerous ones 3 10 hand p53 levels high phenotypes associated aging particularly associated problems skin bone observed 11 reasons important p53 protein levels highly regulated achieved post translational modifications interactions proteins inside cell 5 12 15 interactions p53 members s100 family calcium binding proteins ie s100b particularly intriguing link p53 biology calcium mediated signal transduction pathways
0.5670807.15178678.html.plaintext.txt	8	20 members s100 family ef hand ca2 binding proteins widely distributed human tissue 16 18 s100 proteins given name soluble 100 saturated ammonium sulfate 19 one member s100b 215 kda symmetric homodimer highly conserved 95 among mammals 16 19 manner similar calmodulin ca2 dependent conformational change required s100b bind target proteins p53 20 21 although completely clear s100 proteins affect cell growth s100b several s100 proteins ie s100a1 mts1 interact tumor suppressor protein p53 resulting significantly reduced p53 levels p53 dependent transcription activation target genes inhibited 22 24 primary malignant melanoma cancer cells report s100b interacts directly p53 inhibiting s100b sirna restores functional p53 protein data support notion higher normal levels s100b found malignant melanoma likely contributing tumor progression excessive regulation p53 tumor suppressor protein
0.5670807.15178678.html.plaintext.txt	9	20 members s100 family ef hand ca2 binding proteins widely distributed human tissue 16 18 s100 proteins given name soluble 100 saturated ammonium sulfate 19 one member s100b 215 kda symmetric homodimer highly conserved 95 among mammals 16 19 manner similar calmodulin ca2 dependent conformational change required s100b bind target proteins p53 20 21 although completely clear s100 proteins affect cell growth s100b several s100 proteins ie s100a1 mts1 interact tumor suppressor protein p53 resulting significantly reduced p53 levels p53 dependent transcription activation target genes inhibited 22 24 primary malignant melanoma cancer cells report s100b interacts directly p53 inhibiting s100b sirna restores functional p53 protein data support notion higher normal levels s100b found malignant melanoma likely contributing tumor progression excessive regulation p53 tumor suppressor protein
0.5670807.15178678.html.plaintext.txt	10	experimental procedures top abstract introduction experimental procedures results discussion references cells cell treatments primary human melanoma c8146a cells obtained dr frank l meyskens university california irvine ca cells grown f 10 media invitrogen containing 10 fetal bovine serum human glioblastoma u118 mg cells purchased american type culture collection manassas va grown dulbeccos modified eagles media invitrogen containing 10 fetal bovine serum melanoma cell lines purchased division cancer treatment diagnosis nci frederick national institutes health frederick md grown rpmi 1640 invitrogen containing 10 fetal calf serum human large cell lung carcinoma h1299 cells grown rpmi 1640 containing 10 fetal bovine serum human colorectal carcinoma cell line rko provided al fornace jr nci national institutes health bethesda md cells grown rpmi 1640 containing 10 fetal bovine serum uv source philips 30 watt germicidal lamp intensities uv lamp determined uvx radiometer uvp inc upland ca
0.5670807.15178678.html.plaintext.txt	11	chloramphenicol acetyltransferase cat assays fragment s100b promoter nucleotides nt1 1 3080 genbanktm numbering containing seven consensus p53 binding sites prs100b 1 prs100b 72 three shorter fragments nt 1435 3080 containing prs100b 2 prs100b 7 nt 1679 3080 containing prs100b 3 prs100b 7 nt 1744 3080 containing prs100b 4 prs100b 7 human s100b promoter genbanktm accession number m59486 genbank amplified pcr pgbs 4437 plasmid linda van eldik northwestern university chicago il containing full length human s100b promoter 25 four pcr products inserted kpni xhoi sites pcat3 basic vector promega madison wi used transient transfection cat reporter gene construct containing five gadd45 p53 binding sites p53rex provided al fornace jr nci national institutes health expression vectors used study p53 gadd153 described previously 23 plasmids transiently transfected h1299 cells cat assay performed described previously 23 exception 50 microg s100b promoter 05 microg gadd45 p53 binding site cellular extracts used assay transcription activation s100b promoter endogenous p53 without uv treatment cat assay performed exception p53 plasmid co transfected 25 microg s100b promoter 25 microg gadd45 p53 binding site cellular extracts used assay levels cat activity evaluated phosphorimager amersham biosciences using imagequant software percentage relative errors 15 experiment done quadruplicate
0.5670807.15178678.html.plaintext.txt	12	chloramphenicol acetyltransferase cat assays fragment s100b promoter nucleotides nt1 1 3080 genbanktm numbering containing seven consensus p53 binding sites prs100b 1 prs100b 72 three shorter fragments nt 1435 3080 containing prs100b 2 prs100b 7 nt 1679 3080 containing prs100b 3 prs100b 7 nt 1744 3080 containing prs100b 4 prs100b 7 human s100b promoter genbanktm accession number m59486 genbank amplified pcr pgbs 4437 plasmid linda van eldik northwestern university chicago il containing full length human s100b promoter 25 four pcr products inserted kpni xhoi sites pcat3 basic vector promega madison wi used transient transfection cat reporter gene construct containing five gadd45 p53 binding sites p53rex provided al fornace jr nci national institutes health expression vectors used study p53 gadd153 described previously 23 plasmids transiently transfected h1299 cells cat assay performed described previously 23 exception 50 microg s100b promoter 05 microg gadd45 p53 binding site cellular extracts used assay transcription activation s100b promoter endogenous p53 without uv treatment cat assay performed exception p53 plasmid co transfected 25 microg s100b promoter 25 microg gadd45 p53 binding site cellular extracts used assay levels cat activity evaluated phosphorimager amersham biosciences using imagequant software percentage relative errors 15 experiment done quadruplicate
0.5670807.15178678.html.plaintext.txt	13	small interference rna sirna 2 nt double stranded rna synthesized ambion austin tx standard purification sequence 5 ggaauucauggccuuuguu 3 corresponds s100b c terminal end nt 216 234 plus two dt 3 overhang region s100b chosen region sequence homologous s100 proteins thus specific s100b scramble sirna bought ambion silencer negative control number 1 sirna catalog number 4611 different concentrations sirna 2 20 nm transfected c8146a melanoma cells using ambion siport lipid transfection agent according manufacturers recommendation cells harvested 48 h later analyzed western blots see
0.5670807.15178678.html.plaintext.txt	14	small interference rna sirna 2 nt double stranded rna synthesized ambion austin tx standard purification sequence 5 ggaauucauggccuuuguu 3 corresponds s100b c terminal end nt 216 234 plus two dt 3 overhang region s100b chosen region sequence homologous s100 proteins thus specific s100b scramble sirna bought ambion silencer negative control number 1 sirna catalog number 4611 different concentrations sirna 2 20 nm transfected c8146a melanoma cells using ambion siport lipid transfection agent according manufacturers recommendation cells harvested 48 h later analyzed western blots see
0.5670807.15178678.html.plaintext.txt	15	western blots western blot analyses performed described previously 23 100 microg c8146a protein extracts 100 microg u118mg protein extracts cells lysed radioimmune precipitation assay buffer 50 mm tris hcl ph 75 150 mm nacl 1 non ionic detergent p 40 05 sodium deoxycholate 01 sds 1 mm phenylmethylsulfonyl fluoride 2 microgml leupeptin 5 mm dithiothreitol proteins run 12 polyacrylamide gel transferred onto nitrocellulose reacted either p53 mouse monoclonal antibody 1 oncogene research products boston ma 11000 dilution s100b rabbit polyclonal antibody research diagnostics inc flanders nj 11000 dilution p21 rabbit monoclonal antibody zymed laboratories inc 1100 bcl 2 mouse monoclonal antibody oncogene research products 1100 dilution mdm2 mouse monoclonal antibody oncogene research products 1100 dilution actin mouse monoclonal antibody oncogene research products 15000 dilution control even protein loading blots reacted respective secondary antibodies conjugated horseradish peroxidase reacted chemiluminescence substrate ecl amersham biosciences recommended manufacturer recombinant s100b protein produced purified homogeneity described previously 23 26
0.5670807.15178678.html.plaintext.txt	16	western blots western blot analyses performed described previously 23 100 microg c8146a protein extracts 100 microg u118mg protein extracts cells lysed radioimmune precipitation assay buffer 50 mm tris hcl ph 75 150 mm nacl 1 non ionic detergent p 40 05 sodium deoxycholate 01 sds 1 mm phenylmethylsulfonyl fluoride 2 microgml leupeptin 5 mm dithiothreitol proteins run 12 polyacrylamide gel transferred onto nitrocellulose reacted either p53 mouse monoclonal antibody 1 oncogene research products boston ma 11000 dilution s100b rabbit polyclonal antibody research diagnostics inc flanders nj 11000 dilution p21 rabbit monoclonal antibody zymed laboratories inc 1100 bcl 2 mouse monoclonal antibody oncogene research products 1100 dilution mdm2 mouse monoclonal antibody oncogene research products 1100 dilution actin mouse monoclonal antibody oncogene research products 15000 dilution control even protein loading blots reacted respective secondary antibodies conjugated horseradish peroxidase reacted chemiluminescence substrate ecl amersham biosciences recommended manufacturer recombinant s100b protein produced purified homogeneity described previously 23 26
0.5670807.15178678.html.plaintext.txt	17	co immunoprecipitation c8146a primary malignant melanoma cells harvested washed twice ice cold pbs cell pellets lysed 2 h lysis buffer 50 mm tris hcl ph 75 150 mm nacl 2 mm cacl2 1 mm phenylmethylsulfonyl fluoride 2 microgml leupeptin 05 nonidet p 40 centrifuged 15000 rpm supernatants 1 mg incubated either p53 antibody 1 cross linked agarose beads oncogene research products s100b antibody 2 h 4 degrees c myc mouse monoclonal antibody cross linked agarose bead oncogene research products rabbit polyclonal antibody santa cruz biotechnology used negative controls ie non related antibodies protein agarose beads 50 microl oncogene research products added antibody cell extract mixture reactions mixed gently overnight 4 degrees c beads spun washed six times lysis buffer without detergent loaded 12 polyacrylamide gel sds page samples transferred nitrocellulose membrane incubated control antibody s100b antibody p53 antibody described peroxidase conjugated secondary antibody cross react igg heavy chain jackson immunoresearch west grove pa used detect p53 co immunoprecipitated s100b antibody
0.5670807.15178678.html.plaintext.txt	18	co immunoprecipitation c8146a primary malignant melanoma cells harvested washed twice ice cold pbs cell pellets lysed 2 h lysis buffer 50 mm tris hcl ph 75 150 mm nacl 2 mm cacl2 1 mm phenylmethylsulfonyl fluoride 2 microgml leupeptin 05 nonidet p 40 centrifuged 15000 rpm supernatants 1 mg incubated either p53 antibody 1 cross linked agarose beads oncogene research products s100b antibody 2 h 4 degrees c myc mouse monoclonal antibody cross linked agarose bead oncogene research products rabbit polyclonal antibody santa cruz biotechnology used negative controls ie non related antibodies protein agarose beads 50 microl oncogene research products added antibody cell extract mixture reactions mixed gently overnight 4 degrees c beads spun washed six times lysis buffer without detergent loaded 12 polyacrylamide gel sds page samples transferred nitrocellulose membrane incubated control antibody s100b antibody p53 antibody described peroxidase conjugated secondary antibody cross react igg heavy chain jackson immunoresearch west grove pa used detect p53 co immunoprecipitated s100b antibody
0.5670807.15178678.html.plaintext.txt	19	mobility shift assay electrophoretic mobility shift assay performed essentially described previously 27 exception salmon sperm dna 1 microg purified recombinant p53 used baculovirus expressed p53 obtained proteomics inc baltimore md baculovirus expressed p53 used 06 3 microg binding gadd45 s100b oligonucleotides respectively probes purified reverse phase high pressure liquid chromatography vydac c 4 labeled t4 polynucleotide kinase new england biolabs described previously 27 oligonucleotide sequences s100b promoter matching 20 termed prs100b 3 17 termed prs100b 1 16 termed prs100b 2 nucleotides 20 nucleotide consensus p53 binding site see footnote 2 sense 5 gcc tgg gca agc tct gtg ctt cac aga gca agc ctg tgt 3 sense 5 gtt ctg gga ctt tca cta aac ttc tcc tac cat 3 sense 5 cag agg gca ggc ccg gct ggg ccc tcc tgc tga 3
0.5670807.15178678.html.plaintext.txt	20	mobility shift assay electrophoretic mobility shift assay performed essentially described previously 27 exception salmon sperm dna 1 microg purified recombinant p53 used baculovirus expressed p53 obtained proteomics inc baltimore md baculovirus expressed p53 used 06 3 microg binding gadd45 s100b oligonucleotides respectively probes purified reverse phase high pressure liquid chromatography vydac c 4 labeled t4 polynucleotide kinase new england biolabs described previously 27 oligonucleotide sequences s100b promoter matching 20 termed prs100b 3 17 termed prs100b 1 16 termed prs100b 2 nucleotides 20 nucleotide consensus p53 binding site see footnote 2 sense 5 gcc tgg gca agc tct gtg ctt cac aga gca agc ctg tgt 3 sense 5 gtt ctg gga ctt tca cta aac ttc tcc tac cat 3 sense 5 cag agg gca ggc ccg gct ggg ccc tcc tgc tga 3
0.5670807.15178678.html.plaintext.txt	21	results top abstract introduction experimental procedures results discussion references wild type s100b p53 protein levels primary malignant melanoma cells primary malignant c8146a melanoma cells relatively high levels s100b wild type p53 levels markedly lower cancer cells compared u118 cells little s100b fig 1a observation consistent found transient co transfections s100b p53 levels tumor suppressor protein significantly reduced addition s100b 100 fold 23 using increasing amounts purified recombinant s100b protein fig 1a lanes 3 6 estimated levels s100b melanoma c8146a cells least 50 times higher u118 cells fig 1a verify whether s100b p53 correlation specific c8146a cells could found melanoma cells performed western blots analysis five melanoma cell lines known p53 wild type genotype 28 data shown fig 1b indicate cells relatively low s100b levels ie lox im vi uacc 62 sk mel 5 higher levels p53 whereas uacc 2571 c8146a malme 3m cells s100b levels relatively high p53 levels lower compared melanoma lines indicates s100b p53 correlation ie high s100blow p53 levels consistent least six melanoma cell lines
0.5670807.15178678.html.plaintext.txt	22	view larger version 19k fig 1 s100b wild type p53 levels several cancer cell lines western blots p53 s100b human primary malignant melanoma cells c8146a lane 1 control cells little s100b glioblastoma u118 lane 2 actin levels shown loading controls shown also blots purified recombinant s100b used estimate amount s100b cancer cells lanes 3 6 b western blots p53 s100b six melanoma cell lines wild type p53 genotype 28 actin levels shown loading controls c ratio p53 s100b six cell lines shown corresponding lane numbers 1 6 panel b bar labeled asterisk lox mm cell line scale p53 s100b ratio 118 plus minus 28 together data illustrate skin cancer cells higher s100b protein levels diminished levels wild type p53
0.5670807.15178678.html.plaintext.txt	23	determine whether s100b contributes directly lowering p53 levels melanoma cancer cells sirna corresponding c terminus s100b sirnas100b introduced primary c8146a melanoma cells compared results scrambled sirna interfere s100b production fig 2 addition s100b antisense rna lowered s100b levels 24 plus minus 03 fold correspondingly increases p53 levels 25 plus minus 03 fold observed fig 2 20 nm sirnas100b likewise levels p21 protein bcl 2 hdm2 ie genes activated p53 also regulated comparable amounts addition sirna s100b p53 levels elevated fig 2 results antisense rna indicate s100b contributes directly regulation functional p53 inside primary malignant melanoma cancer cells inhibiting s100b protein production sirnas100b restores active p53
0.5670807.15178678.html.plaintext.txt	24	view larger version 34k fig 2 small interfering rna directed toward s100b sirnas100b restores functional p53 western blot analyses s100b p53 p21 bcl 2 hdm2 actin controls transfection melanoma scrambled sirna sirnas100b densitometry used determine intensities blots fold changes protein levels calculated comparing blots sirnas100b normalization actin corresponding blots concentration scrambled sirna cells harvested 48 h transfection
0.5670807.15178678.html.plaintext.txt	25	s100b interacts p53 malignant melanoma numerous studies characterized high affinity ca2 dependent interaction s100b p53 vitro 20 21 29 31 however critically important determine whether s100b p53 interact directly inside cells co immunoprecipitation s100b p53 complex monitored c8416 melanoma cells fig 3 data fig 3 indicate addition immunoprecipitation s100b s100b antibody co immunoprecipitate p53 lane 1 reciprocal immunoprecipitation experiment performed p53 antibody lane 2 confirmed formation complex p53 s100b primary malignant melanoma c8416 cells control shown nonspecific antibodies isotype could immunoprecipitate p53 lane 3 s100b lane 4 therefore likely direct interaction s100b p53 proteins contributes decreased levels tumor suppressor p53 melanoma elevated s100b
0.5670807.15178678.html.plaintext.txt	26	s100b interacts p53 malignant melanoma numerous studies characterized high affinity ca2 dependent interaction s100b p53 vitro 20 21 29 31 however critically important determine whether s100b p53 interact directly inside cells co immunoprecipitation s100b p53 complex monitored c8416 melanoma cells fig 3 data fig 3 indicate addition immunoprecipitation s100b s100b antibody co immunoprecipitate p53 lane 1 reciprocal immunoprecipitation experiment performed p53 antibody lane 2 confirmed formation complex p53 s100b primary malignant melanoma c8416 cells control shown nonspecific antibodies isotype could immunoprecipitate p53 lane 3 s100b lane 4 therefore likely direct interaction s100b p53 proteins contributes decreased levels tumor suppressor p53 melanoma elevated s100b
0.5670807.15178678.html.plaintext.txt	27	view larger version 59k fig 3 interaction s100b p53 human primary malignant melanoma cancer cells detected co immunoprecipitation ip experiments p53 antibody co immunoprecipitates s100b top reciprocal experiment s100b antibody indicates s100b antibody co immunoprecipitates p53 s100b bottom myc mouse monoclonal antibody rabbit polyclonal antibody used negative controls p53 s100b respectively
0.5670807.15178678.html.plaintext.txt	28	regions s100b promoter bind p53 p53 protein levels rise transcription number genes involved cell cycle apoptosis activated part feedback loop p53 also regulates transcription hdm2 mdm2 mice protein involved ubiquitin dependent degradation p53 7 32 33 situation analogous hdm2 promoter s100b seven regions promoter named prs100b 1 prs100b 7 correspond consensus sequence p53 binding2 fact one dna sequence prs100b 3 matches perfectly 20 nucleotide p53 binding consensus sequence 2020 nucleotide match2
0.5670807.15178678.html.plaintext.txt	29	regions s100b promoter bind p53 p53 protein levels rise transcription number genes involved cell cycle apoptosis activated part feedback loop p53 also regulates transcription hdm2 mdm2 mice protein involved ubiquitin dependent degradation p53 7 32 33 situation analogous hdm2 promoter s100b seven regions promoter named prs100b 1 prs100b 7 correspond consensus sequence p53 binding2 fact one dna sequence prs100b 3 matches perfectly 20 nucleotide p53 binding consensus sequence 2020 nucleotide match2
0.5670807.15178678.html.plaintext.txt	30	mobility shift assays fig 4 performed purified p53 determine whether sequences promoter s100b prs100b 1 prs100b 2 prs100b 3 bona fide p53 binding sites using p53 regulatory sequence gadd45 p53 downstream effector gene 34 positive control data shown fig 4 indicate complex slower mobility generated gadd45 prs100b 3 probes fig 4 lanes 2 5 respectively moreover bands super shifted p53 antibody fig 4 lanes 3 6 respectively thus represent genuine p53 complexes however despite fact prs100b 3 sequence matches consensus sequence perfectly five times protein dna necessary generate protein dna complex prs100b 3 promoter sequence compared data gadd45 sequence fig 4 separate experiment equal concentrations protein dna used band shift assays intensity super shifted dna band measured densitometry 65 plus minus 08 fold lower prs100b 3 promoter sequence gadd45 dna may due fact two variants consensus sequence gadd45 sequence preferred prs100b 3 sequence fig 4 another difference p53 binding sites length intervening dna sequence links two 10 nucleotide stretches dna interact p53 11 nt prs100b 3 versus 0 nt gadd45 fig 4 similar data obtained two p53 consensus sites s100b promoter nt 149 169 prs100b 1 nt 1455 1478 prs100b 2 however sites lower affinity p53 2020 sequence prs100b 3 data shown together data suggest regulation s100b transcription p53 would occur genes higher affinity p53 sites promoters occupied
0.5670807.15178678.html.plaintext.txt	31	view larger version 65k fig 4 mobility shift assays purified p53 bound dna derived third intron gadd45 lanes 1 3 region s100b promoter prs100b 3 2020 match lanes 4 6 free probe p53 shifted p53 antibody p53ab super shifted bands indicated baculovirus expressed p53 used 06 3 microg binding gadd45 s100b oligonucleotides respectively
0.5670807.15178678.html.plaintext.txt	32	transcription activated p53 binds regions s100b promoter full length s100b promoter contains seven p53 binding sites nt 1 3080 prs100b 1 prs100b 72 three shorter constructs containing six sites nt 1435 3080 prs100b 2 prs100b 7 five sites nt 1679 3080 prs100b 3 prs100b 7 four consensus p53 binding sites nt 1744 3080 prs100b 4 prs100b 7 respectively also cloned cat reporter gene construct determine whether p53 affects s100b transcription transient transfections performed p53 null cells h1299 p53 indicated s100b promoter construct activated p53 dependent manner fig 5 lanes 8 11 likewise found endogenous wild type p53 rko cells 34 p53 could also activate s100b promoter constructs uv treatment amplified transcription activation activity found genes activated p53 fig 6 however likely negative regulatory elements exist s100b promoter affect p53 dependent transcription activation s100b cutting s100b promoter back make smaller constructs found increase amount p53 dependent transcription activation cell lines figs 5 6 results surprising however previous studies s100b promoter indicate overall regulation s100 gene complex often cell type specific involves multiple positive negatively regulatory elements 25
0.5670807.15178678.html.plaintext.txt	33	transcription activated p53 binds regions s100b promoter full length s100b promoter contains seven p53 binding sites nt 1 3080 prs100b 1 prs100b 72 three shorter constructs containing six sites nt 1435 3080 prs100b 2 prs100b 7 five sites nt 1679 3080 prs100b 3 prs100b 7 four consensus p53 binding sites nt 1744 3080 prs100b 4 prs100b 7 respectively also cloned cat reporter gene construct determine whether p53 affects s100b transcription transient transfections performed p53 null cells h1299 p53 indicated s100b promoter construct activated p53 dependent manner fig 5 lanes 8 11 likewise found endogenous wild type p53 rko cells 34 p53 could also activate s100b promoter constructs uv treatment amplified transcription activation activity found genes activated p53 fig 6 however likely negative regulatory elements exist s100b promoter affect p53 dependent transcription activation s100b cutting s100b promoter back make smaller constructs found increase amount p53 dependent transcription activation cell lines figs 5 6 results surprising however previous studies s100b promoter indicate overall regulation s100 gene complex often cell type specific involves multiple positive negatively regulatory elements 25
0.5670807.15178678.html.plaintext.txt	34	view larger version 28k fig 5 transcription activation s100b promoter cells h1299 p53 gene eliminated p53 lanes 1 6 controls s100b dna constructstransfections absence p53 lane 7 control transfection p53 absence s100b promoter construct lane 8 co transfection p53 full length s100b promoter transcription activation p53 measured cat activity full length s100b promoter s100b 7p53 includes seven p53 binding sites nt 1 3080 prs100b 1 prs100b 7 lane 9 p53 transcription activation promoter construct s100b six seven p53 binding sites s100b 6p53 nt 1435 3080 prs100b 2 prs100b 7 lane 10 p53 transcription activation s100b promoter construct five seven p53 binding sites nt 1679 3080 prs100b 3 prs100 7 construct still retains prs100b 3 sequence 20 20 nucleotides matching p53 consensus sequence lane 11 p53 transcription activation remainder s100b promoter s100b 4p53 nt 1744 3080 prs100b 4 prs100b 7 four seven consensus p53 binding sites lane 12 positive control showing p53 transcription activation well characterized p53 regulated gene gadd45 lane 13 negative control cat activation expression vector unrelated protein gadd153 s100b cat assays performed 50 microg cell extract whereas control cat assay gadd45 construct performed 05 microg cell extract b bar graph illustrating relative cat activity construct lanes 1 13 panel bar labeled 129 lane 12 scale cat activity 129 plus minus 12 relative percentage conversion
0.5670807.15178678.html.plaintext.txt	35	view larger version 27k fig 6 transcription activation s100b promoter endogenous wild type tumor suppressor protein p53 rko cells without uv treatment western blots p53 s100b human colorectal carcinoma cell line rko uv treatment actin used loading control b lanes 1 7 controls treated uv radiation include following rko cell without transfected construct lane 1 control absence s100b promoter construct lane 2 transcription activation endogenous p53 measured cat activity full length s100b promoter s100b 7p53 includes seven p53 binding sites nt 1 3080 prs100b 1 prs100b 7 lane 3 p53 transcription activation promoter construct s100b six p53 binding sites s100b 6p53 nt 1435 3080 prs100b 2 prs100b 7 lane 4 p53 transcription activation promoter construct s100b five p53 binding sites nt 1679 3080 prs100b 3 prs100 7 lane 5 p53 transcription activation s100b promoter construct nt 1744 3080 prs100b 4 prs100b 7 containing four seven consensus p53 binding sites lane 6 positive control showing p53 transcription activation well characterized p53 regulated gene gadd45 lane 7 lanes 8 14 lanes 1 7 except uv treatment also applied described experimental procedures s100b cat assays performed 25 microg cell extract whereas gadd45 assay performed 25 microg cell extract c bar graph relative cat activity construct lanes 1 14 panel bars labeled numbers 173 404 lanes 7 14 scale cat activities 173 plus minus 11 404 plus minus 21 relative percentage conversions respectively
0.5670807.15178678.html.plaintext.txt	36	band shift assay fig 4 found reporter gene construct containing p53 binding sites gadd45 gene sequence efficiently activated s100b promoter even 10 times less protein extract used cat activity generated gadd45 reporter gene construct higher levels obtained highest s100b activity fig 6 taken together dna binding transcription activation activity assays consistent suggest p53 activate transcription s100b gene tumor suppressor protein levels relatively high compared p53 levels needed activate genes gadd45
0.5670807.15178678.html.plaintext.txt	37	band shift assay fig 4 found reporter gene construct containing p53 binding sites gadd45 gene sequence efficiently activated s100b promoter even 10 times less protein extract used cat activity generated gadd45 reporter gene construct higher levels obtained highest s100b activity fig 6 taken together dna binding transcription activation activity assays consistent suggest p53 activate transcription s100b gene tumor suppressor protein levels relatively high compared p53 levels needed activate genes gadd45
0.5670807.15178678.html.plaintext.txt	38	discussion top abstract introduction experimental procedures results discussion references active form subunit tetrameric p53 binds zn2 contains sandwich two antiparallel sheets serve scaffold loop sheet helix dna binding domain 35 cells stress ie uv radiation dna damage etc elevated levels p53 bind specific dna sequences activate transcription downstream targets including cyclin dependent kinase inhibitor p21wafcip1 cell cycle control proteins cyclin g gadd45 genes involved apoptosis ie bcl2 eventually proteins s100b hdm2 turn negatively regulate p53 protein levels inside cell via feedback control 1 2 32 fig 7 scheme presented p53 regulated hdm2 s100b part feedback control ensure p53 levels get elevated excessive levels
0.5670807.15178678.html.plaintext.txt	39	discussion top abstract introduction experimental procedures results discussion references active form subunit tetrameric p53 binds zn2 contains sandwich two antiparallel sheets serve scaffold loop sheet helix dna binding domain 35 cells stress ie uv radiation dna damage etc elevated levels p53 bind specific dna sequences activate transcription downstream targets including cyclin dependent kinase inhibitor p21wafcip1 cell cycle control proteins cyclin g gadd45 genes involved apoptosis ie bcl2 eventually proteins s100b hdm2 turn negatively regulate p53 protein levels inside cell via feedback control 1 2 32 fig 7 scheme presented p53 regulated hdm2 s100b part feedback control ensure p53 levels get elevated excessive levels
0.5670807.15178678.html.plaintext.txt	40	view larger version 21k fig 7 scheme regulation wild type p53 p53 activated upon dna damage stress regulates transcription genes involved apoptosis ie bax etc cell cycle dependent growth arrest ie p21 etc part feedback control mechanism p53 also regulates transcription genes involved inactivation ie hdm2 s100b part cell growth response ca2 ca2 dependent interaction s100b p53 induces conformational change p53 tetramer dissociation tumor suppressor 29 likely contributes degradation ie perhaps involving hdm2ubiquitin andor protease dependent pathways thus regulation p53 s100b hdm2 ultimately facilitates cell growth atm ataxia telangiectasia mutated kinase atr atm rad 3 related kinase p14arf alternative reading frame human
0.5670807.15178678.html.plaintext.txt	41	s100b affinity p53 promoter regions relatively low figs 4 5 6 suggests regulation s100b p53 would occur higher affinity promoter sites occupied ie gadd45 idea supported p53 transcription activation assays performed shorter constructs s100b promoter figs 5 6 indicates additional negative regulatory elements exist full length promoter reduce p53 dependent transcription activation s100b gene specifically levels p53 protein necessary activate transcription s100b numerous genes ie gadd45 p21 etc already transcribed course scenario one might expect regulation gene s100b involved feedback loop ultimately leads lowering levels functional p53
0.5670807.15178678.html.plaintext.txt	42	s100b affinity p53 promoter regions relatively low figs 4 5 6 suggests regulation s100b p53 would occur higher affinity promoter sites occupied ie gadd45 idea supported p53 transcription activation assays performed shorter constructs s100b promoter figs 5 6 indicates additional negative regulatory elements exist full length promoter reduce p53 dependent transcription activation s100b gene specifically levels p53 protein necessary activate transcription s100b numerous genes ie gadd45 p21 etc already transcribed course scenario one might expect regulation gene s100b involved feedback loop ultimately leads lowering levels functional p53
0.5670807.15178678.html.plaintext.txt	43	interestingly p53 also known regulate transcription another s100 protein s100a2 36 binding p53 binding consensus sequences found promoter3 furthermore several s100 proteins ie s100a1 s100a4 s100a9 consensus p53 binding sequences respective promoters3 likely several s100 proteins also regulated p53 however work needs done general conclusions made functional significance regulatory pathways involving p53 s100 family members
0.5670807.15178678.html.plaintext.txt	44	interestingly p53 also known regulate transcription another s100 protein s100a2 36 binding p53 binding consensus sequences found promoter3 furthermore several s100 proteins ie s100a1 s100a4 s100a9 consensus p53 binding sequences respective promoters3 likely several s100 proteins also regulated p53 however work needs done general conclusions made functional significance regulatory pathways involving p53 s100 family members
0.5670807.15178678.html.plaintext.txt	45	lowering p53 protein levels inside cells s100b observed fig 2 previously 23 likely related ability s100b bind directly p53 fig 3 dissociate p53 tetramer 29 andor cause conformational changes extreme c terminus tetramerization domains tumor suppressor 30 effects s100b may work synergistically hdm2 proteinpathways involved ubiquitin dependent degradation p53 37 although concept needs rigorously established nonetheless important distinction two negative regulatory proteins hdm2 versus s100b s100b interaction c terminus p53 ca2 dependent 21 links p53 biology calcium mediated signaling pathways extracellular growth responses whereas hdm2 binds n terminus p53 calcium independent manner regulated proteins ie p14arfsignaling pathways phosphorylation state p53 33 37 38 fig 7
0.5670807.15178678.html.plaintext.txt	46	lowering p53 protein levels inside cells s100b observed fig 2 previously 23 likely related ability s100b bind directly p53 fig 3 dissociate p53 tetramer 29 andor cause conformational changes extreme c terminus tetramerization domains tumor suppressor 30 effects s100b may work synergistically hdm2 proteinpathways involved ubiquitin dependent degradation p53 37 although concept needs rigorously established nonetheless important distinction two negative regulatory proteins hdm2 versus s100b s100b interaction c terminus p53 ca2 dependent 21 links p53 biology calcium mediated signaling pathways extracellular growth responses whereas hdm2 binds n terminus p53 calcium independent manner regulated proteins ie p14arfsignaling pathways phosphorylation state p53 33 37 38 fig 7
0.5670807.15178678.html.plaintext.txt	47	important understand cancer cells malignant melanoma proliferate even though wild type p53 one possible explanation paradigm elevated levels proteins negatively regulate p53 s100b may culprit specifically overall effect elevated s100b levels wild type p53 could mimic cellular aberrations gene amplification mutations encountered non functional mutants p53 specifically several melanomas wild type p53 higher normal levels s100b prognosis patients generally poorer lower s100b levels 39 41 primary skin cancer cells show direct interaction p53 s100b functional wild type p53 levels restored s100b levels lowered sirna fig 2 result directly implicates s100b regulation wild type p53 consistent large decreases p53 protein levels observed previously transient co transfections p53 s100b 23 results mind perhaps small molecule inhibitor binds s100b blocks s100b p53 interaction restores wild type p53 levels ie sirnas100b mimic could useful therapeutic strategies treatment cancers elevated s100b forms malignant melanoma glioma
0.5670807.15178678.html.plaintext.txt	48	important understand cancer cells malignant melanoma proliferate even though wild type p53 one possible explanation paradigm elevated levels proteins negatively regulate p53 s100b may culprit specifically overall effect elevated s100b levels wild type p53 could mimic cellular aberrations gene amplification mutations encountered non functional mutants p53 specifically several melanomas wild type p53 higher normal levels s100b prognosis patients generally poorer lower s100b levels 39 41 primary skin cancer cells show direct interaction p53 s100b functional wild type p53 levels restored s100b levels lowered sirna fig 2 result directly implicates s100b regulation wild type p53 consistent large decreases p53 protein levels observed previously transient co transfections p53 s100b 23 results mind perhaps small molecule inhibitor binds s100b blocks s100b p53 interaction restores wild type p53 levels ie sirnas100b mimic could useful therapeutic strategies treatment cancers elevated s100b forms malignant melanoma glioma
0.5670807.15178678.html.plaintext.txt	49	footnotes work supported national institutes health grant gm58888 d j w american cancer society grant rpg0004001 ccg d j w costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5670807.15178678.html.plaintext.txt	50	correspondence may addressed dept biochemistry molecular biology university maryland school medicine 108 n greene st baltimore md 21201 tel 410 706 5105 fax 410 706 8297 e mail fcarr001atumarylandedu u d correspondence may addressed tel 410 706 4354 fax 410 706 0458 e mail dweberatumarylandedu u d
0.5670807.15178678.html.plaintext.txt	51	correspondence may addressed dept biochemistry molecular biology university maryland school medicine 108 n greene st baltimore md 21201 tel 410 706 5105 fax 410 706 8297 e mail fcarr001atumarylandedu u d correspondence may addressed tel 410 706 4354 fax 410 706 0458 e mail dweberatumarylandedu u d
0.5670807.15178678.html.plaintext.txt	52	1 abbreviations used nt nucleotides cat chloramphenicol acetyltransferase hdm2 human double mutant 2 sirna small interference rna
0.5670807.15178678.html.plaintext.txt	53	2 regions s100b promoter similar match p53 binding consensus sequence 5 rrrcattagyyy 3 0 13 nt 5 rrrcattagyyy 3 listed nucleotides 1705 1735 s100b promoter termed prs100b 3 5 gggcaagctc 3 11 nt 5 gagcaagcct 3 match perfectly 2020 consensus nucleotide sequence p53 binding six additional p53 binding sites occur s100b promoter including following nucleotides 149 169 prs 100b 1 5 ggactttcac 3 1nt 5 aaacttctcc 3 2172 2292 prs100b 6 5 ggacacatctct 3 1nt 5 aggcatcgtc 3 match 17 nucleotides p53 consensus sequence 1720 nucleotides 1455 1478 prs100b 2 5 gggcaggccc 3 4 nt ggggcctcct 3 2795 2820 prs100b 7 5 cagcaagtcc 3 6nt 5 ctgcttggtc 3 match 16 nucleotides p53 consensus sequence 1620 nucleotides 1995 2021 prs100b 4 5 aaactgggtt 3 7 nt 5 ggacgtgatg 3 2115 2146 prs100b 5 5 attcttgtga 3 12 nt aaactggccc 3 match 15 sites 1520 p53 binding regions third intron gadd45 1920 match 5 gaacatgtct 3 0 nt 5 aagcatgctg 3 hdm2 promoter re1 1820 match 5 ggtcaagttc 3 0 nt 5 agacacgttc 3 re2 1720 match 5 agttaagtcc 3 0 nt 5 tgacttgtct 3 also listed comparison nucleotides shown lower case match consensus sequence
0.5670807.15178678.html.plaintext.txt	54	2 regions s100b promoter similar match p53 binding consensus sequence 5 rrrcattagyyy 3 0 13 nt 5 rrrcattagyyy 3 listed nucleotides 1705 1735 s100b promoter termed prs100b 3 5 gggcaagctc 3 11 nt 5 gagcaagcct 3 match perfectly 2020 consensus nucleotide sequence p53 binding six additional p53 binding sites occur s100b promoter including following nucleotides 149 169 prs 100b 1 5 ggactttcac 3 1nt 5 aaacttctcc 3 2172 2292 prs100b 6 5 ggacacatctct 3 1nt 5 aggcatcgtc 3 match 17 nucleotides p53 consensus sequence 1720 nucleotides 1455 1478 prs100b 2 5 gggcaggccc 3 4 nt ggggcctcct 3 2795 2820 prs100b 7 5 cagcaagtcc 3 6nt 5 ctgcttggtc 3 match 16 nucleotides p53 consensus sequence 1620 nucleotides 1995 2021 prs100b 4 5 aaactgggtt 3 7 nt 5 ggacgtgatg 3 2115 2146 prs100b 5 5 attcttgtga 3 12 nt aaactggccc 3 match 15 sites 1520 p53 binding regions third intron gadd45 1920 match 5 gaacatgtct 3 0 nt 5 aagcatgctg 3 hdm2 promoter re1 1820 match 5 ggtcaagttc 3 0 nt 5 agacacgttc 3 re2 1720 match 5 agttaagtcc 3 0 nt 5 tgacttgtct 3 also listed comparison nucleotides shown lower case match consensus sequence
0.5670807.15178678.html.plaintext.txt	55	3 region s100a2 promoter 2146 2126 genbanktm accession number y07755 genbank nearly matches p53 binding consensus sequence 1820 binds p53 activates p53 dependent transcription reporter gene 36 s100 proteins dna sequences promoters nearly match consensus p53 binding sequences include following s100a1 1520 1011 984 genbanktm accession number u26356 genbank s100a4 1520 x 3 129 107 453 426 680 658 1620 145 119 1720 1466 1437 genbanktm accession number u94663 genbank s100a9 1620 2488 2456 1720 327 322 1820 x 3 204 178 1092 1068 3171 3150 genbanktm accession number aj250496 genbank s100a7 genbanktm accession number af050167 genbank dna sequence promoter closely matches p53 binding consensus sequence promoters s100 protein family members yet available genbanktm nucleotide sequence database
0.5670807.15178678.html.plaintext.txt	56	3 region s100a2 promoter 2146 2126 genbanktm accession number y07755 genbank nearly matches p53 binding consensus sequence 1820 binds p53 activates p53 dependent transcription reporter gene 36 s100 proteins dna sequences promoters nearly match consensus p53 binding sequences include following s100a1 1520 1011 984 genbanktm accession number u26356 genbank s100a4 1520 x 3 129 107 453 426 680 658 1620 145 119 1720 1466 1437 genbanktm accession number u94663 genbank s100a9 1620 2488 2456 1720 327 322 1820 x 3 204 178 1092 1068 3171 3150 genbanktm accession number aj250496 genbank s100a7 genbanktm accession number af050167 genbank dna sequence promoter closely matches p53 binding consensus sequence promoters s100 protein family members yet available genbanktm nucleotide sequence database
0.5670807.15178678.html.plaintext.txt	57	references top abstract introduction experimental procedures results discussion references levine j momand j finlay c 1991 nature 351 453 456crossrefmedline order article via infotrieve levine j 1997 cell 88 323 331medline order article via infotrieve woods d b vousden k h 2001 exp cell res 264 56 66crossrefmedline order article via infotrieve burns f el deiry w 1999 j cell physiol 181 231 23933co2 c 2 vlinktypedoi crossrefmedline order article via infotrieve vousden k h 2000 cell 103 691 694medline order article via infotrieve ryan k m phillips c vousden k h 2001 curr opin cell biol 13 332 337crossrefmedline order article via infotrieve agarwal m l taylor w r chernov m v chernova o b stark g r 1998 j biol chem 273 1 4free full text tyner d venkatachalam choi j jones ghebranious n igelmann h lu x soron g cooper b brayton c hee park thompson karsenty g bradley donehower l 2002 nature 415 45 53crossrefmedline order article via infotrieve minamoto buschmann habelhah h matusevich e tahara h boerresen dale l harris c sidransky d ronai z 2001 oncogene 20 3341 3347crossrefmedline order article via infotrieve jayaraman l prives c 1999 cell mol life sci 55 76 87crossrefmedline order article via infotrieve jimenez g khan h stommel j m wahl g m 1999 oncogene 18 7656 7665crossrefmedline order article via infotrieve meek d w 1997 pathol biol 45 804 814medline order article via infotrieve zimmer d b cornwall e h landar song w 1995 brain res bull 37 417 429crossrefmedline order article via infotrieve donato r 2001 int j biochem cell biol 33 637 668crossrefmedline order article via infotrieve heizmann c w fritz g schafer b w 2002 front biosci 7 1356 1368 moore b 1965 biochem biophys res comm 19 739 744medline order article via infotrieve rustandi r r baldisseri d m weber d j 2000 nat struct biol 7 570 574crossrefmedline order article via infotrieve rustandi r r drohat c baldisseri d m wilder p weber d j 1998 biochemistry 37 1951 1960crossrefmedline order article via infotrieve grigorian m andresen tulchinsky e kriajevska m carlberg c kruse c cohn m ambartsumian n christensen selivanova g lukanidin e 2001 j biol chem 276 22699 22708abstractfree full text lin j blake m tang c zimmer d rustandi r r weber d j carrier f 2001 j biol chem 276 35037 35041abstractfree full text carrier f blake m zimmer d rustandi r r weber d j 1999 proc assoc cancer res 40 102 castets f griffin w marks van eldik l j 1997 brain res 46 208 216crossref amburgey j c abildgaard f starich m r shah hilt d c weber d j 1995 j biomol nmr 6 171 179medline order article via infotrieve carrier f bae smith m l ayers d m fornace j jr 1996mut res 352 79 86medline order article via infotrieve oconnor p m jackman j bae myers g fan mutoh m scudiero d monks sausville e weinstein j n friend fornace j jr kohn k 1997 cancer res 57 4285 4300abstract baudier j delphin c grunwald d khochbin lawrence j j 1992 proc natl acad sci u 89 11627 11631abstract rustandi r r baldisseri d m drohat c weber d j 1999 protein sci 8 1743 1751abstract weber d j rustandi r r carrier f zimmer d b 2000 molecular basis calcium action biology medicine pochet r ed pp 521 539 kluwer academic publishers dordrecht netherlands freedman d wu l levine j 1999 cell mol life sci 55 96 107crossrefmedline order article via infotrieve momand j wu h h dasgupta g 2000 gene 242 15 29crossrefmedline order article via infotrieve kastan m b zhan q el deiry w carrier f jacks walsh w v plunkett b vogelstein b fornace j jr 1992 cell 71 587 597medline order article via infotrieve cho y gorina jeffrey p d pavletich n p 1994 science 265 346 355medline order article via infotrieve tan m heizmann c w guan k schafer b w sun y 1999 febs lett 445 265 268crossrefmedline order article via infotrieve ashcroft m vousden k h 1999 oncogene 18 7637 7643crossrefmedline order article via infotrieve prives c 1998 cell 95 5 8medline order article via infotrieve cochran j lu h f li p x saxton r wen d r 1993 melanoma res 3 325 330medline order article via infotrieve boni r heizman c w doguoglu ilg e c schafer b w dummer r burg g 1997 j cutan pathol 24 76 80medline order article via infotrieve marks petsche d ohanlon d kwong p c stead r dunn r baumal r liao k 1990 exp cell res 187 59 64medline order article via infotrieve
0.5729515.15326223.html.plaintext.txt	0	transcriptional repression p53 promotes bcl 2 insensitive mitochondria independent pathway apoptosis nelly godefroy sylvina bouleau gaetan gruel1 flore renaud vincent rincheval bernard mignotte diana tronik le roux1 jean luc vayssiere
0.5729515.15326223.html.plaintext.txt	1	universite de versaillessaint quentin en yvelines fre 2445 laboratoire de genetique et biologie cellulaire ecole pratique des hautes etudes laboratoire de genetique moleculaire et physiologique 45 avenue des etats unis 78035 versailles cedex france 1 commissariat lenergie atomique cea laboratoire de genomique et radiobiologie de lhematopoiese service de genomique fonctionnelle 2 rue gaston cremieux 91057 evry france
0.5729515.15326223.html.plaintext.txt	2	correspondence addressed tel 33 1 39 25 36 60 fax 33 1 39 25 36 55 email vayssiereatgenetiqueuvsqfr
0.5729515.15326223.html.plaintext.txt	3	correspondence addressed tel 33 1 39 25 36 60 fax 33 1 39 25 36 55 email vayssiereatgenetiqueuvsqfr
0.5729515.15326223.html.plaintext.txt	4	received june 18 2004 revised accepted july 28 2004
0.5729515.15326223.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion conclusions references p53 induce apoptosis various ways including transactivation transrepression transcription independent mechanisms determines choice poorly understood rat embryo fibroblast model caspase inhibition changed outcome p53 activation standard bcl 2 regulated apoptosis caspase independent bcl 2 insensitive cell death phenomenon described previously show caspase inhibition affects cell death commitment decisions modulating apoptotic functions p53 indeed bcl 2 sensitive pathway transactivation dependent signalling activated leading rapid mdm2 mediated degradation p53 contrast bcl 2 insensitive pathway p53 stable associated transrepression dependent signalling study microarrays identified genes regulated p53 absence active caspases
0.5729515.15326223.html.plaintext.txt	6	abstract top abstract introduction materials methods results discussion conclusions references p53 induce apoptosis various ways including transactivation transrepression transcription independent mechanisms determines choice poorly understood rat embryo fibroblast model caspase inhibition changed outcome p53 activation standard bcl 2 regulated apoptosis caspase independent bcl 2 insensitive cell death phenomenon described previously show caspase inhibition affects cell death commitment decisions modulating apoptotic functions p53 indeed bcl 2 sensitive pathway transactivation dependent signalling activated leading rapid mdm2 mediated degradation p53 contrast bcl 2 insensitive pathway p53 stable associated transrepression dependent signalling study microarrays identified genes regulated p53 absence active caspases
0.5729515.15326223.html.plaintext.txt	7	introduction top abstract introduction materials methods results discussion conclusions references balance cell proliferation apoptosis crucial normal development tissue size homeostasis adult mammals one important links proliferation cell death machineries tumour suppressor protein p53 protein promotes cell cycle arrest apoptosis response dna damage strong oncogenic stimuli proliferation 1 p53 phosphoprotein pivotal suppressing cellular transformation tumorigenesis half human cancers p53 inactivated directly result mutations p53 gene many others inactivated indirectly binding viral proteins result alterations genes whose products interact p53 transmit information p53
0.5729515.15326223.html.plaintext.txt	8	introduction top abstract introduction materials methods results discussion conclusions references balance cell proliferation apoptosis crucial normal development tissue size homeostasis adult mammals one important links proliferation cell death machineries tumour suppressor protein p53 protein promotes cell cycle arrest apoptosis response dna damage strong oncogenic stimuli proliferation 1 p53 phosphoprotein pivotal suppressing cellular transformation tumorigenesis half human cancers p53 inactivated directly result mutations p53 gene many others inactivated indirectly binding viral proteins result alterations genes whose products interact p53 transmit information p53
0.5729515.15326223.html.plaintext.txt	9	amount p53 cells principally determined rate degraded sequence specific trancriptional induction mdm2 gene results product mdm2 binds p53 stimulates addition ubiquitin groups c terminus p53 ubiquitinated p53 detected degraded proteasome 2 normal cells p53 gene expression low stress conditions following dna damage post translational changes p53 mdm2 disrupt balance allow p53 activation p53 modified phosphorylation acetylation glycosylation addition ribose events regulate p53 function 1
0.5729515.15326223.html.plaintext.txt	10	amount p53 cells principally determined rate degraded sequence specific trancriptional induction mdm2 gene results product mdm2 binds p53 stimulates addition ubiquitin groups c terminus p53 ubiquitinated p53 detected degraded proteasome 2 normal cells p53 gene expression low stress conditions following dna damage post translational changes p53 mdm2 disrupt balance allow p53 activation p53 modified phosphorylation acetylation glycosylation addition ribose events regulate p53 function 1
0.5729515.15326223.html.plaintext.txt	11	p53 action transcriptional activator role forming tetramers bind dna sequence specific manner using highly conserved dna binding domain transcriptional targets p53 include genes implicated cell cycle regulation including p21 gadd45 14 3 3 34 p53 also induces transcription proapoptotic genes fas noxa killerdr5 bax leads caspase activation help death inducing signalling complex cell membrane level apoptosome mitochondrial level 5 7
0.5729515.15326223.html.plaintext.txt	12	p53 action transcriptional activator role forming tetramers bind dna sequence specific manner using highly conserved dna binding domain transcriptional targets p53 include genes implicated cell cycle regulation including p21 gadd45 14 3 3 34 p53 also induces transcription proapoptotic genes fas noxa killerdr5 bax leads caspase activation help death inducing signalling complex cell membrane level apoptosome mitochondrial level 5 7
0.5729515.15326223.html.plaintext.txt	13	many models transactivation function essential p53 dependent apoptosis 8 10 transrepression function may important 1112 indeed p53 represses transcription number genes including involved regulatory cascades mediating cell proliferation cyclin b rna polymerase apoptosis bcl 2 furthermore p53 mediated repression genes involved cytoskeleton organization stathmin map4 leading decrease microtubule polymerization participates cell cycle arrest apoptosis 13 contrast information available concerning p53 activator mechanism repression occurs less well documented 1415 due large part identified consensus p53 binding site within repressed promoters 1617 genes regulated p53 induced genes principally pro apoptotic repressed genes anti apoptotic important cell survival shown p53 lead transcription independent caspase activation 18 probably direct effect release apoptogenic molecules mitochondria 19 however physiological relevance apparently redundant pro apoptotic property determinism choice unknown
0.5729515.15326223.html.plaintext.txt	14	many models transactivation function essential p53 dependent apoptosis 8 10 transrepression function may important 1112 indeed p53 represses transcription number genes including involved regulatory cascades mediating cell proliferation cyclin b rna polymerase apoptosis bcl 2 furthermore p53 mediated repression genes involved cytoskeleton organization stathmin map4 leading decrease microtubule polymerization participates cell cycle arrest apoptosis 13 contrast information available concerning p53 activator mechanism repression occurs less well documented 1415 due large part identified consensus p53 binding site within repressed promoters 1617 genes regulated p53 induced genes principally pro apoptotic repressed genes anti apoptotic important cell survival shown p53 lead transcription independent caspase activation 18 probably direct effect release apoptogenic molecules mitochondria 19 however physiological relevance apparently redundant pro apoptotic property determinism choice unknown
0.5729515.15326223.html.plaintext.txt	15	previously shown large tumour lt inactivation leads p53 mediated apoptosis rat embryo fibroblasts eg retsaf cell line expressing temperature sensitive mutant tsa58 simian virus 40 sv40 lt antigen 2021 moreover whereas bcl 2 overexpression inhibits apoptosis caspase inhibition surprisingly accelerates apoptosis abolishes protective effect bcl 2 22 z val ala dl asp fluromethylketone zvad mediated caspase inhibition changed outcome p53 activation bcl 2 regulated apoptosis mitochondria caspase independent cell death phenomenon described previously 23
0.5729515.15326223.html.plaintext.txt	16	indeed even though clear today physiological cell death occur complete absence caspases cases apoptotic death without caspase activation reported often caspase independent cell death related paraptosis autophagy non lysosomal cell death 2425 moreover mitochondrial outer membrane permeabilization momp controlled bcl 2 family proteins resides heart several alternative death pathways whatever apoptotic necrotic feature therefore p53 induced cell death program presence zvad appears differ caspase independent alternative pathways one hand apoptosis like nature hand momp independent insensitive bcl 2 protection
0.5729515.15326223.html.plaintext.txt	17	indeed even though clear today physiological cell death occur complete absence caspases cases apoptotic death without caspase activation reported often caspase independent cell death related paraptosis autophagy non lysosomal cell death 2425 moreover mitochondrial outer membrane permeabilization momp controlled bcl 2 family proteins resides heart several alternative death pathways whatever apoptotic necrotic feature therefore p53 induced cell death program presence zvad appears differ caspase independent alternative pathways one hand apoptosis like nature hand momp independent insensitive bcl 2 protection
0.5729515.15326223.html.plaintext.txt	18	show zvad treatment affects cell death commitment decision modulating apoptotic functions p53 indeed absence caspase inhibitor p53 activation promotes bcl 2 sensitive apoptosis transactivation dependent signalling associated rapid mdm2 mediated degradation p53 contrast caspase inhibition triggers bcl 2 insensitive pathway involving stabilization p53 transrepression dependent signalling global study transcriptome led identification genes differentially regulated p53 according two signalling pathways
0.5729515.15326223.html.plaintext.txt	19	show zvad treatment affects cell death commitment decision modulating apoptotic functions p53 indeed absence caspase inhibitor p53 activation promotes bcl 2 sensitive apoptosis transactivation dependent signalling associated rapid mdm2 mediated degradation p53 contrast caspase inhibition triggers bcl 2 insensitive pathway involving stabilization p53 transrepression dependent signalling global study transcriptome led identification genes differentially regulated p53 according two signalling pathways
0.5729515.15326223.html.plaintext.txt	20	materials methods top abstract introduction materials methods results discussion conclusions references cell lines cell culture drugs rat embryo re cells fibroblast culture infected variant sv40 expresses temperature sensitive mutant lt antigen tsa58 26 temperature sensitive retsaf cell line selected isolated 33 degrees c wild type lt immortalizes cells via inhibitory binding p53 tumour suppressor however tsa58 mutant lt interact p53 restrictive temperature thus cells immortalized permissive temperature 33 degrees c whereas restrictive temperature 395 degrees c heat inactivation lt leads release p53 promoting commitment apoptosis 2026
0.5729515.15326223.html.plaintext.txt	21	materials methods top abstract introduction materials methods results discussion conclusions references cell lines cell culture drugs rat embryo re cells fibroblast culture infected variant sv40 expresses temperature sensitive mutant lt antigen tsa58 26 temperature sensitive retsaf cell line selected isolated 33 degrees c wild type lt immortalizes cells via inhibitory binding p53 tumour suppressor however tsa58 mutant lt interact p53 restrictive temperature thus cells immortalized permissive temperature 33 degrees c whereas restrictive temperature 395 degrees c heat inactivation lt leads release p53 promoting commitment apoptosis 2026
0.5729515.15326223.html.plaintext.txt	22	retsaf bcl 2 cell line described previously 2227 cell line bcl 2 overexpression control tetracycline tet system cells propagated 33 degrees c dmem invitrogen supplemented 100 microgml penicillin invitrogen 100 uml streptomycin invitrogen 1 glutamax invitrogen 10 foetal calf serum invitrogen 5 co295 air retsaf bcl 2 cells maintained absence tetracycline one week experiments described allow expression accumulation exogenous bcl 2 inhibitor treatments zvad bachem broad spectrum caspase inhibitor used concentration 100 microm
0.5729515.15326223.html.plaintext.txt	23	retsaf bcl 2 cell line described previously 2227 cell line bcl 2 overexpression control tetracycline tet system cells propagated 33 degrees c dmem invitrogen supplemented 100 microgml penicillin invitrogen 100 uml streptomycin invitrogen 1 glutamax invitrogen 10 foetal calf serum invitrogen 5 co295 air retsaf bcl 2 cells maintained absence tetracycline one week experiments described allow expression accumulation exogenous bcl 2 inhibitor treatments zvad bachem broad spectrum caspase inhibitor used concentration 100 microm
0.5729515.15326223.html.plaintext.txt	24	western blot analysis cells seeded 100 mm dishes incubated 33 degrees c reached 70 confluence dishes incubated 395 degrees c various time periods presence absence 2 microgml tetracycline andor 100 microm zvad cells rinsed cold phosphate buffered saline collected scraper frozen 20 degrees c proteins 80 microg separated sds page 15 acrylamide02 bisacrylamide resolve bax p21 75 acrylamide01 bisacrylamide p53 mdm2 transferred onto polyvinylidene difluoride pvdf membrane boehringer mannheim 28 blots exposed first antibody diluted tris buffered saline tbs5 milk overnight 4 degrees c rinsed tbs05 tween 20 exposed 1 h room temperature horseradish peroxidase conjugated anti rabbit anti mouse anti goat immunoglobulin serum biosystem appropriate first antibody used blots washed tbs immunoreactive bands revealed using amersham ecl kit antibodies used rabbit polyclonal anti bax n 20 santa cruz goat polyclonal anti p21 c 19 santa cruz mouse monoclonal anti p53 pab 122 gift dr e may irsc villejuif france mouse monoclonal anti lt pab 416 gift dr e may irsc villejuif france mouse monoclonal anti mdm2 smp40 santa cruz biotechnology blots normalized reference rat monoclonal anti tubulin mas078 sera lab binding
0.5729515.15326223.html.plaintext.txt	25	western blot analysis cells seeded 100 mm dishes incubated 33 degrees c reached 70 confluence dishes incubated 395 degrees c various time periods presence absence 2 microgml tetracycline andor 100 microm zvad cells rinsed cold phosphate buffered saline collected scraper frozen 20 degrees c proteins 80 microg separated sds page 15 acrylamide02 bisacrylamide resolve bax p21 75 acrylamide01 bisacrylamide p53 mdm2 transferred onto polyvinylidene difluoride pvdf membrane boehringer mannheim 28 blots exposed first antibody diluted tris buffered saline tbs5 milk overnight 4 degrees c rinsed tbs05 tween 20 exposed 1 h room temperature horseradish peroxidase conjugated anti rabbit anti mouse anti goat immunoglobulin serum biosystem appropriate first antibody used blots washed tbs immunoreactive bands revealed using amersham ecl kit antibodies used rabbit polyclonal anti bax n 20 santa cruz goat polyclonal anti p21 c 19 santa cruz mouse monoclonal anti p53 pab 122 gift dr e may irsc villejuif france mouse monoclonal anti lt pab 416 gift dr e may irsc villejuif france mouse monoclonal anti mdm2 smp40 santa cruz biotechnology blots normalized reference rat monoclonal anti tubulin mas078 sera lab binding
0.5729515.15326223.html.plaintext.txt	26	mrna detection 70 confluence retsaf bcl 2 cells overexpressing overexpressing bcl 2 incubated presence absence 100 microm zvad various time periods restrictive temperature 395 degrees c rna isolated guanidium isothiocyanate method 29 mrna assayed either northern blot analysis rt pcr
0.5729515.15326223.html.plaintext.txt	27	northern blot analysis aliquot 20 microg total rna separated electrophoresis 125 agarose gel containing 066 m formaldehyde transferred onto hybond n membrane amersham mrna detected hybridization specific probes stathmin map4 18s rna produced pcr amplification 32p labelled megaprime dna labelling system rpn 1606 amersham
0.5729515.15326223.html.plaintext.txt	28	rt pcr assay determine levels bax p21 mdm2 mrnas rt pcr used described previously 30 specific primers listed table 1 total 20 30 pcr cycles performed according amount mrna cases synthetic tobacco leaf nitrate reductase nr transcripts co reverse transcribed co amplified samples efficiency control 30 amplified products separated 10 acrylamide gel stained ethidium bromide photographed syngene genestore system bands quantified imagequant software
0.5729515.15326223.html.plaintext.txt	29	rt pcr assay determine levels bax p21 mdm2 mrnas rt pcr used described previously 30 specific primers listed table 1 total 20 30 pcr cycles performed according amount mrna cases synthetic tobacco leaf nitrate reductase nr transcripts co reverse transcribed co amplified samples efficiency control 30 amplified products separated 10 acrylamide gel stained ethidium bromide photographed syngene genestore system bands quantified imagequant software
0.5729515.15326223.html.plaintext.txt	30	view table table 1 sequences primers used rt pcr experiments
0.5729515.15326223.html.plaintext.txt	31	dna chip analysis microarrays chips designed used microarray platform service de genomique fonctionelle cea evry france chips development chips described previously preisser et al 31 delmar et al 32 contain 7330 probes probe corresponds particular gene genes spotted two five times redundancy useful evaluate relevance results probes contain 2014 pcr products amplified cdna matrix using primers specific genes involved important biological processes including apoptosis cell cycle stress response chips enriched 1684 mouse cdna clones image consortium research genetics collection 1500 mouse cdna named sdd sdm clones subtractive bank myodistrophic versus normal muscle 1800 clones rat cdna named rdd rdm another subtractive bank atrophied versus normal muscle insert amplified pcr specific primers pcr products 400 2000 bp long pcr products prepared 96 well plates purified ethanol precipitation washed 70 ethanol dried dissolved tedmso 5050 stored 20 degrees c quality size concentration pcr products determined electrophoresis typically dna concentration 50 300 ng microl gels analysed using genetools software syngene merck eurolab fontenay sous bois france size concentration quality automatically annotated file included final differential expression data file pcr products arrayed cmt capstm slides corning using microgrid ii biorobotics arrayed slides stored dark dry place room temperature use hybridization spotted dna cross linked support uv irradiation total energy 260 mj 254 nm
0.5729515.15326223.html.plaintext.txt	32	dna chip analysis microarrays chips designed used microarray platform service de genomique fonctionelle cea evry france chips development chips described previously preisser et al 31 delmar et al 32 contain 7330 probes probe corresponds particular gene genes spotted two five times redundancy useful evaluate relevance results probes contain 2014 pcr products amplified cdna matrix using primers specific genes involved important biological processes including apoptosis cell cycle stress response chips enriched 1684 mouse cdna clones image consortium research genetics collection 1500 mouse cdna named sdd sdm clones subtractive bank myodistrophic versus normal muscle 1800 clones rat cdna named rdd rdm another subtractive bank atrophied versus normal muscle insert amplified pcr specific primers pcr products 400 2000 bp long pcr products prepared 96 well plates purified ethanol precipitation washed 70 ethanol dried dissolved tedmso 5050 stored 20 degrees c quality size concentration pcr products determined electrophoresis typically dna concentration 50 300 ng microl gels analysed using genetools software syngene merck eurolab fontenay sous bois france size concentration quality automatically annotated file included final differential expression data file pcr products arrayed cmt capstm slides corning using microgrid ii biorobotics arrayed slides stored dark dry place room temperature use hybridization spotted dna cross linked support uv irradiation total energy 260 mj 254 nm
0.5729515.15326223.html.plaintext.txt	33	total rna extraction cdna labelling 70 confluence retsaf bcl 2 cells incubated 395 degrees c presence absence 100 microm zvad 16 h rna isolated guanidium isothiocyanate method 29 rna concentrations assessed optical density measurements quality evaluated electrophoresis bioanalyser rna nano assay agilent modified cdna prepared reverse transcriptase superscript 2 gibco brl life technologies according manufacturers protocol presence 20 microg total rna 1 ng luciferase mrna promega control 4 microg oligodt amersham pharmacia biotech dutp aminoallyl sigma dntp mix roche 2 mm except 16 mm aminoallyl dutp 04 mm dttp obtain aminoallyl dutpdttp ratio 41 cdna indirectly labelled incubating modified cdna nh2 cyanine 5 nh2 cyanine 3 01 m sodium bicarbonate buffer 30 min room temperature suppress cross hybridization repetitive dna 10 microg cot 1 cdna gibco brl life technologies 10 microg polya amersham pharmacia biotech 10 microg yeast trna gibco brl life technologies added labelled cdna samples centrifuged 1 h 4 degrees c 13 000 rpm resulting pellet dissolved 60 microl hybridization buffer 50 formamide sigma aldrich 25x denhart sigma aldrich 05 sds gibco brl life technologies 6x sspe gibco brl life technologies
0.5729515.15326223.html.plaintext.txt	34	total rna extraction cdna labelling 70 confluence retsaf bcl 2 cells incubated 395 degrees c presence absence 100 microm zvad 16 h rna isolated guanidium isothiocyanate method 29 rna concentrations assessed optical density measurements quality evaluated electrophoresis bioanalyser rna nano assay agilent modified cdna prepared reverse transcriptase superscript 2 gibco brl life technologies according manufacturers protocol presence 20 microg total rna 1 ng luciferase mrna promega control 4 microg oligodt amersham pharmacia biotech dutp aminoallyl sigma dntp mix roche 2 mm except 16 mm aminoallyl dutp 04 mm dttp obtain aminoallyl dutpdttp ratio 41 cdna indirectly labelled incubating modified cdna nh2 cyanine 5 nh2 cyanine 3 01 m sodium bicarbonate buffer 30 min room temperature suppress cross hybridization repetitive dna 10 microg cot 1 cdna gibco brl life technologies 10 microg polya amersham pharmacia biotech 10 microg yeast trna gibco brl life technologies added labelled cdna samples centrifuged 1 h 4 degrees c 13 000 rpm resulting pellet dissolved 60 microl hybridization buffer 50 formamide sigma aldrich 25x denhart sigma aldrich 05 sds gibco brl life technologies 6x sspe gibco brl life technologies
0.5729515.15326223.html.plaintext.txt	35	hybridization rna obtained cells cultured absence active p53 33 degrees c used control throughout experiments allow comparisons samples experiment repeated four times optimal reproducibility dye swap procedure used ie test sample labelled cy3 control labelled cy5 control stained cy3 test sample labelled cy5 samples denatured 2 min 100 degrees c hybridizations performed specific chambers corning overnight 42 degrees c coverslips sigma aldrich removed immersing slide 2x ssc 01 sds buffer 15 min twice 01x ssc 15 min room temperature orbital shaker slides dried centrifugation 5 min 700 rpm
0.5729515.15326223.html.plaintext.txt	36	hybridization rna obtained cells cultured absence active p53 33 degrees c used control throughout experiments allow comparisons samples experiment repeated four times optimal reproducibility dye swap procedure used ie test sample labelled cy3 control labelled cy5 control stained cy3 test sample labelled cy5 samples denatured 2 min 100 degrees c hybridizations performed specific chambers corning overnight 42 degrees c coverslips sigma aldrich removed immersing slide 2x ssc 01 sds buffer 15 min twice 01x ssc 15 min room temperature orbital shaker slides dried centrifugation 5 min 700 rpm
0.5729515.15326223.html.plaintext.txt	37	image acquisition microarray analysis slides scanned packard scan array express 10 microm resolution tiff images generated imported genepix pro 4 software axon software used alignment image grid spot detection extraction cy5 cy3 intensities spots analysis files imported genespring 61 software silicon genetics first stage analysis normalize data slide lowess method window 40 3334 minimal intensity value needed obtain relevant data evaluated genespring software value 4774 u obtained step important lower intensity values reproducible high standard deviations g gruel c lucchesi pawlik o alibert v frouin kortulewski x gidrol d tronik le roux manuscript preparation spots intensity value threshold three conditions 33 degrees c 395 degrees c 395 degrees c zvad four experiments considered experiment repeated four times use global error model genespring analysis finally 3513 probes giving statistically reproducible results included study
0.5729515.15326223.html.plaintext.txt	38	image acquisition microarray analysis slides scanned packard scan array express 10 microm resolution tiff images generated imported genepix pro 4 software axon software used alignment image grid spot detection extraction cy5 cy3 intensities spots analysis files imported genespring 61 software silicon genetics first stage analysis normalize data slide lowess method window 40 3334 minimal intensity value needed obtain relevant data evaluated genespring software value 4774 u obtained step important lower intensity values reproducible high standard deviations g gruel c lucchesi pawlik o alibert v frouin kortulewski x gidrol d tronik le roux manuscript preparation spots intensity value threshold three conditions 33 degrees c 395 degrees c 395 degrees c zvad four experiments considered experiment repeated four times use global error model genespring analysis finally 3513 probes giving statistically reproducible results included study
0.5729515.15326223.html.plaintext.txt	39	adjust bias arising variations microarray technology self self experiment performed two identical mrna samples labelled different dyes hybridized slide experiment repeated four times two independently prepared samples 33 degrees c condition used 085 genes 303513 probes found vary condition p 005 n 4 confirming reproducibility robustness method expression ratios modulated genes exceed 073 repressed genes 139 activated genes
0.5729515.15326223.html.plaintext.txt	40	adjust bias arising variations microarray technology self self experiment performed two identical mrna samples labelled different dyes hybridized slide experiment repeated four times two independently prepared samples 33 degrees c condition used 085 genes 303513 probes found vary condition p 005 n 4 confirming reproducibility robustness method expression ratios modulated genes exceed 073 repressed genes 139 activated genes
0.5729515.15326223.html.plaintext.txt	41	identify modulated genes applied limits determined self self experiment see previous paragraph rather arbitrary limits biological relevance limits selected genes expression varies beyond random manner ratios 073 139 considered work test p 005 n 4 also used ensure presented ratios significantly different 1
0.5729515.15326223.html.plaintext.txt	42	identify modulated genes applied limits determined self self experiment see previous paragraph rather arbitrary limits biological relevance limits selected genes expression varies beyond random manner ratios 073 139 considered work test p 005 n 4 also used ensure presented ratios significantly different 1
0.5729515.15326223.html.plaintext.txt	43	results top abstract introduction materials methods results discussion conclusions references p53 protein stabilized presence zvad investigated whether zvad dependent regulation apoptosis associated changes p53 status first assayed p53 western blotting permissive temperature 33 degrees c various time periods temperature shift 395 degrees c figure 1 p53 detected permissive temperature inactive state bound sv40 lt antigen temperature shift absence zvad rapid time dependent decrease p53 levels consistent reports p53 induces expression mdm2 gene product induces degradation p53 proteasome conversely decrease p53 abundance observed presence zvad rt pcr analysis showed zvad treatment affect amount p53 transcript data shown regulation p53 abundance zvad seems result post transcriptional mechanism examined effect zvad lt antigen figure 1 lt gave several bands western blots due diverse modifications lt gene following introduction mouse rat cell lines 35 found zvad significantly influence amount lt figure 1 indicating p53 stabilization due changes lt levels
0.5729515.15326223.html.plaintext.txt	44	results top abstract introduction materials methods results discussion conclusions references p53 protein stabilized presence zvad investigated whether zvad dependent regulation apoptosis associated changes p53 status first assayed p53 western blotting permissive temperature 33 degrees c various time periods temperature shift 395 degrees c figure 1 p53 detected permissive temperature inactive state bound sv40 lt antigen temperature shift absence zvad rapid time dependent decrease p53 levels consistent reports p53 induces expression mdm2 gene product induces degradation p53 proteasome conversely decrease p53 abundance observed presence zvad rt pcr analysis showed zvad treatment affect amount p53 transcript data shown regulation p53 abundance zvad seems result post transcriptional mechanism examined effect zvad lt antigen figure 1 lt gave several bands western blots due diverse modifications lt gene following introduction mouse rat cell lines 35 found zvad significantly influence amount lt figure 1 indicating p53 stabilization due changes lt levels
0.5729515.15326223.html.plaintext.txt	45	view larger version 46k figure 1 effect zvad treatment p53 status western blot analysis p53 agt retsaf cells presence absence zvad time following temperature shift 395 degrees c indicated lanes tubulin used loading control
0.5729515.15326223.html.plaintext.txt	46	view larger version 46k figure 1 effect zvad treatment p53 status western blot analysis p53 agt retsaf cells presence absence zvad time following temperature shift 395 degrees c indicated lanes tubulin used loading control
0.5729515.15326223.html.plaintext.txt	47	results suggest zvad inhibits degradation p53 proteasome resulting higher concentration p53 early 8 h restrictive temperature coincides increased rate apoptosis reported previously 22
0.5729515.15326223.html.plaintext.txt	48	results suggest zvad inhibits degradation p53 proteasome resulting higher concentration p53 early 8 h restrictive temperature coincides increased rate apoptosis reported previously 22
0.5729515.15326223.html.plaintext.txt	49	p53 induce transcriptional activation dependent independent apoptotic processes stabilization p53 zvad may lead increased p53 transactivation activity p53 thereby explain accelerated death process observed condition test hypothesis mrnas three p53 target genes p21 bax mdm2 assayed rt pcr absence zvad p53 activation 395 degrees c increased transcription three genes surprisingly presence zvad thus p53 less accumulation messengers figure 2a confirm effect result zvad directly independent p53 compared mrna levels permissive temperature presence absence zvad 24 h addition figure 2a frame intensity p21 bax mdm2 mrnas weak consistent genes poorly expressed absence active p53 furthermore difference according presence absence zvad zvad thus effect p53 inactive
0.5729515.15326223.html.plaintext.txt	50	p53 induce transcriptional activation dependent independent apoptotic processes stabilization p53 zvad may lead increased p53 transactivation activity p53 thereby explain accelerated death process observed condition test hypothesis mrnas three p53 target genes p21 bax mdm2 assayed rt pcr absence zvad p53 activation 395 degrees c increased transcription three genes surprisingly presence zvad thus p53 less accumulation messengers figure 2a confirm effect result zvad directly independent p53 compared mrna levels permissive temperature presence absence zvad 24 h addition figure 2a frame intensity p21 bax mdm2 mrnas weak consistent genes poorly expressed absence active p53 furthermore difference according presence absence zvad zvad thus effect p53 inactive
0.5729515.15326223.html.plaintext.txt	51	view larger version 40k figure 2 effect zvad treatment transcriptional activation function p53 study transcriptional activation p53 targets p21 bax mdm2 mrna amplified rt pcr upper panel time following temperature shift 395 degrees c indicated lanes amplification products quantified using imagequant software lower panel units arbitrary represent expression level gene compared permissive temperature rt pcr synthetic transcripts tobacco nr used control effect zvad three targets permissive temperature shown frame b western blot p21 bax mdm2 conditions mdm2 p21 proteins weak absence active p53 33 degrees c detectable tubulin used loading control effect zuad bax protein permissive temperature shown frame
0.5729515.15326223.html.plaintext.txt	52	view larger version 40k figure 2 effect zvad treatment transcriptional activation function p53 study transcriptional activation p53 targets p21 bax mdm2 mrna amplified rt pcr upper panel time following temperature shift 395 degrees c indicated lanes amplification products quantified using imagequant software lower panel units arbitrary represent expression level gene compared permissive temperature rt pcr synthetic transcripts tobacco nr used control effect zvad three targets permissive temperature shown frame b western blot p21 bax mdm2 conditions mdm2 p21 proteins weak absence active p53 33 degrees c detectable tubulin used loading control effect zuad bax protein permissive temperature shown frame
0.5729515.15326223.html.plaintext.txt	53	tested whether amount protein corresponds amount messenger western blotting figure 2b p21 bax proteins followed abundance messengers proteins accumulated restrictive temperature absence presence zvad even though increases observed presence zvad lower detected absence zvad conversely initial increase protein messenger levels 12 h 395 degrees c changes mdm2 protein level differed amount messenger absence zvad amount mdm2 gradually declined whereas messenger levels maintained presence zvad mdm2 levels stable whereas messenger decreased cf figure 2a b discrepancy protein messenger changes suggests post transcriptional regulation mdm2 confirmed like mrna levels zvad effect bax proteins absence active p53 figure 2b frame condition mdm2 p21 proteins weak detectable
0.5729515.15326223.html.plaintext.txt	54	tested whether amount protein corresponds amount messenger western blotting figure 2b p21 bax proteins followed abundance messengers proteins accumulated restrictive temperature absence presence zvad even though increases observed presence zvad lower detected absence zvad conversely initial increase protein messenger levels 12 h 395 degrees c changes mdm2 protein level differed amount messenger absence zvad amount mdm2 gradually declined whereas messenger levels maintained presence zvad mdm2 levels stable whereas messenger decreased cf figure 2a b discrepancy protein messenger changes suggests post transcriptional regulation mdm2 confirmed like mrna levels zvad effect bax proteins absence active p53 figure 2b frame condition mdm2 p21 proteins weak detectable
0.5729515.15326223.html.plaintext.txt	55	thus p53 activation restrictive temperature induces transactivation target genes transactivation attenuated presence zvad despite greater abundance p53 mdm2 p53 proteins present similar fates lower protein concentrations absence zvad may due ubiquitin ligase function mdm2 p53 promoting proteasomal degradation stabilization p53 mdm2 presence zvad might consequence less efficient entry proteasome caspases inhibited
0.5729515.15326223.html.plaintext.txt	56	thus p53 activation restrictive temperature induces transactivation target genes transactivation attenuated presence zvad despite greater abundance p53 mdm2 p53 proteins present similar fates lower protein concentrations absence zvad may due ubiquitin ligase function mdm2 p53 promoting proteasomal degradation stabilization p53 mdm2 presence zvad might consequence less efficient entry proteasome caspases inhibited
0.5729515.15326223.html.plaintext.txt	57	p53 mediated transcriptional repression involved caspase independent apoptotic pathway surprisingly p53 accumulation presence zvad associated reduced transactivation target genes therefore investigated whether accelerated apoptosis induced zvad involves transcriptional repression activity p53 tested transcription map4 stathmin genes retsaf bcl 2 cells northern blotting products genes regulate microtubule polymerization transcription negatively regulated p53 1336 map4 mrna subject alternative splicing messenger studied full length form 67 kb found p53 activation 395 degrees c correlated transient decrease map4 stathmin mrna levels decrease greater presence zvad figure 3 suggests zvad induced apoptosis results increased transrepression activity p53 also regulation amount p53 involving one caspases may affect p53 functions involved increased amounts p53 associated greater transrepression versus transactivation activity
0.5729515.15326223.html.plaintext.txt	58	p53 mediated transcriptional repression involved caspase independent apoptotic pathway surprisingly p53 accumulation presence zvad associated reduced transactivation target genes therefore investigated whether accelerated apoptosis induced zvad involves transcriptional repression activity p53 tested transcription map4 stathmin genes retsaf bcl 2 cells northern blotting products genes regulate microtubule polymerization transcription negatively regulated p53 1336 map4 mrna subject alternative splicing messenger studied full length form 67 kb found p53 activation 395 degrees c correlated transient decrease map4 stathmin mrna levels decrease greater presence zvad figure 3 suggests zvad induced apoptosis results increased transrepression activity p53 also regulation amount p53 involving one caspases may affect p53 functions involved increased amounts p53 associated greater transrepression versus transactivation activity
0.5729515.15326223.html.plaintext.txt	59	view larger version 46k figure 3 effect zvad treatment transcriptional repression function p53 northern blot analysis stathmin map4 mrnas retsaf cells presence absence zvad time temperature shift 395 degrees c indicated lanes 18s mrna used loading control
0.5729515.15326223.html.plaintext.txt	60	view larger version 46k figure 3 effect zvad treatment transcriptional repression function p53 northern blot analysis stathmin map4 mrnas retsaf cells presence absence zvad time temperature shift 395 degrees c indicated lanes 18s mrna used loading control
0.5729515.15326223.html.plaintext.txt	61	caspase inhibition promotes large scale decrease p53 dependent transcriptional activity unlike genes whose activation p53 induces apoptosis little known genes whose repression p53 contributes apoptosis used dna microarrays identify genes elucidate signalling pathway activated p53 presence zvad
0.5729515.15326223.html.plaintext.txt	62	caspase inhibition promotes large scale decrease p53 dependent transcriptional activity unlike genes whose activation p53 induces apoptosis little known genes whose repression p53 contributes apoptosis used dna microarrays identify genes elucidate signalling pathway activated p53 presence zvad
0.5729515.15326223.html.plaintext.txt	63	transcriptional regulation following p53 activation assessed presence absence zvad rna extracted cells 16 h temperature shift 395 degrees c stage transcriptional modifications mostly reflect onset apoptosis rather cellular destruction process rna corresponding test conditions active p53 395 degrees c presence absence zvad hybridized control rna inactive p53 33 degrees c hybridization performed four times inversion fluorochromes optimize reliability minimize staining artefacts data averaged
0.5729515.15326223.html.plaintext.txt	64	transcriptional regulation following p53 activation assessed presence absence zvad rna extracted cells 16 h temperature shift 395 degrees c stage transcriptional modifications mostly reflect onset apoptosis rather cellular destruction process rna corresponding test conditions active p53 395 degrees c presence absence zvad hybridized control rna inactive p53 33 degrees c hybridization performed four times inversion fluorochromes optimize reliability minimize staining artefacts data averaged
0.5729515.15326223.html.plaintext.txt	65	hybridization rna cells cultured 395 degrees c cells 33 degrees c identified 179 genes significantly activated 14 26 fold 214 significantly repressed 14 10 fold restrictive temperature included many known p53 responsive genes p21 gadd45 igfbp p53 responsive genes absent either pass filters eg bax simply represented chips however similar microarray studies shown previously pattern expression p53 target genes dependent p53 activation status known p53 targets simultaneously activated given condition 37 39 many genes previously identified p53 direct targets also regulated p53 induction described similar studies atpase h transporting hsp70 genes repressed amyloid protein precursor annexin genes activated 37 39 data indicate whether genes primary secondary transcriptional targets p53
0.5729515.15326223.html.plaintext.txt	66	hybridization rna cells cultured 395 degrees c cells 33 degrees c identified 179 genes significantly activated 14 26 fold 214 significantly repressed 14 10 fold restrictive temperature included many known p53 responsive genes p21 gadd45 igfbp p53 responsive genes absent either pass filters eg bax simply represented chips however similar microarray studies shown previously pattern expression p53 target genes dependent p53 activation status known p53 targets simultaneously activated given condition 37 39 many genes previously identified p53 direct targets also regulated p53 induction described similar studies atpase h transporting hsp70 genes repressed amyloid protein precursor annexin genes activated 37 39 data indicate whether genes primary secondary transcriptional targets p53
0.5729515.15326223.html.plaintext.txt	67	presence zvad hybridization 395 degrees c zvad33 degrees c 220 genes activated 385 repressed thus numbers activated genes comparable presence absence zvad twice many genes repressed presence zvad absence interestingly 75 genes repressed absence zvad also repressed presence drug although 215 genes repressed presence drug see venn diagram figure 4
0.5729515.15326223.html.plaintext.txt	68	presence zvad hybridization 395 degrees c zvad33 degrees c 220 genes activated 385 repressed thus numbers activated genes comparable presence absence zvad twice many genes repressed presence zvad absence interestingly 75 genes repressed absence zvad also repressed presence drug although 215 genes repressed presence drug see venn diagram figure 4
0.5729515.15326223.html.plaintext.txt	69	view larger version 12k figure 4 venn diagram representation repressed genes number repressed genes absence zvad represented left circle number repressed genes presence zvad represented right circle number genes repressed absence presence zvad intersection two circles
0.5729515.15326223.html.plaintext.txt	70	view larger version 12k figure 4 venn diagram representation repressed genes number repressed genes absence zvad represented left circle number repressed genes presence zvad represented right circle number genes repressed absence presence zvad intersection two circles
0.5729515.15326223.html.plaintext.txt	71	identify genes specifically modulated zvad used anova parametric test conditions 395 degrees c395 degrees c zvad p 005 moreover among genes ratios expression level 395 degrees c presence zvad absence zvad 073 139 considered relevant
0.5729515.15326223.html.plaintext.txt	72	ninety four genes thereby identified significantly specifically modulated 81 repressed 13 induced p53 active presence zvad genes identified probes sequenced interestingly genes represented one spot chip gave reproducible results example procollagen type iii alpha 1 gene appeared five times negative regulation various procollagen probes allowed estimate experimental variation 0007 absence zvad 0004 presence zvad indicates reproducibility results
0.5729515.15326223.html.plaintext.txt	73	ninety four genes thereby identified significantly specifically modulated 81 repressed 13 induced p53 active presence zvad genes identified probes sequenced interestingly genes represented one spot chip gave reproducible results example procollagen type iii alpha 1 gene appeared five times negative regulation various procollagen probes allowed estimate experimental variation 0007 absence zvad 0004 presence zvad indicates reproducibility results
0.5729515.15326223.html.plaintext.txt	74	classified genes four clusters according specific modulation zvad addition figure 5 table 2 less activated cluster 1 11 genes repressed cluster 2 68 genes activated clusters 3 10 genes less repressed cluster 4 3 genes most8194 86 less expressed presence zvad
0.5729515.15326223.html.plaintext.txt	75	classified genes four clusters according specific modulation zvad addition figure 5 table 2 less activated cluster 1 11 genes repressed cluster 2 68 genes activated clusters 3 10 genes less repressed cluster 4 3 genes most8194 86 less expressed presence zvad
0.5729515.15326223.html.plaintext.txt	76	view larger version 29k figure 5 cluster representation genes differentially regulated zvad addition 94 genes significantly regulated presence zvad p53 active classified four distinct clusters listed table 2 invariant expression ratio 1 represented horizontal line
0.5729515.15326223.html.plaintext.txt	77	view larger version 29k figure 5 cluster representation genes differentially regulated zvad addition 94 genes significantly regulated presence zvad p53 active classified four distinct clusters listed table 2 invariant expression ratio 1 represented horizontal line
0.5729515.15326223.html.plaintext.txt	78	view table table 2 list genes differentially regulated presence zvad
0.5729515.15326223.html.plaintext.txt	79	note genes sensitive temperature shift p53 activation excluded temperature dependent modulations presence absence zvad
0.5729515.15326223.html.plaintext.txt	80	conclusion transcriptosome analysis indicates zvad mediated commitment alternative bcl 2 insensitive programme associated shift transactivation function towards transrepression activity p53 consistent rt pcr northern blot findings
0.5729515.15326223.html.plaintext.txt	81	conclusion transcriptosome analysis indicates zvad mediated commitment alternative bcl 2 insensitive programme associated shift transactivation function towards transrepression activity p53 consistent rt pcr northern blot findings
0.5729515.15326223.html.plaintext.txt	82	discussion top abstract introduction materials methods results discussion conclusions references tumour suppressor protein p53 induces cell cycle arrest apoptosis thus pivotal suppressing cellular transformation tumorigenesis cell cycle arrest mediated transcriptional induction genes products inhibit proteins involved cell cycle progression molecular events lead p53 dependent apoptosis less clear transactivation target genes may involved growing evidence transrepression transcription independent functions central p53 dependent apoptosis 1540 however physiological relevance apparently redundant pro apoptotic properties determinism choice poorly understood absence caspase activity p53 induce bcl 2 insensitive cell death program 2223 report bcl 2 insensitive pathway unmasked zvad one zvad sensitive caspases regulate p53 apoptotic functions modulating activated biochemical properties protein
0.5729515.15326223.html.plaintext.txt	83	discussion top abstract introduction materials methods results discussion conclusions references tumour suppressor protein p53 induces cell cycle arrest apoptosis thus pivotal suppressing cellular transformation tumorigenesis cell cycle arrest mediated transcriptional induction genes products inhibit proteins involved cell cycle progression molecular events lead p53 dependent apoptosis less clear transactivation target genes may involved growing evidence transrepression transcription independent functions central p53 dependent apoptosis 1540 however physiological relevance apparently redundant pro apoptotic properties determinism choice poorly understood absence caspase activity p53 induce bcl 2 insensitive cell death program 2223 report bcl 2 insensitive pathway unmasked zvad one zvad sensitive caspases regulate p53 apoptotic functions modulating activated biochemical properties protein
0.5729515.15326223.html.plaintext.txt	84	caspase inhibition modulates biochemical properties activation alternative pathway associated increased stability accumulation p53 protein restrictive temperature expected result stronger induction p53 target genes explaining accelerating effect zvad p53 induced apoptosis surprisingly found zvad induced p53 accumulation accompanied reduced transcriptional activation effectors discrepancy indicates caspase inhibitor modulates p53 properties transactivation independent apoptotic function p53 required trigger alternative pathway
0.5729515.15326223.html.plaintext.txt	85	caspase inhibition modulates biochemical properties activation alternative pathway associated increased stability accumulation p53 protein restrictive temperature expected result stronger induction p53 target genes explaining accelerating effect zvad p53 induced apoptosis surprisingly found zvad induced p53 accumulation accompanied reduced transcriptional activation effectors discrepancy indicates caspase inhibitor modulates p53 properties transactivation independent apoptotic function p53 required trigger alternative pathway
0.5729515.15326223.html.plaintext.txt	86	several studies consistent p53 promoting apoptosis transcriptional repression activity 12153641 43 certain mutants deleted forms p53 unable induce apoptosis found deficient transrepression transactivation 4445 also positive association p53 dependent repression apoptosis demonstrated models 1546
0.5729515.15326223.html.plaintext.txt	87	therefore evaluated transrepression activity p53 restrictive temperature presence absence caspase inhibitor found genes known repressed p53 map4 stathmin regulated p53 activation presence absence zvad however transrepression transient absence zvad sustained stronger presence zvad suggesting duration determined amount p53
0.5729515.15326223.html.plaintext.txt	88	therefore evaluated transrepression activity p53 restrictive temperature presence absence caspase inhibitor found genes known repressed p53 map4 stathmin regulated p53 activation presence absence zvad however transrepression transient absence zvad sustained stronger presence zvad suggesting duration determined amount p53
0.5729515.15326223.html.plaintext.txt	89	conducted large scale study transcriptome showed caspase inhibition leads extensive changes pattern regulated genes p53 activation restrictive temperature microarray analysis indicated 86 clusters 1 2 94 genes modulated zvad repressed less activated presence drug words genes less expressed caspases inactive thus inhibition caspases modifies contribution different transcription activities p53 apoptosis onset bcl 2 insentive process associated decrease transactivation increase transrepression interestingly none genes activated absence zvad became repressed addition drug none repressed genes became activated presence zvad consistent p53 mediated transactivation transrepression affecting different clusters genes explained introduction
0.5729515.15326223.html.plaintext.txt	90	conducted large scale study transcriptome showed caspase inhibition leads extensive changes pattern regulated genes p53 activation restrictive temperature microarray analysis indicated 86 clusters 1 2 94 genes modulated zvad repressed less activated presence drug words genes less expressed caspases inactive thus inhibition caspases modifies contribution different transcription activities p53 apoptosis onset bcl 2 insentive process associated decrease transactivation increase transrepression interestingly none genes activated absence zvad became repressed addition drug none repressed genes became activated presence zvad consistent p53 mediated transactivation transrepression affecting different clusters genes explained introduction
0.5729515.15326223.html.plaintext.txt	91	various different mechanisms described account p53 mediated repression inhibition nf y transcription factor 4748 regulation p21 leads hypophosphorylation rb transcriptional repression via e2f1 binding 49 implicated however evidence p53 promote sequence specific repression binding proteins like hdac possess deacetylase chromatin condensation properties according model data suggest composition transcriptional machinery complexes recruited p53 promoters might modulated zvad sensitive protease indeed p53 activate transcription interaction coactivators eg p300 cbp proteins histone acetylase hat activity critical transactivation function p53 conversely repress transcription p53 recruits histone deacetylases physical association msin3a time course p53 association msin3a p300 might differ according presence absence zvad interestingly c terminal msin3a interaction domain tetramerization domain p53 overlap 43 therefore interaction could contribute decrease p53 transactivation favour increased transrepression zvad promotes formation complex promoters p53 repressed genes remains unclear
0.5729515.15326223.html.plaintext.txt	92	various different mechanisms described account p53 mediated repression inhibition nf y transcription factor 4748 regulation p21 leads hypophosphorylation rb transcriptional repression via e2f1 binding 49 implicated however evidence p53 promote sequence specific repression binding proteins like hdac possess deacetylase chromatin condensation properties according model data suggest composition transcriptional machinery complexes recruited p53 promoters might modulated zvad sensitive protease indeed p53 activate transcription interaction coactivators eg p300 cbp proteins histone acetylase hat activity critical transactivation function p53 conversely repress transcription p53 recruits histone deacetylases physical association msin3a time course p53 association msin3a p300 might differ according presence absence zvad interestingly c terminal msin3a interaction domain tetramerization domain p53 overlap 43 therefore interaction could contribute decrease p53 transactivation favour increased transrepression zvad promotes formation complex promoters p53 repressed genes remains unclear
0.5729515.15326223.html.plaintext.txt	93	nevertheless fact large number genes repressed presence zvad suggests regulations may also involved least part p53 indirectly controlling either expression activity transcription factors
0.5729515.15326223.html.plaintext.txt	94	function genes modulated zvad striking transcriptional modification associated commitment alternative apoptotic pathway increased repression focused function genes regulated presence zvad order elucidate signalling new apoptotic pathway see figure 5 table 2
0.5729515.15326223.html.plaintext.txt	95	function genes modulated zvad striking transcriptional modification associated commitment alternative apoptotic pathway increased repression focused function genes regulated presence zvad order elucidate signalling new apoptotic pathway see figure 5 table 2
0.5729515.15326223.html.plaintext.txt	96	genes affected repressed presence zvad included genes encoding components extracellular matrix cytoskeleton procollagen myosin others consistent caspase inhibitor accelerating commitment apoptosis indeed observed morphological changes including loss adherence cell shrinking cell rounding rapid presence absence zvad events involve major alterations cytoskeleton interactions cell extracellular matrix
0.5729515.15326223.html.plaintext.txt	97	genes affected repressed presence zvad included genes encoding components extracellular matrix cytoskeleton procollagen myosin others consistent caspase inhibitor accelerating commitment apoptosis indeed observed morphological changes including loss adherence cell shrinking cell rounding rapid presence absence zvad events involve major alterations cytoskeleton interactions cell extracellular matrix
0.5729515.15326223.html.plaintext.txt	98	numerous genes regulated p53 absence zvad repressed p53 caspases inhibited genes thus specifically implicated alternative pathway include genes encoding regulators transcription eg high mobility group nucleosomal binding domain 1 transcription factor e2a interestingly high mobility group nucleosomal binding domain 1 gene hmgn1 encodes activator transcription binds minor groove dna promoting transcription inducing conformational change chromatin 50 hmg 17 gene another member high mobility group family known primary target p53 51 possibly hmgn1 also direct target p53 regulation type transcription factor could trigger process amplification contributing overall transactivation decrease observed presence zvad indeed genes identified analysis reported p53 targets approach discriminate genes directly repressed p53 sequence specific manner genes repressed indirectly cascade regulations another type gene identified study regulators cell cycle including growth arrest specific 6 polymerase beta cell division cycle 2 homolog consistent established ability p53 arrest cell cycle transcriptional regulation furthermore commitment retsaf bcl 2 cells apoptosis associated inability respond appropriately p53 induced negative regulators cell cycle 52
0.5729515.15326223.html.plaintext.txt	99	numerous genes regulated p53 absence zvad repressed p53 caspases inhibited genes thus specifically implicated alternative pathway include genes encoding regulators transcription eg high mobility group nucleosomal binding domain 1 transcription factor e2a interestingly high mobility group nucleosomal binding domain 1 gene hmgn1 encodes activator transcription binds minor groove dna promoting transcription inducing conformational change chromatin 50 hmg 17 gene another member high mobility group family known primary target p53 51 possibly hmgn1 also direct target p53 regulation type transcription factor could trigger process amplification contributing overall transactivation decrease observed presence zvad indeed genes identified analysis reported p53 targets approach discriminate genes directly repressed p53 sequence specific manner genes repressed indirectly cascade regulations another type gene identified study regulators cell cycle including growth arrest specific 6 polymerase beta cell division cycle 2 homolog consistent established ability p53 arrest cell cycle transcriptional regulation furthermore commitment retsaf bcl 2 cells apoptosis associated inability respond appropriately p53 induced negative regulators cell cycle 52
0.5729515.15326223.html.plaintext.txt	100	surprisingly 94 genes regulated zvad included genes known involved apoptosis several possible explanations many apoptotic genes represented array used ii signals given genes pass statistical tests iii apoptotic genes among unidentified regulated genes iv bcl 2 caspase insensitive pathway involves unidentified genes
0.5729515.15326223.html.plaintext.txt	101	surprisingly 94 genes regulated zvad included genes known involved apoptosis several possible explanations many apoptotic genes represented array used ii signals given genes pass statistical tests iii apoptotic genes among unidentified regulated genes iv bcl 2 caspase insensitive pathway involves unidentified genes
0.5729515.15326223.html.plaintext.txt	102	p53 protein level determines activated biochemical properties activation alternative pathway associated increased stability p53 restrictive temperature parallel accumulation mdm2 consequence post transcriptional mechanism presumably two proteins pass rapidly proteasome restrictive temperature absence zvad
0.5729515.15326223.html.plaintext.txt	103	p53 protein level determines activated biochemical properties activation alternative pathway associated increased stability p53 restrictive temperature parallel accumulation mdm2 consequence post transcriptional mechanism presumably two proteins pass rapidly proteasome restrictive temperature absence zvad
0.5729515.15326223.html.plaintext.txt	104	control p53 stability appears central determination p53 apoptotic pathway numerous studies show heterogeneous responses gene transcription p53 activation diverse agents could due p53 protein levels differing according nature stress signal 37 model target genes transactivated p53 transient manner transient nature determined mdm2 mediated degradation p53 contrast could argued transcriptional repression effective repression complexes present promoters repressed genes prolonged periods 4353 protecting p53 degradation caspase inhibition may therefore enhance effectiveness p53 transrepressor note two components proteasome repressed presence zvad cluster 2 dna chip analysis may contribute decrease p53 mdm2 proteasomal degradation condition
0.5729515.15326223.html.plaintext.txt	105	control p53 stability appears central determination p53 apoptotic pathway numerous studies show heterogeneous responses gene transcription p53 activation diverse agents could due p53 protein levels differing according nature stress signal 37 model target genes transactivated p53 transient manner transient nature determined mdm2 mediated degradation p53 contrast could argued transcriptional repression effective repression complexes present promoters repressed genes prolonged periods 4353 protecting p53 degradation caspase inhibition may therefore enhance effectiveness p53 transrepressor note two components proteasome repressed presence zvad cluster 2 dna chip analysis may contribute decrease p53 mdm2 proteasomal degradation condition
0.5729515.15326223.html.plaintext.txt	106	however effect caspase inhibition appears puzzling unlike effect transrepression p53 accumulation promote greater transactivation efficiency mdm2 also accumulates presence zvad probably result inhibition proteasome mediated degradation possible zvad blocks caspase mediated inactivation component regulates via mdm2 stability apoptotic function p53 interestingly hsieh et al 54 report rb mdm2 p53 interact ternary complex rb regulates apoptotic function p53
0.5729515.15326223.html.plaintext.txt	107	however effect caspase inhibition appears puzzling unlike effect transrepression p53 accumulation promote greater transactivation efficiency mdm2 also accumulates presence zvad probably result inhibition proteasome mediated degradation possible zvad blocks caspase mediated inactivation component regulates via mdm2 stability apoptotic function p53 interestingly hsieh et al 54 report rb mdm2 p53 interact ternary complex rb regulates apoptotic function p53
0.5729515.15326223.html.plaintext.txt	108	modification p53 protein depends types stress 38 different types dna damage activate different protein kinases phosphorylate different serine threonine residues protein presence absence zvad may similarly cause different types post transcriptional modification whether modifications qualitatively influence outcome p53 activation remains unclear thus overall transcription pattern cell might depend nature qualitative quantitative p53 status
0.5729515.15326223.html.plaintext.txt	109	modification p53 protein depends types stress 38 different types dna damage activate different protein kinases phosphorylate different serine threonine residues protein presence absence zvad may similarly cause different types post transcriptional modification whether modifications qualitatively influence outcome p53 activation remains unclear thus overall transcription pattern cell might depend nature qualitative quantitative p53 status
0.5729515.15326223.html.plaintext.txt	110	conclusions top abstract introduction materials methods results discussion conclusions references report evidence supporting new paradigm regulation apoptotic function p53 propose new model one zvad sensitive caspases determine outcome p53 activation modulating stability biochemical properties p53 caspases active p53 activation followed rapid mdm2 mediated degradation p53 transactivation dependent apoptotic program engages mitochondrial pathway 23 contrast absence caspase activity p53 activation triggers transrepression dependent signalling alternative bcl 2 insensitive 23 apoptotic program associated stabilization p53 protein
0.5729515.15326223.html.plaintext.txt	111	conclusions top abstract introduction materials methods results discussion conclusions references report evidence supporting new paradigm regulation apoptotic function p53 propose new model one zvad sensitive caspases determine outcome p53 activation modulating stability biochemical properties p53 caspases active p53 activation followed rapid mdm2 mediated degradation p53 transactivation dependent apoptotic program engages mitochondrial pathway 23 contrast absence caspase activity p53 activation triggers transrepression dependent signalling alternative bcl 2 insensitive 23 apoptotic program associated stabilization p53 protein
0.5729515.15326223.html.plaintext.txt	112	important note effect zvad specific p53 lt antigen indeed dominant negative form p53 abolishes proapoptotic action zvad zvad also potentiates p53 induced apoptosis rat primary fibroblasts express lt 23 latter observation reinforces idea caspase dependent control p53 activity physiological relevance nevertheless needs tested human cells
0.5729515.15326223.html.plaintext.txt	113	important note effect zvad specific p53 lt antigen indeed dominant negative form p53 abolishes proapoptotic action zvad zvad also potentiates p53 induced apoptosis rat primary fibroblasts express lt 23 latter observation reinforces idea caspase dependent control p53 activity physiological relevance nevertheless needs tested human cells
0.5729515.15326223.html.plaintext.txt	114	analysis cataloguing p53 targets genes regulated response various conditions like zvad may help connect p53 activation apoptotic network could lead development strategies improve therapeutic treatment
0.5729515.15326223.html.plaintext.txt	115	analysis cataloguing p53 targets genes regulated response various conditions like zvad may help connect p53 activation apoptotic network could lead development strategies improve therapeutic treatment
0.5729515.15326223.html.plaintext.txt	116	acknowledgements thank sebastien gaumer reading manuscript work supported part grants association pour la recherche contre le cancer 4480 grateful conseil regional dile de france association pour la recherche contre le cancer ligue nationale contre le cancer fondation pour la recherche medicale contributed financially equipment used laboratories ng fellow ligue nationale contre le cancer sb supported scholarship ministere de la jeunesse de leducation nationale et de la recherche
0.5729515.15326223.html.plaintext.txt	117	acknowledgements thank sebastien gaumer reading manuscript work supported part grants association pour la recherche contre le cancer 4480 grateful conseil regional dile de france association pour la recherche contre le cancer ligue nationale contre le cancer fondation pour la recherche medicale contributed financially equipment used laboratories ng fellow ligue nationale contre le cancer sb supported scholarship ministere de la jeunesse de leducation nationale et de la recherche
0.5729515.15326223.html.plaintext.txt	118	references top abstract introduction materials methods results discussion conclusions references vogelsteinb laned levineaj 2000 surfing p53 network nature 408 307 310crossrefisimedline
0.5729515.15326223.html.plaintext.txt	119	bustinm 1999 regulation dna dependent activities functional motifs high mobility group chromosomal proteins mol cell biol 19 5237 5246free full text
0.5739836.9582339.html.plaintext.txt	0	identification novel p53 functional domain necessary mediating apoptosis jianhui zhu wenjing zhou jieyuan jiang xinbin chen
0.5739836.9582339.html.plaintext.txt	1	program gene regulation institute molecular medicine genetics medical college georgia augusta georgia 30912
0.5739836.9582339.html.plaintext.txt	2	abstract top abstract introduction procedures results discussion references
0.5739836.9582339.html.plaintext.txt	3	ability p53 induce apoptosis requires sequence specific dna binding activity however transactivation deficient p53gln22 ser23 still induce apoptosis previously shown region residues 23 97 p53 necessary activity effort precisely map domain necessary apoptosis within n terminus found deletion n terminal 23 amino acids compromises abolish p53 induction apoptosis surprisingly p531 42 lacks n terminal 42 amino acids previously defined activation domain retains ability induce apoptosis even higher level wild type p53 extensive deletion eliminates n terminal 63 amino acids renders p53 completely inert mediating apoptosis addition found p531 42 p53gln22 ser23 activate subset cellular p53 targets furthermore showed residues 53 54 critical apoptotic transcriptional activities p531 42 p53gln22 ser23 taken together data suggest within residues 43 63 lie apoptotic domain well another transcriptional activation domain therefore postulate apoptotic activity p53gln22 ser23 p531 42 still transcription dependent
0.5739836.9582339.html.plaintext.txt	4	ability p53 induce apoptosis requires sequence specific dna binding activity however transactivation deficient p53gln22 ser23 still induce apoptosis previously shown region residues 23 97 p53 necessary activity effort precisely map domain necessary apoptosis within n terminus found deletion n terminal 23 amino acids compromises abolish p53 induction apoptosis surprisingly p531 42 lacks n terminal 42 amino acids previously defined activation domain retains ability induce apoptosis even higher level wild type p53 extensive deletion eliminates n terminal 63 amino acids renders p53 completely inert mediating apoptosis addition found p531 42 p53gln22 ser23 activate subset cellular p53 targets furthermore showed residues 53 54 critical apoptotic transcriptional activities p531 42 p53gln22 ser23 taken together data suggest within residues 43 63 lie apoptotic domain well another transcriptional activation domain therefore postulate apoptotic activity p53gln22 ser23 p531 42 still transcription dependent
0.5739836.9582339.html.plaintext.txt	5	introduction top abstract introduction procedures results discussion references
0.5739836.9582339.html.plaintext.txt	6	p53 tumor suppressor protein serves checkpoint maintaining genome stability 1 3 several different biological responses could play role maintaining genome stability strongly correlated wild type p53 function 1 3 following stress conditions presence damaged dna insufficient growth survival factors cellular levels p53 increase leads one least three well understood cellular responses follows cell cycle arrest differentiation apoptosis several factors shown determine cell responds accumulation p53 eg cell type presence several cellular viral proteins 4 8 addition levels p53 given cell dictate response cell lower levels p53 result cell cycle arrest 9 differentiation 10 whereas higher levels result apoptosis 9 10
0.5739836.9582339.html.plaintext.txt	7	p53 tumor suppressor protein serves checkpoint maintaining genome stability 1 3 several different biological responses could play role maintaining genome stability strongly correlated wild type p53 function 1 3 following stress conditions presence damaged dna insufficient growth survival factors cellular levels p53 increase leads one least three well understood cellular responses follows cell cycle arrest differentiation apoptosis several factors shown determine cell responds accumulation p53 eg cell type presence several cellular viral proteins 4 8 addition levels p53 given cell dictate response cell lower levels p53 result cell cycle arrest 9 differentiation 10 whereas higher levels result apoptosis 9 10
0.5739836.9582339.html.plaintext.txt	8	functional domains p53 subjected extensive analysis 1 3 4 transcriptional activation domain shown lie within n terminal residues 1 42 11 12 within region number acidic hydrophobic residues characteristics acidic activator family transcriptional factors 13 indeed double point mutation two hydrophobic amino acids residues 22 23 renders p53 transcriptionally inactive 14 two residues presumably required interaction activation domain tata box binding protein andor tata box binding protein associated factors 15 18
0.5739836.9582339.html.plaintext.txt	9	functional domains p53 subjected extensive analysis 1 3 4 transcriptional activation domain shown lie within n terminal residues 1 42 11 12 within region number acidic hydrophobic residues characteristics acidic activator family transcriptional factors 13 indeed double point mutation two hydrophobic amino acids residues 22 23 renders p53 transcriptionally inactive 14 two residues presumably required interaction activation domain tata box binding protein andor tata box binding protein associated factors 15 18
0.5739836.9582339.html.plaintext.txt	10	well established transcriptional activator p53 regulates p21 cyclin dependent kinase inhibitor 19 21 leads p53 dependent g1 arrest however certain functions p53 required apoptosis transactivation function p53 shown required experimental protocols 22 24 several candidate genes play roles apoptosis activated response p53 induction bax 25 igfbp3 26 pag608 27 killerdr5 28 several redox related pigs genes 29 several studies including observations provided evidence p53 might transcription independent function apoptosis 9 30 32 recently proline rich region residues 60 90 comprises five pxxp motifs p represents proline x amino acid found necessary efficient growth suppression 33 apoptosis 34 serve docking site transactivation independent growth arrest induced gas1 35
0.5739836.9582339.html.plaintext.txt	11	well established transcriptional activator p53 regulates p21 cyclin dependent kinase inhibitor 19 21 leads p53 dependent g1 arrest however certain functions p53 required apoptosis transactivation function p53 shown required experimental protocols 22 24 several candidate genes play roles apoptosis activated response p53 induction bax 25 igfbp3 26 pag608 27 killerdr5 28 several redox related pigs genes 29 several studies including observations provided evidence p53 might transcription independent function apoptosis 9 30 32 recently proline rich region residues 60 90 comprises five pxxp motifs p represents proline x amino acid found necessary efficient growth suppression 33 apoptosis 34 serve docking site transactivation independent growth arrest induced gas1 35
0.5739836.9582339.html.plaintext.txt	12	previously showed region residues 23 97 necessary apoptosis 9 precisely map domain n terminus necessary apoptosis made several new mutants analyses mutants lead identification novel domain residues 43 63 mediate apoptosis activate cellular p53 targets also found double point mutation residues 53 54 completely abolishes transcriptional apoptotic activities mediated novel domain thus hypothesize transcriptional activity located novel domain regulates subset cellular p53 targets responsible apoptosis
0.5739836.9582339.html.plaintext.txt	13	previously showed region residues 23 97 necessary apoptosis 9 precisely map domain n terminus necessary apoptosis made several new mutants analyses mutants lead identification novel domain residues 43 63 mediate apoptosis activate cellular p53 targets also found double point mutation residues 53 54 completely abolishes transcriptional apoptotic activities mediated novel domain thus hypothesize transcriptional activity located novel domain regulates subset cellular p53 targets responsible apoptosis
0.5739836.9582339.html.plaintext.txt	14	experimental procedures top abstract introduction procedures results discussion references
0.5739836.9582339.html.plaintext.txt	15	plasmids mutagenesis mutant p53 cdnas generated polymerase chain reaction using full length wild type p53 cdna template generate p531 23 pair primers used follows forward primer n24 gat cga att cac cat ggg cta ccc ata cga tgt tcc aga tta cgc taa act act tcc tga reverse primer c393 gat cga att ctc agt ctg agt cag gcc ctt generate p531 42 pair primers used follows forward primer n43 gat cga att cac cat ggg cta ccc ata cga tgt tcc aga tta cgc ttt gat gct gtc ccc g reverse primer c393 generate p531 63 pair primers used forward primer n64 gat cga att cac cat ggg cta ccc ata cga tgt tcc aga tta cgc tcc cag aat gcc aga ggc reverse primer c393 generate p53gln22 ser23gln53 ser54 cdna fragments encoding amino acids 1 59 60 393 amplified independently ligated together internal avaii site p53gln22 ser23 cdna used template 14 pair primers cdna fragment encoding amino acids 1 59 follows forward primer n1 gat cga att cac cat ggg cta ccc ata cga tgt tcc aga tta cgc tga gga gcc gca gtc aga tcc reverse primer c59 ttc atc tgg acc tgg gtc ttc agt gct ctg ttg ttc aat atc pair primers cdna fragment encoding amino acids 60 393 follows forward primer n60 act gaa gac cca ggt cca reverse primer c393 generate p531 42gln53 ser54 p53gln22 ser23gln53 ser54 cdna amplified forward primer n43 reverse primer c393 mutations confirmed dna sequencing
0.5739836.9582339.html.plaintext.txt	16	plasmids mutagenesis mutant p53 cdnas generated polymerase chain reaction using full length wild type p53 cdna template generate p531 23 pair primers used follows forward primer n24 gat cga att cac cat ggg cta ccc ata cga tgt tcc aga tta cgc taa act act tcc tga reverse primer c393 gat cga att ctc agt ctg agt cag gcc ctt generate p531 42 pair primers used follows forward primer n43 gat cga att cac cat ggg cta ccc ata cga tgt tcc aga tta cgc ttt gat gct gtc ccc g reverse primer c393 generate p531 63 pair primers used forward primer n64 gat cga att cac cat ggg cta ccc ata cga tgt tcc aga tta cgc tcc cag aat gcc aga ggc reverse primer c393 generate p53gln22 ser23gln53 ser54 cdna fragments encoding amino acids 1 59 60 393 amplified independently ligated together internal avaii site p53gln22 ser23 cdna used template 14 pair primers cdna fragment encoding amino acids 1 59 follows forward primer n1 gat cga att cac cat ggg cta ccc ata cga tgt tcc aga tta cgc tga gga gcc gca gtc aga tcc reverse primer c59 ttc atc tgg acc tgg gtc ttc agt gct ctg ttg ttc aat atc pair primers cdna fragment encoding amino acids 60 393 follows forward primer n60 act gaa gac cca ggt cca reverse primer c393 generate p531 42gln53 ser54 p53gln22 ser23gln53 ser54 cdna amplified forward primer n43 reverse primer c393 mutations confirmed dna sequencing
0.5739836.9582339.html.plaintext.txt	17	mutant p53 cdnas cloned separately tetracycline regulated expression vector 10 3 ecori site resulting plasmids used generate cell lines inducibly express p53
0.5739836.9582339.html.plaintext.txt	18	cell lines transfection selection procedures h1299 cell line purchased american type culture collection grown dulbeccos modified eagles medium supplemented 10 fetal bovine serum 37 degrees c 5 co2 transfections performed using calcium chloride method described 36 cell lines expressing inducible proteins interest generated described previously 9 individual clones screened inducible expression p53 protein western blot analysis using monoclonal antibodies p53 h1299 cell lines inducibly express either wild type p53 p53364 393 p53 3 p53364 393 1 respectively described previously 9 h1299 cell line inducibly expresses p5362 91 p5362 91 51
0.5739836.9582339.html.plaintext.txt	19	cell lines transfection selection procedures h1299 cell line purchased american type culture collection grown dulbeccos modified eagles medium supplemented 10 fetal bovine serum 37 degrees c 5 co2 transfections performed using calcium chloride method described 36 cell lines expressing inducible proteins interest generated described previously 9 individual clones screened inducible expression p53 protein western blot analysis using monoclonal antibodies p53 h1299 cell lines inducibly express either wild type p53 p53364 393 p53 3 p53364 393 1 respectively described previously 9 h1299 cell line inducibly expresses p5362 91 p5362 91 51
0.5739836.9582339.html.plaintext.txt	20	western blot analysis cells collected plates phosphate buffered saline resuspended 1 x sample buffer boiled 5 min western blot analysis performed described previously 37 monoclonal antibodies used detect p53 pab240 pab421 37 affinity purified monoclonal antibody p21 ab 1 purchased oncogene science uniondale ny affinity purified anti actin polyclonal antibodies purchased sigma
0.5739836.9582339.html.plaintext.txt	21	western blot analysis cells collected plates phosphate buffered saline resuspended 1 x sample buffer boiled 5 min western blot analysis performed described previously 37 monoclonal antibodies used detect p53 pab240 pab421 37 affinity purified monoclonal antibody p21 ab 1 purchased oncogene science uniondale ny affinity purified anti actin polyclonal antibodies purchased sigma
0.5739836.9582339.html.plaintext.txt	22	growth rate analysis determine rate cell growth cells seeded 5 10 x 104 cells per 60 mm plate without tetracycline 2 microg per ml medium replaced every 72 h times indicated two plates rinsed phosphate buffered saline twice remove dead cells debris live cells plates trypsinized collected separately cells plate counted three times coulter cell counter average number cells least two plates used growth rate determination
0.5739836.9582339.html.plaintext.txt	23	growth rate analysis determine rate cell growth cells seeded 5 10 x 104 cells per 60 mm plate without tetracycline 2 microg per ml medium replaced every 72 h times indicated two plates rinsed phosphate buffered saline twice remove dead cells debris live cells plates trypsinized collected separately cells plate counted three times coulter cell counter average number cells least two plates used growth rate determination
0.5739836.9582339.html.plaintext.txt	24	facs2 analysis cells seeded 20 x 105 per 90 mm plate without tetracycline three days plating floating dead cells medium live cells plate collected fixed 2 ml 70 ethanol least 30 min facs analysis fixed cells centrifuged resuspended 1 ml phosphate buffered saline solution containing 50 microgml rnase sigma propidium iodide sigma stained cells analyzed fluorescence activated cell sorter facscaliber becton dickinson within 4 h percentage cells sub g1 g0 g1 g2 m phases determined using modfit program percentage cells sub g1 phase used index degree apoptosis
0.5739836.9582339.html.plaintext.txt	25	facs2 analysis cells seeded 20 x 105 per 90 mm plate without tetracycline three days plating floating dead cells medium live cells plate collected fixed 2 ml 70 ethanol least 30 min facs analysis fixed cells centrifuged resuspended 1 ml phosphate buffered saline solution containing 50 microgml rnase sigma propidium iodide sigma stained cells analyzed fluorescence activated cell sorter facscaliber becton dickinson within 4 h percentage cells sub g1 g0 g1 g2 m phases determined using modfit program percentage cells sub g1 phase used index degree apoptosis
0.5739836.9582339.html.plaintext.txt	26	cell viability assay trypan blue exclusion cells seeded 2 x 105 per 90 mm plate without tetracycline three days plating floating cells medium live cells plate collected concentrated centrifugation stained trypan blue sigma 15 min live unstained dead stained cells counted two times hemocytometer percentage dead cells control plates subtracted percentage dead cells experimental plates resulting value used index degree apoptosis
0.5739836.9582339.html.plaintext.txt	27	cell viability assay trypan blue exclusion cells seeded 2 x 105 per 90 mm plate without tetracycline three days plating floating cells medium live cells plate collected concentrated centrifugation stained trypan blue sigma 15 min live unstained dead stained cells counted two times hemocytometer percentage dead cells control plates subtracted percentage dead cells experimental plates resulting value used index degree apoptosis
0.5739836.9582339.html.plaintext.txt	28	rna isolation northern blot analysis total rna isolated using trizol reagent life technologies inc northern blot analysis performed described 37 p21 probe made 10 kilobase pair ecori ecori fragment 19 mdm 2 probe made 21 kilobase pair noti smai fragment 38 bax probe made 290 base pair psti bglii fragment 39 gadd45 probe 400 base pair ecori bamhi fragment 40 gapdh probe made 125 kilobase pair psti psti cdna fragment 41 mcg14 cdna probe 200 base pair polymerase chain reaction fragment identified clontech pcr select cdna subtraction2
0.5739836.9582339.html.plaintext.txt	29	results top abstract introduction procedures results discussion references
0.5739836.9582339.html.plaintext.txt	30	novel domain within residues 43 63 necessary mediating apoptosis previously showed p531 22 lacks n terminal 22 amino acids still induce apoptosis well cell cycle arrest 9 since residues 22 23 critical p53 transcriptional activity 14 decided determine whether p531 23 deletes n terminal 23 amino acids would also able induce apoptosis activate cellular p53 targets
0.5739836.9582339.html.plaintext.txt	31	novel domain within residues 43 63 necessary mediating apoptosis previously showed p531 22 lacks n terminal 22 amino acids still induce apoptosis well cell cycle arrest 9 since residues 22 23 critical p53 transcriptional activity 14 decided determine whether p531 23 deletes n terminal 23 amino acids would also able induce apoptosis activate cellular p53 targets
0.5739836.9582339.html.plaintext.txt	32	previously established cell line expresses high levels wild type p53 called p53 3 9 line established using tetracycline regulated expression system described previously 42 using similar techniques established nine stable cell lines express p531 23 three representative cell lines p531 23 9 10 23 shown fig 1a western blot analysis showed cell lines express p531 23 levels comparable wild type p53 p53 3 cells fig 1a characterize p531 23 looked transcriptional apoptotic activities growth rate cell line p531 23 9 transcriptional activity determined monitoring expression endogenous gene p21 well defined transcriptional target p53 19 found p531 23 still capable activating p21 albeit much less degree wild type p53 fig 1a next growth rates p531 23 9 cells uninduced induced conditions determined cells failed multiply following p53 expression fig 1b exclude potential effects regulator tetracycline andor tet vp16 transactivator 42 cell growth analyzed growth rate cell line h24 1 similarly established express protein results showed growth rates h24 1 cells uninduced tet induced tet conditions nearly identical fig 1c indicating tetracycline tet vp16 transactivator effect cell growth well established percentage cells containing sub g1 dna content reflects extent cells undergoing apoptosis 9 23 31 since p53 induce apoptosis h1299 cells 9 31 facs analysis used observe extent apoptosis determining distribution cells phase cell cycle results showed 18 cells expressing p531 23 sub g1 dna content 3 days induction mutant compared less 5 cells expressing p53 fig 1 d e table trypan blue exclusion assay showed 15 cells dead consistent facs analysis contrast 45 30 cells sub g1 dna content day 3 following expression either wild type p53 transactivation deficient p53gln22 ser23 respectively table facs results also showed number cells phase decreased 38 223 following induction p531 23 cells primarily arrested g1 fig 1 d e similar results obtained using another high p531 23 producer p531 23 10
0.5739836.9582339.html.plaintext.txt	33	previously established cell line expresses high levels wild type p53 called p53 3 9 line established using tetracycline regulated expression system described previously 42 using similar techniques established nine stable cell lines express p531 23 three representative cell lines p531 23 9 10 23 shown fig 1a western blot analysis showed cell lines express p531 23 levels comparable wild type p53 p53 3 cells fig 1a characterize p531 23 looked transcriptional apoptotic activities growth rate cell line p531 23 9 transcriptional activity determined monitoring expression endogenous gene p21 well defined transcriptional target p53 19 found p531 23 still capable activating p21 albeit much less degree wild type p53 fig 1a next growth rates p531 23 9 cells uninduced induced conditions determined cells failed multiply following p53 expression fig 1b exclude potential effects regulator tetracycline andor tet vp16 transactivator 42 cell growth analyzed growth rate cell line h24 1 similarly established express protein results showed growth rates h24 1 cells uninduced tet induced tet conditions nearly identical fig 1c indicating tetracycline tet vp16 transactivator effect cell growth well established percentage cells containing sub g1 dna content reflects extent cells undergoing apoptosis 9 23 31 since p53 induce apoptosis h1299 cells 9 31 facs analysis used observe extent apoptosis determining distribution cells phase cell cycle results showed 18 cells expressing p531 23 sub g1 dna content 3 days induction mutant compared less 5 cells expressing p53 fig 1 d e table trypan blue exclusion assay showed 15 cells dead consistent facs analysis contrast 45 30 cells sub g1 dna content day 3 following expression either wild type p53 transactivation deficient p53gln22 ser23 respectively table facs results also showed number cells phase decreased 38 223 following induction p531 23 cells primarily arrested g1 fig 1 d e similar results obtained using another high p531 23 producer p531 23 10
0.5739836.9582339.html.plaintext.txt	34	view larger version 29k fig 1 n terminal 23 amino acids dispensable apoptosis levels p53 p21 actin p53 3 p531 23 9 10 23 cell lines assayed western blot analysis cell extracts prepared uninduced cells cells induced express wild type p53 p531 23 upper portion blot probed mixture p53 monoclonal antibodies pab421 pab240 actin polyclonal antibody mutant p531 23 migrates faster wild type p53 missing 23 amino acids lower portion blot probed p21 monoclonal antibody b growth rates p531 23 9 cells presence absence p53 measured described experimental procedures c growth rates h24 cells presence absence tetracycline d dna contents quantitated propidium iodide staining fixed cells day 3 following withdrawal tetracycline described experimental procedures e percentages p531 23 9 cells sub g1 g0 g1 g2 m phases presence absence p53 3 days quantitated using modfit program described experimental procedures
0.5739836.9582339.html.plaintext.txt	35	view table table characteristics various mutant p53 proteins
0.5739836.9582339.html.plaintext.txt	36	since p531 23 still capable inducing apoptosis p53 activation domain lies within residues 1 42 11 12 determined whether half residues 24 42 previously defined activation domain required apoptosis end established 16 individual stable cell lines inducibly express p531 42 lacks n terminal 42 amino acids three representative cell lines p531 42 2 5 11 shown fig 2a consistent previous results p53gln22 ser23 activate p21 9 22 33 43 p531 42 minimally activated p21 compared wild type p53 fig 2a determined growth rate high producer p531 42 2 surprisingly found majority cells died within 3 days following induction p531 42 fig 2b addition trypan blue exclusion assay facs analysis showed approximately 50 68 cells underwent apoptosis fig 2c table similar results obtained several cell lines results suggest entire previously defined activation domain within n terminal 42 amino acids dispensable apoptosis fact deletion region enhanced ability p53 induce apoptosis table
0.5739836.9582339.html.plaintext.txt	37	since p531 23 still capable inducing apoptosis p53 activation domain lies within residues 1 42 11 12 determined whether half residues 24 42 previously defined activation domain required apoptosis end established 16 individual stable cell lines inducibly express p531 42 lacks n terminal 42 amino acids three representative cell lines p531 42 2 5 11 shown fig 2a consistent previous results p53gln22 ser23 activate p21 9 22 33 43 p531 42 minimally activated p21 compared wild type p53 fig 2a determined growth rate high producer p531 42 2 surprisingly found majority cells died within 3 days following induction p531 42 fig 2b addition trypan blue exclusion assay facs analysis showed approximately 50 68 cells underwent apoptosis fig 2c table similar results obtained several cell lines results suggest entire previously defined activation domain within n terminal 42 amino acids dispensable apoptosis fact deletion region enhanced ability p53 induce apoptosis table
0.5739836.9582339.html.plaintext.txt	38	view larger version 21k fig 2 p531 42 lacks previously defined activation domain mediate apoptosis levels p53 p21 actin p53 3 p531 42 2 5 11 cell lines assayed western blot analysis b growth rates p531 42 2 cells presence absence p53 c percentages p531 42 2 cells sub g1 g0 g1 g2 m phases presence absence p53 3 days experiments performed identical manner fig 1
0.5739836.9582339.html.plaintext.txt	39	delineate domain n terminus required apoptosis generated seven inducible cell lines expressing p531 63 lacks n terminal 63 amino acids contains intact proline rich region three representative cell lines p531 63 14 22 27 shown fig 3a activity p531 63 analyzed results showed p531 63 unable activate p21 expression fig 3a p531 63 14 cells high p53 producer continued multiply p531 63 induced fig 3b furthermore facs analysis trypan blue exclusion assay showed neither apoptosis cell cycle arrest observed cells expressing p531 63 fig 3c table
0.5739836.9582339.html.plaintext.txt	40	delineate domain n terminus required apoptosis generated seven inducible cell lines expressing p531 63 lacks n terminal 63 amino acids contains intact proline rich region three representative cell lines p531 63 14 22 27 shown fig 3a activity p531 63 analyzed results showed p531 63 unable activate p21 expression fig 3a p531 63 14 cells high p53 producer continued multiply p531 63 induced fig 3b furthermore facs analysis trypan blue exclusion assay showed neither apoptosis cell cycle arrest observed cells expressing p531 63 fig 3c table
0.5739836.9582339.html.plaintext.txt	41	view larger version 21k fig 3 p531 63 lacks n terminal 63 amino acids contains intact pxxp motifs failed induce apoptosis levels p53 p21 actin p53 3 p531 63 14 22 27 cell lines assayed western blot analysis b growth rates p531 63 14 cells presence absence p53 c percentages p531 63 14 cells sub g1 g0 g1 g2 m phases presence absence p53 3 days experiments performed identical manner fig 1
0.5739836.9582339.html.plaintext.txt	42	within residues 43 63 lies another activation domain overlaps domain necessary mediating apoptosis ability transactivation deficient p53gln22 ser23 induce apoptosis leads hypothesis p53 transcription independent apoptotic activity 9 31 33 since p531 42 lacks previously defined activation domain minimally activates p21 determined western blot analysis fig 2a appears induce apoptosis transcription independent manner ascertain whether p531 42 contains transcriptional activity expression patterns four well defined cellular p53 targets p21 mdm2 gadd45 bax analyzed cells expressing p531 42 northern blot analysis fig 4a expression levels genes cells without p53 quantitated phosphorimage scanner fold increase relative mrnas calculated normalization glyceraldehyde 3 phosphate dehydrogenase mrna levels table ii results showed clearly p531 42 significantly activated mdm2 8 fold gadd45 703 fold bax 39 fold minimally activated p21 183 fold expected wild type p53 mutant p53gln22 ser23 activated cellular p53 targets fig 4a table ii control p5364 91 lacks five pxxp motifs examined proline rich domain p53 dispensable transactivation 33 34 expected p5364 91 activated p53 targets fig 4a table ii since p531 63 failed activate p53 regulated genes data shown results suggest another activation domain lies within residues 43 63 clarity designate originally defined activation domain located within residues 1 42 activation domain novel domain activation domain ii
0.5739836.9582339.html.plaintext.txt	43	within residues 43 63 lies another activation domain overlaps domain necessary mediating apoptosis ability transactivation deficient p53gln22 ser23 induce apoptosis leads hypothesis p53 transcription independent apoptotic activity 9 31 33 since p531 42 lacks previously defined activation domain minimally activates p21 determined western blot analysis fig 2a appears induce apoptosis transcription independent manner ascertain whether p531 42 contains transcriptional activity expression patterns four well defined cellular p53 targets p21 mdm2 gadd45 bax analyzed cells expressing p531 42 northern blot analysis fig 4a expression levels genes cells without p53 quantitated phosphorimage scanner fold increase relative mrnas calculated normalization glyceraldehyde 3 phosphate dehydrogenase mrna levels table ii results showed clearly p531 42 significantly activated mdm2 8 fold gadd45 703 fold bax 39 fold minimally activated p21 183 fold expected wild type p53 mutant p53gln22 ser23 activated cellular p53 targets fig 4a table ii control p5364 91 lacks five pxxp motifs examined proline rich domain p53 dispensable transactivation 33 34 expected p5364 91 activated p53 targets fig 4a table ii since p531 63 failed activate p53 regulated genes data shown results suggest another activation domain lies within residues 43 63 clarity designate originally defined activation domain located within residues 1 42 activation domain novel domain activation domain ii
0.5739836.9582339.html.plaintext.txt	44	view larger version 20k fig 4 within residues 43 63 lies another activation domain northern blots prepared using 10 microg total rna isolated uninduced cells cells induced express wild type p53 p531 42 p5362 91 p53gln22 ser23 blots probed p21 mdm2 gadd45 bax gapdh cdnas respectively b northern blot prepared using 10 microg total rna isolated uninduced cells cells induced express wild type p53 p531 42 p5362 91 p53364 393 p53gln22 ser23 blot probed mcg14 cdna c northern blot prepared using 10 microg total rna isolated uninduced cells cells induced express wild type p53 p53gln22 ser23gln53 ser54 p531 42gln53 ser54 blot probed mcg14 cdna
0.5739836.9582339.html.plaintext.txt	45	view table table ii transcriptional activities various mutant p53 proteins
0.5739836.9582339.html.plaintext.txt	46	observations raise following question p53gln22 ser23 fail activate well defined p53 transcriptional targets fig 4a table ii despite fact still contains intact activation domain ii one possibilities p53gln22 ser23 might still able activate subset p53 transcriptional targets yet identified end tested expression patterns several potential p53 targets identified laboratory found one putative p53 transcriptional target mcg14 activated p53gln22 ser23 level comparable wild type p53 p531 42 p5364 91 p53364 393 fig 4b
0.5739836.9582339.html.plaintext.txt	47	observations raise following question p53gln22 ser23 fail activate well defined p53 transcriptional targets fig 4a table ii despite fact still contains intact activation domain ii one possibilities p53gln22 ser23 might still able activate subset p53 transcriptional targets yet identified end tested expression patterns several potential p53 targets identified laboratory found one putative p53 transcriptional target mcg14 activated p53gln22 ser23 level comparable wild type p53 p531 42 p5364 91 p53364 393 fig 4b
0.5739836.9582339.html.plaintext.txt	48	since double point mutation residues 22 23 abolishes transcriptional activity activation domain 14 looked analogous hydrophobic amino acids within activation domain ii two found tryptophan residue 53 phenylalanine residue 54 therefore made identical mutations two amino acids p53gln22 ser23 p531 42 changing tryptophan 53 glutamine phenylalanine 54 serine generate p53gln22 ser23gln53 ser54 p531 42gln53 ser54 established number cell lines inducibly express mutants ability induce apoptosis activate cellular p53 targets similarly analyzed three representative cell lines express either p53gln22 ser23gln53 ser54 p531 42gln53 ser54 shown fig 5 c respectively expected western blot analysis showed p21 activated either mutants fig 5 c bottom panel addition mutants unable induce apoptosis demonstrated rate cell growth fig 5 b d trypan blue exclusion assay facs analysis table furthermore putative cellular p53 target mcg14 activated p531 42 p53gln22 ser23 fig 4b failed activated cells expressing either p53gln22 ser23gln53 ser54 p531 42gln53 ser54 fig 4c results indicate residues 53 54 critical novel domain within residues 43 63 induce apoptosis activate cellular p53 targets
0.5739836.9582339.html.plaintext.txt	49	since double point mutation residues 22 23 abolishes transcriptional activity activation domain 14 looked analogous hydrophobic amino acids within activation domain ii two found tryptophan residue 53 phenylalanine residue 54 therefore made identical mutations two amino acids p53gln22 ser23 p531 42 changing tryptophan 53 glutamine phenylalanine 54 serine generate p53gln22 ser23gln53 ser54 p531 42gln53 ser54 established number cell lines inducibly express mutants ability induce apoptosis activate cellular p53 targets similarly analyzed three representative cell lines express either p53gln22 ser23gln53 ser54 p531 42gln53 ser54 shown fig 5 c respectively expected western blot analysis showed p21 activated either mutants fig 5 c bottom panel addition mutants unable induce apoptosis demonstrated rate cell growth fig 5 b d trypan blue exclusion assay facs analysis table furthermore putative cellular p53 target mcg14 activated p531 42 p53gln22 ser23 fig 4b failed activated cells expressing either p53gln22 ser23gln53 ser54 p531 42gln53 ser54 fig 4c results indicate residues 53 54 critical novel domain within residues 43 63 induce apoptosis activate cellular p53 targets
0.5739836.9582339.html.plaintext.txt	50	view larger version 38k fig 5 double point mutation residues 53 54 renders p53gln22 ser23gln53 ser54 p531 42gln53 ser54 completely inert inducing apoptosis levels p53 p21 actin p53 3 p53gln22 ser23gln53 ser54 9 11 12 cell lines assayed western blot analysis b growth rates p53gln22 ser23gln53 ser54 9 cells presence absence p53 c levels p53 p21 actin p53 3 p531 42gln53 ser54 1 9 11 cell lines assayed western blot analysis d growth rates p531 42gln53 ser54 11 cells presence absence p53 experiments performed identical manner fig 1
0.5739836.9582339.html.plaintext.txt	51	discussion top abstract introduction procedures results discussion references
0.5739836.9582339.html.plaintext.txt	52	p53 protein divided several functional domains 1 3 4 follows activation domain lies within residues 1 42 shown required transcriptional activation repression 11 12 14 44 b newly identified proline rich domain within residues 64 91 necessary efficient growth suppression 33 apoptosis 34 mediating gas1 dependent growth arrest 35 c sequence specific dna binding domain lies within central conserved portion protein 1 3 d nuclear localization signal lies within residues 316 325 1 3 e tetramerization domain lies within residues 334 356 1 3 f c terminal basic domain binds dna nonspecifically regulates sequence specific dna binding activity 1 3
0.5739836.9582339.html.plaintext.txt	53	found within residues 43 63 lies another novel domain necessary apoptosis basis following observations p531 42 lacks n terminal 42 amino acids previously defined activation domain contains strong apoptotic activity ii p531 63 lacks n terminal 63 amino acids contains intact pxxp motifs apoptotic activity iii double point mutation residues 53 54 renders p531 42gln53 ser54 p53gln22 ser23gln53 ser54 completely inert inducing apoptosis iv codon 53 one frequently mutated sites outside dna binding domain p53 gene human tumors 45 underscores importance apoptotic function within residues 43 63 p53 tumor suppression
0.5739836.9582339.html.plaintext.txt	54	novel domain mediate apoptotic activity previously shown p53gln22 ser23 activate several cellular p53 targets 9 14 22 31 43 still capable inducing apoptosis 9 31 34 p53 mutant lacks proline rich region capable activating several p53 targets 33 34 induce apoptosis 33 34 results lead hypothesis p53 transcription dependent independent functions apoptosis however well established p53 mutants defective sequence specific dna binding activity also inert inducing apoptosis 1 3 4 suggesting p53 sequence specific dna binding activity possibly sequence specific transcriptional activity required inducing apoptosis found p531 42 lacks entire previously defined activation domain induces apoptosis also activates mdm2 bax gadd45 genes activation domain ii located residues 43 63 fig 4 table ii since p53gln22 ser23 contains intact activation domain ii hypothesized might still contain transcriptional activity indeed found p53gln22 ser23 activate one putative p53 targets mcg14 furthermore double point mutation residues 53 54 completely abolishes ability p53gln22 ser23gln53 ser54 p531 42gln53 ser54 activate mcg14 induce apoptosis consistent results candau et al 46 recently showed within residues 40 83 lies sub activation domain activate reporter gene control promoter p53 responsive element p53 cotransfected double point mutation residues 53 54 also abolished transcriptional activity sub activation domain results suggest p53 two independent activation domains second activation domain within transcription factor without precedent herpes simplex virus protein vp16 also contains two independent activation domains 47 thus appears response various stress conditions subsequent modifications two independent activation domains might serve intrinsic factor p53 determines whether given p53 target activated although bax mdm2 gadd45 activation domain ii regulated gene products cellular p53 targets might mediate p53 dependent apoptosis basis two observations genes activated p53gln22 ser23 competent inducing apoptosis fig 4a table ii ii genes activated p5362 91 defective inducing apoptosis fig 4a table ii since cell type shown influence cellular response cell cycle arrest apoptosis p53 1 4 8 cellular genetic background might determine modification two activation domains therefore results obtained h1299 cells need confirmed cell types
0.5739836.9582339.html.plaintext.txt	55	novel domain mediate apoptotic activity previously shown p53gln22 ser23 activate several cellular p53 targets 9 14 22 31 43 still capable inducing apoptosis 9 31 34 p53 mutant lacks proline rich region capable activating several p53 targets 33 34 induce apoptosis 33 34 results lead hypothesis p53 transcription dependent independent functions apoptosis however well established p53 mutants defective sequence specific dna binding activity also inert inducing apoptosis 1 3 4 suggesting p53 sequence specific dna binding activity possibly sequence specific transcriptional activity required inducing apoptosis found p531 42 lacks entire previously defined activation domain induces apoptosis also activates mdm2 bax gadd45 genes activation domain ii located residues 43 63 fig 4 table ii since p53gln22 ser23 contains intact activation domain ii hypothesized might still contain transcriptional activity indeed found p53gln22 ser23 activate one putative p53 targets mcg14 furthermore double point mutation residues 53 54 completely abolishes ability p53gln22 ser23gln53 ser54 p531 42gln53 ser54 activate mcg14 induce apoptosis consistent results candau et al 46 recently showed within residues 40 83 lies sub activation domain activate reporter gene control promoter p53 responsive element p53 cotransfected double point mutation residues 53 54 also abolished transcriptional activity sub activation domain results suggest p53 two independent activation domains second activation domain within transcription factor without precedent herpes simplex virus protein vp16 also contains two independent activation domains 47 thus appears response various stress conditions subsequent modifications two independent activation domains might serve intrinsic factor p53 determines whether given p53 target activated although bax mdm2 gadd45 activation domain ii regulated gene products cellular p53 targets might mediate p53 dependent apoptosis basis two observations genes activated p53gln22 ser23 competent inducing apoptosis fig 4a table ii ii genes activated p5362 91 defective inducing apoptosis fig 4a table ii since cell type shown influence cellular response cell cycle arrest apoptosis p53 1 4 8 cellular genetic background might determine modification two activation domains therefore results obtained h1299 cells need confirmed cell types
0.5739836.9582339.html.plaintext.txt	56	intriguing although p53gln22 ser23 contains intact activation domain ii fails activate bax gadd45 mdm2 fig 4a since p531 23 p531 42 activate p53 targets suggests presence first 23 amino acids may mask ability activation domain ii p53gln22 ser23 activate cellular p53 targets alternatively also possible activation domain inactivated double point mutation residues 22 23 n terminal 42 residues might inhibit block interaction co activator adaptor activation domain ii required activation p53 targets mdm2 p21 bax gadd45 activation p53 targets mcg14 important note although activation domain primarily responsible activation p21 level p21 cells expressing either p531 23 p531 42 slightly increased upon p53 induction figs 1a 2a suggesting activation domain ii weakly activate p21 furthermore preliminary studies showed activation p21 compromised double point mutation residues 53 54 p53gln53 ser54 expressed low intermediate level3 consistent idea activation domain ii contributes activation p21 since several clones express various expression levels target genes required determining function targets 48 results remain confirmed
0.5739836.9582339.html.plaintext.txt	57	previously shown overexpression p21 protect human colorectal carcinoma rko cells prostaglandin a2 mediated apoptosis 49 lack p21 expression due homologous deletion p21 gene also renders hct116 colorectal cancer cells susceptible apoptosis following treatment either radiation chemotherapeutic agents 50 addition significant fraction tumors mice deriving p21 hct116 cancer cells completely cured tumors deriving p21 cancer cells underwent regrowth treatment radiation 50 interesting note p53gln22 ser23 p531 42 lack functional activation domain significantly activate p21 fig 2 4 table ii induce apoptosis table strong apoptotic activity conferred p531 42 might due failure activating p21 thus generated mutant p531 42 might better wild type p53 elimination cancer cells therefore potential candidate gene therapy
0.5739836.9582339.html.plaintext.txt	58	previously shown overexpression p21 protect human colorectal carcinoma rko cells prostaglandin a2 mediated apoptosis 49 lack p21 expression due homologous deletion p21 gene also renders hct116 colorectal cancer cells susceptible apoptosis following treatment either radiation chemotherapeutic agents 50 addition significant fraction tumors mice deriving p21 hct116 cancer cells completely cured tumors deriving p21 cancer cells underwent regrowth treatment radiation 50 interesting note p53gln22 ser23 p531 42 lack functional activation domain significantly activate p21 fig 2 4 table ii induce apoptosis table strong apoptotic activity conferred p531 42 might due failure activating p21 thus generated mutant p531 42 might better wild type p53 elimination cancer cells therefore potential candidate gene therapy
0.5739836.9582339.html.plaintext.txt	59	thank bill dynan howard rasmussen initial setup core facility makes work possible c prives constant encouragement grateful mark anderson rhea markowitz dan dransfield critical reading manuscript many suggestions
0.5739836.9582339.html.plaintext.txt	60	thank bill dynan howard rasmussen initial setup core facility makes work possible c prives constant encouragement grateful mark anderson rhea markowitz dan dransfield critical reading manuscript many suggestions
0.5739836.9582339.html.plaintext.txt	61	work supported part grants damd17 94 j 4142 damd17 97 7019 united states department army breast cancer program grant ca76069 01 national institutes healththe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5739836.9582339.html.plaintext.txt	62	work supported part grants damd17 94 j 4142 damd17 97 7019 united states department army breast cancer program grant ca76069 01 national institutes healththe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.5739836.9582339.html.plaintext.txt	63	correspondence addressed cb 2803immag 1120 15th st medical college georgia augusta ga 30912 tel 706 721 8760 fax 706 721 8752 e mail xchenatmailmcgedu u d
0.5739836.9582339.html.plaintext.txt	64	correspondence addressed cb 2803immag 1120 15th st medical college georgia augusta ga 30912 tel 706 721 8760 fax 706 721 8752 e mail xchenatmailmcgedu u d
0.5739836.9582339.html.plaintext.txt	65	2 abbreviation used facs fluorescence activated cell sorter
0.5739836.9582339.html.plaintext.txt	66	references top abstract introduction procedures results discussion references ko l j prives c 1996 genes dev 10 1054 1072crossrefmedline order article via infotrieve lane d p 1992 nature 359 15 16medline order article via infotrieve levine j 1997 cell 88 323 331medline order article via infotrieve gottlieb m oren m 1996 biochim biophys acta 1287 77 102crossrefmedline order article via infotrieve fisher d e 1994 cell 78 539 542medline order article via infotrieve white e 1996 genes dev 10 1 15crossrefmedline order article via infotrieve wu x levine j 1994 proc natl acad sci u 91 3602 3606abstract lowe ruley h e 1993 genes dev 7 535 545abstract chen x ko l j jarayaman l prives c 1996 genes dev 10 2438 2451abstract ronen d schwartz d teitz y goldfinger n rotter v 1996 cell growth differ 7 21 30abstract unger mietz j scheffner m yee c l howley p m 1993 mol cell biol 9 5186 5194 chang j kim d h lee w choi k y sung y c 1995 j biol chem 270 25014 25019abstractfree full text mitchell p j tjian r 1989 science 245 371 378medline order article via infotrieve lin j chen j elenbaas b levine j 1994 genes dev 8 1235 1246abstract lu h levine j 1995 proc natl acad sci u 92 5154 5158abstract thut c chen j l klemm r tjian r 1995 science 267 100 104medline order article via infotrieve horikoshi n usheva chen j levine j weinmann r shenk 1995 mol cell biol 15 227 234abstract liu x miller c w koeffler p h berk j 1993 mol cell biol 13 3291 3300abstract el deiry w tokino velculescu v e levy d b parsons r trent j m lin d mercer w e kinzler k w vogelstein b 1993 cell 75 817 825medline order article via infotrieve xiong y hannon g j zhang h casso d kobayashi r beach d 1993 nature 366 701 704crossrefmedline order article via infotrieve harper j w adami g r wei n keyomarsi k elledge j 1993 cell 75 805 816medline order article via infotrieve attardi l d lowe w brugarolas j jacks 1996 embo j 15 3693 3701medline order article via infotrieve sabbatini p lin j levine j white e 1995 genes dev 9 2184 2192abstract pietenpol j tokino thiagalingam el deiry w kinzler k w vogelstein b 1994 proc natl acad sci u 91 1998 2002abstract miyashita krajewski krajewski m wang h g lin h k liebermann d hoffman b reed j c 1994 oncogene 9 1799 1805medline order article via infotrieve buckbinder l talbott r velasco miguel takenaka faha b seizinger b r kley n 1995 nature 377 646 649crossrefmedline order article via infotrieve israeli d tessler e haupt y elkeles wilder amson r telerman oren m 1997 embo j 16 4384 4392abstractfree full text wu g burns f mcdonald e r iii jiang w meng r krantz d kao g gan d d zhou j y muschel r hamilton r spinner n b markowitz wu g el deiry w 1997 nat genet 17 141 143medline order article via infotrieve polyak k xia y zweier j l kinzler k w vogelstein b 1997 nature 389 300 305crossrefmedline order article via infotrieve caelles c helmberg karin m 1994 nature 370 220 223crossrefmedline order article via infotrieve haupt y rowan shaulian e vousden k oren m 1995 genes dev 9 2170 2183abstract wagner j kokontis j m hay n 1994 genes dev 8 2817 2830abstract walker k k levine j 1996 proc natl acad sci u 93 15335 15340abstractfree full text sakamuro d sabbatini p white e prendergast g c 1997 oncogene 15 887 898crossrefmedline order article via infotrieve ruaro e m collavin l del sal g haffner r oren m levine j schneider c 1997 proc natl acad sci u 94 4675 4680abstractfree full text chen c okayama h 1987 mol cell biol 7 2745 2752medline order article via infotrieve chen x bargonetti j prives c 1995 cancer res 55 4257 4263abstract oliner j d pietenpol j thiagalingam gyuris j kinzler k w vogelstein b 1993 nature 362 857 860crossrefmedline order article via infotrieve oltvai z n milman c l korsmeyer j 1993 cell 74 609 619medline order article via infotrieve smith m l chen zhan q bae chen c y gilmer m kastan m b oconnor p m fornace j jr 1994 science 266 1376 1380medline order article via infotrieve marty f l piechaczyk m sabrouty l dani c jeateur p blanchard j m 1985 nucleic acids res 13 1431 1442abstract resnitzky d gossen m bujard h reed 1994 mol cell biol 14 1669 1679abstract wang x vermeulen w coursen j d gibson m lupold e forrester k xu g elmore l yeh h hoeijmakers j h j harris c c 1996 genes dev 10 1219 1232abstract murphy m hinman levine j 1996 genes dev 10 2971 2980abstract levine j chang dittmer d notterman d silver thorn k welsh d wu m 1994 j lab clin med 123 817 823medline order article via infotrieve candau r scolnick d m darpino p ying c y halazonetis d berger l 1997 oncogene 15 807 816crossrefmedline order article via infotrieve regier j l shen f triezenberg j 1993 proc natl acad sci u 90 883 887abstract yin d x zhu l schimke r 1996 anal biochem 235 195 201crossrefmedline order article via infotrieve gorospe m wang x guyton k z holbrook n k 1996 mol cell biol 16 6654 6660abstract waldman zhang y dillehay l yu j kinzler k vogelstein b williams j 1997 nat med 3 1034 1036medline order article via infotrieve
0.5739836.9582339.html.plaintext.txt	67	copyright 1998 american society biochemistry molecular biology inc
0.57820463.12468545.html.plaintext.txt	0	catalase protects hepg2 cells apoptosis induced dna damaging agents accelerating degradation p53 jingxiang bai arthur cederbaum
0.57820463.12468545.html.plaintext.txt	1	department pharmacology biological chemistry mount sinai school medicine new york new york 10029
0.57820463.12468545.html.plaintext.txt	2	received publication june 24 2002 revised form november 6 2002
0.57820463.12468545.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references
0.57820463.12468545.html.plaintext.txt	4	oxidants h2o2 play role toxicity certain dna damaging agents process often involves tumor suppressor p53 h2o2 rapidly degraded catalase protects cells oxidant injury study effect catalase apoptosis induced dna damaging agents hepg2 cells infected adenovirus containing cdna catalase ad cat forty eight hours infection catalase protein activity increased 7 10 fold compared control cells infected ad lacz treatment vp16 mitomycin c control cells underwent apoptosis p53 dependent manner however overexpression catalase inhibited apoptosis basal levels well vp16 mitomycin c stimulated levels p53 p21 protein decreased catalase overexpressing cells compared control cells however p53 mrna levels decreased catalase difference p53 protein synthesis catalase overexpressing cells control cells however pulse chase experiments indicated p53 protein degradation enhanced catalase overexpressing cells proteasome inhibitors calpeptin prevented catalase mediated decrease p53 content whereas vp16 increased catalase overexpression decreased phosphorylation p53 protein phosphatase inhibitor okadaic acid prevent catalase mediated regulation p53 phosphorylated p53 results demonstrate catalase protects hepg2 cells apoptosis induced dna damaging agents association decreasing p53 phosphorylation latter may lead acceleration degradation p53 protein proteasome complex suggests level catalase may play critical role cell induced resistance effects anti cancer drugs regulate p53 introduction top abstract introduction materials methods results discussion references
0.57820463.12468545.html.plaintext.txt	5	oxidants h2o2 play role toxicity certain dna damaging agents process often involves tumor suppressor p53 h2o2 rapidly degraded catalase protects cells oxidant injury study effect catalase apoptosis induced dna damaging agents hepg2 cells infected adenovirus containing cdna catalase ad cat forty eight hours infection catalase protein activity increased 7 10 fold compared control cells infected ad lacz treatment vp16 mitomycin c control cells underwent apoptosis p53 dependent manner however overexpression catalase inhibited apoptosis basal levels well vp16 mitomycin c stimulated levels p53 p21 protein decreased catalase overexpressing cells compared control cells however p53 mrna levels decreased catalase difference p53 protein synthesis catalase overexpressing cells control cells however pulse chase experiments indicated p53 protein degradation enhanced catalase overexpressing cells proteasome inhibitors calpeptin prevented catalase mediated decrease p53 content whereas vp16 increased catalase overexpression decreased phosphorylation p53 protein phosphatase inhibitor okadaic acid prevent catalase mediated regulation p53 phosphorylated p53 results demonstrate catalase protects hepg2 cells apoptosis induced dna damaging agents association decreasing p53 phosphorylation latter may lead acceleration degradation p53 protein proteasome complex suggests level catalase may play critical role cell induced resistance effects anti cancer drugs regulate p53 introduction top abstract introduction materials methods results discussion references
0.57820463.12468545.html.plaintext.txt	6	many chemotherapeutic drugs including vp16 mitomycin c induce cells undergo apoptosis damage nuclear dna activation wild type p53 major tumor suppressor protein implicated cell cycle control dna repair apoptosis 1 3 reported involved process apoptosis induced dna damaging agents 3 4 increase p53 levels dna damage results large part stabilization p53 protein degradation accumulation p53 occurs increased protein stability presence ongoing translation 4 acute overexpression wild type p53 mediated adenovirus facilitates ability dna damaging drugs induce death cancer normal cells 5 transcription factor p53 protein enhances transcription rate several genes including p21waf1 gadd45 14 3 3 genes involved cell cycle arrest 6 8 bax cd95 noxa puma p53aip1 related p53 dependent apoptosis 9 13
0.57820463.12468545.html.plaintext.txt	7	many chemotherapeutic drugs including vp16 mitomycin c induce cells undergo apoptosis damage nuclear dna activation wild type p53 major tumor suppressor protein implicated cell cycle control dna repair apoptosis 1 3 reported involved process apoptosis induced dna damaging agents 3 4 increase p53 levels dna damage results large part stabilization p53 protein degradation accumulation p53 occurs increased protein stability presence ongoing translation 4 acute overexpression wild type p53 mediated adenovirus facilitates ability dna damaging drugs induce death cancer normal cells 5 transcription factor p53 protein enhances transcription rate several genes including p21waf1 gadd45 14 3 3 genes involved cell cycle arrest 6 8 bax cd95 noxa puma p53aip1 related p53 dependent apoptosis 9 13
0.57820463.12468545.html.plaintext.txt	8	studies variety cell types suggested ros formation may directly related ability dna damaging agents induce apoptosis 14 studies indicate ros downstream mediators p53 dependent apoptosis 15 16 p53 acts regulate intracellular redox state induces apoptosis pathway dependent ros production 17 p53 results apoptosis multi step process including transcriptional induction redox related genes generation ros oxidative degradation mitochondrial components leading apoptosis 15 also evidence ros could regulate apoptosis signal transmitter mediator 16 18 19 however studies indicate apoptosis induced absence detectable oxidative stress cells treated vp 16 cisplatin 20 oxidative stress inhibit apoptosis human lymphoma cells 21
0.57820463.12468545.html.plaintext.txt	9	studies variety cell types suggested ros formation may directly related ability dna damaging agents induce apoptosis 14 studies indicate ros downstream mediators p53 dependent apoptosis 15 16 p53 acts regulate intracellular redox state induces apoptosis pathway dependent ros production 17 p53 results apoptosis multi step process including transcriptional induction redox related genes generation ros oxidative degradation mitochondrial components leading apoptosis 15 also evidence ros could regulate apoptosis signal transmitter mediator 16 18 19 however studies indicate apoptosis induced absence detectable oxidative stress cells treated vp 16 cisplatin 20 oxidative stress inhibit apoptosis human lymphoma cells 21
0.57820463.12468545.html.plaintext.txt	10	catalase anti oxidative enzyme able degrade hydrogen peroxide h2o2 important ros related p53 activation catalase shown protect variety cells oxidative stress induced toxicity 22 laboratory utilized adenoviral catalase expression systems study ability catalase prevent cyp2e1 dependent ros dependent toxicity hepg2 cells 23 24 current study catalase adenovirus used infect hepg2 cells study effects catalase regulation apoptosis modulation p53 expression induced dna damaging agents materials methods top abstract introduction materials methods results discussion references
0.57820463.12468545.html.plaintext.txt	11	catalase anti oxidative enzyme able degrade hydrogen peroxide h2o2 important ros related p53 activation catalase shown protect variety cells oxidative stress induced toxicity 22 laboratory utilized adenoviral catalase expression systems study ability catalase prevent cyp2e1 dependent ros dependent toxicity hepg2 cells 23 24 current study catalase adenovirus used infect hepg2 cells study effects catalase regulation apoptosis modulation p53 expression induced dna damaging agents materials methods top abstract introduction materials methods results discussion references
0.57820463.12468545.html.plaintext.txt	12	reagents propidium iodide purchased molecular probes eugene polyclonal antibody raised rabbit human catalase obtained calbiochem antibodies raised rabbit p53 phosphorylated p53 serine 20 p21 bcl 2 bcl xl obtained santa cruz santa cruz ca horseradish peroxidase conjugated goat anti rabbit igg mem1 fetal bovine serum purchased sigma
0.57820463.12468545.html.plaintext.txt	13	reagents propidium iodide purchased molecular probes eugene polyclonal antibody raised rabbit human catalase obtained calbiochem antibodies raised rabbit p53 phosphorylated p53 serine 20 p21 bcl 2 bcl xl obtained santa cruz santa cruz ca horseradish peroxidase conjugated goat anti rabbit igg mem1 fetal bovine serum purchased sigma
0.57820463.12468545.html.plaintext.txt	14	cell culture recombinant adenovirus infection hepg2 cells cultured mem containing 10 fetal calf serum 100 unitsml penicillin 100 microgml streptomycin 2 mm glutamine humidified atmosphere 5 co2 37 degrees c ad lacz galactosidase expressing replication deficient adenovirus ad cat human catalase expressing replication deficient adenovirus constructed described previously 23 infection cells seeded onto dishes plates grown 60 confluence infected ad lacz ad cat 100 moi forty eight hours infection cells collected assayed catalase expression treated dna damaging agents
0.57820463.12468545.html.plaintext.txt	15	cell culture recombinant adenovirus infection hepg2 cells cultured mem containing 10 fetal calf serum 100 unitsml penicillin 100 microgml streptomycin 2 mm glutamine humidified atmosphere 5 co2 37 degrees c ad lacz galactosidase expressing replication deficient adenovirus ad cat human catalase expressing replication deficient adenovirus constructed described previously 23 infection cells seeded onto dishes plates grown 60 confluence infected ad lacz ad cat 100 moi forty eight hours infection cells collected assayed catalase expression treated dna damaging agents
0.57820463.12468545.html.plaintext.txt	16	cell transfectionhepg2 cells seeded onto 10 cm culture dishes grown 80 confluence expression plasmid vector pcmv p53mt135 clontech containing mutant p53 empty vector pcmv neo transfected hepg2 cells using effectene transfection reagent qiagen according instructions provided manufacturer mutant p53 expression vector encodes mutant p53 protein combines wild type p53 protein dominant negative manner blocks dna binding domain wild type p53 therefore inhibiting activity wild type p53 cells selected mem containing 1 mgml g418 two weeks transfection surviving clones isolated grown large scale stable cell lines overexpression mutant p53 hepg2 mtp53 well cells transfected empty vector hepg2 neo selected maintained mem containing 1 mgml g418
0.57820463.12468545.html.plaintext.txt	17	cell transfectionhepg2 cells seeded onto 10 cm culture dishes grown 80 confluence expression plasmid vector pcmv p53mt135 clontech containing mutant p53 empty vector pcmv neo transfected hepg2 cells using effectene transfection reagent qiagen according instructions provided manufacturer mutant p53 expression vector encodes mutant p53 protein combines wild type p53 protein dominant negative manner blocks dna binding domain wild type p53 therefore inhibiting activity wild type p53 cells selected mem containing 1 mgml g418 two weeks transfection surviving clones isolated grown large scale stable cell lines overexpression mutant p53 hepg2 mtp53 well cells transfected empty vector hepg2 neo selected maintained mem containing 1 mgml g418
0.57820463.12468545.html.plaintext.txt	18	western blotting cell lysates prepared sonicating cells followed centrifugation protein concentration supernatant measured dc protein assay reagent bio rad ten microg denatured protein resolved 10 sds page electroblotted onto nitrocellulose membranes bio rad membrane incubated rabbit anti human catalase polyclonal antibody 11000 followed incubation horseradish peroxidase conjugated goat anti rabbit igg sigma 15000 detection chemiluminescence reaction carried 1 min using ecl kit amersham biosciences followed exposure kodak x omat x ray film eastman kodak co similar western blots carried detect p53 phosphorylated p53 pp53 p21 bcl 2 bcl xl
0.57820463.12468545.html.plaintext.txt	19	western blotting cell lysates prepared sonicating cells followed centrifugation protein concentration supernatant measured dc protein assay reagent bio rad ten microg denatured protein resolved 10 sds page electroblotted onto nitrocellulose membranes bio rad membrane incubated rabbit anti human catalase polyclonal antibody 11000 followed incubation horseradish peroxidase conjugated goat anti rabbit igg sigma 15000 detection chemiluminescence reaction carried 1 min using ecl kit amersham biosciences followed exposure kodak x omat x ray film eastman kodak co similar western blots carried detect p53 phosphorylated p53 pp53 p21 bcl 2 bcl xl
0.57820463.12468545.html.plaintext.txt	20	catalase activity assay validate expression functional catalase catalase activity fresh sonicated cell extracts determined 25 degrees c decomposition hydrogen peroxide catalase followed ultraviolet spectroscopy 240 nm reaction performed using solution 20 mm hydrogen peroxide 50 mm k2hpo4 ph 70 containing 10 microg total cellular protein final volume 1 ml specific activity catalase calculated equation specific activity unitsmg proteinmin a240 nm 1 min x 1000436 x mg protein
0.57820463.12468545.html.plaintext.txt	21	catalase activity assay validate expression functional catalase catalase activity fresh sonicated cell extracts determined 25 degrees c decomposition hydrogen peroxide catalase followed ultraviolet spectroscopy 240 nm reaction performed using solution 20 mm hydrogen peroxide 50 mm k2hpo4 ph 70 containing 10 microg total cellular protein final volume 1 ml specific activity catalase calculated equation specific activity unitsmg proteinmin a240 nm 1 min x 1000436 x mg protein
0.57820463.12468545.html.plaintext.txt	22	intracellular measurement reactive oxygen species ros fluorescence spectrophotometry used measure production intracellular ros 27 dcf da probe previously described 24 briefly hepg2 cells uninfected infected ad cat ad lacz 100 moi 48 h without treatment 50 microm vp16 16 h followed incubation 5 microm dcf da mem 30 min 37 degrees c dark cells washed pbs trypsinized resuspended 3 ml pbs intensity fluorescence immediately read fluorescence spectrophotometer perkinelmer life sciences 650 10s hitachi ltd 503 nm excitation 529 nm emission
0.57820463.12468545.html.plaintext.txt	23	intracellular measurement reactive oxygen species ros fluorescence spectrophotometry used measure production intracellular ros 27 dcf da probe previously described 24 briefly hepg2 cells uninfected infected ad cat ad lacz 100 moi 48 h without treatment 50 microm vp16 16 h followed incubation 5 microm dcf da mem 30 min 37 degrees c dark cells washed pbs trypsinized resuspended 3 ml pbs intensity fluorescence immediately read fluorescence spectrophotometer perkinelmer life sciences 650 10s hitachi ltd 503 nm excitation 529 nm emission
0.57820463.12468545.html.plaintext.txt	24	dna fragmentation assay dna fragmentation pattern dna ladder carried agarose gel electrophoresis cells 1 x 106 treated various reagents scraped centrifuged 1200 rpm 10 min cell pellet resuspended 1 ml lysis buffer consisting 10 mm tris hcl ph 74 10 mm nacl 10 mm edta 100 microgml proteinase k 05 sds incubated 2 h 50 degrees c dna extracted 1 ml phenol ph 80 followed extraction 1 ml phenolchloroform 11 chloroform aqueous phase precipitated 25 volumes ice cold ethanol 01 volume 3 m sodium acetate ph 52 20 degrees c overnight precipitates collected centrifugation 13000 x g 10 min pellets air dried resuspended 50 microl trisedta 10 mm tris 1 mm edta ph 80 buffer supplemented 100 microgml rnase dna loaded onto 15 agarose gel containing ethidium bromide electrophoresed tris acetateedta buffer 2 h 50 v photographed uv illumination
0.57820463.12468545.html.plaintext.txt	25	dna fragmentation assay dna fragmentation pattern dna ladder carried agarose gel electrophoresis cells 1 x 106 treated various reagents scraped centrifuged 1200 rpm 10 min cell pellet resuspended 1 ml lysis buffer consisting 10 mm tris hcl ph 74 10 mm nacl 10 mm edta 100 microgml proteinase k 05 sds incubated 2 h 50 degrees c dna extracted 1 ml phenol ph 80 followed extraction 1 ml phenolchloroform 11 chloroform aqueous phase precipitated 25 volumes ice cold ethanol 01 volume 3 m sodium acetate ph 52 20 degrees c overnight precipitates collected centrifugation 13000 x g 10 min pellets air dried resuspended 50 microl trisedta 10 mm tris 1 mm edta ph 80 buffer supplemented 100 microgml rnase dna loaded onto 15 agarose gel containing ethidium bromide electrophoresed tris acetateedta buffer 2 h 50 v photographed uv illumination
0.57820463.12468545.html.plaintext.txt	26	dna analysis flow cytometry flow cytometry dna analysis used quantify percentage apoptotic cells cells 5 x 105 seeded onto six well plates incubated various reagents different time points cells harvested trypsinization washed pbs followed centrifugation 2000 rpm 10 min cell pellet resuspended 80 ethanol stored 4 degrees c 24 h cells washed twice pbs pellet resuspended pbs containing 100 microgml rnase incubated 37 degrees c 30 min stained propidium iodide 50 microgml analyzed flow cytometry dna analysis described previously 24
0.57820463.12468545.html.plaintext.txt	27	dna analysis flow cytometry flow cytometry dna analysis used quantify percentage apoptotic cells cells 5 x 105 seeded onto six well plates incubated various reagents different time points cells harvested trypsinization washed pbs followed centrifugation 2000 rpm 10 min cell pellet resuspended 80 ethanol stored 4 degrees c 24 h cells washed twice pbs pellet resuspended pbs containing 100 microgml rnase incubated 37 degrees c 30 min stained propidium iodide 50 microgml analyzed flow cytometry dna analysis described previously 24
0.57820463.12468545.html.plaintext.txt	28	p53 synthesis degradation hepg2 cells plated separately 10 fetal bovine serum mem overnight incubation cells infected ad cat ad lacz adenovirus 100 moi forty eight hours latter 50 microm vp16 added cells incubated 16 h medium replaced methionine cysteine free mem plus 10 dialyzed fetal bovine serum 50 microm vp16 cells incubated 2 h pulse labeled 150 microci easytagtm expre35s35s protein labeling mix perkinelmer life sciences 05 2 4 h study rate p53 synthesis one set samples pulse labeled 2 h presence 40 microm cycloheximide inhibitor protein synthesis control analysis p53 synthesis pulse period cells washed 1 x phosphate buffered saline lysed indicated time points 150 microl 10 mm tris hcl buffer ph 74 05 triton x 100 1 mm edta 150 mm nacl 05 sodium deoxycholate 1 sds 1 mm phenylmethylsulfonyl fluoride immunoprecipitated anti p53 igg described
0.57820463.12468545.html.plaintext.txt	29	study rate p53 degradation hepg2 cells treated pulse labeled expre35s35s mix 4 h cells washed 3 times chased complete mem supplemented 300 microgml cold methionine cells washed 1 x phosphate buffered saline lysed chase times 0 2 4 h lysis buffer cases p53 immunoprecipitated rabbit anti human p53 igg protein g agarose follows 40 microl cell lysate 100 microg protein first incubated 10 microl preimmune rabbit serum 15 min followed addition 30 microl 50 vv suspension protein g agarose centrifugation 2 min 13000 rpm supernatant incubated anti p53 igg shaking overnight 4 degrees c followed addition 30 microl suspension protein g agarose samples centrifuged 1 min 13000 rpm pellets washed 3 times lysis buffer lysis buffer plus 2 sds 3 times 01 m tris hcl buffer ph 68 p53 eluted boiling 5 min laemmli buffer samples centrifuged 2 min 13000 rpm remove protein g agarose resolved 8 sds page dried radioactive signal detected exposure kodak x omat x ray film
0.57820463.12468545.html.plaintext.txt	30	study rate p53 degradation hepg2 cells treated pulse labeled expre35s35s mix 4 h cells washed 3 times chased complete mem supplemented 300 microgml cold methionine cells washed 1 x phosphate buffered saline lysed chase times 0 2 4 h lysis buffer cases p53 immunoprecipitated rabbit anti human p53 igg protein g agarose follows 40 microl cell lysate 100 microg protein first incubated 10 microl preimmune rabbit serum 15 min followed addition 30 microl 50 vv suspension protein g agarose centrifugation 2 min 13000 rpm supernatant incubated anti p53 igg shaking overnight 4 degrees c followed addition 30 microl suspension protein g agarose samples centrifuged 1 min 13000 rpm pellets washed 3 times lysis buffer lysis buffer plus 2 sds 3 times 01 m tris hcl buffer ph 68 p53 eluted boiling 5 min laemmli buffer samples centrifuged 2 min 13000 rpm remove protein g agarose resolved 8 sds page dried radioactive signal detected exposure kodak x omat x ray film
0.57820463.12468545.html.plaintext.txt	31	northern blotting total rna isolated using trizol reagent invitrogen ten micrograms rna electrophoresed denaturing conditions formaldehyde containing 1 agarose gels transferred onto genescreen nylon membranes perkinelmer life sciences rna uv cross linked 1200 j x 100 30 prehybridized hybridization oven 2 h 42 degrees c 5 x ssc 1 x ssc 015 m nacl 0015 m sodium citrate 50 formamide 50 mm potassium phosphate ph 65 1 x denhardts solution containing 01 mgml denatured salmon sperm dna cdna probes radiolabeled 32pdctp specific activity 3000 cimmol amersham biosciences using random primer dna labeling kit amersham biosciences immobilized rna hybridized 01 sds 5 x ssc 50 formamide 50 mm potassium phosphate ph 65 1 x denhardts solution 125 x dextran sulfate containing 106 cpmml labeled cdna 01 mgml denatured salmon sperm dna 16 h 42 degrees c blots washed 4 times 15 min 2 x ssc 05 sds 65 degrees c exposed kodak x ray film results top abstract introduction materials methods results discussion references
0.57820463.12468545.html.plaintext.txt	32	northern blotting total rna isolated using trizol reagent invitrogen ten micrograms rna electrophoresed denaturing conditions formaldehyde containing 1 agarose gels transferred onto genescreen nylon membranes perkinelmer life sciences rna uv cross linked 1200 j x 100 30 prehybridized hybridization oven 2 h 42 degrees c 5 x ssc 1 x ssc 015 m nacl 0015 m sodium citrate 50 formamide 50 mm potassium phosphate ph 65 1 x denhardts solution containing 01 mgml denatured salmon sperm dna cdna probes radiolabeled 32pdctp specific activity 3000 cimmol amersham biosciences using random primer dna labeling kit amersham biosciences immobilized rna hybridized 01 sds 5 x ssc 50 formamide 50 mm potassium phosphate ph 65 1 x denhardts solution 125 x dextran sulfate containing 106 cpmml labeled cdna 01 mgml denatured salmon sperm dna 16 h 42 degrees c blots washed 4 times 15 min 2 x ssc 05 sds 65 degrees c exposed kodak x ray film results top abstract introduction materials methods results discussion references
0.57820463.12468545.html.plaintext.txt	33	overexpression catalase hepg2 cells examine capacity ad cat enhance expression activity catalase cells hepg2 cells infected 100 moi ad cat ad lacz 5 bromo 4 chloro 3 indolyl d galactopyranoside x gal assay determined 98 hepg2 cells infected adenovirus reaction conditions 48 h later cell lysates prepared subjected western blot analysis fig 1a shows expression catalase total cell extract cells results densitometric analyses intensity various bands indicated expression catalase total cell extracts cells infected ad cat 7 10 fold higher uninfected hepg2 cells hepg2 cells infected ad lacz similar results obtained measuring catalase activity fig 1b total cellular extracts hepg2 cells infected ad cat catalase activity 7 10 fold higher uninfected hepg2 cells hepg2 cells infected ad lacz
0.57820463.12468545.html.plaintext.txt	34	view larger version 25k fig 1 expression catalase hepg2 cells infected adenovirus hepg2 cells infected ad cat ad lacz 100 moi 48 h later cell extract prepared cell extract uninfected hepg2 cells also prepared control ten micrograms protein loaded onto lane 10 sds polyacrylamide gel electrophoresis followed western blot analysis polyclonal rabbit anti human catalase antibody described materials methods lane 1 uninfected hepg2 cells control lane 2 hepg2 cells infected ad lacz lane 3 hepg2 cells infected ad cat ten micrograms protein cell extracts used measure catalytic activity catalase b specific catalase units unitsmg proteinmin calculated described materials methods first bar uninfected hepg2 cells control second bar hepg2 cells infected ad lacz third bar hepg2 cells infected ad cat mean plus minus sd n 3
0.57820463.12468545.html.plaintext.txt	35	intracellular ros evaluated ros generation measuring dichlorofluorescein fluorescence loading cells 5 microm dcf da recognized dihydrochlorofluorescin may oxidized several oxidants including h2o2 superoxide radical lipid hydroperoxides lipid peroxyl alkoxyl radicals cellular peroxidases 25 26 specific eg h2o2 serves general index ros production absence vp16 control fluorescence 150 arbitrary units fig 2 infection ad lacz effect dcf production infection ad cat decreased fluorescence 45 addition 50 microm vp16 increased dcf production 60 ad lacz effect whereas ad cat decreased fluorescence 40 thus vp16 increased production ros hepg2 cells catalase decreased basal well vp16 stimulated ros generation
0.57820463.12468545.html.plaintext.txt	36	intracellular ros evaluated ros generation measuring dichlorofluorescein fluorescence loading cells 5 microm dcf da recognized dihydrochlorofluorescin may oxidized several oxidants including h2o2 superoxide radical lipid hydroperoxides lipid peroxyl alkoxyl radicals cellular peroxidases 25 26 specific eg h2o2 serves general index ros production absence vp16 control fluorescence 150 arbitrary units fig 2 infection ad lacz effect dcf production infection ad cat decreased fluorescence 45 addition 50 microm vp16 increased dcf production 60 ad lacz effect whereas ad cat decreased fluorescence 40 thus vp16 increased production ros hepg2 cells catalase decreased basal well vp16 stimulated ros generation
0.57820463.12468545.html.plaintext.txt	37	view larger version 20k fig 2 determination intracellular ros fluorescence spectrophotometry used measure intracellular ros 27 dcf da probe hepg2 cells uninfected infected ad cat ad lacz 100 moi 48 h without treatment 50 microm vp16 16 h followed incubation 5 microm dcf da mem 30 min 37 degrees c dark cells washed pbs trypsinized resuspended 3 ml pbs intensity fluorescence immediately read fluorescence spectrophotometer 503 nm excitation 529 nm emission results expressed arbitrary units fluorescence intensity data mean plus minus sd triplicate experiments
0.57820463.12468545.html.plaintext.txt	38	overexpression catalase protects hepg2 cells apoptosis induced dna damaging reagents hepg2 cells plated separately 10 fetal bovine serum mem overnight incubation cells infected ad cat ad lacz adenovirus 100 moi forty eight hours later 500 microm vp16 10 microgml mitomycin c added cells incubated 24 h dna fragmentation dna analysis flow cytometry well cellular morphology changes carried described material methods fig 3a shows results dna fragmentation dna ladder seen either ad lacz lane 2 ad cat lane 3 infected hepg2 cells without treatment treated vp16 lanes 4 5 mitomycin c lanes 6 7 hepg2 cells infected ad lacz showed clear dna ladder lanes 4 6 whereas weak dna ladder seen hepg2 cells infected ad cat lanes 5 7
0.57820463.12468545.html.plaintext.txt	39	view larger version 62k fig 3 expression catalase protects hepg2 cells apoptosis induced vp 16 mitomycin c hepg2 cells infected ad cat ad lacz adenovirus 100 moi forty eight hours later 500 microm vp16 10 microgml mitomycin c added incubated 24 h dna fragmentation dna analysis flow cytometry well morphology changes carried described material methods dna fragmentation lane 1 100 bp dna marker lane 2 ad lacz lane 3 ad cat hepg2 cells infected adenovirus without treatment vp 16 mitomycin c lane 4 ad lacz lane 5 ad cat hepg2 cells treated vp16 infection lane 6 ad lacz lane 7 ad cat hepg2 cells treated mitomycin c infection b dna analysis flow cytometry panels ad lacz b ad cat hepg2 cells infected adenovirus without treatment vp 16 mitomycin c panels c ad lacz d ad cat hepg2 cells treated vp16 infection panels e ad lacz f ad cat hepg2 cells treated mitomycin c infection one three independent experiments shown c morphologic change panels ad lacz b ad cat hepg2 cells infected adenovirus without treatment vp 16 mitomycin c panels c ad lacz d ad cat hepg2 cells treated vp16 infection panels e ad lacz f ad cat hepg2 cells treated mitomycin c infection 100 x
0.57820463.12468545.html.plaintext.txt	40	dna analysis flow cytometry staining propidium iodide used measure percentage apoptotic cells fig 3b 48 h infection either ad lacz ad cat percentage apoptotic cells less 3 absence treatment dna damaging agents fig 3b panels b percentage apoptotic cells increased 25 21 24 h treatment 500 microm vp16 10 microgml mitomycin c respectively fig 3b panels c e hepg2 cells infected ad cat resistant 500 microm vp16 10 microgml mitomycin c induced apoptosis displaying 5 7 apoptotic cells respectively fig 3b panels d f similar results observed studying morphologic changes fig 3c cells infected ad lacz lost normal morphology treated 500 microm vp16 10 microgml mitomycin c 24 h becoming round shape shrinking size panels c e whereas cells infected ad cat retained shape structure panels d f
0.57820463.12468545.html.plaintext.txt	41	overexpression catalase regulates p53 p21 protein bcl 2 bcl xl hepg2 cells investigated expression selected proteins related apoptosis cells infected ad lacz ad cat 48 h without treatment 50 microm vp16 5 microgml mitomycin c 16 h basal level p53 low hepg2 cells likely due short half life wild type p53 basal level p53 even lower cells infected ad cat cells infected ad lacz fig 4 panel treatment vp16 mitomycin c p53 protein level dramatically increased cells infected ad lacz slightly increased cells infected ad cat p21 one downstream genes p53 induced activation p53 p21 protein level also detected western blot coincident p53 p21 protein level dramatically increased cells infected ad lacz treatment vp16 mitomycin c fig 4 panel b infection catalase adenovirus lowered basal well stimulated levels p21 analogous results p53 levels bcl 2 bcl xl two anti apoptotic genes expression proteins different ad lacz ad cat infection without treatment vp16 mitomycin c fig 4 panels c d
0.57820463.12468545.html.plaintext.txt	42	overexpression catalase regulates p53 p21 protein bcl 2 bcl xl hepg2 cells investigated expression selected proteins related apoptosis cells infected ad lacz ad cat 48 h without treatment 50 microm vp16 5 microgml mitomycin c 16 h basal level p53 low hepg2 cells likely due short half life wild type p53 basal level p53 even lower cells infected ad cat cells infected ad lacz fig 4 panel treatment vp16 mitomycin c p53 protein level dramatically increased cells infected ad lacz slightly increased cells infected ad cat p21 one downstream genes p53 induced activation p53 p21 protein level also detected western blot coincident p53 p21 protein level dramatically increased cells infected ad lacz treatment vp16 mitomycin c fig 4 panel b infection catalase adenovirus lowered basal well stimulated levels p21 analogous results p53 levels bcl 2 bcl xl two anti apoptotic genes expression proteins different ad lacz ad cat infection without treatment vp16 mitomycin c fig 4 panels c d
0.57820463.12468545.html.plaintext.txt	43	view larger version 62k fig 4 expression catalase modulates p53 p21 bcl 2 bcl xl protein level hepg2 cells infected ad cat c ad lacz z moi 100 48 h without treatment adding 50 microm vp16 5 microgml mitomycin c mito 16 h 25 microg protein loaded onto lane 10 sds polyacrylamide gel electrophoresis followed western blot analysis polyclonal rabbit anti human p53 p21 b bcl 2 c bcl xl d antibody described materials methods three independent experiments carried
0.57820463.12468545.html.plaintext.txt	44	apoptosis induced vp16 p53 dependent evaluate whether catalase protects hepg2 cells apoptosis induced dna damaging agents regulation p53 protein important first demonstrate p53 required developing apoptosis hepg2 mtp53 hepg2 neo cell lines set stable transfection hepg2 cells expression plasmid vector containing mutant p53 empty vector mutant p53 expression vector encodes mutant p53 protein combines wild type p53 protein dominant negative manner blocks dna binding domain wild type p53 therefore inhibiting activity wild type p53 treatment different concentrations 50 250 500 microm vp16 24 h hepg2 cells transfected empty vector hepg2 neo underwent dna fragmentation fig 5 however weak dna fragmentation observed hepg2 cells transfected mutant p53 expression vector hepg2 mtp53 even maximum concentration vp16 500 microm studied fig 5 results indicate p53 necessary vp16 induced apoptosis hepg2 cells suggest one mechanism catalase protects apoptosis lower intracellular levels p53
0.57820463.12468545.html.plaintext.txt	45	apoptosis induced vp16 p53 dependent evaluate whether catalase protects hepg2 cells apoptosis induced dna damaging agents regulation p53 protein important first demonstrate p53 required developing apoptosis hepg2 mtp53 hepg2 neo cell lines set stable transfection hepg2 cells expression plasmid vector containing mutant p53 empty vector mutant p53 expression vector encodes mutant p53 protein combines wild type p53 protein dominant negative manner blocks dna binding domain wild type p53 therefore inhibiting activity wild type p53 treatment different concentrations 50 250 500 microm vp16 24 h hepg2 cells transfected empty vector hepg2 neo underwent dna fragmentation fig 5 however weak dna fragmentation observed hepg2 cells transfected mutant p53 expression vector hepg2 mtp53 even maximum concentration vp16 500 microm studied fig 5 results indicate p53 necessary vp16 induced apoptosis hepg2 cells suggest one mechanism catalase protects apoptosis lower intracellular levels p53
0.57820463.12468545.html.plaintext.txt	46	view larger version 70k fig 5 decrease normal p53 function confers resistance vp16 induced apoptosis hepg2 neo hepg2 mtp53 cell lines produced described materials methods cells treated 0 50 250 500 microm vp16 24 h dna fragmentation carried described fig 3a one two independent experiments shown
0.57820463.12468545.html.plaintext.txt	47	overexpression catalase regulates p53 protein potentiating p53 protein degradation decreasing p53 protein synthesis mrna levels catalase regulation expression p53 protein basal conditions treatment dna damaging agents could due effect p53 transcription translation protein degradation hepg2 cells infected ad lacz ad cat 48 h without treatment 50 microm vp16 16 h rna isolated northern blot performed using 32pdctp labeled p53 glyceraldehyde 3 phosphate dehydrogenase cdna probes significant difference p53 mrna levels cells infected ad lacz ad cat either basal conditions treatment vp16 fig 6 vp16 treatment dramatically elevated p53 protein levels fig 4 effect p53 mrna levels fig 6 result indicates overexpression catalase decrease transcription p53 gene mrna therefore changes mrna responsible inhibitory effect catalase level p53 protein
0.57820463.12468545.html.plaintext.txt	48	overexpression catalase regulates p53 protein potentiating p53 protein degradation decreasing p53 protein synthesis mrna levels catalase regulation expression p53 protein basal conditions treatment dna damaging agents could due effect p53 transcription translation protein degradation hepg2 cells infected ad lacz ad cat 48 h without treatment 50 microm vp16 16 h rna isolated northern blot performed using 32pdctp labeled p53 glyceraldehyde 3 phosphate dehydrogenase cdna probes significant difference p53 mrna levels cells infected ad lacz ad cat either basal conditions treatment vp16 fig 6 vp16 treatment dramatically elevated p53 protein levels fig 4 effect p53 mrna levels fig 6 result indicates overexpression catalase decrease transcription p53 gene mrna therefore changes mrna responsible inhibitory effect catalase level p53 protein
0.57820463.12468545.html.plaintext.txt	49	view larger version 31k fig 6 expression catalase andor treatment vp 16 change p53 mrna levels wild type hepg2 cells w hepg2 cells infected ad cat c ad lacz z 48 h incubated absence presence 50 microm vp16 16 h rna isolated northern blot analysis performed using 32pdctp labeled p53 glyceraldehyde 3 phosphate dehydrogenase gapdh cdna probes two independent experiments carried
0.57820463.12468545.html.plaintext.txt	50	two possibilities might relate inhibitory effect catalase level p53 protein considered catalase inhibits p53 protein synthesis catalase increases degradation p53 protein pulse labeling pulse chase assays performed investigate possibilities hepg2 cells infected ad lacz ad cat 48 h treated 50 microm vp16 16 h followed pulsing 35s labeled methionine 05 2 4 h p53 protein immunoprecipitated incorporated label quantified sds page recorded x ray film intensity p53 signal increased 2 h pulsing compared 05 h fig 7a validate assay effect cycloheximide determined p53 synthesis inhibited adding 40 microm cycloheximide decrease p53 signal intensity cells infected ad cat compared cells infected ad lacz time point fig 7a indicates overexpression catalase change rate p53 protein synthesis
0.57820463.12468545.html.plaintext.txt	51	two possibilities might relate inhibitory effect catalase level p53 protein considered catalase inhibits p53 protein synthesis catalase increases degradation p53 protein pulse labeling pulse chase assays performed investigate possibilities hepg2 cells infected ad lacz ad cat 48 h treated 50 microm vp16 16 h followed pulsing 35s labeled methionine 05 2 4 h p53 protein immunoprecipitated incorporated label quantified sds page recorded x ray film intensity p53 signal increased 2 h pulsing compared 05 h fig 7a validate assay effect cycloheximide determined p53 synthesis inhibited adding 40 microm cycloheximide decrease p53 signal intensity cells infected ad cat compared cells infected ad lacz time point fig 7a indicates overexpression catalase change rate p53 protein synthesis
0.57820463.12468545.html.plaintext.txt	52	view larger version 90k fig 7 effects expression catalase p53 protein synthesis degradation hepg2 cells infected ad lacz z ad cat c 48 h followed treatment 50 microm vp16 16 h cells pulse labeled 35s labeled methionine 05 2 4 h p53 protein immunoprecipitated amount incorporated label quantified sds page recorded x ray film described materials methods one set experiments cells incubated 40 microm cycloheximide included 2 h determine rate p53 protein degradation chase performed adding cold methionine 0 2 4 h 4 h pulse 35s labeled methionine b c bar graph arbitrary densitometric units p53 bands b two independent experiments carried
0.57820463.12468545.html.plaintext.txt	53	determine rate p53 protein degradation pulse chase performed adding cold methionine 0 2 4 h 4 h pulse 35s labeled methionine compared cells infected ad lacz p53 signal cells infected ad cat considerably lower 2 4 h chase fig 7b quantification fig 7c indicates rate p53 degradation potentiated overexpression catalase presence vp16 p53 levels maintained 4 h chase period ad lacz infected hepg2 cells
0.57820463.12468545.html.plaintext.txt	54	determine rate p53 protein degradation pulse chase performed adding cold methionine 0 2 4 h 4 h pulse 35s labeled methionine compared cells infected ad lacz p53 signal cells infected ad cat considerably lower 2 4 h chase fig 7b quantification fig 7c indicates rate p53 degradation potentiated overexpression catalase presence vp16 p53 levels maintained 4 h chase period ad lacz infected hepg2 cells
0.57820463.12468545.html.plaintext.txt	55	potentiated p53 protein degradation caused catalase overexpression prevented proteasome inhibitors proteasome complex plays important role turnover p53 therefore effect proteasome inhibitors 5 microm lactacystin 10 microm mg115 well calpain inhibitor calpeptin p53 protein levels cells infected ad lacz ad cat determined fig 8 administration lactacystin mg115 increased p53 protein level 3 4 fold ad lacz infected cells treated vp16 likely reflects prevention p53 degradation elevated level p53 vp16 treated cells increased lactacystin mg115 may reflect treatments result decreasing p53 turnover described fig 9 calpeptin affect basal level p53 vp16 stimulated levels ad lacz infected cells fig 8 vp16 treated cells catalase lowered p53 levels 50 60 control calpeptin treated cells 20 25 lactacystin mg115 treated cells thus lowering p53 levels catalase partially prevented diminished administration proteasome inhibitors calpeptin toxicity higher concentrations lactacystin mg115 could evaluated however results consistent role proteasome p53 turnover catalase enhancement turnover
0.57820463.12468545.html.plaintext.txt	56	view larger version 18k fig 8 effect proteasome inhibitors catalase mediated regulation p53 protein levels hepg2 cells infected ad lacz z ad cat c 48 h followed treatment vp16 without vp16 50 microm vp16 absence contl presence proteasome inhibitors 5 microm lactacystin lacta 10 microm mg115 calpain inhibitor 50 microm calpeptin 8 h effects catalase mediated lowering p53 protein evaluated cell extract prepared 25 microg protein loaded onto lane 10sds polyacrylamide gel electrophoresis followed western blot analysis polyclonal rabbit anti human p53 antibody described materials methods one three independent western blot results shown blots scanned band intensity numbers shown specific band
0.57820463.12468545.html.plaintext.txt	57	catalase overexpression decreases phosphorylation p53 p53 activated phosphorylation phosphorylated p53 imported nucleus activate downstream genes p21 bax acting transcription factor addition phosphorylated p53 longer half life unphosphorylated p53 therefore leading p53 accumulation phosphorylation occur several serine residues including serine 9 15 20 392 p53 protein one possible mechanism catalase increases turnover p53 could decreasing formation stable phosphorylated p53 using anti p53 antibody specific antibody recognition phosphorylation p53 serine 20 pp53 level compared total p53 level cells treated vp16 lactacystin vp16 lactacystin increase p53 level however vp16 increased pp53 level fig 9a suggests although lactacystin vp16 increase p53 level decreasing degradation p53 different mechanisms lactacystin inhibits degradation p53 whereas vp16 results formation stable pp53 determine effect catalase p53 phosphorylation hepg2 cells infected ad lacz ad cat treated vp16 different times 0 8 16 24 h immunoblots detect p53 pp53 carried catalase overexpression decreased phosphorylated form p53 association decrease total p53 levels compared lac z expression fig 9b
0.57820463.12468545.html.plaintext.txt	58	catalase overexpression decreases phosphorylation p53 p53 activated phosphorylation phosphorylated p53 imported nucleus activate downstream genes p21 bax acting transcription factor addition phosphorylated p53 longer half life unphosphorylated p53 therefore leading p53 accumulation phosphorylation occur several serine residues including serine 9 15 20 392 p53 protein one possible mechanism catalase increases turnover p53 could decreasing formation stable phosphorylated p53 using anti p53 antibody specific antibody recognition phosphorylation p53 serine 20 pp53 level compared total p53 level cells treated vp16 lactacystin vp16 lactacystin increase p53 level however vp16 increased pp53 level fig 9a suggests although lactacystin vp16 increase p53 level decreasing degradation p53 different mechanisms lactacystin inhibits degradation p53 whereas vp16 results formation stable pp53 determine effect catalase p53 phosphorylation hepg2 cells infected ad lacz ad cat treated vp16 different times 0 8 16 24 h immunoblots detect p53 pp53 carried catalase overexpression decreased phosphorylated form p53 association decrease total p53 levels compared lac z expression fig 9b
0.57820463.12468545.html.plaintext.txt	59	view larger version 16k fig 9 expression catalase decreases phosphorylation p53 protein induced vp16 western blot analysis p53 pp53 levels hepg2 cells treated without 50 microm vp16 absence presence 5 microm lactacystin b hepg2 cells infected ad lacz z ad cat c 48 h followed treatment 50 microm vp16 0 8 16 24 h cell extract prepared western blot analysis carried anti human p53 anti pp53 20 antibody described three independent experiments carried
0.57820463.12468545.html.plaintext.txt	60	decrease p53 phosphorylated p53 levels caused catalase overexpression prevented phosphatase inhibitor okadaic acid phosphorylated p53 dephosphorylated multiple protein phosphatases determine whether phosphatases may involved catalase mediated regulation p53 pp53 broad spectrum phosphatase inhibitor okadaic acid used hepg2 cells infected ad lacz ad cat 48 h followed treatment without 50 microm vp16 presence 100 nm okadaic acid incubating okadaic acid 0 2 4 8 h western blot analysis carried detect level p53 pp53 okadaic acid prevent effect catalase regulation p53 pp53 levels fig 10
0.57820463.12468545.html.plaintext.txt	61	decrease p53 phosphorylated p53 levels caused catalase overexpression prevented phosphatase inhibitor okadaic acid phosphorylated p53 dephosphorylated multiple protein phosphatases determine whether phosphatases may involved catalase mediated regulation p53 pp53 broad spectrum phosphatase inhibitor okadaic acid used hepg2 cells infected ad lacz ad cat 48 h followed treatment without 50 microm vp16 presence 100 nm okadaic acid incubating okadaic acid 0 2 4 8 h western blot analysis carried detect level p53 pp53 okadaic acid prevent effect catalase regulation p53 pp53 levels fig 10
0.57820463.12468545.html.plaintext.txt	62	view larger version 12k fig 10 effect phosphatase inhibitor okadaic acid catalase mediated regulation p53 pp53 protein levels hepg2 cells infected ad lacz z ad cat c 48 h followed treatment without 50 microm vp16 presence 100 nm okadaic acid different periods 0 2 4 8 h western blot analysis cell extracts carried detect level p53 pp53 described three independent experiments carried discussion top abstract introduction materials methods results discussion references
0.57820463.12468545.html.plaintext.txt	63	overexpression catalase protects hepg2 cells apoptosis induced dna damaging agents dna ladder flow cytometry experiments well morphology changes indicated hepg2 cells infected ad cat less sensitive vp16 mitomycin c induced apoptosis hepg2 cells infected ad lacz suggests ros especially h2o2 might involved process apoptosis induced dna damaging drugs studies variety cell types suggest cancer chemotherapeutic drugs induce tumor cell apoptosis part increasing formation ros 14 however studies indicate apoptosis induced absence detectable oxidative stress tumor cells treated vp 16 cisplatin 20 ros may necessarily direct factor cause apoptosis induced dna damaging reagents intracellular ros may modulate apoptotic gene expression subsequently regulates apoptosis thus although catalase protective vp16 mitomycin c induced apoptosis clear h2o2 directly responsible inducing toxicity h2o2 upstream signaling events alter pro anti apoptotic balance hepg2 cells
0.57820463.12468545.html.plaintext.txt	64	overexpression catalase protects hepg2 cells apoptosis induced dna damaging agents dna ladder flow cytometry experiments well morphology changes indicated hepg2 cells infected ad cat less sensitive vp16 mitomycin c induced apoptosis hepg2 cells infected ad lacz suggests ros especially h2o2 might involved process apoptosis induced dna damaging drugs studies variety cell types suggest cancer chemotherapeutic drugs induce tumor cell apoptosis part increasing formation ros 14 however studies indicate apoptosis induced absence detectable oxidative stress tumor cells treated vp 16 cisplatin 20 ros may necessarily direct factor cause apoptosis induced dna damaging reagents intracellular ros may modulate apoptotic gene expression subsequently regulates apoptosis thus although catalase protective vp16 mitomycin c induced apoptosis clear h2o2 directly responsible inducing toxicity h2o2 upstream signaling events alter pro anti apoptotic balance hepg2 cells
0.57820463.12468545.html.plaintext.txt	65	catalase protects hepg2 cells apoptosis lowering p53 protein level consequence increased degradation p53 critical apoptotic gene activated apoptosis overexpression wild type p53 constructs tumor cells able inhibit cell growth initiate apoptosis p53 gene status modulates chemosensitivity non small cell lung cancer cells dna damage induced dna damaging agents vp16 mitomycin c activates p53 mainly protein modification events phosphorylation results p53 protein stabilization accumulation p53 protein due decrease degradation 4 fig 9 b hepg2 cells transfected mutant p53 expression vector hepg2 mtp53 encodes mutant p53 protein decreasing wild type p53 function resistant vp16 induced apoptosis hepg2 cells transfected empty vector hepg2 neo fig 5 indicates apoptosis induced vp16 hepg2 cells p53 dependent hepg2 cells overexpressing catalase mediated adenovirus mediated gene transfer ad cat show lower level basal induced p53 protein control ad lacz cells lowering p53 levels likely mechanism whereby catalase overexpression protects hepg2 cells apoptosis induced dna damaging agents whereas latter induce apoptosis elevating p53 levels differences p53 mrna levels catalase overexpressing cells control cells without treatment dna damaging agents p53 mrna level change treatment vp16 even though p53 protein levels strongly increased thus decrease p53 protein levels catalase overexpression increase p53 levels treatment vp16 due posttranscriptional effects p21 downstream gene target p53 regulated p53 27 hepg2 cells overexpressing catalase also display lower level p21 protein control cells either absence presence treatment dna damaging agents lower levels p21 protein presence catalase may reflect lower levels p53 protein presence catalase results synthesis experiments indicate overexpression catalase change rate p53 protein synthesis however pulse chase experiments reveal p53 protein degradation increased cells infected ad cat compared cells infected ad lacz
0.57820463.12468545.html.plaintext.txt	66	catalase protects hepg2 cells apoptosis lowering p53 protein level consequence increased degradation p53 critical apoptotic gene activated apoptosis overexpression wild type p53 constructs tumor cells able inhibit cell growth initiate apoptosis p53 gene status modulates chemosensitivity non small cell lung cancer cells dna damage induced dna damaging agents vp16 mitomycin c activates p53 mainly protein modification events phosphorylation results p53 protein stabilization accumulation p53 protein due decrease degradation 4 fig 9 b hepg2 cells transfected mutant p53 expression vector hepg2 mtp53 encodes mutant p53 protein decreasing wild type p53 function resistant vp16 induced apoptosis hepg2 cells transfected empty vector hepg2 neo fig 5 indicates apoptosis induced vp16 hepg2 cells p53 dependent hepg2 cells overexpressing catalase mediated adenovirus mediated gene transfer ad cat show lower level basal induced p53 protein control ad lacz cells lowering p53 levels likely mechanism whereby catalase overexpression protects hepg2 cells apoptosis induced dna damaging agents whereas latter induce apoptosis elevating p53 levels differences p53 mrna levels catalase overexpressing cells control cells without treatment dna damaging agents p53 mrna level change treatment vp16 even though p53 protein levels strongly increased thus decrease p53 protein levels catalase overexpression increase p53 levels treatment vp16 due posttranscriptional effects p21 downstream gene target p53 regulated p53 27 hepg2 cells overexpressing catalase also display lower level p21 protein control cells either absence presence treatment dna damaging agents lower levels p21 protein presence catalase may reflect lower levels p53 protein presence catalase results synthesis experiments indicate overexpression catalase change rate p53 protein synthesis however pulse chase experiments reveal p53 protein degradation increased cells infected ad cat compared cells infected ad lacz
0.57820463.12468545.html.plaintext.txt	67	adenovirus mediated gene transfer johnson et al 17 find cells sensitive p53 mediated apoptosis produced ros concomitantly p53 overexpression whereas cells resistant p53 failed produce ros sensitive cells ros production apoptosis inhibited antioxidant treatment results suggest p53 acts regulate intracellular redox state induces apoptosis pathway dependent ros production 17 experiments removing h2o2 expression catalase causes p53 protein level decrease associated resistance apoptosis induced vp16 mitomycin c suggests least hepg2 cells h2o2 regulates apoptosis modulating p53 levels h2o2 acts upstream p53
0.57820463.12468545.html.plaintext.txt	68	adenovirus mediated gene transfer johnson et al 17 find cells sensitive p53 mediated apoptosis produced ros concomitantly p53 overexpression whereas cells resistant p53 failed produce ros sensitive cells ros production apoptosis inhibited antioxidant treatment results suggest p53 acts regulate intracellular redox state induces apoptosis pathway dependent ros production 17 experiments removing h2o2 expression catalase causes p53 protein level decrease associated resistance apoptosis induced vp16 mitomycin c suggests least hepg2 cells h2o2 regulates apoptosis modulating p53 levels h2o2 acts upstream p53
0.57820463.12468545.html.plaintext.txt	69	result high turnover rate p53 protein half life 30 60 min maintained low levels normal proliferating cells 28 response genotoxic stress oncogenic signaling p53 levels rapidly increase mainly protein stabilization important regulator p53 level mdm2 possesses intrinsic e3 ligase activity thus promotes p53 ubiquitination subsequent degradation via proteasome mediated proteolysis 29 overexpression catalase increase p53 protein degradation proteasome inhibitors lactacystin mg115 calpain inhibitor calpeptin could partially block p53 protein lowering caused overexpression catalase consistent overall mechanism catalase lowers p53 levels accelerating p53 degradation
0.57820463.12468545.html.plaintext.txt	70	result high turnover rate p53 protein half life 30 60 min maintained low levels normal proliferating cells 28 response genotoxic stress oncogenic signaling p53 levels rapidly increase mainly protein stabilization important regulator p53 level mdm2 possesses intrinsic e3 ligase activity thus promotes p53 ubiquitination subsequent degradation via proteasome mediated proteolysis 29 overexpression catalase increase p53 protein degradation proteasome inhibitors lactacystin mg115 calpain inhibitor calpeptin could partially block p53 protein lowering caused overexpression catalase consistent overall mechanism catalase lowers p53 levels accelerating p53 degradation
0.57820463.12468545.html.plaintext.txt	71	overexpression catalase specifically regulates p53 protein enhances p53 turnover clear h2o2 specific substrate catalase catalase regulation p53 protein would appear involve function action h2o2 one hypothesis h2o2 may increase level phosphorylated p53 stimulating certain protein kinases implicated phosphorylation p53 inhibiting activity protein phosphatases convert pp53 less stable nonphosphorylated state p53 protein phosphorylated half life increased causes p53 accumulation 30 ros indeed modulate actions p53 kinases p53 phosphatases overexpression catalase may decrease p53 accumulation removing ros h2o2 using specific antibody detecting phosphorylated p53 serine 20 found overexpression catalase prevent phosphorylation p53 induced vp16 low levels pp53 associated low levels total p53 however general phosphatase inhibitor okadaic acid prevent effect catalase regulation p53 pp53 suggests catalase may inhibit activity p53 kinases may activated h2o2 recent studies indicate ros h2o2 induced phosphorylation p53 mediated part polo like kinase 3 30 studies necessary effects ros catalase activities protein kinases implicated phosphorylation p53 protein phosphatases implicated dephosphorylation pp53 chromium vanadate metals cause oxidative stress believed modulate p53 h2o2 31 32 h2o2 may also cause certain modifications p53 protein structure eg thiol oxidation protein effective substrate proteolysis putative stabilizing modifications would prevented rapid removal h2o2 catalase
0.57820463.12468545.html.plaintext.txt	72	overexpression catalase specifically regulates p53 protein enhances p53 turnover clear h2o2 specific substrate catalase catalase regulation p53 protein would appear involve function action h2o2 one hypothesis h2o2 may increase level phosphorylated p53 stimulating certain protein kinases implicated phosphorylation p53 inhibiting activity protein phosphatases convert pp53 less stable nonphosphorylated state p53 protein phosphorylated half life increased causes p53 accumulation 30 ros indeed modulate actions p53 kinases p53 phosphatases overexpression catalase may decrease p53 accumulation removing ros h2o2 using specific antibody detecting phosphorylated p53 serine 20 found overexpression catalase prevent phosphorylation p53 induced vp16 low levels pp53 associated low levels total p53 however general phosphatase inhibitor okadaic acid prevent effect catalase regulation p53 pp53 suggests catalase may inhibit activity p53 kinases may activated h2o2 recent studies indicate ros h2o2 induced phosphorylation p53 mediated part polo like kinase 3 30 studies necessary effects ros catalase activities protein kinases implicated phosphorylation p53 protein phosphatases implicated dephosphorylation pp53 chromium vanadate metals cause oxidative stress believed modulate p53 h2o2 31 32 h2o2 may also cause certain modifications p53 protein structure eg thiol oxidation protein effective substrate proteolysis putative stabilizing modifications would prevented rapid removal h2o2 catalase
0.57820463.12468545.html.plaintext.txt	73	summary results demonstrate catalase protects hepg2 cells apoptosis induced dna damaging agents association decreasing level pp53 leads accelerating degradation p53 protein level catalase may therefore play important role cell induced resistance effects anti cancer drugs modulating cellular levels p53 p53 targets p21 acknowledgement
0.57820463.12468545.html.plaintext.txt	74	summary results demonstrate catalase protects hepg2 cells apoptosis induced dna damaging agents association decreasing level pp53 leads accelerating degradation p53 protein level catalase may therefore play important role cell induced resistance effects anti cancer drugs modulating cellular levels p53 p53 targets p21 acknowledgement
0.57820463.12468545.html.plaintext.txt	75	thank dr james manfredi mount sinai ruttenberg cancer center many helpful suggestions advice
0.57820463.12468545.html.plaintext.txt	76	studies supported niaaa national institutes health grants aa12757 aa06610 united states public health service grantsthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.57820463.12468545.html.plaintext.txt	77	studies supported niaaa national institutes health grants aa12757 aa06610 united states public health service grantsthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.57820463.12468545.html.plaintext.txt	78	correspondence addressed dept pharmacology biological chemistry box 1603 mount sinai school medicine one gustave l levy place new york ny 10029 tel 212 241 7285 fax 212 996 7214 e mail arthurcederbaummssmedu
0.57820463.12468545.html.plaintext.txt	79	correspondence addressed dept pharmacology biological chemistry box 1603 mount sinai school medicine one gustave l levy place new york ny 10029 tel 212 241 7285 fax 212 996 7214 e mail arthurcederbaummssmedu
0.57820463.12468545.html.plaintext.txt	80	published jbc papers press december 4 2002 doi 101074jbcm206273200
0.57820463.12468545.html.plaintext.txt	81	abbreviations used mem minimum essential medium ros reactive oxygen species pbs phosphate buffered saline moi multiplicity infection pp53 phosphorylated p53 27 dcf da 27 dichlorofluorescin diacetate
0.57820463.12468545.html.plaintext.txt	82	references top abstract introduction materials methods results discussion references 1 levine j 1997 cell 88 323 331medline order article via infotrieve 2 liebermann d hoffman b steinman r 1995 oncogene 11 199 210medline order article via infotrieve 3 steller h 1995 science 267 1445 1449medline order article via infotrieve 4 fritsche m haessler c brandner g 1993 oncogene 8 307 318medline order article via infotrieve 5 blagosklonny m v el deiry w 1998 int j cancer 75 933 94030co2 3linktypedoi crossrefmedline order article via infotrieve 6 el deiry w tokino velculescu v e levy d b parsons r trent j m lin d mercer w e kinzler k w vogelstein b 1993 cell 75 817 825medline order article via infotrieve 7 kastan m b zhan q el deiry w carrier f jacks walsh w v plunkett b vogelstein b fornace j jr 1992 cell 71 587 597medline order article via infotrieve 8 hermeking h lengauer c polyak k c zhang l thiagalingam kinzler k w vogelstein b 1997 mol cell 1 3 11medline order article via infotrieve 9 miyashita reed j c 1995 cell 80 293 299medline order article via infotrieve 10 owen schaub l b zhang w cusack j c angelo l santee m fujiwara roth j deisseroth b zhang w w kruzel e 1995 mol cell biol 15 3032 3040abstract 11 oda e ohki r murasawa h nemoto j shibue yamashita tokino taniguchi tanaka n 2000 science 288 1053 1058abstractfree full text 12 yu j zhang l hwang p m kinzler k w vogelstein b 2001 mol cell 7 673 682medline order article via infotrieve 13 oda k arakawa h tanaka matsuda k tanikawa c mori nishimori h tamai k tokino nakamura y taya y 2000 cell 102 849 862medline order article via infotrieve 14 siitonen alaruikka p mantymaa p savolainen e r kavanagh j krejsa c m franklin c c kinnula v koistinen p 1999 ann oncol 10 1361 1367abstract 15 polyak k xia y zweier j l kinzler k w vogelstein b 1997 nature 389 300 305crossrefmedline order article via infotrieve 16 jabs 1999 biochem pharmacol 57 231 245crossrefmedline order article via infotrieve 17 johnson m yu z x ferrans v j lowenstein r finkel 1996 proc natl acad sci u 93 11848 11852abstractfree full text 18 finkel 2001 iubmb life 52 3 6medline order article via infotrieve 19 carmody r j cotter g 2001 redox reports 6 77 90 20 senturker tschirret guth r morrow j levine r shacter e 2002 arch biochem biophys 397 262 272crossrefmedline order article via infotrieve 21 lee y j shacter e 1999 j biol chem 274 19792 19798abstractfree full text 22 bai j cederbaum 2001 biol signals recept 10 189 199crossrefmedline order article via infotrieve 23 bai j cederbaum 2001 j biol chem 276 4315 4321abstractfree full text 24 bai j rodriguez m melendez j cederbaum 1999 j biol chem 274 26217 26224abstractfree full text 25 rota c chignell c f mason r p 1999 free radic biol med 27 873 881crossrefmedline order article via infotrieve 26 bilski p belanger g chignell c f 2002 free radic biol med 33 938 946crossrefmedline order article via infotrieve 27 sato n mizumoto k maehara n kusumoto m nishio urashima ogawa tanaka m 2000 anticancer res 20 837 842medline order article via infotrieve 28 ashcroft m vousden k h 1999 oncogene 18 7637 7643crossrefmedline order article via infotrieve 29 lain midgley c sparks lane e b lane d p 1999 exp cell res 248 457 472crossrefmedline order article via infotrieve 30 xie wang q wu h cogswell j lu l jhanwar uniyal m dai w 2001 j biol chem 276 36194 36199abstractfree full text 31 bagchi d bagchi m stohs j 2001 mol cell biochem 222 149 158crossrefmedline order article via infotrieve 32 huang c zhang z ding m li j ye j leonard shen h m butterworth l lu y costa m rojanasakul y castranova v vallyathan v shi x 2000 j biol chem 275 32516 32522abstractfree full text
0.57820463.12468545.html.plaintext.txt	83	copyright 2003 american society biochemistry molecular biology inc
0.60193133.15471885.html.plaintext.txt	0	phosphorylation p53 key serines dispensable transcriptional activation apoptosis thelma thompson christian tovar hong yang daisy carvajal binh vu qunli xu geoffrey m wahl david c heimbrook lyubomir vassilev
0.60193133.15471885.html.plaintext.txt	1	discovery oncology roche research center hoffmann la roche inc nutley new jersey 07110 gene expression laboratory salk institute biological studies la jolla california 92037
0.60193133.15471885.html.plaintext.txt	2	discovery oncology roche research center hoffmann la roche inc nutley new jersey 07110 gene expression laboratory salk institute biological studies la jolla california 92037
0.60193133.15471885.html.plaintext.txt	3	received publication september 7 2004 revised form october 4 2004
0.60193133.15471885.html.plaintext.txt	4	abstract top abstract introduction experimental procedures results discussion references p53 tumor suppressor key mediator cellular response stress phosphorylation induced multiple stress activated kinases proposed essential p53 stabilization interaction transcriptional co activators activation p53 target genes however genetic studies suggest stress activated phosphorylation may essential p53 activation therefore investigated role p53 phosphorylation six key serine residues ser6 ser15 ser20 ser37 ser46 ser392 p53 activation using nutlin 3 recently developed small molecule mdm2 antagonist show nutlin induce phosphorylation p53 comparison activity unphosphorylated phosphorylated p53 induced genotoxic drugs doxorubicin etoposide hct116 rko cells revealed difference sequence specific dna binding ability transactivate p53 target genes induce p53 dependent apoptosis conclude p53 phosphorylation six major serine sites required activation p53 target genes biological responses vivo
0.60193133.15471885.html.plaintext.txt	5	abstract top abstract introduction experimental procedures results discussion references p53 tumor suppressor key mediator cellular response stress phosphorylation induced multiple stress activated kinases proposed essential p53 stabilization interaction transcriptional co activators activation p53 target genes however genetic studies suggest stress activated phosphorylation may essential p53 activation therefore investigated role p53 phosphorylation six key serine residues ser6 ser15 ser20 ser37 ser46 ser392 p53 activation using nutlin 3 recently developed small molecule mdm2 antagonist show nutlin induce phosphorylation p53 comparison activity unphosphorylated phosphorylated p53 induced genotoxic drugs doxorubicin etoposide hct116 rko cells revealed difference sequence specific dna binding ability transactivate p53 target genes induce p53 dependent apoptosis conclude p53 phosphorylation six major serine sites required activation p53 target genes biological responses vivo
0.60193133.15471885.html.plaintext.txt	6	introduction top abstract introduction experimental procedures results discussion references tumor suppressor p53 transcription factor coordinates complex network cellular proteins evolved protect cells malignant transformation 1 2 response diverse stress factors p53 induces expression different subsets genes leading cell cycle arrest apoptosis dna repair senescence cells stress p53 activation could suppress growth induce apoptosis tight regulation elicited mdm2 3 4 mdm2 gene expression regulated part p53 responsive promoter turn mdm2 protein binds p53 n terminal transactivation domain negatively regulates tumor suppressor function compromising transcriptional regulation additionally mdm2 e3 ubiquitin ligase p53 mdm2 controls p53 half life via ubiquitin dependent degradation negative feedback control mechanism assures p53 mdm2 proteins kept low levels proliferating cells 4
0.60193133.15471885.html.plaintext.txt	7	introduction top abstract introduction experimental procedures results discussion references tumor suppressor p53 transcription factor coordinates complex network cellular proteins evolved protect cells malignant transformation 1 2 response diverse stress factors p53 induces expression different subsets genes leading cell cycle arrest apoptosis dna repair senescence cells stress p53 activation could suppress growth induce apoptosis tight regulation elicited mdm2 3 4 mdm2 gene expression regulated part p53 responsive promoter turn mdm2 protein binds p53 n terminal transactivation domain negatively regulates tumor suppressor function compromising transcriptional regulation additionally mdm2 e3 ubiquitin ligase p53 mdm2 controls p53 half life via ubiquitin dependent degradation negative feedback control mechanism assures p53 mdm2 proteins kept low levels proliferating cells 4
0.60193133.15471885.html.plaintext.txt	8	response stress p53 mdm2 interaction must disrupted enable p53 associate factors needed activation target genes stress induced p53 activation involves post translational modification p53 multiple sites phosphorylation acetylation sumoylation 2 5 modifications mdm2 enhance mdm2 autoubiquitination degradation 6 regard p53 modifications phosphorylation studied intensively proposed play critical role stabilization activation tumor suppressor studies greatly facilitated availability antibodies recognize p53 modified specific phosphoserine phosphothreonine residues review see ref 7 multiple serine 6 9 15 20 33 37 46 315 371 376 378 392 three threonine residues 18 55 81 reported undergo phosphorylation response diverse stresses multiple serinethreonine kinases implicated upstream signaling leading p53 phosphorylation atm atr dna pk chk1 chk2 ck1 p38 cdk2 pkc jnk precise mechanism signaling regulation well understood 8 9 residues n terminal mdm2 binding domain p53 ser20 thr18 shown play critical role interaction two proteins stress induced phosphorylation decreases substantially affinity p53 mdm2 analyzed vitro using peptide substrates 10 12 studies 7 13 led conclusion phosphorylation p53 key mechanism responsible activation tumor suppressor response cellular stress
0.60193133.15471885.html.plaintext.txt	9	response stress p53 mdm2 interaction must disrupted enable p53 associate factors needed activation target genes stress induced p53 activation involves post translational modification p53 multiple sites phosphorylation acetylation sumoylation 2 5 modifications mdm2 enhance mdm2 autoubiquitination degradation 6 regard p53 modifications phosphorylation studied intensively proposed play critical role stabilization activation tumor suppressor studies greatly facilitated availability antibodies recognize p53 modified specific phosphoserine phosphothreonine residues review see ref 7 multiple serine 6 9 15 20 33 37 46 315 371 376 378 392 three threonine residues 18 55 81 reported undergo phosphorylation response diverse stresses multiple serinethreonine kinases implicated upstream signaling leading p53 phosphorylation atm atr dna pk chk1 chk2 ck1 p38 cdk2 pkc jnk precise mechanism signaling regulation well understood 8 9 residues n terminal mdm2 binding domain p53 ser20 thr18 shown play critical role interaction two proteins stress induced phosphorylation decreases substantially affinity p53 mdm2 analyzed vitro using peptide substrates 10 12 studies 7 13 led conclusion phosphorylation p53 key mechanism responsible activation tumor suppressor response cellular stress
0.60193133.15471885.html.plaintext.txt	10	addition proposed role abrogation p53 mdm2 binding stabilization protein p53 phosphorylation also implicated regulation activity however aspect p53 phosphorylation still poorly understood controversial transcriptional activity p53 principal importance function tumor suppressor suggested phosphorylation specific residues affect transcriptional activity p53 andor selectivity toward different subset genes thus determining specific type cellular response stress 5 8 activity p53 transcription factor may influenced several factors ability form active tetramers b sequence specific dna binding c interaction components transcriptional machinery reported ser315 ser392 phosphorylation may regulate oligomerization p53 thus sequence specific dna binding 14 16 ser15 phosphorylation shown enhance interaction p53 transcriptional co activators cbp pcaf 10 17 19 stress induced phosphorylation ser46 implicated activation p53 dependent apoptotic response 20 21 recently prolyl isomerase pin1 reported bind p53 enhance dna binding transcriptional activity binding dependent dna damage induced phosphorylation p53 22 23 taken together observations suggest p53 phosphorylation may play important role stabilization p53 also modulation transcriptional activity hand experiments almost phosphorylation sites p53 mutated demonstrated transiently expressed phosphorylated unphosphorylated p53 differ significantly stability ability transactivate reporter genes p53 null cells 24 furthermore studies using mouse mutants substitutions ser15 ser20 suggest residues essential p53 activation 25 27
0.60193133.15471885.html.plaintext.txt	11	addition proposed role abrogation p53 mdm2 binding stabilization protein p53 phosphorylation also implicated regulation activity however aspect p53 phosphorylation still poorly understood controversial transcriptional activity p53 principal importance function tumor suppressor suggested phosphorylation specific residues affect transcriptional activity p53 andor selectivity toward different subset genes thus determining specific type cellular response stress 5 8 activity p53 transcription factor may influenced several factors ability form active tetramers b sequence specific dna binding c interaction components transcriptional machinery reported ser315 ser392 phosphorylation may regulate oligomerization p53 thus sequence specific dna binding 14 16 ser15 phosphorylation shown enhance interaction p53 transcriptional co activators cbp pcaf 10 17 19 stress induced phosphorylation ser46 implicated activation p53 dependent apoptotic response 20 21 recently prolyl isomerase pin1 reported bind p53 enhance dna binding transcriptional activity binding dependent dna damage induced phosphorylation p53 22 23 taken together observations suggest p53 phosphorylation may play important role stabilization p53 also modulation transcriptional activity hand experiments almost phosphorylation sites p53 mutated demonstrated transiently expressed phosphorylated unphosphorylated p53 differ significantly stability ability transactivate reporter genes p53 null cells 24 furthermore studies using mouse mutants substitutions ser15 ser20 suggest residues essential p53 activation 25 27
0.60193133.15471885.html.plaintext.txt	12	recently reported identification first potent selective small molecule inhibitors p53 mdm2 interaction nutlins 28 compounds bind mdm2 p53 binding pocket high selectivity release p53 negative control leading effective stabilization p53 activation p53 pathway vitro vivo nutlins non genotoxic activate p53 preventing binding mdm2 28 bind p53 protein interfere activities treatment cultured cells mdm2 antagonists cause accumulation p53 protein free phosphorylation ser15 28 therefore nutlins may represent valuable molecular tools studying role p53 phosphorylation natural cellular context show p53 induced mdm2 antagonist nutlin 3 phosphorylated six key serine residues despite lack detectable phosphorylation nutlin induced p53 showed equal better sequence specific dna binding ability transactivate p53 target genes p53 dependent apoptotic activity phosphorylated p53 induced genotoxic drugs doxorubicin etoposide results provide support notion separating mdm2 p53 important step p53 activation phosphorylation required execution p53 biological functions
0.60193133.15471885.html.plaintext.txt	13	recently reported identification first potent selective small molecule inhibitors p53 mdm2 interaction nutlins 28 compounds bind mdm2 p53 binding pocket high selectivity release p53 negative control leading effective stabilization p53 activation p53 pathway vitro vivo nutlins non genotoxic activate p53 preventing binding mdm2 28 bind p53 protein interfere activities treatment cultured cells mdm2 antagonists cause accumulation p53 protein free phosphorylation ser15 28 therefore nutlins may represent valuable molecular tools studying role p53 phosphorylation natural cellular context show p53 induced mdm2 antagonist nutlin 3 phosphorylated six key serine residues despite lack detectable phosphorylation nutlin induced p53 showed equal better sequence specific dna binding ability transactivate p53 target genes p53 dependent apoptotic activity phosphorylated p53 induced genotoxic drugs doxorubicin etoposide results provide support notion separating mdm2 p53 important step p53 activation phosphorylation required execution p53 biological functions
0.60193133.15471885.html.plaintext.txt	14	experimental procedures top abstract introduction experimental procedures results discussion references cells drug treatment hct116 cells purchased atcc manassas va rko cells gift dr b vogelstein johns hopkins oncology center cell lines derived human colon cancer possess wild type p53 cells grown recommended media supplemented 10 heat inactivated fetal bovine serum media serum purchased invitrogen drug treatment 15 x 106 cells seeded 75 cm2 tissue culture flasks 10 ml growth medium 24 h prior treatment incubated doxorubicin etoposide sigma 10 mm stock solution me2so various concentrations 24 h control cells treated equivalent amount me2so rko r cells generated continuous passage rko cells media containing increasing concentrations nutlin 3 05 10 microm 90 day period resistant cell population maintained presence 10 microm nutlin 3 p53 gene status determined genechip p53 assay affymetrix santa clara ca described previously 29
0.60193133.15471885.html.plaintext.txt	15	western blot analysis cells harvested centrifugation resuspended lysis buffer containing 20 mm hepes 350 mm nacl 1 mm mgcl 05 mm edta 05 mm dithiothreitol 20 glycerol 1 nonidet p 40 phosphatase inhibitor mixture protease inhibitor mixture cell pellets sonicated briefly cell debris sedimented brief centrifugation 15000 rpm 4 degrees c supernatants transferred fresh tubes protein content determined bradford assay bio rad western analysis 10 microg total protein loaded onto 4 12 tris glycine polyacrylamide gels subjected electrophoresis proteins visualized ecl chemiluminescence reagents amersham biosciences using primary antibodies specific human p53 sc 263 santa cruz biotechnology santa cruz ca phospho p53 ser6 ser15 ser20 ser37 ser46 ser392 catalog number 9919 cell signaling beverly ma p21 op64 oncogene research products boston ma mdm2 sc 965 santa cruz biotechnology actin sigma secondary antibodies used anti mouse igg horseradish peroxidase linked whole antibody sheep na931v amersham biosciences anti rabbit ig horseradish peroxidase linked donkey fab2 fragment na9340v amersham biosciences
0.60193133.15471885.html.plaintext.txt	16	p53 dna binding enzyme linked immunosorbent assay transamtm p53 transcription factor assay kit active motif carlsbad ca used following manufacturers protocol cell lysates treated cells diluted 2 microgml total protein lysis buffer applied plates containing immobilized oligonucleotide containing p53 consensus binding site 5 ggacatgcccgggcatgtcc 3 1 h incubation room temperature plates washed incubated diluted p53 antibody 11000 another hour diluted anti rabbit horseradish peroxidase conjugated antibody 11000 added previously washed plates developing solution added incubated 8 min allow color development reaction stopped absorbance read 450 nm reference wavelength 650 nm
0.60193133.15471885.html.plaintext.txt	17	p53 dna binding enzyme linked immunosorbent assay transamtm p53 transcription factor assay kit active motif carlsbad ca used following manufacturers protocol cell lysates treated cells diluted 2 microgml total protein lysis buffer applied plates containing immobilized oligonucleotide containing p53 consensus binding site 5 ggacatgcccgggcatgtcc 3 1 h incubation room temperature plates washed incubated diluted p53 antibody 11000 another hour diluted anti rabbit horseradish peroxidase conjugated antibody 11000 added previously washed plates developing solution added incubated 8 min allow color development reaction stopped absorbance read 450 nm reference wavelength 650 nm
0.60193133.15471885.html.plaintext.txt	18	quantitative pcr cells seeded 96 well plates 104 cellswell 24 h prior treatment lysed total rna extracted using abi 6700 robotic work station applied biosystems foster city ca aliquots containing 5 microg total rna converted cdna using taqman reverse transcription reagents kit applied biosystems relative quantity p53 p21 mdm2 transcripts determined taqman using gene specific primerprobe sets 18 rna normalization control sequence primers probes follows p53 forward ctg gga cgg aac agc ttt ga reverse cct ttc ttg cgg aga ttc tct tc probe ctg tgc gcc ggt ctc tcc cag ta p21 forward ctgaga ctc tca ggg tcg aa reverse cgg cgt ttg gag tgg tag aa probe ttg gct cac tgc aag ctc gcc ctt mdm2 forward gct gga gtc cag tgg gtg reverse gat gac tgt agg cca agc taa ttg probe tgg ctc act gca agc tctgcc ct mic 11 macrophage inhibitory cytokine 1 forward ccatgg tgc tca ttc aaa aga c reverse gga agg acc agg act gct cat probe tga ctt gtt agc caa agactg ccactg ca
0.60193133.15471885.html.plaintext.txt	19	quantitative pcr cells seeded 96 well plates 104 cellswell 24 h prior treatment lysed total rna extracted using abi 6700 robotic work station applied biosystems foster city ca aliquots containing 5 microg total rna converted cdna using taqman reverse transcription reagents kit applied biosystems relative quantity p53 p21 mdm2 transcripts determined taqman using gene specific primerprobe sets 18 rna normalization control sequence primers probes follows p53 forward ctg gga cgg aac agc ttt ga reverse cct ttc ttg cgg aga ttc tct tc probe ctg tgc gcc ggt ctc tcc cag ta p21 forward ctgaga ctc tca ggg tcg aa reverse cgg cgt ttg gag tgg tag aa probe ttg gct cac tgc aag ctc gcc ctt mdm2 forward gct gga gtc cag tgg gtg reverse gat gac tgt agg cca agc taa ttg probe tgg ctc act gca agc tctgcc ct mic 11 macrophage inhibitory cytokine 1 forward ccatgg tgc tca ttc aaa aga c reverse gga agg acc agg act gct cat probe tga ctt gtt agc caa agactg ccactg ca
0.60193133.15471885.html.plaintext.txt	20	apoptosis assays cells seeded 24 well tissue culture plates 5 x 104 cellswell 24 h prior drug treatment incubated drug additional 48 h treatment controls established parallel cell line culture medium may contain detached cells collected attached cells trypsinized cells combined corresponding medium collected centrifugation 1500 rpm 10 min 4 degrees c annexin v positive cells quantified using guava nexintm kit guava personal cell analyzer guava technologies hayward ca recommended manufacturer
0.60193133.15471885.html.plaintext.txt	21	apoptosis assays cells seeded 24 well tissue culture plates 5 x 104 cellswell 24 h prior drug treatment incubated drug additional 48 h treatment controls established parallel cell line culture medium may contain detached cells collected attached cells trypsinized cells combined corresponding medium collected centrifugation 1500 rpm 10 min 4 degrees c annexin v positive cells quantified using guava nexintm kit guava personal cell analyzer guava technologies hayward ca recommended manufacturer
0.60193133.15471885.html.plaintext.txt	22	results top abstract introduction experimental procedures results discussion references mdm2 antagonists stabilize p53 activate p53 target genes recently developed class potent selective inhibitors p53 mdm2 interaction 28 compounds called nutlins bind mdm2 p53 pocket high specificity displace p53 complex negative regulator treatment cells encoding wild type p53 nutlins leads p53 stabilization accumulation activation p53 pathway nutlins activate p53 preventing physical interaction mdm2 alter post translational modification status p53 consequently represent valuable molecular probes study contributions post translational modifications p53 function
0.60193133.15471885.html.plaintext.txt	23	results top abstract introduction experimental procedures results discussion references mdm2 antagonists stabilize p53 activate p53 target genes recently developed class potent selective inhibitors p53 mdm2 interaction 28 compounds called nutlins bind mdm2 p53 pocket high specificity displace p53 complex negative regulator treatment cells encoding wild type p53 nutlins leads p53 stabilization accumulation activation p53 pathway nutlins activate p53 preventing physical interaction mdm2 alter post translational modification status p53 consequently represent valuable molecular probes study contributions post translational modifications p53 function
0.60193133.15471885.html.plaintext.txt	24	using mdm2 antagonist nutlin 3 aimed studying functional activity unmodified p53 compared activity p53 modified response treating cells genotoxic drugs etoposide doxorubicin chose colon cancer cell lines hct116 rko possess wild type p53 respond genotoxic stress p53 stabilization activation p53 pathway 28 find optimal treatment condition incubated exponentially growing cells range concentrations etoposide doxorubicin active enantiomer nutlin 3 nutlin 3a 24 h ranges included ic50 ic90 values previously determined proliferationviability assay 28 western analysis cell lysates cells lines revealed dose dependent accumulation p53 target gene products mdm2 p21waf1cip1 fig 1 observed decrease mdm2 p21 level high doxorubicin concentrations likely due protein degradation cells undergoing apoptosis experiment showed nutlin 3a treatment hct116 rko cells activates p53 comparably genotoxic drugs etoposide doxorubicin
0.60193133.15471885.html.plaintext.txt	25	using mdm2 antagonist nutlin 3 aimed studying functional activity unmodified p53 compared activity p53 modified response treating cells genotoxic drugs etoposide doxorubicin chose colon cancer cell lines hct116 rko possess wild type p53 respond genotoxic stress p53 stabilization activation p53 pathway 28 find optimal treatment condition incubated exponentially growing cells range concentrations etoposide doxorubicin active enantiomer nutlin 3 nutlin 3a 24 h ranges included ic50 ic90 values previously determined proliferationviability assay 28 western analysis cell lysates cells lines revealed dose dependent accumulation p53 target gene products mdm2 p21waf1cip1 fig 1 observed decrease mdm2 p21 level high doxorubicin concentrations likely due protein degradation cells undergoing apoptosis experiment showed nutlin 3a treatment hct116 rko cells activates p53 comparably genotoxic drugs etoposide doxorubicin
0.60193133.15471885.html.plaintext.txt	26	view larger version 70k fig 1 stabilization p53 activation p53 target genes human colon cancer cells treated genotoxic drugs mdm2 antagonist exponentially growing hct116 rko cells wild type p53 incubated indicated concentrations etoposide doxorubicin active enantiomer mdm2 antagonist nutlin 3a 24 h levels p53 p21 mdm2 actin unanalyzed cell lysates normalized total protein western blotting
0.60193133.15471885.html.plaintext.txt	27	p53 induced mdm2 antagonists modified key phosphorylation sites previously showed nutlin 1 cause p53 phosphorylation ser15 site typically modified response genotoxic stress 28 observation consistent notion mdm2 antagonists non genotoxic activate damage responsive kinases trigger p53 phosphorylation however conceivable nutlins could possess target activities generate dna damage activate stress related kinases induce p53 modification therefore determined whether nutlin 3a induced p53 phosphorylation six key serine residues ser6 ser15 ser20 ser37 ser46 ser392 using phosphoserine specific antibodies inactive enantiomer nutlin 3b 150 fold lower affinity mdm2 vitro used negative control 28
0.60193133.15471885.html.plaintext.txt	28	p53 induced mdm2 antagonists modified key phosphorylation sites previously showed nutlin 1 cause p53 phosphorylation ser15 site typically modified response genotoxic stress 28 observation consistent notion mdm2 antagonists non genotoxic activate damage responsive kinases trigger p53 phosphorylation however conceivable nutlins could possess target activities generate dna damage activate stress related kinases induce p53 modification therefore determined whether nutlin 3a induced p53 phosphorylation six key serine residues ser6 ser15 ser20 ser37 ser46 ser392 using phosphoserine specific antibodies inactive enantiomer nutlin 3b 150 fold lower affinity mdm2 vitro used negative control 28
0.60193133.15471885.html.plaintext.txt	29	western analysis showed comparable accumulation p53 hct116 rko cells treated etoposide doxorubicin nutlin 3a accumulation observed nutlin 3b doxorubicin treatment induced phosphorylation examined serine residues p53 fig 2 etoposide showed strong phosphorylation signal ser6 ser15 ser20 cell lines ser46 rko cells weaker detectable phosphorylation ser37 ser392 contrast phosphorylation p53 serines undetectable lysates cell lines incubated nutlin 3a nutlin 3b result confirmed extended previous observation made nutlin 1 mdm2 antagonists induce stress related modifications previously correlated p53 activation therefore nutlin activated p53 provides opportunity studying functional contributions phosphorylation p53 function living cells
0.60193133.15471885.html.plaintext.txt	30	western analysis showed comparable accumulation p53 hct116 rko cells treated etoposide doxorubicin nutlin 3a accumulation observed nutlin 3b doxorubicin treatment induced phosphorylation examined serine residues p53 fig 2 etoposide showed strong phosphorylation signal ser6 ser15 ser20 cell lines ser46 rko cells weaker detectable phosphorylation ser37 ser392 contrast phosphorylation p53 serines undetectable lysates cell lines incubated nutlin 3a nutlin 3b result confirmed extended previous observation made nutlin 1 mdm2 antagonists induce stress related modifications previously correlated p53 activation therefore nutlin activated p53 provides opportunity studying functional contributions phosphorylation p53 function living cells
0.60193133.15471885.html.plaintext.txt	31	view larger version 84k fig 2 stabilization p53 mdm2 antagonists involve phosphorylation key serine residues exponentially growing hct116 rko cells incubated etoposide 10 microm doxorubicin 1 microm nutlin 3a 10 microm nutlin 3b 10 microm 24 h levels total p53 p53 phosphorylated specific serine residues analyzed western blotting actin used normalization control
0.60193133.15471885.html.plaintext.txt	32	dna binding activity p53 depend phosphorylation status p53 transcriptional activity paramount importance function tumor suppressor therefore evaluated ability p53 bind dna recognition sequences indication transcriptional activation potential transcription factor used transamtm p53 enzyme linked immunosorbent assay measures relative amount p53 cell lysates bind 20 mer oliginucleotide containing p53 consensus binding site hct116 rko cells incubated range concentrations etoposide doxorubicin nutlin 3a 24 h dna bound p53 assayed cell lysates fig 3 agreement western analyses fig 1 levels dna bound p53 increased dose dependent manner cell lines treated three drugs 14 17 fold elevation p53 rko cells dramatic hct116 cells showed moderate 5 6 fold increase reflects higher basal level p53 cells level p53 induced nutlin 3a higher level induced either etoposide doxorubicin hct116 cells comparable induced drugs 14 fold versus 16 17 fold rko cells data suggest lack detectable phosphorylation six major phosphorylation sites affect ability p53 bind effectively dna response elements
0.60193133.15471885.html.plaintext.txt	33	dna binding activity p53 depend phosphorylation status p53 transcriptional activity paramount importance function tumor suppressor therefore evaluated ability p53 bind dna recognition sequences indication transcriptional activation potential transcription factor used transamtm p53 enzyme linked immunosorbent assay measures relative amount p53 cell lysates bind 20 mer oliginucleotide containing p53 consensus binding site hct116 rko cells incubated range concentrations etoposide doxorubicin nutlin 3a 24 h dna bound p53 assayed cell lysates fig 3 agreement western analyses fig 1 levels dna bound p53 increased dose dependent manner cell lines treated three drugs 14 17 fold elevation p53 rko cells dramatic hct116 cells showed moderate 5 6 fold increase reflects higher basal level p53 cells level p53 induced nutlin 3a higher level induced either etoposide doxorubicin hct116 cells comparable induced drugs 14 fold versus 16 17 fold rko cells data suggest lack detectable phosphorylation six major phosphorylation sites affect ability p53 bind effectively dna response elements
0.60193133.15471885.html.plaintext.txt	34	view larger version 26k fig 3 binding p53 consensus dna sequence affected phosphorylation status vivo hct116 rko cells incubated doxorubicin etoposide nutlins 3a 24 h level p53 protein present cell lysates bind consensus recognition sequence determined transamtm p53 enzyme linked immunosorbent assay calculated fold increase relative control samples
0.60193133.15471885.html.plaintext.txt	35	transcriptional activity p53 affected phosphorylation status next compared transcriptional activities phosphorylated unphosphorylated p53 treatment hct116 rko cells increasing concentrations etoposide doxorubicin nutlin 3a nutlin 3b 24 h measured expression three p53 target genes p21waf1 mdm2 mic 1 quantitative real time pcr genes contain p53 recognition sequences promoter regions strongly depend p53 transcriptional regulation represent diverse functions p53 pathway p21waf1cip1 encodes potent cyclin dependent kinase inhibitor plays key role p53 mediated cell cycle arrest 30 mdm2 p53 negative regulator 31 recently discovered transforming growth factor superfamily member mic 1 secreted protein poorly understood function 32 33
0.60193133.15471885.html.plaintext.txt	36	transcriptional activity p53 affected phosphorylation status next compared transcriptional activities phosphorylated unphosphorylated p53 treatment hct116 rko cells increasing concentrations etoposide doxorubicin nutlin 3a nutlin 3b 24 h measured expression three p53 target genes p21waf1 mdm2 mic 1 quantitative real time pcr genes contain p53 recognition sequences promoter regions strongly depend p53 transcriptional regulation represent diverse functions p53 pathway p21waf1cip1 encodes potent cyclin dependent kinase inhibitor plays key role p53 mediated cell cycle arrest 30 mdm2 p53 negative regulator 31 recently discovered transforming growth factor superfamily member mic 1 secreted protein poorly understood function 32 33
0.60193133.15471885.html.plaintext.txt	37	dose dependent accumulation p53 drug treated cells elicited dose dependent activation three genes cell lines fig 4a relative increase gene expression different cell line probably reflecting differences basal level expression p21 highly elevated hct116 mic 1 showed strongest induction rko cells compare transcriptional activity p53 drug treated cells highest level induction within concentration range plotted drug cell line fig 4b level gene induction nutlin 3a 10 12 fold highest three genes hct116 cells p21 mdm2 rko cells expression mic 1 gene slightly higher doxorubicin treated rko cells fig 4b inactive enantiomer nutlin 3b show significant transcriptional activation genes either cell line confirming activation p53 target genes nutlin 3a due inhibition mdm2 p53 interaction 28
0.60193133.15471885.html.plaintext.txt	38	view larger version 46k fig 4 activation p53 regulated genes cancer cells depend phosphorylation status p53 exponentially growing hct116 rko cells incubated indicated concentration doxorubicin dox etoposide etopo nutlin 3a nutlin 3b 24 h relative expression three p53 regulated genes p21 mdm2 mic 1 determined quantitative pcr plotted relative increase gene activity
0.60193133.15471885.html.plaintext.txt	39	expression p53 target genes measured 24 h drug treatment reach steady state level p53 avoid possible differences timing p53 induction however one could argue p53 phosphorylation accelerates p53 activation antagonizing mdm2 interaction enabling recruitment co activators hand critical step p53 activation involves preventing mdm2 binding nutlin 3a may provide direct rapid route activation since kinase activation p53 modification damage induced degradation mdm2 6 would required intermediate steps investigated possibilities determining kinetics transcriptional activation p21 mic 1 genes 8 h addition doxorubicin 1 microm etoposide 20 microm nutlin 3a 10 microm previous studies demonstrated 1 microm doxorubicin optimal dose p53 induction within 8 h time frame 33 results experiment showed levels p21 mdm2 expression higher equivalent nutlin 3a teated cells cells treated doxorubicin etoposide fig 5 importantly nutlin 3a induced p53 target genes slightly faster genotoxic drugs consistent mechanism action involving direct interference p53 mdm2 binding since nutlin induced p53 detectably phosphorylated six residues analyzed fig 2 doxorubicin induced p53 phosphorylated six etoposide induced p53 phosphorylated strongly least three residues conclude p53 phosphorylation key reported phosphorylation sites dispensable timely robust activation major downstream transcriptional targets vivo
0.60193133.15471885.html.plaintext.txt	40	expression p53 target genes measured 24 h drug treatment reach steady state level p53 avoid possible differences timing p53 induction however one could argue p53 phosphorylation accelerates p53 activation antagonizing mdm2 interaction enabling recruitment co activators hand critical step p53 activation involves preventing mdm2 binding nutlin 3a may provide direct rapid route activation since kinase activation p53 modification damage induced degradation mdm2 6 would required intermediate steps investigated possibilities determining kinetics transcriptional activation p21 mic 1 genes 8 h addition doxorubicin 1 microm etoposide 20 microm nutlin 3a 10 microm previous studies demonstrated 1 microm doxorubicin optimal dose p53 induction within 8 h time frame 33 results experiment showed levels p21 mdm2 expression higher equivalent nutlin 3a teated cells cells treated doxorubicin etoposide fig 5 importantly nutlin 3a induced p53 target genes slightly faster genotoxic drugs consistent mechanism action involving direct interference p53 mdm2 binding since nutlin induced p53 detectably phosphorylated six residues analyzed fig 2 doxorubicin induced p53 phosphorylated six etoposide induced p53 phosphorylated strongly least three residues conclude p53 phosphorylation key reported phosphorylation sites dispensable timely robust activation major downstream transcriptional targets vivo
0.60193133.15471885.html.plaintext.txt	41	view larger version 47k fig 5 kinetics induction p53 target genes depend p53 phosphorylation hct116 rko cells exposed doxorubicin dox1 microm etoposide etopo 20 microm nutlin 3a 10 microm indicated time periods expression p21 mic 1 determined quantitative pcr expressed gene activation relative untreated controls
0.60193133.15471885.html.plaintext.txt	42	apoptotic activity phosphorylated unphosphorylated p53 next examined effect p53 phosphorylation ability induce apoptosis since function critical suppression tumor formation several mouse models 34 35 although p53 phosphorylation key serine residues appears dispensable transcriptional activation may play role functions tumor suppressor specific tissues perhaps proposed transcription independent mechanisms apoptosis 36 37 mechanisms apoptosis induction p53 may involve activation multiple pathways decided measure particular pathway rather use annexin v staining well accepted marker apoptosis induction 38 treated exponentially growing hct116 rko cells concentration range etoposide doxorubicin nutlin 3a nutlin 3b used previous tests see fig 4 48 h determined percentage annexin v positive cells previous studies 28 unpublished data2 suggested 48 h optimal timeframe detection p53 dependent apoptosis agreement previous results hct116 rko cells showed increase population apoptotic cells upon treatment etoposide doxorubicin nutlin 3a nutlin 3b data shown samples highest level apoptosis dose group chosen comparison apoptotic activity p53 fig 6 doxorubicin induced massive apoptosis 90 hct116 rko cells testing positive annexin v etoposide nutlin 3a comparable apoptotic activity nutlin 3b show significant increase apoptotic fraction
0.60193133.15471885.html.plaintext.txt	43	apoptotic activity phosphorylated unphosphorylated p53 next examined effect p53 phosphorylation ability induce apoptosis since function critical suppression tumor formation several mouse models 34 35 although p53 phosphorylation key serine residues appears dispensable transcriptional activation may play role functions tumor suppressor specific tissues perhaps proposed transcription independent mechanisms apoptosis 36 37 mechanisms apoptosis induction p53 may involve activation multiple pathways decided measure particular pathway rather use annexin v staining well accepted marker apoptosis induction 38 treated exponentially growing hct116 rko cells concentration range etoposide doxorubicin nutlin 3a nutlin 3b used previous tests see fig 4 48 h determined percentage annexin v positive cells previous studies 28 unpublished data2 suggested 48 h optimal timeframe detection p53 dependent apoptosis agreement previous results hct116 rko cells showed increase population apoptotic cells upon treatment etoposide doxorubicin nutlin 3a nutlin 3b data shown samples highest level apoptosis dose group chosen comparison apoptotic activity p53 fig 6 doxorubicin induced massive apoptosis 90 hct116 rko cells testing positive annexin v etoposide nutlin 3a comparable apoptotic activity nutlin 3b show significant increase apoptotic fraction
0.60193133.15471885.html.plaintext.txt	44	view larger version 29k fig 6 unphosphorylated p53 induces apoptosis cancer cells detection apoptotic activity annexin v staining proliferating rko cells incubated doxorubicin 1 microm etoposide 20 microm nutlin 3a 10 microm nutlin 3b 10 microm 48 h annexin v positive cells determined using guavanexin kit guava personal cell analyzer annexin v reactivity indicates cells early stages apoptosis dna binding dye 7 aminoactinomycin d penetrate cells compromised integrity used distinguish live dead cells lower left quadrant normal cells lower right live apoptotic cells upper right dead apoptotic cells b apoptosis induced doxorubicin 05 microm etoposide 20 microm nutlin 3a 10 microm nutlin 3b 10 microm hct116 rko cells 48 h treatment apoptotic fraction calculated sum annexin positive live dead cell upper lower right quadrants expressed percentage total cell population
0.60193133.15471885.html.plaintext.txt	45	face value data suggested apoptotic activity correlates level phosphorylation since doxorubicin produces highest level serine phosphorylation best apoptotic response however doxorubicin etoposide drugs known p53 independent cytotoxicity well documented dna damaging drugs induce apoptosis cells p53 mutant deleted 39 therefore difficult separate p53 dependent independent apoptotic activity genotoxic agents tested apoptotic activity doxorubicin etoposide colon cancer cell line sw480 p53 pathway disabled due mutation dna binding domain p53 80 doxorubicin treated 65 etoposide treated sw480 cells tested positive apoptosis confirming ability doxorubicin etoposide induce p53 independent apoptosis data shown result indicates population apoptotic cells doxorubicin treated hct116 rko cells consists cells undergoing p53 dependent independent apoptosis
0.60193133.15471885.html.plaintext.txt	46	face value data suggested apoptotic activity correlates level phosphorylation since doxorubicin produces highest level serine phosphorylation best apoptotic response however doxorubicin etoposide drugs known p53 independent cytotoxicity well documented dna damaging drugs induce apoptosis cells p53 mutant deleted 39 therefore difficult separate p53 dependent independent apoptotic activity genotoxic agents tested apoptotic activity doxorubicin etoposide colon cancer cell line sw480 p53 pathway disabled due mutation dna binding domain p53 80 doxorubicin treated 65 etoposide treated sw480 cells tested positive apoptosis confirming ability doxorubicin etoposide induce p53 independent apoptosis data shown result indicates population apoptotic cells doxorubicin treated hct116 rko cells consists cells undergoing p53 dependent independent apoptosis
0.60193133.15471885.html.plaintext.txt	47	attempt determine p53 dependent apoptotic activity doxorubicin etoposide used variant rko cell line rko r p53 disabled spontaneous mutations p53 gene occurring prolonged incubation rko cells presence nutlin 3 include insertion stop codon position gln144 mutation dna binding domain p53 s240g result rko r cells resistant nutlin 3a works inhibition mdm2 cells wild type p53 28 time rko r cells partially resistant doxorubicin etoposide due p53 independent activities treatment rko r cells doxorubicin etoposide nutlin 3 24 h showed strongly attenuated response three drugs compared rko cells p53 regulated gene p21 partially activated doxorubicin etoposide treated rko r cells cells exposed nutlin 3a fig 7 expression level mdm2 rko r cells affected drug treatment indicates p53 response disabled rko r cells therefore rko r cells genetically closely related rko cells offer good control p53 independent cellular activity
0.60193133.15471885.html.plaintext.txt	48	attempt determine p53 dependent apoptotic activity doxorubicin etoposide used variant rko cell line rko r p53 disabled spontaneous mutations p53 gene occurring prolonged incubation rko cells presence nutlin 3 include insertion stop codon position gln144 mutation dna binding domain p53 s240g result rko r cells resistant nutlin 3a works inhibition mdm2 cells wild type p53 28 time rko r cells partially resistant doxorubicin etoposide due p53 independent activities treatment rko r cells doxorubicin etoposide nutlin 3 24 h showed strongly attenuated response three drugs compared rko cells p53 regulated gene p21 partially activated doxorubicin etoposide treated rko r cells cells exposed nutlin 3a fig 7 expression level mdm2 rko r cells affected drug treatment indicates p53 response disabled rko r cells therefore rko r cells genetically closely related rko cells offer good control p53 independent cellular activity
0.60193133.15471885.html.plaintext.txt	49	view larger version 36k fig 7 p53 pathway disabled rko r cells parental rko resistant rko r cells incubated doxorubicin dox 1 013 2 025 3 05 4 10 microm etoposide etopo 1 25 2 50 3 10 4 20 microm nutlin 3a nutlin 3b 1 125 2 25 3 50 4 10 microm 24 h induction p21 mdm2 expression determined quantitative pcr
0.60193133.15471885.html.plaintext.txt	50	assess apoptotic activity doxorubicin etoposide nutlin 3a incubated rko rko r cells previously established dose range fig 3 48 h quantified annexin v positive cell fraction fig 8 doxorubicin treatment rko r cells induced apoptosis half rate parental cell line 012 025 microm concentration equally high rate 05 10 microm range substantial fraction apoptotic population also found etoposide treated cells nutlin 3a induce detectable apoptosis compared untreated control data confirmed substantial fraction apoptosis rko cells treated high doses doxorubicin etoposide induced p53 independent pathways therefore p53 independent apoptotic activity two genotoxic drugs eg rko r cells deducted total apoptotic activity rko cells residual value represent p53 dependent apoptosis value equal lower nutlin 3a results support conclusion nutlin activated p53 lacking detectable phosphorylation six key serine residues competent induce p53 dependent apoptosis cancer cells wild type p53 levels comparable induced phosphorylated p53
0.60193133.15471885.html.plaintext.txt	51	assess apoptotic activity doxorubicin etoposide nutlin 3a incubated rko rko r cells previously established dose range fig 3 48 h quantified annexin v positive cell fraction fig 8 doxorubicin treatment rko r cells induced apoptosis half rate parental cell line 012 025 microm concentration equally high rate 05 10 microm range substantial fraction apoptotic population also found etoposide treated cells nutlin 3a induce detectable apoptosis compared untreated control data confirmed substantial fraction apoptosis rko cells treated high doses doxorubicin etoposide induced p53 independent pathways therefore p53 independent apoptotic activity two genotoxic drugs eg rko r cells deducted total apoptotic activity rko cells residual value represent p53 dependent apoptosis value equal lower nutlin 3a results support conclusion nutlin activated p53 lacking detectable phosphorylation six key serine residues competent induce p53 dependent apoptosis cancer cells wild type p53 levels comparable induced phosphorylated p53
0.60193133.15471885.html.plaintext.txt	52	view larger version 16k fig 8 apoptotic activity p53 affected phosphorylation status exponentially growing rko rko r cells treated increasing concentration doxorubicin etoposide nutlin 3a 48 h annexin positive apoptotic cell fraction calculated described legend fig 6
0.60193133.15471885.html.plaintext.txt	53	discussion top abstract introduction experimental procedures results discussion references role phosphorylation p53 activation function subject intense studies last decade however despite abundant data numerous studies addressing specific phosphorylation events response diverse stress factors picture still incomplete although several lines evidence point n terminal phosphorylation major mechanism abrogation p53 mdm2 binding role phosphorylation modulation p53 functions still controversial study used recently discovered mdm2 antagonists tools accumulation unphosphorylated p53 two cancer cell lines compared functional activity unphosphorylated p53 stress induced phosphorylated p53 cellular context data demonstrate unphosphorylated p53 fully capable activating downstream signaling p53 pathway equivalent phosphorylated p53 propose therefore phosphorylation residues tested required p53 activation conclusion compatible recent studies showing drugs leptomycin b also activate p53 absence serine 15 phosphorylation 6 40
0.60193133.15471885.html.plaintext.txt	54	discussion top abstract introduction experimental procedures results discussion references role phosphorylation p53 activation function subject intense studies last decade however despite abundant data numerous studies addressing specific phosphorylation events response diverse stress factors picture still incomplete although several lines evidence point n terminal phosphorylation major mechanism abrogation p53 mdm2 binding role phosphorylation modulation p53 functions still controversial study used recently discovered mdm2 antagonists tools accumulation unphosphorylated p53 two cancer cell lines compared functional activity unphosphorylated p53 stress induced phosphorylated p53 cellular context data demonstrate unphosphorylated p53 fully capable activating downstream signaling p53 pathway equivalent phosphorylated p53 propose therefore phosphorylation residues tested required p53 activation conclusion compatible recent studies showing drugs leptomycin b also activate p53 absence serine 15 phosphorylation 6 40
0.60193133.15471885.html.plaintext.txt	55	nutlin treated hct116 rko cells accumulated p53 protein levels comparable levels induced two genotoxic drugs doxorubicin etoposide fig 1 however predicted mechanism action p53 induced interference p53 mdm2 binding show detectable phosphorylation six serine residues previously reported major phosphorylation sites ser6 ser15 ser20 ser37 ser46 ser392 time p53 phosphorylated six serine residues doxorubicin treated cells fig 2 etoposide induced p53 showed comparable level phosphorylation serine residues much weaker undetectable others reflecting differences upstream signaling drugs 41 fact nutlin induced p53 phosphorylated six highly conserved phosphorylation sites makes unlikely potential sites could phosphorylated mdm2 antagonists therefore reasonable speculate p53 stabilized nutlin 3 free phosphorylation perhaps post translational modifications
0.60193133.15471885.html.plaintext.txt	56	nutlin induced p53 hct116 rko cells showed comparable binding activity consensus dna sequence indicating equivalent transactivation potential fig 3 however transactivation properties depend multiple factors best measured native p53 regulated genes vivo end examined activation three different p53 target genes quantitative pcr three reported immediate downstream genes directly regulated p53 test revealed unphosphorylated nutlin induced p53 equal superior activity fig 4 together previous result experiment confirmed phosphorylation status confer p53 higher transactivation potency contrary appears unphosphorylated p53 equivalent possibly better activator three genes cell lines mic 1 activated slightly higher doxorubicin rko cells
0.60193133.15471885.html.plaintext.txt	57	although see effects p53 phosphorylation transcriptional activity p53 three genes two cell lines exclude possibility differences might detected large constellation p53 regulated genes specific conditions specific tissues cell lines however results recent study published preparation manuscript render possibility unlikely jackson et al 42 used isopropyl d thiogalactopyranoside induced p14arf means sequester mdm2 stabilize p53 osteosarcoma cell line u2os arf induced p53 found phosphorylation free five n terminal serine residues ser6 ser9 ser15 ser20 ser37 still phosphorylated c terminal ser392 comparison global gene expression activated partially phosphorylated p53 fully phosphorylated doxorubicin induced p53 dna array analysis revealed genes regulated similarly authors concluded n terminal phosphorylation required transcriptional activation p53 target genes data study derived different tools different cell systems support conclusion p53 phosphorylation dispensable transcriptional activation p53 regulated genes vivo
0.60193133.15471885.html.plaintext.txt	58	although see effects p53 phosphorylation transcriptional activity p53 three genes two cell lines exclude possibility differences might detected large constellation p53 regulated genes specific conditions specific tissues cell lines however results recent study published preparation manuscript render possibility unlikely jackson et al 42 used isopropyl d thiogalactopyranoside induced p14arf means sequester mdm2 stabilize p53 osteosarcoma cell line u2os arf induced p53 found phosphorylation free five n terminal serine residues ser6 ser9 ser15 ser20 ser37 still phosphorylated c terminal ser392 comparison global gene expression activated partially phosphorylated p53 fully phosphorylated doxorubicin induced p53 dna array analysis revealed genes regulated similarly authors concluded n terminal phosphorylation required transcriptional activation p53 target genes data study derived different tools different cell systems support conclusion p53 phosphorylation dispensable transcriptional activation p53 regulated genes vivo
0.60193133.15471885.html.plaintext.txt	59	established p53 functions primarily transcription factor regulates multiple genes involved regulation cell growth homeostasis however transcription independent p53 functions also reported mediate apoptosis experimental conditions 36 37 p53 bind directly mitochondrial proteins induce apoptosis transcription independent manner 43 apoptotic activity p53 complex least understood functions multiple frequently overlapping apoptotic pathways downstream p53 studying one several may significant value fortunately apoptotic pathways converge point irreversible commitment apoptosis quantified measuring established apoptotic marker annexin v reactivity treatment hct116 rko cells active enantiomer nutlin 3 48 h induced apoptosis substantial fraction cell population p53 dependent since inactive enantiomer contribute apoptosis fig 6 apoptotic fraction etoposide treated cells slightly higher doxorubicin induced massive apoptosis 90 cell lines found significant fraction apoptosis induced high doses p53 independent comparing apoptotic fractions isogenic variants containing rko lacking rko r functional p53 pathway fig 8 apoptotic activity doxorubicin etoposide rko r cells subtracted activity parental rko cell line residual activity represent p53 dependent component apoptotic activity drugs maximal residual p53 dependent activity doxorubicin etoposide equal lower activity nutlin 3a result suggests p53 dependent apoptotic activity nutlin induced unphosphorylated p53 equal better activity phosphorylated p53 induced doxorubicin etoposide however one needs acknowledge normalization p53 independent activity could used approximation since p53 dependent independent mechanisms may utilize apoptotic pathways despite possible inaccuracy knowledge first attempt reveal differences apoptotic activity unphosphorylated phosphorylated p53 studies however needed assess possible effect phosphorylation transcription independent apoptotic activity p53
0.60193133.15471885.html.plaintext.txt	60	established p53 functions primarily transcription factor regulates multiple genes involved regulation cell growth homeostasis however transcription independent p53 functions also reported mediate apoptosis experimental conditions 36 37 p53 bind directly mitochondrial proteins induce apoptosis transcription independent manner 43 apoptotic activity p53 complex least understood functions multiple frequently overlapping apoptotic pathways downstream p53 studying one several may significant value fortunately apoptotic pathways converge point irreversible commitment apoptosis quantified measuring established apoptotic marker annexin v reactivity treatment hct116 rko cells active enantiomer nutlin 3 48 h induced apoptosis substantial fraction cell population p53 dependent since inactive enantiomer contribute apoptosis fig 6 apoptotic fraction etoposide treated cells slightly higher doxorubicin induced massive apoptosis 90 cell lines found significant fraction apoptosis induced high doses p53 independent comparing apoptotic fractions isogenic variants containing rko lacking rko r functional p53 pathway fig 8 apoptotic activity doxorubicin etoposide rko r cells subtracted activity parental rko cell line residual activity represent p53 dependent component apoptotic activity drugs maximal residual p53 dependent activity doxorubicin etoposide equal lower activity nutlin 3a result suggests p53 dependent apoptotic activity nutlin induced unphosphorylated p53 equal better activity phosphorylated p53 induced doxorubicin etoposide however one needs acknowledge normalization p53 independent activity could used approximation since p53 dependent independent mechanisms may utilize apoptotic pathways despite possible inaccuracy knowledge first attempt reveal differences apoptotic activity unphosphorylated phosphorylated p53 studies however needed assess possible effect phosphorylation transcription independent apoptotic activity p53
0.60193133.15471885.html.plaintext.txt	61	comparison activities p53 phosphorylated six key serine residues response genotoxic insult unphosphorylated p53 induced mdm2 antagonists revealed phosphorylation status p53 affect main functions tumor suppressor unphosphorylated p53 indistinguishable phosphorylated p53 ability bind dna sequence specific manner activate transcription target genes apoptosis vivo study confirms extends previous observations 24 42 using experimental system allows assessing p53 function natural cellular context reinforces notion phosphorylation dispensable activation p53 transcription factor data also demonstrate importance separating mdm2 p53 key requirement p53 activation raise question achieved vivo light studies showing p53 mutants phosphorylated nonetheless activated equivalently wild type p53 24 recent studies imply key event may actually damage induced phosphorylation mdm2 triggers preferential degradation mdm2 provides effective rapid means removing mdm2 p53 vivo enabling p53 engage transcriptional apparatus target gene induction 6
0.60193133.15471885.html.plaintext.txt	62	comparison activities p53 phosphorylated six key serine residues response genotoxic insult unphosphorylated p53 induced mdm2 antagonists revealed phosphorylation status p53 affect main functions tumor suppressor unphosphorylated p53 indistinguishable phosphorylated p53 ability bind dna sequence specific manner activate transcription target genes apoptosis vivo study confirms extends previous observations 24 42 using experimental system allows assessing p53 function natural cellular context reinforces notion phosphorylation dispensable activation p53 transcription factor data also demonstrate importance separating mdm2 p53 key requirement p53 activation raise question achieved vivo light studies showing p53 mutants phosphorylated nonetheless activated equivalently wild type p53 24 recent studies imply key event may actually damage induced phosphorylation mdm2 triggers preferential degradation mdm2 provides effective rapid means removing mdm2 p53 vivo enabling p53 engage transcriptional apparatus target gene induction 6
0.60193133.15471885.html.plaintext.txt	63	possibility still remains phosphorylation p53 may affect p53 activity independent transcription eg p53 dependent apoptotic pathways however previously published data laboratory support possibility treatment sjsa 1 osteosarcoma cell line 10 microm nutlin 3a leads massive apoptotic death 28 comparable doxorubicin treated rko cells fig 5 higher responsiveness mdm2 antagonists likely due fact mdm2 gene amplification sjsa 1 cells defect p53 pathway cell lines normal mdm2 level eg hct116 rko likely defects p53 dependent apoptotic pathways
0.60193133.15471885.html.plaintext.txt	64	conclusion p53 phosphorylation essential execution major functions p53 pathway one important implication cancer therapy shown mdm2 antagonists stabilize p53 inhibit tumor growth mouse xenografts models human cancer 28 however drugs non genotoxic cause phosphorylation p53 p53 phosphorylation important modulation transcriptional activity effectiveness mdm2 antagonists may limited data support utility mdm2 antagonists single therapeutic agents treating tumors wild type p53 retained intact signaling downstream p53
0.60193133.15471885.html.plaintext.txt	65	conclusion p53 phosphorylation essential execution major functions p53 pathway one important implication cancer therapy shown mdm2 antagonists stabilize p53 inhibit tumor growth mouse xenografts models human cancer 28 however drugs non genotoxic cause phosphorylation p53 p53 phosphorylation important modulation transcriptional activity effectiveness mdm2 antagonists may limited data support utility mdm2 antagonists single therapeutic agents treating tumors wild type p53 retained intact signaling downstream p53
0.60193133.15471885.html.plaintext.txt	66	footnotes costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.60193133.15471885.html.plaintext.txt	67	footnotes costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.60193133.15471885.html.plaintext.txt	68	article selected paper week
0.60193133.15471885.html.plaintext.txt	69	first three authors contributed equally work
0.60193133.15471885.html.plaintext.txt	70	correspondence addressed discovery oncology roche research center hoffmann la roche inc 340 kingsland st nutley nj 07110 tel 973 235 8106 fax 973 235 6185 e mail lyubomirvassilevatrochecom u d
0.60193133.15471885.html.plaintext.txt	71	1 abbreviation used mic 1 macrophage inhibitory cytokine 1
0.60193133.15471885.html.plaintext.txt	72	acknowledgments thank lin wu p53 sequence analysis karl frank help abi 6700 mary simcox critically reading manuscript
0.60193133.15471885.html.plaintext.txt	73	references top abstract introduction experimental procedures results discussion references levine j 1997 cell 88 323 331medline order article via infotrieve vogelstein b lane d levine j 2000 nature 408 307 310crossrefmedline order article via infotrieve freedman d wu l levine j 1999 cell mol life sci 55 96 107crossrefmedline order article via infotrieve michael d oren m 2003 semin cancer biol 13 49 58crossrefmedline order article via infotrieve brooks c l gu w 2003 curr opin cell biol 15 164 171crossrefmedline order article via infotrieve stommel j m wahl g m 2004 embo j 23 1547 1556abstractfree full text apella e anderson c w 2001 eur j biochem 268 2764 2772abstractfree full text jimenez g khan h stommel j m wahl g m 1999 oncogene 18 7656 7665crossrefmedline order article via infotrieve ljungman m 2000 neoplasia 2 208 225medline order article via infotrieve sakaguchi k herrera j e saito miki bustin m vassilev anderson c w appella e 1998 genes dev 12 2831 2841abstractfree full text craig l burch l vojtesek b mikutowska j thompson hupp r 1999 biochem j 342 133 141crossrefmedline order article via infotrieve schon o friedler bycroft m freund m fersht r 2002 j mol biol 323 491 501crossrefmedline order article via infotrieve meek d w 1999 oncogene 18 7666 7675crossrefmedline order article via infotrieve wang y prives c 1995 nature 376 88 91crossrefmedline order article via infotrieve hao m lowy m kapoor m deffie liu g lozano g 1996 j biol chem 271 29380 29385abstractfree full text sakaguchi k sakamoto h lewis m anderson c w erickson j w appella e xie d 1997 biochemistry 36 10117 10124crossrefmedline order article via infotrieve lambert p f kashanchi f radonovich m f shiekhattar r brady j n 1998 j biol chem 273 33048 33053abstractfree full text dumaz n meek d w 1999 embo j 18 7002 7010abstractfree full text liu l scolnick d m trievel r c zhang h b marmorstein r halazonetis d berger l 1999 mol cell biol 19 1202 1209abstractfree full text dorazi g cecchinelli b bruno manni higashimoto y saito gostissa m coen marchetti del sal g piaggio g fanciulli m appella e soddu 2002 nat cell biol 4 11 19crossrefmedline order article via infotrieve saito goodarzi higashimoto y noda y lees miller p appella e anderson c w 2002 j biol chem 277 12491 12494abstractfree full text zheng h h zhou x z murray uchida wulf g gu l tang x lu k p xiao z x 2002 nature 419 849 853crossrefmedline order article via infotrieve zacchi p gostissa m uchida salvagno c avolio f volinia ronai z blandino g schneider c del sal g 2002 nature 419 853 857crossrefmedline order article via infotrieve ashcroft m kubbutat m h vousden k h 1999 mol cell biol 19 1751 1758abstractfree full text wu z earle j saito anderson c w appella e xu y 2002 mol cell biol 22 2441 2449abstractfree full text chao c hergenhahn m kaeser m d wu z saito iggo r hollstein m appella e xu y 2003 j biol chem 278 41028 41033abstractfree full text sluss h k armata h gallant j jones n 2004 mol cell biol 24 976 984abstractfree full text vassilev l vu b graves b carvajal d podlaski f filipovic z kong n kammlott u lukacs c klein c fotouhi n liu e 2004 science 303 844 848abstractfree full text ahrendt halachmi chow j wu l halachmi n yang c wehage jen j sidransky d 1999 proc natl acad sci u 96 7382 7387abstractfree full text el deiry w tokino velculescu v e levy d b parsons r trent j m lin d mercer w e kinzler k w vogelstein b 1993 cell 75 817 825medline order article via infotrieve picksley m lane d p 1993 bioessays 15 689 690medline order article via infotrieve tan m wang y guan k sun y 2000 proc natl acad sci u 97 109 114abstractfree full text yang h filipovic z brown d breit n vassilev l 2003 mol cancer ther 2 1023 1029abstractfree full text symonds h krall l remington l saenz robles m lowe jacks van dyke 1994 cell 78 703 711medline order article via infotrieve schmitt c lowe w 2002 j mol med 80 137 146crossrefmedline order article via infotrieve caelles c helmberg karin m 1994 nature 370 220 223crossrefmedline order article via infotrieve haupt y rowan shaulian e kazaz vousden k oren m 1997 leukemia 11 suppl 3 337 339medline order article via infotrieve steensma d p timm m witzig e 2003 methods mol med 85 323 332medline order article via infotrieve perego p corna e de cesare m gatti l polizzi d pratesi g supino r zunino f 2001 curr med chem 8 31 37medline order article via infotrieve xirodimas d p stephen c w lane d p 2001 exp cell res 270 66 77crossrefmedline order article via infotrieve saito yamaguchi h higashimoto y chao c xu y fornace j jr appella e anderson c w 2003 j biol chem 278 37536 37544abstractfree full text jackson m w agarwal m k agarwal m l agarwal stanhope baker p williams b r stark g r 2004 oncogene 23 4477 4487crossrefmedline order article via infotrieve mihara m erster zaika petrenko o chittenden pancoska p moll u m 2003 mol cell 11 577 590medline order article via infotrieve
0.6023452.12427754.html.plaintext.txt	0	phosphorylation hsp90 binding mediate heat shock stabilization p53 chuangui wang jiandong chen
0.6023452.12427754.html.plaintext.txt	1	molecular oncology program h lee moffitt comprehensive cancer center research institute tampa florida 33612
0.6023452.12427754.html.plaintext.txt	2	molecular oncology program h lee moffitt comprehensive cancer center research institute tampa florida 33612
0.6023452.12427754.html.plaintext.txt	3	received publication july 6 2002 revised form november 7 2002
0.6023452.12427754.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references
0.6023452.12427754.html.plaintext.txt	5	p53 tumor suppressor stabilized activated diverse stress signals study investigated mechanism p53 activation heat shock found heat shock inhibited p53 ubiquitination caused accumulation p53 post transcriptional level heat shock induced phosphorylation p53 serine 15 atm kinase dependent fashion may contribute partially heat induced p53 accumulation however p53 accumulation also occurred heat shock atm deficient cells heat shock induced conformational change wild type p53 binding hsp90 inhibition hsp90 p53 interaction geldanamycin prevented p53 accumulation partially atm wild type cells completely atm deficient cells therefore phosphorylation interaction hsp90 contribute stabilization p53 heat shock introduction top abstract introduction materials methods results discussion references
0.6023452.12427754.html.plaintext.txt	6	p53 tumor suppressor stabilized activated diverse stress signals study investigated mechanism p53 activation heat shock found heat shock inhibited p53 ubiquitination caused accumulation p53 post transcriptional level heat shock induced phosphorylation p53 serine 15 atm kinase dependent fashion may contribute partially heat induced p53 accumulation however p53 accumulation also occurred heat shock atm deficient cells heat shock induced conformational change wild type p53 binding hsp90 inhibition hsp90 p53 interaction geldanamycin prevented p53 accumulation partially atm wild type cells completely atm deficient cells therefore phosphorylation interaction hsp90 contribute stabilization p53 heat shock introduction top abstract introduction materials methods results discussion references
0.6023452.12427754.html.plaintext.txt	7	p53 tumor suppressor important regulator cellular response stress abnormal cell proliferation dna damage normal cells p53 maintained low level rapid degradation ubiquitin dependent proteasome pathway 1 response different stress stimuli including ionizing radiation uv hypoxia p53 activated stabilized transcription factor activated p53 induces expression p21waf1 gadd45 bax p53aip puma others turn induce cell cycle arrest apoptosis 2
0.6023452.12427754.html.plaintext.txt	8	p53 tumor suppressor important regulator cellular response stress abnormal cell proliferation dna damage normal cells p53 maintained low level rapid degradation ubiquitin dependent proteasome pathway 1 response different stress stimuli including ionizing radiation uv hypoxia p53 activated stabilized transcription factor activated p53 induces expression p21waf1 gadd45 bax p53aip puma others turn induce cell cycle arrest apoptosis 2
0.6023452.12427754.html.plaintext.txt	9	level p53 cells mainly regulated post transcriptional level mdm21 oncoprotein mdm2 binds p53 promotes ubiquitination acting ubiquitin e3 ligase 3 5 expression mdm2 activated p53 transcription level 6 7 forming negative feedback loop maintain p53 low levels date stress signals activate p53 known interfere ability mdm2 promote p53 degradation phosphorylation p53 induction mdm2 inhibitor arf inhibition mdm2 expression 1 2 phosphorylation mdm2 atm may also play role p53 activation dna damage 8 mdm2 binding domain n terminus p53 contains several phosphorylation sites 9 10 recent studies 11 12 suggest dna damage phosphorylation ser 15 atm kinase ser 20 human chk2 plays important roles p53 stabilization interfering mdm2 binding
0.6023452.12427754.html.plaintext.txt	10	level p53 cells mainly regulated post transcriptional level mdm21 oncoprotein mdm2 binds p53 promotes ubiquitination acting ubiquitin e3 ligase 3 5 expression mdm2 activated p53 transcription level 6 7 forming negative feedback loop maintain p53 low levels date stress signals activate p53 known interfere ability mdm2 promote p53 degradation phosphorylation p53 induction mdm2 inhibitor arf inhibition mdm2 expression 1 2 phosphorylation mdm2 atm may also play role p53 activation dna damage 8 mdm2 binding domain n terminus p53 contains several phosphorylation sites 9 10 recent studies 11 12 suggest dna damage phosphorylation ser 15 atm kinase ser 20 human chk2 plays important roles p53 stabilization interfering mdm2 binding
0.6023452.12427754.html.plaintext.txt	11	previous reports 13 17 show heat shock 1 h 43 degrees c also induces p53 accumulation wild type p53 cell lines contributes cell cycle arrest apoptosis heat shock clinically useful facilitating treatment certain tumors gliomas combination chemotherapy ionizing radiation 18 20 therefore investigating mechanism p53 accumulation heat shock important understanding p53 response physiologically relevant stress previous study 22 suggests p53 accumulation response heat result general stress induced increase protein synthesis heat causes reduction overall cellular protein synthesis heat shock reported induce dna damage 21 suggesting may stabilize activate p53 part dna damage response pathways recent study shows 15 increase p53 mrna level heat treatment 172 glioma cells suggesting mechanism induction transcriptional level
0.6023452.12427754.html.plaintext.txt	12	previous reports 13 17 show heat shock 1 h 43 degrees c also induces p53 accumulation wild type p53 cell lines contributes cell cycle arrest apoptosis heat shock clinically useful facilitating treatment certain tumors gliomas combination chemotherapy ionizing radiation 18 20 therefore investigating mechanism p53 accumulation heat shock important understanding p53 response physiologically relevant stress previous study 22 suggests p53 accumulation response heat result general stress induced increase protein synthesis heat causes reduction overall cellular protein synthesis heat shock reported induce dna damage 21 suggesting may stabilize activate p53 part dna damage response pathways recent study shows 15 increase p53 mrna level heat treatment 172 glioma cells suggesting mechanism induction transcriptional level
0.6023452.12427754.html.plaintext.txt	13	stabilization p53 also occurs tumor cells mutated p53 result accumulation high levels missense mutations p53 dna binding core domain cause conformational change stable association molecular chaperones hsp70 hsp90 23 24 hsp90 binding shown contribute accumulation mutant p53 many client proteins 25 27 recent studies show 28 29 binding hsp90 inhibits ability mdm2 promote p53 ubiquitination degradation resulting stabilization mutant p53 mdm2 hsp90 appears inactivate mdm2 blocking central domain mdm2 normally involved regulation arf thereby mimicking effect arf prevent mutant p53 degradation 29
0.6023452.12427754.html.plaintext.txt	14	stabilization p53 also occurs tumor cells mutated p53 result accumulation high levels missense mutations p53 dna binding core domain cause conformational change stable association molecular chaperones hsp70 hsp90 23 24 hsp90 binding shown contribute accumulation mutant p53 many client proteins 25 27 recent studies show 28 29 binding hsp90 inhibits ability mdm2 promote p53 ubiquitination degradation resulting stabilization mutant p53 mdm2 hsp90 appears inactivate mdm2 blocking central domain mdm2 normally involved regulation arf thereby mimicking effect arf prevent mutant p53 degradation 29
0.6023452.12427754.html.plaintext.txt	15	although role hsp90 mutant p53 stabilization well established evidence date contributes stabilization wild type p53 stress molecular chaperones associate certain proteins transient manner folding heat shock response wild type p53 form stable complex hsp90 normal growth conditions dna damage induce p53 conformational change hsp90 unlikely play role dna damage response however p53 structurally unstable protein undergoes conformational change denaturation temperatures 40 degrees c vitro 30 work graeber et al 31 also indicates heat shock alters conformation wild type p53 allowing formation p53 hsc70 complex therefore possible hsp90 binding also interacts wild type p53 heat shock plays role stabilizing p53 mechanisms similar stabilization mutant p53
0.6023452.12427754.html.plaintext.txt	16	although role hsp90 mutant p53 stabilization well established evidence date contributes stabilization wild type p53 stress molecular chaperones associate certain proteins transient manner folding heat shock response wild type p53 form stable complex hsp90 normal growth conditions dna damage induce p53 conformational change hsp90 unlikely play role dna damage response however p53 structurally unstable protein undergoes conformational change denaturation temperatures 40 degrees c vitro 30 work graeber et al 31 also indicates heat shock alters conformation wild type p53 allowing formation p53 hsc70 complex therefore possible hsp90 binding also interacts wild type p53 heat shock plays role stabilizing p53 mechanisms similar stabilization mutant p53
0.6023452.12427754.html.plaintext.txt	17	study investigated role p53 conformational change interaction hsp90 stabilization p53 heat shock furthermore examined phosphorylation status p53 heat shock treatment results showed heat shock induced p53 accumulation promoting atm dependent serine 15 phosphorylation complex formation hsp90 mechanisms contribute p53 stabilization heat shock results identified first example hsp90 participation regulating wild type p53 stress response materials methods top abstract introduction materials methods results discussion references
0.6023452.12427754.html.plaintext.txt	18	study investigated role p53 conformational change interaction hsp90 stabilization p53 heat shock furthermore examined phosphorylation status p53 heat shock treatment results showed heat shock induced p53 accumulation promoting atm dependent serine 15 phosphorylation complex formation hsp90 mechanisms contribute p53 stabilization heat shock results identified first example hsp90 participation regulating wild type p53 stress response materials methods top abstract introduction materials methods results discussion references
0.6023452.12427754.html.plaintext.txt	19	cell lines reagents tumor cell lines 172 glioblastoma wt p53 u2os osteosarcoma wt p53 dld 1 colon carcinoma mt p53241s f obtained atcc mcf 7 breast tumor wt p53 cells provided dr arnold j levine epstein barr virus immortalized human lymphocyte normal control nc 607 atm patient 29 kindly provided dr kevin brown louisiana state university health science center 172 mcf 7 u2os h1299 dld 1 cultured dulbeccos modified eagles medium containing 10 vv fetal bovine serum nc 607 29 cells grown rpmi 1640 medium 20 fetal bovine serum geldanamycin sigma okadaic acid lc laboratories dissolved dimethyl sulfoxide 1 mm used 4 microm 01 microgml respectively mg132 dissolved ethanol used working concentration 30 microm 5 h
0.6023452.12427754.html.plaintext.txt	20	cell lines reagents tumor cell lines 172 glioblastoma wt p53 u2os osteosarcoma wt p53 dld 1 colon carcinoma mt p53241s f obtained atcc mcf 7 breast tumor wt p53 cells provided dr arnold j levine epstein barr virus immortalized human lymphocyte normal control nc 607 atm patient 29 kindly provided dr kevin brown louisiana state university health science center 172 mcf 7 u2os h1299 dld 1 cultured dulbeccos modified eagles medium containing 10 vv fetal bovine serum nc 607 29 cells grown rpmi 1640 medium 20 fetal bovine serum geldanamycin sigma okadaic acid lc laboratories dissolved dimethyl sulfoxide 1 mm used 4 microm 01 microgml respectively mg132 dissolved ethanol used working concentration 30 microm 5 h
0.6023452.12427754.html.plaintext.txt	21	heat shock cells growing exponentially 10 cm dishes 37 degrees c transferred co2 incubator 43 degrees c 2 h heat shock cells cultured co2 incubator 37 degrees c various periods
0.6023452.12427754.html.plaintext.txt	22	heat shock cells growing exponentially 10 cm dishes 37 degrees c transferred co2 incubator 43 degrees c 2 h heat shock cells cultured co2 incubator 37 degrees c various periods
0.6023452.12427754.html.plaintext.txt	23	immunoprecipitation western blot cells lysed radioimmune precipitation buffer 1 sodium deoxycholate 01 sds 1 triton x 100 50 mm tris ph 74 150 mm nacl 1 mm phenylmethylsulfonyl fluoride 20 100 microg protein fractionated sds page transferred immobilon p filters millipore filter blocked 1 h pbs containing 5 nonfat dry milk 01 tween 20 incubated 1 h 3g9 mdm2 32 1 p53 bd biosciences pbs containing 5 nonfat dry milk bound primary antibody detected incubating 1 h hrp goat anti mouse igg hrp protein filter developed using ecl plus reagent amersham biosciences hsp90 detected mouse anti hsp90 antibody stressgen p53 phosphorylation analyzed ser 9 ser 15 ser 20 ser 37 ser 46 ser 392 using anti phospho p53 polyclonal antibodies cell signaling technology immunoprecipitation western blot analysis cells lysed lysis buffer 50 mm tris hcl ph 80 5 mm edta 150 mm nacl 05 nonidet p 40 1 mm phenylmethylsulfonyl fluoride containing 10 mm molybdate stabilize p53 hsp90 complex 1000 microg protein precleared protein sepharose beads sigma immunoprecipitated p53 antibody pab1801 pab1620 pab240 4 h 4 degrees c beads washed lysis buffer immunoprecipitate fractionated sds page followed western blot p53 hsp90 detection ubiquitinated p53 western blot cells lysed laemmli sds sample buffer immediately boiled 3 min subjecting sds page lysates clarified centrifugation 14000 x g 15 min 4 degrees c
0.6023452.12427754.html.plaintext.txt	24	immunoprecipitation western blot cells lysed radioimmune precipitation buffer 1 sodium deoxycholate 01 sds 1 triton x 100 50 mm tris ph 74 150 mm nacl 1 mm phenylmethylsulfonyl fluoride 20 100 microg protein fractionated sds page transferred immobilon p filters millipore filter blocked 1 h pbs containing 5 nonfat dry milk 01 tween 20 incubated 1 h 3g9 mdm2 32 1 p53 bd biosciences pbs containing 5 nonfat dry milk bound primary antibody detected incubating 1 h hrp goat anti mouse igg hrp protein filter developed using ecl plus reagent amersham biosciences hsp90 detected mouse anti hsp90 antibody stressgen p53 phosphorylation analyzed ser 9 ser 15 ser 20 ser 37 ser 46 ser 392 using anti phospho p53 polyclonal antibodies cell signaling technology immunoprecipitation western blot analysis cells lysed lysis buffer 50 mm tris hcl ph 80 5 mm edta 150 mm nacl 05 nonidet p 40 1 mm phenylmethylsulfonyl fluoride containing 10 mm molybdate stabilize p53 hsp90 complex 1000 microg protein precleared protein sepharose beads sigma immunoprecipitated p53 antibody pab1801 pab1620 pab240 4 h 4 degrees c beads washed lysis buffer immunoprecipitate fractionated sds page followed western blot p53 hsp90 detection ubiquitinated p53 western blot cells lysed laemmli sds sample buffer immediately boiled 3 min subjecting sds page lysates clarified centrifugation 14000 x g 15 min 4 degrees c
0.6023452.12427754.html.plaintext.txt	25	northern blot total cellular rna isolated using rneasy kit qiagen twenty micrograms total rna fractionated formaldehyde denaturing gel transferred onto biotrans membrane icn filter hybridized random primed probe synthesized using p53 cdna fragment hybridization carried buffer containing 1 sds 1 m nacl 10 dextransulfate 18 h 65 degrees c filter washed 2 x ssc buffer 03 m nacl 003 m sodium citrate exposed film detection glyceraldehyde 3 phosphate dehydrogenase mrna glyceraldehyde phosphate dehydrogenase filter stripped rehybridized full length 12 kilobase human glyceraldehyde 3 phosphate dehydrogenase cdna probe
0.6023452.12427754.html.plaintext.txt	26	northern blot total cellular rna isolated using rneasy kit qiagen twenty micrograms total rna fractionated formaldehyde denaturing gel transferred onto biotrans membrane icn filter hybridized random primed probe synthesized using p53 cdna fragment hybridization carried buffer containing 1 sds 1 m nacl 10 dextransulfate 18 h 65 degrees c filter washed 2 x ssc buffer 03 m nacl 003 m sodium citrate exposed film detection glyceraldehyde 3 phosphate dehydrogenase mrna glyceraldehyde phosphate dehydrogenase filter stripped rehybridized full length 12 kilobase human glyceraldehyde 3 phosphate dehydrogenase cdna probe
0.6023452.12427754.html.plaintext.txt	27	immunofluorescence staining cells cultured chamber slides fixed acetonemethanol 11 3 min room temperature blocked pbs containing 10 normal goat serum 20 min incubated anti p53 monoclonal antibody pab1801 rabbit anti mdm2 polyclonal serum pbs 10 normal goat serum 2 h slides washed pbs containing 01 triton x 100 incubated fluorescein isothiocyanate labeled goat anti mouse igg rhodamine labeled goat anti rabbit igg pbs 10 normal goat serum 1 h washed pbs 01 triton x 100 mounted results top abstract introduction materials methods results discussion references
0.6023452.12427754.html.plaintext.txt	28	immunofluorescence staining cells cultured chamber slides fixed acetonemethanol 11 3 min room temperature blocked pbs containing 10 normal goat serum 20 min incubated anti p53 monoclonal antibody pab1801 rabbit anti mdm2 polyclonal serum pbs 10 normal goat serum 2 h slides washed pbs containing 01 triton x 100 incubated fluorescein isothiocyanate labeled goat anti mouse igg rhodamine labeled goat anti rabbit igg pbs 10 normal goat serum 1 h washed pbs 01 triton x 100 mounted results top abstract introduction materials methods results discussion references
0.6023452.12427754.html.plaintext.txt	29	accumulation p53 response heat shock determine effect heat shock p53 mdm2 expression levels 172 cells incubated 43 degrees c 2 h returned 37 degrees c 4 16 h protein levels p53 mdm2 measured western blot results showed p53 mdm2 levels increased significantly 4 h heat shock fig 1 b quantitation level p53 loading titration indicated heat shock caused 6 8 fold increase p53 level 4 h termination heat treatment data shown found p53 levels also induced heat shock two cell lines u2os mcf 7 data shown also examined localization p53 mdm2 172 cells heat shock immunofluorescence staining results confirmed increase p53 mdm2 levels 4 h heat shock showed p53 mainly accumulated nucleus experimental conditions fig 1c
0.6023452.12427754.html.plaintext.txt	30	accumulation p53 response heat shock determine effect heat shock p53 mdm2 expression levels 172 cells incubated 43 degrees c 2 h returned 37 degrees c 4 16 h protein levels p53 mdm2 measured western blot results showed p53 mdm2 levels increased significantly 4 h heat shock fig 1 b quantitation level p53 loading titration indicated heat shock caused 6 8 fold increase p53 level 4 h termination heat treatment data shown found p53 levels also induced heat shock two cell lines u2os mcf 7 data shown also examined localization p53 mdm2 172 cells heat shock immunofluorescence staining results confirmed increase p53 mdm2 levels 4 h heat shock showed p53 mainly accumulated nucleus experimental conditions fig 1c
0.6023452.12427754.html.plaintext.txt	31	view larger version 67k fig 1 induction p53 target mdm2 heat shock 172 cells incubated 43 degrees c 2 h cultured 37 degrees c indicated times protein extracts subjected western blot analysis using specific antibodies b heat shock induced p53 target mdm2 172 cells incubated 43 degrees c 2 h analyzed p53 mdm2 expression returning 37 degrees c 4 h c double immunofluorescence staining p53 mdm2 172 cells 4 h heat shock upper panels p53 lower panels mdm2 ctrl control cells 37 degrees c hs cells treated heat shock mg132 cells treated 30 microm mg132 4 h cpt cells treated 1 microm camptothecin 6 h
0.6023452.12427754.html.plaintext.txt	32	investigate mechanism p53 accumulation mrna levels p53 determined northern blot results showed p53 mrna level 172 mcf 7 cells change heat shock fig 2a therefore increased p53 protein expression attributed increase transcription test whether p53 stabilized heat shock 172 cells treated heat shock proteasome inhibitor mg132 magnitude p53 accumulation mg132 treatment provided indication rapidly p53 degraded ubiquitin dependent proteasomes result showed control cells 4 h treatment mg132 caused significant increase p53 level however heat shock mg132 treatment lead increase p53 level compared heat shock alone fig 2b indicating already stabilized suggested increased p53 level reduced p53 degradation proteasomes
0.6023452.12427754.html.plaintext.txt	33	investigate mechanism p53 accumulation mrna levels p53 determined northern blot results showed p53 mrna level 172 mcf 7 cells change heat shock fig 2a therefore increased p53 protein expression attributed increase transcription test whether p53 stabilized heat shock 172 cells treated heat shock proteasome inhibitor mg132 magnitude p53 accumulation mg132 treatment provided indication rapidly p53 degraded ubiquitin dependent proteasomes result showed control cells 4 h treatment mg132 caused significant increase p53 level however heat shock mg132 treatment lead increase p53 level compared heat shock alone fig 2b indicating already stabilized suggested increased p53 level reduced p53 degradation proteasomes
0.6023452.12427754.html.plaintext.txt	34	view larger version 35k fig 2 stabilization p53 heat shock p53 gadph mrna levels determined northern blot control heat shock treated cells b p53 protein levels determined 172 cells 4 h heat shock presence absence 30 microm mg132 c p53 ubiquitination level determined rapid lysis sds sample buffer western blot amount control loaded increased 8 fold 4 h time point match increased p53 heat treated cells
0.6023452.12427754.html.plaintext.txt	35	p53 turnover regulated mdm2 mediated ubiquitination examined level p53 ubiquitination direct lysis sds sample buffer preserved polyubiquitinated forms p53 western blot lysate showed high molecular weight bands ubiquitinated p53 significantly reduced immediately heat shock fig 2c significant recovery p53 ubiquitination 4 h heat shock may high level mdm2 expression time point start recovery process fig 1b therefore ability mdm2 promote p53 ubiquitination inhibited heat shock consistent increase p53 stability
0.6023452.12427754.html.plaintext.txt	36	p53 turnover regulated mdm2 mediated ubiquitination examined level p53 ubiquitination direct lysis sds sample buffer preserved polyubiquitinated forms p53 western blot lysate showed high molecular weight bands ubiquitinated p53 significantly reduced immediately heat shock fig 2c significant recovery p53 ubiquitination 4 h heat shock may high level mdm2 expression time point start recovery process fig 1b therefore ability mdm2 promote p53 ubiquitination inhibited heat shock consistent increase p53 stability
0.6023452.12427754.html.plaintext.txt	37	phosphorylation p53 172 cells heat shock camptothecin cpt treatment well established stability p53 regulated phosphorylation examined phosphorylation status p53 several different sites heat shock dna damaging agent cpt used positive control furthermore control increased levels p53 protein heat shock also used mg132 treatment induce p53 accumulation 37 degrees c antibodies recognizing different phosphorylated serine residues p53 used western blot detection phosphorylated p53 results showed significant increase phosphorylation level ser 15 heat shock fig 3 phosphorylation ser 20 also reproducibly induced heat shock although less induced cpt treatment phosphorylation level ser 46 induced cpt heat shock anti phospho ser 392 antibody also detect change heat shock fig 3 whereas uv irradiation control induced moderate increase signal expected fig 3 bottom panels 33 results ser 9 ser 37 phosphorylation uninformative induced heat shock cpt control data shown summary heat shock selectively induced phosphorylation p53 ser 15 ser 20 suggesting involvement atm human chk2 kinases
0.6023452.12427754.html.plaintext.txt	38	phosphorylation p53 172 cells heat shock camptothecin cpt treatment well established stability p53 regulated phosphorylation examined phosphorylation status p53 several different sites heat shock dna damaging agent cpt used positive control furthermore control increased levels p53 protein heat shock also used mg132 treatment induce p53 accumulation 37 degrees c antibodies recognizing different phosphorylated serine residues p53 used western blot detection phosphorylated p53 results showed significant increase phosphorylation level ser 15 heat shock fig 3 phosphorylation ser 20 also reproducibly induced heat shock although less induced cpt treatment phosphorylation level ser 46 induced cpt heat shock anti phospho ser 392 antibody also detect change heat shock fig 3 whereas uv irradiation control induced moderate increase signal expected fig 3 bottom panels 33 results ser 9 ser 37 phosphorylation uninformative induced heat shock cpt control data shown summary heat shock selectively induced phosphorylation p53 ser 15 ser 20 suggesting involvement atm human chk2 kinases
0.6023452.12427754.html.plaintext.txt	39	view larger version 69k fig 3 phosphorylation p53 different serine residues response heat shock dna damage 172 cells heated 43 degrees c 2 h cultured 37 degrees c 4 h control cells treated 30 microm mg132 1 microm cpt 20 jm2 uv 6 h 37 degrees c cells lysed buffer containing okadaic acid identical amounts protein extracts subjected western blot analysis using phospho peptide specific antibodies raised indicated sites p53 total levels p53 determined western blot mixture 1 pab1801
0.6023452.12427754.html.plaintext.txt	40	phosphorylation p53 ser 15 atm dependent ser 15 phosphorylation p53 dna damage carried atm kinase 34 therefore investigated role atm ser 15 phosphorylation heat shock using immortalized lymphocytes derived normal nc 607 patients 29 results showed ser 15 phosphorylation induced heat shock atm deficient lymphocytes whereas strong induction observed normal lymphocytes fig 4 therefore ser 15 phosphorylation heat shock dependent atm kinase
0.6023452.12427754.html.plaintext.txt	41	phosphorylation p53 ser 15 atm dependent ser 15 phosphorylation p53 dna damage carried atm kinase 34 therefore investigated role atm ser 15 phosphorylation heat shock using immortalized lymphocytes derived normal nc 607 patients 29 results showed ser 15 phosphorylation induced heat shock atm deficient lymphocytes whereas strong induction observed normal lymphocytes fig 4 therefore ser 15 phosphorylation heat shock dependent atm kinase
0.6023452.12427754.html.plaintext.txt	42	view larger version 70k fig 4 accumulation p53 phosphorylation serine 15 nc 607 normal 29 atm deficient lymphocytes cells heated 43 degrees c 2 h cultured 37 degrees c 4 h indicated amounts total cellular proteins analyzed p53 level western blot mixture 1 pab1801 serine 15 phosphorylation level determined phospho ser 15 specific western blot
0.6023452.12427754.html.plaintext.txt	43	similar 172 cells heat shock also caused 3 fold induction p53 protein level normal lymphocytes although ser 15 phosphorylation level change atm deficient lymphocytes heat shock p53 level still moderately increased 3 fold fig 4 therefore phosphorylation ser 15 atm contributed absolutely required p53 accumulation heat shock result also suggested additional mechanisms contribute p53 stabilization heat shock
0.6023452.12427754.html.plaintext.txt	44	similar 172 cells heat shock also caused 3 fold induction p53 protein level normal lymphocytes although ser 15 phosphorylation level change atm deficient lymphocytes heat shock p53 level still moderately increased 3 fold fig 4 therefore phosphorylation ser 15 atm contributed absolutely required p53 accumulation heat shock result also suggested additional mechanisms contribute p53 stabilization heat shock
0.6023452.12427754.html.plaintext.txt	45	p53 conformational change heat shock test hypothesis heat shock caused wild type p53 conformational change p53 precipitated mutant specific pab240 wild type specific pab1620 antibodies 35 pab240 recognizes hydrophobic peptide sequences p53 normally packed inside dna binding core domain 36 therefore exposure pab240 epitope indicative misfolded p53 result showed control 172 cells p53 could precipitated efficiently pab1620 weakly pab240 fig 5a conversely heat shock significantly increased reaction pab240 cells harvested 2 h heat shock treatment fig 5a although significant fraction p53 also retained pab1620 reactivity 4 h heat shock highest point p53 accumulation p53 reactivity pab1620 increased strongly pab240 reactivity reduced significantly therefore rapid recovery p53 conformation back wild type status heat shock result also showed change p53 conformation correlated level p53 ubiquitination fig 2c immediately heat shock significant reduction ubiquitinated p53 species recovered near control level 4 h heat shock therefore change p53 conformation may also play role stabilizing p53
0.6023452.12427754.html.plaintext.txt	46	p53 conformational change heat shock test hypothesis heat shock caused wild type p53 conformational change p53 precipitated mutant specific pab240 wild type specific pab1620 antibodies 35 pab240 recognizes hydrophobic peptide sequences p53 normally packed inside dna binding core domain 36 therefore exposure pab240 epitope indicative misfolded p53 result showed control 172 cells p53 could precipitated efficiently pab1620 weakly pab240 fig 5a conversely heat shock significantly increased reaction pab240 cells harvested 2 h heat shock treatment fig 5a although significant fraction p53 also retained pab1620 reactivity 4 h heat shock highest point p53 accumulation p53 reactivity pab1620 increased strongly pab240 reactivity reduced significantly therefore rapid recovery p53 conformation back wild type status heat shock result also showed change p53 conformation correlated level p53 ubiquitination fig 2c immediately heat shock significant reduction ubiquitinated p53 species recovered near control level 4 h heat shock therefore change p53 conformation may also play role stabilizing p53
0.6023452.12427754.html.plaintext.txt	47	view larger version 64k fig 5 conformational change wild type p53 interaction hsp90 heat shock 172 cells treated heat shock p53 immunoprecipitated wild type specific pab1620 mutant specific pab240 using identical amounts cell lysate followed western blot 1 b 172 cells immunoprecipitated pab1801 heat shock using identical amounts cell lysate followed anti hsp90 western blot control 172 dld 1 mutant p53 cells maintained 37 degrees c
0.6023452.12427754.html.plaintext.txt	48	wild type p53 binds hsp90 heat shock hsp90 binding important preventing degradation many cellular proteins including mutant p53 disruption hsp90 mutant p53 binding leads destabilization p53 ubiquitin dependent proteasomes 25 27 29 37 heat shock induced significant conformational change wild type p53 asked whether hsp90 also regulates wild type p53 stability binding p53 preventing degradation mdm2
0.6023452.12427754.html.plaintext.txt	49	wild type p53 binds hsp90 heat shock hsp90 binding important preventing degradation many cellular proteins including mutant p53 disruption hsp90 mutant p53 binding leads destabilization p53 ubiquitin dependent proteasomes 25 27 29 37 heat shock induced significant conformational change wild type p53 asked whether hsp90 also regulates wild type p53 stability binding p53 preventing degradation mdm2
0.6023452.12427754.html.plaintext.txt	50	test binding hsp90 p53 conformation independent pab1801 antibody used precipitate p53 cell lysate harvested 2 4 h heat shock coprecipitated hsp90 detected western blot p53 precipitate using hsp90 specific antibody results showed hsp90 coprecipitate wild type p53 control 172 cultures without heat shock treatment fig 5b however significant amounts hsp90 coprecipitated mutant p53 protein dld 1 cells 37 degrees c also wild type p53 heat treated 172 cells fig 5b binding p53 hsp90 stronger 2 h heat shock 4 h p53 present 4 h lysate yet amount hsp90 coprecipitated increase fig 5b consistent significant recovery wild type p53 conformation ubiquitination level observed time point therefore heat shock induced transient association wild type p53 hsp90
0.6023452.12427754.html.plaintext.txt	51	test binding hsp90 p53 conformation independent pab1801 antibody used precipitate p53 cell lysate harvested 2 4 h heat shock coprecipitated hsp90 detected western blot p53 precipitate using hsp90 specific antibody results showed hsp90 coprecipitate wild type p53 control 172 cultures without heat shock treatment fig 5b however significant amounts hsp90 coprecipitated mutant p53 protein dld 1 cells 37 degrees c also wild type p53 heat treated 172 cells fig 5b binding p53 hsp90 stronger 2 h heat shock 4 h p53 present 4 h lysate yet amount hsp90 coprecipitated increase fig 5b consistent significant recovery wild type p53 conformation ubiquitination level observed time point therefore heat shock induced transient association wild type p53 hsp90
0.6023452.12427754.html.plaintext.txt	52	inhibition hsp90 prevents p53 accumulation heat shock binding hsp90 mutant p53 known cause p53 stabilization 25 27 29 37 therefore examined role hsp90 wild type p53 stability heat shock 172 nc 607 29 cells treated heat shock presence absence hsp90 inhibitor geldanamycin level p53 measured western blot 4 h heat shock results showed without heat shock geldanamycin treatment significantly affect p53 level however geldanamycin prevented accumulation p53 heat shock atm deficient 29 cells fig 6a suggesting hsp90 function important p53 accumulation inhibitory effect geldanamycin complete 172 nc 607 cells probably atm mediated phosphorylation also contributed p53 stabilization
0.6023452.12427754.html.plaintext.txt	53	inhibition hsp90 prevents p53 accumulation heat shock binding hsp90 mutant p53 known cause p53 stabilization 25 27 29 37 therefore examined role hsp90 wild type p53 stability heat shock 172 nc 607 29 cells treated heat shock presence absence hsp90 inhibitor geldanamycin level p53 measured western blot 4 h heat shock results showed without heat shock geldanamycin treatment significantly affect p53 level however geldanamycin prevented accumulation p53 heat shock atm deficient 29 cells fig 6a suggesting hsp90 function important p53 accumulation inhibitory effect geldanamycin complete 172 nc 607 cells probably atm mediated phosphorylation also contributed p53 stabilization
0.6023452.12427754.html.plaintext.txt	54	view larger version 68k fig 6 hsp90 inhibitor geldanamycin blocks p53 accumulation heat shock cells treated heat shock presence absence 4 microm geldanamycin ga p53 levels determined western blot 4 h b effect geldanamycin p53 hsp90 binding heat shock determined treating cells presence 4 microm geldanamycin immunoprecipitation p53 pab1801 4 h heat shock coprecipitation hsp90 detected western blot amounts cell lysate used precipitation adjusted contain similar amount p53
0.6023452.12427754.html.plaintext.txt	55	geldanamycin binds atp binding site hsp90 often reduces binding client proteins 26 confirm geldanamycin blocked hsp90 p53 binding heat shock 172 nc 607 29 cells treated heat shock geldanamycin hsp90 p53 binding detected p53 immunoprecipitation followed hsp90 western blot result showed geldanamycin treatment reduced hsp90 p53 coprecipitation three cell lines fig 6b therefore inhibition hsp90 p53 binding heat shock prevented p53 accumulation discussion top abstract introduction materials methods results discussion references
0.6023452.12427754.html.plaintext.txt	56	geldanamycin binds atp binding site hsp90 often reduces binding client proteins 26 confirm geldanamycin blocked hsp90 p53 binding heat shock 172 nc 607 29 cells treated heat shock geldanamycin hsp90 p53 binding detected p53 immunoprecipitation followed hsp90 western blot result showed geldanamycin treatment reduced hsp90 p53 coprecipitation three cell lines fig 6b therefore inhibition hsp90 p53 binding heat shock prevented p53 accumulation discussion top abstract introduction materials methods results discussion references
0.6023452.12427754.html.plaintext.txt	57	results described show short term exposure elevated temperature causes accumulation activation wild type p53 increased p53 expression level induction p53 transcription mrna level change heat stress similar forms p53 stress response reduced ubiquitination degradation appears major cause accumulation heat shock stabilized p53 functional inducing expression downstream target genes shown contribute cell cycle arrest apoptosis response heat shock 13 15 therefore p53 activation heat shock functionally relevant response environmental stress
0.6023452.12427754.html.plaintext.txt	58	results described show short term exposure elevated temperature causes accumulation activation wild type p53 increased p53 expression level induction p53 transcription mrna level change heat stress similar forms p53 stress response reduced ubiquitination degradation appears major cause accumulation heat shock stabilized p53 functional inducing expression downstream target genes shown contribute cell cycle arrest apoptosis response heat shock 13 15 therefore p53 activation heat shock functionally relevant response environmental stress
0.6023452.12427754.html.plaintext.txt	59	ubiquitination degradation p53 mainly regulated mdm2 many p53 responses environmental cellular stresses cause p53 stabilization interfering mdm2 function phosphorylation p53 mdm2 inhibition mdm2 expression inactivation mdm2 expression arf implicated wild type p53 accumulation 1 38 furthermore stabilization mutant p53 involves binding molecular chaperones hsp90 25 27 37 hsp90 mutant p53 complex resistant mdm2 mediated ubiquitination degradation mdm2 bound p53 complex inactivated hsp90 29 hsp90 appears conceal arf binding site mdm2 hsp90 p53 mdm2 complexes prevent mdm2 ubiquitinating p53 result mdm2 mutant p53 become stabilized tumor cells expressing mutant p53 28 previously showed dissociation hsp90 geldanamycin treatment restores ubiquitination degradation mutant p53 29 therefore hsp90 mutant p53 complex also causes p53 stabilization interfering mdm2 activity
0.6023452.12427754.html.plaintext.txt	60	ubiquitination degradation p53 mainly regulated mdm2 many p53 responses environmental cellular stresses cause p53 stabilization interfering mdm2 function phosphorylation p53 mdm2 inhibition mdm2 expression inactivation mdm2 expression arf implicated wild type p53 accumulation 1 38 furthermore stabilization mutant p53 involves binding molecular chaperones hsp90 25 27 37 hsp90 mutant p53 complex resistant mdm2 mediated ubiquitination degradation mdm2 bound p53 complex inactivated hsp90 29 hsp90 appears conceal arf binding site mdm2 hsp90 p53 mdm2 complexes prevent mdm2 ubiquitinating p53 result mdm2 mutant p53 become stabilized tumor cells expressing mutant p53 28 previously showed dissociation hsp90 geldanamycin treatment restores ubiquitination degradation mutant p53 29 therefore hsp90 mutant p53 complex also causes p53 stabilization interfering mdm2 activity
0.6023452.12427754.html.plaintext.txt	61	molecular chaperones hsp70 hsp90 recognize exposed hydrophobic regions misfolded proteins nascent polypeptides ligand binding sites steroid hormone receptors 26 39 wild type p53 structurally unstable protein readily undergoes conformational change 40 degrees c vitro 30 point mutations dna binding domain disrupt proper folding cause structural change physiological temperatures different mutations lead different temperature sensitivities mutations val 138 remain functional conformationally wild type 32 degrees c lose activity 39 degrees c 40 many hot spot mutations found human tumors cause significant conformational changes complete loss activity physiological temperature 41 therefore conceivable heat shock also causes transient conformational change wild type p53 similar misfolding caused structural mutations resulting binding hsp90
0.6023452.12427754.html.plaintext.txt	62	molecular chaperones hsp70 hsp90 recognize exposed hydrophobic regions misfolded proteins nascent polypeptides ligand binding sites steroid hormone receptors 26 39 wild type p53 structurally unstable protein readily undergoes conformational change 40 degrees c vitro 30 point mutations dna binding domain disrupt proper folding cause structural change physiological temperatures different mutations lead different temperature sensitivities mutations val 138 remain functional conformationally wild type 32 degrees c lose activity 39 degrees c 40 many hot spot mutations found human tumors cause significant conformational changes complete loss activity physiological temperature 41 therefore conceivable heat shock also causes transient conformational change wild type p53 similar misfolding caused structural mutations resulting binding hsp90
0.6023452.12427754.html.plaintext.txt	63	suggest heat shock causes transient misfolding wild type p53 attracts binding hsp90 hsp90 binding would prevent p53 aggregation facilitate refolding process however hsp90 binding would also prevent mdm2 mediated degradation manner similar stabilization mutant p53 hsp90 37 degrees c unlike mutant p53 fold properly even presence molecular chaperones heat denatured wild type p53 efficiently refolded chaperones 37 degrees c therefore conformational change heat shock transient p53 level begins decrease several hours heat shock correlates return normal p53 ubiquitination level
0.6023452.12427754.html.plaintext.txt	64	suggest heat shock causes transient misfolding wild type p53 attracts binding hsp90 hsp90 binding would prevent p53 aggregation facilitate refolding process however hsp90 binding would also prevent mdm2 mediated degradation manner similar stabilization mutant p53 hsp90 37 degrees c unlike mutant p53 fold properly even presence molecular chaperones heat denatured wild type p53 efficiently refolded chaperones 37 degrees c therefore conformational change heat shock transient p53 level begins decrease several hours heat shock correlates return normal p53 ubiquitination level
0.6023452.12427754.html.plaintext.txt	65	however hsp90 appears regulator p53 stabilization heat shock hsp90 inhibitor geldanamycin cause complete block p53 accumulation atm wild type cell lines found heat shock also induced phosphorylation p53 ser 15 ser 20 sites important regulating stability transcription activity p53 1 phosphorylation ser 15 ser 20 dependent atm kinase activity atm mediated activation human chk2 kinase suggesting heat shock activate atm kinase induce p53 accumulation part phosphorylation previous study 21 shows heat shock causes low levels dna damage results also showed heat shock induced phosphorylation p53 ser 15 ser 20 whereas dna damaging agent camptothecin induced stronger phosphorylation ser 15 ser 20 well additional phosphorylation ser 46 consistent requirement severe dna damage inducing ser 46 phosphorylation 42 therefore heat shock may activate atm inducing low level dna damage turn activates p53 phosphorylation p53 mdm2 8 dna damage mediated dephosphorylation mdm2 acidic domain may also play role stabilization p53 43 course study miyakoda et al 17 also reported phosphorylation p53 ser 15 occurs heat shock atm dependent fashion consistent finding
0.6023452.12427754.html.plaintext.txt	66	however hsp90 appears regulator p53 stabilization heat shock hsp90 inhibitor geldanamycin cause complete block p53 accumulation atm wild type cell lines found heat shock also induced phosphorylation p53 ser 15 ser 20 sites important regulating stability transcription activity p53 1 phosphorylation ser 15 ser 20 dependent atm kinase activity atm mediated activation human chk2 kinase suggesting heat shock activate atm kinase induce p53 accumulation part phosphorylation previous study 21 shows heat shock causes low levels dna damage results also showed heat shock induced phosphorylation p53 ser 15 ser 20 whereas dna damaging agent camptothecin induced stronger phosphorylation ser 15 ser 20 well additional phosphorylation ser 46 consistent requirement severe dna damage inducing ser 46 phosphorylation 42 therefore heat shock may activate atm inducing low level dna damage turn activates p53 phosphorylation p53 mdm2 8 dna damage mediated dephosphorylation mdm2 acidic domain may also play role stabilization p53 43 course study miyakoda et al 17 also reported phosphorylation p53 ser 15 occurs heat shock atm dependent fashion consistent finding
0.6023452.12427754.html.plaintext.txt	67	summary atm mediated phosphorylation conformation mediated hsp90 binding cooperate cause p53 accumulation response heat stress results identify first example hsp90 plays role regulating wild type p53 stability response stress conformational change p53 suggested occur absence heat stress based change reactivity conformation specific antibodies 44 therefore interesting investigate whether hsp90 plays role regulating p53 stability physiological processes acknowledgement
0.6023452.12427754.html.plaintext.txt	68	summary atm mediated phosphorylation conformation mediated hsp90 binding cooperate cause p53 accumulation response heat stress results identify first example hsp90 plays role regulating wild type p53 stability response stress conformational change p53 suggested occur absence heat stress based change reactivity conformation specific antibodies 44 therefore interesting investigate whether hsp90 plays role regulating p53 stability physiological processes acknowledgement
0.6023452.12427754.html.plaintext.txt	69	would like thank dr kevin brown providing atm deficient cells
0.6023452.12427754.html.plaintext.txt	70	work supported american cancer society grant rsg cne 102445 national institutes health grant ca88406 j cthe costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.6023452.12427754.html.plaintext.txt	71	correspondence addressed h lee moffitt cancer center mrc3057a 12902 magnolia dr tampa fl 33612 tel 813 903 6822 fax 813 903 6817 e mail jchenmoffittusfedu
0.6023452.12427754.html.plaintext.txt	72	correspondence addressed h lee moffitt cancer center mrc3057a 12902 magnolia dr tampa fl 33612 tel 813 903 6822 fax 813 903 6817 e mail jchenmoffittusfedu
0.6023452.12427754.html.plaintext.txt	73	published jbc papers press november 8 2002 doi 101074jbcm206697200
0.6023452.12427754.html.plaintext.txt	74	abbreviations used mdm murine double minute arf alternative reading frame atm ataxia telangiectasin mutated protein kinase e3 ubiquitin protein isopeptide ligase pbs phosphate buffered saline hrp horseradish peroxidase cpt camptothecin nc normal control
0.6023452.12427754.html.plaintext.txt	75	references top abstract introduction materials methods results discussion references 1 prives c hall p 1999 j pathol 187 112 12633co2 vlinktypedoi crossrefmedline order article via infotrieve 2 balint e vousden k h 2002 br j cancer 85 1813 1823crossref 3 haupt y maya r kazaz oren m 1997 nature 387 296 299crossrefmedline order article via infotrieve 4 kubbutat m h g jones n vousden k h 1997 nature 387 299 303crossrefmedline order article via infotrieve 5 honda r tanaka h yasuda h 1997 febs lett 420 25 27crossrefmedline order article via infotrieve 6 wu x bayle j h olson d levine j 1993 genes dev 7 1126 1132abstract 7 barak y juven haffner r oren m 1993 embo j 12 461 468abstract 8 maya r balass m kim shkedy d leal j f shifman o moas m buschmann ronai z shiloh y kastan m b katzir e oren m 2001 genes dev 15 1067 1077abstractfree full text 9 shieh y ikeda m taya y prives c 1997 cell 91 325 334medline order article via infotrieve 10 ashcroft m kubbutat m h vousden k h 1999 mol cell biol 19 1751 1758abstractfree full text 11 shieh y ahn j tamai k taya y prives c 2000 genes dev 14 289 300abstractfree full text 12 chehab n h malikzay appel m halazonetis d 2000 genes dev 14 278 288abstractfree full text 13 nitta m okamura h aizawa yamaizumi m 1997 oncogene 15 561 568crossrefmedline order article via infotrieve 14 miyakoda m nakahata k suzuki k kodama watanabe m 1999 biochem biophys res commun 266 377 381crossrefmedline order article via infotrieve 15 ohnishi wang x ohnishi k matsumoto h takahashi 1996 j biol chem 271 14510 14513abstractfree full text 16 fuse yoon k w kato yamada k 1998 neurosurgery 42 843 849medline order article via infotrieve 17 miyakoda m suzuki k kodama watanabe m 2002 oncogene 21 1090 1096crossrefmedline order article via infotrieve 18 witkamp j de bree e van goethem r zoetmulder f 2002 cancer treat rev 27 365 374 19 takahashi emi y hasuda kakeji y maehara y sugimachi k 2002 surgery 131 s78 s84medline order article via infotrieve 20 ohnishi k ohnishi 2002 int j hypertherm 17 415 427crossref 21 minisini m p kantengwa polla b 1994 mutat res 315 169 179medline order article via infotrieve 22 mccormick w penman 1969 j mol biol 39 315 333medline order article via infotrieve 23 hinds p w finlay c frey b levine j 1987 mol cell biol 7 2863 2869medline order article via infotrieve 24 selkirk j k merrick b stackhouse b l c 1994 appl theor electrophor 4 11 18medline order article via infotrieve 25 nagata y anan yoshida mizukami taya y fujiwara kato h saya h nakao m 1999 oncogene 18 6037 6049crossrefmedline order article via infotrieve 26 buchner j 1999 trends biochem sci 24 136 141crossrefmedline order article via infotrieve 27 whitesell l sutphin p d pulcini e j martinez j d cook p h 1998 mol cell biol 18 1517 1524abstractfree full text 28 peng y chen l li c lu w agrawal chen j 2001 j biol chem 276 6874 6878abstractfree full text 29 peng y chen l li c lu w chen j 2001 j biol chem 276 40583 40590abstractfree full text 30 bullock n henckel j dedecker b johnson c m nikolova p v proctor m r lane d p fersht r 1997 proc natl acad sci u 94 14338 14342abstractfree full text 31 graeber g peterson j f tsai m monica k fornace j jr giaccia j 1994 mol cell biol 14 6264 6277abstract 32 chen j marechal v levine j 1993 mol cell biol 13 4107 4114abstract 33 lu h taya y ikeda m levine j 1998 proc natl acad sci u 95 6399 6402abstractfree full text 34 banin moyal l shieh y taya y anderson c w chessa l smorodinsky n prives c reiss y shiloh y ziv y 1998 science 281 1674 1677abstractfree full text 35 gannon j v greaves r iggo r lane d p 1990 embo j 9 1595 1602abstract 36 cho y gorina jeffrey p d pavletich n p 1994 science 265 346 355medline order article via infotrieve 37 blagosklonny m v toretsky j neckers l 1995 oncogene 11 933 939medline order article via infotrieve 38 zhang y xiong y 2001 cell growth differ 12 175 186abstractfree full text 39 pearl l h prodromou c 2001 curr opin struct biol 10 46 51crossref 40 pochampally r fodera b chen l lu w chen j 1999 j biol chem 274 15271 15277abstractfree full text 41 friedlander p legros y soussi prives c 1996 j biol chem 271 25468 25478abstractfree full text 42 oda k arakawa h tanaka matsuda k tanikawa c mori nishimori h tamai k tokino nakamura y taya y 2000 cell 102 849 862medline order article via infotrieve 43 blattner c hay meek d w lane d p 2002 mol cell biol 22 6170 6182abstractfree full text 44 zhang w hu g estey e hester j deisseroth 1992 oncogene 7 1645 1647medline order article via infotrieve
0.6023452.12427754.html.plaintext.txt	76	copyright 2003 american society biochemistry molecular biology inc
0.61247855.12853603.html.plaintext.txt	0	replication damaged dna vitro blocked p53 jianmin zhou carol prives
0.61247855.12853603.html.plaintext.txt	1	department biological sciences columbia university new york ny 10027 usa
0.61247855.12853603.html.plaintext.txt	2	correspondence addressed tel 1 212 854 2557 fax 1 212 865 8246 email privesatcubspsbiocolumbiaedu u d present address jianmin zhou division biology california institute technology pasadena ca 91125 usa
0.61247855.12853603.html.plaintext.txt	3	correspondence addressed tel 1 212 854 2557 fax 1 212 865 8246 email privesatcubspsbiocolumbiaedu u d present address jianmin zhou division biology california institute technology pasadena ca 91125 usa
0.61247855.12853603.html.plaintext.txt	4	received resubmission 28 april 2003 accepted 20 may 2003
0.61247855.12853603.html.plaintext.txt	5	abstract top abstract introduction materials methods results discussion references tumor suppressor protein p53 may roles functions addition well documented ability serve sequence specific transcriptional activator response dna damage showed previously p53 block replication polyomavirus origin containing dna py ori dna vitro p53 binding sites present late side py ori extended observations also examined whether p53 might able bind directly inhibit replication damaged dna found p53 strongly inhibits replication irradiated py ori dna inhibition requires central dna binding domain extreme c terminus p53 protein endogenous p53 binding site lies within py origin required ability p53 block initiation replication irradiated py ori dna suggesting possibility dna looping caused p53 binding non specifically sites dna damage specifically endogenous site polyomavirus origin results thus suggest possibility circumstances p53 might serve direct regulator dna replication suggest well additional function cooperation two autonomous dna binding domains
0.61247855.12853603.html.plaintext.txt	6	abstract top abstract introduction materials methods results discussion references tumor suppressor protein p53 may roles functions addition well documented ability serve sequence specific transcriptional activator response dna damage showed previously p53 block replication polyomavirus origin containing dna py ori dna vitro p53 binding sites present late side py ori extended observations also examined whether p53 might able bind directly inhibit replication damaged dna found p53 strongly inhibits replication irradiated py ori dna inhibition requires central dna binding domain extreme c terminus p53 protein endogenous p53 binding site lies within py origin required ability p53 block initiation replication irradiated py ori dna suggesting possibility dna looping caused p53 binding non specifically sites dna damage specifically endogenous site polyomavirus origin results thus suggest possibility circumstances p53 might serve direct regulator dna replication suggest well additional function cooperation two autonomous dna binding domains
0.61247855.12853603.html.plaintext.txt	7	introduction top abstract introduction materials methods results discussion references p53 tumor suppressor protein accumulates nuclei cells response various forms stress including dna damage stabilized p53 arrest cells g1 andor g2 cause apoptosis functions sequence specific transcriptional regulator reviews see 1 3 p53 protein possesses structural domains characteristic transcriptional activators including activation region n terminus sequence specific dna binding region within central portion oligomerization domain within c terminal region addition genes regulating cell cycle cell death p53 stimulate transcription genes encoding products affect dna synthesis repair example one well studied p53 target genes p21cip1waf1 inhibit cyclin dependent kinases 4 also bind inactivate pcna plays essential role dna replication facilitating processive dna synthesis polymerase 5 moreover p53 activates rrm2bp53r2 gene 6 ddb2 damage specific dna binding protein 2 gene 78 plays distinct roles dna repair
0.61247855.12853603.html.plaintext.txt	8	introduction top abstract introduction materials methods results discussion references p53 tumor suppressor protein accumulates nuclei cells response various forms stress including dna damage stabilized p53 arrest cells g1 andor g2 cause apoptosis functions sequence specific transcriptional regulator reviews see 1 3 p53 protein possesses structural domains characteristic transcriptional activators including activation region n terminus sequence specific dna binding region within central portion oligomerization domain within c terminal region addition genes regulating cell cycle cell death p53 stimulate transcription genes encoding products affect dna synthesis repair example one well studied p53 target genes p21cip1waf1 inhibit cyclin dependent kinases 4 also bind inactivate pcna plays essential role dna replication facilitating processive dna synthesis polymerase 5 moreover p53 activates rrm2bp53r2 gene 6 ddb2 damage specific dna binding protein 2 gene 78 plays distinct roles dna repair
0.61247855.12853603.html.plaintext.txt	9	although mentioned p53 protein embodies classical features sequence specific transcriptional activator one property rather unique possesses second essentially autonomous dna binding region extreme c terminus 9 region protein shown facilitate required interaction p53 various forms damaged altered dna including deletioninsertion mismatches dna ends well double single strand breaks review see 10 function region fully clarified also shown able regulate mode central region recognizes dna review see 11
0.61247855.12853603.html.plaintext.txt	10	although mentioned p53 protein embodies classical features sequence specific transcriptional activator one property rather unique possesses second essentially autonomous dna binding region extreme c terminus 9 region protein shown facilitate required interaction p53 various forms damaged altered dna including deletioninsertion mismatches dna ends well double single strand breaks review see 10 function region fully clarified also shown able regulate mode central region recognizes dna review see 11
0.61247855.12853603.html.plaintext.txt	11	although p53 clearly involved regulating transcription numerous targets several lines evidence suggesting p53 may play transcription independent roles cells well mutant p53 proteins lost transcriptional transactivation capacity retain ability arrest cell growth varying extents 12 16 conversely loss growth suppressor function reported p53 mutants retain transcriptional activity 17 19 recent study jaks et al 20 showed cells treated dna damaging drug camptothecin p53 accumulation rather transactivation p21 required g1 arrest strongly suggesting p53 may play transcription independent roles cells fact possible conditions p53 may play direct role regulating dna synthesis various experimental results suggest p53 protein may inhibit dna replication transcription independent manner c terminally truncated form p53 protein p53c30 also dna binding active form p53 protein reported inhibit xenopus nuclear dna replication transcription independent manner 21 p53 may inhibit initiation dna replication directly binding rp 22 24 single stranded dna binding protein required dna replication p53 protein also blocks replication sv40 dna vitro binding inactivating sv40 large antigen 25 27 additionally although p53 protein bind inhibit polyoma large antigen also able inhibit replication polyomavirus origin containing dna py ori dna vitro although case necessary p53 specific binding sites present template origin containing plasmid 28
0.61247855.12853603.html.plaintext.txt	12	although p53 clearly involved regulating transcription numerous targets several lines evidence suggesting p53 may play transcription independent roles cells well mutant p53 proteins lost transcriptional transactivation capacity retain ability arrest cell growth varying extents 12 16 conversely loss growth suppressor function reported p53 mutants retain transcriptional activity 17 19 recent study jaks et al 20 showed cells treated dna damaging drug camptothecin p53 accumulation rather transactivation p21 required g1 arrest strongly suggesting p53 may play transcription independent roles cells fact possible conditions p53 may play direct role regulating dna synthesis various experimental results suggest p53 protein may inhibit dna replication transcription independent manner c terminally truncated form p53 protein p53c30 also dna binding active form p53 protein reported inhibit xenopus nuclear dna replication transcription independent manner 21 p53 may inhibit initiation dna replication directly binding rp 22 24 single stranded dna binding protein required dna replication p53 protein also blocks replication sv40 dna vitro binding inactivating sv40 large antigen 25 27 additionally although p53 protein bind inhibit polyoma large antigen also able inhibit replication polyomavirus origin containing dna py ori dna vitro although case necessary p53 specific binding sites present template origin containing plasmid 28
0.61247855.12853603.html.plaintext.txt	13	also reports supporting possibility roles p53 regulating responding altered dna replication vivo dna synthesis blocked p53 inhibits entry mitosis 29 several cell lines p53 transcriptionally dysfunctional dna synthesis blocked 30 p53 protein prevents mammalian dna reduplication following release mitotic spindle checkpoint transcription independent manner 13 addition p53 inhibits replication py papillomavirus origin containing dnas cell specific way p53 represses replication viral origins human chinese hamster cells fails mouse cells 31 33 evidence supporting possibility direct interaction p53 dna replication machinery provided observations p53 localized foci replication nuclei herpes virus infected cells 34 p53 imported nucleus xenopus oocyte upon fertilization although first 12 rapid cell cycles occur without transcription genome 35
0.61247855.12853603.html.plaintext.txt	14	also reports supporting possibility roles p53 regulating responding altered dna replication vivo dna synthesis blocked p53 inhibits entry mitosis 29 several cell lines p53 transcriptionally dysfunctional dna synthesis blocked 30 p53 protein prevents mammalian dna reduplication following release mitotic spindle checkpoint transcription independent manner 13 addition p53 inhibits replication py papillomavirus origin containing dnas cell specific way p53 represses replication viral origins human chinese hamster cells fails mouse cells 31 33 evidence supporting possibility direct interaction p53 dna replication machinery provided observations p53 localized foci replication nuclei herpes virus infected cells 34 p53 imported nucleus xenopus oocyte upon fertilization although first 12 rapid cell cycles occur without transcription genome 35
0.61247855.12853603.html.plaintext.txt	15	continue explore possible alternative roles functions p53 study tested possibility p53 affects replication damaged dna templates found p53 block initial stage replication irradiated plasmid containing py replication origin inhibition requires specific binding p53 core domain non specific binding c terminus discuss implications findings including likelihood effects seen require dna looping p53
0.61247855.12853603.html.plaintext.txt	16	continue explore possible alternative roles functions p53 study tested possibility p53 affects replication damaged dna templates found p53 block initial stage replication irradiated plasmid containing py replication origin inhibition requires specific binding p53 core domain non specific binding c terminus discuss implications findings including likelihood effects seen require dna looping p53
0.61247855.12853603.html.plaintext.txt	17	materials methods top abstract introduction materials methods results discussion references plasmids vw16pycat contains 16 p53 binding sites rgc refers p53 binding site ribosomal gene cluster late side py replication origin plasmid used miller et al vogelstein kinzler respective studies 2836 pbe102 described previously contains a2 strain py wild type sequences extending bcli site nucleotide 5022 ecori site nucleotide 1562 inserted pml vector containing neo coding sequences 37 construct vw16pycatbsm1 bsm p53 binding site mutant vw16pycatbsm2 oligonucleotides 5 cgcctccaaggcgccagttctattttgataaattgcctctggaagc 3 5 cgcctccaaggcgccagacatgtttggacaagttccctctggaagc 3 used forward primer respectively mediate pcr directed mutagenesis oligonucleotide 5 ccctcgaggtcgacggtatcg 3 pbluescript ii sk sequence used reverse primer similarly two forward primers oligonucleotide 5 acaggagatcctgccccggca 3 neo sequence reverse primer used construct pbe102bsm1 pbe102bsm2 pcr products 588 814 bp recovered digested pstinari nari respectively 140 621 bp fragments ligated respective vectors pstinari digestion product vw16pycat 39 kb fragment recovered nari digestion pbe102
0.61247855.12853603.html.plaintext.txt	18	materials methods top abstract introduction materials methods results discussion references plasmids vw16pycat contains 16 p53 binding sites rgc refers p53 binding site ribosomal gene cluster late side py replication origin plasmid used miller et al vogelstein kinzler respective studies 2836 pbe102 described previously contains a2 strain py wild type sequences extending bcli site nucleotide 5022 ecori site nucleotide 1562 inserted pml vector containing neo coding sequences 37 construct vw16pycatbsm1 bsm p53 binding site mutant vw16pycatbsm2 oligonucleotides 5 cgcctccaaggcgccagttctattttgataaattgcctctggaagc 3 5 cgcctccaaggcgccagacatgtttggacaagttccctctggaagc 3 used forward primer respectively mediate pcr directed mutagenesis oligonucleotide 5 ccctcgaggtcgacggtatcg 3 pbluescript ii sk sequence used reverse primer similarly two forward primers oligonucleotide 5 acaggagatcctgccccggca 3 neo sequence reverse primer used construct pbe102bsm1 pbe102bsm2 pcr products 588 814 bp recovered digested pstinari nari respectively 140 621 bp fragments ligated respective vectors pstinari digestion product vw16pycat 39 kb fragment recovered nari digestion pbe102
0.61247855.12853603.html.plaintext.txt	19	proteins baculovirus expressed ha tagged p53 protein purified described 38 active ha p53 immunopurified using pab421 antibody latent ha p53 ha p53c30 immunopurified using mab12ca5 antibody oxidized ha p53 prepared similarly except extraction elution dialysis done buffers lacking dtt py large antigen immunopurified baculovirus infected sf21 cells described previously 26
0.61247855.12853603.html.plaintext.txt	20	proteins baculovirus expressed ha tagged p53 protein purified described 38 active ha p53 immunopurified using pab421 antibody latent ha p53 ha p53c30 immunopurified using mab12ca5 antibody oxidized ha p53 prepared similarly except extraction elution dialysis done buffers lacking dtt py large antigen immunopurified baculovirus infected sf21 cells described previously 26
0.61247855.12853603.html.plaintext.txt	21	replication py dna vitro extracts mouse fm3a cells prepared described 26 standard replication reaction mixtures 50 microl contained 40 mm creatine phosphate ph 80 7 mm mgcl2 05 mm dtt 4 mm atp 200 microm ctp utp gtp 100 microm ttp dgtp dctp 20 microm datp 003 microm 32pdatp 100 microg creatine kinaseml 300 ng template plasmid 05 1 microg py antigen fm3a cell extract 300 400 microg protein reaction mixtures incubated 33 degrees c 3 h replication products analyzed either acid precipitation phosphoimaging analysis agarose gels following dpni treatment purified replication products molecular dynamics phosphoimager replication irradiated pbe102 purified pbe102 plasmid first irradiated water final concentration 300 ng microl used template replication reactions
0.61247855.12853603.html.plaintext.txt	22	replication py dna vitro extracts mouse fm3a cells prepared described 26 standard replication reaction mixtures 50 microl contained 40 mm creatine phosphate ph 80 7 mm mgcl2 05 mm dtt 4 mm atp 200 microm ctp utp gtp 100 microm ttp dgtp dctp 20 microm datp 003 microm 32pdatp 100 microg creatine kinaseml 300 ng template plasmid 05 1 microg py antigen fm3a cell extract 300 400 microg protein reaction mixtures incubated 33 degrees c 3 h replication products analyzed either acid precipitation phosphoimaging analysis agarose gels following dpni treatment purified replication products molecular dynamics phosphoimager replication irradiated pbe102 purified pbe102 plasmid first irradiated water final concentration 300 ng microl used template replication reactions
0.61247855.12853603.html.plaintext.txt	23	electrophoretic mobility shift assay emsa performed described 39 oligonucleotide probe containing 3 fold rgc site follows 5 aattccccggatcgccttgcctggacttgcctggccttgccttttcgatccgggg 3 oligonucleotide containing wild type mutant p53 binding site created digesting 621 bp nari digestion product pbe102 pbe102bsm1 pbe102bsm2 hinfi resulting 411 bp oligonucleotide fragment represents py sequence nucleotide 5076 89 gel purified end labeled reaction mixtures 20 microl contained 4 microl 5x emsa buffer 100 mm hepes ph 79 125 mm kcl 05 mm edta 50 glycerol 10 mm mgcl2 1 microl 40 mm spermidine 1 microl 10 mm dtt 1 microl 05 np 40 1 microl 60 mgml double stranded polydi dc 2 microl 1 mgml bovine serum albumin 1 ng 32p labeled probe dna proteins indicated reaction mixtures incubated 20 min ice subjected electrophoresis 4 native polyacrylamide gels 4 degrees c gels dried autoradiographed
0.61247855.12853603.html.plaintext.txt	24	electrophoretic mobility shift assay emsa performed described 39 oligonucleotide probe containing 3 fold rgc site follows 5 aattccccggatcgccttgcctggacttgcctggccttgccttttcgatccgggg 3 oligonucleotide containing wild type mutant p53 binding site created digesting 621 bp nari digestion product pbe102 pbe102bsm1 pbe102bsm2 hinfi resulting 411 bp oligonucleotide fragment represents py sequence nucleotide 5076 89 gel purified end labeled reaction mixtures 20 microl contained 4 microl 5x emsa buffer 100 mm hepes ph 79 125 mm kcl 05 mm edta 50 glycerol 10 mm mgcl2 1 microl 40 mm spermidine 1 microl 10 mm dtt 1 microl 05 np 40 1 microl 60 mgml double stranded polydi dc 2 microl 1 mgml bovine serum albumin 1 ng 32p labeled probe dna proteins indicated reaction mixtures incubated 20 min ice subjected electrophoresis 4 native polyacrylamide gels 4 degrees c gels dried autoradiographed
0.61247855.12853603.html.plaintext.txt	25	results top abstract introduction materials methods results discussion references p53 requires sequence specific dna binding function inhibit vitro replication polyoma origin dna reported previously 28 wild type human p53 strongly inhibits replication dna plasmid vw16pycat containing multiple copies p53 binding site rgc cloned adjacent late side py origin replication dna plasmid containing mutated binding sites affected p53 please refer fig 8 depiction py ori early late sides moreover study two tumor derived core domain p53 mutants trp 248 273 shown unable inhibit replication vw16pycat findings implicated sequence specific dna binding p53 requirement ability repress py ori dna replication confirm extend studies examined ability various forms p53 differing ability bind dna inhibit replication vw16pycat mouse fm3a cell extracts note although fm3a cells reported contain wild type p53 whose protein levels increased uv irradiation 40 extracts used experiments unstressed cells contain little detectable p53 data shown
0.61247855.12853603.html.plaintext.txt	26	results top abstract introduction materials methods results discussion references p53 requires sequence specific dna binding function inhibit vitro replication polyoma origin dna reported previously 28 wild type human p53 strongly inhibits replication dna plasmid vw16pycat containing multiple copies p53 binding site rgc cloned adjacent late side py origin replication dna plasmid containing mutated binding sites affected p53 please refer fig 8 depiction py ori early late sides moreover study two tumor derived core domain p53 mutants trp 248 273 shown unable inhibit replication vw16pycat findings implicated sequence specific dna binding p53 requirement ability repress py ori dna replication confirm extend studies examined ability various forms p53 differing ability bind dna inhibit replication vw16pycat mouse fm3a cell extracts note although fm3a cells reported contain wild type p53 whose protein levels increased uv irradiation 40 extracts used experiments unstressed cells contain little detectable p53 data shown
0.61247855.12853603.html.plaintext.txt	27	view larger version 12k figure 8 model showing dna looping mediated p53 py core origin region origin positioned late early regions comprises rich stretch region dyad symmetry dyad containing antigen binding sites inverted repeat ir endogenous p53 binding site p53 bs located close origin gray bar early side p53 protein represented sphere tetramers exogenous p53 binding sites either sequence specific sites sites dna damage represented x
0.61247855.12853603.html.plaintext.txt	28	view larger version 12k figure 8 model showing dna looping mediated p53 py core origin region origin positioned late early regions comprises rich stretch region dyad symmetry dyad containing antigen binding sites inverted repeat ir endogenous p53 binding site p53 bs located close origin gray bar early side p53 protein represented sphere tetramers exogenous p53 binding sites either sequence specific sites sites dna damage represented x
0.61247855.12853603.html.plaintext.txt	29	shown previously jayaraman et al 39 n terminally ha tagged p53 protein immunopurified using affinity column containing c terminal specific monoclonal antibody pab421 ha p53 pab421 active sequence specific dna binding similarly purified p53 protein preparation ha p53 flu affinity column contained ha antibody mab12ca5 basis difference fully understood may related observations interactions pab421 p53 c terminus cases stimulate ability bind dna 41 also shown p53 purified absence reducing agents ha p53 flu dtt inert dna binding 394243 contrast well documented p53 lacking c terminus ha p53c30 flu bind extremely well dna 4144 four different forms ha tagged p53 prepared tested ability affect replication vw16pycat py ori dna expected equivalent quantities p53 protein preparations ha p53c30 flu ha p53 pab421 ha p53 flu ha p53 flu dtt descending affinities oligonucleotide probe contains three copies rgc site fig 1a b abilities different forms p53 protein inhibit replication vw16pycat vitro measured incorporation labeled deoxynucleotide progeny dna fig 1c dpni resistant dna detected 1 vertical agarose gel fig 1d reflected relative abilities bind dna note presence dpni resistant dna suggested damp incorporation measured produced replication synthesis tested core domain hot spot p53 mutant ha p53his 175 flu well n terminally mutated form p53 ha p53gln 22ser 23 flu shown defective transactivation p53 target genes active sequence specific dna binding 45 shown figure 2 wild type ha p53 flu ha p53gln 22ser 23 flu bound oligonucleotide probe containing three copies rgc sites similar extents expected ha p53his 175 flu failed interact rgc sites correspondingly wild type ha p53 flu ha p53gln 22ser 23 flu inhibited replication vw16pycat dose dependent fashion ha p53his 175 flu failed results thus strongly support conclusion essential feature required p53 block dna replication specific binding py ori dna template furthermore fact ha p53gln 22ser 23 flu functions like wild type ha p53 flu inhibiting replication vw16pycat suggests inhibition require interaction n terminus cellular proteins bind activation domain
0.61247855.12853603.html.plaintext.txt	30	shown previously jayaraman et al 39 n terminally ha tagged p53 protein immunopurified using affinity column containing c terminal specific monoclonal antibody pab421 ha p53 pab421 active sequence specific dna binding similarly purified p53 protein preparation ha p53 flu affinity column contained ha antibody mab12ca5 basis difference fully understood may related observations interactions pab421 p53 c terminus cases stimulate ability bind dna 41 also shown p53 purified absence reducing agents ha p53 flu dtt inert dna binding 394243 contrast well documented p53 lacking c terminus ha p53c30 flu bind extremely well dna 4144 four different forms ha tagged p53 prepared tested ability affect replication vw16pycat py ori dna expected equivalent quantities p53 protein preparations ha p53c30 flu ha p53 pab421 ha p53 flu ha p53 flu dtt descending affinities oligonucleotide probe contains three copies rgc site fig 1a b abilities different forms p53 protein inhibit replication vw16pycat vitro measured incorporation labeled deoxynucleotide progeny dna fig 1c dpni resistant dna detected 1 vertical agarose gel fig 1d reflected relative abilities bind dna note presence dpni resistant dna suggested damp incorporation measured produced replication synthesis tested core domain hot spot p53 mutant ha p53his 175 flu well n terminally mutated form p53 ha p53gln 22ser 23 flu shown defective transactivation p53 target genes active sequence specific dna binding 45 shown figure 2 wild type ha p53 flu ha p53gln 22ser 23 flu bound oligonucleotide probe containing three copies rgc sites similar extents expected ha p53his 175 flu failed interact rgc sites correspondingly wild type ha p53 flu ha p53gln 22ser 23 flu inhibited replication vw16pycat dose dependent fashion ha p53his 175 flu failed results thus strongly support conclusion essential feature required p53 block dna replication specific binding py ori dna template furthermore fact ha p53gln 22ser 23 flu functions like wild type ha p53 flu inhibiting replication vw16pycat suggests inhibition require interaction n terminus cellular proteins bind activation domain
0.61247855.12853603.html.plaintext.txt	31	view larger version 42k figure 1 p53 inhibits replication py ori dna sequence specific dna binding dependent manner ha tagged human p53 purified infected insect cells either pab421 column ha p53 pab421 mab12ca5 column ha p53 flu without dtt similarly flu tagged p53c30 1 363 purified mab12ca5 column 300 600 ng protein run sds page gel silver stained m lane contains molecular mass marker proteins b increasing amounts protein 10 20 40 ng added emsa reaction mixtures including probe 32p end labeled oligonucleotide containing three rgc p53 binding sites c increasing amounts 200 400 600 ng type p53 protein added reaction mixtures containing 300 ng vw16pycat plasmid dna 600 ng py large antigen replication measured acid precipitation replicated dna percentages represent average five separate experiments bars showing sample standard error d replication products one experiment purified analyzed dpni digestion c control
0.61247855.12853603.html.plaintext.txt	32	view larger version 42k figure 1 p53 inhibits replication py ori dna sequence specific dna binding dependent manner ha tagged human p53 purified infected insect cells either pab421 column ha p53 pab421 mab12ca5 column ha p53 flu without dtt similarly flu tagged p53c30 1 363 purified mab12ca5 column 300 600 ng protein run sds page gel silver stained m lane contains molecular mass marker proteins b increasing amounts protein 10 20 40 ng added emsa reaction mixtures including probe 32p end labeled oligonucleotide containing three rgc p53 binding sites c increasing amounts 200 400 600 ng type p53 protein added reaction mixtures containing 300 ng vw16pycat plasmid dna 600 ng py large antigen replication measured acid precipitation replicated dna percentages represent average five separate experiments bars showing sample standard error d replication products one experiment purified analyzed dpni digestion c control
0.61247855.12853603.html.plaintext.txt	33	view larger version 26k figure 2 wild type n terminal mutant p53gln22ser23 central core domain mutant p53his175 inhibit replication py ori dna baculovirus expressed wild type mutant ha p53 proteins 300 600 ng immunopurified mab12ca5 column analyzed silver stained sds polyacrylamide gel indicated m lane contains molecular marker proteins b increasing amounts protein 10 20 40 ng added emsa reaction mixtures containing end labeled rgc probe figure 1 c effects wt ha p53 flu ha p53gln22ser23 flu ha p53his175 flu replication plasmid vw16pycat compared replication measured acid precipitation replicated dna percentages represent average three separate experiments bars showing sample standard error
0.61247855.12853603.html.plaintext.txt	34	view larger version 26k figure 2 wild type n terminal mutant p53gln22ser23 central core domain mutant p53his175 inhibit replication py ori dna baculovirus expressed wild type mutant ha p53 proteins 300 600 ng immunopurified mab12ca5 column analyzed silver stained sds polyacrylamide gel indicated m lane contains molecular marker proteins b increasing amounts protein 10 20 40 ng added emsa reaction mixtures containing end labeled rgc probe figure 1 c effects wt ha p53 flu ha p53gln22ser23 flu ha p53his175 flu replication plasmid vw16pycat compared replication measured acid precipitation replicated dna percentages represent average three separate experiments bars showing sample standard error
0.61247855.12853603.html.plaintext.txt	35	p53 binding site py origin region required inhibition replication vw16pycat p53 course earlier study consensus p53 binding site early side py core origin spanning nucleotides 66 85 identified showed p53 protect site dnase digestion 28 however determine whether interaction p53 site required p53 block replication constructs containing binding sites late side origin determine role endogenous p53 binding site inhibition replication vw16pycat p53 two mutant plasmids vw16pycatbsm1 bsm p53 binding site mutant vw16pycatbsm2 constructed mutated forms endogenous p53 binding site fig 3a pyori bsm1 two sets essential c g nucleotides p53 consensus sequence mutated pyori bsm2 altered conform perfect p53 consensus sequence test affinity p53 protein three different sequences used two different approaches figure 3b shows result gel mobility shift assay ha p53 flu bound end labeled 411 bp oligonucleotide fragments excised respective vw16pycat derivatives py nucleotide 5076 89 figure 3c shows gel mobility shift assay three rgc sites containing oligonucleotide fig 1b labeled probe increasing amounts plasmid vw16pycat vw16pycatbsm1 vw16pycatbsm2 competitor dnas expected results methods show ha p53 flu protein highest affinity pyori bsm2 minimal affinity pyori bsm1
0.61247855.12853603.html.plaintext.txt	36	p53 binding site py origin region required inhibition replication vw16pycat p53 course earlier study consensus p53 binding site early side py core origin spanning nucleotides 66 85 identified showed p53 protect site dnase digestion 28 however determine whether interaction p53 site required p53 block replication constructs containing binding sites late side origin determine role endogenous p53 binding site inhibition replication vw16pycat p53 two mutant plasmids vw16pycatbsm1 bsm p53 binding site mutant vw16pycatbsm2 constructed mutated forms endogenous p53 binding site fig 3a pyori bsm1 two sets essential c g nucleotides p53 consensus sequence mutated pyori bsm2 altered conform perfect p53 consensus sequence test affinity p53 protein three different sequences used two different approaches figure 3b shows result gel mobility shift assay ha p53 flu bound end labeled 411 bp oligonucleotide fragments excised respective vw16pycat derivatives py nucleotide 5076 89 figure 3c shows gel mobility shift assay three rgc sites containing oligonucleotide fig 1b labeled probe increasing amounts plasmid vw16pycat vw16pycatbsm1 vw16pycatbsm2 competitor dnas expected results methods show ha p53 flu protein highest affinity pyori bsm2 minimal affinity pyori bsm1
0.61247855.12853603.html.plaintext.txt	37	view larger version 26k figure 3 endogenous p53 binding site py origin required p53 inhibit replication py ori dna sequence wild type py genome spanning py nucleotides 66 85 endogenous p53 binding site pyori bs two mutant forms sequence pyori bsm1 pyori bsm2 shown p53 consensus binding sequence bold characters show mutated deoxynucleotides b increasing amounts purified ha p53 flu 10 20 40 ng added emsa reaction mixtures including end labeled 411 bp oligonucleotide fragments spanning py nucleotides 5076 89 containing either wild type py sequence pyori bsm1 pyori bsm2 indicated c increasing amounts unlabeled plasmids vw16pycat vw16pycatbsm1 vw16pycatbsm2 100 300 900 ng added emsa reaction mixtures containing 20 ng purified ha p53 flu protein 1 ng end labeled rgc oligonucleotide probe d effects ha p53 flu replication vw16pycat vw16pycatbsm1 vw16pycatbsm2 compared
0.61247855.12853603.html.plaintext.txt	38	view larger version 26k figure 3 endogenous p53 binding site py origin required p53 inhibit replication py ori dna sequence wild type py genome spanning py nucleotides 66 85 endogenous p53 binding site pyori bs two mutant forms sequence pyori bsm1 pyori bsm2 shown p53 consensus binding sequence bold characters show mutated deoxynucleotides b increasing amounts purified ha p53 flu 10 20 40 ng added emsa reaction mixtures including end labeled 411 bp oligonucleotide fragments spanning py nucleotides 5076 89 containing either wild type py sequence pyori bsm1 pyori bsm2 indicated c increasing amounts unlabeled plasmids vw16pycat vw16pycatbsm1 vw16pycatbsm2 100 300 900 ng added emsa reaction mixtures containing 20 ng purified ha p53 flu protein 1 ng end labeled rgc oligonucleotide probe d effects ha p53 flu replication vw16pycat vw16pycatbsm1 vw16pycatbsm2 compared
0.61247855.12853603.html.plaintext.txt	39	used three different plasmids template py ori dna replication assay interestingly absence p53 vw16pycatbsm2 replication efficiency close vw16pycat vw16pycatbsm1 replicated 3 4 fold efficiently two plasmids data shown since endogenous p53 binding site located two antigen binding consensus pentanucleotides spanning nucleotides 62 66 95 99 may weaker base pairs constructed pyori bsm1 make easier antigen unwind origin dna presence ha p53 flu protein replication vw16pycatbsm2 inhibited even efficiently replication vw16pycat replication vw16pycatbsm1 affected ha p53 flu fig 3d results thus show ability p53 inhibit replication vw16pycat closely correlates affinity p53 endogenous p53 binding site support conclusion p53 inhibits replication vw16pycat dna binding dependent manner
0.61247855.12853603.html.plaintext.txt	40	used three different plasmids template py ori dna replication assay interestingly absence p53 vw16pycatbsm2 replication efficiency close vw16pycat vw16pycatbsm1 replicated 3 4 fold efficiently two plasmids data shown since endogenous p53 binding site located two antigen binding consensus pentanucleotides spanning nucleotides 62 66 95 99 may weaker base pairs constructed pyori bsm1 make easier antigen unwind origin dna presence ha p53 flu protein replication vw16pycatbsm2 inhibited even efficiently replication vw16pycat replication vw16pycatbsm1 affected ha p53 flu fig 3d results thus show ability p53 inhibit replication vw16pycat closely correlates affinity p53 endogenous p53 binding site support conclusion p53 inhibits replication vw16pycat dna binding dependent manner
0.61247855.12853603.html.plaintext.txt	41	p53 inhibits replication radiation damaged intact pbe102 interest expand observations ask might considered physiologically relevant question whether p53 block replication damaged dna hypothetically feasible p53 contains another autonomous dna recognition region within c terminal domain binds several forms dna including dna damaged irradiation review see 10 well dna single 4 nt gaps jahn jzhou cprives unpublished data thus would dna damage randomly introduced py genome allow replication py dna inhibited p53 end irradiated plasmid pbe102 contains wild type py sequence extending nucleotide 5022 1562 37 examined ability p53 inhibit replication plasmid pbe102 contains endogenous p53 binding site early side origin lacks additional p53 binding sites replication affected p53 26 shown figure 4a b increasing doses ionizing radiation reduced ability pbe102 serve replication template ha p53 flu added reaction mixtures replication pbe102 pre treated doses irradiation inhibited p53 concentration dependent manner
0.61247855.12853603.html.plaintext.txt	42	p53 inhibits replication radiation damaged intact pbe102 interest expand observations ask might considered physiologically relevant question whether p53 block replication damaged dna hypothetically feasible p53 contains another autonomous dna recognition region within c terminal domain binds several forms dna including dna damaged irradiation review see 10 well dna single 4 nt gaps jahn jzhou cprives unpublished data thus would dna damage randomly introduced py genome allow replication py dna inhibited p53 end irradiated plasmid pbe102 contains wild type py sequence extending nucleotide 5022 1562 37 examined ability p53 inhibit replication plasmid pbe102 contains endogenous p53 binding site early side origin lacks additional p53 binding sites replication affected p53 26 shown figure 4a b increasing doses ionizing radiation reduced ability pbe102 serve replication template ha p53 flu added reaction mixtures replication pbe102 pre treated doses irradiation inhibited p53 concentration dependent manner
0.61247855.12853603.html.plaintext.txt	43	view larger version 34k figure 4 p53 inhibits replication repair synthesis irradiated py ori dna ha p53 flu protein 600 ng added dna replication reaction mixtures plasmid pbe102 300 ng pre treated increasing dosages irradiation used template b effects ha p53 flu protein replication intact pbe102 pbe102 pre treated 35 gy 70 gy irradiation compared n 5 c replicated dna one experiment 600 ng ha p53 flu protein added reaction mixture containing 300 ng pbe102 pre treated 70 gy irradiation purified analyzed dpni digestion dpni resistant dna molecules replication products low molecular weight dpni digested dna molecules repair products d increasing amounts ha p53 flu protein 200 400 600 ng added replication reaction mixtures 300 ng irradiated pbe102 70 gy lacking py antigen dna products purified analyzed dpni digestion
0.61247855.12853603.html.plaintext.txt	44	view larger version 34k figure 4 p53 inhibits replication repair synthesis irradiated py ori dna ha p53 flu protein 600 ng added dna replication reaction mixtures plasmid pbe102 300 ng pre treated increasing dosages irradiation used template b effects ha p53 flu protein replication intact pbe102 pbe102 pre treated 35 gy 70 gy irradiation compared n 5 c replicated dna one experiment 600 ng ha p53 flu protein added reaction mixture containing 300 ng pbe102 pre treated 70 gy irradiation purified analyzed dpni digestion dpni resistant dna molecules replication products low molecular weight dpni digested dna molecules repair products d increasing amounts ha p53 flu protein 200 400 600 ng added replication reaction mixtures 300 ng irradiated pbe102 70 gy lacking py antigen dna products purified analyzed dpni digestion
0.61247855.12853603.html.plaintext.txt	45	although presence antigen majority damp incorporation vitro using irradiated pbe102 template likely due replication synthesis possibility excluded repair synthesis detected labeled deoxynucleotide incorporation could also inhibited p53 therefore dpni resistance replication products examined order distinguish replication synthesis repair synthesis interestingly ha p53 flu inhibited exclusively replication synthesis repair synthesis affected fig 4c verify result examined ability ha p53 flu affect repair irradiated pbe102 absence antigen virtually nucleotides incorporated sites repair synthesis ha p53 flu affect activities fig 4d thus results show p53 specifically inhibit replication repair radiation damaged py ori dna template
0.61247855.12853603.html.plaintext.txt	46	although presence antigen majority damp incorporation vitro using irradiated pbe102 template likely due replication synthesis possibility excluded repair synthesis detected labeled deoxynucleotide incorporation could also inhibited p53 therefore dpni resistance replication products examined order distinguish replication synthesis repair synthesis interestingly ha p53 flu inhibited exclusively replication synthesis repair synthesis affected fig 4c verify result examined ability ha p53 flu affect repair irradiated pbe102 absence antigen virtually nucleotides incorporated sites repair synthesis ha p53 flu affect activities fig 4d thus results show p53 specifically inhibit replication repair radiation damaged py ori dna template
0.61247855.12853603.html.plaintext.txt	47	since c terminus required interaction p53 irradiated dna 46 tested whether region necessary ability p53 block replication damaged ori dna shown figure 5a among four different forms p53 protein used figure 1 ha p53 pab421 ha p53 flu inhibited replication irradiated pbe102 fact ha p53 flu relatively effective blocking synthesis damaged ori dna intact ori dna containing rgc binding sites neither ha p53c30 flu oxidized ha p53 flu dtt inhibited replication irradiated pbe102 thus c terminus p53 required block replication plasmids bearing p53 binding sites indispensable p53 inhibition replication damaged plasmids fact ha p53 flu dtt inert however suggested sequence specific dna binding p53 also component repressive effect replication damaged ori dna conclusion supported experiment described
0.61247855.12853603.html.plaintext.txt	48	since c terminus required interaction p53 irradiated dna 46 tested whether region necessary ability p53 block replication damaged ori dna shown figure 5a among four different forms p53 protein used figure 1 ha p53 pab421 ha p53 flu inhibited replication irradiated pbe102 fact ha p53 flu relatively effective blocking synthesis damaged ori dna intact ori dna containing rgc binding sites neither ha p53c30 flu oxidized ha p53 flu dtt inhibited replication irradiated pbe102 thus c terminus p53 required block replication plasmids bearing p53 binding sites indispensable p53 inhibition replication damaged plasmids fact ha p53 flu dtt inert however suggested sequence specific dna binding p53 also component repressive effect replication damaged ori dna conclusion supported experiment described
0.61247855.12853603.html.plaintext.txt	49	view larger version 27k figure 5 inhibition replication irradiated py ori dna requires p53 c terminus well endogenous p53 binding site py origin effects four different forms p53 protein shown figure 1a replication pbe102 70 gy compared n 4 b dna products one experiment using ha p53 pab421 ha p53c30 flu analyzed dpni digestion lower part gel containing repair products exposed three times longer autoradiography c effects ha p53 flu protein replication pbe102 pbe102bsm1 pbe102bsm2 compared n 4
0.61247855.12853603.html.plaintext.txt	50	view larger version 27k figure 5 inhibition replication irradiated py ori dna requires p53 c terminus well endogenous p53 binding site py origin effects four different forms p53 protein shown figure 1a replication pbe102 70 gy compared n 4 b dna products one experiment using ha p53 pab421 ha p53c30 flu analyzed dpni digestion lower part gel containing repair products exposed three times longer autoradiography c effects ha p53 flu protein replication pbe102 pbe102bsm1 pbe102bsm2 compared n 4
0.61247855.12853603.html.plaintext.txt	51	inhibition replication irradiated pbe102 requires endogenous p53 binding site fact endogenous p53 binding site late side origin required inhibition replication plasmids bearing p53 binding sites led question whether site also required inhibitory effect p53 irradiated pbe102 test plasmids pbe102bsm1 pbe102bsm2 constructed endogenous p53 binding site mutated bsm1 bsm2 respectively shown fig 3a indeed contrast wild type pbe102bsm2 replication irradiated pbe102bsm1 inhibited ha p53 flu fig 5c indicating endogenous p53 binding site required p53 inhibit replication radiation damaged py ori dna
0.61247855.12853603.html.plaintext.txt	52	inhibition replication irradiated pbe102 requires endogenous p53 binding site fact endogenous p53 binding site late side origin required inhibition replication plasmids bearing p53 binding sites led question whether site also required inhibitory effect p53 irradiated pbe102 test plasmids pbe102bsm1 pbe102bsm2 constructed endogenous p53 binding site mutated bsm1 bsm2 respectively shown fig 3a indeed contrast wild type pbe102bsm2 replication irradiated pbe102bsm1 inhibited ha p53 flu fig 5c indicating endogenous p53 binding site required p53 inhibit replication radiation damaged py ori dna
0.61247855.12853603.html.plaintext.txt	53	remained possible ability p53 bind irradiated dna might facilitate ability inhibit replication pbe102 mechanism require irradiation pbe102 plasmid thus p53 might bind simultaneously irradiated plasmid c terminus another unirradiated plasmid interaction central domain endogenous binding site would somehow prevent replication unirradiated plasmid test mixed untreated pbe102 irradiated pbluescript py origin therefore support dna replication py large antigen complemented vitro dna replication system observed endogenous p53 binding site dna lesions caused irradiation work trans making dna replication inhibited ha p53 flu fig 6a similarly ha p53c30 flu c terminal domain p53 ha p53300 393 flu binds preferentially consensus site dna damage sites respectively work trans either fig 6b
0.61247855.12853603.html.plaintext.txt	54	remained possible ability p53 bind irradiated dna might facilitate ability inhibit replication pbe102 mechanism require irradiation pbe102 plasmid thus p53 might bind simultaneously irradiated plasmid c terminus another unirradiated plasmid interaction central domain endogenous binding site would somehow prevent replication unirradiated plasmid test mixed untreated pbe102 irradiated pbluescript py origin therefore support dna replication py large antigen complemented vitro dna replication system observed endogenous p53 binding site dna lesions caused irradiation work trans making dna replication inhibited ha p53 flu fig 6a similarly ha p53c30 flu c terminal domain p53 ha p53300 393 flu binds preferentially consensus site dna damage sites respectively work trans either fig 6b
0.61247855.12853603.html.plaintext.txt	55	view larger version 24k figure 6 dna lesions template required cis replication pbe102 inhibited p53 protein increasing amounts ha p53 flu protein 200 400 600 ng added replication reaction mixtures containing either 300 ng irradiated pbe102 70 gy 200 ng untreated pbe102 together 200 ng irradiated pbluescript dna products purified analyzed dpni digestion b effects c terminal domain p53 ha p53300 393 flu ha p53c30 flu 200 400 600 ng combination two replication irradiated pbe102 70 gy compared full length ha p53 flu n 3
0.61247855.12853603.html.plaintext.txt	56	view larger version 24k figure 6 dna lesions template required cis replication pbe102 inhibited p53 protein increasing amounts ha p53 flu protein 200 400 600 ng added replication reaction mixtures containing either 300 ng irradiated pbe102 70 gy 200 ng untreated pbe102 together 200 ng irradiated pbluescript dna products purified analyzed dpni digestion b effects c terminal domain p53 ha p53300 393 flu ha p53c30 flu 200 400 600 ng combination two replication irradiated pbe102 70 gy compared full length ha p53 flu n 3
0.61247855.12853603.html.plaintext.txt	57	inhibition replication irradiated pbe102 p53 takes place initiation stage dna replication feasible design vitro replication experiments determine step inhibited p53 first demonstrated sv40 ori dna replication reaction mixtures deprived deoxynucleotides pre incubated antigen pre synthesis complex forms 47 complex unable begin elongation thus possible determine whether p53 inhibition dna replication occurs elongation initiation stage adding replication mixtures either addition deoxynucleotides pre incubation antigen carried 10 min ha p53 flu protein 600 ng added incubated 10 min followed addition deoxynucleotides allow elongation fig 7 dna replication treatment compared replication reaction mixtures ha p53 flu added without pre incubation compare lane 3 lane 5 lane 4 lane 6 ha p53 flu inhibited replication vw16pycat damaged pbe102 templates without antigen pre incubation antigen allowed form pre synthesis complex origin however ha p53 flu longer able inhibit replication either template fig 7 result inhibition replication types template happens beginning dna replication suggests p53 may inhibit replication two different types templates mechanism
0.61247855.12853603.html.plaintext.txt	58	inhibition replication irradiated pbe102 p53 takes place initiation stage dna replication feasible design vitro replication experiments determine step inhibited p53 first demonstrated sv40 ori dna replication reaction mixtures deprived deoxynucleotides pre incubated antigen pre synthesis complex forms 47 complex unable begin elongation thus possible determine whether p53 inhibition dna replication occurs elongation initiation stage adding replication mixtures either addition deoxynucleotides pre incubation antigen carried 10 min ha p53 flu protein 600 ng added incubated 10 min followed addition deoxynucleotides allow elongation fig 7 dna replication treatment compared replication reaction mixtures ha p53 flu added without pre incubation compare lane 3 lane 5 lane 4 lane 6 ha p53 flu inhibited replication vw16pycat damaged pbe102 templates without antigen pre incubation antigen allowed form pre synthesis complex origin however ha p53 flu longer able inhibit replication either template fig 7 result inhibition replication types template happens beginning dna replication suggests p53 may inhibit replication two different types templates mechanism
0.61247855.12853603.html.plaintext.txt	59	view larger version 90k figure 7 inhibition replication vw16pycat irradiated pbe102 takes place initiation stage dna replication replication reactions containing either vw16pycat lanes 1 3 5 irradiated pbe102 lanes 2 4 6 performed two conditions lanes 3 4 1 mg py antigen pre incubated 10 min template plasmid 300 ng fm3a cell extract 400 mg 33 degrees c ha p53 pab421 600 ng deoxynucleotides added reaction mixtures lanes 5 6 amounts antigen ha p53 pab421 added simultaneously reaction mixtures lanes 1 4 controls p53 added replication determined previous figures n 3
0.61247855.12853603.html.plaintext.txt	60	view larger version 90k figure 7 inhibition replication vw16pycat irradiated pbe102 takes place initiation stage dna replication replication reactions containing either vw16pycat lanes 1 3 5 irradiated pbe102 lanes 2 4 6 performed two conditions lanes 3 4 1 mg py antigen pre incubated 10 min template plasmid 300 ng fm3a cell extract 400 mg 33 degrees c ha p53 pab421 600 ng deoxynucleotides added reaction mixtures lanes 5 6 amounts antigen ha p53 pab421 added simultaneously reaction mixtures lanes 1 4 controls p53 added replication determined previous figures n 3
0.61247855.12853603.html.plaintext.txt	61	discussion top abstract introduction materials methods results discussion references study extended previous conclusion p53 must bind specifically undamaged py ori dna order block replication showed endogenous p53 binding site adjacent core py origin essential inhibition found dna lesions caused ionizing radiation also recruit p53 thereby facilitate inhibition replication damaged dna taken together results show replication py dna inhibited p53 protein endogenous p53 binding site early side origin well strong p53 interactions template required interactions mediated either central core c terminal domains
0.61247855.12853603.html.plaintext.txt	62	discussion top abstract introduction materials methods results discussion references study extended previous conclusion p53 must bind specifically undamaged py ori dna order block replication showed endogenous p53 binding site adjacent core py origin essential inhibition found dna lesions caused ionizing radiation also recruit p53 thereby facilitate inhibition replication damaged dna taken together results show replication py dna inhibited p53 protein endogenous p53 binding site early side origin well strong p53 interactions template required interactions mediated either central core c terminal domains
0.61247855.12853603.html.plaintext.txt	63	results reflect possibility virtually dna binding protein present sufficiently high quantities may inhibit replication radiation damaged ori dna arguing results showing 28 p53 needs able interact specifically endogenous p53 binding site early side ori well dna lesions caused irradiation p53 needs specific non specific dna binding domains cause inhibition ii p53 blocks specifically initiation elongation stage ori dna synthesis thus unlikely p53 blocking replication random non specific binding damaged dna also noteworthy ito et al 48 showed transcription factor ap1 stimulates initial stage vitro replication py ori dna plasmid containing ap1 binding site result argues possibility sequence specific interactor dna vicinity py ori obligatorily inhibit replication
0.61247855.12853603.html.plaintext.txt	64	results reflect possibility virtually dna binding protein present sufficiently high quantities may inhibit replication radiation damaged ori dna arguing results showing 28 p53 needs able interact specifically endogenous p53 binding site early side ori well dna lesions caused irradiation p53 needs specific non specific dna binding domains cause inhibition ii p53 blocks specifically initiation elongation stage ori dna synthesis thus unlikely p53 blocking replication random non specific binding damaged dna also noteworthy ito et al 48 showed transcription factor ap1 stimulates initial stage vitro replication py ori dna plasmid containing ap1 binding site result argues possibility sequence specific interactor dna vicinity py ori obligatorily inhibit replication
0.61247855.12853603.html.plaintext.txt	65	explain mechanism underlying inhibition py dna p53 several possibilities suggested binding flanking consensus sites lesion sites p53 may sequester away proteins essential replication machinery rp antigen ii p53 binding site close replication origin endogenous p53 site py dna may block access replication initiation complex origin iii p53 may also function anti helicase 49 counteract helicase activity antigen re annealing denatured dna around origin iv binding separate sites p53 may loop dna around origin therefore produce steric hindrance replication initiation results presented paper strongly support dna looping model fig 8 endogenous p53 binding site early side cis p53 binding site late side adjacent py origin required dna replication inhibited p53 shown previously p53 binding separate single consensus sequences indeed bend loop dna dna looping p53 may play important role transactivation certain promoters 5051 far remains tested whether p53 also loop dna binding separate dna lesions suggested result separately binding consensus sequence lesion sites
0.61247855.12853603.html.plaintext.txt	66	explain mechanism underlying inhibition py dna p53 several possibilities suggested binding flanking consensus sites lesion sites p53 may sequester away proteins essential replication machinery rp antigen ii p53 binding site close replication origin endogenous p53 site py dna may block access replication initiation complex origin iii p53 may also function anti helicase 49 counteract helicase activity antigen re annealing denatured dna around origin iv binding separate sites p53 may loop dna around origin therefore produce steric hindrance replication initiation results presented paper strongly support dna looping model fig 8 endogenous p53 binding site early side cis p53 binding site late side adjacent py origin required dna replication inhibited p53 shown previously p53 binding separate single consensus sequences indeed bend loop dna dna looping p53 may play important role transactivation certain promoters 5051 far remains tested whether p53 also loop dna binding separate dna lesions suggested result separately binding consensus sequence lesion sites
0.61247855.12853603.html.plaintext.txt	67	interesting discover endogenous p53 binding site adjacent py origin mutated bsm1 bind p53 replication efficiency mutant plasmid increased 3 4 fold data shown fact wild type polyomavirus genome contains endogenous p53 binding consensus site provides intriguing possibility polyomavirus may indeed use host p53 protein regulate amplicational replications amplicational replication small dna tumor viruses normally initiated entry viral genome cell nucleus leads rapid increase copy number virus genome 32 amplicational replication viral genome essential establishment viral infection controlled order avoid replication unscheduled death host cells prior synthesis late genes production infectious particles tempting speculate polyomavirus uses p53 cellular factor control amplicational replication experiments required test possibility small dna tumor viruses generally encode proteins interact modulate activity p53 thereby regulate p53 dependent apoptosis host cells example large antigen sv40 2652 e1b protein adenovirus 53 x antigen hepatitis b virus 5455 viral proteins interact p53 thereby modulate p53 dependent apoptosis far protein encoded py genome identified interacts regulates activity p53 protein supports likelihood polyomavirus uses p53 cellular factor keep amplicational replication check
0.61247855.12853603.html.plaintext.txt	68	interesting discover endogenous p53 binding site adjacent py origin mutated bsm1 bind p53 replication efficiency mutant plasmid increased 3 4 fold data shown fact wild type polyomavirus genome contains endogenous p53 binding consensus site provides intriguing possibility polyomavirus may indeed use host p53 protein regulate amplicational replications amplicational replication small dna tumor viruses normally initiated entry viral genome cell nucleus leads rapid increase copy number virus genome 32 amplicational replication viral genome essential establishment viral infection controlled order avoid replication unscheduled death host cells prior synthesis late genes production infectious particles tempting speculate polyomavirus uses p53 cellular factor control amplicational replication experiments required test possibility small dna tumor viruses generally encode proteins interact modulate activity p53 thereby regulate p53 dependent apoptosis host cells example large antigen sv40 2652 e1b protein adenovirus 53 x antigen hepatitis b virus 5455 viral proteins interact p53 thereby modulate p53 dependent apoptosis far protein encoded py genome identified interacts regulates activity p53 protein supports likelihood polyomavirus uses p53 cellular factor keep amplicational replication check
0.61247855.12853603.html.plaintext.txt	69	original conception p53 checkpoint factor proposed dna damage would induce transient g1 arrest cells wild type mutant p53 allow time damaged dna repaired continuation cell cycle 56 tempting speculate p53 may participate directly pathway stops slows dna replication rapidly transcription dependent p21e2f pathway although p53 believed interact various forms dna damage c terminus biological function interaction elucidated study using ionizing radiation damaged py ori dna plasmids able demonstrate vitro experiments potential new function p53 namely direct inhibition initiation dna replication dna binding dependent manner noted p53 dependent dna replication checkpoint demonstrated 57 fact p53 shown transcriptionally impaired accumulates blocked phase 30 known however whether onset phase radiation damaged templates might prevented initiating replication result direct interactions p53 acknowledged replication py ori dna embodies several features distinct yet poorly understood process mammalian genomic dna replication nevertheless noteworthy p53 could exert effect initial stages py ori dna synthesis initiated p53 ineffective inhibiting ongoing replication thus based biochemical observations existing body knowledge p53 cells possible p53 might serve prevent onset phase function transcription factor ability bind damaged dna prevent initiation dna synthesis phase initiated would follow p53 would longer effective inhibition pre initiated replication forks even stalled
0.61247855.12853603.html.plaintext.txt	70	original conception p53 checkpoint factor proposed dna damage would induce transient g1 arrest cells wild type mutant p53 allow time damaged dna repaired continuation cell cycle 56 tempting speculate p53 may participate directly pathway stops slows dna replication rapidly transcription dependent p21e2f pathway although p53 believed interact various forms dna damage c terminus biological function interaction elucidated study using ionizing radiation damaged py ori dna plasmids able demonstrate vitro experiments potential new function p53 namely direct inhibition initiation dna replication dna binding dependent manner noted p53 dependent dna replication checkpoint demonstrated 57 fact p53 shown transcriptionally impaired accumulates blocked phase 30 known however whether onset phase radiation damaged templates might prevented initiating replication result direct interactions p53 acknowledged replication py ori dna embodies several features distinct yet poorly understood process mammalian genomic dna replication nevertheless noteworthy p53 could exert effect initial stages py ori dna synthesis initiated p53 ineffective inhibiting ongoing replication thus based biochemical observations existing body knowledge p53 cells possible p53 might serve prevent onset phase function transcription factor ability bind damaged dna prevent initiation dna synthesis phase initiated would follow p53 would longer effective inhibition pre initiated replication forks even stalled
0.61247855.12853603.html.plaintext.txt	71	clear often sequence specific p53 binding sites reside vicinity mammalian replication origins intriguing however two first cellular p53 binding sites identified found vicinity putative human replication origins 58 ever increasing number transcriptional targets p53 suggests may large numbers binding sites genome besides polyomavirus specific p53 binding sites also identified sv40 replication origin 59 remains studied whether dna looping p53 occurs suggested study plays functional roles regulating dna replication cells
0.61247855.12853603.html.plaintext.txt	72	clear often sequence specific p53 binding sites reside vicinity mammalian replication origins intriguing however two first cellular p53 binding sites identified found vicinity putative human replication origins 58 ever increasing number transcriptional targets p53 suggests may large numbers binding sites genome besides polyomavirus specific p53 binding sites also identified sv40 replication origin 59 remains studied whether dna looping p53 occurs suggested study plays functional roles regulating dna replication cells
0.61247855.12853603.html.plaintext.txt	73	acknowledgements ella freulich thanked excellent technical assistance scott miller subarna bhattacharyya thanked helpful suggestions work supported nih grant ca58316 cp
0.61247855.12853603.html.plaintext.txt	74	acknowledgements ella freulich thanked excellent technical assistance scott miller subarna bhattacharyya thanked helpful suggestions work supported nih grant ca58316 cp
0.61247855.12853603.html.plaintext.txt	75	references top abstract introduction materials methods results discussion references privesc hallpa 1999 p53 pathway j pathol 187 112 12633co2 vlinktypedoi crossrefisimedline
0.6178579.12972501.html.plaintext.txt	0	apoptosis p53 network susan haupt1 michael berger2 zehavit goldberg2 ygal haupt2
0.6178579.12972501.html.plaintext.txt	1	1 department pharmacy hebrew university hadassah medical school jerusalem 91120 israel 2 lautenberg center general tumor immunology hebrew university hadassah medical school jerusalem 91120 israel
0.6178579.12972501.html.plaintext.txt	2	author correspondence e mail hauptatmdhujiacil u d
0.6178579.12972501.html.plaintext.txt	3	summary top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references exposure cellular stress trigger p53 tumor suppressor sequence specific transcription factor induce cell growth arrest apoptosis choice cellular responses influenced many factors including type cell stress action p53 co activators p53 stimulates wide network signals act two major apoptotic pathways extrinsic death receptor pathway triggers activation caspase cascade intrinsic mitochondrial pathway shifts balance bcl 2 family towards pro apoptotic members promoting formation apoptosome consequently caspase mediated apoptosis impact two apoptotic pathways may enhanced converge bid p53 target majority apoptotic effects mediated induction specific apoptotic target genes however p53 also promote apoptosis transcription independent mechanism certain conditions thus multitude mechanisms employed p53 ensure efficient induction apoptosis stage tissue stress signal specific manner manipulation apoptotic functions p53 constitutes attractive target cancer therapy
0.6178579.12972501.html.plaintext.txt	4	key words p53 apoptosis caspase mitochondria transcriptional activation
0.6178579.12972501.html.plaintext.txt	5	introduction top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references prevention cancer profoundly dependent p53 tumor suppressor protein ability p53 eliminate excess damaged infected cells apoptosis kerr et al 1972 vital proper regulation cell proliferation multi cellular organisms huang strasser 2000 p53 activated external internal stress signals promote nuclear accumulation active form turn p53 induces either viable cell growth arrest apoptosis latter activity crucial tumor suppression growth inhibitory activities p53 prevent proliferation cells damaged dna potential neoplastic transformation addition p53 contributes cellular processes differentiation dna repair angiogenesis also appear vital tumor suppression reviewed vogt sionov haupt 1999
0.6178579.12972501.html.plaintext.txt	6	key player cellular response stress p53 serves major obstruction tumorigenesis obstacle removed order allow tumor development indeed approximately 50 human cancers bear p53 gene mutations majority remaining cancer cases p53 activity compromised alternative mechanisms vogelstein et al 2000 involve elevation expression levels p53 inhibitors mdm2 e6 protein hpv silencing key p53 co activators arf vogelstein et al 2000 vogt sionov et al 2001
0.6178579.12972501.html.plaintext.txt	7	key player cellular response stress p53 serves major obstruction tumorigenesis obstacle removed order allow tumor development indeed approximately 50 human cancers bear p53 gene mutations majority remaining cancer cases p53 activity compromised alternative mechanisms vogelstein et al 2000 involve elevation expression levels p53 inhibitors mdm2 e6 protein hpv silencing key p53 co activators arf vogelstein et al 2000 vogt sionov et al 2001
0.6178579.12972501.html.plaintext.txt	8	normal conditions p53 short lived protein p53 inhibitor mdm2 hdm2 humans largely responsible keeping p53 state mdm2 inhibits transcriptional activity p53 importantly promotes degradation proteasome however status p53 drastically altered cells exposed stress including dna damage untimely expression oncogenes hypoxia nucleotide depletion reviewed giaccia kastan 1998 p53 activation involves stabilization protein enhancement dna binding transcriptional activity changes p53 mediated extensive post translational modifications p53 protein protein interactions cooperating factors ultimately activation p53 leads cell growth arrest senescence apoptosis choice depends summation incoming signals cellular context see apoptotic function p53 critical tumor suppression reconstitution inactive p53 dependent apoptotic pathways attractive approach currently explored anti cancer treatment review recent developments understanding p53 mediated apoptosis references relevant exhaustive reviews subject made appropriate sections
0.6178579.12972501.html.plaintext.txt	9	normal conditions p53 short lived protein p53 inhibitor mdm2 hdm2 humans largely responsible keeping p53 state mdm2 inhibits transcriptional activity p53 importantly promotes degradation proteasome however status p53 drastically altered cells exposed stress including dna damage untimely expression oncogenes hypoxia nucleotide depletion reviewed giaccia kastan 1998 p53 activation involves stabilization protein enhancement dna binding transcriptional activity changes p53 mediated extensive post translational modifications p53 protein protein interactions cooperating factors ultimately activation p53 leads cell growth arrest senescence apoptosis choice depends summation incoming signals cellular context see apoptotic function p53 critical tumor suppression reconstitution inactive p53 dependent apoptotic pathways attractive approach currently explored anti cancer treatment review recent developments understanding p53 mediated apoptosis references relevant exhaustive reviews subject made appropriate sections
0.6178579.12972501.html.plaintext.txt	10	growth inhibition p53 cell cycle arrest apoptosis top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references p53 transcription factor activates vital damage containment procedures restrict aberrant cell growth response dna damage oncogene activation hypoxia loss normal cell contacts giaccia kastan 1998 lohrum vousden 1999 restricts cellular growth inducing senescence cell cycle arrest g1 andor g2 phase apoptosis jin levine 2001 exact criteria influence p53 stimulate cell cycle arrest apoptosis partially understood subject intense study several general factors influence decision include p53 expression levels type stress signal cell type cellular context time exposure stress reviewed balint vousden 2001 vogt sionov haupt 1999 several intriguing observations recently provided insight apparent intricacies cell fate determination examples described involve binding p53 canonical binding sequence target genes el deiry et al 1992 note however p53 also activate target genes non canonical sequence first example p53 induced gene 3 pig3 implicated accumulation reactive oxygen species apoptosis induction polyak et al 1997 pig3 induced p53 microsatellite sequence within untranslated region contente et al 2002 another recently described example gene encoding pro apoptotic phosphatase pac1 induced binding p53 novel palindromic binding site yin et al 2003 might represent new mechanism transcriptional regulation apoptotic genes p53 differs already described see
0.6178579.12972501.html.plaintext.txt	11	redox determination p53 gene regulation top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references nucleotide sequence binding site p53 within promoters target genes critical determinant response stress uv light irradiation exposure response dna damage binding affinity p53 promoter cell cycle regulating gene p21wafcip1 p21 unchanged whereas binding promoter dna repair associated gene gadd45 reduced due primarily oxidation cys277 residing within human p53 contacts third base first pyrimidine residue p53 binding consensus pentamer atgpypypy p53 binding element p21 5 gaacatgtcccaacatgttg 3 gadd45 5 gaacatgtctaagcatgctg 3 critical residues determine binding cys277 indicated red consensus fitting bases uppercase although mechanism p53 cys277 oxidation unclear may associated production oxygen radicals induced response exposure high dose uv light buzek et al 2002
0.6178579.12972501.html.plaintext.txt	12	reducing conditions affinity p53 gadd45 promoter increased suggests reduction cys277 necessary enable binding p53 c rich binding sequences gadd45 intriguingly seo et al found reduction residues cys275 cys277 selenomethionine major dietary source selenium caused p53 recruit p53 binding redox factor ref1 activate dna repair machinery induction gadd45 without affecting cell growth seo et al 2002 thus redox state p53 cys277 appears serve switch activating dna repair machinery selective activation p53 dependent dna repair activity proposed novel approach cancer prevention gudkov 2002
0.6178579.12972501.html.plaintext.txt	13	p53 co activators top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references interaction p53 transcriptional co activators also influences affinity promoters therefore plausible specific co factors expressed particular cellular context determine repertoire p53 target genes induced consequently whether cell undergoes growth arrest apoptosis even particular apoptotic pathway fig 1 may subject availability co activators rozenfeld granot et al 2002
0.6178579.12972501.html.plaintext.txt	14	view larger version 60k fig 1 model p53 mediated apoptosis model depicts involvement p53 extrinsic intrinsic apoptotic pathways p53 target genes shown red convergence two pathways bid shown
0.6178579.12972501.html.plaintext.txt	15	myc protein implicated important determinant choice p53 induced growth arrest apoptosis myc inhibits growth arrest response uv light irradiation dna damage inflicted reactive oxygen species sheen dickson 2002 vafa et al 2002 absence myc cells exposed uv light arrest p53 miz 1 dna binding myc interacting zinc finger 1 dependent manner activation p21 however myc present exposure uv triggers recruitment miz 1 proximal promoter region p21 interaction effectively represses p21 induction p53 activators herold et al 2002 seoane et al 2002 intriguingly repression appears specific p21 p53 target genes p53 upregulated modulator apoptosis puma pig3 induced block p21 induction shifts balance away growth arrest towards apoptosis seoane et al 2002 noted however arrested cells necessarily protected apoptosis example normal thymocytes mature lymphocytes undergo p53 mediated apoptosis certain stress conditions strasser et al 1994 interaction p53 several proteins specifically enhances induction apoptotic target genes apoptosis stimulating proteins p53 aspp example increases dna binding transactivation activity p53 promoters apoptotic genes eg bax pig3 failing promote binding p21 promoter mechanism remains defined samuels lev et al 2001
0.6178579.12972501.html.plaintext.txt	16	myc protein implicated important determinant choice p53 induced growth arrest apoptosis myc inhibits growth arrest response uv light irradiation dna damage inflicted reactive oxygen species sheen dickson 2002 vafa et al 2002 absence myc cells exposed uv light arrest p53 miz 1 dna binding myc interacting zinc finger 1 dependent manner activation p21 however myc present exposure uv triggers recruitment miz 1 proximal promoter region p21 interaction effectively represses p21 induction p53 activators herold et al 2002 seoane et al 2002 intriguingly repression appears specific p21 p53 target genes p53 upregulated modulator apoptosis puma pig3 induced block p21 induction shifts balance away growth arrest towards apoptosis seoane et al 2002 noted however arrested cells necessarily protected apoptosis example normal thymocytes mature lymphocytes undergo p53 mediated apoptosis certain stress conditions strasser et al 1994 interaction p53 several proteins specifically enhances induction apoptotic target genes apoptosis stimulating proteins p53 aspp example increases dna binding transactivation activity p53 promoters apoptotic genes eg bax pig3 failing promote binding p21 promoter mechanism remains defined samuels lev et al 2001
0.6178579.12972501.html.plaintext.txt	17	novel insight interplay p53 family members p63 p73 induction apoptosis recently revealed flores et al flores et al 2002 study effect p63 p73 p53 transcriptional activity using selection knockout mouse embryo fibroblasts mefs defined two distinct classes target gene whereas p53 alone sufficient induction p21 mdm2 induction apoptotic genes perp bax noxa requires p53 together p63 p73 finding demonstrates essential role p63 p73 efficient induction apoptotic target genes p53 mechanism cooperation currently unknown may involve enhanced binding andor stabilization transcription complex promoters p53 apoptotic target genes cooperative action three members urist prives 2002 addition contribution p63 p73 apoptotic function p53 play important role precise control cell death normal mouse development p73 also plays role induction cell death response dna damage process involving cooperation abl tyrosine kinase p73 reviewed shaul 2000
0.6178579.12972501.html.plaintext.txt	18	p53 mediated apoptosis top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references exacting discrimination p53 arrest apoptotic functions critical identification importance latter tumor suppression strong link apoptotic function p53 tumor suppression demonstrated using transgenic mice bearing sv40 large antigen lt mutant inhibited prb function without directly compromising p53 activity p53 mediated growth arrest however impaired mice owing prb loss function apoptotic activity functional mice develop choroid plexus tumors slow rate owing continuous p53 dependent apoptosis elimination p53 mice crossbreeding p53 null mice resulted aggressive tumor development finding suggested tumor suppression primarily due p53 mediated apoptosis reviewed vogt sionov haupt 1999 compelling insight fundamental question came recent study using e micro myc mediated lymphoma mouse model apoptotic pathway lymphoma cells blocked either retroviral expression bcl 2 dominant negative caspase 9 effect block growth lymphomas tested recipient mice apoptosis impaired cells selection p53 mutations contrast cells intact apoptotic pathways remarkably apoptosis impaired lymphoma cells expressing functional p53 integrity genome cell cycle checkpoints maintained taken together studies support notion apoptosis critical function p53 tumor suppression
0.6178579.12972501.html.plaintext.txt	19	p53 mediates apoptosis matter intensive study since first demonstrated yonish rouach et al 1991 numerous publications recently described importance p53 transcriptional regulation components extrinsic intrinsic pathways however target gene products unequivocally established essential p53 dependent apoptosis induction discuss supporting evidence p53 also able promote apoptosis transcription independent apoptotic mechanisms certain conditions p53 induces apoptosis absence transcription protein synthesis eg caelles et al 1994 moreover transcriptionally inactive mutants p53 induce apoptosis certain cell types haupt et al 1995 pias protein inhibitor activated stat blocks binding p53 dna inhibit p53 mediated apoptosis nelson et al 2001 general transcription independent apoptotic activities p53 demonstrated transformed cells rather normal cells eg lymphocytes fibroblasts presumably activities p53 require cooperation apoptotic factors instance e2f 1 transcription factor retinoblastoma protein pathway reviewed vogt sionov haupt 1999 experimental cell transformation may mimic various stages tumor development apoptotic function p53 activated becomes critical suppression tumor progression apoptotic activities p53 may sufficient induce apoptosis non transformed cells normal thymocytes whereas transcription dependent independent apoptotic functions p53 often described separately appear complement therefore discuss contributions together context extrinsic intrinsic apoptotic pathways
0.6178579.12972501.html.plaintext.txt	20	extrinsic intrinsic apoptotic pathways top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references p53 implicated induction recently understood two distinct apoptotic signaling pathways lead activation aspartate specific cysteine proteases caspases mediate apoptosis fig 1 extrinsic pathway involves engagement particular death receptors belong tumor necrosis factor receptor tnf r family formation death inducing signaling complex disc ashkenazi dixit 1998 leads cascade activation caspases including caspase 8 caspase 3 turn induce apoptosis intrinsic pathway triggered response dna damage associated mitochondrial depolarization release cytochrome c mitochondrial intermembrane space cytoplasm cytochrome c apoptotic protease activating factor 1 apaf 1 procaspase 9 form complex termed apoptosome caspase 9 activated promotes activation caspase 3 caspase 6 caspase 7 reviewed nicholson thornberry 2003 recent studies however link extrinsic intrinsic pathways lending support idea converging rather distinct pathways gross et al 1999 li et al 1998
0.6178579.12972501.html.plaintext.txt	21	extrinsic pathway top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references p53 activate extrinsic apoptotic pathway induction genes encoding three transmembranes proteins fas dr5 perp cell surface receptor fas cd95apo 1 member tnf r family receptors key component extrinsic death pathway nagata golstein 1995 fas activated binding ligand fasl expressed predominantly cells muzio 1998 p53 induces fas mrna expression binding elements found promoter first intron fas gene muller et al 1998 induction occurs response irradiation appears strictly tissue specific bouvard et al 2000 p53 dependent fas mrna induction demonstrated spleen thymus kidney lung heart liver bouvard et al 2000 however least lymphocytes fas appears dispensable p53 dependent apoptosis fuchs et al 1997 oconnor et al 2000 importance fas p53 target cell types remains elucidated
0.6178579.12972501.html.plaintext.txt	22	addition stimulating fas transcription overexpressed p53 may enhance levels fas cell surface promoting trafficking fas receptor golgi bennett et al 1998 may allow p53 rapidly sensitize cells fas induced apoptosis transcription dependent effect operates p53 promotes fas trafficking understood
0.6178579.12972501.html.plaintext.txt	23	second member receptor family induced p53 dr5killer death domain containing receptor tnf related apoptosis inducing ligand trail dr5 induced p53 response dna damage wu et al 1997 turn promotes cell death caspase 8 reviewed ashkenazi dixit 1998 dr5 induction cell type specific whole body irradiation induces dr5 expression spleen small intestine thymus burns et al 2001 consistent dr5 participating p53 mediated response dna damage tissues strikingly mefs exposed dna damage doxorubicin similar levels dr5 identified cells undergoing g1 arrest apoptosis attardi et al 2000 thus contribution dr5 different p53 determined cell fates remains clarified
0.6178579.12972501.html.plaintext.txt	24	second member receptor family induced p53 dr5killer death domain containing receptor tnf related apoptosis inducing ligand trail dr5 induced p53 response dna damage wu et al 1997 turn promotes cell death caspase 8 reviewed ashkenazi dixit 1998 dr5 induction cell type specific whole body irradiation induces dr5 expression spleen small intestine thymus burns et al 2001 consistent dr5 participating p53 mediated response dna damage tissues strikingly mefs exposed dna damage doxorubicin similar levels dr5 identified cells undergoing g1 arrest apoptosis attardi et al 2000 thus contribution dr5 different p53 determined cell fates remains clarified
0.6178579.12972501.html.plaintext.txt	25	another apoptotic gene perp induced mefs response dna damage cells transduced either e2f 1 adenoviral e1a protein targets prb thereby releasing active e2f 1 context perp probably cooperates e2f 1 induce apoptosis perp putative tetraspan transmembrane protein represents new member pmp 22gas family proteins implicated cell growth regulation kinetics perp induction response dna damage presence p53 responsive element perp promoter support notion direct p53 target role perp apoptosis suggested significantly higher levels perp mrna cells undergoing apoptosis arresting cells however mechanism perp contributes p53 mediated apoptosis yet defined attardi et al 2000
0.6178579.12972501.html.plaintext.txt	26	another apoptotic gene perp induced mefs response dna damage cells transduced either e2f 1 adenoviral e1a protein targets prb thereby releasing active e2f 1 context perp probably cooperates e2f 1 induce apoptosis perp putative tetraspan transmembrane protein represents new member pmp 22gas family proteins implicated cell growth regulation kinetics perp induction response dna damage presence p53 responsive element perp promoter support notion direct p53 target role perp apoptosis suggested significantly higher levels perp mrna cells undergoing apoptosis arresting cells however mechanism perp contributes p53 mediated apoptosis yet defined attardi et al 2000
0.6178579.12972501.html.plaintext.txt	27	intrinsic pathway top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references intrinsic apoptotic pathway dominated bcl 2 family proteins governs release cytochrome c mitochondria cory adams 2002 kuwana et al 2002 bcl 2 family comprises anti apoptotic pro survival pro apoptotic members family members classified basis structural similarity bcl 2 homology bh domains bh1 bh2 bh3 bh4 transmembrane domain bh3 domain present members essential heterodimerization among members minimum domain required proapoptotic function kelekar thompson 1998 yu et al 2001 bcl 2 family divisible three classes pro survival proteins whose members structurally similar bcl 2 bcl xl pro apoptotic proteins bax bak structurally similar bcl 2 bcl xl antagonize pro survival functions pro apoptotic bh3 proteins bouillet strasser 2002 intriguingly key subset bcl 2 family genes p53 targets including bax noxa puma recently identified bid
0.6178579.12972501.html.plaintext.txt	28	bax first member group shown induced p53 p53 responsive elements recently unequivocally identified bax gene thornborrow et al 2002 response stress activation bax forms homodimer releases cytochrome c mitochondria skulachev 1998 results caspase 9 activation reviewed adams cory 1998 requirement bax p53 mediated apoptosis appears cell type dependent bax required apoptotic response developing nervous system irradiation chong et al 2000 contributes chemotherapy induced killing e1a expressing fibroblasts mccurrach et al 1997
0.6178579.12972501.html.plaintext.txt	29	contrast equivalent levels bax induced mefs undergoing either arrest apoptosis understood indicate bax dictate cellular fate cells attardi et al 2000 addition colonic epithelia undergoing apoptosis response irradiation bax appear essential pritchard et al 1999
0.6178579.12972501.html.plaintext.txt	30	fascinating explanation apparent enigmatic role bax apoptosis induction recently offered context puma puma gene also directly induced p53 response dna damage p53 responsive elements within first intron puma humans puma encodes two bh3 domain containing proteins puma puma ss nakano vousden 2001 yu et al 2001 vital balance puma p21 identified determine onset arrest death response exogenous p53 expression also hypoxia human colorectal cancer cells growth arrest activation p21 normal response p53 expression cells p21 disrupted cells die apoptosis however puma disrupted apoptosis prevented bax absolutely required puma mediated apoptosis puma expression promotes mitochondrial translocation mulitmerization bax culminating apoptosis induction yu et al 2003 thus although p53 bind bax promoter affinity weak contrast p21 puma binding kaeser iggo 2002 bax thus participates death response indirect target p53 puma yu et al 2003
0.6178579.12972501.html.plaintext.txt	31	fascinating explanation apparent enigmatic role bax apoptosis induction recently offered context puma puma gene also directly induced p53 response dna damage p53 responsive elements within first intron puma humans puma encodes two bh3 domain containing proteins puma puma ss nakano vousden 2001 yu et al 2001 vital balance puma p21 identified determine onset arrest death response exogenous p53 expression also hypoxia human colorectal cancer cells growth arrest activation p21 normal response p53 expression cells p21 disrupted cells die apoptosis however puma disrupted apoptosis prevented bax absolutely required puma mediated apoptosis puma expression promotes mitochondrial translocation mulitmerization bax culminating apoptosis induction yu et al 2003 thus although p53 bind bax promoter affinity weak contrast p21 puma binding kaeser iggo 2002 bax thus participates death response indirect target p53 puma yu et al 2003
0.6178579.12972501.html.plaintext.txt	32	another p53 target gene noxa contains single p53 responsive element promoter induced response x ray irradiation oda et al 2000 noxa encodes bh3 protein hence likely contribute p53 mediated apoptosis similar manner puma bax although yet demonstrated thus appears response dna damage p53 activates intrinsic mitochondrial apoptotic pathway inducing expression least three bcl 2 pro apoptotic family members shifting balance towards pro apoptotic effects
0.6178579.12972501.html.plaintext.txt	33	apoptosome activation p53 top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references formation apoptosome requires release cytochrome c apaf 1 mitochondria formation complex pro caspase 9 adams cory 2002 p53 promotes cytochrome c release induction target genes encoding bh3 proteins importantly p53 also induces apaf 1 expression response element within apaf 1 promoter kannan et al 2001 moroni et al 2001 robles et al 2001 rozenfeld granot et al 2002 induction p53 boosted e2f 1 induces apaf 1 expression activates p53 arf dependent manner moroni et al 2001 apaf 1 required stress induced p53 dependent apoptosis fibroblasts also induction apoptosis myc caspase 9 essential downstream component soengas et al 1999 another study response ir thymocytes apaf 1caspase 9 null mice compared normal mice comparison revealed impaired response neither protection apoptosis normal sensitivity ir induced death marsden et al 2002 apparent difference may represent different role apoptosome myc expressing fibroblasts versus normal thymocytes may also suggest apoptosome contribute p53 mediated apoptosis perhaps essential occur least thymocytes
0.6178579.12972501.html.plaintext.txt	34	caspase activation caspase 9 caspase 2 respond changes mitochondrial potential whereas caspase 8 caspase 10 sense activation death receptors initiator caspases cleave pro enzyme forms effector caspases caspase 3 caspase 6 caspase 7 allowing digestion essential targets affect cell viability fig 1 maclachlan el deiry 2002 intriguingly p53 boosts activation caspase cascade transcription dependent independent mechanisms response irradiation nucleus depleted s100 cell free extracts p53 activate caspase 8 ding et al 1998 depletion inactivation caspase 8 cell free extracts completely prevents effect significantly attenuates overall apoptosis induced wild type p53 however etoposide uv mediated death fibroblasts derived caspase 8 deficient mice impaired varfolomeev et al 1998 thus caspase 8 contribute although always essential dna damaged induced death
0.6178579.12972501.html.plaintext.txt	35	caspase activation caspase 9 caspase 2 respond changes mitochondrial potential whereas caspase 8 caspase 10 sense activation death receptors initiator caspases cleave pro enzyme forms effector caspases caspase 3 caspase 6 caspase 7 allowing digestion essential targets affect cell viability fig 1 maclachlan el deiry 2002 intriguingly p53 boosts activation caspase cascade transcription dependent independent mechanisms response irradiation nucleus depleted s100 cell free extracts p53 activate caspase 8 ding et al 1998 depletion inactivation caspase 8 cell free extracts completely prevents effect significantly attenuates overall apoptosis induced wild type p53 however etoposide uv mediated death fibroblasts derived caspase 8 deficient mice impaired varfolomeev et al 1998 thus caspase 8 contribute although always essential dna damaged induced death
0.6178579.12972501.html.plaintext.txt	36	p53 stimulates caspase 6 conventional mechanism response dna damage p53 directly induces caspase 6 expression response element within third intron gene maclachlan el deiry 2002 caspase 6 cleaves nuclear envelope protein lamin several transcription factors galande et al 2001 caspase 6 plays important role p53 induced neuronal cell death major protein involved cleavage amyloid precursor protein leblanc et al 1999
0.6178579.12972501.html.plaintext.txt	37	p53 stimulates caspase 6 conventional mechanism response dna damage p53 directly induces caspase 6 expression response element within third intron gene maclachlan el deiry 2002 caspase 6 cleaves nuclear envelope protein lamin several transcription factors galande et al 2001 caspase 6 plays important role p53 induced neuronal cell death major protein involved cleavage amyloid precursor protein leblanc et al 1999
0.6178579.12972501.html.plaintext.txt	38	p53 localization mitochondria top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references p53 also participates apoptosis induction acting directly mitochondria localization p53 mitochondria occurs response apoptotic signals precedes cytochrome c release procaspase 3 activation importantly redirecting p53 mitochondria using mitochondrial import leader peptides sufficient induce apoptosis p53 deficient saos 2 cells marchenko et al 2000 recently mihara et al also extended finding show p53 promotes permeabilization outer mitochondrial membrane forming complexes protective bcl xl bcl 2 proteins interestingly p53 binds dna binding domain bcl xl tumor derived transactivation deficient mutants p53 interact bcl xl hence promote mitochondrial apoptotic events even though localize mitochondria mihara et al 2003 separating two activities p53 may shed light biological relevance p53 localization mitochondria since p53 mediate apoptosis without dna binding domain haupt et al 1995 likely mitochondrial localization p53 transcription independent mechanism p53 promotes apoptosis
0.6178579.12972501.html.plaintext.txt	39	bid link extrinsic intrinsic apoptotic pathways top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references pro apoptotic bid distinguished unique ability connect activation extrinsic death receptor pathway activation mitochondrial disruption processes associated intrinsic pathway activation bid involves cleavage cytoplasmic bid caspase 8 expose new n terminal glycine residue undergoes post translational myristoylation myristoylated bid translocates mitochondria inserts membrane activates bax bak initiate mitochondrial events leading apoptosome formation bid gene transcriptionally regulated p53 response irradiation response elements first intron human gene promoter mouse gene bid mrna increases p53 dependent manner splenic red pulp colonic epithelium however correlation increase bid protein levels needs shown cellular chemosensitivity dna damaging agents adriamycin 5 fluorouracil appears critically dependent presence wild type p53 bid bid null cells resistant effects drugs sax et al 2002 p53 therefore appears promote convergence intrinsic extrinsic pathways bid regulation
0.6178579.12972501.html.plaintext.txt	40	p53 mediated abrogation survival signals akt pathway top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references binding mitogens cytokines cell surface receptors including insulin receptor epidermal growth factor receptor egfr platelet derived growth factor receptor pdgfr actions oncogenes ras her2neu transduced phosphoinositide 3 kinase pi3k activating signaling pathways promote cell proliferation viability fig 2 pi3k comprises p85 regulatory subunit interacts phosphorylated receptor tyrosine kinases 110 kda subunit localizes membrane upon receptor binding response change redox state caused h2o2 induced oxidative stress p85 upregulated p53 p85 involved p53 dependent apoptotic response h2o2 mefs precise role cell death unclear pi3k activates akt serinethreonine kinase phosphorylation ser473 3 phosphoinositide dependent kinase pdk1 lawlor alessi 2001 turn akt phosphorylates range targets function promote cell survival including major inhibitor p53 mdm2 reviewed mayo donner 2002 phosphorylation enhances nuclear accumulation mdm2 augments mdm2 interaction p300 reduces affinity mdm2 p19arf reviewed testa bellacosa 2001 consequently akt augments inhibition destabilization p53 mdm2 fig 2 interestingly stress induced activation p53 counteracts inhibitory effects survival pathway multiple mechanisms fig 2 first p53 promotes caspase mediated cleavage subsequent degradation akt protein gottlieb et al 2002 second p53 induces expression pten tumor suppressor gene encodes phosphatase dephosphorylates pi3k thereby impairing akt activation reviewed mayo donner 2002 third p53 induces expression cyclin g turn recruits phosphatase pp2ab mdm2 p53 complex dephosphorylates mdm2 akt phosphorylation sites feedback loops determine survival versus apoptotic outcome interplay p53 akt survival pathway fig 2 reviewed oren et al 2002 fine balance often interrupted cancer either mutations pten amplification mdm2 mayo donner 2002
0.6178579.12972501.html.plaintext.txt	41	view larger version 43k fig 2 model regulation p53 akt pathway growthsurvival conditions stress signals negative regulation p53 akt induced response survival signals mdm2 activation pathway leads inhibition destruction p53 stress conditions pathways blocked cleavage degradation akt inhibition pi3k pten activities induced p53 model survival achieved inhibition p53 akt whereas apoptosis achieved counteracting akt p53 p53 target genes shown red green arrows represent activation whereas red arrows represent inhibition
0.6178579.12972501.html.plaintext.txt	42	p53 mediated cancer therapy top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references stimulation disabled p53 pathways suggested potential mode therapy cancer potential approaches include introducing wild type p53 genetically empowering aberrant p53 molecules perform wild type functions intervening activate directly targets p53 apoptotic pathways gene therapy based introduction wild type p53 reviewed wen et al 2003 elimination mutant p53 expressing cells reviewed post 2002 undergoing clinical trials restoration wild type conformation structurally contorted p53 dna binding mutants demonstrated using peptide constructs small molecular weight synthetic molecules reviewed bullock fersht 2001 synthetic peptides derived c terminus p53 induce p53 dependent apoptosis tumor cells restore specific dna binding transcription functions mutant p53 vitro abarzua et al 1996 selivanova et al 1997 selivanova et al 1999 vivo activity peptides associated increase levels fas receptor cell surface p53 dependent mechanism independent transcription kim et al 1999 small synthetic peptides derived p53 binding protein introduced restore sequence specific dna binding activity mutant p53 friedler et al 2002 expense complexity synthesizing synthetic peptides stability limitations stimulated screening small easily synthesized molecules greater therapeutic potential prima p53 reactivation induction massive apoptosis small molecular weight molecule provokes apoptosis transcription dependent fashion conformational manipulation p53 mutants restore sequence specific dna binding bykov et al 2002 cp 31398 another small synthetic molecule foster et al 1999 capacity restore wild type p53 function apoptosis growth arrest induction mutants wang et al 2003 however exposure also associated elevation steady state wild type p53 levels induced dna damage smith fornace 2002 takimoto et al 2002 cp 31398 suggested trigger apoptosis intrinsic baxmitochondrialcaspase 9 pathway luu et al 2002 additional responses involving increased dr5 cell surface exposure reduction p53 ubiquitination also associated molecule wang et al 2003
0.6178579.12972501.html.plaintext.txt	43	conclusion top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references deconstruction p53 mediated apoptosis reveals extensive network signaling pathways triggered p53 ensure appropriate response given stress intriguingly p53 intervene every major step apoptotic pathways extrinsic death receptor signaling convergent pathway component bid intrinsic mitochondria pathways involving apoptosome formation culminating direct caspase activation many effects mediated activation specific p53 target genes addition p53 able activate apoptotic pathways transcription independent mechanisms including direct shuttling p53 mitochondrial membrane likely unraveled future complex apoptotic network required one possible reason may ensure rapid response another specific sets target genes might activated given set conditions stage tissue stimulus specific manner alternatively active p53 may induce set target genes different conditions specificity determined cellular factors currently examples support options defining effect variables p53 transcriptional activity using genome wide expression analysis may help answer fundamental questions analyses likely shed new light determinants cellular decision growth arrest apoptosis
0.6178579.12972501.html.plaintext.txt	44	acknowledgments grateful mati goldberg drawing illustrations owing space limitations many original important studies cited directly rather recent reviews work yhs laboratory supported research career development award israel cancer research fund israel science foundation ministry health grant ministry science culture sport israel dkfz israel cancer association ber lehmsdorf memorial fund memory late prof nathan training part research grant 1 fy01 177 march dimes birth defects foundation
0.6178579.12972501.html.plaintext.txt	45	acknowledgments grateful mati goldberg drawing illustrations owing space limitations many original important studies cited directly rather recent reviews work yhs laboratory supported research career development award israel cancer research fund israel science foundation ministry health grant ministry science culture sport israel dkfz israel cancer association ber lehmsdorf memorial fund memory late prof nathan training part research grant 1 fy01 177 march dimes birth defects foundation
0.6178579.12972501.html.plaintext.txt	46	references top summary introduction growth inhibition p53 redox determination p53 p53 co activators p53 mediated apoptosis extrinsic intrinsic extrinsic pathway intrinsic pathway apoptosome activation p53 p53 localization bid link p53 mediated abrogation p53 mediated cancer therapy conclusion references
0.629985.15753095.html.plaintext.txt	0	transcriptional blockade induces p53 dependent apoptosis associated translocation p53 mitochondria yoshimi arima masayuki nitta shinji kuninaka dongwei zhang toshiyoshi fujiwara yoichi taya mitsuyoshi nakao hideyuki saya
0.629985.15753095.html.plaintext.txt	1	department tumor genetics biology graduate school medical sciences kumamoto university kumamoto 860 8556 division surgical oncology department surgery okayama university graduate school medicine dentistry okayama 700 8558 national cancer center research institute radiobiology division tsukiji chuo ku tokyo 104 0045 department regeneration medicine institute molecular embryology genetics kumamoto university 2 2 1 honjo kumamoto 860 0811 japan
0.629985.15753095.html.plaintext.txt	2	received publication september 16 2004 revised form february 3 2005
0.629985.15753095.html.plaintext.txt	3	abstract top abstract introduction materials methods results discussion references tumor suppressor p53 functions transcriptional activator induce cell cycle arrest apoptosis response dna damage although p53 also shown mediate apoptosis manner independent transactivation activity mechanism conditions trigger cell death remained largely unknown shown inhibition rna polymerase ii mediated transcription amanitin rna interference induced p53 dependent apoptosis inhibition pol ii mediated transcription resulted regulation p21cip1 caused transcriptional suppression protein degradation despite eliciting p53 accumulation allowing cells progress phase undergo apoptosis cell death require transcription p53 target genes preceded translocation accumulated p53 mitochondria data thus suggested blockade pol ii mediated transcription induced p53 accumulation mitochondria critical factor eliciting p53 dependent transcription independent apoptosis
0.629985.15753095.html.plaintext.txt	4	abstract top abstract introduction materials methods results discussion references tumor suppressor p53 functions transcriptional activator induce cell cycle arrest apoptosis response dna damage although p53 also shown mediate apoptosis manner independent transactivation activity mechanism conditions trigger cell death remained largely unknown shown inhibition rna polymerase ii mediated transcription amanitin rna interference induced p53 dependent apoptosis inhibition pol ii mediated transcription resulted regulation p21cip1 caused transcriptional suppression protein degradation despite eliciting p53 accumulation allowing cells progress phase undergo apoptosis cell death require transcription p53 target genes preceded translocation accumulated p53 mitochondria data thus suggested blockade pol ii mediated transcription induced p53 accumulation mitochondria critical factor eliciting p53 dependent transcription independent apoptosis
0.629985.15753095.html.plaintext.txt	5	introduction top abstract introduction materials methods results discussion references apoptosis genetically controlled mechanism cell death essential elimination unwanted cells normal development maintenance tissue homeostasis tumor suppressor protein p53 induces either cell cycle arrest apoptosis response variety cellular stresses including dna damage oncogene activation hypoxia 1 3 loss p53 function therefore results failure remove damaged cells contributes tumor development resistance cancer cells therapies based induction dna damage
0.629985.15753095.html.plaintext.txt	6	introduction top abstract introduction materials methods results discussion references apoptosis genetically controlled mechanism cell death essential elimination unwanted cells normal development maintenance tissue homeostasis tumor suppressor protein p53 induces either cell cycle arrest apoptosis response variety cellular stresses including dna damage oncogene activation hypoxia 1 3 loss p53 function therefore results failure remove damaged cells contributes tumor development resistance cancer cells therapies based induction dna damage
0.629985.15753095.html.plaintext.txt	7	well established p53 transcriptional regulator p53 mediated apoptosis response dna damage predominantly attributable transcriptional activation genes encode apoptotic effectors bh3 proteins noxa puma bax p53aip1 perp 4 9 well transcriptional repression genes antiapoptotic proteins bcl 2 10 survivin 11 addition transcriptional regulation however recent evidence suggested existence transcription independent pathway p53 mediated apoptosis 12 13 fraction p53 molecules accumulate damaged cells translocates mitochondria translocation sufficient p53 induce permeabilization outer mitochondrial membrane formation complexes protective proteins bcl xl bcl 2 resulting release cytochrome c cytosol 14 15 mechanism relative activities transcription dependent transcription independent pathways p53 mediated apoptosis regulated however remained unclear
0.629985.15753095.html.plaintext.txt	8	well established p53 transcriptional regulator p53 mediated apoptosis response dna damage predominantly attributable transcriptional activation genes encode apoptotic effectors bh3 proteins noxa puma bax p53aip1 perp 4 9 well transcriptional repression genes antiapoptotic proteins bcl 2 10 survivin 11 addition transcriptional regulation however recent evidence suggested existence transcription independent pathway p53 mediated apoptosis 12 13 fraction p53 molecules accumulate damaged cells translocates mitochondria translocation sufficient p53 induce permeabilization outer mitochondrial membrane formation complexes protective proteins bcl xl bcl 2 resulting release cytochrome c cytosol 14 15 mechanism relative activities transcription dependent transcription independent pathways p53 mediated apoptosis regulated however remained unclear
0.629985.15753095.html.plaintext.txt	9	lesions transcribed strand dna induced high concentrations chemotherapeutic agents cisplatin high doses uv radiation trigger ubiquitination consequent degradation large subunit ls1 rna polymerase ii pol ii resulting transcriptional collapse recruitment dna repair proteins 16 17 prolonged blockage pol ii dependent transcription caused failure repair dna lesions results cell death apoptosis 18 furthermore amanitin specific inhibitor pol ii dependent transcription also induces apoptosis 19 given pol ii responsible transcription protein coding genes new transcription proapoptotic genes would expected contribute apoptosis induced pol ii inhibition degradation although possible cell death triggered impaired expression downstream survival factors precise mechanism apoptosis elicited transcriptional blockade remains unknown
0.629985.15753095.html.plaintext.txt	10	lesions transcribed strand dna induced high concentrations chemotherapeutic agents cisplatin high doses uv radiation trigger ubiquitination consequent degradation large subunit ls1 rna polymerase ii pol ii resulting transcriptional collapse recruitment dna repair proteins 16 17 prolonged blockage pol ii dependent transcription caused failure repair dna lesions results cell death apoptosis 18 furthermore amanitin specific inhibitor pol ii dependent transcription also induces apoptosis 19 given pol ii responsible transcription protein coding genes new transcription proapoptotic genes would expected contribute apoptosis induced pol ii inhibition degradation although possible cell death triggered impaired expression downstream survival factors precise mechanism apoptosis elicited transcriptional blockade remains unknown
0.629985.15753095.html.plaintext.txt	11	investigated molecular mechanism apoptosis occurs response transcriptional block caused exposure cells amanitin rna interference high dose uv radiation inhibition transcription resulted accumulation p53 massive cell death normal fibroblasts hct116 human colon carcinoma cells p53 without induction apparent dna damage although new transcription various p53 target genes blocked result pol ii inhibition accumulation p53 required apoptosis also found fraction accumulated p53 molecules including phosphorylated ser15 ser46 translocated mitochondria addition found pol ii inhibition induces regulation cyclin dependent kinase inhibitor p21cip1 p21waf1 target gene product p53 allowing cells enter phase undergo apoptosis observations support notion blockage pol ii dependent transcription triggers p53 mediated transcription independent apoptosis
0.629985.15753095.html.plaintext.txt	12	investigated molecular mechanism apoptosis occurs response transcriptional block caused exposure cells amanitin rna interference high dose uv radiation inhibition transcription resulted accumulation p53 massive cell death normal fibroblasts hct116 human colon carcinoma cells p53 without induction apparent dna damage although new transcription various p53 target genes blocked result pol ii inhibition accumulation p53 required apoptosis also found fraction accumulated p53 molecules including phosphorylated ser15 ser46 translocated mitochondria addition found pol ii inhibition induces regulation cyclin dependent kinase inhibitor p21cip1 p21waf1 target gene product p53 allowing cells enter phase undergo apoptosis observations support notion blockage pol ii dependent transcription triggers p53 mediated transcription independent apoptosis
0.629985.15753095.html.plaintext.txt	13	materials methods top abstract introduction materials methods results discussion references cell lines cell culture parental p53 p21 p53 p21 hct116 cells kindly provided b vogelstein mrc 5 cells cultured 37 degrees c dulbeccos modified eagles mediumf 12 supplemented 10 fetal bovine serum without antibiotics humidified atmosphere containing 5 co2 unless designated otherwise hct116 cells used experiments parental cells cells incubated amanitin sigma mg132 calbiochem adriamycin sigma aphidicolin wako osaka japan z val ala aspome fmk enzyme systems products livermore ca actinomycin d sigma indicated
0.629985.15753095.html.plaintext.txt	14	materials methods top abstract introduction materials methods results discussion references cell lines cell culture parental p53 p21 p53 p21 hct116 cells kindly provided b vogelstein mrc 5 cells cultured 37 degrees c dulbeccos modified eagles mediumf 12 supplemented 10 fetal bovine serum without antibiotics humidified atmosphere containing 5 co2 unless designated otherwise hct116 cells used experiments parental cells cells incubated amanitin sigma mg132 calbiochem adriamycin sigma aphidicolin wako osaka japan z val ala aspome fmk enzyme systems products livermore ca actinomycin d sigma indicated
0.629985.15753095.html.plaintext.txt	15	expression plasmids sirna transfection plasmid expressing wild type p53 truncated form p53 p531 39 deletion n terminus 39 amino acid constructed subcloning corresponding cdna fragment pcdna3 expression plasmids transfected cells using fugene 6 reagent roche applied science colonies selected complete medium containing g418 800 microgml invitrogen
0.629985.15753095.html.plaintext.txt	16	expression plasmids sirna transfection plasmid expressing wild type p53 truncated form p53 p531 39 deletion n terminus 39 amino acid constructed subcloning corresponding cdna fragment pcdna3 expression plasmids transfected cells using fugene 6 reagent roche applied science colonies selected complete medium containing g418 800 microgml invitrogen
0.629985.15753095.html.plaintext.txt	17	rnai experiments conducted described previously 20 used following target sequence pol ii large subunit sirna 475aactgaagcgaatgtctgtga495 21 nucleotide chimeric rna dna duplexes obtained japan bioservices co ltd saitama japan cells transfected annealed sirnas use oligofectamine invitrogen control used gl 2 duplex target luciferase gene 21
0.629985.15753095.html.plaintext.txt	18	rnai experiments conducted described previously 20 used following target sequence pol ii large subunit sirna 475aactgaagcgaatgtctgtga495 21 nucleotide chimeric rna dna duplexes obtained japan bioservices co ltd saitama japan cells transfected annealed sirnas use oligofectamine invitrogen control used gl 2 duplex target luciferase gene 21
0.629985.15753095.html.plaintext.txt	19	uv irradiation cells washed pbs exposed uv radiation 254 nm dose 2 30 40 jm2 incubated fresh medium indicated times indicated incubated 100 nm pifithrin calbiochem 3 h uv irradiation
0.629985.15753095.html.plaintext.txt	20	uv irradiation cells washed pbs exposed uv radiation 254 nm dose 2 30 40 jm2 incubated fresh medium indicated times indicated incubated 100 nm pifithrin calbiochem 3 h uv irradiation
0.629985.15753095.html.plaintext.txt	21	cell cycle analysis cells collected exposure trypsin washed pbs fixed ice cold 70 ethanol stored 20 degrees c subsequently washed twice pbs incubated 30 min room temperature rnase 100 microgml stained pi 25 microgml 30 min flow cytometry performed facscalibur instrument data analyzed cellquest software bd biosciences assay brdurd incorporation cells labeled 10 microm brdurd fixed denatured 30 min room temperature pbs containing 2 n hcl washed pbs incubated 30 min 11 dilution fluorescein conjugated mouse mab brdurd bd biosciences counterstained pi analyzed flow cytometry
0.629985.15753095.html.plaintext.txt	22	cell cycle analysis cells collected exposure trypsin washed pbs fixed ice cold 70 ethanol stored 20 degrees c subsequently washed twice pbs incubated 30 min room temperature rnase 100 microgml stained pi 25 microgml 30 min flow cytometry performed facscalibur instrument data analyzed cellquest software bd biosciences assay brdurd incorporation cells labeled 10 microm brdurd fixed denatured 30 min room temperature pbs containing 2 n hcl washed pbs incubated 30 min 11 dilution fluorescein conjugated mouse mab brdurd bd biosciences counterstained pi analyzed flow cytometry
0.629985.15753095.html.plaintext.txt	23	measurement apoptosis apoptosis evaluated flow cytometric determination fraction cells sub g1 dna content well detection dna fragmentation use cell death detection enzyme linked immunosorbent assay plus assay kit roche applied science detection cells early stage apoptosis cells fixed 70 ethanol stained 60 min room temperature 1100 dilution m30 cytodeath antibody roche applied science recognizes specific caspase cleavage product cytokeratin 18 pbs containing 1 bovine serum albumin 01 tween 20 incubated 30 min fluorescein isothiocyanate conjugated secondary antibodies counterstained pi analyzed flow cytometry
0.629985.15753095.html.plaintext.txt	24	measurement apoptosis apoptosis evaluated flow cytometric determination fraction cells sub g1 dna content well detection dna fragmentation use cell death detection enzyme linked immunosorbent assay plus assay kit roche applied science detection cells early stage apoptosis cells fixed 70 ethanol stained 60 min room temperature 1100 dilution m30 cytodeath antibody roche applied science recognizes specific caspase cleavage product cytokeratin 18 pbs containing 1 bovine serum albumin 01 tween 20 incubated 30 min fluorescein isothiocyanate conjugated secondary antibodies counterstained pi analyzed flow cytometry
0.629985.15753095.html.plaintext.txt	25	immunoblot analysis details immunoblot analysis various antibodies used described supplemental materials methods
0.629985.15753095.html.plaintext.txt	26	immunofluorescence analysis cells washed tbs incubated 2 min room temperature 37 formaldehyde washed tbs fixed 80 methanol 5 min room temperature stained following primary antibodies 1 h room temperature mouse mab 1 p53 11000 dilution rabbit polyclonal antibodies p53 1100 dilution fl393 santa cruz biotechnology rabbit polyclonal antibodies pol ii ls n 20 1500 dilution rabbit polyclonal antibodies h2ax 1 100 dilution trevigen washing tbs cells incubated fluorescein isothiocyanate conjugated secondary antibodies counterstained pi mounted 14 diazabicyclo 222 octaneglycerol observed confocal laser scanning microscope fluoview olympus mitochondria stained mitotracker red molecular probes staining brdurd cells labeled 10 microm brdurd 24 h harvesting fixed denatured 15 min 2 n hcl washed tbs incubated fluorescein conjugated mouse mab brdurd
0.629985.15753095.html.plaintext.txt	27	immunofluorescence analysis cells washed tbs incubated 2 min room temperature 37 formaldehyde washed tbs fixed 80 methanol 5 min room temperature stained following primary antibodies 1 h room temperature mouse mab 1 p53 11000 dilution rabbit polyclonal antibodies p53 1100 dilution fl393 santa cruz biotechnology rabbit polyclonal antibodies pol ii ls n 20 1500 dilution rabbit polyclonal antibodies h2ax 1 100 dilution trevigen washing tbs cells incubated fluorescein isothiocyanate conjugated secondary antibodies counterstained pi mounted 14 diazabicyclo 222 octaneglycerol observed confocal laser scanning microscope fluoview olympus mitochondria stained mitotracker red molecular probes staining brdurd cells labeled 10 microm brdurd 24 h harvesting fixed denatured 15 min 2 n hcl washed tbs incubated fluorescein conjugated mouse mab brdurd
0.629985.15753095.html.plaintext.txt	28	semiquantitative rt pcr analysis total rna isolated cells use rneasy spin column kit qiagen 25 microg converted cdna superscript ii reverse transcriptase invitrogen exponential phase pcr determined 22 30 cycles allow semiquantitative comparisons among cdna samples subjected identical reactions pcr protocol included initial denaturation 95 degrees c 5 min followed 30 cycles pol ii ls 25 cycles p53 p21cip1 bax gadd45 p53dinp1 22 cycles noxa gapdh 95 degrees c 1 min 55 60 degrees c 1 min 72 degrees c 1 min performed geneamp pcr system 9700 perkinelmer life sciences pcr products separated electrophoresis 2 agarose gels
0.629985.15753095.html.plaintext.txt	29	semiquantitative rt pcr analysis total rna isolated cells use rneasy spin column kit qiagen 25 microg converted cdna superscript ii reverse transcriptase invitrogen exponential phase pcr determined 22 30 cycles allow semiquantitative comparisons among cdna samples subjected identical reactions pcr protocol included initial denaturation 95 degrees c 5 min followed 30 cycles pol ii ls 25 cycles p53 p21cip1 bax gadd45 p53dinp1 22 cycles noxa gapdh 95 degrees c 1 min 55 60 degrees c 1 min 72 degrees c 1 min performed geneamp pcr system 9700 perkinelmer life sciences pcr products separated electrophoresis 2 agarose gels
0.629985.15753095.html.plaintext.txt	30	adenovirus infection four replication deficient recombinant adenoviral vectors used present study described previously 22 23 ad5cmv p53 ad5cmv p21cip1 ad5cmv p27kip1 encode wild type human p53 p21cip1 p27kip1 respectively control human cytomegalovirus promoter ad5cmv luc vector encoding luciferase used control adenoviruses propagated titrated permissive 293 cell line viral infection titers determined described previously 24 cells 3 x 105 plated 24 h infection cultured indicated times adenovirus multiplicity infection 100 plaque forming units per cell
0.629985.15753095.html.plaintext.txt	31	adenovirus infection four replication deficient recombinant adenoviral vectors used present study described previously 22 23 ad5cmv p53 ad5cmv p21cip1 ad5cmv p27kip1 encode wild type human p53 p21cip1 p27kip1 respectively control human cytomegalovirus promoter ad5cmv luc vector encoding luciferase used control adenoviruses propagated titrated permissive 293 cell line viral infection titers determined described previously 24 cells 3 x 105 plated 24 h infection cultured indicated times adenovirus multiplicity infection 100 plaque forming units per cell
0.629985.15753095.html.plaintext.txt	32	subcellular fractionation adherent floating cells 2 x 107 harvested washed pbs mitochondrial cytosolic fractions isolated use optiprep mitochondria isolation kit pierce reagent based method mitochondrial pellet lysed sds sample buffer cytosolic supernatant concentrated microcon device millipore size cut 10 kda analysis sds page immunoblotting
0.629985.15753095.html.plaintext.txt	33	subcellular fractionation adherent floating cells 2 x 107 harvested washed pbs mitochondrial cytosolic fractions isolated use optiprep mitochondria isolation kit pierce reagent based method mitochondrial pellet lysed sds sample buffer cytosolic supernatant concentrated microcon device millipore size cut 10 kda analysis sds page immunoblotting
0.629985.15753095.html.plaintext.txt	34	results top abstract introduction materials methods results discussion references inhibition pol ii dependent transcription induces p53 mediated apoptosis evaluate role p53 transcriptional blockade mediated cell death treated p53 knock hct116 cells 25 versus parental control cells amanitin specific inhibitor pol ii dependent transcription amanitin binds directly ls pol ii 26 specifically induces ubiquitination consequent degradation 27 consistent previous observations 28 cells treated amanitin manifested time dependent decrease total amount mrna unable resume mrna synthesis2 shown fig 1a flow cytometry revealed exposure parental hct116 p53 cells amanitin resulted substantial increase size sub g1 apoptotic cell population however knock p53 p53 markedly reduced sensitivity hct116 cells death induced amanitin indicating apoptosis elicited pol ii inhibitors p53 dependent
0.629985.15753095.html.plaintext.txt	35	results top abstract introduction materials methods results discussion references inhibition pol ii dependent transcription induces p53 mediated apoptosis evaluate role p53 transcriptional blockade mediated cell death treated p53 knock hct116 cells 25 versus parental control cells amanitin specific inhibitor pol ii dependent transcription amanitin binds directly ls pol ii 26 specifically induces ubiquitination consequent degradation 27 consistent previous observations 28 cells treated amanitin manifested time dependent decrease total amount mrna unable resume mrna synthesis2 shown fig 1a flow cytometry revealed exposure parental hct116 p53 cells amanitin resulted substantial increase size sub g1 apoptotic cell population however knock p53 p53 markedly reduced sensitivity hct116 cells death induced amanitin indicating apoptosis elicited pol ii inhibitors p53 dependent
0.629985.15753095.html.plaintext.txt	36	validate results used rna interference rnai abrogate expression pol ii large subunit alternative approach inhibit pol ii dependent transcription transfection cells small interfering rnas sirna specific pol ii large subunit resulted reduction levels protein supplemental fig s1 similar data obtained amanitin depletion pol ii significantly induced apoptosis p53 hct116 cells p53 hct116 cells fig 1a
0.629985.15753095.html.plaintext.txt	37	validate results used rna interference rnai abrogate expression pol ii large subunit alternative approach inhibit pol ii dependent transcription transfection cells small interfering rnas sirna specific pol ii large subunit resulted reduction levels protein supplemental fig s1 similar data obtained amanitin depletion pol ii significantly induced apoptosis p53 hct116 cells p53 hct116 cells fig 1a
0.629985.15753095.html.plaintext.txt	38	confirm whether amanitin induces cell death activation apoptotic pathways performed enzyme linked immunosorbent based assay measures level cytoplasmic nucleosomal dna fragments fig 1b consistent data obtained flow cytometry amanitin induced substantially larger increase amount cytoplasmic dna fragments p53 hct116 cells p53 cells microscopic observation hct116 cells stained pi also revealed amanitin induced marked increase proportion cells fragmented chromatin supplemental fig s2 characteristic apoptosis given p53 hct116 cells resistant amanitin induced apoptosis fig 1 b next examined whether restoration p53 expression cells renders sensitive effect amanitin adenovirus mediated expression p53 luciferase indeed restored sensitivity p53 cells amanitin induced apoptosis fig 1c supplemental fig s3 supporting notion p53 expression required effect amanitin addition apoptosis induced amanitin completely blocked presence caspase inhibitor z val ala aspome fmk fig 1d results indicate inhibition pol ii dependent transcription promotes p53 caspase dependent apoptosis
0.629985.15753095.html.plaintext.txt	39	view larger version 33k fig 1 inhibition pol ii dependent transcript induces p53 caspase dependent apoptosis hct116 cells induction p53 dependent apoptosis hct116 human colon carcinoma cells p53 p53 hct116 cells incubated amanitin 10 microgml 24 h pol ii ls sirna 48 h extent apoptosis determined flow cytometry b amanitin induces dna fragmentation p53 hct116 cells hct116 cells p53 p53 incubated without amanitin 10 microgml 24 h amount cytoplasmic histone associated dna fragments determined quantitative sandwich enzyme linked immunosorbent assay substrate reaction time 10 min data presented 405490 nm absorbance ratio means plus minus sd values three independent experiments c amanitin induced apoptosis p53 hct116 cells expressing exogenous p53 cells infected 24 h recombinant adenoviruses encoding luciferase ad luc p53 ad p53 incubated absence presence amanitin 10 microgml 24 h treated cells subjected flow cytometric analysis apoptosis d caspase dependence amanitin induced apoptosis hct116 cells cells p53 treated amanitin 10 microgml absence presence 20 microm z val ala aspome fmk 24 h extent apoptosis determined flow cytometry
0.629985.15753095.html.plaintext.txt	40	amanitin induces pol ii degradation p53 accumulation without dna double strand breaks amanitin induces ubiquitination c terminal domain ls pol ii 29 consequent proteasome mediated protein degradation 27 examined effect amanitin abundance ls pol ii p53 p53 hct116 cells immunoblot fig 2a immunofluorescence supplemental fig s4 analyses toxin induced degradation pol ii ls types hct116 cells suggesting p53 contribute amanitin induced pol ii degradation
0.629985.15753095.html.plaintext.txt	41	amanitin induces pol ii degradation p53 accumulation without dna double strand breaks amanitin induces ubiquitination c terminal domain ls pol ii 29 consequent proteasome mediated protein degradation 27 examined effect amanitin abundance ls pol ii p53 p53 hct116 cells immunoblot fig 2a immunofluorescence supplemental fig s4 analyses toxin induced degradation pol ii ls types hct116 cells suggesting p53 contribute amanitin induced pol ii degradation
0.629985.15753095.html.plaintext.txt	42	given apoptosis induced amanitin shown p53 dependent next examined effect drug amount p53 consistent previous observations 19 28 30 immunoblot analysis revealed amanitin elicited accumulation p53 p53 hct116 cells fig 2a accumulation p53 inhibition pol ii also confirmed depletion pol ii large subunit using sirna supplemental fig s1
0.629985.15753095.html.plaintext.txt	43	given apoptosis induced amanitin shown p53 dependent next examined effect drug amount p53 consistent previous observations 19 28 30 immunoblot analysis revealed amanitin elicited accumulation p53 p53 hct116 cells fig 2a accumulation p53 inhibition pol ii also confirmed depletion pol ii large subunit using sirna supplemental fig s1
0.629985.15753095.html.plaintext.txt	44	verify p53 accumulation elicited amanitin attributable induction dna damage checked presence h2ax complex marker dna double strand breaks dsbs 31 32 amanitin treated hct116 cells immunofluorescence analysis avoid detection dsbs attributable apoptotic dna fragmentation examined cells presence h2ax foci 18 h exposure drugs fig 2b whereas adriamycin induced formation h2ax foci amanitin even though substantial p53 accumulation apparent time point results suggest accumulation p53 induced amanitin caused induction dsbs
0.629985.15753095.html.plaintext.txt	45	verify p53 accumulation elicited amanitin attributable induction dna damage checked presence h2ax complex marker dna double strand breaks dsbs 31 32 amanitin treated hct116 cells immunofluorescence analysis avoid detection dsbs attributable apoptotic dna fragmentation examined cells presence h2ax foci 18 h exposure drugs fig 2b whereas adriamycin induced formation h2ax foci amanitin even though substantial p53 accumulation apparent time point results suggest accumulation p53 induced amanitin caused induction dsbs
0.629985.15753095.html.plaintext.txt	46	accumulation activation p53 regulated post translational modifications including protein phosphorylation acetylation 33 given phosphorylation p53 contributes stabilization activation protein examined time course p53 phosphorylation ser15 ser46 p53 hct116 cells treated adriamycin amanitin fig 2c adriamycin induced ser15 phosphorylation apparent 3 h p53 accumulation increase extent phosphorylation ser46 apparent 6 h consistent delay phosphorylation residue compared ser15 observed previously adriamycin treated cells 6 contrast increase extent ser46 phosphorylation apparent 12 h coincident onset p53 accumulation ser15 phosphorylation detected 24 h cells treated amanitin results thus suggest amanitin triggers slower p53 response comparison adriamycin may activate signaling pathway differs responsible p53 stabilization response dna damage
0.629985.15753095.html.plaintext.txt	47	accumulation activation p53 regulated post translational modifications including protein phosphorylation acetylation 33 given phosphorylation p53 contributes stabilization activation protein examined time course p53 phosphorylation ser15 ser46 p53 hct116 cells treated adriamycin amanitin fig 2c adriamycin induced ser15 phosphorylation apparent 3 h p53 accumulation increase extent phosphorylation ser46 apparent 6 h consistent delay phosphorylation residue compared ser15 observed previously adriamycin treated cells 6 contrast increase extent ser46 phosphorylation apparent 12 h coincident onset p53 accumulation ser15 phosphorylation detected 24 h cells treated amanitin results thus suggest amanitin triggers slower p53 response comparison adriamycin may activate signaling pathway differs responsible p53 stabilization response dna damage
0.629985.15753095.html.plaintext.txt	48	view larger version 40k fig 2 induction pol ii ls degradation p53 phosphorylation accumulation hct116 cells amanitin amanitin induced pol ii ls degradation p53 accumulation cells p53 p53 incubated presence indicated concentrations amanitin 24 h cell lysates subjected immunoblot analysis antibodies pol ii ls p53 1 tubulin loading control iio hyperphosphorylated form pol ii iia hypophosphorylated form pol ii b amanitin induce dna double strand breaks cells p53 treated amanitin 10 microgml adriamycin 500 ngml 18 h stained antibodies h2ax green counterstained pi red merged images shown right panels scale bars 20 microm c phosphorylation accumulation p53 induced adriamycin amanitin cells p53 treated adriamycin 500 ngml amanitin 10 microgml indicated times cell lysates subjected immunoblot analysis antibodies pol ii ls p53 1 p53 phosphorylated ser15 p53 phosphorylated ser46 p21cip1 membrane stained coomassie brilliant blue cbb show equal loading samples
0.629985.15753095.html.plaintext.txt	49	transcription p53 target genes blocked amanitin treated cells amanitin blocks pol ii dependent gene transcription therefore next confirmed p53 mediated apoptosis induced amanitin independent transactivation activity p53 use semiquantitative rt pcr analysis determined amounts mrnas derived various p53 target genes including p21cip1 bax noxa gadd45 34 p53dinp1 35 hct116 cells treated adriamycin amanitin 24 h fig 3 whereas adriamycin increased abundance mrnas p53 target genes examined amanitin abundance p53 mrna reduced treatment cells amanitin exposure adriamycin additionally time course experiments showed expression p53 target genes regulated amanitin treated cells throughout treatment period data shown data suggest transcriptional blockade triggers p53 dependent apoptosis dependent upon p53 mediated changes gene expression
0.629985.15753095.html.plaintext.txt	50	transcription p53 target genes blocked amanitin treated cells amanitin blocks pol ii dependent gene transcription therefore next confirmed p53 mediated apoptosis induced amanitin independent transactivation activity p53 use semiquantitative rt pcr analysis determined amounts mrnas derived various p53 target genes including p21cip1 bax noxa gadd45 34 p53dinp1 35 hct116 cells treated adriamycin amanitin 24 h fig 3 whereas adriamycin increased abundance mrnas p53 target genes examined amanitin abundance p53 mrna reduced treatment cells amanitin exposure adriamycin additionally time course experiments showed expression p53 target genes regulated amanitin treated cells throughout treatment period data shown data suggest transcriptional blockade triggers p53 dependent apoptosis dependent upon p53 mediated changes gene expression
0.629985.15753095.html.plaintext.txt	51	view larger version 49k fig 3 inhibition amanitin transcription 53 target genes hct116 cells incubated 24 h absence presence adriamycin 500 ngml amanitin 10 microgml abundance mrnas indicated proteins determined semiquantitative rt pcr analysis gapdh glyceraldehyde 3 phosphate dehydrogenase
0.629985.15753095.html.plaintext.txt	52	view larger version 26k fig 4 translocation p53 mitochondria response transcriptional blockade immunofluorescence localization p53 mitochondria amanitin treated cells mrc 5 cells incubated absence presence amanitin 10 microgml 48 h stained antibodies p53 fl393 green mitotracker red merged images shown right panels b enrichment p53 mitochondrial fraction cells treated amanitin mitochondrial mito cytosolic cyto fractions prepared mrc 5 cells subjected immunoblot analysis antibodies cytosolic proteins tubulin pcna mitochondrial proteins bcl 2 cytochrome oxidase iv cox iv upper panels mitochondrial cytosolic fractions mrc 5 cells also subjected immunoblot analysis antibodies p53 1 p53 phosphorylated ser15 ser46 cells exposed amanitin 48 h middle lower panels
0.629985.15753095.html.plaintext.txt	53	translocation p53 mitochondria amanitin treated cells recent studies suggested p53 dependent apoptosis occur absence gene transcription 12 13 fraction p53 molecules accumulate response dna damage translocates mitochondria thereby promotes apoptosis 14 15 therefore examined whether p53 molecules accumulate response transcriptional blockade translocate mitochondria confocal microscopic analysis carried using mrc 5 human normal fibroblasts wild type p53 mrc 5 cells suitable investigating subcellular distribution endogenous p53 cells flat large morphology easily observed cytoplasmic structures also confirmed amanitin elicits p53 accumulation apoptosis mrc 5 cells supplemental fig s5 b observed hct116 cells although p53 protein detectable low level nuclei untreated cells present increased amounts amanitin treated cells localized mitochondria substantial proportion cells fig 4a cell fractionation experiments also demonstrate p53 accumulated amanitin treatment primarily detected mitochondrial fractions mitochondrial p53 molecules phosphorylated ser15 andor ser46 fig 4b findings thus suggest p53 molecules accumulate response transcriptional blockade translocate mitochondria may activate apoptotic program
0.629985.15753095.html.plaintext.txt	54	translocation p53 mitochondria amanitin treated cells recent studies suggested p53 dependent apoptosis occur absence gene transcription 12 13 fraction p53 molecules accumulate response dna damage translocates mitochondria thereby promotes apoptosis 14 15 therefore examined whether p53 molecules accumulate response transcriptional blockade translocate mitochondria confocal microscopic analysis carried using mrc 5 human normal fibroblasts wild type p53 mrc 5 cells suitable investigating subcellular distribution endogenous p53 cells flat large morphology easily observed cytoplasmic structures also confirmed amanitin elicits p53 accumulation apoptosis mrc 5 cells supplemental fig s5 b observed hct116 cells although p53 protein detectable low level nuclei untreated cells present increased amounts amanitin treated cells localized mitochondria substantial proportion cells fig 4a cell fractionation experiments also demonstrate p53 accumulated amanitin treatment primarily detected mitochondrial fractions mitochondrial p53 molecules phosphorylated ser15 andor ser46 fig 4b findings thus suggest p53 molecules accumulate response transcriptional blockade translocate mitochondria may activate apoptotic program
0.629985.15753095.html.plaintext.txt	55	amanitin treatment induce g1 arrest allows phase entry amanitin increased size cell population phase p53 independent manner fig 1a depletion pol ii ls sirna also increased population phase cells comparison control sirna treatment fig 1a therefore investigate effect amanitin cell cycle progression hct116 cells first incubated amanitin reagents alone absence presence nocodazole induces cell cycle arrest prometaphase activation spindle assembly checkpoint consistent previous observations 36 treatment cells actinomycin d rna polymerase inhibitor adriamycin resulted g1 g2 arrest respectively fig 5a contrast cells treated amanitin incorporated brdurd accumulated predominantly phase 61 neither arrested g1 entered m phase regardless whether exposed nocodazole fig 5 b whereas retinoblastoma protein prb dephosphorylated cells treated adriamycin highly phosphorylated amanitin treated cells fig 5c cells exposed dna polymerase inhibitor aphidicolin induced phase arrest furthermore abundance icbp90 nuclear protein whose expression regulated dna damage induced g1 arrest 20 affected treatment hct116 cells amanitin whereas decreased treatment adriamycin actinomycin d fig 5d together findings suggest cells exposed amanitin progress g1 transition arrest phase
0.629985.15753095.html.plaintext.txt	56	next investigated mechanism amanitintreated cells able enter phase even though manifest accumulation p53 dna damage known induce expression cyclin dependent kinase cdk inhibitor p21cip1 via p53 dependent transactivation 25 p21cip1 binds inhibits activity pcna complexes cdk2 cyclin cyclin e thereby blocking progression cells g1 37 given levels p21cip1 protein mrna regulated amanitin treated cells sirna mediated pol ii depleted cells figs 2c 3 supplemental fig s1 cells might able enter phase despite p53 accumulation address issue monitored changes levels p21cip1 cell cycle progression amanitin treated cells fig 5e hct116 cells synchronized metaphase nocodazole treatment released fresh medium containing amanitin actinomycin d latter stabilizes p53 regulates p21cip1 expression induces g1 arrest size g1 population markedly reduced sub g1 apoptotic population increased cells treated amanitin compared corresponding populations cells treated actinomycin d left untreated immunoblot analysis revealed amount p21cip1 protein reduced cells exposed amanitin although markedly increased response actinomycin d fig 5e
0.629985.15753095.html.plaintext.txt	57	next investigated mechanism amanitintreated cells able enter phase even though manifest accumulation p53 dna damage known induce expression cyclin dependent kinase cdk inhibitor p21cip1 via p53 dependent transactivation 25 p21cip1 binds inhibits activity pcna complexes cdk2 cyclin cyclin e thereby blocking progression cells g1 37 given levels p21cip1 protein mrna regulated amanitin treated cells sirna mediated pol ii depleted cells figs 2c 3 supplemental fig s1 cells might able enter phase despite p53 accumulation address issue monitored changes levels p21cip1 cell cycle progression amanitin treated cells fig 5e hct116 cells synchronized metaphase nocodazole treatment released fresh medium containing amanitin actinomycin d latter stabilizes p53 regulates p21cip1 expression induces g1 arrest size g1 population markedly reduced sub g1 apoptotic population increased cells treated amanitin compared corresponding populations cells treated actinomycin d left untreated immunoblot analysis revealed amount p21cip1 protein reduced cells exposed amanitin although markedly increased response actinomycin d fig 5e
0.629985.15753095.html.plaintext.txt	58	abundance p21cip1 regulated transcriptional induction also ubiquitin mediated proteasomal degradation 38 examine whether amanitin induced regulation p21cip1 expression attributable protein degradation ubiquitin proteasome pathway treated hct116 cells amanitin presence mg132 proteasome inhibitor decrease amount p21cip1 induced amanitin prevented mg132 fig 5f indicating p21cip1 undergoes ubiquitin mediated proteolysis response amanitin thus transcriptional suppression protein degradation appear prevent accumulation p21cip1 amanitin treated cells thereby lead phase entry
0.629985.15753095.html.plaintext.txt	59	abundance p21cip1 regulated transcriptional induction also ubiquitin mediated proteasomal degradation 38 examine whether amanitin induced regulation p21cip1 expression attributable protein degradation ubiquitin proteasome pathway treated hct116 cells amanitin presence mg132 proteasome inhibitor decrease amount p21cip1 induced amanitin prevented mg132 fig 5f indicating p21cip1 undergoes ubiquitin mediated proteolysis response amanitin thus transcriptional suppression protein degradation appear prevent accumulation p21cip1 amanitin treated cells thereby lead phase entry
0.629985.15753095.html.plaintext.txt	60	view larger version 50k fig 5 treatment amanitin induces g1 transition phase accumulation hct116 cells entry amanitin treated cells phase cells incubated absence cont presence amanitin 10 microgml ama adriamycin 500 ngml adr actinomycin d 20 nm actd 18 h presence 10 microm brdurd additional 5 h subjected flow cytometric analysis cell cycle status upper panels parallel incubations nocodazole 100 ngml noc added culture medium 12 h analysis induce metaphase arrest lower panels b inhibition mitotic entry amanitin cells incubated absence presence amanitin adriamycin actinomycin d 24 h additional presence nocodazole 12 h cells examined phase contrast microscopy percentage mitotic cells determined visual inspection total 200 cells per condition c phosphorylation prb amanitin treated cells cells incubated absence presence amanitin adriamycin aphidicolin 1 microgml 24 h cell lysates subjected immunoblot analysis antibodies prb prb phosphorylated serines 795 780 807 811 d icbp90 expression amanitin treated cells cells incubated absence presence amanitin adriamycin actinomycin d 36 h cell lysates subjected immunoblot analysis antibodies icbp90 proliferating cell nuclear antigen used loading control abundance pcna affected three agents e regulation p21cip1 amanitin treated cells cells synchronized metaphase nocodazole treatment released fresh medium absence presence amanitin actinomycin d indicated times subjected flow cytometric analysis dna content left panels immunoblot analysis antibodies p53 1 p21cip1 right panels f degradation p21cip1 ubiquitin proteasome pathway amanitin treated cells cells incubated without amanitin 12 h additional absence presence 10 microm mg132 12 h cell lysates subjected immunoblot analysis antibodies indicated membrane stained coomassie brilliant blue cbb show equal loading samples g regulation cyclin b amanitin treated cells cells incubated absence presence amanitin adriamycin actinomycin d 24 h absence presence nocodazole 12 h cell lysates subjected immunoblot analysis p53 p21cip1 cyclin b untreated cells similarly analyzed membrane stained coomassie brilliant blue show equal loading samples
0.629985.15753095.html.plaintext.txt	61	activation cyclin b cdc2 complex key event transition g2 m phase 39 investigate mechanism phase arrest amanitin treated cells assessed level cyclin b hct116 cells fig 5g immunoblot analysis revealed cyclin b detectable cells treated amanitin suggesting cells prevented entering mitosis result regulation cyclin
0.629985.15753095.html.plaintext.txt	62	activation cyclin b cdc2 complex key event transition g2 m phase 39 investigate mechanism phase arrest amanitin treated cells assessed level cyclin b hct116 cells fig 5g immunoblot analysis revealed cyclin b detectable cells treated amanitin suggesting cells prevented entering mitosis result regulation cyclin
0.629985.15753095.html.plaintext.txt	63	amanitin treated cells undergo apoptosis entry phase nocodazole synchronization revealed amanitin induced apoptosis 14 h release cells metaphase arrest fig 5e time coincides approximately g1 transition therefore investigated whether cells treated amanitin undergo apoptosis enter phase hct116 cells synchronized g0 g1 serum deprivation re exposed serum absence presence amanitin fig 6a cells treated amanitin exhibited marked delay progression phase compared control cells addition treatment amanitin resulted large increase number cells positive m30 cytodeath antibody recognizes specific caspase cleavage product cytokeratin 18 marker early apoptosis time 24 h release cells began accumulate phase fig 6a furthermore apoptotic marker detected amanitin treated cells early phase g2 m phase suggesting amanitin induces p53 dependent apoptosis cells enter phase notion supported immunocyto chemical finding amanitin treated cells p53 localized mitochondria preferentially incorporate brdurd indicating entered phase fig 6b
0.629985.15753095.html.plaintext.txt	64	amanitin treated cells undergo apoptosis entry phase nocodazole synchronization revealed amanitin induced apoptosis 14 h release cells metaphase arrest fig 5e time coincides approximately g1 transition therefore investigated whether cells treated amanitin undergo apoptosis enter phase hct116 cells synchronized g0 g1 serum deprivation re exposed serum absence presence amanitin fig 6a cells treated amanitin exhibited marked delay progression phase compared control cells addition treatment amanitin resulted large increase number cells positive m30 cytodeath antibody recognizes specific caspase cleavage product cytokeratin 18 marker early apoptosis time 24 h release cells began accumulate phase fig 6a furthermore apoptotic marker detected amanitin treated cells early phase g2 m phase suggesting amanitin induces p53 dependent apoptosis cells enter phase notion supported immunocyto chemical finding amanitin treated cells p53 localized mitochondria preferentially incorporate brdurd indicating entered phase fig 6b
0.629985.15753095.html.plaintext.txt	65	next tested possibility induction g1 arrest able block amanitin induced apoptosis hct116 cells plant amino acid mimosine blocks cell cycle late g1 phase inducing regulation cdk inhibitor p27kip1 transcriptional post transcriptional levels 40 mimosine markedly inhibited amanitin induced increase size sub g1 apoptotic cell population fig 6c adenovirus mediated overexpression cdk inhibitors p21cip1 p27kip1 also induced cell cycle arrest g1 phase prevented amanitin induced apoptosis fig 6d specifically results suggest phase entry required apoptosis induced transcriptional blockade
0.629985.15753095.html.plaintext.txt	66	next tested possibility induction g1 arrest able block amanitin induced apoptosis hct116 cells plant amino acid mimosine blocks cell cycle late g1 phase inducing regulation cdk inhibitor p27kip1 transcriptional post transcriptional levels 40 mimosine markedly inhibited amanitin induced increase size sub g1 apoptotic cell population fig 6c adenovirus mediated overexpression cdk inhibitors p21cip1 p27kip1 also induced cell cycle arrest g1 phase prevented amanitin induced apoptosis fig 6d specifically results suggest phase entry required apoptosis induced transcriptional blockade
0.629985.15753095.html.plaintext.txt	67	accumulation p53 regulation p21cip1 lead apoptosis examined whether regulation p21cip1 also required induction apoptosis amanitin treatment p21 hct116 cells amanitin resulted p53 accumulation massive apoptosis fig 7a finding raised hypothesis p53 accumulation without p21cip1 induction triggers apoptosis thus constructed condition adenovirus mediated overexpression p53 p21 cells found combination induces massive apoptosis without amanitin treatment fig 7b furthermore pifithrin specific inhibitor p53 mediated transcriptional activation 41 inhibit induction apoptosis p21 hct116 cells overexpression p53 fig 7b suggesting transactivation activity p53 contribute effect findings suggest possibility p53 mediated transactivation independent apoptosis triggered accumulation p53 without p21cip1 induction
0.629985.15753095.html.plaintext.txt	68	accumulation p53 regulation p21cip1 lead apoptosis examined whether regulation p21cip1 also required induction apoptosis amanitin treatment p21 hct116 cells amanitin resulted p53 accumulation massive apoptosis fig 7a finding raised hypothesis p53 accumulation without p21cip1 induction triggers apoptosis thus constructed condition adenovirus mediated overexpression p53 p21 cells found combination induces massive apoptosis without amanitin treatment fig 7b furthermore pifithrin specific inhibitor p53 mediated transcriptional activation 41 inhibit induction apoptosis p21 hct116 cells overexpression p53 fig 7b suggesting transactivation activity p53 contribute effect findings suggest possibility p53 mediated transactivation independent apoptosis triggered accumulation p53 without p21cip1 induction
0.629985.15753095.html.plaintext.txt	69	verify transcriptional blockade induces p53 mediated transcription independent apoptosis used cells expressing transactivation deficient p53 established p53 hct116 cells stably expressing wild type p53 truncated form p53 1 39 supplemental fig s6 p53 1 39 lacks n terminal transactivation domain residues 1 39 thus unable transactivate p21cip1 expression 42 treatment amanitin induced apoptosis cells expressing wild type p53 also cells expressing p53 1 39 although p53 hct116 cells insensitive amanitin treatment fig 7c results thus support hypothesis apoptosis induced transcriptional blockade p53 dependent transactivation independent
0.629985.15753095.html.plaintext.txt	70	verify transcriptional blockade induces p53 mediated transcription independent apoptosis used cells expressing transactivation deficient p53 established p53 hct116 cells stably expressing wild type p53 truncated form p53 1 39 supplemental fig s6 p53 1 39 lacks n terminal transactivation domain residues 1 39 thus unable transactivate p21cip1 expression 42 treatment amanitin induced apoptosis cells expressing wild type p53 also cells expressing p53 1 39 although p53 hct116 cells insensitive amanitin treatment fig 7c results thus support hypothesis apoptosis induced transcriptional blockade p53 dependent transactivation independent
0.629985.15753095.html.plaintext.txt	71	high dose uv irradiation induces transcription independent p53 mediated apoptosis showed inhibition pol ii amanitin treatment sirna approach resulted p53 accumulation without p21cip1 induction leading apoptosis wanted find whether biological condition inducing type cell death reported previously 16 exposure hct116 cells high dose uv radiation 30 jm2 induced ubiquitin mediated degradation pol ii ls resulting transcriptional blockade apoptosis 24 h treatment fig 7d right panel treatment actually induced p53 accumulation p21cip1 regulation fig 7d left panel biochemical effects identical amanitin pol ii ls sirna addition high dose uv induced p53 predominantly detected mitochondrial fraction fig 7e together findings thus suggest accumulation p53 mitochondria regulation p21cip1 resulted transcriptional blockade leads apoptosis high dose uv irradiated cells
0.629985.15753095.html.plaintext.txt	72	high dose uv irradiation induces transcription independent p53 mediated apoptosis showed inhibition pol ii amanitin treatment sirna approach resulted p53 accumulation without p21cip1 induction leading apoptosis wanted find whether biological condition inducing type cell death reported previously 16 exposure hct116 cells high dose uv radiation 30 jm2 induced ubiquitin mediated degradation pol ii ls resulting transcriptional blockade apoptosis 24 h treatment fig 7d right panel treatment actually induced p53 accumulation p21cip1 regulation fig 7d left panel biochemical effects identical amanitin pol ii ls sirna addition high dose uv induced p53 predominantly detected mitochondrial fraction fig 7e together findings thus suggest accumulation p53 mitochondria regulation p21cip1 resulted transcriptional blockade leads apoptosis high dose uv irradiated cells
0.629985.15753095.html.plaintext.txt	73	discussion top abstract introduction materials methods results discussion references blockade pol ii dependent transcription shown previously trigger cell death signal 28 however mechanism underlies apoptosis remained undefined furthermore recent observations revealed p53 directly translocate mitochondria induce apoptosis transactivation independent manner 14 15 mechanisms triggering apoptosis remained unclear provide evidence links two events inhibition pol ii amanitin treatment rnai approach high dose uv irradiation induces p53 accumulation without induction p21cip1 entry cells phase p53 dependent transactivation independent cell death mediated translocation p53 mitochondria data thus yield new insight mechanism cell death induced transcriptional blockade
0.629985.15753095.html.plaintext.txt	74	discussion top abstract introduction materials methods results discussion references blockade pol ii dependent transcription shown previously trigger cell death signal 28 however mechanism underlies apoptosis remained undefined furthermore recent observations revealed p53 directly translocate mitochondria induce apoptosis transactivation independent manner 14 15 mechanisms triggering apoptosis remained unclear provide evidence links two events inhibition pol ii amanitin treatment rnai approach high dose uv irradiation induces p53 accumulation without induction p21cip1 entry cells phase p53 dependent transactivation independent cell death mediated translocation p53 mitochondria data thus yield new insight mechanism cell death induced transcriptional blockade
0.629985.15753095.html.plaintext.txt	75	inhibition pol ii amanitin induces p53 accumulation p53 dependent apoptosis apoptosis induced amanitin markedly greater extent p53 hct116 cells corresponding p53 cells blocked presence caspase inhibitor indicating transcriptional blockade induces p53 dependent caspase mediated apoptosis furthermore notion supported finding amanitin resistant p53 cells underwent apoptosis expression exogenous p53 accumulation p53 appeared attributable inhibition p53 degradation given amount p53 mrna actually reduced amanitin treatment findings consistent previous results 43 showing accumulation p53 induced inhibition pol ii dependent transcription results regulation mdm2 gene transcription therefore addition mdm2 regulation mediated pathway signaling triggered modification p53 protein may contribute p53 accumulation fact also found amanitin induces p53 phosphorylation phosphorylation p53 mediated various stress activated kinases 44 contributes stabilization activation protein dna damaging agent adriamycin induced phosphorylation p53 ser15 reportedly mediated kinase ataxia telangiectasia mutated 45 results p53 accumulation ser46 contrast amanitin induced p53 phosphorylation ser46 phosphorylation p53 ser15 former reaction coincided accumulation p53 transcriptional blockade amanitin might thus result activation stress activated kinases distinct activated dna damaging agents phosphorylate thereby stabilize p53 indeed caffeine inhibitor ataxia telangiectasia mutated atm kinase atm rad3 related atr kinase inhibit amanitin induced p53 phosphorylation accumulation2 suggesting kinases contribute effects amanitin also found transcriptional blockade activate chk1 supplemental fig s7 furthermore amanitin induce p53 accumulation m059j cells 46 deficient catalytic subunit dna dependent protein kinase supplemental fig s8 suggesting possible role dna dependent protein kinases phosphorylation p53 response transcriptional blockade absence dna damage
0.629985.15753095.html.plaintext.txt	76	inhibition pol ii amanitin induces p53 accumulation p53 dependent apoptosis apoptosis induced amanitin markedly greater extent p53 hct116 cells corresponding p53 cells blocked presence caspase inhibitor indicating transcriptional blockade induces p53 dependent caspase mediated apoptosis furthermore notion supported finding amanitin resistant p53 cells underwent apoptosis expression exogenous p53 accumulation p53 appeared attributable inhibition p53 degradation given amount p53 mrna actually reduced amanitin treatment findings consistent previous results 43 showing accumulation p53 induced inhibition pol ii dependent transcription results regulation mdm2 gene transcription therefore addition mdm2 regulation mediated pathway signaling triggered modification p53 protein may contribute p53 accumulation fact also found amanitin induces p53 phosphorylation phosphorylation p53 mediated various stress activated kinases 44 contributes stabilization activation protein dna damaging agent adriamycin induced phosphorylation p53 ser15 reportedly mediated kinase ataxia telangiectasia mutated 45 results p53 accumulation ser46 contrast amanitin induced p53 phosphorylation ser46 phosphorylation p53 ser15 former reaction coincided accumulation p53 transcriptional blockade amanitin might thus result activation stress activated kinases distinct activated dna damaging agents phosphorylate thereby stabilize p53 indeed caffeine inhibitor ataxia telangiectasia mutated atm kinase atm rad3 related atr kinase inhibit amanitin induced p53 phosphorylation accumulation2 suggesting kinases contribute effects amanitin also found transcriptional blockade activate chk1 supplemental fig s7 furthermore amanitin induce p53 accumulation m059j cells 46 deficient catalytic subunit dna dependent protein kinase supplemental fig s8 suggesting possible role dna dependent protein kinases phosphorylation p53 response transcriptional blockade absence dna damage
0.629985.15753095.html.plaintext.txt	77	view larger version 24k fig 6 importance entry phase amanitin induced apoptosis hct116 cells induction apoptosis entry amanitin treated cells phase confluent cells cultured medium containing 05 serum 3 days induce synchronization g0 g1 phase incubated indicated times medium containing 10 serum absence cont presence amanitin ama 10 microgml cells analyzed flow cytometry dna content alone left panels dna content m30 cytodeath antigen right panels b translocation p53 mitochondria phase amanitin treated cells mrc 5 cells incubated amanitin 24 h presence 10 microm brdurd 24 h subjected immunofluorescence analysis antibodies brdurd green p53 fl393 red c inhibition apoptosis amanitin treated cells mimosine induced g1 arrest cells incubated first without 50 microm mimosine 45 h additional absence presence amanitin 24 h percentage apoptotic cells sub g1 dna content determined flow cytometry d prevention amanitin induced apoptosis overexpression p21cip1 p27kip1 cells infected recombinant adenoviruses encoding luciferase ad luc p21cip1 ad p21 p27kip1 ad p27 24 h incubated absence presence amanitin 24 h subjected immunoblot analysis p21cip1 p27kip1 upper panels flow cytometric analysis apoptosis lower panel
0.629985.15753095.html.plaintext.txt	78	view larger version 31k fig 7 apoptosis triggered accumulation p53 regulation p21cip1 enhanced amanitin induced apoptosis hct116 cells lacking p21cip1 cells p21 incubated without cont amanitin ama 24 h immunoblotted antibodies pol ii ls p53 1 p21cip1 actin loading control cells also subjected flow cytometric analyses apoptosis b induction apoptosis p21 hct116 cells overexpression p53 cells incubated without 100 nm pifithrin pf 3 h infected adenoviral vector luciferase p53 24 h continued absence presence pifithrin subjected immunoblot analysis p53 left panel flow cytometric analysis apoptosis right panel cbb coomassie brilliant blue c amanitin induces apoptosis p53 hct116 cells expressing transactivation deficient p53 p53 hct116 cells stably expressing wild type p53 truncated form p53 p53 1 39 incubated amanitin 10 microgml 24 h extent apoptosis determined flow cytometry d accumulation p53 regulation p21cip1 apoptosis induced high dose uv irradiation hct116 cells parental cells p53 p21 exposed uv radiation 0 2 30 jm2 absence presence 10 microm mg132 cells harvested 6 h irradiation subjected immunoblot analysis pol ii ls p53 p21cip1 left panels harvested 6 24 h irradiation subjected flow cytometric analysis apoptosis right panel e accumulation p53 mitochondrial fraction cells exposed uv radiation mitochondrial mito cytosolic cyto fractions mrc 5 cells subjected immunoblot analysis antibodies p53 1 24 h exposed uv radiation 40 jm2 presence pifithrin
0.629985.15753095.html.plaintext.txt	79	cells treated amanitin undergo apoptosis entry phase accumulation p53 response dna damage results transcriptional activation p53 target genes whose products either induce cell cycle arrest p21cip1 trigger apoptosis however found expression p21cip1 regulated amanitin result suppression gene transcription ubiquitin dependent protein degradation amanitin treated cells thus prevented arresting g1 phase addition found abundance p27kip1 another cdk2 inhibitor also regulated amanitin treatment hct116 mrc 5 cells supplemental fig s9 thus despite fact accumulate p53 cells treated amanitin proceed phase confirmed status prb phosphorylation flow cytometric analysis dna content brdurd incorporation regulation p21cip1 p27kip1 might possibly due cleavage cpp32 like caspase apoptosis 47 however abundance p21cip1 amanitin treated hct116 cells reduced prior appearance apoptotic phenotype fig 2c moreover skp2 subunit skp1 cullin f box protein ubiquitin ligase controls proteolysis p27kip1 p21cip1 48 50 regulated amanitin treated hct116 cells supplemental fig s10 suggesting signaling activated transcriptional blockade results activation skp2 mediates regulation p21cip1 p27kip1
0.629985.15753095.html.plaintext.txt	80	cells treated amanitin undergo apoptosis entry phase accumulation p53 response dna damage results transcriptional activation p53 target genes whose products either induce cell cycle arrest p21cip1 trigger apoptosis however found expression p21cip1 regulated amanitin result suppression gene transcription ubiquitin dependent protein degradation amanitin treated cells thus prevented arresting g1 phase addition found abundance p27kip1 another cdk2 inhibitor also regulated amanitin treatment hct116 mrc 5 cells supplemental fig s9 thus despite fact accumulate p53 cells treated amanitin proceed phase confirmed status prb phosphorylation flow cytometric analysis dna content brdurd incorporation regulation p21cip1 p27kip1 might possibly due cleavage cpp32 like caspase apoptosis 47 however abundance p21cip1 amanitin treated hct116 cells reduced prior appearance apoptotic phenotype fig 2c moreover skp2 subunit skp1 cullin f box protein ubiquitin ligase controls proteolysis p27kip1 p21cip1 48 50 regulated amanitin treated hct116 cells supplemental fig s10 suggesting signaling activated transcriptional blockade results activation skp2 mediates regulation p21cip1 p27kip1
0.629985.15753095.html.plaintext.txt	81	overexpression exogenous p53 markedly enhanced cell death p21 hct116 cells fig 7b suggesting entry cells phosphorylated accumulated p53 regulated p21cip1 phase important trigger apoptosis induced transcriptional blockade several lines evidence suggest transcriptional blockade elicits cell death cells enter phase 1 synchronized cells released nocodazole block presence amanitin underwent pronounced apoptosis phase fig 5e 2 induction g1 arrest treatment cells mimosine overexpression p21cip1 p27kip1 resulted marked suppression amanitin induced apoptosis fig 6d 3 withdrawal mimosine amanitin treated cells led massive apoptosis fig 6c inhibition cdk activity induction cell cycle arrest p21cip1 shown previously play important role protecting cells apoptosis 51 52 together various observations suggest transcriptional block inhibition pol ii activity results cell cycle arrest dna replication induces apoptosis phase
0.629985.15753095.html.plaintext.txt	82	overexpression exogenous p53 markedly enhanced cell death p21 hct116 cells fig 7b suggesting entry cells phosphorylated accumulated p53 regulated p21cip1 phase important trigger apoptosis induced transcriptional blockade several lines evidence suggest transcriptional blockade elicits cell death cells enter phase 1 synchronized cells released nocodazole block presence amanitin underwent pronounced apoptosis phase fig 5e 2 induction g1 arrest treatment cells mimosine overexpression p21cip1 p27kip1 resulted marked suppression amanitin induced apoptosis fig 6d 3 withdrawal mimosine amanitin treated cells led massive apoptosis fig 6c inhibition cdk activity induction cell cycle arrest p21cip1 shown previously play important role protecting cells apoptosis 51 52 together various observations suggest transcriptional block inhibition pol ii activity results cell cycle arrest dna replication induces apoptosis phase
0.629985.15753095.html.plaintext.txt	83	transcriptional blockade induces translocation p53 mitochondria consequent apoptosis phase many genes whose products mediate p53 dependent cell death identified several p53 target genes encode proteins localize mitochondria affect mitochondrial membrane potential important determinant mitochondrial apoptotic signaling proteins include bax noxa puma p53aip1 found accumulation p53 induced amanitin result transcriptional activation p53 target genes examined furthermore abundance bax apaf 1 also p53 inducible gene products 53 affected amanitin treatment hct116 cells supplemental fig s11 observations thus suggest apoptosis induced transcriptional blockade mediated p53 transcription independent manner
0.629985.15753095.html.plaintext.txt	84	transcriptional blockade induces translocation p53 mitochondria consequent apoptosis phase many genes whose products mediate p53 dependent cell death identified several p53 target genes encode proteins localize mitochondria affect mitochondrial membrane potential important determinant mitochondrial apoptotic signaling proteins include bax noxa puma p53aip1 found accumulation p53 induced amanitin result transcriptional activation p53 target genes examined furthermore abundance bax apaf 1 also p53 inducible gene products 53 affected amanitin treatment hct116 cells supplemental fig s11 observations thus suggest apoptosis induced transcriptional blockade mediated p53 transcription independent manner
0.629985.15753095.html.plaintext.txt	85	evidence suggests p53 able directly engage major apoptotic pathways cell promoting death receptor signaling mitochrondrial perturbations without requiring gene induction fraction accumulated p53 molecules also translocates mitochondria thereby promotes apoptosis cells dna damage 15 p53 protein directly induces permeabilization outer mitochondrial membrane forming complexes protective proteins bcl xl bcl 2 resulting release cytochrome c cytosol also shown activate induce translocation bax mitochondria resulting cytochrome c release 54 however specific cellular contexts trigger transcription independent translocation p53 mitochondria remain obscure found amanitin mediated transcriptional blockade induces p53 localization mitochondria substantial proportion bax molecules also translocates mitochondria amanitin treated mrc 5 cells supplemental fig s12 moreover p53 molecules translocated mitochondria amanitin treated cells included phosphorylated ser15 ser46 translocation detected cells phase based evidence speculate p53 molecules accumulate response transcriptional blockade trigger apoptosis directly acting mitochondria
0.629985.15753095.html.plaintext.txt	86	evidence suggests p53 able directly engage major apoptotic pathways cell promoting death receptor signaling mitochrondrial perturbations without requiring gene induction fraction accumulated p53 molecules also translocates mitochondria thereby promotes apoptosis cells dna damage 15 p53 protein directly induces permeabilization outer mitochondrial membrane forming complexes protective proteins bcl xl bcl 2 resulting release cytochrome c cytosol also shown activate induce translocation bax mitochondria resulting cytochrome c release 54 however specific cellular contexts trigger transcription independent translocation p53 mitochondria remain obscure found amanitin mediated transcriptional blockade induces p53 localization mitochondria substantial proportion bax molecules also translocates mitochondria amanitin treated mrc 5 cells supplemental fig s12 moreover p53 molecules translocated mitochondria amanitin treated cells included phosphorylated ser15 ser46 translocation detected cells phase based evidence speculate p53 molecules accumulate response transcriptional blockade trigger apoptosis directly acting mitochondria
0.629985.15753095.html.plaintext.txt	87	biological significance p53 mediated apoptosis induced transcriptional blockade induction dna lesions high doses uv radiation results ubiquitination degradation pol ii ls transcriptional collapse recruitment dna repair proteins 16 17 prolonged inhibition transcription result failure repair dna lesions results cell death apoptosis 18 indeed found high dose uv radiation induced pol ii degradation p53 accumulation regulation p21cip1 expression p53 dependent apoptosis similar effects amanitin treatment uv irradiation shown previously induce transcription c jun gene modulate association p53 promoter p21cip1 gene resulting repression p21cip1 gene activation cell death 55 therefore addition c jun mediated pathway signaling triggered transcriptional blockade sites unrepaired dna lesions may contribute uv induced apoptosis p53 dependent pathway
0.629985.15753095.html.plaintext.txt	88	biological significance p53 mediated apoptosis induced transcriptional blockade induction dna lesions high doses uv radiation results ubiquitination degradation pol ii ls transcriptional collapse recruitment dna repair proteins 16 17 prolonged inhibition transcription result failure repair dna lesions results cell death apoptosis 18 indeed found high dose uv radiation induced pol ii degradation p53 accumulation regulation p21cip1 expression p53 dependent apoptosis similar effects amanitin treatment uv irradiation shown previously induce transcription c jun gene modulate association p53 promoter p21cip1 gene resulting repression p21cip1 gene activation cell death 55 therefore addition c jun mediated pathway signaling triggered transcriptional blockade sites unrepaired dna lesions may contribute uv induced apoptosis p53 dependent pathway
0.629985.15753095.html.plaintext.txt	89	interesting know much transactivation independent apoptosis contributes p53 mediated cell death hct116 p53 cells treated adriamycin presence amanitin cell death significantly enhanced comparison adriamycin treatment alone even though p53 mediated gene expression blocked supplemental fig s13 observation implies p53 accumulated dna damage elicit apoptosis via transactivation dependent independent pathways
0.629985.15753095.html.plaintext.txt	90	interesting know much transactivation independent apoptosis contributes p53 mediated cell death hct116 p53 cells treated adriamycin presence amanitin cell death significantly enhanced comparison adriamycin treatment alone even though p53 mediated gene expression blocked supplemental fig s13 observation implies p53 accumulated dna damage elicit apoptosis via transactivation dependent independent pathways
0.629985.15753095.html.plaintext.txt	91	reported recently many common dna damaging agents cisplatin topoisomerase inhibitor camptothecin known interfere transcription 56 therefore translocation p53 mitochondria may serve fail safe mechanism elicit apoptosis eliminating cells whose transcription blocked severe irreparable dna damages supplemental fig s14 loss function mutations p53 gene might thus abrogate transcription dependent mitochondrion dependent apoptotic activities p53 thereby lead survival transformed cells
0.629985.15753095.html.plaintext.txt	92	reported recently many common dna damaging agents cisplatin topoisomerase inhibitor camptothecin known interfere transcription 56 therefore translocation p53 mitochondria may serve fail safe mechanism elicit apoptosis eliminating cells whose transcription blocked severe irreparable dna damages supplemental fig s14 loss function mutations p53 gene might thus abrogate transcription dependent mitochondrion dependent apoptotic activities p53 thereby lead survival transformed cells
0.629985.15753095.html.plaintext.txt	93	footnotes work supported grant cancer research ministry education science culture japan h costs publication article defrayed part payment page charges article must therefore hereby marked advertisement accordance 18 usc section 1734 solely indicate fact
0.629985.15753095.html.plaintext.txt	94	line version article available httpwwwjbcorg contains materials methods reference figs s1 s14
0.629985.15753095.html.plaintext.txt	95	correspondence addressed dept tumor genetics biology graduate school medical sciences kumamoto university 1 1 1 honjo kumamoto 860 8556 japan tel 81 96 373 5116 fax 81 96 373 5120 e mail hsayaatgpokumamoto uacjp u d
0.629985.15753095.html.plaintext.txt	96	correspondence addressed dept tumor genetics biology graduate school medical sciences kumamoto university 1 1 1 honjo kumamoto 860 8556 japan tel 81 96 373 5116 fax 81 96 373 5120 e mail hsayaatgpokumamoto uacjp u d
0.629985.15753095.html.plaintext.txt	97	1 abbreviations used ls large subunit cdk cyclin dependent kinase dsb dna double strand break pcna proliferating cell nuclear antigen pi propidium iodide pol ii rna polymerase ii prb retinoblastoma protein brdurd bromodeoxyuridine sirna small interfering rnas rnai rna interference z benzyloxycarbonyl fmk fluoromethyl ketone pbs phosphate buffered saline tbs tris buffered saline mab monoclonal antibody rt reverse transcription atm ataxia telangiectasia mutated atr atm rad3 related
0.629985.15753095.html.plaintext.txt	98	acknowledgments thank r ohki kind gift mutant p53 expression plasmids members department tumor genetics biology gene technology center kumamoto university important suggestions contributions experiments
0.629985.15753095.html.plaintext.txt	99	acknowledgments thank r ohki kind gift mutant p53 expression plasmids members department tumor genetics biology gene technology center kumamoto university important suggestions contributions experiments
0.629985.15753095.html.plaintext.txt	100	references top abstract introduction materials methods results discussion references oren m 1994 semin cancer biol 5 221 227medline order article via infotrieve ko l j prives c 1996 genes dev 10 1054 1072crossrefmedline order article via infotrieve levine j 1997 cell 88 323 331crossrefmedline order article via infotrieve oda e ohki r murasawa h nemoto j shibue yamashita tokino taniguchi tanaka n 2000 science 288 1053 1058abstractfree full text miyashita reed j c 1995 cell 80 293 299crossrefmedline order article via infotrieve oda k arakawa h tanaka matsuda k tanikawa c mori nishimori h tamai k tokino nakamura y taya y 2000 cell 102 849 862crossrefmedline order article via infotrieve yu j zhang l hwang p m kinzler k w vogelstein b 2001 mol cell 7 673 682crossrefmedline order article via infotrieve nakano k vousden k h 2001 mol cell 7 683 694crossrefmedline order article via infotrieve attardi l d reczek e e cosmas c demicco e g mccurrach m e lowe w jacks 2000 genes dev 14 704 718abstractfree full text shen y shenk 1994 proc natl acad sci u 91 8940 8944abstractfree full text hoffman w h biade zilfou j chen j murphy m 2002 j biol chem 277 3247 3257abstractfree full text caelles c helmberg karin m 1994 nature 370 220 223crossrefmedline order article via infotrieve haupt y rowan shaulian e vousden k h oren m 1995 genes dev 9 2170 2183abstract marchenko n d zaika moll u m 2000 j biol chem 275 16202 16212abstractfree full text mihara m erster zaika petrenko o chittenden pancoska p moll u m 2003 mol cell 11 577 590crossrefmedline order article via infotrieve luo z zheng j lu y bregman d b 2001 mutat res 486 259 274medline order article via infotrieve lee k b wang d lippard j sharp p 2002 proc natl acad sci u 99 4239 4244abstractfree full text friedberg e walker g siede w 1995 dna repair mutagenesis american society microbiology washington d c andera l wasylyk b 1997 mol med 3 852 863medline order article via infotrieve arima y hirota bronner c mousli m fujiwara niwa ishikawa h saya h 2004 genes cells 9 131 142abstractfree full text elbashir m harborth j lendeckel w yalcin weber k tuschl 2001 nature 411 494 498crossrefmedline order article via infotrieve zhang w w fang x branch c d mazur w french b roth j 1993 biotechniques 15 868 872medline order article via infotrieve kanegae y lee g sato y tanaka m nakai m sakaki sugano saito 1995 nucleic acids res 23 3816 3821abstract miyake h hanada n nakamura h kagawa fujiwara hara eto h gohji k arakawa kamidono saya h 1998 oncogene 16 933 943crossrefmedline order article via infotrieve bunz f dutriaux lengauer c waldman zhou brown j p sedivy j m kinzler k w vogelstein b 1998 science 282 1497 1501abstractfree full text bushnell d cramer p kornberg r d 2002 proc natl acad sci u 99 1218 1222abstractfree full text nguyen v giannoni f dubois m f seo j vigneron m kedinger c bensaude o 1996 nucleic acids res 24 2924 2929abstractfree full text ljungman m zhang f chen f rainbow j mckay b c 1999 oncogene 18 583 592crossrefmedline order article via infotrieve mitsui sharp p 1999 proc natl acad sci u 96 6054 6059abstractfree full text yamaizumi m sugano 1994 oncogene 9 2775 2784medline order article via infotrieve rogakou e p pilch d r orr h ivanova v bonner w m 1998 j biol chem 273 5858 5868abstractfree full text rogakou e p boon c redon c bonner w m 1999 j cell biol 146 905 916abstractfree full text brooks c l gu w 2003 curr opin cell biol 15 164 171crossrefmedline order article via infotrieve kastan m b zhan q el deiry w carrier f jacks walsh w v plunkett b vogelstein b fornace j jr 1992 cell 71 587 597crossrefmedline order article via infotrieve okamura arakawa h tanaka nakanishi h ng c c taya y monden m nakamura y 2001 mol cell 8 85 94crossrefmedline order article via infotrieve khan q dipple anderson l m 2002 mol carcinog 33 1 8crossrefmedline order article via infotrieve sherr c j roberts j m 1999 genes dev 13 1501 1512free full text bloom j amador v bartolini f demartino g pagano m 2003 cell 115 71 82crossrefmedline order article via infotrieve norbury c nurse p 1992 annu rev biochem 61 441 470crossrefmedline order article via infotrieve wang g miskimins r miskimins w k 2000 exp cell res 254 64 71crossrefmedline order article via infotrieve komarov p g komarova e kondratov r v christov tselkov k coon j chernov m v gudkov v 1999 science 285 1733 1737abstractfree full text venot c maratrat m sierra v conseiller e debussche l 1999 oncogene 18 2405 2410crossrefmedline order article via infotrieve blagosklonny m v demidenko z n fojo 2002 cell cycle 1 67 74medline order article via infotrieve gottifredi v shieh y prives c 2000 cold spring harbor symp quant biol 65 483 488crossrefmedline order article via infotrieve banin moyal l shieh taya y anderson c w chessa l smorodinsky n prives c reiss y shiloh y ziv y 1998 science 281 1674 1677abstractfree full text lees miller p godbout r chan d w weinfeld m day r iii barron g m allalunis turner j 1995 science 267 1183 1185medline order article via infotrieve levkau b koyama h raines e w clurman b e herren b orth k roberts j m ross r 1998 mol cell 1 553 563crossrefmedline order article via infotrieve bornstein g bloom j sitry shevah d nakayama k pagano m hershko 2003 j biol chem 278 25752 25757abstractfree full text reed 2003 nat rev mol cell biol 4 855 864crossrefmedline order article via infotrieve bendjennat m boulaire j jascur brickner h barbier v sarasin fotedar fotedar r 2003 cell 114 599 610crossrefmedline order article via infotrieve wang j walsh k 1996 science 273 359 361abstract gorospe m wang x guyton k z holbrook n j 1996 mol cell biol 16 6654 6660abstract soengas m alarcon r m yoshida h giaccia j hakem r mak w lowe w 1999 science 284 156 159abstractfree full text chipuk j e kuwana bouchier hayes l droin n m newmeyer d d schuler m green d r 2004 science 303 1010 1014abstractfree full text shaulian e schreiber m piu f beeche m wagner e f karin m 2000 cell 103 897 907crossrefmedline order article via infotrieve ljungman m lane d p 2004 nat rev cancer 4 727 737crossrefmedline order article via infotrieve
0.6555275.15205365.html.plaintext.txt	0	p53 pathway therapy professor sir david lane
0.6555275.15205365.html.plaintext.txt	1	department surgery molecular oncology ninewells hospital university dundee dundee dd1 9sy uk
0.6555275.15205365.html.plaintext.txt	2	25 years since first description p53 protein shown play key role tumour suppression aging new discoveries function control p53 continue emerge every month attempts exploit system develop better therapeutics diagnostics beginning successful clinic 12
0.6555275.15205365.html.plaintext.txt	3	25 years since first description p53 protein shown play key role tumour suppression aging new discoveries function control p53 continue emerge every month attempts exploit system develop better therapeutics diagnostics beginning successful clinic 12
0.6555275.15205365.html.plaintext.txt	4	genetics p53 pathway
0.6555275.15205365.html.plaintext.txt	5	current model p53 function tumour suppressor protein acts highly regulated transcription factor normally p53 unstable protein present minute concentrations cell even small amounts p53 fully active transcription factor negative regulator protein mdm2 binds cells exposed wide variety aberrant growth signals p53 protein activated stabilized triggers expression downstream genes p21 trigger cell cycle arrest puma triggers apoptosis response potentially lethal since mice p53 lack mdm2 die early development pre implantation stage 34 response vital control tumour growth mice lack p53 develop spontaneous early onset malignancies 5 recently however another aspect p53 regulation emerged two mouse models p53 activity modulated increased expression n terminally truncated form protein accelerated aging phenotypes seen 6 8 thus p53 response needs finely controlled order provide adequate tumour suppression without promoting accelerated aging
0.6555275.15205365.html.plaintext.txt	6	current model p53 function tumour suppressor protein acts highly regulated transcription factor normally p53 unstable protein present minute concentrations cell even small amounts p53 fully active transcription factor negative regulator protein mdm2 binds cells exposed wide variety aberrant growth signals p53 protein activated stabilized triggers expression downstream genes p21 trigger cell cycle arrest puma triggers apoptosis response potentially lethal since mice p53 lack mdm2 die early development pre implantation stage 34 response vital control tumour growth mice lack p53 develop spontaneous early onset malignancies 5 recently however another aspect p53 regulation emerged two mouse models p53 activity modulated increased expression n terminally truncated form protein accelerated aging phenotypes seen 6 8 thus p53 response needs finely controlled order provide adequate tumour suppression without promoting accelerated aging
0.6555275.15205365.html.plaintext.txt	7	haploinsufficiency genetic biochemical studies demonstrated rich variety genes pathways act control p53 function thresholds must act concert precisely control activity p53 pathways nearly always disrupted cancer cells need avoid full p53 response grow survive genetic studies helped clarify importance key players pathway also suggested suitable points therapeutic intervention huge number biochemical cell biological studies p53 protein hard evaluate genetic models provide increasingly firm basis build core understanding p53 pathway studies responses heterozygote wild type null mice p53 demonstrated unequivocally p53 locus obey knudsens two hit hypothesis instead clear evidence haploinsufficiency locus thus cells contain single copy p53 gene opposed two copies show impaired response radiation induced apoptosis tumours arise mice quite frequently retain wild type allele 9 also seems occur tumours individuals li fraumeni syndrome tumours show loss single wild type parental allele implies regulation p53 system exceptionally tightly controlled gene dosage transcription critical method p53 threshold set
0.6555275.15205365.html.plaintext.txt	8	haploinsufficiency genetic biochemical studies demonstrated rich variety genes pathways act control p53 function thresholds must act concert precisely control activity p53 pathways nearly always disrupted cancer cells need avoid full p53 response grow survive genetic studies helped clarify importance key players pathway also suggested suitable points therapeutic intervention huge number biochemical cell biological studies p53 protein hard evaluate genetic models provide increasingly firm basis build core understanding p53 pathway studies responses heterozygote wild type null mice p53 demonstrated unequivocally p53 locus obey knudsens two hit hypothesis instead clear evidence haploinsufficiency locus thus cells contain single copy p53 gene opposed two copies show impaired response radiation induced apoptosis tumours arise mice quite frequently retain wild type allele 9 also seems occur tumours individuals li fraumeni syndrome tumours show loss single wild type parental allele implies regulation p53 system exceptionally tightly controlled gene dosage transcription critical method p53 threshold set
0.6555275.15205365.html.plaintext.txt	9	implications hypomorphic mdm2 allele support tight control p53 system emerges elegant studies mouse model carries hypomorphic allele mdm2 gene 10 12 mdm2 protein binds p53 targets degradation acting ubiquitin e3 ligase results specific ubiquitination p53 mice mdm2 locus phenotype evident mice express slightly lower level mdm2 single hypomorphic allele thymic ablation poor weight gain bone marrow intestinal cell loss evident phenotypes dependant wild type p53 require exogenous signal data strongly suggest p53 always active target tissues mdm2 rate limiting negative regulator normally expressed roughly three times level needed repress p53 function fact inactivation mdm2 related gene mdmx mdm4 13 also gives p53 dependant early embryonic lethal phenotype implied less well studied gene also must critical controlling p53 compensated mdm2
0.6555275.15205365.html.plaintext.txt	10	implications hypomorphic mdm2 allele support tight control p53 system emerges elegant studies mouse model carries hypomorphic allele mdm2 gene 10 12 mdm2 protein binds p53 targets degradation acting ubiquitin e3 ligase results specific ubiquitination p53 mice mdm2 locus phenotype evident mice express slightly lower level mdm2 single hypomorphic allele thymic ablation poor weight gain bone marrow intestinal cell loss evident phenotypes dependant wild type p53 require exogenous signal data strongly suggest p53 always active target tissues mdm2 rate limiting negative regulator normally expressed roughly three times level needed repress p53 function fact inactivation mdm2 related gene mdmx mdm4 13 also gives p53 dependant early embryonic lethal phenotype implied less well studied gene also must critical controlling p53 compensated mdm2
0.6555275.15205365.html.plaintext.txt	11	p19arf locus regulators p53 genes control p53 function also verified genetic analysis upstream genes atm chk2 clearly act regulate p53 response negative regulator mdm2 p19arf fascinatingly p19arf acts critical activator p53 suppresses tumour genesis alter phenotype mdm2 hypomorphic mice 11 implies normal regulation p53 modulated p19arf p19arf control pathway activated early events tumorigenic process genes modulate wild type p53 function fragments p53 mutant p53 point mutations p53 inactivate function also act dominant negative mutants thus seen act oncogenes transgenic mouse models affect two n terminal truncations promote aging subtler however seem activate wild type function perhaps act selectively promote p53 function p53 responsive promoters finally two p53 related genes p63 p73 could also modulate p53 responses vivo 14 recently study ubiquitin pathway identified two new e3 p53 cop1 15 pirh2 16 proteins thus negative regulation p53 seems occur least four e3 e3 like proteins cop1 pirh2 mdm2 mdm4 three cop1 pirh2 mdm2 p53 induced genes creates complex responsive control circuit able fine tune p53 response another new gene also looks though may powerful modulator response deubiquitinating enzyme hausp 17 19 genetic studies using knock mice established p53 must intact n terminal transactivation domain function tumour suppressor knock mouse expresses p53 mutant amino acids 25 26 20 longer able suppress tumorigenesis fact despite expressing high levels mutant p53 protein identical phenotype p53 null mouse large number genes identified potential stream targets p53 activation suppression three established critical importance vivo pro apoptotic genes noxa puma 2122 cell cycle regulatory cdk inhibitor p21 knock downstream response genes clear affect phenotype p53 dependant dna damage response none knock mice dramatic tumour prone phenotype p53 null mice
0.6555275.15205365.html.plaintext.txt	12	p19arf locus regulators p53 genes control p53 function also verified genetic analysis upstream genes atm chk2 clearly act regulate p53 response negative regulator mdm2 p19arf fascinatingly p19arf acts critical activator p53 suppresses tumour genesis alter phenotype mdm2 hypomorphic mice 11 implies normal regulation p53 modulated p19arf p19arf control pathway activated early events tumorigenic process genes modulate wild type p53 function fragments p53 mutant p53 point mutations p53 inactivate function also act dominant negative mutants thus seen act oncogenes transgenic mouse models affect two n terminal truncations promote aging subtler however seem activate wild type function perhaps act selectively promote p53 function p53 responsive promoters finally two p53 related genes p63 p73 could also modulate p53 responses vivo 14 recently study ubiquitin pathway identified two new e3 p53 cop1 15 pirh2 16 proteins thus negative regulation p53 seems occur least four e3 e3 like proteins cop1 pirh2 mdm2 mdm4 three cop1 pirh2 mdm2 p53 induced genes creates complex responsive control circuit able fine tune p53 response another new gene also looks though may powerful modulator response deubiquitinating enzyme hausp 17 19 genetic studies using knock mice established p53 must intact n terminal transactivation domain function tumour suppressor knock mouse expresses p53 mutant amino acids 25 26 20 longer able suppress tumorigenesis fact despite expressing high levels mutant p53 protein identical phenotype p53 null mouse large number genes identified potential stream targets p53 activation suppression three established critical importance vivo pro apoptotic genes noxa puma 2122 cell cycle regulatory cdk inhibitor p21 knock downstream response genes clear affect phenotype p53 dependant dna damage response none knock mice dramatic tumour prone phenotype p53 null mice
0.6555275.15205365.html.plaintext.txt	13	increased understanding control p53 pathway derives genetic studies raised many points pathway may modulated inactivated pharmaceutical manipulation p53 pathway within grasp sobering reflection however derives consideration probable affects functional polymorphisms loci human population thus expect coding non coding polymorphisms multiple control loci segregating population means one readily imagine gene combinations give reduced tumour protection accelerated aging phenotypes
0.6555275.15205365.html.plaintext.txt	14	increased understanding control p53 pathway derives genetic studies raised many points pathway may modulated inactivated pharmaceutical manipulation p53 pathway within grasp sobering reflection however derives consideration probable affects functional polymorphisms loci human population thus expect coding non coding polymorphisms multiple control loci segregating population means one readily imagine gene combinations give reduced tumour protection accelerated aging phenotypes
0.6555275.15205365.html.plaintext.txt	15	inactivation p53 human tumours
0.6555275.15205365.html.plaintext.txt	16	mutation p53 common route p53 pathway inactivated human cancers mutation coding region p53 gene mutations extensively catalogued provided powerful database examining mutational spectra compared predicted environmental causes cancer man mutations occur many sites within gene common class mutation point mis sense mutation central dna binding domain protein mutant proteins accumulate high levels tumour cells readily detected antibody staining mutations act dominant negative mutations full length mutant protein form mixed inactive oligomers wild type protein mutants seem defective transcription factors formed basis yeast based functional assay mutant p53 detection structural physical biochemical studies mutant proteins helped promote understanding mutations many different locations protein inactivate function current model would suggest core dna binding domain p53 stable body temperature thus small structural alterations sufficient destabilize protein completely consistent finding many mutant p53 proteins temperature sensitive expressed lower temperature regain p53 wild type activity also helps explain antibodies epitopes within folded core protein exposed many different p53 mutations 23 28 discussed later property instability may allow development novel mutant p53 reactivating compounds p53 unstable reasonable suppose property may allow rapid breakdown close regulation would difficult switch stable protein knowledge affects p53 mutations still incomplete however systems mutant proteins appeared gained new functions beyond simply acting dominant negative p53 mutants models make clear p53 often described domain structure domains strong interconnection thus small mutation n terminal domain p53 cause second site reversion temperature sensitive mutation dna binding core protein 29 accumulation mutant p53 proteins cancer cells yet understood attractive model loss p53 transcription reduces level e3 ligases p53 accumulates however mechanisms may play knock mouse model expresses mutant p53 protein tissues p53 protein accumulation seems occur cancer cells tjacks personal communication
0.6555275.15205365.html.plaintext.txt	17	mutation p53 common route p53 pathway inactivated human cancers mutation coding region p53 gene mutations extensively catalogued provided powerful database examining mutational spectra compared predicted environmental causes cancer man mutations occur many sites within gene common class mutation point mis sense mutation central dna binding domain protein mutant proteins accumulate high levels tumour cells readily detected antibody staining mutations act dominant negative mutations full length mutant protein form mixed inactive oligomers wild type protein mutants seem defective transcription factors formed basis yeast based functional assay mutant p53 detection structural physical biochemical studies mutant proteins helped promote understanding mutations many different locations protein inactivate function current model would suggest core dna binding domain p53 stable body temperature thus small structural alterations sufficient destabilize protein completely consistent finding many mutant p53 proteins temperature sensitive expressed lower temperature regain p53 wild type activity also helps explain antibodies epitopes within folded core protein exposed many different p53 mutations 23 28 discussed later property instability may allow development novel mutant p53 reactivating compounds p53 unstable reasonable suppose property may allow rapid breakdown close regulation would difficult switch stable protein knowledge affects p53 mutations still incomplete however systems mutant proteins appeared gained new functions beyond simply acting dominant negative p53 mutants models make clear p53 often described domain structure domains strong interconnection thus small mutation n terminal domain p53 cause second site reversion temperature sensitive mutation dna binding core protein 29 accumulation mutant p53 proteins cancer cells yet understood attractive model loss p53 transcription reduces level e3 ligases p53 accumulates however mechanisms may play knock mouse model expresses mutant p53 protein tissues p53 protein accumulation seems occur cancer cells tjacks personal communication
0.6555275.15205365.html.plaintext.txt	18	routes p53 inactivation half human tumours retain wild type p53 tumour suppressor function p53 bypassed systems one route inactivation upstream signalling pathways thus chk2 mutations reported breast cancers tumours arise patients atm loss p19arf expression common many cancers amplification expression mdm2 may occur 9 cancers cervical cancers expression hpv e6 protein inactivates p53 probable components p53 response pathway uncovered possible see many new ways pathway abrogated role cop1 pirh2 hausp example yet determined overexpression survival signals anti apototic proteins also help tumour cells evade p53 activity
0.6555275.15205365.html.plaintext.txt	19	routes p53 inactivation half human tumours retain wild type p53 tumour suppressor function p53 bypassed systems one route inactivation upstream signalling pathways thus chk2 mutations reported breast cancers tumours arise patients atm loss p19arf expression common many cancers amplification expression mdm2 may occur 9 cancers cervical cancers expression hpv e6 protein inactivates p53 probable components p53 response pathway uncovered possible see many new ways pathway abrogated role cop1 pirh2 hausp example yet determined overexpression survival signals anti apototic proteins also help tumour cells evade p53 activity
0.6555275.15205365.html.plaintext.txt	20	therapy p53 pathway implications p53 pathway treatment cancer appreciated last decade many current treatments trigger p53 response normal tumour tissue critical question whether p53 status tumour affects chance response treatment animal models dramatic affects seen p53 wild type tumours responding much better chemotherapeutic drugs data obtained human material less clear cut reflects genetic complexity human cancer technical difficulties working patient samples possibility many wild type p53 tumours may defects pathway encouraging perhaps discovery development therapies based understanding p53 pathway
0.6555275.15205365.html.plaintext.txt	21	therapy p53 pathway implications p53 pathway treatment cancer appreciated last decade many current treatments trigger p53 response normal tumour tissue critical question whether p53 status tumour affects chance response treatment animal models dramatic affects seen p53 wild type tumours responding much better chemotherapeutic drugs data obtained human material less clear cut reflects genetic complexity human cancer technical difficulties working patient samples possibility many wild type p53 tumours may defects pathway encouraging perhaps discovery development therapies based understanding p53 pathway
0.6555275.15205365.html.plaintext.txt	22	p53 gene therapy delivery wt p53 using adenoviral expression vector approved china part radiotherapygene therapy combination head neck cancer similar p53 virus late stage clinical trial usa 30 delivery virus tumour cells possible bystander affects possibly immune phenomena may acting make therapies effective possible design active variants p53 introducing mutations block binding negative regulator mdm2 stabilize core structure protein clearly offer superior performance model systems work needed see maintain excellent safety features wild type p53 virus human trials
0.6555275.15205365.html.plaintext.txt	23	p53 gene therapy delivery wt p53 using adenoviral expression vector approved china part radiotherapygene therapy combination head neck cancer similar p53 virus late stage clinical trial usa 30 delivery virus tumour cells possible bystander affects possibly immune phenomena may acting make therapies effective possible design active variants p53 introducing mutations block binding negative regulator mdm2 stabilize core structure protein clearly offer superior performance model systems work needed see maintain excellent safety features wild type p53 virus human trials
0.6555275.15205365.html.plaintext.txt	24	onyx 0 15 e1b region deletion mutant wild type adenovirus first reported replicate preferentially cells lacked wild type p53 31 exciting concept proved complex closer analysis viruses selective replication tumour cells seems depend tumour cells expressing host proteins compensate e1b mutant viruses deficiencies nuclear export 32 nevertheless encouraging clinical responses seen hoped development therapy potential attack systemic disseminated disease continue
0.6555275.15205365.html.plaintext.txt	25	onyx 0 15 e1b region deletion mutant wild type adenovirus first reported replicate preferentially cells lacked wild type p53 31 exciting concept proved complex closer analysis viruses selective replication tumour cells seems depend tumour cells expressing host proteins compensate e1b mutant viruses deficiencies nuclear export 32 nevertheless encouraging clinical responses seen hoped development therapy potential attack systemic disseminated disease continue
0.6555275.15205365.html.plaintext.txt	26	rescuing mutant p53 number approaches rescue mutant p53 proposed screening programmes yielded promising early leads shown activity animal models exact mechanism action compounds disputed early work suggested peptides derived c terminus p53 could activate dna binding function mutant p53 proteins 33 37 mechanism affect widely discussed complete consensus achieved strikingly however last year dowdy 38 colleagues shown c terminal peptide fused cell transport sequence derived d amino acids stability completely cure aggressive intraperitoneal tumour mice
0.6555275.15205365.html.plaintext.txt	27	rescuing mutant p53 number approaches rescue mutant p53 proposed screening programmes yielded promising early leads shown activity animal models exact mechanism action compounds disputed early work suggested peptides derived c terminus p53 could activate dna binding function mutant p53 proteins 33 37 mechanism affect widely discussed complete consensus achieved strikingly however last year dowdy 38 colleagues shown c terminal peptide fused cell transport sequence derived d amino acids stability completely cure aggressive intraperitoneal tumour mice
0.6555275.15205365.html.plaintext.txt	28	non genotoxic activation p53 therapy inhibiting p53 mdm2 interaction intense study activation p53 response revealed number ways turn p53 response without causing dna damage tumours retain wild type p53 approaches may yield exciting new treatment options extensive analysis p53 mdm2 interaction using synthetic peptide libraries phage display peptide scaffolds 39 42 demonstrated blocking interaction able activate p53 induce growth arrest apoptosis solved crystal structure interaction peptide database allowed two groups develop small molecule inhibitors interaction trigger p53 response 43 elegant work group compounds called nutlins shown activate p53 blocking p53 binding mdm2 xenograft models lead molecules demonstrated excellent tumour growth control without toxicity results greatly encouraged pharmaceutical industry validating mdm2 inhibition therapeutic target establishing protein protein interactions appropriate targets small molecule drugs
0.6555275.15205365.html.plaintext.txt	29	non genotoxic activation p53 therapy inhibiting p53 mdm2 interaction intense study activation p53 response revealed number ways turn p53 response without causing dna damage tumours retain wild type p53 approaches may yield exciting new treatment options extensive analysis p53 mdm2 interaction using synthetic peptide libraries phage display peptide scaffolds 39 42 demonstrated blocking interaction able activate p53 induce growth arrest apoptosis solved crystal structure interaction peptide database allowed two groups develop small molecule inhibitors interaction trigger p53 response 43 elegant work group compounds called nutlins shown activate p53 blocking p53 binding mdm2 xenograft models lead molecules demonstrated excellent tumour growth control without toxicity results greatly encouraged pharmaceutical industry validating mdm2 inhibition therapeutic target establishing protein protein interactions appropriate targets small molecule drugs
0.6555275.15205365.html.plaintext.txt	30	small molecule activators p53 response screening assays based p53 reporter cells identified many small molecules activate p53 response without causing dna damage particularly potent activator nuclear export inhibitor leptomycin b 44 46 streptomycete antibiotic binds inhibits nuclear exportin protein crm1 inhibition export activates p53 dependent transcription dramatically must affect many proteins well cell based studies shown much cell cycle apoptotic response leptomycin b p53 dependent normal cells recover leptomycin induced p53 dependent growth arrest compound induces apoptotic death p53 wild type human tumour cells molecules non genotoxic activators p53 response include cdk inhibitor roscovitine 4748 r isomer cyc202 compound currently clinical trial cyc202 appears induce p53 partially inhibiting transcription link transcription signalling p53 currently focus intense study may represent unifying principal p53 pathway senses cellular stress invoke p53 system
0.6555275.15205365.html.plaintext.txt	31	small molecule activators p53 response screening assays based p53 reporter cells identified many small molecules activate p53 response without causing dna damage particularly potent activator nuclear export inhibitor leptomycin b 44 46 streptomycete antibiotic binds inhibits nuclear exportin protein crm1 inhibition export activates p53 dependent transcription dramatically must affect many proteins well cell based studies shown much cell cycle apoptotic response leptomycin b p53 dependent normal cells recover leptomycin induced p53 dependent growth arrest compound induces apoptotic death p53 wild type human tumour cells molecules non genotoxic activators p53 response include cdk inhibitor roscovitine 4748 r isomer cyc202 compound currently clinical trial cyc202 appears induce p53 partially inhibiting transcription link transcription signalling p53 currently focus intense study may represent unifying principal p53 pathway senses cellular stress invoke p53 system
0.6555275.15205365.html.plaintext.txt	32	p53 protein controlled multiple negative regulators activators ensure achieves high therapeutic index protecting organism cancer whilst damaging many stem cells order escape p53 pathway nearly human cancers either mutated p53 gene altered sensitivity effectiveness pathway cancer cells exceptionally sensitive reactivation p53 function therefore treatments achieve promise exceptionally effective use p53 gene therapy already approved several small molecules activate p53 pathway without non specific toxicity development one small molecule cdk inhibitor phase 11 clinical trial expanding knowledge p53 pathway means strategies manipulate p53 pathway emerging rapidly one predict next 25 years see knowledge fascinating protein put extensive clinical use benefit patients worldwide
0.6555275.15205365.html.plaintext.txt	33	p53 protein controlled multiple negative regulators activators ensure achieves high therapeutic index protecting organism cancer whilst damaging many stem cells order escape p53 pathway nearly human cancers either mutated p53 gene altered sensitivity effectiveness pathway cancer cells exceptionally sensitive reactivation p53 function therefore treatments achieve promise exceptionally effective use p53 gene therapy already approved several small molecules activate p53 pathway without non specific toxicity development one small molecule cdk inhibitor phase 11 clinical trial expanding knowledge p53 pathway means strategies manipulate p53 pathway emerging rapidly one predict next 25 years see knowledge fascinating protein put extensive clinical use benefit patients worldwide
0.6555275.15205365.html.plaintext.txt	34	dlane founder director cso cyclacel limited company developing cyc202 cancer therapy
0.6555275.15205365.html.plaintext.txt	35	view larger version 19k fig 1 p53 induced genes p53 active induces three classes genes established genetically essential function one class exemplified cdk inhibitor protein p21 cause cell cycle arrest another class exemplified bh3 domain proteins puma noxa promote apoptosis third class genes exemplified mdm2 pirh2 cop1 act negative regulate p53 activity activity group negative regulators turn moderated hausp arf proteins
0.6555275.15205365.html.plaintext.txt	36	view larger version 23k fig 2 activity mdm2 e3 ligase inhibited mdm2 acting ubiquitinate promoting auto ubiquitination degradation activity counteracted hausp isopeptidase stabilize activate mdm2 removal hausp therefore activate p53 reducing activity mdm2 inhibitor p53 function
0.6555275.15205365.html.plaintext.txt	37	view larger version 25k fig 3 three different e3 ligases p53 described cop1 mdm2 pirh2 act promote ubiquitination degradation p53 hausp isopeptidase reverse reactions
0.7534733.15817608.html.plaintext.txt	0	p53 story layers complexity received accepted march 29 2005
0.7534733.15817608.html.plaintext.txt	1	department pathology school medicine university otago dunedin new zealand 1 oncology research centre prince wales hospital randwick nsw australia school medicine university new south wales kensington nsw australia
0.7534733.15817608.html.plaintext.txt	2	correspondence addressed tel 64 3 479 7165 fax 64 3 479 7136 email antonybraithwaiteatstonebowotagoacnz
0.7534733.15817608.html.plaintext.txt	3	correspondence addressed tel 64 3 479 7165 fax 64 3 479 7136 email antonybraithwaiteatstonebowotagoacnz
0.7534733.15817608.html.plaintext.txt	4	abstract top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references report summary presentations 12th international p53 workshop held november 2004 dunedin new zealand convenor organizing committee antony braithwaite university otago dunedin janice royds paul jackson also members organizing committee 61 oral presentations 101 posters
0.7534733.15817608.html.plaintext.txt	5	abbreviations aip1 apoptosis inducing protein 1 alt alternative lengthening telomeres aspp ankrin repeats sh3 domains poly proline chk checkpoint kinases chk1 chk2 gbm glioblastoma multiforme hipk2 homeodomain interacting kinases hmec human mammary epithelial cells normal lcl lymphoblastoid cell lines snp single nucleotide polymorphism sts soft tissue sarcoma tm telomere maintenance tpa thyroid papillary tumour vhmec variant human mammary epithelial cells wt wild type
0.7534733.15817608.html.plaintext.txt	6	introduction top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references 1992 david lane described p53 guardian genome 1 established paradigm embodying p53 tumour suppressor essence p53 dna damage sensor acted prevent accumulation genetic lesions might contribute tumourigenesis model could explain role p53 cell cycle control apoptosis also stabilization p53 exposure uv radiation dna damaging agents need p53 function compromised tumourigenesis indeed seemed like p53 story might solved soon time intervening years however clearly demonstrated naive expectation know role p53 extends participation diverse array signalling pathways associated cellular stress dna damage figure 1 recent studies even raised possibility p53 may involved pathways little cancer
0.7534733.15817608.html.plaintext.txt	7	view larger version 34k fig 1 complex signalling pathway p53 diagram outlines range cellular stresses activate p53 lists modifiers partners discussed meeting comprehensive list stresses modifiers outputs involved p53 pathway
0.7534733.15817608.html.plaintext.txt	8	light 25th anniversary discovery p53 12th international p53 workshop held dunedin new zealand november 2004 take home message latest biennial gathering p53 researchers could summarized one word complexity learnt p53 complex many levels genomic structure regulation function fact far complex one us could possibly imagined theme complexity established opening address david lane continued throughout meeting report endeavoured cover many oral presentations possible inevitably omitted addition paid particular attention describing highlights areas new investigation going research appear integral p53 field
0.7534733.15817608.html.plaintext.txt	9	light 25th anniversary discovery p53 12th international p53 workshop held dunedin new zealand november 2004 take home message latest biennial gathering p53 researchers could summarized one word complexity learnt p53 complex many levels genomic structure regulation function fact far complex one us could possibly imagined theme complexity established opening address david lane continued throughout meeting report endeavoured cover many oral presentations possible inevitably omitted addition paid particular attention describing highlights areas new investigation going research appear integral p53 field
0.7534733.15817608.html.plaintext.txt	10	p53 part growing family proteins top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references new isoforms 25 years working gene thought encoded single protein novel discovery probably important ramifications much p53 field identification several new alternatively spliced isoforms human p53 reported j cbourdon dlane dundee scotland using technique ensure full length capped p53 mrna molecules analysed identified numerous start sites transcription two mrna species initiated different start sites exon 1 p1 p1 one mrna derived promoter p2 within intron 4 primers based exon 11 also identified three splice variants exon 9 thus p53 total 12 possible mrnas 9 proteins although still early days clear isoforms show different patterns expression within tissues cell lines key area investigation determine isoforms function interestingly one isoform np53 dominant negative inhibitor wild type wt p53 transactivation apoptosis assays reported n terminal truncation p73 relative p53 isoforms p53 abundantly expressed tumours suggesting possible role carcinogenesis furthermore existence dominant negative isoforms provides explanation impaired p53 response absence coding region mutations
0.7534733.15817608.html.plaintext.txt	11	p63p73 although major feature conference several talks discussed p63 p73 relatives p53 given similarity different protein isoforms encoded genes using domain structure p53 model xchen birmingham al usa mapping domains isoforms p63 p73 critical transcriptional activation growth arrest apoptosis showed particular two activation domains p53 amino acid residues 1 42 43 63 represented full length n terminally deleted n versions p63 p73 critical three functions
0.7534733.15817608.html.plaintext.txt	12	p63p73 although major feature conference several talks discussed p63 p73 relatives p53 given similarity different protein isoforms encoded genes using domain structure p53 model xchen birmingham al usa mapping domains isoforms p63 p73 critical transcriptional activation growth arrest apoptosis showed particular two activation domains p53 amino acid residues 1 42 43 63 represented full length n terminally deleted n versions p63 p73 critical three functions
0.7534733.15817608.html.plaintext.txt	13	tstiewe wurzburg germany showed reduction p73 expression sufficient induce telomerase activity telomerase negative cells suggesting p73 could endogenous repressor telomerase activity stiewe also showed htert downregulated p73 upregulated ectopic expression dominant negative np73 data agree observations p73 upregulation accompanies differentiation turn coupled loss telomerase activity
0.7534733.15817608.html.plaintext.txt	14	absence functional p53 p73 phosphorylated acetylated dna damage activate pro apoptotic genes described pin 1 propyl isomerase important regulator p53 gdel sal trieste italy examining role prolyl isomerase activation p73 studies elegantly demonstrate clear requirement pin 1 regulating stability conformation p73 dna damage ability p73 activate gene expression induce apoptosis furthermore showed c abl regulates pin 1 modulation p73 phosphorylating amino acid residue tyr99 thus linking p73 one signalling pathways regulates p53
0.7534733.15817608.html.plaintext.txt	15	absence functional p53 p73 phosphorylated acetylated dna damage activate pro apoptotic genes described pin 1 propyl isomerase important regulator p53 gdel sal trieste italy examining role prolyl isomerase activation p73 studies elegantly demonstrate clear requirement pin 1 regulating stability conformation p73 dna damage ability p73 activate gene expression induce apoptosis furthermore showed c abl regulates pin 1 modulation p73 phosphorylating amino acid residue tyr99 thus linking p73 one signalling pathways regulates p53
0.7534733.15817608.html.plaintext.txt	16	upstream signalling p53 top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references control p53 activity major area research activity essentially control exerted p53 function via post translational modifications andor interacting proteins areas well represented meeting
0.7534733.15817608.html.plaintext.txt	17	modifications p53 thought part signalling process directs p53 carry particular task whether cell cycle arrest apoptosis dna repair process p53 plays role however importance particular modification regulating p53 function unclear many conflicting reports conflicts evident meeting also may well reflect use different assay systems analysis limited p53 target genes vitro versus vivo approaches
0.7534733.15817608.html.plaintext.txt	18	modifications p53 thought part signalling process directs p53 carry particular task whether cell cycle arrest apoptosis dna repair process p53 plays role however importance particular modification regulating p53 function unclear many conflicting reports conflicts evident meeting also may well reflect use different assay systems analysis limited p53 target genes vitro versus vivo approaches
0.7534733.15817608.html.plaintext.txt	19	post translational modifications phosphorylation yshieh taipei taiwan addressed role checkpoint kinases chk1 chk2 p53 regulation showed addition phosphorylation known n terminal residues phosphorylation ser313 ser314 thr377 ser378 also found furthermore downregulation chk1 chk2 reduced phosphorylation ser20 expected also reduced acetylation lys382 leading poor induction cdkn1a gene encoding cyclin inhibitory protein p21waf1cip1 data suggest chk1 chk2 may regulate p53 function several ways n terminal phosphorylation data serve emphasize importance c terminus regulating p53 function theme repeated throughout meeting addition interesting note germline mutations chk2 found li fraumeni families wt tp53 evidence apparent complexity chk2 regulation p53 function provided yhaupt jerusalem israel specific mutation pro82 prevented binding chk2 chk2 dependent phosphorylation ser20 dna damage attempts identify functional relevance aspect haupt looked role pin 1 facilitating chk2 modulation p53 previous studies shown activation stabilization p53 pin 1 requires specific phosphorylation p53 ser33 tyr81 tyr150 experiments pin1 mouse fibroblasts used show pin 1 also essential phosphorylation ser23 mouse p53 equivalent ser20 human p53 stabilization p53 haupt also showed pin 1 enhances formation chk2p53 complexes early dna damage requires pro82 therefore proposed model p53 phosphorylation specific residues permits binding pin 1 alters conformation p53 allow binding chk2 chk2 phosphorylates ser20 thus releasing p53 mdm 2 stabilizingactivating p53 similar conclusion respect phosphorylation role pin 1 regulating interaction p53 mdm 2 reached gdel sal trieste italy
0.7534733.15817608.html.plaintext.txt	20	however cprives new york usa unable demonstrate n terminal phosphorylation mouse p53 chk2 dna damage downregulation chk1 chk2 sirna failed affect p53 function dna damage questioning importance phosphorylation regulating p53 function lgiono jmanfredis group new york usa using artificial system involving tetracycline regulated p53 expression therefore involving dna damage reported p53 phosphorylated ser6 poorly phosphorylated ser15 ser37 yet binds dna efficiently least p53 response element cdkn1a promoter furthermore using proteosome inhibitors elevate p53 levels showed dna binding either vitro vivo affected absence phosphorylation ser15 ser392 acetylation lys382 post translational modifications required p53 activity required probable answer p53 may carry many functions reached threshold concentration may need told activate specific promoter processes phosphorylation acetylation interacting proteins example abraithwaite dunedin nz also failed observe phosphorylation n terminal residues using hormone inducible p53 still obtained activation cdkn1a mdm 2 promoters however induction noxa bax promoters observed
0.7534733.15817608.html.plaintext.txt	21	support idea phosphorylation specific residues controls p53 specificity least part came presentation ssoddu rome italy phosphorylation ser46 known important p53 induce apoptosis least instances yet kinase responsible ser46 phosphorylation unknown data soddus work suggested enzyme could hipk2 homeodomain interacting kinase 2 member novel serthr kinase family studies initiated observation thyroid papillary tumours tpa wt p53 yet high levels anti apoptotic protein galectin 3 expression normally repressed wt p53 soddu showed tumours allelic loss chr7q32 34 encompasses hipk2 gene locus wt p53 repress galectin 3 hipk2 present hipk2 activates apoptotic pathway involves phosphorylation p53 ser46 inhibition p53 mediated repression galectin 3
0.7534733.15817608.html.plaintext.txt	22	ubiquitination mdm 2 control p53 stability seems clear discussion much activity p53 dependent concentration also discussed later thus post translational modifications also level p53 must regulated precisely comprehensive analysis enzymes required ubiquitination p53 dlane dundee scotland identified ubch5bc e2 like protein involved controlling levels p53 mdm 2 knockdown ubch5bc increased levels p53 p53 transcriptionally inactive still bound mdm 2 also modified ubch5bc activation stabilized p53 thus requires removal bound mdm 2 results conjunction recent discovery p53 mdm 2 modified ubiquitin like nedd8 well characterized regulator p27kip1 ib levels demonstrate least two pathways resulting ubiquitination inactivation p53 pathways involve mdm 2 two step stabilization subsequent inactivation p53 nedd pathway ubch5bc ubiquitinate p53 mdm 2 understanding new complexity p53 regulation important implications design use therapeutic modulators p53mdm 2 interaction addition work presented mrossi gmelinos group leicester uk showed p63 p73 also subject tight control ubiquitin like degradation processes reported discovery new nedd like e3 ligase called aip4itch downregulates p73 upon dna damage
0.7534733.15817608.html.plaintext.txt	23	ubiquitination mdm 2 control p53 stability seems clear discussion much activity p53 dependent concentration also discussed later thus post translational modifications also level p53 must regulated precisely comprehensive analysis enzymes required ubiquitination p53 dlane dundee scotland identified ubch5bc e2 like protein involved controlling levels p53 mdm 2 knockdown ubch5bc increased levels p53 p53 transcriptionally inactive still bound mdm 2 also modified ubch5bc activation stabilized p53 thus requires removal bound mdm 2 results conjunction recent discovery p53 mdm 2 modified ubiquitin like nedd8 well characterized regulator p27kip1 ib levels demonstrate least two pathways resulting ubiquitination inactivation p53 pathways involve mdm 2 two step stabilization subsequent inactivation p53 nedd pathway ubch5bc ubiquitinate p53 mdm 2 understanding new complexity p53 regulation important implications design use therapeutic modulators p53mdm 2 interaction addition work presented mrossi gmelinos group leicester uk showed p63 p73 also subject tight control ubiquitin like degradation processes reported discovery new nedd like e3 ligase called aip4itch downregulates p73 upon dna damage
0.7534733.15817608.html.plaintext.txt	24	consistent data presented meeting gwahl la jolla usa showed normal fibroblasts dna damage induces phosphorylation ser15 p53 occurred 2 h prior induction cdkn1a mdm 2 means phosphorylation ser15 always equate active p53 protein time however p53 becomes much stable mdm 2 becomes unstable proteosome inhibitors block mdm 2 degradation inhibited transactivation function p53 system suggesting decrease mdm 2 stability contributed p53 activation thus sufficient dna damage mdm 2 stability reduced p53 becomes activated without requirement phosphorylation data provide possible explanation p53 functional absence n terminal phosphorylation also p53 mutants lacking conserved serine threonine residues see thus p53 level may critical determiner function
0.7534733.15817608.html.plaintext.txt	25	consistent data presented meeting gwahl la jolla usa showed normal fibroblasts dna damage induces phosphorylation ser15 p53 occurred 2 h prior induction cdkn1a mdm 2 means phosphorylation ser15 always equate active p53 protein time however p53 becomes much stable mdm 2 becomes unstable proteosome inhibitors block mdm 2 degradation inhibited transactivation function p53 system suggesting decrease mdm 2 stability contributed p53 activation thus sufficient dna damage mdm 2 stability reduced p53 becomes activated without requirement phosphorylation data provide possible explanation p53 functional absence n terminal phosphorylation also p53 mutants lacking conserved serine threonine residues see thus p53 level may critical determiner function
0.7534733.15817608.html.plaintext.txt	26	add complexity mdm 2 regulation moren rehovot israel described studies reporting mdm 2 directly bind core histones mdm 2 mono ubiquitinates h2a h2b vitro gal4 dna binding reporter system mdm 2 repressed transcription gal4 response promoter suggesting mdm 2 might repress transcription via changes chromatin using chip analysis oren also showed mdm 2 complex p53 cdkn1a promoter vivo ubiquitinate residues h2b data imply mdm 2 may drive gene silencing right via chromatin modification
0.7534733.15817608.html.plaintext.txt	27	add complexity mdm 2 regulation moren rehovot israel described studies reporting mdm 2 directly bind core histones mdm 2 mono ubiquitinates h2a h2b vitro gal4 dna binding reporter system mdm 2 repressed transcription gal4 response promoter suggesting mdm 2 might repress transcription via changes chromatin using chip analysis oren also showed mdm 2 complex p53 cdkn1a promoter vivo ubiquitinate residues h2b data imply mdm 2 may drive gene silencing right via chromatin modification
0.7534733.15817608.html.plaintext.txt	28	new p53 binding proteins common agents induce post translational modifications p53 p53 binding proteins appear important instructing specific response p53 list proteins continues expand several new members discussed meeting
0.7534733.15817608.html.plaintext.txt	29	new p53 binding proteins common agents induce post translational modifications p53 p53 binding proteins appear important instructing specific response p53 list proteins continues expand several new members discussed meeting
0.7534733.15817608.html.plaintext.txt	30	ytaya tokyo japan reported cytoplasmic protein clathrin normally plays role formation coated pits vesicle transport binds p53 influences function reported clathrin binds n terminus s46f mutant particular interestingly phosphorylation residue reported important ability p53 induce apoptosis see data reported soddu went show transfection reporter assays clathrin enhanced p53 dependent activation apoptosis inducing protein 1 aip1 p53 dependent promoters particularly marked s46f mutant addition rnai studies showed downregulation clathrin partially ablated ability p53 transactivate several target genes uv exposure
0.7534733.15817608.html.plaintext.txt	31	binding p53 y box factor yb1 reported abraithwaite yb1 binds c terminus p53 like clathrin generally located cytoplasm yb1 translocates nucleus response various stresses regulates transcription several tumour associated genes tumours nuclear localization expression yb1 associated drug resistance poor prognosis braithwaite showed yb1 requires transcriptionally active p53 translocation appear require direct binding nucleus showed yb1 partially inhibits p53 activity genes bax noxa involved apoptosis inhibited yb1 cdkn1a mdm 2 inhibited however knockdown yb1 antisense oligonucleotides increased noxa expression p53 dependent manner braithwaite proposed yb1 reduces ability p53 bind target promoters low affinity apoptotic pathway partial inhibition p53 function may contribute cancer formation
0.7534733.15817608.html.plaintext.txt	32	interesting p53 binding partner discovered 2 years ago gdel sal trieste italy pin 1 propyl isomerase pin 1 induces conformational change phosphorylated p53 facilitating post translational modifications particularly acetylation sense important regulator p53 function often expressed common human cancers prostate breast pin 1 also influences p53 regulation mdm 2 see haupt appears analogous effects p73
0.7534733.15817608.html.plaintext.txt	33	interesting p53 binding partner discovered 2 years ago gdel sal trieste italy pin 1 propyl isomerase pin 1 induces conformational change phosphorylated p53 facilitating post translational modifications particularly acetylation sense important regulator p53 function often expressed common human cancers prostate breast pin 1 also influences p53 regulation mdm 2 see haupt appears analogous effects p73
0.7534733.15817608.html.plaintext.txt	34	xlu london uk expanded work pro apoptotic aspp called comprise ankrin repeats sh3 domains poly proline domain proteins effect p53 function ankyrin repeats bind p53 within n terminus interest note polymorphism arg72 binds aspp lesser extent pro72 aspp proteins bind p53 augment ability p53 transactivate pro apoptotic genes effect ability p53 transactivate cell cycle genes although data presented showing similar selective influence aspp proteins p73 p63 much talk focused regulation aspp function biochemical studies showed aspp1 substrate map kinase mapk aspp1 aspp2 stabilized mapk interestingly rnai downregulation ras inhibited aspp1 aspp2 mediated p53 dependent apoptosis demonstrating aspp proteins link p53 dependent apoptosis ras signalling pathway studies looking transcriptional regulation aspp1 aspp2 found binding motifs e2f 3 aspp1 4 aspp2 2 common aspp1 promoters e2f 1 could bind motifs confirmed vivo chromatin immunoprecipitation chip vitro reporter assays e2f 3 also shown activate promoters however e2f 1 e2f 2 strongly activate aspp2 promoter transfection e2f 1 able induce aspp1 aspp2 mrna leading proposal induction aspp1 aspp2 e2f 1 might sensitize cells apoptosis
0.7534733.15817608.html.plaintext.txt	35	finally importance tgfss regulator p53 function discussed mbarcellus hoff berkeley usa using cells derived tgfss1 knockout mice found radiation induced p53 dependent growth arrest apoptosis defective defect associated absence ser15 phosphorylation overall change p53 levels observed also direct interaction tgfss p53 addition studies small molecule inhibitors tgfss signalling led similar conclusion tgfss regulator p53 dna damage response additional evidence link tgfss p53 pathways provided magarwal cleveland usa showed tgfss mediates p53 dependent protective cell cycle arrest response dntp imbalance
0.7534733.15817608.html.plaintext.txt	36	apoptosis top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references becoming increasingly clear regulation p53 dependent apoptosis complex simple terms process divided three parts tells p53 induce apoptosis ii mechanisms involved iii downstream effectors first part dealt often involves post translational modifications andor interactions proteins session meeting dealt principally latter two components
0.7534733.15817608.html.plaintext.txt	37	many years thought like induction cell cycle arrest induction apoptosis p53 due solely transactivation pro apoptotic genes however transactivation independent apoptosis occur cells area pioneered umoll new york usa believes p53 induces mitochondrial apoptosis directly support showed convincing evidence p53 associating mitochondria association occurred p53 dependent apoptosis radiosensitive tissues spleen thymus earlier transactivation also showed p53 binds anti apoptotic proteins bcl 2 bcl xl using modelling techniques predicted bcl 2 bcl xl would bind p53 within central specific dna binding domain using classic cytochrome c cyt c release assay showed tumour derived mutants p53 defective binding bcl xl prevent cyt c release mitochondria mmurphy philadelphia usa provided independent evidence certain p53 mutants oligomerize fail bind bak consequence defective p53 dependent mitochondrial apoptosis data suggest tumour derived mutants double hit ie induce mitochondrial death transcriptionally inactive
0.7534733.15817608.html.plaintext.txt	38	many years thought like induction cell cycle arrest induction apoptosis p53 due solely transactivation pro apoptotic genes however transactivation independent apoptosis occur cells area pioneered umoll new york usa believes p53 induces mitochondrial apoptosis directly support showed convincing evidence p53 associating mitochondria association occurred p53 dependent apoptosis radiosensitive tissues spleen thymus earlier transactivation also showed p53 binds anti apoptotic proteins bcl 2 bcl xl using modelling techniques predicted bcl 2 bcl xl would bind p53 within central specific dna binding domain using classic cytochrome c cyt c release assay showed tumour derived mutants p53 defective binding bcl xl prevent cyt c release mitochondria mmurphy philadelphia usa provided independent evidence certain p53 mutants oligomerize fail bind bak consequence defective p53 dependent mitochondrial apoptosis data suggest tumour derived mutants double hit ie induce mitochondrial death transcriptionally inactive
0.7534733.15817608.html.plaintext.txt	39	support direct role p53 mitochondrion provided dgreen san diego usa developed sophisticated model system using isolated outer inner mitochondrial membrane vesicles well synthetic lipid vesicles containing dextran examine individual bcl 2 family proteins function apoptosis pro apoptotic members bcl 2 family act permeabilize outer mitochondrial membranes without requirement inner membranes mitochondrial proteins result cyt c released manner sudden rapid complete using system looked induction apoptosis p53 intact cells cytoplasts concluded nucleus dispensable apoptosis look function endogenous p53 apoptosis purified native p53 various cell lines uv treatment well several p53 mutants including pro deleted polyproline domain residues 62 92 examined interaction bcl 2 family proteins ability induce cyt c release based studies proposed model whereby stabilization p53 accumulates cytoplasm held inactive bcl xl nuclear p53 activates bax puma transcription puma accumulates cytoplasm p53 liberated bcl xl puma bax activated p53 cyt c released cell death occurs
0.7534733.15817608.html.plaintext.txt	40	support direct role p53 mitochondrion provided dgreen san diego usa developed sophisticated model system using isolated outer inner mitochondrial membrane vesicles well synthetic lipid vesicles containing dextran examine individual bcl 2 family proteins function apoptosis pro apoptotic members bcl 2 family act permeabilize outer mitochondrial membranes without requirement inner membranes mitochondrial proteins result cyt c released manner sudden rapid complete using system looked induction apoptosis p53 intact cells cytoplasts concluded nucleus dispensable apoptosis look function endogenous p53 apoptosis purified native p53 various cell lines uv treatment well several p53 mutants including pro deleted polyproline domain residues 62 92 examined interaction bcl 2 family proteins ability induce cyt c release based studies proposed model whereby stabilization p53 accumulates cytoplasm held inactive bcl xl nuclear p53 activates bax puma transcription puma accumulates cytoplasm p53 liberated bcl xl puma bax activated p53 cyt c released cell death occurs
0.7534733.15817608.html.plaintext.txt	41	astrasser melbourne australia investigated roles puma noxa p53 dependent apoptosis generating specific knockout mice thymocytes noxa mice died radiation exposure various dna damaging agents similar cells puma mice resistant fibroblasts puma mice also much resistant apoptosis compared noxa fibroblasts concluded neither noxa puma required normal development puma lesser extent noxa involved mediating p53 dependent apoptosis although tissue differences noted interestingly also showed loss puma protected cells diverse p53 independent cytotoxics staurosporine glucocortocids phorbol ester cytokine withdrawal suggesting puma specific p53 pathways crossing puma mice e micro myc mice found loss puma accelerated tumour growth consistent role tumour suppressor tshibue tokyo japan also generated noxa puma knockout mice similar results strasser isolated thymocytes embryo fibroblasts
0.7534733.15817608.html.plaintext.txt	42	interesting presentation given rrahman kwimans group stockholm sweden long known p53 represses htert talk tables turned htert antagonizes ability p53 induce apoptosis may clinical relevance see royds
0.7534733.15817608.html.plaintext.txt	43	p53 dna damage repair top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references although required dna repair p53 facilitates nucleotide excision repair global transcription coupled repair base excision repair charris bethesda md usa lwiesmuller ulm germany extended role p53 dna repair repair dna damage occurring replication stress harris presented evidence p53 downstream atr kinase chk 1 kinase 53bp1 blm helicase response holliday junctions hj replication intermediates enhances endonuclease activity mus81 candidate resolvase hjs functions governor excessive rates homologous recombination wiesmuller also presented data indicating p53 restrains rad51 dependent dna exchange events involving imperfectly homologous sequences p53 may also contribute recombinative repair recruited specific repair complexes molecular interactions topoisomerase binding partners studies establish transcription independent dependent mutifunctionality p53 dna damage repair response
0.7534733.15817608.html.plaintext.txt	44	animal models top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references tumour derived p53 mutations almost always missense mutations heterozygous gene disruptions rare addition spectrum tumours seen p53 knockout mice quite different seen humans including li fraumeni syndrome observations combined considerable body vitro data led conclusion p53 mutants gain function tumourigenesis notion supported presentation moren rehovot israel showing mutant p53 specifically regulate expression cd95 egr1 msp resulting inhibition apoptosis issue gain function also explored vivo using conditional knock mutations mice using approach kolive group tjacks cambridge ma usa tiwakuma glozanos group houston usa reported results studies analysing function mr172h hr175h structural mutant mr270h hr273h dna contact mutant olive generated mutantwt mutantnull wtnull mice saw significant difference overall survival however tumour spectra different mice mutant p53 significantly carcinomas brain tumours endothelial tumours r175h whereas mice mutant p53 r175h showed decreased haematological tumours importantly also novel tumours mutantnull mice concluded different p53 mutants exhibit clear gain function different mutants different effects may tissue specific
0.7534733.15817608.html.plaintext.txt	45	lattardi palo alto usa used similar approach rather using tumour mutants examined importance p53 transactivation function vivo generating knock mice p53 gene mutated residues 25 26 abolish transactivation mdm 2 binding looking various p53 parameters fibroblasts derived mice confirmed mutant markedly defective gene activation conditions used also defective cell cycle arrest apoptosis however treatment specific differences example mutation could induce bax expression dna damage completely defective induction cdkn1a noxa interestingly unable obtain homozygous mutant mice owing embryonic lethality data suggest transcriptionally competent p53 required normal embryogenesis yet paradoxically mice deleted tp53 generally develop normal fashion although significant proportion female tp53 null mice show ex encephaly attardis mutant mice therefore may gain function yet described
0.7534733.15817608.html.plaintext.txt	46	gwahl la jolla usa also engineered knock mouse 7 c terminal lysine residues changed arginine 7kr indicated elsewhere review modifications residues thought important dictating nature p53 response dna damage wahl showed however mice cells derived behaved essentially cells wt p53 thus conflict critical post translational modifications p53 function
0.7534733.15817608.html.plaintext.txt	47	interesting variation use transgenic knockout mice reported ablackburn canberra australia looking modifiers mammary gland tumourigenesis one characteristic li fraumeni families early onset breast cancer 50 risk 50 years age developed mouse model li fraumeni p53 balbc background incidence mammary tumours high whereas c57bl6 background mice resistant formation tumours crossing two strains mice carrying linkage analysis second generation offsprings identified region chromosome 7 suprmam1 chromosome 2 suprmam2 linked increased frequency reduced latency tumour onset
0.7534733.15817608.html.plaintext.txt	48	interesting variation use transgenic knockout mice reported ablackburn canberra australia looking modifiers mammary gland tumourigenesis one characteristic li fraumeni families early onset breast cancer 50 risk 50 years age developed mouse model li fraumeni p53 balbc background incidence mammary tumours high whereas c57bl6 background mice resistant formation tumours crossing two strains mice carrying linkage analysis second generation offsprings identified region chromosome 7 suprmam1 chromosome 2 suprmam2 linked increased frequency reduced latency tumour onset
0.7534733.15817608.html.plaintext.txt	49	dbulavin singapore used approach replacing mouse p53 gene human p53 swap mice mice develop spontaneous tumours live twice long p53 null counterparts furthermore induction swap p53 ionizing radiation induce apoptosis thymus spleen even surprisingly crosses e micro myc mice swap p53 prevent rapid onset tumourigenesis thus although approach novel swap p53 behaves differently expectations merits unclear
0.7534733.15817608.html.plaintext.txt	50	models tumourigenesis top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references role p53 tumourigenesis explored cell culture animal systems several groups vrotter rehovot israel ttlsty san francisco usa looking genetic changes occur primary cells progress initial culture immortalization eventually tumourigenesis rotters study primary fibroblasts transfected retrovirus expressing htert induce immortalization followed mutant p53 andor ha ras induce tumourigenic phenotype stage expression microarray performed based changes gene expression concluded initial slow fast growth stage associated loss ink4a expression reflects defect differentiation loss p53 leads continued proliferation genomic instability fully transformed cells characteristics permit vivo tumour growth details doubt unveiled next meeting
0.7534733.15817608.html.plaintext.txt	51	study tlsty molecular pathways underlying tumourigenesis breast epithelial cells investigated normal human mammary epithelial cells hmec grown rare variant vhmec produced propagated beyond hayflick barrier tlsty showed cells uncoupled tight controls linking cell division dna replication associated loss p16ink4a expression hypermethylation p16ink4a gene promoter hmec normal p16ink4a vhmec silenced p16ink4a examined noted levels p53 p21waf1cip1 high vhmec low hmec biochemical studies indicated p16ink4a might regulating p53 stability reciprocal relationship p16ink4a p53 expressions however true fibroblasts silencing p16ink4a expression occurs islands cells normal breast suggestion represents early stage tumorigenesis
0.7534733.15817608.html.plaintext.txt	52	study tlsty molecular pathways underlying tumourigenesis breast epithelial cells investigated normal human mammary epithelial cells hmec grown rare variant vhmec produced propagated beyond hayflick barrier tlsty showed cells uncoupled tight controls linking cell division dna replication associated loss p16ink4a expression hypermethylation p16ink4a gene promoter hmec normal p16ink4a vhmec silenced p16ink4a examined noted levels p53 p21waf1cip1 high vhmec low hmec biochemical studies indicated p16ink4a might regulating p53 stability reciprocal relationship p16ink4a p53 expressions however true fibroblasts silencing p16ink4a expression occurs islands cells normal breast suggestion represents early stage tumorigenesis
0.7534733.15817608.html.plaintext.txt	53	elegant two step mouse model multistage skin carcinogenesis developed chris kemp seattle usa initial treatment dmba results ha ras gene mutation continuous exposure tpa leads mutation p53 loss remaining p53 allele finally amplification mutated h ras gene group demonstrated clear progression normal cells papillomas tumours metastases model knowing p53 activated either dna damage via atm atr via oncogene activation via p19arf asked activation pathway regulates p53 tumour suppressor activity end tumours generated atm p19arf p53 mice tumours irrespective stage ha ras mutations confirming initiating event consistent pathway p53 levels elevated papillomas normal atm mice tumours p19arf mice absence p53 function accelerated malignant conversion papilloma carcinoma p19arf mice p53 mice associated metastasis supporting idea induction p53 suppressed metastasis importance p19arf p53 induction shown fact loss heterozygosity loh arf carcinomas overcame need subsequent loh tp53 data support idea system selection p53 mutations due external stress dna damage ie signalling via atm rather results directly signalling initiating oncogenic lesion via p19arf importantly data provide explanation mutational alteration p53 often late event development human malignancies
0.7534733.15817608.html.plaintext.txt	54	elegant two step mouse model multistage skin carcinogenesis developed chris kemp seattle usa initial treatment dmba results ha ras gene mutation continuous exposure tpa leads mutation p53 loss remaining p53 allele finally amplification mutated h ras gene group demonstrated clear progression normal cells papillomas tumours metastases model knowing p53 activated either dna damage via atm atr via oncogene activation via p19arf asked activation pathway regulates p53 tumour suppressor activity end tumours generated atm p19arf p53 mice tumours irrespective stage ha ras mutations confirming initiating event consistent pathway p53 levels elevated papillomas normal atm mice tumours p19arf mice absence p53 function accelerated malignant conversion papilloma carcinoma p19arf mice p53 mice associated metastasis supporting idea induction p53 suppressed metastasis importance p19arf p53 induction shown fact loss heterozygosity loh arf carcinomas overcame need subsequent loh tp53 data support idea system selection p53 mutations due external stress dna damage ie signalling via atm rather results directly signalling initiating oncogenic lesion via p19arf importantly data provide explanation mutational alteration p53 often late event development human malignancies
0.7534733.15817608.html.plaintext.txt	55	p53 clinic top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references significance polymorphisms although tp53 mutation tumours commonplace clearly contributes malignant development role natural tp53 variants polymorphisms variants p53 signalling pathway area much less explored despite polymorphisms influence p53 function clearly shown mmurphy philadelphia usa demonstrated arg72 variant induce apoptosis vitro much efficiently pro72 variant ser47 normally pro47 appears altered transactivation ability mresnick chapel hill usa well identified several p53 response element variants affect expression level downstream target gene transcription
0.7534733.15817608.html.plaintext.txt	56	importance natural genetic variants alevine new jersey usa outstanding talk identified 1335 single nucleotide polymorphisms snps associated 82 genes directly involved p53 pathway vast majority non coding regions analysis mdm 2 promoter identified snp within first intron nucleotide 309 within general population 12 gg 40 gt 48 tt wt functional analysis predicts g makes better sp1 binding motif confirmed using gel shift assays increases transcriptional activity sp1 reporter assays importance cells sp1 endogenous levels mdm 2 higher cells gg tt consequence cells resistant apoptotic cell death tt cells less active p53 available high affinity promoters activated
0.7534733.15817608.html.plaintext.txt	57	importance natural genetic variants alevine new jersey usa outstanding talk identified 1335 single nucleotide polymorphisms snps associated 82 genes directly involved p53 pathway vast majority non coding regions analysis mdm 2 promoter identified snp within first intron nucleotide 309 within general population 12 gg 40 gt 48 tt wt functional analysis predicts g makes better sp1 binding motif confirmed using gel shift assays increases transcriptional activity sp1 reporter assays importance cells sp1 endogenous levels mdm 2 higher cells gg tt consequence cells resistant apoptotic cell death tt cells less active p53 available high affinity promoters activated
0.7534733.15817608.html.plaintext.txt	58	clinical level analysis 115 independent lymphoblastoid cell lines lcl derived caucasion african american patients showed normal distribution snps proportion cells undergoing apoptotic cell death response dna damage 11 cell lines highest resistance death patients gg evidence clinical relevance came study li fraumeni patients cohort patients germany adult soft tissue sarcoma sts breast cancer earlier age onset 10 15 years sts breast cancer 5 years earlier patients gg versus tt 309 also significantly increased association snp309 occurrence secondary cancers li fraumeni patients
0.7534733.15817608.html.plaintext.txt	59	clinical level analysis 115 independent lymphoblastoid cell lines lcl derived caucasion african american patients showed normal distribution snps proportion cells undergoing apoptotic cell death response dna damage 11 cell lines highest resistance death patients gg evidence clinical relevance came study li fraumeni patients cohort patients germany adult soft tissue sarcoma sts breast cancer earlier age onset 10 15 years sts breast cancer 5 years earlier patients gg versus tt 309 also significantly increased association snp309 occurrence secondary cancers li fraumeni patients
0.7534733.15817608.html.plaintext.txt	60	p53 gliomas glioblastoma multiforme gbm lethal form brain tumour characterized frequent recurrence gbm highly invasive resistant apoptosis almost completely refractory treatment ekim luebeck germany presented interesting talk interaction p53 ets 1 progression glioblastoma expression activation transcription factor ets 1 increases expression pro invasive genes mmps pre senilin integrins invasive gbm well documented underlying molecular basis unknown showed wt p53 binds ets 1 inhibits ability activate pro invasive genes ets 1 induction thromboxane mrna inhibited p53 binding p53 ets 1 transient transfections ets 1 also complexes several p53 mutants enhance ability ets 1 activate transcription data suggest gbm selection wt p53 function result aid upregulation pro invasive genes ets 1 related talk jroyds dunedin nz examined relationship tp53 mutations telomere maintenance tm gliomas two mechanisms tm described gliomas one requiring enzyme telomerase recombinational method designated alternative lengthening telomeres alt latter mechanism described detail rreddel sydney australia demonstrated alt manifested rapid increase telomere length appearance nuclei alt associated pml bodies moreover showed alt repressed sequestration mre11rad50nbs1 recombination complex sp100 royds found high correlation tp53 mutations alt telomerase since alt based telomere specific recombination events p53 strong repressor recombination data suggest loss p53 early tumourigenesis might facilitate acquisition alt interestingly alt found associated significantly better outcome telomerase patients high grade gliomas however correlation wt tp53 telomerase gliomas wt tp53 gliomas showed high expression p21waf1cip1 apoptosis data rahman showing htert inhibits p53 directed apoptosis may provide explanation findings
0.7534733.15817608.html.plaintext.txt	61	p53 gliomas glioblastoma multiforme gbm lethal form brain tumour characterized frequent recurrence gbm highly invasive resistant apoptosis almost completely refractory treatment ekim luebeck germany presented interesting talk interaction p53 ets 1 progression glioblastoma expression activation transcription factor ets 1 increases expression pro invasive genes mmps pre senilin integrins invasive gbm well documented underlying molecular basis unknown showed wt p53 binds ets 1 inhibits ability activate pro invasive genes ets 1 induction thromboxane mrna inhibited p53 binding p53 ets 1 transient transfections ets 1 also complexes several p53 mutants enhance ability ets 1 activate transcription data suggest gbm selection wt p53 function result aid upregulation pro invasive genes ets 1 related talk jroyds dunedin nz examined relationship tp53 mutations telomere maintenance tm gliomas two mechanisms tm described gliomas one requiring enzyme telomerase recombinational method designated alternative lengthening telomeres alt latter mechanism described detail rreddel sydney australia demonstrated alt manifested rapid increase telomere length appearance nuclei alt associated pml bodies moreover showed alt repressed sequestration mre11rad50nbs1 recombination complex sp100 royds found high correlation tp53 mutations alt telomerase since alt based telomere specific recombination events p53 strong repressor recombination data suggest loss p53 early tumourigenesis might facilitate acquisition alt interestingly alt found associated significantly better outcome telomerase patients high grade gliomas however correlation wt tp53 telomerase gliomas wt tp53 gliomas showed high expression p21waf1cip1 apoptosis data rahman showing htert inhibits p53 directed apoptosis may provide explanation findings
0.7534733.15817608.html.plaintext.txt	62	p53 colorectal cancer results large international study prognostic significance tp53 mutations colorectal cancer involving 3583 cases 25 different research groups outlined biacopetta perth australia mutation tp53 found associated markers poor prognosis vascular lymphatic invasion advanced dukes stage interestingly tumours distal colon mutations p53 give rise truncated protein associated worse survival response adjuvant chemotherapy favourable patients dukes c stage rectal tumours harboured wt tp53
0.7534733.15817608.html.plaintext.txt	63	regulation p53 function top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references notwithstanding role played p53 mitochondrion p53 undoubtedly function transcription factor context clear p53 binds motifs within promoters selected group target genes via central hydrophobic domain however also c terminal non specific dna binding domain whose function remains somewhat controversial furthermore question remains p53 recognizes specific binding motifs within genome whole much recognition process appears dependent c terminus
0.7534733.15817608.html.plaintext.txt	64	c terminus p53 using gel shift assay based system estimate affinity different p53 proteins bind linear double stranded oligonucleotides cprives new york usa provided intriguing data suggest p53 might find specific motifs sliding along linear dna function requires c terminus support idea provided mkulesz martin oregon usa using combination chip western blotting analysis showed wt mouse p53 much efficient binding activating cdkn1a promoter vivo mouse alternative splice variant p53as contains different c terminus suggested non specific dna binding facilitates localization p53 specific response elements via sliding mechanism tested looking binding p53 genomic dna p53as form binds genomic dna much slowly wtp53 perhaps p53 located dna damage slides along dna locate binding motifs promoters rapid response stress
0.7534733.15817608.html.plaintext.txt	65	c terminus p53 using gel shift assay based system estimate affinity different p53 proteins bind linear double stranded oligonucleotides cprives new york usa provided intriguing data suggest p53 might find specific motifs sliding along linear dna function requires c terminus support idea provided mkulesz martin oregon usa using combination chip western blotting analysis showed wt mouse p53 much efficient binding activating cdkn1a promoter vivo mouse alternative splice variant p53as contains different c terminus suggested non specific dna binding facilitates localization p53 specific response elements via sliding mechanism tested looking binding p53 genomic dna p53as form binds genomic dna much slowly wtp53 perhaps p53 located dna damage slides along dna locate binding motifs promoters rapid response stress
0.7534733.15817608.html.plaintext.txt	66	data importance c terminus provided kharms mcnaughton xchens group birmingham al usa showed p53 activation domain 2 amino acid residues 43 63 required transcription pro apoptotic insulin like growth factor binding protein 3 igfbp3 c terminal basic domain amino acid residues 364 393 inhibitory activation domain 1 amino acid residues 1 42 controls inhibitory action c terminus inhibition apoptosis thus alleviated deletion domains c termini p63 p73 also inhibit induction igfbp3
0.7534733.15817608.html.plaintext.txt	67	transcriptional regulation p53 discussed elsewhere report several lines evidence point multiple mechanisms p53 regulates transcriptional activation functional variation p53 mutants cofactor diversity differences binding motifs differences stress specific responses addition differences promoter architecture different p53 response genes eg cdkn1a promoter possesses two p53 binding sequences upstream tatainr element fasapo1 promoter one p53 binding motif downstream inr pten p53 binding motif adjacent gc rich sequence generally believed p53 links upstream enhancer factors mediators basal transcription machinery advent chip allowed detailed vivo analyses p53 dependent activation transcription using time course chip approach bemerson la jolla usa presented results elegant studies relationship core transcription factors p53 responses p53 target promoters different types dna damage focusing cdkn1a promoter prior uv dna damage p53 bound motifs unphosphorylated ser15 histone acetyl transferase hat bound p53 tbp bound tata box also present transcription taf250 recruited tbp pre initiation complex uv damage promoter active contrast tfiib rna polymerase ii bound damage present damage rna polymerase ii unphosphorylated active non elongating form enzyme elongation activity activated shortly uv damage histone acetylation taf250 recruitment occur prior phosphorylation ser15 p53 stabilization p53 therefore cdkn1a promoter poised action response dna damage however induction transient tfiib quickly lost rna polymerase ii rebind transcription sustained contrast cdkn1a response doxorubicin biphasic exposure recruitment taf250 cdkn1a promoter increase tfiib initial burst ready go transcription loss rna polymerase ii increase tfiib means tfiib tends stay promoter recruit rna polymerase ii therefore another wave transcription
0.7534733.15817608.html.plaintext.txt	68	transcriptional regulation p53 discussed elsewhere report several lines evidence point multiple mechanisms p53 regulates transcriptional activation functional variation p53 mutants cofactor diversity differences binding motifs differences stress specific responses addition differences promoter architecture different p53 response genes eg cdkn1a promoter possesses two p53 binding sequences upstream tatainr element fasapo1 promoter one p53 binding motif downstream inr pten p53 binding motif adjacent gc rich sequence generally believed p53 links upstream enhancer factors mediators basal transcription machinery advent chip allowed detailed vivo analyses p53 dependent activation transcription using time course chip approach bemerson la jolla usa presented results elegant studies relationship core transcription factors p53 responses p53 target promoters different types dna damage focusing cdkn1a promoter prior uv dna damage p53 bound motifs unphosphorylated ser15 histone acetyl transferase hat bound p53 tbp bound tata box also present transcription taf250 recruited tbp pre initiation complex uv damage promoter active contrast tfiib rna polymerase ii bound damage present damage rna polymerase ii unphosphorylated active non elongating form enzyme elongation activity activated shortly uv damage histone acetylation taf250 recruitment occur prior phosphorylation ser15 p53 stabilization p53 therefore cdkn1a promoter poised action response dna damage however induction transient tfiib quickly lost rna polymerase ii rebind transcription sustained contrast cdkn1a response doxorubicin biphasic exposure recruitment taf250 cdkn1a promoter increase tfiib initial burst ready go transcription loss rna polymerase ii increase tfiib means tfiib tends stay promoter recruit rna polymerase ii therefore another wave transcription
0.7534733.15817608.html.plaintext.txt	69	interestingly affinity rna polymerase ii cdkn1a promoter highest amongst p53 target genes along genes associated growth arrest dna repair promoters plenty paused rna polymerase ii compared apoptotic response genes analysis fasapo1 promoter low levels paused bound rna polymerase ii showed recruitment taf250 response uv doxorubicin low levels bound tfiib paused rna polymerase ii remain constant damage uv doxorubicin case little pre initiation complex present dna damage persists afterwards therefore initiation transcription p53 delayed compared cdkn1a results provide basis explanation p53 generates rapid cell cycle arrest responses delayed apoptotic responses
0.7534733.15817608.html.plaintext.txt	70	interestingly affinity rna polymerase ii cdkn1a promoter highest amongst p53 target genes along genes associated growth arrest dna repair promoters plenty paused rna polymerase ii compared apoptotic response genes analysis fasapo1 promoter low levels paused bound rna polymerase ii showed recruitment taf250 response uv doxorubicin low levels bound tfiib paused rna polymerase ii remain constant damage uv doxorubicin case little pre initiation complex present dna damage persists afterwards therefore initiation transcription p53 delayed compared cdkn1a results provide basis explanation p53 generates rapid cell cycle arrest responses delayed apoptotic responses
0.7534733.15817608.html.plaintext.txt	71	p53 based therapies top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references given prevalence p53 mutations human cancer ultimate goal investigations regulation functions p53 develop novel rational therapeutics treatment wide range malignancies majority investigations focused two main areas one targeting mdm 2p53 interaction equivalent e6p53 complex mjiang jmilners group york uk aims alter conformation mutant p53 proteins order reactivate wt p53 functions former perspective nutlins appear promising candidates nutlins cis imidazolines small molecules inhibit p53mdm 2 interaction mimicking binding three critical p53 amino acids leu26 trp23 ph19 within p53mdm 2 binding domain impressive presentation lvassiliev new jersey usa showed cells wt p53 mutant p53 nutlins cause dose dependent elevation p53 protein p53 transcriptional activity global effect nutlin p53 gene activation verified gene array profiling nutlins also efficiently inhibit clonogenic growth induce apoptosis cells wt p53 dose dependent fashion beauty nutlins need dna damaging agents activate p53 see signalling section xenograft models nutlins proved effective paclitaxel higher doses completely abrogate tumour growth obvious pathology agents appear show great promise new cancer therapeutics
0.7534733.15817608.html.plaintext.txt	72	several studies attempted large scale screening small molecules might reactivate mutant p53 h cang afershts group cambridge uk provided preliminary data nmr approach could used evaluate effects small molecule effects p53 structure thus allowing rationale design molecules using nmr sensitive tool screening novel molecules bind weakly p53 might refined advantage system compounds bind alter p53 structure detected approach automated high throughput screening advanced stage kwiman stockholm sweden reported efforts identify small molecules might used reactivate normal p53 function mutants using high throughput screen small molecules able induce growth arrest apoptosis cells stably expressing mutant r273h originally identified prima 1 prima 1 inhibits tumourigenesis human xenografts may prove useful sensitizing cells killing current anticancer drugs biochemical studies suggest sensitization may result increased levels mutant p53 induced low levels drug eg cisplatin increases available pool p53 reactivation prima 1 mind proposed agent capable elevating mutant p53 levels might synergize prima 1 kill cells using similar approach group also identified another small compound mira 1 also reactivate mutant p53
0.7534733.15817608.html.plaintext.txt	73	finally cdrummond auckland nz described compound called sn28049 upregulates death receptors fas dr5 preferentially cytotoxic tumour cells wt p53 activity
0.7534733.15817608.html.plaintext.txt	74	p53 future top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references end formal presentations one co discoverers p53 alevine new jersey asked speculate next chapter p53 research might commenting areas represented meeting thought next period 13th international p53 workshop new york 2006 would learn lot gain function tumour associated p53 mutant proteins transcriptional repression p53 role p53 cellular senescence example mutants gain function behave way transcriptional repression biological meaning p53 induce senescence increased use transgenic knock mutant mice help answer many questions gain function mutants well yeast based genetic screens
0.7534733.15817608.html.plaintext.txt	75	however beyond role tumour suppression regard many complex signalling pathways p53 appears involved figure 1 levine proposed p53 may ubiquitous sensor stress involved prevention possibly aging related disorders suggested may include diabetes arthritis atherosclerosis inflammatory diseases indeed evidence already 2 4 even psychological stresses thus rather acting prevent genetic lesions accumulating somatic tissues lead cancer p53 may act dampen many physiological stresses may unchecked lead disorders responses may often beneficial short term long term dysregulation cause damage body organs resulting premature ageing cumulative wear tear known allostatic load 5 idea p53 may important control allostatic load exciting may well account large diversity signals appear activate p53 handle might obtained analysing patients polymorphisms tp53 members p53 pathway snp309 discussed correlating various ageing related phenotypes interesting see anyone picks gauntlet data time next meeting potentially opening even areas investigation next generation p53 researchers
0.7534733.15817608.html.plaintext.txt	76	however beyond role tumour suppression regard many complex signalling pathways p53 appears involved figure 1 levine proposed p53 may ubiquitous sensor stress involved prevention possibly aging related disorders suggested may include diabetes arthritis atherosclerosis inflammatory diseases indeed evidence already 2 4 even psychological stresses thus rather acting prevent genetic lesions accumulating somatic tissues lead cancer p53 may act dampen many physiological stresses may unchecked lead disorders responses may often beneficial short term long term dysregulation cause damage body organs resulting premature ageing cumulative wear tear known allostatic load 5 idea p53 may important control allostatic load exciting may well account large diversity signals appear activate p53 handle might obtained analysing patients polymorphisms tp53 members p53 pathway snp309 discussed correlating various ageing related phenotypes interesting see anyone picks gauntlet data time next meeting potentially opening even areas investigation next generation p53 researchers
0.7534733.15817608.html.plaintext.txt	77	final analysis perhaps timeless words tseliot 6 reflect evolving nature p53 research shall cease exploration
0.7534733.15817608.html.plaintext.txt	78	end exploring
0.7534733.15817608.html.plaintext.txt	79	arrive started
0.7534733.15817608.html.plaintext.txt	80	know place first time
0.7534733.15817608.html.plaintext.txt	81	conflict interest statement none declared
0.7534733.15817608.html.plaintext.txt	82	references top abstract introduction p53 part upstream signalling p53 apoptosis p53 dna damage animal models models tumourigenesis p53 clinic regulation p53 function p53 based therapies p53 future references lanedp 1992 p53 guardian genome nature 358 15 16crossrefisimedline merchedaj williamse chanl 2003 macrophage specific p53 expression plays crucial role atherosclerosis development plaque remodeling arterioscler thromb vasc biol 23 1608 1614abstractfree full text fiordalisof leria cessellid limanaf safaib nadal ginardb anversap kajsturaj 2001 hyperglycemia activates p53 p53 regulated genes leading myocyte cell death diabetes 50 2363 2375abstractfree full text hofsethlj saitos hussainsp et al 2003 nitric oxide induced cellular stress p53 activation chronic inflammation proc natl acad sci usa 100 143 148abstractfree full text mcewenbs 1998 protective damaging effects stress mediators new engl j med 338 171 179free full text eliotts 1969 four quartets complete poems plays tseliot st edmundsbury press suffolk uk part 111 p 195 article abstract full text pdf versions article 2671161 recent bgi091v1 alert article cited alert correction posted services email article friend similar articles journal similar articles isi web science similar articles pubmed alert new issues journal add personal archive download citation manager request permissions google scholar articles braithwaite w articles jackson p pubmed pubmed citation articles braithwaite w articles jackson p online issn 1460 2180 print issn 0143 3334 copyright 2006 oxford university press oxford journals oxford university press site map terms conditions privacy policy frequently asked questions oxford university press sites oxford university press american national biography booksellers information service childrens fiction poetry childrens reference corporate special sales dictionaries dictionary national biography digital reference english language teaching higher education textbooks humanities international education unit law medicine music online products oxford english dictionary reference rights permissions science school books social sciences short introductions worlds classics
